PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Augustine, T; Chaudhary, P; Gupta, K; Islam, S; Ghosh, P; Santra, MK; Mitra, D				Augustine, Tracy; Chaudhary, Priyanka; Gupta, Kailash; Islam, Sehbanul; Ghosh, Payel; Santra, Manas Kumar; Mitra, Debashis			Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCFcyclin F E3 Ligase Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SMALL-MOLECULE INHIBITION; CELL-CYCLE; ANTIVIRAL ACTIVITY; DEPENDENT MANNER; ENZYME APOBEC3G; IN-VITRO; REPLICATION; EXPRESSION; NEF	Cyclin F protein, also known as FBXO1, is the largest among all cyclins and oscillates in the cell cycle like other cyclins. Apart from being a G(2)/M cyclin, cyclin F functions as the substratebinding subunit of SCFcyclin F E3 ubiquitin ligase. In a gene expression analysis performed to identify novel gene modulations associated with cell cycle dysregulation during HIV-1 infection in CD4(+) T cells, we observed down-regulation of the cyclin F gene (CCNF). Later, using gene overexpression and knockdown studies, we identified cyclin F as negatively influencing HIV-1 viral infectivity without any significant impact on virus production. Subsequently, we found that cyclin F negatively regulates the expression of viral protein Vif (viral infectivity factor) at the protein level. We also identified a novel hostpathogen interaction between cyclin F and Vif protein in T cells during HIV-1 infection. Mutational analysis of a cyclin F-specific amino acid motif in the C-terminal region of Vif indicated rescue of the protein from cyclin F-mediated down-regulation. Subsequently, we showed that Vif is a novel substrate of the SCFcyclin F E3 ligase, where cyclin F mediates the ubiquitination and proteasomal degradation of Vif through physical interaction. Finally, we showed that cyclin F augments APOBEC3G expression through degradation of Vif to regulate infectivity of progeny virions. Taken together, our results demonstrate that cyclin F is a novel F-box protein that functions as an intrinsic cellular regulator of HIV-1 Vif and has a negative regulatory effect on the maintenance of viral infectivity by restoring APOBEC3G expression.	[Augustine, Tracy; Chaudhary, Priyanka; Gupta, Kailash; Islam, Sehbanul; Santra, Manas Kumar; Mitra, Debashis] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India; [Ghosh, Payel] Savitribai Phule Pune Univ, Bioinformat Ctr, Pune 411007, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Savitribai Phule Pune University	Mitra, D (corresponding author), Natl Ctr Cell Sci, Lab HIV Res, Pune 411007, Maharashtra, India.	dmitra@nccs.res.in		Islam, Sehbanul/0000-0003-2686-2787	National Centre for Cell Science, Pune, India; Indian Council of Medical Research (ICMR); University Grant Commission (UGC) research fellowship; DBT research fellowship; Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India	National Centre for Cell Science, Pune, India; Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); University Grant Commission (UGC) research fellowship(University Grants Commission, India); DBT research fellowship; Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India, in the form of a Tata Innovation Fellowship (to D. M.) and by intramural support from the National Centre for Cell Science, Pune, India. This work also was supported by a research fellowship (to T. A.) from the Indian Council of Medical Research (ICMR), a University Grant Commission (UGC) research fellowship (to K. G.), and a DBT research fellowship (to S. I.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no conflicts of interest with the contents of this article.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Aiken C, 2011, NATURE, V472, P305, DOI 10.1038/472305a; Anderson BD, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500296; Arora S, 2014, J VIROL, V88, P9141, DOI 10.1128/JVI.00619-14; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAI C, 1994, EMBO J, V13, P6087, DOI 10.1002/j.1460-2075.1994.tb06955.x; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Bogerd HP, 2015, P NATL ACAD SCI USA, V112, pE7249, DOI 10.1073/pnas.1516305112; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Charrasse S, 1999, CELL GROWTH DIFFER, V10, P611; Chiu YL, 2009, PHILOS T R SOC B, V364, P689, DOI 10.1098/rstb.2008.0193; COATES K, 1995, J GEN VIROL, V76, P837, DOI 10.1099/0022-1317-76-4-837; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; CULLEN BR, 1990, VIROLOGY, V178, P1, DOI 10.1016/0042-6822(90)90373-Y; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Dang Y, 2008, J BIOL CHEM, V283, P13124, DOI 10.1074/jbc.M708728200; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Dussart S, 2004, BIOCHEM BIOPH RES CO, V315, P66, DOI 10.1016/j.bbrc.2004.01.023; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Farrow MA, 2005, AIDS RES HUM RETROV, V21, P565, DOI 10.1089/aid.2005.21.565; Fujita M, 2004, MICROBES INFECT, V6, P791, DOI 10.1016/j.micinf.2004.04.011; Fung TK, 2002, J BIOL CHEM, V277, P35140, DOI 10.1074/jbc.M205503200; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; Goff SP, 2003, CELL, V114, P281, DOI 10.1016/S0092-8674(03)00602-0; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Imai K, 2009, FEBS J, V276, P7124, DOI 10.1111/j.1742-4658.2009.07424.x; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; Izumi T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-1; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Khan SZ, 2011, J BIOL CHEM, V286, P22943, DOI 10.1074/jbc.M110.201194; Klein DK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6800; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kyei GB, 2015, CELL HOST MICROBE, V17, P98, DOI 10.1016/j.chom.2014.11.009; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leng J, 2014, CELL HOST MICROBE, V15, P717, DOI 10.1016/j.chom.2014.05.011; Madani N, 2000, J VIROL, V74, P5982, DOI 10.1128/JVI.74.13.5982-5987.2000; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Miyakawa K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7945; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Munch J, 2007, J VIROL, V81, P13852, DOI 10.1128/JVI.00904-07; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Ran XZ, 2016, CURR HIV RES, V14, P217, DOI 10.2174/1570162X14999160224100541; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; SCHWARTZ S, 1991, VIROLOGY, V183, P677, DOI 10.1016/0042-6822(91)90996-O; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Tetzlaff MT, 2004, MOL CELL BIOL, V24, P2487, DOI 10.1128/MCB.24.6.2487-2498.2004; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Valera MS, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0181-5; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walter D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10530; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wichroski MJ, 2005, J BIOL CHEM, V280, P8387, DOI 10.1074/jbc.M408048200; Yang ZY, 2014, NAT MED, V20, P808, DOI 10.1038/nm.3657; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zuo T, 2012, J VIROL, V86, P5497, DOI 10.1128/JVI.06957-11	72	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5349	5363		10.1074/jbc.M116.765842	http://dx.doi.org/10.1074/jbc.M116.765842			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28184007	hybrid, Green Published			2022-12-26	WOS:000397875500017
J	Cashmore, TJ; Klatt, S; Yamaryo-Botte, Y; Brammananth, R; Rainczuk, AK; McConville, MJ; Crellin, PK; Coppel, RL				Cashmore, Tamaryn J.; Klatt, Stephan; Yamaryo-Botte, Yoshiki; Brammananth, Rajini; Rainczuk, Arek K.; McConville, Malcolm J.; Crellin, Paul K.; Coppel, Ross L.			Identification of a Membrane Protein Required for Lipomannan Maturation and Lipoarabinomannan Synthesis in Corynebacterineae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WALL ARABINAN BIOSYNTHESIS; MYCOBACTERIAL CELL-WALL; PHOSPHATIDYLINOSITOL MANNOSIDES; DEFICIENT MUTANT; LEISHMANIA-MAJOR; CLONING VECTORS; MYCOLIC ACIDS; TUBERCULOSIS; GLUTAMICUM; ARABINOFURANOSYLTRANSFERASE	Mycobacterium tuberculosis and related Corynebacterineae synthesize a family of lipomannans (LM) and lipoarabinomann-ans (LAM) that are abundant components of the multilaminate cell wall and essential virulence factors in pathogenic species. Here we describe a new membrane protein, highly conserved in all Corynebacterineae, that is required for synthesis of full-length LM and LAM. Deletion of the Corynebacterium glutamicum NCgl2760 gene resulted in a complete loss of mature LM/LAM and the appearance of a truncated LM (t-LM). Complementation of the mutant with the NCgl2760 gene fully restored LM/LAM synthesis. Structural studies, including monosaccharide analysis, methylation linkage analysis, and mass spectrometry of native LM species, indicated that the Delta NCgl2760 t-LM comprised a series of short LM species (8-27 residues long) containing an alpha 1-6-linked mannose backbone with greatly reduced alpha 1-2-mannose side chains and no arabinose caps. The structure of the Delta NCgl2760 t-LM was similar to that of the t-LM produced by a C.glutamicum mutant lacking the mptA gene, encoding a membrane alpha 1-6-mannosyltransferase involved in extending the alpha 1-6-mannan backbone of LM intermediates. Interestingly, NCgl2760 lacks any motifs or homology to other proteins of known function. Attempts to delete the NCgl2760 orthologue in Mycobacterium smegmatis were unsuccessful, consistent with previous studies indicating that the M. tuberculosis orthologue, Rv0227c, is an essential gene. Together, these data suggest that NCgl2760/Rv0227c plays a critical role in the elongation of the mannan backbone of mycobacterial and corynebacterial LM, further highlighting the complexity of lipoglycan pathways of Corynebacterineae.	[Cashmore, Tamaryn J.; Brammananth, Rajini; Rainczuk, Arek K.; Crellin, Paul K.; Coppel, Ross L.] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Cashmore, Tamaryn J.; Brammananth, Rajini; Rainczuk, Arek K.; Crellin, Paul K.; Coppel, Ross L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Klatt, Stephan; Yamaryo-Botte, Yoshiki; McConville, Malcolm J.] Univ Melbourne, Bio21 Inst Mol Sci & Biotechnol, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia	Monash University; Monash University; University of Melbourne	Crellin, PK (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.	paul.crellin@monash.edu		Crellin, Paul K/0000-0002-2017-4935; Klatt, Stephan/0000-0003-0064-3367; Yamaryo-Botte, Yoshiki/0000-0002-9349-4411; Coppel, Ross/0000-0002-4476-9124	National Health and Medical Research Council of Australia (NHMRC) [1064466]; Australian Research Council (ARC) Centre of Excellence in Structural and Functional Microbial Genomics [COE562063]; ARC Discovery [140101244]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); ARC Discovery(Australian Research Council)	This work was supported by National Health and Medical Research Council of Australia (NHMRC) Project Grant 1064466, Australian Research Council (ARC) Centre of Excellence in Structural and Functional Microbial Genomics Grant COE562063, and ARC Discovery Grant 140101244. The authors declare that they have no conflicts of interest with the contents of this article.	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200; Alderwick LJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001299; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Belardinelli JM, 2016, ACS INFECT DIS, V2, P702, DOI 10.1021/acsinfecdis.6b00095; Birch HL, 2008, MOL MICROBIOL, V69, P1191, DOI 10.1111/j.1365-2958.2008.06354.x; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; Dinadayala P, 2006, J BIOL CHEM, V281, P20027, DOI 10.1074/jbc.M603395200; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Haites RE, 2005, J BIOL CHEM, V280, P10981, DOI 10.1074/jbc.M413443200; Jankute M, 2015, ANNU REV MICROBIOL, V69, P405, DOI 10.1146/annurev-micro-091014-104121; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; Lea-Smith DJ, 2008, J BIOL CHEM, V283, P6773, DOI 10.1074/jbc.M707139200; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Maeda N, 2003, J BIOL CHEM, V278, P5513, DOI 10.1074/jbc.C200586200; Rodriguez DM, 2012, PEPTIDES, V38, P208, DOI 10.1016/j.peptides.2012.08.023; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P7385; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P19611; McKean S, 2005, MICROBES INFECT, V7, P1352, DOI 10.1016/j.micinf.2005.05.002; Mishra AK, 2008, MOL MICROBIOL, V68, P1595, DOI 10.1111/j.1365-2958.2008.06265.x; Mishra AK, 2008, ANTON LEEUW INT J G, V94, P277, DOI 10.1007/s10482-008-9243-1; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Mishra AK, 2011, MOL MICROBIOL, V80, P1241, DOI 10.1111/j.1365-2958.2011.07640.x; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Mishra AK, 2009, J BACTERIOL, V191, P4465, DOI 10.1128/JB.01729-08; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Rainczuk AK, 2012, J BIOL CHEM, V287, P42726, DOI 10.1074/jbc.M112.373415; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; Seidel M, 2007, J BIOL CHEM, V282, P14729, DOI 10.1074/jbc.M700271200; Seidel M, 2007, GLYCOBIOLOGY, V17, P210, DOI 10.1093/glycob/cwl066; Shi LB, 2006, J BIOL CHEM, V281, P19512, DOI 10.1074/jbc.M513846200; Skovierova H, 2009, GLYCOBIOLOGY, V19, P1235, DOI 10.1093/glycob/cwp116; Stoop EJM, 2013, CELL MICROBIOL, V15, P2093, DOI 10.1111/cmi.12175; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Strohmeier GR, 1999, MICROBES INFECT, V1, P709, DOI 10.1016/S1286-4579(99)80072-0; Tatituri RVV, 2007, J BIOL CHEM, V282, P4561, DOI 10.1074/jbc.M608695200; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; Vercellone A, 1998, FRONT BIOSCI-LANDMRK, V3, pE149; Yamaryo-Botte Y, 2015, ACS CHEM BIOL, V10, P734, DOI 10.1021/cb5007689; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	51	14	14	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4976	4986		10.1074/jbc.M116.772202	http://dx.doi.org/10.1074/jbc.M116.772202			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28167532	hybrid, Green Published			2022-12-26	WOS:000397590400019
J	Mast, N; Anderson, KW; Lin, JB; Li, Y; Turko, IV; Tatsuoka, C; Bjorkhem, I; Pikuleva, IA				Mast, Natalia; Anderson, Kyle W.; Lin, Joseph B.; Li, Yong; Turko, Illarion V.; Tatsuoka, Curtis; Bjorkhem, Ingemar; Pikuleva, Irina A.			Cytochrome P450 27A1 Deficiency and Regional Differences in Brain Sterol Metabolism Cause Preferential Cholestanol Accumulation in the Cerebellum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID BIOSYNTHETIC ENZYME; CEREBROTENDINOUS XANTHOMATOSIS; CHOLESTEROL HOMEOSTASIS; ESCHERICHIA-COLI; LIVER-MITOCHONDRIA; DIRECT EXPRESSION; MOUSE RETINA; MICE; MECHANISM; 27-HYDROXYLASE	Cytochrome P450 27A1 (CYP27A1 or sterol 27-hydroxylase) is a ubiquitous, multifunctional enzyme catalyzing regio-and stereospecific hydroxylation of different sterols. In humans, complete CYP27A1 deficiency leads to cerebrotendinous xanthomatosis or nodule formation in tendons and brain (preferentially in the cerebellum) rich in cholesterol and cholestanol, the 5 alpha-saturated analog of cholesterol. In Cyp27a1(-/-) mice, xanthomas are not formed, despite a significant cholestanol increase in the brain and cerebellum. The mechanism behind cholestanol production has been clarified, yet little is known about its metabolism, except that CYP27A1 might metabolize cholestanol. It also is unclear why CYP27A1 deficiency results in preferential cholestanol accumulation in the cerebellum. We hypothesized that cholestanol might be metabolized by CYP46A1, the principal cholesterol 24-hydroxylase in the brain. We quantified sterols along with CYP27A1 and CYP46A1 in mouse models (Cyp27a1(-/-), Cyp46a1(-/-), Cyp27a1(-/-,) Cyp46a1(-/-), and two wild type strains) and human brain specimens. In vitro experiments with purified P450s were conducted as well. We demonstrate that CYP46A1 is involved in cholestanol removal from the brain and that several factors contribute to the preferential increase in cholestanol in the cerebellum arising from CYP27A1 deficiency. These factors include (i) low cerebellar abundance of CYP46A1 and high cerebellar abundance of CYP27A1, the lack of which probably selectively increases the cerebellar cholestanol production; (ii) spatial separation in the cerebellum of cholesterol/ cholestanol-metabolizing P450s from a pool of metabolically available cholestanol; and (iii) weak cerebellar regulation of cholesterol biosynthesis. We identified a new physiological role of CYP46A1, an important brain enzyme and cytochrome P450 that could be activated pharmacologically.	[Mast, Natalia; Lin, Joseph B.; Li, Yong; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd, Cleveland, OH 44106 USA; [Tatsuoka, Curtis] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Anderson, Kyle W.; Turko, Illarion V.] Natl Inst Stand & Technol, Biomol Measurement Div, Gaithersburg, MD 20899 USA; [Anderson, Kyle W.; Turko, Illarion V.] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Bjorkhem, Ingemar] Karolinska Inst, Dept Lab Med, Div Clin Chem, S-14186 Huddinge, Sweden	Case Western Reserve University; Case Western Reserve University; National Institute of Standards & Technology (NIST) - USA; Karolinska Institutet	Pikuleva, IA (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	iap8@case.edu		Lin, Joseph/0000-0001-6667-9018; Anderson, Kyle/0000-0002-2808-3026; Bjorkhem, Ingemar/0000-0002-0575-9425; Pikuleva, Irina/0000-0001-9742-6232	National Institutes of Health [GM62882, P30, EY011373]; NATIONAL EYE INSTITUTE [P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM62882 ( to I. A. P) and P30 Core Grant EY011373. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Certain commercial materials, instruments, and equipment are identified in this manuscript in order to specify the experimental procedure as completely as possible. In no case does such identification imply a recommendation or endorsement by the National Institute of Standards and Technology nor does it imply that the materials, instruments, or equipment identified are necessarily the best available for the purpose.	Anderson KW, 2016, J BIOL CHEM, V291, P11876, DOI 10.1074/jbc.M116.723577; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Bavner A, 2010, J LIPID RES, V51, P2722, DOI 10.1194/jlr.M008326; Bhattacharyya AK, 2007, J LIPID RES, V48, P185, DOI 10.1194/jlr.M600113-JLR200; BJORKHEM I, 1992, J BIOL CHEM, V267, P19872; BJORKHEM I, 1987, HEPATOLOGY, V7, P266, DOI 10.1002/hep.1840070210; BJORKHEM I, 1974, BIOCHIM BIOPHYS ACTA, V337, P129, DOI 10.1016/0005-2760(74)90046-0; Bjorkhem I, 2013, CURR OPIN LIPIDOL, V24, P283, DOI 10.1097/MOL.0b013e328362df13; Bjorkhem I, 2010, BIOCHEM BIOPH RES CO, V396, P46, DOI 10.1016/j.bbrc.2010.02.140; Bogaert L. v., 1937, ANN MED, V42, P69; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; BUCHMANN MS, 1987, BIOCHIM BIOPHYS ACTA, V922, P111, DOI 10.1016/0005-2760(87)90144-5; CALI JJ, 1991, J BIOL CHEM, V266, P7779; Dubrac S, 2005, J LIPID RES, V46, P76, DOI 10.1194/jlr.M400219-JLR200; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Heverin M, 2005, J LIPID RES, V46, P1047, DOI 10.1194/jlr.M500024-JLR200; Honda A, 2001, J LIPID RES, V42, P291; Jack CR, 2015, JAMA NEUROL, V72, P511, DOI 10.1001/jamaneurol.2014.4821; Liao WL, 2008, ANAL BIOCHEM, V377, P55, DOI 10.1016/j.ab.2008.03.016; Liao WL, 2011, J PROTEOME RES, V10, P241, DOI 10.1021/pr1008898; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Mast N, 2006, BIOCHEMISTRY-US, V45, P4396, DOI 10.1021/bi052654w; Mast N, 2004, ARCH BIOCHEM BIOPHYS, V428, P99, DOI 10.1016/j.abb.2004.05.012; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2014, J BIOL CHEM, V289, P3529, DOI 10.1074/jbc.M113.532846; Mast N, 2012, MOL PHARMACOL, V82, P824, DOI 10.1124/mol.112.080424; Mast N, 2011, INVEST OPHTH VIS SCI, V52, P594, DOI 10.1167/iovs.10-6021; MASUMOTO O, 1988, J BIOL CHEM, V263, P14256; Meaney S, 2007, J LIPID RES, V48, P944, DOI 10.1194/jlr.M600529-JLR200; Mignarri A, 2016, J INHERIT METAB DIS, V39, P75, DOI 10.1007/s10545-015-9873-1; OFTEBRO H, 1980, J CLIN INVEST, V65, P1418, DOI 10.1172/JCI109806; Omarova S, 2012, J CLIN INVEST, V122, P3012, DOI 10.1172/JCI63816; Panzenboeck U, 2007, J LIPID RES, V48, P1167, DOI 10.1194/jlr.M700027-JLR200; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Pikuleva IA, 1997, ARCH BIOCHEM BIOPHYS, V343, P123, DOI 10.1006/abbi.1997.0142; Puglielli L, 2005, J CLIN INVEST, V115, P2556, DOI 10.1172/JCI23610; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Rosen H, 1998, J BIOL CHEM, V273, P14805, DOI 10.1074/jbc.273.24.14805; Saadane A, 2014, AM J PATHOL, V184, P2403, DOI 10.1016/j.ajpath.2014.05.024; SAGARA Y, 1992, FEBS LETT, V300, P208, DOI 10.1016/0014-5793(92)80847-A; SAGARA Y, 1993, BIOL PHARM BULL, V16, P627; Seyama Yousuke, 2003, Journal of Medicinal Food, V6, P217, DOI 10.1089/10966200360716634; SKREDE S, 1985, SCAND J CLIN LAB INV, V45, P15; SKREDE S, 1985, J BIOL CHEM, V260, P77; SKREDE S, 1988, J LIPID RES, V29, P157; SKREDE S, 1985, J CLIN INVEST, V75, P448, DOI 10.1172/JCI111719; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; VOGEL MW, 1989, J NEUROSCI, V9, P3454; von Bahr S, 2002, ARTERIOSCL THROM VAS, V22, P1129, DOI 10.1161/01.ATV.0000022600.61391.A5; White MA, 2008, ACTA CRYSTALLOGR D, V64, P487, DOI 10.1107/S0907444908004046; WIKVALL K, 1984, J BIOL CHEM, V259, P3800; Zheng WC, 2015, J LIPID RES, V56, P81, DOI 10.1194/jlr.M053439	55	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4913	4924		10.1074/jbc.M116.774760	http://dx.doi.org/10.1074/jbc.M116.774760			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28190002	hybrid, Green Published			2022-12-26	WOS:000397590400014
J	Farias-Curtidor, N; Barragan-Barrera, DC; Chavez-Carreno, PA; Jimenez-Pinedo, C; Palacios, DM; Caicedo, D; Trujillo, F; Caballero, S				Farias-Curtidor, Nohelia; Barragan-Barrera, Dalia C.; Alejandra Chavez-Carreno, Paula; Jimenez-Pinedo, Cristina; Palacios, Daniel M.; Caicedo, Dalila; Trujillo, Fernando; Caballero, Susana			Range extension for the common dolphin (Delphinus sp.) to the Colombian Caribbean, with taxonomic implications from genetic barcoding and phylogenetic analyses	PLOS ONE			English	Article							MOLECULAR-IDENTIFICATION; POPULATION-STRUCTURE; SOUTHERN AUSTRALIA; ATLANTIC-OCEAN; MITOCHONDRIAL; NUCLEAR; DNA; SURVEILLANCE; SYSTEMATICS; CETACEANS	The nearest known population of common dolphins (Delphinus sp.) to the Colombian Caribbean occurs in a fairly restricted range in eastern Venezuela. These dolphins have not been previously reported in the Colombian Caribbean, likely because of a lack of study of the local cetacean fauna. We collected cetacean observations in waters of the Guajira Department, northern Colombia (similar to 11 degrees N, 73 degrees W) during two separate efforts: (a) a seismic vessel survey (December 2009 D March 2010), and (b) three coastal surveys from small boats ( May-July 2012, May 2013, and May 2014). Here we document ten sightings of common dolphins collected during these surveys, which extend the known range of the species by similar to 1000 km into the southwestern Caribbean. We also collected nine skin biopsies in 2013 and 2014. In order to determine the taxonomic identity of the specimens, we conducted genetic barcoding and phylogenetic analyses using two mitochondrial markers, the Control Region (mtDNA) and Cytochrome b (Cytb). Results indicate that these specimens are genetically closer to the short-beaked common dolphin (Delphinus delphis) even though morphologically they resemble a long-beaked form (Delphinus sp.). However, the specific taxonomic status of common dolphins in the Caribbean and in the Western Atlantic remains unresolved. It is also unclear whether the distribution of the species between northern Colombia and eastern Venezuela is continuous or disjoined, or whether they can be considered part of the same stock.	[Farias-Curtidor, Nohelia] Conjunto Caeli Reservado, Cajica, Colombia; [Barragan-Barrera, Dalia C.; Alejandra Chavez-Carreno, Paula; Caballero, Susana] Univ Los Andes, Dept Ciencias Biol, LEMVA, Lab J 202, Bogota, Colombia; [Barragan-Barrera, Dalia C.] Fdn Macuat Colombia, Medellin, Colombia; [Alejandra Chavez-Carreno, Paula] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Jimenez-Pinedo, Cristina] Zona Rural Piedras Coloradas S-N, Las Grutas, Rio Negro, Argentina; [Palacios, Daniel M.] Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Newport, OR 97365 USA; [Caicedo, Dalila; Trujillo, Fernando] Fdn Omacha, Bogota, Colombia	Universidad de los Andes (Colombia); Duke University; Oregon State University	Caballero, S (corresponding author), Univ Los Andes, Dept Ciencias Biol, LEMVA, Lab J 202, Bogota, Colombia.	sj.caballero26@uniandes.edu.co	Barragán-Barrera, Dalia C./ABA-2913-2020; Palacios, Daniel M./B-9180-2008	Barragán-Barrera, Dalia C./0000-0003-4023-9908; Palacios, Daniel M./0000-0001-7069-7913	Society for Marine Mammalogy; Universidad de los Andes [1821]; Universidad de los Andes	Society for Marine Mammalogy; Universidad de los Andes; Universidad de los Andes	This study was supported by the Society for Marine Mammalogy (DB, 2014); the "Proyecto Semilla - 2013-2 Call for Funding of Research Category: Master and Doctoral students, project 'Genetic structure and diversity of bottlenose dolphins Tursiops truncatus (Montagu,1821) (Cetacea:Delphinidae) in La Guajira, Colombian Caribbean'" from Universidad de los Andes (DB, 2014); and the "Proyecto Semilla - 2015-1 Call for Funding of Research Category: Master and Doctoral students, project 'Occurrence, distribution and preliminary genetic status of delphinids in La Guajira, Colombian Caribbean'" from Universidad de los Andes (DB, 2015).	Aguayo CG, 1954, CIRCULARES MUSEO BIB, V13, P1125; Amaral AR, 2007, MAR BIOL, V151, P1967, DOI 10.1007/s00227-007-0635-y; Amaral AR, 2012, MOL PHYLOGENET EVOL, V64, P243, DOI 10.1016/j.ympev.2012.04.004; AMOS B, 1991, P99; Andrade CA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001549; Andrade CA, 2005, CONTINENTAL SHELF RE, V25; [Anonymous], 2002, NCBI HDB; Baker CS, 2003, TRENDS ECOL EVOL, V18, P271, DOI 10.1016/S0169-5347(03)00101-0; Baker CS, 1998, MOL ECOL, V7, P695, DOI 10.1046/j.1365-294x.1998.00384.x; Bell Catherine H., 2002, Australian Mammalogy, V24, P1; Bilgmann K, 2008, ANIM CONSERV, V11, P518, DOI 10.1111/j.1469-1795.2008.00213.x; Burmeister H., 1866, Annals & Magazine of Natural History, Vxviii, P99; Caballero S, 2008, MOL PHYLOGENET EVOL, V46, P252, DOI 10.1016/j.ympev.2007.10.015; Casinos A., 1984, ACTA ZOOL FENN, V172, P141; CORREDOR JE, 1979, DEEP-SEA RES, V26, P731, DOI 10.1016/0198-0149(79)90010-4; Cunha HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140251; Cuni LA, 1918, MEMORIAS SOC CUBANA, P83; CURL H, 1960, DEEP-SEA RES, V7, P183, DOI 10.1016/0146-6313(60)90024-1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2009, GENEIOUS PROV4 8 5; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duchene S, 2012, REMOVE REDUNDANT TAX; Esteves Maria Alejandra, 2007, Aquatic Mammals, V33, P229, DOI 10.1578/AM.33.2.2007.229; EVANS W.E., 1982, DISTRIBUTION AND DIF, VIV, P45; Gilson A, 1998, CALIF FISH GAME, V84, P159; GORDON AL, 1967, J GEOPHYS RES, V72, P6207, DOI 10.1029/JZ072i024p06207; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heyning John E., 1994, Contributions in Science (Los Angeles), V442, P1; *IWC, 2007, J CETACEAN RES MAN S, V9, P297; Jefferson T.A., 2015, COMPREHENSIVE GUIDE; Jefferson TA, 2002, MAR MAMMAL SCI, V18, P787, DOI 10.1111/j.1748-7692.2002.tb01074.x; Jefferson TA, 2009, MAR BIOL, V156, P1109, DOI 10.1007/s00227-009-1152-y; Juri Eduardo, 2012, Marine Biodiversity Records, V5, P1; Kingston SE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-245; Kingston SE, 2004, J HERED, V95, P1, DOI 10.1093/jhered/esh010; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; LeDuc RG, 1999, MAR MAMMAL SCI, V15, P619, DOI 10.1111/j.1748-7692.1999.tb00833.x; Lonin SA, 2010, J GEOPHYS RES, V115, P1; Mirimin L, 2009, MAR BIOL, V156, P821, DOI 10.1007/s00227-008-1120-y; Moller L, 2011, MAR BIOL, V158, P113, DOI 10.1007/s00227-010-1546-x; MULLERKARGER FE, 1994, CONT SHELF RES, V14, P199, DOI 10.1016/0278-4343(94)90013-2; Murphy S, 2006, MAR MAMMAL SCI, V22, P573, DOI 10.1111/j.1748-7692.2006.00037.x; Natoli A, 2006, J EVOLUTION BIOL, V19, P943, DOI 10.1111/j.1420-9101.2005.01033.x; Oviedo L, J MARINE BIOL ASS UK; Paramo J, 2011, REV BIOL MAR OCEANOG, V46, P421, DOI 10.4067/S0718-19572011000300011; Perrin W. F., 2004, WORKSH SHORTC CET TA, P26; Perrin WF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P255; Pinela AM, 2011, J ZOOL, V284, P239, DOI 10.1111/j.1469-7998.2011.00798.x; Querouil S, 2010, MAR BIOL, V157, P2567, DOI 10.1007/s00227-010-1519-0; Rambaut A., 2014, TRACER V1 6; Rambaut A., 2014, TREEANNOTATOR V1 8 2; Ramirez Carroz Sonsiree, 2004, Boletin del Centro de Investigaciones Biologicas Universidad del Zulia, V38, P140; ROSEL PE, 1994, MAR BIOL, V119, P159, DOI 10.1007/BF00349552; Ross HA, 2003, J HERED, V94, P111, DOI 10.1093/jhered/esg027; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Segura-Garcia I, 2011, THESIS; Stockin KA, 2014, MAR MAMMAL SCI, V30, P44, DOI 10.1111/mms.12027; Tavares M, 2010, MAMMAL REV, V40, P40, DOI 10.1111/j.1365-2907.2009.00154.x; Tezanos-Pinto G, 2011, NEW ZEAL J MAR FRESH, V1, P1; Tzika AC, 2010, CONSERV GENET, V11, P2207, DOI 10.1007/s10592-010-0106-8; Viricel A, 2012, MAR MAMMAL SCI, V28, P37, DOI 10.1111/j.1748-7692.2010.00460.x; Whitt Amy D., 2011, Latin American Journal of Aquatic Mammals, V9, P65	62	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171000	10.1371/journal.pone.0171000	http://dx.doi.org/10.1371/journal.pone.0171000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192446	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800014
J	Hradilova, N; Sadilkova, L; Palata, O; Mysikova, D; Mrazkova, H; Lischke, R; Spisek, R; Adkins, I				Hradilova, Nada; Sadilkova, Lenka; Palata, Ondrej; Mysikova, Dagmar; Mrazkova, Hana; Lischke, Robert; Spisek, Radek; Adkins, Irena			Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN; TUMOR-CELLS; IMMUNE-RESPONSES; CLINICAL-TRIAL; PHASE-I; PEPTIDE; IMMUNIZATION; DEATH; THERAPY; GENES	High hydrostatic pressure (HHP) induces immunogenic death of tumor cells which confer protective anti-tumor immunity in vivo. Moreover, DC pulsed with HHP-treated tumor cells induced therapeutic effect in mouse cancer model. In this study, we tested the immunogenicity, stability and T cell stimulatory activity of human monocyte-derived dendritic cell (DC)based HHP lung cancer vaccine generated in GMP compliant serum free medium using HHP 250 MPa. DC pulsed with HHP-killed lung cancer cells and poly(I:C) enhanced DC maturation, chemotactic migration and production of pro-inflammatory cytokines after 24h. Moreover, DC-based HHP lung cancer vaccine showed functional plasticity after transfer into serum-containing media and stimulation with LPS or CD40L after additional 24h. LPS and CD40L stimulation further differentially enhanced the expression of costimulatory molecules and production of IL-12p70. DC-based HHP lung cancer vaccine decreased the number of CD4(+) CD25(+) Foxp3(+) T regulatory cells and stimulated IFN-gamma-producing tumor antigenspecific CD4(+) and CD8(+) T cells from non-small cell lung cancer (NSCLC) patients. Tumor antigen specific CD8(+) and CD4(+) T cell responses were detected in NSCLC patient's against a selected tumor antigens expressed by lung cancer cell lines used for the vaccine generation. We also showed for the first time that protein antigen from HHP-killed lung cancer cells is processed and presented by DC to CD8(+) T cells. Our results represent important preclinical data for ongoing NSCLC Phase I/II clinical trial using DC-based active cellular immunotherapy (DCVAC/LuCa) in combination with chemotherapy and immune enhancers.	[Hradilova, Nada; Sadilkova, Lenka; Palata, Ondrej; Spisek, Radek; Adkins, Irena] SOTIO, Prague, Czech Republic; [Hradilova, Nada; Palata, Ondrej; Spisek, Radek; Adkins, Irena] Charles Univ Prague, Fac Med 2, Dept Immunol, Prague, Czech Republic; [Hradilova, Nada; Palata, Ondrej; Mysikova, Dagmar; Mrazkova, Hana; Lischke, Robert; Spisek, Radek; Adkins, Irena] Univ Hosp Motol, Prague, Czech Republic; [Mysikova, Dagmar; Mrazkova, Hana; Lischke, Robert] Charles Univ Prague, Fac Med 1, Dept Surg 3, Thorac & Lung Transplantat Div, Prague, Czech Republic	Charles University Prague; Motol University Hospital; Charles University Prague	Adkins, I (corresponding author), SOTIO, Prague, Czech Republic.; Adkins, I (corresponding author), Charles Univ Prague, Fac Med 2, Dept Immunol, Prague, Czech Republic.; Adkins, I (corresponding author), Univ Hosp Motol, Prague, Czech Republic.	adkins@sotio.com	Palata, Ondřej/N-2764-2017; Faltova, Hana/D-6279-2017; Lischke, Robert/E-6087-2017; Mysikova, Dagmar/D-7011-2017	Palata, Ondřej/0000-0003-3264-9384; Faltova, Hana/0000-0003-2221-4950; Lischke, Robert/0000-0002-0578-1833; Mysikova, Dagmar/0000-0002-0400-6253	Charles Universityin Prague, Czech Republic, project GAUK [458216]	Charles Universityin Prague, Czech Republic, project GAUK	The authors declare that this study was supported by Sotio a.s. This study was further supported by the Charles Universityin Prague, Czech Republic, project GAUK No.458216 granted to OP. This does not alterouradherence to PLOS ONE policies on sharing data and materials. The specific roles of these authors are articulated in the 'author contributions' section.	Abdi K, 2012, J IMMUNOL, V188, P5981, DOI 10.4049/jimmunol.1102868; Adkins I, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.968434; Alanio C, 2010, BLOOD, V115, P3718, DOI 10.1182/blood-2009-10-251124; Atanackovic D, 2004, J IMMUNOL, V172, P3289, DOI 10.4049/jimmunol.172.5.3289; Babatz J, 2006, CANCER IMMUNOL IMMUN, V55, P268, DOI 10.1007/s00262-005-0021-x; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Brunsvig PF, 2011, CLIN CANCER RES, V17, P6847, DOI 10.1158/1078-0432.CCR-11-1385; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chang GC, 2005, CANCER-AM CANCER SOC, V103, P763, DOI 10.1002/cncr.20843; Coulie PG, 2005, CURR OPIN IMMUNOL, V17, P320, DOI 10.1016/j.coi.2005.03.002; Datta Jashodeep, 2014, Yale Journal of Biology and Medicine, V87, P491; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Engell-Noerregaard L, 2013, CANCER IMMUNOL IMMUN, V62, P17, DOI 10.1007/s00262-012-1306-5; Fucikova J, 2014, INT J CANCER, V135, P1165, DOI 10.1002/ijc.28766; Fucikova J, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-223; Grunwald C, 2006, INT J CANCER, V118, P2522, DOI 10.1002/ijc.21669; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; He XS, 2003, J INFECT DIS, V187, P1075, DOI 10.1086/368218; Hirschowitz EA, 2004, J CLIN ONCOL, V22, P2808, DOI 10.1200/JCO.2004.01.074; Hirschowitz EA, 2007, LUNG CANCER, V57, P365, DOI 10.1016/j.lungcan.2007.04.002; Hirschowitz EA, 2011, J THORAC ONCOL, V6, P169, DOI 10.1097/JTO.0b013e3181fb5c22; Karanikas V, 2008, CANCER BIOL THER, V7, P345, DOI 10.4161/cbt.7.3.5424; Kontani K, 2003, INT J MOL MED, V12, P493; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Mellstedt H, 2011, LUNG CANCER, V73, P11, DOI 10.1016/j.lungcan.2011.02.023; Mikyskova R, 2016, INT J ONCOL, V48, P953, DOI 10.3892/ijo.2015.3314; Morse MA, 2005, CLIN CANCER RES, V11, P3017, DOI 10.1158/1078-0432.CCR-04-2172; MUKHERJI B, 1995, P NATL ACAD SCI USA, V92, P8078, DOI 10.1073/pnas.92.17.8078; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Perroud MW, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-65; Rouas R, 2004, INT IMMUNOL, V16, P767, DOI 10.1093/intimm/dxh077; Sheikh NA, 2013, CANCER IMMUNOL IMMUN, V62, P137, DOI 10.1007/s00262-012-1317-2; Skachkova O. V., 2013, Experimental Oncology, V35, P109; Tajima K, 2003, LUNG CANCER-J IASLC, V42, P23, DOI 10.1016/S0169-5002(03)00244-7; Takahashi H, 2013, EUR J CANCER, V49, P852, DOI 10.1016/j.ejca.2012.11.005; Takahashi N, 2012, CANCER SCI, V103, P150, DOI 10.1111/j.1349-7006.2011.02106.x; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Truxova I, 2014, IMMUNOL LETT, V160, P39, DOI 10.1016/j.imlet.2014.03.010; Ueda Y, 2004, INT J ONCOL, V24, P909; Um SJ, 2010, LUNG CANCER, V70, P188, DOI 10.1016/j.lungcan.2010.02.006; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Yannelli JR, 2005, LUNG CANCER, V47, P337, DOI 10.1016/j.lungcan.2004.08.008	45	22	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171539	10.1371/journal.pone.0171539	http://dx.doi.org/10.1371/journal.pone.0171539			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187172	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300028
J	Thompson, C; Rahim, S; Arnold, J; Hielscher, A				Thompson, Christopher; Rahim, Sahar; Arnold, Jeremiah; Hielscher, Abigail			Loss of caveolin-1 alters extracellular matrix protein expression and ductal architecture in murine mammary glands	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; INVASIVE BREAST-CANCER; TUMOR-SUPPRESSOR GENE; MAMMOGRAPHIC DENSITY; TENASCIN-C; FIBRONECTIN EXPRESSION; PROSTATE-CANCER; COLLAGEN; PROGRESSION; CELLS	The extracellular matrix (ECM) is abnormal in breast tumors and has been reported to contribute to breast tumor progression. One factor, which may drive ongoing matrix synthesis in breast tumors, is the loss of stromal caveolin-1 (cav-1), a scaffolding protein of caveolae, which has been linked to breast tumor aggressiveness. To determine whether loss of cav-1 results in the abnormal expression of matrix proteins, mammary glands from cav-1-/- and cav-1 +/+ mice were investigated for differences in expression of several ECM proteins. In addition, the presence of myofibroblasts, changes in the vessel density, and differences in duct number and size were assessed in the mammary glands of both animal models. Using immunohistochemistry, expression of fibronectin, tenascin-C, collagens and alpha SMA were significantly increased in the mammary glands of cav-1-/- mice. Second harmonic generation revealed more organized collagen fibers in cav-1-/- glands and supported immunohistochemical analyses of increased collagen abundance in the glands of cav-1-/- mice. Analysis of the ductal structure demonstrated a significant increase in the number of proliferating ducts in addition to significant increases in the duct circumference and area in cav1 -/- glands compared to cav-1 +/+ glands. Differences in microvessel density weren't apparent between the animal models. In summary, we found that the loss of cav-1 resulted in increased ECM and alpha-SMA protein expression in murine mammary glands. Furthermore, we found that an abnormal ductal architecture accompanied the loss of cav-1. These data support a role for cav-1 in maintaining mammary gland structure.	[Thompson, Christopher; Rahim, Sahar; Arnold, Jeremiah; Hielscher, Abigail] Georgia Philadelphia Coll Osteopath Med, Dept Biomed Sci, Suwanee, GA 30024 USA		Hielscher, A (corresponding author), Georgia Philadelphia Coll Osteopath Med, Dept Biomed Sci, Suwanee, GA 30024 USA.	abigailhi@pcom.edu	Thompson, Christopher/GZH-1662-2022	Thompson, Christopher/0000-0002-6284-1919	Philadelphia College of Osteopathic Medicine Centers for Chronic Disorders of Aging	Philadelphia College of Osteopathic Medicine Centers for Chronic Disorders of Aging	Support was provided by the Philadelphia College of Osteopathic Medicine Centers for Chronic Disorders of Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622; Ayala G, 2013, J PATHOL, V231, P77, DOI 10.1002/path.4217; Bae YK, 2013, HUM PATHOL, V44, P2028, DOI 10.1016/j.humpath.2013.03.006; Balanis N, 2013, J BIOL CHEM, V288, P17954, DOI 10.1074/jbc.M113.475277; Barcus CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116891; Belanger MM, 2004, CHEST, V125, p106S, DOI 10.1378/chest.125.5_suppl.106S; Boyd N F, 2001, Curr Oncol Rep, V3, P314, DOI 10.1007/s11912-001-0083-7; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Brownfield DG, 2013, CURR BIOL, V23, P703, DOI 10.1016/j.cub.2013.03.032; Castello-Cros R, 2011, CELL CYCLE, V10, P2140, DOI 10.4161/cc.10.13.16227; Chan EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149799; Chang SH, 2009, AM J PATHOL, V175, P1768, DOI 10.2353/ajpath.2009.090171; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; Cloos PAC, 2003, BREAST CANCER RES, V5, pR103, DOI 10.1186/bcr607; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Fang M, 2014, TUMOR BIOL, V35, P2871, DOI 10.1007/s13277-013-1511-7; Fraley SI, 2015, SCI REP-UK, V5, DOI 10.1038/srep14580; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Guttery DS, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2618; Han QQ, 2014, J MED BIOL ENG, V34, P130, DOI 10.5405/jmbe.1445; Hielscher A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147600; Hielscher AC, 2012, AM J PHYSIOL-CELL PH, V302, pC1243, DOI 10.1152/ajpcell.00011.2012; Hino M, 2003, SURG TODAY, V33, P486, DOI 10.1007/s10595-002-2538-4; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hocking DC, 2002, J CELL BIOL, V158, P175, DOI 10.1083/jcb.200112031; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Kakkad SM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116017; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kobayashi Y, 2016, MOL VIS, V22, P436; Lee H, 2002, AM J PATHOL, V161, P1357, DOI 10.1016/S0002-9440(10)64412-4; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Mercier I, 2008, CANCER BIOL THER, V7, P1212, DOI 10.4161/cbt.7.8.6220; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Otranto M, 2012, CELL ADHES MIGR, V6, P203, DOI 10.4161/cam.20377; Pontiggia O, 2012, BREAST CANCER RES TR, V133, P459, DOI 10.1007/s10549-011-1766-x; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Pucci M, 2015, CANCER GENOM PROTEOM, V12, P143; Qian N, 2011, CANCER SCI, V102, P1590, DOI 10.1111/j.1349-7006.2011.01985.x; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Simpkins SA, 2012, J PATHOL, V227, P490, DOI 10.1002/path.4034; Sloan EK, 2009, AM J PATHOL, V174, P2035, DOI 10.2353/ajpath.2009.080924; Sotgia F, 2009, AM J PATHOL, V174, P746, DOI 10.2353/ajpath.2009.080658; Sottile J, 2005, MOL BIOL CELL, V16, P757, DOI 10.1091/mbc.e04-08-0672; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Soucy PA, 2009, MATRIX BIOL, V28, P273, DOI 10.1016/j.matbio.2009.04.005; Tahir SA, 2008, CANCER RES, V68, P731, DOI 10.1158/0008-5472.CAN-07-2668; Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673; Williams TM, 2006, AM J PATHOL, V169, P1784, DOI 10.2353/ajpath.2006.060590; Williams TM, 2003, MOL BIOL CELL, V14, P1027, DOI 10.1091/mbc.E02-08-0503; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Witkiewicz AK, 2009, CELL CYCLE, V8, P1654, DOI 10.4161/cc.8.11.8544; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Yamashita M, 2012, BREAST CANCER-TOKYO, V19, P170, DOI 10.1007/s12282-010-0234-5	64	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172067	10.1371/journal.pone.0172067	http://dx.doi.org/10.1371/journal.pone.0172067			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187162	Green Submitted, Green Published, gold			2022-12-26	WOS:000394244300078
J	Nagarajan, B; Sankaranarayanan, NV; Patel, BB; Desai, UR				Nagarajan, Balaji; Sankaranarayanan, Nehru Viji; Patel, Bhaumik B.; Desai, Umesh R.			A molecular dynamics-based algorithm for evaluating the glycosaminoglycan mimicking potential of synthetic, homogenous, sulfated small molecules	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; CANCER STEM-CELLS; 2-O-SULFO-ALPHA-L-IDURONIC ACID; ALLOSTERIC INHIBITION; STRUCTURAL BIOLOGY; SIGNALING PATHWAY; CRYSTAL-STRUCTURE; HIGH-SPECIFICITY; HEPARAN-SULFATE; NON-SACCHARIDE	Glycosaminoglycans (GAGs) are key natural biopolymers that exhibit a range of biological functions including growth and differentiation. Despite this multiplicity of function, natural GAG sequences have not yielded drugs because of problems of heterogeneity and synthesis. Recently, several homogenous non-saccharide glycosaminoglycan mimetics (NSGMs) have been reported as agents displaying major therapeutic promise. Yet, it remains unclear whether sulfated NSGMs structurally mimic sulfated GAGs. To address this, we developed a three-step molecular dynamics (MD)-based algorithm to compare sulfated NSGMs with GAGs. In the first step of this algorithm, parameters related to the range of conformations sampled by the two highly sulfated molecules as free entities in water were compared. The second step compared identity of binding site geometries and the final step evaluated comparable dynamics and interactions in the protein-bound state. Using a test case of interactions with fibroblast growth factor-related proteins, we show that this three-step algorithm effectively predicts the GAG structure mimicking property of NSGMs. Specifically, we show that two unique dimeric NSGMs mimic hexameric GAG sequences in the protein-bound state. In contrast, closely related monomeric and trimeric NSGMs do not mimic GAG in either the free or bound states. These results correspond well with the functional properties of NSGMs. The results show for the first time that appropriately designed sulfated NSGMs can be good structural mimetics of GAGs and the incorporation of a MD-based strategy at the NSGM library screening stage can identify promising mimetics of targeted GAG sequences.	[Nagarajan, Balaji; Sankaranarayanan, Nehru Viji; Desai, Umesh R.] Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA 23284 USA; [Nagarajan, Balaji; Sankaranarayanan, Nehru Viji; Desai, Umesh R.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Patel, Bhaumik B.] Hunter Holmes Muire VA Med Ctr, Richmond, VA USA; [Patel, Bhaumik B.] Virginia Commonwealth Univ, Dept Internal Med, Div Hematol Oncol & Palliat Care, Richmond, VA USA; [Patel, Bhaumik B.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; Virginia Commonwealth University	Desai, UR (corresponding author), Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA 23284 USA.; Desai, UR (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA.	urdesai@vcu.edu	Nagarajan, Balaji/K-6924-2019; Desai, Umesh/D-3741-2013	Desai, Umesh/0000-0002-1976-6597; Nagarajan, Balaji/0000-0003-3892-6178; Sankaranarayanan, Nehru Viji/0000-0002-2870-9164	NIH [HL107152, HL090586, HL128639]; VCU	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VCU	This work was supported by grants from the NIH, including HL107152, HL090586 and HL128639, and internal funds from VCU.; We thank Prof. Glen Kellogg and Prof. Neel Scarsdale of VCU for computational support. We also thank the availability of research resources from National Center for Research Resources (S10 RR027411) to VCU. This work was supported in part by grants from the NIH including HL107152, HL090586 and HL128639.	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Al-Horani RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160189; Al-Horani RA, 2015, THROMB RES, V136, P379, DOI 10.1016/j.thromres.2015.04.017; Al-Horani RA, 2015, MOLECULES, V20, P608, DOI 10.3390/molecules20010608; Al-Horani RA, 2013, J MED CHEM, V56, P867, DOI 10.1021/jm301338q; Argade MD, 2014, J MED CHEM, V57, P3559, DOI 10.1021/jm5002698; Becker CF, 2005, CARBOHYD RES, V340, P1499, DOI 10.1016/j.carres.2005.03.018; Munoz-Garcia JC, 2013, GLYCOBIOLOGY, V23, P1220, DOI 10.1093/glycob/cwt058; Case D.A., 2022, AMBER; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Case DA, 2012, AMBER, V13; Coombe Deirdre R, 2012, Handb Exp Pharmacol, P361, DOI 10.1007/978-3-642-23056-1_16; Desai UR, 2013, FUTURE MED CHEM, V5, P1363, DOI 10.4155/fmc.13.117; Dvorak P, 2006, FEBS LETT, V580, P2869, DOI 10.1016/j.febslet.2006.01.095; ERIKSSON AE, 1993, PROTEIN SCI, V2, P1274, DOI 10.1002/pro.5560020810; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Feng Y, 2012, CELL PROLIFERAT, V45, P413, DOI 10.1111/j.1365-2184.2012.00837.x; Ferro V, 2007, SEMIN THROMB HEMOST, V33, P557, DOI 10.1055/s-2007-982088; Gandhi NS, 2010, CARBOHYD RES, V345, P689, DOI 10.1016/j.carres.2009.12.020; Gunnarsson GT, 2002, J MED CHEM, V45, P1233, DOI 10.1021/jm020012q; Gunnarsson GT, 2002, J MED CHEM, V45, P4460, DOI 10.1021/jm020132y; Haley EM, 2014, CANCER LETT, V346, P1, DOI 10.1016/j.canlet.2013.12.003; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Imberty A, 2000, CHEM REV, V100, P4567, DOI 10.1021/cr990343j; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karuturi R, 2013, J MED CHEM, V56, P2415, DOI 10.1021/jm301757v; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Mehta AY, 2014, J MED CHEM, V57, P3030, DOI 10.1021/jm4020026; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Mizuno S, 2013, INT J MOL SCI, V14, P888, DOI 10.3390/ijms14010888; Moshtagh N., 2006, COMPUTES MINIMUM VOL; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Mulloy B, 2016, PHARMACOL REV, V68, P76, DOI 10.1124/pr.115.011247; Ori A, 2009, MOL CELL PROTEOMICS, V8, P2256, DOI 10.1074/mcp.M900031-MCP200; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Patel NJ, 2014, ACS CHEM BIOL, V9, P1826, DOI 10.1021/cb500402f; Patel NJ, 2016, ONCOTARGET; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pol-Fachin L, 2008, CARBOHYD RES, V343, P1435, DOI 10.1016/j.carres.2008.04.016; Pomin VH, 2015, CURR OPIN STRUC BIOL, V34, P17, DOI 10.1016/j.sbi.2015.05.007; Presta M., 2008, ANGIOGENESIS INTEGRA, P77, DOI DOI 10.1111/WRR.12195; Raman K, 2012, BIOORG MED CHEM LETT, V22, P4467, DOI 10.1016/j.bmcl.2012.04.014; Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Samsonov SA, 2014, J CHEM INF MODEL, V54, P582, DOI 10.1021/ci4006047; Sankaranarayanan NV, 2014, GLYCOBIOLOGY, V24, P1323, DOI 10.1093/glycob/cwu077; Sankaranarayanan NV, 2015, METHODS MOL BIOL, V1229, P289, DOI 10.1007/978-1-4939-1714-3_24; Sattelle BM, 2013, BIOMACROMOLECULES, V14, P1149, DOI 10.1021/bm400067g; Sattelle BM, 2010, J AM CHEM SOC, V132, P13132, DOI 10.1021/ja1054143; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sidhu PS, 2013, J MED CHEM, V56, P5059, DOI 10.1021/jm400369q; Sterner E, 2013, BIOCHEMISTRY-US, V52, P9009, DOI 10.1021/bi401284r; TVAROSKA I, 1989, ADV CARBOHYD CHEM BI, V47, P45; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Woods RJ, 2010, CURR OPIN STRUC BIOL, V20, P575, DOI 10.1016/j.sbi.2010.07.005; Yeh BK, 2002, MOL CELL BIOL, V22, P7184, DOI 10.1128/MCB.22.20.7184-7192.2002; ZHANG JD, 1991, P NATL ACAD SCI USA, V88, P3446, DOI 10.1073/pnas.88.8.3446	66	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171619	10.1371/journal.pone.0171619	http://dx.doi.org/10.1371/journal.pone.0171619			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182755	gold, Green Submitted, Green Published			2022-12-26	WOS:000394231800080
J	Wu, B; Xiao, F; Li, PW; Du, Y; Lin, JQ; Ming, KH; Chen, B; Lei, XX; Xu, BL; Liu, DY				Wu, Bin; Xiao, Feng; Li, Peiwen; Du, Yan; Lin, Jinqiong; Ming, Kaihua; Chen, Bin; Lei, Xiuxia; Xu, Banglao; Liu, Dayu			Ultrasensitive detection of serum hepatitis B virus by coupling ultrafiltration DNA extraction with real-time PCR	PLOS ONE			English	Article							VERSANT HBV DNA-3.0; PLASMID DNA; VIRAL LOAD; TAQMAN HBV; ASSAY; MEMBRANES; QUANTIFICATION; TRANSMISSION; QUANTITATION; SYSTEM	Background A simple and reliable DNA extraction of hepatitis B virus (HBV) is critical in developing an ultrasensitive detection method for HBV infection. Current commercially available serum Hepatitis B Virus (HBV) DNA extraction methods are time-consuming, expensive and/or require specialized equipment, which hinders wide adoption of clinical laboratories. This study offers a report on an ultrasensitive HBV DNA detection method by coupling serum HBV DNA extraction by ultrafiltration (UF) with real-time PCR (qPCR) detection. Methods Serum proteins were precipitated by phenol to release HBV DNA in the supernatant which was then transferred to the UF devices. The resultant DNA concentrate was eluted and released into qPCR pre-mixture. The UF-qPCR assay performance, including recovery rate, linearity, detection sensitivity, precision and diagnostic accuracy that compared to the CAP-CTM V2.0 assay by analyzing batched low viral load clinical samples was evaluated. Results The recovery rate of the UF-based HBV DNA extraction method was above 80%. The assay linearity was demonstrated with a slope of 0.95 and R-2 values of 0.99. Limit-of-detection (LOD) of the UF-qPCR assay was determined to be 12.1IU/ml. The coefficient of variation (CV) of HBV quantitation for high, low and limit titer samples was 2.28%, 5.77% and 25.59%, respectively. Accuracy of the UF-qPCR assay was confirmed with the reference panel, and there was a strong correlation between these two methods (R-2 = 0.55, p < 0.01). Conclusions The UF-qPCR assay is reliable, highly sensitive, affordable and time-saving, and the method can be used for ultrasensitive detection of serum HBV.	[Wu, Bin; Xiao, Feng; Li, Peiwen; Du, Yan; Lin, Jinqiong; Ming, Kaihua; Chen, Bin; Lei, Xiuxia; Xu, Banglao; Liu, Dayu] Affiliated Hosp Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Lab Med, Guangzhou, Guangdong, Peoples R China; [Ming, Kaihua; Chen, Bin; Lei, Xiuxia; Xu, Banglao; Liu, Dayu] Clin Mol Med & Mol Diag Key Lab Guangdong Prov, Guangzhou, Guangdong, Peoples R China		Lei, XX; Liu, DY (corresponding author), Affiliated Hosp Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Lab Med, Guangzhou, Guangdong, Peoples R China.; Lei, XX; Liu, DY (corresponding author), Clin Mol Med & Mol Diag Key Lab Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	leixx999@163.com; ruark@126.com						Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Arkhangelsky E, 2008, DESALINATION, V227, P111, DOI 10.1016/j.desal.2007.07.017; ARRIBAS JR, 1995, J CLIN MICROBIOL, V33, P1580, DOI 10.1128/JCM.33.6.1580-1583.1995; Bilad MR, 2014, BIOTECHNOL ADV, V32, P1283, DOI 10.1016/j.biotechadv.2014.07.008; Cha BH, 2009, BIOSENS BIOELECTRON, V25, P130, DOI 10.1016/j.bios.2009.06.015; Ciotti M, 2008, J CLIN MICROBIOL, V46, P1517, DOI 10.1128/JCM.02046-07; FAGAN EA, 1985, J VIROL METHODS, V12, P251, DOI 10.1016/0166-0934(85)90136-3; Garbuglia AR, 2007, J VIROL METHODS, V146, P274, DOI 10.1016/j.jviromet.2007.07.005; Goldar A, 2004, EUR PHYS J E, V14, P211, DOI 10.1140/epje/i2004-10011-7; Goosen MFA, 2004, SEP SCI TECHNOL, V39, P2261, DOI 10.1081/SS-120039343; HANCHER CW, 1973, BIOTECHNOL BIOENG, V15, P677, DOI 10.1002/bit.260150404; HIRASAKI T, 1995, J MEMBRANE SCI, V106, P123, DOI 10.1016/0376-7388(95)00082-N; Hochberger S, 2006, J CLIN VIROL, V35, P373, DOI 10.1016/j.jcv.2006.01.003; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Kramvis A, 1996, J CLIN MICROBIOL, V34, P2731, DOI 10.1128/JCM.34.11.2731-2733.1996; Lai MW, 2012, GASTROENTEROLOGY, V143, P400, DOI 10.1053/j.gastro.2012.05.002; Latulippe DR, 2008, BIOTECHNOL BIOENG, V99, P390, DOI 10.1002/bit.21575; Latulippe DR, 2007, J MEMBRANE SCI, V294, P169, DOI 10.1016/j.memsci.2007.02.033; Lee KB, 2012, FOOD ENVIRON VIROL, V4, P68, DOI 10.1007/s12560-012-9077-x; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Liang Y, 2011, ALIMENT PHARM THER, V34, P344, DOI 10.1111/j.1365-2036.2011.04738.x; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Lindh M, 2005, J CLIN MICROBIOL, V43, P4251, DOI 10.1128/JCM.43.8.4251-4254.2005; Liu PB, 2012, J MICROBIOL METH, V88, P155, DOI 10.1016/j.mimet.2011.11.007; Liu YP, 2015, WORLD J GASTROENTERO, V21, P11954, DOI 10.3748/wjg.v21.i42.11954; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lu YQ, 2006, WORLD J GASTROENTERO, V12, P7365, DOI 10.3748/wjg.v12.i45.7365; Nyan DC, 2014, CLIN INFECT DIS, V59, P16, DOI 10.1093/cid/ciu210; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Pas SD, 2000, J CLIN MICROBIOL, V38, P2897, DOI 10.1128/JCM.38.8.2897-2901.2000; Portilho MM, 2015, J VIROL METHODS, V223, P40, DOI 10.1016/j.jviromet.2015.07.010; Pyne MT, 2012, J CLIN MICROBIOL, V50, P2337, DOI 10.1128/JCM.00746-12; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Ronsin C, 2006, J CLIN MICROBIOL, V44, P1390, DOI 10.1128/JCM.44.4.1390-1399.2006; Thibault V, 2007, J CLIN MICROBIOL, V45, P3948, DOI 10.1128/JCM.01180-07; *WHO GUID APPR GUI, 2015, GUID PREV CAR TREATM; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; Yao CY, 2013, SENSOR ACTUAT B-CHEM, V181, P382, DOI 10.1016/j.snb.2013.01.063; Yeh ML, 2014, J CLIN VIROL, V60, P206, DOI 10.1016/j.jcv.2014.04.008	39	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170290	10.1371/journal.pone.0170290	http://dx.doi.org/10.1371/journal.pone.0170290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182626	gold, Green Submitted, Green Published			2022-12-26	WOS:000394231800010
J	Blanco, AM; Gomez-Boronat, M; Alonso-Gomez, AL; Yufa, R; Unniappan, S; Delgado, MJ; Valenciano, AI				Melisa Blanco, Ayelen; Gomez-Boronat, Miguel; Luis Alonso-Gomez, Angel; Yufa, Roman; Unniappan, Suraj; Jesus Delgado, Maria; Isabel Valenciano, Ana			Characterization of Ghrelin O-Acyltransferase (GOAT) in goldfish (Carassius auratus)	PLOS ONE			English	Article							DES-ACYL GHRELIN; CIRCADIAN SYSTEM; EXPRESSION; IDENTIFICATION; MODULATION; ACCURACY; PEPTIDE; ENZYME	Ghrelin is the only known hormone posttranslationally modified with an acylation. This modification is crucial for most of ghrelin's physiological effects and is catalyzed by the polytopic enzyme ghrelin O-acyltransferase (GOAT). The aim of this study was to characterize GOAT in a teleost model, goldfish (Carassius auratus). First, the full-length cDNA sequence was obtained by RT-PCR and rapid amplification of cDNA ends methods. Two highly homologous cDNAs of 1491 and 1413 bp, respectively, named goat-V1 and goat-V2 were identified. Deduced protein sequences (393 and 367 amino acids, respectively) are predicted to present 11 and 9 transmembrane regions, respectively, and both contain two conserved key residues proposed to be involved in catalysis: asparagine 273 and histidine 304. RTqPCR revealed that both forms of goat mRNAs show a similar widespread tissue distribution, with the highest expression in the gastrointestinal tract and gonads and less but considerable expression in brain, pituitary, liver and adipose tissue. Immunostaining of intestinal sections showed the presence of GOAT immunoreactive cells in the intestinal mucosa, some of which colocalize with ghrelin. Using an in vitro approach, we observed that acylated ghrelin downregulates GOAT gene and protein levels in cultured intestine in a time-dependent manner. Finally, we found a rhythmic oscillation of goat mRNA expression in the hypothalamus, pituitary and intestinal bulb of goldfish fed at midday, but not at midnight. Together, these findings report novel data characterizing GOAT, and offer new information about the ghrelinergic system in fish.	[Melisa Blanco, Ayelen; Gomez-Boronat, Miguel; Luis Alonso-Gomez, Angel; Jesus Delgado, Maria; Isabel Valenciano, Ana] Univ Complutense Madrid, Fac Biol, Dept Fisiol Fisiol Anim 2, Madrid, Spain; [Yufa, Roman] York Univ, Dept Biol, Toronto, ON, Canada; [Unniappan, Suraj] Univ Saskatchewan, Dept Vet Biomed Sci, Western Coll Vet Med, Lab Integrat Neuroendocrinol, Saskatoon, SK, Canada	Complutense University of Madrid; York University - Canada; University of Saskatchewan	Valenciano, AI (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Fisiol Fisiol Anim 2, Madrid, Spain.	aivalenciano@bio.ucm.es	Delgado, María J/I-3856-2017; Delgado, María J./I-3535-2017; Alonso-Gómez, Ángel L/F-4033-2016; BORONAT, MIGUEL GOMEZ/R-7225-2019; Valenciano, Ana Isabel/F-4119-2016	Delgado, María J/0000-0002-1185-9377; Delgado, María J./0000-0002-1185-9377; Alonso-Gómez, Ángel L/0000-0003-3219-2265; BORONAT, MIGUEL GOMEZ/0000-0003-4902-5252; Valenciano, Ana Isabel/0000-0002-0416-2192; Blanco, Ayelen Melisa/0000-0002-7683-4154	Spanish Ministerio de Economia y Competitividad (MINECO) [AGL2016-74857 C3-2-R]; Natural Sciences and Engineering Research Council (NSERC) of Canada [341292-2012-RGPIN, 429436-2012-RGPAS]; Saskatchewan Health Research Foundation (SHRF); Canada Foundation for Innovation	Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Saskatchewan Health Research Foundation (SHRF); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This study was supported by the Spanish Ministerio de Economia y Competitividad (MINECO; AGL2016-74857 C3-2-R) to MJD, and partly by a Discovery Grant (341292-2012-RGPIN), and Discovery Accelerator Supplement (429436-2012-RGPAS) award from the Natural Sciences and Engineering Research Council (NSERC) of Canada, an Establishment grant from Saskatchewan Health Research Foundation (SHRF) and John R. Evans Leaders Fund from the Canada Foundation for Innovation to SU. AMB and MGB are predoctoral fellows from the Spanish Ministerio de Educacion, Cultura y Deporte and MINECO, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WJ, 2010, CELL PHYSIOL BIOCHEM, V26, P707, DOI 10.1159/000322338; Blanco AM, 2016, J COMP PHYSIOL B, V186, P727, DOI 10.1007/s00360-016-0986-0; Blanco AM, 2017, J EXP BIOL; Blanco AM, 2016, ANAT REC, V299, P748, DOI 10.1002/ar.23346; Chang SC, 2009, MOL MEMBR BIOL, V26, P104, DOI 10.1080/09687680802706432; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; DELGADO MJ, 1993, GEN COMP ENDOCR, V92, P143, DOI 10.1006/gcen.1993.1151; Delhanty PJ, 2013, ENDOCR DEV, V25, P112, DOI 10.1159/000346059; Delporte C, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/518909; Gahete MD, 2014, J ENDOCRINOL, V220, pR1, DOI 10.1530/JOE-13-0391; Gomez R, 2009, ARTHRITIS RHEUM-US, V60, P1704, DOI 10.1002/art.24522; Gonzalez CR, 2008, J MOL ENDOCRINOL, V41, P415, DOI 10.1677/JME-08-0102; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hatef A, 2015, GHRELIN O ACYL TRANS; Heppner KM, 2011, CURR OPIN ENDOCRINOL, V18, P50, DOI 10.1097/MED.0b013e328341e1d3; Isorna E, 2017, J ENDOCRINOL, V232, pR141, DOI 10.1530/JOE-16-0330; Jonsson E, 2013, GEN COMP ENDOCR, V187, P79, DOI 10.1016/j.ygcen.2013.03.013; Kaiya H, 2013, GEN COMP ENDOCR, V181, P187, DOI 10.1016/j.ygcen.2012.10.015; Khatib MN, 2015, J CLIN DIAGN RES; Kitazawa T, 2012, GEN COMP ENDOCR, V178, P539, DOI 10.1016/j.ygcen.2012.06.025; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Konturek SJ, 2004, J PHYSIOL PHARMACOL, V55, P137; Koukkari WL, 2006, CHRONOBIOMETRY ANAL, P577; LARHAMMAR D, 1994, MOL PHYLOGENET EVOL, V3, P59, DOI 10.1006/mpev.1994.1007; Lear PV, 2010, ENDOCRINOLOGY, V151, P3286, DOI 10.1210/en.2009-1205; Lim CT, 2011, ENDOCR J, V58, P707, DOI 10.1507/endocrj.K11E-117; Lim CT, 2011, REV ENDOCR METAB DIS, V12, P173, DOI 10.1007/s11154-011-9169-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuda K, 2006, PEPTIDES, V27, P2321, DOI 10.1016/j.peptides.2006.03.028; Mohan H, 2013, ENDOCR DEV, V25, P16, DOI 10.1159/000346039; Nisembaum LG, 2014, GEN COMP ENDOCR, V205, P287, DOI 10.1016/j.ygcen.2014.03.016; Nugent T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-169; Ohgusu H, 2009, BIOCHEM BIOPH RES CO, V386, P153, DOI 10.1016/j.bbrc.2009.06.001; Pagac M, 2011, J BIOL CHEM, V286, P36438, DOI 10.1074/jbc.M111.256511; Romero A, 2010, EUR J ENDOCRINOL, V163, P1, DOI 10.1530/EJE-10-0099; Sakata I, 2009, AM J PHYSIOL-ENDOC M, V297, pE134, DOI 10.1152/ajpendo.90859.2008; Sanchez-Bretano A, 2016, J COMP PHYSIOL B, V186, P73, DOI 10.1007/s00360-015-0936-2; Sanchez-Bretano A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141043; Sato T, 2012, J BIOCHEM, V151, P119, DOI 10.1093/jb/mvr134; Satou M, 2010, ENDOCRINOLOGY, V151, P4765, DOI 10.1210/en.2010-0412; Shen HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002399; Shin YK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012729; Shlimun A, 2011, INT J PEPT, V2011, P1; Stengel A, 2010, BIOCHEM BIOPH RES CO, V392, P67, DOI 10.1016/j.bbrc.2009.12.169; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor MS, 2015, BIOORG CHEM, V62, P64, DOI 10.1016/j.bioorg.2015.07.003; Taylor MS, 2013, J BIOL CHEM, V288, P32211, DOI 10.1074/jbc.M113.510313; Unniappan S, 2004, AM J PHYSIOL-REG I, V286, pR1093, DOI 10.1152/ajpregu.00669.2003; Unniappan S, 2010, GEN COMP ENDOCR, V167, P340, DOI 10.1016/j.ygcen.2009.12.003; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yang J, 2013, BIOINFORMATICS, V29, P2579, DOI 10.1093/bioinformatics/btt440; Yannielli PC, 2007, J NEUROSCI, V27, P2890, DOI 10.1523/JNEUROSCI.3913-06.2007	53	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171874	10.1371/journal.pone.0171874	http://dx.doi.org/10.1371/journal.pone.0171874			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178327	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000393712500076
J	Ozer, B; Sezerman, U				Ozer, Bugra; Sezerman, Ugur			An integrative study on the impact of highly differentially methylated genes on expression and cancer etiology	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; DNA METHYLATION; LUNG-CANCER; COLORECTAL-CANCER; FUNDAMENTAL ROLE; CPG-METHYLATION; THYROID-CANCER; COLON-CANCER; CELL-GROWTH; HYPOMETHYLATION	DNA methylation is an important epigenetic phenomenon that plays a key role in the regulation of expression. Most of the studies on the topic of methylation's role in cancer mechanisms include analyses based on differential methylation, with the integration of expression information as supporting evidence. In the present study, we sought to identify methylationdriven patterns by also integrating protein-protein interaction information. We performed integrative analyses of DNA methylation, expression, SNP and copy number data on paired samples from six different cancer types. As a result, we found that genes that show a methylation change larger than 32.2% may influence cancer-related genes via fewer interaction steps and with much higher percentages compared with genes showing a methylation change less than 32.2%. Additionally, we investigated whether there were shared cancer mechanisms among different cancer types. Specifically, five cancer types shared a change in AGTR1 and IGF1 genes, which implies that there may be similar underlying disease mechanisms among these cancers. Additionally, when the focus was placed on distinctly altered genes within each cancer type, we identified various cancer-specific genes that are also supported in the literature and may play crucial roles as therapeutic targets. Overall, our novel graph-based approach for identifying methylation-driven patterns will improve our understanding of the effects of methylation on cancer progression and lead to improved knowledge of cancer etiology.	[Ozer, Bugra] Sabanci Univ, Fac Engn & Nat Sci, Biol Sci & Bioengn Program, Istanbul, Turkey; [Sezerman, Ugur] Acibadem Univ, Dept Biostat & Med Informat, Istanbul, Turkey	Sabanci University; Acibadem University	Ozer, B (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Biol Sci & Bioengn Program, Istanbul, Turkey.	bugraozer@sabanciuniv.edu	SEZERMAN, OSMAN U/X-6441-2018	Sezerman, Osman Ugur/0000-0003-0905-6783				Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Akiyama Y, 2003, AM J PATHOL, V163, P1911, DOI 10.1016/S0002-9440(10)63549-3; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Alvaro D, 2006, AM J PATHOL, V169, P877, DOI 10.2353/ajpath.2006.050464; Badal V, 2003, J VIROL, V77, P6227, DOI 10.1128/JVI.77.11.6227-6234.2003; Bartlett TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143178; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLOCH D, 1966, J AM STAT ASSOC, V61, P852, DOI 10.2307/2282794; Butcher LM, 2015, METHODS, V72, P21, DOI 10.1016/j.ymeth.2014.10.036; Campbell CE, 1998, INT J CANCER, V78, P182, DOI 10.1002/(SICI)1097-0215(19981005)78:2<182::AID-IJC11>3.3.CO;2-D; Cheung HH, 2009, BIRTH DEFECTS RES C, V87, P335, DOI 10.1002/bdrc.20163; Cui HM, 2002, CANCER RES, V62, P6442; Dai YN, 2015, CANCER CAUSE CONTROL, V26, P1245, DOI 10.1007/s10552-015-0617-1; De S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003137; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Fang WT, 2014, INT J CANCER, V135, P809, DOI 10.1002/ijc.28734; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feinberg AP, 2002, CANCER RES, V62, P6784; Fraga MF, 2004, CANCER RES, V64, P5527, DOI 10.1158/0008-5472.CAN-03-4061; Galm O, 2006, BLOOD REV, V20, P1, DOI 10.1016/j.blre.2005.01.006; Gehlenborg N., R PACKAGE VERSION 1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gevaert O, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0579-8; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Goh L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017810; Gunes EG, 2009, MOL MED REP, V2, P1029, DOI 10.3892/mmr_00000210; Guo SC, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-014-0035-3; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Heist RS, 2012, J THORAC ONCOL, V7, P924, DOI 10.1097/JTO.0b013e31824cc334; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Jhala NC, 2005, ARCH PATHOL LAB MED, V129, P481; Jiao YM, 2014, BIOINFORMATICS, V30, P2360, DOI 10.1093/bioinformatics/btu316; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kanemoto M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-641; Kim JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-526; Kimura ET, 2003, CANCER RES, V63, P1454; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kramer HB, 2016, NUCLEIC ACIDS RES, V44, P582, DOI 10.1093/nar/gkv948; Lee ST, 2016, NUCLEIC ACIDS RES, V44, P1105, DOI 10.1093/nar/gkv1038; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Ma X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073436; Major JM, 2010, BRIT J CANCER, V103, P132, DOI 10.1038/sj.bjc.6605722; Mansuroglu T, 2009, EUR J GASTROEN HEPAT, V21, P1206, DOI 10.1097/MEG.0b013e328317f4ef; Marcucci G, 2014, J CLIN ONCOL, V32, P548, DOI 10.1200/JCO.2013.50.6337; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Okamoto K, 2010, INT J ONCOL, V37, P1251, DOI 10.3892/ijo_00000776; Ozer B, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S12-S7; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; QIAGEN, 2016, QIAGEN ONC TUM SUPPR; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roy I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090400; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Soares MJ, 2009, MODERN PATHOL, V22, P744, DOI 10.1038/modpathol.2009.43; Stuver SO, 2000, INT J CANCER, V87, P118, DOI 10.1002/1097-0215(20000701)87:1<118::AID-IJC17>3.0.CO;2-W; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taccaliti A, 2011, CURR GENOMICS, V12, P618, DOI 10.2174/138920211798120835; TADA M, 1992, CANCER, V69, P1115; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wan J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1271-4; Wang Yun, 2005, Sheng Li Ke Xue Jin Zhan, V36, P71; Wei JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9699; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yoo S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004898; Yoshiji H, 2011, CURR CANCER DRUG TAR, V11, P431, DOI 10.2174/156800911795538084; Zhao M, 2016, NUCLEIC ACIDS RES, V44, pD1023, DOI 10.1093/nar/gkv1268	81	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171694	10.1371/journal.pone.0171694	http://dx.doi.org/10.1371/journal.pone.0171694			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178311	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500060
J	Roesch, LFW; Silveira, RC; Corso, AL; Dobbler, PT; Mai, V; Rojas, BS; Laureano, AM; Procianoy, RS				Wurdig Roesch, Luiz Fernando; Silveira, Rita C.; Corso, Andrea L.; Dobbler, Priscila Thiago; Mai, Volker; Rojas, Bruna S.; Laureano, Alvaro M.; Procianoy, Renato S.			Diversity and composition of vaginal microbiota of pregnant women at risk for transmitting Group B Streptococcus treated with intrapartum penicillin	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIA; STABILITY	Background Administering intravenous antibiotics during labor to women at risk for transmitting Group B Streptococcus (GBS) can prevent infections in newborns. However, the impact of intrapartum antibiotic prophylaxis on mothers' microbial community composition is largely unknown. We compared vaginal microbial composition in pregnant women experiencing preterm birth at <= 32 weeks gestation that received intrapartum antibiotic prophylaxis with that in controls. Methods Microbiota in vaginal swabs collected shortly before delivery from GBS positive women that received penicillin intravenously during labor or after premature rupture of membranes was compared to controls. Microbiota was analyzed by 16S rRNA sequencing using the PGM Ion Torrent to determine the effects of penicillin use during hospitalization and GBS status on its composition. Results Penicillin administration was associated with an altered vaginal microbial community composition characterized by increased microbial diversity. Lactobacillus sp. contributed only 13.1% of the total community in the women that received penicillin compared to 88.1% in the controls. Streptococcus sp. were present in higher abundance in GBS positive woman compared to controls, with 60% of the total vaginal microbiota in severe cases identified as Streptococcus sp. Conclusions Vaginal communities of healthy pregnant women were dominated by Lactobacillus sp. and contained low diversity, while Group B Streptococcus positive women receiving intrapartum antibiotic prophylaxis had a modified vaginal microbiota composition with low abundance of Lactobacillus but higher microbial diversity.	[Wurdig Roesch, Luiz Fernando; Dobbler, Priscila Thiago; Laureano, Alvaro M.] Univ Fed Pampa, Ctr Interdisciplinar Pesquisas Biotecnol CIP Biot, Campus Sao Gabriel, Sao Gabriel, RS, Brazil; [Silveira, Rita C.; Corso, Andrea L.; Rojas, Bruna S.; Procianoy, Renato S.] Univ Fed Rio Grande do Sul, Unidade Neonatol, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Mai, Volker] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL USA; [Mai, Volker] Univ Florida, Coll Med, Emerging Pathogens Inst, Gainesville, FL USA	Universidade Federal do Pampa; Universidade Federal do Rio Grande do Sul; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Procianoy, RS (corresponding author), Univ Fed Rio Grande do Sul, Unidade Neonatol, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.	rprocianoy@gmail.com	Dobbler, Priscila Caroline Thiago/E-4387-2018; Roesch, Luiz/GRS-4638-2022; Roesch, Luiz F W/D-2838-2009; Procianoy, Renato/I-5133-2014	Dobbler, Priscila Caroline Thiago/0000-0002-7681-5463; Roesch, Luiz F W/0000-0003-1450-8828; Procianoy, Renato/0000-0001-8297-4164; Laureano, Alvaro/0000-0001-5455-3709; Corso, Andrea Lucia/0000-0003-1118-1145; SILVEIRA, RITA DE CASSIA/0000-0002-2982-2652	Bill and Melinda Gates Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologio (CNPQ); DECIT/Ministerio da Saude do Brasil [401596/2013-3]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Conselho Nacional de Desenvolvimento Cientifico e Tecnologio (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); DECIT/Ministerio da Saude do Brasil	This work was supported by a grant from Bill and Melinda Gates Foundation, Conselho Nacional de Desenvolvimento Cientifico e Tecnologio (CNPQ) and DECIT/Ministerio da Saude do Brasil, Grant number 401596/2013-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; Boskey ER, 2001, HUM REPROD, V16, P1809, DOI 10.1093/humrep/16.9.1809; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2012, ISME J, V6, P1089, DOI 10.1038/ismej.2011.162; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; GARDNER SE, 1979, AM J OBSTET GYNECOL, V135, P1062, DOI 10.1016/0002-9378(79)90737-3; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; HernuYndez-Rodruiguez C., 2011, INFECT DIS OBSTET GY, V2011, P1, DOI 10.1155/2011/851485; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; Li LW, 2016, SCI REP-UK, V6, DOI 10.1038/srep31448; MacIntyre DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08988; Mayer BT, 2015, J INFECT DIS, V212, P793, DOI 10.1093/infdis/jiv079; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Nuriel-Ohayon M, 2016, FRONT MICROBIOL, P7; Oksanen J., 2016, R PACKAG; Pybus V, 1999, MICROBES INFECT, V1, P285, DOI 10.1016/S1286-4579(99)80024-0; Pylro VS, 2014, J MICROBIOL METH, V107, P30, DOI 10.1016/j.mimet.2014.08.018; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sleator RD, 2010, MED HYPOTHESES, V74, P214, DOI 10.1016/j.mehy.2009.08.047; Sobel, 1999, CURR INFECT DIS REP, V1, P379, DOI DOI 10.1007/S11908-999-0045-Z; Stokholm J, 2014, CLIN MICROBIOL INFEC, V20, P629, DOI 10.1111/1469-0691.12411; Stoll BJ, 2005, PEDIATR INFECT DIS J, V24, P635, DOI 10.1097/01.inf.0000168749.82105.64; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116	36	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0169916	10.1371/journal.pone.0169916	http://dx.doi.org/10.1371/journal.pone.0169916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178310	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500004
J	Weitsman, G; Mitchell, NJ; Evans, R; Cheung, A; Kalber, TL; Bofinger, R; Fruhwirth, GO; Keppler, M; Wright, ZVF; Barber, PR; Gordon, P; de Koning, T; Wulaningsih, W; Sander, K; Vojnovic, B; Ameer-Beg, S; Lythgoe, M; Arnold, JN; Arstad, E; Festy, F; Hailes, HC; Tabor, AB; Ng, T				Weitsman, G.; Mitchell, N. J.; Evans, R.; Cheung, A.; Kalber, T. L.; Bofinger, R.; Fruhwirth, G. O.; Keppler, M.; Wright, Z. V. F.; Barber, P. R.; Gordon, P.; de Koning, T.; Wulaningsih, W.; Sander, K.; Vojnovic, B.; Ameer-Beg, S.; Lythgoe, M.; Arnold, J. N.; Arstad, E.; Festy, F.; Hailes, H. C.; Tabor, A. B.; Ng, T.			Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; NEGATIVE BREAST-CANCER; TUMOR-CELL MIGRATION; PHASE-II TRIAL; COLORECTAL-CANCER; PEPTIDE LIGAND; DELIVERY; MACROPHAGES; PHOSPHORYLATION; QUANTIFICATION	Despite decades of research in the epidermal growth factor receptor (EGFR) signalling field, and many targeted anti-cancer drugs that have been tested clinically, the success rate for these agents in the clinic is low, particularly in terms of the improvement of overall survival. Intratumoral heterogeneity is proposed as a major mechanism underlying treatment failure of these moleculetargeted agents. Here we highlight the application of fluorescence lifetime microscopy (FLIM)-based biosensing to demonstrate intratumoral heterogeneity of EGFR activity. For sensing EGFR activity in cells, we used a genetically encoded CrkII-based biosensor which undergoes conformational changes upon tyrosine-221 phosphorylation by EGFR. We transfected this biosensor into EGFR-positive tumour cells using targeted lipopolyplexes bearing EGFR-binding peptides at their surfaces. In a murine model of basal-like breast cancer, we demonstrated a significant degree of intratumoral heterogeneity in EGFR activity, as well as the pharmacodynamic effect of a radionuclide-labeled EGFR inhibitor in situ. Furthermore, a significant correlation between high EGFR activity in tumour cells and macrophage-tumour cell proximity was found to in part account for the intratumoral heterogeneity in EGFR activity observed. The same effect of macrophage infiltrate on EGFR activation was also seen in a colorectal cancer xenograft. In contrast, a non-small cell lung cancer xenograft expressing a constitutively active EGFR conformational mutant exhibited macrophage proximity-independent EGFR activity. Our study validates the use of this methodology to monitor therapeutic response in terms of EGFR activity. In addition, we found iNOS gene induction in macrophages that are cultured in tumour cell-conditioned media as well as an iNOS activity-dependent increase in EGFR activity in tumour cells. These findings point towards an immune microenvironment-mediated regulation that gives rise to the observed intratumoral heterogeneity of EGFR signalling activity in tumour cells in vivo.	[Weitsman, G.; Evans, R.; Cheung, A.; Fruhwirth, G. O.; Keppler, M.; Ameer-Beg, S.; Ng, T.] Kings Coll London, Randall Div, Richard Dimbleby Dept Canc Res, Rm 232D,New Hunts House,Guys Med Sch Campus, London SE1 1UL, Greater London, England; [Weitsman, G.; Evans, R.; Cheung, A.; Fruhwirth, G. O.; Keppler, M.; de Koning, T.; Ameer-Beg, S.; Arnold, J. N.; Ng, T.] Kings Coll London, Div Canc Studies, Rm 232D,New Hunts House,Guys Med Sch Campus, London SE1 1UL, Greater London, England; [Mitchell, N. J.; Bofinger, R.; Wright, Z. V. F.; Hailes, H. C.; Tabor, A. B.] UCL, Dept Chem, London WC1H 0AJ, Greater London, England; [Cheung, A.; Gordon, P.; Ng, T.] Kings Coll London, Breast Canc Now Res Unit, London, England; [Kalber, T. L.; Lythgoe, M.] UCL, Div Med, UCL Ctr Adv Biomed Imaging, London, England; [Barber, P. R.; Vojnovic, B.] Canc Res UK, Dept Oncol, Gray Labs, London, England; [Barber, P. R.; Vojnovic, B.] MRC, Oxford Inst Radiat Oncol, Oxford, England; [Wulaningsih, W.] Kings Coll London, Div Canc Studies, Canc Epidemiol Grp, London, England; [Sander, K.; Arstad, E.] UCL, Inst Nucl Med, London, England; [Festy, F.] Kings Coll London, Dent Inst, Tissue Engn & Biophoton, Guys Hosp Campus, London, England; [Ng, T.] UCL, UCL Canc Inst, Paul Ogorman Bldg, London, England; [Fruhwirth, G. O.] Kings Coll London, St Thomas Hosp, Div Imaging Sci & Biomed Engn, Dept Imaging Chem & Biol, London SE1 7EH, England; [Mitchell, N. J.] Univ Nottingham, Sch Chem, Univ Pk, Nottingham NG7 2RD, England	University of London; King's College London; University of London; King's College London; University of London; University College London; University of London; King's College London; University of London; University College London; Cancer Research UK; University of Oxford; University of London; King's College London; University of London; University College London; University of London; King's College London; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Nottingham	Ng, T (corresponding author), Kings Coll London, Randall Div, Richard Dimbleby Dept Canc Res, Rm 232D,New Hunts House,Guys Med Sch Campus, London SE1 1UL, Greater London, England.; Ng, T (corresponding author), Kings Coll London, Div Canc Studies, Rm 232D,New Hunts House,Guys Med Sch Campus, London SE1 1UL, Greater London, England.; Tabor, AB (corresponding author), UCL, Dept Chem, London WC1H 0AJ, Greater London, England.	a.b.tabor@ucl.ac.uk; tony.ng@kcl.ac.uk	Arnold, James/ABE-3900-2021; Mitchell, Nicholas/N-7555-2015; Evans, Rachel/GYU-7083-2022; Vojnovic, Borivoj/AAV-4756-2021; Fruhwirth, Gilbert/AAP-5559-2021	Arnold, James/0000-0002-6949-0613; Mitchell, Nicholas/0000-0002-9041-1852; Vojnovic, Borivoj/0000-0001-9013-3816; Fruhwirth, Gilbert/0000-0002-1438-2674; Kalber, Tammy/0000-0002-3378-3748; Evans, Rachel/0000-0002-3723-2249; Hailes, Helen/0000-0001-5574-4742; Bofinger, Robin/0000-0002-3866-1301; Arstad, Erik/0000-0002-3240-2106; Ng, Tony/0000-0003-3894-5619; Lythgoe, Mark/0000-0002-4945-0171; Ameer-Beg, Simon/0000-0001-5227-575X	Cancer Research-UK [C1519/A6906, C5255/A15935]; King's College London-UCL Comprehensive Cancer Imaging Centre (CRUK EPSRC); EU; EC GRANT [259881]; The European Research Council [335326]; National Institute of Health Research (NIHR) Biomedical Research Centre; St Thomas' NHS Foundation Trust; King's College London; Cancer Research UK [15677, 16463, 21840] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/L006472/1] Funding Source: researchfish; EPSRC [EP/L006472/1] Funding Source: UKRI	Cancer Research-UK(Cancer Research UK); King's College London-UCL Comprehensive Cancer Imaging Centre (CRUK EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU(European Commission); EC GRANT; The European Research Council(European Research Council (ERC)); National Institute of Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); St Thomas' NHS Foundation Trust; King's College London(General Electric); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Cancer Research-UK (grants C1519/A6906 and C5255/A15935); the King's College London-UCL Comprehensive Cancer Imaging Centre (CRUK & EPSRC) and in association with the MRC and DoH; by the EU FP7 grants IMAGINT (EC GRANT: 259881); by The European Research Council (335326). National Institute of Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London.	Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375; Barber PR, 2009, J R SOC INTERFACE, V6, pS93, DOI 10.1098/rsif.2008.0451.focus; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Carey LA, 2012, J CLIN ONCOL, V30, P2615, DOI 10.1200/JCO.2010.34.5579; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dickler MN, 2008, CLIN CANCER RES, V14, P7878, DOI 10.1158/1078-0432.CCR-08-0141; Fan QM, 2014, CANCER LETT, V352, P160, DOI 10.1016/j.canlet.2014.05.008; Fan YS, 2013, GENET TEST MOL BIOMA, V17, P515, DOI 10.1089/gtmb.2012.0510; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Fruhwirth GO, 2014, J NUCL MED, V55, P686, DOI 10.2967/jnumed.113.127480; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Grosse SM, 2010, FASEB J, V24, P2301, DOI 10.1096/fj.09-144220; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Hurley CA, 2004, J ORG CHEM, V69, P980, DOI 10.1021/jo035422g; Hurley CA, 2008, ORG BIOMOL CHEM, V6, P2554, DOI 10.1039/b719702k; Irshad S, 2011, CURR OPIN ONCOL, V23, P566, DOI 10.1097/CCO.0b013e32834bf8ae; Kasic T, 2011, EUR J IMMUNOL, V41, P1843, DOI 10.1002/eji.201040868; Keese M, 2005, J BIOL CHEM, V280, P27826, DOI 10.1074/jbc.M504485200; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kudsiova L, 2011, MOL PHARMACEUT, V8, P1831, DOI 10.1021/mp2001796; Kullberg M, 2013, J CONTROL RELEASE, V172, P730, DOI 10.1016/j.jconrel.2013.08.300; Kurokawa K, 2001, J BIOL CHEM, V276, P31305, DOI 10.1074/jbc.M104341200; Li ZH, 2005, FASEB J, V19, P1978, DOI 10.1096/fj.05-4058com; Mantovani A, 2015, J EXP MED, V212, P435, DOI 10.1084/jem.20150295; Medina OP, 2011, J CONTROL RELEASE, V149, P292, DOI 10.1016/j.jconrel.2010.10.024; Mickler FM, 2012, NANO LETT, V12, P3417, DOI 10.1021/nl300395q; Mitchell N, 2013, BIOMATERIALS, V34, P1179, DOI 10.1016/j.biomaterials.2012.09.070; Modi S, 2006, CLIN BREAST CANCER, V7, P270, DOI 10.3816/CBC.2006.n.040; Molon B, 2011, J EXP MED, V208, P1949, DOI 10.1084/jem.20101956; Mustapa MFM, 2007, BIOCHEMISTRY-US, V46, P12930, DOI 10.1021/bi701014y; Mustapa MFM, 2009, BIOCONJUGATE CHEM, V20, P518, DOI 10.1021/bc800450r; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Nobis M, 2013, CANCER RES, V73, P4674, DOI 10.1158/0008-5472.CAN-12-4545; Nuciforo P, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0561-8; Ongarora BG, 2012, J MED CHEM, V55, P3725, DOI 10.1021/jm201544y; Oppenheim DE, 2014, BRIT J CANCER, V110, P1221, DOI 10.1038/bjc.2014.35; Pal A, 2006, MOL IMAGING BIOL, V8, P262, DOI 10.1007/s11307-006-0049-0; Park SY, 2010, INT J PHARMACEUT, V383, P178, DOI 10.1016/j.ijpharm.2009.08.039; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Pietras K, 2002, CANCER RES, V62, P5476; Pietras K, 2001, CANCER RES, V61, P2929; Prabhakar U, 2013, CANCER RES, V73, P2412, DOI 10.1158/0008-5472.CAN-12-4561; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Song SX, 2009, FASEB J, V23, P1396, DOI 10.1096/fj.08-117002; Switzer CH, 2012, MOL CANCER RES, V10, P1203, DOI 10.1158/1541-7786.MCR-12-0124; Tagawa T, 2002, GENE THER, V9, P564, DOI 10.1038/sj.gt.3301686; de Ilarduya CT, 2010, EUR J PHARM SCI, V40, P159, DOI 10.1016/j.ejps.2010.03.019; Wang AZ, 2008, CHEMMEDCHEM, V3, P1311, DOI 10.1002/cmdc.200800091; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823	56	10	11	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 22	2017	36	25					3618	3628		10.1038/onc.2016.522	http://dx.doi.org/10.1038/onc.2016.522			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY3NL	28166195	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-26	WOS:000403878600011
J	Val-Laillet, D; Besson, M; Guerin, S; Coquery, N; Randuineau, G; Kanzari, A; Quesnel, H; Bonhomme, N; Bolhuis, JE; Kemp, B; Blat, S; Le Huerou-Luron, I; Clouard, C				Val-Laillet, David; Besson, Marie; Guerin, Sylvie; Coquery, Nicolas; Randuineau, Gwenaelle; Kanzari, Ameni; Quesnel, Helene; Bonhomme, Nathalie; Bolhuis, J. Elizabeth; Kemp, Bas; Blat, Sophie; Le Huerou-Luron, Isabelle; Clouard, Caroline			A maternal Western diet during gestation and lactation modifies offspring's microbiota activity, blood lipid levels, cognitive responses, and hippocampal neurogenesis in Yucatan pigs	FASEB JOURNAL			English	Article						early nutrition; development; eating behavior; metabolism; brain	GUT-BRAIN AXIS; HIGH-FAT DIET; BIRTH-WEIGHT PIGLETS; DISCRIMINATION TASK; FOOD PREFERENCES; SUS-SCROFA; OBESITY; PERFORMANCE; LIFE; HOLEBOARD	A suboptimal early nutritional environment (i.e., excess of energy, sugar, and fat intake) can increase susceptibility to diseases and neurocognitive disorders. The purpose of this study was to investigate in nonobese Yucatan minipigs (Sus scrofa) the impact of maternal diet [standard diet (SD) vs. Western diet (WD)] during gestation and 25 d of lactation on milk composition, blood metabolism, and microbiota activity of sows (n = 17) and their piglets (n= 65), andonspatial cognition(n= 51), hippocampal plasticity(n= 17), and food preferences/motivation(n= 51) in the progeny. Milk dry matter and lipid content, as well as plasma total cholesterol and free fatty acid (FFA) concentrations (P < 0.05) were higher in WD than in SD sows. Microbiota activity decreased in both WD sows and 100-d-old piglets (P < 0.05 or P < 0.10, depending on short-chain FAs [SCFAs]). At weaning [postnatal day (PND) 25], WD piglets had increased blood triglyceride and FFA levels (P<0.01). Both SD and WD piglets consumed more of a known SD than an unknown high-fat and -sucrose (HFS) diet (P < 0.0001), but were quicker to obtain HFS rewards compared with SD rewards (P < 0.01). WD piglets had higher working memory (P = 0.015) and reference memory (P< 0.001) scores, which may reflect better cognitive abilities in the task context and a higher motivation for the food rewards. WD piglets had a smaller hippocampal granular cell layer (P=0.03) and decreased neurogenesis (P< 0.005), but increased cell proliferation (P < 0.001). A maternal WD during gestation and lactation, even in the absence of obesity, has significant consequences for piglets' blood lipid levels, microbiota activity, gut-brain axis, and neurocognitive abilities after weaning.-Val-Laillet, D., Besson, M., Guerin, S., Coquery, N., Randuineau, G., Kanzari, A., Quesnel, H., Bonhomme, N., Bolhuis, J. E., Kemp, B., Blat, S., Le Huerou-Luron, I., Clouard, C. A maternal Western diet during gestation and lactation modifies offspring's microbiota activity, blood lipid levels, cognitive responses, and hippocampal neurogenesis in Yucatan pigs.	[Val-Laillet, David; Besson, Marie; Guerin, Sylvie; Coquery, Nicolas; Randuineau, Gwenaelle; Kanzari, Ameni; Blat, Sophie; Le Huerou-Luron, Isabelle] INRA, Unite Rech 1341, Alimentat & Adaptat Digest Nerveuses & Comporteme, St Gilles, France; [Quesnel, Helene; Bonhomme, Nathalie] INRA, PEGASE, UMR 1348, St Gilles, France; [Quesnel, Helene; Bonhomme, Nathalie] Agrocampus Ouest, UMR PEGASE 1348, Rennes, France; [Bolhuis, J. Elizabeth; Kemp, Bas; Clouard, Caroline] Wageningen Univ Res, Dept Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands	INRAE; INRAE; Institut Agro; Agrocampus Ouest; Wageningen University & Research	Val-Laillet, D (corresponding author), INRA, UR ADNC 1341, F-35590 St Gilles, France.	david.val-laillet@inra.fr	coquery, nicolas/N-9206-2019; Val-Laillet, David/B-4328-2008; coquery, nicolas/GQP-5662-2022; Clouard, Caroline/K-1255-2014; VAL-LAILLET, David/AAH-6454-2021	coquery, nicolas/0000-0002-4687-5924; Val-Laillet, David/0000-0002-6256-7737; coquery, nicolas/0000-0002-4687-5924; Clouard, Caroline/0000-0002-5562-6057; Luron, Isabelle/0000-0002-1769-5246	INRA Diet Impact and Determinants: Interactions and Transitions (DID'IT) Metaprogramme; University of Tunis (Tunis, Tunisia)	INRA Diet Impact and Determinants: Interactions and Transitions (DID'IT) Metaprogramme; University of Tunis (Tunis, Tunisia)	The authors thank Walter Gerrits (Animal Nutrition Group, Wageningen University) and Franz Josef van der Staay (Department of Farm Animal Health, Utrecht University, the Netherlands) for valuable methodological suggestions. The authors also thank the efforts and cooperation of the technical staff at Institut National de la Recherche Agronomique (INRA), St Gilles, and especially Isabelle Nogret, Veronique Rome, Thibaud Le Mouel, Eric Bobillier, Armel Delalande, Mickael Genissel, Julien Georges, Regis Janvier, Alain Chauvin, Francis Le Gouevec, and Vincent Piedvache in conducting laboratory analyses and taking care of the animals, and Coraline Ladoues for her investment in the brain immunohistochemistry work. This study was funded by the INRA Diet Impact and Determinants: Interactions and Transitions (DID'IT) Metaprogramme in the context of the SweetLipKid project coordinated by Sophie Nicklaus. A. K. received a grant from the University of Tunis (Tunis, Tunisia). The authors declare no conflicts of interest.	Albuquerque KT, 2006, NUTRITION, V22, P820, DOI 10.1016/j.nut.2006.04.009; Antonides A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00291; Antonides A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00043; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2001, BRIT MED BULL, V60, P69, DOI 10.1093/bmb/60.1.69; Bienenstock J, 2015, NUTR REV, V73, P28, DOI 10.1093/nutrit/nuv019; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Bolhuis JE, 2013, ANIM COGN, V16, P845, DOI 10.1007/s10071-013-0646-7; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Clouard C, 2012, ANIMAL, V6, P118, DOI 10.1017/S1751731111001315; Clouard C, 2016, FASEB J, V30, P2466, DOI 10.1096/fj.201500208R; Clouard C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154698; De Jonge FH, 2008, APPL ANIM BEHAV SCI, V114, P93, DOI 10.1016/j.applanim.2008.01.004; Du Y, 2012, GENE DEV, V26, P1306, DOI 10.1101/gad.191031.112; Dyer JS, 2011, SEMIN REPROD MED, V29, P266, DOI 10.1055/s-0031-1275521; Farr S, 2016, CURR OPIN LIPIDOL, V27, P1, DOI 10.1097/MOL.0000000000000254; Galley JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113026; Gareau MG, 2014, ADV EXP MED BIOL, V817, P357, DOI 10.1007/978-1-4939-0897-4_16; Gieling ET, 2012, PEDIATR RES, V71, P71, DOI 10.1038/pr.2011.5; Haagensen AMJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079429; Haggarty P., PLACENTA SA, V23, pS28; Helrich K., 1990, ASS OFFICIAL ANAL CH; Hermans MP, 1999, DIABETES, V48, P1779, DOI 10.2337/diabetes.48.9.1779; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kornum BR, 2011, NEUROSCI BIOBEHAV R, V35, P437, DOI 10.1016/j.neubiorev.2010.05.004; Le Bourgot C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107508; McGuire W, 2010, SEMIN FETAL NEONAT M, V15, P108, DOI 10.1016/j.siny.2009.09.005; Monk C, 2013, J CHILD PSYCHOL PSYC, V54, P115, DOI 10.1111/jcpp.12000; Murphy E, 2013, APPL ANIM BEHAV SCI, V148, P64, DOI 10.1016/j.applanim.2013.07.011; Myles IA, 2013, J IMMUNOL, V191, P3200, DOI 10.4049/jimmunol.1301057; Naef L, 2011, NEUROSCIENCE, V176, P225, DOI 10.1016/j.neuroscience.2010.12.037; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; Ochoa M, 2015, EUR J NUTR, V54, P1, DOI 10.1007/s00394-014-0776-y; Ong ZY, 2014, ACTA PHYSIOL, V210, P127, DOI 10.1111/apha.12132; Patten AR, 2013, NEUROSCIENCE, V254, P173, DOI 10.1016/j.neuroscience.2013.09.024; Peleg-Raibstein D, 2012, BEHAV BRAIN RES, V233, P398, DOI 10.1016/j.bbr.2012.05.027; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Sebert SP, 2005, INT J OBESITY, V29, P324, DOI 10.1038/sj.ijo.0802823; Sefcikova Z, 2011, PHYSIOL RES, V60, P337, DOI 10.33549/physiolres.931939; Sola-Oriol D, 2009, J ANIM SCI, V87, P571, DOI 10.2527/jas.2008-0951; Teegarden SL, 2009, NEUROSCIENCE, V162, P924, DOI 10.1016/j.neuroscience.2009.05.029; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; Val-Laillet D, 2010, BRIT J NUTR, V104, P1719, DOI 10.1017/S0007114510002667; Val-Laillet D, 2011, OBESITY, V19, P749, DOI 10.1038/oby.2010.292; Vallet JL, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-55; van der Staay FJ, 2012, NEUROSCI BIOBEHAV R, V36, P379, DOI 10.1016/j.neubiorev.2011.07.008; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Williams L, 2014, BBA-MOL BASIS DIS, V1842, P507, DOI 10.1016/j.bbadis.2013.07.006	51	50	51	0	43	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2037	2049		10.1096/fj.201601015R	http://dx.doi.org/10.1096/fj.201601015R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28167496				2022-12-26	WOS:000399195500024
J	Greer, JMH; Hamilton, C; McMullon, MEG; Riby, DM; Riby, LM				Greer, Joanna M. H.; Hamilton, Colin; McMullon, Mhairi E. G.; Riby, Deborah M.; Riby, Leigh M.			An event related potential study of ihibitory and attentional control in Williams syndrome adults	PLOS ONE			English	Article							AGE-RELATED-CHANGES; LONG-TERM-MEMORY; DOWN-SYNDROME; EXECUTIVE FUNCTIONS; RESPONSE-INHIBITION; GENETIC INFLUENCES; COGNITIVE CONTROL; STIMULUS NOVELTY; VISUAL-STIMULI; TASK	The primary aim of the current study was to employ event-related potentials (ERPs) methodology to disentangle the mechanisms related to inhibitory control in older adults with Williams syndrome (WS). Eleven older adults with WS (mean age 42), 16 typically developing adults (mean age 42) and 13 typically developing children (mean age 12) participated in the study. ERPs were recorded during a three-stimulus visual oddball task, during which participants were required to make a response to a rare target stimulus embedded in a train of frequent non-target stimuli. A task -irrelevant infrequent stimulus was also present at randomised intervals during the session. The P3a latency data response related to task -irrelevant stimulus processing was delayed in WS. In addition, the early perceptual N2 amplitude was attenuated. These data are indicative of compromised early monitoring of perceptual input, accompanied by appropriate orientation of responses to task -irrelevant stimuli. However, the P3a delay suggests inefficient evaluation of the task -irrelevant stimuli. These data are discussed in terms of deficits in the disengagement of attentional processes, and the regulation of monitoring processes required for successful inhibition.	[Greer, Joanna M. H.; Hamilton, Colin; McMullon, Mhairi E. G.; Riby, Leigh M.] Northumbria Univ, Dept Psychol, Newcastle Upon Tyne, Tyne & Wear, England; [Riby, Deborah M.] Univ Durham, Dept Psychol, Durham, England	Northumbria University; Durham University	Riby, LM (corresponding author), Northumbria Univ, Dept Psychol, Newcastle Upon Tyne, Tyne & Wear, England.	leigh.riby@northumbria.ac.uk	Riby, Deborah M/G-8474-2013	Riby, Deborah M/0000-0001-5747-8441	Psychology department at Northumbria University	Psychology department at Northumbria University	The research was conducted as part of a PhD thesis, therefore there was no source of external or internal funding apart from the student's travel expenses supplied by the Psychology department at Northumbria University.	Atkinson J, 2011, PROG BRAIN RES, V189, P261, DOI 10.1016/B978-0-444-53884-0.00029-4; Bachiller A, 2015, SCHIZOPHR RES, V169, P318, DOI 10.1016/j.schres.2015.09.028; Barron E., 2011, PSYCHOL SCI; Barry RJ, 2009, INT J PSYCHOPHYSIOL, V71, P124, DOI 10.1016/j.ijpsycho.2008.09.009; Brinkman MJR, 2007, CLIN NEUROPHYSIOL, V118, P1517, DOI 10.1016/j.clinph.2007.04.002; Brock J, 2007, DEV PSYCHOPATHOL, V19, P97, DOI 10.1017/S095457940707006X; Brown JH, 2003, NEUROPSYCHOLOGIA, V41, P1037, DOI 10.1016/S0028-3932(02)00299-3; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Chiang MC, 2007, NEUROIMAGE, V36, P1096, DOI 10.1016/j.neuroimage.2007.04.024; Clery H, 2013, PSYCHOPHYSIOLOGY, V50, P240, DOI 10.1111/psyp.12006; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Conroy MA, 2007, J PSYCHOPHYSIOL, V21, P22, DOI 10.1027/0269-8803.21.1.22; Cornish K, 2007, CORTEX, V43, P672, DOI 10.1016/S0010-9452(08)70497-0; Costanzo F, 2013, RES DEV DISABIL, V34, P1770, DOI 10.1016/j.ridd.2013.01.024; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Daffner KR, 2015, BIOL PSYCHOL; del Re EC, 2015, PSYCHIAT RES-NEUROIM, V231, P126, DOI 10.1016/j.pscychresns.2014.11.012; Donchin E., 1978, EVENT RELAT BRAIN PO, V349, P411; Dunn L. M., 1997, BRIT PICTURE VOCABUL; Escera C, 2001, EUR J NEUROSCI, V14, P877, DOI 10.1046/j.0953-816x.2001.01707.x; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Frigerio E, 2006, NEUROPSYCHOLOGIA, V44, P254, DOI 10.1016/j.neuropsychologia.2005.05.008; Goldstein A, 2002, PSYCHOPHYSIOLOGY, V39, P781, DOI 10.1017/S004857720201048X; Greer J, 2013, RES DEV DISABIL, V34, P4170, DOI 10.1016/j.ridd.2013.08.041; Grice SJ, 2001, NEUROREPORT, V12, P2697, DOI 10.1097/00001756-200108280-00021; Haas BW, 2009, J NEUROSCI, V29, P1132, DOI 10.1523/JNEUROSCI.5324-08.2009; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Hocking DR, 2013, DEVELOPMENTAL SCI, V16, P428, DOI 10.1111/desc.12042; Jarrold C, 2007, CORTEX, V43, P233, DOI 10.1016/S0010-9452(08)70478-7; Jarvinen-Pasley A, 2010, NEUROPSYCHOLOGIA, V48, P456, DOI 10.1016/j.neuropsychologia.2009.10.003; JOHNSON R, 1993, PSYCHOPHYSIOLOGY, V30, P90; Jones W, 2000, J COGNITIVE NEUROSCI, V12, P30, DOI 10.1162/089892900561968; Kahkonen S, 2002, CLIN NEUROPHYSIOL, V113, P1894, DOI 10.1016/S1388-2457(02)00305-X; Karmiloff-Smith A, 2013, Q J EXP PSYCHOL, V66, P1, DOI 10.1080/17470218.2012.744424; Key APF, 2011, J NEURODEV DISORD, V3, P28, DOI 10.1007/s11689-010-9064-1; Key AP, 2015, SOCIAL NEUROSCIENCE; Kim H, 2014, HUM BRAIN MAPP, V35, P2265, DOI 10.1002/hbm.22326; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kopp B, 2014, BRAIN COGNITION, V85, P209, DOI 10.1016/j.bandc.2013.12.008; Landau B, 2006, COGNITION, V100, P483, DOI 10.1016/j.cognition.2005.06.005; Lincoln A, 2002, NEUROCASE, V8, P226, DOI 10.1093/neucas/8.3.226; Little K, 2013, RES DEV DISABIL, V34, P959, DOI 10.1016/j.ridd.2012.11.020; Menghini D, 2010, J INTELL DISABIL RES, V54, P418, DOI 10.1111/j.1365-2788.2010.01287.x; Mervis CB, 2000, MENT RETARD DEV D R, V6, P148; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P380, DOI 10.1038/nrn1906; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P991, DOI 10.1038/nn1494; Mills DL, 2013, DEV NEUROPSYCHOL, V38, P613, DOI 10.1080/87565641.2013.825617; Mills DL, 2000, J COGNITIVE NEUROSCI, V12, P47, DOI 10.1162/089892900561977; Mobbs D, 2007, BIOL PSYCHIAT, V62, P256, DOI 10.1016/j.biopsych.2006.05.041; Morris CA, 2000, ANNU REV GENOM HUM G, V1, P461; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osborne A, 2016, RES PSYCHOL BEHAV SC, V4, P1, DOI DOI 10.12691/rpbs-4-1-1; Osborne Lucy R., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S146239940700035X; Osorio A, 2012, RES DEV DISABIL, V33, P1169, DOI 10.1016/j.ridd.2012.02.003; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Polich J, 2003, BRAIN TOPOGR, V15, P141, DOI 10.1023/A:1022637732495; Polich J., 2003, THEORETICAL OVERVIEW; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Porter MA, 2005, DEV NEUROPSYCHOL, V27, P275, DOI 10.1207/s15326942dn2702_5; Porter MA, 2007, NEUROPSYCHOLOGIA, V45, P2839, DOI 10.1016/j.neuropsychologia.2007.05.006; Reiss AL, 2004, J NEUROSCI, V24, P5009, DOI 10.1523/JNEUROSCI.5272-03.2004; Rhodes SM, 2011, J CLIN EXP NEUROPSYC, V33, P147, DOI 10.1080/13803395.2010.495057; Rhodes SM, 2010, NEUROPSYCHOLOGIA, V48, P1216, DOI 10.1016/j.neuropsychologia.2009.12.021; Riby DM, 2014, J INTELL DISABIL RES, V58, P572, DOI 10.1111/jir.12055; Riby DM, 2008, NEUROPSYCHOLOGIA, V46, P2855, DOI 10.1016/j.neuropsychologia.2008.05.003; Riby DM, 2011, J AUTISM DEV DISORD, V41, P1228, DOI 10.1007/s10803-010-1141-5; Riby LM, 2013, BRAIN COGNITION, V81, P215, DOI 10.1016/j.bandc.2012.10.011; Riby LM, 2013, EXPT PSYCHOL; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Scerif G, 2004, DEVELOPMENTAL SCI, V7, P116, DOI 10.1111/j.1467-7687.2004.00327.x; Searcy YM, 2004, AM J MENT RETARD, V109, P231, DOI 10.1352/0895-8017(2004)109<231:TRBAAI>2.0.CO;2; Segalowitz SJ, 2004, BRAIN COGNITION, V55, P116, DOI 10.1016/s0278-2626(03)00283-5; Sergeant J, 2000, NEUROSCI BIOBEHAV R, V24, P7, DOI 10.1016/S0149-7634(99)00060-3; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Smit DJA, 2007, TWIN RES HUM GENET, V10, P335, DOI 10.1375/twin.10.2.335; Smith AD, 2009, PERCEPTION, V38, P694, DOI 10.1068/p6050; Smith JL, 2008, CLIN NEUROPHYSIOL, V119, P704, DOI 10.1016/j.clinph.2007.11.042; Sokhadze E, 2009, APPL PSYCHOPHYS BIOF, V34, P37, DOI 10.1007/s10484-009-9074-5; St- Louis- Deschenes M, 2015, PEDIAT THERAPEUT, V5, P2161, DOI DOI 10.4172/2161-0665.1000238; Steiner GZ, 2013, PSYCHOPHYSIOLOGY, V50, P187, DOI 10.1111/j.1469-8986.2012.01491.x; Stige S, 2007, DEV NEUROPSYCHOL, V32, P563, DOI 10.1080/87565640701361096; Thomas KM, 1996, ELECTROEN CLIN NEURO, V98, P294, DOI 10.1016/0013-4694(95)00280-4; Van der Molen MJW, 2012, CLIN NEUROPHYSIOL, V123, P720, DOI 10.1016/j.clinph.2011.08.023; Velanova K, 2007, CEREB CORTEX, V17, P1033, DOI 10.1093/cercor/bhl013; Vicari S, 2005, DEV MED CHILD NEUROL, V47, P305, DOI 10.1017/S0012162205000599; Wetzel N, 2013, PSYCHOPHYSIOLOGY, V50, P920, DOI 10.1111/psyp.12072	87	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0170180	10.1371/journal.pone.0170180	http://dx.doi.org/10.1371/journal.pone.0170180			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187205	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000394244300005
J	Lin, SC; Wang, SY; Pasquale, LR; Singh, K; Lin, SC				Lin, Shuai-Chun; Wang, Sophia Y.; Pasquale, Louis R.; Singh, Kuldev; Lin, Shan C.			The relation between exercise and glaucoma in a South Korean population-based sample	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; OCULAR BLOOD-FLOW; OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; INTRAOCULAR-PRESSURE CHANGES; NUTRITION EXAMINATION SURVEY; PHYSICAL-ACTIVITY; OXIDATIVE STRESS; AUTONOMIC DYSFUNCTION; VARIABILITY ANALYSIS	Purpose To investigate the association between exercise and glaucoma in a South Korean population-based sample. Design Population-based, cross-sectional study. Participants A total of 11,246 subjects, 40 years and older who underwent health care assessment as part of the 2008-2011 Korean National Health and Nutrition Examination Survey. Methods Variables regarding the duration (total minutes per week), frequency (days per week), and intensity of exercise (vigorous, moderate exercise and walking) as well as glaucoma prevalence were ascertained for 11,246 survey participants. Demographic, comorbidity, and health-related behavior information was obtained via interview. Multivariable logistic regression analyses were performed to determine the association between the exercise-related parameters and odds of a glaucoma diagnosis. Main outcome measure(s) Glaucoma defined by International Society for Geographical and Epidemiological Ophthalmology criteria. Results Overall, 336 (2.7%) subjects met diagnostic criteria for glaucomatous disease. After adjustment for potential confounding variables, subjects engaged in vigorous exercise 7 days per week had higher odds of having glaucoma compared with those exercising 3 days per week (Odds Ratio [OR] 3.33, 95% confidence interval [Cl] 1.16-9.54). High intensity of exercise, as categorized by the guidelines of the American College of Sports Medicine (ACSM), was also associated with greater glaucoma prevalence compared with moderate intensity of exercise (OR 1.55, 95% Cl 1.03-2.33). There was no association between other exercise parameters including frequency of moderate exercise, walking, muscle strength exercise, flexibility training, or total minutes of exercise per week, and the prevalence of glaucoma. In sub-analyses stratifying by gender, the association between frequency of vigorous exercise 7 days per week and glaucoma diagnosis remained significant in men (OR 6.05, 95% Cl 1.67-21.94) but not in women (OR 0.96 95% Cl: 0.23-3.97). A U-shaped association between exercise intensity and glaucoma prevalence was noted in men (OR 1.71, 95% Cl 1.09-2.69 for low intensity versus moderate intensity; OR 2.19, 95% Cl 1.25-3.85 for high intensity versus moderate intensity). Conclusion In a South Korean population sample, daily vigorous exercise was associated with higher glaucoma prevalence. In addition, the intensity of exercise was positively associated with glaucoma diagnosis in men but not women.	[Lin, Shuai-Chun; Lin, Shan C.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Lin, Shuai-Chun] Natl Yang Ming Univ, Dept Med, Taipei, Taiwan; [Wang, Sophia Y.] Univ Michigan, Kellogg Eye Inst, Ann Arbor, MI 48109 USA; [Pasquale, Louis R.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Glaucoma Serv, Boston, MA USA; [Pasquale, Louis R.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA; [Singh, Kuldev] Stanford Univ, Dept Ophthalmol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; National Yang Ming Chiao Tung University; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Stanford University	Lin, SC (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	LinS@vision.ucsf.edu		Wang, Sophia/0000-0003-0916-9403	National Eye Institute P30 Core Grant For Vision Research; Man May See, Inc; Research to Prevent Blindness Unrestricted Grant; Harvard Glaucoma Center of Excellence;  [EY015473]	National Eye Institute P30 Core Grant For Vision Research; Man May See, Inc; Research to Prevent Blindness Unrestricted Grant(Research to Prevent Blindness (RPB)); Harvard Glaucoma Center of Excellence; 	This study was supported by the National Eye Institute P30 Core Grant For Vision Research (Dr. ShanC. Lin); by That Man May See, Inc (Dr. Shan C. Lin); by Research to Prevent Blindness Unrestricted Grant (Dr. Shan C. Lin); by the Harvard Glaucoma Center of Excellence and by EY015473 (Dr. Louis R. Pasquale).None of the sponsors or funding organizations had a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, orapproval of the manuscript; and decision to submit the manuscript for publication.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Anderson DR, 1999, SURV OPHTHALMOL, V43, pS5, DOI 10.1016/S0039-6257(99)00046-6; [Anonymous], 2010, ACSMS GUIDELINES EXE; ARMSTRONG RB, 1983, J APPL PHYSIOL, V54, P80, DOI 10.1152/jappl.1983.54.1.80; Baskaran M, 2006, OPHTHALMOLOGY, V113, P1327, DOI 10.1016/j.ophtha.2006.02.063; Bengtsson B, 2008, OPHTHALMOLOGY, V115, P2044, DOI 10.1016/j.ophtha.2008.05.031; Boltz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082351; Budenz DL, 2006, OPHTHALMOLOGY, V113, P2137, DOI 10.1016/j.ophtha.2006.06.022; Chon B, 2013, INVEST OPHTH VIS SCI, V54, P6570, DOI 10.1167/iovs.13-12173; Chrysostomou V., 2016, AGING CELL; Chrysostomou V, 2014, NEUROBIOL AGING, V35, P1722, DOI 10.1016/j.neurobiolaging.2014.01.019; CRUICKSHANKS KJ, 1995, OPHTHALMOLOGY, V102, P1177, DOI 10.1016/S0161-6420(95)30893-7; Dickerman RD, 1999, NEUROL RES, V21, P243, DOI 10.1080/01616412.1999.11740925; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Evans DW, 1999, BRIT J OPHTHALMOL, V83, P809, DOI 10.1136/bjo.83.7.809; Feke GT, 2008, OPHTHALMOLOGY, V115, P246, DOI 10.1016/j.ophtha.2007.04.055; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Fuchsjager-Mayrl G, 2004, INVEST OPHTH VIS SCI, V45, P834, DOI 10.1167/iovs.03-0461; Galambos P, 2006, OPHTHALMOLOGY, V113, P1832, DOI 10.1016/j.ophtha.2006.05.030; Gale J, 2009, SURV OPHTHALMOL, V54, P349, DOI 10.1016/j.survophthal.2009.02.005; GRUNWALD JE, 1984, OPHTHALMOLOGY, V91, P1690; Gugleta K, 2003, INVEST OPHTH VIS SCI, V44, P1573, DOI 10.1167/iovs.02-0521; HAYNES WL, 1992, OPHTHALMOLOGY, V99, P1096; Iester M, 2007, OPHTHALMOLOGICA, V221, P180, DOI 10.1159/000099298; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Kang HK, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002089; Khan JC, 2002, BRIT J OPHTHALMOL, V86, P1089, DOI 10.1136/bjo.86.10.1089; Kim YK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE.]; Knudtson MD, 2006, BRIT J OPHTHALMOL, V90, P1461, DOI 10.1136/bjo.2006.103796; KRISKA AM, 1991, J CLIN EPIDEMIOL, V44, P1207, DOI 10.1016/0895-4356(91)90153-Z; Kruk J, 2016, MINI-REV MED CHEM, V16, P241, DOI 10.2174/1389557516666151120114605; LANIGAN LP, 1989, EYE, V3, P39, DOI 10.1038/eye.1989.6; LANIGAN LP, 1988, EYE, V2, P412, DOI 10.1038/eye.1988.75; Lee HT, 2015, CORONARY ARTERY DIS, V26, P66, DOI 10.1097/MCA.0000000000000165; Lee SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148412; Lin SC, 2014, JAMA OPHTHALMOL, V132, P1414, DOI 10.1001/jamaophthalmol.2014.2876; Lovasik JV, 2003, INVEST OPHTH VIS SCI, V44, P2126, DOI 10.1167/iovs.02-0825; Moreno MC, 2004, FREE RADICAL BIO MED, V37, P803, DOI 10.1016/j.freeradbiomed.2004.06.001; Morgan AJ, 2007, BRIT J OPHTHALMOL, V91, P385, DOI 10.1136/bjo.2006.098574; Movaffaghy A, 1998, EXP EYE RES, V67, P561, DOI 10.1006/exer.1998.0556; Na KS, 2010, J GLAUCOMA, V19, P377, DOI 10.1097/IJG.0b013e3181c4ae58; Okuno T, 2006, EYE, V20, P796, DOI 10.1038/sj.eye.6702004; Okuno T, 2004, EYE, V18, P697, DOI 10.1038/sj.eye.6700749; PASSO MS, 1991, ARCH OPHTHALMOL-CHIC, V109, P1096, DOI 10.1001/archopht.1991.01080080056027; Pournaras CJ, 2004, EUR J OPHTHALMOL, V14, P226, DOI 10.1177/112067210401400307; Ramulu PY, 2012, OPHTHALMOLOGY, V119, P1159, DOI 10.1016/j.ophtha.2012.01.013; Riccadonna M, 2003, J GLAUCOMA, V12, P156, DOI 10.1097/00061198-200304000-00011; Risner D, 2009, J GLAUCOMA, V18, P429, DOI 10.1097/IJG.0b013e31818fa5f3; Riva CE, 1997, GRAEF ARCH CLIN EXP, V235, P618, DOI 10.1007/BF00946937; ROBINSON F, 1986, INVEST OPHTH VIS SCI, V27, P722; ROSEN DA, 1959, ARCH OPHTHALMOL-CHIC, V62, P810; Sacca SC, 2008, PROG BRAIN RES, V173, P385, DOI 10.1016/S0079-6123(08)01127-8; Schuman JS, 2000, OPHTHALMOLOGY, V107, P127, DOI 10.1016/S0161-6420(99)00015-9; Terry AL, 2010, OPHTHAL EPIDEMIOL, V17, P411, DOI 10.3109/09286586.2010.528575; Ulrich A, 1996, OPHTHALMIC SURG LAS, V27, P746; van Landingham SW, 2012, OPHTHALMOLOGY, V119, P2486, DOI 10.1016/j.ophtha.2012.06.034; Vieira GM, 2006, ARCH OPHTHALMOL-CHIC, V124, P1251, DOI 10.1001/archopht.124.9.1251; Wierzbowska J, 2012, BRIT J OPHTHALMOL, V96, P624, DOI 10.1136/bjophthalmol-2011-300945; Williams PT, 2009, MED SCI SPORT EXER, V41, P1566, DOI 10.1249/MSS.0b013e31819e420f; Yannuzzi LA, 1996, ARCH OPHTHALMOL-CHIC, V114, P545; Zanon-Moreno V, 2008, J GLAUCOMA, V17, P263, DOI 10.1097/IJG.0b013e31815c3a7f; Zeyen T, 2005, Bull Soc Belge Ophtalmol, P53; Zwierko T, 2010, EUR J OPHTHALMOL, V20, P381, DOI 10.1177/112067211002000219	64	15	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171441	10.1371/journal.pone.0171441	http://dx.doi.org/10.1371/journal.pone.0171441			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187143	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300023
J	Halvarsson, C; Eliasson, P; Jonsson, JI				Halvarsson, Camilla; Eliasson, Pernilla; Jonsson, Jan-Ingvar			Pyruvate dehydrogenase kinase 1 is essential for transplantable mouse bone marrow hematopoietic stem cell and progenitor function	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; HYPOXIC NICHE; MULTIPOTENT PROGENITORS; LINEAGE COMMITMENT; HIF-1-ALPHA; GROWTH; DIFFERENTIATION; IDENTIFICATION; ACTIVATION; ADAPTATION	Background Accumulating evidence suggests that hypoxic areas in the bone marrow are crucial for maintenance of hematopoietic stem cells (HSCs) by supporting a quiescent state of cell cycle and regulating the transplantation capacity of long-term (LT)-HSCs. In addition, HSCs seem to express a metabolic profile of energy production away from mitochondrial oxidative phosphorylation in favor of glycolysis. At oxygen deprivation, hypoxia inducible factor 1 alpha (HIF-1 alpha) is known to induce glycolytic enzymes as well as suppressing mitochondrial energy production by inducing pyruvate dehydrogenase kinase 1 (Pdk1) in most cell types. It has not been established whether PDK1 is essential for HSC function and mediates hypoxia-adapting functions in HSCs. While the Pdk gene family contains four members (Pdk1-4), it was recently shown that Pdk2 and Pdk4 have an important role in regulating LT-HSCs. Principle findings Here we demonstrate that PDK1 activity is crucial for transplantable HSC function. Whereas Pdkl, Pdk2, and Pdk3 transcripts were expressed at higher levels in different subtypes of HSCs compared to differentiated cells, we could not detect any major differences in expression between LT-HSCs and more short-term HSCs and multipotent progenitors. When studying HIF-1 alpha-mediated regulation of Pdk activity in vitro, Pdk1 was the most robust target regulated by hypoxia, whereas Pdk2, Pdk3, and Pdk4 were not affected. Contrary, genetic ablation in a cre-inducible Hif-1 alpha knockout mouse did not support a link between HIF-1 alpha and Pdk1. Silencing of Pdk1 by shRNA lentiviral gene transfer partially impaired progenitor colony formation in vitro and had a strong negative effect on both long-term and short-term engraftment in mice. Conclusions Our study demonstrates that PDK1 has broad effects in hematopoiesis and is a critical factor for engraftment of both HSCs and multipotent progenitors upon transplantation to recipient mice. While Pdk1 was a robust hypoxia-inducible gene mediated by HIF-1 alpha in vitro, we could not find evidence of any in vivo links between Pdk1 and HIF-1 alpha.	[Halvarsson, Camilla; Eliasson, Pernilla; Jonsson, Jan-Ingvar] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Halvarsson, Camilla; Jonsson, Jan-Ingvar] Linkoping Univ, Linkoping Integrat Regenerat Med Ctr, Linkoping, Sweden	Linkoping University; Linkoping University	Jonsson, JI (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.; Jonsson, JI (corresponding author), Linkoping Univ, Linkoping Integrat Regenerat Med Ctr, Linkoping, Sweden.	jan-ingvar.jonsson@liu.se		Jonsson, Jan-Ingvar/0000-0003-4814-978X	Swedish Research Council; Swedish Cancer Society; Swedish Childhood Cancer Foundation; County Council of Ostergotland; Faculty of Medicine at Linkoping University; Ollie and Elof Ericssons Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); County Council of Ostergotland; Faculty of Medicine at Linkoping University; Ollie and Elof Ericssons Foundation(Ericsson)	This work was supported by grants from: Swedish Research Council, http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html; Swedish Cancer Society, https://www.cancerfonden.se/om-cancerfonden/about-the-swedish-cancer-society; Swedish Childhood Cancer Foundation, https://www.barncancerfonden.se/in-english/; County Council of Ostergotland, http://www.regionostergotland.se/Forskning-och-innovation/Samverkan-kring-forskning/Organisation-och-beslutsvagar/FoU-gruppen/; Faculty of Medicine at Linkoping University, https://liu.se/medfak/?l=en; and Ollie and Elof Ericssons Foundation, http://oestiftelse.se/ansokan.html.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Boulais PE, 2015, BLOOD, V125, P2621, DOI 10.1182/blood-2014-09-570192; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Eliasson P, 2010, EXP HEMATOL, V38, P301, DOI 10.1016/j.exphem.2010.01.005; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Klimmeck D, 2012, MOL CELL PROTEOMICS, V11, P286, DOI 10.1074/mcp.M111.016790; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Kondo M, 2010, IMMUNOL REV, V238, P37, DOI 10.1111/j.1600-065X.2010.00963.x; Krock BL, 2015, BLOOD, V125, P3263, DOI 10.1182/blood-2014-10-607267; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Morikawa T, 2015, PFLUGERS ARCH EUROPE; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pedersen M, 2008, BIOCHEM BIOPH RES CO, V377, P98, DOI 10.1016/j.bbrc.2008.09.102; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376; Ryan HE, 2000, CANCER RES, V60, P4010; Shima H, 2009, BIOCHEM BIOPH RES CO, V378, P467, DOI 10.1016/j.bbrc.2008.11.056; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tang Y, 2012, EXP HEMATOL, V40, P879, DOI 10.1016/j.exphem.2012.07.005; Vukovic M, 2016, BLOOD, V127, P2841, DOI 10.1182/blood-2015-10-677138; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159	37	13	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171714	10.1371/journal.pone.0171714	http://dx.doi.org/10.1371/journal.pone.0171714			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182733	Green Submitted, gold, Green Published			2022-12-26	WOS:000394231800095
J	Lyon, A; Powers, AK; Gross, JB; O'Quin, KE				Lyon, Anastasia; Powers, Amanda K.; Gross, Joshua B.; O'Quin, Kelly E.			Two - three loci control scleral ossicle formation via epistasis in the cavefish Astyanax mexicanus	PLOS ONE			English	Article							BLIND CAVEFISH; REGRESSIVE EVOLUTION; SKELETAL ELEMENTS; EYE; FGF8; DEGENERATION; FOREBRAIN; SHH	The sclera is the protective outer layer of the eye. In fishes, birds, and reptiles, the sclera may be reinforced with additional bony elements called scleral ossicles. Teleost fish vary in the number and size of scleral ossicles; however, the genetic mechanisms responsible for this variation remain poorly understood. In this study, we examine the inheritance of scleral ossicles in the Mexican tetra, Astyanax mexicanus, which exhibits both a cave morph and a surface fish morph. As these morphs and their hybrids collectively exhibit zero, one, and two scleral ossicles, they represent a microcosm of teleost scleral ossicle diversity. Our previous research in F2 hybrids of cavefish from Pachon cave and surface fish from Texas suggested that three genes likely influence the formation of scleral ossicles in this group through an epistatic threshold model of inheritance, though our sample size was small. In this study, we expand our sample size using additional hybrids of Pachon cavefish and Mexican surface fish to (1) confirm the threshold model of inheritance, (2) refine the number of genes responsible for scleral ossicle formation, and (3) increase our power to detect quantitative trait loci (QTL) for this trait. To answer these three questions, we scored surface fish and cavefish F2 hybrids for the presence of zero, one, or two scleral ossicles. We then analyzed their distribution among the F2 hybrids using a chi-square (chi(2)) test, and used a genetic linkage map of over 100 microsatellite markers to identify QTL responsible for scleral ossicle number. We found that inheritance of scleral ossicles follows an epistatic threshold model of inheritance controlled by two genes, which contrasts the three-locus model estimated from our previous study. Finally, the combined analysis of hybrids from both crosses identified two strong QTL for scleral ossicle number on linkage groups 4.2 and 21, and a weaker QTL on linkage group 4.1. Scleral ossification remains a complex trait with limited knowledge of its genetic basis. This study provides new insight into the number and location of genes controlling the formation of scleral ossicles in a teleost fish species.	[Lyon, Anastasia; O'Quin, Kelly E.] Ctr Coll Danville, Biol Program, Danville, KY 40422 USA; [Powers, Amanda K.; Gross, Joshua B.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH USA	University System of Ohio; University of Cincinnati	O'Quin, KE (corresponding author), Ctr Coll Danville, Biol Program, Danville, KY 40422 USA.	koquin@umd.edu		Lyon, Anastasia/0000-0002-7365-4035	NIDCR NIH HHS [R01 DE025033] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025033] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABBOTT U. K., 1957, JOUR HEREDITY, V48, P63; Albertson RC, 2007, DEV BIOL, V306, P505, DOI 10.1016/j.ydbio.2007.03.025; Alunni A, 2007, J COMP NEUROL, V505, P221, DOI 10.1002/cne.21488; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Coghill LM, 2014, MOL PHYLOGENET EVOL, V79, P368, DOI 10.1016/j.ympev.2014.06.029; Duench K, 2012, DEV BIOL, V365, P251, DOI 10.1016/j.ydbio.2012.02.016; Dufton M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050308; Franklin T., 2007, JISC, P1; Franz-Odendaal TA, 2008, ANAT REC, V291, P161, DOI 10.1002/ar.20639; Franz-Odendaal TA, 2006, J MORPHOL, V267, P1326, DOI 10.1002/jmor.10479; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P1244, DOI 10.1002/dvdy.20718; Gross JB, 2014, GENETICS, V196, P1303, DOI 10.1534/genetics.114.161661; Gross JB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-105; Gross JB, 2008, P NATL ACAD SCI USA, V105, P20106, DOI 10.1073/pnas.0806238105; Hall B.K., 2015, BONES CARTILAGE DEV; Hanken J., 1981, Functional Photography, V16, P22; Jeffery WR, 2009, ANNU REV GENET, V43, P25, DOI 10.1146/annurev-genet-102108-134216; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; MITCHELL RW, 1977, SPEC PUBL MUS TEXAS, V12, P1; Mok HK, 2012, ZOOL STUD, V51, P1490; O'Quin K, 2016, BIOLOGY AND EVOLUTION OF THE MEXICAN CAVEFISH, P111, DOI 10.1016/B978-0-12-802148-4.00006-2; O'Quin KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142208; O'Quin KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057281; PALMOSKI MJ, 1970, J EXP ZOOL, V174, P157, DOI 10.1002/jez.1401740205; Pottin K, 2011, DEVELOPMENT, V138, P2467, DOI 10.1242/dev.054106; Protas M, 2007, CURR BIOL, V17, P452, DOI 10.1016/j.cub.2007.01.051; Schneider RA, 2001, DEVELOPMENT, V128, P2755; Smoak K. D, 1983, T AM MICROSCOPICAL S, P135; Wells KL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-257; Wilkens H, 1988, EVOL BIOL, V23, P367; Yamamoto Y, 2004, NATURE, V431, P844, DOI 10.1038/nature02864; Yamamoto Y, 2003, EVOL DEV, V5, P435, DOI 10.1046/j.1525-142X.2003.03050.x; Yoshizawa M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-108	33	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171061	10.1371/journal.pone.0171061	http://dx.doi.org/10.1371/journal.pone.0171061			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182695	Green Published, gold			2022-12-26	WOS:000394231800029
J	Mooney, R; Quinlan, LR; Corley, G; Godfrey, A; Osborough, C; Laighin, GO				Mooney, Robert; Quinlan, Leo R.; Corley, Gavin; Godfrey, Alan; Osborough, Conor; Laighin, Gearoid O.			Evaluation of the Finis Swimsense (R) and the Garmin Swim (TM) activity monitors for swimming performance and stroke kinematics analysis	PLOS ONE			English	Article							INTER-ARM COORDINATION; FRONT-CRAWL; ENERGY-COST; VELOCITY	Aims The study aims were to evaluate the validity of two commercially available swimming activity monitors for quantifying temporal and kinematic swimming variables. Methods Ten national level swimmers (5 male, 5 female; 15.3 +/- 1.3years; 164.8 +/- 12.9cm; 62.4 +/- 11.1kg; 425 +/- 66 FINA points) completed a set protocol comprising 1,500m of swimming involving all four competitive swimming strokes. Swimmers wore the Finis Swimsense and the Garmin Swim activity monitors throughout. The devices automatically identified stroke type, swim distance, lap time, stroke count, stroke rate, stroke length and average speed. Video recordings were also obtained and used as a criterion measure to evaluate performance. Results A significant positive correlation was found between the monitors and video for the identification of each of the four swim strokes (Garmin: X-2 (3) = 31.292, p<0.05; Finis:X-2 (3) = 33.004, p<0.05). No significant differences were found for swim distance measurements. Swimming laps performed in the middle of a swimming interval showed no significant difference from the criterion (Garmin: bias -0.065, 95% confidence intervals -3.828-6.920; Finis bias -0.02, 95% confidence intervals -3.095-3.142). However laps performed at the beginning and end of an interval were not as accurately timed. Additionally, a statistical difference was found for stroke count measurements in all but two occasions (p<0.05). These differences affect the accuracy of stroke rate, stroke length and average speed scores reported by the monitors, as all of these are derived from lap times and stroke counts. Conclusions Both monitors were found to operate with a relatively similar performance level and appear suited for recreational use. However, issues with feature detection accuracy may be related to individual variances in stroke technique. It is reasonable to expect that this level of error would increase when the devices are used by recreational swimmers rather than elite swimmers. Further development to improve accuracy of feature detection algorithms, specifically for lap time and stroke count, would also increase their suitability within competitive settings.	[Mooney, Robert; Corley, Gavin; Laighin, Gearoid O.] NUI Galway, Sch Engn & Informat, Elect & Elect Engn, Galway, Ireland; [Mooney, Robert; Corley, Gavin; Laighin, Gearoid O.] NUI Galway, Natl Ctr Biomed Engn Sci, Bioelect Res Cluster, Galway, Ireland; [Quinlan, Leo R.] NUI Galway, Sch Med, Physiol, Galway, Ireland; [Quinlan, Leo R.; Laighin, Gearoid O.] NUI Galway, CURAM, SFI Ctr Res Med Devices, Galway, Ireland; [Godfrey, Alan] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England; [Osborough, Conor] Manchester Metropolitan Univ, Dept Exercise & Sports Sci, Crewe, England	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Newcastle University - UK; Manchester Metropolitan University	Quinlan, LR (corresponding author), NUI Galway, Sch Med, Physiol, Galway, Ireland.; Quinlan, LR (corresponding author), NUI Galway, CURAM, SFI Ctr Res Med Devices, Galway, Ireland.	leo.quinlan@nuigalway.ie	ÓLaighin, Gearóid/A-5239-2009; Quinlan, Leo R/N-4117-2014	ÓLaighin, Gearóid/0000-0002-1885-814X; Quinlan, Leo R/0000-0002-4011-6732; Godfrey, Alan/0000-0003-4049-9291	Irish Research Council Enterprise Partnership Scheme; Swim Ireland [EPSPG\2012\361]	Irish Research Council Enterprise Partnership Scheme; Swim Ireland	This research is funded by the Irish Research Council Enterprise Partnership Scheme in conjunction with Swim Ireland (Grant award reference EPSPG\2012\361).	Anthony JJ, 2010, US Patent, Patent No. [US 20100210975A1, 20100210975]; Bachlin M, 2012, PERVASIVE MOB COMPUT, V8, P68, DOI 10.1016/j.pmcj.2011.05.003; Barden JM, 2011, J SPORT SCI, V29, P517, DOI 10.1080/02640414.2010.543912; Beanland E, 2014, J SCI MED SPORT, V17, P234, DOI 10.1016/j.jsams.2013.04.007; Brage S, 2003, MED SCI SPORT EXER, V35, P1447, DOI 10.1249/01.MSS.0000079078.62035.EC; Carstensen B., 2008, INT J BIOSTATISTICS, V4; Chollet D, 2004, INT J SPORTS MED, V25, P486, DOI 10.1055/s-2004-820943; CRAIG AB, 1985, MED SCI SPORT EXER, V17, P625, DOI 10.1249/00005768-198512000-00001; Crawford D, 2009, INDEPENDENT SPORT PA; Dadashi F, 2012, SENSORS-BASEL, V12, P12927, DOI 10.3390/s121012927; Davey N., 2008, SPORT TECHNOL, V1, P202, DOI [10.1080/19346182.2008.9648474, DOI 10.1002/JST.59]; East D. J., 1970, NZ J HLTH PHYS ED RE, V3, P16; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Figueiredo P, 2012, HUM MOVEMENT SCI, V31, P1200, DOI 10.1016/j.humov.2012.01.006; Finis, 2010, SWIMS PERF MON QUICK, P13; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Garmin, 2013, GARM SWIM OWN MAN, P6; Hellard P, 2008, J SPORT SCI, V26, P35, DOI 10.1080/02640410701332515; Kelly E, 2012, SWIMMING IRELAND STA; King GA, 2004, MED SCI SPORT EXER, V36, P1244, DOI 10.1249/01.MSS.0000132379.09364.F8; Komar J, 2012, HUM MOVEMENT SCI, V31, P620, DOI 10.1016/j.humov.2011.07.011; Maglischo E.W., 2003, SWIMMING FASTEST; Mooney R, 2015, J SPORTS SCI, V34, P1; Mooney R., 2015, SPORT EXERC MED OPEN, V1, P133, DOI [10.17140/SEMOJ-1-121, DOI 10.17140/SEMOJ-1-121]; Mooney R, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010018; Nikodelis T, 2005, J SPORT SCI, V23, P737, DOI 10.1080/02640410400021955; Oh DJ, 2015, J EXERC REHABIL, V11, P48, DOI 10.12965/jer.150185; Ohgi Y., 2003, SPORTS ENG, V6, P113, DOI [10.1007/BF02903532, DOI 10.1007/BF02903532]; Ohgi Y, 2014, PROCEDIA ENGINEER, V72, P829, DOI 10.1016/j.proeng.2014.06.036; Osborough CD, 2010, HUM MOVEMENT SCI, V29, P921, DOI 10.1016/j.humov.2010.05.009; Roy A, 2009, J BIOPHARM STAT, V19, P150, DOI 10.1080/10543400802535141; Schnitzler C, 2010, INT J SPORTS MED, V31, P875, DOI 10.1055/s-0030-1265149; Seifert L, 2004, J SPORT SCI, V22, P651, DOI 10.1080/02640410310001655787; Seifert L, 2010, HUM MOVEMENT SCI, V29, P103, DOI 10.1016/j.humov.2009.05.003; Seifert L, 2008, J STRENGTH COND RES, V22, P1670, DOI 10.1519/JSC.0b013e318182029d; Siirtola P., 2011, Proceedings 2011 IEEE Symposium on Computational Intelligence and Data Mining (CIDM 2011), P156, DOI 10.1109/CIDM.2011.5949430; Stamm A, 2013, SPORTS ENG, V16, P1, DOI 10.1007/s12283-012-0107-6; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Wilkerson DP, 2012, EUR J APPL PHYSIOL, V112, P4127, DOI 10.1007/s00421-012-2397-6; Zhao Q, 2009, J ELECTRON IMAGING, V18, DOI 10.1117/1.3247860	41	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170902	10.1371/journal.pone.0170902	http://dx.doi.org/10.1371/journal.pone.0170902			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178301	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000393712500017
J	Onywera, H; Maman, D; Inzaule, S; Auma, E; Were, K; Fredrick, H; Owiti, P; Opollo, V; Etard, JF; Mukui, I; Kim, AA; Zeh, C				Onywera, Harris; Maman, David; Inzaule, Seth; Auma, Erick; Were, Kennedy; Fredrick, Harrison; Owiti, Prestone; Opollo, Valarie; Etard, Jean-Francois; Mukui, Irene; Kim, Andrea A.; Zeh, Clement			Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naIve persons in rural western Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; GENETIC DIVERSITY; INDIVIDUALS; PREVALENCE; THERAPY; TRANSMISSION; MUTATIONS; TYPE-1; IMPACT; WOMEN	HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Saharan Africa with the rollout of antiretroviral (ARV) therapy. Such data are, however, limited in Kenya, where HIV-1 drug resistance testing is not routinely performed. From a population-based household survey conducted between September and November 2012 in rural western Kenya, we retrospectively assessed HIV-1 TDR baseline rates, its determinants, and genetic diversity among drug-na ve persons aged 15-59 years with acute HIV-1 infections (AHI) and recent HIV-1 infections (RHI) as determined by nucleic acid amplification test and both Limiting Antigen and BioRad avidity immunoassays, respectively. HIV-1 po/sequences were scored for drug resistance mutations using Stanford HIVdb and WHO 2009 mutation guidelines. HIV-1 subtyping was computed in MEGA6. Eighty seven (93.5%) of the eligible samples were successfully sequenced. Of these, 8 had at least one TDR mutation, resulting in a TDR prevalence of 9.2% (95% CI 4.7-17.1). No TDR was observed among persons with AHI (n = 7). TDR prevalence was 4.6% (95% CI 1.8-11.2) for nucleoside reverse transcriptase inhibitors (NRTIs), 6.9% (95% CI 3.2-14.2) for non- nucleoside reverse transcriptase inhibitors (NNRTIs), and 1.2% (95% CI 0.2-6.2) for protease inhibitors. Three (3.4% 95% CI 0.8-10.1) persons had dual-class NRTI/NNRTI resistance. Predominant TDR mutations in the reverse transcriptase included K103N/S (4.6%) and M184V (2.3%); only M461/L (1.1%) occurred in the protease. All the eight persons were predicted to have different grades of resistance to the ARV regimens, ranging from potential low-level to high-level resistance. HIV-1 subtype distribution was heterogeneous: A (57.5%), C (6.9%), D (21.8%), G (2.3%), and circulating recombinant forms (11.5%). Only low CD4 count was associated with TDR (p = 0.0145). Our findings warrant the need for enhanced HIV-1 TDR monitoring in order to inform on population-based therapeutic guidelines and public health interventions.	[Onywera, Harris; Inzaule, Seth; Auma, Erick; Were, Kennedy; Fredrick, Harrison; Owiti, Prestone; Opollo, Valarie] Kenya Med Res Inst KEMRI, CGHR, Kisumu, Kenya; [Maman, David] MSF, Epictr, Paris, France; [Etard, Jean-Francois] Univ Montpellier, TransVIHMI, IRD, UMI 233,INSERM,U 1175, Montpellier, France; [Mukui, Irene] Minist Hlth, Natl AIDS & STI Control Programme NASCOP, Nairobi, Kenya; [Kim, Andrea A.] US Ctr Dis Control & Prevent CDC, Nairobi, Kenya; [Zeh, Clement] US Ctr Dis Control & Prevent CDC, Kisumu, Kenya	Kenya Medical Research Institute; Doctors Without Borders; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Onywera, H (corresponding author), Kenya Med Res Inst KEMRI, CGHR, Kisumu, Kenya.; Zeh, C (corresponding author), US Ctr Dis Control & Prevent CDC, Kisumu, Kenya.	do79harris@gmail.com; cbz2@cdc.gov	Onywera, Harris/AAM-6198-2021; Etard, Jean-Francois/V-4865-2019; Mukui, Irene/GYE-0151-2022; Etard, Jean François/A-9630-2008	Onywera, Harris/0000-0002-7298-4921; Etard, Jean-Francois/0000-0002-4873-0788; Etard, Jean François/0000-0002-4873-0788; Maman, David/0000-0002-9839-3011; Mukui, Irene/0000-0002-3699-1841	Medecins Sans Frontieres (MSF)	Medecins Sans Frontieres (MSF)	This work was funded by the Medecins Sans Frontieres (MSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2011, AIDS, V25, P2183, DOI 10.1097/QAD.0b013e32834bbbe9; Atun R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001045; Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; Chan Philip A., 2009, HIV Therapy, V3, P447, DOI [10.2217/hiv.09.30, 10.2217/HIV.09.30]; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Fisher R, 2012, J VIROL, V86, P6231, DOI 10.1128/JVI.06541-11; Guha SK, 2012, MED UPDATE 2012, P84; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hamers RL, 2008, ANTIVIR THER, V13, P625; Hamers RL, 2013, CURR OPIN HIV AIDS, V8, P19, DOI 10.1097/COH.0b013e32835b7f94; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hassan AS, 2013, AIDS RES HUM RETROV, V29, P129, DOI [10.1089/aid.2012.0167, 10.1089/AID.2012.0167]; Hirsch MS, 2003, CLIN INFECT DIS, V37, P113, DOI 10.1086/375597; Hosseinipour MC, 2013, J INFECT DIS, V207, pS49, DOI 10.1093/infdis/jit107; Hurt CB, 2009, ANTIVIR THER, V14, P673; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Jain V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015510; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Lal RB, 2005, INDIAN J MED RES, V121, P287; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Lee GQ, 2014, AIDS RES HUM RETROV, V30, P896, DOI [10.1089/aid.2014.0043, 10.1089/AID.2014.0043]; Lihana RW, 2009, AIDS RES HUM RETROV, V25, P1211, DOI 10.1089/aid.2009.0007; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Longosz AF, 2014, AIDS RES HUM RETROV, V30, P339, DOI [10.1089/aid.2013.0169, 10.1089/AID.2013.0169]; Maman D, 2014, NDHIWA HIV IMPACT PO; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Ministry of Health, 2014, KEN HIV PREV REV ROA; NASCOP, 2013, KEN AIDS IND SURV 20; Ndembi N, 2008, AIDS RES HUM RETROV, V24, P889, DOI 10.1089/aid.2007.0317; Ndembi N, 2013, AIDS RES HUM RETROV, V29, P788, DOI [10.1089/AID.2012.0123, DOI 10.1089/AID.2012.0123]; Ndembi N, 2011, AIDS, V25, P905, DOI 10.1097/QAD.0b013e328346260f; Nichols BE, 2014, AIDS, V28, P73, DOI 10.1097/01.aids.0000433239.01611.52; Nieburg P, 2011, HIV PREVENTION INJEC; Pillay D, 2006, AIDS, V20, P21, DOI 10.1097/01.aids.0000196172.35056.b7; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Readhead AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040533; Ruelle J, 2013, AIDS RES HUM RETROV, V29, P1306, DOI [10.1089/aid.2013.0108, 10.1089/AID.2013.0108]; Sigallof KCE, 2012, AIDS RES HUM RETROV, V27, P1; Skoura L, 2013, CLIN MICROBIOL INFEC, V19, pE169, DOI 10.1111/1469-0691.12124; Somi GR, 2008, ANTIVIR THER, V13, P77; Ssemwanga D, 2012, AIDS RES HUM RETROV, V28, P1784, DOI [10.1089/aid.2012.0090, 10.1089/AID.2012.0090]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang MW, 2012, INTERVIROLOGY, V55, P98, DOI 10.1159/000331998; Templeton AR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-54; UNAIDS, 2020, UNAIDS 2020 GLOB REP; UNAIDS/WHO, 2011, 1S ASS REC 2NF EST H; Wainberg MA, 2011, RETROVIROLOGY S2, V8, pO14; Wei XR, 2011, J CLIN VIROL, V50, P148, DOI 10.1016/j.jcv.2010.11.006; Westreich D, 2007, J INFECT DIS, V195, P837, DOI 10.1086/511276; WHO, 2012, M REP FRAM METR SUPP; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11; Yang CF, 2004, AIDS RES HUM RETROV, V20, P565, DOI 10.1089/088922204323087822; Yanik EL, 2012, JAIDS-J ACQ IMM DEF, V61, P258, DOI 10.1097/QAI.0b013e3182618f05; Yebra G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026757; Zeh C, 2015, CROI, P625; Zhou ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028184	64	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171124	10.1371/journal.pone.0171124	http://dx.doi.org/10.1371/journal.pone.0171124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178281	Green Submitted, gold, Green Published			2022-12-26	WOS:000393712500025
J	Schoberl, I; Wedl, M; Beetz, A; Kotrschal, K				Schoeberl, Iris; Wedl, Manuela; Beetz, Andrea; Kotrschal, Kurt			Psychobiological Factors Affecting Cortisol Variability in Human-Dog Dyads	PLOS ONE			English	Article							GENDER-DIFFERENCES; STRANGE SITUATION; EMOTIONAL CONTAGION; SALIVARY CORTISOL; MAJOR DEPRESSION; CIRCADIAN-RHYTHM; SEX-DIFFERENCES; STRESS; RESPONSES; BEHAVIOR	Stress responses within dyads are modulated by interactions such as mutual emotional support and conflict. We investigated dyadic psychobiological factors influencing intra-individual cortisol variability in response to different challenging situations by testing 132 owners and their dogs in a laboratory setting. Salivary cortisol was measured and questionnaires were used to assess owner and dog personality as well as owners' social attitudes towards the dog and towards other humans. We calculated the individual coefficient of variance of cortisol (iCV = sd/mean*100) over the different test situations as a parameter representing individual variability of cortisol concentration. We hypothesized that high cortisol variability indicates efficient and adaptive coping and a balanced individual and dyadic social performance. Female owners of male dogs had lower iCV than all other owner gender-dog sex combinations (F = 14.194, p<0.001), whereas owner Agreeableness (NEO-FFI) scaled positively with owner iCV (F=4.981, p = 0.028). Dogs of owners high in Neuroticism (NEO-FFI) and of owners who were insecure -ambivalently attached to their dogs (FERT), had low iCV (F= 4.290, p = 0.041 and F= 5.948, p = 0.016), as had dogs of owners with human -directed separation anxiety (RSQ) or dogs of owners with a strong desire of independence (RSQ) (F= 7.661, p= 0.007 and F= 9.192, p = 0.003). We suggest that both owner and dog social characteristics influence dyadic cortisol variability, with the human partner being more influential than the dog. Our results support systemic approaches (i.e. considering the social context) in science and in counselling.	[Schoeberl, Iris; Wedl, Manuela; Kotrschal, Kurt] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Schoeberl, Iris; Wedl, Manuela; Kotrschal, Kurt] Univ Vienna, Core Facil Konrad Lorenz Res Stn, Grunau Im Almtal, Austria; [Beetz, Andrea] Univ Rostock, Inst Sonderpadagog Entwicklungsforderung & Rehabi, Dept Special Educ, Rostock, Germany	University of Vienna; University of Vienna; University of Rostock	Schoberl, I (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.; Schoberl, I (corresponding author), Univ Vienna, Core Facil Konrad Lorenz Res Stn, Grunau Im Almtal, Austria.	iris.schoeberl@univie.ac.at			Austrian Science Fund (FWF) [P23345]; PhD program Cognition and Communication from the Austrian Science Fund (FWF) [W1234-G17]; Austrian Science Fund (FWF) [P 23345] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); PhD program Cognition and Communication from the Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The study was funded by the Austrian Science Fund (FWF; https://WWW.fwf.ac.at/en/): Project P23345 to KK and MW, and the PhD program Cognition and Communication from the Austrian Science Fund (FWF): Project W1234-G17 to KK. The funding agencies were not involved in the collection, analysis and interpretation of data.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Ainsworth M.D.S., 1978, PATTERNS ATTACHMENT, DOI DOI 10.4324/9780203758045; Albuquerque N, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0883; Aureli F., 2000, NATURAL CONFLICT RES; Beerda B, 1999, PHYSIOL BEHAV, V66, P243, DOI 10.1016/S0031-9384(98)00290-X; Beetz AM, 2004, INT C HUM AN INT IAH; Beetz A, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00234, 10.3389/fpsyg.2012.00352]; Ben-Ner A, 2004, J ECON PSYCHOL, V25, P581, DOI 10.1016/S0167-4870(03)00065-5; Berns GS, 2015, BEHAV PROCESS, V110, P37, DOI 10.1016/j.beproc.2014.02.011; Berns GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038027; Blair C, 2005, CHILD DEV, V76, P554, DOI 10.1111/j.1467-8624.2005.00863.x; Bonein A., 2009, J SOCIO-ECON, V38, P779; Borkenau P., 1993, NEO FUNF FAKTOREN IN; BOWLBY J, 1969, ATTACHMENT LOSS, DOI DOI 10.1177/000306518403200125; Cobb ML, 2016, DOMEST ANIM ENDOCRIN, V57, P31, DOI 10.1016/j.domaniend.2016.04.003; Cockrem JF, 2013, GEN COMP ENDOCR, V181, P45, DOI 10.1016/j.ygcen.2012.11.025; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; Costa PT, 2007, REVISED NEO PERSONAL; DeVries AC, 2003, PHYSIOL BEHAV, V79, P399, DOI 10.1016/S0031-9384(03)00152-5; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Duranton C, 2015, J VET BEHAV, V10, P513, DOI 10.1016/j.jveb.2015.08.008; Ellis BJ, 2006, DEV REV, V26, P175, DOI 10.1016/j.dr.2006.02.004; Fanous A, 2002, PSYCHOL MED, V32, P719, DOI 10.1017/S003329170200541X; Frantz LAF, 2016, SCIENCE, V352, P1228, DOI 10.1126/science.aaf3161; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Friedmann E, 2000, COMPANION ANIMALS AND US, P125; George C., 2008, HDB ATTACHMENT THEOR, V2, P833; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Griffin DW, 1994, ATTACHMENT PROCESSES, P17, DOI DOI 10.1037//0022-3514.67.3.430; Heiming RS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.026.2009; Hennessy MB, 1998, APPL ANIM BEHAV SCI, V61, P63, DOI 10.1016/S0168-1591(98)00179-8; Herzog HA, 2007, ANTHROZOOS, V20, P7, DOI 10.2752/089279307780216687; Johansson AC, 2008, EUR J PAIN, V12, P633, DOI 10.1016/j.ejpain.2007.10.009; Julius H, 2012, ATTACHMENT TO PETS; Karlson B, 2011, STRESS HEALTH, V27, pE11, DOI 10.1002/smi.1330; Kelly MM, 2008, J BEHAV THER EXP PSY, V39, P87, DOI 10.1016/j.jbtep.2007.02.003; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; Kikusui T, 2006, PHILOS T R SOC B, V361, P2215, DOI 10.1098/rstb.2006.1941; Kirschbaum Clemens, 1999, Noise Health, V1, P57; Kolevska J, 2003, ACTA VET BRNO, V72, P599, DOI 10.2754/avb200372040599; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kotrschal K, 2009, BEHAV PROCESS, V81, P383, DOI 10.1016/j.beproc.2009.04.001; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Ley JM, 2009, APPL ANIM BEHAV SCI, V119, P85, DOI 10.1016/j.applanim.2009.02.027; Ligout S, 2009, P 7 INT VET BEH M, P143; Lynn R, 1997, J SOC PSYCHOL, V137, P369, DOI 10.1080/00224549709595447; Main M., 1990, ATTACHMENT PRESCHOOL, P161, DOI DOI 10.1016/J.NCL.2015.11.007; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Merola I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047653; Meyer I, 2014, J VET BEHAV, V9, P143, DOI 10.1016/j.jveb.2014.03.002; Muller CA, 2015, CURR BIOL, V25, P601, DOI 10.1016/j.cub.2014.12.055; Nagasawa M, 2011, ANIM COGN, V14, P525, DOI 10.1007/s10071-011-0386-5; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nicolson N, 2007, HDB PHYSL RES METHOD, P37, DOI DOI 10.4135/9781412976244.N3; O'Connell LA, 2012, SCIENCE, V336, P1154, DOI 10.1126/science.1218889; OFarrell V, 1997, APPL ANIM BEHAV SCI, V52, P205, DOI 10.1016/S0168-1591(96)01123-9; Osborne JW., 2004, PRACTICAL ASSESSMENT, V9, P1, DOI [10.7275/QF69-7K43, DOI 10.7275/QF69-7K43, 10.7275/qf69-7k43]; PALAZZOLO DL, 1987, EXP GERONTOL, V22, P379, DOI 10.1016/0531-5565(87)90019-2; Palme R, 1997, Z SAUGETIERKD, V62, P192; Poesel A, 2006, ANIM BEHAV, V72, P531, DOI 10.1016/j.anbehav.2005.10.022; Prato-Previde E, 2006, ETHOLOGY, V112, P64, DOI 10.1111/j.1439-0310.2006.01123.x; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; Roberts SB, 1999, PSYCHOL MED, V29, P1101, DOI 10.1017/S0033291799008739; Romero T, 2014, P NATL ACAD SCI USA, V111, P9085, DOI 10.1073/pnas.1322868111; Scheiber IBR, 2005, BEHAVIOUR, V142, P1535, DOI 10.1163/156853905774831873; Schleidt WM, 2003, EVOLUTION COGNITION, V9; Schoberl I, 2016, J VET BEHAV, V11, P77, DOI 10.1016/j.jveb.2015.09.007; Schoberl I, 2015, BEHAV RES METHODS, V47, P1356, DOI 10.3758/s13428-014-0546-z; Schoberl I, 2012, ANTHROZOOS, V25, P199, DOI 10.2752/175303712X13316289505422; Solomon J, 2014, INT SOC ANTR ISAZ AN; Somppi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143047; Spangler G, 1998, INT J BEHAV DEV, V22, P681, DOI 10.1080/016502598384126; Steffanowski A, 2001, STORUNGSSPEZIFISCHE; Sumegi Z, 2014, APPL ANIM BEHAV SCI, V160, P106, DOI 10.1016/j.applanim.2014.09.001; Sutter M, 2009, EXP ECON, V12, P318, DOI 10.1007/s10683-009-9217-9; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Turcsan B, 2015, ANIM COGN, V18, P83, DOI 10.1007/s10071-014-0779-3; Underwood J, 2000, LEARN INSTR, V10, P447, DOI 10.1016/S0959-4752(00)00008-6; Urquiza-Haas EG, 2015, ANIM BEHAV, V109, P167, DOI 10.1016/j.anbehav.2015.08.011; Uvnas-Moberg K, 1998, PSYCHONEUROENDOCRINO, V23, P819, DOI 10.1016/S0306-4530(98)00056-0; Veen G, 2009, METABOLISM, V58, P821, DOI 10.1016/j.metabol.2009.02.009; Vollrath M, 2001, SCAND J PSYCHOL, V42, P335, DOI 10.1111/1467-9450.00245; von Holst D, 1998, ADV STUD BEHAV, V27, P1; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814; Wang GD, 2016, CELL RES, V26, P21, DOI 10.1038/cr.2015.147; Wascher CAF, 2008, J COMP PSYCHOL, V122, P100, DOI 10.1037/0735-7036.122.1.100; Waugh CE, 2008, J RES PERS, V42, P1031, DOI 10.1016/j.jrp.2008.02.005; Wedl M, 2015, ANTHROZOOS, V28, P601, DOI 10.1080/08927936.2015.1070002; Wedl M, 2010, INTERACT STUD, V11, P482, DOI 10.1075/is.11.3.09wed; Wedl M, 2009, ANTHROZOOS, V22, P383, DOI 10.2752/089279309X12538695316220; Yong MH, 2014, BEHAV PROCESS, V108, P155, DOI 10.1016/j.beproc.2014.10.006; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Zilcha-Mano S, 2011, J RES PERS, V45, P345, DOI 10.1016/j.jrp.2011.04.001	96	25	25	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170707	10.1371/journal.pone.0170707	http://dx.doi.org/10.1371/journal.pone.0170707			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1UY	28178272	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500012
J	Hagos, S; Hailemariam, D; WoldeHanna, T; Lindtjorn, B				Hagos, Seifu; Hailemariam, Damen; WoldeHanna, Tasew; Lindtjorn, Bernt			Spatial heterogeneity and risk factors for stunting among children under age five in Ethiopia: A Bayesian geo-statistical model	PLOS ONE			English	Article							NUTRITIONAL-STATUS; MALNUTRITION; GROWTH	Background Understanding the spatial distribution of stunting and underlying factors operating at mesoscale is of paramount importance for intervention designing and implementations. Yet, little is known about the spatial distribution of stunting and some discrepancies are documented on the relative importance of reported risk factors. Therefore, the present study aims at exploring the spatial distribution of stunting at meso-(district) scale, and evaluates the effect of spatial dependency on the identification of risk factors and their relative contribution to the occurrence of stunting and severe stunting in a rural area of Ethiopia. Methods A community based cross sectional study was conducted to measure the occurrence of stunting and severe stunting among children aged 0-59 months. Additionally, we collected relevant information on anthropometric measures, dietary habits, parent and child-related demographic and socio-economic status. Latitude and longitude of surveyed households were also recorded. Local Anselin Moran's I was calculated to investigate the spatial variation of stunting prevalence and identify potential local pockets (hotspots) of high prevalence. Finally, we employed a Bayesian geo-statistical model, which accounted for spatial dependency structure in the data, to identify potential risk factors for stunting in the study area. Results Overall, the prevalence of stunting and severe stunting in the district was 43.7% [95% CI: 40.9, 46.4] and 21.3% [95% CI: 19.5, 23.3] respectively. We identified statistically significant clusters of high prevalence of stunting (hotspots) in the eastern part of the district and clusters of low prevalence (cold spots) in the western. We found out that the inclusion of spatial structure of the data into the Bayesian model has shown to improve the fit for stunting model. The Bayesian geo-statistical model indicated that the risk of stunting increased as the child's age increased (OR 4.74; 95% Bayesian credible interval [BCI]: 3.35-6.58) and among boys (OR 1.28; 95% BCI; 1.12-1.45). However, maternal education and household food security were found to be protective against stunting and severe stunting. Conclusion Stunting prevalence may vary across space at different scale. For this, it's important that nutrition studies and, more importantly, control interventions take into account this spatial heterogeneity in the distribution of nutritional deficits and their underlying associated factors. The findings of this study also indicated that interventions integrating household food insecurity in nutrition programs in the district might help to avert the burden of stunting.	[Hagos, Seifu; Hailemariam, Damen] Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Addis Ababa, Ethiopia; [Hagos, Seifu; Lindtjorn, Bernt] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [WoldeHanna, Tasew] Univ Addis Ababa, Coll Business & Econ, Dept Econ, Addis Ababa, Ethiopia	Addis Ababa University; University of Bergen; Addis Ababa University	Hagos, S (corresponding author), Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Addis Ababa, Ethiopia.; Hagos, S (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	seif_h23@yahoo.com	Lindtjorn, Bernt/K-9465-2018	Lindtjorn, Bernt/0000-0002-6267-6984	Center for International Health at the University of Bergen	Center for International Health at the University of Bergen	We would like to acknowledge the Center for International Health at the University of Bergen for funding the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu M, 2015, NUTRITION, V31, P964, DOI 10.1016/j.nut.2015.01.013; Ali D, 2013, J NUTR, V143, P2015, DOI 10.3945/jn.113.175182; [Anonymous], 2001, ETH DEM HLTH SURV 20; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Asfaw M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1370-9; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2013, LANCET, P382; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; *CENTR STAT AG, 2006, ETH DEM HLTH SURV 20; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Central Statistical Agency [Ethiopia], 2014, ETH MIN DEM HLTH SUR; Checkley W, 2003, AM J EPIDEMIOL, V157, P166, DOI 10.1093/aje/kwf179; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; de Onis M, 2013, MATERNAL CHILD NU S2, V9; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Dewey KG, 2011, MATERNAL CHILD NU S3, V7; Frost MB, 2005, SOC SCI MED, V60, P395, DOI 10.1016/j.socscimed.2004.05.010; Gebreyesus S.H., 2015, BMC NUTR, V1, P2, DOI [DOI 10.1186/2055-0928-1-1, 10.1186/2055-0928-1-2]; Herrador Z, 2014, PLOS ONE, V9; Humphries DL, 2015, J NUTR; Kandala NB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-261; Kandala NB, 2009, POPUL SPACE PLACE, V15, P461, DOI 10.1002/psp.524; Khatab K, 2010, AM J TROP MED HYG, V82, P653, DOI 10.4269/ajtmh.2010.09-0501; Lemma F, 2013, LANCET, V382, P488, DOI 10.1016/S0140-6736(13)61054-5; Lindtjorn B, 2002, J HLTH POPULATION NU, V20; Medhin G, 2010, BMC PUBLIC HLTH, P10; Mulugeta A, 2010, E AFRICAN MED J, V87; Outes I, 2013, EC HUMAN BIOL, V11; Petrou S, 1982, SOCIAL SCI MED, V71; Pfeiffer D, 2010, SPATIAL ANAL EPIDEMI; Psaki S, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-24; ROWLAND MGM, 1988, AM J CLIN NUTR, V47, P134, DOI 10.1093/ajcn/47.1.134; ROWLAND MGM, 1977, BRIT J NUTR, V37, P441, DOI 10.1079/BJN19770047; Scrimshaw N S, 1968, Monogr Ser World Health Organ, V57, P3; Singh A, 2014, LANCET GLOBAL HLTH, V2; Smith L.C., 2000, EXPLAINING CHILD MAL; Stein AD, 2005, MATERNAL CHILD NUTR, V1; Stewart CP, 2013, MATERNAL CHILD NU S2, V9; Subramanyam MA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000424; Umeta M, 2003, J NUTR, V133, P1064, DOI 10.1093/jn/133.4.1064; UNICEF, 1990, STRATEGY FOR IMPROVI; Victora CG, 2008, LANCET, V371; Vollmer S., 2014, LANCET GLOBAL HLTH, V2	43	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170785	10.1371/journal.pone.0170785	http://dx.doi.org/10.1371/journal.pone.0170785			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170407	gold, Green Published, Green Submitted			2022-12-26	WOS:000393705500011
J	Kim, SE; Choo, J; Yoon, J; Chu, JR; Bae, YJ; Lee, S; Park, T; Sung, MK				Kim, Sung-Eun; Choo, Jinsil; Yoon, Joon; Chu, Jae Ryang; Bae, Yun Jung; Lee, Seungyeoun; Park, Taesung; Sung, Mi-Kyung			Genome-wide analysis identifies colonic genes differentially associated with serum leptin and insulin concentrations in C57BL/6J mice fed a high-fat diet	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INDUCED OBESITY; ULCERATIVE-COLITIS; NHE3-DEFICIENT MICE; COLORECTAL-CANCER; ADIPOSE-TISSUE; EXPRESSION; RESISTANCE; AUTOTAXIN; RISK	Obesity-induced chronic inflammation is known to increase the risk of ulcerative colitis, Crohn's disease, and colorectal cancer. Accumulating evidence suggests that leptin and insulin are key molecules linking obesity with diseases of the lower intestine. Here, we identified serum phenotype-associated genes in the colon of diet-induced obese mice as early biomarkers of obesity-associated colonic diseases. C57BL/6J mice were fed with either normal diet (ND, 15% of fat calories) or high-fat diet (HFD, 45% of fat calories) for 8 weeks. Serum concentrations of insulin, insulin-like growth factor-1 (IGF-1), leptin, and adiponectin were measured as obesity-related phenotypic markers. Genome-wide gene expression profiles of colon tissue were determined, followed by statistical analyses to detect differentially expressed and serum phenotype-associated genes. HFD-fed mice showed higher serum concentrations of leptin (P < 0.001) and insulin (P < 0.01) than those in the ND group, whereas serum IGF-1 and adiponectin concentrations did not differ between the two dietary groups. Among differentially expressed genes affected by HFD, 135, 128, 110, and 341 genes were associated with serum levels of leptin, insulin, IGF-1, and adiponectin, respectively. We identified 17 leptin-associated genes and 4 insulin-associated genes that inversely responded to HFD and ND. Among these, leptin-associated Peli3 (Pellino E3 ubiquitin protein ligase family member 3), Creb1 (cAMP responsive element binding protein 1), and Enpp2 (ectonucleotide pyrophosphatase/phosphodiesterase 2, autotaxin) and insulinassociated Centg1 (AGAP2, ArfGAP with GTPase domain) are reported to play a role either in obesity or colonic diseases. mRNA expression of these genes was validated by RTqPCR. Our data suggest Peli3, Creb1, Enpp2, and Centg1 as potential early biomarker candidates for obesity-induced pathophysiological changes in the colon. Future studies verifying the function of these candidates are needed for the prevention, early detection, and treatment of colon diseases.	[Kim, Sung-Eun; Sung, Mi-Kyung] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Choo, Jinsil; Chu, Jae Ryang] Sookmyung Womens Univ, Dept Life Syst, Seoul, South Korea; [Yoon, Joon; Park, Taesung] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Bae, Yun Jung] Shinhan Univ, Div Food Sci & Culinary Arts, Gyeonggi Do, South Korea; [Lee, Seungyeoun] Sejong Univ, Dept Math & Stat, Seoul, South Korea; [Park, Taesung] Seoul Natl Univ, Dept Stat, Seoul, South Korea	Sookmyung Women's University; Sookmyung Women's University; Seoul National University (SNU); Sejong University; Seoul National University (SNU)	Sung, MK (corresponding author), Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea.	mksung@sm.ac.kr		BAE, YUN JUNG/0000-0003-1185-3095; Yoon, Joon/0000-0002-9509-119X	SRC program (Center for Food & Nutritional Genomics) [2015R1A5A6001906]; Mid-Career Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2015R1A2A2A01004607]	SRC program (Center for Food & Nutritional Genomics); Mid-Career Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by the SRC program (Center for Food & Nutritional Genomics: No.2015R1A5A6001906) and the Mid-Career Research Program (No.2015R1A2A2A01004607) of the National Research Foundation of Korea (NRF, www.nrt.re.kr/nrf_eng_cms/) funded by the Ministry of Education, Science and Technology to M-KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awada R, 2014, J CELL BIOCHEM, V115, P2123, DOI 10.1002/jcb.24889; Ben QW, 2012, GASTROENTEROLOGY, V142, P762, DOI 10.1053/j.gastro.2011.12.050; Boutin JA, 2009, CELL MOL LIFE SCI, V66, P3009, DOI 10.1007/s00018-009-0056-9; Buffart TE, 2008, BRIT J CANCER, V99, P1802, DOI 10.1038/sj.bjc.6604777; Cattaneo E, 2011, EMBO MOL MED, V3, P334, DOI 10.1002/emmm.201100141; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chan CB, 2010, DIABETES, V59, P883, DOI 10.2337/db09-1404; Chiappini F, 2011, J BIOL CHEM, V286, P8094, DOI 10.1074/jbc.M110.178186; Duan J, 2007, OBESITY, V15, P2624, DOI 10.1038/oby.2007.314; Endo H, 2011, GUT, V60, P1363, DOI 10.1136/gut.2010.235754; Fan H, 2008, MOL MED, V14, P422, DOI 10.2119/2007-00106.Fan; Fonseca-Camarillo G, 2012, INFLAMM BOWEL DIS, V18, P1197, DOI 10.1002/ibd.22968; Galamb O, 2009, CELL ONCOL, V31, P19, DOI 10.3233/CLO-2009-0458; Giegerich AK, 2014, AUTOPHAGY, V10, P1937, DOI 10.4161/auto.32178; Huang XF, 2009, OBES REV, V10, P610, DOI 10.1111/j.1467-789X.2009.00607.x; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Khalili H, 2015, INFLAMM BOWEL DIS, V21, P361, DOI 10.1097/MIB.0000000000000283; Kim YJ, 2008, NUTR RES, V28, P414, DOI 10.1016/j.nutres.2008.03.015; Korkmaz H, 2014, EUR J GASTROEN HEPAT, V26, P725, DOI 10.1097/MEG.0000000000000104; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Larmonier CB, 2013, AM J PHYSIOL-GASTR L, V305, pG667, DOI 10.1152/ajpgi.00189.2013; Laubitz D, 2008, AM J PHYSIOL-GASTR L, V295, pG63, DOI 10.1152/ajpgi.90207.2008; Leclerc D, 2013, CANCER PREV RES, V6, P1171, DOI 10.1158/1940-6207.CAPR-13-0198; Lind GE, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-13; Liu X, 2007, ONCOGENE, V26, P4918, DOI 10.1038/sj.onc.1210290; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Ma RQ, 2015, ONCOL LETT, V10, P957, DOI 10.3892/ol.2015.3355; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Miller RS, 2008, J NUTR, V138, P1033, DOI 10.1093/jn/138.6.1033; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Moon HS, 2013, GUT, V62, P561, DOI 10.1136/gutjnl-2012-302092; Nishimura S, 2014, DIABETES, V63, P4154, DOI 10.2337/db13-1694; Oh HY, 2013, GENES NUTR, V8, P301, DOI 10.1007/s12263-012-0322-6; Park SY, 2012, INT J OBESITY, V36, P273, DOI 10.1038/ijo.2011.83; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Priyamvada S, 2015, INFLAMM BOWEL DIS, V21, P2926, DOI 10.1097/MIB.0000000000000504; Qi Q, 2013, ACTA PHARMACOL SIN, V34, P991, DOI 10.1038/aps.2013.71; REIFENBERGER G, 1994, CANCER RES, V54, P4299; Roberts DL, 2015, ONCOTARGET, V6, P10786, DOI 10.18632/oncotarget.3198; Schauvliege R, 2007, J CELL MOL MED, V11, P453, DOI 10.1111/j.1582-4934.2007.00040.x; Schmidt DR, 2011, J BIOL CHEM, V286, P2425, DOI 10.1074/jbc.M110.181230; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Sitaraman S, 2004, FASEB J, V18, P696, DOI 10.1096/fj.03-0422fje; Spielbauer B, 2005, MOL NUTR FOOD RES, V49, P908, DOI 10.1002/mnfr.200500033; Sung MK, 2010, BIOTECHNOL J, V5, P930, DOI 10.1002/biot.201000165; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Teixeira LG, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-204; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Tuzun A, 2004, J GASTROEN HEPATOL, V19, P429, DOI 10.1111/j.1440-1746.2003.03300.x; Valentini L, 2009, NUTRITION, V25, P172, DOI 10.1016/j.nut.2008.07.020; Volat FE, 2012, DIABETES, V61, P2796, DOI 10.2337/db11-1297; Wang R, 2014, CELL DEATH DIFFER, V21, P427, DOI 10.1038/cdd.2013.163; Wang R, 2012, AM J PHYSIOL-GASTR L, V303, pG209, DOI 10.1152/ajpgi.00500.2011; Wu XY, 2014, WORLD J GASTROENTERO, V20, P16268, DOI 10.3748/wjg.v20.i43.16268; Zimmet PZ, 1998, INT J OBESITY, V22, P171, DOI 10.1038/sj.ijo.0800559	57	11	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171664	10.1371/journal.pone.0171664	http://dx.doi.org/10.1371/journal.pone.0171664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170448	Green Submitted, Green Published, gold			2022-12-26	WOS:000393705500050
J	Derogis, PBM; Sanches, LR; de Aranda, VF; Colombini, MP; Mangueira, CLP; Katz, M; Faulhaber, ACL; Mendes, CEA; Ferreira, CED; Franca, CN; Guerra, JCD				Matos Derogis, Priscilla Bento; Sanches, Livia Rentas; de Aranda, Valdir Fernandes; Colombini, Marjorie Paris; Pitangueira Mangueira, Cristovao Luis; Katz, Marcelo; Leme Faulhaber, Adriana Caschera; Albers Mendes, Claudio Ernesto; dos Santos Ferreira, Carlos Eduardo; Franca, Carolina Nunes; de Campos Guerra, Joao Carlos			Determination of rivaroxaban in patient's plasma samples by anti-Xa chromogenic test associated to High Performance Liquid Chromatography tandem Mass Spectrometry (HPLC-MS/MS)	PLOS ONE			English	Article							DIRECT ORAL ANTICOAGULANTS; VENOUS THROMBOEMBOLISM; ACCURATE DETERMINATION; INHIBITOR RIVAROXABAN; TOTAL HIP; DABIGATRAN; ASSAYS; APIXABAN; REPLACEMENT; PREVENTION	Rivaroxaban is an oral direct factor Xa inhibitor, therapeutically indicated in the treatment of thromboembolic diseases. As other new oral anticoagulants, routine monitoring of rivaroxaban is not necessary, but important in some clinical circumstances. In our study a high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method was validated to measure rivaroxaban plasmatic concentration. Our method used a simple sample preparation, protein precipitation, and a fast chromatographic run. It was developed a precise and accurate method, with a linear range from 2 to 500 ng/mL, and a lower limit of quantification of 4 pg on column. The new method was compared to a reference method (anti-factor Xa activity) and both presented a good correlation (r = 0.98, p < 0.001). In addition, we validated hemolytic, icteric or lipemic plasma samples for rivaroxaban measurement by HPLC-MS/MS without interferences. The chromogenic and HPLC-MS/MS methods were highly correlated and should be used as clinical tools for drug monitoring. The method was applied successfully in a group of 49 real-life patients, which allowed an accurate determination of rivaroxaban in peak and trough levels.	[Matos Derogis, Priscilla Bento; Sanches, Livia Rentas; de Aranda, Valdir Fernandes; Colombini, Marjorie Paris; Pitangueira Mangueira, Cristovao Luis; Katz, Marcelo; Leme Faulhaber, Adriana Caschera; Albers Mendes, Claudio Ernesto; dos Santos Ferreira, Carlos Eduardo; de Campos Guerra, Joao Carlos] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [Franca, Carolina Nunes] Santo Amaro Univ UNISA, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Universidade de Santo Amaro (UNISA)	Guerra, JCD (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, Brazil.	joao.guerra@einstein.br	França, Carolina Nunes/J-2429-2015	França, Carolina Nunes/0000-0002-4167-4293; Mangueira, Cristovao/0000-0002-4227-3723; Bento Matos Cruz Derogis, Priscilla/0000-0003-2345-3996				[Anonymous], 1989, 11184487EN, DOI [10.1208/aapsj0903042, DOI 10.1208/AAPSJ0903042]; Baglin T, 2013, J THROMB HAEMOST, V11, P122, DOI 10.1111/jth.12227; Baglin T, 2013, J Thromb Haemost, DOI 10.1111/jth.12149; Baglin T, 2012, BRIT J HAEMATOL, V159, P427, DOI 10.1111/bjh.12052; Bardy G, 2015, THROMB RES, V136, P396, DOI 10.1016/j.thromres.2015.05.015; Buller HR, 2008, BLOOD, V112, P2242, DOI 10.1182/blood-2008-05-160143; Burness CB, 2014, DRUGS, V74, P243, DOI 10.1007/s40265-013-0174-4; Douxfils J, 2013, THROMB HAEMOSTASIS, V110, P723, DOI 10.1160/TH13-04-0274; Duggan ST, 2009, DRUGS, V69, P1829, DOI 10.2165/11200890-000000000-00000; Gosselin RC, 2014, ARCH PATHOL LAB MED, V138, P1680, DOI 10.5858/arpa.2013-0750-OA; Gous T, 2014, THER DRUG MONIT, V36, P597, DOI 10.1097/FTD.0000000000000059; Grebe Stefan Kg, 2011, Clin Biochem Rev, V32, P5; Haas S, 2009, EUR J HAEMATOL, V82, P339, DOI 10.1111/j.1600-0609.2009.01230.x; Harenberg J, 2016, CLIN CHEM LAB MED, V54, P275, DOI 10.1515/cclm-2015-0389; Hughes NC, 2007, AAPS J, V9, pE353, DOI 10.1208/aapsj0903042; Iqbal M, 2015, J THROMB THROMBOLYS, V39, P79, DOI 10.1007/s11239-014-1121-2; Korostelev M, 2014, J PHARMACEUT BIOMED, V100, P230, DOI 10.1016/j.jpba.2014.08.011; Kreutz R, 2012, FUND CLIN PHARMACOL, V26, P27, DOI 10.1111/j.1472-8206.2011.00981.x; Kuhn J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145478; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Lindhoff-Last E, 2010, THER DRUG MONIT, V32, P673, DOI 10.1097/FTD.0b013e3181f2f264; Mani H, 2012, THROMB HAEMOSTASIS, V108, P191, DOI 10.1160/TH11-12-0832; Mueck W, 2008, THROMB HAEMOSTASIS, V100, P453, DOI 10.1160/07-12-0714; Mueck W, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-10; Rathbun S, 2015, THROMB RES, V135, P394, DOI 10.1016/j.thromres.2014.11.017; Rohde G, 2008, J CHROMATOGR B, V872, P43, DOI 10.1016/j.jchromb.2008.07.015; Samama MM, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-11; Samama MM, 2011, THROMB RES, V127, P497, DOI 10.1016/j.thromres.2010.09.008; Schmitz EMH, 2014, J THROMB HAEMOST, V12, P1636, DOI 10.1111/jth.12702; Thomas TF, 2013, CLIN THER, V35, P4, DOI 10.1016/j.clinthera.2012.12.005; Tripodi A, 2013, J THROMB HAEMOST, V11, P576, DOI 10.1111/jth.12166; Van Eeckhaut A, 2009, J CHROMATOGR B, V877, P2198, DOI 10.1016/j.jchromb.2009.01.003; Vera-Aguilera Jesus, 2016, Adv Hematol, V2016, P4054806, DOI 10.1155/2016/4054806; Vogeser M, 2008, CLIN BIOCHEM, V41, P649, DOI 10.1016/j.clinbiochem.2008.02.017; Wiesen MHJ, 2016, CHEST, V150, pE1, DOI 10.1016/j.chest.2016.01.021	35	25	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171272	10.1371/journal.pone.0171272	http://dx.doi.org/10.1371/journal.pone.0171272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170419	Green Submitted, gold, Green Published			2022-12-26	WOS:000393705500027
J	von Saltzwedel, H; Scheu, S; Schaefer, I				von Saltzwedel, Helge; Scheu, Stefan; Schaefer, Ina			Genetic structure and distribution of Parisotoma notabilis (Collembola) in Europe: Cryptic diversity, split of lineages and colonization patterns	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; HYBRID ZONE; HEXAPODA; PHYLOGEOGRAPHY; BIODIVERSITY; SUCCESSION; SPECIATION; RESPONSES	Climatic and biome changes of the past million years influenced the population structure and genetic diversity of soil-living arthropods in Europe. However, their effects on the genetic structure of widespread and abundant soil animal species such as the Collembola Parisotoma notabilis remain virtually unknown. This generalist and parthenogenetic species is an early colonizer of disturbed habitats and often occurs in human modified environments. To investigate ancient climatic influence and recent distributions on the genetic structure of P. notabilis we analyzed populations on a pan-European scale using three genetic markers differing in substitution rates. The results showed that P. notabilis comprises several genetic lineages with distinct distribution ranges that diverged in the Miocene. Genetic distances of COI between lineages ranged between 15% and 18% and molecular clock estimates suggest Late Miocene divergences considering the standard arthropod rate of 2.3% per my. Compared to other soil-living arthropods like oribatid mites, European lineages of P. notabilis are rather young and genetically uniform. The close association with anthropogenic habitats presumably contributed to rapid spread in Europe.	[von Saltzwedel, Helge; Scheu, Stefan; Schaefer, Ina] Georg August Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Gottingen, Germany	University of Gottingen	von Saltzwedel, H (corresponding author), Georg August Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Gottingen, Germany.	hsaltzw1@gwdg.de	Scheu, Stefan/H-7049-2015		Deutsche Forschungsgemeinschaft [SCHE 376/13-1 u. 13-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (SCHE 376/13-1 u. 13-2).	[Anonymous], 2010, ARCTIC ANTARCIT ALP, V42, P422; Avise John C., 1994, pi; Bell G, 1982, MASTERPIECE NATURE E; Birky CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052544; Birky CW, 2005, HYDROBIOLOGIA, V546, P29, DOI 10.1007/s10750-005-4097-2; Bohme M, 2008, EARTH PLANET SC LETT, V275, P393, DOI 10.1016/j.epsl.2008.09.011; Bohme M, 2003, PALAEOGEOGR PALAEOCL, V195, P389, DOI 10.1016/S0031-0182(03)00367-5; Boyer SL, 2007, MOL ECOL, V16, P4999, DOI 10.1111/j.1365-294X.2007.03555.x; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Bruch AA, 2007, PALAEOGEOGR PALAEOCL, V253, P1, DOI 10.1016/j.palaeo.2007.03.030; Chahartaghi M, 2005, SOIL BIOL BIOCHEM, V37, P1718, DOI 10.1016/j.soilbio.2005.02.006; Chahartaghi M, 2006, PEDOBIOLOGIA, V50, P331, DOI 10.1016/j.pedobi.2006.06.001; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Collins MM, 2013, ANN CARNEGIE MUS, V82, P193, DOI 10.2992/007.082.0204; DAVIS MB, 1983, ANN MO BOT GARD, V70, P550, DOI 10.2307/2992086; Deharveng L., 2012, CNFRA BIOL SOLS, V48, P33; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ezard T, 2009, SPECIES LIMITS THRES; Fiera C, 2012, BIOL J LINN SOC, V105, P498, DOI 10.1111/j.1095-8312.2011.01816.x; FJELLBERG A, 1977, ENTOMOL SCAND, V8, P9, DOI 10.1163/187631277X00026; Fjellberg A, 1980, IDENTIFICATION KEYS; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fountain MT, 2004, ECOTOXICOLOGY, V13, P555, DOI 10.1023/B:ECTX.0000037192.70167.00; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garcia-Gomez A, 2009, PESQUI AGROPECU BRAS, V44, P911, DOI 10.1590/S0100-204X2009000800016; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heethoff M, 2007, J EVOLUTION BIOL, V20, P392, DOI 10.1111/j.1420-9101.2006.01183.x; Hewitt G.M., 2001, INTEGRATING ECOLOGY, P271; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hopkin S.P., 2007, KEY COLLEMBOLA SPRIN; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingimarsdottir M, 2012, OECOLOGIA, V170, P745, DOI 10.1007/s00442-012-2334-8; Jimenez-Moreno G, 2010, REV PALAEOBOT PALYNO, V162, P403, DOI 10.1016/j.revpalbo.2009.08.001; Kempson D., 1963, Pedobiologia, V3, P1; Kovac L, 2005, PEDOBIOLOGIA, V49, P29, DOI 10.1016/j.pedobi.2004.07.009; Kutnik M, 2004, MOL ECOL, V13, P3099, DOI 10.1111/j.1365-294X.2004.02294.x; Kuznetsova NA, 2006, PEDOBIOLOGIA, V50, P157, DOI 10.1016/j.pedobi.2005.12.004; Lindberg N, 2005, APPL SOIL ECOL, V28, P163, DOI 10.1016/j.apsoil.2004.07.003; Mila B, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-192; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Osborne CP, 2006, PHILOS T R SOC B, V361, P173, DOI 10.1098/rstb.2005.1737; Patel S, 2015, MOL ECOL, V24, P643, DOI 10.1111/mec.13049; Ponge JF, 2008, PEDOBIOLOGIA, V52, P19, DOI 10.1016/j.pedobi.2008.01.005; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Porco D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046056; POTAPOV M B, 1991, Acta Zoologica Cracoviensia, V34, P267; Pound MJ, 2012, EARTH-SCI REV, V112, P1, DOI 10.1016/j.earscirev.2012.02.005; Retallack GJ, 2001, J GEOL, V109, P407, DOI 10.1086/320791; Rosenberger M, 2013, PEDOBIOLOGIA, V56, P79, DOI 10.1016/j.pedobi.2012.11.003; RUSEK J, 1984, ACTA ENTOMOL BOHEMOS, V81, P343; Salamon JA, 2009, EUR J SOIL BIOL, V45, P199, DOI 10.1016/j.ejsobi.2008.12.005; Salicini I, 2013, J BIOGEOGR, V40, P1182, DOI 10.1111/jbi.12062; Scheu S, 1996, BIODIVERS CONSERV, V5, P235, DOI 10.1007/BF00055833; Shaw Peter, 2013, Soil Organisms, V85, P161; Sommer RS, 2005, MAMMAL REV, V35, P156, DOI 10.1111/j.1365-2907.2005.00063.x; Soto-Adames FN, 2002, MOL PHYLOGENET EVOL, V25, P27, DOI 10.1016/S1055-7903(02)00250-6; Stamatakis A, 2009, PARALLEL COMPUTING T, P288; Tastard E, 2012, J EVOLUTION BIOL, V25, P388, DOI 10.1111/j.1420-9101.2011.02433.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torricelli G, 2010, GENE, V449, P30, DOI 10.1016/j.gene.2009.09.006; Tully T, 2006, PEDOBIOLOGIA, V50, P95, DOI 10.1016/j.pedobi.2005.11.003; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; von Saltzwedel H, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0719-8; Wanner M, 2002, EUR J SOIL BIOL, V38, P137, DOI 10.1016/S1164-5563(02)01135-4; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	70	12	12	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170909	10.1371/journal.pone.0170909	http://dx.doi.org/10.1371/journal.pone.0170909			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170395	Green Published, gold, Green Submitted			2022-12-26	WOS:000393705500013
J	Kashiwagi, S; Asano, Y; Goto, W; Takada, K; Takahashi, K; Noda, S; Takashima, T; Onoda, N; Tomita, S; Ohsawa, M; Hirakawa, K; Ohira, M				Kashiwagi, Shinichiro; Asano, Yuka; Goto, Wataru; Takada, Koji; Takahashi, Katsuyuki; Noda, Satoru; Takashima, Tsutomu; Onoda, Naoyoshi; Tomita, Shuhei; Ohsawa, Masahiko; Hirakawa, Kosei; Ohira, Masaichi			Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HALICHONDRIN-B; METASTASIS; CELLS; MECHANISM; DISCOVERY; SUBTYPES; IMPACT; SOIL; EMT	Background Eribulin mesylate (eribulin) is currently indicated for treatment of locally advanced or metastatic breast cancer (MBC). It is a cytotoxic agent with unique mechanisms that suppress epithelial-mesenchymal transition (EMT) of cancer cells. On the other hand, Tumor-infiltrating lymphocytes (TILs), which are considered indicators of immune response monitoring, have been reported as prognostic factors and predictors of therapeutic efficacy. We thought that eribulin, which has an EMT-inhibiting mechanism, may produce an antitumor effect by improving the immune microenvironment, and in this study investigated the effects of breast cancer eribulin chemotherapy on the immune microenvironment with TILs as a marker. Methods TILs was evaluated in 52 patients with MBC who underwent chemotherapy with eribulin. The correlation between TILs evaluated according to the standard method, and prognosis, including the efficacy of eribulin chemotherapy, was investigated retrospectively. Results Of the 52 MBC patients, 29 (55.8%) were in the high TILs group and 23 (44.2%) were in the low TILs group. The high TILs group included significantly more triple-negative breast cancer (TNBC) (p = 0.008) than the low TILs group. In an analysis of outcomes, TNBC patients in the high TILs group had significantly longer disease-free survival than TNBC patients in the low TILs group (p = 0.033, log-rank), but no significant differences were seen in all breast cancer patients (p = 0.489, log-rank) or in non-TNBC patients (p = 0.878, log-rank). In a multivariate analysis of recurrence in TNBC patients, being in the high TILs group was again an independent factor for a good outcome (p = 0.031, HR = 0.063). Conclusion The results of this study suggest that TILs may be useful as a predictive marker of the therapeutic effect of eribulin chemotherapy in TNBC.	[Kashiwagi, Shinichiro; Asano, Yuka; Goto, Wataru; Takada, Koji; Noda, Satoru; Takashima, Tsutomu; Onoda, Naoyoshi; Hirakawa, Kosei; Ohira, Masaichi] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka, Japan; [Takahashi, Katsuyuki; Tomita, Shuhei] Osaka City Univ, Grad Sch Med, Dept Pharmacol, Osaka, Japan; [Ohsawa, Masahiko] Osaka City Univ, Grad Sch Med, Dept Diagnost Pathol, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Kashiwagi, S (corresponding author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka, Japan.	spqv9ke9@view.ocn.ne.jp	Kashiwagi, Shinichiro/AAC-7070-2019; Kashiwagi, Shinichiro/AAE-5243-2020	Kashiwagi, Shinichiro/0000-0002-0460-9599; Kashiwagi, Shinichiro/0000-0002-0460-9599; TAKAHASHI, KATSUYUKI/0000-0001-9183-0760	Grants-in-Aid for Scientific Research [17K08602] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		BAI R, 1991, J BIOL CHEM, V266, P15882; Cortes J, 2011, LANCET, V377, P914, DOI 10.1016/S0140-6736(11)60070-6; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Floor S, 2011, ONCOGENE, V30, P4609, DOI 10.1038/onc.2011.184; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; HIRATA J, 1986, LEUKEMIA RES, V10, P1441, DOI 10.1016/0145-2126(86)90011-1; Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kaufman PA, 2015, J CLIN ONCOL, V33, P594, DOI 10.1200/JCO.2013.52.4892; Kocian P, 2011, HUM IMMUNOL, V72, P1022, DOI 10.1016/j.humimm.2011.07.312; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Kuznetsov G, 2004, CANCER RES, V64, P5760, DOI 10.1158/0008-5472.CAN-04-1169; Ledford H, 2010, NATURE, V468, P608, DOI 10.1038/468608a; Lee WS, 2013, ANN SURG ONCOL, V20, P697, DOI 10.1245/s10434-012-2752-1; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liu H, 2012, CANCER IMMUNOL IMMUN, V61, P1849, DOI 10.1007/s00262-012-1231-7; Loi S, 2014, ANN ONCOL, V25, P1544, DOI 10.1093/annonc/mdu112; Mao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115103; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; Mathot L, 2012, CANCER SCI, V103, P626, DOI 10.1111/j.1349-7006.2011.02195.x; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Ono M, 2012, BREAST CANCER RES TR, V132, P793, DOI 10.1007/s10549-011-1554-7; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Terashima M, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-417; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Twelves C, 2015, BREAST CANCER RES TR, V149, P313, DOI 10.1007/s10549-014-3245-7; Yoshida T, 2014, BRIT J CANCER, V110, P1497, DOI 10.1038/bjc.2014.80; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	30	66	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170634	10.1371/journal.pone.0170634	http://dx.doi.org/10.1371/journal.pone.0170634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166544	Green Published, gold, Green Submitted			2022-12-26	WOS:000393700100011
J	Thaker, YR; Recino, A; Raab, M; Jabeen, A; Wallberg, M; Fernandez, N; Rudd, CE				Thaker, Youg R.; Recino, Asha; Raab, Monika; Jabeen, Asma; Wallberg, Maja; Fernandez, Nelson; Rudd, Christopher E.			Activated Cdc42-associated kinase 1 (ACK1) binds the sterile alpha motif (SAM) domain of the adaptor SLP-76 and phosphorylates proximal tyrosines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; CONTAINING LEUKOCYTE PHOSPHOPROTEIN; SIGNAL-TRANSDUCTION; PROTEIN SLP-76; CD4 RECEPTOR; COMPLEX; TCR; MICROCLUSTERS; TRANSCRIPTION; P56LCK	The adaptor protein Src homology 2 domain-containing leukocyte phosphoprotein of 76 kDa (SLP-76) plays a crucial role in T cell activation by linking antigen receptor (T cell receptor, TCR) signals to downstream pathways. At its N terminus, SLP-76 has three key tyrosines (Tyr-113, Tyr-128, and Tyr-145, "3Y") as well as a sterile alpha motif (SAM) domain whose function is unclear. We showed previously that the SAM domain has two binding regions that mediate dimer and oligomer formation. In this study, we have identified SAM domain-carrying non-receptor tyrosine kinase, activated Cdc42-associated tyrosine kinase 1 (ACK1; also known as Tnk2, tyrosine kinase non-receptor 2) as a novel binding partner of SLP-76. Co-precipitation, laser-scanning confocal microscopy, and in situ proximity analysis confirmed the binding of ACK1 to SLP-76. Further, the interaction was induced in response to the anti-TCR ligation and abrogated by the deletion of SLP-76 SAM domain (Delta SAM) or mutation of Tyr-113, Tyr-128, and Tyr-145 to phenylalanine (3Y3F). ACK1 induced phosphorylation of the SLP-76 N-terminal tyrosines (3Y) dependent on the SAM domain. Further, ACK1 promoted calcium flux and NFAT-AP1 promoter activity and decreased the motility of murine CD4(+) primary T cells on ICAM-1-coated plates, an event reversed by a small molecule inhibitor of ACK1 (AIM-100). These findings identify ACK1 as a novel SLP-76-associated protein-tyrosine kinase that modulates early activation events in T cells.	[Thaker, Youg R.; Recino, Asha; Wallberg, Maja; Rudd, Christopher E.] Univ Cambridge, Cell Signaling Sect, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England; [Raab, Monika] Goethe Univ Frankfurt, Sch Med, Dept Obstet & Gynecol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Jabeen, Asma; Fernandez, Nelson] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Rudd, Christopher E.] Maisonneuve Rosemont Hosp, Oncol Res Ctr, Div Immunol, Montreal, PQ H1T 2M4, Canada; [Rudd, Christopher E.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	University of Cambridge; Goethe University Frankfurt; University of Essex; Universite de Montreal; Universite de Montreal	Thaker, YR (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02151 USA.	youg_thaker@hms.harvard.edu	Rudd, Christopher E/ABF-7259-2021; Thaker, Youg/K-6083-2016; Rudd, Christopher E/GOH-2021-2022	Thaker, Youg/0000-0002-6496-1017; Rudd, Christopher E/0000-0001-5295-9019	Wellcome Trust [092627/Z/10/Z]; National Centre for the Replacement [NC/M001083/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Centre for the Replacement	This work was supported by Wellcome Trust Grant 092627/Z/10/Z (to E. R.).	Bailey S, 2006, J IMMUNOL METHODS, V311, P220, DOI 10.1016/j.jim.2006.02.005; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; Barda-Saad M, 2010, EMBO J, V29, P2315, DOI 10.1038/emboj.2010.133; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bubeck W. J., 1996, J BIOL CHEM, V271, P19641; BURGESS KE, 1991, EUR J IMMUNOL, V21, P1663, DOI 10.1002/eji.1830210712; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; daSilva AJ, 1997, BIOCHEM SOC T, V25, P361, DOI 10.1042/bst0250361; Fang N, 1996, J IMMUNOL, V157, P3769; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Jabeen A, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111963; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; Johnson PE, 2006, NAT STRUCT MOL BIOL, V13, P177, DOI 10.1038/nsmb1039; Jordan MS, 2006, J IMMUNOL, V176, P2430, DOI 10.4049/jimmunol.176.4.2430; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Liu HB, 2015, MOL CELL, V59, P840, DOI 10.1016/j.molcel.2015.07.015; Liu HB, 2013, J BIOL CHEM, V288, P29539, DOI 10.1074/jbc.M112.424846; Liu HB, 2010, P NATL ACAD SCI USA, V107, P10166, DOI 10.1073/pnas.0909112107; Mahajan K, 2015, ONCOGENE, V34, P4162, DOI 10.1038/onc.2014.350; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Prieto-Echagile V., 2011, J SIGNAL TRANSDUCT, V2011; Prieto-Echague V, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-42; Purbhoo MA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000645; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Rasband W., 2006, IMAGEJ; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Rudd CE, 1998, CURR BIOL, V8, pR805, DOI 10.1016/S0960-9822(07)00505-2; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Samelson LE, 1999, COLD SPRING HARB SYM, V64, P259, DOI 10.1101/sqb.1999.64.259; Schneider H, 2000, J BIOL CHEM, V275, P3835, DOI 10.1074/jbc.275.6.3835; Sem KP, 2002, MOL CELL BIOL, V22, P3685, DOI 10.1128/MCB.22.11.3685-3697.2002; Shen SD, 2009, BLOOD, V114, P74, DOI 10.1182/blood-2008-09-177832; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stubbington MJT, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0045-x; Thaker YR, 2015, IMMUNOL LETT, V163, P113, DOI 10.1016/j.imlet.2014.10.020; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wang HY, 2009, P NATL ACAD SCI USA, V106, P12436, DOI 10.1073/pnas.0900510106; Wang HY, 2004, J EXP MED, V200, P1063, DOI 10.1084/jem.20040780; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Xie BH, 2015, INT J ONCOL, V46, P2057, DOI 10.3892/ijo.2015.2910; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	52	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6281	6290		10.1074/jbc.M116.759555	http://dx.doi.org/10.1074/jbc.M116.759555			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28188290	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000399538700022
J	Cannan, WJ; Rashid, I; Tomkinson, AE; Wallace, SS; Pederson, DS				Cannan, Wendy J.; Rashid, Ishtiaque; Tomkinson, Alan E.; Wallace, Susan S.; Pederson, David S.			The Human Ligase III alpha-XRCC1 Protein Complex Performs DNA Nick Repair after Transient Unwrapping of Nucleosomal DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; SINGLE-STRAND BREAK; RNA-POLYMERASE-II; CORE PARTICLE; RECOMBINANT HISTONES; MAMMALIAN-CELLS; IN-VITRO; CHROMATIN; BINDING; GENE	Reactive oxygen species generate potentially cytotoxic and mutagenic lesions in DNA, both between and within the nucleosomes that package DNA in chromatin. The vast majority of these lesions are subject to base excision repair (BER). Enzymes that catalyze the first three steps in BER can act at many sites in nucleosomes without the aid of chromatin-remodeling agents and without irreversibly disrupting the host nucleosome. Here we show that the same is true for a protein complex comprising DNA ligase III alpha and the scaffolding protein X-ray repair cross-complementing protein 1 (XRCC1), which completes the fourth and final step in (short-patch) BER. Using in vitro assembled nucleosomes containing discretely positioned DNA nicks, our evidence indicates that the ligase III alpha-XRCC1 complex binds to DNA nicks in nucleosomes only when they are exposed by periodic, spontaneous partial unwrapping of DNA from the histone octamer; that the scaffolding protein XRCC1 enhances the ligation; that the ligation occurs within a complex that ligase III alpha-XRCC1 forms with the host nucleosome; and that the ligase III alpha-XRCC1-nucleosome complex decays when ligation is complete, allowing the host nucleosome to return to its native configuration. Taken together, our results illustrate ways in which dynamic properties intrinsic to nucleosomes may contribute to the discovery and efficient repair of base damage in chromatin.	[Cannan, Wendy J.; Wallace, Susan S.; Pederson, David S.] Univ Vermont, Dept Microbiol & Mol Genet, Rm 220,Stafford Bldg,95 Carrigan Dr, Burlington, VT 05405 USA; [Rashid, Ishtiaque; Tomkinson, Alan E.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Rashid, Ishtiaque; Tomkinson, Alan E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Rashid, Ishtiaque; Tomkinson, Alan E.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of Vermont; University of New Mexico; University of New Mexico; University of New Mexico	Pederson, DS (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Rm 220,Stafford Bldg,95 Carrigan Dr, Burlington, VT 05405 USA.	david.pederson@uvm.edu	Classen, Scott/AAY-8176-2020; Cannan, Wendy J/L-6359-2016	Cannan, Wendy J/0000-0002-7629-8611; Wallace, Susan S./0000-0002-3906-0321	NCI, National Institutes of Health [P01CA098993, CA92584]; NIEHS, National Institutes of Health [ES012512]; NATIONAL CANCER INSTITUTE [P01CA092584, P01CA098993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012512] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NCI, National Institutes of Health Grants P01CA098993 (to S.S.W.) and CA92584 (to A.E.T.) and NIEHS, National Institutes of Health Grant ES012512 (to A.E.T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Arakawa H, 2015, GENES-BASEL, V6, P385, DOI 10.3390/genes6020385; Bielinsky AK, 1999, MOL CELL, V3, P477, DOI 10.1016/S1097-2765(00)80475-X; Campalans A, 2013, NUCLEIC ACIDS RES, V41, P3115, DOI 10.1093/nar/gkt025; Cannan WJ, 2014, J BIOL CHEM, V289, P19881, DOI 10.1074/jbc.M114.571588; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; Chen X, 2009, DNA REPAIR, V8, P961, DOI 10.1016/j.dnarep.2009.06.002; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cotner-Gohara E, 2008, J BIOL CHEM, V283, P10764, DOI 10.1074/jbc.M708175200; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Czaja W, 2014, DNA REPAIR, V16, P35, DOI 10.1016/j.dnarep.2014.01.002; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; DONG F, 1990, P NATL ACAD SCI USA, V87, P5724, DOI 10.1073/pnas.87.15.5724; Duclos S, 2012, ISSUES TOXICOL, V13, P115, DOI 10.1039/9781849732925-00115; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Flaus A, 1996, P NATL ACAD SCI USA, V93, P1370, DOI 10.1073/pnas.93.4.1370; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Friedberg E. C., 2005, DNA REPAIR MUTAGENES, P9; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Krude T, 1999, EUR J BIOCHEM, V263, P1, DOI 10.1046/j.1432-1327.1999.00508.x; Kukshal V, 2015, NUCLEIC ACIDS RES, V43, P7021, DOI 10.1093/nar/gkv652; Kulaeva OI, 2013, BBA-GENE REGUL MECH, V1829, P76, DOI 10.1016/j.bbagrm.2012.08.015; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maher RL, 2013, DNA REPAIR, V12, P964, DOI 10.1016/j.dnarep.2013.08.010; Mani RS, 2004, BIOCHEMISTRY-US, V43, P16505, DOI 10.1021/bi048615m; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Maskell DP, 2015, NATURE, V523, P366, DOI 10.1038/nature14495; Menoni H, 2007, MOL CELL BIOL, V27, P5949, DOI 10.1128/MCB.00376-07; Nakanishi S, 2007, NUCLEIC ACIDS RES, V35, P4313, DOI 10.1093/nar/gkm436; Odell ID, 2013, J CELL PHYSIOL, V228, P258, DOI 10.1002/jcp.24134; Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11; Odell ID, 2010, DNA REPAIR, V9, P134, DOI 10.1016/j.dnarep.2009.11.005; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; PEDERSON DS, 1986, P NATL ACAD SCI USA, V83, P7206, DOI 10.1073/pnas.83.19.7206; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; Prasad R, 2012, NUCLEIC ACIDS RES, V40, P11571, DOI 10.1093/nar/gks898; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; Thastrom A, 2004, METHODS, V33, P33, DOI 10.1016/j.ymeth.2003.10.018; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Tims HS, 2011, J MOL BIOL, V411, P430, DOI 10.1016/j.jmb.2011.05.044; Tomkinson AE, 2013, GENE, V531, P150, DOI 10.1016/j.gene.2013.08.061; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Weren RDA, 2015, NAT GENET, V47, P668, DOI 10.1038/ng.3287; Ye Y, 2012, BIOCHEMISTRY-US, V51, P6028, DOI 10.1021/bi3006412	62	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5227	5238		10.1074/jbc.M116.736728	http://dx.doi.org/10.1074/jbc.M116.736728			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28184006	Green Published, hybrid			2022-12-26	WOS:000397875500007
J	Jabbari, A; Mousavian, M; Seyedi, SM; Bakavoli, M; Sadeghian, H				Jabbari, Atena; Mousavian, Mina; Seyedi, Seyed Mohamad; Bakavoli, Mehdi; Sadeghian, Hamid			O-prenylated 3-carboxycoumarins as a novel class of 15-LOX-1 inhibitors	PLOS ONE			English	Article							POTENT 15-LIPOXYGENASE INHIBITORS; ARACHIDONATE 15-LIPOXYGENASE; HUMAN EOSINOPHILS; PURIFICATION; ACID; LIPOXYGENASES; RETICULOCYTE; LEUKOCYTES; EXPRESSION; MECHANISM	Allyloxy, Isopentenyloxy, geranyloxy and farnesyloxy derivatives of 3-carboxycoumarin, at position 5, 6, 7, and 8, were synthesized and their inhibitory potency against human 15-lipoxygenase-1 (human 15-LOX-1) were determined. Among the synthetic coumarins, O-allyl and O-isopentenyl derivatives demonstrated no considerable lipoxygenase inhibition while O-geranyl and O-farnesyl derivatives demonstrated potent inhibitory activity. 5-farnesyloxy-3-carboxycoumarin demonstrated the most potent inhibitory activity by IC50 = 0.74 mu M while 6-farnesyloxy-3-carboxycoumarin was the weakest inhibitor among farnesyl analogs (IC50 = 10.4 mu M). Bonding affinity of the designed molecular structures toward 15-LOX-1 3D structure complexed with RS75091, as potent 15-LOX-1 inhibitor, was studied by utilizing docking analysis. There was a direct relationship between lipoxygenase inhibitory potency and prenyl length chain. The ability of the prenyl portion to fill the lipophilic pocket which is formed by Ile663, Ala404, Arg403, Ile400, Ile173 and Phe167 side chains can explain the observed relationship. Similarity rate between the docked models and complexed form of RS75091, from point of view of configuration and conformation, could explain inhibitory potency variation between each prenyloxy substitution of 3-carboxycoumarins.	[Jabbari, Atena; Seyedi, Seyed Mohamad; Bakavoli, Mehdi] Ferdowsi Univ Mashhad, Fac Sci, Dept Chem, Mashhad, Iran; [Mousavian, Mina] Payame Noor Univ, Dept Biol, Mashhad, Iran; [Sadeghian, Hamid] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran; [Sadeghian, Hamid] Mashhad Univ Med Sci, Sch Paramed Sci, Dept Lab Sci, Mashhad, Iran	Ferdowsi University Mashhad; Payame Noor University; Mashhad University Medical Science; Mashhad University Medical Science	Sadeghian, H (corresponding author), Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran.; Sadeghian, H (corresponding author), Mashhad Univ Med Sci, Sch Paramed Sci, Dept Lab Sci, Mashhad, Iran.	sadeghianh@mums.ac.ir		Sadeghian, Hamid/0000-0001-7894-5002				Berhenke LF, 1944, U.S. Patent., Patent No. [2:338,569, 2338569]; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Creaven BS, 2006, INORG CHIM ACTA, V359, P3976, DOI 10.1016/j.ica.2006.04.006; Eleftheriadis N, 2015, EUR J MED CHEM, V94, P265, DOI 10.1016/j.ejmech.2015.03.007; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; Grullich C, 2001, FEBS LETT, V489, P51, DOI 10.1016/S0014-5793(01)02080-4; Heidelbaugh TM, 2011, Coumarin compounds as receptor modulator with therapeutic utility, Patent No. [WO/2011/050054, 2011050054]; Iranshahi M, 2012, EUR J MED CHEM, V57, P134, DOI 10.1016/j.ejmech.2012.09.006; Jabbari A, 2012, BIOORGAN MED CHEM, V20, P5518, DOI 10.1016/j.bmc.2012.07.025; Kelavkar UP, 2000, CARCINOGENESIS, V21, P1777; KROSCHWALD P, 1989, BIOCHEM BIOPH RES CO, V160, P954, DOI 10.1016/0006-291X(89)92528-X; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1168, P73, DOI 10.1016/0005-2760(93)90268-E; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1169, P80, DOI 10.1016/0005-2760(93)90085-N; Maccarrone M, 2001, CELL DEATH DIFFER, V8, P776, DOI 10.1038/sj.cdd.4400908; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mytilineou C, 2002, PARKINSONISM RELAT D, V8, P385, DOI 10.1016/S1353-8020(02)00018-4; NADEL JA, 1991, J CLIN INVEST, V87, P1139, DOI 10.1172/JCI115110; Nadendla R.R., 2005, PRINCIPLES ORGANIC M; Nikpour M, 2013, MED CHEM RES, V22, P5036, DOI 10.1007/s00044-013-0506-7; Sadeghian H, 2016, EXPERT OPIN THER PAT, V26, P65, DOI 10.1517/13543776.2016.1113259; Sadeghian H, 2009, BIOORGAN MED CHEM, V17, P2327, DOI 10.1016/j.bmc.2009.02.009; Samoszuk M, 2006, AM J HEMATOL, V81, P552, DOI 10.1002/ajh.20551; Shah RC, 1938, J CHEM SOC, P1828, DOI 10.1039/jr9380001828; SIGAL E, 1988, BIOCHEM BIOPH RES CO, V150, P376, DOI 10.1016/0006-291X(88)90531-1; Spindler SA, 1997, BIOCHEM BIOPH RES CO, V239, P775, DOI 10.1006/bbrc.1997.7471; Suardiaz R, 2016, J CHEM THEO IN PRESS; Toledo L, 2010, J PHYS CHEM B, V114, P7037, DOI 10.1021/jp912120n; van Leyen K, 2006, STROKE, V37, P3014, DOI 10.1161/01.STR.0000249004.25444.a5; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9	29	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171789	10.1371/journal.pone.0171789	http://dx.doi.org/10.1371/journal.pone.0171789			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182779	Green Published, gold			2022-12-26	WOS:000394231800112
J	Kaida, K; Itaguchi, Y; Iwaki, S				Kaida, Kosuke; Itaguchi, Yoshihiro; Iwaki, Sunao			Interactive effects of visuomotor perturbation and an afternoon nap on performance and the flow experience	PLOS ONE			English	Article							MOTOR SEQUENCE; SLEEP; MEMORY; ADAPTATION; CONSOLIDATION; IMPLICIT; STRIATUM; IMAGERY; STATES; SPORT	The present study was designed (1) to clarify the relationship between the flow experience and improvements in visuomotor skills, (2) to examine the effects of rotating the axis of a computer mouse on visuomotor skills, and (3) to investigate the effects of sleep for improving visuomotor skills. Participants (N = 18) responded to Perturbation and nap (PER+Nap), No-perturbation and nap (NoPER+Nap) and Perturbation and rest (PER+Rest) conditions. In the PER+Nap condition, participants conducted a visuomotor tracking task using a computer mouse, which was accompanied by perturbation caused by rotating the axis of their mouse. After the task, they took a 90 min nap. In NoPER+Nap condition, they conducted the same visuomotor task without any perturbation and took a nap. In the PER+Rest condition, participants conducted the task with the perturbation and took a 90 min break spent reading magazines instead of taking a nap. Results indicated (1) the flow experience did not occur when participants' skills and the degree of the visuomotor challenge were matching, (2) improvements of visuomotor skills occurred regardless of the perturbation, (3) improvements of visuomotor skills occurred unrelated to the flow experience, or to mood states, and (4) improvements of visuomotor performance occurred regardless of sleep. These findings suggest that improvements of visuomotor skills occur regardless of mood status and occur independently of perturbations by axis rotation. The study also suggests that the acquisition of skills is related to merely the time elapsed since learning, rather than to sleep.	[Kaida, Kosuke; Iwaki, Sunao] Natl Inst Adv Ind Sci & Technol, Inst Informat Technol & Human Factors, Tsukuba, Ibaraki, Japan; [Itaguchi, Yoshihiro] Keio Univ, Dept Syst Design Engn, Yokohama, Kanagawa, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Keio University	Kaida, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Inst Informat Technol & Human Factors, Tsukuba, Ibaraki, Japan.	kaida.kosuke@aist.go.jp	Itaguchi, Yoshihiro/AAK-7239-2020; Iwaki, Sunao/B-1079-2011	Itaguchi, Yoshihiro/0000-0002-2033-2171; Iwaki, Sunao/0000-0002-7123-7203	JSPS KAKENHI [16K13511]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by JSPS KAKENHI Grant No. 16K13511	Albouy G, 2013, PLOS ONE, V8; Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Albouy G, 2013, J SLEEP RES, V22, P144, DOI 10.1111/j.1365-2869.2012.01059.x; Asakawa K, 2010, J HAPPINESS STUD, V11, P205, DOI 10.1007/s10902-008-9132-3; Backhaus W, 2016, NEUROBIOL LEARN MEM, V131, P147, DOI 10.1016/j.nlm.2016.03.017; Bakker AB, 2011, PSYCHOL SPORT EXERC, V12, P442, DOI 10.1016/j.psychsport.2011.02.003; Bedard P, 2014, NEUROIMAGE, V101, P225, DOI 10.1016/j.neuroimage.2014.07.009; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL; Csikszentmihalyi M, 1997, FINDING FLOW; de Manzano O, 2010, EMOTION, V10, P301, DOI 10.1037/a0018432; de Manzano O, 2013, NEUROIMAGE, V67, P1, DOI 10.1016/j.neuroimage.2012.10.072; Debarnot U, 2011, COGN AFFECT BEHAV NE, V11, P541, DOI 10.3758/s13415-011-0052-z; Debarnot U, 2009, SLEEP, V32, P1559, DOI 10.1093/sleep/32.12.1559; Dinges DF, 1997, SLEEP, V20, P267; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Henriques DYP, 2012, J MOTOR BEHAV, V44, P435, DOI 10.1080/00222895.2012.659232; Iber C., 2007, AASM MANUAL SCORING; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Imamizu H, 2012, CEREBELLUM, V11, P325, DOI 10.1007/s12311-010-0241-2; Ishimura I, 2008, THESIS; Jackson SA, 1998, J SPORT EXERCISE PSY, V20, P358, DOI 10.1123/jsep.20.4.358; Kaida K, 2014, JIDOUSYAGIZYUTSU, V68, P59; Kaida K, 2012, ERGONOMICS, V55, P1340, DOI 10.1080/00140139.2012.715681; Kaida K, 2012, IND HEALTH, V50, P189; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Landsness EC, 2009, SLEEP, V32, P1273; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Morita Y, 2012, SLEEP BIOL RHYTHMS, V10, P302, DOI 10.1111/j.1479-8425.2012.00576.x; Payne JD, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00108; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Prehn-Kristensen A, 2009, J EXP CHILD PSYCHOL, V104, P132, DOI 10.1016/j.jecp.2009.01.005; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rieth CA, 2010, BEHAV BRAIN RES, V214, P470, DOI 10.1016/j.bbr.2010.05.052; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Swann C, 2012, PSYCHOL SPORT EXERC, V13, P807, DOI 10.1016/j.psychsport.2012.05.006; Tucker MA, 2006, NEUROBIOL LEARN MEM, V86, P241, DOI 10.1016/j.nlm.2006.03.005; van der Helm E, 2011, SLEEP MED CLIN, V6, P31, DOI 10.1016/j.jsmc.2010.12.010; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wilhelm I, 2008, LEARN MEMORY, V15, P373, DOI 10.1101/lm.803708	40	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171907	10.1371/journal.pone.0171907	http://dx.doi.org/10.1371/journal.pone.0171907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182742	gold, Green Submitted, Green Published			2022-12-26	WOS:000394231800132
J	Kubota, C; Meng, C; Son, YJ; Lewis, M; Spalholz, H; Tronstad, R				Kubota, Chieri; Meng, Chao; Son, Young-Jun; Lewis, Myles; Spalholz, Hans; Tronstad, Russell			Horticultural, systems-engineering and economic evaluations of short-term plant storage techniques as a labor management tool for vegetable grafting nurseries	PLOS ONE			English	Article							LOW-TEMPERATURE STORAGE; LED-LOW LIGHT; ROOT TEMPERATURE; CUCUMBER CULTIVARS; FIGLEAF GOURD; SIMULATION; PRESERVATION; INTENSITY; SEEDLINGS; QUALITY	This transdisciplinary study has a three-fold systems approach in evaluating a horticultural technology: 1) horticultural evaluations, 2) economic and resource analyses, and 3) systems engineering analyses, using low temperature storage as an example technology. Vegetable grafting is a technique to produce value-added seedlings but requires labor intensive nursery operations. Low temperature storage of seedlings for a short period of time can reduce peak production, but has not been evaluated at the extent demonstrated in this paper. Seedlings of 22 genotypes of Cucurbitaceae (cucurbit family) and Solanaceae (nightshade family) were evaluated for storability under selected temperatures and photosynthetic photon flux. Storability of Cucurbitaceous seedlings varied between 2 to 4 weeks at 12 degrees C and 13 mu mol m(-2) s(-1). Solanaceous seedlings were generally storable for 4 weeks at 12 degrees C and 13 mu mol m(-2) s(-1), but tomato seedlings could be stored for 4 weeks at 10 degrees C and 5 mu mol m(-2) s(-1). Capital and weekly operational costs of a low temperature storage system with a design that meets environmental requirements were estimated as $671 to $708 per m(2) footprint and $0.79 to $2.21 per m(2) footprint per week, respectively. Electricity costs per plant was less than 0.1 cents for 2 to 4 weeks of storage. Using a schedule-optimization heuristic and a logistics simulator previously developed for grafting nursery operations, six production scenarios consisting of two crops (tomato or watermelon) and three production peak patterns were examined to evaluate the impact of including low temperature storage. While the overall average costs of grafting labor were not significantly different, maximum labor demand and grafting labor cost during the peak production week were reduced by 31% to 50% and 14% to 30% by using storage, respectively. Therefore, low temperature storage can be an effective means to address the issue of labor management in grafting nurseries.	[Kubota, Chieri; Lewis, Myles; Spalholz, Hans] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Meng, Chao; Son, Young-Jun] Univ Arizona, Dept Syst & Ind Engn, Tucson, AZ 85721 USA; [Tronstad, Russell] Univ Arizona, Dept Agr & Resource Econ, Tucson, AZ 85721 USA; [Meng, Chao] Valdosta State Univ, Dept Mkt & Int Business, Valdosta, GA USA	University of Arizona; University of Arizona; University of Arizona; University System of Georgia; Valdosta State University	Kubota, C (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA.	ckubota@email.arizona.edu		Lewis, Myles/0000-0002-9812-5156				Ahn SJ, 1999, SCI HORTIC-AMSTERDAM, V81, P397, DOI 10.1016/S0304-4238(99)00042-4; Augusto V, 2015, P 2015 WINT SIM C DE, P1503; Calvin L., 2010, ERR106 US DEP AGR EC; Davis AR, 2008, CRIT REV PLANT SCI, V27, P50, DOI 10.1080/07352680802053940; Ding M, 2011, HORTSCIENCE, V46, P993, DOI 10.21273/HORTSCI.46.7.993; Fujiwara K, 2005, HORTTECHNOLOGY, V15, P781, DOI 10.21273/HORTTECH.15.4.0781; Heins RD, 1995, ACTA HORTIC, P285, DOI 10.17660/ActaHortic.1995.396.34; Justus I, 2010, SCI HORTIC-AMSTERDAM, V125, P47, DOI 10.1016/j.scienta.2010.02.020; Khan A, 2004, EXPANDED PRODUCTION, P35; Kubota C, 1995, ACTA HORTIC, P103, DOI 10.17660/ActaHortic.1995.393.11; Kubota C, 2002, SCI HORTIC-AMSTERDAM, V94, P13, DOI 10.1016/S0304-4238(01)00382-X; LEE JM, 1994, HORTSCIENCE, V29, P235, DOI 10.21273/HORTSCI.29.4.235; Lee JM, 2010, SCI HORTIC-AMSTERDAM, V127, P93, DOI 10.1016/j.scienta.2010.08.003; Lee S, 2004, J EXP BOT, V56, P955; Lewis M, 2014, HORTSCIENCE, V49, P917, DOI 10.21273/HORTSCI.49.7.917; Liu CI, 2002, IEEE T INTELL TRANSP, V3, P12, DOI 10.1109/6979.994792; Louws FJ, 2010, SCI HORTIC-AMSTERDAM, V127, P127, DOI 10.1016/j.scienta.2010.09.023; Mawlana M, 2015, AUTOMAT CONSTR, V60, P25, DOI 10.1016/j.autcon.2015.09.005; Meng C, 2014, COMPUT ELECTRON AGR, V102, P73, DOI 10.1016/j.compag.2014.01.007; Nelson JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099010; Ohyama K., 1998, Journal of Society of High Technology in Agriculture, V10, P96; Park JS, 2009, EUR J HORTIC SCI, V74, P21; Rivard CL, 2010, HORTTECHNOLOGY, V20, P794, DOI 10.21273/HORTTECH.20.4.794; Rusnock CF, 2013, IIE 2013 ANN C P JAN, P2485; Snoddy GS, 1926, J APPL PSYCHOL, V10, P1, DOI 10.1037/h0075814; Son YJ, 2003, COMPUT IND ENG, V45, P141, DOI 10.1016/S0360-8352(03)00023-8; Spalholz H., 2013, THESIS U ARIZONA; TACHIBANA S, 1987, J JPN SOC HORTIC SCI, V55, P461, DOI 10.2503/jjshs.55.461; TACHIBANA S, 1982, J JPN SOC HORTIC SCI, V51, P299, DOI 10.2503/jjshs.51.299; Zhang ZS, 2015, SCI REP-UK, V5, DOI 10.1038/srep13094	30	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170614	10.1371/journal.pone.0170614	http://dx.doi.org/10.1371/journal.pone.0170614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182757	Green Submitted, Green Published, gold			2022-12-26	WOS:000394231800015
J	Li, YH; Yu, SF; Gu, GZ; Chen, GS; Zheng, YX; Jiao, J; Zhou, WH; Wu, H; Zhang, ZR; Zhang, HL; He, LH; Yang, QY; Xu, XR				Li, Yanhong; Yu, Shanfa; Gu, Guizhen; Chen, Guoshun; Zheng, Yuxin; Jiao, Jie; Zhou, Wenhui; Wu, Hui; Zhang, Zengrui; Zhang, Huanling; He, Lihua; Yang, Qiuyue; Xu, Xiangrong			Polymorphisms of heat shock protein 70 genes (HSPA1A, HSPA1B and HSPA1L) and susceptibility of noise-induced hearing loss in a Chinese population: A case-control study	PLOS ONE			English	Article							HSP70 GENES; ASSOCIATION; WORKERS; EXPOSURE; SMOKING; RISK; SOD2; CAT	Noise-induced hearing loss (NIHL) is the second-most frequent form of sensorineural hearing loss. When exposed to the same noise, some workers develop NIHL while others do not, suggesting that NIHL may be associated with genetic factors. To explore the relationship between single nucleotide polymorphisms (SNPs) in heat shock protein 70 (HSP70) genes (HSPA1A, HSPA1B and HSPA1L) and susceptibility to NIHL in Han Chinese workers exposed to noise, a case-control association study was carried out with 286 hearing loss cases and 286 matched with gender, age, type of work, and exposure time, drawn from a population of 3790 noise-exposed workers. Four SNPs were selected and genotyped. Subsequently, the effects of the alleles and genotypes of the three HSP70 genes (HSPA1A, HSPA1B and HSPA1L) on NIHL were analyzed by using a conditional logistic regression. A generalized multiple dimensionality reduction (GMDR) was applied to further detect an interaction between the four SNPs. Compared with the combined genotypes CC/TC, carriers of the TT genotype of rs2763979 appeared to show greater susceptibility to NIHL (P = 0.042, adjusted OR = 1.731, 95% CI 1.021-2.935). A significant interaction between rs2763979 and CNE was found (P = 0.029), and a significant association was found between TT of s2763979 and NIHL (P = 0.024, adjusted OR = 5.694, 95% CI 1.256-25.817) in the 96 dB (A) <= CNE < 101 dB (A) group. The results suggest that the rs2763979 locus of the HSP70 genes may be associated with susceptibility to NIHL in Chinese individuals, and other HSP70 genes may also be susceptibility genes for NIHL, but the results must be further replicated in additional independent sample sets.	[Li, Yanhong; Yu, Shanfa; Gu, Guizhen; Jiao, Jie; Zhou, Wenhui; Wu, Hui; Zhang, Zengrui] Henan Prov Inst Occupat Hlth, Zhengzhou, Peoples R China; [Chen, Guoshun; Zhang, Huanling] Wugang Inst Occupat Hlth, Wugang, Peoples R China; [Zheng, Yuxin] Chinese Ctr Dis Control & Prevent, Natl Inst Occupat Hlth & Poison Control, Beijing, Peoples R China; [He, Lihua; Yang, Qiuyue; Xu, Xiangrong] Peking Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Occupational Health & Poison Control, Chinese Center for Disease Control & Prevention; Peking University	Yu, SF (corresponding author), Henan Prov Inst Occupat Hlth, Zhengzhou, Peoples R China.	yu-shanfa@163.com	zhang, zengrui/HGB-6209-2022		National Natural Science Foundation of the People's Republic of China [81372940]; National Science and Technology Infrastructure Program of the People's Republic of China [2014BAI12B03]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Infrastructure Program of the People's Republic of China	This study was supported by the National Natural Science Foundation of the People's Republic of China (81372940) and the Research Fund from the National Science and Technology Infrastructure Program of the People's Republic of China (2014BAI12B03).	Abreu-Silva RS, 2011, ANN HUM BIOL, V38, P210, DOI 10.3109/03014460.2010.513774; Carlsson PI, 2005, HEARING RES, V202, P87, DOI 10.1016/j.heares.2004.09.005; Chang NC, 2007, OTOLARYNG HEAD NECK, V137, P603, DOI 10.1016/j.otohns.2007.04.022; Chang NC, 2011, AUDIOL NEURO-OTOL, V16, P168, DOI 10.1159/000317119; Chang NC, 2009, AM J OTOLARYNG, V30, P396, DOI 10.1016/j.amjoto.2008.08.001; Fortunato G, 2004, CLIN CHEM, V50, P2012, DOI 10.1373/clinchem.2004.037788; Konings A, 2007, HUM MOL GENET, V16, P1872, DOI 10.1093/hmg/ddm135; Konings A, 2009, EUR J HUM GENET, V17, P329, DOI 10.1038/ejhg.2008.172; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Liberman MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162726; LIM DJ, 1986, AM J OTOLARYNG, V7, P73, DOI 10.1016/S0196-0709(86)80037-0; Liu JP, 2007, CLIN CHIM ACTA, V384, P64, DOI 10.1016/j.cca.2007.05.021; Liu YM, 2010, DIS MARKERS, V28, P137, DOI [10.1155/2010/753073, 10.3233/DMA-2010-0693]; Liu YM, 2010, ACTA OTO-LARYNGOL, V130, P477, DOI 10.3109/00016480903253587; Mandal K, 2005, ANN THORAC SURG, V79, P865, DOI 10.1016/j.athoracsur.2004.08.018; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MILNER CM, 1990, IMMUNOGENETICS, V32, P242; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Ni CH, 2007, CHINESE MED J-PEKING, V120, P1309, DOI 10.1097/00029330-200708010-00003; Rachiotis G, 2006, AURIS NASUS LARYNX, V33, P381, DOI 10.1016/j.anl.2006.03.008; Samson J, 2007, NEUROSCI RES, V57, P143, DOI 10.1016/j.neures.2006.09.019; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Shen HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089662; Sliwinska-Kowalska M, 2008, AM J HUM BIOL, V20, P481, DOI 10.1002/ajhb.20744; Sliwinska-Kowalska M, 2013, MUTAT RES-REV MUTAT, V752, P61, DOI 10.1016/j.mrrev.2012.11.001; Sulkowski Wieslaw J, 2004, Otolaryngol Pol, V58, P233; Van Laer L, 2006, HUM MUTAT, V27, P786, DOI 10.1002/humu.20360; Vargas-Alarcon G, 2002, ANN RHEUM DIS, V61, P48, DOI 10.1136/ard.61.1.48; Wang SL, 2014, BIOMED ENVIRON SCI, V27, P965, DOI 10.3967/bes2014.131; Wild DC, 2005, CLIN OTOLARYNGOL, V30, P517, DOI 10.1111/j.1749-4486.2005.01105.x; Xie HW, 2015, EAR HEAR; Yang M, 2006, CELL STRESS CHAPERON, V11, P233, DOI 10.1379/CSC-192R.1; Zhou F, 2005, CELL STRESS CHAPERON, V10, P349, DOI 10.1379/CSC-156.1	33	9	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171722	10.1371/journal.pone.0171722	http://dx.doi.org/10.1371/journal.pone.0171722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182740	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800096
J	Pan, H; Gu, LQ; Liu, BJ; Li, YP; Wang, YH; Bai, XN; Li, L; Wang, BS; Peng, Q; Yao, ZGG; Tang, ZG				Pan, Hao; Gu, Liqun; Liu, Binjie; Li, Yiping; Wang, Yuehong; Bai, Xinna; Li, Long; Wang, Baisheng; Peng, Qian; Yao, Zhigang; Tang, Zhangui			Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinoma	PLOS ONE			English	Article							MICRORNA-21 TARGETS; PROTEOMIC ANALYSIS; COLORECTAL-CANCER; IDENTIFICATION; TRANSFORMATION; EXPRESSION; MIR-21; GENES; METHYLATION; METASTASIS	It is widely accepted that oral squamous cell carcinoma (OSCC) is a major contributor to the incidence and mortality of neck and head cancer. Tropomyosin-1 (TPM1), which is expressed at a low level, has been considered a prominent tumor-suppressing gene in a variety of solid tumors, although the precise mechanism of the TPM1 gene in OSCC progression remains unknown. We found that TPM1 expression levels decreased in OSCC patients and OSCC cell lines. The overall and cancer-specific survival of patients who exhibited low TPM1 levels were inferior to those of patients who had high TPM1 levels. It was also found that OSCC patients who suffered from disease stageI-II were more likely to have an up-regulated TPM1 expression level, and OSCC patients with lymph node metastasis had a higher probability of exhibiting reduced TPM1 expression. We show that overexpression of TPM1 can promote cell apoptosis and inhibit migration. Our results suggest that TPM1 can suppress tumors in OSCC, and the TPM1 expression level is related to OSCC patient prognosis.	[Pan, Hao; Gu, Liqun; Wang, Baisheng; Peng, Qian; Tang, Zhangui] Cent S Univ, Xiangya Stomatol Hosp, Dept Oral & Maxillofacial Surg, Changsha, Hunan, Peoples R China; [Pan, Hao; Gu, Liqun; Liu, Binjie; Li, Yiping; Wang, Yuehong; Bai, Xinna; Li, Long; Wang, Baisheng; Peng, Qian; Yao, Zhigang; Tang, Zhangui] Cent S Univ, Sch Stomatol, Changsha, Hunan, Peoples R China; [Liu, Binjie] Cent S Univ, Xiangya Stomatol Hosp, Dept Periodont, Changsha, Hunan, Peoples R China; [Li, Yiping; Wang, Yuehong] Cent S Univ, Xiangya Stomatol Hosp, Dept Prosthodont, Changsha, Hunan, Peoples R China; [Bai, Xinna] Cent S Univ, Xiangya Stomatol Hosp, Dept Conservat Dent & Endodont, Changsha, Hunan, Peoples R China; [Li, Long; Yao, Zhigang] Cent S Univ, Xiangya Stomatol Hosp, Dept Oral Pathol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University	Tang, ZG (corresponding author), Cent S Univ, Xiangya Stomatol Hosp, Dept Oral & Maxillofacial Surg, Changsha, Hunan, Peoples R China.; Tang, ZG (corresponding author), Cent S Univ, Sch Stomatol, Changsha, Hunan, Peoples R China.	tangzhangui@aliyun.com						Ali S, 2011, AM J TRANSL RES, V3, P28; Bailey Mark J, 2013, J Carcinog, V12, P10, DOI 10.4103/1477-3163.114216; Campa MJ, 2016, CANCER IMMUNOL IMMUN, V65, P171, DOI 10.1007/s00262-015-1787-0; Chen C, 2016, ONCOTARGETS THER, V9, P1545, DOI 10.2147/OTT.S98807; Chinn SB, 2015, J CLIN ONCOL, V33, P3269, DOI 10.1200/JCO.2015.61.2929; Dube S, 2015, INT J BREAST CANCER, V2015, DOI 10.1155/2015/859427; Dube S, 2016, ONCOL REP, V35, P3143, DOI 10.3892/or.2016.4732; He QY, 2004, PROTEOMICS, V4, P271, DOI 10.1002/pmic.200300550; Helfman DM, 2008, ADV EXP MED BIOL, V644, P124; Hu J, 2013, P NATL ACAD SCI USA, V110, P14520, DOI 10.1073/pnas.1308610110; Johnson N W, 2011, Adv Dent Res, V23, P237, DOI 10.1177/0022034511402082; Khori V, 2015, EUR J PHARMACOL, V765, P179, DOI 10.1016/j.ejphar.2015.08.031; Langer W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-676; Li DQ, 2006, PROTEOMICS, V6, P3352, DOI 10.1002/pmic.200500617; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Liao SJ, 2012, BREAST CANCER RES TR, V133, P853, DOI 10.1007/s10549-011-1844-0; Lodi G, 2016, COCHRANE DB SYST REV, V7, DOI [10.1002/14651858.CD001829.pub4, DOI 10.1002/14651858.CD001829]; Ma YM, 2016, FRONT MED-PRC, V10, P278, DOI 10.1007/s11684-016-0453-z; Masthan KMK, 2012, ASIAN PAC J CANCER P, V13, P3573, DOI 10.7314/APJCP.2012.13.8.3573; Mlakar V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-282; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; Qi YJ, 2005, PROTEOMICS, V5, P2960, DOI 10.1002/pmic.200401175; Redwood C, 2013, J MUSCLE RES CELL M, V34, P285, DOI 10.1007/s10974-013-9358-5; Rosko AJ, 2016, OFFICIAL J AM ACAD O; Tang HY, 2013, J PROTEOMICS, V89, P165, DOI 10.1016/j.jprot.2013.06.016; Thiel UJE, 2011, J ORAL PATHOL MED, V40, P369, DOI 10.1111/j.1600-0714.2010.00982.x; Varga AE, 2005, ONCOGENE, V24, P5043, DOI 10.1038/sj.onc.1208688; Wang J, 2015, ONCOL REP, V33, P1326, DOI 10.3892/or.2015.3733; Wang Y, 2014, GENE, V533, P389, DOI 10.1016/j.gene.2013.09.038; Wang Z, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-383; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Xie S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116517; Zare M, 2012, MOL CARCINOGEN, V51, P796, DOI 10.1002/mc.20847; Zhang SK, 2015, CHINESE J CANCER RES, V27, P44, DOI 10.3978/j.issn.1000-9604.2015.01.03; Zheng G, 2016, J MOL MED; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	39	22	24	7	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0168900	10.1371/journal.pone.0168900	http://dx.doi.org/10.1371/journal.pone.0168900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182650	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800004
J	Rzewuska, M; de Azevedo-Marques, JM; Coxon, D; Zanetti, ML; Zanetti, ACG; Franco, LJ; Santos, JLF				Rzewuska, Magdalena; de Azevedo-Marques, Joao Mazzoncini; Coxon, Domenica; Zanetti, Maria Lucia; Guidorizzi Zanetti, Ana Carolina; Franco, Laercio Joel; Ferreira Santos, Jair Licio			Epidemiology of multimorbidity within the Brazilian adult general population: Evidence from the 2013 National Health Survey (PNS 2013)	PLOS ONE			English	Article							PRIMARY-CARE; CHRONIC DISEASES; CONSULTATION; DEPRESSION; PREVALENCE; PATTERNS; DESIGN; GENDER; INCOME	Middle-income countries are facing a growing challenge of adequate health care provision for people with multimorbidity. The objectives of this study were to explore the distribution of multimorbidity and to identify patterns of multimorbidity in the Brazilian general adult population. Data from 60202 adults, aged >= 18 years that completed the individual questionnaire of the National Health Survey 2013 (Portuguese: Pesquisa Nacional de SaudePNS) was used. We defined multimorbidity as the presence of two or more chronic conditions, including self-reported diagnoses and responses to the 9-item Patient Health Questionnaire for depression. Multivariate Poisson regression analyses were used to explore relationship between multimorbidity and demographic factors. Exploratory tetrachoric factor analysis was performed to identify multimorbidity patterns. 24.2% (95% CI 23.524.9) of the study population were multimorbid, with prevalence rate ratios being significantly higher in women, older people and those with lowest educational level. Multimorbidity occurred earlier in women than in men, with half of the women and men aged 5559 years and 6569 years, respectively, were multimorbid. The absolute number of people with multimorbidity was approximately 2.5-fold higher in people younger than 65 years than older counterparts (9920 vs 3945). Prevalence rate ratios of any mental health disorder significantly increased with the number of physical conditions. 46.7% of the persons were assigned to at least one of three identified patterns of multimorbidity, including: "cardio-metabolic", "musculoskeletal-mental" and "respiratory" disorders. Multimorbidity in Brazil is as common as in more affluent countries. Women in Brazil develop diseases at younger ages than men. Our findings can inform a national action plan to prevent multimorbidity, reduce its burden and align health-care services more closely with patients' needs.	[Rzewuska, Magdalena] Univ Sao Paulo, Ribeirao Preto Sch Med, Community Hlth Postgrad Program, Ribeirao Preto, SP, Brazil; [de Azevedo-Marques, Joao Mazzoncini; Franco, Laercio Joel; Ferreira Santos, Jair Licio] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Social Med, Ribeirao Preto, SP, Brazil; [Coxon, Domenica] Univ Edinburgh, Ctr Populat Hlth Sci, Lothian, Scotland; [Zanetti, Maria Lucia; Guidorizzi Zanetti, Ana Carolina] Univ Sao Paulo, Ribeirao Preto Coll Nursing, WHO Collaborating Ctr Nursing Res Dev, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Edinburgh; Universidade de Sao Paulo; World Health Organization	Rzewuska, M (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Community Hlth Postgrad Program, Ribeirao Preto, SP, Brazil.	magda.rzewuska@yahoo.co.uk	de azevedo-marques, joao mazzoncini/J-3172-2014; Zanetti, Ana Carolina G./H-6954-2013; de azevedo marques, joão mazzoncini/AAQ-8464-2020	de azevedo-marques, joao mazzoncini/0000-0002-3100-3883; Zanetti, Ana Carolina G./0000-0003-0011-4510; Rzewuska, Magdalena/0000-0003-4642-1196	Brazilian Ministry of Health [328 159]; Science without Borders Programme for "Young Talent Attraction" (CAPES) [CSF-PAJT - 88887.090476/2014-00]	Brazilian Ministry of Health; Science without Borders Programme for "Young Talent Attraction" (CAPES)	The survey data used in the study was financed by the Brazilian Ministry of Health (no. 328 159, 26 June 2013). Magdalena Rzewuska is funded by the Science without Borders Programme for Young Talent Attraction (CAPES, grant number: CSF-PAJT - 88887.090476/2014-00). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Andrade LH, 2010, BRAZ J MED BIOL RES, V43, P483, DOI 10.1590/S0100-879X2010007500024; [Anonymous], 2005, PREV CHRON DIS VIT I; Ballester Dinarte Alexandre, 2005, Sao Paulo Med. J., V123, P72, DOI 10.1590/S1516-31802005000200008; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Lima AFBD, 2011, REV BRAS PSIQUIATR, V33, P245, DOI 10.1590/S1516-44462011000300007; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Brazil Health Ministry D Health Care Secretary, 2012, NAT PROGR ACC QUAL I; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Capilheira MF, 2006, REV SAUDE PUBL, V40, P436, DOI 10.1590/S0034-89102006000300011; dos Santos Palazzo L, 2001, Aten Primaria, V28, P543; Elhayany, 1995, BMC PUBLIC HEALTH, V24, P167; Field A., 2013, DISCOVERING STAT USI; Fortin M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-686; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Garin N, 2016, J GERONTOL A-BIOL, V71, P205, DOI 10.1093/gerona/glv128; Goncalves DA, 2013, GEN HOSP PSYCHIAT, V35, P304, DOI 10.1016/j.genhosppsych.2013.01.003; Gregorio G, 2012, REV BRAS PSIQUIATR, V34, P434, DOI 10.1016/j.rbp.2012.05.006; Gross R, 1996, Public Health Rev, V24, P167; Hunt K, 2011, J HEALTH SERV RES PO, V16, P108, DOI 10.1258/jhsrp.2010.009131; IBGE-Instituto Brasileiro de Geografia e Estatistica, 2014, PESQ NAC SAUD 2013 P; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Kubinger K., 2003, PSYCHOL SCI, V45, P106, DOI DOI 10.1177/014662169101500105; Latinovic R, 2006, J NEUROL NEUROSUR PS, V77, P385, DOI 10.1136/jnnp.2005.073221; Ledesma RD, 2007, PRACT ASSESS RES EVA, V12, P1, DOI [https://doi.org/10.7275/wjnc-nm63, DOI 10.7275/WJNC-NM63]; Leite ID, 2015, CAD SAUDE PUBLICA, V31, P1551, DOI 10.1590/0102-311X00111614; Malta Deborah Carvalho, 2015, Rev. bras. epidemiol., V18, P3, DOI 10.1590/1980-5497201500060002; Mercer S., 2014, ABC MULTIMORBIDITY; Moffat K, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0344-4; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Muka T, 2015, EUR J EPIDEMIOL, V30, P251, DOI 10.1007/s10654-014-9984-2; Munhoz TN, 2016, J AFFECT DISORDERS, V192, P226, DOI 10.1016/j.jad.2015.12.038; Nunes BP, 2016, INT J PUBLIC HEALTH, P1; Osborn R, 2014, HEALTH AFFAIR, V33, P2247, DOI 10.1377/hlthaff.2014.0947; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Rao CR, 2006, HDB STAT; Rasmussen B, 2015, EC COSTS ABSENTEEISM; Ryan A, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0355-9; Santos IS, 2013, CAD SAUDE PUBLICA, V29, P1533, DOI [10.1590/S0102-311X2013001200006, 10.1590/0102-311X00144612]; Machado VDS, 2012, MENOPAUSE, V19, P569, DOI 10.1097/gme.0b013e3182455963; Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Schoen C, 2011, HEALTH AFFAIR, V30, P2437, DOI 10.1377/hlthaff.2011.0923; Schoen C, 2010, HEALTH AFFAIR, V29, P2323, DOI 10.1377/hlthaff.2010.0862; Sinnott C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003610; Smith SM, 2016, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006560.pub3, 10.1002/14651858.CD006560.pub4]; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Szwarcwald CL, 2014, CIENC SAUDE COLETIVA, V19, P333, DOI 10.1590/1413-81232014192.14072012; Valentini W, 2004, REV SAUDE PUBL, V38, P522, DOI 10.1590/S0034-89102004000400007; Vegda K, 2009, BMC HEALTH SERV RES, V9, P1; Wang YY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003320; WHO, 2008, PHARMAFORUM 0121; Willadsen TG, 2016, SCAND J PRIM HEALTH, V34, P112, DOI 10.3109/02813432.2016.1153242; Wilson P, 2008, PSYCHOLOGIST, V21, P866; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; World Health Organization, 2013, GLOB ACT PLAN PREV C; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	59	37	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171813	10.1371/journal.pone.0171813	http://dx.doi.org/10.1371/journal.pone.0171813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182778	Green Submitted, Green Published, gold			2022-12-26	WOS:000394231800118
J	Aguayo, J; Mostert, D; Fourrier-Jeandel, C; Cerf-Wendling, I; Hostachy, B; Viljoen, A; Ioos, R				Aguayo, Jaime; Mostert, Diane; Fourrier-Jeandel, Celine; Cerf-Wendling, Isabelle; Hostachy, Bruno; Viljoen, Altus; Ioos, Renaud			Development of a hydrolysis probe-based real-time assay for the detection of tropical strains of Fusarium oxysporum f. sp cubense race 4	PLOS ONE			English	Article							VEGETATIVE COMPATIBILITY GROUPS; MEDIATED ISOTHERMAL AMPLIFICATION; SENSITIVE DETECTION; RAPID DETECTION; HIGH-THROUGHPUT; PCR; BANANA; PLANT; WILT; SOIL	Fusarium oxysporum f. sp. cubense (Foc) is one of the most important threats to global banana production. Strategies to control the pathogen are lacking, with plant resistance offering the only long-term solution, if sources of resistance are available. Prevention of introduction of Foc into disease-free areas thus remains a key strategy to continue sustainable banana production. In recent years, strains of Foc affecting Cavendish bananas have destroyed plantations in a number of countries in Asia and in the Middle East, and one African country. One vegetative compatibility group (VCG), 01213/16, is considered the major threat to bananas in tropical and subtropical climatic conditions. However, other genetically related VCGs, such as 0121, may potentially jeopardize banana cultures if they were introduced into disease-free areas. To prevent the introduction of these VCGs into disease-free Cavendish banana-growing countries, a real-time PCR test was developed to accurately detect both VCGs. A previously described putative virulence gene was used to develop a specific combination of hydrolysis probe/primers for the detection of tropical Foc race 4 strains. The real-time PCR parameters were optimized by following a statistical approach relying on orthogonal arrays and the Taguchi method in an attempt to enhance sensitivity and ensure high specificity of the assay. This study also assessed critical performance criteria, such as repeatability, reproducibility, robustness, and specificity, with a large including set of 136 F. oxysporum isolates, including 73 Foc pathogenic strains representing 24 VCGs. The validation data demonstrated that the new assay could be used for regulatory testing applications on banana plant material and can contribute to preventing the introduction and spread of Foc strains affecting Cavendish bananas in the tropics.	[Aguayo, Jaime; Fourrier-Jeandel, Celine; Cerf-Wendling, Isabelle; Ioos, Renaud] ANSES, LSV, Unite Mycol, Domaine De Pixerecourt, Malzeville, France; [Mostert, Diane; Viljoen, Altus] Univ Stellenbosch, Fac AgriSci, Dept Plant Pathol, Matieland, South Africa; [Hostachy, Bruno] ANSES, LSV, Unite Ravageurs & Agents Pathogenes Tropicaux, St Pierre, Reunion, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Stellenbosch University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES)	Aguayo, J (corresponding author), ANSES, LSV, Unite Mycol, Domaine De Pixerecourt, Malzeville, France.	jaime.aguayo@anses.fr		Aguayo, Jaime/0000-0002-7552-0655; Viljoen, Altus/0000-0001-7146-0491; Mostert, Diane/0000-0002-3382-8555; Ioos, Renaud/0000-0001-9359-5098	Agence Nationale de Securite Sanitaire de ('Alimentation, de l'Environnement et du Travail (ANSES)-Laboratoire de la Sante des Vegetaux; Plant Pathology laboratory of the University of Stellenbosch	Agence Nationale de Securite Sanitaire de ('Alimentation, de l'Environnement et du Travail (ANSES)-Laboratoire de la Sante des Vegetaux; Plant Pathology laboratory of the University of Stellenbosch	This research was funded by the Agence Nationale de Securite Sanitaire de ('Alimentation, de l'Environnement et du Travail (ANSES)-Laboratoire de la Sante des Vegetaux and the Plant Pathology laboratory of the University of Stellenbosch.	[Anonymous], 2014, TECHNICAL MANUAL PRE, DOI DOI 10.1093/nar/gkm306; [Anonymous], 2010, EPPO B, V40, P5, DOI DOI 10.1111/J.1365-2338.2009.02347.X; Arzanlou M, 2007, PHYTOPATHOLOGY, V97, P1112, DOI 10.1094/PHYTO-97-9-1112; Ballantyne KN, 2008, FORENS SCI INT-GEN S, V1, P7, DOI 10.1016/j.fsigss.2007.10.050; Bentley S, 1998, PHYTOPATHOLOGY, V88, P1283, DOI 10.1094/PHYTO.1998.88.12.1283; Besseris GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108973; BOEHM EWA, 1994, MOL PLANT MICROBE IN, V7, P196, DOI 10.1094/MPMI-7-0196; Boonham N, 2008, EUR J PLANT PATHOL, V121, P355, DOI 10.1007/s10658-008-9284-3; Bustin Stephen A, 2014, Biomol Detect Quantif, V2, P35; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butler D, 2013, NATURE, V504, P195, DOI 10.1038/504195a; Cai L, 2011, FUNGAL DIVERS, V50, P121, DOI 10.1007/s13225-011-0127-8; Chen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091824; Chen QH, 2013, EUR J PLANT PATHOL, V137, P597, DOI 10.1007/s10658-013-0273-9; COBB BD, 1994, NUCLEIC ACIDS RES, V22, P3801, DOI 10.1093/nar/22.18.3801; Dabrowski W, 2003, FEMS MICROBIOL LETT, V218, P51, DOI 10.1016/S0378-1097(02)01183-7; Daniells JW, 2011, ACTA HORTIC, V897, P475; de Sousa MV, 2014, PLANT PATHOLOGY; Dita MA, 2013, ACTA HORTIC, V986, P127, DOI 10.17660/ActaHortic.2013.986.11; Dita MA, 2010, PLANT PATHOL, V59, P348, DOI 10.1111/j.1365-3059.2009.02221.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fourie G, 2011, INFECT GENET EVOL, V11, P533, DOI 10.1016/j.meegid.2011.01.012; Fourie G, 2009, APPL ENVIRON MICROB, V75, P4770, DOI 10.1128/AEM.00370-09; Fox J, 2015, PACKAGE CAR; Fraser-Smith S, 2014, PLANT PATHOL, V63, P1044, DOI 10.1111/ppa.12184; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Garcia-Bastidas F, 2014, PLANT DIS, V98, P694, DOI 10.1094/PDIS-09-13-0954-PDN; Ghag SB, 2015, INT J PEST MANAGE, V61, P250, DOI 10.1080/09670874.2015.1043972; Groenewald S, 2006, MYCOL RES, V110, P297, DOI 10.1016/j.mycres.2005.10.004; Grosdidier M, 2016, PLANT PATHOLOGY; Harper SJ, 2010, PHYTOPATHOLOGY, V100, P1282, DOI 10.1094/PHYTO-06-10-0168; Ioos R, 2009, PHYTOPATHOLOGY, V99, P582, DOI 10.1094/PHYTO-99-5-0582; Kema GHJ, 2013, NATURE, V504, P218, DOI 10.1038/504218b; Koenig RL, 1997, PHYTOPATHOLOGY, V87, P915, DOI 10.1094/PHYTO.1997.87.9.915; Li BJ, 2013, EUR J PLANT PATHOL, V135, P903, DOI 10.1007/s10658-012-0136-9; Li C, 2013, FUNGAL GENOMICS BIOL; Li MH, 2013, CAN J PLANT PATHOL, V35, P482, DOI 10.1080/07060661.2013.828321; Lievens B, 2008, PEST MANAG SCI, V64, P781, DOI 10.1002/ps.1564; Lievens B, 2006, PLANT SCI, V171, P155, DOI 10.1016/j.plantsci.2006.03.009; Lievens B, 2009, FEMS MICROBIOL LETT, V300, P201, DOI 10.1111/j.1574-6968.2009.01783.x; Lin YH, 2013, EUR J PLANT PATHOL, V135, P395, DOI 10.1007/s10658-012-0096-0; Lin YH, 2009, EUR J PLANT PATHOL, V123, P353, DOI 10.1007/s10658-008-9372-4; McTaggart AR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005475; Molina A, 2010, MITIGATING THREAT BA, V1571, P2010; Nel B, 2006, PLANT PATHOL, V55, P207, DOI 10.1111/j.1365-3059.2006.01343.x; Ordonez N., 2015, PLANT DIS; Ordonez N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005197; Peng J, 2014, J APPL MICROBIOL, V117, P1740, DOI 10.1111/jam.12645; Peng Y, 2007, J APPL MICROBIOL, V103, P2095, DOI 10.1111/j.1365-2672.2007.03440.x; PLOETZ RC, 1988, PLANT DIS, V72, P325, DOI 10.1094/PD-72-0325; Ploetz RC, 2006, PHYTOPATHOLOGY, V96, P653, DOI 10.1094/PHYTO-96-0653; Ploetz RC, 2015, ANN REV PHYTOPATHOLO, V53; Ploetz RC, 2015, CROP PROTECTION; Ploetz RC, 2006, PLANT HLTH PROGR; PO EP, 2010, EPPO B, V40, P350; Pocasangre LE, 2011, RAISING AWARENESS TH, P331; Rao Ravella Sreenivas, 2008, Biotechnology Journal, V3, P510, DOI 10.1002/biot.200700201; Riska J., 2012, Journal of Agricultural and Biological Science, V7, P244; Schaad NW, 2002, CAN J PLANT PATHOL, V24, P250; Sutherland R., 2013, South African Journal of Science, V109, P61; Thanakiatkrai P, 2012, INT J LEGAL MED, V126, P161, DOI 10.1007/s00414-011-0558-5; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Dam P, 2016, ENV MICROBIOLOGY; van der Does HC, 2008, ENVIRON MICROBIOL, V10, P1475, DOI 10.1111/j.1462-2920.2007.01561.x; Wang JT, 2013, OCEAN ENG, V63, P8, DOI 10.1016/j.oceaneng.2013.01.028; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yang L, 2015, CHINA FOOD SECUR, V2015, P1, DOI DOI 10.1177/0954405414523752; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	68	23	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171767	10.1371/journal.pone.0171767	http://dx.doi.org/10.1371/journal.pone.0171767			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178348	Green Submitted, Green Published, gold			2022-12-26	WOS:000393712500069
J	Asamitsu, K; Hirokawa, T; Okamoto, T				Asamitsu, Kaori; Hirokawa, Takatsugu; Okamoto, Takashi			MD simulation of the Tat/Cyclin T1/CDK9 complex revealing the hidden catalytic cavity within the CDK9 molecule upon Tat binding	PLOS ONE			English	Article							RNA-POLYMERASE-II; CARBOXYL-TERMINAL DOMAIN; PROTEINS SPECIFICALLY ASSOCIATE; INHIBIT HIV TRANSCRIPTION; CYCLIN T1 PROTEINS; FACTOR P-TEFB; ELONGATION COMPLEX; 7SK SNRNA; IN-VIVO; KINASE	In this study, we applied molecular dynamics (MD) simulation to analyze the dynamic behavior of the Tat/CycT1/CDK9 tri-molecular complex and revealed the structural changes of P-TEFb upon Tat binding. We found that Tat could deliberately change the local flexibility of CycT1. Although the structural coordinates of the H1 and H2 helices did not substantially change, H1', H2', and H3' exhibited significant changes en masse. Consequently, the CycT1 residues involved in Tat binding, namely Tat-recognition residues (TRRs), lost their flexibility with the addition of Tat to P-TEFb. In addition, we clarified the structural variation of CDK9 in complex with CycT1 in the presence or absence of Tat. Interestingly, Tat addition significantly reduced the structural variability of the T-loop, thus consolidating the structural integrity of P-TEFb. Finally, we deciphered the formation of the hidden catalytic cavity of CDK9 upon Tat binding. MD simulation revealed that the PITALRE signature sequence of CDK9 flips the inactive kinase cavity of CDK9 into the active form by connecting with Thr186, which is crucial for its activity, thus presumably recruiting the substrate peptide such as the C-terminal domain of RNA pol II. These findings provide vital information for the development of effective novel anti-HIV drugs with CDK9 catalytic activity as the target.	[Asamitsu, Kaori; Okamoto, Takashi] Nagoya City Univ, Dept Mol & Cellular Biol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Hirokawa, Takatsugu] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Tokyo, Japan; [Hirokawa, Takatsugu] Univ Tsukuba, Div Biomed Sci, Fac Med, Tsukuba, Ibaraki, Japan	Nagoya City University; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Okamoto, T (corresponding author), Nagoya City Univ, Dept Mol & Cellular Biol, Grad Sch Med Sci, Nagoya, Aichi, Japan.; Hirokawa, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Tokyo, Japan.; Hirokawa, T (corresponding author), Univ Tsukuba, Div Biomed Sci, Fac Med, Tsukuba, Ibaraki, Japan.	t-hirokawa@aist.go.jp; tokamoto@med.nagoya-cu.ac.jp		Asamitsu, Kaori/0000-0001-5333-8011	Asahi Grass Foundation; Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science, and technology (MEXT); Japen Agency for Medical Research and Development (AMED); Junwakai Foundtion, Aujo, Japan	Asahi Grass Foundation; Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science, and technology (MEXT); Japen Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Junwakai Foundtion, Aujo, Japan	This research was partially supported by the Asahi Grass Foundation, the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science, and technology (MEXT), the Japen Agency for Medical Research and Development (AMED) and Junwakai Foundtion, Aujo, Japan.	Ammosova T, 2005, J BIOL CHEM, V280, P36364, DOI 10.1074/jbc.M503673200; Ammosova T, 2011, J BIOL CHEM, V286, P3798, DOI 10.1074/jbc.M110.196493; Asamitsu K, 2016, GENES CELLS, V21, P706, DOI 10.1111/gtc.12375; Asamitsu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119451; Asamitsu K, 2011, J MOL BIOL, V410, P887, DOI 10.1016/j.jmb.2011.04.061; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Bowers KJ, 2006, P 2006 ACMIEEE C SUP, P4343; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; D'Orso I, 2012, MOL CELL BIOL, V32, P4780, DOI 10.1128/MCB.00206-12; D'Orso I, 2010, NAT STRUCT MOL BIOL, V17, P815, DOI 10.1038/nsmb.1827; De Luca A, 2003, J CELL PHYSIOL, V194, P101, DOI 10.1002/jcp.10196; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Filomia F, 2010, BIOORGAN MED CHEM, V18, P6805, DOI 10.1016/j.bmc.2010.07.047; Fujinaga K, 1999, P NATL ACAD SCI USA, V96, P1285, DOI 10.1073/pnas.96.4.1285; Garber ME, 1998, COLD SPRING HARB SYM, V63, P371, DOI 10.1101/sqb.1998.63.371; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Gold MO, 1998, J VIROL, V72, P4448, DOI 10.1128/JVI.72.5.4448-4453.1998; He NH, 2011, P NATL ACAD SCI USA, V108, pE636, DOI 10.1073/pnas.1107107108; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; HERRMANN CH, 1995, J VIROL, V69, P1612, DOI 10.1128/JVI.69.3.1612-1620.1995; Hornak V, 2006, J AM CHEM SOC, V128, P2812, DOI 10.1021/ja058211x; Jadlowsky JK, 2008, J GEN VIROL, V89, P2783, DOI 10.1099/vir.0.2008/002857-0; Jadlowsky JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-63; Jin HX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124673; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, GLOBAL REPORT UNAIDS; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Mbonye UR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003338; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Miller F, 2005, J BIOL CHEM, V280, P7985, DOI 10.1074/jbc.M413160200; Muniz L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001152; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Raha T, 2005, PLOS BIOL, V3, P221, DOI 10.1371/journal.pbio.0030044; Ramakrishnan R, 2012, J CELL PHYSIOL, V227, P609, DOI 10.1002/jcp.22760; Ramakrishnan Rajesh, 2011, BMC Res Notes, V4, P260, DOI 10.1186/1756-0500-4-260; Ramakrishnan R, 2009, J LEUKOCYTE BIOL, V86, P1345, DOI 10.1189/jlb.0509309; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Schulze-Gahmen U, 2014, ELIFE, V3, DOI 10.7554/eLife.02375; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Toth G, 2006, BIOCHEMISTRY-US, V45, P6606, DOI 10.1021/bi060188k; Verstraete N, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-50; Victoriano AFB, 2012, AIDS RES HUM RETROV, V28, P125, DOI [10.1089/aid.2011.0263, 10.1089/AID.2011.0263]; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yang XZ, 1996, J VIROL, V70, P4576, DOI 10.1128/JVI.70.7.4576-4584.1996; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	56	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171727	10.1371/journal.pone.0171727	http://dx.doi.org/10.1371/journal.pone.0171727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178316	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500063
J	Barman, S; Kwon, YK				Barman, Shohag; Kwon, Yung-Keun			A novel mutual information-based Boolean network inference method from time-series gene expression data	PLOS ONE			English	Article							REGULATORY NETWORKS	Background Inferring a gene regulatory network from time-series gene expression data in systems biology is a challenging problem. Many methods have been suggested, most of which have a scalability limitation due to the combinatorial cost of searching a regulatory set of genes. In addition, they have focused on the accurate inference of a network structure only. Therefore, there is a pressing need to develop a network inference method to search regulatory genes efficiently and to predict the network dynamics accurately. Results In this study, we employed a Boolean network model with a restricted update rule scheme to capture coarse-grained dynamics, and propose a novel mutual information-based Boolean network inference (MIBNI) method. Given time-series gene expression data as an input, the method first identifies a set of initial regulatory genes using mutual information-based feature selection, and then improves the dynamics prediction accuracy by iteratively swapping a pair of genes between sets of the selected regulatory genes and the other genes. Through extensive simulations with artificial datasets, MIBNI showed consistently better performance than six well-known existing methods, REVEAL, Best-Fit, RelNet, CST, CLR, and BIBN in terms of both structural and dynamics prediction accuracy. We further tested the proposed method with two real gene expression datasets for an Escherichia coli gene regulatory network and a fission yeast cell cycle network, and also observed better results using MIBNI compared to the six other methods. Conclusions Taken together, MIBNI is a promising tool for predicting both the structure and the dynamics of a gene regulatory network.	[Barman, Shohag; Kwon, Yung-Keun] Univ Ulsan, Sch Elect Engn, Ulsan, South Korea	University of Ulsan	Kwon, YK (corresponding author), Univ Ulsan, Sch Elect Engn, Ulsan, South Korea.	kwonyk@ulsan.ac.kr	Barman, Shohag/AHA-5980-2022		Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2015R1D1A1A09060910]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2015R1D1A1A09060910) [http://www.nrf.re.kr/nrf.eng_crns/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, ANAL GENE EXPRESSION; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BATTITI R, 1994, IEEE T NEURAL NETWOR, V5, P537, DOI 10.1109/72.298224; Berestovsky N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066031; Butte AJ, PAC S BIOCOMPUTING20; Chen T, PAC S BIOC, P29; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Han ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115806; Imoto S, PAC S BIOCOMPUTING20, P175; Karlebach G, 2013, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2013-11; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kim H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-37; Lahdesmaki H, 2003, MACH LEARN, V52, P147, DOI 10.1023/A:1023905711304; Li P, 2014, EURASIP J BIOINFORM, DOI 10.1186/s13637-014-0012; Liang S, PAC S BIOC; Macqueen J., 1967, P 5 BERK S MATH STAT, P281; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; Maucher M, 2011, BIOINFORMATICS, V27, P1529, DOI 10.1093/bioinformatics/btr166; Narendra V, 2011, GENOMICS, V97, P7, DOI 10.1016/j.ygeno.2010.10.003; Ouyang HJ, 2014, EURASIP J BIOINFORM, DOI 10.1186/s13637-014-0010-5; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Villaverde AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096732; Zhang Xiao, 2012, Sheng Wu Gong Cheng Xue Bao, V28, P104; Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154	26	32	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171097	10.1371/journal.pone.0171097	http://dx.doi.org/10.1371/journal.pone.0171097			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178334	Green Submitted, Green Published, gold			2022-12-26	WOS:000393712500024
J	Leegwater, NC; Bakker, AD; Hogervorst, JMA; Nolte, PA; Klein-Nulend, J				Leegwater, Nick C.; Bakker, Astrid D.; Hogervorst, Jolanda M. A.; Nolte, Peter A.; Klein-Nulend, Jenneke			Hypothermia reduces VEGF-165 expression, but not osteogenic differentiation of human adipose stem cells under hypoxia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STROMAL-VASCULAR FRACTION; NITRIC-OXIDE SYNTHASE; BONE-MARROW; REPERFUSION INJURY; IN-VIVO; ISCHEMIA/REPERFUSION INJURY; SKELETAL-MUSCLE; TISSUE; CRYOTHERAPY	Cryotherapy is successfully used in the clinic to reduce pain and inflammation after musculoskeletal damage, and might prevent secondary tissue damage under the prevalent hypoxic conditions. Whether cryotherapy reduces mesenchymal stem cell (MSC) number and differentiation under hypoxic conditions, causing impaired callus formation is unknown. We aimed to determine whether hypothermia modulates proliferation, apoptosis, nitric oxide production, VEGF gene and protein expression, and osteogenic/chondrogenic differentiation of human MSCs under hypoxia. Human adipose MSCs were cultured under hypoxia (37 degrees C, 1% O-2), hypothermia and hypoxia (30 degrees C, 1% O-2), or control conditions (37 degrees C, 20% O-2). Total DNA, protein, nitric oxide production, alkaline phosphatase activity, gene expression, and VEGF protein concentration were measured up to day 8. Hypoxia enhanced K167 expression at day 4. The combination of hypothermia and hypoxia further enhanced K167 gene expression compared to hypoxia alone, but was unable to prevent the 1.2-fold reduction in DNA amount caused by hypoxia at day 4. Addition of hypothermia to hypoxic cells did not alter the effect of hypoxia alone on BAX-to-BCL-2 ratio, alkaline phosphatase activity, gene expression of SOX9, COL1, or osteocalcin, or nitric oxide production. Hypothermia decreased the stimulating effect of hypoxia on VEGF-165 gene expression by 6-fold at day 4 and by 2-fold at day 8. Hypothermia also decreased VEGF protein expression under hypoxia by 2.9-fold at day 8. In conclusion, hypothermia decreased VEGF-165 gene and protein expression, but did not affect differentiation, or apoptosis of MSCs cultured under hypoxia. These in vitro results implicate that hypothermia treatment in vivo, applied to alleviate pain and inflammation, is not likely to harm early stages of callus formation.	[Leegwater, Nick C.; Nolte, Peter A.] Spaarne Hosp, Dept Orthopaed, Hoofddorp, Netherlands; [Bakker, Astrid D.; Hogervorst, Jolanda M. A.; Klein-Nulend, Jenneke] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands; [Bakker, Astrid D.; Hogervorst, Jolanda M. A.; Klein-Nulend, Jenneke] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Klein-Nulend, Jenneke] ACTA VU Univ Amsterdam, Dept Oral Cell Biol, Amsterdam, Netherlands	Spaarne Hospital; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Klein-Nulend, J (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands.; Klein-Nulend, J (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.; Klein-Nulend, J (corresponding author), ACTA VU Univ Amsterdam, Dept Oral Cell Biol, Amsterdam, Netherlands.	j.kleinnulend@acta.nl	Nolte, Peter albertus/F-3657-2012; Bakker, Astrid Diana/AAD-1286-2019	Nolte, Peter albertus/0000-0002-7474-2715; 				Adie S, 2010, J ARTHROPLASTY, V25, P709, DOI 10.1016/j.arth.2009.07.010; Agata H, 2010, TISSUE ENG PT A, V16, P663, DOI [10.1089/ten.tea.2009.0500, 10.1089/ten.TEA.2009.0500]; Bastidas-Coral AP, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1318256; Bornes TD, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0075-4; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Choi EK, 2015, INT J SURG, V22, P74, DOI 10.1016/j.ijsu.2015.08.016; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Coassin M, 2010, BRIT J OPHTHALMOL, V94, P1678, DOI 10.1136/bjo.2009.168864; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; Faustini M, 2010, TISSUE ENG PART C-ME, V16, P1515, DOI [10.1089/ten.tec.2010.0214, 10.1089/ten.TEC.2010.0214]; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Hicok KC, 2004, TISSUE ENG, V10, P371, DOI 10.1089/107632704323061735; Holwerda SW, 2013, SPORTS HEALTH, V5, P27, DOI 10.1177/1941738112450863; Horst K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154788; Janda J, 2016, ARCH DERMATOL RES, V308, P239, DOI 10.1007/s00403-016-1628-9; Juhl M, 2016, SCAND J CLIN LAB INV, V76, P93, DOI 10.3109/00365513.2015.1099723; Jurgens WJFM, 2008, CELL TISSUE RES, V332, P415, DOI 10.1007/s00441-007-0555-7; Kim JH, 2012, STEM CELLS DEV, V21, P2212, DOI 10.1089/scd.2011.0561; Knippenberg M, 2007, TISSUE ENG, V13, P2495, DOI 10.1089/ten.2006.0420; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; Lee JS, 2015, BONE, V78, P34, DOI 10.1016/j.bone.2015.04.044; Leegwater NC, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1000-4; LOWRY OH, 1955, METHOD ENZYMOL, V4, P371; Lu J, 2014, WORLD J EMERG MED, V5, P298, DOI 10.5847/wjem.j.issn.1920-8642.2014.04.010; Luo C, 2015, NEURAL REGEN RES, V10, P153, DOI 10.4103/1673-5374.150725; Malladi P, 2006, AM J PHYSIOL-CELL PH, V290, pC1139, DOI 10.1152/ajpcell.00415.2005; Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1; Merrick Mark A., 1993, Journal of Athletic Training, V28, P241; Messina A, 2000, LAB INVEST, V80, P423, DOI 10.1038/labinvest.3780047; Naaijkens BA, 2012, CELL TISSUE RES, V348, P119, DOI 10.1007/s00441-012-1360-5; Park JW, 2005, MICROSURG, V25, P606, DOI 10.1002/micr.20175; Patel JJ, 2012, EXP CELL RES, V318, P2237, DOI 10.1016/j.yexcr.2012.06.021; Peterson B, 2005, TISSUE ENG, V11, P120, DOI 10.1089/ten.2005.11.120; Prins HJ, 2016, STEM CELL TRANSL MED, V5, P1362, DOI 10.5966/sctm.2015-0369; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schaser KD, 2007, AM J SPORT MED, V35, P93, DOI 10.1177/0363546506294569; Shui CX, 2001, J BONE MINER RES, V16, P731, DOI 10.1359/jbmr.2001.16.4.731; Stalman A, 2011, J BONE JOINT SURG AM, V93A, P1961, DOI 10.2106/JBJS.J.01790; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Tjabringa GS, 2006, STEM CELLS, V24, P2262, DOI 10.1634/stemcells.2005-0625; van Esterik FAS, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1934270; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Yodmuang S, 2015, STEM CELL REV REP, V11, P228, DOI 10.1007/s12015-015-9584-x; Yoo HI, 2016, KOREAN J PHYSIOL PHA, V20, P53, DOI 10.4196/kjpp.2016.20.1.53; Zhang HF, 2008, BRAIN RES, V1198, P182, DOI 10.1016/j.brainres.2008.01.007; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540; Zhou NA, 2015, CELL PHYSIOL BIOCHEM, V36, P44, DOI 10.1159/000374052; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488	52	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171492	10.1371/journal.pone.0171492	http://dx.doi.org/10.1371/journal.pone.0171492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166273	Green Published, gold, Green Submitted			2022-12-26	WOS:000393700100048
J	Min, LJ; Kobayashi, Y; Mogi, M; Tsukuda, K; Yamada, A; Yamauchi, K; Abe, F; Iwanami, J; Xiao, JZ; Horiuchi, M				Min, Li-Juan; Kobayashi, Yodai; Mogi, Masaki; Tsukuda, Kana; Yamada, Akio; Yamauchi, Koji; Abe, Fumiaki; Iwanami, Jun; Xiao, Jin-Zhong; Horiuchi, Masatsugu			Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE; ANIMAL-MODEL; DEMENTIA; IMPAIRMENT; INFLAMMATION; PERINDOPRIL; HYPERTENSION; ASSOCIATION	There is a growing interest in identifying natural food ingredients that may serve to prevent dementia such as that due to Alzheimer disease (AD). Peptides derived from food proteins have been demonstrated to have various physiological activities such as a hypotensive action. Recent findings have indicated possible associations of hypertension with AD progression, and suggest that angiotensin converting enzyme (ACE) inhibitors with potential to pass through the blood brain barrier (BBB) may reduce the risk of AD. In this study, we investigated the effect of milk peptide (CH-3) on cognitive function in AD model mice. CH-3 contains a tripeptide (methionine-lysine-proline, MKP) that has been found to have a strong ACE inhibitory effect and the potential to pass through the BBB. Adult male ddY mice were used in this study, and an animal model of AD was induced by intracerebroventricular (ICV) injection of A beta 1-42. CH-3 (250 mg/kg/day) or MKP (0.5 mg/kg/day) was orally administered every day starting 2 days before ICV injection. At 3 weeks after ICV injection, cognitive function was evaluated by the Morris water maze test. Brain samples were obtained after behavioral testing, and expression of inflammatory cytokines and NADPH oxidase subunits was measured by real-time quantitative RT-PCR. ICV injection of A beta 1-42 significantly impaired cognitive function compared with that in PBS-injected mice. Daily administration of CH-3 markedly attenuated this A beta 1-42-induced cognitive decline. A beta 1-42 injection significantly enhanced the expression of tumor necrosis factor-alpha (TNF-alpha), inducible nitric oxide synthase (iNOS) and p22(phox) in the mouse hippocampus compared with PBS injection, and showed a tendency to increase the expression of monocyte chemoattractant protein-1 (MCP-1), p47(phox) and gp91(phox), whereas CH-3 treatment markedly reduced A beta 1-42-induced TNF-alpha, MCP-1, iNOS, p47(phox) and gp91(phox) expression. Finally, administration of MKP also attenuated A beta 1-42-induced cognitive impairment with an increase in cerebral blood flow. The present study demonstrated that repeated oral administration of CH-3 to AD model mice not only improved cognitive function but also suppressed the expression of inflammatory cytokines and production of oxidative stress, and suggests its therapeutic potential for preventing cognitive impairment in AD.	[Min, Li-Juan; Mogi, Masaki; Tsukuda, Kana; Iwanami, Jun; Horiuchi, Masatsugu] Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan; [Kobayashi, Yodai; Yamada, Akio; Yamauchi, Koji; Abe, Fumiaki; Xiao, Jin-Zhong] Morinaga Milk Ind Co Ltd, Zama, Kanagawa, Japan	Ehime University; Morinaga Milk Industry Company, Ltd	Mogi, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan.	mmogi@m.ehime-u.ac.jp	Mogi, Masaki/ABH-2011-2020	Mogi, Masaki/0000-0002-0275-9198	Morinaga Milk Industry Co., Ltd.; JSPS [25293310, 25462220, 15K19974, 26860567]	Morinaga Milk Industry Co., Ltd.; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors received no specific funding for this work. Morinaga Milk Industry Co., Ltd., provided support in the form of salaries for authors Y.K., A.Y., K.Y., F.A. and J.X., but did not have any role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are described in the 'author contributions' section. Moreover, this study was supported by JSPS KAKENHI [Grant Number 25293310 to M.H., 25462220 to M.M., 15K19974 to J.I., and 26860567 to L.-J.M.] and research grants from Morinaga Milk Industry Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkam T, 2008, BEHAV BRAIN RES, V189, P100, DOI 10.1016/j.bbr.2007.12.014; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; BARNES JM, 1989, BRAIN RES, V491, P136, DOI 10.1016/0006-8993(89)90095-4; BARNES JM, 1990, BRAIN RES, V507, P341, DOI 10.1016/0006-8993(90)90294-L; Chalmers J, 2003, J HYPERTENS, V21, pS9, DOI 10.1097/00004872-200306005-00003; Ciobica A, 2009, ACTA NEUROL BELG, V109, P171; Dong YF, 2011, FASEB J, V25, P2911, DOI 10.1096/fj.11-182873; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Kawasaki T, 2000, J HUM HYPERTENS, V14, P519, DOI 10.1038/sj.jhh.1001065; Kehoe PG, 2007, LANCET NEUROL, V6, P373, DOI 10.1016/S1474-4422(07)70077-7; Knecht S, 2008, HYPERTENSION, V51, P663, DOI 10.1161/HYPERTENSIONAHA.107.105577; Lee YJ, 2010, ARCH PHARM RES, V33, P1539, DOI 10.1007/s12272-010-1006-7; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; McNaull BBA, 2010, GERONTOLOGY, V56, P3, DOI 10.1159/000237873; Miners S, 2009, AM J TRANSL RES, V1, P163; Mogi M, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/169649; Murray BA, 2007, CURR PHARM DESIGN, V13, P773, DOI 10.2174/138161207780363068; Nagai M, 2010, AM J HYPERTENS, V23, P116, DOI 10.1038/ajh.2009.212; NGUYEN DCA, 2013, ANTIOXID REDOX SIGN, V19, P1110, DOI DOI 10.1089/ARS.2012.4641; Ninomiya T, 2011, HYPERTENSION, V58, P22, DOI 10.1161/HYPERTENSIONAHA.110.163055; Ohrui T, 2004, J AM GERIATR SOC, V52, P649, DOI 10.1111/j.1532-5415.2004.52178_7.x; Ongali B, 2014, NEUROBIOL DIS, V68, P126, DOI 10.1016/j.nbd.2014.04.018; Paganelli R, 2002, EXP GERONTOL, V37, P257, DOI 10.1016/S0531-5565(01)00191-7; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Sakata A, 2009, BRAIN RES, V1300, P14, DOI 10.1016/j.brainres.2009.08.068; Shimohama S, 2000, BIOCHEM BIOPH RES CO, V273, P5, DOI 10.1006/bbrc.2000.2897; Sink KM, 2009, ARCH INTERN MED, V169, P1195, DOI 10.1001/archinternmed.2009.175; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; Takeda S, 2009, BRAIN RES, V1280, P137, DOI 10.1016/j.brainres.2009.05.035; Tokunaga KH, 2004, BIOL PHARM BULL, V27, P189, DOI 10.1248/bpb.27.189; Tsukuda K, 2008, HYPERTENSION, V51, P528, DOI 10.1161/HYPERTENSIONAHA.107.101634; Tsukuda K, 2009, HYPERTENSION, V54, P782, DOI 10.1161/HYPERTENSIONAHA.109.136879; Van Dam D, 2011, BRIT J PHARMACOL, V164, P1285, DOI 10.1111/j.1476-5381.2011.01299.x; Watabe T, 2013, J NUCL MED, V54, P283, DOI 10.2967/jnumed.112.109751; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yamada A, 2013, FOOD CHEM, V141, P3781, DOI 10.1016/j.foodchem.2013.06.089; Yamada K, 2010, BRAIN RES, V1352, P176, DOI 10.1016/j.brainres.2010.07.006	38	36	38	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171515	10.1371/journal.pone.0171515	http://dx.doi.org/10.1371/journal.pone.0171515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158298	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700090
J	Sun, TH; Li, CT; Xiong, LF; Ning, ZY; Leung, F; Peng, SL; Lu, WW				Sun, Tianhao; Li, Chen-Tian; Xiong, Lifeng; Ning, Ziyu; Leung, Frankie; Peng, Songlin; Lu, William W.			miR-375-3p negatively regulates osteogenesis by targeting and decreasing the expression levels of LRP5 and beta-catenin	PLOS ONE			English	Article							BONE-FORMATION; DIFFERENTIATION; PROLIFERATION; OSTEOPOROSIS; APOPTOSIS; CELLS; MASS	Wnt signaling pathways are essential for bone formation. Previous studies showed that Wnt signaling pathways were regulated by miR-375. Thus, we aim to explore whether miR-375 could affect osteogenesis. In the present study, we investigated the roles of miR-375 and its downstream targets. Firstly, we revealed that miR-375-3p negatively modulated osteogenesis by suppressing positive regulators of osteogenesis and promoting negative regulators of osteogenesis. In addition, the results of TUNEL cell apoptosis assay showed that miR-3753p induced MC3T3-E1 cell apoptosis. Secondly, miR-375-3p targeted low -density lipoprotein receptor -related protein 5 (LRP5), a co -receptor of the Wnt signaling pathways, and 13catenin as determined by luciferase activity assay, and it decreased the expression levels of LRP5 and p-catenin. Thirdly, the decline of protein levels of p-catenin was determined by immunocytochemistry and immunofluorescence. Finally, silence of LRP5 in osteoblast precursor cells resulted in diminished cell viability and cell proliferation as detected by WST-1based colorimetric assay. Additionally, all the parameters including the relative bone volume from pCT measurement suggested that LRP5 knockout in mice resulted in a looser and worse -connected trabeculae. The mRNA levels of important negative modulators relating to osteogenesis increased after the functions of LRP5 were blocked in mice. Last but not least, the expression levels of LRP5 increased during the osteogenesis of MC3T3-E1, while the levels of P-catenin decreased in bone tissues from osteoporotic patients with vertebral compression fractures. In conclusion, we revealed miR-375-3p negatively regulated osteogenesis by targeting LRP5 and p-catenin. In addition, loss of functions of LRP5 damaged bone formation in vivo. Clinically, miR-375-3p and its targets might be used as diagnostic biomarkers for osteoporosis and might be also as novel therapeutic agents in osteoporosis treatment. The relevant products of miR-375-3p might be developed into molecular drugs in the future. These molecules could be used in translational medicine.	[Sun, Tianhao; Li, Chen-Tian; Leung, Frankie; Lu, William W.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthopaed & Traumatol, Hong Kong, Peoples R China; [Sun, Tianhao; Peng, Songlin] Jinan Univ, Coll Med 2, Shenzhen Peoples Hosp, Dept Spine Surg, Shenzhen, Peoples R China; [Xiong, Lifeng] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Ning, Ziyu] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Jinan University; University of Hong Kong; University of Hong Kong	Leung, F; Lu, WW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthopaed & Traumatol, Hong Kong, Peoples R China.; Peng, SL (corresponding author), Jinan Univ, Coll Med 2, Shenzhen Peoples Hosp, Dept Spine Surg, Shenzhen, Peoples R China.	klleunga@hku.hk; songlin824@gmail.com; wwlu@hku.hk	Li, Chentian/GZN-1242-2022; Li, Chentian/GZN-1189-2022	Li, Chentian/0000-0002-9362-5952; Li, Chentian/0000-0002-9362-5952; Peng, Songlin/0000-0002-4042-7071	National Natural Science Foundation of China [NSFC81371989, NSFC81270967]; Guangdong Science and Technology Department Project [2015A030313776, 2016A050503008]; Shenzhen Municipal Science and Technology Innovation Committee Project [CXZZ20151015151249563, CXZZ20150401152251209, JCYJ20140416122812013]; General Research Fund of Research Grant Council of Hong Kong [RGC 715213, RGC 17205714]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department Project; Shenzhen Municipal Science and Technology Innovation Committee Project; General Research Fund of Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by grants from the National Natural Science Foundation of China (NSFC81371989 and NSFC81270967), Guangdong Science and Technology Department Project (2015A030313776, 2016A050503008), Shenzhen Municipal Science and Technology Innovation Committee Project (CXZZ20151015151249563, CXZZ20150401152251209 and JCYJ20140416122812013), and General Research Fund of Research Grant Council of Hong Kong (RGC 715213 and RGC 17205714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgers TA, 2013, BONE, V54, P244, DOI 10.1016/j.bone.2013.02.022; Cantafio MEG, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.59; Chen Jia-Shing, 2014, BMC Res Notes, V7, P15, DOI 10.1186/1756-0500-7-15; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Delgado-Calle J, 2016, BONE; Guo Y, 2016, ONCOL REP, V36, P952, DOI 10.3892/or.2016.4852; Jacobsen CM, 2016, BONE, V90, P127, DOI 10.1016/j.bone.2016.06.005; Javaheri B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035726; Jin HT, 2015, BONE, V71, P63, DOI 10.1016/j.bone.2014.07.039; Joiner DM, 2013, TRENDS ENDOCRIN MET, V24, P31, DOI 10.1016/j.tem.2012.10.003; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Lian L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101633; Maupin KA, 2013, BONE RES, V1, DOI 10.4248/BR201301004; Miao CG, 2015, IMMUNOL LETT, V164, P1, DOI 10.1016/j.imlet.2015.01.003; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Riddle RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063323; Rivadeneira F, 2016, TRENDS ENDOCRIN MET, V27, P262, DOI 10.1016/j.tem.2016.03.006; Selth LA, 2016, ONCOGENE; Sun TH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020236; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wang Y, 2013, NUCLEIC ACIDS RES, V41, P3833, DOI 10.1093/nar/gks1460; Xing LP, 2005, BIOCHEM BIOPH RES CO, V328, P709, DOI 10.1016/j.bbrc.2004.11.072; Xu L., 2016, ONCOTARGET; Xu LL, 2016, ONCOTARGET, V7, P40644, DOI 10.18632/oncotarget.9811; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yano M, 2012, ENDOCR J, V59, P653, DOI 10.1507/endocrj.EJ12-0022; Yu X, 2016, INT J GYNECOL CANCER, V26, P851, DOI 10.1097/IGC.0000000000000711; Zhong ZDA, 2015, DEV DYNAM, V244, P1347, DOI 10.1002/dvdy.24316; Zhong ZDA, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.13	30	33	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171281	10.1371/journal.pone.0171281	http://dx.doi.org/10.1371/journal.pone.0171281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158288	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700052
J	Lin, C; Liao, W; Jian, Y; Peng, Y; Zhang, X; Ye, L; Cui, Y; Wang, B; Wu, X; Xiong, Z; Wu, S; Li, J; Wang, X; Song, L				Lin, C.; Liao, W.; Jian, Y.; Peng, Y.; Zhang, X.; Ye, L.; Cui, Y.; Wang, B.; Wu, X.; Xiong, Z.; Wu, S.; Li, J.; Wang, X.; Song, L.			CGI-99 promotes breast cancer metastasis via autocrine interleukin-6 signaling	ONCOGENE			English	Article							INFLUENZA-VIRUS POLYMERASE; LYMPH-NODE METASTASIS; C14ORF166 OVEREXPRESSION; MONOCLONAL-ANTIBODY; PRECLINICAL MODELS; TUMOR PROGRESSION; MULTIPLE-MYELOMA; CELLULAR-PROTEIN; BINDING PROTEIN; POOR-PROGNOSIS	Metastatic relapse remains largely incurable and a major challenge of clinical management in breast cancer, but the underlying mechanisms are poorly understood. Herein, we report that CGI-99 is overexpressed in breast cancer tissues from patients with metastatic recurrence within 5 years. High CGI-99 significantly predicts poorer 5-year metastasis-free patient survival. We find that CGI-99 increases breast cancer stem cell properties, and potentiates efficient tumor lung colonization and outgrowth in vivo. Furthermore, we demonstrate that CGI-99 activates the autocrine interleukin-6 (IL-6)/STAT3 signaling by increasing the accumulation and activity of RNA polymerase II and p300 cofactor at the proximal promoter of IL-6. Importantly, delivery of the IL-6receptor humanized monoclonal antibody tocilizumab robustly abrogates CGI-99-induced metastasis in vivo. Finally, we find that high levels of CGI-99 are significantly correlated with STAT3 hyperactivation in breast cancer patients. These findings reveal a potential mechanism for constitutive activation of autocrine IL-6/STAT3 signaling and may suggest a novel target for clinical intervention in breast cancer.	[Lin, C.; Zhang, X.; Ye, L.; Cui, Y.; Wang, B.; Wu, X.; Wu, S.; Song, L.] Sun Yat Sen Univ, State Key Lab Oncol South China, Canc Ctr, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Liao, W.; Jian, Y.] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Peng, Y.] Guangdong Country Garden Sch, Guangzhou, Guangdong, Peoples R China; [Xiong, Z.; Wang, X.] Sun Yat Sen Univ, Canc Ctr, Dept Breast Surg, Guangzhou 510060, Guangdong, Peoples R China; [Li, J.] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Southern Medical University - China; Sun Yat Sen University; Sun Yat Sen University	Wang, X (corresponding author), Sun Yat Sen Univ, Canc Ctr, Dept Breast Surg, Guangzhou 510060, Guangdong, Peoples R China.; Song, L (corresponding author), Sun Yat Sen Univ, Canc Ctr, Dept Expt Res, State Key Lab Oncol Southern China, 651 Dongfend Rd, Guangzhou 510060, Guangdong, Peoples R China.	wangxi@sysucc.org.cn; songlb@sysucc.org.cn	Song, LB/AAL-1968-2020; Wang, Bin/AAJ-6007-2020; Lin, Chuyong/AAA-9931-2020; Zhang, Xin/C-2464-2017	Wang, Bin/0000-0002-9093-5381; Lin, Chuyong/0000-0003-4887-5386; Zhang, Xin/0000-0001-6036-2685; Ye, Liping/0000-0002-2263-0631	Ministry of Science and Technology of China [973-2014CB910604]; Natural Science Foundation of China [81472546, 81672854, 81530082, 81272198, 81572687, 81325013, 91529301, 81572688]; Science and Technology of Guangdong Province [2016A030308002, 2014A030313008, 2014A030313220]; Science and Technology Program of Guangzhou [15020077]; Guangdong Esophageal Cancer Institute [M201409]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology of Guangdong Province; Science and Technology Program of Guangzhou; Guangdong Esophageal Cancer Institute	This work was supported by the Ministry of Science and Technology of China grant (no. 973-2014CB910604); Natural Science Foundation of China (no. 81472546, 81672854, 81530082, 81272198, 81572687, 81325013, 91529301 and 81572688), the Science and Technology of Guangdong Province (no. 2016A030308002, 2014A030313008 and 2014A030313220), Science and Technology Program of Guangzhou (no. 15020077) and Guangdong Esophageal Cancer Institute (no. M201409).	Ando K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102436; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cheang TY, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0805-0; Conze D, 2001, CANCER RES, V61, P8851; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Cui YZ, 2009, INT J CANCER, V124, P1614, DOI 10.1002/ijc.24163; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; Dijkgraaf EM, 2015, ANN ONCOL, V26, P2141, DOI 10.1093/annonc/mdv309; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Guo JH, 2009, CANCER SCI, V100, P2292, DOI 10.1111/j.1349-7006.2009.01324.x; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Howng SL, 2004, FEBS LETT, V566, P162, DOI 10.1016/j.febslet.2004.04.024; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jeong EG, 2008, CLIN CANCER RES, V14, P3716, DOI 10.1158/1078-0432.CCR-07-4839; Kroon P, 2013, CANCER RES, V73, P5288, DOI 10.1158/0008-5472.CAN-13-0874; Lai CH, 2000, GENOME RES, V10, P703, DOI 10.1101/gr.10.5.703; Larive RM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4881; Lee JW, 2011, J PROTEOME RES, V10, P4522, DOI 10.1021/pr200338d; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Perez-Gonzalez A, 2006, J MOL BIOL, V362, P887, DOI 10.1016/j.jmb.2006.07.085; Perez-Gonzalez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090957; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rodriguez-Frandsen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep20744; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Song LX, 2011, MOL CANCER THER, V10, P481, DOI 10.1158/1535-7163.MCT-10-0502; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Vainchenker W, 2013, ONCOGENE, V32, P2601, DOI 10.1038/onc.2012.347; Voorhees PM, 2007, CLIN CANCER RES, V13, P6469, DOI 10.1158/1078-0432.CCR-07-1293; Voorhees PM, 2009, BRIT J HAEMATOL, V145, P481, DOI 10.1111/j.1365-2141.2009.07647.x; Yang L, 2015, TUMOR BIOL, V36, P7977, DOI 10.1007/s13277-015-3518-8; Yokoe T, 1997, ANTICANCER RES, V17, P695; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang GJ, 1999, ANTICANCER RES, V19, P1427; Zhang WJ, 2016, TUMOR BIOL, V37, P369, DOI 10.1007/s13277-015-3806-3	48	24	24	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 29	2017	36	26					3695	3705		10.1038/onc.2016.525	http://dx.doi.org/10.1038/onc.2016.525			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY9WM	28166202				2022-12-26	WOS:000404349700005
J	van Attekum, MHA; Terpstra, S; Slinger, E; von Lindern, M; Moerland, PD; Jongejan, A; Kater, AP; Eldering, E				van Attekum, M. H. A.; Terpstra, S.; Slinger, E.; von Lindern, M.; Moerland, P. D.; Jongejan, A.; Kater, A. P.; Eldering, E.			Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia	ONCOGENE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; IN-VIVO; B-CELLS; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; UP-REGULATION; CLL CELLS; T-CELLS; APOPTOSIS; EXPRESSION	Protective interactions with bystander cells in micro-environmental niches, such as lymph nodes (LNs), contribute to survival and therapy resistance of chronic lymphocytic leukemia (CLL) cells. This is caused by a shift in expression of B-cell lymphoma 2 (BCL-2) family members. Pro-survival proteins B-cell lymphoma-extra large (BCL-XL), BCL-2-related protein A1 (BFL-1) and myeloid leukemia cell differentiation protein 1 (MCL-1) are upregulated by LN-residing T cells through CD40L interaction, presumably via nuclear factor (NF)-kappa B signaling. Macrophages (M phi s) also reside in the LN, and are assumed to provide important supportive functions for CLL cells. However, if and how M phi s are able to induce survival is incompletely known. We first established that M phi s induced survival because of an exclusive upregulation of MCL-1. Next, we investigated the mechanism underlying MCL-1 induction by M phi s in comparison with CD40L. Genome-wide expression profiling of in vitro M phi-and CD40L-stimulated CLL cells indicated activation of the phosphoinositide 3-kinase (PI3K)-V-Akt murine thymoma viral oncogene homolog (AKT)-mammalian target of rapamycin (mTOR) pathway, which was confirmed in ex vivo CLL LN material. Inhibition of PI3K-AKT-mTOR signaling abrogated MCL-1 upregulation and survival by M phi s, as well as CD40 stimulation. MCL-1 can be regulated at multiple levels, and we established that AKT leads to increased MCL-1 translation, but does not affect MCL-1 transcription or protein stabilization. Furthermore, among M phi-secreted factors that could activate AKT, we found that induction of MCL-1 and survival critically depended on C-C motif chemokine receptor-1 (CCR1). In conclusion, this study indicates that two distinct micro-environmental factors, CD40L and M phi s, signal via CCR1 to induce AKT activation resulting in translational stabilization of MCL-1, and hence can contribute to CLL cell survival.	[van Attekum, M. H. A.; Terpstra, S.; Slinger, E.; Kater, A. P.] Univ Amsterdam, Acad Med Ctr, Dept Hematol, Amsterdam, Netherlands; [van Attekum, M. H. A.; Terpstra, S.; Slinger, E.; Eldering, E.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Noord Holland, Netherlands; [von Lindern, M.] Sanquin Res, Dept Hematopoiesis, Amsterdam, Netherlands; [Moerland, P. D.; Jongejan, A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands; [Kater, A. P.; Eldering, E.] Lymphoma & Myeloma Ctr Amsterdam LYMMCARE, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Eldering, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Noord Holland, Netherlands.	e.eldering@amc.nl	von Lindern, Marieke/AAH-2350-2020; Moerland, Perry/AAG-1425-2020	Moerland, Perry/0000-0002-2357-3659; von Lindern, Marieke/0000-0001-6162-6320	Dutch Cancer Foundation (Dutch Cancer Society Clinical Fellowship) [UVA 2011-5097]	Dutch Cancer Foundation (Dutch Cancer Society Clinical Fellowship)	We thank Richard Volckmann for his help with the analysis of the microarray data, Jannie Borst for providing the BFL-1 antibody and Steven Pals for providing us with the CLL LN slides. APK is a Dutch Cancer Foundation fellow. This work was supported by the Dutch Cancer Foundation (Dutch Cancer Society Clinical Fellowship UVA 2011-5097).	Allen JC, 2011, BLOOD, V117, P2414, DOI 10.1182/blood-2010-08-301176; Awan FT, 2009, BLOOD, V113, P535, DOI 10.1182/blood-2008-08-173450; Balakrishnan K, 2010, BLOOD, V116, P1083, DOI 10.1182/blood-2009-10-246199; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Ballou LM, 2007, J BIOL CHEM, V282, P24463, DOI 10.1074/jbc.M704741200; Baudot AD, 2009, ONCOGENE, V28, P3261, DOI 10.1038/onc.2009.179; Buggins AGS, 2010, CANCER RES, V70, P7523, DOI 10.1158/0008-5472.CAN-10-1634; Burger JA, 2000, BLOOD, V96, P2655; Burger JA, 2011, HEMATOL-AM SOC HEMAT, P96, DOI 10.1182/asheducation-2011.1.96; Castillo JJ, 2012, EXPERT OPIN INV DRUG, V21, P15, DOI 10.1517/13543784.2012.640318; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Delgado-Martin C, 2011, J BIOL CHEM, V286, P37222, DOI 10.1074/jbc.M111.294116; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Hallaert DYH, 2008, BLOOD, V112, P5141, DOI 10.1182/blood-2008-03-146704; Hanna BS, 2016, LEUKEMIA, V30, P570, DOI 10.1038/leu.2015.305; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Johansson Staffan, 1997, Frontiers in Bioscience (online), V2, pD126; Kitada S, 1998, BLOOD, V91, P3379, DOI 10.1182/blood.V91.9.3379; Kitada S, 1999, BRIT J HAEMATOL, V106, P995, DOI 10.1046/j.1365-2141.1999.01642.x; Longo PG, 2008, BLOOD, V111, P846, DOI 10.1182/blood-2007-05-089037; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; Martinez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123352; Masek T, 2011, METHODS MOL BIOL, V703, P293, DOI 10.1007/978-1-59745-248-9_20; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Mojsa B, 2014, CELLS-BASEL, V3, P418, DOI 10.3390/cells3020418; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; Olsson A, 2007, BRIT J CANCER, V97, P769, DOI 10.1038/sj.bjc.6603951; Pascutti MF, 2013, BLOOD, V122, P3010, DOI 10.1182/blood-2012-11-467670; Pepper C, 2008, BLOOD, V112, P3807, DOI 10.1182/blood-2008-05-157131; Pradelli LA, 2010, ONCOGENE, V29, P1641, DOI 10.1038/onc.2009.448; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; Saxena A, 2004, AM J HEMATOL, V75, P22, DOI 10.1002/ajh.10453; Smit LA, 2007, BLOOD, V109, P1660, DOI 10.1182/blood-2006-05-021683; Su CC, 2007, J IMMUNOL, V179, P4589, DOI 10.4049/jimmunol.179.7.4589; Takai S, 2007, MOL CELL ENDOCRINOL, V267, P46, DOI 10.1016/j.mce.2006.12.036; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tromp JM, 2010, ONCOGENE, V29, P5071, DOI 10.1038/onc.2010.248; Ueda T, 2010, P NATL ACAD SCI USA, V107, P13984, DOI 10.1073/pnas.1008136107; van Attekum MHA, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.20; Vary TC, 2007, J NUTR, V137, P1835, DOI 10.1093/jn/137.8.1835; Vogler M, 2008, CELL DEATH DIFFER, V15, P820, DOI 10.1038/cdd.2008.25; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75	46	11	11	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 29	2017	36	26					3651	3660		10.1038/onc.2016.515	http://dx.doi.org/10.1038/onc.2016.515			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY9WM	28192408	Green Published, hybrid			2022-12-26	WOS:000404349700001
J	Grzelak, CA; Sigglekow, ND; Tirnitz-Parker, JEE; Hamson, EJ; Warren, A; Maneck, B; Chen, JB; Patkunanathan, B; Boland, J; Cheng, R; Shackel, NA; Seth, D; Bowen, DG; Martelotto, LG; Watkins, DN; McCaughan, GW				Grzelak, Candice Alexandra; Sigglekow, Nicholas David; Tirnitz-Parker, Janina Elke Eleonore; Hamson, Elizabeth Jane; Warren, Alessandra; Maneck, Bharvi; Chen, Jinbiao; Patkunanathan, Bramilla; Boland, Jade; Cheng, Robert; Shackel, Nicholas Adam; Seth, Devanshi; Bowen, David Geoffrey; Martelotto, Luciano Gaston; Watkins, D. Neil; McCaughan, Geoffrey William			Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease	PLOS ONE			English	Article							PRIMARY CILIA; PROGENITOR CELLS; STEM-CELLS; OVAL CELLS; PATHWAY; MICE; FIBROSIS; REGENERATION; DIVERSITY; HEPATITIS	Canonical Hedgehog (Hh) signaling in vertebrate cells occurs following Smoothened activation/translocation into the primary cilia (Pc), followed by a GLI transcriptional response. Nonetheless, GLI activation can occur independently of the canonical Hh pathway. Using a murine model of liver injury, we previously identified the importance of canonical Hh signaling within the Pc+ liver progenitor cell (LPC) population and noted that SMO-independent, GLI-mediated signals were important in multiple Pc-ve GLI2(+) intrahepatic populations. This study extends these observations to human liver tissue, and analyses the effect of GLI inhibition on LPC viability/gene expression. Human donor and cirrhotic liver tissue specimens were evaluated for SHH, GLI2 and Pc expression using immunofluorescence and qRT-PCR. Changes to viability and gene expression in LPCs in vitro were assessed following GLI inhibition. Identification of Pc (as a marker of canonical Hh signaling) in human cirrhosis was predominantly confined to the ductular reaction and LPCs. In contrast, GLI2 was expressed in multiple cell populations including Pc-ve endothelium, hepatocytes, and leukocytes. HSCs/myofibroblasts (>99%) expressed GLI2, with only 1.92% displaying Pc. In vitro GLI signals maintained proliferation/viability within LPCs and GLI inhibition affected the expression of genes related to stemness, hepatocyte/biliary differentiation and Hh/Wnt signaling. At least two mechanisms of GLI signaling (Pc/SMOdependent and Pc/SMO-independent) mediate chronic liver disease pathogenesis. This may have significant ramifications for the choice of Hh inhibitor (anti-SMO or anti-GLI) suitable for clinical trials. We also postulate GLI delivers a pro-survival signal to LPCs whilst maintaining stemness.	[Grzelak, Candice Alexandra; Sigglekow, Nicholas David; Hamson, Elizabeth Jane; Maneck, Bharvi; Chen, Jinbiao; Patkunanathan, Bramilla; Boland, Jade; Cheng, Robert; Shackel, Nicholas Adam; Seth, Devanshi; Bowen, David Geoffrey; McCaughan, Geoffrey William] Centenary Inst, Liver Injury & Canc, Camperdown, NSW, Australia; [Tirnitz-Parker, Janina Elke Eleonore] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Biomed Sci, Bentley, WA, Australia; [Warren, Alessandra] Univ Sydney, Ageing & Alzheimers Inst, Concord Hosp, Ctr Educ & Res Ageing, Sydney, NSW, Australia; [Warren, Alessandra] Univ Sydney, ANZAC Res Inst, Concord Hosp, Sydney, NSW, Australia; [Maneck, Bharvi; Shackel, Nicholas Adam; Bowen, David Geoffrey; McCaughan, Geoffrey William] RPAH, AW Morrow Gastroenterol & Liver Ctr, Camperdown, NSW, Australia; [Shackel, Nicholas Adam; McCaughan, Geoffrey William] Univ Sydney, Fac Med, Sydney, NSW, Australia; [Martelotto, Luciano Gaston] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Watkins, D. Neil] Garvan Inst, Kinghorn Canc Ctr, Darlinghurst, NSW, Australia	University of Sydney; Centenary Institute; Curtin University; Concord Repatriation General Hospital; University of Sydney; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of Sydney; Memorial Sloan Kettering Cancer Center; Garvan Institute of Medical Research	McCaughan, GW (corresponding author), Centenary Inst, Liver Injury & Canc, Camperdown, NSW, Australia.; McCaughan, GW (corresponding author), RPAH, AW Morrow Gastroenterol & Liver Ctr, Camperdown, NSW, Australia.; McCaughan, GW (corresponding author), Univ Sydney, Fac Med, Sydney, NSW, Australia.	g.mccaughan@centenary.org.au	Chen, Jinbiao/N-9905-2019; Chen, Jinbiao/J-5868-2013; Research Institute, ANZAC/CAE-9030-2022; Martelotto, Luciano/D-1946-2015	Chen, Jinbiao/0000-0003-0339-5880; Chen, Jinbiao/0000-0003-0339-5880; Grzelak, Candice/0000-0001-8645-4297; MCCAUGHAN, GEOFFREY/0000-0002-1483-1636; Martelotto, Luciano/0000-0002-9625-1183; Tirnitz-Parker, Janina/0000-0002-3558-5892; Bowen, David/0000-0002-7965-5581	National Health and Medical Research Council [571408]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded by the National Health and Medical Research Council, Program Grant #571408 (GWM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberger F, 2014, SEMIN CELL DEV BIOL, V33, P93, DOI 10.1016/j.semcdb.2014.05.003; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Candice AG, 2015, HEPATOLOGY, V61, P1770, DOI 10.1002/hep.27432; Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Grzelak CA, 2014, J HEPATOL, V61, P1451, DOI 10.1016/j.jhep.2014.08.019; Grzelak CA, 2014, J HEPATOL, V60, P143, DOI 10.1016/j.jhep.2013.08.012; Guy CD, 2015, HEPATOLOGY, V61, P98, DOI 10.1002/hep.27235; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jung Y, 2008, GASTROENTEROLOGY, V134, P1532, DOI 10.1053/j.gastro.2008.02.022; Kiprilov EN, 2008, J CELL BIOL, V180, P897, DOI 10.1083/jcb.200706028; Kohn-Gaone J, 2016, AM J PHYSIOL-GASTR L, V310, pG143, DOI 10.1152/ajpgi.00215.2015; Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6; Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203; Marican NHJ, 2016, STEM CELL REP, V6, P798, DOI 10.1016/j.stemcr.2016.04.004; Masyuk AI, 2008, DEV DYNAM, V237, P2007, DOI 10.1002/dvdy.21530; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Moshai EF, 2014, AM J RESP CELL MOL, V51, P11, DOI 10.1165/rcmb.2013-0154OC; Omenetti A, 2007, LAB INVEST, V87, P499, DOI 10.1038/labinvest.3700537; Omenetti A, 2011, J HEPATOL, V54, P366, DOI 10.1016/j.jhep.2010.10.003; Paku S, 2001, AM J PATHOL, V158, P1313, DOI 10.1016/S0002-9440(10)64082-5; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Rangwala F, 2011, J PATHOL, V224, P401, DOI 10.1002/path.2888; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Sicklick JK, 2016, PHASE IB STUDY SINGL; Syn WK, 2009, GASTROENTEROLOGY, V137, P1478, DOI 10.1053/j.gastro.2009.06.051; Syn WK, 2009, EUR J IMMUNOL, V39, P1879, DOI 10.1002/eji.200838890; Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Xie GH, 2013, GUT, V62, P299, DOI 10.1136/gutjnl-2011-301494; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032	39	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171480	10.1371/journal.pone.0171480	http://dx.doi.org/10.1371/journal.pone.0171480			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187190	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300024
J	Agwu, AL; Fleishman, JA; Mahiane, G; Nonyane, BAS; Althoff, KN; Yehia, BR; Berry, SA; Rutstein, R; Nijhawan, A; Mathews, C; Aberg, JA; Keruly, JC; Moore, RD; Gebo, KA				Agwu, Allison L.; Fleishman, John A.; Mahiane, Guy; Nonyane, Bareng Aletta Sanny; Althoff, Keri N.; Yehia, Baligh R.; Berry, Stephen A.; Rutstein, Richard; Nijhawan, Ank; Mathews, Christopher; Aberg, Judith A.; Keruly, Jeanne C.; Moore, Richard D.; Gebo, Kelly A.		HIV Res Network	Comparing longitudinal CD4 responses to cART among non-perinatally HIV-infected youth versus adults: Results from the HIVRN Cohort	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; YOUNG-ADULTS; CELL COUNT; FOLLOW-UP; VIROLOGICAL SUPPRESSION; IMMUNOLOGICAL OUTCOMES; IMMUNE RECONSTITUTION; INITIATING HAART; UNITED-STATES	Background Youth have residual thymic tissue and potentially greater capacity for immune reconstitution than adults after initiation of combination antiretroviral therapy (cART). However, youth face behavioral and psychosocial challenges that may make them more likely than adults to delay ART initiation and less likely to attain similar CD4 outcomes after initiating cART. This study compared CD4 outcomes over time following cART initiation between ART-naive non-perinatally HIV-infected (nPHIV) youth (13-24 years-old) and adults (>= 25-44 years-old). Methods Retrospective analysis of ART-naive nPHIV individuals 13-44 years-old, who initiated their first cART between 2008 and 2011 at clinical sites in the HIV Research Network. A linear mixed model was used to assess the association between CD4 levels after cART initiation and age (13-24, 25-34, 35-44 years), accounting for random variation within participants and between sites, and adjusting for key variables including gender, race/ethnicity, viral load, gaps in care (defined as >365 days between CD4 tests), and CD4 levels prior to cART initiation (baseline CD4). Results Among 2,595 individuals (435 youth; 2,160 adults), the median follow-up after cART initiation was 179 weeks (IQR 92-249). Baseline CD4 was higher for youth (320 cells/mm(3)) than for ages 25-34 (293) or 35-44 (258). At 239 weeks after cART initiation, median unadjusted CD4 was higher for youth than adults (576 vs. 539 and 476 cells/mm(3), respectively), but this difference was not significant when baseline CD4 was controlled. Compared to those with baseline CD4 <= 200 cells/mm(3), individuals with baseline CD4 of 201-500 and >500 cells/mm(3) had greater predicted CD4 levels: 390, 607, and 831, respectively. Additionally, having no gaps in care and higher viral load were associated with better CD4 outcomes. Conclusions Despite having residual thymic tissue, youth attain similar, not superior, CD4 gains as adults. Early ART initiation with minimal delay is as essential to optimizing outcomes for youth as it is for their adult counterparts.	[Agwu, Allison L.] Johns Hopkins Sch Med, Dept Pediat, Div Pediat Infect Dis, Baltimore, MD 21205 USA; [Agwu, Allison L.; Berry, Stephen A.; Keruly, Jeanne C.; Gebo, Kelly A.] Johns Hopkins Sch Med, Div Infect Dis, Dept Med, Baltimore, MD 21205 USA; [Fleishman, John A.] Agcy Healthcare Res & Qual, Ctr Financing Access & Cost Trends, Rockville, MD USA; [Mahiane, Guy] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Nonyane, Bareng Aletta Sanny] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Althoff, Keri N.] Johns Hopkins Med Inst, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Yehia, Baligh R.] Univ Penn, Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Rutstein, Richard] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA; [Nijhawan, Ank] UT Southwestern Med Ctr, Dept Internal Med, Parkland Hlth & Hosp Syst, Dallas, TX USA; [Mathews, Christopher] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Aberg, Judith A.] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Moore, Richard D.] Johns Hopkins Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Agency for Healthcare Research & Quality; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins Medicine	Agwu, AL (corresponding author), Johns Hopkins Sch Med, Dept Pediat, Div Pediat Infect Dis, Baltimore, MD 21205 USA.	ageorg10@jhmi.edu	Gebo, Kelly/AHA-7533-2022; Nonyane, Bareng A.S./AAC-8118-2020; Althoff, Keri N/HGC-5595-2022	Gebo, Kelly/0000-0003-4010-398X; Nonyane, Bareng A.S./0000-0001-5633-7487; Althoff, Keri/0000-0002-5068-6595; Korthuis, Philip/0000-0001-5556-3597	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI112477] Funding Source: NIH RePORTER; NIAID NIH HHS [K23 AI112477] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agwu AL, 2014, JAMA PEDIATR, V168, P381, DOI 10.1001/jamapediatrics.2013.4531; Agwu AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18579; Agwu AL, 2011, JAIDS-J ACQ IMM DEF, V58, P100, DOI 10.1097/QAI.0b013e31822327df; Althoff KN, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-45; Althoff KN, 2010, AIDS, V24, P2467, DOI 10.1097/QAD.0b013e32833e6d14; Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; [Anonymous], GUID US ANT AG HIV 1; [Anonymous], 2008, AIDS, V22, P1463, DOI [10.1097/QAD.0b013e3282f88d02, DOI 10.1097/QAD.0B013E3282F88D02]; Asfaw A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122583; Blum RW, 2002, J ADOLESCENT HEALTH, V31, P28, DOI 10.1016/S1054-139X(02)00411-1; Centers for Disease CNCfHA Viral Hepatitis STD and TB Prevention, 2012, MOR HALF YOUNG HIV I; Chaisson RE, 2000, JAMA-J AM MED ASSOC, V284, P3128, DOI 10.1001/jama.284.24.3128; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; El-Sadr WM, 2008, ANN INTERN MED, V149, P289, DOI 10.7326/0003-4819-149-5-200809020-00003; Farmer C, 2016, J PEDIAT INF DIS SOC, V5, P39, DOI 10.1093/jpids/piu102; Fleishman JA, 2012, JAIDS-J ACQ IMM DEF, V60, P249, DOI 10.1097/QAI.0b013e318258c696; Flynn PM, 2007, AIDS RES HUM RETROV, V23, P1208, DOI 10.1089/aid.2006.0290; Flynn PM, 2004, J INFECT DIS, V190, P271, DOI 10.1086/421521; Gagliardo C, 2014, CLIN INFECT DIS, V58, P865, DOI 10.1093/cid/ciu003; Gebo Kelly A, 2003, Hopkins HIV Rep, V15, P5; Gebo Kelly A, 2008, Aging health, V4, P615, DOI 10.2217/1745509X.4.6.615; Gutierrez F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000089; Hakim FT, 1997, BLOOD, V90, P3789, DOI 10.1182/blood.V90.9.3789; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Lewis J, 2012, J INFECT DIS, V205, P548, DOI 10.1093/infdis/jir787; Lifson AR, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-2; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Luz PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093039; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Moore RD, 2012, CLIN INFECT DIS, V55, P1242, DOI 10.1093/cid/cis654; Mpondo BC, 2016, J SEXUALLY TRANSMITT, V2016; Murphy DA, 2005, ARCH PEDIAT ADOL MED, V159, P764, DOI 10.1001/archpedi.159.8.764; Murphy DA, 2003, ARCH PEDIAT ADOL MED, V157, P249, DOI 10.1001/archpedi.157.3.249; Naar-King S, 2010, AIDS CARE, V22, P475, DOI 10.1080/09540120903220279; Nglazi MD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-21; Rudy BJ, 2006, AIDS RES HUM RETROV, V22, P213, DOI 10.1089/aid.2006.22.213; Rudy BJ, 2015, JAIDS-J ACQ IMM DEF, V69, P52, DOI 10.1097/QAI.0000000000000549; Rudy BJ, 2009, AIDS PATIENT CARE ST, V23, P185, DOI 10.1089/apc.2008.0162; Ryscavage PA, 2011, JAIDS-J ACQ IMM DEF, V58, P193, DOI [10.1097/QAI.0B013E31822D7564, 10.1097/QAI.0b013e31822d7564]; Sabin CA, 2008, AIDS, V22, P1463; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Siberry GK, 2011, JAIDS-J ACQ IMM DEF, V57, P223, DOI 10.1097/QAI.0b013e318218e068; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Touloumi G, 2006, JAIDS-J ACQ IMM DEF, V42, P554, DOI 10.1097/01.qai.0000230321.85911.db; Tumbarello M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-46; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; World Health Organization, 2015, GUID START ANT THER	52	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171125	10.1371/journal.pone.0171125	http://dx.doi.org/10.1371/journal.pone.0171125			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182675	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800035
J	Borysov, SS; Geilhufe, RM; Balatsky, AV				Borysov, Stanislav S.; Geilhufe, R. Matthias; Balatsky, Alexander V.			Organic materials database: An open-access online database for data mining	PLOS ONE			English	Article							DENSITY-FUNCTIONAL THEORY; CRYSTALLOGRAPHY OPEN DATABASE; TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; HIGH-THROUGHPUT; ULTRASOFT PSEUDOPOTENTIALS; MATERIALS INFORMATICS; CRYSTAL-STRUCTURES; ELECTRON-GAS; BASIS-SET	We present an organic materials database (OMDB) hosting thousands of Kohn-Sham electronic band structures, which is freely accessible online at http://omdb.diracmaterials.org. The OMDB focus lies on electronic structure, density of states and other properties for purely organic and organometallic compounds that are known to date. The electronic band structures are calculated using density functional theory for the crystal structures contained in the Crystallography Open Database. The OMDB web interface allows users to retrieve materials with specified target properties using non-trivial queries about their electronic structure. We illustrate the use of the OMDB and how it can become an organic part of search and prediction of novel functional materials via data mining techniques. As a specific example, we provide data mining results for metals and semiconductors, which are known to be rare in the class of organic materials.	[Borysov, Stanislav S.; Geilhufe, R. Matthias; Balatsky, Alexander V.] KTH Royal Inst Technol, Ctr Quantum Mat, Nordita, Roslagstullsbacken 23, SE-10691 Stockholm, Sweden; [Borysov, Stanislav S.; Geilhufe, R. Matthias; Balatsky, Alexander V.] Stockholm Univ, Roslagstullsbacken 23, SE-10691 Stockholm, Sweden; [Balatsky, Alexander V.] ETH, Inst Theoret Studies, CH-8092 Zurich, Switzerland	Nordic Institute for Theoretical Physics; Royal Institute of Technology; Stockholm University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Borysov, SS (corresponding author), KTH Royal Inst Technol, Ctr Quantum Mat, Nordita, Roslagstullsbacken 23, SE-10691 Stockholm, Sweden.; Borysov, SS (corresponding author), Stockholm Univ, Roslagstullsbacken 23, SE-10691 Stockholm, Sweden.	borysov@kth.se	Geilhufe, Matthias/S-5773-2018; Borysov, Stanislav/O-7465-2017	Geilhufe, Matthias/0000-0001-9285-0165; Borysov, Stanislav/0000-0003-2810-9203	Swedish Research Council [638-2013-9243]; Knut and Alice Wallenberg Foundation; European Research Council under the European Union's Seventh Framework Program FP/2207-2013 [DM-321031]; Villum Foundation through the Villum Center for Dirac Materials; Walter Haefner Foundation; ETH Zurich Foundation; Villum Fonden [00011744] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Research Council under the European Union's Seventh Framework Program FP/2207-2013; Villum Foundation through the Villum Center for Dirac Materials; Walter Haefner Foundation; ETH Zurich Foundation(ETH Zurich); Villum Fonden(Villum Fonden)	This work is supported by the Swedish Research Council, Grant No. 638-2013-9243, http://www.vr.se/; Knut and Alice Wallenberg Foundation, https://www.wallenberg.com/kaw/; European Research Council under the European Union's Seventh Framework Program (FP/2207-2013)/ERC Grant Agreement No. DM-321031, https//erc.europa.eu/; Villum Foundation through the Villum Center for Dirac Materials; Dr. Max Rossler; Walter Haefner Foundation; and ETH Zurich Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.104518; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Chan MKY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.196403; Curtarolo S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.135503; Curtarolo S, 2013, NAT MATER, V12, P191, DOI [10.1038/nmat3568, 10.1038/NMAT3568]; Curtarolo S, 2012, COMP MATER SCI, V58, P218, DOI 10.1016/j.commatsci.2012.02.005; Curtarolo S, 2012, COMP MATER SCI, V58, P227, DOI 10.1016/j.commatsci.2012.02.002; Ebert H, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/9/096501; Geilhufe R. M., ARXIV161104316; Geilhufe RM, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.041103; Gershenson ME, 2006, REV MOD PHYS, V78, P973, DOI 10.1103/RevModPhys.78.973; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; GODBY RW, 1988, PHYS REV B, V37, P10159, DOI 10.1103/PhysRevB.37.10159; Grazulis S, 2012, NUCLEIC ACIDS RES, V40, pD420, DOI 10.1093/nar/gkr900; Grazulis S, 2009, J APPL CRYSTALLOGR, V42, P726, DOI 10.1107/S0021889809016690; Guerra CF, 1998, THEOR CHEM ACC, V99, P391, DOI 10.1007/s002140050021; Hafner J, 2008, J COMPUT CHEM, V29, P2044, DOI 10.1002/jcc.21057; HALL SR, 1991, ACTA CRYSTALLOGR A, V47, P655, DOI 10.1107/S010876739101067X; HEDIN L, 1965, PHYS REV, V139, pA796, DOI 10.1103/PhysRev.139.A796; Heyd J, 2005, J CHEM PHYS, V123, DOI [10.1063/1.2085170, 10.1063/1.1760074]; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Hoppe H, 2004, J MATER RES, V19, P1924, DOI 10.1557/JMR.2004.0252; Ichimura K, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.114707; Jain A, 2013, APL MATER, V1, DOI 10.1063/1.4812323; Jain A, 2011, COMP MATER SCI, V50, P2295, DOI 10.1016/j.commatsci.2011.02.023; Johnson KA, 1998, PHYS REV B, V58, P15548, DOI 10.1103/PhysRevB.58.15548; Jones RO, 2015, REV MOD PHYS, V87, P897, DOI 10.1103/RevModPhys.87.897; Keogh EJ, KDD, P24; Kim DH, 2012, ANNU REV BIOMED ENG, V14, P113, DOI [10.1146/annurev-bioeng-071811-150018, 10.1146/annurev.bioeng-071811-150018]; Klintenberg M, 2014, APPL PHYS RES, P6, DOI [10.5539/apr.v6n4p31, DOI 10.5539/APR.V6N4P31]; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; KRESSE G, 1994, J PHYS-CONDENS MAT, V6, P8245, DOI 10.1088/0953-8984/6/40/015; Lejaeghere K, 2016, SCIENCE, V351, DOI 10.1126/science.aad3000; Luders M, 2001, J PHYS-CONDENS MAT, V13, P8587, DOI 10.1088/0953-8984/13/38/305; MacDiarmid AG, 2001, ANGEW CHEM INT EDIT, V40, P2581, DOI 10.1002/1521-3773(20010716)40:14<2581::AID-ANIE2581>3.0.CO;2-2; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI [10.1103/PhysRevB.13.5188, 10.1103/PhysRevB.16.1746]; Morgan D, 2005, MEAS SCI TECHNOL, V16, P296, DOI 10.1088/0957-0233/16/1/039; Nathan A, 2012, P IEEE, V100, P1486, DOI 10.1109/JPROC.2012.2190168; Nayak SK, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.155105; Ong SP, 2013, COMP MATER SCI, V68, P314, DOI 10.1016/j.commatsci.2012.10.028; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Rajan K, 2005, MATER TODAY, V8, P38, DOI 10.1016/S1369-7021(05)71123-8; Rasmussen FA, 2015, J PHYS CHEM C, V119, P13169, DOI 10.1021/acs.jpcc.5b02950; Rodgers JR, 2006, MRS BULL, V31, P975, DOI 10.1557/mrs2006.223; Sariciftci NS., 2013, ORGANIC PHOTOVOLTAIC, V60; Sarmiento-Perez R, 2015, CHEM MATER, V27, P5957, DOI 10.1021/acs.chemmater.5b02026; Setyawan W, 2011, ACS COMB SCI, V13, P382, DOI 10.1021/co200012w; Tajima N, 2000, J PHYS SOC JPN, V69, P543, DOI 10.1143/JPSJ.69.543; Thiess A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.235103; Tikkanen J, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/3/036001; Uji S, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/2/020301; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Vitos L, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.014107; WANG CS, 1983, PHYS REV LETT, V51, P597, DOI 10.1103/PhysRevLett.51.597; Wehling TO, 2014, ADV PHYS, V63, P1, DOI 10.1080/00018732.2014.927109; Xianping Ge, 2000, Proceedings. KDD-2000. Sixth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P81; Zeller R, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/29/294215	61	41	43	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171501	10.1371/journal.pone.0171501	http://dx.doi.org/10.1371/journal.pone.0171501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182744	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800066
J	Lackner, A; Ficjan, A; Stradner, MH; Hermann, J; Unger, J; Stamm, T; Stummvoll, G; Dur, M; Graninger, WB; Dejaco, C				Lackner, Angelika; Ficjan, Anja; Stradner, Martin H.; Hermann, Josef; Unger, Julia; Stamm, Tanja; Stummvoll, Georg; Duer, Mona; Graninger, Winfried B.; Dejaco, Christian			It's more than dryness and fatigue: The patient perspective on health-related quality of life in Primary Sjogren's Syndrome - A qualitative study	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; STANDARD MEASURES; DISEASE-ACTIVITY; REPORTED INDEX; PREVALENCE; VALIDATION; DISABILITY; PEOPLE	Objectives In Primary Sjogren's Syndrome (PSS), there is an apparent lack of data concerning the perspectives of patients, their needs, preferences and difficulties of daily life. This qualitative study was conducted to explore perspectives and needs of patients with PSS that influence health related quality of life (HRQL). Methods We recruited 20 PSS patients fulfilling the American-European consensus classification criteria out of the PSS cohort of the Medical University Graz, Austria. In total, 6 focus group sessions (with three to four patients per group) were performed. A modified meaning condensation procedure was used to analyse the data. Results The interview analysis resulted in 484 meaning units, 254 subconcepts and 86 concepts. The identified concepts were grouped into three dimensions: physical dimension, psychological & emotional challenges and social life & daily living. A dependency between the three categories was identified. The concepts most commonly reported by patients were related to the physical dimension: pain and dryness as well as complaints associated with/provoked by these symptoms. Patients also reported shortness of breath, fatigue und constipation. Conclusions This qualitative study underpins that HRQL in PSS patients is affected by several factors. The problems are not limited to dryness, pain and fatigue while the complaints secondary to these symptoms are important to patients with PSS significantly affecting physical, psychological and social life components of HRQL. A disease-specific patient related outcome measures for clinical practice and trials should be developed considering the different aspects of HRQL in PSS.	[Lackner, Angelika; Ficjan, Anja; Stradner, Martin H.; Hermann, Josef; Graninger, Winfried B.; Dejaco, Christian] Med Univ Graz, Dept Internal Med, Div Rheumatol & Immunol, Graz, Austria; [Unger, Julia] Univ Appl Sci JOANNEUM, Inst Occupat Therapy, Dept Hlth Studies, Bad Gleichenberg, Austria; [Stamm, Tanja; Stummvoll, Georg] Med Univ Vienna, Div Rheumatol, Vienna, Austria; [Duer, Mona] IMC Univ Appl Sci Krems, Krems An Der Donau, Austria; [Duer, Mona] Med Univ Vienna, Dept Pediat & Adolescent Med, Div Neonatol Pediat Intens Care & Neuropediat, Vienna, Austria; [Dejaco, Christian] Hosp Bruneck, South Tyrolean Hlth Trust, Rheumatol Serv, Brunico, Italy	Medical University of Graz; Medical University of Vienna; Medical University of Vienna	Dejaco, C (corresponding author), Med Univ Graz, Dept Internal Med, Div Rheumatol & Immunol, Graz, Austria.; Dejaco, C (corresponding author), Hosp Bruneck, South Tyrolean Hlth Trust, Rheumatol Serv, Brunico, Italy.	christian.dejaco@gmx.net	Graninger, Winfried/AAI-7192-2020; Stradner, Martin H/D-6473-2011; Unger, Julia/AAW-5017-2020	Stradner, Martin H/0000-0002-7884-6626; Graninger, Winfried/0000-0002-3489-3439; Dejaco, Christian/0000-0002-0173-0668				Avis M., 2005, QUAL RES HLTH CARE, P3; Coenen M, 2012, QUAL LIFE RES, V21, P359, DOI 10.1007/s11136-011-9943-2; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Gossec L, 2011, ANN RHEUM DIS, V70, P935, DOI 10.1136/ard.2010.142901; Gossec L, 2014, ANN RHEUM DIS, V73, P1012, DOI 10.1136/annrheumdis-2014-205207; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hackett K, 2012, BRIT J OCCUP THER, V75, P247, DOI 10.4276/030802212X13361458480441; Harboe E, 2009, ANN RHEUM DIS, V68, P1541, DOI 10.1136/ard.2008.098301; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; JACOBSSON LTH, 1989, J AUTOIMMUN, V2, P521, DOI 10.1016/0896-8411(89)90185-6; Kotsis K, 2014, RHEUMATOL INT, V34, P1671, DOI 10.1007/s00296-014-3008-0; Kvale S., 1996, INTERVIEW INTRO QUAL; Lendrem D, 2014, ANN RHEUM DIS, V73, P1362, DOI 10.1136/annrheumdis-2012-202863; Liang Y, 2014, ANN RHEUM DIS, V73, P1151, DOI 10.1136/annrheumdis-2013-203305; McSweeny A J, 1995, Dis Mon, V41, P1; Meijer JM, 2009, RHEUMATOLOGY, V48, P1077, DOI 10.1093/rheumatology/kep141; Ng WF, 2010, RHEUMATOLOGY, V49, P844, DOI 10.1093/rheumatology/keq009; Ngo DYJ, 2016, BMC ORAL HEALTH, V16, DOI 10.1186/s12903-016-0165-4; Patel R, 2014, CLIN EPIDEMIOL, V6, P247, DOI 10.2147/CLEP.S47399; Patton M. Q., 1990, QUALITATIVE EVALUATI; Ramos-Casals M, 2005, ANN RHEUM DIS, V64, P347, DOI 10.1136/ard.2004.025676; Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014; Segal BM, 2012, ACTA NEUROL SCAND, V125, P272, DOI 10.1111/j.1600-0404.2011.01530.x; Segal B, 2008, ARTHRIT RHEUM-ARTHR, V59, P1780, DOI 10.1002/art.24311; Seror R, 2013, ARTHRIT CARE RES, V65, P1358, DOI 10.1002/acr.21991; Seror R., 2014, ANN RHEUM DIS; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Stamm T, 2014, MUSCULOSKELET CARE, V12, P22, DOI 10.1002/msc.1047; Stamm TA, 2007, ARTHRIT RHEUM-ARTHR, V57, P1287, DOI 10.1002/art.23013; Stamm TA, 2007, ARTHRIT RHEUM-ARTHR, V57, P487, DOI 10.1002/art.22605; Stamm TA, 2011, ANN RHEUM DIS, V70, P1074, DOI 10.1136/ard.2010.148767; Strombeck B, 2000, SCAND J RHEUMATOL, V29, P20; Sutcliffe N, 1998, J RHEUMATOL, V25, P63; van Leeuwen N, 2016, J CLIN PSYCHOL MED S, V23, P77, DOI 10.1007/s10880-015-9432-9; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; ZHANG NZ, 1995, J RHEUMATOL, V22, P659	36	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172056	10.1371/journal.pone.0172056	http://dx.doi.org/10.1371/journal.pone.0172056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182787	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800147
J	Nakamura, T; Matsumine, A; Matsusaka, M; Mizumoto, K; Mori, M; Yoshizaki, T; Matsubara, T; Asanuma, K; Sudo, A				Nakamura, Tomoki; Matsumine, Akihiko; Matsusaka, Miki; Mizumoto, Keitaro; Mori, Mayuko; Yoshizaki, Tomoya; Matsubara, Takao; Asanuma, Kunihiro; Sudo, Akihiro			Analysis of pulmonary nodules in patients with high-grade soft tissue sarcomas	PLOS ONE			English	Article							LUNG-CANCER; METASTASES; CT	Nowadays, small pulmonary nodules are easily detectable in patients with soft tissue sarcomas (STSs) because of highly improved computed tomography (CT) technologies. The purpose of this study was to determine the frequency and significance of the pulmonary nodules detected by CT in high-grade STS patients. 124 patients with high-grade STS were retrospectively reviewed. There were 72 males (57%) and 52 females (43%). Patients' average age was 61 years (median (quartiles) 66 years (48-75), range 8-94 years). Pulmonary nodules were detected in 49 (39.5%) of 124 patients by CT scanning at first presentation. Of 49 patients with nodules at first presentation, 34 (69.4%) had benign lesions, and 13 (26.5%) had metastatic nodules. One patient (2%) had primary lung cancer and the remaining one with one nodule could not be definitively diagnosed due to a short follow-up time. 30 patients (24.1%) of 124 patients developed pulmonary nodules during their clinical progression. Seven (23.3%) had benign lesions, whereas 21 (70%) had metastatic lesions. Primary lung cancer was detected in two patients (6.7%). The size and timing of detection of a pulmonary nodule significantly affected the final clinical diagnosisby multivariate analysis. We conclude that pulmonary nodules can be detected highly frequently in patients with high-grade STSs because of improved CT technologies. Careful follow-up is needed if nodules are detected after initial treatment or during the clinical course of the disease.	[Nakamura, Tomoki; Matsumine, Akihiko; Matsubara, Takao; Asanuma, Kunihiro; Sudo, Akihiro] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie, Japan; [Matsusaka, Miki; Mizumoto, Keitaro; Mori, Mayuko; Yoshizaki, Tomoya] Mie Univ, Sch Med, Tsu, Mie, Japan	Mie University; Mie University	Nakamura, T (corresponding author), Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie, Japan.	tomoki66@clin.medic.mie-u.ac.jp						Bacci G, 1997, CANCER-AM CANCER SOC, V79, P245; Billingsley KG, 1999, ANN SURG, V229, P602, DOI 10.1097/00000658-199905000-00002; Ferguson PC, 2011, CANCER-AM CANCER SOC, V117, P372, DOI 10.1002/cncr.25418; Fortes DL, 2008, EUR J CARDIO-THORAC, V34, P1223, DOI 10.1016/j.ejcts.2008.09.007; Hanamiya M, 2012, EUR J RADIOL, V81, P152, DOI 10.1016/j.ejrad.2010.08.013; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Iagaru A, 2006, NUCL MED COMMUN, V27, P795, DOI 10.1097/01.mnm.0000237986.31597.86; Kane John M. III, 2002, Sarcoma, V6, P69, DOI 10.1080/1357714021000022168; Kattan MW, 2002, J CLIN ONCOL, V20, P791, DOI 10.1200/JCO.2002.20.3.791; LILLINGTON GA, 1993, CLIN CHEST MED, V14, P111; Nakamura T, 2011, ONCOL LETT, V2, P315, DOI 10.3892/ol.2011.238; Nakamura T, 2009, CLIN EXP METASTAS, V26, P713, DOI 10.1007/s10585-009-9270-y; Pollock RE, 1996, CANCER, V78, P2247, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2247::AID-CNCR29>3.3.CO;2-B; Reinhardt MJ, 2006, EUR J NUCL MED MOL I, V33, P134, DOI 10.1007/s00259-005-1901-1; Rissing S, 2007, CLIN ORTHOP RELAT R, P118, DOI 10.1097/BLO.0b013e31805d8606; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; Zagars GK, 2003, CANCER, V97, P2530, DOI 10.1002/cncr.11365	17	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172148	10.1371/journal.pone.0172148	http://dx.doi.org/10.1371/journal.pone.0172148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182790	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800150
J	Burnet, JB; Faraj, T; Cauchie, HM; Joaquim-Justo, C; Servais, P; Prevost, M; Dorner, SM				Burnet, Jean-Baptiste; Faraj, Tarek; Cauchie, Henry-Michel; Joaquim-Justo, Celia; Servais, Pierre; Prevost, Michele; Dorner, Sarah M.			How does the cladoceran Daphnia pulex affect the fate of Escherichia coli in water?	PLOS ONE			English	Article							FRESH-WATER; COMMUNITY STRUCTURE; FILTERING RATES; DRINKING-WATER; FECAL BACTERIA; BODY-SIZE; SURVIVAL; ZOOPLANKTON; PREDATION; MAGNA	The faecal indicator Escherichia coli plays a central role in water quality assessment and monitoring. It is therefore essential to understand its fate under various environmental constraints such as predation by bacterivorous zooplankton. Whereas most studies have examined how protozooplankton communities (heterotrophic nanoflagellates and ciliates) affect the fate of E. coli in water, the capacity of metazooplankton to control the faecal indicator remains poorly understood. In this study, we investigated how the common filter-feeding cladoceran, Daphnia pulex, affects the fate of E. coli under different experimental conditions. Daphnia ingested E. coli and increased its loss rates in water, but the latter rates decreased from 1.65 d(-1) to 0.62 d(-1) after a 1,000-fold reduction in E. coli initial concentrations, due to lower probability of encounter between Daphnia and E. coli. The combined use of culture and PMA qPCR (viability-qPCR) demonstrated that exposure to Daphnia did not result into the formation of viable but non-culturable E. coli cells. In lake water, a significant part of E. coli population loss was associated with matrix-related factors, most likely due to predation by other bacterivorous biota and/or bacterial competition. However, when exposing E. coli to a D. pulex gradient (from 0 to 65 ind. L-1), we observed an increasing impact of Daphnia on E. coli loss rates, which reached 0.47 d(-1) in presence of 65 ind. L-1. Our results suggest that the filter-feeder can exert a non-negligible predation pressure on E. coli, especially during seasonal Daphnia population peaks. Similar trials using other Daphnia species as well as stressed E. coli cells will increase our knowledge on the capacity of this widespread zooplankter to control E. coli in freshwater resources. Based on our results, we strongly advocate the use of natural matrices to study these biotic interactions in order to avoid overestimation of Daphnia impact.	[Burnet, Jean-Baptiste; Faraj, Tarek; Dorner, Sarah M.] Polytech Montreal, Dept Civil Geol & Min Engn, Canada Res Chair Source Water Protect, Montreal, PQ, Canada; [Cauchie, Henry-Michel] Luxembourg Inst Sci & Technol, Environm Res & Innovat, Esch Sur Alzette, Luxembourg; [Joaquim-Justo, Celia] Univ Liege, Inst Chim, Lab Ecol Anim & Ecotoxicol, Liege, Belgium; [Servais, Pierre] Univ Libre Bruxelles, Ecol Syst Aquat, Campus Plaine,CP 221,Blvd Triomphe, Brussels, Belgium; [Prevost, Michele] Polytech Montreal, Dept Civil Geol & Min Engn, NSERC Ind Chair Drinking Water, Montreal, PQ, Canada	Universite de Montreal; Polytechnique Montreal; Luxembourg Institute of Science & Technology; University of Liege; Universite Libre de Bruxelles; Universite de Montreal; Polytechnique Montreal	Burnet, JB (corresponding author), Polytech Montreal, Dept Civil Geol & Min Engn, Canada Res Chair Source Water Protect, Montreal, PQ, Canada.	jean-baptiste.burnet@polymtl.ca	Cauchie, Henry-Michel FV/K-8123-2014	Cauchie, Henry-Michel FV/0000-0003-4780-6100; Burnet, Jean-Baptiste/0000-0002-6126-0338	National Research Fund, Luxembourg; Marie Curie Actions of the European Commission (FP7-COFUND); NSERC; Canada Research Chair (CRC) in Source Water Protection	National Research Fund, Luxembourg(Luxembourg National Research Fund); Marie Curie Actions of the European Commission (FP7-COFUND); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair (CRC) in Source Water Protection	The present study has been financially supported by the National Research Fund, Luxembourg, and co-funded under the Marie Curie Actions of the European Commission (FP7-COFUND), NSERC, as well as by the Canada Research Chair (CRC) in Source Water Protection.; The authors would like to thank Dr Marc Schallenberg for providing insightful comments on the manuscript. The authors also thank Yves Fontaine, Audrey Lafrenaye, Rose-Mery Yagh-mour and Jacinthe Mailly for their excellent technical support as well as Prof. Remy Tadonleke and Prof. Bernadette Pinel-Alloul for their help with zooplankton. The present study has been financially supported by the National Research Fund, Luxembourg and co-funded under the Marie Curie Actions of the European Commission (FP7-COFUND), NSERC, as well as by the Canada Research Chair (CRC) in Source Water Protection.	Barcina I, 1997, FEMS MICROBIOL ECOL, V23, P1, DOI 10.1111/j.1574-6941.1997.tb00385.x; Bichai F, 2008, CAN J MICROBIOL, V54, P509, DOI [10.1139/W08-039, 10.1139/w08-039]; Bichai F, 2010, WATER RES, V44, P1072, DOI 10.1016/j.watres.2009.09.001; Blaustein RA, 2013, WATER RES, V47, P569, DOI 10.1016/j.watres.2012.10.027; Boehm AB, 2005, WATER RES, V39, P3565, DOI 10.1016/j.watres.2005.06.026; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; BRENDELBERGER H, 1991, LIMNOL OCEANOGR, V36, P884, DOI 10.4319/lo.1991.36.5.0884; BURNS CW, 1968, LIMNOL OCEANOGR, V13, P675, DOI 10.4319/lo.1968.13.4.0675; Cangelosi GA, 2014, APPL ENVIRON MICROB, V80, P5884, DOI 10.1128/AEM.01763-14; Cauchie HM, 2000, J PLANKTON RES, V22, P2263, DOI 10.1093/plankt/22.12.2263; Chern EC, 2011, LETT APPL MICROBIOL, V52, P298, DOI 10.1111/j.1472-765X.2010.03001.x; Connelly SJ, 2007, APPL ENVIRON MICROB, V73, P7277, DOI 10.1128/AEM.01206-07; DABORN GR, 1978, CAN J ZOOL, V56, P1392, DOI 10.1139/z78-192; DAVIES J, 1985, HYDROBIOLOGIA, V120, P103, DOI 10.1007/BF00032130; Degans H, 2002, FEMS MICROBIOL ECOL, V42, P137, DOI 10.1111/j.1574-6941.2002.tb01003.x; Fittipaldi M, 2012, J MICROBIOL METH, V91, P276, DOI 10.1016/j.mimet.2012.08.007; Forro L, 2008, HYDROBIOLOGIA, V595, P177, DOI 10.1007/s10750-007-9013-5; FOX HM, 1952, NATURE, V169, P1051, DOI 10.1038/1691051b0; Freese HM, 2013, HYDROBIOLOGIA, V715, P63, DOI 10.1007/s10750-012-1375-7; GOPHEN M, 1974, NATURE, V247, P393, DOI 10.1038/247393a0; GUDE H, 1988, HYDROBIOLOGIA, V159, P63, DOI 10.1007/BF00007368; HADAS O, 1983, HYDROBIOLOGIA, V102, P163, DOI 10.1007/BF00006343; HANEY JF, 1985, LIMNOL OCEANOGR, V30, P397, DOI 10.4319/lo.1985.30.2.0397; HELGEN JC, 1987, HYDROBIOLOGIA, V154, P113, DOI 10.1007/BF00026835; Jackson BP, 2009, ANAL BIOANAL CHEM, V394, P911, DOI 10.1007/s00216-009-2768-y; Jurgens K, 1999, APPL ENVIRON MICROB, V65, P1241; JURGENS K, 1994, ARCH HYDROBIOL, V131, P55; JURGENS K, 1994, MARINE MICROBIAL FOOD WEBS, 1994, VOL 8, NO 1 AND 2, P295; Kamjunke N, 1999, J PLANKTON RES, V21, P1175, DOI 10.1093/plankt/21.6.1175; KING CH, 1991, LIMNOL OCEANOGR, V36, P829, DOI 10.4319/lo.1991.36.5.0829; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; KVAM OV, 1995, HYDROBIOLOGIA, V307, P177, DOI 10.1007/BF00032010; Lin T, 2016, WATER RES, V89, P20, DOI 10.1016/j.watres.2015.11.015; Lurling M, 2003, J PLANKTON RES, V25, P967, DOI 10.1093/plankt/25.8.967; MCCAMBRIDGE J, 1980, APPL ENVIRON MICROB, V40, P907, DOI 10.1128/AEM.40.5.907-911.1980; McMAHON J. W., 1965, LIMNOL OCEANOGR, V10, P105; Menon P, 2003, WATER RES, V37, P4151, DOI 10.1016/S0043-1354(03)00349-X; Ndong M, 2014, WATER RES, V56, P98, DOI 10.1016/j.watres.2014.02.023; Pau C, 2013, WATER RES, V47, P181, DOI 10.1016/j.watres.2012.09.047; PETERSON BJ, 1978, LIMNOL OCEANOGR, V23, P1039, DOI 10.4319/lo.1978.23.5.1039; Pilati A, 2004, FRESHWATER BIOL, V49, P913, DOI 10.1111/j.1365-2427.2004.01234.x; RHODES MW, 1988, APPL ENVIRON MICROB, V54, P2902, DOI 10.1128/AEM.54.12.2902-2907.1988; RIEMANN B, 1985, APPL ENVIRON MICROB, V50, P187, DOI 10.1128/AEM.50.2.187-193.1985; SANDERS RW, 1989, LIMNOL OCEANOGR, V34, P673, DOI 10.4319/lo.1989.34.4.0673; Schallenberg M, 2005, APPL ENVIRON MICROB, V71, P5085, DOI 10.1128/AEM.71.9.5085-5088.2005; Servais P, 2009, CAN J MICROBIOL, V55, P905, DOI [10.1139/W09-043, 10.1139/w09-043]; SHERR BF, 1987, APPL ENVIRON MICROB, V53, P958, DOI 10.1128/AEM.53.5.958-965.1987; Simek K, 1997, AQUAT MICROB ECOL, V12, P49, DOI 10.3354/ame012049; Stott R, 2003, WATER SCI TECHNOL, V47, P77, DOI 10.2166/wst.2003.0166; TEZUKA Y, 1971, Japanese Journal of Ecology, V21, P127; Thouvenot A, 1999, J PLANKTON RES, V21, P1659, DOI 10.1093/plankt/21.9.1659; US EPA Environmental Protection Agency, 2002, PUBLICATION USEPA, p4303T; USEPA, 2006, LT2ESWTR LONG TERM 2; VAQUE D, 1992, J PLANKTON RES, V14, P307, DOI 10.1093/plankt/14.2.307; Walters SP, 2009, WATER RES, V43, P4929, DOI 10.1016/j.watres.2009.05.047; Wanjugi P, 2013, ENVIRON MICROBIOL, V15, P517, DOI 10.1111/j.1462-2920.2012.02877.x; Wcislo R, 2000, POL J ENVIRON STUD, V9, P215; Whitman RL, 2008, SCI TOTAL ENVIRON, V390, P448, DOI 10.1016/j.scitotenv.2007.10.014; WIEDNER C, 1995, HYDROBIOLOGIA, V302, P89, DOI 10.1007/BF00027033	59	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171705	10.1371/journal.pone.0171705	http://dx.doi.org/10.1371/journal.pone.0171705			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178322	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000393712500061
J	Dullin, C; Ufartes, R; Larsson, E; Martin, S; Lazzarini, M; Tromba, G; Missbach-Guentner, J; Pinkert-Leetsch, D; Katschinski, DM; Alves, F				Dullin, Christian; Ufartes, Roser; Larsson, Emanuel; Martin, Sabine; Lazzarini, Marcio; Tromba, Giuliana; Missbach-Guentner, Jeannine; Pinkert-Leetsch, Diana; Katschinski, Doerthe M.; Alves, Frauke			mu CT of ex-vivo stained mouse hearts and embryos enables a precise match between 3D virtual histology, classical histology and immunochemistry	PLOS ONE			English	Article							TISSUE	The small size of the adult and developing mouse heart poses a great challenge for imaging in preclinical research. The aim of the study was to establish a phosphotungstic acid (PTA) ex-vivo staining approach that efficiently enhances the x-ray attenuation of soft-tissue to allow high resolution 3D visualization of mouse hearts by synchrotron radiation based pCT (SRpCT) and classical pCT. We demonstrate that SRpCT of PTA stained mouse hearts ex vivo allows imaging of the cardiac atrium, ventricles, myocardium especially its fibre structure and vessel walls in great detail and furthermore enables the depiction of growth and anatomical changes during distinct developmental stages of hearts in mouse embryos. Our x-ray based virtual histology approach is not limited to SRpCT as it does not require monochromatic and/or coherent x-ray sources and even more importantly can be combined with conventional histological procedures. Furthermore, it permits volumetric measurements as we show for the assessment of the plaque volumes in the aortic valve region of mice from an ApoE-/- mouse model. Subsequent, Masson-Goldner trichrome staining of paraffin sections of PTA stained samples revealed intact collagen and muscle fibres and positive staining of CD31 on endothelial cells by immunohistochemistry illustrates that our approach does not prevent immunochemistry analysis. The feasibility to scan hearts already embedded in paraffin ensured a 100% correlation between virtual cut sections of the CT data sets and histological heart sections of the same sample and may allow in future guiding the cutting process to specific regions of interest. In summary, since our CT based virtual histology approach is a powerful tool for the 3D depiction of morphological alterations in hearts and embryos in high resolution and can be combined with classical histological analysis it may be used in preclinical research to unravel structural alterations of various heart diseases.	[Dullin, Christian; Missbach-Guentner, Jeannine; Alves, Frauke] Univ Med Ctr, Inst Diagnost & Intervent Radiol, Gottingen, Germany; [Dullin, Christian; Larsson, Emanuel; Tromba, Giuliana] Synchrotron Light Source Elettra, Trieste, Italy; [Ufartes, Roser; Martin, Sabine; Lazzarini, Marcio; Alves, Frauke] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, Gottingen, Germany; [Martin, Sabine] Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, Gottingen, Germany; [Missbach-Guentner, Jeannine; Pinkert-Leetsch, Diana; Alves, Frauke] Univ Med Ctr, Clin Haematol & Med Oncol, Gottingen, Germany; [Katschinski, Doerthe M.] Univ Med Ctr, Inst Cardiovasc Physiol, Gottingen, Germany	University of Gottingen; Max Planck Society; University of Gottingen; University of Gottingen	Dullin, C (corresponding author), Univ Med Ctr, Inst Diagnost & Intervent Radiol, Gottingen, Germany.; Dullin, C (corresponding author), Synchrotron Light Source Elettra, Trieste, Italy.	Christian.dullin@med.uni-goettingen.de	Larsson, Emanuel/A-5807-2019	Larsson, Emanuel/0000-0002-3586-5763; Dullin, Christian/0000-0003-4297-8077	Cluster of Excellence; German Research Foundation (DFG) [DU 1403/1-1]; 'EXTREMA' COST action [MP1207]; COST action [MP1203]; 'Talents3' mobility fellowship of the Italian region 'Friuli Venezia Giulia'; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain	Cluster of Excellence; German Research Foundation (DFG)(German Research Foundation (DFG)); 'EXTREMA' COST action; COST action(European Cooperation in Science and Technology (COST)); 'Talents3' mobility fellowship of the Italian region 'Friuli Venezia Giulia'; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG))	Sabine Martin was funded through the Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain. Christian Dullin was supported by the German Research Foundation (DFG, DU 1403/1-1) and by the 'EXTREMA' COST action MP1207 action, the COST action MP1203 and by the 'Talents3' mobility fellowship of the Italian region 'Friuli Venezia Giulia'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels M, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.048103; Beltran MA, 2010, 2D 3D XRAY PHASE RET, V6423; Cardiff RD, 2014, COLD SPRING HARB PRO, V2014; Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482; Dunmore-Buyze PJ, 2014, CONTRAST MEDIA MOL I; Dweck MR, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.004805; HELANDER KG, 1994, BIOTECH HISTOCHEM, V69, P177, DOI 10.3109/10520299409106282; Johnson JT, 2006, PLOS GENET, V2, P471, DOI 10.1371/journal.pgen.0020061; Keggin JF, 1933, NATURE, V131, P908, DOI 10.1038/131908b0; Lang S, 2014, J APPL PHYS, V116, DOI 10.1063/1.4897225; Martin S, 2016, MOL NEUROBIOL; Masson P., 1929, J TECH METHODS, V12, P75; McAteer MA, 2004, ARTERIOSCL THROM VAS, V24, P2384, DOI 10.1161/01.ATV.0000146811.19029.fb; Metscher BD, 2009, MICROCT DEV BIOL VER, P632; Metscher BD, 2011, MICROCT MOL IMAGING, P2301; Metscher BD, 2009, MICROCT COMP MORPHOL, V11; Montanari F., 2003, SYRMEP TOMO PROJECT; Nakashima Y, 1994, ARTERIOSCLER THROMB, P133; Pauwels E, 2013, J MICROSC-OXFORD, V250, P21, DOI 10.1111/jmi.12013; QUINTARELLI G, 1971, J HISTOCHEM CYTOCHEM, V19, P641, DOI 10.1177/19.11.641; Rastogi V., 2013, J CLIN DIAGN RES; Robinson PS, 2007, DEV FUNCTIONAL TISSU; Rouillard AD, 2014, PROG BIOPHYS MOL BIO; Schulz G, 2011, J NEUROSCI METH, V202, P17, DOI 10.1016/j.jneumeth.2011.08.031; Shinohara M, 2007, AM J PHYSIOL-HEART C, V294, pH1094; Tromba G, 2010, SYRMEP BEAMLINE ELET, P18; WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P475, DOI 10.1083/jcb.4.4.475; Zanette I, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4848595	28	41	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170597	10.1371/journal.pone.0170597	http://dx.doi.org/10.1371/journal.pone.0170597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178293	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500011
J	Ni, YW; Teng, T; Li, RT; Simonyi, A; Sun, GY; Lee, JC				Ni, Yawen; Teng, Tao; Li, Runting; Simonyi, Agnes; Sun, Grace Y.; Lee, James C.			TNF alpha alters occludin and cerebral endothelial permeability: Role of p38MAPK	PLOS ONE			English	Article							PHOSPHORYLATION; MECHANISM; DISRUPTION	Occludin is a key tight junction (TJ) protein in cerebral endothelial cells (CECs) playing an important role in modulating blood-brain barrier (BBB) functions. This protein (65kDa) has been shown to engage in many signaling pathways and phosphorylation by both tyrosine and threonine kinases. Despite yet unknown mechanisms, pro-inflammatory cytokines and endotoxin (lipopolysaccharides, LPS) may alter TJ proteins in CECs and BBB functions. Here we demonstrate the responses of occludin in an immortalized human cerebral endothelial cell line (hCMEC/D3) to stimulation by TNFa (10 ng/mL), IL-1 beta (10 ng/mL) and LPS (100 ng/mL). Exposing cells to TNFa resulted in a rapid and transient upward band-shift of occludin, suggesting of an increase in phosphorylation. Exposure to IL-1 beta produced significantly smaller effects and LPS produced almost no effects on occludin band-shift. TNFa also caused transient stimulation of p38MAPK and ERK1/2 in hCMEC/D3 cells, and the occludin band-shift induced by TNFa was suppressed by SB202190, an inhibitor for p38MAPK, and partly by U0126, the MEK1/2-ERK1/2 inhibitor. Cells treated with TNFa and IL-1 beta but not LPS for 24 h resulted in a significant (p < 0.001) decrease in the expression of occludin, and the decrease could be partially blocked by SB202190, the inhibitor for p38MAPK. Treatment with TNF alpha also altered cell morphology and enhanced permeability of the CEC layer as measured by the FITC-dextran assay and the trans-endothelial electrical resistances (TEER). However, treatment with SB202190 alone could not effectively reverse the TNF alpha-induced morphology changes or the enhanced permeability changes. These results suggest that despite effects of TNF alpha on p38MAPK-mediated occludin phosphorylation and expression, these changes are not sufficient to avert the TNF alpha-induced alterations on cell morphology and permeability.	[Ni, Yawen] Univ Missouri, Dept Bioengn, Columbia, MO 65211 USA; [Teng, Tao; Lee, James C.] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA; [Li, Runting; Simonyi, Agnes; Sun, Grace Y.] Univ Missouri, Dept Biochem, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Missouri System; University of Missouri Columbia	Lee, JC (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.	leejam@uic.edu	Teng, Tao/T-1557-2017	Teng, Tao/0000-0003-4078-1545	National Institute on Aging [R01 AG044404-04]; NATIONAL INSTITUTE ON AGING [R01AG044404] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by R01 AG044404-04 from the National Institute on Aging to JCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lopez-Ramirez MA, 2012, J IMMUNOL, V189, P3130, DOI 10.4049/jimmunol.1103460; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Banks WA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0434-1; Boivin MA, 2009, J INTERF CYTOK RES, V29, P45, DOI 10.1089/jir.2008.0128; Bolinger MT, 2016, MOL CELL BIOL, V36, P2051, DOI 10.1128/MCB.00053-16; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Cui Wei, 2007, Zhonghua Nei Ke Za Zhi, V46, P478; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; Grethe S, 2004, EXP CELL RES, V298, P632, DOI 10.1016/j.yexcr.2004.05.007; Kant S, 2011, GENE DEV, V25, P2069, DOI 10.1101/gad.17224711; Modur V, 1996, J BIOL CHEM, V271, P13094, DOI 10.1074/jbc.271.22.13094; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ozaki H, 1999, J IMMUNOL, V163, P553; Qin LH, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/120641; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Sun GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141509; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; Xu C, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12636	23	61	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170346	10.1371/journal.pone.0170346	http://dx.doi.org/10.1371/journal.pone.0170346			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170408	Green Published, Green Submitted, gold			2022-12-26	WOS:000393705500004
J	Yang, MQ; Li, DZ; Wen, J; Yi, TS				Yang, Mei-Qing; Li, De-Zhu; Wen, Jun; Yi, Ting-Shuang			Phylogeny and biogeography of the amphi-Pacific genus Aphananthe	PLOS ONE			English	Article							DNA-SEQUENCE DATA; NORTHERN-HEMISPHERE; ULMACEAE URTICALES; SOUTHEAST-ASIA; INDIAN-OCEAN; EASTERN ASIA; INTERCONTINENTAL DISJUNCTIONS; GEOGRAPHIC RANGE; CHLOROPLAST DNA; PLATE-TECTONICS	Aphananthe is a small genus of five species showing an intriguing amphi-Pacific distribution in eastern, southern and southeastern Asia, Australia, and Mexico, also with one species in Madagascar. The phylogenetic relationships of Aphananthe were reconstructed with two nuclear (ITS & ETS) and two plastid (psbA-trnH & trnL-trnF) regions. Clade divergence times were estimated with a Bayesian approach, and the ancestral areas were inferred using the dispersal-extinction-cladogenesis and Bayesian Binary MCMC analyses. Aphananthe was supported to be monophyletic, with the eastern Asian A. aspera resolved as sister to a clade of the remaining four species. Aphananthe was inferred to have originated in the Late Cretaceous (71.5 mya, with 95% HPD: 66.6-81.3 mya), and the crown age of the genus was dated to be in the early Miocene (19.1 mya, with 95% HPD: 12.4-28.9 mya). The fossil record indicates that Aphananthe was present in the high latitude thermophilic forests in the early Tertiary, and experienced extinctions from the middle Tertiary onwards. Aphananthe originated in Europe based on the inference that included fossil and extant species, but eastern Asia was estimated to be the ancestral area of the clade of the extant species of Aphananthe. Both the West Gondwanan vicariance hypothesis and the boreotropics hypothesis could be excluded as explanation for its amphi-Pacific distribution. Long-distance dispersals out of eastern Asia into North America, southern and southeastern Asia and Australia, and Madagascar during the Miocene account for its wide intercontinental disjunct distribution.	[Yang, Mei-Qing; Li, De-Zhu; Yi, Ting-Shuang] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China; [Yang, Mei-Qing] Baotou Med Coll, Baotou, Inner Mongolia, Peoples R China; [Wen, Jun] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Baotou Medical College; Smithsonian Institution; Smithsonian National Museum of Natural History	Yi, TS (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China.; Wen, J (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA.	wenj@si.edu; tingshuangyi@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X	National Key Basic Research Program of China [2014CB954100-01]; National Natural Science Foundation [31129001, 31500181]; Talent Project of Yunnan Province [2011CI042]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Talent Project of Yunnan Province	This study was supported by grants from the National Key Basic Research Program of China (Grant No. 2014CB954100-01), the National Natural Science Foundation (Project No. 31129001), the Talent Project of Yunnan Province (Project No. 2011CI042), and National Natural Science Foundation (Project No. 31500181).	Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; Antonelli A, 2011, SYST BIOL, V60, P596, DOI 10.1093/sysbio/syr062; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; Bazinet AL, 2014, SYST BIOL, V63, P812, DOI 10.1093/sysbio/syu031; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Chandler M. E. J., 1964, LOWER TERTIARY FLORA; Choi SK, 2010, IAWA J, V31, P95, DOI 10.1163/22941932-90000009; Christenhusz MJM, 2013, BOT J LINN SOC, V171, P277, DOI 10.1111/j.1095-8339.2012.01301.x; Conti E, 2002, EVOLUTION, V56, P1931; Crisp MD, 2009, EVOLUTION, V63, P2257, DOI 10.1111/j.1558-5646.2009.00728.x; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Davis CC, 2002, EVOLUTION, V56, P2395; Donoghue MJ, 2004, PHILOS T R SOC B, V359, P1633, DOI 10.1098/rstb.2004.1538; Dorofeev P., 1982, FOSSIL FLOWERING PLA, V2; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2009, GENEIOUS; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Farris JS, 1995, CLADISTICS, V11, P377, DOI 10.1111/j.1096-0031.1995.tb00096.x; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Floyd A.G., 1989, RAINFOREST TREES MAI; Fritsch PW, 2015, J BIOGEOGR, V42, P891, DOI 10.1111/jbi.12442; Fu LG., 2003, FLORA CHINA, P1; Fuchs J, 2006, MOL PHYLOGENET EVOL, V39, P186, DOI 10.1016/j.ympev.2005.07.020; GIANNASI DE, 1978, TAXON, V27, P331, DOI 10.2307/1220369; Goswami BN, 2003, P INDIAN AS-EARTH, V112, P61; Hall R, 2001, FAUNAL AND FLORAL MIGRATIONS AND EVOLUTION IN SE ASIA-AUSTRALASIA, P35; Hall R, 2009, BLUMEA, V54, P148, DOI 10.3767/000651909X475941; Hamilton MB, 1999, MOL ECOL, V8, P521; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harvey PH, 1998, P ROY SOC B-BIOL SCI, V265, P1691, DOI 10.1098/rspb.1998.0490; Ickert-Bond SM, 2006, MOL PHYLOGENET EVOL, V39, P512, DOI 10.1016/j.ympev.2005.12.003; Jonsson KA, 2006, J BIOGEOGR, V33, P1155, DOI 10.1111/j.1365-2699.2006.01507.x; Knobloch E, 1986, ROZPRAVY STRED HO ST, V47, P1; Kubitzki K., 1996, FLORISTIC CHARACTERI, P65; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LAVIN M, 1993, AM J BOT, V80, P1, DOI 10.2307/2445114; Leroy J. F., 1961, Journal d'Agriculture tropicale, V8, P72; Leroy Jean-F., 1946, BULL MUS NATION HIST NAT [PARIS], V18, P118; Li R, 2016, J SYST EVOL, V54, P453, DOI 10.1111/jse.12196; Li R, 2014, J SYST EVOL, V52, P431, DOI 10.1111/jse.12052; Li R, 2013, SYST BOT, V38, P536, DOI 10.1600/036364413X666606; Li YQ, 2009, SYST BOT, V34, P521, DOI 10.1600/036364409789271263; Manchester S.R., 1994, PALEONTOGRAPHICA AM, V58, P1; Manchester S.R., 1981, OREGON GEOLOGY, V43, P75; Manchester SR, 2002, INT J PLANT SCI, V163, P725, DOI 10.1086/341513; McKenna MC, 1973, IMPLICATIONCONTINE, V1, P291; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Morley R. J., 2007, P1, DOI 10.1007/978-3-540-48842-2_1; Morley R.J., 2000, ORIGIN EVOLUTION TRO; Morley RJ, 2003, PERSPECT PLANT ECOL, V6, P5, DOI 10.1078/1433-8319-00039; Morley RJ., 1998, BIOGEOGRAPHY GEOLOGI, V22, P211; Moyle RG, 2012, SYST BIOL, V61, P631, DOI 10.1093/sysbio/sys027; Nauheimer L, 2012, NEW PHYTOL, V195, P938, DOI 10.1111/j.1469-8137.2012.04220.x; Nauheimer L, 2012, MOL PHYLOGENET EVOL, V63, P43, DOI 10.1016/j.ympev.2011.12.011; New AL, 2005, PHILOS T ROY SOC A, V363, P151, DOI 10.1098/rsta.2004.1484; OGINUMA K, 1990, BOT MAG TOKYO, V103, P113, DOI 10.1007/BF02489620; Prive-Gill C, 1999, REV PALAEOBOT PALYNO, V107, P191, DOI 10.1016/S0034-6667(99)00017-2; RAMBAUT A, 2004, TRACER VERSION 1 3; Reddy S, 2012, P ROY SOC B-BIOL SCI, V279, P2062, DOI 10.1098/rspb.2011.2380; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Reid EM., 1933, LONDON CLAY FLORA; Renner SS, 2004, PHILOS T R SOC B, V359, P1485, DOI 10.1098/rstb.2004.1530; Richardson J.E., 2012, BIOTIC EVOLUTION ENV, P138, DOI DOI 10.1017/CBO9780511735882.008; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Rogl VF., 1999, MIOCENE LAND MAMMALS, P39; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rutschmann F, 2004, INT J PLANT SCI, V165, pS69, DOI 10.1086/383335; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Silvertown J, 2005, J ECOL, V93, P653, DOI 10.1111/j.1365-2745.2005.01038.x; Silvertown J, 2004, J ECOL, V92, P168, DOI 10.1111/j.1365-2745.2004.00853.x; Sirichamorn Y, 2014, J BIOGEOGR, V41, P882, DOI 10.1111/jbi.12262; [宋葆华 Song Baohua], 2002, [植物分类学报, Acta Phytotaxonomica Sinica], V40, P125; Song BH, 2001, PLANT SYST EVOL, V228, P107, DOI 10.1007/s006060170041; Su YCF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-153; Sytsma KJ, 2002, AM J BOT, V89, P1531, DOI 10.3732/ajb.89.9.1531; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAKASO T, 1990, BOT MAG TOKYO, V103, P25, DOI 10.1007/BF02488408; Thomas DC, 2012, J BIOGEOGR, V39, P98, DOI 10.1111/j.1365-2699.2011.02596.x; THORNE RF, 1972, Q REV BIOL, V47, P365, DOI 10.1086/407399; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; Ueda K, 1997, J PLANT RES, V110, P171, DOI 10.1007/BF02509305; van Hinsbergen DJJ, 2012, P NATL ACAD SCI USA, V109, P7659, DOI 10.1073/pnas.1117262109; van Steenis CGGJ, 1962, BLUMEA, V11, P266; Voelker G, 2008, J EVOLUTION BIOL, V21, P1779, DOI 10.1111/j.1420-9101.2008.01588.x; Warren BH, 2010, CLADISTICS, V26, P526, DOI 10.1111/j.1096-0031.2009.00300.x; Weeks A, 2005, MOL PHYLOGENET EVOL, V35, P85, DOI 10.1016/j.ympev.2004.12.021; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wen J, 1996, MOL PHYLOGENET EVOL, V6, P167, DOI 10.1006/mpev.1996.0069; Wen J., 2011, Contributions from the United States National Herbarium, V57, P5; Wen J, 2001, INT J PLANT SCI, V162, pS117, DOI 10.1086/322940; Wen J., 2010, DARWINS HERITAGE TOD, P252; Wen J, 2016, J SYST EVOL, V54, P469, DOI 10.1111/jse.12222; Wiegrefe SJ, 1998, PLANT SYST EVOL, V210, P249, DOI 10.1007/BF00985671; WOLFE JA, 1975, ANN MO BOT GARD, V62, P264, DOI 10.2307/2395198; Xie L, 2010, MOL PHYLOGENET EVOL, V56, P675, DOI 10.1016/j.ympev.2010.02.018; Yang MQ, 2013, TAXON, V62, P473, DOI 10.12705/623.9; Yi TS, 2004, MOL PHYLOGENET EVOL, V33, P861, DOI 10.1016/j.ympev.2004.07.006; Yoshikawa Tetsuro, 2009, Journal of Ecology and Field Biology, V32, P137; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhou LL, 2012, J BIOGEOGR, V39, P322, DOI 10.1111/j.1365-2699.2011.02598.x	106	13	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171405	10.1371/journal.pone.0171405	http://dx.doi.org/10.1371/journal.pone.0171405			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170425	gold, Green Submitted, Green Published			2022-12-26	WOS:000393705500036
J	Alexander, L; Woeste, K				Alexander, Lisa; Woeste, Keith			Pollen gene flow, male reproductive success, and genetic correlations among offspring in a northern red oak (Quercus rubra L.) seed orchard	PLOS ONE			English	Article							MATING PATTERNS; PATERNITY ANALYSIS; WIND-POLLINATION; MICROSATELLITE MARKERS; MOLECULAR MARKERS; BUR OAK; PINE; CONTAMINATION; EUCALYPTUS; PHENOLOGY	Northern red oak is a high-value hardwood used for lumber, furniture and veneer. Intensively managed northern red oak seed orchards are required to obtain genetic gain for trait improvement. Data from conifer seed orchards and natural and managed stands of hardwood trees have shed light on the distance over which pollen can move, and underscore the need for managerial attention to seed orchard design, placement, and maintenance. We used eleven microsatellite markers to investigate pollen gene flow, female mate choice, and male reproductive success in a clonal seed orchard of northern red oak based on paternity analysis of seed orchard offspring in progeny tests. Nearly all (93%) offspring were sired by a male parent within the seed orchard. The mean number of male parents per year was 69.5, or 47.6% of all clones in the seed orchard. Female clones in the early phenology group had more offspring sired from extra-orchard pollen (13%) than clones in the intermediate (5%) and late (1%) phenology groups. Distance was the largest influence on pollination success, and pollination occurred most often by male trees in the same subline as the maternal tree. Males in the early phenology group sired more offspring overall in the progeny pool and more offspring per mother tree than males in the intermediate or late phenology groups. Average genetic correlations among all OP progeny ranged between 0.2557 and 0.3529 with a mean of 0.28 +/- 0.01. The importance of progeny test genotyping for northern red oak improvement likely is increasing with the demand for improved varieties. The current study demonstrated the feasibility of post hoc assembly of full-sib families for genetic analysis.	[Alexander, Lisa; Woeste, Keith] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Woeste, Keith] Purdue Univ, USDA, US Forest Serv, Northern Res Stn,Hardwood Tree Improvement & Rege, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); United States Forest Service	Alexander, L (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	Lisa.Alexander@ars.usda.gov			Fred M. van Eck Foundation	Fred M. van Eck Foundation	LA received partial funding from the Fred M. van Eck Foundation for Purdue University. KW received no specific funding for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams W. T., 1992, New Forests, V6, P217, DOI 10.1007/BF00120646; Aldrich PR, 2003, SILVAE GENET, V52, P176; Aldrich PR, 2002, MOL ECOL NOTES, V2, P472, DOI 10.1046/j.1471-8286.2002.00282.x; Alexander LW, 2016, CAN J FOREST RES, V46, P629, DOI 10.1139/cjfr-2015-0312; ASKEW GR, 1994, THEOR APPL GENET, V88, P267, DOI 10.1007/BF00225908; Bai WN, 2006, ANN BOT-LONDON, V98, P397, DOI 10.1093/aob/mcl111; Buiteveld J., 2001, Forest Genetics, V8, P331; Burczyk J, 2002, MOL ECOL, V11, P2379, DOI 10.1046/j.1365-294X.2002.01603.x; Burczyk J, 1996, HEREDITY, V77, P251, DOI 10.1038/hdy.1996.139; Burczyk JL, 1997, HEREDITY, V79, P638, DOI 10.1038/hdy.1997.210; Chaix G, 2003, THEOR APPL GENET, V107, P705, DOI 10.1007/s00122-003-1294-0; Doerksen TK, 2008, CAN J FOREST RES, V38, P1742, DOI 10.1139/X08-025; Dow BD, 1998, J HERED, V89, P62, DOI 10.1093/jhered/89.1.62; Dow BD, 1998, NEW FOREST, V15, P161, DOI 10.1023/A:1006557904751; ELKASSABY YA, 1986, SILVAE GENET, V35, P240; ERICKSON VJ, 1990, CAN J FOREST RES, V20, P1672, DOI 10.1139/x90-220; FRIEDMAN ST, 1985, THEOR APPL GENET, V69, P609, DOI 10.1007/BF00251112; Friedman ST, 1981, P 16 SO FOR TREE IMP; Grattapaglia D, 2004, THEOR APPL GENET, V109, P192, DOI 10.1007/s00122-004-1617-9; Hansen OK, 2008, FOREST ECOL MANAG, V256, P1167, DOI 10.1016/j.foreco.2008.06.032; Hansen OK, 2006, CAN J FOREST RES, V36, P1054, DOI 10.1139/X05-299; Hansen OK, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010028; Gaspar MJ, 2009, TREE GENET GENOMES, V5, P609, DOI 10.1007/s11295-009-0213-1; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kimura MK, 2012, PLANT ECOL, V213, P1477, DOI 10.1007/s11258-012-0105-6; Knapp EE, 2001, OECOLOGIA, V128, P48, DOI 10.1007/s004420000623; Kumar S, 2005, MOL BREEDING, V15, P55, DOI 10.1007/s11032-004-2059-4; Lambeth C, 2001, THEOR APPL GENET, V103, P930, DOI 10.1007/s001220100627; Lexer C, 1999, THEOR APPL GENET, V99, P185, DOI 10.1007/s001220051223; Lindgren D, 1998, CAN J FOREST RES, V28, P276, DOI 10.1139/cjfr-28-2-276; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Nielsen UB, 2007, SCAND J FOREST RES, V22, P99, DOI 10.1080/02827580701231597; OWENS JN, 1995, TREE PHYSIOL, V15, P477, DOI 10.1093/treephys/15.7-8.477; Pakkanen A, 2000, SCAND J FOREST RES, V15, P399, DOI 10.1080/028275800750172574; Plomion C, 2001, CAN J FOREST RES, V31, P1816, DOI 10.1139/cjfr-31-10-1816; Robichaud RL, 2007, THESIS; SCHOEN DJ, 1987, GENETICS, V116, P141; Skroppa T., 1994, Forest Genetics, V1, P13; Slavov GT, 2005, CAN J FOREST RES, V35, P1592, DOI 10.1139/X05-082; SORENSEN FC, 1988, FOREST SCI, V34, P102; SORK VL, 1993, ECOLOGY, V74, P528, DOI 10.2307/1939313; Squillace A. E., 1974, Silvae Genetica, V23, P149; Stoehr MU, 2002, CAN J FOREST RES, V32, P469, DOI 10.1139/X01-222; Streiff R, 1999, MOL ECOL, V8, P831, DOI 10.1046/j.1365-294X.1999.00637.x; Victory ER, 2006, AM J BOT, V93, P118, DOI 10.3732/ajb.93.1.118; White T. L., 2007, FOREST GENETICS	46	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171598	10.1371/journal.pone.0171598	http://dx.doi.org/10.1371/journal.pone.0171598			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166543	Green Published, Green Submitted, gold			2022-12-26	WOS:000393700100057
J	Zhang, YH; Zang, WC; Qin, LM; Zheng, L; Cao, Y; Yan, ZG; Yi, XL; Zeng, HH; Liu, ZT				Zhang, Yahui; Zang, Wenchao; Qin, Lumei; Zheng, Lei; Cao, Ying; Yan, Zhenguang; Yi, Xianliang; Zeng, Honghu; Liu, Zhengtao			Water Quality Criteria for Copper Based on the BLM Approach in the Freshwater in China	PLOS ONE			English	Article							BIOTIC LIGAND MODEL; DISSOLVED ORGANIC-CARBON; TROUT ONCORHYNCHUS-MYKISS; SPECIES SENSITIVITY DISTRIBUTIONS; AQUATIC LIFE CRITERIA; ACUTE TOXICITY; DAPHNIA-MAGNA; FIELD VALIDATION; FATHEAD MINNOWS; MATTER SOURCE	The bioavailability and toxicity of metals to aquatic organisms are highly dependent on water quality parameters in freshwaters. The biotic ligand model (BLM) for copper is an approach to generate the water quality criteria (WQC) with water chemistry in the ambient environment. However, few studies were carried out on the WQCs for copper based on the BLM approach in China. In the present study, the toxicity for copper to native Chinese aquatic organisms was conducted and the published toxicity data with water quality parameters to Chinese aquatic species were collected to derive the WQCs for copper by the BLM approach. The BLM-based WQCs (the criterion maximum criteria (CMC) and the criterion continuous concentration (CCC)) for copper in the freshwater for the nation and in the Taihu Lake were obtained. The CMC and CCC values for copper in China were derived to be 1.391 mu g/L and 0.495 mu g/L, respectively, and the CMC and CCC in the Taihu Lake were 32.194 mu g/L and 9.697 mu g/L. The high concentration of dissolved organic carbon might be a main reason which resulted in the higher WQC values in the Taihu Lake. The WQC of copper in the freshwater would provide a scientific foundation for water quality standards and the environment risk assessment in China.	[Zhang, Yahui; Zheng, Lei; Cao, Ying; Yan, Zhenguang; Liu, Zhengtao] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, State Environm Protect Key Lab Ecol Effects & Ris, Beijing, Peoples R China; [Zang, Wenchao] MEP, Solid Waste & Chem Management Ctr, Beijing, Peoples R China; [Qin, Lumei] Guangxi Polytech Construct, Nanning, Guangxi Provinc, Peoples R China; [Qin, Lumei; Zeng, Honghu] Guilin Univ Technol, Coll Environm Sci & Engn, Guilin, Guangxi Provinc, Peoples R China; [Yi, Xianliang] Dalian Univ Technol, Dalian, Liaoning Provin, Peoples R China	Chinese Research Academy of Environmental Sciences; Guilin University of Technology; Dalian University of Technology	Yan, ZG; Liu, ZT (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, State Environm Protect Key Lab Ecol Effects & Ris, Beijing, Peoples R China.	zgyan@craes.org.cn; liuzt@craes.org.cn			National Science and Technology Project of Water Pollution Control and Abatement of China [2012ZX07501-003]; National Natural Science Foundation of the People's Republic of China [21407139]; Science and Technology Basic Work of Science and Technology [2014FY120600]	National Science and Technology Project of Water Pollution Control and Abatement of China; National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Science and Technology Basic Work of Science and Technology	This work was financially supported by the National Science and Technology Project of Water Pollution Control and Abatement of China (2012ZX07501-003) (http://nwpcp.mep.gov.cn/), the National Natural Science Foundation of the Peoples Republic of China (21407139) (http://www.nsfc.gov.cn/) and the Science and Technology Basic Work of Science and Technology (2014FY120600) (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTM, 1993, STAND GUID COND AC T, P88; Bianchini A, 2004, INT CONGR SER, V1275, P189, DOI 10.1016/j.ics.2004.08.074; CCME. Council of Ministers of the Environment, 2007, PROT DER WAT QUAL GU; Chen ZZ, 2010, ENVIRON SCI TECHNOL, V44, P3580, DOI 10.1021/es1003457; Cheng SP, 2003, ENVIRON SCI POLLUT R, V10, P192, DOI 10.1065/espr2002.11.141.1; [丛宁 Cong Ning], 2005, [扬州大学学报. 农业与生命科学版, Journal of Yangzhou University], V26, P89; Craven AM, 2012, ENVIRON SCI TECHNOL, V46, P9948, DOI 10.1021/es301015p; De Schamphelaere KAC, 2003, ENVIRON TOXICOL CHEM, V22, P2454, DOI 10.1897/02-499; De Schamphelaere KAC, 2002, COMP BIOCHEM PHYS C, V133, P243, DOI 10.1016/S1532-0456(02)00087-X; De Schamphelaere KAC, 2002, ENVIRON SCI TECHNOL, V36, P48, DOI 10.1021/es000253s; de Schamphelaere KAC, 2007, ENVIRON TOXICOL CHEM, V26, P535, DOI 10.1897/06-247R.1; Di Toro DM, 2001, ENVIRON TOXICOL CHEM, V20, P2383, DOI 10.1002/etc.5620201034; Erickson RJ, 1996, ENVIRON TOXICOL CHEM, V15, P181, DOI 10.1002/etc.5620150217; Feng CL, 2012, ENVIRON SCI TECHNOL, V46, P10877, DOI 10.1021/es303500n; Ignacio RD, 2005, ENVIRON SCI TECHNOL, V39, P1542, DOI 10.1021/es040545j; Janssen CR, 2003, ENVIRON INT, V28, P793, DOI 10.1016/S0160-4120(02)00126-5; Jia XY, 2005, RES ENV SCI, V5, P26; Jin XW, 2012, ENVIRON SCI POLLUT R, V19, P609, DOI 10.1007/s11356-011-0594-1; Kennedy CJ, 2012, ENVIRON TOXICOL CHEM, V31, P2281, DOI 10.1002/etc.1948; Kong ZM, 1998, ENVIRON POLLUT, V99, P279, DOI 10.1016/S0269-7491(97)00111-5; Liu CQ, J ANHUI AGR SCI; MacRae RK, 1999, ENVIRON TOXICOL CHEM, V18, P1180, DOI 10.1002/etc.5620180616; Marr JCA, 1999, CAN J FISH AQUAT SCI, V56, P1471, DOI 10.1139/cjfas-56-8-1471; MEADOR JP, 1991, AQUAT TOXICOL, V19, P13, DOI 10.1016/0166-445X(91)90025-5; MOUNT DI, 1968, WATER RES, V2, P215, DOI 10.1016/0043-1354(68)90027-4; Niyogi S, 2004, ENVIRON SCI TECHNOL, V38, P6177, DOI 10.1021/es0496524; OECD (Organization for Economic Cooperation and Development), OECD GUID TEST CHEM; PLAYLE RC, 1993, CAN J FISH AQUAT SCI, V50, P2678, DOI 10.1139/f93-291; Ryan AC, 2009, ENVIRON TOXICOL CHEM, V28, P1663, DOI 10.1897/08-361.1; Santore RC, 2001, ENVIRON TOXICOL CHEM, V20, P2397, DOI [10.1002/etc.5620201035, 10.1897/1551-5028(2001)020&lt;2397:BLMOTA&gt;2.0.CO;2]; Schwartz ML, 2004, ENVIRON TOXICOL CHEM, V23, P2889, DOI 10.1897/03-561.1; Tsushima K, 2010, CHEMOSPHERE, V80, P563, DOI 10.1016/j.chemosphere.2010.04.031; USEPA, 2007, AQ LIF AMB FRESHW QU; USEPA, 1985, PB85227049 USEPA; Wang Chunyan, 2013, Asian Journal of Ecotoxicology, V8, P998, DOI 10.7524/AJE.1673-5897.20110916001; Wang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076624; Wang J, 1992, ACTA ECOL SINICA, V12, P201; Wang N, 2011, ENVIRON TOXICOL CHEM, V30, P2115, DOI 10.1002/etc.596; Wang Wan-bin, 2014, Huanjing Kexue, V35, P3947; Wang XN, 2013, J HAZARD MATER, V260, P1017, DOI 10.1016/j.jhazmat.2013.07.007; Wang XN, 2014, ENVIRON SCI POLLUT R, V21, P168, DOI 10.1007/s11356-013-2110-2; Wang Zhen, 2014, Asian Journal of Ecotoxicology, V9, P640, DOI 10.7524/AJE.1673-589720140531001; Warne Michael St J., 2008, Australasian Journal of Ecotoxicology, V14, P1; Wu FC, 2010, ENVIRON SCI TECHNOL, V44, P7992, DOI 10.1021/es1029365; Wu JY, 2015, ENVIRON POLLUT, V196, P141, DOI 10.1016/j.envpol.2014.09.024; Yan H, 2001, ENV SCI, V22, P23; Yan ZG, 2012, ENVIRON POLLUT, V162, P86, DOI 10.1016/j.envpol.2011.11.007; Yang L., 2003, J S CHINA NORMAL U, V2, P101, DOI [10.6054/j.jscnun.2003.05.021, DOI 10.6054/J.JSCNUN.2003.05.021]; Yang SW, 2014, SCI TOTAL ENVIRON, V470, P677, DOI 10.1016/j.scitotenv.2013.09.094; Yu T, 2012, ENVIRON MONIT ASSESS, V184, P4367, DOI 10.1007/s10661-011-2270-9; Zhou LH, 1994, J XIAMEN FISHERIES C, V16, P11; Zhou T, 2014, ENV SCI, V35, P332; Zhou W.M., 1991, RES ENV SCI, P9, DOI DOI 10.13198/j.res.1991.06.11.zhouwm.002.; ZITKO P, 1973, B ENVIRON CONTAM TOX, V10, P265, DOI 10.1007/BF01684814	54	16	17	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170105	10.1371/journal.pone.0170105	http://dx.doi.org/10.1371/journal.pone.0170105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166229	gold, Green Submitted, Green Published			2022-12-26	WOS:000393700100005
J	Gracia, MJ; Moreno, C; Ferrer, M; Sanz, A; Peribanez, MA; Estrada, R				Jesus Gracia, Maria; Moreno, Carlos; Ferrer, Montserrat; Sanz, Alfredo; Angel Peribanez, Miguel; Estrada, Rosa			Field efficacy of acaricides against Varroa destructor	PLOS ONE			English	Article							APIS-MELLIFERA HYMENOPTERA; JACOBSONI ACARI; PARASITIC MITES; PLANT-EXTRACTS; ESSENTIAL OILS; COLONIES; THYMOL; PERSISTENCE; APIGUARD; RESIDUE	Field trials were conducted in Northeast Spain (Aragon) to evaluate the effectiveness of two acaricides against Varroa destructor. These experiments took into account the season of the year, apiary, colony, and developmental state and strength of the colony. The acaricides used were a synthetic (amitraz, Apivar (R)) and a natural (formulated from Api Life Var (R), thymol oil and thymol alcohol) product. The treatments used in the present study reduce high infestations of V. destructor, although they do not eliminate the infestation. Similar efficacies between treatments were found. Nevertheless, the efficacy of a treatment depends on the apiary where applied. Moreover, the detected variability in the apiary and hive poses a challenge to the identification of the significant factors. Therefore, more field studies to assess efficacies in several apiaries are needed to obtain a better understanding of the effects of the applied treatments.	[Jesus Gracia, Maria; Angel Peribanez, Miguel; Estrada, Rosa] Univ Zaragoza CITA, Fac Vet, Dept Patol Anim, Parasitol & Enfermedades Parasitarias, Zaragoza, Spain; [Moreno, Carlos] Univ Zaragoza CITA, Fac Vet, Dept Anat Embriol & Genet Anim, Genet Anim, Zaragoza, Spain; [Ferrer, Montserrat] Diputacio Gen Aragon, Dept Agr & Alimentac, Serv Ordenac & Sanidad Anim, Zaragoza, Spain; [Sanz, Alfredo] Asociacio Apicola, ARNA, Zaragoza, Spain		Gracia, MJ (corresponding author), Univ Zaragoza CITA, Fac Vet, Dept Patol Anim, Parasitol & Enfermedades Parasitarias, Zaragoza, Spain.	mjgracia@unizar.es	, Miguel/ABF-5399-2020	Peribanez, Miguel A/0000-0003-3436-776X	Spanish Government, INIA [API 98-008]	Spanish Government, INIA	This study was carried out with the financial contribution of the Spanish Government, INIA project (API 98-008).	Accorti M, 1986, APICOLTURA, V2, P165; [Anonymous], ESTRATEGIA CONTROL V; Arculeo P., 2002, ATT CONV AMA 2 RUOL; Bulacio Cagnolo N., 2010, InVet, V12, P85; Calderone NW, 1999, J ECON ENTOMOL, V92, P253, DOI 10.1093/jee/92.2.253; CALDERONE NW, 1995, J ECON ENTOMOL, V88, P1211, DOI 10.1093/jee/88.5.1211; Calderone NW, 1997, J ECON ENTOMOL, V90, P1080, DOI 10.1093/jee/90.5.1080; Carmona M, 2002, VIDA APIC, V113, P35; CHIESA F, 1991, APIDOLOGIE, V22, P135, DOI 10.1051/apido:19910206; Chuda-Mickiewicz Bozena, 2007, Journal of Apicultural Science, V51, P47; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Emsen B, 2009, J ANIM VET ADV, V8, P1004; EVANS PD, 1980, NATURE, V287, P60, DOI 10.1038/287060a0; Faucon JP, 2007, REV MED VET-TOULOUSE, V158, P283; Ferrer-Dufol M, 1995, J APICULT RES, V34, P147, DOI 10.1080/00218839.1995.11100899; Flores J. M., 2000, VIDA APICOLA, V104, P26; Floris I, 2004, J ECON ENTOMOL, V97, P187, DOI 10.1603/0022-0493-97.2.187; Floris I, 2001, APIDOLOGIE, V32, P577, DOI 10.1051/apido:2001145; Giovenazzo P, 2011, EXP APPL ACAROL, V55, P65, DOI 10.1007/s10493-011-9447-3; Imdorf A, 1999, APIDOLOGIE, V30, P209, DOI 10.1051/apido:19990210; IMDORF A, 1995, BEE WORLD, V76, P77, DOI 10.1080/0005772X.1995.11099245; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Mattila HR, 1999, AM BEE J, V139, P947; Mattila HR, 2000, AM BEE J, V140, P969; Molins-Marin JL, 1987, VIDA APICOLA, V21, P32; OIE (World Organisation for Animal Health), 2008, MAN DIAGN TESTS VACC, V6, P424; Pohorecka K, 2008, P 25 SCI C AP PUL PO, P83; Rademacher E, 2006, APIDOLOGIE, V37, P98, DOI 10.1051/apido:2005063; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Schmidt S. V., 2008, Agro Sur, V36, P8; Semkiw P, 2013, J APIC SCI, V57, P107, DOI 10.2478/jas-2013-0012; Vallon J., 2007, B TECH APIC, V34, P49; Vanengelsdorp D, 2008, J ECON ENTOMOL, V101, P256, DOI 10.1603/0022-0493(2008)101[256:SFOHBH]2.0.CO;2	33	18	19	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171633	10.1371/journal.pone.0171633	http://dx.doi.org/10.1371/journal.pone.0171633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158303	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700116
J	Walker, XJ; Frey, MD; Conway, AJ; Jean, M; Johnstone, JF				Walker, Xanthe J.; Frey, Matthew D.; Conway, Alexandra J.; Jean, Melanie; Johnstone, Jill F.			Impacts of fire on non-native plant recruitment in black spruce forests of interior Alaska	PLOS ONE			English	Article							CANADIAN WEEDS; TREE RECRUITMENT; BOREAL FOREST; COMMUNITIES; INVASIONS; BIOLOGY; SUSCEPTIBILITY; ECOSYSTEMS	Climate change is expected to increase the extent and severity of wildfires throughout the boreal forest. Historically, black spruce (Picea mariana (Mill.) B.S.P.) forests in interior Alaska have been relatively free of non-native species, but the compounding effects of climate change and an altered fire regime could facilitate the expansion of non-native plants. We tested the effects of wildfire on non-native plant colonization by conducting a seeding experiment of non-native plants on different substrate types in a burned black spruce forest, and surveying for non-native plants in recently burned and mature black spruce forests. We found few non-native plants in burned or mature forests, despite their high roadside presence, although invasion of some burned sites by dandelion (Taraxacum officinale) indicated the potential for non-native plants to move into burned forest. Experimental germination rates were significantly higher on mineral soil compared to organic soil, indicating that severe fires that combust much of the organic layer could increase the potential for non-native plant colonization. We conclude that fire disturbances that remove the organic layer could facilitate the invasion of non-native plants providing there is a viable seed source and dispersal vector.	[Walker, Xanthe J.] No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA; [Frey, Matthew D.; Conway, Alexandra J.; Jean, Melanie; Johnstone, Jill F.] Univ Saskatchewan, Dept Biol, Saskatoon, SK, Canada	Northern Arizona University; University of Saskatchewan	Walker, XJ (corresponding author), No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA.	xanthe.walker@gmail.com	Johnstone, Jill F./C-9204-2009; Walker, Xanthe/K-1649-2019; Jean, Mélanie/AAG-2814-2019	Johnstone, Jill F./0000-0001-6131-9339; Walker, Xanthe/0000-0002-2448-691X; Jean, Mélanie/0000-0002-7393-5566	U. S. Department of Defense's Strategic Environmental Research and Development Program (SERDP) [RC-2109]	U. S. Department of Defense's Strategic Environmental Research and Development Program (SERDP)	Funding for this research was provided by the U. S. Department of Defenses Strategic Environmental Research and Development Program (SERDP) under project RC-2109.	AARSSEN LW, 1986, CAN J PLANT SCI, V66, P711, DOI 10.4141/cjps86-092; [Anonymous], 2002, PLANTS DAT VERS 3 5; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Carlson M.L., 2008, INVASIVENESS RANKING; Conn JS, 2008, ARCT ANTARCT ALP RES, V40, P298, DOI 10.1657/1523-0430(06-007)[CONN]2.0.CO;2; Conn JS, 2011, ARCT ANTARCT ALP RES, V43, P343, DOI 10.1657/1938-4246-43.3.343; DENSMORE RV, 2001, EXOTIC PLANTS ALASKA; DYRNESS CT, 1983, CAN J FOREST RES, V13, P879, DOI 10.1139/x83-118; Fife D, 2014, FIFER COLLECTION MIS; Flannigan M, 2009, GLOBAL CHANGE BIOL, V15, P549, DOI 10.1111/j.1365-2486.2008.01660.x; Frey M, 2013, THESIS; Greene DF, 2007, CAN J FOREST RES, V37, P1012, DOI 10.1139/X06-245; Hollingsworth TN, 2006, CAN J FOREST RES, V36, P1781, DOI 10.1139/X06-061; Johnstone J, 2006, ECOSYSTEMS, V9, P14, DOI 10.1007/s10021-004-0042-x; Kasischke ES, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025677; Kutner M., 2005, APPL LINEAR STAT MOD; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Maron JL, 1996, OECOLOGIA, V105, P302, DOI 10.1007/BF00328732; Nolen A., 2002, VETCH INFESTATIONS A, P39; Osterkamp TE, 1999, PERMAFROST PERIGLAC, V10, P17, DOI 10.1002/(SICI)1099-1530(199901/03)10:1&lt;17::AID-PPP303&gt;3.0.CO;2-4; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rose M, 2004, OECOLOGIA, V139, P467, DOI 10.1007/s00442-004-1527-1; Royer F, 1999, WEEDS NO US CANADA G; Sanderson LA, 2012, FORESTRY, P1; Spellman KV, 2014, BIOL INVASIONS, V16, P1879, DOI 10.1007/s10530-013-0633-6; Stewart-Wade SM, 2002, CAN J PLANT SCI, V82, P825, DOI 10.4141/P01-010; TURKINGTON RA, 1978, CAN J PLANT SCI, V58, P523, DOI 10.4141/cjps78-078; VANCLEVE K, 1983, CAN J FOREST RES, V13, P894; Villano K. L., 2008, INVASIVE PLANT SPREA; WHITSON TD, 1991, WEEDS W	32	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171599	10.1371/journal.pone.0171599	http://dx.doi.org/10.1371/journal.pone.0171599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158284	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700106
J	Wakim, J; Arman, E; Becker-Herman, S; Kramer, MP; Bakos, E; Shachar, I; Elson, A				Wakim, J.; Arman, E.; Becker-Herman, S.; Kramer, M. P.; Bakos, E.; Shachar, I.; Elson, A.			The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia	ONCOGENE			English	Article							RECEPTOR-TYPE-O; HEPATOCELLULAR-CARCINOMA; MOLECULAR-CLONING; MOUSE MODEL; EXPRESSION; CLL; GENE; KINASE; TRANSFORMATION; METHYLATION	The tyrosine phosphatase PTPROt is a suggested tumor suppressor (TS) in B-cell chronic lymphocytic leukemia (CLL), and its expression is reduced in this disease. In order to examine how reduced PTPROt expression affects CLL in vivo we induced CLL in PTPROt-targeted mice. Unexpectedly, loss of both Ptprot alleles delayed disease detection and progression and lengthened survival relative to mice carrying two intact alleles, indicating that PTPROt fulfills a novel tumor-promoting role in CLL. Tumor cells from mice lacking PTPROt exhibited reduced B-cell receptor (BCR)-induced signaling, as well as increased apoptosis and autophagy. Inhibition of BCR/Src signaling in CLL cells induced their apoptosis, indicating that these findings are linked causally. These results suggest a cell-autonomous mechanism for the weakened CLL phenotype of PTPROt-deficient mice and uncover non-redundant roles for PTPROt in support of BCR signaling and survival of CLL cells. In contrast, loss of only one Ptprot allele induced earlier detection and progression of CLL and reduced survival, consistent with a tumor-suppressing role for PTPROt. Tumor cells from mice lacking one or both Ptprot allele exhibited increased interleukin-10 (IL-10) expression and signaling, factors known to support CLL; cells lacking one Ptprot alleles exhibited normal BCR signaling and cell death rates. We conclude that loss of one Ptprot allele promotes CLL, most likely by activating IL-10 signaling. Loss of both Ptprot alleles also reduces BCR signaling and increases cell death rates, offsetting the IL-10 effects and reducing the severity of the disease. PTPROt thus functions as an obligate haploinsufficient TS in CLL, where its expression levels determine its role as a promoter or inhibitor of the tumorigenic process in mice. Partial loss of PTPROt generates the strongest disease phenotype, suggesting that its intermediate expression levels in CLL are selected for.	[Wakim, J.; Arman, E.; Elson, A.] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel; [Becker-Herman, S.; Kramer, M. P.; Bakos, E.; Shachar, I.] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Elson, A (corresponding author), Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel.	ari.elson@weizmann.ac.il	Kramer, Matthias/L-1782-2016; Kramer, Matthias P/A-6224-2009	Kramer, Matthias/0000-0002-0289-5261; Elson, Ari/0000-0001-9808-9135	German-Israeli Helmholtz Research School in Cancer Biology; Israel Cancer Research Foundation; Minerva Foundation; Federal German Ministry for Education and Research; Kekst Family Center for Medical Genetics	German-Israeli Helmholtz Research School in Cancer Biology; Israel Cancer Research Foundation; Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Kekst Family Center for Medical Genetics	We thank Professor Carlo Croce for the E mu-TCL1 mice, Professor Zvulun Elazar for the anti-LC3 antibodies, Dr Rebecca Haffner-Krausz for help in preparing PTPROt-targeted mice, Ms Ofira Higfa and Mr Neriah Sharabi for expert animal care, Dr Ron Rotkopf for help with statistical analyses, Dr Ayala Sharp and Mr Eitan Ariel for help with FACS analyses, and Dr Gil Hornung for assistance with analysis of IL-10 expression. JW is supported in part by a studentship from the German-Israeli Helmholtz Research School in Cancer Biology. This study was supported by project grants from the Israel Cancer Research Foundation, from the Minerva Foundation with funds from the Federal German Ministry for Education and Research, and from the Kekst Family Center for Medical Genetics, to AE. AE is the incumbent of the Marshall and Renette Ezralow Professorial Chair.	Aguiar RCT, 1999, BLOOD, V94, P2403, DOI 10.1182/blood.V94.7.2403.419k39_2403_2413; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Amoui M, 2004, AM J PHYSIOL-CELL PH, V287, pC874, DOI 10.1152/ajpcell.00294.2003; Amoui M, 2003, J BIOL CHEM, V278, P44273, DOI 10.1074/jbc.M303933200; Asbagh LA, 2014, ONCOTARGET, V5, P10070, DOI 10.18632/oncotarget.2458; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Burger JA, 2013, TRENDS IMMUNOL, V34, P592, DOI 10.1016/j.it.2013.07.002; Chen LF, 2006, BLOOD, V108, P3428, DOI 10.1182/blood-2006-03-013821; Chong SY, 2001, GENES IMMUN, V2, P239, DOI 10.1038/sj.gene.6363773; DiLillo DJ, 2013, LEUKEMIA, V27, P170, DOI 10.1038/leu.2012.165; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Fayad L, 2001, BLOOD, V97, P256, DOI 10.1182/blood.V97.1.256; Forconi F, 2015, BLOOD, V126, P573, DOI 10.1182/blood-2015-03-567388; Gallardo M, 2015, CANCER CELL, V28, P486, DOI 10.1016/j.ccell.2015.09.001; Galletti G, 2016, CELL REP, V14, P1748, DOI 10.1016/j.celrep.2016.01.042; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hanna BS, 2016, LEUKEMIA, V30, P570, DOI 10.1038/leu.2015.305; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hou JJ, 2013, HEPATOLOGY, V57, P678, DOI 10.1002/hep.25980; Hsu SH, 2013, J CELL BIOCHEM, V114, P1810, DOI 10.1002/jcb.24525; Iacovelli S, 2015, BLOOD, V125, P1578, DOI 10.1182/blood-2014-07-587790; Jones JA, 2014, BLOOD, V123, P1455, DOI 10.1182/blood-2013-09-453092; Juszczynski P, 2009, BLOOD, V114, P5315, DOI 10.1182/blood-2009-02-204362; Kara IO, 2007, ADV THER, V24, P29, DOI 10.1007/BF02849990; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lau KHW, 2012, AM J PHYSIOL-CELL PH, V302, pC1676, DOI 10.1152/ajpcell.00042.2012; Lau KHW, 2006, J CELL BIOCHEM, V97, P940, DOI 10.1002/jcb.20667; Levy-Apter E, 2014, J BIOL CHEM, V289, P36048, DOI 10.1074/jbc.M114.603548; Motiwala T, 2004, P NATL ACAD SCI USA, V101, P13844, DOI 10.1073/pnas.0405451101; Motiwala T, 2015, LEUKEMIA, V29, P1350, DOI 10.1038/leu.2014.341; Motiwala T, 2003, ONCOGENE, V22, P6319, DOI 10.1038/sj.onc.1206750; Motiwala T, 2007, CLIN CANCER RES, V13, P3174, DOI 10.1158/1078-0432.CCR-06-1720; Motiwala T, 2011, BLOOD, V118, P6132, DOI 10.1182/blood-2011-01-323147; Motiwala T, 2010, J CELL BIOCHEM, V110, P846, DOI 10.1002/jcb.22593; Motiwala T, 2009, J BIOL CHEM, V284, P455, DOI 10.1074/jbc.M802840200; Orchard JA, 2004, LANCET, V363, P105, DOI 10.1016/S0140-6736(03)15260-9; PIXLEY FJ, 1995, J BIOL CHEM, V270, P27339, DOI 10.1074/jbc.270.45.27339; Saulep-Easton D, 2016, LEUKEMIA, V30, P163, DOI 10.1038/leu.2015.174; Saulep-Easton D, 2014, LEUKEMIA, V28, P2005, DOI 10.1038/leu.2014.105; Sheng MHC, 2009, J BIOL CHEM, V284, P11531, DOI 10.1074/jbc.M808324200; Simonetti G, 2014, BLOOD, V124, P1010, DOI 10.1182/blood-2014-05-577122; Teitell MA, 2005, NAT REV CANCER, V5, P640, DOI 10.1038/nrc1672; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; White HN, 1998, EUR J IMMUNOL, V28, P3268, DOI 10.1002/(SICI)1521-4141(199810)28:10&lt;3268::AID-IMMU3268&gt;3.0.CO;2-F; WIGGINS RC, 1995, GENOMICS, V27, P174, DOI 10.1006/geno.1995.1021; Wu LW, 1996, BIOCHEM J, V316, P515, DOI 10.1042/bj3160515; Yan XJ, 2006, P NATL ACAD SCI USA, V103, P11713, DOI 10.1073/pnas.0604564103; Yu M, 2012, MOL CELL BIOL, V32, P3913, DOI 10.1128/MCB.00068-12; Zanesi N, 2012, CURR PHARM DESIGN, V18, P3363, DOI 10.2174/138161212801227104	51	7	7	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 29	2017	36	26					3686	3694		10.1038/onc.2016.523	http://dx.doi.org/10.1038/onc.2016.523			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY9WM	28166196				2022-12-26	WOS:000404349700004
J	Yang, GL; Zhao, ZL; Qin, TT; Wang, D; Chen, LJ; Xiang, R; Xi, Z; Jiang, RC; Zhang, ZS; Zhang, JN; Li, LY				Yang, Gui-Li; Zhao, Zilong; Qin, Ting-Ting; Wang, Dong; Chen, Lijuan; Xiang, Rong; Xi, Zhen; Jiang, Rongcai; Zhang, Zhi-Song; Zhang, Jianning; Li, Lu-Yuan			TNFSF15 inhibits VEGF-stimulated vascular hyperpermeability by inducing VEGFR2 dephosphorylation	FASEB JOURNAL			English	Article						DR3; vascular integrity; SHP-1	ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE SYNTHASE; INDUCED ANGIOGENESIS; CELL; PERMEABILITY; EXPRESSION; ACTIVATION; PHOSPHORYLATION; RECEPTOR-2; SUPPRESSES	Vascular hyperpermeability is critical in ischemic diseases, including stroke and myocardial infarction, as well as in inflammation and cancer. It is well known that the VEGF-VEGFR2 signaling pathways are pivotal in promoting vascular permeability; however, counterbalancing mechanisms that restrict vascular permeability to maintain the integrity of blood vessels are not yet fully understood. We report that TNF superfamily member 15 (TNFSF15), a cytokine largely produced by vascular endothelial cells and a specific inhibitor of the proliferation of these same cells, can inhibit VEGF-induced vascular permeability in vitro and in vivo, and that death receptor 3 (DR3), a cell surface receptor of TNFSF15, mediates TNFSF15-induced dephosphorylation of VEGFR2. Src homology region 2 domain-containing phosphatase-1 (SHP-1) becomes associated with DR3 upon TNFSF15 interaction with the latter. In addition, a protein complex consisting of VEGFR2, DR3, and SHP-1 is formed in response to the effects of TNFSF15 and VEGF on endothelial cells. It is plausible that this protein complex provides a structural basis for the molecular mechanism in which TNFSF15 induces the inhibition of VEGF-stimulated vascular hyperpermeability.-Yang, G.-L., Zhao, Z., Qin, T.-T., Wang, D., Chen, L., Xiang, R., Xi, Z., Jiang, R., Zhang, Z.-S., Zhang, J., Li. L.-Y. TNFSF15 inhibits VEGF-stimulated vascular hyperpermeability by inducing VEGFR2 dephosphorylation.	[Yang, Gui-Li; Qin, Ting-Ting; Zhang, Zhi-Song; Li, Lu-Yuan] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Coll Pharm, Key Lab Med Chem Biol, Tianjin, Peoples R China; [Yang, Gui-Li; Qin, Ting-Ting; Zhang, Zhi-Song; Li, Lu-Yuan] Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin, Peoples R China; [Xiang, Rong] Nankai Univ, Sch Med, Dept Immunol, Tianjin, Peoples R China; [Xi, Zhen] Nankai Univ, Dept Biol Chem, Coll Chem, Tianjin, Peoples R China; [Yang, Gui-Li; Zhao, Zilong; Wang, Dong; Jiang, Rongcai; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Key Lab Post Neuroinjury Repair & Regenerat Cent, Minist Educ & Tianjin City,Tianjin Neurol Inst, Tianjin, Peoples R China; [Chen, Lijuan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China	Nankai University; Nankai University; Nankai University; Nankai University; Tianjin Medical University; Sichuan University	Zhang, ZS (corresponding author), Nankai Univ, Coll Pharm, Room 306,38 Tongyan Rd, Tianjin 300350, Peoples R China.; Li, LY (corresponding author), Nankai Univ, State Key Lab Med Chem Biol Bldg, Room 325,38 Tongyan Rd, Tianjin 300350, Peoples R China.	zzs@nankai.edu.cn; liluyuan@nankai.edu.cn	Zhao, Zilong/AAZ-2196-2020		Natural Science Foundation of China [81272356, 81330029, 81501069, 81271359, 81671221, 81672740, 81671380, 81601068]; Tianjin Research Program of Application Foundation and Advanced Technology [14ZCZDSY00179]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology	The authors thank Tairan Bai (Nankai University College of Pharmacy) for skillful technical assistance.This study is supported, in part, by Natural Science Foundation of China Grants 81272356 (to L.-Y.L.), 81330029 (to J.Z.), 81501069 (to G.- L.Y.), 81271359 and 81671221 (to R.J.), 81672740 (to Z.- S.Z.), 81671380 (to D.W.), and 81601068 (to Z.Z.); and Tianjin Research Program of Application Foundation and Advanced Technology Grant 14ZCZDSY00179 (to R.J.).The authors declare no conflicts of interest.	Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Bhattacharya Resham, 2008, J Mol Signal, V3, P8, DOI 10.1186/1750-2187-3-8; Chew LJ, 2002, FASEB J, V16, P742, DOI 10.1096/fj.01-0757fje; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Chu LY, 2013, BLOOD, V122, P1822, DOI 10.1182/blood-2013-01-482315; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; Deng WM, 2012, ANGIOGENESIS, V15, P71, DOI 10.1007/s10456-011-9244-y; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayes AJ, 2000, BRIT J CANCER, V83, P1154, DOI 10.1054/bjoc.2000.1437; Hedl M, 2014, P NATL ACAD SCI USA, V111, P13451, DOI 10.1073/pnas.1404178111; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Hou W, 2005, CLIN CANCER RES, V11, P5595, DOI 10.1158/1078-0432.CCR-05-0384; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jiang F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050615; Kim SH, 2012, BLOOD, V120, P4892, DOI 10.1182/blood-2012-05-428243; Kirton JP, 2010, MICROVASC RES, V79, P193, DOI 10.1016/j.mvr.2010.02.009; Lal BK, 2001, MICROVASC RES, V62, P252, DOI 10.1006/mvre.2001.2338; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Lazarus Alon, 2011, Proc Am Thorac Soc, V8, P508, DOI 10.1513/pats.201102-021MW; Lee SJ, 2010, LAB INVEST, V90, P374, DOI 10.1038/labinvest.2009.136; Lu Y, 2014, ANGIOGENESIS, V17, P529, DOI 10.1007/s10456-013-9397-y; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Nagy JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006544; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Qi JW, 2013, P NATL ACAD SCI USA, V110, P13863, DOI 10.1073/pnas.1304529110; Qin TT, 2015, J PATHOL, V237, P307, DOI 10.1002/path.4577; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Satchi-Fainaro R, 2005, CANCER CELL, V7, P251, DOI 10.1016/j.ccr.2005.02.007; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Sinha S, 2009, J CELL SCI, V122, P3385, DOI 10.1242/jcs.053124; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tian F, 2007, J IMMUNOL, V179, P3742, DOI 10.4049/jimmunol.179.6.3742; Tian F, 2009, BLOOD, V113, P5352, DOI 10.1182/blood-2008-08-173773; Tian XY, 2014, J BIOL CHEM, V289, P5168, DOI 10.1074/jbc.M113.493924; Vohra PK, 2012, AM J PHYSIOL-LUNG C, V302, pL185, DOI 10.1152/ajplung.00274.2010; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wu HM, 1999, AM J PHYSIOL-HEART C, V276, pH535, DOI 10.1152/ajpheart.1999.276.2.H535; Xu LX, 2014, INT J BIOCHEM CELL B, V55, P109, DOI 10.1016/j.biocel.2014.08.015; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yu JY, 2001, CIRC RES, V89, P1161, DOI 10.1161/hh2401.101909; Yuksel H, 2013, NEUROL SCI, V34, P1941, DOI 10.1007/s10072-013-1411-z; Zhai YF, 1999, INT J CANCER, V82, P131, DOI 10.1002/(SICI)1097-0215(19990702)82:1<131::AID-IJC22>3.3.CO;2-F; Zhai YF, 1999, FASEB J, V13, P181, DOI 10.1096/fasebj.13.1.181; Zhang K, 2016, ONCOTARGET, V7, P69436, DOI 10.18632/oncotarget.11683; Zhang WJ, 2012, P NATL ACAD SCI USA, V109, P10388, DOI 10.1073/pnas.1205210109; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649	60	12	13	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2001	2012		10.1096/fj.201600800R	http://dx.doi.org/10.1096/fj.201600800R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28183800				2022-12-26	WOS:000399195500021
J	Lee, HJ; Lee, DY; Mariappan, MM; Feliers, D; Ghosh-Choudhury, G; Abboud, HE; Gorin, Y; Kasinath, BS				Lee, Hak Joo; Lee, Doug Yoon; Mariappan, Meenalakshmi M.; Feliers, Denis; Ghosh-Choudhury, Goutam; Abboud, Hanna E.; Gorin, Yves; Kasinath, Balakuntalam S.			Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); diabetic nephropathy; laminin; oxidative stress; reactive oxygen species (ROS)	ACTIVATED PROTEIN-KINASE; DIABETIC-NEPHROPATHY; FIBRONECTIN EXPRESSION; SODIUM HYDROSULFIDE; OXIDATIVE STRESS; ANGIOTENSIN-II; MOUSE MODEL; TGF-BETA; NOX4; RENOPROTECTION	High-glucose increases NADPH oxidase 4 (NOX4) expression, reactive oxygen species generation, and matrix protein synthesis by inhibiting AMP-activated protein kinase (AMPK) in renal cells. Because hydrogen sulfide (H2S) inhibits high glucose-induced matrix protein increase by activating AMPK in renal cells, we examined whether H2S inhibits high glucose-induced expression of NOX4 and matrix protein and whether H2S and NO pathways are integrated. High glucose increased NOX4 expression and activity at 24 h in renal proximal tubular epithelial cells, which was inhibited by sodium hydrosulfide (NaHS), a source of H2S. High glucose decreased AMPK phosphorylation and activity, which was restored by NaHS. Compound C, an AMPK inhibitor, prevented NaHS inhibition of high glucose-induced NOX4 expression. NaHS inhibition of high glucose-induced NOX4 expression was abrogated by N()-nitro-l-arginine methyl ester, an inhibitor of NOS. NaHS unexpectedly augmented the expression of inducible NOS (iNOS) but not endothelial NOS. iNOS siRNA and 1400W, a selective iNOS inhibitor, abolished the ameliorative effects of NaHS on high glucose-induced NOX4 expression, reactive oxygen species generation, and, matrix laminin expression. Thus, H2S recruits iNOS to generate NO to inhibit high glucose-induced NOX4 expression, oxidative stress, and matrix protein accumulation in renal epithelial cells; the two gasotransmitters H2S and NO and their interaction may serve as therapeutic targets in diabetic kidney disease.	[Lee, Hak Joo; Lee, Doug Yoon; Mariappan, Meenalakshmi M.; Feliers, Denis; Ghosh-Choudhury, Goutam; Abboud, Hanna E.; Gorin, Yves; Kasinath, Balakuntalam S.] Univ Texas Hlth Sci Ctr San Antonio, MC7882,7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Lee, Hak Joo; Mariappan, Meenalakshmi M.; Feliers, Denis; Ghosh-Choudhury, Goutam; Abboud, Hanna E.; Kasinath, Balakuntalam S.] South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Kasinath, BS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, MC7882,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	Kasinath@uthscsa.edu		Feliers, Denis/0000-0003-1952-1386	University of Texas Health Science Center at San Antonio (UTHSCSA); NCI, National Institutes of Health [P30 CA54174]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077295, R29DK050190, R37DK033665, R01DK050190, R01DK033665, R01DK079996] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001340, I01BX000926] Funding Source: NIH RePORTER	University of Texas Health Science Center at San Antonio (UTHSCSA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	Images were generated in the Core Optical Imaging Facility, which is supported by University of Texas Health Science Center at San Antonio (UTHSCSA) and NCI, National Institutes of Health Grant P30 CA54174 (Cancer Therapy & Research Center (CTRC) at UTHSCSA).	Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Calvert JW, 2010, CIRCULATION, V122, P11, DOI 10.1161/CIRCULATIONAHA.109.920991; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; Das F, 2013, J BIOL CHEM, V288, P7756, DOI 10.1074/jbc.M113.455782; Eid AA, 2013, MOL CELL BIOL, V33, P3439, DOI 10.1128/MCB.00217-13; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Fang L, 2013, NEPHROL DIAL TRANSPL, V28, P1751, DOI 10.1093/ndt/gfs391; Ganster F, 2010, CRIT CARE, V14, DOI 10.1186/cc9257; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Gorin Y, 2015, AM J PHYSIOL-RENAL, V308, pF1276, DOI 10.1152/ajprenal.00396.2014; Gorin Y, 2013, FREE RADICAL BIO MED, V61, P130, DOI 10.1016/j.freeradbiomed.2013.03.014; Gorin Y, 2013, CLIN SCI, V125, P361, DOI 10.1042/CS20130065; Ha TS, 1999, J AM SOC NEPHROL, V10, P1931; Han WH, 2011, ANTIOXID REDOX SIGN, V15, P2121, DOI 10.1089/ars.2010.3821; Huang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097315; Jeong KH, 2009, AM J NEPHROL, V29, P274, DOI 10.1159/000158635; Jha JC, 2016, DIABETOLOGIA, V59, P379, DOI 10.1007/s00125-015-3796-0; Jha JC, 2014, J AM SOC NEPHROL, V25, P1237, DOI 10.1681/ASN.2013070810; Jiang F, 2014, REDOX BIOL, V2, P267, DOI 10.1016/j.redox.2014.01.012; Kamat PK, 2015, J CELL PHYSIOL, V230, P378, DOI 10.1002/jcp.24722; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kasinath B. S., 2003, CONT DIABETES DIABET, P97; Khodo SN, 2012, J AM SOC NEPHROL, V23, P1967, DOI 10.1681/ASN.2012040373; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Lee DY, 2013, J BIOL CHEM, V288, P28668, DOI 10.1074/jbc.M113.470971; Lee HJ, 2015, J BIOL CHEM, V290, P12014, DOI 10.1074/jbc.M114.615377; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; Lee JH, 2013, AM J PHYSIOL-RENAL, V304, pF686, DOI 10.1152/ajprenal.00148.2012; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Lu XH, 2010, AM J PHYSIOL-LUNG C, V299, pL559, DOI 10.1152/ajplung.00090.2010; Park KM, 2003, J BIOL CHEM, V278, P27256, DOI 10.1074/jbc.M301778200; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Poon BY, 2003, CIRCULATION, V108, P1107, DOI 10.1161/01.CIR.0000086321.04702.AC; Qian J, 2012, FREE RADICAL BIO MED, V52, P1806, DOI 10.1016/j.freeradbiomed.2012.02.029; Salloum FN, 2009, CIRCULATION, V120, pS31, DOI 10.1161/CIRCULATIONAHA.108.843979; Scheele W, 2016, J AM SOC NEPHROL, V27, P3459, DOI 10.1681/ASN.2015050473; Sedeek M, 2013, CLIN SCI, V124, P191, DOI 10.1042/CS20120330; Selemidis S, 2007, CARDIOVASC RES, V75, P349, DOI 10.1016/j.cardiores.2007.03.030; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Si JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107832; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Thallas-Bonke V, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12192; Tonolo G, 2014, INT J NEPHROL RENOV, V7, P107, DOI 10.2147/IJNRD.S37883; Trachtman H, 2002, PEDIATR NEPHROL, V17, P20, DOI 10.1007/s004670200004; Wang R, 2014, TRENDS BIOCHEM SCI, V39, P227, DOI 10.1016/j.tibs.2014.03.003; Wang R, 2012, P NATL ACAD SCI USA, V109, P8801, DOI 10.1073/pnas.1206646109; Wang YW, 2015, MOL CELL BIOCHEM, V399, P189, DOI 10.1007/s11010-014-2245-6; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Yamamoto J, 2013, CLIN EXP NEPHROL, V17, P32, DOI 10.1007/s10157-012-0670-y; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; You YH, 2016, J AM SOC NEPHROL, V27, P466, DOI 10.1681/ASN.2015030302; Yuan P, 2011, NEPHROL DIAL TRANSPL, V26, P2119, DOI 10.1093/ndt/gfq749; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798; Zhou X, 2014, J BIOL CHEM, V289, P28827, DOI 10.1074/jbc.M114.596593	55	33	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5665	5675		10.1074/jbc.M116.766758	http://dx.doi.org/10.1074/jbc.M116.766758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28188286	Green Published, hybrid			2022-12-26	WOS:000398813200005
J	Vashi, N; Andrabi, SBA; Ghanwat, S; Suar, M; Kumar, D				Vashi, Nimi; Andrabi, Syed Bilal Ahmad; Ghanwat, Swapnil; Suar, Mrutyunjay; Kumar, Dhiraj			Ca2+-dependent Focal Exocytosis of Golgi-derived Vesicles Helps Phagocytic Uptake in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; PLECKSTRIN HOMOLOGY DOMAIN; ADP-RIBOSYLATION FACTOR-1; NEURONAL CALCIUM SENSOR-1; PLASMA-MEMBRANE REPAIR; MYCOBACTERIUM-TUBERCULOSIS; NEUROTRANSMITTER RELEASE; INTRACELLULAR CA2+; MAMMALIAN-CELLS; ARF FAMILY	The role of Golgi apparatus during phagocytic uptake by macrophages has been ruled out in the past. Notably, all such reports were limited to Fc gamma receptor-mediated phagocytosis. Here, we unravel a highly devolved mechanism for recruitment of Golgi-derived secretory vesicles during phagosome biogenesis, which was important for uptake of most cargos, except the IgG-coated ones. We report recruitment of mannosidase-IIpositive Golgi-derived vesicles during uptake of diverse targets, including latex beads, Escherichia coli, Salmonella typhimurium, and Mycobacterium tuberculosis in human and mouse macrophages. The recruitment of mannosidase-II vesicles was an early event mediated by focal exocytosis and coincided with the recruitment of transferrin receptor, VAMP3, and dynamin-2. Brefeldin A treatment inhibited mannosidase-II recruitment and phagocytic uptake of serum-coated or-uncoated latex beads and E. coli. However, consistent with previous studies, brefeldin A treatment did not affect uptake of IgG-coated latex beads. Mechanistically, recruitment of mannosidase- II vesicles during phagocytic uptake required Ca2+ from both extra-and intracellular sources apart from PI3K, microtubules, and dynamin-2. Extracellular Ca2+ via voltagegated Ca2+ channels established a Ca2+-dependent local phosphatidylinositol 1,4,5-trisphosphate gradient, which guides the focal movement of Golgi-derived vesicles to the site of uptake. We confirmed Golgi-derived vesicles recruited during phagocytosis were secretory vesicles as their recruitment was sensitive to depletion of VAMP2 or NCS1, whereas recruitment of the recycling endosome marker VAMP3 was unaffected. Depletion of both VAMP2 and NCS1 individually resulted in the reduced uptake by macrophages. Together, the study provides a previously unprecedented role of Golgi-derived secretory vesicles in phagocytic uptake, the key innate defense function.	[Vashi, Nimi; Andrabi, Syed Bilal Ahmad; Ghanwat, Swapnil; Kumar, Dhiraj] Int Ctr Genet Engn & Biotechnol, Cellular Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India; [Suar, Mrutyunjay] KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, Orissa, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Kalinga Institute of Industrial Technology (KIIT)	Kumar, D (corresponding author), Int Ctr Genet Engn & Biotechnol, Cellular Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	dhiraj@icgeb.res.in	Vashi, Nimi K/AFS-1039-2022	Vashi, Nimi K/0000-0002-1930-9206; Andrabi, Syed Bilal Ahmad/0000-0003-3009-0425; Suar, Mrutyunjay/0000-0003-4815-5477	Department of Biotechnology	Department of Biotechnology	The work related to M. tuberculosis infections was carried out at Department of Biotechnology-funded Tuberculosis Aerosol Challenge Facility at International Centre for Genetic Engineering and Biotechnology. We thank Prof. Sarman Singh for access to the flow cytometer at All India Institute of Medical Sciences and Purnima Kumar for help in the confocal microscopy. We thank C-CAMP, National Center for Biological Sciences, Bangalore, India, for the mass spectrometry facility.	Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Alix E, 2011, J CELL BIOL, V195, P943, DOI 10.1083/jcb.201105019; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; BAINTON DF, 1989, AM J PATHOL, V134, P15; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; Becker T, 2005, P NATL ACAD SCI USA, V102, P4022, DOI 10.1073/pnas.0409219102; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Braun V, 2006, BIOL CELL, V98, P195, DOI 10.1042/BC20050021; Braun V, 2007, MOL BIOL CELL, V18, P4921, DOI 10.1091/mbc.E07-04-0392; Caceres PS, 2014, J BIOL CHEM, V289, P23951, DOI 10.1074/jbc.M114.589333; CANNON GJ, 1992, J CELL SCI, V101, P907; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; CHURCH J, 1994, MOL PHARMACOL, V45, P747; Czibener C, 2006, J CELL BIOL, V174, P997, DOI 10.1083/jcb.200605004; Dai SP, 2007, TRAFFIC, V8, P1365, DOI 10.1111/j.1600-0854.2007.00613.x; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Di AK, 2003, MOL BIOL CELL, V14, P2016, DOI 10.1091/mbc.e02-09-0626; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Drecktrah D, 2006, TRAFFIC, V7, P39, DOI 10.1111/j.1600-0854.2005.00360.x; Faundez V, 1997, J CELL BIOL, V138, P505, DOI 10.1083/jcb.138.3.505; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gillingham AK, 2016, TRENDS CELL BIOL, V26, P399, DOI 10.1016/j.tcb.2016.02.005; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Haynes LP, 2005, J BIOL CHEM, V280, P6047, DOI 10.1074/jbc.M413090200; Henley JR, 1996, J CELL BIOL, V133, P761, DOI 10.1083/jcb.133.4.761; Holevinsky KO, 1998, BIOPHYS J, V75, P2577, DOI 10.1016/S0006-3495(98)77703-3; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Jutras I, 2005, ANNU REV CELL DEV BI, V21, P511, DOI 10.1146/annurev.cellbio.20.010403.102755; Kochegarov AA, 2003, CELL CALCIUM, V33, P145, DOI 10.1016/S0143-4160(02)00239-7; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Krauss M, 2008, J BIOL CHEM, V283, P27717, DOI 10.1074/jbc.M804528200; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Li SK, 2014, DIABETOLOGIA, V57, P809, DOI 10.1007/s00125-013-3143-2; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Liu YW, 2011, TRAFFIC, V12, P1620, DOI 10.1111/j.1600-0854.2011.01250.x; Lundqvist-Gustafsson H, 2000, CELL CALCIUM, V27, P353, DOI 10.1054/ceca.2000.0130; Mendez M, 2011, J BIOL CHEM, V286, P28608, DOI 10.1074/jbc.M111.225839; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; Mosser D M, 1994, Immunol Ser, V60, P99; Niedergang F, 2004, CURR OPIN CELL BIOL, V16, P422, DOI 10.1016/j.ceb.2004.06.006; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Scalettar BA, 2002, J CELL SCI, V115, P2399; Shen C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9852; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steegmaier M, 1999, MOL BIOL CELL, V10, P1957, DOI 10.1091/mbc.10.6.1957; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; STENDAHL O, 1994, SCIENCE, V265, P1439, DOI 10.1126/science.8073285; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; TARDIEUX I, 1992, CELL, V71, P1117, DOI 10.1016/S0092-8674(05)80061-3; Togo T, 1999, J CELL SCI, V112, P719; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; VICKER MG, 1977, EXP CELL RES, V109, P127, DOI 10.1016/0014-4827(77)90052-0; Vinet AF, 2008, J IMMUNOL, V181, P5289, DOI 10.4049/jimmunol.181.8.5289; Warnock DE, 1997, MOL BIOL CELL, V8, P2553, DOI 10.1091/mbc.8.12.2553; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	76	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5144	5165		10.1074/jbc.M116.743047	http://dx.doi.org/10.1074/jbc.M116.743047			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28174296	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000397875500001
J	Patil, AV; Hsieh, TS				Patil, Ajay Vitthal; Hsieh, Tao-Shih			Ribosomal Protein S3 Negatively Regulates Unwinding Activity of RecQ-like Helicase 4 through Their Physical Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTHMUND-THOMSON-SYNDROME; DNA-REPAIR ACTIVITIES; BASE EXCISION-REPAIR; BIOCHEMICAL-CHARACTERIZATION; GENOTOXIC STRESS; DAMAGE; RPS3; REPLICATION; BINDING; DOMAIN	Human RecQ-like helicase 4 (RECQL4) plays crucial roles in replication initiation and DNA repair; however, the contextual regulation of its unwinding activity is not fully described. Mutations in RECQL4 have been linked to three diseases including Rothmund-Thomson syndrome, which is characterized by osteoskeletal deformities, photosensitivity, and increased osteosarcoma susceptibility. Understanding regulation of RECQL4 helicase activity by interaction partners will allow deciphering its role as an enzyme and a signaling cofactor in different cellular contexts. We became interested in studying the interaction of RECQL4 with ribosomal protein S3 (RPS3) because previous studies have shown that RPS3 activity is sometimes associated with phenotypes mimicking those of mutated RECQL4. RPS3 is a small ribosomal protein that also has extraribosomal functions, including apurnic-apyrimi-dinic endonuclease-like activity suggested to be important during DNA repair. Here, we report a functional and physical interaction between RPS3 and RECQL4 and show that this interaction may be enhanced during cellular stress. We show that RPS3 inhibits ATPase, DNA binding, and helicase activities of RECQL4 through their direct interaction. Further domain analysis shows that N-terminal 1-320 amino acids of RECQL4 directly interact with the C-terminal 94-244 amino acids of RPS3 (C-RPS3). Biochemical analysis of C-RPS3 revealed that it comprises a standalone apurnic-apyrimidinic endonuclease-like domain. We used U2OS cells to show that oxidative stress and UV exposure could enhance the interaction between nuclear RPS3 and RECQL4. Regulation of RECQL4 biochemical activities by RPS3 along with nuclear interaction during UV and oxidative stress may serve to modulate active DNA repair.	[Patil, Ajay Vitthal; Hsieh, Tao-Shih] Acad Sinica, Taiwan Int Grad Program, Mol & Cell Biol, Taipei 115, Taiwan; [Patil, Ajay Vitthal; Hsieh, Tao-Shih] Acad Sinica, Inst Cellular & Organism Biol, 128,Acad Rd,Sec 2, Taipei 11529, Taiwan; [Patil, Ajay Vitthal; Hsieh, Tao-Shih] Grad Inst Life Sci, Natl Def Med Ctr, Taipei 114, Taiwan; [Hsieh, Tao-Shih] Duke Univ Med Ctr, Dept Biochem, Durham, NC 27710 USA	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Defense Medical Center; Duke University	Patil, AV (corresponding author), Acad Sinica, Taiwan Int Grad Program, Mol & Cell Biol, Taipei 115, Taiwan.; Patil, AV (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, 128,Acad Rd,Sec 2, Taipei 11529, Taiwan.; Patil, AV (corresponding author), Grad Inst Life Sci, Natl Def Med Ctr, Taipei 114, Taiwan.	ajaypatil@gate.sinica.edu.tw			Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan	Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan(Academia Sinica - Taiwan)	We are grateful to Dr. Ting-Fang Wang and Dr. Meng-Chao Yao (Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan) for suggestions and support. We thank Wen-Hsiang Tsai for technical assistance. We thank John O'Brien and Marcus J. Calkins (Academia Sinica) for suggestions on the manuscript as native English speakers.	Ahn B, 2004, J BIOL CHEM, V279, P53465, DOI 10.1074/jbc.M409624200; Capp C, 2010, CRIT REV BIOCHEM MOL, V45, P233, DOI 10.3109/10409231003786086; Capp C, 2009, J BIOL CHEM, V284, P30845, DOI 10.1074/jbc.M109.008052; Croteau DL, 2012, TRENDS GENET, V28, P624, DOI 10.1016/j.tig.2012.08.003; Fan W, 2008, J BIOL CHEM, V283, P29037, DOI 10.1074/jbc.M801928200; Ghosh AK, 2012, J BIOL CHEM, V287, P196, DOI 10.1074/jbc.M111.295063; Hegde V, 2001, J BIOL CHEM, V276, P27591, DOI 10.1074/jbc.M101213200; Hegde V, 2007, DNA REPAIR, V6, P94, DOI 10.1016/j.dnarep.2006.09.004; Heyde V, 2006, DNA REPAIR, V5, P810, DOI 10.1016/j.dnarep.2006.04.001; Hoki Y, 2003, HUM MOL GENET, V12, P2293, DOI 10.1093/hmg/ddg254; Jang CY, 2012, BIOCHEM BIOPH RES CO, V429, P57, DOI 10.1016/j.bbrc.2012.10.093; Keller H, 2014, NUCLEIC ACIDS RES, V42, P12614, DOI 10.1093/nar/gku993; KIM J, 1995, J BIOL CHEM, V270, P13620, DOI 10.1074/jbc.270.23.13620; Kim SH, 2005, BIOCHEM BIOPH RES CO, V328, P962, DOI 10.1016/j.bbrc.2005.01.045; Kim TS, 2009, BBA-MOL CELL RES, V1793, P395, DOI 10.1016/j.bbamcr.2008.10.017; Lachapelle S, 2011, J PROTEOME RES, V10, P1216, DOI 10.1021/pr100990s; Larizza L, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-2; Lee SB, 2010, J BIOL CHEM, V285, P29457, DOI 10.1074/jbc.M110.131367; Lu H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.168; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Marino F, 2016, SCI REP-UK, V6, DOI 10.1038/srep21501; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Nagao-Kitamoto H, 2015, CANCER LETT, V356, P855, DOI 10.1016/j.canlet.2014.10.042; Ng AJM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005160; Ohlenschlager O, 2012, NUCLEIC ACIDS RES, V40, P8309, DOI 10.1093/nar/gks591; Rossi ML, 2010, DNA REPAIR, V9, P796, DOI 10.1016/j.dnarep.2010.04.003; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Schurman SH, 2009, HUM MOL GENET, V18, P3470, DOI 10.1093/hmg/ddp291; Seong KM, 2012, FEBS LETT, V586, P356, DOI 10.1016/j.febslet.2011.12.030; Singh DK, 2010, AGING CELL, V9, P358, DOI 10.1111/j.1474-9726.2010.00562.x; Suzuki T, 2009, J BIOCHEM, V146, P327, DOI 10.1093/jb/mvp074; Tian Y, 2015, ONCOTARGET, V6, P29614, DOI 10.18632/oncotarget.4868; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2011, NAT IMMUNOL, V12, P335, DOI 10.1038/ni.2007; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Werner SR, 2006, BIOCHEM BIOPH RES CO, V345, P403, DOI 10.1016/j.bbrc.2006.04.093; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13; Yacoub A, 1996, EMBO J, V15, P2306, DOI 10.1002/j.1460-2075.1996.tb00584.x; Yadavilli S, 2007, DNA REPAIR, V6, P1453, DOI 10.1016/j.dnarep.2007.04.009; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003	42	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4313	4325		10.1074/jbc.M116.764324	http://dx.doi.org/10.1074/jbc.M116.764324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28159839	Green Published, hybrid			2022-12-26	WOS:000395837100028
J	Chierico, L; Rizzello, L; Guan, LJ; Joseph, AS; Lewis, A; Battaglia, G				Chierico, Luca; Rizzello, Loris; Guan, Lijuan; Joseph, Adrian Steve; Lewis, Andrew; Battaglia, Giuseppe			The role of the two splice variants and extranuclear pathway on Ki-67 regulation in non-cancer and cancer cells	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; MITOTIC CHROMOSOMES; QUALITY-CONTROL; ANTIBODY KI-67; BREAST-CANCER; CHAPERONE BIP; PROLIFERATION; ANTIGEN; CYCLE; KI67	Ki-67 is a nuclear protein that has been used in cancer diagnostic because of its specific cell-cycle dependent expression profile. After quantifying and characterising the expression level of Ki-67, as a function of the cell cycle, we found out that the two main splice variants of the protein (i.e. a and (3) are differently regulated in non-cancerous and cancerous cells both at mRNA and protein level. We were able to correlate the presence of the a variant of the protein with the progression through the interphase of cell cycle. We also observed that the different expression profiles correspond to different degradation pathways for non-cancerous and cancerous cells. Furthermore, Ki-67 is continuously regulated and degraded via proteasome system in both cell types, suggesting an active control of the protein. However we also observed a putative extranuclear elimination pathway of Ki-67 where it is transported to the Golgi apparatus. Our evidence in the different expression of the splice variants may represent a milestone for the development of new targets for cancer diagnostic and prognostic. Additionally, the unexpected extranuclear elimination of Ki-67 strongly suggests that this protein must be looked at also outside of the "nuclear box", as thought to date.	[Chierico, Luca; Rizzello, Loris; Guan, Lijuan; Joseph, Adrian Steve; Battaglia, Giuseppe] UCL, Dept Chem, London, England; [Lewis, Andrew] Biocompatibles UK Ltd, Farnham Business Pk,Weydon Lane, Farnham, Surrey, England	University of London; University College London; Biocompatibles International PLC	Rizzello, L; Battaglia, G (corresponding author), UCL, Dept Chem, London, England.	l.rizzello@ucl.ac.uk; g.battaglia@ucl.ac.uk	Battaglia, Giuseppe/I-2142-2013; Rizzello, Loris/HDM-2610-2022	Battaglia, Giuseppe/0000-0003-3349-6770; Rizzello, Loris/0000-0002-8230-853X	Biocompatibles UK Ltd; BTG/Biocompatibles	Biocompatibles UK Ltd; BTG/Biocompatibles	Biocompatibles UK Ltd provided support in the form of salaries for authors LC and AL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors thank Miss Silvia Bianco for the design of the cartoon. L.C. thanks BTG/Biocompatibles for sponsoring his studentship.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Boge A, 2012, FASEB J, P26; Booth DG, 2014, KI 67 IS PP1 INTERAC; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Cuylen S, 2016, NATURE, V535, P308, DOI 10.1038/nature18610; Derganc J, 2013, TRENDS BIOCHEM SCI, V38, P576, DOI 10.1016/j.tibs.2013.08.006; Endl E, 2000, EXP CELL RES, V257, P231, DOI 10.1006/excr.2000.4888; Endl E, 1997, CYTOMETRY, V29, P233, DOI 10.1002/(SICI)1097-0320(19971101)29:3<233::AID-CYTO6>3.0.CO;2-C; Endl E, 2000, J CELL PHYSIOL, V182, P371, DOI 10.1002/(SICI)1097-4652(200003)182:3<371::AID-JCP8>3.0.CO;2-J; GERDES J, 1984, J IMMUNOL, V133, P1710; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Jakobsen JN, 2013, LUNG CANCER, V79, P1, DOI 10.1016/j.lungcan.2012.10.008; Kill IR, 1996, J CELL SCI, V109, P1253; Kimata Y, 2011, CURR OPIN CELL BIOL, V23, P135, DOI 10.1016/j.ceb.2010.10.008; Makino DL, 2013, NAT REV MOL CELL BIO, V14, P654, DOI 10.1038/nrm3657; Onn A, 2010, NAT STRUCT MOL BIOL, V17, P924, DOI 10.1038/nsmb0810-924; Pathmanathan N, 2013, J CLIN PATHOL, V66, P512, DOI 10.1136/jclinpath-2012-201085; Pimpl P, 2006, PLANT CELL, V18, P198, DOI 10.1105/tpc.105.036665; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Rustandi RR, 2012, ELECTROPHORESIS, V33, P2790, DOI 10.1002/elps.201200095; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Starborg M, 1996, J CELL SCI, V109, P143; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	32	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171815	10.1371/journal.pone.0171815	http://dx.doi.org/10.1371/journal.pone.0171815			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187152	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300045
J	De Smet, L; Hatjina, F; Ioannidis, P; Hamamtzoglou, A; Schoonvaere, K; Francis, F; Meeus, I; Smagghe, G; de Graaf, DC				De Smet, Lina; Hatjina, Fani; Ioannidis, Pavlos; Hamamtzoglou, Anna; Schoonvaere, Karel; Francis, Frederic; Meeus, Ivan; Smagghe, Guy; de Graaf, Dirk C.			Stress indicator gene expression profiles, colony dynamics and tissue development of honey bees exposed to sub-lethal doses of imidacloprid in laboratory and field experiments	PLOS ONE			English	Article							HYPOPHARYNGEAL GLANDS; NEONICOTINOIDS; PESTICIDES; AGE; QUANTIFICATION; MANAGEMENT; ACARICIDES; PROTEIN; WORKERS; BROOD	In this study, different context-dependent effects of imidacloprid exposure on the honey bee response were studied. Honey bees were exposed to different concentrations of imidacloprid during a time period of 40 days. Next to these variables, a laboratory-field comparison was conducted. The influence of the chronic exposure on gene expression levels was determined using an in-house developed microarray targeting different immunity-related and detoxification genes to determine stress-related gene expression changes. Increased levels of the detoxification genes encoding, CYP9Q3 and CYT P450, were detected in imidacloprid- exposed honey bees. The different context-dependent effects of imidacloprid exposure on honey bees were confirmed physiologically by decreased hypopharyngeal gland sizes. Honey bees exposed to imidacloprid in laboratory cages showed a general immunosuppression and no detoxification mechanisms were triggered significantly, while honey bees infield showed a resilient response with an immune stimulation at later time points. However, the treated colonies had a brood and population decline tendency after the first brood cycle in the field. In conclusion, this study highlighted the different context-dependent effects of imidacloprid exposure on the honey bee response. These findings warn for possible pitfalls concerning the generalization of results based on specific experiments with short exposure times. The increased levels of CYT P450 and CYP9Q3 combined with an immune response reaction can be used as markers for bees which are exposed to pesticides in the field.	[De Smet, Lina; Schoonvaere, Karel; de Graaf, Dirk C.] Univ Ghent, Fac Sci, Lab Mol Entomol & Bee Pathol, Ghent, Belgium; [Hatjina, Fani; Ioannidis, Pavlos; Hamamtzoglou, Anna] Hellen Agr Org DEMETER, Inst Anim Sci, Div Apiculture, Nea Moudania, Greece; [Francis, Frederic] Univ Liege, Gembloux AgrobioTech, Dept Funct & Evolut Entomol, Liege, Belgium; [Meeus, Ivan; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Ghent, Belgium	Ghent University; University of Liege; Ghent University	De Smet, L (corresponding author), Univ Ghent, Fac Sci, Lab Mol Entomol & Bee Pathol, Ghent, Belgium.	lina.desmet@ugent.be	de Graaf, Dirk C./HGD-4017-2022; Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313; De Smet, Lina/0000-0002-8005-2059	Belgian Science Policy (BELSPO) [BR/132/A1/BELBEES]; EC-Greek Government project (EC) [797/07]	Belgian Science Policy (BELSPO)(Belgian Federal Science Policy Office); EC-Greek Government project (EC)	This work was supported by Belgian Science Policy (BELSPO; BR/132/A1/BELBEES; Multi-disciplinary assessment of BELgian wild BEE decline to adapt mitigation management policy), EC-Greek Government project (EC Dir. 797/07; Effect of neonicotinoids and air pollution on honey bees). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aufauvre J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091686; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger Bruno, 2005, Brazilian Journal of Morphological Sciences, V22, P1; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bloch G, 2010, P NATL ACAD SCI USA, V107, P11240, DOI 10.1073/pnas.1003265107; Boily M, 2013, ENVIRON SCI POLLUT R, V20, P5603, DOI 10.1007/s11356-013-1568-2; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Brandt A, 2016, J INSECT PHYSIOL, V86, P40, DOI 10.1016/j.jinsphys.2016.01.001; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Costa C, 2012, J APIC SCI, V56, P147, DOI 10.2478/v10289-012-0015-9; CRAILSHEIM K, 1989, J INSECT PHYSIOL, V35, P595, DOI 10.1016/0022-1910(89)90121-2; Cresswell JE, 2014, PEST MANAG SCI, V70, P332, DOI 10.1002/ps.3569; Cresswell JE, 2012, ZOOLOGY, V115, P365, DOI 10.1016/j.zool.2012.05.003; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Derecka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068191; Deseyn J, 2005, APIDOLOGIE, V36, P49, DOI 10.1051/apido:2004068; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Gregorc A, 2012, J INSECT PHYSIOL, V58, P1042, DOI 10.1016/j.jinsphys.2012.03.015; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Hatjina F, 2013, APIDOLOGIE, V44, P467, DOI 10.1007/s13592-013-0199-4; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hrassnigg N, 1998, J INSECT PHYSIOL, V44, P393, DOI 10.1016/S0022-1910(98)00022-5; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; KNECHT D, 1990, APIDOLOGIE, V21, P457, DOI 10.1051/apido:19900507; Lass A, 1996, INSECT SOC, V43, P347, DOI 10.1007/BF01258408; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Malone LA, 2004, APIDOLOGIE, V35, P655, DOI 10.1051/apido:2004063; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Garrido PM, 2013, J INSECT PHYSIOL, V59, P113, DOI 10.1016/j.jinsphys.2012.10.019; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Ravoet J, 2016, ENTOMOLOGICAL SCI; Rhodes J, 2003, 03049 NSW AGR RUR IN; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; Skerl MIS, 2010, APIDOLOGIE, V41, P73, DOI 10.1051/apido/2009051; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stork A., 1999, MR55099; Suryanarayanan Sainath, 2013, Insects, V4, P153, DOI 10.3390/insects4010153; Tapparo A, 2011, J ENVIRON MONITOR, V13, P1564, DOI 10.1039/c1em10085h; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wilde J, 2016, J APICULTURAL RES; Williams GR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14621; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Winston M., 1987, The biology of the honey bee.; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Wu-Smart J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32108	58	51	52	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171529	10.1371/journal.pone.0171529	http://dx.doi.org/10.1371/journal.pone.0171529			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182641	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800070
J	Getahun, B; Nkosi, ZZ				Getahun, Belete; Nkosi, Zethu Zerish			Satisfaction of patients with directly observed treatment strategy in Addis Ababa, Ethiopia: A mixed-methods study	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; CARE; SERVICES; DOTS	Background Directly observed treatment, short course (DOTS) strategy has been a cornerstone for Tuberculosis (TB) control programs in developing countries. However, in Ethiopia satisfaction level of patients' with TB with the this strategy is not well understood. Therefore, the study aimed to assess the satisfaction level of patients with TB with the DOTS. Method Explanatory sequential mixed method design was carried out in Addis Ababa, Ethiopia. Interviewer-administered questionnaire with 601 patients with TB who were on follow-up was employed in the quantitative approach. In the qualitative approach telephonic-interview with 25 persons lost to follow-up and focus group discussions with 23 TB experts were conducted. Result Sixty seven percent of respondent was satisfied with the DOTS. Rural residency (AOR = 3.4, 95% CI 1.6, 7.6), having TB symptoms (AOR = 0.6, 95% CI 0.4, 0.94) and treatment supporter (AOR = 4.3, 95% CI 2.7, 6.8) were associated with satisfaction with DOTS. In qualitative finding, all persons lost to follow-up were dissatisfied while TB experts enlightened lack of evidence to affirm the satisfaction level of patients with DOTS. Explored factors contributing to satisfaction include: on time availability of health care providers, DOTS service delivery process, general condition of health care facilities, nutritional support and transportation. Conclusion DOTS is limited to satisfy patients with TB and lacks a consistent system that determines the satisfaction level of patients with TB. Therefore, DOTS strategy needs to have a system to captures patients' satisfaction level to respond on areas that need progress to improve DOTS service quality.	[Getahun, Belete; Nkosi, Zethu Zerish] Univ South Africa, Dept Hlth Studies, Coll Human Sci, Pretoria, South Africa; [Getahun, Belete] Univ Addis Ababa, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia	University of South Africa; Addis Ababa University	Getahun, B (corresponding author), Univ South Africa, Dept Hlth Studies, Coll Human Sci, Pretoria, South Africa.; Getahun, B (corresponding author), Univ Addis Ababa, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia.	bgetahun150@gmail.com	Nkosi, Zethu/AAG-3980-2020					Addis Ababa City Adminstration Finnance and Economic Development Buraueu, 2013, ADD AB POP IM; Addis Ababa City Adminstration Health Buraeu, 2015, ANN ACT REP; Ahmad I, 2010, GOMAL J MED SCI, V9; Al-Abri Rashid, 2014, Oman Med J, V29, P3, DOI 10.5001/omj.2014.02; Bahrampour A., 2005, Eastern Mediterranean Health Journal, V11, P905; Berhe G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-537; Bhattacherjee A., 2012, SOCIAL SCI RES PRINC, V2nd \; Biadglegne F., 2013, INT J MED MED SCI, V5, P85, DOI DOI 10.5897/IJMMS12.142; Central Statistical Agency of Ethiopia, 2014, POP PROJ ETH ALL REG; Chimbindi N, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-32; Dansereau E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009700; Diacona HA, 2012, SWISS MED WKLY, V142, P1; Donabedian A, 2005, MILBANK Q, V83, P691, DOI 10.1111/j.1468-0009.2005.00397.x; Federal Democratic Republic of Ethiopia Ministry of Health, 2015, ETH NAT HLTH CAR QUA; Federal Democratic Republic of Ethiopia Ministry of Health, 2011, P 6 NAT TB RES WORKS; Federal democratic republic of Ethiopia Ministry of Health, 2015, HLTH SECT TRANSF PLA; Federal Democratic Republic of Ethiopia Ministry of Health, 2012, HLTH HLTH REL IND; Federal Democratic Republic of Ethiopia MoH, 2013, GUID CLIN PROGR MAN, V5; Gebreegziabher S., 2016, J TUBERC RES, V4, P23, DOI DOI 10.4236/JTR.2016.41004; Gebrezgabiher G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150560; Getahun B, 2013, BRAZ J INFECT DIS, V17, P521, DOI 10.1016/j.bjid.2012.12.010; Gupta S., 2015, J ADV MED DENT SCI R, V3, P34; Hamusse SD, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25382; Marshall G.B., 2011, DESIGNING QUALITATIV; Nezenega ZS, 2013, BMC HEALTH SERV RES, V13, P1; Onyeonoro UU, 2015, HEALTH SERV INSIGHTS, V8, P25, DOI 10.4137/HSI.S27177; Otu A. A., 2013, Asian Pacific Journal of Tropical Disease, V3, P227, DOI 10.1016/S2222-1808(13)60045-6; Palha PF, 2012, REV ESC ENFERM USP, V46, P342, DOI 10.1590/S0080-62342012000200011; Paulson T., 2013, NATURE; Pefoyo AJ, 2013, BMC RES NOTES, V6, P1; Portela MC, 2014, REV SAUDE PUBL, V48, P497, DOI 10.1590/S0034-8910.2014048004793; Rahmqvist M, 2010, INT J QUALITY H 0203; Sagbakken M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-11; Sisay Solomon, 2014, BMC Res Notes, V7, P44, DOI 10.1186/1756-0500-7-44; Srivastav S, 2014, ANN TROP MED PUBLIC, V7, P116, DOI 10.4103/1755-6783.146398; van der Eijk M, 2013, PARKINSONISM RELAT D, V19, P923, DOI 10.1016/j.parkreldis.2013.04.022; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, GLOB TUB REP 2013; Yin Robert K., 2015, QUALITATIVE RES STAR; Young GJ, 2000, MED CARE, V38, P325, DOI 10.1097/00005650-200003000-00009	40	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171209	10.1371/journal.pone.0171209	http://dx.doi.org/10.1371/journal.pone.0171209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182754	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800045
J	Brown, PM; Harford, TJ; Agrawal, V; Yen-Lieberman, B; Rezaee, F; Piedimonte, G				Brown, Paul M.; Harford, Terri J.; Agrawal, Vandana; Yen-Lieberman, Belinda; Rezaee, Fariba; Piedimonte, Giovanni			Prenatal Exposure to Respiratory Syncytial Virus Alters Postnatal Immunity and Airway Smooth Muscle Contractility during Early-Life Reinfections	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; DISEASE SEVERITY; INTERFERON-GAMMA; YOUNG-CHILDREN; INFECTION; BRONCHIOLITIS; INFANTS; ALLERGY; CELLS; ASTHMA	Maternal viral infections can have pathological effects on the developing fetus which last long after birth. Recently, maternal-fetal transmission of respiratory syncytial virus (RSV) was shown to cause postnatal airway hyperreactivity (AHR) during primary early-life reinfection; however, the influence of prenatal exposure to RSV on offspring airway immunity and smooth muscle contractility during recurrent postnatal reinfections remains unknown. Therefore, we sought to determine whether maternal RSV infection impairs specific aspects of cell-mediated offspring immunity during early-life reinfections and the mechanisms leading to AHR. Red fluorescent protein-expressing recombinant RSV (rrRSV) was inoculated into pregnant rat dams at midterm, followed by primary and secondary postnatal rrRSV inoculations of their offspring at early-life time points. Pups and weanlings were tested for specific lower airway leukocyte populations by flow cytometry; serum cytokine/chemokine concentrations by multiplex ELISA and neurotrophins concentrations by standard ELISA; and ex vivo lower airway smooth muscle (ASM) contraction by physiological tissue bath. Pups born to RSV-infected mothers displayed elevated total CD3(+) T cells largely lacking CD4(+) and CD8(+) surface expression after both primary and secondary postnatal rrRSV infection. Cytokine/chemokine analyses revealed reduced IFN-gamma, IL-2, IL-12, IL-17A, IL-18, and TNF-alpha, as well as elevated nerve growth factor (NGF) expression. Prenatal exposure to RSV also increased ASM reactivity and contractility during early-life rrRSV infection compared to non-exposed controls. We conclude that maternal RSV infection can predispose offspring to postnatal lower airways dysfunction by altering immunity development, NGF signaling, and ASM contraction during early-life RSV reinfections.	[Brown, Paul M.; Harford, Terri J.; Agrawal, Vandana; Yen-Lieberman, Belinda; Rezaee, Fariba; Piedimonte, Giovanni] Cleveland Clin Fdn, Lerner Res Inst, Ctr Pediat Res, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Brown, Paul M.; Harford, Terri J.; Agrawal, Vandana; Yen-Lieberman, Belinda; Rezaee, Fariba; Piedimonte, Giovanni] Cleveland Clin Fdn, Inst Pediat, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Brown, Paul M.; Harford, Terri J.; Agrawal, Vandana; Yen-Lieberman, Belinda; Rezaee, Fariba; Piedimonte, Giovanni] Childrens Hosp, Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Piedimonte, G (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Ctr Pediat Res, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Piedimonte, G (corresponding author), Cleveland Clin Fdn, Inst Pediat, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Piedimonte, G (corresponding author), Childrens Hosp, Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA.	piedimg@ccf.org	Rezaee, Fariba/AAI-1437-2021	Rezaee, Fariba/0000-0002-7625-3341; Harford, Terri/0000-0001-6590-0673	NIH [R01 HL061007, K08 Al112781]; Lerner Research Institute; Cleveland Clinic Children's Hospital of the Cleveland Clinic Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI112781] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lerner Research Institute; Cleveland Clinic Children's Hospital of the Cleveland Clinic Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R01 HL061007 (GP), by NIH K08 Al112781 (FR), and by the Lerner Research Institute and Cleveland Clinic Children's Hospital of the Cleveland Clinic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CAR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5547; Bonini S, 1996, P NATL ACAD SCI USA, V93, P10955, DOI 10.1073/pnas.93.20.10955; Bont L, 2001, J INFECT DIS, V184, P355, DOI 10.1086/322035; Brown PM, 2015, PAEDIATR RESPIR REV, V16, P232, DOI 10.1016/j.prrv.2015.05.005; Byington CL, 2015, PEDIATRICS, V135, pE24, DOI 10.1542/peds.2014-2151; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Darwich L, 2009, IMMUNOLOGY, V126, P386, DOI 10.1111/j.1365-2567.2008.02905.x; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Gonzalez PA, 2013, CURR MOL MED, V13, P1122; Gonzalez PA, 2009, CURR MED CHEM, V16, P4609, DOI 10.2174/092986709789760724; Graham BS, 2000, IMMUNOPHARMACOLOGY, V48, P237, DOI 10.1016/S0162-3109(00)00233-2; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Habibi MS, 2015, AM J RESP CRIT CARE, V191, P1040, DOI 10.1164/rccm.201412-2256OC; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; Hu CP, 2002, AM J PHYSIOL-LUNG C, V283, pL494, DOI 10.1152/ajplung.00414.2001; Jozwik A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10224; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kim L., RESP SYNCYTIAL VIRUS; Kirin BK, 2013, BIOCHEM MEDICA, V23, P112, DOI 10.11613/BM.2013.014; Li XQ, 2006, J VIROL, V80, P537, DOI 10.1128/JVI.80.1.537-540.2006; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; Manti S, 2016, NEUROTROPHINS VITAMI, V104; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Mella C, 2013, J INFECT DIS, V207, P564, DOI 10.1093/infdis/jis721; Menchise A, 2011, FETAL PEDIATR PATHOL, V30, P64, DOI 10.3109/15513815.2010.505632; MOK JYQ, 1984, ARCH DIS CHILD, V59, P306, DOI 10.1136/adc.59.4.306; Munir S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001336; MURRAY M, 1992, ARCH DIS CHILD, V67, P482, DOI 10.1136/adc.67.4.482; Noble V, 1997, ARCH DIS CHILD, V76, P315, DOI 10.1136/adc.76.4.315; Openshaw PJM, 2003, PEDIATR INFECT DIS J, V22, pS58, DOI 10.1097/00006454-200302001-00009; Piedimonte G, 2004, PEDIATR RES, V55, P657, DOI 10.1203/01.PDR.0000112244.72924.26; Piedimonte G, 2014, PEDIATR REV, V35, P519, DOI 10.1542/pir.35-12-519; Piedimonte G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061309; Rohwedder A, 1998, J MED VIROL, V54, P320, DOI 10.1002/(SICI)1096-9071(199804)54:4&lt;320::AID-JMV13&gt;3.0.CO;2-J; Sasser JM, 2008, AM J PHYSIOL-RENAL, V294, pF1342, DOI 10.1152/ajprenal.00067.2008; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; SIMS DG, 1978, BRIT MED J, V1, P11, DOI 10.1136/bmj.1.6104.11; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Sweetman LL, 2005, PEDIATR NEUROL, V32, P307, DOI 10.1016/j.pediatrneurol.2005.01.010; Techaarpornkul S, 2001, J VIROL, V75, P6825, DOI 10.1128/JVI.75.15.6825-6834.2001; Torres JP, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-125; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Wright M, 2011, PEDIATR PULM, V46, P324, DOI 10.1002/ppul.21377; Wu J, 2014, BURNS TRAUMA, V2, DOI [10.4103/2321-3868.124771, 10.4103/2321-3868.113326]; Yui I, 2003, J MED VIROL, V70, P481, DOI 10.1002/jmv.10421	49	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0168786	10.1371/journal.pone.0168786	http://dx.doi.org/10.1371/journal.pone.0168786			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178290	gold, Green Submitted, Green Published			2022-12-26	WOS:000393712500001
J	Farago, B; Kollar, T; Szabo, K; Budai, C; Losonczi, E; Bernath, G; Csenki-Bakos, Z; Urbanyi, B; Pribenszky, C; Horvath, A; Cserepes, J				Farago, Bernadett; Kollar, Timea; Szabo, Katalin; Budai, Csilla; Losonczi, Eszter; Bernath, Gergely; Csenki-Bakos, Zsolt; Urbanyi, Bela; Pribenszky, Csaba; Horvath, Akos; Cserepes, Judit			Stimulus-triggered enhancement of chilling tolerance in zebrafish embryos	PLOS ONE			English	Article							HIGH HYDROSTATIC-PRESSURE; DANIO-RERIO EMBRYOS; CARPIO L. EMBRYOS; LABEO-ROHITA; CRYOPROTECTANT; VITRIFICATION; SENSITIVITY; PERMEABILITY; STRESS; PRESERVATION	Background Cryopreservation of zebrafish embryos is still an unsolved problem despite market demand and massive efforts to preserve genetic variation among numerous existing lines. Chilled storage of embryos might be a step towards developing successful cryopreservation, but no methods to date have worked. Methods In the present study, we applied a novel strategy to improve the chilling tolerance of zebra fish embryos by introducing a preconditioning hydrostatic pressure treatment to the embryos. In our experiments, 26-somites and Prim-5 stage zebrafish embryos were chilled at 0 degrees C for 24 hours after preconditioning. Embryo survival rate, ability to reach maturation and fertilizing capacity were tested. Results Our results indicate that applied preconditioning technology made it possible for the chilled embryos to develop normally until maturity, and to produce healthy offspring as normal, thus passing on their genetic material successfully. Treated embryos had a significantly higher survival and better developmental rate, moreover the treated group had a higher ratio of normal morphology during continued development. While all controls from chilled embryos died by 30 day-post-fertilization, the treated group reached maturity (similar to 90-120 days) and were able to reproduce, resulting in offspring in expected quantity and quality. Conclusions Based on our results, we conclude that the preconditioning technology represents a significant improvement in zebrafish embryo chilling tolerance, thus enabling a long-time survival.Furthermore, as embryonic development is arrested during chilled storage this technology also provides a solution to synchronize or delay the development.	[Farago, Bernadett; Szabo, Katalin; Budai, Csilla; Losonczi, Eszter; Cserepes, Judit] Appl Cell Technol Ltd, Budapest, Hungary; [Kollar, Timea; Bernath, Gergely; Csenki-Bakos, Zsolt; Urbanyi, Bela; Horvath, Akos] Szent Istvan Univ, Dept Aquaculture, Godollo, Hungary; [Pribenszky, Csaba] Univ Vet Sci, Fac Anim Hyg & Herdhlth & Vet Ethol, Budapest, Hungary	Hungarian University of Agriculture & Life Sciences; University of Veterinary Medicine Budapest	Cserepes, J (corresponding author), Appl Cell Technol Ltd, Budapest, Hungary.; Horvath, A (corresponding author), Szent Istvan Univ, Dept Aquaculture, Godollo, Hungary.	horvath.akos@mkk.szie.hu; judit.cserepes@appcelltech.com	Horvath, Akos/F-8248-2013; Kollár, Tímea/K-6193-2019	Horvath, Akos/0000-0001-9760-2478; Kollár, Tímea/0000-0002-9689-287X; Csenki-Bakos, Zsolt/0000-0003-1750-2296; Bernath, Gergely/0000-0001-5055-3349	National Research, Development and Innovation Office [KMR_12-1-2012-0436]; European Cooperation in Science and Technology [9878-3/2016/FEKUT]; Hungarian Government (Research Centre of Excellence) [11476-3/2016/FEKUT]; Applied Cell Technology ltd	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); Hungarian Government (Research Centre of Excellence); Applied Cell Technology ltd	This research was funded by National Research, Development and Innovation Office (KMR_12-1-2012-0436, nkfih.gov.hu), European Cooperation in Science and Technology (9878-3/2016/FEKUT, www.cost.eu) and Hungarian Government (Research Centre of Excellence - 11476-3/2016/FEKUT, www.nemzetikivalosag.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors who received the funding: BF TK KS CB EL ZC GB BU AH JC. The research was also funded by the owners of Applied Cell Technology ltd. These funders provided support in the form of salaries for authors (BF, KS, CB, EL, JC), but did not have any role in the study, design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The specific roles of these authors are articulated in the authors contribution section.	Ahammad MM, 2003, THERIOGENOLOGY, V60, P1409, DOI 10.1016/S0093-691X(03)00118-3; Ahammad MM, 2003, CRYOBIOLOGY, V46, P2, DOI 10.1016/S0011-2240(02)00138-4; Ahammad MM, 2002, CRYOBIOLOGY, V44, P114, DOI 10.1016/S0011-2240(02)00012-3; Ahammad MM, 1998, CRYOBIOLOGY, V37, P318, DOI 10.1006/cryo.1998.2127; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Beirao J, 2006, AQUACULTURE, V261, P897, DOI 10.1016/j.aquaculture.2006.07.039; Cabrita E, 2003, CRYOBIOLOGY, V47, P204, DOI 10.1016/j.cryobiol.2003.10.001; Callesen H, 2010, REPROD FERT DEVELOP, V22, P40, DOI 10.1071/RD09213; Cardona-Costa J, 2007, CRYOLETTERS, V28, P303; Desai K, 2015, CRYOBIOLOGY, V71, P1, DOI 10.1016/j.cryobiol.2015.06.009; Desai K, 2015, ZEBRAFISH, V12, P111, DOI 10.1089/zeb.2013.0961; Du Y, 2008, REPRODUCTION, V135, P13, DOI 10.1530/REP-07-0362; Hagedorn M, 1997, CRYOBIOLOGY, V34, P251, DOI 10.1006/cryo.1997.2002; Hagedorn M, 1997, J EXP ZOOL, V278, P356, DOI 10.1002/(SICI)1097-010X(19970815)278:6&lt;356::AID-JEZ3&gt;3.0.CO;2-N; Hagedorn M, 2004, CRYOBIOLOGY, V49, P181, DOI 10.1016/j.cryobiol.2004.07.001; HAGEDORN M, 2011, CRYOPRESERVATION AQU, P483; HARVEY B, 1983, CRYOBIOLOGY, V20, P432, DOI 10.1016/0011-2240(83)90033-0; Horvath A, 2016, REPROD FERT DEVELOP, V28, P475, DOI 10.1071/RD14118; Jiang ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21215; Kikuchi K, 2016, THERIOGENOLOGY, V86, P170, DOI 10.1016/j.theriogenology.2016.04.029; Lahnsteiner F, 2009, THERIOGENOLOGY, V72, P333, DOI 10.1016/j.theriogenology.2009.03.003; Lambertini M, 2016, BMC MED, V14, DOI 10.1186/s12916-015-0545-7; Liu XH, 1999, CRYOBIOLOGY, V39, P236, DOI 10.1006/cryo.1999.2206; Liu XH, 1998, CRYO-LETT, V19, P309; Long Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-612; Magli MC, 2008, HUM REPROD, V23, P1253, DOI 10.1093/humrep/den068; Mara L, 2013, ANIM REPROD SCI, V138, P25, DOI 10.1016/j.anireprosci.2013.02.006; Parnpai R, 2016, THERIOGENOLOGY, V86, P214, DOI 10.1016/j.theriogenology.2016.04.034; Popovic L., 2013, Proceedings of the New Zealand Society of Animal Production, V73, P83; Pribenszky C, 2005, ANIM REPROD SCI, V87, P143, DOI 10.1016/j.anireprosci.2004.09.007; Pribenszky C, 2012, REPROD DOMEST ANIM, V47, P197, DOI 10.1111/j.1439-0531.2012.02076.x; Pribenszky C, 2011, REPROD FERT DEVELOP, V23, P48, DOI 10.1071/RD10231; Pribenszky C, 2010, BIOL REPROD, V83, P690, DOI 10.1095/biolreprod.110.083386; Robles V, 2005, THERIOGENOLOGY, V64, P1633, DOI 10.1016/j.theriogenology.2005.04.014; Robles V, 2004, THERIOGENOLOGY, V61, P1367, DOI 10.1016/j.theriogenology.2003.08.010; Schattman GL, 2015, NEW ENGL J MED, V373, P1755, DOI 10.1056/NEJMcp1307341; Siqueira E, 2011, REPROD FERT DEVELOP, V23, P585, DOI 10.1071/RD10203; Szaraz L, 2014, CRYOBIOLOGY, V69, P266, DOI 10.1016/j.cryobiol.2014.07.016; Valdez DM, 2005, THERIOGENOLOGY, V64, P112, DOI 10.1016/j.theriogenology.2004.11.006	39	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171520	10.1371/journal.pone.0171520	http://dx.doi.org/10.1371/journal.pone.0171520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166301	gold, Green Submitted, Green Published			2022-12-26	WOS:000393700100049
J	Victoriano-Romero, E; Valencia-Diaz, S; Toledo-Hernandez, VH; Flores-Palacios, A				Victoriano-Romero, Elizabeth; Valencia-Diaz, Susana; Hugo Toledo-Hernandez, Victor; Flores-Palacios, Alejandro			Dispersal limitation of Tillandsia species correlates with rain and host structure in a central Mexican tropical dry forest	PLOS ONE			English	Article							VASCULAR EPIPHYTES; GERMINATION; BROMELIACEAE; PREFERENCE; ABUNDANCE; RECURVATA; CATOPSIS	Seed dispersal permits the colonization of favorable habitats and generation of new populations, facilitating escape from habitats that are in decline. There is little experimental evidence of the factors that limit epiphyte dispersion towards their hosts. In a tropical dry forest in central Mexico, we monitored the phenology of dispersion of epiphyte species of the genus Tillandsia; we tested experimentally whether precipitation could cause failures in seed dispersal and whether seed capture differs among vertical strata and between host species with high (Bursera copallifera) and low (Conzattia multiflora) epiphyte loads. With the exception of one species that presents late dispersion and low abundance, all of the species disperse prior to the onset of the rainy season. However, early rains immobilize the seeds, affecting up to 24% of the fruits in species with late dispersion. We observed that Tillandsia seeds reach both Bursera and Conzattia hosts, but found that adherence to the host is 4-5 times higher in Bursera. Furthermore, seeds liberated from Bursera travel shorter distances and up to half may remain within the same crown, while the highest seed capture takes place in the upper strata of the trees. We conclude that dispersion of Tillandsia seeds is limited by early rains and by the capture of seeds within the trees where populations concentrate. This pattern of capture also helps to explain the high concentrations of epiphytes in certain hosts, while trees with few epiphytes can be simultaneously considered deficient receivers and efficient exporters of seeds.	[Victoriano-Romero, Elizabeth; Hugo Toledo-Hernandez, Victor; Flores-Palacios, Alejandro] Univ Autonoma Estado Morelos, Ctr Invest Biodiversidad & Conservac CIByC, Av Univ, Cuernavaca, Morelos, Mexico; [Valencia-Diaz, Susana] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol CEIB, Av Univ, Cuernavaca, Morelos, Mexico	Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos	Flores-Palacios, A (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Biodiversidad & Conservac CIByC, Av Univ, Cuernavaca, Morelos, Mexico.	alejandro.florez@uaem.mx	Valencia-díaz, Susana/ABB-4670-2020; Flores-Palacios, Alejandro/T-7074-2017	Flores-Palacios, Alejandro/0000-0002-2000-9964; Valencia Diaz, Susana/0000-0002-0089-226X; Toledo-Hernandez, Victor H./0000-0002-1119-2189; Victoriano Romero, Elizabeth/0000-0001-9665-7012	CONACyT-Ciencia Basica [80027];  [PROMEP/103.5/05/1901]	CONACyT-Ciencia Basica; 	This research was supported by grants to AFP (75%, PROMEP/103.5/05/1901), to the Red "Sistematica y Ecologia en Comunidades Forestales y Cultivos (18%, PROMEP 2009-2010) and CONACyT-Ciencia Basica 80027 (7%). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Vergara-Torres CA, 2010, J TROP ECOL, V26, P563, DOI 10.1017/S0266467410000349; BENNETT BC, 1987, B TORREY BOT CLUB, V114, P265, DOI 10.2307/2996464; Benzing D.H., 1990, VASCULAR EPIPHYTES; Bernal R, 2005, CAN J BOT, V83, P1238, DOI 10.1139/b05-076; Cascante-Marin A, 2009, J TROP ECOL, V25, P63, DOI 10.1017/S0266467408005622; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Crawley M. J., 2013, R BOOK; Flores-Palacios A, 2015, SCI HORTIC-AMSTERDAM, V187, P72, DOI 10.1016/j.scienta.2015.03.003; GARCIA-FRANCO J G, 1988, Phytologia, V65, P73; GENTRY AH, 1987, ANN MO BOT GARD, V74, P205, DOI 10.2307/2399395; Harper J. L., 1977, Population biology of plants.; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; JOHANSSON D, 1974, Acta Phytogeographica Suecica, V59, P1; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Lobel S, 2006, J ECOL, V94, P856, DOI 10.1111/j.1365-2745.2006.01114.x; Lopez-Villalobos A, 2008, PLANT ECOL, V198, P265, DOI 10.1007/s11258-008-9402-5; MADISON M, 1977, Selbyana, V2, P1; Mondragon D, 2006, SOUTHWEST NAT, V51, P462, DOI 10.1894/0038-4909(2006)51[462:SDAGOT]2.0.CO;2; Munzbergova Z, 2005, OECOLOGIA, V145, P1, DOI 10.1007/s00442-005-0052-1; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Orozco-Ibarrola OA, 2015, BOT J LINN SOC, V177, P50, DOI 10.1111/boj.12225; Ruiz-Cordova JP, 2014, FLORA, V209, P375, DOI 10.1016/j.flora.2014.06.003; Palaci CA, 2004, SYST BOT, V29, P518, DOI 10.1600/0363644041744473; Pounden E, 2008, J ECOL, V96, P591, DOI 10.1111/j.1365-2745.2008.01380.x; Ruiz-Rivera C.A., 2001, SAN ANDRES CAL CULTO; Siegel S, 2014, ESTADISTICA PARAMETR; Sotelo-Caro O, 2016, THESIS; Valencia-Diaz S, 2010, J TROP ECOL, V26, P571, DOI 10.1017/S0266467410000374; Wagner K, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plu092; Wester S, 2011, J TROP ECOL, V27, P115, DOI 10.1017/S0266467410000593; Winkler M, 2005, ANN BOT-LONDON, V95, P1039, DOI 10.1093/aob/mci115; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zotz G, 1997, ECOGRAPHY, V20, P264, DOI 10.1111/j.1600-0587.1997.tb00370.x; Zotz G, 2013, BOT J LINN SOC, V171, P453, DOI 10.1111/boj.12010	35	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171614	10.1371/journal.pone.0171614	http://dx.doi.org/10.1371/journal.pone.0171614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158320	Green Submitted, gold, Green Published			2022-12-26	WOS:000396161700112
J	Heller, S; Penrose, HM; Cable, C; Biswas, D; Nakhoul, H; Baddoo, M; Flemington, E; Crawford, SE; Savkovic, SD				Heller, Sandra; Penrose, Harrison M.; Cable, Chloe; Biswas, Debjani; Nakhoul, Hani; Baddoo, Melody; Flemington, Erik; Crawford, Susan E.; Savkovic, Suzana D.			Reduced mitochondrial activity in colonocytes facilitates AMPK alpha 2-dependent inflammation	FASEB JOURNAL			English	Article						intestine; RNA-seq; inflammatory bowel disease; rho(0) cells	OXIDATIVE-PHOSPHORYLATION SYSTEM; OXYGEN SPECIES PRODUCTION; BOWEL-DISEASE; INTESTINAL INFLAMMATION; UNCOUPLING PROTEIN-2; ULCERATIVE-COLITIS; NLRP3 INFLAMMASOME; LACKING MTDNA; RHO(0) CELLS; MICE	Intestinal inflammation is associated with low levels of mucosal ATP, highlighting the importance of mitochondrial function associated with ATP production in the pathophysiology of the disease. In the inflamed colon of humans and mice, we found decreased levels of mitochondrial complex cytochromec oxidase I/IV and lower ATP levels. Thus, we generated colonic rho(0) cells with reduced mitochondrial function linked to ATP production by selective depletion of mitochondrial DNA. In these cells, RNA sequencing revealed a substantial number of differentially expressed transcripts, among which 240 belonged to inflammatory pathways activated in human inflamed colon and TNF-alpha-treated cells (false discovery rate < 0.05). TNF-alpha treatment of colonic rho(0) cells augmented IL-8 expression by 9-fold (P < 0.01) via NF-kappa B compared to TNF-alpha-treated control. Moreover, reduced mitochondrial function facilitated TNF-alpha-mediated NF-kappa B luciferase promoter activity as a result of lowered inhibitory I kappa B alpha (nuclear factor of kappa light polypeptide gene enhancer in B-cell inhibitor, a), leading to elevated NF-kappa B. In cells with reduced mitochondrial function, TNF-alpha facilitated AMPK alpha 2 activation by 8-fold (P < 0.01), which was involved in NF-kappa B-dependent IL-8 expression. Last, in human and mouse colon, anti-TNF-alpha treatment restored reduced mitochondria-dependent inflammation. We propose that selective targeting of this novel mechanism provides new treatment opportunities for intestinal inflammation.-Heller, S., Penrose, H. M., Cable, C., Biswas, D., Nakhoul, H., Baddoo, M., Flemington, E., Crawford, S. E., Savkovic, S. D. Reduced mitochondrial activity incolonocytes facilitates AMPK alpha 2-dependent inflammation.	[Heller, Sandra; Penrose, Harrison M.; Cable, Chloe; Biswas, Debjani; Nakhoul, Hani; Baddoo, Melody; Flemington, Erik; Savkovic, Suzana D.] Tulane Univ, Dept Pathol & Lab Med, 1430 Tulane Ave SL-79, New Orleans, LA 70112 USA; [Crawford, Susan E.] Univ Chicago, Pritzker Sch Med, NorthShore Res Inst, Dept Surg, Evanston, IL USA	Tulane University; NorthShore University Health System; University of Chicago	Savkovic, SD (corresponding author), Tulane Univ, Dept Pathol & Lab Med, 1430 Tulane Ave SL-79, New Orleans, LA 70112 USA.	ssavkovi@tulane.edu		Cable, Chloe/0000-0002-6878-5698; Heller, Sandra/0000-0002-8704-2646; Penrose, Harrison/0000-0001-7957-5066	U.S. National Institutes of Health, National Cancer Institute RO1 [CA160809]; NATIONAL CANCER INSTITUTE [P01CA214091, R01CA160809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106676] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute RO1; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a U.S. National Institutes of Health, National Cancer Institute RO1 award (CA160809). The authors thank the University of Wisconsin Biotechnology Center DNA Sequencing Facility for providing next-generation sequencing facilities and services.	Arnould T, 2003, FASEB J, V17, P2145, DOI 10.1096/fj.03-0075fje; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bar F, 2013, GASTROENTEROLOGY, V145, P1055, DOI 10.1053/j.gastro.2013.07.015; Bai AP, 2010, J PHARMACOL EXP THER, V333, P717, DOI 10.1124/jpet.109.164954; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Barroso E, 2011, BIOCHEM PHARMACOL, V81, P534, DOI 10.1016/j.bcp.2010.12.004; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Beltran B, 2010, INFLAMM BOWEL DIS, V16, P76, DOI 10.1002/ibd.21027; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boekema EJ, 2007, J BIOL CHEM, V282, P1, DOI 10.1074/jbc.R600031200; BUFFINTON GD, 1995, FREE RADICAL RES, V22, P131, DOI 10.3109/10715769509147535; Chang KW, 2015, FOOD FUNCT, V6, P3334, DOI [10.1039/C5FO00513B, 10.1039/c5fo00513b]; Chevallet M, 2006, ELECTROPHORESIS, V27, P1574, DOI 10.1002/elps.200500704; Cunningham KE, 2016, J BIOL CHEM, V291, P10184, DOI 10.1074/jbc.M115.688812; Dashdorj A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-178; Garcia JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075; Gardet A, 2012, CURR OPIN IMMUNOL, V24, P522, DOI 10.1016/j.coi.2012.08.001; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Heller S, 2016, AM J PHYSIOL-GASTR L, V310, pG844, DOI 10.1152/ajpgi.00407.2015; Heller S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073207; Hsieh SY, 2006, PROTEOMICS, V6, P5322, DOI 10.1002/pmic.200500541; Kepp O, 2011, NAT IMMUNOL, V12, P199, DOI 10.1038/ni0311-199; Kim A, 2015, TOX RESEARCH, V31, P323, DOI 10.5487/TR.2015.31.4.323; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kmiez Zbigniew, 1998, Archivum Immunologiae et Therapiae Experimentalis, V46, P143; Koh SJ, 2014, J GASTROEN HEPATOL, V29, P502, DOI 10.1111/jgh.12435; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kucharzik T, 2005, GUT, V54, P1565, DOI 10.1136/gut.2004.061168; Kukat A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn124; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JX, 2013, ADV IMMUNOL, V119, P135, DOI 10.1016/B978-0-12-407707-2.00005-9; LI K, 1995, AM J PHYSIOL-CELL PH, V269, pC1265, DOI 10.1152/ajpcell.1995.269.5.C1265; Lister R, 2005, MOL MEMBR BIOL, V22, P87, DOI 10.1080/09687860500041247; MEYER RR, 1969, BIOCHEM BIOPH RES CO, V34, P238, DOI 10.1016/0006-291X(69)90637-8; MUKAIDA N, 1991, ADV EXP MED BIOL, V305, P31; Oz HS, 2005, J NUTR BIOCHEM, V16, P297, DOI 10.1016/j.jnutbio.2004.09.007; Pagliarini DJ, 2013, GENE DEV, V27, P2615, DOI 10.1101/gad.229724.113; Park DW, 2014, AM J PHYSIOL-LUNG C, V307, pL735, DOI 10.1152/ajplung.00165.2014; Podolsky DK, 1997, J GASTROENTEROL, V32, P122, DOI 10.1007/BF01213309; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; ROEDIGER WEW, 1980, LANCET, V2, P712; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; Scharl M, 2009, J BIOL CHEM, V284, P27952, DOI 10.1074/jbc.M109.046292; Shekhawat PS, 2007, MOL GENET METAB, V92, P315, DOI 10.1016/j.ymgme.2007.08.002; Shkoda A, 2007, J PROTEOME RES, V6, P1114, DOI 10.1021/pr060433m; Sidoti-de Fraisse C, 1998, ONCOGENE, V17, P1639, DOI 10.1038/sj.onc.1202094; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Snoeks L, 2008, INFECT IMMUN, V76, P4677, DOI 10.1128/IAI.00227-08; Snoeks L, 2009, LAB INVEST, V89, P1053, DOI 10.1038/labinvest.2009.66; Szczepanowska J, 2012, BBA-BIOENERGETICS, V1817, P1740, DOI 10.1016/j.bbabio.2012.02.028; Tang GJ, 2011, FREE RADICAL BIO MED, V50, P1492, DOI 10.1016/j.freeradbiomed.2011.02.030; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Yu X, 2009, GENES IMMUN, V10, P601, DOI 10.1038/gene.2009.29; Zhang HJ, 2012, J GASTROEN HEPATOL, V27, P603, DOI 10.1111/j.1440-1746.2011.06879.x; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4	61	15	17	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2013	2025		10.1096/fj.201600976R	http://dx.doi.org/10.1096/fj.201600976R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28183804	Green Published			2022-12-26	WOS:000399195500022
J	Chen, YD; Porter, K; Osawa, M; Augustus, AM; Milam, SL; Joshi, C; Osteryoung, KW; Erickson, HP				Chen, Yaodong; Porter, Katie; Osawa, Masaki; Augustus, Anne Marie; Milam, Sara L.; Joshi, Chandra; Osteryoung, Katherine W.; Erickson, Harold P.			The Chloroplast Tubulin Homologs FtsZA and FtsZB from the Red Alga Galdieria sulphuraria Co-assemble into Dynamic Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVISION PROTEIN FTSZ; BACTERIAL-CELL-DIVISION; PLASTID DIVISION; IN-VITRO; ESCHERICHIA-COLI; HIGHER-PLANTS; EVOLUTION; RINGS; REORGANIZATION; POLYMERIZATION	FtsZ is a homolog of eukaryotic tubulin and is present in almost all bacteria and many archaea, where it is the major cytoskeletal protein in the Z ring, required for cell division. Unlike some other cell organelles of prokaryotic origin, chloroplasts have retained FtsZ as an essential component of the division machinery. However, chloroplast FtsZs have been challenging to study because they are difficult to express and purify. To this end, we have used a FATT tag expression system to produce as soluble proteins the two chloroplast FtsZs from Galdieria sulphuraria, a thermophilic red alga. GsFtsZA and GsFtsZB assembled individually in the presence of GTP, forming large bundles of protofilaments. GsFtsZA also assembled in the presence of GDP, the first member of the FtsZ/tubulin superfamily to do so. Mixtures of GsFtsZA and GsFtsZB assembled protofilament bundles and hydrolyzed GTP at a rate approximately equal to the sum of their individual rates, suggesting a random co-assembly. GsFtsZA assembly by itself in limiting GTP gave polymers that remained stable for a prolonged time. However, when GsFtsZB was added, the co-polymers disassembled with enhanced kinetics, suggesting that the GsFtsZB regulates and enhances disassembly dynamics. GsFtsZA-mts (where mts is a membrane-targeting amphipathic helix) formed Z ring-like helices when expressed in Escherichia coli. Co-expression of GsFtsZB (without an mts) gave co-assembly of both into similar helices. In summary, we provide biochemical evidence that GsFtsZA assembles as the primary scaffold of the chloroplast Z ring and that GsFtsZB co-assembly enhances polymer disassembly and dynamics.	[Chen, Yaodong] Northwest Univ, Coll Life Sci, Xian 710069, Shaanxi, Peoples R China; [Chen, Yaodong; Osawa, Masaki; Augustus, Anne Marie; Milam, Sara L.; Joshi, Chandra; Erickson, Harold P.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Porter, Katie; Osteryoung, Katherine W.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Joshi, Chandra] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA	Northwest University Xi'an; Duke University; Michigan State University; Cornell University	Erickson, HP (corresponding author), Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA.	h.erickson@cellbio.duke.edu	Chen, Yaodong/X-8923-2019	Chen, Yaodong/0000-0002-3751-0923	National Science Foundation [1121943]; National Institutes of Health [GM66014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066014] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant 1121943 (to K. W. O. and H. P. E.) and National Institutes of Health Grant GM66014 (to H. P. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Bisson AW, 2015, P NATL ACAD SCI USA, V112, pE2130, DOI 10.1073/pnas.1414242112; Chen YD, 2008, J BIOL CHEM, V283, P8102, DOI 10.1074/jbc.M709163200; Chen YD, 2011, BIOCHEMISTRY-US, V50, P4675, DOI 10.1021/bi200106d; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; El-Kafafi ES, 2005, BIOCHEM J, V387, P669, DOI 10.1042/BJ20041281; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; Kiefel BR, 2006, INT REV CYTOL, V254, P151, DOI 10.1016/S0074-7696(06)54004-5; Kiefel BR, 2004, PROTIST, V155, P105, DOI 10.1078/1434461000168; Lawlor D. W., 2001, PHOTOSYNTHESIS MOL P; Leger MM, 2015, P NATL ACAD SCI USA, V112, P10239, DOI 10.1073/pnas.1421392112; Lohse S, 2006, PLANT CELL PHYSIOL, V47, P1124, DOI 10.1093/pcp/pcj083; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Maple J, 2005, PLANT J, V43, P811, DOI 10.1111/j.1365-313X.2005.02493.x; Matsui T, 2012, ACTA CRYSTALLOGR D, V68, P1175, DOI 10.1107/S0907444912022640; McAndrew RS, 2001, PLANT PHYSIOL, V127, P1656, DOI 10.1104/pp.010542; Milam SL, 2012, BIOPHYS J, V103, P59, DOI 10.1016/j.bpj.2012.05.035; Miraldi ER, 2008, BIOPHYS J, V95, P2470, DOI 10.1529/biophysj.107.126219; Miyagishima S, 2010, CURR OPIN MICROBIOL, V13, P738, DOI 10.1016/j.mib.2010.10.004; Miyagishima SY, 2004, J MOL EVOL, V58, P291, DOI 10.1007/s00239-003-2551-1; Olson BJSC, 2010, J BIOL CHEM, V285, P20634, DOI 10.1074/jbc.M110.122614; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osteryoung KW, 2014, ANNU REV PLANT BIOL, V65, P443, DOI 10.1146/annurev-arplant-050213-035748; Osteryoung KW, 1998, PLANT CELL, V10, P1991, DOI 10.1105/tpc.10.12.1991; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; Sangawa T, 2013, PROTEIN SCI, V22, P840, DOI 10.1002/pro.2254; Santner AA, 2012, BIOCHEMISTRY-US, V51, P7250, DOI 10.1021/bi300653m; Sato M, 2007, PLANTA, V227, P177, DOI 10.1007/s00425-007-0605-0; Schmitz AJ, 2009, MOL PLANT, V2, P1211, DOI 10.1093/mp/ssp077; Schonknecht G, 2013, SCIENCE, V339, P1207, DOI 10.1126/science.1231707; Smith AG, 2010, FEBS LETT, V584, P166, DOI 10.1016/j.febslet.2009.11.044; Sontag CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007253; Strepp R, 1998, P NATL ACAD SCI USA, V95, P4368, DOI 10.1073/pnas.95.8.4368; Takahara M, 1999, PLANT CELL PHYSIOL, V40, P784, DOI 10.1093/oxfordjournals.pcp.a029606; Tan CM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003592; TerBush AD, 2012, J CELL BIOL, V199, P623, DOI 10.1083/jcb.201205114; Vitha S, 2003, PLANT CELL, V15, P1918, DOI 10.1105/tpc.013292; Vitha S, 2001, J CELL BIOL, V153, P111, DOI 10.1083/jcb.153.1.111; Yoshida Y, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.95, 10.1038/nplants.2016.95]; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	46	11	12	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5207	5215		10.1074/jbc.M116.767715	http://dx.doi.org/10.1074/jbc.M116.767715			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28174299	Green Published, hybrid			2022-12-26	WOS:000397875500005
J	Zych, K; Snoek, BL; Elvin, M; Rodriguez, M; Van der Velde, KJ; Arends, D; Westra, HJ; Swertz, MA; Poulin, G; Kammenga, JE; Breitling, R; Jansen, RC; Li, Y				Zych, Konrad; Snoek, Basten L.; Elvin, Mark; Rodriguez, Miriam; Van der Velde, K. Joeri; Arends, Danny; Westra, Harm-Jan; Swertz, Morris A.; Poulin, Gino; Kammenga, Jan E.; Breitling, Rainer; Jansen, Ritsert C.; Li, Yang			reGenotyper: Detecting mislabeled samples in genetic data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NATURAL VARIATION DATA; C. ELEGANS; MIX-UPS; EXPRESSION; QTL; DISEASE; IDENTIFICATION; PERTURBATION; POPULATIONS	In high-throughput molecular profiling studies, genotype labels can be wrongly assigned at various experimental steps; the resulting mislabeled samples seriously reduce the power to detect the genetic basis of phenotypic variation. We have developed an approach to detect potential mislabeling, recover the "ideal" genotype and identify "best-matched " labels for mislabeled samples. On average, we identified 4% of samples as mislabeled in eight published datasets, highlighting the necessity of applying a "data cleaning" step before standard data analysis.	[Zych, Konrad; Arends, Danny; Jansen, Ritsert C.; Li, Yang] Univ Groningen, Groningen Bioinformat Ctr, Groningen, Netherlands; [Snoek, Basten L.; Rodriguez, Miriam; Kammenga, Jan E.] Wageningen Univ, Nematol Lab, Wageningen, Netherlands; [Elvin, Mark; Poulin, Gino] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Van der Velde, K. Joeri; Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, Genom Coordinat Ctr, Groningen, Netherlands; [Westra, Harm-Jan] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Westra, Harm-Jan] Brigham & Womens Hosp, Dept Med, Div Rheumatol, 75 Francis St, Boston, MA 02115 USA; [Westra, Harm-Jan] Harvard Med Sch, Boston, MA USA; [Westra, Harm-Jan] Partners Ctr Personalized Genet Med, Boston, MA USA; [Westra, Harm-Jan] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Breitling, Rainer] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester, Lancs, England; [Li, Yang] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	University of Groningen; Wageningen University & Research; University of Manchester; University of Groningen; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Manchester; University of Groningen	Li, Y (corresponding author), Univ Groningen, Groningen Bioinformat Ctr, Groningen, Netherlands.; Li, Y (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	yang.li@rug.nl	Arends, Danny/C-5368-2012; Li, Yang/HGT-8446-2022; Snoek, Basten L/E-4713-2014	Arends, Danny/0000-0001-8738-0162; Li, Yang/0000-0003-4022-7341; Snoek, Basten L/0000-0001-5321-2996; Breitling, Rainer/0000-0001-7173-0922; Poulin, Gino/0000-0003-1016-348X	7th Framework Programme of the European Commission under the Research Project PANACEA [222936]; Netherlands Organisation for Scientific Research (NWO) VENI grant [863.13.011]; Dutch Carbohydrate Competence Center; European Regional Development Fund; Dutch Ministry of Economic Affairs; Municipality of Groningen; Province of Groningen [CCC WP23]	7th Framework Programme of the European Commission under the Research Project PANACEA; Netherlands Organisation for Scientific Research (NWO) VENI grant(Netherlands Organization for Scientific Research (NWO)); Dutch Carbohydrate Competence Center; European Regional Development Fund(European Commission); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Municipality of Groningen; Province of Groningen	This work was supported by the 7th Framework Programme of the European Commission under the Research Project PANACEA [Contract No. 222936 to RCJ and JEK]; the Netherlands Organisation for Scientific Research (NWO) VENI grant [no 863.13.011 to YL]; and the Dutch Carbohydrate Competence Center, which is is co-financed by the European Regional Development Fund, the Dutch Ministry of Economic Affairs (as part of Pieken in de Delta, the governments regional economic agenda), the Municipality of Groningen and the Province of Groningen [CCC WP23 to KZ] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert FW, 2014, NATURE, V506, P494, DOI 10.1038/nature12904; Arends D, 2012, BIOINFORMATICS, V28, P1042, DOI 10.1093/bioinformatics/bts049; Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Baggerly KA, 2009, ANN APPL STAT, V3, P1309, DOI 10.1214/09-AOAS291; Baute J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0735-9; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Broman KW, 2015, G3-GENES GENOM GENET, V5, P2177, DOI 10.1534/g3.115.019778; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buyske S, 2009, HUM HERED, V67, P287, DOI 10.1159/000194981; Danjou F, 2015, NAT GENET, V47, P1264, DOI 10.1038/ng.3307; Draisma HHM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8208; Ekstrom CT, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1772; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Gutteling EW, 2006, HEREDITY; JANSEN RC, 1994, GENETICS, V138, P871; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jansen RC, 2007, HDB STAT GENETICS, P589; Li Y, 2008, TRENDS GENET, V24, P518, DOI 10.1016/j.tig.2008.08.001; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Li Y, 2010, TRENDS GENET, V26, P493, DOI 10.1016/j.tig.2010.09.002; Lynch AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041815; Neto EC, 2008, GENETICS, V179, P1089, DOI 10.1534/genetics.107.085167; Ongen H, 2014, NATURE, V512, P87, DOI 10.1038/nature13602; Peirce JL, 2006, MAMM GENOME, V17, P643, DOI 10.1007/s00335-005-0187-8; Raffler J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005487; Rockman MV, 2010, SCIENCE, V330, P372, DOI 10.1126/science.1194208; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2012, NAT GENET, V44, P603, DOI 10.1038/ng.2248; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Snoek LB, 2013, NUCLEIC ACIDS RES, V41, pD738, DOI 10.1093/nar/gks1124; van der Velde KJ, 2014, NUCLEIC ACIDS RES, V42, pD794, DOI 10.1093/nar/gkt1044; Vinuela A, 2010, GENOME RES, V20, P929, DOI 10.1101/gr.102160.109; Westra HJ, 2011, BIOINFORMATICS, V27, P2104, DOI 10.1093/bioinformatics/btr323; Zhang XL, 2015, NAT GENET, V47, P345, DOI 10.1038/ng.3220	35	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171324	10.1371/journal.pone.0171324	http://dx.doi.org/10.1371/journal.pone.0171324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192439	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800019
J	Arranz, FJ; Peinado, JM				Arranz, F. J.; Peinado, J. M.			A mesoscopic stochastic model for the specific consumption rate in substrate-limited microbial growth	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; KINETICS; TRANSPORTERS; CULTURES	The specific consumption rate of substrate, as well as the associated specific growth rate, is an essential parameter in the mathematical description of substrate-limited microbial growth. In this paper we develop a completely new kinetic model of substrate transport, based on recent knowledge on the structural biology of transport proteins, which correctly describes very accurate experimental results at near-zero substrate concentration values found in the literature, where the widespread Michaelis-Menten model fails. Additionally, our model converges asymptotically to Michaelis-Menten predictions as substrate concentration increases. Instead of the single active site enzymatic reaction of Michaelis-Menten type, the proposed model assumes a multi-site kinetics, simplified as an apparent all-or-none mechanism for the transport, which is controlled by means of the local substrate concentration in the close vicinity of the transport protein. Besides, the model also assumes that this local concentration is not equal to the mean substrate concentration experimentally determined in the culture medium. Instead, we propose that it fluctuates with a mostly exponential distribution of Weibull type.	[Arranz, F. J.] UPM, Grp Sist Complejos, Av Puerta Hierro 2-4, Madrid 28040, Spain; [Peinado, J. M.] UCM, Fac Biol, Dept Microbiol III, Madrid 28040, Spain; [Arranz, F. J.; Peinado, J. M.] UCM UPM, CEI Campus Moncloa, Madrid, Spain	Universidad Politecnica de Madrid; Complutense University of Madrid; Universidad Politecnica de Madrid	Arranz, FJ (corresponding author), UPM, Grp Sist Complejos, Av Puerta Hierro 2-4, Madrid 28040, Spain.; Peinado, JM (corresponding author), UCM, Fac Biol, Dept Microbiol III, Madrid 28040, Spain.; Arranz, FJ; Peinado, JM (corresponding author), UCM UPM, CEI Campus Moncloa, Madrid, Spain.	fj.arranz@upm.es; jpeinado@ucm.es	Saiz, Francisco Javier Arranz/N-7377-2013	Saiz, Francisco Javier Arranz/0000-0003-1270-0701	Ministry of Economy and Competitiveness-Spain [MTM2015-63914, AGL2014-53928]	Ministry of Economy and Competitiveness-Spain	This research was supported by the Ministry of Economy and Competitiveness-Spain under Grants No. MTM2015-63914 and No. AGL2014-53928.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BIOCHEMISTRY-US, V50, P8264, DOI [10.1021/bi201284u], DOI 10.1021/BI201284U]; Boender LGM, 2009, APPL ENVIRON MICROB, V75, P5607, DOI 10.1128/AEM.00429-09; BUTTON DK, 1993, ANTON LEEUW INT J G, V63, P225, DOI 10.1007/BF00871220; Chaplin MF., 1990, EC ARGUMENT IMMOBILI, P80; Conde A, 2010, INT J BIOCHEM CELL B, V42, P857, DOI 10.1016/j.biocel.2009.12.012; Diallinas G, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00207; Diderich JA, 1999, J BIOL CHEM, V274, P15350, DOI 10.1074/jbc.274.22.15350; Hill AV, 1910, J PHYSL, V40, piv, DOI DOI 10.1371/JOURNAL.PONE.0041098; Michaelis L, 1913, BIOCHEM Z, V49, P333; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Naftalin RJ, 2010, J MEMBRANE BIOL, V234, P75, DOI 10.1007/s00232-010-9228-7; Ribes J, 2004, WATER RES, V38, P4502, DOI 10.1016/j.watres.2004.08.017; Roels JA, 1983, ENERGETICS KINETICS, P237; Snoep JL, 2009, MICROBIOL-SGM, V155, P1699, DOI 10.1099/mic.0.023119-0; VANUDEN N, 1969, ANNU REV MICROBIOL, V23, P473; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Westrhoff HV, 1987, THERMODYNAMICS CONTR, P343; Yu L, 2007, APPL MICROBIOL BIOT, V73, P1241, DOI 10.1007/s00253-006-0717-7	18	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171717	10.1371/journal.pone.0171717	http://dx.doi.org/10.1371/journal.pone.0171717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187189	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000394244300039
J	Evans, RK; Toews, MD; Sial, AA				Evans, Richard K.; Toews, Michael D.; Sial, Ashfaq A.			Diel periodicity of Drosophila suzukii (Diptera: Drosophilidae) under field conditions	PLOS ONE			English	Article							SPOTTED-WING DROSOPHILA; CREPUSCULAR ACTIVITY; POPULATION-GROWTH; TEMPERATURE; MELANOGASTER; OVIPOSITION; HUMIDITY; LIGHT; RESISTANCE; MOONLIGHT	Drosophila suzukii Matsumura (Diptera: Drosophilidae), an economically important pest of blueberry and other thin-skinned fruits, persists and prolifically reproduces under seemingly lethal climatic conditions in the field. However, behavioral and physiological mechanisms employed by D. suzukii to tolerate such extreme climatic conditions in the field are unknown. The primary objective of this project was to investigate diel periodicity of D. suzukii and their reproductive success under field conditions as related by climatic factors such as temperature and relative humidity. Results show that D. suzukii reproductive success was significantly higher during the night (including dawn and dusk periods) than the day in terms of oviposition, pupation, adult eclosion, and the number of progeny per female. Female D. suzukii reproductive success was not significantly different between specific regions of a blueberry bush in relation to the amount of shade provided by the canopy. Our studies indicate that D. suzukii flight activity is crepuscular and is sensitive to fluctuations in temperature and relative humidity. Results also suggest that the majority of fly activity during peak hours is concentrated in areas around the border and within the center of blueberry orchards with little activity in the surrounding wooded areas. These findings suggest that D. suzukii prefers microclimate with mild temperatures and high humidity, and does not function well when exposed to direct sunlight with extreme heat. The authors propose that D. suzukii management strategies should be implemented during the early morning and immediately before darkness to maximize efficacy.	[Evans, Richard K.; Toews, Michael D.; Sial, Ashfaq A.] Univ Georgia, Coll Agr & Environm Sci, Dept Entomol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Sial, AA (corresponding author), Univ Georgia, Coll Agr & Environm Sci, Dept Entomol, Athens, GA 30602 USA.	ashsial@uga.edu		Toews, Michael D./0000-0003-1880-5926; Sial, Ashfaq/0000-0001-5471-1818	U.S. Department of Agriculture, National Institute of Food and Agriculture under Specialty Crop Research Initiative [2015-5 1181-24252]; Organic Agriculture Research and Extension Initiative [2015-51300-24154]; Extension Implementation Program [2014-70006-22533]; Georgia Blueberry Growers Association; Georgia Agricultural Commodity Commission	U.S. Department of Agriculture, National Institute of Food and Agriculture under Specialty Crop Research Initiative; Organic Agriculture Research and Extension Initiative; Extension Implementation Program; Georgia Blueberry Growers Association; Georgia Agricultural Commodity Commission	This research was partially supported by grants from the U.S. Department of Agriculture, National Institute of Food and Agriculture under Specialty Crop Research Initiative (Award # 2015-5 1181-24252), Organic Agriculture Research and Extension Initiative (Award # 2015-51300-24154), Extension Implementation Program (Award # 2014-70006-22533), Georgia Blueberry Growers Association, and Georgia Agricultural Commodity Commission for Blue berries to AAS.	Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bolda M., 2011, UCANR BLOG; Bubliy OA, 2012, J EVOLUTION BIOL, V25, P1180, DOI 10.1111/j.1420-9101.2012.02506.x; Chen Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/504896; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; Currie J, 2009, BMC BIOL, V7, P19, DOI [10.1038/nature10991, DOI 10.1038/NATURE10991]; Dalton DT, 2011, PEST MANAG SCI, V67, P1368, DOI 10.1002/ps.2280; David JR, 2005, J EVOLUTION BIOL, V18, P838, DOI 10.1111/j.1420-9101.2005.00914.x; De J, 2012, J BIOL RHYTHM, V27, P280, DOI 10.1177/0748730412448360; Diepenbrock LM, 2016, CROP PROT, V81, P76, DOI 10.1016/j.cropro.2015.12.012; Doge JD, 2015, BIOL INVASIONS, V17, P2461, DOI 10.1007/s10530-015-0889-0; eFly Group, 2012, SPOTTED WING DROSOPH, V1, P8; Emiljanowicz LM, 2014, J ECON ENTOMOL, V107, P1392, DOI 10.1603/EC13504; Fasolo AG, 2004, BIOL J LINN SOC, V83, P197, DOI 10.1111/j.1095-8312.2004.00380.x; Flerchinger GN, 2015, AGR FOREST METEOROL, V213, P251, DOI 10.1016/j.agrformet.2015.07.007; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Hamby KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068472; Hardin JA, 2015, ENTOMOL EXP APPL, V156, P59, DOI 10.1111/eea.12311; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Hoffmann AA, 2003, J EVOLUTION BIOL, V16, P614, DOI 10.1046/j.1420-9101.2003.00561.x; Kempinger L, 2009, CHRONOBIOL INT, V26, P151, DOI 10.1080/07420520902747124; Ki Y, 2015, NEUROSCIENTIST, V21, P503, DOI 10.1177/1073858415577083; Kinjo H, 2013, J ECON ENTOMOL, V106, P1767, DOI 10.1603/EC12505; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Lin QC, 2014, FLA ENTOMOL, V97, P1434, DOI 10.1653/024.097.0418; Liu SS, 1999, B ENTOMOL RES, V89, P53, DOI 10.1017/S0007485399000073; Mainali BP, 2015, J STORED PROD RES, V63, P47, DOI 10.1016/j.jspr.2015.05.008; McQuate GT, 2013, J ASIA-PAC ENTOMOL, V16, P1, DOI 10.1016/j.aspen.2012.08.003; Muller GA, 2012, REV BRAS ENTOMOL, V56, P111, DOI 10.1590/S0085-56262012005000006; Overgaard J, 2011, J THERM BIOL, V36, P409, DOI 10.1016/j.jtherbio.2011.07.005; Petavy G, 2001, J THERM BIOL, V26, P29, DOI 10.1016/S0306-4565(00)00022-X; Rivas GBS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-278; Roets F, 2013, J INSECT CONSERV, V17, P279, DOI 10.1007/s10841-012-9507-y; Roubos CR, 2010, FLA ENTOMOL, V93, P283, DOI 10.1653/024.093.0220; Schlichting M, 2015, J BIOL RHYTHM, V30, P117, DOI 10.1177/0748730415575245; Singh K, 2015, PLOS ONE, V10; Soares Felipe Augusto, 2015, Revista de Patologia Tropical, V44, P77, DOI 10.5216/rpt.v44i1.34817; Suter RB, 2014, J ARACHNOL, V42, P178, DOI 10.1636/J13-66.1; Tochen S, 2014, ENVIRON ENTOMOL, V43, P501, DOI 10.1603/EN13200; Turner JRG, 2013, BIOL J LINN SOC, V110, P305, DOI 10.1111/bij.12145; Van Timmeren S, 2013, CROP PROT, V54, P126, DOI 10.1016/j.cropro.2013.08.003; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Wei J, 2015, J ECON ENTOMOL, V108, P1915, DOI 10.1093/jee/tov135; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Wiman NG, 2014, PLOS ONE, V9, P14; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Zar J. H., 1999, BIOSTATISTICAL ANALY	47	39	40	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171718	10.1371/journal.pone.0171718	http://dx.doi.org/10.1371/journal.pone.0171718			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187140	gold, Green Published, Green Submitted			2022-12-26	WOS:000394244300040
J	Kok, PH; Akhir, MFM; Tangang, F; Husain, ML				Kok, Poh Heng; Akhir, Mohd Fadzil Mohd; Tangang, Fredolin; Husain, Mohd Lokman			Spatiotemporal trends in the southwest monsoon wind-driven upwelling in the southwestern part of the South China Sea	PLOS ONE			English	Article							INTERANNUAL VARIABILITY; SURFACE TEMPERATURE; NORTHWEST AFRICA; SYSTEM; COAST; CIRCULATION; WESTERN; STRESS	This study analyzes two wind-induced upwelling mechanisms, namely, Ekman transport and Ekman pumping that occur during the southwest monsoon. The results suggest that the coastline of the east coast of Peninsular Malaysia (ECPM) is affected by upwelling with spatiotemporal variations. Characterization of upwelling by using wind-induced upwelling indexes (UIw) indicate the existence of favorable upwelling conditions from May to September. Upwelling intensity increased in May and peaked in August before declining in September, decreasing intensity from the southern tip towards the northern tip along the coastline of the ECPM. The existence of upwelling along the ECPM has resulted in an important difference between the SSTs of the inshore and the oceanic regions. Nonetheless, the use of the SST gradient between the inshore and the oceanic SSTs to characterize upwelling (U/ssT) was found to be unsuitable because the SST along the ECPM was affected by water advection from the Java Sea and incessant changes in the SST. In order to indicate the major contributor of wind-induced upwelling along the ECPM in terms of the spatiotemporal scale, a comparison between Ekman transport and Ekman pumping was drawn by integrating Ekman pumping with respect to the distance where the positive wind stress curl existed. The estimation of Ekman transport and Ekman pumping indicated that Ekman pumping played a major role in contributing towards upwelling in any particular month during the southwest monsoon along the entire coastline of the ECPM as compared to Ekman transport, which contributed towards more than half of the total upwelling transport. By dividing the ECPM into three coastal sections, we observed that Ekman pumping was relatively predominant in the middle and northern coasts, whereas both Ekman transport and Ekman pumping were equally prevalent in the southern coast.	[Kok, Poh Heng; Akhir, Mohd Fadzil Mohd; Husain, Mohd Lokman] Univ Malaysia Terengganu, Inst Oceanog & Environm, Kuala Terengganu, Terengganu, Malaysia; [Tangang, Fredolin] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Bangi, Selangor, Malaysia; [Husain, Mohd Lokman] Univ Malaysia Terengganu, Sch Marine & Environm Sci, Kuala Terengganu, Terengganu, Malaysia	Universiti Malaysia Terengganu; Universiti Kebangsaan Malaysia; Universiti Malaysia Terengganu	Akhir, MFM (corresponding author), Univ Malaysia Terengganu, Inst Oceanog & Environm, Kuala Terengganu, Terengganu, Malaysia.	mfadzil@umt.edu.my	Tangang, Fredolin/ABA-4058-2020; Kok, Poh Heng/D-8605-2015; Akhir, Mohd Fadzil/AAC-3711-2019	Tangang, Fredolin/0000-0002-4919-1800; Kok, Poh Heng/0000-0002-2570-6291; Akhir, Mohd Fadzil/0000-0003-2055-1988	Science Fund, Ministry of Science, Technology and Innovation (MOSTI); Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education Malaysia [04-01-02-SF0747]; Higher Institution Center of Excellence (HICoE) of Institute of Oceanography and Environment (INOS), Universiti Malaysia Terengganu (UMT)	Science Fund, Ministry of Science, Technology and Innovation (MOSTI); Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); Higher Institution Center of Excellence (HICoE) of Institute of Oceanography and Environment (INOS), Universiti Malaysia Terengganu (UMT)	This study was supported by the Science Fund, Ministry of Science, Technology and Innovation (MOSTI), 04-01-02-SF0747 and Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education Malaysia, FRGS/1/2015/WAB09/UMT/03/2 for data collection and analysis; Higher Institution Center of Excellence (HICoE) of Institute of Oceanography and Environment (INOS), Universiti Malaysia Terengganu (UMT), TJ 66928 for supporting data collection and analysis and preparation of the manuscript.	Akhir M. F., 2014, INT J OCEANOGR, V2014, P1; Akhir M.F., 2015, OPEN J MAR SCI, V5, P273, DOI [10.4236/ojms.2015.53022, DOI 10.4236/OJMS.2015.53022]; Alvarez I, 2011, CONT SHELF RES, V31, P388, DOI 10.1016/j.csr.2010.07.009; [Anonymous], 2009, J GEOPHYS RES, V1, P1; Aristegui J, 2009, PROG OCEANOGR, V83, P33, DOI 10.1016/j.pocean.2009.07.031; Bakun A., 1977, CALCOFI REPORTS, V19, P107; Bakun A., 1973, SSRF671 NOAA NMFS; Belkin IM, 2007, ICES ANN SCI C HELS, P1; Berrisford P, 2009, ERA REP SER, P1; Castelao RM, 2012, J PHYS OCEANOGR, V42, P2073, DOI 10.1175/JPO-D-11-0224.1; Castelao RM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025182; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; Chereskin TK, 2009, OCEAN CURRENTS, P525; Chu PC, 1998, J GEOPHYS RES-OCEANS, V103, P21637, DOI 10.1029/98JC02096; Cole J, 2000, INT J REMOTE SENS, V21, P1597, DOI 10.1080/014311600209922; Cropper TE, 2014, DEEP-SEA RES PT I, V86, P94, DOI 10.1016/j.dsr.2014.01.007; Daryabor F, 2014, SAINS MALAYS, V43, P389; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Dippner JW, 2007, OCEAN DYNAM, V57, P46, DOI 10.1007/s10236-006-0091-0; ECMWF, 2007, CY31R1 IFS ECMWF, P1; Ekman VW., 1905, ARKIV MAT ASTRON FIZ, V2, P1; FANG G, 2006, J GEOPHYS RES, V111, P1; Feldman GC, 2014, OCEAN COLOR WEB; Gan JP, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2007JC004660; Garrison T., 2007, OCEANOGRAPHY INVITAT; Gomez-Gesteira M, 2008, ANN NY ACAD SCI, V1146, P320, DOI 10.1196/annals.1446.004; Huang QZ, 1994, CEANOGRAPHY CHINA SE, V1, P39; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; Jayaram Chiranjivi, 2010, Ocean Science Journal, V45, P27, DOI 10.1007/s12601-010-0003-6; Jing Z, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007142; Jing ZY, 2009, CONT SHELF RES, V29, P467, DOI 10.1016/j.csr.2008.11.008; Kok PH, 2015, CONT SHELF RES, V110, P1, DOI 10.1016/j.csr.2015.09.010; Kuo NJ, 2004, REMOTE SENS ENVIRON, V89, P106, DOI 10.1016/j.rse.2003.10.009; Kuo NJ, 2000, REMOTE SENS ENVIRON, V74, P463, DOI 10.1016/S0034-4257(00)00138-3; Lehmann A, 2008, J MARINE SYST, V74, pS3, DOI 10.1016/j.jmarsys.2008.02.010; Mann KH, 2006, DYNAMICS MARINE ECOS; Morgan J.R., 1983, ATLAS MARINE POLICY, P4; *NOAA, 2006, 2 MIN GRIDD GLOB REL; NYKJAER L, 1994, J GEOPHYS RES-OCEANS, V99, P14197, DOI 10.1029/94JC00814; Perez-Santos I, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006292; Pickett MH, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001902; Pohlmann T., 1987, 3 DIMENSIONAL MODELS, P245, DOI 10.1016/S0422-9894(08)70451-3; Pond S., 1983, INTRO DYNAMICAL OCEA; Roxy M, 2012, CLIM DYNAM, V39, P1209, DOI 10.1007/s00382-011-1118-x; Santos AMP, 2005, J MAR RES, V63, P359, DOI 10.1357/0022240053693671; Segar D. A., 2007, INTRO OCEAN SCI; SHAW PT, 1994, DEEP-SEA RES PT I, V41, P1663, DOI 10.1016/0967-0637(94)90067-1; SMITH R L, 1968, Oceanography and Marine Biology an Annual Review, V6, P11; Sverdrup H.U., 1942, OCEANS THEIR PHYS CH, P1065; Taira K., 1996, MALAYS J OCEANOGR, V52, P251, DOI [10.1007/BF02235673, DOI 10.1007/BF02235673]; TALLEY L., 2011, DESCRIPTIVE PHYS OCE; Thurman H. V., 2004, INTRO OCEANOGRAPHY; TRENBERTH KE, 1990, J PHYS OCEANOGR, V20, P1742, DOI 10.1175/1520-0485(1990)020<1742:TMACIG>2.0.CO;2; Wang D, 2012, J GEOPHYS RES, V117, P1; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Wyrtki K., 1961, PHYS OCEANOGRAPHY SE; Xie SP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001867; Yoshida K., 1995, REC OCEANOGR WORKS J, V2, P8	59	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171979	10.1371/journal.pone.0171979	http://dx.doi.org/10.1371/journal.pone.0171979			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187215	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300065
J	Shin, SS; Song, JH; Hwang, B; Noh, DH; Park, SL; Kim, WT; Park, SS; Kim, WJ; Moon, SK				Shin, Seung-Shick; Song, Jun-Hui; Hwang, Byungdoo; Noh, Dae-Hwa; Park, Sung Lyea; Kim, Won Tae; Park, Sung-Soo; Kim, Wun-Jae; Moon, Sung-Kwon			HSPA6 augments garlic extract-induced inhibition of proliferation, migration, and invasion of bladder cancer EJ cells; Implication for cell cycle dysregulation, signaling pathway alteration, and transcription factor-associated MMP-9 regulation	PLOS ONE			English	Article							UP-REGULATION; DIALLYL TRISULFIDE; EXPRESSION; GROWTH; ACTIVATION; APOPTOSIS; INACTIVATION; SUPPRESSES	Although recent studies have demonstrated the anti-tumor effects of garlic extract (GE), the exact molecular mechanism is still unclear. In this study, we investigated the molecular mechanism associated with the inhibitory action of GE against bladder cancer EJ cell responses. Treatment with GE significantly inhibited proliferation of EJ cells dose-dependently through G2/M-phase cell cycle arrest. This G2/M-phase cell cycle arrest by GE was due to the activation of ATM and CHK2, which appears to inhibit phosphorylation of Cdc25C (Ser216) and Cdc2 (Thr14/Tyr15), this in turn was accompanied by down-regulation of cyclin B1 and up-regulation of p21WAF1. Furthermore, GE treatment was also found to induce phosphorylation of MAPK (ERK1/2, p38MAPK, and JNK) and AKT. In addition, GE impeded the migration and invasion of EJ cells via inhibition of MMP-9 expression followed by decreased binding activities of AP-1, Sp-1, and NF-KB motifs. Based on microarray data sets, we selected Heat shock protein A6 (HSPA6) as the most up-regulated gene responsible for the inhibitory effects of GE. Interestingly, overexpression of HSPA6 gene resulted in an augmentation effect with GE inhibiting proliferation, migration, and invasion of EJ cells. The augmentation effect of HSPA6 was verified by enhancing the induction of G2/M-phasemediated ATM-CHK2-Cdc25C-p21WAF1-Cdc2 cascade, phosphorylation of MAPK and AKT signaling, and suppression of transcription factor-associated MMP-9 regulation in response to GE in EJ cells. Overall, our novel results indicate that HSPA6 reinforces the GE-mediated inhibitory effects of proliferation, migration, and invasion of EJ cells and may provide a new approach for therapeutic treatment of malignancies.	[Shin, Seung-Shick; Park, Sung-Soo] Jeju Natl Univ, Dept Food Sci & Nutr, Jeju, South Korea; [Song, Jun-Hui; Hwang, Byungdoo; Noh, Dae-Hwa; Park, Sung Lyea; Moon, Sung-Kwon] Chung Ang Univ, Dept Food & Nutr, Anseong, South Korea; [Kim, Won Tae; Kim, Wun-Jae] Chungbuk Natl Univ, Dept Urol, Cheongju, Chungbuk, South Korea	Jeju National University; Chung Ang University; Chungbuk National University	Moon, SK (corresponding author), Chung Ang Univ, Dept Food & Nutr, Anseong, South Korea.	sumoon66@dreamwiz.com		Shin, Seung-Shick/0000-0002-8536-2056	National Research Foundation of Korea (NRF) - government of Korea (MSIP) [2014007036]	National Research Foundation of Korea (NRF) - government of Korea (MSIP)(National Research Foundation of Korea)	This study was supported by a National Research Foundation of Korea (NRF) grant by the government of Korea (MSIP) (no. 2014007036), http://www.nrf.re.kr/.	Bianco FJ, 1998, CLIN CANCER RES, V4, P3011; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Calvo-Gomez O, 2004, J CHROMATOGR A, V1036, P91, DOI 10.1016/j.chroma.2004.02.072; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Cho TM, 2014, FOOD CHEM TOXICOL, V64, P344, DOI 10.1016/j.fct.2013.12.009; Das A, 2007, CANCER-AM CANCER SOC, V110, P1083, DOI 10.1002/cncr.22888; DAVIES B, 1993, CANCER RES, V53, P5365; Dong MH, 2014, BIOMED REP, V2, P250, DOI 10.3892/br.2014.226; Hosono T, 2005, J BIOL CHEM, V280, P41487, DOI 10.1074/jbc.M507127200; Huang J, 2015, MOL NUTR FOOD RES, V59, P1063, DOI 10.1002/mnfr.201400668; IBERL B, 1990, PLANTA MED, V56, P320, DOI 10.1055/s-2006-961198; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Khalouei S, 2014, CELL STRESS CHAPERON, V19, P321, DOI 10.1007/s12192-013-0459-2; Kim KH, 2013, INT J MOL MED, V32, P67, DOI 10.3892/ijmm.2013.1362; Lai KC, 2013, ENVIRON TOXICOL, V28, P479, DOI 10.1002/tox.20737; Lee SJ, 2013, J BIOL CHEM, V288, P5539, DOI 10.1074/jbc.M112.410233; Lee SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040267; Liu Y, 2015, J SENSORS, V2015, DOI 10.1155/2015/903981; Luke C, 2010, INTERN MED J, V40, P357, DOI 10.1111/j.1445-5994.2009.01980.x; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; Noonan EJ, 2007, CELL STRESS CHAPERON, V12, P393, DOI 10.1379/CSC-278e.1; Nutt JE, 2003, BJU INT, V91, P99, DOI 10.1046/j.1464-410X.2003.04020.x; Qiu LH, 2006, ONCOL REP, V16, P907; Ramirez VP, 2015, CELL STRESS CHAPERON, V20, P95, DOI 10.1007/s12192-014-0529-0; Redondo-Gonzalez E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/168682; Reis ST, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-18; SATO H, 1993, ONCOGENE, V8, P395; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Seiler R, 2011, J CLIN PATHOL, V64, P1078, DOI 10.1136/jclinpath-2011-200153; Suda S, 2014, BIOSCI BIOTECH BIOCH, V78, P1415, DOI 10.1080/09168451.2014.921563; Tang HL, 2013, CANCER LETT, V340, P72, DOI 10.1016/j.canlet.2013.06.027; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang YM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-8	34	35	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171860	10.1371/journal.pone.0171860	http://dx.doi.org/10.1371/journal.pone.0171860			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187175	gold, Green Published, Green Submitted			2022-12-26	WOS:000394244300053
J	Datson, NA; Gonzalez-Barriga, A; Kourkouta, E; Weij, R; van de Giessen, J; Mulders, S; Kontkanen, O; Heikkinen, T; Lehtimaki, K; van Deutekom, JCT				Datson, Nicole A.; Gonzalez-Barriga, Anchel; Kourkouta, Eleni; Weij, Rudie; van de Giessen, Jeroen; Mulders, Susan; Kontkanen, Outi; Heikkinen, Taneli; Lehtimaki, Kimmo; van Deutekom, Judith C. T.			The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain	PLOS ONE			English	Article							MUTANT HUNTINGTIN; SEX-DIFFERENCES; DISEASE; PHENOTYPE; MODELS; PROGRESSION; INHIBITION; MECHANISMS; STRIATUM; DARPP-32	The aim of these studies was to demonstrate the therapeutic capacity of an antisense oligonucleotide with the sequence (CUG) 7 targeting the expanded CAG repeat in huntingtin (HTT) mRNA in vivo in the R6/2 N-terminal fragment and Q175 knock-in Huntington's disease (HD) mouse models. In a first study, R6/2 mice received six weekly intracerebroventricular infusions with a low and high dose of (CUG) 7 and were sacrificed 2 weeks later. A 15-60% reduction of both soluble and aggregated mutant HTT protein was observed in striatum, hippocampus and cortex of (CUG) 7-treated mice. This correction at the molecular level resulted in an improvement of performance in multiple motor tasks, increased whole brain and cortical volume, reduced levels of the gliosis marker myo-inositol, increased levels of the neuronal integrity marker N-aceyl aspartate and increased mRNA levels of the striatal marker Darpp-32. These neuroanatomical and neurochemical changes, together with the improved motor performance, suggest that treatment with (CUG) 7 ameliorates basal ganglia dysfunction. The HTT-lowering was confirmed by an independent study in Q175 mice using a similar (CUG) 7 AON dosing regimen, further demonstrating a lasting reduction of mutant HTT protein in striatum, hippocampus and cortex for up to 18 weeks post last infusion along with an increase in motor activity. Based on these encouraging results, (CUG) 7 may thus offer an interesting alternative HTT-lowering strategy for HD.	[Datson, Nicole A.; Gonzalez-Barriga, Anchel; Kourkouta, Eleni; Weij, Rudie; van de Giessen, Jeroen; Mulders, Susan; van Deutekom, Judith C. T.] BioMarin Nederland BV, Leiden, Netherlands; [Kontkanen, Outi; Heikkinen, Taneli; Lehtimaki, Kimmo] Charles River Discovery Res Serv, Kuopio, Finland		Datson, NA (corresponding author), BioMarin Nederland BV, Leiden, Netherlands.	nicole.datson@bmm.com	Lehtimäki, Kimmo K/A-6018-2009; Datson, Nicole A./O-8797-2014; González-Barriga, Anchel/G-5765-2016	Lehtimäki, Kimmo K/0000-0003-2750-8229; González-Barriga, Anchel/0000-0001-7072-5494; Datson, Nicole/0000-0003-2887-0238; Kourkouta, Eleni/0000-0002-6178-0712				Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; Bettencourt C, 2010, NEUROGENETICS, V11, P193, DOI 10.1007/s10048-009-0216-y; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Busan S, 2013, BIOCHEMISTRY-US, V52, P8219, DOI 10.1021/bi401129r; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Cepeda-Prado E, 2012, J NEUROSCI, V32, P6456, DOI 10.1523/JNEUROSCI.0388-12.2012; Cummings DM, 2009, J NEUROSCI, V29, P10371, DOI 10.1523/JNEUROSCI.1592-09.2009; Dorner JL, 2007, BEHAV BRAIN RES, V178, P90, DOI 10.1016/j.bbr.2006.12.004; Evers MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024308; Frank S, 2014, NEUROTHERAPEUTICS, V11, P153, DOI 10.1007/s13311-013-0244-z; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Jenkins BG, 2000, J NEUROCHEM, V74, P2108, DOI 10.1046/j.1471-4159.2000.0742108.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Markianos M, 2005, ANN NEUROL, V57, P520, DOI 10.1002/ana.20428; Menalled L, 2014, MOVEMENT DISORD, V29, P1375, DOI 10.1002/mds.26006; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; MYERS RH, 1991, ARCH NEUROL-CHICAGO, V48, P800, DOI 10.1001/archneur.1991.00530200036015; Nalavade R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.276; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Renoir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022133; Rosas HD, 2003, NEUROLOGY, V60, P1615, DOI 10.1212/01.WNL.0000065888.88988.6E; Rue L, 2016, J CLIN INVEST, V126, P4319, DOI 10.1172/JCI83185; Saudou F, 2016, NEURON, V89, P910, DOI 10.1016/j.neuron.2016.02.003; Smith KM, 2014, EXP NEUROL, V259, P44, DOI 10.1016/j.expneurol.2014.03.010; Southwell AL, 2014, MOL THER, V22, P2093, DOI 10.1038/mt.2014.153; Sturrock A, 2015, MOVEMENT DISORD, V30, P393, DOI 10.1002/mds.26118; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Tkac I, 2007, J NEUROCHEM, V100, P1397, DOI 10.1111/j.1471-4159.2006.04323.x; van Dellen A, 2000, NEUROREPORT, V11, P3751, DOI 10.1097/00001756-200011270-00032; van den Bogaard SJA, 2014, J HUNTINGTONS DIS, V3, P377, DOI 10.3233/JHD-140117; Wild EJ, 2014, MOVEMENT DISORD, V29, P1434, DOI 10.1002/mds.26007; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Zacharoff L, 2012, J CEREBR BLOOD F MET, V32, P502, DOI 10.1038/jcbfm.2011.157; Zarringhalam K, 2012, BEHAV BRAIN RES, V229, P216, DOI 10.1016/j.bbr.2012.01.015; Zielonka D, 2013, PARKINSONISM RELAT D, V19, P192, DOI 10.1016/j.parkreldis.2012.09.012; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	42	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171127	10.1371/journal.pone.0171127	http://dx.doi.org/10.1371/journal.pone.0171127			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182673	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800036
J	Ghosh, SKB; Hunter, WB; Park, AL; Gundersen-Rindal, DE				Ghosh, Saikat Kumar B.; Hunter, Wayne B.; Park, Alexis L.; Gundersen-Rindal, Dawn E.			Double strand RNA delivery system for plant-sap-feeding insects	PLOS ONE			English	Article							MARMORATED STINK BUG; GENETIC INTERFERENCE; RISK-ASSESSMENT; KNOCKDOWN; INGESTION; HEMIPTERA	Double-stranded RNA (dsRNA)-mediated gene silencing, also known as RNA interference (RNAi), has been a breakthrough technology for functional genomic studies and represents a potential tool for the management of insect pests. Since the inception of RNAi numerous studies documented successful introduction of exogenously synthesized dsRNA or siRNA into an organism triggering highly efficient gene silencing through the degradation of endogenous RNA homologous to the presented siRNA. Managing hemipteran insect pests, especially Halyomorpha halys (Stal) (Heteroptera: Pentatomidae), the brown marmorated stink bug (BMSB), is critical to food productivity. BMSB was recently introduced into North America where it is both an invasive agricultural pest of high value specialty, row, and staple crops, as well as an indoor nuisance pest. RNAi technology may serve as a viable tool to manage this voracious pest, but delivery of dsRNA to piercing-sucking insects has posed a tremendous challenge. Effective and practical use of RNAi as molecular biopesticides for biocontrol of insects like BMSB in the environment requires that dsRNAs be delivered in vivo through ingestion. Therefore, the key challenge for molecular biologists in developing insect-specific molecular biopesticides is to find effective and reliable methods for practical delivery of stable dsRNAs such as through oral ingestion. Here demonstrated is a reliable delivery system of effective insect-specific dsRNAs through oral feeding through a new delivery system to induce a significant decrease in expression of targeted genes such as JHAMT and Vg. This state-of-the-art delivery method overcomes environmental delivery challenges so that RNAi is induced through insect-specific dsRNAs orally delivered to hemipteran and other insect pests.	[Ghosh, Saikat Kumar B.; Park, Alexis L.; Gundersen-Rindal, Dawn E.] ARS, USDA, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA; [Hunter, Wayne B.] ARS, USDA, Hort Res Lab, Ft Pierce, FL USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Gundersen-Rindal, DE (corresponding author), ARS, USDA, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA.	dawn.gundersen-rindal@ars.usda.gov	hunter, wayne/AAB-9096-2020; Ghosh, Saikat/AAD-1176-2022	hunter, wayne/0000-0001-8603-3337; 				Allen ML, 2007, GENET MOL RES, V6, P206; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Anderson BE, 2012, DERMATITIS, V23, P170, DOI 10.1097/DER.0b013e318260d7be; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Bachman PM, 2016, REGUL TOXICOL PHARM, V81, P77, DOI 10.1016/j.yrtph.2016.08.001; Bansal R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152730; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Baum JA, 2014, ADV INSECT PHYSIOL, V47, P249, DOI 10.1016/B978-0-12-800197-4.00005-1; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Burand JP, 2013, J INVERTEBR PATHOL, V112, pS68, DOI 10.1016/j.jip.2012.07.012; Christiaens O, 2014, CURR OPIN INSECT SCI, V6, P15, DOI 10.1016/j.cois.2014.09.012; De Andrade E., 2016, RNA INTERFERENCE; Doane CC, 1981, USDA TECHNICAL B; Dubelman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093155; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gantier MP, 2007, CYTOKINE GROWTH F R, V18, P363, DOI 10.1016/j.cytogfr.2007.06.016; GREEN PJ, 1994, ANNU REV PLANT PHYS, V45, P421, DOI 10.1146/annurev.pp.45.060194.002225; Hail D. A., 2010, P 10 ANN ZEBR CHIP R, P183; Hunter W.B., 2010, P S P 2010 PIERC DIS, P24; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Hunter WB, 2012, SOUTHWEST ENTOMOL, V37, P85, DOI 10.3958/059.037.0110; Ivashuta S, 2015, RNA, V21, P840, DOI 10.1261/rna.048116.114; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khrimian A, 2014, J NAT PROD, V77, P1708, DOI 10.1021/np5003753; Kola VSR, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00119; Kolliopoulou A, 2014, CURR OPIN INSECT SCI, V6, P28, DOI 10.1016/j.cois.2014.09.019; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mertz TL, 2012, J ALLERGY CLIN IMMUN, V130, P999, DOI 10.1016/j.jaci.2012.06.016; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Peiffer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088483; Roberts AF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00958; Rodrigues T.B., 2016, MANAGEMENT INSECT PE; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Sparks ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111646; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Walshe DP, 2009, INSECT MOL BIOL, V18, P11, DOI 10.1111/j.1365-2583.2008.00839.x; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Wynant N, 2014, INSECT BIOCHEM MOLEC, V46, P1, DOI 10.1016/j.ibmb.2013.12.008; Xu JW, 2014, BIOL INVASIONS, V16, P153, DOI 10.1007/s10530-013-0510-3; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005	56	44	45	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171861	10.1371/journal.pone.0171861	http://dx.doi.org/10.1371/journal.pone.0171861			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182760	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800125
J	Hou, L; Hellerstein, S; Vitonis, A; Zou, LY; Ruan, Y; Wang, X; Zhang, WY				Hou, Lei; Hellerstein, Susan; Vitonis, Allison; Zou, Liying; Ruan, Yan; Wang, Xin; Zhang, Weiyuan			Cross sectional study of mode of delivery and maternal and perinatal outcomes in mainland China	PLOS ONE			English	Article							CESAREAN DELIVERY; CARE; SHANGHAI; HEALTH	Background Cesarean delivery (CD) rates have risen globally with nearly 50% of the non-indicated CDs worldwide in China and Brazil. In China's One Child Policy era (1979-015) most deliveries were women having their only child. Family size is a major determinant of the safety of medically non-indicated CD or CD on maternal request. The goal of this study is to document CD rates, indications, and analyze the relative safety of non-indicated CD compared to SVD and intrapartum CD. Methods Univariate and multivariate logistic regression analyses of the association between mode of delivery and short-term maternal and perinatal outcomes were performed on a cross-section of all deliveries at 39 hospitals in 14 provinces of China in 2011, presented as adjusted odds ratio (aOR), 99% confidence intervals (CI). Findings Among 108,847 deliveries, 59,415 were CD (54.6%) with 20.8% of deliveries or 38.2% of all cesareans were non-indicated CD. Compared to SVD, antepartum non-indicated CD was associated with a decreased likelihood of post-partum hemorrhage (PPH) (aOR = 0.80, CI = 0.69-0.92) and was not associated with maternal death or combined severe outcomes (maternal death, transfusion, or hysterectomy). Intrapartum indicated CD was associated with an increased risk of PPH (aOR = 1.68, CI = 1.50-.89) compared to SVD. Compared to SVD, antepartum non-indicated CD was associated with lower likelihood of neonatal death (aOR = 0.14, CI = 0.06-.34), neonatal ICU admission (aOR = 0.50, CI = 0.36-.69), 5-minute Apgar<4 (aOR = 0.06, CI = 0.10-0.36), and respiratory distress syndrome (RDS) (aOR = 0.31, CI = 0.16-.58), but not significantly associated with changes in rates of infection, hypoxic ischemic encephalopathy (HIEE), birth trauma or meconium aspiration rates. Conclusions In 2011 when 81% of deliveries were women having their first child antepartum non-indicated CD had short-term maternal and perinatal outcomes as safe as SVD. Now that all Chinese women can have a second child the safety profile may change.	[Hou, Lei; Zou, Liying; Ruan, Yan; Wang, Xin; Zhang, Weiyuan] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Obstet, Beijing, Peoples R China; [Hellerstein, Susan; Vitonis, Allison] Brigham & Womens Hosp, Harvard Med Sch, Dept Obstet & Gynecol, Boston, MA 02115 USA	Capital Medical University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zhang, WY (corresponding author), Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Obstet, Beijing, Peoples R China.	zhangwy9921@hotmail.com			Health industry special funds for Public Benefit Research Foundation; Ministry of Health, People's Republic of China [201002013]	Health industry special funds for Public Benefit Research Foundation; Ministry of Health, People's Republic of China	SH, AV - unfunded. WZ - This project was supported by "Health industry special funds for Public Benefit Research Foundation" from the Ministry of Health, People's Republic of China (Grant number 201002013).	[Anonymous], 2013, Obstet Gynecol, V121, P904, DOI 10.1097/01.AOG.0000428647.67925.d3; [Anonymous], 2006, NIH Consens State Sci Statements, V23, P1; [Anonymous], 1985, THEORETICAL EPIDEMIO; Blustein J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2410; Cheng PJ, 2016, BJOG-INT J OBSTET GY, V123, P7, DOI 10.1111/1471-0528.14290; Cui Hao-sheng, 2013, Beijing Da Xue Xue Bao Yi Xue Ban, V45, P422; Deng W, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-285; Guise JM, 2010, OBSTET GYNECOL, V115, P1267, DOI 10.1097/AOG.0b013e3181df925f; Hellerstein S, 2015, BJOG-INT J OBSTET GY, V122, P160, DOI 10.1111/1471-0528.12971; Hellerstein S, 2016, BIRTH-ISS PERINAT C, V43, P193, DOI 10.1111/birt.12231; Lee Y. M., 2008, CURRENT OPINION OBST, V20, P1; Liu XH, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.043; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; National Institute for Health and Clinical Excellence, 2011, CAES SECT CLIN GUID; Ogden CL, PREVALENCE OBESITY A; Qian J., 2012, J POPUL DEV, V5, P39; Shen Y., 2011, J PRACTICAL OBSTET G, P183; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5; Zhu Yi-bo, 2012, Zhonghua Yi Xue Za Zhi, V92, P1734	20	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171779	10.1371/journal.pone.0171779	http://dx.doi.org/10.1371/journal.pone.0171779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182668	Green Submitted, Green Published, gold			2022-12-26	WOS:000394231800108
J	Huang, CC; Kuo, SC; Yeh, YW; Chen, CY; Yen, CH; Liang, CS; Ho, PS; Lu, RB; Huang, SY				Huang, Chang-Chih; Kuo, Shin-Chang; Yeh, Yi-Wei; Chen, Chun-Yen; Yen, Che-Hung; Liang, Chih-Sung; Ho, Pei-Shen; Lu, Ru-Band; Huang, San-Yuan			The SLC6A3 gene possibly affects susceptibility to late-onset alcohol dependence but not specific personality traits in a Han Chinese population	PLOS ONE			English	Article							DOPAMINE TRANSPORTER GENE; NOVELTY SEEKING; DAT1 GENE; SIGNIFICANT ASSOCIATION; NUCLEUS-ACCUMBENS; POLYMORPHISMS; SEROTONIN; DISORDERS; RELEASE; QUESTIONNAIRE	Dopaminergic dysfunction has an important role in the pathoetiology of alcohol dependence (AD). The purpose of this study was to determine whether the solute carrier family 6 member 3 (SLC6A3) gene (also known as the dopamine transporter DAT gene) was associated with AD, and whether variants in the SLC6A3 locus were associated with specific personality traits in patients with AD. Sixteen polymorphisms in SLC6A3 were analyzed using 637 patients with AD and 523 healthy controls. To reduce clinical heterogeneity, patients were classified into two subgroups: early-onset AD (EOAD) and late-onset AD (LOAD). The Tridimensional Personality Questionnaire was used to assess the personality traits novelty seeking (NS) and harm avoidance (HA) in the patients with AD. Using allele frequency and genotype distribution comparisons and logistic regression analysis, we found evidence of association between rs6350 and AD (P < 0.05). Following subgroup analysis, we confirmed evidence of an association in patients with LOAD (P = 0.003), but not in patients with EOAD. Heterozygous carriers of the A allele have a nearly 3 times greater risk to develop LOAD compared to individuals who do not have an A allele. Although we found that patients with AD had higher NS and HA scores compared to controls (P < 0.001), we did not find evidence of association between SLC6A3 polymorphisms and either NS or HA in patients with AD using linear regression analysis. The findings from our study indicate that the SLC6A3 gene may have a role in susceptibility to late-onset AD in the Han Chinese population.	[Huang, Chang-Chih; Kuo, Shin-Chang; Yeh, Yi-Wei; Chen, Chun-Yen; Yen, Che-Hung; Huang, San-Yuan] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Huang, Chang-Chih] Taipei Buddhist Tzu Chi Gen Hosp, Dept Psychiat, New Taipei, Taiwan; [Kuo, Shin-Chang; Yeh, Yi-Wei; Chen, Chun-Yen; Huang, San-Yuan] Triserv Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Yen, Che-Hung] Chiayi Yang Ming Hosp, Dept Internal Med, Dept Div Neurol, Chiayi, Taiwan; [Liang, Chih-Sung; Ho, Pei-Shen] Triserv Gen Hosp, Beitou Branch, Dept Psychiat, Taipei, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ, Dept Psychiat, Inst Behav Med, Coll Med, Tainan, Taiwan	National Defense Medical Center; Buddhist Tzu Chi General Hospital; Tri-Service General Hospital; Tri-Service General Hospital; National Cheng Kung University	Huang, SY (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	hsy@mail.ndmctsgh.edu.tw	Liang, Chih-Sung/V-6720-2019	Liang, Chih-Sung/0000-0003-1138-5586; Yeh, Yi-Wei/0000-0001-8690-6206; Chen, Chun-Yen/0000-0002-8330-9569				Almasy L, 2003, ANN MED, V35, P337, DOI 10.1080/07853890310004903; Ando B, 2014, SUBST USE MISUSE, V49, P418, DOI 10.3109/10826084.2013.841250; Anghelescu I, 2010, WORLD J BIOL PSYCHIA, V11, P382, DOI [10.1080/15622970701775058, 10.3109/15622970701775058]; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Brodie MS, 1999, ALCOHOL CLIN EXP RES, V23, P1848, DOI 10.1111/j.1530-0277.1999.tb04082.x; Chen WJ, 2002, COMPR PSYCHIAT, V43, P158, DOI 10.1053/comp.2002.30797; Chen YC, 2011, J STUD ALCOHOL DRUGS, V72, P752, DOI 10.15288/jsad.2011.72.752; Cloninger CR, 1996, ALCOHOL HEALTH RES W, V20, P18; CLONINGER CR, 1995, NAT MED, V1, P623, DOI 10.1038/nm0795-623; Crum RM, 2005, DRUG ALCOHOL DEPEN, V79, P71, DOI 10.1016/j.drugalcdep.2005.01.001; Dobashi I, 1997, PSYCHIATR GENET, V7, P87, DOI 10.1097/00041444-199722000-00006; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Erjavec GN, 2014, PROG NEURO-PSYCHOPH, V54, P321, DOI 10.1016/j.pnpbp.2014.07.002; ESHLEMAN AJ, 1994, MOL PHARMACOL, V45, P312; Evren C, 2012, DRUG ALCOHOL REV, V31, P81, DOI 10.1111/j.1465-3362.2011.00303.x; Fairbanks LA, 2011, GENES BRAIN BEHAV, V10, P683, DOI 10.1111/j.1601-183X.2011.00707.x; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Hong CJ, 2003, J NEURAL TRANSM, V110, P345, DOI 10.1007/s00702-002-0790-8; Huang CC, 2015, EUR ARCH PSY CLIN N, V265, P281, DOI 10.1007/s00406-014-0570-0; Huang CC, 2011, PHARMACOGENET GENOM, V21, P94, DOI 10.1097/FPC.0b013e3283424d94; Huang SY, 2010, SCHIZOPHR RES, V116, P68, DOI 10.1016/j.schres.2009.10.004; Jiao X, 2006, BRAIN RES, V1073, P175, DOI 10.1016/j.brainres.2005.12.009; Kazantseva A, 2011, PROG NEURO-PSYCHOPH, V35, P1033, DOI 10.1016/j.pnpbp.2011.02.013; Kelada SN, 2005, PHARMACOGENET GENOM, V15, P659, DOI 10.1097/01.fpc.0000170917.04275.d6; Kranzler HR, 2011, J CLIN PSYCHOPHARM, V31, P22, DOI 10.1097/JCP.0b013e31820465fa; Krebs RM, 2011, NEUROIMAGE, V58, P647, DOI 10.1016/j.neuroimage.2011.06.038; Le Strat Y, 2008, ALCOHOL CLIN EXP RES, V32, P27, DOI 10.1111/j.1530-0277.2007.00552.x; Leggio L, 2009, NEUROPSYCHOL REV, V19, P115, DOI 10.1007/s11065-008-9080-z; Lind PA, 2009, PSYCHIAT GENET, V19, P117, DOI 10.1097/YPG.0b013e32832a4f7b; Littlefield AK, 2010, SOC PERSONAL PSYCHOL, V4, P767, DOI 10.1111/j.1751-9004.2010.00296.x; Ma YL, 2016, ALCOHOL CLIN EXP RES, V40, P1443, DOI 10.1111/acer.13104; Martinez D, 2005, BIOL PSYCHIAT, V58, P779, DOI 10.1016/j.biopsych.2005.04.044; Meszaros K, 1999, ALCOHOL CLIN EXP RES, V23, P483, DOI 10.1097/00000374-199903000-00015; Mittleman G, 2011, ALCOHOL, V45, P325, DOI 10.1016/j.alcohol.2010.12.006; Muller SE, 2008, NEUROPSYCHOBIOLOGY, V57, P159, DOI 10.1159/000147469; Pascale E, 2015, ALCOHOL ALCOHOLISM, V50, P259, DOI 10.1093/alcalc/agv014; Pettinati HM, 2000, ALCOHOL CLIN EXP RES, V24, P1041, DOI 10.1111/j.1530-0277.2000.tb04648.x; Prescott CA, 2006, BEHAV GENET, V36, P473, DOI 10.1007/s10519-006-9072-9; Sabol SZ, 1999, HEALTH PSYCHOL, V18, P7, DOI 10.1037/0278-6133.18.1.7; Schmid B, 2009, ADDICT BIOL, V14, P489, DOI 10.1111/j.1369-1600.2009.00171.x; Schosser A, 2010, WORLD J BIOL PSYCHIA, V11, P417, DOI 10.3109/15622970801935586; Shibuya N, 2009, BEHAV BRAIN RES, V203, P23, DOI 10.1016/j.bbr.2009.04.008; Tan A T, 1981, Prog Biochem Pharmacol, V18, P224; Tzeng NS, 2015, DRUG ALCOHOL DEPEN, V149, P100, DOI 10.1016/j.drugalcdep.2015.01.030; Ueno S, 1999, MOL PSYCHIATR, V4, P552, DOI 10.1038/sj.mp.4000562; van de Giessen EM, 2009, J NUCL MED, V50, P45, DOI 10.2967/jnumed.108.053652; van der Zwaluw CS, 2009, PHARMACOGENOMICS, V10, P853, DOI 10.2217/PGS.09.24; Wingo T, 2015, J NEUROIMMUNE PHARM; Wu X, 2009, PROG MOD BIOMED, V9, P1440; Xu MQ, 2011, PROG NEURO-PSYCHOPH, V35, P1255, DOI 10.1016/j.pnpbp.2010.11.001; Yeh YW, 2010, GENES BRAIN BEHAV, V9, P638, DOI 10.1111/j.1601-183X.2010.00597.x; YOSHIMOTO K, 1992, ALCOHOL, V9, P17, DOI 10.1016/0741-8329(92)90004-T	54	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171170	10.1371/journal.pone.0171170	http://dx.doi.org/10.1371/journal.pone.0171170			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182634	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800039
J	Li, DW; Fang, KY; Li, YJ; Chen, DL; Liu, XH; Dong, ZP; Zhou, FF; Guo, GY; Shi, F; Xu, CX; Li, YP				Li, Dawen; Fang, Keyan; Li, Yingjun; Chen, Deliang; Liu, Xiaohong; Dong, Zhipeng; Zhou, Feifei; Guo, Guoyang; Shi, Feng; Xu, Chenxi; Li, Yanping			Climate, intrinsic water-use efficiency and tree growth over the past 150 years in humid subtropical China	PLOS ONE			English	Article							SUMMER TEMPERATURE RECONSTRUCTION; CARBON-ISOTOPE DISCRIMINATION; ATMOSPHERIC CO2; ANNUAL PRECIPITATION; TIBETAN PLATEAU; RADIAL GROWTH; DELTA-C-13; RECORD; CELLULOSE; FORESTS	Influence of long-term changes in climate and CO2 concentration on intrinsic water-use efficiency (iWUE), defined as the ratio between net photosynthesis (A) and leaf conductance (g), and tree growth remain not fully revealed in humid subtropical China, which is distinct from other arid subtropical areas with dense coverage of broadleaf forests. This study presented the first tree-ring stable carbon isotope (delta C-13) and iWUE series of Pinus massoniana from 1865 to 2013 in Fujian province, humid subtropical China, and the first tree-ring width standard chronology during the period of 1836-2013 for the Niumulin Nature Reserve (NML). Tree-ring width growth was limited by precipitation in July-August (r = 0.40, p < 0.01). The tree-ring carbon isotope discrimination (Delta C-13) was mainly controlled by the sunshine hours (r = -0.66, p < 0.001) and relative humidity (r = 0.58, p < 0.001) in September-October, a season with rapid latewood formation in this area. The iWUE increased by 42.6% and the atmospheric CO2 concentration (c(a)) explained 92.6% of the iWUE variance over the last 150 years. The steady increase in iWUE suggests an active response with a proportional increase in intercellular CO2 concentration (c(i)) in response to increase in c(a). The contribution of iWUE to tree growth in the study region is not conspicuous, which points to influences of other factors such as climate.	[Li, Dawen; Fang, Keyan; Li, Yingjun; Dong, Zhipeng; Zhou, Feifei; Guo, Guoyang; Li, Yanping] Fujian Normal Univ, Coll Geog Sci, Inst Geog, Key Lab Humid Subtrop Ecogeog Proc,Minist Educ, Fuzhou, Peoples R China; [Fang, Keyan; Chen, Deliang] Univ Gothenburg, Dept Earth Sci, Reg Climate Grp, Gothenburg, Sweden; [Liu, Xiaohong] Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Lanzhou, Peoples R China; [Shi, Feng; Xu, Chenxi] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China	Fujian Normal University; University of Gothenburg; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS	Fang, KY (corresponding author), Fujian Normal Univ, Coll Geog Sci, Inst Geog, Key Lab Humid Subtrop Ecogeog Proc,Minist Educ, Fuzhou, Peoples R China.; Fang, KY (corresponding author), Univ Gothenburg, Dept Earth Sci, Reg Climate Grp, Gothenburg, Sweden.	kujanfang@gmail.com	Chen, Deliang/A-5107-2013; Xu, Chenxi/AAI-2686-2020; dong, zhipeng/AFN-4971-2022	Chen, Deliang/0000-0003-0288-5618; Xu, Chenxi/0000-0001-7747-0033; 	National Natural Science Foundation of China [41471172, U1405231]; Fellowship for Distinguished Young Scholars of Fujian Province [2015J06008]; Minjiang Special-term Professor fellowship; Biodiversity and Ecosystem Services in a Changing Climate of Sweden; Swedish Foundation for International Cooperation in Research and Higher Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fellowship for Distinguished Young Scholars of Fujian Province; Minjiang Special-term Professor fellowship; Biodiversity and Ecosystem Services in a Changing Climate of Sweden; Swedish Foundation for International Cooperation in Research and Higher Education	This research is funded by the National Natural Science Foundation of China (41471172 and U1405231) (http://www.nsfc.gov.cn/), the Fellowship for Distinguished Young Scholars of Fujian Province (2015J06008) and the Minjiang Special-term Professor fellowship. Support from Biodiversity and Ecosystem Services in a Changing Climate of Sweden (http://www.becc.lu.se/) and the Swedish Foundation for International Cooperation in Research and Higher Education (http://www. stint.se/en/scholarships_and_grants/initiation_ grants) are also appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Hayles L, 2011, GLOBAL CHANGE BIOL, V17, P2095, DOI 10.1111/j.1365-2486.2010.02373.x; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Linares JC, 2012, GLOBAL CHANGE BIOL, V18, P1000, DOI 10.1111/j.1365-2486.2011.02566.x; Chen D, 2016, SCI CHINA EARTH SCI, V59, P328, DOI 10.1007/s11430-015-5188-1; Chen F, 2012, INT J CLIMATOL, V32, P1089, DOI 10.1002/joc.2327; Chen F, 2012, THEOR APPL CLIMATOL, V109, P141, DOI 10.1007/s00704-011-0563-0; Cook E. R., 1985, TIME SERIES ANAL APP; Cook ER, 2013, CLIM DYNAM, P1; COPLEN TB, 1995, NATURE, V375, P285, DOI 10.1038/375285a0; DARRALL NM, 1989, PLANT CELL ENVIRON, V12, P1, DOI 10.1111/j.1365-3040.1989.tb01913.x; Duan JP, 2013, J CLIMATE, V26, P4749, DOI 10.1175/JCLI-D-12-00332.1; Duan JP, 2012, CLIM DYNAM, V39, P919, DOI 10.1007/s00382-011-1232-9; EHLERINGER JR, 1995, TREE PHYSIOL, V15, P105, DOI 10.1093/treephys/15.2.105; Fang KY, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034010; Fang KY, 2009, IAWA J, V30, P443, DOI 10.1163/22941932-90000231; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Feng XH, 1998, OECOLOGIA, V117, P19, DOI 10.1007/s004420050626; Feng XH, 1999, GEOCHIM COSMOCHIM AC, V63, P1891, DOI 10.1016/S0016-7037(99)00088-5; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Frank DC, 2015, NAT CLIM CHANGE, V5, P579, DOI 10.1038/nclimate2614; Fritts H. C., 1976, TREE RING CLIMATE; Gagen M, 2007, HOLOCENE, V17, P435, DOI 10.1177/0959683607077012; Gou XH, 2010, CHINESE SCI BULL, V55, P4179, DOI 10.1007/s11434-010-4215-z; Green JW, 1963, METHODS CARBOHYDRATE, P9; Hafner P, 2014, CLIM DYNAM, V43, P971, DOI 10.1007/s00382-013-1864-z; Haupt M, 2011, CLIMATIC CHANGE, V105, P243, DOI [10.1007/s10584-010-9862-1, 10.1007/S10584-010-9862-1]; Hietz P, 2005, TREE PHYSIOL, V25, P745, DOI 10.1093/treephys/25.6.745; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Huang JG, 2007, CRIT REV PLANT SCI, V26, P265, DOI 10.1080/07352680701626978; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; Laumer W, 2009, RAPID COMMUN MASS SP, V23, P1934, DOI 10.1002/rcm.4105; Leavitt SW, 2008, CHEM GEOL, V252, P52, DOI 10.1016/j.chemgeo.2008.01.014; Levesque M, 2014, NEW PHYTOL, V203, P94, DOI 10.1111/nph.12772; Lewis SL, 2004, PHILOS T R SOC B, V359, P437, DOI 10.1098/rstb.2003.1432; Li JB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025803; Li Y, 2016, CLIMATE RES, V67; Liang EY, 2008, GLOBAL PLANET CHANGE, V61, P313, DOI 10.1016/j.gloplacha.2007.10.008; Liu HY, 2013, GLOBAL CHANGE BIOL, V19, P2500, DOI 10.1111/gcb.12217; Liu XH, 2014, TREE PHYSIOL, V34, P966, DOI 10.1093/treephys/tpu067; Liu XH, 2012, CHEM GEOL, V291, P104, DOI 10.1016/j.chemgeo.2011.10.001; Liu Y, 2014, QUATERNARY SCI REV, V93, P67, DOI 10.1016/j.quascirev.2014.03.023; Loader NJ, 2007, TERR ECOL SER, V1, P27; Loader NJ, 1997, CHEM GEOL, V136, P313, DOI 10.1016/S0009-2541(96)00133-7; Luo Y, 1996, GLOBAL BIOGEOCHEMICA, V10, P1287; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Saurer M, 2004, GLOBAL CHANGE BIOL, V10, P2109, DOI 10.1111/j.1365-2486.2004.00869.x; Shao X, 2010, QUATERNARY SCI REV, V29, P2111, DOI 10.1016/j.quascirev.2010.05.005; Sheng H, 2010, GLOBAL CHANGE BIOL, V16, P1107, DOI 10.1111/j.1365-2486.2009.01988.x; Sheppard PR, 2004, CLIM DYNAM, V23, P869, DOI 10.1007/s00382-004-0473-2; Sleen PVD, 2015, BIOMATERIALS, V8, P5221; Stocks MA, 1968, INTRO TREE RING DATI; Tei S, 2014, POLAR SCI, V8, P183, DOI 10.1016/j.polar.2013.12.002; Wang WZ, 2012, FOREST ECOL MANAG, V275, P14, DOI 10.1016/j.foreco.2012.02.027; Waterhouse JS, 2004, QUATERNARY SCI REV, V23, P803, DOI 10.1016/j.quascirev.2003.06.011; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wright WE, 2014, CLIM DYNAM, V44, P1645; Wu G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00198; Xu C, 2013, J GEOPHYS RES ATMOSP; Xu GB, 2013, TREES-STRUCT FUNCT, V27, P465, DOI 10.1007/s00468-013-0855-3; Yang B, 2014, P NATL ACAD SCI USA, V111, P2903, DOI 10.1073/pnas.1319238111; Young GHF, 2010, HOLOCENE, V20, P315, DOI 10.1177/0959683609351902; [俞亚勋 Yu Yaxun], 2003, [冰川冻土, Journal of Glaciology and Geocryology], V25, P149; Zhang QB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9062; Zhang Y., 2016, J SUBTROPICAL RESOUR, V11, P59	65	21	24	8	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172045	10.1371/journal.pone.0172045	http://dx.doi.org/10.1371/journal.pone.0172045			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182751	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800146
J	Li, WZ; Teng, XH; Zhang, HF; Liu, T; Wang, Q; Yuan, GH; Guo, XR				Li, Wei-zheng; Teng, Xiao-hui; Zhang, Hong-fei; Liu, Ting; Wang, Qiong; Yuan, Guohui; Guo, Xian-ru			Comparative host selection responses of specialist (Helicoverpa assulta) and generalist (Helicoverpa armigera) moths in complex plant environments	PLOS ONE			English	Article							VOLATILE EMISSIONS; OVIPOSITION PREFERENCE; HUBNER LEPIDOPTERA; LARVAL PERFORMANCE; RECEPTOR NEURONS; CAPSICUM-ANNUUM; BEHAVIOR; COTTON; NOCTUIDAE; HERBIVORE	We tested the behavioral responses of ovipositing females and natal larvae of two sibling species, a generalist Helicoverpa armigera (Hubner) and a specialist Helicoverpa assulta (Guenee), to odor sources emitted from different combinations of six plant species (tobacco, Nicotiana tabacum; hot pepper, Capsicum annuum; tomato, Solanum esculentum; cotton, Gossypium hirsutum; peanut, Arachis hypogaea; maize, Zea mays). Under the conditions of plant materials versus corresponding controls, both stages of both species could find their corresponding host plants. However, H. assulta females and larvae exhibited a supersensitive and an insensitive response, respectively. Under the conditions of tobacco paired with each plant species, H. assulta females exhibited more specialized ovipositional response to tobacco than its sibling. When each plant species were combined with tobacco and tested against tobacco reference, peanut played an opposite role in the two species in their ovipositional responses to tobacco, and cotton can enhance the approaching response of H. armigera larvae when combined with tobacco. It seems that two attractive host plants also can act antagonistically with respect to host selection of the generalist via volatile exchange. Tomato should better be excluded from host list of H. assulta.	[Li, Wei-zheng; Teng, Xiao-hui; Zhang, Hong-fei; Liu, Ting; Wang, Qiong; Yuan, Guohui; Guo, Xian-ru] Henan Agr Univ, Coll Plant Protect, Dept Entomol, Zhengzhou, Henan Province, Peoples R China	Henan Agricultural University	Yuan, GH; Guo, XR (corresponding author), Henan Agr Univ, Coll Plant Protect, Dept Entomol, Zhengzhou, Henan Province, Peoples R China.	hnndygh@126.com; guoxianru@126.com		Yuan, Guohui/0000-0003-0173-4383	National Natural Science Foundation of China [31572331, 31471772]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (31572331) and The National Natural Science Foundation of China (31471772).	Ahn SJ, 2011, J INSECT PHYSIOL, V57, P1212, DOI 10.1016/j.jinsphys.2011.05.015; Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Lopez YIA, 2012, J CHEM ECOL, V38, P1376, DOI 10.1007/s10886-012-0201-z; Benda ND, 2011, ENVIRON ENTOMOL, V40, P1478, DOI 10.1603/EN09335; Cardoza YJ, 2002, J CHEM ECOL, V28, P161, DOI 10.1023/A:1013523104853; Cianfrogna JA, 2002, J CHEM ECOL, V28, P1365, DOI 10.1023/A:1016244402019; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cunningham JP, 2014, J ECON ENTOMOL, V107, P881, DOI 10.1603/EC14036; Finch S, 2000, ENTOMOL EXP APPL, V96, P91, DOI 10.1023/A:1004058518179; Glendinning JI, 2009, J COMP PHYSIOL A, V195, P591, DOI 10.1007/s00359-009-0434-7; Hegde M, 2011, J CHEM ECOL, V37, P741, DOI 10.1007/s10886-011-9980-x; Hull CD, 2004, J CHEM ECOL, V30, P2071, DOI 10.1023/B:JOEC.0000045596.13384.7e; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Jallow MFA, 2004, CROP PROT, V23, P955, DOI 10.1016/j.cropro.2004.02.008; Jallow MFA, 1999, AUST J ENTOMOL, V38, P359, DOI 10.1046/j.1440-6055.1999.00131.x; JALLOW MFA, 1995, J AUST ENTOMOL SOC, V34, P281; Lee HS, 2006, CHEMOECOLOGY, V16, P153, DOI 10.1007/s00049-006-0341-0; Liu ZD, 2010, ENVIRON ENTOMOL, V39, P552, DOI 10.1603/EN09129; Malezieux E, 2012, AGRON SUSTAIN DEV, V32, P15, DOI 10.1007/s13593-011-0027-z; MCCALL PJ, 1994, J CHEM ECOL, V20, P3039, DOI 10.1007/BF02033709; Megido RC, 2014, ARTHROPOD-PLANT INTE, V8, P293, DOI 10.1007/s11829-014-9315-2; MITCHELL ER, 1990, J CHEM ECOL, V16, P1817, DOI 10.1007/BF01020496; Ngumbi E, 2009, J CHEM ECOL, V35, P1009, DOI 10.1007/s10886-009-9700-y; Ninkovic V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069431; Proffit M, 2011, J CHEM ECOL, V37, P565, DOI 10.1007/s10886-011-9961-0; Rajapakse CNK, 2007, ARTHROPOD-PLANT INTE, V1, P17, DOI 10.1007/s11829-007-9003-6; Rajapakse CNK, 2006, PHYSIOL ENTOMOL, V31, P270, DOI 10.1111/j.1365-3032.2006.00517.x; RENWICK JAA, 1994, ANNU REV ENTOMOL, V39, P377, DOI 10.1146/annurev.en.39.010194.002113; Reudler Talsma JH, 2008, ARTHROPOD-PLANT INTE, V2, P63, DOI 10.1007/s11829-008-9039-2; Rodriguez-Saona C, 2001, J CHEM ECOL, V27, P679, DOI 10.1023/A:1010393700918; Rostelien T, 2005, CHEM SENSES, V30, P443, DOI 10.1093/chemse/bji039; Shikano I, 2010, ARTHROPOD-PLANT INTE, V4, P197, DOI 10.1007/s11829-010-9100-9; Srinivasan R, 2006, CURR SCI INDIA, V90, P846; Stranden M, 2003, CHEMOECOLOGY, V13, P143, DOI 10.1007/s00049-003-0242-4; Sun JG, 2012, ARTHROPOD-PLANT INTE, V6, P375, DOI 10.1007/s11829-012-9190-7; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; Wu Kun-Jun, 2006, Acta Entomologica Sinica, V49, P421; Xue HJ, 2008, NATURWISSENSCHAFTEN, V95, P639, DOI 10.1007/s00114-008-0367-y	38	5	5	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171948	10.1371/journal.pone.0171948	http://dx.doi.org/10.1371/journal.pone.0171948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182679	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800137
J	Omidvar, V; Mohorianu, I; Dalmay, T; Zheng, Y; Fei, ZJ; Pucci, A; Mazzucato, A; Vecerova, V; Sedlarova, M; Fellner, M				Omidvar, Vahid; Mohorianu, Irina; Dalmay, Tamas; Zheng, Yi; Fei, Zhangjun; Pucci, Anna; Mazzucato, Andrea; Vecerova, Vendula; Sedlarova, Michaela; Fellner, Martin			Transcriptional regulation of male-sterility in 7B-1 male-sterile tomato mutant	PLOS ONE			English	Article							TAPETUM-DEGENERATION-RETARDATION; MALE REPRODUCTIVE DEVELOPMENT; ANTHER DEVELOPMENT; DIFFERENTIAL EXPRESSION; STAMENLESS-2 MUTANT; RNA-SEQ; GENE; RICE; POLLEN; LYCOPERSICON	The 78-1 tomato (Solanum lycopersicum L. cv Rutgers) is a male-sterile mutant with enhanced tolerance to abiotic stress, which makes it a potential candidate for hybrid seed breeding and stress engineering. To underline the molecular mechanism regulating the male-sterility in 78-1, transcriptomic profiles of the 78-1 male -sterile and wild type (WT) anthers were studied using mRNA sequencing (RNA-Seq). In total, 768 differentially expressed genes (DEGs) were identified, including 132 up -regulated and 636 down -regulated transcripts. Gene ontology (GO) enrichment analysis of DEGs suggested a general impact of the 78-1 mutation on metabolic processes, such as proteolysis and carbohydrate catabolic process. Sixteen candidates with key roles in regulation of anther development were subjected to further analysis using qRT-PCR and in situ hybridization. Cytological studies showed several defects associated with anther development in the 78-1 mutant, including unsynchronized anther maturation, dysfunctional meiosis, arrested microspores, defect in callose degradation and abnormal tapetum development. TUNEL assay showed a defect in programmed cell death (PCD) of tapetal cells in 78-1 anthers. The present study provides insights into the transcriptome of the 78-1 mutant. We identified several genes with altered expression level in 78-1 (including beta-1,3 glucanase, GA2oxs, cystatin, cysteine protease, pectinesterase, TA29, and actin) that could potentially regulate anther developmental processes, such as meiosis, tapetum development, and cell-wall formation/degradation.	[Omidvar, Vahid; Fellner, Martin] Palacky Univ, Ctr Reg Hana Biotechnol & Agr Res, Lab Growth Regulators, Stechtitelu 27, Olomouc, Czech Republic; [Omidvar, Vahid; Fellner, Martin] Inst Expt Bot AS CR, Stechtitelu 27, Olomouc, Czech Republic; [Mohorianu, Irina] Univ East Anglia, Sch Comp Sci, Norwich, Norfolk, England; [Mohorianu, Irina; Dalmay, Tamas] Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England; [Zheng, Yi; Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst, Ithaca, NY USA; [Pucci, Anna; Mazzucato, Andrea] Univ Tuscia, Dept Agr & Forestry Sci, Viterbo, Italy; [Vecerova, Vendula; Sedlarova, Michaela] Palacky Univ, Fac Sci, Dept Bot, Slechtitelu 27, Olomouc, Czech Republic	Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of East Anglia; University of East Anglia; Cornell University; Boyce Thompson Institute for Plant Research; Tuscia University; Palacky University Olomouc	Omidvar, V; Fellner, M (corresponding author), Palacky Univ, Ctr Reg Hana Biotechnol & Agr Res, Lab Growth Regulators, Stechtitelu 27, Olomouc, Czech Republic.; Omidvar, V; Fellner, M (corresponding author), Inst Expt Bot AS CR, Stechtitelu 27, Olomouc, Czech Republic.	vahid.omidvar@gmail.com; martin.fellner@upol.cz	Mazzucato, Andrea/AEA-1650-2022; Fellner, Martin/B-2068-2010; Fei, Zhangjun/H-5152-2012; SEDLÁŘOVÁ, Michaela/L-2055-2018; Mohorianu, Irina/J-2549-2019; Dalmay, Tamas/E-1377-2011	SEDLÁŘOVÁ, Michaela/0000-0003-2319-1033; Mohorianu, Irina/0000-0003-4863-761X; Dalmay, Tamas/0000-0003-1492-5429	Operational Programs Education for Competitiveness-European Social Fund [CZ.1.07/2.3.00/30.0004]; Ministry of Education, Youth and Sports [L01204]; Biotechnology and Biological Sciences Research Council [BB/G008078/1] Funding Source: researchfish; BBSRC [BB/G008078/1] Funding Source: UKRI	Operational Programs Education for Competitiveness-European Social Fund; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Operational Programs Education for Competitiveness-European Social Fund, project no. CZ.1.07/2.3.00/30.0004 to MF, and by Ministry of Education, Youth and Sports, project no. L01204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MGM, 1997, PLANT J, V12, P615, DOI 10.1046/j.1365-313X.1997.00615.x; Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Bergougnoux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045255; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Canales C, 2002, CURR BIOL, V12, P1718, DOI 10.1016/S0960-9822(02)01151-X; Distelfeld A, 2012, PLANT MOL BIOL, V78, P515, DOI 10.1007/s11103-012-9881-6; Dong X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072178; Emmanuel E, 2002, CURR OPIN PLANT BIOL, V5, P112, DOI 10.1016/S1369-5266(02)00237-6; Fellner M, 2002, PLANTA, V214, P675, DOI 10.1007/s004250100671; Fellner M, 2001, J EXP BOT, V52, P725, DOI 10.1093/jexbot/52.357.725; Fu ZZ, 2014, PLANT CELL, V26, P1512, DOI 10.1105/tpc.114.123745; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Gorguet B, 2009, THEOR APPL GENET, V118, P1199, DOI 10.1007/s00122-009-0974-9; Gorman SW, 1997, CRIT REV PLANT SCI, V16, P31, DOI 10.1080/713608142; Gu JN, 2014, PLANT J, V80, P1005, DOI 10.1111/tpj.12694; Guo RX, 2006, THEOR APPL GENET, V112, P1271, DOI 10.1007/s00122-006-0228-z; Huang F, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-89; Ito T, 2007, PLANT CELL, V19, P3549, DOI 10.1105/tpc.107.054536; JACOBSEN SE, 1991, PLANT PHYSIOL, V97, P409, DOI 10.1104/pp.97.1.409; Jeong HJ, 2014, J EXP BOT; Jung KH, 2005, PLANT CELL, V17, P2705, DOI 10.1105/tpc.105.034090; Kaneko M, 2003, PLANT J, V35, P104, DOI 10.1046/j.1365-313X.2003.01780.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim OK, 2010, PLANTA, V232, P353, DOI 10.1007/s00425-010-1178-x; KOLTUNOW AM, 1990, PLANT CELL, V2, P1201, DOI 10.1105/tpc.2.12.1201; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lazan H, 2004, PLANT PHYSIOL BIOCH, V42, P847, DOI 10.1016/j.plaphy.2004.10.007; Li Han, 2011, J Biomed Biotechnol, V2011, P281651, DOI 10.1155/2011/281651; Li L, 2015, PLANTA, V241, P157, DOI 10.1007/s00425-014-2160-9; Li N, 2006, PLANT CELL, V18, P2999, DOI 10.1105/tpc.106.044107; Liu ZH, 2010, J INTEGR PLANT BIOL, V52, P670, DOI 10.1111/j.1744-7909.2010.00959.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu PL, 2014, PLANT PHYSIOL, V164, P1893, DOI 10.1104/pp.113.233387; Lu Q, 2005, MOL GENET GENOMICS, V273, P507, DOI 10.1007/s00438-005-1155-4; Mamun ANK, 2007, INDIAN J EXP BIOL, V45, P1022; MARIANI C, 1990, NATURE, V347, P737, DOI 10.1038/347737a0; Martin A, 2006, PLANT CELL, V18, P3252, DOI 10.1105/tpc.106.042689; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Nakamura A, 2003, BIOSCI BIOTECH BIOCH, V67, P68, DOI 10.1271/bbb.67.68; Nawaz-ul-Rehman MS, 2007, MOL BIOTECHNOL, V36, P159, DOI 10.1007/s12033-007-0025-1; Niu NN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2396; Omidvar V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2077-0; Omidvar V, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2015.02.0008; Omidvar V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121864; Piffanelli P, 1998, SEX PLANT REPROD, V11, P65, DOI 10.1007/s004970050122; Plackett ARG, 2012, PLANT CELL, V24, P941, DOI 10.1105/tpc.111.095109; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RASTOGI R, 1988, AM J BOT, V75, P513, DOI 10.2307/2444216; Rhee SY, 1998, PLANT J, V15, P79, DOI 10.1046/j.1365-313X.1998.00183.x; RICK. CHARLES M., 1948, HILGARDIA, V18, P599; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rong Z, 1996, ACTA BOT SIN, V38, P582; ROSS JJ, 1995, PLANT J, V7, P513, DOI 10.1046/j.1365-313X.1995.7030513.x; Sawhney V. K., 1997, Pollen biotechnology for crop production and improvement., P183, DOI 10.1017/CBO9780511525469.010; SAWHNEY VK, 1988, CAN J BOT, V66, P2013, DOI 10.1139/b88-275; Sawhney VK, 2004, J HORTIC SCI BIOTECH, V79, P138, DOI 10.1080/14620316.2004.11511726; Schreiber DN, 2004, PLANT PHYSIOL, V134, P1069, DOI 10.1104/pp.103.030577; Scott RJ, 2004, PLANT CELL, V16, pS46, DOI 10.1105/tpc.017012; Sheoran IS, 2009, J PROTEOMICS, V71, P624, DOI 10.1016/j.jprot.2008.10.006; SHUKLA A, 1994, PHYSIOL PLANTARUM, V91, P522, DOI 10.1111/j.1399-3054.1994.tb02983.x; SINGH S, 1992, PLANT SCI, V86, P147, DOI 10.1016/0168-9452(92)90160-N; SINGH S, 1992, PLANT CELL ENVIRON, V15, P373, DOI 10.1111/j.1365-3040.1992.tb00986.x; Smith MB, 2001, CROP SCI, V41, P702, DOI 10.2135/cropsci2001.413702x; Sun YJ, 2007, J INTEGR PLANT BIOL, V49, P60, DOI 10.1111/j.1744-7909.2006.00408.x; Tabuchi M, 2005, PLANT J, V42, P641, DOI 10.1111/j.1365-313X.2005.02406.x; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Vizcay-Barrena G, 2006, J EXP BOT, V57, P2709, DOI 10.1093/jxb/erl032; Wilson ZA, 2001, PLANT J, V28, P27, DOI 10.1046/j.1365-313X.2001.01125.x; Xu CG, 2013, PROTOPLASMA, V250, P415, DOI 10.1007/s00709-012-0386-6; Xu J, 2010, PLANT CELL, V22, P91, DOI 10.1105/tpc.109.071803; Yang C, 2007, PLANT CELL, V19, P3530, DOI 10.1105/tpc.107.054981; Yang X, 2014, J INTEGR PLANT BIOL; Yui R, 2003, PLANT J, V34, P57, DOI 10.1046/j.1365-313X.2003.01704.x; Zhang DS, 2008, MOL PLANT, V1, P599, DOI 10.1093/mp/ssn028; Zhang JY, 2012, J SCI FOOD AGR, V92, P3046, DOI 10.1002/jsfa.5722; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463; Zhao DZ, 2002, GENE DEV, V16, P2021, DOI 10.1101/gad.997902; Zhu J, 2008, PLANT J, V55, P266, DOI 10.1111/j.1365-313X.2008.03500.x; Zhu J, 2011, J INTEGR PLANT BIOL, V53, P892, DOI 10.1111/j.1744-7909.2011.01078.x; Zhu Y, 2010, PLANT MOL BIOL, V72, P111, DOI 10.1007/s11103-009-9556-0	82	14	15	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170715	10.1371/journal.pone.0170715	http://dx.doi.org/10.1371/journal.pone.0170715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178307	Green Published, gold, Green Accepted			2022-12-26	WOS:000393712500013
J	Cortez-Toledo, O; Schnair, C; Sangngern, P; Metzger, D; Chao, LC				Cortez-Toledo, Omar; Schnair, Caitlin; Sangngern, Peer; Metzger, Daniel; Chao, Lily C.			Nur77 deletion impairs muscle growth during developmental myogenesis and muscle regeneration in mice	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; IMPROVES METABOLIC PARAMETERS; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; NUCLEAR RECEPTORS; STRIATED-MUSCLE; FIBER GROWTH; STEM-CELLS; IN-VIVO; ATROPHY	Muscle atrophy is a prevalent condition in illness and aging. Identifying novel pathways that control muscle mass may lead to therapeutic advancement. We previously identified Nur77 as a transcriptional regulator of glycolysis in skeletal muscle. More recently, we showed that Nur77 expression also controls myofiber size in mice. It was unknown, however, whether Nur77's regulation of muscle size begins during developmental myogenesis or only in adulthood. To determine the importance of Nur77 throughout muscle growth, we examined myofiber size at E18.5, 3 weeks postnatal age, and in young adult mice. Using the global Nur77(-/-) mice, we showed that Nur77 deficiency reduced myofiber size as early as E18.5. The reduction in myofiber size became more pronounced by 3 weeks of age. We observed comparable reduction in myofiber size in young myofiber-specific Nur77-knockout mice. These findings suggest that Nur77's effect on muscle growth is intrinsic to its expression in differentiating myofibers, and not dependent on its expression in myogenic stem cells. To determine the importance of Nur77 expression in muscle accretion in mature mice, we generated an inducible-, muscle-specific, Nur77-deficient mouse model. We demonstrated that tamoxifen-induced deletion of Nur77 in 3-month-old mice reduced myofiber size. This change was accompanied by increased activity of Smad2 and FoxO3, two negative regulators of muscle mass. The role of Nur77 in muscle growth was further elaborated in the cardiotoxin-induced muscle regeneration model. Compared to wildtype mice, regenerated myofibers were smaller in Nur77(-/-) mice. However, when normalized to saline-injected muscle, the recovery of sarcoplasmic area was comparable between Nur77(-/-) and wildtype mice. These findings suggest that Nur77 deficiency compromises myofiber growth, but not the regenerative capacity of myogenic progenitor cells. Collectively, the findings presented here demonstrate Nur77 as an important regulator of muscle growth both during prenatal and postnatal myogenesis.	[Cortez-Toledo, Omar; Schnair, Caitlin; Sangngern, Peer; Chao, Lily C.] Childrens Hosp Los Angeles, Ctr Endocrinol Diabet & Metab, Los Angeles, CA 90027 USA; [Metzger, Daniel] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS UMR7104, INSERM U964, Illkirch Graffenstaden, France; [Chao, Lily C.] Univ Southern Calif, Keck Sch Med, Dept Biochem Mol Biol, Los Angeles, CA 90007 USA	Children's Hospital Los Angeles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Southern California	Chao, LC (corresponding author), Childrens Hosp Los Angeles, Ctr Endocrinol Diabet & Metab, Los Angeles, CA 90027 USA.; Chao, LC (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Biochem Mol Biol, Los Angeles, CA 90007 USA.	lchao@chla.usc.edu		Metzger, Daniel/0000-0002-5555-046X	Saban Research Institute	Saban Research Institute	The study was funded by The Saban Research Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrechek ER, 2002, MOL CELL BIOL, V22, P4714, DOI 10.1128/MCB.22.13.4714-4722.2002; BAUMAN WA, 1994, METABOLISM, V43, P749, DOI 10.1016/0026-0495(94)90126-0; Bentzinger CF, 2013, BIOESSAYS, V35, P231, DOI 10.1002/bies.201200063; Bertaggia E, 2012, AM J PHYSIOL-CELL PH, V302, pC587, DOI 10.1152/ajpcell.00142.2011; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bruusgaard JC, 2006, J APPL PHYSIOL, V100, P2024, DOI 10.1152/japplphysiol.00913.2005; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Catoire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051066; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Chao LC, 2012, J LIPID RES, V53, P2610, DOI 10.1194/jlr.M029355; Chao LC, 2009, DIABETES, V58, P2788, DOI 10.2337/db09-0763; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Clemmons DR, 2004, HORM RES, V62, P77, DOI 10.1159/000080763; Danon MJ, 2007, CLIN BIOCHEM, V40, P46, DOI 10.1016/j.clinbiochem.2006.09.002; Das S, 2015, CELL METAB, V21, P868, DOI 10.1016/j.cmet.2015.05.006; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; DUCKWORTH WC, 1980, DIABETES, V29, P906, DOI 10.2337/diabetes.29.11.906; Flaig R, 2005, J BIOL CHEM, V280, P19250, DOI 10.1074/jbc.M413175200; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Kanzleiter T, 2005, PHYSIOL GENOMICS, V24, P37, DOI 10.1152/physiolgenomics.00204.2005; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Leger B, 2009, MUSCLE NERVE, V40, P69, DOI 10.1002/mus.21293; Li MS, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0091-8; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; McCarthy JJ, 2010, CURR OPIN CLIN NUTR, V13, P230, DOI 10.1097/MCO.0b013e32833781b5; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Myers SA, 2009, MOL CELL ENDOCRINOL, V309, P101, DOI 10.1016/j.mce.2009.05.006; Nilwik R, 2013, EXP GERONTOL, V48, P492, DOI 10.1016/j.exger.2013.02.012; O'Neill BT, 2016, J CLIN INVEST, V126, P3433, DOI 10.1172/JCI86522; ONTELL M, 1984, AM J ANAT, V171, P133, DOI 10.1002/aja.1001710202; Pasut A, 2012, METHODS MOL BIOL, V798, P53, DOI 10.1007/978-1-61779-343-1_3; Ramirez-Herrick AM, 2011, BLOOD, V117, P2681, DOI 10.1182/blood-2010-02-267906; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schakman O, 2013, INT J BIOCHEM CELL B, V45, P2163, DOI 10.1016/j.biocel.2013.05.036; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; SMITH TH, 1992, DEV BIOL, V149, P16, DOI 10.1016/0012-1606(92)90260-N; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Suetta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051238; Tando T, 2016, J BIOL CHEM, V291, P12184, DOI 10.1074/jbc.M115.680579; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Tontonoz P, 2015, MOL CELL BIOL, V35, P1125, DOI 10.1128/MCB.00715-14; Tsai S, 2015, J CLIN INVEST, V125, P2952, DOI 10.1172/JCI77361; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Wu XX, 2007, ENDOCRINE, V31, P5, DOI 10.1007/s12020-007-0007-x; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334	68	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171268	10.1371/journal.pone.0171268	http://dx.doi.org/10.1371/journal.pone.0171268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170423	Green Published, gold, Green Submitted			2022-12-26	WOS:000393705500026
J	Perera, RS; Ding, XC; Tully, F; Oliver, J; Bright, N; Bell, D; Chiodini, PL; Gonzalez, IJ; Polley, SD				Perera, Rushini S.; Ding, Xavier C.; Tully, Frank; Oliver, James; Bright, Nigel; Bell, David; Chiodini, Peter L.; Gonzalez, Iveth J.; Polley, Spencer D.			Development and clinical performance of high throughput loop-mediated isothermal amplification for detection of malaria	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; BLOOD; LAMP; KIT; SENSITIVITY; POINT	Background Accurate and efficient detection of sub-microscopic malaria infections is crucial for enabling rapid treatment and interruption of transmission. Commercially available malaria LAMP kits have excellent diagnostic performance, though throughput is limited by the need to prepare samples individually. Here, we evaluate the clinical performance of a newly developed high throughput (HTP) sample processing system for use in conjunction with the Eiken malaria LAMP kit. Methods The HTP system utilised dried blood spots (DBS) and liquid whole blood (WB), with parallel sample processing of 94 samples per run. The system was evaluated using 699 samples of known infection status pre-determined by gold standard nested PCR. Results The sensitivity and specificity of WB-HTP-LAMP was 98.6% (95% CI, 95.7-100), and 99.7% (95% CI, 99.2-100); sensitivity of DBS-HTP-LAMP was 97.1% (95% CI, 93.1-100), and specificity 100% against PCR. At parasite densities greater or equal to 2 parasites/mu L, WB and DBS HTP-LAMP showed 100% sensitivity and specificity against PCR. At densities less than 2 p/mu L, WB-HTP-LAMP sensitivity was 88.9% (95% CI, 77.1-100) and specificity was 99.7% (95% CI, 99.2-100); sensitivity and specificity of DBS-HTP-LAMP was 77.8% (95% CI, 54.3-99.5) and 100% respectively. Conclusions The HTP-LAMP system is a highly sensitive diagnostic test, with the potential to allow large scale population screening in malaria elimination campaigns.	[Perera, Rushini S.; Chiodini, Peter L.] Univ Coll London Hosp NHS Fdn Trust, Hosp Trop Dis, Dept Clin Parasitol, London, England; [Ding, Xavier C.; Gonzalez, Iveth J.] FIND, CH-1202 Geneva, Switzerland; [Tully, Frank; Oliver, James] 42 Technol Ltd, St Ives, Cambs, England; [Bright, Nigel] Porvair Sci Ltd, Norwich, Norfolk, England; [Bell, David] Global Good Fund, Intellectual Ventures Lab, Bellevue, WA USA; [Chiodini, Peter L.] London Sch Hyg & Trop Med, Keppel St, London, England; [Chiodini, Peter L.; Polley, Spencer D.] Hlth Serv Labs LLP, Hosp Trop Dis, Dept Clin Parasitol, London, England	University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University College London; Foundation For Innovative New Diagnostics; Intellectual Ventures; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine	Perera, RS (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Hosp Trop Dis, Dept Clin Parasitol, London, England.	Rushini.Perera@uclh.nhs.uk			BMBF (German Ministry of Research and Education) through KfW (German Development Bank) Grant name : BMBF Kfw [202060457]; National Institute for Health Research University College Londan Hospitals Biomedical Research Centre; FIND	BMBF (German Ministry of Research and Education) through KfW (German Development Bank) Grant name : BMBF Kfw; National Institute for Health Research University College Londan Hospitals Biomedical Research Centre; FIND	This work was supported by FIND, with funding from BMBF (German Ministry of Research and Education) through KfW (German Development Bank) Grant name: BMBF Kfw Grant number: 202060457. PLC is supported by the National Institute for Health Research University College Londan Hospitals Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin-Schmidt B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169037; Aydin-Schmidt B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103905; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Britton S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004443; Britton S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0848-3; Cook J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0573-y; FIND, MAN STAND OP PROC MA; Han ET, 2013, EXPERT REV MOL DIAGN, V13, P205, DOI [10.1586/erm.12.144, 10.1586/ERM.12.144]; Hopkins H, 2008, J INFECT DIS, V197, P510, DOI 10.1086/526502; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Lucchi N. W., 2016, PLOS ONE, V11; Lucchi NW, 2016, SCI REP-UK, V6, DOI 10.1038/srep36808; Modak SS, 2016, INFECT DIS RES TREAT, V9; Morris U, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0731-2; Mouatcho JC, 2013, J MED MICROBIOL, V62, P1491, DOI 10.1099/jmm.0.052506-0; Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179; Padley DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-139; Poirot E, 2013, COCHRANE DATABASE SY, V12; Polley SD, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0558-x; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Polley SD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-62; Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10; Poon LLM, 2006, CLIN CHEM, V52, P303; Rakotonirina H, 2008, AM J TROP MED HYG, V78, P217, DOI 10.4269/ajtmh.2008.78.217; Shokoples SE, 2009, J CLIN MICROBIOL, V46; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Vallejo AF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003453; WHO, 1999, NEW PERSP MAL DIAGN; WHO, 2015, GLOB TECHN STRAT MAL; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2015, WORLD MAL REP 2015; World Health Organization, 2014, EV REV GROUP MAL DIA	34	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171126	10.1371/journal.pone.0171126	http://dx.doi.org/10.1371/journal.pone.0171126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166235	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000393700100025
J	Ruskin, DN; Murphy, MI; Slade, SL; Masino, SA				Ruskin, David N.; Murphy, Michelle I.; Slade, Sierra L.; Masino, Susan A.			Ketogenic diet improves behaviors in a maternal immune activation model of autism spectrum disorder	PLOS ONE			English	Article							ADENYLOSUCCINATE LYASE DEFICIENCY; FETAL-BRAIN-DEVELOPMENT; OF-THE-LITERATURE; ADULT MICE; METABOLISM; ADENOSINE; INFECTION; EPILEPTOGENESIS; SYMPTOMS; CHILDREN	Prenatal factors influence autism spectrum disorder (ASD) incidence in children and can increase ASD symptoms in offspring of animal models. These may include maternal immune activation (MIA) due to viral or bacterial infection during the first trimesters. Unfortunately, regardless of ASD etiology, existing drugs are poorly effective against core symptoms. For nearly a century a ketogenic diet (KD) has been used to treat seizures, and recent insights into mechanisms of ASD and a growing recognition that immune/inflammatory conditions exacerbate ASD risk has increased interest in KD as a treatment for ASD. Here we studied the effects of KD on core ASD symptoms in offspring exposed to MIA. To produce MIA, pregnant C57BI/6 mice were injected with the viral mimic polyinosinic-polycytidylic acid; after weaning offspring were fed KD or control diet for three weeks. Consistent with an ASD phenotype of a higher incidence in males, control diet-fed MIA male offspring were not social and exhibited high levels of repetitive self-directed behaviors; female offspring were unaffected. However, KD feeding partially or completely reversed all MIA-induced behavioral abnormalities in males; it had no effect on behavior in females. KD-induced metabolic changes of reduced blood glucose and elevated blood ketones were quantified in offspring of both sexes. Prior work from our laboratory and others demonstrate KDs improve relevant behaviors in several ASD models, and here we demonstrate clear benefits of KD in the MIA model of ASD. Together these studies suggest a broad utility for metabolic therapy in improving core ASD symptoms, and support further research to develop and apply ketogenic and/or metabolic strategies in patients with ASD.	[Ruskin, David N.; Murphy, Michelle I.; Slade, Sierra L.; Masino, Susan A.] Trinity Coll, Dept Psychol, Neurosci Program, Hartford, CT 06106 USA	Trinity College	Ruskin, DN (corresponding author), Trinity Coll, Dept Psychol, Neurosci Program, Hartford, CT 06106 USA.	david.ruskin@trincoll.edu			National Institute of Neurological Disease and Stroke [NS066392, NS065957]; National Center for Complementary and Integrative Health [AT008742]; National Center for Complementary & Integrative Health [R15AT008742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065957, R15NS066392] Funding Source: NIH RePORTER	National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Complementary and Integrative Health; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work received support from the following sources: National Institute of Neurological Disease and Stroke, NS066392, NS 065957 (SAM), www.ninds.nih.gov/ and the National Center for Complementary and Integrative Health, AT008742 (DNR), https://nccih.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahn Y, 2014, DEV NEUROSCI-BASEL, V36, P371, DOI 10.1159/000362645; Arvio Maria, 2010, Duodecim, V126, P557; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Atladottir HO, 2012, PEDIATRICS, V130, pE1447, DOI 10.1542/peds.2012-1107; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Castro K., 2016, NUTR NEUROS IN PRESS; Castro K, 2015, RES AUTISM SPECT DIS, V20, P31, DOI 10.1016/j.rasd.2015.08.005; Chen JY, 2016, J HUNTINGTONS DIS, V5, P65, DOI 10.3233/JHD-150181; Dupuis N, 2015, EPILEPSIA, V56, pe95, DOI 10.1111/epi.13038; Eapen V, 2011, AUTISM NEURODEVELOPM, P103; El-Ansary A, 2010, CLIN BIOCHEM, V43, P63, DOI 10.1016/j.clinbiochem.2009.09.008; Evangeliou A, 2003, J CHILD NEUROL, V18, P113, DOI 10.1177/08830738030180020501; Frye RE, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-37; GALEF BG, 1983, ANIM BEHAV, V31, P748, DOI 10.1016/S0003-3472(83)80232-2; Gano LB, 2014, J LIPID RES, V55, P2211, DOI 10.1194/jlr.R048975; Grindstaff JL, 2012, HORM BEHAV, V62, P337, DOI 10.1016/j.yhbeh.2012.04.005; HAAS RH, 1986, AM J MED GENET, V24, P225; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Herbert MR, 2013, J CHILD NEUROL, V28, P975, DOI 10.1177/0883073813488668; Jiang Y, 2012, NEUROSCI LETT, V508, P22, DOI 10.1016/j.neulet.2011.12.002; Jurecka A, 2014, NEUROPEDIATRICS, V45, P50, DOI 10.1055/s-0033-1337335; Kawamura M, 2014, J LIPID RES, V55, P2254, DOI 10.1194/jlr.M046755; Kawamura M, 2010, J NEUROSCI, V30, P3886, DOI 10.1523/JNEUROSCI.0055-10.2010; Lee BK, 2015, BRAIN BEHAV IMMUN, V44, P100, DOI 10.1016/j.bbi.2014.09.001; Liebhaber GM, 2003, J CHILD NEUROL, V18, P74, DOI 10.1177/08830738030180011801; Lusardi TA, 2015, NEUROPHARMACOLOGY, V99, P500, DOI 10.1016/j.neuropharm.2015.08.007; Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011; Marie S, 2002, AM J HUM GENET, V71, P14, DOI 10.1086/341036; Masino SA, 2009, CURR NEUROPHARMACOL, V7, P257, DOI 10.2174/157015909789152164; Masino S.A., 2015, HOMEOSTATIC CONTROL, P586; Masino SA, 2013, NEUROPHARMACOLOGY, V68, P116, DOI 10.1016/j.neuropharm.2012.08.013; Masino SA, 2011, NEUROSCI LETT, V500, P1, DOI 10.1016/j.neulet.2011.06.007; Masino SA, 2011, J CLIN INVEST, V121, P2679, DOI 10.1172/JCI57813; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Mueller BR, 2007, PHYSIOL BEHAV, V91, P55, DOI 10.1016/j.physbeh.2007.01.017; Nandivada P, 2016, LIPIDS, V51, P703, DOI 10.1007/s11745-016-4156-7; Napoli E, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00069; Naviaux JC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.33; Naviaux RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057380; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Page T, 2002, PROG NEURO-PSYCHOPH, V26, P397, DOI 10.1016/S0278-5846(01)00249-4; Page T, 2000, BBA-MOL BASIS DIS, V1500, P291, DOI 10.1016/S0925-4439(99)00113-1; Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001; Patterson PH, 2002, CURR OPIN NEUROBIOL, V12, P115, DOI 10.1016/S0959-4388(02)00299-4; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Ruskin DN, 2017, PHYSIOL BEHAV, V168, P138, DOI 10.1016/j.physbeh.2016.10.023; Ruskin DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065021; Ruskin DN, 2013, J PAIN, V14, P467, DOI 10.1016/j.jpain.2012.12.015; Ruskin DN, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00033; Smith J, 2016, BEHAV BRAIN RES, V304, P67, DOI 10.1016/j.bbr.2016.02.015; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Spilioti M, 2016, EUR J PAEDIATR NEURO, V20, P555, DOI 10.1016/j.ejpn.2016.04.003; Spilioti M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00858; Todorova MT, 2000, EPILEPSIA, V41, P933, DOI 10.1111/j.1528-1157.2000.tb00275.x; Verpeut JL, 2016, PHYSIOL BEHAV, V161, P90, DOI 10.1016/j.physbeh.2016.04.001; Weissman JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003815; Xuan ICY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104433; Zerbo O, 2015, J AUTISM DEV DISORD, V45, P4015, DOI 10.1007/s10803-013-2016-3; Zilkha N, NEUROSCIENC IN PRESS; [No title captured]	60	58	58	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171643	10.1371/journal.pone.0171643	http://dx.doi.org/10.1371/journal.pone.0171643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166277	gold, Green Published, Green Submitted			2022-12-26	WOS:000393700100058
J	Sinapayen, L; Masumori, A; Ikegami, T				Sinapayen, Lana; Masumori, Atsushi; Ikegami, Takashi			Learning by stimulation avoidance: A principle to control spiking neural networks dynamics	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; SYNAPTIC PLASTICITY; CORTICAL-NEURONS; VISUAL-CORTEX; MODEL; STDP; MEMORY; RAT	Learning based on networks of real neurons, and learning based on biologically inspired models of neural networks, have yet to find general learning rules leading to widespread applications. In this paper, we argue for the existence of a principle allowing to steer the dynamics of a biologically inspired neural network. Using carefully timed external stimulation, the network can be driven towards a desired dynamical state. We term this principle "Learning by Stimulation Avoidance" (LSA). We demonstrate through simulation that the minimal sufficient conditions leading to LSA in artificial networks are also sufficient to reproduce learning results similar to those obtained in biological neurons by Shahaf and Marom, and in addition explains synaptic pruning. We examined the underlying mechanism by simulating a small network of 3 neurons, then scaled it up to a hundred neurons. We show that LSA has a higher explanatory power than existing hypotheses about the response of biological neural networks to external simulation, and can be used as a learning rule for an embodied application: learning of wall avoidance by a simulated robot. In other works, reinforcement learning with spiking networks can be obtained through global reward signals akin simulating the dopamine system; we believe that this is the first project demonstrating sensory- motor learning with random spiking networks through Hebbian learning relying on environmental conditions without a separate reward system.	[Sinapayen, Lana; Masumori, Atsushi; Ikegami, Takashi] Univ Tokyo, Ikegami Lab, Tokyo, Japan; [Sinapayen, Lana] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan	University of Tokyo; University of Tokyo	Sinapayen, L (corresponding author), Univ Tokyo, Ikegami Lab, Tokyo, Japan.; Sinapayen, L (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan.	lana@sacral.c.u-tokyo.ac.jp		Sinapayen, Lana/0000-0003-2270-2954; Masumori, Atsushi/0000-0001-7150-0684	 [24300080]		This work was supported by Grant-in-Aid for Scientific Research (Studies on 343 HomeoDynamics with Cultivated Neural Circuits and Embodied Artificial Neural Net-344 works; 24300080).	Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Bush D, 2010, NEURAL COMPUT, V22, P2059, DOI 10.1162/NECO_a_00003-Bush; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Chadderdon GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047251; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; GUTHRIE ER, 1946, PSYCHOL BULL, V43, P1, DOI 10.1037/h0061712; Hebb Donald O., 1949, ORG BEHAV; Hull C.L., 1943, PRINCIPLES BEHAV INT, DOI DOI 10.2307/1416955; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Jacob V, 2007, J NEUROSCI, V27, P1271, DOI 10.1523/JNEUROSCI.4264-06.2007; Lisman J., 2010, SPIKE TIMING DEPENDE, V26, P53; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; Masumori A, 2015, 13 EUR C ART LIF ECA, P373; MEINECKE DL, 1987, J COMP NEUROL, V261, P388, DOI 10.1002/cne.902610305; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Neymotin SA, 2013, NEURAL COMPUT, V25, P3263, DOI 10.1162/NECO_a_00521; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Shefi O, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021905; Sinapayen L, 2015, 13 EUR C ART LIF ECA, P175; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005	28	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170388	10.1371/journal.pone.0170388	http://dx.doi.org/10.1371/journal.pone.0170388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158309	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700011
J	Zhang, G; Gao, F				Zhang, Ge; Gao, Feng			Quantitative analysis of correlation between AT and GC biases among bacterial genomes	PLOS ONE			English	Article							ASYMMETRIC SUBSTITUTION PATTERNS; REPLICATION FORK; LAGGING STRANDS; ORIC REGIONS; DIRECTION; DATABASE; SKEW	Due to different replication mechanisms between the leading and lagging strands, nucleotide composition asymmetries widely exist in bacterial genomes. A general consideration reveals that the leading strand is enriched in Guanine (G) and Thymine (T), and the lagging strand shows richness in Adenine (A) and Cytosine (C). However, some bacteria like Bacillus subtilis have been discovered composing more A than T in the leading strand. To investigate the difference, we analyze the nucleotide asymmetry from the aspect of AT and GC bias correlations. In this study, we propose a windowless method, the Z-curve Correlation Coefficient (ZCC) index, based on the Z-curve method, and analyzed more than 2000 bacterial genomes. We find that the majority of bacteria reveal negative correlations between AT and GC biases, while most genomes in Firmicutes and Tenericutes have positive ZCC indexes. The presence of PolC, purine asymmetry and stronger genes preference in the leading strand are not confined to Firmicutes, but also likely to happen in other phyla dominated by positive ZCC indexes. This method also provides a new insight into other relevant features like aerobism, and can be applied to analyze the correlation between RY (Purine and Pyrimidine) and MK (Amino and Keto) bias and so on.	[Zhang, Ge; Gao, Feng] Tianjin Univ, Dept Phys, Tianjin, Peoples R China; [Gao, Feng] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin, Peoples R China; [Gao, Feng] Tianjin Univ, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, SynBio Res Platform, Tianjin, Peoples R China	Tianjin University; Tianjin University; Tianjin University	Gao, F (corresponding author), Tianjin Univ, Dept Phys, Tianjin, Peoples R China.; Gao, F (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin, Peoples R China.; Gao, F (corresponding author), Tianjin Univ, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, SynBio Res Platform, Tianjin, Peoples R China.	fgao@tju.edu.cn	Gao, Feng/C-9913-2009	Gao, Feng/0000-0002-9563-3841	National Natural Science Foundation of China [31571358, 21621004, 31171238]; China National 863 High-Tech Program [2015AA020101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National 863 High-Tech Program(National High Technology Research and Development Program of China)	This work was funded by National Natural Science Foundation of China (Grant Nos. 31571358, 21621004, and 31171238) and the China National 863 High-Tech Program (2015AA020101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Dervyn E, 2001, SCIENCE, V294, P1716, DOI 10.1126/science.1066351; Eppinger M, 2004, NAT REV MICROBIOL, V2, P872, DOI 10.1038/nrmicro1024; Frank AC, 1999, GENE, V238, P65, DOI 10.1016/S0378-1119(99)00297-8; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gao F, 2007, BIOINFORMATICS, V23, P1866, DOI 10.1093/bioinformatics/btm255; Gao F, 2014, CURR GENOMICS, V15, P104, DOI 10.2174/1389202915999140328162938; Gao F, 2013, NUCLEIC ACIDS RES, V41, pD90, DOI 10.1093/nar/gks990; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Guo FB, 2012, CURR GENOMICS, V13, P2, DOI 10.2174/138920212799034794; Higgins HP., 2007, MOL MICROBIOL, V64, P42, DOI [10.1111/j.1365-2958.2007.05596.x, DOI 10.1111/J.1365-2958.2007.05596.X]; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hu JF, 2007, GENOMICS, V90, P186, DOI 10.1016/j.ygeno.2007.04.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Lao PJ, 2000, GENOME RES, V10, P228, DOI 10.1101/gr.10.2.228; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Ludwig W., 2009, BERGEYS MANUAL SYSTE; Marin A, 2008, J THEOR BIOL, V253, P508, DOI 10.1016/j.jtbi.2008.04.004; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Qu HZ, 2010, RES MICROBIOL, V161, P838, DOI 10.1016/j.resmic.2010.09.015; Saha SK, 2014, BMC GENOMICS, V164, P828; Tillier ERM, 2000, J MOL EVOL, V50, P249, DOI 10.1007/s002399910029; Timinskas K, 2014, NUCLEIC ACIDS RES, V42, P1393, DOI 10.1093/nar/gkt900; Zhang R, 2014, CURR GENOMICS, V15, P78, DOI 10.2174/1389202915999140328162433; Zhang Z, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-63	28	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171408	10.1371/journal.pone.0171408	http://dx.doi.org/10.1371/journal.pone.0171408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158313	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700075
J	Luo, S; Li, Y; Ma, R; Liu, J; Xu, P; Zhang, H; Tang, K; Ma, J; Liu, N; Zhang, Y; Sun, Y; Ji, T; Liang, X; Yin, X; Liu, Y; Tong, W; Niu, Y; Wang, N; Wang, X; Huang, B				Luo, S.; Li, Y.; Ma, R.; Liu, J.; Xu, P.; Zhang, H.; Tang, K.; Ma, J.; Liu, N.; Zhang, Y.; Sun, Y.; Ji, T.; Liang, X.; Yin, X.; Liu, Y.; Tong, W.; Niu, Y.; Wang, N.; Wang, X.; Huang, B.			Downregulation of PCK2 remodels tricarboxylic acid cycle in tumor-repopulating cells of melanoma	ONCOGENE			English	Article							CYTOSOLIC PHOSPHOENOLPYRUVATE CARBOXYKINASE; ATP-CITRATE LYASE; CANCER; GROWTH; INHIBITION; ADAPTATION; EXPRESSION; SUCCINATE; FUMARATE; FH	For cancer cells to proliferate, a balance must be built between biomass-forming, glucose-metabolized intermediates and ATP production. How intrinsic glucose carbon flow regulates this balance remains unclear. Here we show that mitochondrial phosphoenolpyruvate carboxykinase (PCK2), the hub molecule linking tricarboxylic acid (TCA) cycle, glycolysis and gluconeogenesis by conversion of mitochondrial oxaloacetate (OAA) to phosphoenolpyruvate, regulates glucose carbon flow direction in stem-like cells that repopulate tumors (tumor-repopulating cells (TRCs)). PCK2 downregulation accelerated biosynthesis and transportation of citrate from mitochondria to the cytosol, leading to cytosolic glucose carbon flow via OAA-malate-pyruvate and acetyl-CoA-fatty acid pathways in TRCs. On the other hand, downregulating PCK2 hindered fumarate carbon flows in TCA cycle, leading to attenuated oxidative phosphorylation. In pathological terms, PCK2 overexpression slowed TRC growth in vitro and impeded tumorigenesis in vivo. Overall, our work unveiled unexpected glucose carbon flows of TRCs in melanoma that have implications for targeting metabolic aspects of melanoma.	[Luo, S.; Li, Y.; Ma, R.; Liu, J.; Xu, P.; Tang, K.; Ma, J.; Liu, N.; Zhang, Y.; Sun, Y.; Ji, T.; Huang, B.] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan, Peoples R China; [Zhang, H.; Liang, X.; Yin, X.; Liu, Y.; Wang, X.; Huang, B.] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing, Peoples R China; [Zhang, H.; Liang, X.; Yin, X.; Liu, Y.; Huang, B.] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Dong Dan San Tiao 5, Beijing 100005, Peoples R China; [Zhang, H.; Liang, X.; Yin, X.; Liu, Y.; Tong, W.; Niu, Y.; Wang, X.; Huang, B.] Peking Union Med Coll, Dong Dan San Tiao 5, Beijing 100005, Peoples R China; [Tong, W.; Niu, Y.] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathol, Beijing, Peoples R China; [Wang, N.] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Lab Cell Biomech & Regenerat Med, Wuhan, Peoples R China; [Wang, N.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL USA	Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Huazhong University of Science & Technology; University of Illinois System; University of Illinois Urbana-Champaign	Huang, B (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Dong Dan San Tiao 5, Beijing 100005, Peoples R China.; Huang, B (corresponding author), Peking Union Med Coll, Dong Dan San Tiao 5, Beijing 100005, Peoples R China.	tjhuangbo@hotmail.com	Ma, Ruihua/K-2183-2019	Li, Yong/0000-0001-8265-577X; Liu, Na/0000-0001-9903-1314; luo, shunqun/0000-0002-5728-2112	National Basic Research Program of China [2014CB542100]; National Natural Science Foundation of China [81472653, 81530080, 81661128007]; CAMS Initiative for Innovative Medicine [2016-I2M-1-007]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Initiative for Innovative Medicine	This work was supported by National Basic Research Program of China (2014CB542100), National Natural Science Foundation of China (81472653, 81530080, 81661128007) and CAMS Initiative for Innovative Medicine (2016-I2M-1-007).	Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Cairns RA, 2006, NAT REV CANCER, V11, P85; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Costello LC, 2005, MOL CELL BIOCHEM, V280, P1, DOI 10.1007/s11010-005-8841-8; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Klein WM, 2007, MODERN PATHOL, V20, P102, DOI 10.1038/modpathol.3800720; Kolukula VK, 2014, ONCOTARGET, V5, P1212, DOI 10.18632/oncotarget.1831; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Leithner K, 2015, ONCOGENE, V34, P1044, DOI 10.1038/onc.2014.47; Li Y, 2015, CANCER RES, V75, P1191, DOI 10.1158/0008-5472.CAN-14-2615; Liu J, 2012, NAT MATER, V11, P734, DOI [10.1038/nmat3361, 10.1038/NMAT3361]; Mendez-Lucas A, 2014, J BIOL CHEM, V289, P22090, DOI 10.1074/jbc.M114.566927; Montal ED, 2015, MOL CELL, V60, P571, DOI 10.1016/j.molcel.2015.09.025; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Vincent EE, 2015, MOL CELL, V60, P195, DOI 10.1016/j.molcel.2015.08.013; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Yang H, 2015, EMBO J, V34, P1110, DOI 10.15252/embj.201591041; Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112; Zelle RM, 2008, APPL ENVIRON MICROB, V74, P2766, DOI 10.1128/AEM.02591-07	27	34	37	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 22	2017	36	25					3609	3617		10.1038/onc.2016.520	http://dx.doi.org/10.1038/onc.2016.520			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY3NL	28166201				2022-12-26	WOS:000403878600010
J	Regnell, SE; Hessner, MJ; Jia, S; Akesson, L; Stenlund, H; Moritz, T; La Torre, D; Lernmark, A				Regnell, Simon E.; Hessner, Martin J.; Jia, Shuang; Akesson, Lina; Stenlund, Hans; Moritz, Thomas; La Torre, Daria; Lernmark, Ake			Longitudinal analysis of hepatic transcriptome and serum metabolome demonstrates altered lipid metabolism following the onset of hyperglycemia in spontaneously diabetic biobreeding rats	PLOS ONE			English	Article							ORNITHINE DECARBOXYLASE; ISLET AUTOIMMUNITY; GENETIC DISSECTION; NOD MICE; BB RAT; TYPE-1; CHILDREN; PLASMA; IDENTIFICATION; LYMPHOPENIA	Type 1 diabetes is associated with abberations of fat metabolism before and after the clinical onset of disease. It has been hypothesized that the absence of the effect of insulin in the liver contributes to reduced hepatic fat synthesis. We measured hepatic gene expression and serum metabolites before and after the onset of hyperglycemia in a BioBreeding rat model of type 1 diabetes. Functional pathway annotation identified that lipid metabolism was differentially expressed in hyperglycemic rats and that these pathways significantly overlapped with genes regulated by insulin. 17 serum metabolites significantly changed in concentration. All but 2 of the identified metabolites had previously been reported in type 1 diabetes, and carbohydrates were overall the most upregulated class of metabolites. We conclude that lack of insulin in the liver contributes to the changes in fat metabolism observed in type 1 diabetes. Further studies are needed to understand the clinical consequences of a lack of insulin in the liver in patients with type 1 diabetes.	[Regnell, Simon E.; Akesson, Lina; La Torre, Daria; Lernmark, Ake] Lund Univ, Dept Clin Sci, Diabet & Celiac Dis Unit, Clin Res Ctr, Malmo, Sweden; [Regnell, Simon E.; Akesson, Lina; La Torre, Daria; Lernmark, Ake] Skane Univ Hosp, Malmo, Sweden; [Hessner, Martin J.; Jia, Shuang] Med Coll Wisconsin, Childrens Hosp Wisconsin, Childrens Res Inst, Max McGee Natl Res Ctr Juvenile Diabet, Milwaukee, WI 53226 USA; [Stenlund, Hans; Moritz, Thomas] Swedish Univ Agr Sci, Swedish Metabol Ctr, Umea, Sweden	Lund University; Lund University; Skane University Hospital; Children's Hospital of Wisconsin; Medical College of Wisconsin; Swedish University of Agricultural Sciences	Regnell, SE (corresponding author), Lund Univ, Dept Clin Sci, Diabet & Celiac Dis Unit, Clin Res Ctr, Malmo, Sweden.; Regnell, SE (corresponding author), Skane Univ Hosp, Malmo, Sweden.	simon.regnell@med.lu.se	Lernmark, Åke/F-8140-2015	Lernmark, Åke/0000-0003-1735-0499; Regnell, Simon/0000-0002-6672-8972; Stenlund, Hans/0000-0001-9943-296X; Moritz, Thomas/0000-0002-4258-3190	Swedish Research Council [K2011-54X-15312-07-6]; Juvenile Diabetes Research Foundation; Swedish Diabetes Foundation; SUS Funds; Skke County Council for Research and Development; National Institutes of Health [R01A1078713]; Children's Hospital of Wisconsin Foundation; Knut and Alice Wallenberg Foundation; UPSC Berzelii project; Biobanking and Molecular Resource Infrastructure of Sweden; Swedish Child Diabetes Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swedish Diabetes Foundation; SUS Funds; Skke County Council for Research and Development; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Wisconsin Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); UPSC Berzelii project; Biobanking and Molecular Resource Infrastructure of Sweden; Swedish Child Diabetes Foundation	AL has received support for this study from the Swedish Research Council (K2011-54X-15312-07-6), the Juvenile Diabetes Research Foundation, The Swedish Diabetes Foundation, SUS Funds, and the Skke County Council for Research and Development. MJH was supported by National Institutes of Health grant R01A1078713 and The Children's Hospital of Wisconsin Foundation. TM has received support from the Knut and Alice Wallenberg Foundation, the UPSC Berzelii project, and Biobanking and Molecular Resource Infrastructure of Sweden. SER and AL received a grant from the Swedish Child Diabetes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKANUMA Y, 1988, DIABETOLOGIA, V31, P831; Akesson L, 2008, EXP CLIN ENDOCR DIAB, V116, P475, DOI 10.1055/s-2008-1062713; Akesson L, 2011, METABOLOMICS, V7, P593, DOI 10.1007/s11306-011-0278-3; [Anonymous], 2011, COMM UPD GUID CAR US; Atkinson MA, 2009, CURR OPIN ENDOCRINOL, V16, P279, DOI 10.1097/MED.0b013e32832e06ba; Balderas C, 2013, ELECTROPHORESIS, V34, P2882, DOI 10.1002/elps.201300062; Chen XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139019; Dutta T, 2012, DIABETES, V61, P1004, DOI 10.2337/db11-0874; Fahrmann J, 2015, AM J PHYSIOL-ENDOC M, V308, pE978, DOI 10.1152/ajpendo.00019.2015; Fuller JM, 2009, PHYSIOL GENOMICS, V38, P89, DOI 10.1152/physiolgenomics.00015.2009; Fuller JM, 2006, DIABETES, V55, P3351, DOI 10.2337/db06-0715; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grapov D, 2015, METABOLOMICS, V11, P425, DOI 10.1007/s11306-014-0706-2; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YY, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-171; In't Veld P, 2007, DIABETES, V56, P2400, DOI 10.2337/db07-0416; JACOB HJ, 1992, NAT GENET, V2, P56, DOI 10.1038/ng0992-56; Kaldunski M, 2010, DIABETES, V59, P2375, DOI 10.2337/db10-0372; La Torre D, 2013, DIABETES, V62, P3951, DOI 10.2337/db13-0215; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; LEVINE JH, 1980, DIABETES, V29, P532, DOI 10.2337/diabetes.29.7.532; Llaurado G, 2014, J CLIN ENDOCR METAB; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Madsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035445; Mochida T, 2011, MOL GENET METAB, V103, P406, DOI 10.1016/j.ymgme.2011.05.002; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Overgaard AJ, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0889-1; Perseghin G, 2005, DIABETOLOGIA, V48, P2615, DOI 10.1007/s00125-005-0014-5; Regnell SE, 2013, DIABETIC MED, V30, P155, DOI 10.1111/dme.12099; Regnell SE, 2015, METABOLISM, V64, P872, DOI 10.1016/j.metabol.2015.04.002; Regnell Simon E, 2011, Rev Diabet Stud, V8, P454, DOI 10.1900/RDS.2011.8.454; Schauer N, 2005, FEBS LETT, V579, P1332, DOI 10.1016/j.febslet.2005.01.029; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sysi-Aho M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002257; Thomson SC, 2001, J CLIN INVEST, V107, P217, DOI 10.1172/JCI10963; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ugarte M, 2012, GENOME MED, V4, DOI 10.1186/gm334; Verges B, 2009, DIABETES METAB, V35, P353, DOI 10.1016/j.diabet.2009.04.004; YAMANOUCHI T, 1987, DIABETES, V36, P709, DOI 10.2337/diabetes.36.6.709; Zhang SC, 2008, ANAL BIOCHEM, V383, P76, DOI 10.1016/j.ab.2008.07.041; Zuppi C, 2002, CLIN CHEM, V48, P660	41	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171372	10.1371/journal.pone.0171372	http://dx.doi.org/10.1371/journal.pone.0171372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192442	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423800023
J	Aldhoon, B; Wichterle, D; Peichl, P; Cihak, R; Kautzner, J				Aldhoon, Bashar; Wichterle, Dan; Peichl, Petr; Cihak, Robert; Kautzner, Josef			Outcomes of ventricular tachycardia ablation in patients with structural heart disease: The impact of electrical storm	PLOS ONE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; PROPHYLACTIC CATHETER ABLATION; PRIMARY PREVENTION; NONISCHEMIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; CLINICAL PREDICTORS; SINGLE-CENTER; NONINDUCIBILITY; THERAPY; TERM	Aims To investigate predictors of long-term outcomes after catheter ablation (CA) for ventricular tachycardia (VT) and the impact of electrical storm (ES) prior to index ablation procedures. Methods We studied consecutive patients with structural heart disease and VT (n = 328; age: 63 +/- 12 years; 88% males; 72% ischaemic cardiomyopathy; LVEF: 32 +/- 12%) who had undergone CA. According to presenting arrhythmia at baseline, they were divided into ES (n = 93, 28%) and non-ES groups. Clinical predictors of all-cause mortality were investigated and a clinically useful risk score (SCORE) was constructed. Results During a median follow-up of 927 days (IQR: 564-1626), 67% vs. 60% of patients (p = 0.05) experienced VT recurrence in the ES vs. the non-ES group, respectively; and 41% vs. 32% patients died (p = 0.02), respectively. Five factors were independently associated with mortality: age >70 years (hazard ratio (HR): 1.6, 95% confidence interval (CI): 1.1-2.4, p = 0.01), NYHA class >= 3 (HR: 1.9, 95% CI: 1.2-2.9, p = 0.005), a serum creatinine level >1.3 mg/dL (HR: 1.6, 95% CI: 1.1-2.3, p = 0.02), LVEF <= 25% (HR: 2.4, 95% CI: 1.6-3.5, p = 0.00004), and amiodarone therapy (HR: 1.5, 95% CI: 1.0-2.2, p = 0.03). A risk SCORE ranging from 0-4 (1 point for either high-risk age, NYHA, creatinine, or LVEF) correlated with mortality. ES during index ablation independently predicted mortality only in patients with a SCORE <= 1. Conclusions Advanced LV dysfunction, older age, higher NYHA class, renal dysfunction, and amiodarone therapy, but not ES, were predictors of poor outcomes after CA for VT in the total population. However, ES did predict mortality in a low-risk sub-group of patients.	[Aldhoon, Bashar; Wichterle, Dan; Peichl, Petr; Cihak, Robert; Kautzner, Josef] Inst Clin & Expt Med IKEM, Dept Cardiol, Prague, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM)	Aldhoon, B (corresponding author), Inst Clin & Expt Med IKEM, Dept Cardiol, Prague, Czech Republic.	bashar.aldhoon@ikem.cz	Wichterle, Dan/G-7611-2017; Peichl, Petr/AAZ-9509-2021; Peichl, Petr/L-7255-2018	Wichterle, Dan/0000-0002-0448-5143; Peichl, Petr/0000-0002-5625-0071; Peichl, Petr/0000-0002-5625-0071; Aldhoon, Bashar/0000-0002-1845-847X				Bansch D, 2000, J AM COLL CARDIOL, V36, P566, DOI 10.1016/S0735-1097(00)00726-9; Brigadeau F, 2006, EUR HEART J, V27, P700, DOI 10.1093/eurheartj/ehi726; Calkins H, 2000, J AM COLL CARDIOL, V35, P1905, DOI 10.1016/S0735-1097(00)00615-X; Carbucicchio C, 2008, CIRCULATION, V117, P462, DOI 10.1161/CIRCULATIONAHA.106.686534; Della Bella P, 2013, CIRCULATION, V127, P1359, DOI 10.1161/CIRCULATIONAHA.112.000872; Deneke T, 2011, AM J CARDIOL, V108, P233, DOI 10.1016/j.amjcard.2011.03.030; Dinov B, 2015, CIRC-ARRHYTHMIA ELEC, V8, P598, DOI 10.1161/CIRCEP.114.002295; Dinov B, 2014, CIRCULATION, V129, P728, DOI 10.1161/CIRCULATIONAHA.113.003063; Exner DV, 2001, CIRCULATION, V104, P1564, DOI 10.1161/hc3801.096395; Gatzoulis KA, 2005, EUROPACE, V7, P184, DOI 10.1016/j.eupc.2005.01.003; Ghanbari H, 2014, CIRC-ARRHYTHMIA ELEC, V7, P677, DOI 10.1161/CIRCEP.113.001404; Guerra F, 2014, EUROPACE, V16, P347, DOI 10.1093/europace/eut304; Hayashi T, 2013, EUROPACE, V15, P1507, DOI 10.1093/europace/eut050; Kozeluhova M, 2011, EUROPACE, V13, P109, DOI 10.1093/europace/euq364; Kuck KH, 2010, LANCET, V375, P31, DOI 10.1016/S0140-6736(09)61755-4; Peichl P, 2014, CIRC-ARRHYTHMIA ELEC, V7, P684, DOI 10.1161/CIRCEP.114.001530; Piers SRD, 2013, CIRC-ARRHYTHMIA ELEC, V6, P513, DOI 10.1161/CIRCEP.113.000089; Reddy VY, 2007, NEW ENGL J MED, V357, P2657, DOI 10.1056/NEJMoa065457; Sesselberg HW, 2007, HEART RHYTHM, V4, P1395, DOI 10.1016/j.hrthm.2007.07.013; Tanner H, 2010, J CARDIOVASC ELECTR, V21, P47, DOI 10.1111/j.1540-8167.2009.01563.x	20	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171830	10.1371/journal.pone.0171830	http://dx.doi.org/10.1371/journal.pone.0171830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187168	gold, Green Submitted, Green Published			2022-12-26	WOS:000394244300047
J	Dishman, RK; Dowda, M; McIver, KL; Saunders, RP; Pate, RR				Dishman, Rod K.; Dowda, Marsha; McIver, Kerry L.; Saunders, Ruth P.; Pate, Russell R.			Naturally-occurring changes in social-cognitive factors modify change in physical activity during early adolescence	PLOS ONE			English	Article							MIDDLE-SCHOOL GIRLS; LONGITUDINAL ANALYSIS; ACTIVITY PLAN; MISSING DATA; 12TH GRADE; CHILDREN; BEHAVIOR; QUESTIONNAIRES; INTERVENTIONS; DETERMINANTS	Purpose To determine whether naturally-occurring changes in children's motives and beliefs are associated with the steep decline in physical activity observed from childhood to early adolescence. Methods Latent growth modeling was applied in longitudinal tests of social-cognitive influences, and their interactions, on physical activity in a large cohort of boys and girls evaluated annually between 5th and 7th grades. Results Measurement equivalence of motives and beliefs was confirmed between boys and girls. After adjustment for gender and maturity differences, physical activity declined less in children who reported the least decreases in self-efficacy for overcoming barriers to activity and perceived parental support. Physical activity also declined less in students who persistently felt they had more parental and friend support for activity compared to those who reported the largest decrease in support from friends. After further adjustment for race, the decline in physical activity was less in those who had the largest decrease in perceived barriers and maintained a favorable perception of their neighborhood environment. Changes in enjoyment and social motives were unrelated to change in physical activity. Conclusion Using an objective measure of physical activity, we confirm that naturally-occurring changes in children's beliefs about barriers to physical activity and their ability to overcome them, as well as perceptions of their neighborhood environment and social support, are concurrent with age-related declines in children's physical activity. The longitudinal findings confirm these putative social-cognitive mediators as plausible, interacting targets of interventions designed to mitigate the marked decline in physical activity that occurs during the transition between elementary and middle schools.	[Dishman, Rod K.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Dowda, Marsha; McIver, Kerry L.; Pate, Russell R.] Univ South Carolina, Dept Exercise Sci, Columbia, SC 29208 USA; [Saunders, Ruth P.] Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA	University System of Georgia; University of Georgia; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Dishman, RK (corresponding author), Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA.	rdishman@uga.edu	Dishman, Rodney/AAG-8047-2019		National Heart, Lung and Blood Institute [R01HL091002]	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was funded by a grant from the This study was funded by grant number R01HL091002 from the National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov/). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; American Community Survey, 2010, 2006 2010 AM COMM SU, DOI [10.1093/jpepsy/jsp031PMID:19433571, DOI 10.1093/JPEPSY/JSP031]; [Anonymous], PHYS ACT GUID AM MID; Atkin AJ, 2016, PREV MED, V87, P167, DOI 10.1016/j.ypmed.2016.02.040; Bandura A., 1986, SOCIAL FDN THOUGHT A, P1; Cairney J, 2014, MED SCI SPORT EXER, V46, P730, DOI 10.1249/MSS.0000000000000168; Catellier DJ, 2005, MED SCI SPORT EXER, V37, pS555, DOI 10.1249/01.mss.0000185651.59486.4e; Corder K, 2015, BRIT J SPORT MED, V49, P730, DOI 10.1136/bjsports-2013-093190; Corder K, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-69; Craggs C, 2011, AM J PREV MED, V40, P645, DOI 10.1016/j.amepre.2011.02.025; Cumming SP, 2014, SCAND J MED SCI SPOR, V24, pe20, DOI 10.1111/sms.12103; Dishman RK, 2002, PREV MED, V34, P100, DOI 10.1006/pmed.2001.0959; Dishman RK, 2005, MED SCI SPORT EXER, V37, P478, DOI 10.1249/01.MSS.0000155391.62733.A7; Dishman RK, 2013, J PEDIATR PSYCHOL, V38, P563, DOI 10.1093/jpepsy/jst013; Dishman RK, 2010, J PEDIATR PSYCHOL, V35, P188, DOI 10.1093/jpepsy/jsp042; Dishman RK, 2010, J PEDIATR PSYCHOL, V35, P72, DOI 10.1093/jpepsy/jsp031; Dishman RK, 2009, J PEDIATR PSYCHOL, V34, P441, DOI 10.1093/jpepsy/jsn100; Dowda M, 2007, PREV MED, V44, P153, DOI 10.1016/j.ypmed.2006.10.001; Dowda M, 2009, ANN BEHAV MED, V37, P77, DOI 10.1007/s12160-009-9080-0; Dumith SC, 2012, PEDIATR EXERC SCI, V24, P58, DOI 10.1123/pes.24.1.58; Elder JP, 2007, HEALTH EDUC RES, V22, P155, DOI 10.1093/her/cyl059; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Evenson KR, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-28; Hearst MO, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-8; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kraus WE, 2015, CIRCULATION, V131, P1932, DOI 10.1161/CIR.0000000000000203; Kremers SPJ, 2007, AM J PREV MED, V32, P163, DOI 10.1016/j.amepre.2006.10.006; Kriemler S, 2011, BRIT J SPORT MED, V45, P923, DOI 10.1136/bjsports-2011-090186; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Kwon S, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-68; Labbrozzi D, 2013, J ADOLESCENCE, V36, P759, DOI 10.1016/j.adolescence.2013.06.002; Laird Y, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0405-7; Lubans DR, 2008, PREV MED, V47, P463, DOI 10.1016/j.ypmed.2008.07.011; MacCallum RC, 2006, PSYCHOL METHODS, V11, P19, DOI 10.1037/1082-989X.11.1.19; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Rodrigues AMM, 2010, PEDIATR EXERC SCI, V22, P442, DOI 10.1123/pes.22.3.442; Malina RM, 2014, J SPORT SCI, V32, P424, DOI 10.1080/02640414.2013.828850; Meredith W, 2006, MED CARE, V44, pS69, DOI 10.1097/01.mlr.0000245438.73837.89; Metcalf B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5888; Metcalf BS, 2015, MED SCI SPORT EXER, V47, P2084, DOI 10.1249/MSS.0000000000000644; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Motl RW, 2000, PREV MED, V31, P584, DOI 10.1006/pmed.2000.0735; Muthen L. K., 2006, MPLUS STAT ANAL LATE; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; O'Connor TM, 2009, AM J PREV MED, V37, P141, DOI 10.1016/j.amepre.2009.04.020; Pate RR, 2014, J PHYS ACT HEALTH, V11, P461, DOI 10.1123/jpah.2014-0072; Plotnikoff RC, 2013, PREV MED, V56, P245, DOI 10.1016/j.ypmed.2013.01.013; Prins RG, 2010, HEALTH EDUC RES, V25, P489, DOI 10.1093/her/cyq024; Ramires VV, 2015, J PHYS ACT HEALTH, V12, P1344, DOI 10.1123/jpah.2014-0222; Ryan R., 2007, INTRINSIC MOTIVATION, P1; Ryan RM, 1997, INT J SPORT PSYCHOL, V28, P335; Sallis JF, 2002, PEDIATR EXERC SCI, V14, P30, DOI 10.1123/pes.14.1.30; Saunders RP, 1997, PREV MED, V26, P241, DOI 10.1006/pmed.1996.0134; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Sherar LB, 2010, PEDIATR EXERC SCI, V22, P332, DOI 10.1123/pes.22.3.332; Strath SJ, 2012, MED SCI SPORT EXER, V44, pS77, DOI 10.1249/MSS.0b013e3182399eb1; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; United States. Department of Health and Human Services, 2008, PHYS ACT GUID AM; van Sluijs EMF, 2011, BRIT J SPORT MED, V45, P914, DOI 10.1136/bjsports-2011-090187; Yao CA, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0163-y	61	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172040	10.1371/journal.pone.0172040	http://dx.doi.org/10.1371/journal.pone.0172040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187192	gold, Green Submitted, Green Published			2022-12-26	WOS:000394244300071
J	Salei, N; Hellberg, L; Kohl, J; Laskay, T				Salei, Natallia; Hellberg, Lars; Koehl, Joerg; Laskay, Tamas			Enhanced survival of Leishmania major in neutrophil granulocytes in the presence of apoptotic cells	PLOS ONE			English	Article							COMPLEMENT RECEPTORS; TNF-ALPHA; PHAGOCYTOSIS; CLEARANCE; PROMASTIGOTES; INFECTION; NECROSIS; PHOSPHORYLATION; SUSCEPTIBILITY; INVOLVEMENT	Neutrophil granulocytes are the first leukocytes that encounter and phagocytose Leishmania major (L. major) parasites in the infected skin. The parasites can nonetheless survive within neutrophils. However, the mechanisms enabling the survival of Leishmania within neutrophils are still elusive. Previous findings indicated that human neutrophils can engulf apoptotic cells. Since apoptotic neutrophils are abundant in infected tissues, we hypothesized that the uptake of apoptotic cells results in diminished anti-leishmanial activity and, consequently, contributes to enhanced survival of the parasites at the site of infection. In the present study, we demonstrated that L. major-infected primary human neutrophils acquire enhanced capacity to engulf apoptotic cells. This was associated with increased expression of the complement receptors 1 and 3 involved in phagocytosis of apoptotic cells. Next, we showed that ingestion of apoptotic cells affects neutrophil antimicrobial functions. We observed that phagocytosis of apoptotic cells by neutrophils downregulates the phosphorylation of p38 MAPK and PKC delta, the kinases involved in activation of NADPH oxidase and hence reactive oxygen species (ROS) production. In line, uptake of apoptotic cells inhibits TNF- and L. major-induced ROS production by neutrophils. Importantly, we found that the survival of Leishmania in neutrophils is strongly enhanced in neutrophils exposed to apoptotic cells. Together, our findings reveal that apoptotic cells promote L. majorsurvival within neutrophils by downregulating critical antimicrobial functions. This suggests that the induction of enhanced uptake of apoptotic cells represents a novel evasion mechanism of the parasites that facilitates their survival in neutrophil granulocytes.	[Salei, Natallia; Hellberg, Lars; Laskay, Tamas] Univ Lubeck, Dept Infect Dis & Microbiol, Lubeck, Germany; [Koehl, Joerg] Univ Lubeck, Inst System Inflammat Res, Lubeck, Germany	University of Lubeck; University of Lubeck	Laskay, T (corresponding author), Univ Lubeck, Dept Infect Dis & Microbiol, Lubeck, Germany.	Tamas.Laskay@uksh.de	Laskay, Tamás/E-9190-2013; Koehl, Joerg/C-8531-2011	Laskay, Tamás/0000-0002-4212-8366; Koehl, Joerg/0000-0003-1121-3178	DFG (German Research Foundation) [IRTG1911]	DFG (German Research Foundation)(German Research Foundation (DFG))	This work was supported by DFG (German Research Foundation) IRTG1911 project B4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso L, 2008, J LEUKOCYTE BIOL, V84, P389, DOI 10.1189/jlb.0108018; ALVAREZ V, 1991, KIDNEY INT, V40, P899, DOI 10.1038/ki.1991.291; BRIHEIM G, 1984, INFECT IMMUN, V45, P1; BUCHMULLER Y, 1981, J RETICULOENDOTH SOC, V29, P181; Byrne A, 2002, J IMMUNOL, V168, P1968, DOI 10.4049/jimmunol.168.4.1968; CHANG KP, 1981, AM J TROP MED HYG, V30, P322, DOI 10.4269/ajtmh.1981.30.322; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; DASILVA RP, 1989, J IMMUNOL, V143, P617; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; FALLMAN M, 1993, J IMMUNOL, V151, P330; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Green DR, 2016, CELL DEATH DIFFER, V23, P915, DOI 10.1038/cdd.2015.172; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Gullstrand B, 2012, J RHEUMATOL, V39, P1619, DOI 10.3899/jrheum.111511; Hart SP, 1997, J IMMUNOL, V159, P919; Hume DA, 2008, NAT IMMUNOL, V9, P12, DOI 10.1038/ni0108-12; Johann AM, 2006, CELL DEATH DIFFER, V13, P1533, DOI 10.1038/sj.cdd.4401832; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Kilpatrick LE, 2010, J LEUKOCYTE BIOL, V87, P153, DOI 10.1189/jlb.0408230; Kirchner T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/849136; Laskay T, 1997, J IMMUNOL, V158, P1246; Laufs H, 2002, INFECT IMMUN, V70, P826, DOI 10.1128/IAI.70.2.826-835.2002; LIEW FY, 1990, IMMUNOLOGY, V69, P570; Makni-Maalej K, 2013, BIOCHEM PHARMACOL, V85, P92, DOI 10.1016/j.bcp.2012.10.010; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Mevorach D, 2000, ANN NY ACAD SCI, V926, P226; Mollinedo F, 2010, J BIOL CHEM, V285, P34528, DOI 10.1074/jbc.M110.125302; Morelli AE, 2003, BLOOD, V101, P611, DOI 10.1182/blood-2002-06-1769; MURRAY HW, 1981, J EXP MED, V153, P1302, DOI 10.1084/jem.153.5.1302; MURRAY HW, 1981, J EXP MED, V153, P1690, DOI 10.1084/jem.153.6.1690; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; Nauta AJ, 2002, EUR J IMMUNOL, V32, P1726, DOI 10.1002/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Rabehi L, 2001, INFECT IMMUN, V69, P4590, DOI 10.1128/IAI.69.7.4590-4599.2001; Ribeiro-Gomes FL, 2004, J IMMUNOL, V172, P4454, DOI 10.4049/jimmunol.172.7.4454; ROBLEDO S, 1994, J IMMUNOL, V152, P1265; Rochael NC, 2015, SCI REP-UK, V5, DOI 10.1038/srep18302; Sarkar A, 2013, MED MICROBIOL IMMUN, V202, P25, DOI 10.1007/s00430-012-0246-1; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; SOLBACH W, 1986, J IMMUNOL, V137, P702; TITUS RG, 1989, J EXP MED, V170, P2097, DOI 10.1084/jem.170.6.2097; Tuon FF, 2008, INFECT IMMUN, V76, P866, DOI 10.1128/IAI.01090-07; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	52	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171850	10.1371/journal.pone.0171850	http://dx.doi.org/10.1371/journal.pone.0171850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187163	Green Published, Green Submitted, gold			2022-12-26	WOS:000394244300050
J	Hamasaki, T; Harada, G; Nakamichi, N; Kabayama, S; Teruya, K; Fugetsu, B; Gong, W; Sakata, I; Shirahata, S				Hamasaki, Takeki; Harada, Gakuro; Nakamichi, Noboru; Kabayama, Shigeru; Teruya, Kiichiro; Fugetsu, Bunshi; Gong, Wei; Sakata, Ichiro; Shirahata, Sanetaka			Electrochemically reduced water exerts superior reactive oxygen species scavenging activity in HT1080 cells than the equivalent level of hydrogen-dissolved water	PLOS ONE			English	Article							MOLECULAR-HYDROGEN; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; LIFE-SPAN; ANTIOXIDANT; MECHANISM; DAMAGE; MICE; NANOPARTICLES; EXTENSION	Electrochemically reduced water (ERW) is produced near a cathode during electrolysis and exhibits an alkaline pH, contains richly dissolved hydrogen, and contains a small amount of platinum nanoparticles. ERW has reactive oxygen species (ROS)-scavenging activity and recent studies demonstrated that hydrogen-dissolved water exhibits ROS-scavenging activity. Thus, the antioxidative capacity of ERW is postulated to be dependent on the presence of hydrogen levels; however, there is no report verifying the role of dissolved hydrogen in ERW. In this report, we clarify whether the responsive factor for antioxidative activity in ERW is dissolved hydrogen. The intracellular ROS scavenging activity of ERW and hydrogen-dissolved water was tested by both fluorescent stain method and immuno spin trapping assay. We confirm that ERW possessed electrolysis intensity-dependent intracellular ROS-scavenging activity, and ERW exerts significantly superior ROS-scavenging activity in HT1080 cells than the equivalent level of hydrogen-dissolved water. ERW retained its ROS-scavenging activity after removal of dissolved hydrogen, but lost its activity when autoclaved. An oxygen radical absorbance capacity assay, the 2,2-diphenyl-1-picrylhydrazyl assay and chemiluminescence assay could not detect radical-scavenging activity in both ERW and hydrogen-dissolved water. These results indicate that ERW contains electrolysis-dependent hydrogen and an additional antioxidative factor predicted to be platinum nanoparticles.	[Hamasaki, Takeki; Harada, Gakuro; Nakamichi, Noboru; Teruya, Kiichiro; Shirahata, Sanetaka] Kyushu Univ, Dept Biosci & Biotechnol, Fac Agr, Higashi Ku, Fukuoka, Japan; [Kabayama, Shigeru] Nihon Trim Co Ltd, Kita Ku, Osaka, Japan; [Fugetsu, Bunshi; Gong, Wei] Univ Tokyo, IPRC, Bunkyo Ku, Tokyo, Japan; [Sakata, Ichiro] Univ Tokyo, Policy Alternat Res Inst, Bunkyo Ku, Tokyo, Japan	Kyushu University; University of Tokyo; University of Tokyo	Shirahata, S (corresponding author), Kyushu Univ, Dept Biosci & Biotechnol, Fac Agr, Higashi Ku, Fukuoka, Japan.	sirahata@grt.kyushu-u.ac.jp	Takeki, Tomikawa/AAC-8060-2019; Fugetsu, Bunshi/AAC-2514-2021	Gong, Wei/0000-0002-6990-3107; SAKATA, ICHIRO/0000-0001-5881-3790				Bisko A., 2007, ACS-AGR CONSPEC SCI, V72, P279; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; CARPENTER JH, 1966, LIMNOL OCEANOGR, V11, P264, DOI 10.4319/lo.1966.11.2.0264; Dudonne S, 2009, J AGR FOOD CHEM, V57, P1768, DOI 10.1021/jf803011r; Duhin A, 2014, APPL SURF SCI, V313, P159, DOI 10.1016/j.apsusc.2014.05.178; Hamasaki T, 2008, LANGMUIR, V24, P7354, DOI 10.1021/la704046f; Hamasaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102218; Huang DJ, 2002, J AGR FOOD CHEM, V50, P4437, DOI 10.1021/jf0201529; Huang KC, 2003, KIDNEY INT, V64, P704, DOI 10.1046/j.1523-1755.2003.00118.x; Kamimura N, 2011, OBESITY, V19, P1396, DOI 10.1038/oby.2011.6; Kashiwagi T, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/869121; Li YP, 2002, CYTOTECHNOLOGY, V40, P139, DOI 10.1023/A:1023936421448; Li YP, 2011, CYTOTECHNOLOGY, V63, P119, DOI 10.1007/s10616-010-9317-6; Maeda H, 2004, ANGEW CHEM INT EDIT, V43, P2389, DOI 10.1002/anie.200452381; Nakayama M, 2010, NEPHROL DIAL TRANSPL, V25, P3026, DOI 10.1093/ndt/gfq196; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; REETZ MT, 1994, J AM CHEM SOC, V116, P7401, DOI 10.1021/ja00095a051; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; Shirahata S, 1997, BIOCHEM BIOPH RES CO, V234, P269, DOI 10.1006/bbrc.1997.6622; Shirahata S, 2012, TRENDS FOOD SCI TECH, V23, P124, DOI 10.1016/j.tifs.2011.10.009; Song GH, 2015, FREE RADICAL BIO MED, V87, P58, DOI 10.1016/j.freeradbiomed.2015.06.018; Spulber S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042078; Tsai CF, 2009, FOOD CHEM TOXICOL, V47, P2031, DOI 10.1016/j.fct.2009.05.021; Uscatequi AV, 2013, ELECTROCHIM ACTA, V109, P283; Yan HX, 2011, BIOSCI BIOTECH BIOCH, V75, P1295, DOI 10.1271/bbb.110072; Yan HX, 2010, BIOSCI BIOTECH BIOCH, V74, P2011, DOI 10.1271/bbb.100250; Yano Research Institute Ltd, 2014, FACT VIEW WAT COND W, P60; Yokota T, 2015, CLIN EXP OPHTHALMOL, V43, P568, DOI 10.1111/ceo.12525; Yu JH, 2015, TOXICOL LETT, V238, P11, DOI 10.1016/j.toxlet.2015.08.010; Zhai Y, 2015, EXP MOL PATHOL, V98, P268, DOI 10.1016/j.yexmp.2015.03.005	30	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171192	10.1371/journal.pone.0171192	http://dx.doi.org/10.1371/journal.pone.0171192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182635	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800042
J	Tiotiu, A; Chenuel, B; Foucaud, L; Demoulin, B; Demoulin-Alexikova, S; Christov, C; Poussel, M				Tiotiu, Angelica; Chenuel, Bruno; Foucaud, Laurent; Demoulin, Bruno; Demoulin-Alexikova, Silvia; Christov, Christo; Poussel, Mathias			Lack of desensitization of the cough reflex in ovalbumin-sensitized rabbits during exercise	PLOS ONE			English	Article							INDUCED BRONCHOCONSTRICTION; MUSCULAR-CONTRACTION; INFLAMMATORY CELLS; GUINEA-PIGS; AIRWAY; ASTHMA; MODEL; RESPONSES; BRONCHODILATION; TRANSMISSION	Introduction Cough is a major symptom of asthma frequently experienced during exercise but little is known about interactions between cough and exercise. The goal of our study was to clarify the potential modulation of the cough reflex (CR) by exercise in a spontaneously breathing anaesthetized animal model of airway eosinophilic inflammation. Materials & methods Ten ovalbumin (OVA) sensitized adult rabbits and 8 controls were studied. The ventilatory response to direct tracheal stimulation, performed both at rest and during exercise was determined to quantify the incidence and the sensitivity of the CR. Broncho-alveolar lavages (BAL) and cell counts were performed to assess the level of the airway inflammation following OVA-induced sensitization. Exercise was mimicked by Electrically induced hindlimb Muscular Contractions (EMC). Results Among 494 tracheal stimulations, 261 were performed at rest and 233 at exercise. OVA challenges in sensitized rabbits caused a significant increase in the percentage of eosinophils (p = 0.008) in BAL. EMC increased minute ventilation by 36% and 35% in OVA and control rabbits respectively, compared to rest values. The sensitivity of the CR decreased during exercise compared to baseline in control rabbits (p = 0.0313) while it remained unchanged in OVA rabbits. Conclusion The desensitization of the CR during exercise in control rabbits was abolished in OVA rabbits. The precise role of airway inflammation in this lack of CR desensitization needs to be further investigated but it might contribute to the exercise-induced cough in asthmatics.	[Tiotiu, Angelica; Chenuel, Bruno; Foucaud, Laurent; Demoulin, Bruno; Demoulin-Alexikova, Silvia; Poussel, Mathias] Univ Lorraine, EA DevAH Dev Adaptat & Disadvantage 3450, Cardioresp Regulat & Motor Control, Vandoeuvre Les Nancy, France; [Tiotiu, Angelica] CHRU Nancy, Dept Pulmonol, Nancy, France; [Chenuel, Bruno; Poussel, Mathias] CHRU Nancy, Pulm Funct Testing & Exercise Physiol, Nancy, France; [Christov, Christo] Univ Lorraine, Dept Histol, Vandoeuvre Les Nancy, France	Universite de Lorraine; CHU de Nancy; CHU de Nancy; Universite de Lorraine	Tiotiu, A (corresponding author), Univ Lorraine, EA DevAH Dev Adaptat & Disadvantage 3450, Cardioresp Regulat & Motor Control, Vandoeuvre Les Nancy, France.; Tiotiu, A (corresponding author), CHRU Nancy, Dept Pulmonol, Nancy, France.	a.tiotiu@chru-nancy.fr	Poussel, Mathias/AAH-6433-2020; Demoulin-Alexikova, Silvia/AAQ-4732-2020; Tiotiu, Angelica/GVT-6259-2022; Chenuel, Bruno/G-4320-2015	Poussel, Mathias/0000-0002-4386-8606; Chenuel, Bruno/0000-0001-6619-6577				Ali S, 1996, J PHARMACOL EXP THER, V278, P639; Anderson SD, 2000, J ALLERGY CLIN IMMUN, V106, P453, DOI 10.1067/mai.2000.109822; Belvisi MG, 2004, THORAX, V59, P438, DOI 10.1136/thx.2003.013490; BLOOM JW, 1988, IMMUNOPHARMACOLOGY, V15, P157, DOI 10.1016/0162-3109(88)90027-6; Bolser DC, 2006, RESP PHYSIOL NEUROBI, V152, P255, DOI 10.1016/j.resp.2006.01.008; Bonham AC, 2004, PULM PHARMACOL THER, V17, P453, DOI 10.1016/j.pupt.2004.09.008; Boulet LP, 2015, NEW ENGL J MED, V372, P641, DOI 10.1056/NEJMra1407552; Brozmanova M, 2006, PHYSIOL RES, V55, P577, DOI 10.33549/physiolres.930840; Chambers MA, 2000, INFECT IMMUN, V68, P7094, DOI 10.1128/IAI.68.12.7094-7099.2000; Chung KF, 2013, LANCET RESP MED, V1, P414, DOI 10.1016/S2213-2600(13)70043-2; Clay E, 2016, J PHARMACOL EXP THER, V357, P73, DOI 10.1124/jpet.115.230227; CROSS BA, 1982, J PHYSIOL-LONDON, V329, P37, DOI 10.1113/jphysiol.1982.sp014289; Del Giacco SR, 2015, EUR CLIN RESPIR J, V2, DOI 10.3402/ecrj.v2.27984; Duz M, 2010, RES VET SCI, V89, P266, DOI 10.1016/j.rvsc.2010.03.005; Fontana GA, 2002, J APPL PHYSIOL, V93, P1723, DOI 10.1152/japplphysiol.00326.2002; FUJIMURA M, 1992, THORAX, V47, P441, DOI 10.1136/thx.47.6.441; Gu QH, 2008, AM J PHYSIOL-LUNG C, V294, pL544, DOI 10.1152/ajplung.00271.2007; Hallstrand TS, 2012, CURR OPIN ALLERGY CL, V12, P42, DOI 10.1097/ACI.0b013e32834ecc67; Hallstrand TS, 2009, CURR ALLERGY ASTHM R, V9, P18, DOI 10.1007/s11882-009-0003-8; Hallstrand TS, 2005, AM J RESP CRIT CARE, V172, P679, DOI 10.1164/rccm.200412-1667OC; Haouzi P, 2005, J PHYSIOL-LONDON, V569, P975, DOI 10.1113/jphysiol.2005.089649; HERD CM, 1994, BRIT J PHARMACOL, V112, P292, DOI 10.1111/j.1476-5381.1994.tb13067.x; HERD CM, 1995, EUR J PHARMACOL, V282, P111, DOI 10.1016/0014-2999(95)00291-R; HOFFMANGOETZ L, 1994, IMMUNOL TODAY, V15, P382, DOI 10.1016/0167-5699(94)90177-5; JACKSON DM, 1988, BRIT J PHARMACOL, V93, P609, DOI 10.1111/j.1476-5381.1988.tb10317.x; Kamaruzaman NA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/691830; Keir S, 2008, PULM PHARMACOL THER, V21, P721, DOI 10.1016/j.pupt.2008.01.005; Kennedy MD, 2015, SCANDINAVIAN J MED S; Kingham PJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1229, DOI 10.1152/ajplung.00278.2001; Kodesh E, 2011, AM J PHYSIOL-REG I, V300, pR917, DOI 10.1152/ajpregu.00270.2010; Larsson K, 1998, EUR RESPIR J, V12, P825, DOI 10.1183/09031936.98.12040825; Lavorini F, 2010, J APPL PHYSIOL, V108, P1061, DOI 10.1152/japplphysiol.00423.2009; Liu Q, 2001, CLIN EXP ALLERGY, V31, P474, DOI 10.1046/j.1365-2222.2001.00989.x; Marchal F, 2008, RESP PHYSIOL NEUROBI, V160, P224, DOI 10.1016/j.resp.2007.10.002; Marchal F, 2012, RESP PHYSIOL NEUROBI, V180, P311, DOI 10.1016/j.resp.2011.12.006; MARSH WR, 1985, AM REV RESPIR DIS, V131, P875; McGovern AE, 2012, NEUROSCIENCE, V207, P148, DOI 10.1016/j.neuroscience.2012.01.029; Millqvist Eva, 2015, Temperature (Austin), V2, P172, DOI 10.1080/23328940.2015.1012979; Mutolo D, 2016, PULM PHARMACOL THER, V38, P1, DOI 10.1016/j.pupt.2016.04.001; Petak F, 2006, ANESTH ANALG, V103, P103, DOI 10.1213/01.ane.0000221439.87488.08; PINCKARD RN, 1977, J IMMUNOL, V119, P2185; Poussel M, 2014, PULM PHARMACOL THER, V27, P96, DOI 10.1016/j.pupt.2013.07.005; Poussel M, 2012, RESP PHYSIOL NEUROBI, V183, P20, DOI 10.1016/j.resp.2012.05.021; Schelegle ES, 2001, AM J PATHOL, V158, P333, DOI 10.1016/S0002-9440(10)63973-9; Schweitzer C, 2011, RESP PHYSIOL NEUROBI, V177, P169, DOI 10.1016/j.resp.2011.03.013; SHAMPAIN MP, 1982, AM REV RESPIR DIS, V126, P493; Sikand P, 2007, J PHYSIOL-LONDON, V581, P631, DOI 10.1113/jphysiol.2006.118620; TURNER DL, 1991, J EXP BIOL, V160, P309; Varechova S, 2012, PULM PHARMACOL THER, V25, P242, DOI 10.1016/j.pupt.2012.03.006; Varechova S, 2011, BRATISL MED J, V112, P136; Varechova S, 2010, PULM PHARMACOL THER, V23, P397, DOI 10.1016/j.pupt.2010.05.008; Verratti V, 2009, J BIOL REG HOMEOS AG, V23, P203; Widdicombe J, 2001, RESP PHYSIOL, V125, P3, DOI 10.1016/S0034-5687(00)00201-2; WIDDICOMBE JG, 1954, J PHYSIOL-LONDON, V123, P55, DOI 10.1113/jphysiol.1954.sp005033; WIDDICOMBE JG, 1954, J PHYSIOL-LONDON, V123, P71, DOI 10.1113/jphysiol.1954.sp005034; Widdicombe J, 2009, PULM PHARMACOL THER, V22, P143, DOI 10.1016/j.pupt.2008.12.009	56	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171862	10.1371/journal.pone.0171862	http://dx.doi.org/10.1371/journal.pone.0171862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182749	Green Submitted, Green Published, gold			2022-12-26	WOS:000394231800126
J	Massafra, V; Milona, A; Vos, HR; Burgering, BMT; van Mil, SWC				Massafra, Vittoria; Milona, Alexandra; Vos, Harmjan R.; Burgering, Boudewijn M. T.; van Mil, Saskia W. C.			Quantitative liver proteomics identifies FGF19 targets that couple metabolism and proliferation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSFORMING GROWTH-FACTOR-BETA-1; HEME OXYGENASE-1; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; BREAST-CANCER; X RECEPTOR; TRANSGENIC MICE; CELLS	Fibroblast growth factor 19 (FGF19) is a gut -derived peptide hormone that is produced following activation of Farnesoid X Receptor (FXR). FGF19 is secreted and signals to the liver, where it contributes to the homeostasis of bile acid (BA), lipid and carbohydrate metabolism. FGF19 is a promising therapeutic target for the metabolic syndrome and cholestatic diseases, but enthusiasm for its use has been tempered by FGF19-mediated induction of proliferation and hepatocellular carcinoma. To inform future rational design of FGF19-variants, we have conducted temporal quantitative proteomic and gene expression analyses to identify FGF19-targets related to metabolism and proliferation. Mice were fasted for 16 hours, and injected with human FGF19 (1 mg/kg body weight) or vehicle. Liver protein extracts (containing "light" lysine) were mixed 1:1 with a spike-in protein extract from C-13(6) -lysine metabolically labelled mouse liver (containing "heavy" lysine) and analysed by LC-MS/MS. Our analyses provide a resource of FGF19 target proteins in the liver. 189 proteins were upregulated (>= 1.5 folds) and 73 proteins were downregulated (<= -1.5 folds) by FGF19. FGF19 treatment decreased the expression of proteins involved in fatty acid (FA) synthesis, i.e., Fabp5, Scd1, and Acsl3 and increased the expression of Acox1, involved in FA oxidation. As expected, FGF19 increased the expression of proteins known to drive proliferation (i.e., Tgfbi, Vcam1, Anxa2 and Hdlbp). Importantly, many of the FGF19 targets (i.e., Pdk4, Apoa4, Fas and Stat3) have a dual function in both metabolism and cell proliferation. Therefore, our findings challenge the development of FGF19-variants that fully uncouple metabolic benefit from mitogenic potential.	[Massafra, Vittoria; Milona, Alexandra; Vos, Harmjan R.; Burgering, Boudewijn M. T.; van Mil, Saskia W. C.] UMC Utrecht, Ctr Mol Med, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	van Mil, SWC (corresponding author), UMC Utrecht, Ctr Mol Med, Utrecht, Netherlands.	S.W.C.vanMil@umcutrecht.nl	van Mil, Saskia WC/C-3751-2009	van Mil, Saskia WC/0000-0002-7850-5012; Vos, Harmjan/0000-0002-4696-6068	Netherlands Organization for Scientific Research (NWO) [917.11.365]; FP7 Marie Curie Actions IAPP (FXR-IBD) [611979]; Utrecht University Support Grant; Wilhelmina Children's Hospital Research Fund; Proteins At Work (NWO)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); FP7 Marie Curie Actions IAPP (FXR-IBD); Utrecht University Support Grant; Wilhelmina Children's Hospital Research Fund; Proteins At Work (NWO)	S.W.C.v.M. is supported by the Netherlands Organization for Scientific Research (NWO) Project VIDI (917.11.365), FP7 Marie Curie Actions IAPP (FXR-IBD, 611979), the Utrecht University Support Grant, Wilhelmina Children's Hospital Research Fund. H.R.V. is supported by Proteins At Work (NWO).	Argmann CA, 2001, ARTERIOSCL THROM VAS, V21, P2011, DOI 10.1161/hq1201.099426; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Carter CJ, 2007, NEUROCHEM INT, V50, P12, DOI 10.1016/j.neuint.2006.07.007; Cerdeira AS, 2013, J IMMUNOL, V190, P3939, DOI 10.4049/jimmunol.1202582; Chambers RC, 2003, AM J PATHOL, V162, P533, DOI 10.1016/S0002-9440(10)63847-3; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Degirolamo C, 2016, NAT REV DRUG DISCOV, V15, P51, DOI 10.1038/nrd.2015.9; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Grabias BM, 2012, FASEB J, V26, P4131, DOI 10.1096/fj.12-207324; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Han B, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0335-z; Hill-Kapturczak N, 2000, J BIOL CHEM, V275, P40904, DOI 10.1074/jbc.M006621200; Hirschey MD, 2015, SEMIN CANCER BIOL, V35, pS129, DOI 10.1016/j.semcancer.2015.10.002; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Hu YW, 2010, J ATHEROSCLER THROMB, V17, P493, DOI 10.5551/jat.3152; Ilyas M, 1999, P NATL ACAD SCI USA, V96, P3087, DOI 10.1073/pnas.96.6.3087; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Kall L, 2008, J PROTEOME RES, V7, P40, DOI 10.1021/pr700739d; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Knittel T, 1999, AM J PATHOL, V154, P153, DOI 10.1016/S0002-9440(10)65262-5; KUTTY RK, 1994, J CELL PHYSIOL, V159, P371; Latasa MU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052711; Lian N, 2012, J BIOL CHEM, V287, P35975, DOI 10.1074/jbc.M112.372458; Lin CC, 2007, EUR J PHARMACOL, V560, P101, DOI 10.1016/j.ejphar.2007.01.025; Luo J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009098; Luo XP, 2005, ENDOCRINOLOGY, V146, P1097, DOI 10.1210/en.2004-1377; Miura S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-56; Miyata M, 2011, BIOL PHARM BULL, V34, P1885, DOI 10.1248/bpb.34.1885; Miyazaki YJ, 2002, ONCOGENE, V21, P798, DOI 10.1038/sj.onc.1205126; Murase S, 2013, J BIOL CHEM, V288, P20151, DOI 10.1074/jbc.M113.470583; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Pellacani A, 1998, CIRC RES, V83, P396, DOI 10.1161/01.RES.83.4.396; Pilbeam C, 1997, ENDOCRINOLOGY, V138, P4672, DOI 10.1210/en.138.11.4672; Popova AP, 2010, AM J PHYSIOL-LUNG C, V298, pL735, DOI 10.1152/ajplung.00347.2009; Potthoff MJ, 2011, CELL METAB, V13, P729, DOI 10.1016/j.cmet.2011.03.019; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shan B, 2008, J BIOL CHEM, V283, P21065, DOI 10.1074/jbc.M802786200; Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; SKONIER J, 1994, DNA CELL BIOL, V13, P571, DOI 10.1089/dna.1994.13.571; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Traylor A, 2007, AM J PHYSIOL-RENAL, V293, pF885, DOI 10.1152/ajprenal.00519.2006; Uriarte I, 2015, INT J CANCER, V136, P2469, DOI 10.1002/ijc.29287; Uriarte I, 2013, GUT, V62, P899, DOI 10.1136/gutjnl-2012-302945; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Weeks BH, 2001, CANCER RES, V61, P7435; Wilson CA, 2005, BREAST CANCER RES, V7, pR1058, DOI 10.1186/bcr1343; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wu AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017868; Wu B, 2012, CELL PROLIFERAT, V45, P189, DOI 10.1111/j.1365-2184.2012.00820.x; Wu J, 2011, ONCOGENE, V30, P4410, DOI 10.1038/onc.2011.149; Wu XL, 2010, P NATL ACAD SCI USA, V107, P14158, DOI 10.1073/pnas.1009427107; Wu YZ, 2007, BBA-MOL CELL RES, V1773, P427, DOI 10.1016/j.bbamcr.2006.11.017; Xie Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep18751; Zhang F, 2009, J PROTEOME RES, V8, P5041, DOI 10.1021/pr900461c; Zhang Zheng, 2012, Mol Biol (Mosk), V46, P628; Zhou M, 2014, CANCER RES, V74, P3306, DOI 10.1158/0008-5472.CAN-14-0208	64	24	26	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171185	10.1371/journal.pone.0171185	http://dx.doi.org/10.1371/journal.pone.0171185			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178326	Green Submitted, Green Published, gold			2022-12-26	WOS:000393712500031
J	Le Parc, A; Karav, S; Rouquie, C; Maga, EA; Bunyatratchata, A; Barile, D				Le Parc, Annabelle; Karav, Sercan; Rouquie, Camille; Maga, Elizabeth A.; Bunyatratchata, Apichaya; Barile, Daniela			Characterization of recombinant human lactoferrin N-glycans expressed in the milk of transgenic cows	PLOS ONE			English	Article							LARGE-SCALE PRODUCTION; LIQUID-CHROMATOGRAPHY; BREAST-MILK; GLYCOSYLATION; OLIGOSACCHARIDES; SUPPLEMENTATION; PROTEINS; INFANTS; CLONING	Lactoferrin (LF) is one of the most abundant bioactive glycoproteins in human milk. Glycans attached through N-glycosidic bonds may contribute to Lactoferrin functional activities. In contrast, LF is present in trace amounts in bovine milk. Efforts to increase LF concentration in bovine milk led to alternative approaches using transgenic cows to express human lactoferrin (hLF). This study investigated and compared N-glycans in recombinant human lactoferrin (rhLF), bovine lactoferrin (bLF) and human lactoferrin by Nano-LC-Chip-Q-TOF Mass Spectrometry. The results revealed a high diversity of N-glycan structures, including fucosylated and sialylated complex glycans that may contribute additional bioactivities. rhLF, bLF and hLF had 23, 27 and 18 N-glycans respectively with 8 N-glycan in common overall. rhLF shared 16 N-glycan with bLF and 9 N-glycan with hLF while bLF shared 10 N-glycan with hLF. Based on the relative abundances of N-glycan types, rhLF and hLF appeared to contain mostly neutral complex/ hybrid N-glycans (81% and 52% of the total respectively) whereas bLF was characterized by high mannose glycans (65%). Interestingly, the majority of hLF N-glycans were fucosylated (88%), whereas bLF and rhLF had only 9% and 20% fucosylation, respectively. Overall, this study suggests that rhLF N-glycans share more similarities to bLF than hLF.	[Le Parc, Annabelle; Rouquie, Camille; Bunyatratchata, Apichaya; Barile, Daniela] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Karav, Sercan] Canakkale 18 Mart Univ, Dept Mol Biol & Genet, Canakkale, Turkey; [Maga, Elizabeth A.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Barile, Daniela] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA	University of California System; University of California Davis; Canakkale Onsekiz Mart University; University of California System; University of California Davis; University of California System; University of California Davis	Barile, D (corresponding author), Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.; Barile, D (corresponding author), Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA.	dbarile@ucdavis.edu	barile, daniela/AAA-3892-2020	barile, daniela/0000-0002-3889-1596; Rouquie, Camille/0000-0002-8290-7778	National Institutes of Health [R01AT007079, R01AT008759]; USDA NIFA Hatch project [232719]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA NIFA Hatch project	Support was provided by the National Institutes of Health awards R01AT007079 and R01AT008759, USDA NIFA Hatch project 232719.	Asakuma S, 2008, EUR J CLIN NUTR, V62, P488, DOI 10.1038/sj.ejcn.1602738; Barboza M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015248; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Edde L, 2001, AM J PHYSIOL-GASTR L, V281, pG1140, DOI 10.1152/ajpgi.2001.281.5.G1140; Field CJ, 2005, J NUTR, V135, P1; HENNART PF, 1991, AM J CLIN NUTR, V53, P32, DOI 10.1093/ajcn/53.1.32; Jantscher-Krenn E, 2012, BRIT J NUTR, V108, P1839, DOI 10.1017/S0007114511007392; Karav S, 2015, BIOTECHNOLOGY PROGR; Karav S, 2016, APPL ENVIRON MICROB; Karav S, 2016, APPL ENVIRON MICROB, V82, P3622, DOI 10.1128/AEM.00547-16; Karav S, 2015, ENZYME MICROB TECH, V77, P46, DOI 10.1016/j.enzmictec.2015.05.007; Krenkova J, 2009, J CHROMATOGR A, V1216, P3252, DOI 10.1016/j.chroma.2009.02.036; Kronewitter SR, 2010, J PROTEOME RES, V9, P4952, DOI 10.1021/pr100202a; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; L Parc A, 2015, BIOTECHNOL PROGR, V31, P1323, DOI [10.1002/btpr.2133, DOI 10.1002/BTPR.2133]; L Parc A, 2015, BIOTECHNOLOGY PROGR; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Parc A, 2014, ELECTROPHORESIS, V35, P1560, DOI 10.1002/elps.201300619; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; Li QL, 2014, MOL BIOL REP, V41, P2119, DOI 10.1007/s11033-014-3061-5; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; Manzoni P, 2009, JAMA-J AM MED ASSOC, V302, P1421, DOI 10.1001/jama.2009.1403; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553; Nwosu CC, 2012, J PROTEOME RES, V11, P2912, DOI 10.1021/pr300008u; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Patel BK, 2012, ISRN GASTROENTEROLOG, V2012; Rudloff S, 1996, ACTA PAEDIATR, V85, P598, DOI 10.1111/j.1651-2227.1996.tb14095.x; Samyn-Petit B, 2003, EUR J BIOCHEM, V270, P3235, DOI 10.1046/j.1432-1033.2003.03706.x; SANCHEZ L, 1992, J FOOD SCI, V57, P873, DOI 10.1111/j.1365-2621.1992.tb14313.x; Shental-Bechor D, 2009, CURR OPIN STRUC BIOL, V19, P524, DOI 10.1016/j.sbi.2009.07.002; Silva SV, 2005, INT DAIRY J, V15, P1, DOI 10.1016/j.idairyj.2004.04.009; Stefanova G, 2008, BIOL PLANTARUM, V52, P423, DOI 10.1007/s10535-008-0086-4; Suzuki YA, 2003, J PEDIATR GASTR NUTR, V36, P190, DOI 10.1097/00005176-200302000-00007; Thomassen EAJ, 2005, TRANSGENIC RES, V14, P397, DOI 10.1007/s11248-005-3233-0; van Berkel PHC, 2002, NAT BIOTECHNOL, V20, P484, DOI 10.1038/nbt0502-484; van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4; Varki A., 2009, BIOL ROLES GLYCANS; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Yu HQ, 2012, J BIOTECHNOL, V161, P198, DOI 10.1016/j.jbiotec.2012.06.035; Yu TA, 2011, GLYCOBIOLOGY, V21, P206, DOI 10.1093/glycob/cwq151	43	26	26	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171477	10.1371/journal.pone.0171477	http://dx.doi.org/10.1371/journal.pone.0171477			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170415	Green Published, Green Submitted, gold			2022-12-26	WOS:000393705500039
J	Li, YH; Song, ZH; Kerr, KA; Moeser, AJ				Li, Yihang; Song, Zehe; Kerr, Katelyn A.; Moeser, Adam J.			Chronic social stress in pigs impairs intestinal barrier and nutrient transporter function, and alters neuro-immune mediator and receptor expression	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; IRRITABLE-BOWEL-SYNDROME; MAST-CELL ACTIVATION; DSS-INDUCED COLITIS; PSYCHOLOGICAL STRESS; GROWING PIGS; VISCERAL HYPERALGESIA; EPITHELIAL BARRIER; SIGNALING PATHWAYS; SPACE ALLOWANCE	Psychosocial stress is a major factor driving gastrointestinal (GI) pathophysiology and disease susceptibility in humans and animals. The mechanisms governing susceptibility to stress-induced GI disease remain poorly understood. In the present study, we investigated the influence of chronic social stress (CSS) in pigs, induced by 7 d of chronic mixing/crowding stress, on intestinal barrier and nutrient transport function, corticotropin releasing factor (CRF) signaling and immunological responses. Results from this study showed that CSS resulted in a significant impairment of ileal and colonic barrier function indicated by reduced transepithelial electrical resistance (TER) in the ileum and increased FD4 flux in the ileum (by 0.8 fold) and colon (by 0.7 fold). Ileal sodium glucose linked transporter 1 (SGLT-1) function, measured as glucose-induced changes in short-circuit current (I-sc), was diminished (by 52%) in CSS pigs, associated with reduced body weight gain and feed efficiency. Although reductions in SGLT-1 function were observed in CSS pigs, mRNA expression for SGLT-1, villus heights were increased in CSS pigs. Corticotropin releasing factor (CRF) mRNA was upregulated (by 0.9 fold) in the ileum of CSS pigs but not in the colon. Urocortin 2 (Ucn2) mRNA was upregulated (by 1.5 fold) in the colon of CSS pigs, but not in the ileum. In CSS pigs, a downregulation of pro-inflammatory cytokines mRNA (IL1B, TNFA, IL8, and IL6) was observed in both ileum and colon, compared with controls. In contrast CSS induced a marked upregulation of mRNA for IL10 and mast cell chymase gene (CMA1) in the ileum and colon. Together, these data demonstrate that chronic stress in pigs results in significant alterations in intestinal barrier and nutrient transport function and neuro-immune mediator and receptor expression.	[Li, Yihang; Kerr, Katelyn A.; Moeser, Adam J.] Michigan State Univ, Gastrointestinal Stress Biol Lab, E Lansing, MI 48824 USA; [Li, Yihang; Moeser, Adam J.] Michigan State Univ, Coll Vet Med, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Song, Zehe] Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China; [Moeser, Adam J.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Moeser, Adam J.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Zhejiang University; Michigan State University; Michigan State University	Moeser, AJ (corresponding author), Michigan State Univ, Gastrointestinal Stress Biol Lab, E Lansing, MI 48824 USA.; Moeser, AJ (corresponding author), Michigan State Univ, Coll Vet Med, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA.; Moeser, AJ (corresponding author), Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.; Moeser, AJ (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	moeserad@cvm.msu.edu		Moeser, Adam/0000-0003-3068-627X	Foundation for the National Institutes of Health [HD072968, DK084313]	Foundation for the National Institutes of Health	This research was supported by the Foundation for the National Institutes of Health grants HD072968 and DK084313. Adam Moeser is the Matilda R. Wilson Endowed Chair of Large Animal Clinical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini A, 2010, PSYCHOSOMATICS, V51, P14, DOI 10.1176/appi.psy.51.1.14; Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Boudry G, 2007, AM J PHYSIOL-REG I, V292, pR862, DOI 10.1152/ajpregu.00655.2006; Bradford K, 2012, CLIN GASTROENTEROL H, V10, P385, DOI 10.1016/j.cgh.2011.12.018; Caron G, 2001, J IMMUNOL, V167, P3682, DOI 10.4049/jimmunol.167.7.3682; Castagliuolo I, 1996, AM J PHYSIOL-GASTR L, V271, pG884, DOI 10.1152/ajpgi.1996.271.5.G884; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Chan CY, 2013, IMMUNITY, V38, P349, DOI 10.1016/j.immuni.2012.10.019; de Punder K, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00223; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gourcerol G, 2011, GASTROENTEROLOGY, V140, P1586, DOI 10.1053/j.gastro.2011.01.039; Guilarte M, 2007, GUT, V56, P203, DOI 10.1136/gut.2006.100594; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Hardin J, 2000, GUT, V47, P184, DOI 10.1136/gut.47.2.184; Hasdemir B, 2016, AM J PHYSIOL REGUL I; Hoffman JM, 2016, AM J PATHOL, V186, P134, DOI 10.1016/j.ajpath.2015.09.013; Hyun Y, 1998, J ANIM SCI, V76, P2771; Kiank C, 2006, BRAIN BEHAV IMMUN, V20, P359, DOI 10.1016/j.bbi.2005.10.151; Kirshenbaum AS, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-45; Kokkotou E, 2006, J IMMUNOL, V177, P3355, DOI 10.4049/jimmunol.177.5.3355; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P591; la Fleur SE, 2005, P NATL ACAD SCI USA, V102, P7647, DOI 10.1073/pnas.0408531102; Larauche M, 2008, AM J PHYSIOL-GASTR L, V294, pG1033, DOI 10.1152/ajpgi.00507.2007; Lee CY, 2013, CLIN EXP PHARMACOL P, V40, P385, DOI 10.1111/1440-1681.12096; Lennon EM, 2013, INFLAMM BOWEL DIS, V19, P712, DOI 10.1097/MIB.0b013e3182802a4e; Li YH, 2016, J NUTR, V146, P1499, DOI 10.3945/jn.116.231621; Li YH, 2014, J NUTR, V144, P1935, DOI 10.3945/jn.114.194787; Liu S, 2016, NEUROGASTROENT MOTIL, V28, P281, DOI 10.1111/nmo.12725; McLamb BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059838; Medland JE, 2016, NEUROGASTROENTEROL M; Melgar S, 2008, STRESS, V11, P348, DOI 10.1080/10253890701820166; Million M, 2006, GUT, V55, P172, DOI 10.1136/gut.2004.051391; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V293, pG413, DOI 10.1152/ajpgi.00304.2006; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG173, DOI 10.1152/ajpgi.00197.2006; Moss AC, 2007, GUT, V56, P1210, DOI 10.1136/gut.2006.110668; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Pearce SC, 2014, J ANIM SCI, V92, P5444, DOI 10.2527/jas.2014-8407; Perry SJ, 2005, J BIOL CHEM, V280, P11560, DOI 10.1074/jbc.M412914200; Piliponsky AM, 2012, AM J PATHOL, V181, P875, DOI 10.1016/j.ajpath.2012.05.013; Reber SO, 2006, ENDOCRINOLOGY, V147, P4968, DOI 10.1210/en.2006-0347; Reber SO, 2008, STRESS, V11, P225, DOI 10.1080/10253890701733351; Rupp B, 2000, EUR J IMMUNOL, V30, P2954, DOI 10.1002/1521-4141(200010)30:10<2954::AID-IMMU2954>3.0.CO;2-S; Santos J, 2000, AM J PHYSIOL-GASTR L, V278, pG847, DOI 10.1152/ajpgi.2000.278.6.G847; Santos J, 2008, PSYCHONEUROENDOCRINO, V33, P1248, DOI 10.1016/j.psyneuen.2008.07.002; Schweer WP, 2016, J ANIM SCI, V94, P523, DOI 10.2527/jas.2015-9836; Schwetz I, 2005, AM J PHYSIOL-GASTR L, V289, pG704, DOI 10.1152/ajpgi.00498.2004; Smith F, 2010, AM J PHYSIOL-GASTR L, V298, pG352, DOI 10.1152/ajpgi.00081.2009; Tache Y, 1999, Can J Gastroenterol, V13 Suppl A, p18A; Tache Y, 2004, BRIT J PHARMACOL, V141, P1321, DOI 10.1038/sj.bjp.0705760; Tache Y, 2015, J NEUROGASTROENTEROL, V21, P8, DOI 10.5056/jnm14162; Vicario M, 2012, PSYCHONEUROENDOCRINO, V37, P65, DOI 10.1016/j.psyneuen.2011.05.005; Videlock EJ, 2009, GASTROENTEROLOGY, V137, P1954, DOI 10.1053/j.gastro.2009.08.058; Wolter BF, 2000, J ANIM SCI, V78, P2062; Zhang L, 2016, J NEUROGASTROENTEROL, V22, P181, DOI 10.5056/jnm15137	56	31	32	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171617	10.1371/journal.pone.0171617	http://dx.doi.org/10.1371/journal.pone.0171617			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170426	Green Published, Green Submitted, gold			2022-12-26	WOS:000393705500046
J	Gayrard, N; Ficheux, A; Duranton, F; Guzman, C; Szwarc, I; Vetromile, F; Cazevieille, C; Brunet, P; Servel, MF; Argiles, A; Le Quintrec, M				Gayrard, Nathalie; Ficheux, Alain; Duranton, Flore; Guzman, Caroline; Szwarc, Ilan; Vetromile, Fernando; Cazevieille, Chantal; Brunet, Philippe; Servel, Marie-Francoise; Argiles, Angel; Le Quintrec, Moglie			Consequences of increasing convection onto patient care and protein removal in hemodialysis	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; ONLINE HEMODIAFILTRATION; ULTRAFILTRATION COEFFICIENT; SERUM-ALBUMIN; UREMIC TOXINS; DIALYSIS; POSTDILUTION; EFFICIENCY; MODALITY	Introduction Recent randomised controlled trials suggest that on-line hemodiafiltration (OL-HDF) improves survival, provided that it reaches high convective volumes. However, there is scant information on the feasibility and the consequences of modifying convection volumes in clinics. Methods Twelve stable dialysis patients were treated with high-flux 1.8 m(2) polysulphone dialyzers and 4 levels of convection flows (Q(UF)) based on K-G(D-UF) monitoring of the system, for 1 week each. The consequences on dialysis delivery (transmembrane pressure (TMP), number of alarms, % of achieved prescribed convection) and efficacy (mass removal of low and high molecular weight compounds) were analysed. Results TMP increased exponentially with Q(UF) (p < 0.001 for N > 56,000 monitoring values). Beyond 21 L/session, this resulted into frequent TMP alarms requiring nursing staff interventions (mean +/- SEM: 10.3 +/- 2.2 alarms per session, p < 0.001 compared to lower convection volumes). Optimal convection volumes as assessed by K-G(D-UF)-max were 20.6 +/- 0.4 L/session, whilst 4 supplementary litres were obtained in the maximum situation (24.5 +/- 0.6 L/session) but the proportion of sessions achieving the prescribed convection volume decreased from 94% to only 33% (p < 0.001). Convection increased high molecular weight compound removal and shifted the membrane cut-off towards the higher molecular weight range. Conclusions Reaching high convection volumes as recommended by the recent RCTs (> 20L) is feasible by setting an HDF system at its optimal conditions based upon the K-G(D-UF) monitoring. Prescribing higher convection volumes resulted in instability of the system, provoked alarms, was bothersome for the nursing staff and the patients, rarely achieved the prescribed convection volumes and increased removal of high molecular weight compounds, notably albumin.	[Gayrard, Nathalie; Ficheux, Alain; Duranton, Flore; Guzman, Caroline; Argiles, Angel] Univ Montpellier, RD Nephrol, Montpellier, France; [Gayrard, Nathalie; Ficheux, Alain; Duranton, Flore; Guzman, Caroline; Argiles, Angel] Univ Montpellier, EA7288, Montpellier, France; [Szwarc, Ilan; Vetromile, Fernando; Servel, Marie-Francoise; Argiles, Angel] Ctr Dialyse Nephrol Dialyse St Guilhem, Sete, France; [Cazevieille, Chantal] INM Montpellier, CoMET, NRI Facil, Montpellier, France; [Brunet, Philippe] Univ Aix Marseille, Hop La Concept, Serv Nephrol, Marseille, France; [Brunet, Philippe; Argiles, Angel] ERA EDTA EUTox, European Uraem Toxin Working Grp ESAO, Krems, Austria; [Le Quintrec, Moglie] CHU Montpellier, Hop Lapeyronie, Serv Nephrol & Transplantat, Montpellier, France	Universite de Montpellier; Universite de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; CHU de Montpellier	Argiles, A (corresponding author), Univ Montpellier, RD Nephrol, Montpellier, France.; Argiles, A (corresponding author), Univ Montpellier, EA7288, Montpellier, France.; Argiles, A (corresponding author), Ctr Dialyse Nephrol Dialyse St Guilhem, Sete, France.; Argiles, A (corresponding author), ERA EDTA EUTox, European Uraem Toxin Working Grp ESAO, Krems, Austria.	oargiles@rd-n.org	gayrard, nathalie/AAO-2888-2020; FICHEUX, Alain/ABD-6370-2021; Duranton, Flore/ABB-6225-2021	gayrard, nathalie/0000-0001-8283-8429; FICHEUX, Alain/0000-0003-3958-4210; Duranton, Flore/0000-0003-3202-0551; Le Quintrec, Moglie/0000-0002-5857-1207; Argiles, Angel/0000-0001-7029-4532				Ahrenholz P, 1997, INT J ARTIF ORGANS, V20, P81, DOI 10.1177/039139889702000206; Ahrenholz PG, 2004, CLIN NEPHROL, V62, P21; Argiles A, 1997, KIDNEY INT, V52, P530, DOI 10.1038/ki.1997.364; ARGILES A, 1987, KIDNEY INT, V32, P714, DOI 10.1038/ki.1987.265; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; ERA-EDTA Registry, 2012, ERA EDTA REG ANN REP; Ficheux A, 2000, KIDNEY INT, V57, P1755, DOI 10.1038/sj.ki.4495464; Ficheux A, 2016, NEPHROL DIAL TRANSPL; Ficheux A, 2015, NEPHROL DIAL TRANSPL, V30, P204, DOI 10.1093/ndt/gft493; Ficheux A, 2011, NEPHROL DIAL TRANSPL, V26, P636, DOI 10.1093/ndt/gfq510; Grooteman MPC, 2012, J AM SOC NEPHROL, V23, P1087, DOI 10.1681/ASN.2011121140; HENDERSON LW, 1975, J LAB CLIN MED, V85, P372; Henderson LW, 1967, ASAIO J, V13, P216; Joyeux V, 2008, INT J ARTIF ORGANS, V31, P928, DOI 10.1177/039139880803101102; KERR PB, 1992, KIDNEY INT, V41, P1035, DOI 10.1038/ki.1992.157; Krieter DH, 2005, KIDNEY INT, V67, P349, DOI 10.1111/j.1523-1755.2005.00088.x; Maduell F, 2015, NEFROLOGIA, V35, P50, DOI 10.3265/Nefrologia.pre2014.Sep.12726; Maduell F, 2013, J AM SOC NEPHROL, V24, P487, DOI 10.1681/ASN.2012080875; Mares J, 2009, KIDNEY INT, V76, P404, DOI 10.1038/ki.2009.138; Meert N, 2009, NEPHROL DIAL TRANSPL, V24, P562, DOI 10.1093/ndt/gfn522; NIWA T, 1995, AM J NEPHROL, V15, P463, DOI 10.1159/000168887; Ok E, 2013, NEPHROL DIAL TRANSPL, V28, P192, DOI 10.1093/ndt/gfs407; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Panichi V, 2012, INT J ARTIF ORGANS, V35, P435, DOI 10.5301/ijao.5000106; Polkinghorne K, ANZDATA REGISTRY REP; Sichart JM, 2011, CONTRIB NEPHROL, V175, P163, DOI 10.1159/000333634; Smith JR, 2016, AM J KIDNEY DIS; Takahashi R, 2012, AM J NEPHROL, V36, P136, DOI 10.1159/000339940; Tattersall J, 2007, NEPHROL DIAL TRANSPL, V22, P5, DOI 10.1093/ndt/gfm022; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x	30	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171179	10.1371/journal.pone.0171179	http://dx.doi.org/10.1371/journal.pone.0171179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166268	Green Published, gold, Green Submitted			2022-12-26	WOS:000393700100028
J	Wang, R; Li, FQ; Zhang, W; Zhang, XM; Qu, C; Tetreau, G; Sun, LJ; Luo, C; Zhou, JJ				Wang, Ran; Li, Fengqi; Zhang, Wei; Zhang, Xiaoman; Qu, Cheng; Tetreau, Guillaume; Sun, Lujuan; Luo, Chen; Zhou, Jingjiang			Identification and expression profile analysis of odorant binding protein and chemosensory protein genes in Bemisia tabaci MED by head transcriptome	PLOS ONE			English	Article							PHEROMONE-BINDING; CHILO-SUPPRESSALIS; SEX-PHEROMONES; HEMIPTERA; BIOTYPE; ANNOTATION; RECEPTORS; INSECTS; CLONING; CHINA	Odorant binding proteins (OBPs) and chemosensory proteins (CSPs) of arthropods are thought to be involved in chemical recognition which regulates pivotal behaviors including host choice, copulation and reproduction. In insects, OBPs and CSPs located mainly in the antenna but they have not been systematically characterized yet in Bemisia tabaci which is a cryptic species complex and could damage more than 600 plant species. In this study, among the 106,893 transcripts in the head assembly, 8 OBPs and 13 CSPs were identified in B. tabaci MED based on head transcriptomes of adults. Phylogenetic analyses were conducted to investigate the relationships of B. tabaci OBPs and CSPs with those from several other important Hemipteran species, and the motif-patterns between Hemiptera OBPs and CSPs were also compared by MEME. The expression profiles of the OBP and CSP genes in different tissues of B. tabaci MED adults were analyzed by real-time qPCR. Seven out of the 8 OBPs found in B. tabaci MED were highly expressed in the head. Conversely, only 4 CSPs were enriched in the head, while the other nine CSPs were specifically expressed in other tissues. Our findings pave the way for future research on chemical recognition of B. tabaci at the molecular level.	[Wang, Ran; Li, Fengqi; Zhang, Wei; Zhang, Xiaoman; Qu, Cheng; Luo, Chen] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Tetreau, Guillaume] Univ Perpignan, Lab Interact Hotes Pathogenes Environm, Perpignan, France; [Sun, Lujuan] Chinese Acad Agr Sci, Agr Informat Inst, Beijing, Peoples R China; [Zhou, Jingjiang] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England	Beijing Academy of Agriculture & Forestry; Ifremer; Universite Perpignan Via Domitia; Chinese Academy of Agricultural Sciences; Agriculture Information Institute, CAAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Luo, C (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China.	luochen1010@126.com	Tetreau, Guillaume/K-1283-2012	Tetreau, Guillaume/0000-0003-3360-4786; Wang, Ran/0000-0002-8199-6895	National Natural Science Foundation of China [31471773, 31601635]; Beijing Academy of Agriculture and Forestry Sciences [QNJJ201610]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Academy of Agriculture and Forestry Sciences	This work was supported partly by National Natural Science Foundation of China (31471773 and 31601635) and the earmarked fund from Beijing Academy of Agriculture and Forestry Sciences (QNJJ201610).	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Blackman RL, 1998, B ENTOMOL RES, V88, P213, DOI 10.1017/S0007485300025785; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; Chang HT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13093; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; COHEN S, 1966, PHYTOPATHOLOGY, V56, P1127; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui HH, 2016, COMP BIOCH PHYSL D; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Gotzek D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016289; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13800; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073524; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Gu XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125159; He P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028921; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Honson NS, 2005, RECENT ADV PHYTOCHEM, V39, P227; Hull JJ, 2014, INSECT MOL BIOL, V23, P78, DOI 10.1111/imb.12064; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jeong YT, 2013, NEURON, V79, P725, DOI 10.1016/j.neuron.2013.06.025; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li RH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/743716; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li X, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/431476; Liu NY, 2015, INT J BIOL SCI, V11, P1036, DOI 10.7150/ijbs.12020; Liu NY, 2015, COMP BIOCHEM PHYS A, V180, P23, DOI 10.1016/j.cbpa.2014.11.005; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Liu YL, 2014, J EXP BIOL, V217, P1821, DOI 10.1242/jeb.102020; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Ma L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149591; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; MOHANTY A K, 1987, Journal of Entomological Research (New Delhi), V11, P15; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nateshan HM, 1996, ANN APPL BIOL, V26, P179; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Pan HP, 2011, J ECON ENTOMOL, V104, P978, DOI 10.1603/EC11009; Paula DP, 2016, INSECT MOL BIOL, V25, P580, DOI 10.1111/imb.12243; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Rebijith KB, 2016, APPL BIOCHEM BIOTECH, V178, P251, DOI 10.1007/s12010-015-1869-7; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Sun YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032759; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tunstall NE, 2012, ADV EXP MED BIOL, V739, P59, DOI 10.1007/978-1-4614-1704-0_4; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Wang R, 2016, J ASIA-PAC ENTOMOL, V19, P195, DOI 10.1016/j.aspen.2016.01.005; Wang Ran, 2016, Journal of Plant Protection, V43, P32; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Xie W, 2014, SCI REP-UK, V4, DOI 10.1038/srep04088; Xu PJ, 2010, MOL BIOL REP, V37, P2265, DOI 10.1007/s11033-009-9715-z; Xu Ya-Long, 2009, BMC Genomics, V10, P1; Xue WX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161839; Yang K, 2016, GENE, V591, P425, DOI 10.1016/j.gene.2016.06.052; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yuan HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140562; Zhao X., 2015, PLOS ONE, V10, pE137166; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou SS, 2014, COMP BIOCHEM PHYS D, V9, P31, DOI 10.1016/j.cbd.2013.12.002	69	38	41	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171739	10.1371/journal.pone.0171739	http://dx.doi.org/10.1371/journal.pone.0171739			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166541	Green Submitted, Green Published, gold			2022-12-26	WOS:000393700100068
J	Tonks, ID; Mukhopadhyay, P; Schroder, WA; Sorolla, A; Mould, AW; Handoko, HY; Ferguson, B; Muller, HK; Keith, P; Hayward, NK; Walker, GJ; Kay, GF				Tonks, I. D.; Mukhopadhyay, P.; Schroder, W. A.; Sorolla, A.; Mould, A. W.; Handoko, H. Y.; Ferguson, B.; Muller, H. K.; Keith, P.; Hayward, N. K.; Walker, G. J.; Kay, G. F.			Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation	ONCOGENE			English	Article							RETINOBLASTOMA PROTEIN; TARGETED DISRUPTION; CDK INHIBITORS; IN-VIVO; P107; RB; PHOSPHORYLATION; P130; PRB; P53	Deregulation of p16INK4A is a critical event in melanoma susceptibility and progression. It is generally assumed that the major effect of loss of p16 function is mediated through the CDK-cyclin pathway via its influence on the pocket protein (PP) pRb. However, there are also two other PPs, p107 and p130, which, when phosphorylated by CDK-cyclin complexes, play a role in permitting cell progression. Cohorts of mice carrying melanocyte-specific knockouts (KOs) of various combinations of the three PPs were generated. Mice null for pRb, p107, p130 or any combination of double mutants did not develop melanoma. Surprisingly, melanocyte-specific loss of all three PPs facilitated melanoma development (median age of onset 308 days, penetrance 40% at 1 year). Tumorigenesis was exacerbated by Trp53 co-deletion (median age of onset 275 days, penetrance 82% at 1 year), with cell culture studies indicating that this difference may result from the apoptotic role of Trp53. Melanomas in PP; Trp53-deficient mice lacked either Ras or Braf mutations, and hence developed in the absence of constitutive MAPK pathway activation. The lag period between induction of total PP or PP/Trp53 KO and melanoma development indicates that additional genetic or epigenetic alterations may account for neoplastic progression. However, exome sequencing of PP; Trp53 KO melanomas failed to reveal any additional recurrent driver mutations. Analysis of the putative mutation signature of the PP; Trp53 KO melanomas suggests that melanocytes are primed for transformation via a mutagenic mechanism involving an excess of T>G substitutions, but not involving a preponderance of C>T substitutions at CpG sites, which is the case for most spontaneous cancers not driven by a specific carcinogen. In sum, deregulation of all three PPs appears central to neoplastic progression for melanoma, and the customary reference to the p16(INKA)/CDK4/pRB pathway may no longer be accurate; all PPs are potentially critical targets of CDK-cyclins in melanoma.	[Tonks, I. D.; Mukhopadhyay, P.; Schroder, W. A.; Mould, A. W.; Handoko, H. Y.; Ferguson, B.; Keith, P.; Hayward, N. K.; Walker, G. J.; Kay, G. F.] QIMR Berghofer Med Res Inst, Cell & Mol Biol Dept, Herston, Qld, Australia; [Sorolla, A.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia; [Mould, A. W.] Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford, England; [Muller, H. K.] Univ Tasmania, Sch Med, Dept Pathol, Hobart, Tas, Australia; [Keith, P.] Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Western Australia; University of Oxford; University of Tasmania; University of Queensland	Walker, GJ (corresponding author), QIMR Berghofer Med Res Inst, 300 Herston Rd, Herston, Qld 4006, Australia.	Graeme.Walker@qimrberghofer.edu.au	Sorolla, Anabel/E-2546-2012; hayward, nick/AAV-8802-2020; hayward, nicholas/C-1367-2015; , Herlina/F-4193-2015	Sorolla, Anabel/0000-0001-8238-8763; Ferguson, Blake/0000-0002-5643-6976; hayward, nicholas/0000-0003-4760-1033; Mould, Arne/0000-0002-2004-4348; , Herlina/0000-0003-3153-2248	Cancer Council of Queensland; National Health and Medical Research Council Fellowship	Cancer Council of Queensland(Cancer Council Queensland); National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by research grants and fellowships to GFK and GW from the Cancer Council of Queensland. NKH is supported by a National Health and Medical Research Council Fellowship. We are grateful to Linda Chin and Marcus Bosenberg for the gift of the Tyr::CreERT2 mice.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Damsky WE, 2010, PIGM CELL MELANOMA R, V23, P853, DOI 10.1111/j.1755-148X.2010.00777.x; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; Epe B, 2012, PHOTOCH PHOTOBIO SCI, V11, P98, DOI 10.1039/c1pp05190c; Ferguson Blake, 2015, Methods Mol Biol, V1267, P251, DOI 10.1007/978-1-4939-2297-0_11; Ferguson B, 2010, PIGM CELL MELANOMA R, V23, P771, DOI 10.1111/j.1755-148X.2010.00752.x; Grana X, 1998, ONCOGENE, V17, P3365, DOI 10.1038/sj.onc.1202575; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen K, 2001, EMBO J, V20, P422, DOI 10.1093/emboj/20.3.422; Hayward NK, 2003, ONCOGENE, V22, P3053, DOI 10.1038/sj.onc.1206445; Huang PH, 2015, MOL CELL ONCOL, V3; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; Leng XH, 2002, MOL CELL BIOL, V22, P2242, DOI 10.1128/MCB.22.7.2242-2254.2002; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; MINTZ B, 1993, P NATL ACAD SCI USA, V90, P8817, DOI 10.1073/pnas.90.19.8817; Mukhopadhyay P, 2016, ONCOGENE, V35, P3342, DOI 10.1038/onc.2015.386; Ruiz S, 2003, DEVELOPMENT, V130, P2341, DOI 10.1242/dev.00453; Sadasivam S, 2013, NAT REV CANCER, V13, P585, DOI 10.1038/nrc3556; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sotillo R, 2001, P NATL ACAD SCI USA, V98, P13312, DOI 10.1073/pnas.241338598; Tonks ID, 2006, PIGM CELL RES, V19, P260, DOI 10.1111/j.1600-0749.2006.00321.x; Tonks ID, 2010, PIGM CELL MELANOMA R, V23, P564, DOI 10.1111/j.1755-148X.2010.00722.x; Tonks ID, 2005, PIGM CELL RES, V18, P252, DOI 10.1111/j.1600-0749.2005.00245.x; Walker GJ, 2011, PIGM CELL MELANOMA R, V24, P1158, DOI 10.1111/j.1755-148X.2011.00923.x; Yang GA, 2005, J INVEST DERMATOL, V125, P1242, DOI 10.1111/j.0022-202X.2005.23931.x; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	36	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 29	2017	36	26					3789	3795		10.1038/onc.2016.511	http://dx.doi.org/10.1038/onc.2016.511			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY9WM	28192409				2022-12-26	WOS:000404349700014
J	Yaseen, S; Demopulos, G; Dudler, T; Yabuki, M; Wood, CL; Cummings, WJ; Tjoelker, LW; Fujita, T; Sacks, S; Garred, P; Andrew, P; Sim, RB; Lachmann, PJ; Wallis, R; Lynch, N; Schwaeble, WJ				Yaseen, Sadam; Demopulos, Gregory; Dudler, Thomas; Yabuki, Munehisa; Wood, Christi L.; Cummings, W. Jason; Tjoelker, Larry W.; Fujita, Teizo; Sacks, Steven; Garred, Peter; Andrew, Peter; Sim, Robert B.; Lachmann, Peter J.; Wallis, Russell; Lynch, Nicholas; Schwaeble, Wilhelm J.			Lectin pathway effector enzyme mannan-binding lectin-associated serine protease-2 can activate native complement C3 in absence of C4 and/or C2	FASEB JOURNAL			English	Article						innate immunity; opsonization; post-ischemic inflammation; activation bypass	PATTERN-RECOGNITION MOLECULES; COLLECTIN LIVER 1; INITIATION COMPLEX; REPERFUSION INJURY; PROTEIN; MASP-1; COMPONENT; AND-2; MBL; DEFICIENCY	All 3 activation pathways of complement-the classic pathway (CP), the alternative pathway, and the lectin pathway (LP)-converge into a common central event: the cleavage and activation of the abundant third complement component, C3, via formation of C3-activating enzymes (C3 convertases). The fourth complement component, C4, and the second component, C2, are indispensable constituents of the C3 convertase complex, C4bC2a, which is formed by both the CP and the LP. Whereas in the absence of C4, CP can no longer activate C3, LP retains a residual but physiologically critical capacity to convert native C3 into its activation fragments, C3a and C3b. This residual C4 and/or C2 bypass route is dependent on LP-specific mannan-binding lectin-associated serine protease-2. By using various serum sources with defined complement deficiencies, we demonstrate that, under physiologic conditions LP-specific C4 and/or C2 bypass activation of C3 is mediated by direct cleavage of native C3 by mannan-binding lectin-associated serine protease-2 bound to LP-activation complexes captured on ligand-coated surfaces.-Yaseen, S., Demopulos, G., Dudler, T., Yabuki, M., Wood, C. L., Cummings, W. J., Tjoelker, L. W., Fujita, T., Sacks, S., Garred, P., Andrew, P., Sim, R. B., Lachmann, P. J., Wallis, R., Lynch, N., Schwaeble, W. J. Lectin pathway effector enzyme mannan-binding lectin-associated serine protease-2 can activate native complement C3 in absence of C4 and/or C2.	[Yaseen, Sadam; Andrew, Peter; Sim, Robert B.; Wallis, Russell; Lynch, Nicholas; Schwaeble, Wilhelm J.] Univ Leicester, Dept Infect Immun & Inflammat, MSB Univ Rd, Leicester LE1 9HN, Leics, England; [Yaseen, Sadam; Demopulos, Gregory; Dudler, Thomas; Yabuki, Munehisa; Wood, Christi L.; Cummings, W. Jason; Tjoelker, Larry W.] Omeros Corp, Seattle, WA USA; [Yaseen, Sadam] Univ Mosul, Dept Biol, Mosul, Iraq; [Fujita, Teizo] Fukushima Med Univ, Fukushima Prefectural Gen Hyg Inst, Fukushima, Japan; [Sacks, Steven] Kings Coll London, MRC, Ctr Transplantat, Guys Campus, London, England; [Garred, Peter] Univ Copenhagen, Dept Clin Immunol, Lab Mol Med, Rigshosp, Copenhagen, Denmark; [Lachmann, Peter J.] Univ Cambridge, Dept Vet Med, Cambridge, England	University of Leicester; University of Mosul; Fukushima Medical University; University of London; King's College London; Rigshospitalet; University of Copenhagen; University of Cambridge	Schwaeble, WJ (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, MSB Univ Rd, Leicester LE1 9HN, Leics, England.	ws5@le.ac.uk	Thielens, Nicole M/F-2512-2013; Lachmann, P J/I-7968-2019; Andrew, Peter W/G-7526-2012	Thielens, Nicole M/0000-0002-7354-0302; Lachmann, P J/0000-0003-2849-3524; Lynch, Nicholas/0000-0003-3803-3329; Wallis, Russell/0000-0002-8705-5295; Garred, Peter/0000-0002-2876-8586; Schwaeble, Wilhelm/0000-0001-8927-0864; Sacks, Steven/0000-0001-6361-9095	Medical Research Council [G0801952]; Omeros Corp.; Medical Research Council [G0700859] Funding Source: researchfish; Novo Nordisk Fonden [NNF13SA0009309] Funding Source: researchfish; MRC [G0700859, G0801952] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Omeros Corp.; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are grateful to Drs. Peter Gal and Geza Ambrus (Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences, Budapest, Hungary) for providing enzymatically active recombinant truncated MASP-1 and MASP-2 expressed in E. coli. This work was supported by Medical Research Council Grant G0801952 (to W.S.) and Omeros Corp. Omeros Corp. developed the MASP-2 inhibitor mAb HG4 and the clinical candidate inhibitor OMS721 that successfully completed stage 2 of clinical trials and is advancing clinical-stage development programs focused on complement- related thrombotic microangiopathies and complement- mediated renal pathologies. G.D. is the founder and CEO,and owns an equity interest in Omeros Corp. S.Y., T.D., M.Y., C.L. W.,W. J.C., and L.W. T.are employees of, and each owns an equity interest in, Omeros Corp. W. J.S. is a member of the scientific advisory board and owns an equity interest in Omeros Corp. P.J.L. is a member of the scientific advisory board of Omeros Corp.	Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Asgari E, 2014, FASEB J, V28, P3996, DOI 10.1096/fj.13-246306; Axelgaard E, 2013, J BIOL CHEM, V288, P23407, DOI 10.1074/jbc.M113.492603; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; Collard CD, 2000, AM J PATHOL, V156, P1549, DOI 10.1016/S0002-9440(10)65026-2; Degn SE, 2014, P NATL ACAD SCI USA, V111, P13445, DOI 10.1073/pnas.1406849111; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Dobo J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31877; Farrar CA, 2016, J CLIN INVEST, V126, P1911, DOI 10.1172/JCI83000; Fischer MB, 1996, J IMMUNOL, V157, P549; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Hajela K, 2002, IMMUNOBIOLOGY, V205, P467, DOI 10.1078/0171-2985-00147; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Harboe M, 2009, MOL IMMUNOL, V47, P373, DOI 10.1016/j.molimm.2009.09.005; Heja D, 2012, J BIOL CHEM, V287, P20290, DOI 10.1074/jbc.M112.354332; Henriksen ML, 2013, J IMMUNOL, V191, P6117, DOI 10.4049/jimmunol.1302121; Herbert AP, 2015, J IMMUNOL, V195, P4986, DOI 10.4049/jimmunol.1501388; Iwaki D, 2006, J IMMUNOL, V177, P8626, DOI 10.4049/jimmunol.177.12.8626; Iwaki D, 2011, J IMMUNOL, V187, P3751, DOI 10.4049/jimmunol.1100280; Kenawy HI, 2012, IMMUNOBIOLOGY, V217, P272, DOI 10.1016/j.imbio.2011.10.001; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2; Lin T, 2006, AM J PATHOL, V168, P1241, DOI 10.2353/ajpath.2006.050360; Ma YJ, 2013, J INNATE IMMUN, V5, P242, DOI 10.1159/000345356; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; MATSUSHITA M, 1995, IMMUNOBIOLOGY, V194, P443, DOI 10.1016/S0171-2985(11)80110-5; May J E, 1973, J Immunol, V111, P1671; Moller-Kristensen M, 2007, INT IMMUNOL, V19, P141, DOI 10.1093/intimm/dxl131; Orsini F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0684-6; Orsini F, 2012, CIRCULATION, V126, P1484, DOI 10.1161/CIRCULATIONAHA.112.103051; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; Rossi V, 2001, J BIOL CHEM, V276, P40880, DOI 10.1074/jbc.M105934200; Schwaeble W, 2002, IMMUNOBIOLOGY, V205, P455, DOI 10.1078/0171-2985-00146; Schwaeble W. J., 2013, International Patent, Patent No. [WO2013/192240, 2013192240]; Schwaeble W. J., 2013, International Patent, Patent No. [WO2013/180834, 2013180834]; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Selander B, 2006, J CLIN INVEST, V116, P1425, DOI 10.1172/JCI25982; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; STEUER KLK, 1989, J IMMUNOL, V143, P2256; Stover CM, 1999, J IMMUNOL, V162, P3481; Takahashi M, 1999, INT IMMUNOL, V11, P859, DOI 10.1093/intimm/11.5.859; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Thiel S, 2000, J IMMUNOL, V165, P878, DOI 10.4049/jimmunol.165.2.878; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Thiel S, 2012, CLIN EXP IMMUNOL, V169, P38, DOI 10.1111/j.1365-2249.2012.04584.x; Vorup-Jensen T, 2000, J IMMUNOL, V165, P2093, DOI 10.4049/jimmunol.165.4.2093; Wallis R, 1999, J IMMUNOL, V163, P4953; Wallis R, 2007, J BIOL CHEM, V282, P7844, DOI 10.1074/jbc.M606326200; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Walsh MC, 2005, J IMMUNOL, V175, P541, DOI 10.4049/jimmunol.175.1.541; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490	57	32	32	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2210	2219		10.1096/fj.201601306R	http://dx.doi.org/10.1096/fj.201601306R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28188176	Green Submitted			2022-12-26	WOS:000399195500038
J	Hsu, MH; Baer, BR; Rettie, AE; Johnson, EF				Hsu, Mei-Hui; Baer, Brian R.; Rettie, Allan E.; Johnson, Eric F.			The Crystal Structure of Cytochrome P450 4B1 (CYP4B1) Monooxygenase Complexed with Octane Discloses Several Structural Adaptations for omega-Hydroxylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COVALENT HEME-BINDING; CHAIN FATTY-ACIDS; SUBSTRATE-BINDING; 20-HYDROXYEICOSATETRAENOIC ACID; GENETIC-VARIATION; ESCHERICHIA-COLI; RABBIT CYP4B1; OXIDATION; ENZYMES; P450	P450 family 4 fatty acid omega-hydroxylases preferentially oxygenate primary C-H bonds over adjacent, energetically favored secondary C-H bonds, but the mechanism explaining this intriguing preference is unclear. To this end, the structure of rabbit P450 4B1 complexed with its substrate octane was determined by X-ray crystallography to define features of the active site that contribute to a preference for omega-hydroxylation. The structure indicated that octane is bound in a narrow active-site cavity that limits access of the secondary C-H bond to the reactive intermediate. A highly conserved sequence motif on helix I contributes to positioning the terminal carbon of octane for omega-hydroxylation. Glu-310 of this motif auto-catalytically forms an ester bond with the heme 5-methyl, and the immobilized Glu-310 contributes to substrate positioning. The preference for omega-hydroxylation was decreased in an E310A mutant having a shorter side chain, but the overall rates of metabolism were retained. E310D and E310Q substitutions having longer side chains exhibit lower overall rates, likely due to higher conformational entropy for these residues, but they retained high preferences for octane omega-hydroxylation. Sequence comparisons indicated that active-site residues constraining octane for omega-hydroxylation are conserved in family 4 P450s. Moreover, the heme 7-propionate is positioned in the active site and provides additional restraints on substrate binding. In conclusion, P450 4B1 exhibits structural adaptations for omega-hydroxylation that include changes in the conformation of the heme and changes in a highly conserved helix I motif that is associated with selective oxygenation of unactivated primary C-H bonds.	[Hsu, Mei-Hui; Johnson, Eric F.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Baer, Brian R.; Rettie, Allan E.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	Scripps Research Institute; University of Washington; University of Washington Seattle	Johnson, EF (corresponding author), Scripps Res Inst tute, MEM 255, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	johnson@scripps.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750, R01GM031001, R01GM049054, P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, NIGMS Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baer BR, 2005, BIOCHEMISTRY-US, V44, P13914, DOI 10.1021/bi051267j; Baer BR, 2007, BIOCHEMISTRY-US, V46, P11598, DOI 10.1021/bi701064b; Baer BR, 2006, DRUG METAB REV, V38, P451, DOI 10.1080/03602530600688503; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; Berka K, 2013, J PHYS CHEM B, V117, P11556, DOI 10.1021/jp4059559; BJORKHEM I, 1978, J LIPID RES, V19, P585; Borbulevych OY, 2014, ACTA CRYSTALLOGR D, V70, P1233, DOI 10.1107/S1399004714002260; Cheesman MJ, 2003, ARCH BIOCHEM BIOPHYS, V416, P17, DOI 10.1016/S0003-9861(03)00278-9; de Montellano PRO, 2008, DRUG METAB REV, V40, P405, DOI [10.1080/03602530802186439, 10.1080/03602530802186439 ]; de Montellano PRO, 2016, RSC METALLOBIO SER, V4, P3; de Visser SP, 2004, J AM CHEM SOC, V126, P8362, DOI 10.1021/ja048528h; Denisov IG, 2012, J INORG BIOCHEM, V108, P150, DOI 10.1016/j.jinorgbio.2011.11.026; Edson KZ, 2013, CURR TOP MED CHEM, V13, P1429; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fan F, 2015, CURR OPIN NEPHROL HY, V24, P37, DOI 10.1097/MNH.0000000000000088; Fisher MB, 1998, BIOCHEM BIOPH RES CO, V248, P352, DOI 10.1006/bbrc.1998.8842; GASSER R, 1989, MOL PHARMACOL, V35, P617; GOTOH O, 1992, J BIOL CHEM, V267, P83; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Jefcoate C R, 1978, Methods Enzymol, V52, P258; JENKINS CM, 1994, J BIOL CHEM, V269, P27401; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; Johnston JB, 2011, ARCH BIOCHEM BIOPHYS, V507, P86, DOI 10.1016/j.abb.2010.08.011; Joyce MG, 2004, J BIOL CHEM, V279, P23287, DOI 10.1074/jbc.M401717200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAM W, 1978, J LIPID RES, V19, P591; KORZEKWA KR, 1990, J AM CHEM SOC, V112, P7042, DOI 10.1021/ja00175a040; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laffer CL, 2008, HYPERTENSION, V51, P767, DOI 10.1161/HYPERTENSIONAHA.107.102921; Laffer CL, 2014, J AM SOC HYPERTENS, V8, P475, DOI 10.1016/j.jash.2014.04.011; LeBrun LA, 2002, BIOCHEMISTRY-US, V41, P5931, DOI 10.1021/bi025527y; LeBrun LA, 2002, J BIOL CHEM, V277, P12755, DOI 10.1074/jbc.M112155200; Lockhart CM, 2014, INVEST OPHTH VIS SCI, V55, P5572, DOI 10.1167/iovs.13-13717; Mak PJ, 2008, BIOPOLYMERS, V89, P1045, DOI 10.1002/bip.21058; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; MORTENSEN PB, 1981, BIOCHIM BIOPHYS ACTA, V666, P394, DOI 10.1016/0005-2760(81)90298-8; Nakano M, 2012, MOL PHARMACOL, V82, P679, DOI 10.1124/mol.112.080085; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Olsen L, 2006, J MED CHEM, V49, P6489, DOI 10.1021/jm060551l; PALMER CNA, 1993, BIOCHIM BIOPHYS ACTA, V1172, P161, DOI 10.1016/0167-4781(93)90285-L; Roberts BR, 2005, PROTEIN SCI, V14, P2414, DOI 10.1110/ps.051459705; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200; Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39; Stark K, 2005, ARCH BIOCHEM BIOPHYS, V441, P174, DOI 10.1016/j.abb.2005.07.003; Stark K, 2008, FEBS J, V275, P3706, DOI 10.1111/j.1742-4658.2008.06518.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; WOLF CR, 1982, MOL PHARMACOL, V22, P738; Wu CC, 2014, CARDIOL REV, V22, P1, DOI 10.1097/CRD.0b013e3182961659; Zheng YM, 2003, BIOCHEMISTRY-US, V42, P4601, DOI 10.1021/bi020667t; Zollner A, 2009, BIOL CHEM, V390, P313, DOI 10.1515/BC.2009.030	60	30	32	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5610	5621		10.1074/jbc.M117.775494	http://dx.doi.org/10.1074/jbc.M117.775494			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28167536	Green Published, hybrid			2022-12-26	WOS:000397875500040
J	King, C; Raicu, V; Hristova, K				King, Christopher; Raicu, Valerica; Hristova, Kalina			Understanding the FRET Signatures of Interacting Membrane Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; DIMERIZATION; DOMAIN; COMPLEXES; CHANNEL; STOICHIOMETRY; ACTIVATION; EFFICIENCY; DIMERS; CELLS	FRET is an indispensable experimental tool for studying membrane proteins. Currently, two models are available for researchers to determine the oligomerization state of membrane proteins in a static quenching FRET experiment: the model of Veatch and Stryer, derived in 1977, and the kinetic theory- based model for intraoligomeric FRET, derived in 2007. Because of confinement in two dimensions, a substantial amount of FRET is generated by energy transfer between fluorophores located in separate oligomers in the two-dimensional bilayer. This interoligomeric FRET (also known as stochastic, bystander, or proximity FRET) is not accounted for in either model. Here, we use the kinetic theory formalism to describe the dependence of the FRET efficiency measured in an experiment (i.e. the "total apparentFRETefficiency") on the interoligomeric FRET due to random proximity within the bilayer and the intraoligomeric FRET resulting from protein-protein interactions. We find that data analysis with both models without consideration of the proximity FRET leads to incorrect conclusions about the oligomeric state of the protein. We show that knowledge of the total surface densities of fluorophore-labeled membrane proteins is essential for correctly interpreting the measured total apparent FRET efficiency. We also find that bulk, two-color, static quenching FRET experiments are best suited for the study of monomeric, dimerizing, or dimeric proteins but have limitations in discerning the order of larger oligomers. The theory and methodology described in this work will allow researchers to extract meaningful parameters from static quenching FRET measurements in biological membranes.	[Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [King, Christopher; Hristova, Kalina] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA; [Raicu, Valerica] Univ Wisconsin, Dept Phys, Milwaukee, WI 53211 USA	Johns Hopkins University; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Milwaukee	Hristova, K (corresponding author), Dept Mat Sci & Engn, 3400 N Charles St, Baltimore, MD 21212 USA.	kh@jhu.edu		King, Christopher/0000-0002-2400-5717	National Science Foundation (NSF) [MCB 1157687]; National Institutes of Health [GM068619]; NSF Graduate Research Fellowship [DGE-1232825]; NSF [PFI-1114305, PHY-1058470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068619] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation (NSF) Grant MCB 1157687 and National Institutes of Health Grant GM068619 (to K. H.), NSF Graduate Research Fellowship DGE-1232825 (to C. K.), and NSF Grants PFI-1114305 and PHY-1058470 (to V. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blin S, 2014, J BIOL CHEM, V289, P28202, DOI 10.1074/jbc.M114.600437; Bohme I, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-16; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Chen LR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001195; Chen LR, 2010, J AM CHEM SOC, V132, P3628, DOI 10.1021/ja910692u; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clegg R. M, 1996, FLUORESCENCE IMAGING, V137, P179; Digman MA, 2009, P NATL ACAD SCI USA, V106, P2170, DOI 10.1073/pnas.0806036106; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; He LJ, 2012, BBA-BIOMEMBRANES, V1818, P995, DOI 10.1016/j.bbamem.2011.07.044; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Huang YJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14107; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kavran JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03772; King C, 2016, INTEGR BIOL-UK, V8, P216, DOI 10.1039/c5ib00202h; King C, 2014, BIOPHYS J, V106, P1309, DOI 10.1016/j.bpj.2014.01.039; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li E, 2010, CELL ADHES MIGR, V4, P249, DOI 10.4161/cam.4.2.10725; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Mathiasen S, 2014, NAT METHODS, V11, P931, DOI [10.1038/nmeth.3062, 10.1038/NMETH.3062]; Mishra AK, 2016, BIOCHEM J, V473, P3819, DOI 10.1042/BCJ20160422; Mishra AK, 2015, BIOCHEM J, V466, P263, DOI 10.1042/BJ20141321; Needham SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13307; Patowary S, 2015, BIOPHYS J, V108, P1613, DOI 10.1016/j.bpj.2015.02.021; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Press W, 1989, NUMERICAL RECIPES AR; Raicu V, 2007, J BIOL PHYS, V33, P109, DOI 10.1007/s10867-007-9046-z; Raicu V, 2010, NANOSCOPY AND MULTIDIMENSIONAL OPTICAL FLUORESCENCE MICROSCOPY; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Sampieri A, 2009, CELL CALCIUM, V45, P439, DOI 10.1016/j.ceca.2009.02.010; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Singh DR, 2017, BBA-MOL CELL RES, V1864, P31, DOI 10.1016/j.bbamcr.2016.10.011; Singh DR, 2016, BBA-GEN SUBJECTS, V1860, P1922, DOI 10.1016/j.bbagen.2016.06.004; Singh DR, 2015, J BIOL CHEM, V290, P27271, DOI 10.1074/jbc.M115.676866; Singh DR, 2015, BIOCHEM J, V471, P101, DOI 10.1042/BJ20150433; SNYDER B, 1982, BIOPHYS J, V40, P137, DOI 10.1016/S0006-3495(82)84468-8; VEATCH W, 1977, J MOL BIOL, V113, P89, DOI 10.1016/0022-2836(77)90042-0; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wang X.F, 1996, FLUORESCENCE IMAGING; WOLBER PK, 1979, BIOPHYS J, V28, P197, DOI 10.1016/S0006-3495(79)85171-1	46	39	39	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5291	5310		10.1074/jbc.M116.764282	http://dx.doi.org/10.1074/jbc.M116.764282			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28188294	Green Published, hybrid			2022-12-26	WOS:000397875500013
J	Kroczynska, B; Blyth, GT; Rafidi, RL; Majchrzak-Kita, B; Xu, L; Saleiro, D; Kosciuczuk, EM; Jemielity, J; Su, B; Altman, JK; Eklund, EA; Fish, EN; Platanias, LC				Kroczynska, Barbara; Blyth, Gavin T.; Rafidi, Robert L.; Majchrzak-Kita, Beata; Xu, Lucy; Saleiro, Diana; Kosciuczuk, Ewa M.; Jemielity, Jacek; Su, Bing; Altman, Jessica K.; Eklund, Elizabeth A.; Fish, Eleanor N.; Platanias, Leonidas C.			Central Regulatory Role for SIN1 in Interferon gamma (IFN gamma) Signaling and Generation of Biological Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-INHIBITORY RESPONSES; MESSENGER-RNA TRANSLATION; RICTOR-MTOR COMPLEX; I INTERFERONS; MAMMALIAN TARGET; APLASTIC-ANEMIA; PHOSPHORYLATION; PATHWAY; AKT	The precise signaling mechanisms by which type II IFN receptors control expression of unique genes to induce biological responses remain to be established. We provide evidence that Sin1, a known element of the mammalian target of rapamycin complex 2 (mTORC2), is required for IFN gamma-induced phosphorylation and activation of AKT and that such activation mediates downstream regulation of mTORC1 and its effectors. These events play important roles in the assembly of the eukaryotic translation initiation factor 4F (eIF4F) andmRNAtranslation of IFN-stimulated genes. Interestingly, IFN gamma-induced tyrosine phosphorylation of STAT1 is reduced in cells with targeted disruption of Sin1, leading to decreased transcription of several IFN gamma-inducible genes in an mTORC2-independent manner. Additionally, our studies establish that Sin1 is essential for generation of type II IFN-dependent antiviral effects and antiproliferative responses in normal and malignant hematopoiesis. Together, our findings establish an important role for Sin1 in both transcription and translation of IFN-stimulated genes and type II IFN-mediated biological responses, involving both mTORC2-dependent and -independent functions.	[Kroczynska, Barbara; Blyth, Gavin T.; Rafidi, Robert L.; Xu, Lucy; Saleiro, Diana; Kosciuczuk, Ewa M.; Altman, Jessica K.; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Kroczynska, Barbara; Blyth, Gavin T.; Rafidi, Robert L.; Xu, Lucy; Saleiro, Diana; Kosciuczuk, Ewa M.; Altman, Jessica K.; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Kroczynska, Barbara] Northwestern Univ, Dept Radiat Oncol, Chicago, IL 60611 USA; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 2M1, Canada; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M1, Canada; [Kosciuczuk, Ewa M.; Altman, Jessica K.; Eklund, Elizabeth A.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Div Hematol Oncol, Chicago, IL 60612 USA; [Jemielity, Jacek] Univ Warsaw, Ctr New Technol, PL-02097 Warsaw, Poland; [Su, Bing] Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA; [Su, Bing] Yale Univ, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Su, Bing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200000, Peoples R China; [Su, Bing] Shanghai Jiao Tong Univ, Sch Med, Dept Microbiol & Immunol, Shanghai 200000, Peoples R China	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Warsaw; Yale University; Yale University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, 303 E Super Ave,Lurie 3-125, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Jemielity, Jacek/E-2635-2013; Kosciuczuk, Ewa Maria/AAD-2815-2022	Jemielity, Jacek/0000-0001-7633-788X; 	National Institutes of Health [CA155566, CA161796, CA77816, CA121192, T32 CA080621]; Department of Veterans Affairs [I01CX000916]; NCI; National Science Centre (Poland) [UMO-2013/09/B/ ST5/01341]; National Natural Science Foundation of China [31470845, 81430033]; Shanghai Science and Technology Commission [13JC1404700]; NATIONAL CANCER INSTITUTE [T32CA080621, R01CA077816, P30CA060553, R01CA161796, R01CA121192, R01CA155566] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Centre (Poland); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants CA155566, CA161796, CA77816, and CA121192 and by Department of Veterans Affairs Grant I01CX000916. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NCI, National Institutes of Health, Grant T32 CA080621; Supported by National Science Centre (Poland) Grant UMO-2013/09/B/ ST5/01341; Supported by National Natural Science Foundation of China Grants 31470845 and 81430033 and Shanghai Science and Technology Commission Grant 13JC1404700	Aimbetov R, 2012, ONCOGENE, V31, P2115, DOI 10.1038/onc.2011.404; Baechler EC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3531; Beauchamp EM, 2013, ONCOGENE, V32, P3923, DOI 10.1038/onc.2012.567; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Gade P, 2012, P NATL ACAD SCI USA, V109, P10316, DOI 10.1073/pnas.1119273109; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang KZ, 2014, SEMIN CELL DEV BIOL, V36, P79, DOI 10.1016/j.semcdb.2014.09.011; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Jemielity J, 2012, ORG BIOMOL CHEM, V10, P8570, DOI 10.1039/c2ob26060c; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kaufman HL, 2013, NAT REV CLIN ONCOL, V10, P588, DOI 10.1038/nrclinonc.2013.153; Kaur S, 2008, J IMMUNOL, V181, P7316, DOI 10.4049/jimmunol.181.10.7316; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaur S, 2014, J BIOL CHEM, V289, P6581, DOI 10.1074/jbc.M113.537852; Kaur S, 2012, P NATL ACAD SCI USA, V109, P7723, DOI 10.1073/pnas.1118122109; Killestein J, 2011, NAT REV NEUROL, V7, P221, DOI 10.1038/nrneurol.2011.22; KOTENKO SV, 1995, J BIOL CHEM, V270, P20915, DOI 10.1074/jbc.270.36.20915; Kroczynska B, 2016, J BIOL CHEM, V291, P2389, DOI 10.1074/jbc.M115.664995; Kroczynska B, 2014, J INTERF CYTOK RES, V34, P289, DOI 10.1089/jir.2013.0148; Kroczynska B, 2011, J BIOL CHEM, V286, P1147, DOI 10.1074/jbc.M110.183566; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Larsen TS, 2013, LEUKEMIA RES, V37, P1041, DOI 10.1016/j.leukres.2013.06.012; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li C, 2014, BIOCHEM BIOPH RES CO, V450, P646, DOI 10.1016/j.bbrc.2014.06.030; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mehrotra S, 2013, J BIOL CHEM, V288, P23814, DOI 10.1074/jbc.M113.476192; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2013, J INTERF CYTOK RES, V33, P143, DOI 10.1089/jir.2013.0019; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Saleiro D, 2016, CYTOKINE GROWTH F R, V29, P17, DOI 10.1016/j.cytogfr.2016.03.008; Saleiro D, 2015, TRENDS IMMUNOL, V36, P21, DOI 10.1016/j.it.2014.10.006; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sassano A, 2015, MOL CELL BIOL, V35, P2684, DOI 10.1128/MCB.00019-15; Shiloh R, 2014, APOPTOSIS, V19, P286, DOI 10.1007/s10495-013-0924-5; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Verma A, 2002, J IMMUNOL, V168, P5984, DOI 10.4049/jimmunol.168.12.5984; Wahren-Herlenius M, 2013, LANCET, V382, P819, DOI 10.1016/S0140-6736(13)60954-X; Wang SZ, 2004, ENDOCRINOLOGY, V145, P5820, DOI 10.1210/en.2004-0991; Warminski M, 2015, EUR J ORG CHEM, V2015, P6153, DOI 10.1002/ejoc.201500672; Yang G, 2015, CELL REP, V12, P937, DOI 10.1016/j.celrep.2015.07.016; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777	65	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4743	4752		10.1074/jbc.M116.757666	http://dx.doi.org/10.1074/jbc.M116.757666			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28174303	hybrid, Green Published			2022-12-26	WOS:000397585100029
J	Angelani, CR; Caramelo, JJ; Curto, LM; Delfino, JAM				Angelani, Carla R.; Caramelo, Julio J.; Curto, Lucrecia M.; Delfino, Jose A. M.			Structural coalescence underlies the aggregation propensity of a beta-barrel protein motif	PLOS ONE			English	Article							ACID-BINDING-PROTEIN; CIRCULAR-DICHROISM; LIGAND-BINDING; PREDICTION; TRIFLUOROETHANOL; DELTA-98-DELTA; PEPTIDES; DISORDER	A clear understanding of the structural foundations underlying protein aggregation is an elusive goal of central biomedical importance. A step toward this aim is exemplified by the 13 barrel motif represented by the intestinal fatty acid binding protein (IFABP) and two abridged all-beta sheet forms (Delta 980 and Delta 078 Delta). At odds with the established notion that a perturbation of the native fold should necessarily favor a buildup of intermediate forms with an enhanced tendency to aggregate, the intrinsic stability (Delta G degrees(H2O)) of these proteins does not bear a straightforward correlation with their trifluoroethanol (TFE)-induced aggregation propensity. In view of this fact, we found it more insightful to delve into the connection between structure and stability under sub-aggregating conditions (10% TFE). In the absence of the co-solvent, the abridged variants display a common native-like region decorated with a disordered C-terminal stretch. Upon TFE addition, an increase in secondary structure content is observed, assimilating them to the parent protein. In this sense, TFE perturbs a common native like region while exerting a global compaction effect. Importantly, in all cases, fatty acid binding function is preserved. Interestingly, energetic as well as structural diversity in aqueous solution evolves into a common conformational ensemble more akin in stability. These facts reconcile apparent paradoxical findings related to stability and rates of aggregation. This scenario likely mimics the accrual of aggregation-prone species in the population, an early critical event for the development of fibrillation.	[Angelani, Carla R.; Curto, Lucrecia M.; Delfino, Jose A. M.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, Buenos Aires, DF, Argentina; [Angelani, Carla R.; Curto, Lucrecia M.; Delfino, Jose A. M.] Univ Buenos Aires, Fac Farm & Bioquim, Consejo Nacl Invest Cient & Tecn, Inst Quim & Fisicoquim Biol IQUIFIB, Buenos Aires, DF, Argentina; [Caramelo, Julio J.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Caramelo, Julio J.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires IIBBA, Buenos Aires, DF, Argentina; [Caramelo, Julio J.] Fdn Inst Leloir, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Leloir Institute	Curto, LM; Delfino, JAM (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, Buenos Aires, DF, Argentina.; Curto, LM; Delfino, JAM (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Consejo Nacl Invest Cient & Tecn, Inst Quim & Fisicoquim Biol IQUIFIB, Buenos Aires, DF, Argentina.	lcurto@qb.ffyb.uba.ar; delfino@qb.ffyb.uba.ar		Curto, Lucrecia/0000-0002-4335-5309	University of Buenos Aires (UBACyT) [Q-405]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 0540]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 2014-2757]	University of Buenos Aires (UBACyT)(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This research has been supported by grants to JMD and LMC from the University of Buenos Aires (UBACyT Q-405), the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET PIP 0540) and the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT PICT 2014-2757).	Angelani CR, 2014, BBA-PROTEINS PROTEOM, V1844, P1599, DOI 10.1016/j.bbapap.2014.06.002; Arighi CN, 2003, BIOCHEMISTRY-US, V42, P7539, DOI 10.1021/bi020680d; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Curto LM, 2015, PROSTAG LEUKOTR ESS, V93, P37, DOI 10.1016/j.plefa.2014.08.001; Curto LM, 2005, BIOCHEMISTRY-US, V44, P13847, DOI 10.1021/bi051080s; Curto LM, 2012, BIOPHYS J, V103, P1929, DOI 10.1016/j.bpj.2012.09.002; Dalessio PM, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20463; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Franchini GR, 2009, PROTEIN SCI, V18, P2592, DOI 10.1002/pro.273; Habchi J, 2015, SCI ADV; Hackl EV, 2014, BIOPOLYMERS, V101, P591, DOI 10.1002/bip.22422; Hoh JH, 1998, PROTEINS, V32, P223, DOI 10.1002/(SICI)1097-0134(19980801)32:2<223::AID-PROT8>3.0.CO;2-L; Hong DP, 1999, J AM CHEM SOC, V121, P8427, DOI 10.1021/ja990833t; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Lakowicz J. R., PRINCIPLES FLUORESCE; Lin K, 2005, BIOINFORMATICS, V21, P152, DOI 10.1093/bioinformatics/bth487; Curto LM, 2009, PROTEIN SCI, V18, P735, DOI 10.1002/pro.71; Mukhopadhyay K, 1998, BIOPHYS CHEM, V74, P175, DOI 10.1016/S0301-4622(98)00177-X; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Povey JF, 2007, J STRUCT BIOL, V157, P329, DOI 10.1016/j.jsb.2006.07.008; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; SACCHETTINI JC, 1992, J BIOL CHEM, V267, P23534; Schmid FX., 1989, SPECTRAL METHODS CHA, P251; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yeh SR, 2001, BIOCHEMISTRY-US, V40, P4205, DOI 10.1021/bi0155044	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0170607	10.1371/journal.pone.0170607	http://dx.doi.org/10.1371/journal.pone.0170607			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187186	Green Published, Green Submitted, gold			2022-12-26	WOS:000394244300007
J	Mummert, A; Weiss, H				Mummert, Anna; Weiss, Howard			Controlling viral outbreaks: Quantitative strategies	PLOS ONE			English	Article							STAGED-PROGRESSION MODEL; MOUTH-DISEASE; GLOBAL DYNAMICS; FOOT; TRANSMISSION; EPIDEMIOLOGY; EMERGENCE; EBOLA	Preparing for and responding to outbreaks of serious livestock infectious diseases are critical measures to safeguard animal health, public health, and food supply. Almost all of the current control strategies are empirical, and mass culling or "stamping out" is frequently the principal strategy for controlling epidemics. However, there are ethical, ecological, and economic reasons to consider less drastic control strategies. Here we use modeling to quantitatively study the efficacy of different control measures for viral outbreaks, where the infectiousness, transmissibility and death rate of animals commonly depends on their viral load. We develop a broad theoretical framework for exploring and understanding this heterogeneity. The model includes both direct transmission from infectious animals and indirect transmission from an environmental reservoir. We then incorporate a large variety of control measures, including vaccination, antivirals, isolation, environmental disinfection, and several forms of culling, which may result in fewer culled animals. We provide explicit formulae for the basic reproduction number, R-0, for each intervention and for combinations. We evaluate the control methods for a realistic simulated outbreak of low pathogenic avian influenza on a mid-sized turkey farm. In this simulated outbreak, culling results in more total dead birds and dramatically more when culling all of the infected birds.	[Mummert, Anna] Marshall Univ, Dept Math, Huntington, WV 25755 USA; [Weiss, Howard] Georgia Inst Technol, Sch Math, Atlanta, GA 30332 USA	Marshall University; University System of Georgia; Georgia Institute of Technology	Mummert, A (corresponding author), Marshall Univ, Dept Math, Huntington, WV 25755 USA.	mummerta@marshall.edu						ANDERSON R M, 1991; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Charleston B, 2011, SCIENCE, V332, P726, DOI 10.1126/science.1199884; Dal Pozzo F, 2014, REV SCI TECHNIQUE IN, V33; de Rueda CB, 2015, VET RES, V46, DOI 10.1186/s13567-015-0156-5; deJong MCM, 1995, PREV VET MED, V25, P183, DOI 10.1016/0167-5877(95)00538-2; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dion E, 2011, ECOL MODEL, V222, P2059, DOI 10.1016/j.ecolmodel.2011.03.026; Ducatez M, 2014, PREPRINT; Dwyer RM, 2004, VET CLIN N AM-EQUINE, V20, P531, DOI 10.1016/j.cveq.2004.07.001; FAO OIE, 2007, GLOB STRAT PROGR CON; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Grace D, 2012, MAPPING POVERTY ZOON; Guo HB, 2006, MATH BIOSCI ENG, V3, P513, DOI 10.3934/mbe.2006.3.513; Guo Hongbin, 2008, Journal of Biological Dynamics, V2, P154, DOI 10.1080/17513750802120877; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Heath S. E., 2012, Animal Frontiers, V2, P60; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Jacob JP, 2014, AVIAN INFLUENZA POUL, pPS38; Jewell CP, 2009, J R SOC INTERFACE, V6, P1145, DOI 10.1098/rsif.2008.0433; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Merck, MERCK VET MANUAL; Minh PQ, 2011, SPAT SPATIO-TEMPORAL, V2, P49, DOI 10.1016/j.sste.2010.11.001; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Saenz RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045059; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Shim E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005503; Shivaprasad HL, 2000, REV SCI TECH OIE, V19, P405, DOI 10.20506/rst.19.2.1222; Srikantiah Sridhar, 2008, Indian J Med Ethics, V5, P52; Tildesley MJ, 2008, P ROY SOC B-BIOL SCI, V275, P1459, DOI 10.1098/rspb.2008.0006; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067; WEBSTER RG, 1986, J ANTIMICROB CHEMOTH, V18, P157, DOI 10.1093/jac/18.Supplement_B.157; Whiting TL, 2003, CAN VET J, V44, P805	39	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171199	10.1371/journal.pone.0171199	http://dx.doi.org/10.1371/journal.pone.0171199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187137	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300014
J	Xie, YY; Wang, Q; Wang, CL; Che, XJ; Shao, XH; Xu, Y; Ni, ZH; Mou, S				Xie, Yuanyuan; Wang, Qin; Wang, Chunlin; Che, Xiajing; Shao, Xinghua; Xu, Yao; Ni, Zhaohui; Mou, Shan			Association between the levels of urine kidney injury molecule-1 and the progression of acute kidney injury in the elderly	PLOS ONE			English	Article							DISEASE; RISK; BIOMARKERS	Background The factors influencing the prognosis of acute kidney injury (AKI) were analyzed in a group of elderly AKI patients to determine the markers of early prognosis. Methods A total of 258 patients were screened, and 201 patients were enrolled in the study. Eventually, 184 AKI patients were included in the study, including 79 elderly AKI patients (>60 years old). During one year of follow-up, renal function changes were observed, and the risk factors that influenced the prognosis of AKI were analyzed. Results When AKI occurred, the urine kidney injury molecule-1 (uKIM-1) level was significantly higher in the progressive deterioration of renal function group than in the renal function stable group. The ROC curve analysis revealed that the area under the curve for poor progressive deterioration of renal function as predicted by the uKIM-1 level was 0.681. At a cutoff point of 2.46 ng/mg, the sensitivity was 71.9% and the specificity was 70.0%. In elderly AKI patients, uKIM-1 levels exceeding 2.46 ng/mg were positively associated with poor kidney prognosis. Conclusions Elderly AKI patients are at risk of developing progressive deterioration of renal function. In elderly AKI patients, the high uKIM-1 level may predict the prognosis of kidney function and may be used as an early screening indicator of poor kidney prognosis.	[Xie, Yuanyuan; Wang, Qin; Wang, Chunlin; Che, Xiajing; Shao, Xinghua; Xu, Yao; Ni, Zhaohui; Mou, Shan] Shanghai Jiao Tong Univ, Dept Nephrol, Mol Cell Lab Kidney Dis, Ren Ji Hosp,Sch Med, Shanghai, Peoples R China; [Xie, Yuanyuan; Wang, Qin; Wang, Chunlin; Che, Xiajing; Shao, Xinghua; Xu, Yao; Ni, Zhaohui; Mou, Shan] Shanghai Ctr Peritoneal Dialysis Res, Shanghai, Peoples R China	Shanghai Jiao Tong University	Ni, ZH; Mou, S (corresponding author), Shanghai Jiao Tong Univ, Dept Nephrol, Mol Cell Lab Kidney Dis, Ren Ji Hosp,Sch Med, Shanghai, Peoples R China.; Ni, ZH; Mou, S (corresponding author), Shanghai Ctr Peritoneal Dialysis Res, Shanghai, Peoples R China.	profnizh@126.com; shan_mou@shsmu.edu.cn	shao, xinghua/GVU-8320-2022	mou, shan/0000-0003-4160-1681	Hong Kong, Macao and Taiwan Science & Technology Cooperation Program of China [2014DFT30090]; National Natural Science Foundation of China [81373865, 81370794, 81573748, 81570604]; Science and Technology Commission of Shanghai Municipality, China [14140903200]; Program of Shanghai Academic Research Leader [16XD1401900]; Shanghai Health Bureau [ZHYY-ZXYJHZX-1-02]	Hong Kong, Macao and Taiwan Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); Program of Shanghai Academic Research Leader; Shanghai Health Bureau	The study was sponsored by the Hong Kong, Macao and Taiwan Science & Technology Cooperation Program of China (2014DFT30090) and the National Natural Science Foundation of China (81373865, 81370794, 81573748 and 81570604), as well as by grants (14140903200) from the Science and Technology Commission of Shanghai Municipality, China. The study was also sponsored by Program of Shanghai Academic Research Leader (16XD1401900). Program ZHYY-ZXYJHZX-1-02 from the Shanghai Health Bureau was also included in the funding report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 2011, J AM SOC NEPHROL, V22, P28, DOI 10.1681/ASN.2010090934; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Coca SG, 2010, AM J KIDNEY DIS, V56, P122, DOI 10.1053/j.ajkd.2009.12.034; Doi K, 2012, KIDNEY INT, V82, P1114, DOI 10.1038/ki.2012.266; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; Leung KCW, 2013, NAT REV NEPHROL, V9, P77, DOI 10.1038/nrneph.2012.280; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; Muriithi AK, 2015, KIDNEY INT, V87, P458, DOI 10.1038/ki.2014.294; Nejat M, 2012, KIDNEY INT, V81, P1254, DOI 10.1038/ki.2012.23; Siew ED, 2015, KIDNEY INT, V87, P46, DOI 10.1038/ki.2014.293; Siew ED, 2011, J AM SOC NEPHROL, V22, P810, DOI 10.1681/ASN.2010080796; van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175; Xie YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112865; Xue W, 2014, NEPHROLOGY, V19, P186, DOI 10.1111/nep.12173	20	1	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171076	10.1371/journal.pone.0171076	http://dx.doi.org/10.1371/journal.pone.0171076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187124	gold, Green Published, Green Submitted			2022-12-26	WOS:000394244300009
J	Hoogeveen, EK; Geleijnse, JM; Giltay, EJ; Soedamah-Muthu, SS; de Goede, J; Griep, LMO; Stijnen, T; Kromhout, D				Hoogeveen, Ellen K.; Geleijnse, Johanna M.; Giltay, Erik J.; Soedamah-Muthu, Sabita S.; de Goede, Janette; Griep, Linda M. Oude; Stijnen, Theo; Kromhout, Daan			Kidney function and specific mortality in 60-80 years old post-myocardial infarction patients: A 10-year follow-up study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ALPHA OMEGA TRIAL; N-3 FATTY-ACIDS; CYSTATIN-C; MYOCARDIAL-INFARCTION; NONCARDIOVASCULAR MORTALITY; CARDIOVASCULAR OUTCOMES; SERUM CREATININE; RENAL-FUNCTION; UNITED-STATES	Chronic kidney disease (CKD) is highly prevalent among older post-myocardial infarction (MI) patients. It is not known whether CKD is an independent risk factor for mortality in older post-MI patients with optimal cardiovascular drug-treatment. Therefore, we studied the relation between kidney function and all-cause and specific mortality among older post-MI patients, without severe heart failure, who are treated with state-of-the-art pharmacotherapy. From 2002-2006, 4,561 Dutch post-MI patients were enrolled and followed until death or January 2012. We estimated Glomerular Filtration Rate (eGFR) with cystatin C (cysC) and creatinine (cr) using the CKD-EPI equations and analyzed the relation with any and major causes of death using Cox models and restricted cubic splines. Mean (SD) for age was 69 years (5.6), 79% were men, 17% smoked, 21% had diabetes, 90% used antihypertensive drugs, 98% used antithrombotic drugs and 85% used statins. Patients were divided into four categories of baseline eGFR(cysC): >= 90 (33%; reference), 60-89 (47%), 30-59 (18%), and < 30 (2%) ml/min/1.73m(2). Median follow-up was 6.4 years. During follow-up, 873 (19%) patients died: 370 (42%) from cardiovascular causes, 309 (35%) from cancer, and 194 (22%) from other causes. After adjustment for age, sex and classic cardiovascular risk factor, hazard ratios (95%-confidence intervals) for any death according to the four eGFRcysC categories were: 1 (reference), 1.4 (1.1-1.7), 2.9 (2.3-3.6) and 4.4 (3.0-6.4). The hazard ratios of all-cause and cause-specific mortality increased linearly below kidney functions of 80 ml/min/1.73 m(2). Weaker results were obtained for eGFR(cr). To conclude, we found in optimal cardiovascular drug-treated post-MI patients an inverse graded relation between kidney function and mortality for both cardiovascular as well as non-cardiovascular causes. Risk of mortality increased linearly below kidney function of about 80 ml/min/1.73 m(2)	[Hoogeveen, Ellen K.] Jeroen Bosch Hosp, Dept Nephrol, Den Bosch, Netherlands; [Hoogeveen, Ellen K.] Leiden Univ, Med Ctr, Dept Epidemiol, Leiden, Netherlands; [Hoogeveen, Ellen K.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Geleijnse, Johanna M.; Soedamah-Muthu, Sabita S.; de Goede, Janette; Griep, Linda M. Oude; Kromhout, Daan] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Giltay, Erik J.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Stijnen, Theo] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands	Jeroen Bosch Ziekenhuis; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hoogeveen, EK (corresponding author), Jeroen Bosch Hosp, Dept Nephrol, Den Bosch, Netherlands.; Hoogeveen, EK (corresponding author), Leiden Univ, Med Ctr, Dept Epidemiol, Leiden, Netherlands.; Hoogeveen, EK (corresponding author), Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.	ellen.hoogeveen@planet.nl	Geleijnse, Johanna Marianna M/B-5749-2012; Hoogeveen, Ellen K./I-2947-2019; Giltay, Erik J./AAL-9948-2021; Oude Griep, Linda/M-5112-2013	Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Hoogeveen, Ellen K./0000-0002-5482-2013; Oude Griep, Linda/0000-0001-7697-7473	Royal Netherlands Academy of Arts and Sciences; Dutch Kidney Foundation [PV41]; Netherlands Heart Foundation [2000T401]; US National Institutes of Health [HL076200]; Dutch Kidney Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076200] Funding Source: NIH RePORTER	Royal Netherlands Academy of Arts and Sciences; Dutch Kidney Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Kidney Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The contribution of Prof. Daan Kromhout to this article was funded by the Royal Netherlands Academy of Arts and Sciences. Financial support was obtained from the Dutch Kidney Foundation (PV41) by Dr. Ellen K. Hoogeveen, the Netherlands Heart Foundation (2000T401), and US National Institutes of Health (HL076200) by Prof. Daan Kromhout. The grant from the Dutch Kidney Foundation covered baseline examinations of kidney function. The grant of the Netherlands Heart Foundation covered baseline examinations and mortality follow-up. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors express their gratitude to Eveline Waterham MSc for data management. We are indebted to Dr. Eric Melse for graphic art work. The contribution of prof. Daan Kromhout to this article was funded by the Royal Netherlands Academy of Arts and Sciences. Financial support was obtained from the Dutch Kidney Foundation (PV41) by dr. Ellen K. Hoogeveen, the Netherlands Heart Foundation (2000T401), and US National Institutes of Health (HL076200) by prof. Daan Kromhout. The grant from the Dutch Kidney Foundation covered baseline examinations of kidney function. The grant of the Netherlands Heart Foundation covered baseline examinations and mortality follow-up. The funding organizations had no role in the design of the study, data collection, data analysis, interpretation, writing of the report or the decision to submit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Berger JS, 2013, AM J CARDIOL, V112, P737, DOI 10.1016/j.amjcard.2013.04.055; Bian ZX, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-64; Choudhury D, 2011, NAT REV NEPHROL, V7, P706, DOI 10.1038/nrneph.2011.104; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Duprez DA, 2013, HYPERTENSION, V61, P542, DOI 10.1161/HYPERTENSIONAHA.111.00272; Eijkelkamp WBA, 2007, AM J CARDIOL, V100, P7, DOI 10.1016/j.amjcard.2007.02.047; Fried LF, 2005, J AM SOC NEPHROL, V16, P3728, DOI 10.1681/ASN.2005040384; Geleijnse JM, 2010, AM HEART J, V159, P539, DOI 10.1016/j.ahj.2009.12.033; Giltay EJ, 2003, CLIN CHEM, V49, P652, DOI 10.1373/49.4.652; Glassock RJ, 2012, KIDNEY INT, V82, P270, DOI 10.1038/ki.2012.65; Grams ME, 2013, AM J KIDNEY DIS, V62, P245, DOI 10.1053/j.ajkd.2013.03.009; Grubb A, 2010, CLIN CHEM LAB MED, V48, P1619, DOI 10.1515/CCLM.2010.318; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Harrell Jr F. E., 2001, SPRINGER SERIES IN S; Hoogeveen EK, 2014, EUR J PREV CARDIOL, V21, P1429, DOI 10.1177/2047487313494295; Hoogeveen EK, 2014, CLIN J AM SOC NEPHRO, V9, P1676, DOI 10.2215/CJN.10441013; Iff S, 2014, AM J KIDNEY DIS, V63, P23, DOI 10.1053/j.ajkd.2013.07.008; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Mafham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025920; Major RW, 2015, CLIN J AM SOC NEPHRO, V10, P732, DOI 10.2215/CJN.07460714; Marks A, 2013, FAM PRACT, V30, P282, DOI 10.1093/fampra/cms079; Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; Raymond NT, 2007, NEPHROL DIAL TRANSPL, V22, P3214, DOI 10.1093/ndt/gfm396; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Singh D, 2007, NEPHROL DIAL TRANSPL, V22, P1087, DOI 10.1093/ndt/gfl744; Vogelzang JL, 2015, NEPHROL DIAL TRANSPL, V30, P1028, DOI 10.1093/ndt/gfv007; Winearls CG, 2011, NEPHRON CLIN PRACT, V119, pC2, DOI 10.1159/000328013	38	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171868	10.1371/journal.pone.0171868	http://dx.doi.org/10.1371/journal.pone.0171868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182761	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800127
J	Oh, PC; Lee, K; Kim, TH; Moon, J; Park, HW; Jang, HJ; Park, SD; Kwon, SW; Suh, J; Kang, WC				Oh, Pyung Chun; Lee, Kyounghoon; Kim, Tae-Hoon; Moon, Jeonggeun; Park, Hyun Woo; Jang, Ho-Jun; Park, Sang-Don; Kwon, Sung Woo; Suh, Jon; Kang, Woong Chol			Prognostic impact of alkaline phosphatase measured at time of presentation in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction	PLOS ONE			English	Article							MAINTENANCE HEMODIALYSIS-PATIENTS; C-REACTIVE PROTEIN; VASCULAR CALCIFICATION; ARTERY-DISEASE; ASSOCIATION; MORTALITY; PREDICTOR; OUTCOMES; MEN	Background Serum alkaline phosphatase (ALP) has been shown to be a prognostic factor in several subgroups of patients due to its promotion of vascular calcification. However, the prognostic impact of serum ALP level in ST-segment elevation myocardial infarction (STEMI) patients with a relatively low calcification burden has not been determined. We aimed to investigate the association of ALP level measured at time of presentation on clinical outcomes in patients with STEMI requiring primary percutaneous coronary intervention (PCI). Methods A total of 1178 patients with STEMI undergoing primary PCI between 2007 and 2014 were retrospectively enrolled from the INTERSTELLAR registry and classified into tertiles by ALP level (<64, 65-82, or >83 IU/L). The primary study outcome was a major adverse cardiac or cerebrovascular event (MACCE), defined as the composite of all-cause death, non-fatal myocardial infarction, non-fatal stroke, and ischemia-driven revascularization. Results Median follow-up duration was 25 months (interquartile range, 10-39 months). The incidence of MACCE significantly increased as ALP level increased, that is, for the <64, 65-82, and >83 IU/L tertiles incidences were 8.7%, 11.7%, and 15.7%, respectively; p for trend = 0.003). After adjustment for potential confounders, the adjusted hazard ratios for MACCE in the middle and highest tertiles were 1.69 (95% CI 1.01-2.81) and 2.46 (95% CI 1.48-4.09), respectively, as compared with the lowest ALP tertile. Conclusions Elevated ALP level at presentation, but within the higher limit of normal, was found to be independently associated with higher risk of MACCE after primary PCI in patients with STEMI.	[Oh, Pyung Chun; Lee, Kyounghoon; Moon, Jeonggeun; Kang, Woong Chol] Gachon Univ, Gil Med Ctr, Cardiol, Incheon, South Korea; [Kim, Tae-Hoon; Jang, Ho-Jun] Sejong Gen Hosp, Cardiol, Bucheon, South Korea; [Park, Hyun Woo; Suh, Jon] Soon Chun Hyang Univ, Bucheon Hosp, Cardiol, Bucheon, South Korea; [Park, Sang-Don; Kwon, Sung Woo] Inha Univ Hosp, Cardiol, Incheon, South Korea	Gachon University; Sejong General Hospital; Soonchunhyang University; Inha University; Inha University Hospital	Kang, WC (corresponding author), Gachon Univ, Gil Med Ctr, Cardiol, Incheon, South Korea.; Suh, J (corresponding author), Soon Chun Hyang Univ, Bucheon Hosp, Cardiol, Bucheon, South Korea.	immanuel@schmc.ac.kr; kangwch@gilhospital.com	Kim, Tae-Hoon/AAG-3292-2021	Kim, Tae-Hoon/0000-0002-4032-1285	Boryung Pharmaceutical Company, Republic of Korea	Boryung Pharmaceutical Company, Republic of Korea	This work was supported by research grant from the Boryung Pharmaceutical Company, Republic of Korea (P.C.O.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AM, 2011, INT J ANGIOL, V20, P135, DOI 10.1055/s-0031-1284434; Birrer R, 2007, INTERNAL MED, V46, P1063, DOI 10.2169/internalmedicine.46.0059; Borekci A, 2016, KOREAN CIRC J, V46, P15, DOI 10.4070/kcj.2016.46.1.15; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Dong L, 2015, AM J CARDIOL, V115, P860, DOI 10.1016/j.amjcard.2015.01.008; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kovesdy CP, 2010, NEPHROL DIAL TRANSPL, V25, P3003, DOI 10.1093/ndt/gfq144; Lee SJ, 2013, KOREAN CIRC J, V43, P73, DOI 10.4070/kcj.2013.43.2.73; Moon J, 2016, AM J CARDIOLOGY; Moon J, 2014, INT J CARDIOL, V177, P442, DOI 10.1016/j.ijcard.2014.09.002; Park JB, 2013, EUR HEART J, V34, P920, DOI 10.1093/eurheartj/ehs419; Park SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159416; Regidor DL, 2008, J AM SOC NEPHROL, V19, P2193, DOI 10.1681/ASN.2008010014; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Schenker MP, 2008, CIRCULATION, V117, P1693, DOI 10.1161/CIRCULATIONAHA.107.717512; Schoppet M, 2008, KIDNEY INT, V73, P989, DOI 10.1038/ki.2008.104; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Shantouf R, 2009, CLIN J AM SOC NEPHRO, V4, P1106, DOI 10.2215/CJN.06091108; Tomoda H, 2000, AM HEART J, V140, P324, DOI 10.1067/mhj.2000.108244; Tonelli M, 2009, CIRCULATION, V120, P1784, DOI 10.1161/CIRCULATIONAHA.109.851873; Van Campenhout A, 2009, ATHEROSCLEROSIS, V204, P321, DOI 10.1016/j.atherosclerosis.2008.09.033; Wannamethee SG, 2013, ARTERIOSCL THROM VAS, V33, P1070, DOI 10.1161/ATVBAHA.112.300826; Webber M, 2010, CLIN CHEM LAB MED, V48, P167, DOI 10.1515/CCLM.2010.052	24	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171914	10.1371/journal.pone.0171914	http://dx.doi.org/10.1371/journal.pone.0171914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182682	gold, Green Submitted, Green Published			2022-12-26	WOS:000394231800133
J	Sugrue, KF; Zohn, IE				Sugrue, Kelsey F.; Zohn, Irene E.			Mechanism for generation of left isomerism in Ccdc40 mutant embryos	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; NODAL EXPRESSION; LATERAL PLATE; INTRAFLAGELLAR TRANSPORT; SIGNALING PATHWAY; SONIC-HEDGEHOG; PRIMARY CILIUM; MOUSE EMBRYOS; FLUID-FLOW; DEFECTS	Leftward fluid flow in the mouse node is generated by cilia and is critical for initiating asymmetry of the left-right axis. Coiled-coil domain containing-40 (Ccdc40) plays an evolutionarily conserved role in the assembly of motile cilia and establishment of the left-right axis. Approximately one-third of Ccdc40(lnks) mutant embryos display situs defects and here we investigate the underlying mechanism. Ccdc40(lnks) mutants show delayed induction of markers of the left-lateral plate mesoderm (L-LPM) including Lefty1, Lefty2 and Nodal. Consistent with defective cilia motility compromising fluid flow across the node, initiation of asymmetric perinodal Cerberus like-2 (Cerl2) expression is delayed and then randomized. This is followed by delayed and then randomized asymmetric Nodal expression around the node. We propose a model to explain how left isomerism arises in a proportion of Ccdc40(lnks) mutants. We postulate that with defective motile cilia, Cerl2 expression remains symmetric and Nodal is antagonized equally on both sides of the node. This effectively reduces Nodal activation bilaterally, leading to reduced and delayed activation of Nodal and its antagonists in the LPM. This model is further supported by the failure to establish Nodal expression in the left-LPM with reduced Nodal gene dosage in Ccdc40(lnks/lnks); Nodal(LacZ/+) mutants causing a predominance of right not left isomerism. Together these results suggest a model where cilia generated fluid flow in the node functions to ensure robust Nodal activation and a timely left-sided developmental program in the LPM.	[Sugrue, Kelsey F.] George Washington Univ, Inst Biomed Sci, Washington, DC USA; [Sugrue, Kelsey F.; Zohn, Irene E.] Childrens Natl Med Ctr, Ctr Neurosci Res, Childrens Res Inst, Washington, DC 20010 USA	George Washington University; Children's National Health System	Zohn, IE (corresponding author), Childrens Natl Med Ctr, Ctr Neurosci Res, Childrens Res Inst, Washington, DC 20010 USA.	izohn@cnmcresearch.org		Sugrue, Kelsey/0000-0001-8629-0958; Zohn, Irene/0000-0001-7688-682X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090257] Funding Source: NIH RePORTER; NICHD NIH HHS [U54 HD090257] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Antony D, 2013, HUM MUTAT, V34, P462, DOI 10.1002/humu.22261; Aylsworth AS, 2001, AM J MED GENET, V101, P345, DOI 10.1002/ajmg.1219.abs; Basu B, 2008, CURR TOP DEV BIOL, V85, P151, DOI 10.1016/S0070-2153(08)00806-5; Becker-Heck A, 2012, DYNEINS STRUCTURE BI; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Blanchon S, 2012, J MED GENET, V49, P410, DOI 10.1136/jmedgenet-2012-100867; Brennan J, 2002, GENE DEV, V16, P2339, DOI 10.1101/gad.1016202; Brueckner M, 2007, CIRCULATION, V115, P2793, DOI 10.1161/CIRCULATIONAHA.107.699256; Casey B, 1998, HUM MOL GENET, V7, P1565, DOI 10.1093/hmg/7.10.1565; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hogan B, 1994, MANIPULATING THE MOU; Holmes G, 2001, DEV DYNAM, V222, P301, DOI 10.1002/dvdy.1182; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Kawasumi A, 2011, DEV BIOL, V353, P321, DOI 10.1016/j.ydbio.2011.03.009; Kitajima K, 2013, DEV BIOL, V380, P222, DOI 10.1016/j.ydbio.2013.05.011; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Larkins CE, 2012, DEV BIOL, V367, P15, DOI 10.1016/j.ydbio.2012.04.011; Leitch CC, 2014, J CELL SCI, V127, P2407, DOI 10.1242/jcs.130344; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Lopes SS, 2010, DEVELOPMENT, V137, P3625, DOI 10.1242/dev.054452; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Marques S, 2004, GENE DEV, V18, P2342, DOI 10.1101/gad.306504; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Meno C, 2001, DEV CELL, V1, P127, DOI 10.1016/S1534-5807(01)00006-5; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Nakamura T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2319; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Norris DP, 2002, DEVELOPMENT, V129, P3455; Oh SP, 2002, DEV DYNAM, V224, P279, DOI 10.1002/dvdy.10103; Oh SP, 1997, GENE DEV, V11, P1812, DOI 10.1101/gad.11.14.1812; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Oki S, 2007, DEVELOPMENT, V134, P3893, DOI 10.1242/dev.009464; Oki S, 2009, DEVELOPMENT, V136, P3917, DOI 10.1242/dev.039305; Peeters H, 2006, EUR J MED GENET, V49, P349, DOI 10.1016/j.ejmg.2005.12.003; Pennekamp Petra, 2015, Cilia, V4, P1, DOI 10.1186/s13630-014-0010-9; Praveen Kavita, 2015, F1000Prime Rep, V7, P36, DOI 10.12703/P7-36; Przemeck GKH, 2003, DEVELOPMENT, V130, P3, DOI 10.1242/dev.00176; Ramsdell AF, 2005, DEV BIOL, V288, P1, DOI 10.1016/j.ydbio.2005.07.038; RASHBASS P, 1991, NATURE, V353, P348, DOI 10.1038/353348a0; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Saijoh Y, 2003, DEV BIOL, V256, P160, DOI 10.1016/S0012-1606(02)00121-5; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Shinohara K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1624; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; Supp DM, 1999, DEVELOPMENT, V126, P5495; Sutherland MJ, 2009, AM J MED GENET C, V151C, P307, DOI 10.1002/ajmg.c.30228; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; Yamamoto M, 2003, DEVELOPMENT, V130, P1795, DOI 10.1242/dev.00408; Yoshiba S, 2012, SCIENCE, V338, P226, DOI 10.1126/science.1222538; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	71	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171180	10.1371/journal.pone.0171180	http://dx.doi.org/10.1371/journal.pone.0171180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182636	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800040
J	Wang, DY; Wang, Q; Wang, YL; Xiang, XG; Huang, LQ; Jin, XH				Wang, De-Yi; Wang, Qiang; Wang, Ying-Li; Xiang, Xiao-Guo; Huang, Lu-Qi; Jin, Xiao-Hua			Evaluation of DNA barcodes in Codonopsis (Campanulaceae) and in some large angiosperm plant genera	PLOS ONE			English	Article							LAND PLANTS; IDENTIFICATION; ORCHIDACEAE; COMPLEMENTS; EVOLUTION; TAXONOMY; HISTORY; GENOMES; PROMISE; SPACER	DNA barcoding is expected to be one of the most promising tools in biological taxonomy. However, there have been no agreements on which core barcode should be used in plants, especially in species-rich genera with wide geographical distributions. To evaluate their discriminatory power in large genera, four of the most widely used DNA barcodes, including three plastid regions (matK, rbcL, trnH-psbA) and nuclear internal transcribed spacer (nrITS), were tested in seven species-rich genera (Ficus, Pedicularis, Rhodiola, Rhododendron, Viburnum, Dendrobium and Lysimachia) and a moderate size genus, Codonopsis. All of the sequences from the aforementioned seven large genera were downloaded from NCBI. The related barcodes for Codonopsis were newly generated in this study. Genetics distances, DNA barcoding gaps and phylogenetic trees of the four single barcodes and their combinations were calculated and compared in the seven genera. As for single barcode, nrITS has the most variable sites, the clearest intra- and inter-specific divergences and the highest discrimination rates in the seven genera. Among the combinations of barcodes, ITS +matK performed better than all the single barcodes in most cases and even the three- and four-loci combinations in the seven genera. Therefore, we recommend ITS+matK as the core barcodes for large plant genera.	[Wang, De-Yi; Wang, Qiang; Xiang, Xiao-Guo; Jin, Xiao-Hua] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Wang, De-Yi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Ying-Li] Baotou Med Coll, Baotou City, Inner Mongolia, Peoples R China; [Huang, Lu-Qi] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, Beijing, Peoples R China; [Jin, Xiao-Hua] Chinese Acad Sci, SEABRI, Southeast Asia Biodivers Res Inst, Mengla, Yunnan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Baotou Medical College; China Academy of Chinese Medical Sciences; National Resource Center for Chinese Materia Medica, CACMS; Chinese Academy of Sciences	Jin, XH (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.; Huang, LQ (corresponding author), China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, Beijing, Peoples R China.; Jin, XH (corresponding author), Chinese Acad Sci, SEABRI, Southeast Asia Biodivers Res Inst, Mengla, Yunnan, Peoples R China.	huangluqi01@163.com; xiaohuajin@ibcas.ac.cn		Deyi, Wang/0000-0003-2140-2482				Alves TLS, 2014, MOL ECOL RESOUR, V14, P324, DOI 10.1111/1755-0998.12182; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P573, DOI 10.1111/1755-0998.12089; Averyanov LV, 2016, PHYTOTAXA, V266, P289, DOI 10.11646/phytotaxa.266.4.6; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Clement WL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-73; Cosner ME, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-27; Cristescu ME, 2014, TRENDS ECOL EVOL, V29, P566, DOI 10.1016/j.tree.2014.08.001; Dong WP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08348; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Guo YW, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0156323, 10.1007/s11468-015-0008-1]; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hossen MJ, 2016, PHYTOTHER RES, V30, P347, DOI 10.1002/ptr.5553; IBM Corp, 2010, IBM SPSS STAT WIND V; Jiao Li-Juan, 2013, Plant Diversity and Resources, V35, P715, DOI 10.7677/ynzwyj201313064; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knox EB, 2014, P NATL ACAD SCI USA, V111, P11097, DOI 10.1073/pnas.1403363111; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Li CY, 2009, J CHROMATOGR A, V1216, P2124, DOI 10.1016/j.chroma.2008.10.080; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li DZ, 2011, J SYST EVOL, V49, P165, DOI 10.1111/j.1759-6831.2011.00137.x; Li HQ, 2012, MOL ECOL RESOUR, V12, P783, DOI 10.1111/j.1755-0998.2012.03147.x; Liu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153008; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Morris KE, 1997, BOT BULL ACAD SINICA, V38, P277; Ojeda DI, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu050; Podlech XLD, 2010, FLORA CHINA, V25, P328; Raskoti BB, 2015, CLADISTICS; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang YL, 2016, CHIN MED-UK, V11, DOI 10.1186/s13020-015-0072-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Van der Niet T, 2014, ANN BOT-LONDON, V113, P301, DOI 10.1093/aob/mct193; Vassou SL, 2015, GENE, V559, P86, DOI 10.1016/j.gene.2015.01.025; Von Raab-Straube E, 2014, WILLDENOWIA, V44, P287, DOI 10.3372/wi.44.44211; Wang Q, 2014, J SYST EVOL, V52, P541, DOI 10.1111/jse.12096; Xiang XG, 2011, MOL ECOL RESOUR, V11, P1012, DOI 10.1111/j.1755-0998.2011.03044.x; Xu SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115168; Yan LJ, 2015, MOL ECOL RESOUR, V15, P932, DOI 10.1111/1755-0998.12353; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x; Zhang JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119921; Zhao YB, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00696; Zheng SH, 2014, EVIDENCE BASED COMPL	60	9	12	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170286	10.1371/journal.pone.0170286	http://dx.doi.org/10.1371/journal.pone.0170286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182623	gold, Green Submitted, Green Published			2022-12-26	WOS:000394231800009
J	Yang, YF; Tan, MJ; Dai, YW				Yang, Yifei; Tan, Minjia; Dai, Yuewei			An improved CS-LSSVM algorithm-based fault pattern recognition of ship power equipments	PLOS ONE			English	Article							LOCATION	A ship power equipments' fault monitoring signal usually provides few samples and the data's feature is non-linear in practical situation. This paper adopts the method of the least squares support vector machine (LSSVM) to deal with the problem of fault pattern identification in the case of small sample data. Meanwhile, in order to avoid involving a local extremum and poor convergence precision which are induced by optimizing the kernel function parameter and penalty factor of LSSVM, an improved Cuckoo Search (CS) algorithm is proposed for the purpose of parameter optimization. Based on the dynamic adaptive strategy, the newly proposed algorithm improves the recognition probability and the searching step length, which can effectively solve the problems of slow searching speed and low calculation accuracy of the CS algorithm. A benchmark example demonstrates that the CS-LSSVM algorithm can accurately and effectively identify the fault pattern types of ship power equipments.	[Yang, Yifei; Dai, Yuewei] Nanjing Univ Sci & Technol, Sch Automat, Nanjing, Jiangsu, Peoples R China; [Yang, Yifei; Tan, Minjia; Dai, Yuewei] Jiangsu Univ Sci & Technol, Sch Elect & Informat, Zhenjiang, Jiangsu, Peoples R China	Nanjing University of Science & Technology; Jiangsu University of Science & Technology	Yang, YF (corresponding author), Nanjing Univ Sci & Technol, Sch Automat, Nanjing, Jiangsu, Peoples R China.; Yang, YF (corresponding author), Jiangsu Univ Sci & Technol, Sch Elect & Informat, Zhenjiang, Jiangsu, Peoples R China.	seayyf@163.com		Tan, Minjia/0000-0003-1946-6516				Aminian F, 2002, IEEE T INSTRUM MEAS, V51, P544, DOI 10.1109/TIM.2002.1017726; Cao S.-G., 2008, J CHINA U MIN TECHNO, V18, P172; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Gencoglu MT, 2009, EXPERT SYST APPL, V36, P10789, DOI 10.1016/j.eswa.2009.02.021; Gu Yanping, 2010, Journal of Tsinghua University (Science and Technology), V50, P1063; Guan T, 2015, ACM T INTEL SYST TEC, V7, DOI 10.1145/2795234; [贺淼 He Miao], 2014, [计算机与应用化学, Computers and Applied Chemistry], V31, P961; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Ji RR, 2016, PATTERN RECOGN, V59, P268, DOI 10.1016/j.patcog.2016.03.016; Ji RR, 2015, ACM T INTEL SYST TEC, V6, DOI 10.1145/2597181; Ji RR, 2014, IEEE T IMAGE PROCESS, V23, P3099, DOI 10.1109/TIP.2014.2324291; Li HL, 2015, THESIS; Liu Xin-ni, 2013, Computer Engineering, V39, P274, DOI 10.3969/j.issn.1000-3428.2013.07.061; MANTEGNA RN, 1994, PHYS REV E, V49, P4677, DOI 10.1103/PhysRevE.49.4677; Pan HL, 2016, NEUROCOMPUTING, V175, P644, DOI 10.1016/j.neucom.2015.10.104; Shen MH, 2006, TELCOMMUNICATION ENG, V04, P9; van Gestel T, 2004, MACH LEARN, V54, P5, DOI 10.1023/B:MACH.0000008082.80494.e0; Yang XS, 2009, WOR CONG NAT BIOL, P210, DOI 10.1109/nabic.2009.5393690; Zhang Y, 2015, SIGNAL PROCESS, V112, P17, DOI 10.1016/j.sigpro.2014.08.029; Zheng Hongqing, 2013, Computer Engineering and Applications, V49, P68, DOI 10.3778/j.issn.1002-8331.1112-0292	20	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171246	10.1371/journal.pone.0171246	http://dx.doi.org/10.1371/journal.pone.0171246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182678	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800050
J	de Freitas, JR; Bennie, J; Mantovani, W; Gaston, KJ				de Freitas, Juliana Ribeirao; Bennie, Jon; Mantovani, Waldir; Gaston, Kevin J.			Exposure of tropical ecosystems to artificial light at night: Brazil as a case study	PLOS ONE			English	Article							PROTECTED AREA; ORIENTATION; POLLUTION; COLEOPTERA; EROSION; BATS	Artificial nighttime lighting from streetlights and other sources has a broad range of biological effects. Understanding the spatial and temporal levels and patterns of this lighting is a key step in determining the severity of adverse effects on different ecosystems, vegetation, and habitat types. Few such analyses have been conducted, particularly for regions with high biodiversity, including the tropics. We used an intercalibrated version of the Defense Meteorological Satellite Program's Operational Linescan System (DMSP/OLS) images of stable nighttime lights to determine what proportion of original and current Brazilian vegetation types are experiencing measurable levels of artificial light and how this has changed in recent years. The percentage area affected by both detectable light and increases in brightness ranged between 0 and 35% for native vegetation types, and between 0 and 25% for current vegetation (i.e. including agriculture). The most heavily affected areas encompassed terrestrial coastal vegetation types (restingas and mangroves), Semideciduous Seasonal Forest, and Mixed Ombrophilous Forest. The existing small remnants of Lowland Deciduous and Semideciduous Seasonal Forests and of Campinarana had the lowest exposure levels to artificial light. Light pollution has not often been investigated in developing countries but our data show that it is an environmental concern.	[de Freitas, Juliana Ribeirao; Mantovani, Waldir] Univ Sao Paulo, IEE Inst Energia & Ambiente, Sao Paulo, SP, Brazil; [Bennie, Jon] Univ Exeter, Coll Life & Environm Sci, Ctr Geog Environm & Soc, Penryn, Cornwall, England; [Bennie, Jon; Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	Universidade de Sao Paulo; University of Exeter; University of Exeter	de Freitas, JR (corresponding author), Univ Sao Paulo, IEE Inst Energia & Ambiente, Sao Paulo, SP, Brazil.	freitasjuliana.r@yahoo.com	MANTOVANI, WALDIR/C-5177-2014	MANTOVANI, WALDIR/0000-0002-9394-6860; Gaston, Kevin J./0000-0002-7235-7928	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [99999.008943/2014-01]; European Research Council through the European Union's Seventh Framework Programme/ERC [268504]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); European Research Council through the European Union's Seventh Framework Programme/ERC	This research was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) through scholarship granted to J.R.F under the overseas exchange program PDSE-Programa de doutorado Sanduiche no exterior, process number 99999.008943/2014-01. See http://www.capes. gov.br/component/content/article?id=4561. It was also supported by the European Research Council through the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement number 268504 to K.J.G. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Arendt J, 1998, REV REPROD, V3, P13, DOI 10.1530/revreprod/3.1.13; Ashkenazi L, 2012, J EXP BIOL, V215, P4034, DOI 10.1242/jeb.073429; Bennie J, 2015, REMOTE SENS-BASEL, V7, P2715, DOI 10.3390/rs70302715; Bennie J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0131; Bennie J, 2014, SCI REP-UK, V4, DOI 10.1038/srep03789; Bennie JJ, 2014, P NATL ACAD SCI USA, V111, P13727, DOI 10.1073/pnas.1216063110; Buurman M, 2015, DESCRIPTION GLOBIOM, P1; Byrne M, 2003, J COMP PHYSIOL A, V189, P411, DOI 10.1007/s00359-003-0415-1; Campos RC, 2013, REV BRAS ENTOMOL, V57, P47, DOI 10.1590/S0085-56262013000100008; Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; Costa C, 2000, MONGR TERC MILENIO, V1, P99; Dacke M, 2004, P ROY SOC B-BIOL SCI, V271, P361, DOI 10.1098/rspb.2003.2594; Dacke M, 2003, NATURE, V424, P33, DOI 10.1038/424033a; Dacke M, 2013, CURR BIOL, V23, P298, DOI 10.1016/j.cub.2012.12.034; Davies TW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01722; Day J, 2015, ANIM CONSERV, V18, P512, DOI 10.1111/acv.12200; Duffy JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12042; Falchi F, 2016, NEW WORLD ATLAS ARTI, P1; FAO, 2007, 153 FAO; Gaston KJ, 2015, CONSERV BIOL, V29, P1132, DOI 10.1111/cobi.12462; Gaston KJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0133; Gaston KJ, 2014, ENVIRON REV, V22, P323, DOI 10.1139/er-2014-0005; Gaston KJ, 2014, OECOLOGIA, V176, P917, DOI 10.1007/s00442-014-3088-2; Gaston KJ, 2013, BIOL REV, V88, P912, DOI 10.1111/brv.12036; Hagen O., 2015, ADV ENTOMOLOGY, V03, P24, DOI [10.4236/ae.2015.31004, DOI 10.4236/AE.2015.31004]; Han B, 2015, SEOUL, V29, P441; Holker F, 2010, TRENDS ECOL EVOL, V25, P681, DOI 10.1016/j.tree.2010.09.007; IBAMA-Instituto Brasileiro do Meio Ambiente e dos Recursos Renovaveis, 1995, DIAR OF UN BRAS PROI; IBGE, 2013, ATL CENS DEM 2010; IBGE, 2004, MAP VEG BRAS; IBGE [Instituto Brasileiro de Geografia e Estatistica], 2012, MAN TECN GEOC, V2nd; Kyba CCM, 2015, SCI REP-UK, V5, DOI 10.1038/srep08409; Kyba CCM, 2013, LANDSCAPE ECOL, V28, P1637, DOI 10.1007/s10980-013-9936-3; Le Tallec T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079250; Lewanzik D, 2014, J APPL ECOL, V51, P388, DOI 10.1111/1365-2664.12206; Lewinsohn TM, 2005, CONSERV BIOL, V19, P619, DOI 10.1111/j.1523-1739.2005.00680.x; Lins J, 2009, CHECK LIST, V5, P364; Lorne Jacquelyn Kay, 2007, Endangered Species Research, V3, P23, DOI 10.3354/esr003023; Luz JL, 2011, BIOTA NEOTROP, V11, P161, DOI 10.1590/S1676-06032011000400016; Ma T, 2012, REMOTE SENS ENVIRON, V124, P99, DOI 10.1016/j.rse.2012.04.018; Macgregor CJ, 2015, ECOL ENTOMOL, V40, P187, DOI 10.1111/een.12174; Matzke EB, 1936, AM J BOT, V23, P446, DOI 10.2307/2436035; Miller MW, 2006, CONDOR, V108, P130, DOI 10.1650/0010-5422(2006)108[0130:AEOLPO]2.0.CO;2; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oprea M, 2009, BRAZ J BIOL, V69, P1073, DOI 10.1590/S1519-69842009000500010; Picchi MS, 2013, J INSECT CONSERV, V17, P797, DOI 10.1007/s10841-013-9562-z; Rodriguez A, 2012, ANIM CONSERV, V15, P519, DOI 10.1111/j.1469-1795.2012.00544.x; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; van Geffen KG, 2014, ECOL EVOL, V4, P2082, DOI 10.1002/ece3.1090; van Langevelde F, 2011, BIOL CONSERV, V144, P2274, DOI 10.1016/j.biocon.2011.06.004; Viviani VR, 2010, BIOTA NEOTROP, V10, P103, DOI 10.1590/S1676-06032010000200013; World Bank Group, 2016, IL CID BRAS MOD NEG	53	18	18	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171655	10.1371/journal.pone.0171655	http://dx.doi.org/10.1371/journal.pone.0171655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178352	Green Published, Green Submitted, gold			2022-12-26	WOS:000393712500057
J	Ito, R; Narita, S; Huang, M; Nara, T; Numakura, K; Takayama, K; Tsuruta, H; Maeno, A; Saito, M; Inoue, T; Tsuchiya, N; Satoh, S; Habuchi, T				Ito, Ryuichi; Narita, Shintaro; Huang, Mingguo; Nara, Taketoshi; Numakura, Kazuyuki; Takayama, Koichiro; Tsuruta, Hiroshi; Maeno, Atsushi; Saito, Mitsuru; Inoue, Takamitsu; Tsuchiya, Norihiko; Satoh, Shigeru; Habuchi, Tomonori			The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the "obesity paradox"	PLOS ONE			English	Article							PROSTATE-CANCER PROGRESSION; BODY-MASS INDEX; SERUM ADIPONECTIN; APOPTOSIS; PROLIFERATION; EXPRESSION; SURVIVAL; RECEPTOR	Although obesity increases the risk of renal cell carcinoma (RCC), obese patients with RCC experience longer survival than non-obese patients. However, the mechanism of this "obesity paradox" is unknown. We examined the impact of preoperative BMI, serum total adiponectin (sAd) level, total adiponectin secretion from perinephric adipose tissue, and intratumoral expression of adiponectin receptors on RCC aggressiveness and survival. We also investigated the mechanism underlying enhanced cancer aggressiveness in RCC cells stimulated with exogenous adiponectin. Overweight and obese patients had significantly lower grade cancers than normal patients in all patients and in those without metastasis (p = 0.003 and p = 0.027, respectively). Cancer-specific survival was significantly longer in overweight and obese patients than in normal patients in all patients (p = 0.035). There was a weak inverse correlation between sAd level and BMI in RCC patients (r = -0.344, p = 0.002). Tumor size was slightly correlated with sAd level, and high sAd was significantly associated with poor overall survival rates in patients with non-metastatic RCC (p = 0.035). Adiponectin levels in perinephric adipose tissue and intratumoral AdipoRl/R2 expression were not correlated with RCC aggressiveness or survival. Proliferation significantly increased in 786-0 and Caki-2 cells exposed to exogenous adiponectin, whereas cell invasion and migration were unaffected. In addition, exogenous adiponectin significantly inhibited starvation-and metformin-induced apoptosis, and up-regulated p-AMPK and Bcl-xL levels. In summary, low BMI and high adiponectin levels are associated with aggressive cell behaviors and poor survival in surgically-treated RCC patients. The effects of adiponectin on proliferation and apoptosis might underlie the "obesity paradox" of RCC.	[Ito, Ryuichi; Narita, Shintaro; Huang, Mingguo; Numakura, Kazuyuki; Takayama, Koichiro; Tsuruta, Hiroshi; Maeno, Atsushi; Saito, Mitsuru; Inoue, Takamitsu; Habuchi, Tomonori] Akita Univ, Grad Sch Med, Dept Urol, Akita, Japan; [Narita, Shintaro; Huang, Mingguo; Inoue, Takamitsu; Habuchi, Tomonori] Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan; [Nara, Taketoshi] Yamagata Univ, Dept Urol, Grad Sch Med, Yamagata, Japan; [Satoh, Shigeru] Akita Univ Hosp, Ctr Kidney Dis & Transplantat, Akita, Japan	Akita University; Yamagata University; Akita University	Narita, S (corresponding author), Akita Univ, Grad Sch Med, Dept Urol, Akita, Japan.; Narita, S (corresponding author), Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan.	nari6202@gipc.akita-u.ac.jp	Tsuchiya, Norihiko/H-6538-2019; Narita, Shintaro/H-3017-2019	Inoue, Takamitsu/0000-0002-1362-4344	Kakenhi Grant for scientific research by the Japan Society for the Promotion of Science [25462466, 26670695, 16H02679]; Japan Agency for Medical Research and Development	Kakenhi Grant for scientific research by the Japan Society for the Promotion of Science; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by a Kakenhi Grant for scientific research by the Japan Society for the Promotion of Science (No. 25462466, 26670695 and 16H02679) and Japan Agency for Medical Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Bewick V, 2004, CRIT CARE, V8, P130, DOI 10.1186/cc2836; Choi Y, 2013, INT J CANCER, V132, P625, DOI 10.1002/ijc.27639; Chou Sharon H., 2010, Hormones & Cancer, V1, P136, DOI 10.1007/s12672-010-0017-7; de Martino M, 2016, EUR UROL FOCUS, V2, P197, DOI 10.1016/j.euf.2015.06.012; Donin NM, 2016, CANCER EPIDEM BIOMAR, V25, P1326, DOI 10.1158/1055-9965.EPI-16-0226; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Finley DS, 2009, J UROLOGY, V182, P1621, DOI 10.1016/j.juro.2009.06.015; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gandhi R, 2016, J OBES, V2016, DOI 10.1155/2016/8746268; Gavrila A, 2003, J CLIN ENDOCR METAB, V88, P2838, DOI 10.1210/jc.2002-021721; Gobe G, 2002, CANCER INVEST, V20, P324, DOI 10.1081/CNV-120001177; Hakimi AA, 2013, JNCI-J NATL CANCER I, V105, P1862, DOI 10.1093/jnci/djt310; Horiguchi A, 2008, JPN J CLIN ONCOL, V38, P106, DOI 10.1093/jjco/hym158; Huang MG, 2011, CARCINOGENESIS, V32, P1589, DOI 10.1093/carcin/bgr182; Jaramillo S, 2010, J AGR FOOD CHEM, V58, P10869, DOI 10.1021/jf102669p; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Laurent V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10230; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nagaprashantha LD, 2011, CARCINOGENESIS, V32, P568, DOI 10.1093/carcin/bgr021; Ogunwobi OO, 2006, REGUL PEPTIDES, V134, P105, DOI 10.1016/j.regpep.2006.02.001; Philippova M, 2009, CELL SIGNAL, V21, P1035, DOI 10.1016/j.cellsig.2009.01.035; Phillips SA, 2003, DIABETES, V52, P667, DOI 10.2337/diabetes.52.3.667; Pinthus JH, 2008, EUR UROL, V54, P866, DOI 10.1016/j.eururo.2008.02.044; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Sun YY, 2010, BIOFACTORS, V36, P179, DOI 10.1002/biof.83; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zadra G, 2015, MOL CANCER RES, V13, P1059, DOI 10.1158/1541-7786.MCR-15-0068; Zhang XL, 2015, INT J CLIN EXP PATHO, V8, P2823	30	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171615	10.1371/journal.pone.0171615	http://dx.doi.org/10.1371/journal.pone.0171615			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178338	gold, Green Submitted, Green Published			2022-12-26	WOS:000393712500053
J	Tayabali, AF; Coleman, G; Crosthwait, J; Nguyen, KC; Zhang, Y; Shwed, P				Tayabali, Azam F.; Coleman, Gordon; Crosthwait, Jennifer; Nguyen, Kathy C.; Zhang, Yan; Shwed, Philip			Composition and pathogenic potential of a microbial bioremediation product used for crude oil degradation	PLOS ONE			English	Article							COMAMONAS-KERSTERSII; BACTERIAL CONSORTIUM; BISPHENOL-A; SOIL; BIODEGRADATION	A microbial bioremediation product (MBP) used for large-scale oil degradation was investigated for microbial constituents and possible pathogenicity. Aerobic growth on various media yielded >10(8) colonies mL(-1). Full-length 16S rDNA sequencing and fatty acid profiling from morphologically distinct colonies revealed >= 13 distinct genera. Full-length 16S rDNA library sequencing, by either Sanger or long-read PacBio technology, suggested that up to 21% of the MBP was composed of Arcobacter. Other high abundance microbial constituents (>6%) included the genera Proteus, Enterococcus, Dysgonomonas and several genera in the order Bacteroidales. The MBP was most susceptible to ciprofloxacin, doxycycline, gentamicin, and meropenam. MBP exposure of human HT29 and A549 cells caused significant cytotoxicity, and bacterial growth and adherence. An acellular MBP filtrate was also cytotoxic to HT29, but not A549. Both MBP and filtrate exposures elevated the neutrophil chemoattractant IL-8. In endotracheal murine exposures, bacterial pulmonary clearance was complete after one-week. Elevation of pro-inflammatory cytokines IL-1 beta, IL-6, and TNF-alpha, and chemokines KC and MCP-1 occurred between 2h and 48h post-exposure, followed by restoration to baseline levels at 96h. Cytokine/chemokine signalling was accompanied by elevated blood neutrophils and monocytes at 4h and 48h, respectively. Peripheral acute phase response markers were maximal at 24h. All indicators examined returned to baseline values by 168h. In contrast to HT29, but similar to A549 observations, MBP filtrate did not induce significant murine effects with the indicators examined. The results demonstrated the potentially complex nature of MBPs and transient immunological effects during exposure. Products containing microbes should be scrutinized for pathogenic components and subjected to characterisation and quality validation prior to commercial release.	[Tayabali, Azam F.; Coleman, Gordon; Crosthwait, Jennifer; Nguyen, Kathy C.; Zhang, Yan; Shwed, Philip] Hlth Canada, Ctr Environm Hlth, Hlth Environm & Consumer Safety Branch, Biotechnol Lab,Environm Hlth Sci & Res Bur, Ottawa, ON, Canada	Health Canada	Tayabali, AF (corresponding author), Hlth Canada, Ctr Environm Hlth, Hlth Environm & Consumer Safety Branch, Biotechnol Lab,Environm Hlth Sci & Res Bur, Ottawa, ON, Canada.	azam.tayabali@canada.ca		Shwed, Philip/0000-0002-8009-2085	Health Canada intramural funds	Health Canada intramural funds	Financial support for this research was provided by Health Canada intramural funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almuzara MN, 2013, J CLIN MICROBIOL, V51, P1998, DOI 10.1128/JCM.00659-13; Balamayooran G, 2010, AM J RESP CELL MOL, V43, P5, DOI 10.1165/rcmb.2009-0047TR; Biswas JS, 2014, J CLIN MICROBIOL, V52, P3134, DOI 10.1128/JCM.00909-14; Cangelosi GA, 2014, APPL ENVIRON MICROB, V80, P5884, DOI 10.1128/AEM.01763-14; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ebringer A, 2014, APMIS, V122, P363, DOI 10.1111/apm.12154; Ferreira S, 2016, CRIT REV MICROBIOL, V42, P364, DOI 10.3109/1040841X.2014.954523; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Herold S, 2011, ACUTE LUNG INJURY MA, V2; Juwarkar AA, 2010, REV ENVIRON SCI BIO, V9, P215, DOI 10.1007/s11157-010-9215-6; Kalra A, 2011, TREATMENT ENDOCARDIT, V15, pe222; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Lade H, 2015, EXCLI J, V14, P158, DOI 10.17179/excli2014-642; Leng T, 2009, RETINA-J RET VIT DIS, V29, P1019, DOI 10.1097/01.iae.0000357756.22868.2d; Li B, 2014, FUTURE MICROBIOL, V9, P1071, DOI [10.2217/FMB.14.48, 10.2217/fmb.14.48]; Luber P, 2003, J CLIN MICROBIOL, V41, P1062, DOI 10.1128/JCM.41.3.1062-1068.2003; Mackova M, 2009, ENVIRON SCI POLLUT R, V16, P817, DOI 10.1007/s11356-009-0240-3; Matsumura Y, 2015, BIOCONTROL SCI, V20, P35, DOI 10.4265/bio.20.35; Miller CS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056018, 10.1371/journal.pone.0081692]; Opota O, 2014, J CLIN MICROBIOL, V52, P1009, DOI 10.1128/JCM.02942-13; Patel VR, 2015, WATER SCI TECHNOL, V72, P311, DOI 10.2166/wst.2015.208; Peng YH, 2015, J HAZARD MATER, V286, P285, DOI 10.1016/j.jhazmat.2014.12.051; Qiao J, 2014, FRONT ENV SCI ENG, V8, P293, DOI 10.1007/s11783-013-0561-9; Ramarao N, 2013, TOXINS, V5, P1119, DOI 10.3390/toxins5061119; Samarajeewa AD, 2015, J MICROBIOL METH, V108, P103, DOI 10.1016/j.mimet.2014.11.013; Seligy VL, 1999, J IND MICROBIOL BIOT, V22, P565, DOI 10.1038/sj.jim.2900625; Shah AH, 2011, TRENDS FOOD SCI TECH, V22, P225, DOI 10.1016/j.tifs.2011.01.010; Shong J, 2012, CURR OPIN BIOTECH, V23, P798, DOI 10.1016/j.copbio.2012.02.001; Tayabali AF, 2000, ENVIRON HEALTH PERSP, V108, P919, DOI 10.2307/3435049; Tayabali AF, 2012, COMP VIRULENCE POTEN, V7; Tayabali AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143604; Tayabali AF, 2011, TOXICOL ENVIRON CHEM, V93, P314, DOI 10.1080/02772248.2010.526784; Tsui TL, 2011, J MICROBIOL IMMUNOL, V44, P67, DOI 10.1016/j.jmii.2011.01.013; Wang Gang, 2008, 2008 7th IEEE International Symposium on Network Computing and Applications (NCA), P93, DOI 10.1109/NCA.2008.27; Wick EC, 2010, CURR OPIN INFECT DIS, V23, P470, DOI 10.1097/QCO.0b013e32833da1eb	35	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171911	10.1371/journal.pone.0171911	http://dx.doi.org/10.1371/journal.pone.0171911			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178315	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500078
J	Yamamoto, D; Hernandes, RT; Liberatore, AMA; Abe, CM; de Souza, RB; Romao, FT; Sperandio, V; Koh, IH; Gomes, TAT				Yamamoto, Denise; Hernandes, Rodrigo T.; Liberatore, Ana Maria A.; Abe, Cecilia M.; de Souza, Rodrigo B.; Romao, Fabiano T.; Sperandio, Vanessa; Koh, Ivan H.; Gomes, Tania A. T.			Escherichia albertii, a novel human enteropathogen, colonizes rat enterocytes and translocates to extra-intestinal sites	PLOS ONE			English	Article							M-CELLS; COLI STRAINS; BACTERIAL TRANSLOCATION; EPITHELIAL-CELLS; EPEC SEROGROUPS; CACO-2 CELLS; PEYERS PATCH; CARRY EAE; ADHERENCE; INVASION	Diarrhea is the second leading cause of death of children up to five years old in the developing countries. Among the etiological diarrheal agents are atypical enteropathogenic Escherichia coli (aEPEC), one of the diarrheagenic E. coli pathotypes that affects children and adults, even in developed countries. Currently, genotypic and biochemical approaches have helped to demonstrate that some strains classified as aEPEC are actually E. albertii, a recently recognized human enteropathogen. Studies on particular strains are necessary to explore their virulence potential in order to further understand the underlying mechanisms of E. albertii infections. Here we demonstrated for the first time that infection of fragments of rat intestinal mucosa is a useful tool to study the initial steps of E. albertii colonization. We also observed that an E. albertii strain can translocate from the intestinal lumen to Mesenteric Lymph Nodes and liver in a rat model. Based on our finding of bacterial translocation, we investigated how E. albertii might cross the intestinal epithelium by performing infections of M-like cells in vitro to identify the potential in vivo translocation route. Altogether, our approaches allowed us to draft a general E. albertii infection route from the colonization till the bacterial spreading in vivo.	[Yamamoto, Denise; Hernandes, Rodrigo T.; Romao, Fabiano T.; Gomes, Tania A. T.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med UNIFESP EPM, Sao Paulo, Brazil; [Hernandes, Rodrigo T.] Univ Estadual Paulista, UNESP, Dept Microbiol & Imunol, Inst Biociencia, Botucatu, SP, Brazil; [Liberatore, Ana Maria A.; de Souza, Rodrigo B.; Koh, Ivan H.] Univ Fed Sao Paulo, Dept Cirurgia, Escola Paulista Med UNIFESP EPM, Sao Paulo, Brazil; [Abe, Cecilia M.] Inst Butantan, Lab Biol Celular, Sao Paulo, Brazil; [Romao, Fabiano T.; Sperandio, Vanessa] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol & Biochem, Dallas, TX 75390 USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP); Instituto Butantan; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yamamoto, D; Gomes, TAT (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med UNIFESP EPM, Sao Paulo, Brazil.	dyamamoto@unifesp.br; tatg.amaral@unifesp.br	Liberatore, Ana M.A./K-9208-2013; Abe, Cecilia/F-1518-2013; Alvim Liberatore, Ana Maria/AAE-5587-2022; de Souza, Rodrigo Barbosa/AAV-8234-2021; Gomes, Tânia Aparecida Tardelli/H-3950-2012; Abe, Cecilia/AAM-6374-2021; Hernandes, Rodrigo T./AAW-5835-2020; Koh, ivan/ABB-2084-2021	Liberatore, Ana M.A./0000-0003-2626-973X; Abe, Cecilia/0000-0003-0218-9372; Alvim Liberatore, Ana Maria/0000-0003-2626-973X; Gomes, Tânia Aparecida Tardelli/0000-0002-4525-8705; Koh, ivan/0000-0001-5076-789X; Barbosa de Souza, Rodrigo/0000-0002-7068-3906; Reis, AlessanRSS/0000-0001-8486-7469	FUNDACAO DE AM PARO A PESQUISA DO ESTADO DE SAO PAULO (FAPESP) [2011/12664-5]; COORDENACAO DE APERFEICOAMENTO DE PESSOAL DE NIVEL SUPERIOR (CAPES) [AUX-PE-PNPD 2350/2011]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI053067] Funding Source: NIH RePORTER	FUNDACAO DE AM PARO A PESQUISA DO ESTADO DE SAO PAULO (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); COORDENACAO DE APERFEICOAMENTO DE PESSOAL DE NIVEL SUPERIOR (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from FUNDACAO DE AM PARO A PESQUISA DO ESTADO DE SAO PAULO (FAPESP 2011/12664-5) to TATG and COORDENACAO DE APERFEICOAMENTO DE PESSOAL DE NIVEL SUPERIOR (CAPES AUX-PE-PNPD 2350/2011) to TATG and DY. The funders had no role in studydesign, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SL, 2003, J CLIN MICROBIOL; Albert MJ, 1992, J MED MICROBIOL; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Cieza RJ, 2015, INFECT IMMUN, V83, P1904, DOI 10.1128/IAI.03003-14; Corr SC, 2008, FEMS IMMUNOL MED MIC, V52, P2, DOI 10.1111/j.1574-695X.2007.00359.x; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Deng WY, 2001, INFECT IMMUN, V69, P6323, DOI 10.1128/IAI.69.10.6323-6335.2001; DONNENBERG MS, 1992, INFECT IMMUN, V60, P3953, DOI 10.1128/IAI.60.10.3953-3961.1992; Dupont A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005616; Elliott SJ, 1997, MICROB PATHOGENESIS, V23, P113, DOI 10.1006/mpat.1997.0135; Etienne-Mesmin L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023594; Fitzhenry RJ, 2002, INFECT IMMUN, V70, P4362, DOI 10.1128/IAI.70.8.4362-4368.2002; GANNON VPJ, 1993, J CLIN MICROBIOL, V31, P1268, DOI 10.1128/JCM.31.5.1268-1274.1993; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Gill N, 2011, CELL MICROBIOL, V13, P660, DOI 10.1111/j.1462-5822.2011.01578.x; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; GRUTZKAU A, 1990, GUT, V31, P1011, DOI 10.1136/gut.31.9.1011; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Hernandes RT, 2013, INFECT IMMUN, V81, P3793, DOI 10.1128/IAI.00620-13; Hernandes RT, 2011, APPL ENVIRON MICROB, V77, P8391, DOI 10.1128/AEM.05376-11; Hernandes RT, 2009, FEMS MICROBIOL LETT, V297, P137, DOI 10.1111/j.1574-6968.2009.01664.x; Hernandes RT, 2008, CELL MICROBIOL, V10, P415, DOI 10.1111/j.1462-5822.2007.01054.x; Huys G, 2003, INT J SYST EVOL MICR, V53, P807, DOI 10.1099/ijs.0.02475-0; INMAN LR, 1983, J CLIN INVEST, V71, P1, DOI 10.1172/JCI110737; Jepson MA, 2003, CELLULAR MICROBIOLOG; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; KNUTTON S, 1995, METHOD ENZYMOL, V253, P145; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; Koh IHJ, 1996, TRANSPLANT P, V28, P2667; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; La Ragione RM, 2002, APPL ENV MICROBIOL; Law RJ, 2013, IN VITRO IN VIVO MOD, DOI [10.1101/cshperspect.a009977, DOI 10.1101/CSHPERSPECT.A009977]; LEVINE MM, 1985, J INFECT DIS, V152, P550, DOI 10.1093/infdis/152.3.550; Liberatore AMA, 2011, BRAZ J MED BIOL RES, V44, P1018, DOI 10.1590/S0100-879X2011007500105; Luck SN, 2005, INFECT IMMUN, V73, P3063, DOI 10.1128/IAI.73.5.3063-3071.2005; Martinez-Argudo I, 2007, CELL MICROBIOL, V9, P1538, DOI 10.1111/j.1462-5822.2007.00891.x; McCormick BA, 1998, INFECT IMMUN, V66, P4237; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Navarro-Garcia F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/374395; Oaks JL, 2010, EMERG INFECT DIS; Ooka T, 2015, GENOME BIOL EVOL, V7, P3170, DOI 10.1093/gbe/evv211; Ooka T, 2013, EMERG INFECT DIS, V19, P144, DOI 10.3201/eid1901.120646; Ooka T, 2012, EMERG INFECT DIS, V18, P488, DOI 10.3201/eid1803.111401; Pacheco VCR, 2014, PATHOG DIS, V70, P167, DOI 10.1111/2049-632X.12112; Peralta-Ramirez J, ESPF INTERACTS NUCL, DOI [10.1128/IAI.00072-08, DOI 10.1128/IAI.00072-08]; Pielage JF, 2007, INT J BIOCHEM CELL B, V39, P1886, DOI 10.1016/j.biocel.2007.05.009; Romao FT, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0299-y; Rosa ACP, 2001, FEMS MICROBIOL LETT, V200, P117, DOI 10.1016/S0378-1097(01)00212-9; Sampaio Suely C F, 2011, Open Microbiol J, V5, P65, DOI 10.2174/1874285801105010065; Sansonetti Philippe J, 2006, Can J Infect Dis Med Microbiol, V17, P117; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Shaw RK, 2005, INFECT IMMUN, V73, P1243, DOI 10.1128/IAI.73.2.1243-1251.2005; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385; Vieira MAM, 2001, J INFECT DIS, V183, P762, DOI 10.1086/318821; Weflen AW, 2010, CELL MICROBIOL, V12, P919, DOI 10.1111/j.1462-5822.2010.01440.x; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Yamamoto D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-146	62	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171385	10.1371/journal.pone.0171385	http://dx.doi.org/10.1371/journal.pone.0171385			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178312	Green Submitted, Green Published, gold			2022-12-26	WOS:000393712500039
J	Zhang, XD; Gohlich, D				Zhang, Xudong; Goehlich, Dietmar			A hierarchical estimator development for estimation of tire-road friction coefficient	PLOS ONE			English	Article							EXTENDED KALMAN FILTER; NEURAL-NETWORK; VEHICLE; STATE	The effect of vehicle active safety systems is subject to the friction force arising from the contact of tires and the road surface. Therefore, an adequate knowledge of the tire-road friction coefficient is of great importance to achieve a good performance of these control systems. This paper presents a tire-road friction coefficient estimation method for an advanced vehicle configuration, four-motorized-wheel electric vehicles, in which the longitudinal tire force is easily obtained. A hierarchical structure is adopted for the proposed estimation design. An upper estimator is developed based on unscented Kalman filter to estimate vehicle state information, while a hybrid estimation method is applied as the lower estimator to identify the tire-road friction coefficient using general regression neural network (GRNN) and Bayes' theorem. GRNN aims at detecting road friction coefficient under small excitations, which are the most common situations in daily driving. GRNN is able to accurately create a mapping from input parameters to the friction coefficient, avoiding storing an entire complex tire model. As for large excitations, the estimation algorithm is based on Bayes' theorem and a simplified "magic formula" tire model. The integrated estimation method is established by the combination of the above-mentioned estimators. Finally, the simulations based on a high-fidelity CarSim vehicle model are carried out on different road surfaces and driving maneuvers to verify the effectiveness of the proposed estimation method.	[Zhang, Xudong; Goehlich, Dietmar] Tech Univ Berlin, Prod Dev Methods & Mechatron, Berlin, Germany	Technical University of Berlin	Zhang, XD (corresponding author), Tech Univ Berlin, Prod Dev Methods & Mechatron, Berlin, Germany.	xudong.zhang@campus.tu-berlin.de	Zhang, Xudong/AAO-6455-2020	Zhang, Xudong/0000-0002-3943-1428	China Sponsorship Council [201306030007]; Technische Universitat Berlin	China Sponsorship Council; Technische Universitat Berlin	Funded by: China Sponsorship Council Award Number: 201306030007. Grant Recipient: Xudong Zhang. Technische Universitat Berlin Award Number: N/A. Grant Recipient: Dietmar Gohlich. Open Access Publication Funds of Technische Universitat Berlin Award Number: N/A. Grant Recipient: Xudong Zhang.	Ahn C, 2009, AM CONTR C 2009 ACC; Antonov S, 2011, VEHICLE SYST DYN, V49, P1497, DOI 10.1080/00423114.2010.527994; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Chen Y, 2011, IEEE T VEH TECHNOL, V60, P839, DOI 10.1109/TVT.2011.2106811; Cho K, 2012, CONTR APPL CCA 2012; Esmailzadeh E, 2001, VEHICLE SYST DYN, V35, P163, DOI 10.1076/vesd.35.3.163.2047; Gao S, 2015, P INT C MOD SIM APPL; He HW, 2014, ENERGIES, V7, P3748, DOI 10.3390/en7063748; Holzmann Frederic, 2006, COMP AID CONTR SYST; Hsu Y-HJ, 2006, INT S ADV VEH CONTR; Julier S. J., 1997, AEROSENSE 97; Kandepu R, 2008, J PROCESS CONTR, V18, P753, DOI 10.1016/j.jprocont.2007.11.004; Muller S, 2003, J DYN SYST-T ASME, V125, P607, DOI 10.1115/1.1636773; Pacejka HB, 2005, TYRE VEHICLE DYNAMIC, V2nd; Pasterkamp WR, 1997, VEHICLE SYST DYN, V27, P409, DOI 10.1080/00423119708969339; Pingping GHWBL, 2014, CHINESE J MECH ENG, V27, P1; Rajamani R, 2010, IEEE CONTR SYST MAG, V30, P54, DOI 10.1109/MCS.2010.937006; Ray LR, 1997, AUTOMATICA, V33, P1819, DOI 10.1016/S0005-1098(97)00093-9; Ray LR, 1995, AM CONTR C P 1995; Ren HB, 2014, VEHICLE SYST DYN, V52, P1047, DOI 10.1080/00423114.2014.918629; Riehm M, 2012, COLD REG SCI TECHNOL, V83-84, P71, DOI 10.1016/j.coldregions.2012.06.004; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Van Zanten AT, 2000, BOSCH ESP SYSTEMS 5; Wan E., 2000, AD SYST SIGN PROC CO; Wang RR, 2013, CONTROL ENG PRACT, V21, P65, DOI 10.1016/j.conengprac.2012.09.009; Zareian A, 2016, P I MECH ENG K-J MUL, V230, P52, DOI 10.1177/1464419315573353	27	20	21	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171085	10.1371/journal.pone.0171085	http://dx.doi.org/10.1371/journal.pone.0171085			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178332	Green Submitted, Green Published, gold			2022-12-26	WOS:000393712500023
J	Shang, XP; Fu, XF; Zhang, P; Sheng, MY; Song, JQ; He, F; Qiu, YW; Wu, HC; Lu, QB; Feng, Y; Lin, JF; Chen, EF; Chai, CL				Shang, Xiaopeng; Fu, Xiaofei; Zhang, Peng; Sheng, Minyang; Song, Jianqiang; He, Fan; Qiu, Yinwei; Wu, Haocheng; Lu, Qinbao; Feng, Yan; Lin, Junfen; Chen, Enfu; Chai, Chengliang			An outbreak of norovirus-associated acute gastroenteritis associated with contaminated barrelled water in many schools in Zhejiang, China	PLOS ONE			English	Article							UNITED-STATES; BOARDING SCHOOL; SOUTH CHINA; SURVEILLANCE; AUSTRIA	Objectives More than 900 students and teachers at many schools in Jiaxing city developed acute gastroenteritis in February 2014. An immediate epidemiological investigation was conducted to identify the pathogen, infection sources and route of transmission. Methods The probable cases and confirmed cases were defined as students or teachers with diarrhoea or vomiting present since the term began in February 2014. An active search was conducted for undiagnosed cases among students and teachers. Details such as demographic characteristics, gastrointestinal symptoms, and drinking water preference and frequency were collected via a uniform epidemiological questionnaire. A case-control study was implemented, and odds ratios (ORs) and 95% confidence intervals were calculated. Rectal swabs from several patients, food handlers and barrelled water factory workers, as well as water and food samples, were collected to test for potential bacteria and viruses. Results A total of 924 cases fit the definition of the probable case, including 8 cases of laboratory-confirmed norovirus infection at 13 schools in Jiaxing city between February 12 and February 21, 2014. The case-control study demonstrated that barrelled water was a risk factor (OR: 20.15, 95% CI: 2.59-156.76) and that bottled water and boiled barrelled water were protective factors (OR: 0.31, 95% CI: 0.13-0.70, and OR: 0.36, 95% CI: 0.16-0.77). A total of 11 rectal samples and 8 barrelled water samples were detected as norovirus-positive, and the genotypes of viral strains were the same (GII). The norovirus that contaminated the barrelled water largely came from the asymptomatic workers. Conclusions This acute gastroenteritis outbreak was caused by barrelled water contaminated by norovirus. The outbreak was controlled after stopping the supply of barrelled water. The barrelled water supply in China represents a potential source of acute gastroenteritis outbreaks due to the lack of surveillance and supervision. Therefore, more attention should be paid to this area.	[Shang, Xiaopeng; He, Fan; Qiu, Yinwei; Wu, Haocheng; Lu, Qinbao; Feng, Yan; Lin, Junfen; Chen, Enfu; Chai, Chengliang] Zhejiang Prov Ctr Dis Control & Prevent, Dept Publ Hlth Surveillance & Advisory, Hangzhou, Zhejiang, Peoples R China; [Fu, Xiaofei] Ctr Dis Jiaxing City, Dept Communicable Dis Control & Prevent, Jiaxing, Zhejiang, Peoples R China; [Zhang, Peng] Ctr Dis Control & Prevent Huzhou City, Dept Ctr Off, Huzhou, Zhejiang, Peoples R China; [Sheng, Minyang] Ctr Dis Control & Prevent Haining Cty, Dept Ctr Off, Jiaxing, Zhejiang, Peoples R China; [Song, Jianqiang] Ctr Dis Control & Prevent Haiyan Cty, Dept Ctr Off, Jiaxing, Zhejiang, Peoples R China; [Feng, Yan; Chen, Enfu] Zhejiang Prov Ctr Dis Control & Prevent, Dept Communicable Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Chai, Chengliang] Zhejiang Prov Ctr Dis Control & Prevent, Dept TB Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention	Chen, EF; Chai, CL (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Publ Hlth Surveillance & Advisory, Hangzhou, Zhejiang, Peoples R China.; Chen, EF (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Communicable Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.; Chai, CL (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept TB Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	enfchen@cdc.zj.cn; chaicl0428@163.com		SHANG, XIAOPENG/0000-0002-6500-8762	Medical Research Program of Zhejiang province [2017KY283, 2015ZHA003, 2015RCB008]	Medical Research Program of Zhejiang province	This research was supported by the Medical Research Program of Zhejiang province (2017KY283, 2015ZHA003, 2015RCB008). As the first author of this manuscript, Xiaopeng Shang received the program (2017KY283). Haocheng Wu and Qinbao Lu received the programs (2015ZHA003, 2015RCB008), and they contributed analysis tools and analyzed the data of the manuscript.	Amy Zlot, 2015, AM J TRANSPLANT, V15, P2001, DOI [10.1111/ajt.13404, DOI 10.1111/AJT.13404]; Di Bartolo I, 2015, NEW MICROBIOL, V38, P109; Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085; Gao Shi-Gen, 2011, HIN J SCH HLTH, V32, P1530; He YQ, 2010, FOOD ENVIRON VIROL, V2, P207, DOI 10.1007/s12560-010-9047-0; Hedlund KO, 2000, J INFECT DIS, V181, pS275, DOI 10.1086/315585; Hua Ding, 2010, DIS SURVEILLANCE, V25, P279; Inouye S, 2000, J INFECT DIS, V181, pS270, DOI 10.1086/315593; Kuo HW, 2009, WIEN KLIN WOCHENSCHR, V121, P120, DOI 10.1007/s00508-008-1131-1; Lee RM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-446; Li Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-283; Lin YC, 2015, INT J INFECT DIS, V37, P25, DOI 10.1016/j.ijid.2015.05.021; Lopmam BA, 2003, EMERG INFECT DIS, V9, P90; Mei Lin, 2007, J APPL PREVENTIVE ME, V13, P11; Phillips G, 2010, EPIDEMIOL INFECT, V138, P1454, DOI 10.1017/S0950268810000439; Robilotti E, 2015, CLIN MICROBIOL REV, V28, P134, DOI 10.1128/CMR.00075-14; Seitz SR, 2011, APPL ENVIRON MICROB, V77, P6884, DOI 10.1128/AEM.05806-11; Song Jian-Qiang, 2015, ZHEJIANG J PREVENTIV, P1045; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Widdowson MA, 2005, EMERG INFECT DIS, V11, P95, DOI 10.3201/eid1101.040426; Xue CY, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1092; Zhang Rui, 2013, Comput Math Methods Med, V2013, P834192, DOI 10.1155/2013/834192	22	13	17	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171307	10.1371/journal.pone.0171307	http://dx.doi.org/10.1371/journal.pone.0171307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170414	gold, Green Published			2022-12-26	WOS:000393705500032
J	Chen, Y; Luo, Y; Curry, P; Timme, R; Melka, D; Doyle, M; Parish, M; Hammack, TS; Allard, MW; Brown, EW; Strain, EA				Chen, Yi; Luo, Yan; Curry, Phillip; Timme, Ruth; Melka, David; Doyle, Matthew; Parish, Mickey; Hammack, Thomas S.; Allard, Marc W.; Brown, Eric W.; Strain, Errol A.			Assessing the genome level diversity of Listeria monocytogenes from contaminated ice cream and environmental samples linked to a listeriosis outbreak in the United States	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MOBILE GENETIC ELEMENTS; PROCESSING PLANTS; SEQUENCE DATA; STRAINS; PHYLOGENIES; VIRULENCE; CLONES; PHAST; FOOD	A listeriosis outbreak in the United States implicated contaminated ice cream produced by one company, which operated 3 facilities. We performed single nucleotide polymorphism (SNP)-based whole genome sequencing (WGS) analysis on Listeria monocytogenes from food, environmental and clinical sources, identifying two clusters and a single branch, belonging to PCR serogroup IIb and genetic lineage I. WGS Cluster I, representing one outbreak strain, contained 82 food and environmental isolates from Facility I and 4 clinical isolates. These isolates differed by up to 29 SNPs, exhibited 9 pulsed-field gel electrophoresis (PFGE) profiles and multilocus sequence typing (MLST) sequence type (ST) 5 of clonal complex 5 (CC5). WGS Cluster II contained 51 food and environmental isolates from Facility II, 4 food isolates from Facility I and 5 clinical isolates. Among them the isolates from Facility II and clinical isolates formed a clade and represented another outbreak strain. Isolates in this clade differed by up to 29 SNPs, exhibited 3 PFGE profiles and ST5. The only isolate collected from Facility III belonged to singleton ST489, which was in a single branch separate from Clusters I and II, and was not associated with the outbreak. WGS analyses clustered together outbreak-associated isolates exhibiting multiple PFGE profiles, while differentiating them from epidemiologically unrelated isolates that exhibited outbreak PFGE profiles. The complete genome of a Cluster I isolate allowed the identification and analyses of putative prophages, revealing that Cluster I isolates differed by the gain or loss of three putative prophages, causing the banding pattern differences among all 3 AscI-PFGE profiles observed in Cluster I isolates. WGS data suggested that certain ice cream varieties and/or production lines might have contamination sources unique to them. The SNP-based analysis was able to distinguish CC5 as a group from non-CC5 isolates and differentiate among CC5 isolates from different outbreaks/incidents.	[Chen, Yi; Luo, Yan; Curry, Phillip; Timme, Ruth; Melka, David; Doyle, Matthew; Parish, Mickey; Hammack, Thomas S.; Allard, Marc W.; Brown, Eric W.; Strain, Errol A.] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA	US Food & Drug Administration (FDA)	Chen, Y (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	yi.chen@fda.hhs.gov		Doyle, Matthew/0000-0002-6779-5704; Timme, Ruth/0000-0002-9705-5897				Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32; Allard MW, 2016, J CLIN MICROBIOL; [Anonymous], 2006, THESIS U TEXAS AUSTI; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bertels F, 2014, MOL BIOL EVOL, V31, P1077, DOI 10.1093/molbev/msu088; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P961, DOI 10.1128/AEM.71.2.961-967.2005; CDC (Centers for Disease Control and Prevention), 2014, MULT OUTBR LIST LINK; Centers for Disease Control and Prevention, 2015, MULT OUTBR LIST LINK, DOI [10.3201/eid1901.121167, DOI 10.3201/EID1901.121167]; Centers for Disease Control and Prevention, 2015, MULT OUTBR LIST LINK; Chen Y, 2016, INT J FOOD MICROBIOL, V241, P15, DOI [10.1016/j.ijfoodmicro, DOI 10.1016/J.IJFOODMICRO]; Chen Y, 2016, APPL ENVIRON MICROB, DOI [10.3201/eid2012.140993, DOI 10.3201/EID2012.140993]; Chen Y, 2008, J CLIN MICROBIOL, V46, P1478, DOI 10.1128/JCM.01873-07; Chen Y, 2016, J FOOD PROTECT, V79, P1828, DOI 10.4315/0362-028X.JFP-16-208; Chen Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00764; Chen YY, 2016, APPL ENVIRON MICROB, V82, P2156, DOI 10.1128/AEM.03718-15; Davis S, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.20; den Bakker HC, 2012, APPL ENVIRON MICROB, V78, P1876, DOI 10.1128/AEM.06969-11; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Goff H.D., 2013, ICE CREAM, V7th, DOI DOI 10.1007/978-1-4614-6096-1; Gorski L, 2006, APPL ENVIRON MICROB, V72, P776, DOI 10.1128/AEM.72.1.776-783.2006; Hitchins A. D., 2016, DETECTION AND ENUMER; Holch A, 2013, APPL ENVIRON MICROB, V79, P2944, DOI 10.1128/AEM.03715-12; Jackson B. R., 2016, CLIN INFECT DIS; Jackson BR, 2015, MMWR-MORBID MORTAL W, V64, P282; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Kvistholm Jensen A, 2016, CLIN INFECT DIS, DOI [10.1128/AEM.03715-12, DOI 10.1128/AEM.03715-12]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lomonaco S, 2013, EMERG INFECT DIS, V19, P147, DOI 10.3201/eid1901.121167; McCollum JT, 2013, NEW ENGL J MED, V369, P944, DOI 10.1056/NEJMoa1215837; Moura A, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.185; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; Perez-Trallero E, 2014, EMERG INFECT DIS, V20, P2155, DOI 10.3201/eid2012.140993; Pettengill JB, 2014, PEERJ, V2, DOI 10.7717/peerj.620; Pightling Arthur W, 2015, BMC Res Notes, V8, P748, DOI 10.1186/s13104-015-1689-4; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Schmid D, 2014, CLIN MICROBIOL INFEC, V20, P431, DOI 10.1111/1469-0691.12638; Schmitz-Esser S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00380; Verghese B, 2011, APPL ENVIRON MICROB, V77, P3279, DOI 10.1128/AEM.00546-11; Wang QN, 2015, J CLIN MICROBIOL, V53, P3492, DOI 10.1128/JCM.00202-15; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Zilelidou E, 2016, APPL ENV MICROBIOL	46	45	48	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171389	10.1371/journal.pone.0171389	http://dx.doi.org/10.1371/journal.pone.0171389			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166293	Green Submitted, Green Published, gold			2022-12-26	WOS:000393700100037
J	Cannistraci, A; Federici, G; Addario, A; Di Pace, AL; Grassi, L; Muto, G; Collura, D; Signore, M; De Salvo, L; Sentinelli, S; Simone, G; Costantini, M; Nanni, S; Farsetti, A; Coppola, V; De Maria, R; Bonci, D				Cannistraci, A.; Federici, G.; Addario, A.; Di Pace, A. L.; Grassi, L.; Muto, G.; Collura, D.; Signore, M.; De Salvo, L.; Sentinelli, S.; Simone, G.; Costantini, M.; Nanni, S.; Farsetti, A.; Coppola, V.; De Maria, R.; Bonci, D.			C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition	ONCOGENE			English	Article							ANDROGEN-RECEPTOR GENE; PROSTATE-CANCER; MICRORNA SIGNATURES; INCREASED SURVIVAL; C-MET; METASTASIS; EXPRESSION; GROWTH; PHOSPHORYLATION; PROGRESSION	Although a significant subset of prostate tumors remain indolent during the entire life, the advanced forms are still one of the leading cause of cancer-related death. There are not reliable markers distinguishing indolent from aggressive forms. Here we highlighted a new molecular circuitry involving microRNA and coding genes promoting cancer progression and castration resistance. Our preclinical and clinical data demonstrated that c-Met activation increases miR-130b levels, inhibits androgen receptor expression, promotes cancer spreading and resistance to hormone ablation therapy. The relevance of these findings was confirmed on patients' samples and by in silico analysis on an independent patient cohort from Taylor's platform. Data suggest c-Met/miR-130b axis as a new prognostic marker for patients' risk assessment and as an indicator of therapy resistance. Our results propose new biomarkers for therapy decision-making in all phases of the pathology. Data may help identify high-risk patients to be treated with adjuvant therapy together with alternative cure for castration-resistant forms while facilitating the identification of possible patients candidates for anti-Met therapy. In addition, we demonstrated that it is possible to evaluate Met/miR-130b axis expression in exosomes isolated from peripheral blood of surgery candidates and advanced patients offering a new non-invasive tool for active surveillance and therapy monitoring.	[Cannistraci, A.; Federici, G.; Addario, A.; Di Pace, A. L.; Grassi, L.; Signore, M.; Coppola, V.; Bonci, D.] Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy; [Federici, G.; Grassi, L.; De Salvo, L.; Sentinelli, S.; Simone, G.; Costantini, M.; Bonci, D.] Regina Elena Inst Canc Res, Rome, Italy; [Di Pace, A. L.] Sapienza Univ Rome, Histol & Med Embryol Sect, Dept Anat Histol Forens & Orthopaed Sci, Rome, Italy; [Muto, G.; Collura, D.] S Giovanni Bosco Hosp, Dept Urol, Turin, Italy; [Muto, G.] Campus Biomed Univ, Dept Urol, Rome, Italy; [Nanni, S.] Univ Cattolica, Inst Med Pathol, Rome, Italy; [Farsetti, A.] CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [De Maria, R.] Univ Cattolica, Inst Gen Pathol, Largo Francesco Vito 1, I-00168 Rome, Italy; [De Maria, R.] Policlin Gemelli, Largo Francesco Vito 1, I-00168 Rome, Italy	Istituto Superiore di Sanita (ISS); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome; University Campus Bio-Medico - Rome Italy; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Bonci, D (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.; De Maria, R (corresponding author), Univ Cattolica, Inst Gen Pathol, Largo Francesco Vito 1, I-00168 Rome, Italy.; De Maria, R (corresponding author), Policlin Gemelli, Largo Francesco Vito 1, I-00168 Rome, Italy.	ruggero.demaria@unicatt.it; desiree.bonci@iss.it	Addario, Antonio/AAC-4707-2022; Signore, Michele/J-8563-2016; Farsetti, Antonella/I-8710-2018; Federici, Giulia/AAC-8820-2019; Di Pace, Anna Laura/K-6494-2016; Bonci, Desiree/K-6488-2016; De Maria, Ruggero/S-6385-2019; simone, giuseppe/K-9607-2016; Coppola, Valeria/K-5120-2016	Addario, Antonio/0000-0001-8527-8738; Signore, Michele/0000-0002-0262-842X; Farsetti, Antonella/0000-0002-8603-7925; Federici, Giulia/0000-0002-4684-0270; Di Pace, Anna Laura/0000-0002-1712-9033; Bonci, Desiree/0000-0002-2472-5140; De Maria, Ruggero/0000-0003-2255-0583; simone, giuseppe/0000-0002-4868-9025; Coppola, Valeria/0000-0002-5745-2572; collura, devis/0000-0002-8964-5248; Muto, Giovanni/0000-0003-3593-6450	National Ministry of Health; Italy-USA microRNA program; Italian Association for Cancer (AIRC); Fondazione Roma	National Ministry of Health; Italy-USA microRNA program; Italian Association for Cancer (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Roma(Fondazione RomaEuropean Commission)	We thank Giuseppe Loreto and Tania Merlino for their technical support. We thank Alessandra Boe for cytofluorimetric analysis. This manuscript was supported by National Ministry of Health, Under-forty researcher (2012) and Italy-USA microRNA program to DB and the Italian Association for Cancer (AIRC) and Fondazione Roma funding to RDM.	Adolfsson J, 2008, BJU INT, V102, P10, DOI 10.1111/j.1464-410X.2008.07585.x; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; BRAWN PN, 1989, BRIT J CANCER, V59, P85, DOI 10.1038/bjc.1989.16; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Colangelo T, 2013, NEOPLASIA, V15, P1204, DOI 10.1593/neo.13998; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; D'Amico Anthony V, 2004, J Urol, V172, pS42, DOI 10.1097/01.ju.0000141845.99899.12; D'Amico AV, 2004, NEW ENGL J MED, V351, P125, DOI 10.1056/NEJMoa032975; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; DEAN M, 1987, MOL CELL BIOL, V7, P921, DOI 10.1128/MCB.7.2.921; Dean M, 1987, Haematol Blood Transfus, V31, P464; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Federici G, 2013, MOL CANCER RES, V11, P676, DOI 10.1158/1541-7786.MCR-12-0690; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gregory CW, 2001, CANCER RES, V61, P2892; Haas GP, 2008, CAN J UROL, V15, P3866; Nguyen HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063219; ISAACS JT, 1981, CANCER RES, V41, P5070; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Knudsen BS, 2004, ADV CANCER RES, V91, P31, DOI 10.1016/S0065-230X(04)91002-0; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li BL, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0484-0; Li P, 2002, AM J PATHOL, V161, P1467, DOI 10.1016/S0002-9440(10)64422-7; Liu AM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000825; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Maeda A, 2006, BIOCHEM BIOPH RES CO, V347, P1158, DOI 10.1016/j.bbrc.2006.07.040; Matias PM, 2002, J MED CHEM, V45, P1439, DOI 10.1021/jm011072j; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Mueller C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023780; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Pierobon M, 2015, ONCOGENE, V34, P805, DOI 10.1038/onc.2014.16; Reisinger K, 2003, J CELL SCI, V116, P225, DOI 10.1242/jcs.00237; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sozzi G, 2014, J CLIN ONCOL, V32, P768, DOI 10.1200/JCO.2013.50.4357; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Taplin ME, 1999, CANCER RES, V59, P2511; Taplin ME, 2003, J CLIN ONCOL, V21, P2673, DOI 10.1200/JCO.2003.11.102; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; TILLEY WD, 1990, CANCER RES, V50, P5382; Varkaris A, 2011, EXPERT OPIN INV DRUG, V20, P1677, DOI 10.1517/13543784.2011.631523; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Verhoef EI, 2016, ONCOTARGET, V7, P31029, DOI 10.18632/oncotarget.8829; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Zhao G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073803	58	28	28	2	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 29	2017	36	26					3718	3728		10.1038/onc.2016.505	http://dx.doi.org/10.1038/onc.2016.505			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY9WM	28192399				2022-12-26	WOS:000404349700007
J	Cirillo, F; Resmini, G; Ghiroldi, A; Piccoli, M; Bergante, S; Tettamanti, G; Anastasia, L				Cirillo, Federica; Resmini, Giulia; Ghiroldi, Andrea; Piccoli, Marco; Bergante, Sonia; Tettamanti, Guido; Anastasia, Luigi			Activation of the hypoxia-inducible factor 1 alpha promotes myogenesis through the noncanonical Wnt pathway, leading to hypertrophic myotubes	FASEB JOURNAL			English	Article						HIF-1 alpha; MyoD; skeletal muscle differentiation; myoblasts	SKELETAL-MUSCLE; O-2 HOMEOSTASIS; CELL BIOLOGY; STEM-CELLS; FACTOR-I; MYOD; DIFFERENTIATION; OXYGEN; DEGRADATION; HIF-1-ALPHA	satellite cells, which are resident in hypoxic niches in the tissue. Hypoxia has been recognized as a key factor to maintain stem cells in an undifferentiated state. Herein we report that hypoxia plays a fundamental role also in activating myogenesis. In particular, we found that the activation of the hypoxia-inducible factor (HIF)-1 alpha under hypoxia, in murine skeletal myoblasts, leads to activation of MyoD through the noncanonical Wnt/beta-catenin pathway. Moreover, chemical inhibition of HIF-1 alpha activity significantly reduces differentiation, thus confirming its crucial role in the process. Furthermore, hypoxia-preconditioned myoblasts, once induced to differentiate under normoxic conditions, tend to form hypertrophic myotubes. These results support the notion that hypoxia plays a pivotal role in activating the regeneration process by directly inducing myogenesis through HIF-1 alpha. Although preliminary, these findings may suggest new perspective for novel therapeutic targets in the treatment of several muscle diseases.-Cirillo, F., Resmini, G., Ghiroldi, A., Piccoli, M., Bergante, S., Tettamanti, G., Anastasia, L. Activation of the hypoxia-inducible factor 1 alpha promotes myogenesis through the noncanonical Wnt pathway, leading to hypertrophic myotubes.	[Cirillo, Federica; Resmini, Giulia; Ghiroldi, Andrea; Piccoli, Marco; Bergante, Sonia; Tettamanti, Guido; Anastasia, Luigi] IRCCS, Policlin San Donato, Lab Stem Cells Tissue Engn, Milan, Italy; [Anastasia, Luigi] Univ Milan, Dept Biomed Sci Hlth, Piazza Malan 2, I-20097 Milan, Italy	IRCCS Policlinico San Donato; University of Milan	Anastasia, L (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Piazza Malan 2, I-20097 Milan, Italy.	luigi.anastasia@unimi.it	Anastasia, Luigi/AAN-1964-2020; bergante, sonia/AAI-1215-2019; Cirillo, Federica/ABE-3480-2020; Ghiroldi, Andrea/AAO-4409-2020; Piccoli, Marco/S-3731-2019	Anastasia, Luigi/0000-0002-0712-2161; Cirillo, Federica/0000-0002-0196-5977; Ghiroldi, Andrea/0000-0002-2896-7390; Piccoli, Marco/0000-0002-9461-2715; Resmini, Giulia/0000-0002-7494-7673	The Italian Ministry of Health [GR-2010-2321515]	The Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by Grant GR-2010-2321515 from The Italian Ministry of Health (to L.A.). The authors declare no conflicts of interest.	Abraham ST, 2016, IN VITRO CELL DEV-AN, V52, P935, DOI 10.1007/s11626-016-0058-5; Bareja A, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-2; Belizario JE, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2197-2; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bentzinger CF, 2014, J CELL BIOL, V205, P97, DOI 10.1083/jcb.201310035; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bernard P, 2008, BIOL CELL, V100, P167, DOI 10.1042/BC20070072; Di Carlo A, 2004, J BIOL CHEM, V279, P16332, DOI 10.1074/jbc.M313931200; Floyd ZE, 2001, J BIOL CHEM, V276, P22468, DOI 10.1074/jbc.M009388200; Francetic T, 2011, TRANSCR-AUSTIN, V2, P109, DOI 10.4161/trns.2.3.15829; Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Majmundar AJ, 2015, DEVELOPMENT, V142, P2405, DOI 10.1242/dev.123026; Majmundar AJ, 2012, MOL CELL BIOL, V32, P36, DOI 10.1128/MCB.05857-11; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Pampin JB, 2006, J FORENSIC SCI, V51, P120, DOI 10.1111/j.1556-4029.2005.00014.x; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Price FD, 2007, BBA-MOL BASIS DIS, V1772, P272, DOI 10.1016/j.bbadis.2006.08.011; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tanaka Shingo, 2011, J Mol Signal, V6, P12, DOI 10.1186/1750-2187-6-12; Vlaminck B, 2007, FEBS J, V274, P5533, DOI 10.1111/j.1742-4658.2007.06072.x; von Maltzahn J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3869; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yablonka-Reuveni Z, 2011, J HISTOCHEM CYTOCHEM, V59, P1041, DOI 10.1369/0022155411426780	43	18	20	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2146	2156		10.1096/fj.201600878R	http://dx.doi.org/10.1096/fj.201600878R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28188178				2022-12-26	WOS:000399195500033
J	Glasser, NR; Wang, BX; Hoy, JA; Newman, DK				Glasser, Nathaniel R.; Wang, Benjamin X.; Hoy, Julie A.; Newman, Dianne K.			The Pyruvate and alpha-Ketoglutarate Dehydrogenase Complexes of Pseudomonas aeruginosa Catalyze Pyocyanin and Phenazine-1-carboxylic Acid Reduction via the Subunit Dihydrolipoamide Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOAMIDE DEHYDROGENASE; SECONDARY METABOLISM; ANAEROBIC SURVIVAL; ELECTRON-TRANSPORT; CRYSTAL-STRUCTURE; REDOX; BIOSYNTHESIS; FLUORESCENS; EXPRESSION; GLUTATHIONE	Phenazines are a class of redox-active molecules produced by diverse bacteria and archaea. Many of the biological functions of phenazines, such as mediating signaling, iron acquisition, and redox homeostasis, derive from their redox activity. Although prior studies have focused on extracellular phenazine oxidation by oxygen and iron, here we report a search for reductants and catalysts of intracellular phenazine reduction in Pseudomonas aeruginosa. Enzymatic assays in cell-free lysate, together with crude fractionation and chemical inhibition, indicate that P. aeruginosa contains multiple enzymes that catalyze the reduction of the endogenous phenazines pyocyanin and phenazine-1-carboxylic acid in both cytosolic and membrane fractions. We used chemical inhibitors to target general enzyme classes and found that an inhibitor of flavoproteins and heme-containing proteins, diphenyleneiodonium, effectively inhibited phenazine reduction in vitro, suggesting that most phenazine reduction derives from these enzymes. Using natively purified proteins, we demonstrate that the pyruvate and pi-ketoglutarate dehydrogenase complexes directly catalyze phenazine reduction with pyruvate or alpha-ketoglutarate as electron donors. Both complexes transfer electrons to phenazines through the common subunit dihydrolipoamide dehydrogenase, a flavoprotein encoded by the gene lpdG. Although we were unable to co-crystallize LpdG with an endogenous phenazine, we report its X-ray crystal structure in the apo-form (refined to 1.35 angstrom), bound to NAD(+) (1.45 angstrom), and bound to NADH(1.79 angstrom). In contrast to the notion that phenazines support intracellular redox homeostasis by oxidizing NADH, our work suggests that phenazines may substitute for NAD(+) in LpdG and other enzymes, achieving the same end by a different mechanism.	[Glasser, Nathaniel R.; Wang, Benjamin X.; Hoy, Julie A.; Newman, Dianne K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Newman, Dianne K.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Newman, DK (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Newman, DK (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	dkn@caltech.edu		Wang, Benjamin/0000-0002-5270-6043	Howard Hughes Medical Institute; National Institutes of Health [5R01HL117328-03]; National Science Foundation [1144469]; Amgen Scholars Program; National Science Foundation Graduate Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117328] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Amgen Scholars Program(Amgen); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Howard Hughes Medical Institute, National Institutes of Health Grant 5R01HL117328-03, National Science Foundation Grant 1144469, and the Amgen Scholars Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a National Science Foundation Graduate Research Fellowship.	Abken HJ, 1998, J BACTERIOL, V180, P2027, DOI 10.1128/JB.180.8.2027-2032.1998; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ARMSTRONG AV, 1971, J MED MICROBIOL, V4, P263, DOI 10.1099/00222615-4-2-263; Babin BM, 2016, P NATL ACAD SCI USA, V113, pE597, DOI 10.1073/pnas.1514412113; Berkholz DS, 2008, J MOL BIOL, V382, P371, DOI 10.1016/j.jmb.2008.06.083; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; BURNS G, 1989, J BACTERIOL, V171, P665, DOI 10.1128/jb.171.2.665-668.1989; Carter DE, 2003, TOXICOL APPL PHARM, V193, P309, DOI 10.1016/j.taap.2003.07.009; Cezairliyan B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003101; Corran HS, 1939, BIOCHEM J, V33, P793, DOI 10.1042/bj0330793; COX CD, 1986, INFECT IMMUN, V52, P263, DOI 10.1128/IAI.52.1.263-270.1986; Das T., 2016, MICROB BIOFILMS IMPO, V13, P23, DOI [10.5772/63497, DOI 10.5772/63497]; de Kok A, 1998, BBA-PROTEIN STRUCT M, V1385, P353, DOI 10.1016/S0167-4838(98)00079-X; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Dietrich LEP, 2013, J BACTERIOL, V195, P1371, DOI 10.1128/JB.02273-12; Elema B, 1931, RECL TRAV CHIM PAY-B, V50, P807; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Friedheim E, 1931, J BIOL CHEM, V91, P355; Friedheim EAH, 1934, BIOCHEM J, V28, P173, DOI 10.1042/bj0280173; FRIEDHEIM ERNST A. H., 1931, JOUR EXP MED, V54, P207, DOI 10.1084/jem.54.2.207; Gessard C., 1882, THESIS; Glasser NR, 2014, MOL MICROBIOL, V92, P399, DOI 10.1111/mmi.12566; GRUYS KJ, 1989, BIOCHEMISTRY-US, V28, P9071, DOI 10.1021/bi00449a018; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3; HERBERT RB, 1969, J CHEM SOC C, P2517, DOI 10.1039/j39690002517; Hernandez ME, 2001, CELL MOL LIFE SCI, V58, P1562, DOI 10.1007/PL00000796; HOLLIMAN FG, 1969, J CHEM SOC C, P2514, DOI 10.1039/j39690002514; HOLLSTEIN U, 1971, BIOCHEMISTRY-US, V10, P497, DOI 10.1021/bi00779a023; Huang JF, 2012, APPL ENVIRON MICROB, V78, P5016, DOI 10.1128/AEM.00026-12; Hunter RC, 2013, MBIO, V4, DOI 10.1128/mBio.00557-13; JEYASEELAN K, 1980, J GEN MICROBIOL, V120, P393; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalli A, 2012, PROTEOMICS, V12, P21, DOI 10.1002/pmic.201100464; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kasozi DM, 2011, REDOX REP, V16, P154, DOI 10.1179/174329211X13049558293678; Kern S. E., 2013, THESIS; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MATTEVI A, 1992, PROTEINS, V13, P336, DOI 10.1002/prot.340130406; MATTEVI A, 1993, J MOL BIOL, V230, P1200, DOI 10.1006/jmbi.1993.1236; Mavrodi DV, 1998, J BACTERIOL, V180, P2541, DOI 10.1128/JB.180.9.2541-2548.1998; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonald M, 2001, J AM CHEM SOC, V123, P9459, DOI 10.1021/ja011243+; Michaelis L, 1931, J BIOL CHEM, V92, P211; Morales DK, 2010, MOL MICROBIOL, V78, P1379, DOI 10.1111/j.1365-2958.2010.07414.x; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; PATEL MS, 1995, METHOD ENZYMOL, V252, P186; Petrova OE, 2012, MOL MICROBIOL, V86, P819, DOI 10.1111/mmi.12018; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Price-Whelan A. M., 2009, THESIS; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Ramos I, 2010, RES MICROBIOL, V161, P187, DOI 10.1016/j.resmic.2010.01.003; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; SAHLMAN L, 1989, J BIOL CHEM, V264, P8039; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sullivan NL, 2011, ACS CHEM BIOL, V6, P893, DOI 10.1021/cb200094w; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Wang Y, 2008, ENVIRON SCI TECHNOL, V42, P2380, DOI 10.1021/es702290a; Wang Y, 2011, J BACTERIOL, V193, P3606, DOI 10.1128/JB.00396-11; Wang Y, 2010, J BACTERIOL, V192, P365, DOI 10.1128/JB.01188-09; Williams HD, 2007, ADV MICROB PHYSIOL, V52, P1, DOI 10.1016/S0065-2911(06)52001-6; Williamson KS, 2012, J BACTERIOL, V194, P2062, DOI 10.1128/JB.00022-12; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227	72	14	14	4	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5593	5607		10.1074/jbc.M116.772848	http://dx.doi.org/10.1074/jbc.M116.772848			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28174304	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000397875500037
J	Gatla, HR; Zou, Y; Uddin, MM; Singha, B; Bu, PL; Vancura, A; Vancurova, I				Gatla, Himavanth R.; Zou, Yue; Uddin, Mohammad M.; Singha, Bipradeb; Bu, Pengli; Vancura, Ales; Vancurova, Ivana			Histone Deacetylase (HDAC) Inhibition Induces IkB Kinase (IKK)-dependent Interleukin-8/CXCL8 Expression in Ovarian Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; SMALL INTERFERING RNA; EPITHELIAL OVARIAN; GROWTH-FACTOR; UP-REGULATION; APOPTOSIS; RECEPTOR; ACETYLATION; INCREASES	Overexpression of the pro-angiogenic chemokine IL-8 (CXCL8) is associated with a poor prognosis in several solid tumors, including epithelial ovarian cancer (EOC). Even though histone deacetylase (HDAC) inhibition has shown remarkable antitumor activity in hematological malignancies, it has been less effective in solid tumors, including EOC. Here we report results that may explain the decreased efficiency of HDAC inhibition in EOC, based on our data demonstrating that HDAC inhibition specifically induces expression of IL-8/CXCL8 in SKOV3, CAOV3, andOVCAR3cells. Suppression or neutralization of vorinostat-induced IL-8/CXCL8 potentiates the vorinostat inhibitory effect on cell viability and proliferation. The IL-8/CXCL8 expression induced by vorinostat in EOC cells is dependent on IkB kinase (IKK) activity and associated with a gene-specific recruitment of IKK beta and IKK-dependent recruitment of p65 NFkB to the IL-8/CXCL8 promoter. In addition, HDACinhibition induces acetylation of p65 and histone H3 and their IL-8/CXCL8 promoter occupancy. In vivo results demonstrate that combining vorinostat and the IKK inhibitor Bay 117085 significantly reduces tumor growth in nude mice compared with control untreated mice or either drug alone. Mice in the combination group had the lowest IL-8/CXCL8 tumor levels and the lowest tumor expression of the murine neutrophil [7/4] antigen, indicating reduced neutrophil infiltration. Together, our results demonstrate that HDAC inhibition specifically induces IL-8/CXCL8 expression in EOC cells and that the mechanism involves IKK, suggesting that using IKK inhibitors may increase the effectiveness of HDAC inhibitors when treating ovarian cancer and other solid tumors characterized by increased IL-8/CXCL8 expression.	[Gatla, Himavanth R.; Zou, Yue; Uddin, Mohammad M.; Bu, Pengli; Vancura, Ales; Vancurova, Ivana] St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, New York, NY 11439 USA; [Singha, Bipradeb] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA	Saint John's University; The Wistar Institute	Vancurova, I (corresponding author), St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, New York, NY 11439 USA.	vancuroi@stjohns.edu	Gatla, Himavanth/AAP-7955-2021; Bu, Pengli/J-3575-2019	Bu, Pengli/0000-0003-2576-0607; zou, yue/0000-0002-6999-8329; Vancura, Ales/0000-0002-5895-1218	St.John's University; National Institutes of Health [CA173452, CA202775]; NATIONAL CANCER INSTITUTE [R15CA173452, R15CA202775] Funding Source: NIH RePORTER	St.John's University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by St. John's University and by National Institutes of Health Grants CA173452 and CA202775 (to I. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Annunziata CM, 2010, CANCER-AM CANCER SOC, V116, P3276, DOI 10.1002/cncr.25190; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Campbell LM, 2013, PHARMACEUTICALS, V6, P929, DOI 10.3390/ph6080929; CERRETTI DP, 1993, GENOMICS, V18, P410, DOI 10.1006/geno.1993.1486; Chang TP, 2015, J IMMUNOL, V194, P2942, DOI 10.4049/jimmunol.1402610; Chavey C, 2008, MOL PHARMACOL, V74, P1359, DOI 10.1124/mol.108.047332; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen MY, 2011, CANCER-AM CANCER SOC, V117, P4424, DOI 10.1002/cncr.26073; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Dai Y, 2011, J BIOL CHEM, V286, P34036, DOI 10.1074/jbc.M111.284216; Duan JM, 2007, MOL CANCER THER, V6, P37, DOI 10.1158/1535-7163.MCT-05-0285; Fan XD, 2007, J BIOL CHEM, V282, P11658, DOI 10.1074/jbc.M607705200; Fantin VR, 2007, CLIN CANCER RES, V13, P7237, DOI 10.1158/1078-0432.CCR-07-2114; Galdieri L, 2016, J BIOL CHEM, V291, P25154, DOI 10.1074/jbc.M116.742247; Grant S, 2007, NAT REV DRUG DISCOV, V6, P21, DOI 10.1038/nrd2227; Grassadonia Antonino, 2013, Cancers (Basel), V5, P919, DOI 10.3390/cancers5030919; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Huang S, 2000, CANCER RES, V60, P5334; Ivarsson K, 2000, ACTA OBSTET GYN SCAN, V79, P777, DOI 10.1034/j.1600-0412.2000.079009777.x; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Khabele D, 2007, CANCER BIOL THER, V6, P795, DOI 10.4161/cbt.6.5.4007; Khabele D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00111; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Mabuchi S, 2004, J BIOL CHEM, V279, P23477, DOI 10.1074/jbc.M313709200; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Matulonis U, 2015, CANCER CHEMOTH PHARM, V76, P417, DOI 10.1007/s00280-015-2813-9; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; Mayo MW, 2003, J BIOL CHEM, V278, P18980, DOI 10.1074/jbc.M211695200; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; Modesitt SC, 2008, GYNECOL ONCOL, V109, P182, DOI 10.1016/j.ygyno.2008.01.009; Natoli G, 2012, IMMUNOL REV, V246, P183, DOI 10.1111/j.1600-065X.2012.01103.x; Nomiyama H, 2010, CYTOKINE GROWTH F R, V21, P253, DOI 10.1016/j.cytogfr.2010.03.004; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Randall BK, 2004, SURGERY, V136, P416, DOI 10.1016/j.surg.2004.05.018; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Sanacora S, 2015, BIOCHEM BIOPH RES CO, V460, P375, DOI 10.1016/j.bbrc.2015.03.041; Singha B, 2015, ONCOTARGET, V6, P26347, DOI [10.18632/oncotarget.4713, 10.18632/oncotarget.4613]; Singha B, 2015, BIOMOLECULES, V5, P223, DOI 10.3390/biom5010223; Singha B, 2014, J BIOL CHEM, V289, P2687, DOI 10.1074/jbc.M113.502641; Sonnemann J, 2008, ONCOL REP, V20, P219; Strait KA, 2005, MOL CANCER THER, V4, P603, DOI 10.1158/1535-7163.MCT-04-0107; Stronach EA, 2015, ONCOTARGET, V6, P31593, DOI 10.18632/oncotarget.3415; Takada Y, 2004, ONCOGENE, V23, P9247, DOI 10.1038/sj.onc.1208169; Takai N, 2010, J ONCOL, V2010, DOI 10.1155/2010/458431; Venkatakrishnan G, 2000, J BIOL CHEM, V275, P6868, DOI 10.1074/jbc.275.10.6868; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang Y, 2005, CELL MOL IMMUNOL, V2, P365; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wilson AJ, 2011, CANCER BIOL THER, V12, P484, DOI 10.4161/cbt.12.6.15956; Xu L, 2000, ONCOL RES, V12, P97, DOI 10.3727/096504001108747567; Yang G, 2010, CLIN CANCER RES, V16, P3875, DOI 10.1158/1078-0432.CCR-10-0483; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zhang CL, 2005, J INVEST DERMATOL, V125, P1045, DOI 10.1111/j.0022-202X.2005.23925.x	61	29	29	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5043	5054		10.1074/jbc.M116.771014	http://dx.doi.org/10.1074/jbc.M116.771014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28167529	Green Published, hybrid			2022-12-26	WOS:000397590400025
J	Goth, CK; Tuhkanen, HE; Khan, H; Lackman, JJ; Wang, SJ; Narimatsu, Y; Hansen, LH; Overall, CM; Clausen, H; Schjoldager, KT; Petaja-Repo, UE				Goth, Christoffer K.; Tuhkanen, Hanna E.; Khan, Hamayun; Lackman, Jarkko J.; Wang, Shengjun; Narimatsu, Yoshiki; Hansen, Lasse H.; Overall, Christopher M.; Clausen, Henrik; Schjoldager, Katrine T.; Petaja-Repo, Ulla E.			Site-specific O-Glycosylation by Polypeptide N-Acetylgalactosaminyltransferase 2 (GalNAc-transferase T2) Co-regulates beta(1)- Adrenergic Receptor N-terminal Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA(1)-ADRENERGIC RECEPTOR; SUBSTRATE SPECIFICITIES; ENDOPLASMIC-RETICULUM; LINKED GLYCOSYLATION; QUALITY-CONTROL; IN-VIVO; IDENTIFICATION; ECTODOMAIN; BINDING; METALLOPROTEINASES	The beta(1)-adrenergic receptor (beta(1)AR) is a G protein-coupled receptor (GPCR) and the predominant adrenergic receptor subtype in the heart, where it mediates cardiac contractility and the force of contraction. Although it is the most important target for beta(1)-adrenergic antagonists, such as beta(1)-blockers, relatively little is yet known about its regulation. We have shown previously that beta(1)AR undergoes constitutive and regulated N-terminal cleavage participating in receptor down-regulation and, moreover, that the receptor is modified by O-glycosylation. Here we demonstrate that the polypeptide GalNAc-transferase 2 (GalNAcT2) specifically O-glycosylates beta(1)AR at five residues in the extracellular N terminus, including the Ser-49 residue at the location of the common S49G single-nucleotide polymorphism. Using in vitro O-glycosylation and proteolytic cleavage assays, a cell line deficient in O-glycosylation, GalNAc-T-edited cell line model systems, and a GalNAc-T2 knock-out rat model, we show that GalNAc-T2 co-regulates the metalloproteinase-mediated limited proteolysis of beta(1)AR. Furthermore, we demonstrate that impaired O-glycosylation and enhanced proteolysis lead to attenuated receptor signaling, because the maximal response elicited by the beta(1)AR agonist isoproterenol and its potency in a cAMPaccumulation assay were decreased in HEK293 cells lacking GalNAc-T2. Our findings reveal, for the first time, aGPCRas a target for co-regulatory functions of site-specific O-glycosylation mediated by a unique GalNAc-T isoform. The results provide a new level of beta(1)AR regulation that may open up possibilities for new therapeutic strategies for cardiovascular diseases.	[Goth, Christoffer K.; Wang, Shengjun; Narimatsu, Yoshiki; Clausen, Henrik; Schjoldager, Katrine T.] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Tuhkanen, Hanna E.; Khan, Hamayun; Lackman, Jarkko J.; Petaja-Repo, Ulla E.] Univ Oulu, Res Unit Biomed, Med Res Ctr Oulu, POB 5000, FI-90014 Oulu, Finland; [Hansen, Lasse H.] Copenhagen Univ Hosp, Dept Clin Biochem, Rigshosp, DK-2100 Copenhagen O, Denmark; [Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of Copenhagen; University of Oulu; Rigshospitalet; University of Copenhagen; University of British Columbia; University of British Columbia	Schjoldager, KT (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.; Petaja-Repo, UE (corresponding author), Univ Oulu, Res Unit Biomed, Med Res Ctr Oulu, POB 5000, FI-90014 Oulu, Finland.	Schjoldager@sund.ku.dk; ulla.petaja-repo@oulu.fi	Petäjä-Repo, Ulla/AAV-6115-2021; clausen, henrik/AAD-8016-2021; Khan, Hamayun/GNO-9295-2022; Narimatsu, Yoshiki/G-8388-2019	Khan, Hamayun/0000-0001-6325-6255; Hansen, Lasse Holst/0000-0001-6517-0412; Clausen, Henrik/0000-0002-0915-5055; Goth, Christoffer/0000-0002-5766-1411; Lackman, Jarkko/0000-0002-0422-5157; Narimatsu, Yoshiki/0000-0003-1428-5695	Danish Research Councils; University of Copenhagen; Novo Nordisk Foundation; Danish National Research Foundation [DNRF107]; Neye Foundation; MRC Oulu and Magnus Ehrnrooth Foundation	Danish Research Councils(Det Frie Forskningsrad (DFF)); University of Copenhagen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation(Danmarks Grundforskningsfond); Neye Foundation; MRC Oulu and Magnus Ehrnrooth Foundation	This work was supported by the Danish Research Councils (including a Sapere Aude Research Talent Grant to K.T.S.), a program of excellence grant from the University of Copenhagen, the Novo Nordisk Foundation, Danish National Research Foundation Grant DNRF107 (to H.C.), the Neye Foundation (to C.G.), and the MRC Oulu and Magnus Ehrnrooth Foundation (to U.E.P.-R.).	Ahles A, 2014, PHARMACOL REV, V66, P598, DOI 10.1124/pr.113.008219; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; BRISTOW MR, 1989, MOL PHARMACOL, V35, P295; Cavalli M, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0183-x; Coleman JLJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1089; Couet J, 1996, J BIOL CHEM, V271, P4545; Dorn GW, 2009, MOL PHARMACOL, V76, P466, DOI 10.1124/mol.109.056572; Eckhard U, 2016, MATRIX BIOL, V49, P37, DOI 10.1016/j.matbio.2015.09.003; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Grantcharova E, 2002, J BIOL CHEM, V277, P43933, DOI 10.1074/jbc.M208407200; Hakalahti AE, 2013, MOL PHARMACOL, V83, P129, DOI 10.1124/mol.112.080440; Hakalahti AE, 2010, J BIOL CHEM, V285, P28850, DOI 10.1074/jbc.M110.149989; Halim A, 2013, J PROTEOME RES, V12, P573, DOI 10.1021/pr300963h; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Khetarpal SA, 2016, CELL METAB, V24, P234, DOI 10.1016/j.cmet.2016.07.012; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Klenk C, 2010, J BIOL CHEM, V285, P8665, DOI 10.1074/jbc.M109.058685; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; KRIEGER M, 1989, METHOD CELL BIOL, V32, P57; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Lackman JJ, 2014, J BIOL CHEM, V289, P17830, DOI 10.1074/jbc.M114.566273; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Levery SB, 2015, BBA-GEN SUBJECTS, V1850, P33, DOI 10.1016/j.bbagen.2014.09.026; Levin MC, 2002, J BIOL CHEM, V277, P30429, DOI 10.1074/jbc.M200681200; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Magrane J, 1999, FEBS LETT, V451, P56, DOI 10.1016/S0014-5793(99)00494-9; Maqbool A, 1999, LANCET, V353, P897, DOI 10.1016/S0140-6736(99)00549-8; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; Mattila SO, 2016, J CELL SCI, V129, P1366, DOI 10.1242/jcs.176115; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; Michineau S, 2006, BIOCHEMISTRY-US, V45, P2699, DOI 10.1021/bi051674v; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Monk KR, 2015, MOL PHARMACOL, V88, P617, DOI 10.1124/mol.115.098749; Osuala K, 2012, PHYSIOL GENOMICS, V44, P934, DOI 10.1152/physiolgenomics.00180.2011; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Rathz DA, 2002, J CARDIOVASC PHARM, V39, P155, DOI 10.1097/00005344-200202000-00001; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Sadeghi H, 1999, GLYCOBIOLOGY, V9, P731, DOI 10.1093/glycob/9.7.731; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Schlage P, 2015, MATRIX BIOL, V44-46, P232, DOI 10.1016/j.matbio.2015.01.003; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; van den Berg CW, 2012, IMMUNOBIOLOGY, V217, P935, DOI 10.1016/j.imbio.2012.01.005; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Yang Z, 2015, NAT BIOTECHNOL, V33, P842, DOI 10.1038/nbt.3280	60	27	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4714	4726		10.1074/jbc.M116.730614	http://dx.doi.org/10.1074/jbc.M116.730614			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28167537	hybrid, Green Published			2022-12-26	WOS:000397585100027
J	Naderipour, A; Zin, AAM; Bin Habibuddin, MH; Miveh, MR; Guerrero, JM				Naderipour, Amirreza; Zin, Abdullah Asuhaimi Mohd; Bin Habibuddin, Mohd Hafiz; Miveh, Mohammad Reza; Guerrero, Josep M.			An improved synchronous reference frame current control strategy for a photovoltaic grid-connected inverter under unbalanced and nonlinear load conditions	PLOS ONE			English	Article							POWER QUALITY; COMPENSATION; FILTERS	In recent years, renewable energy sources have been considered the most encouraging resources for grid and off-grid power generation. This paper presents an improved current control strategy for a three-phase photovoltaic grid-connected inverter (GCI) under unbalanced and nonlinear load conditions. It is challenging to suppress the harmonic content in the output current below a pre-set value in the GCI. It is also difficult to compensate for unbalanced loads even when the grid is under disruption due to total harmonic distortion (THD) and unbalanced loads. The primary advantage and objective of this method is to effectively compensate for the harmonic current content of the grid current and microgrid without the use of any compensation devices, such as active and passive filters. This method leads to a very low THD in both the GCI currents and the current exchanged with the grid. The control approach is designed to control the active and reactive power and harmonic current compensation, and it also corrects the system unbalance. The proposed control method features the synchronous reference frame (SRF) method. Simulation results are presented to demonstrate the effective performance of the proposed method.	[Naderipour, Amirreza; Zin, Abdullah Asuhaimi Mohd; Bin Habibuddin, Mohd Hafiz; Miveh, Mohammad Reza] Univ Teknol Malaysia, Fac Elect Engn, Utm Skudai, Johor, Malaysia; [Guerrero, Josep M.] Aalborg Univ, Inst Energy Technol, Aalborg, Denmark	Universiti Teknologi Malaysia; Aalborg University	Zin, AAM (corresponding author), Univ Teknol Malaysia, Fac Elect Engn, Utm Skudai, Johor, Malaysia.	abdullah@fke.utm.my	Guerrero, Josep M./D-5519-2014; Guerrero, Josep M./Y-2929-2019; Naderipour, Amirreza/ABD-1421-2020	Guerrero, Josep M./0000-0001-5236-4592; Naderipour, Amirreza/0000-0002-1466-1702; Habibuddin, Mohd Hafiz/0000-0002-5591-3072	Universiti Teknologi Malaysia (UTM) [15H65]; Ministry of Higher Education (MOHE)	Universiti Teknologi Malaysia (UTM); Ministry of Higher Education (MOHE)(Ministry of Higher Education & Scientific Research (MHESR))	The authors sincerely would like to express their appreciation to the Universiti Teknologi Malaysia (UTM) for supporting this work through GUP Grant (Vote No: 15H65) and Ministry of Higher Education (MOHE) for providing funds to carry out the research reported in this paper.r The authors sincerely would like to express their appreciation to the Universiti Teknologi Malaysia (UTM) for supporting this work through GUP Grant (Vote No: 15H65) and Ministry of Higher Education (MOHE) for providing funds to carry out the research reported in this paper. Furthermore, I would also like to thank Aalborg University, Aalborg East, Denmark, for their cooperation.	Abbes M, 2012, ELECTR POW SYST RES, V88, P52, DOI 10.1016/j.epsr.2012.01.018; Akagi H, 1996, IEEE T IND APPL, V32, P1312, DOI 10.1109/28.556633; Arruda LN, 2001, IEEE IND APPLIC SOC, P2655, DOI 10.1109/IAS.2001.955993; Blaabjerg F, 2006, IEEE T IND ELECTRON, V53, P1398, DOI 10.1109/TIE.2006.881997; Chen Z, 2005, IEEE T POWER DELIVER, V20, P1719, DOI 10.1109/TPWRD.2004.834349; Cordeschi N, 2013, COMPUT NETW, V57, P3479, DOI 10.1016/j.comnet.2013.08.002; Das JC, 2003, IEEE PULP P, P187, DOI 10.1109/PAPCON.2003.1216916; Dou H, 2016, PERS UBIQUIT COMPUT, V20, P681, DOI 10.1007/s00779-016-0941-9; Golovanov N, 2013, ENERGIES, V6, P634, DOI 10.3390/en6020634; Guerrero JM, 2009, IEEE T IND ELECTRON, V56, P726, DOI 10.1109/TIE.2008.2009274; Hamzeh M, 2014, IEEE T SMART GRID, V5, P167, DOI 10.1109/TSG.2013.2263842; Hamzeh M, 2012, IEEE T POWER SYST, V27, P2225, DOI 10.1109/TPWRS.2012.2193906; Hossain MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131279; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Humada AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152766; Jara AJ, 2015, 2015 IEEE 29TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS WORKSHOPS WAINA 2015, P668, DOI 10.1109/WAINA.2015.169; Jiang DD, 2016, IEEE INTERNET THINGS, V3, P1437, DOI 10.1109/JIOT.2016.2613111; Jou HL, 2008, IEEE T POWER ELECTR, V23, P2775, DOI 10.1109/TPEL.2008.2003015; Khunjar WO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044846; Naderipour A, 2016, ELECTRON WORLD, V122, P42; Ranjbar Mahmoud, 2011, 2011 2nd Power Electronics, Drive Systems & Technologies Conference (PEDSTC 2011), P111, DOI 10.1109/PEDSTC.2011.5742401; Salam Z., 2006, ELEKTR J ELECT ENG, V8, P17; Samrat NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130678; Savaghebi M, 2013, IEEE T IND ELECTRON, V60, P1390, DOI 10.1109/TIE.2012.2185914; Shi P, 2015, MIXED H INFINITY PAS; Shojafar M, 2015, IEEE INT CONF COMM, P1800, DOI 10.1109/ICCW.2015.7247442; Teodorescu R, 2004, IEEE T POWER ELECTR, V19, P1323, DOI 10.1109/TPEL.2004.833452; Timbus A, 2009, IEEE T POWER ELECTR, V24, P654, DOI 10.1109/TPEL.2009.2012527; Trinh Q-N, 2014, ENHANCED GRID CURREN; Twining E, 2003, IEEE T POWER ELECTR, V18, P888, DOI 10.1109/TPEL.2003.810838; Wei JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133725; Xu GB, 2016, SMART GRID: NETWORKING, DATA MANAGEMENT, AND BUSINESS MODELS, P73; Yang XY, 2015, SENSORS-BASEL, V15, P20799, DOI 10.3390/s150820799; Zhong QC, 2013, IEEE T IND ELECTRON, V60, P1344, DOI 10.1109/TIE.2012.2187415; Zin AAM, 2016, ELECT LETT IET	35	19	19	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0164856	10.1371/journal.pone.0164856	http://dx.doi.org/10.1371/journal.pone.0164856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192436	Green Published, gold			2022-12-26	WOS:000394423800001
J	Daude, E; Mazumdar, S; Solanki, V				Daude, Eric; Mazumdar, Sumit; Solanki, Vandana			Widespread fear of dengue transmission but poor practices of dengue prevention: A study in the slums of Delhi, India	PLOS ONE			English	Article							FEVER; AWARENESS; KNOWLEDGE	Background This study has been conducted to throw light on the knowledge and practices related to dengue fever among the poor population living in Delhi's slums. Materials A household survey was conducted in 2013 among 3,350 households. The households were stratified by a number of variables related to socio-economic status and health events such as hospitalisation. The data collection was completed through face-to-face interviews conducted with the help of 25 field investigators. Results About 8% of the households had at least one diagnosed dengue case. In comparison to the population surveyed, teenagers (15-19 years) and adults (30-34 years) were more affected whereas children under four years of age were underrepresented. Housewives are more affected by dengue (24%) compared to their share of the population surveyed (17%). Despite the fact that 77% of the respondents are worried about mosquitoes, only 43% of them monitor environment to avoid the presence of breeding sites. Conclusion One cannot exclude the possibility that though young children under the age of four years are exposed to the virus, either their cases were asymptomatic or family members infected during this period had potentially more serious symptoms leading to hospitalisation. This result could thus be explained by budget-related health choices made by this population which do not favour small children. Educational programs should target housewives to improve their impact, as they are the ones mostly responsible for water storage and cleanliness of the house and its neighbourhood. Even with a dengue experience and potentially an acute perception of the risk and its factors, a proper management of environmental conditions is lacking. This along with the fact that word-of-mouth is the main source of information quoted should be a message for municipality health workers to give door-to-door information on how to prevent breeding sites and dengue infection.	[Daude, Eric; Solanki, Vandana] Natl Ctr Sci Res, Ctr Social Sci & Humanities, Delhi, India; [Mazumdar, Sumit] Inst Publ Hlth, Kalyani, W Bengal, India		Daude, E (corresponding author), Natl Ctr Sci Res, Ctr Social Sci & Humanities, Delhi, India.	eric.daude@cnrs.fr	Daude, Eric/P-4133-2014	Daude, Eric/0000-0001-8656-3346	Center for Social Sciences and Humanities; Extra-muralgrants of the Indian Council for Medical Research, Social and Behavioural Research	Center for Social Sciences and Humanities; Extra-muralgrants of the Indian Council for Medical Research, Social and Behavioural Research	The study, data collection and analysis was part of a larger project supported under the 'Extra-muralgrants of the Indian Council for Medical Research, Social and Behavioural Research'. The preparation of manuscript was supported by the Center for Social Sciences and Humanities.	Acharya Anita, 2005, Journal of Vector Borne Diseases, V42, P122; Afreen N, 2014, PLOS CURRENTS OUTBRE; BALAYA S, 1969, INDIAN J MED RES, V57, P767; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Castro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081875; Chakravarti A, 2012, T ROY SOC TROP MED H, V106, P273, DOI 10.1016/j.trstmh.2011.12.007; Chen LH, 2008, MED CLIN N AM, V92, P1409, DOI 10.1016/j.mcna.2008.07.005; Chinnakali P, 2012, N AM J MED SCI, V4, P278, DOI 10.4103/1947-2714.97210; Dar L, 1999, EMERG INFECT DIS, V5, P589, DOI 10.3201/eid0504.990427; Diesh P, 1972, J COMMUN DIS, V4, P8; Eric Daude, 2016, Economic and Political Weekly, V51, P77; Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Hairi Farizah, 2003, Asia Pac J Public Health, V15, P37, DOI 10.1177/101053950301500107; Itrat A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002620; KABRA SK, 1992, B WORLD HEALTH ORGAN, V70, P105; Kumari R, 2011, TROP MED INT HEALTH, V16, P949, DOI 10.1111/j.1365-3156.2011.02789.x; Mazumdar S, 2014, EQUITY IMPACTS TARGE; Pandey A, 2007, J CLIN VIROL, V40, P87, DOI 10.1016/j.jcv.2007.05.011; Rao C, 1985, INDIAN J MED RES, V82, P271; Scheper-Hughes Nancy, 1993, DEATH WEEPING VIOLEN; Singh N. P., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1174; Singh R. K., 2011, Dengue Bulletin, V35, P131; Spiegel Jerry, 2005, EcoHealth, V2, P273, DOI 10.1007/s10393-005-8388-x; Telle O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146539; van Benthem BHB, 2002, TROP MED INT HEALTH, V7, P993, DOI 10.1046/j.1365-3156.2002.00950.x; Vikram Kumar, 2015, International Journal of Mosquito Research, V2, P83; Vikram K, 2016, ACTA TROP, V153, P21, DOI 10.1016/j.actatropica.2015.09.025; World Health Organization (WHO), 2012, GLOB STRAT DENG PREV	29	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171543	10.1371/journal.pone.0171543	http://dx.doi.org/10.1371/journal.pone.0171543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187147	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000394244300029
J	de Jong, M; Cranendonk, A; Twisk, JWR; van Weissenbruch, MM				de Jong, Miranda; Cranendonk, Anneke; Twisk, Jos W. R.; van Weissenbruch, Mirjam M.			IGF-I and relation to growth in infancy and early childhood in very-low-birth-weight infants and term born infants	PLOS ONE			English	Article							PREMATURE-INFANTS; PRETERM INFANTS; METABOLIC SYNDROME; INSULIN; LEPTIN; RETINOPATHY; COMPONENTS	Background In very-low-birth-weight infants IGF-I plays an important role in postnatal growth restriction and is probably also involved in growth restriction in childhood. We compared IGF-I and its relation to growth in early childhood in very-low-birth-weight infants and term appropriate for gestational age born infants. Methods We included 41 very-low-birth-weight and 64 term infants. Anthropometry was performed at all visits to the outpatient clinic. IGF-I and insulin were measured in blood samples taken at 6 months and 2 years corrected age (very-low-birth-weight children) and at 3 months, 1 and 2 years (term children). Results Over the first 2 years of life growth parameters are lower in very-low-birth-weight children compared to term children, but the difference in length decreases significantly. During the first 2 years of life IGF-I is higher in very-low-birth-weight children compared to term children. In both groups there is a significant relationship between IGF-I and (change in) length and weight over the first 2 years of life and between insulin and change in total body fat. Conclusions Considering the relation of IGF-I to growth and the decrease in difference in length, higher IGF-I levels in very-low-birth-weight infants in early childhood probably have an important role in catch-up growth in length.	[de Jong, Miranda] Albert Schweitzer Hosp, Dept Pediat, Dordrecht, Netherlands; [Cranendonk, Anneke; van Weissenbruch, Mirjam M.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Div Neonatol, Amsterdam, Netherlands; [Twisk, Jos W. R.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands	Albert Schweitzer Ziekenhuis; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Weissenbruch, MM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Div Neonatol, Amsterdam, Netherlands.	m.vanweissenbruch@vumc.nl		van Weissenbruch, Mirjam M/0000-0002-8086-9552				Beardsall K, 2008, NEW ENGL J MED, V359, P1873, DOI 10.1056/NEJMoa0803725; Cutfield WS, 2004, GROWTH HORM IGF RES, V14, pS130, DOI 10.1016/j.ghir.2004.03.028; DAUNCEY MJ, 1977, ARCH DIS CHILD, V52, P223, DOI 10.1136/adc.52.3.223; de Jong M, 2015, PEDIATR RES, V78, P476, DOI 10.1038/pr.2015.128; de Jong M, 2015, PEDIATR RES, V78, P457, DOI 10.1038/pr.2015.118; de Jong M, 2014, HORM RES PAEDIAT, V81, P43, DOI 10.1159/000355597; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Hansen-Pupp I, 2011, J CLIN ENDOCR METAB, V96, P1129, DOI 10.1210/jc.2010-2440; Hansen-Pupp I, 2011, PEDIATR RES, V69, P448, DOI 10.1203/PDR.0b013e3182115000; Hikino S, 2001, PEDIATR RES, V50, P732, DOI 10.1203/00006450-200112000-00017; Kajantie E, 2002, J CLIN ENDOCR METAB, V87, P2171, DOI 10.1210/jc.87.5.2171; Kistner A, 2014, ACTA PAEDIATR, V103, P1198, DOI 10.1111/apa.12751; Kwinta P, 2011, J PEDIATR ENDOCR MET, V24, P651, DOI 10.1515/JPEM.2011.264; LINEHAM JD, 1986, EARLY HUM DEV, V13, P37, DOI 10.1016/0378-3782(86)90096-4; Lo HC, 2005, JPEN-PARENTER ENTER, V29, P87, DOI 10.1177/014860710502900287; Lofqvist C, 2006, PEDIATRICS, V117, P1930, DOI 10.1542/peds.2005-1926; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; Ohkawa N, 2010, ACTA PAEDIATR, V99, P37, DOI 10.1111/j.1651-2227.2009.01516.x; Okuma C, 2013, HORM RES PAEDIAT, V79, P197, DOI 10.1159/000348517; Patel L, 2007, PEDIATR RES, V61, P99, DOI 10.1203/01.pdr.0000250036.34522.f1; POLLACK RN, 1992, CLIN OBSTET GYNECOL, V35, P99, DOI 10.1097/00003081-199203000-00015; RAJARAM S, 1995, PEDIATR RES, V37, P581, DOI 10.1203/00006450-199505000-00004; Tjoa ML, 2003, J REPROD IMMUNOL, V59, P29, DOI 10.1016/S0165-0378(02)00085-2; van de Lagemaat M, 2013, HORM RES PAEDIAT, V80, P92, DOI 10.1159/000351710	25	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171650	10.1371/journal.pone.0171650	http://dx.doi.org/10.1371/journal.pone.0171650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182752	Green Published, gold			2022-12-26	WOS:000394231800085
J	Hromadnikova, I; Kotlabova, K; Ivankova, K; Krofta, L				Hromadnikova, Ilona; Kotlabova, Katerina; Ivankova, Katarina; Krofta, Ladislav			First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR	PLOS ONE			English	Article							PLACENTA-SPECIFIC MICRORNAS; HUMAN CHORIONIC-GONADOTROPIN; PREGNANCY-ASSOCIATED MICRORNAS; EXPRESSION PROFILES; PLASMA-PROTEIN; MATERNAL CIRCULATION; GROWTH RESTRICTION; MESSENGER-RNA; CELL MICRORNA; PAPP-A	Objectives A nested case control study of a longitudinal cohort comparing pregnant women enrolled at 10 to 13 gestational weeks was carried out to evaluate risk assessment for preeclampsia and IUGR based on circulating placental specific C19MC microRNAs in early pregnancy. Methods The expression of placental specific C19MC microRNAs (miR-516b-5p, miR-517-5p, miR-518b, miR-520a-5p, miR-520h, and miR-525-5p) was determined in plasma samples from pregnancies that subsequently developed preeclampsia (n = 21), IUGR (n = 18), and 58 normal pregnancies using real-time PCR and comparative Ct method relative to synthetic Caenorhabditis elegans microRNA (cel-miR-39). Results Circulating C19MC microRNAs were up-regulated (miR-517-5p, p = 0.005; miR-518b, p = 0.013; miR-520h, p = 0.021) or showed a trend toward up-regulation in patients destined to develop preeclampsia (miR-520a-5p, p = 0.067; miR-525-5p, p = 0.073). MiR-517-5p had the best predictive performance for preeclampsia with a sensitivity of 42.9%, a specificity of 86.2%, a PPV of 52.9% and a NPV of 80.6%. The combination of all examined circulating C19MC microRNAs had no advantage over using only the miR-517-5p biomarker to predict the occurrence of preeclampsia (a sensitivity of 20.6%, a specificity of 90.8%, a PPV of 44.8%, and a NPV of 76.0%). Conclusions Up-regulation of miR-517-5p, miR-518b and miR-520h was associated with a risk of later development of preeclampsia. First trimester screening of extracellular miR-517-5p identified a proportion of women with subsequent preeclampsia. No circulating C19MC microRNA biomarkers were identified that could predict later occurrence of IUGR.	[Hromadnikova, Ilona; Kotlabova, Katerina] Charles Univ Prague, Fac Med 3, Dept Mol Biol & Cell Pathol, Prague, Czech Republic; [Ivankova, Katarina; Krofta, Ladislav] Charles Univ Prague, Fac Med 3, Inst Care Mother & Child, Prague, Czech Republic	Charles University Prague; Charles University Prague	Hromadnikova, I (corresponding author), Charles Univ Prague, Fac Med 3, Dept Mol Biol & Cell Pathol, Prague, Czech Republic.	Ilona.Hromadnikova@lf3.cuni.cz	Hromadnikova, Ilona/E-1957-2017; Ivánková, Katarína/GYE-0290-2022	Hromadnikova, Ilona/0000-0002-4396-3304; Kotlabova, Katerina/0000-0002-8824-4653	Charles University research program PRVOUKP32 and PROGRES Q34	Charles University research program PRVOUKP32 and PROGRES Q34	Work was supported by the Charles University research program PRVOUKP32 and PROGRES Q34.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manus cript	[Anonymous], 2002, OBSTET GYNECOL, V99, P159; ARBEILLE P, 1988, EUR J OBSTET GYN R B, V29, P261, DOI 10.1016/0028-2243(88)90066-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bortolin-Cavaille ML, 2009, NUCLEIC ACIDS RES, V37, P3464, DOI 10.1093/nar/gkp205; Canini S, 2008, FERTIL STERIL, V89, P174, DOI 10.1016/j.fertnstert.2007.02.024; Chambers AE, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-113; Chang YW, 2014, ANN SURG ONCOL, V21, pS687, DOI 10.1245/s10434-014-3812-5; Cheng N, 2002, CYTOKINE GROWTH F R, V13, P75, DOI 10.1016/S1359-6101(01)00031-4; Cnattingius S, 2004, AM J MED GENET A, V130A, P365, DOI 10.1002/ajmg.a.30257; Crovetto F, 2016, ULTRASOUND OBSTET GY; DiFederico E, 1999, AM J PATHOL, V155, P293, DOI 10.1016/S0002-9440(10)65123-1; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Flor I, 2012, BIOCHEM BIOPH RES CO, V422, P411, DOI 10.1016/j.bbrc.2012.05.004; Frische EW, 2010, DEV BIOL, V340, P1, DOI 10.1016/j.ydbio.2009.12.043; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gu Y, 2013, AM J PHYSIOL-ENDOC M, V304, pE836, DOI 10.1152/ajpendo.00660.2012; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Higashijima A, 2013, PRENATAL DIAG, V33, P214, DOI 10.1002/pd.4045; Hromadnikova I, 2016, THROMB RES, V137, P126, DOI 10.1016/j.thromres.2015.11.032; Hromadnikova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113735; Hromadnikova I, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/186041; Hromadnikova I, 2012, DNA CELL BIOL, V31, P1221, DOI 10.1089/dna.2011.1530; Hromadnikova I, 2012, J MOL DIAGN, V14, P160, DOI 10.1016/j.jmoldx.2011.11.003; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huppertz B, 2004, J SOC GYNECOL INVEST, V11, P353, DOI 10.1016/j.jsgi.2004.06.002; Huppertz Berthold, 2014, Pregnancy Hypertens, V4, P244, DOI [10.1016/j.preghy.2014.04.015, 10.1016/j.preghy.2014.04.016]; Ishibashi O, 2012, HYPERTENSION, V59, P265, DOI 10.1161/HYPERTENSIONAHA.111.180232; Karahasanovic A, 2014, CLIN CHEM LAB MED, V52, P521, DOI 10.1515/cclm-2013-0338; Keung MH, 2016, J GINSENG RES, V40, P151, DOI 10.1016/j.jgr.2015.07.002; Kotlabova K, 2011, J REPROD IMMUNOL, V89, P185, DOI 10.1016/j.jri.2011.02.006; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leslie K, 2011, BEST PRACT RES CL OB, V25, P343, DOI 10.1016/j.bpobgyn.2011.01.002; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Luque A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04882; Merkerova M, 2010, STEM CELLS DEV, V19, P17, DOI 10.1089/scd.2009.0071; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Morales-Prieto DM, 2012, PLACENTA, V33, P725, DOI 10.1016/j.placenta.2012.05.009; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Nelson DM, 1996, PLACENTA, V17, P387, DOI 10.1016/S0143-4004(96)90019-3; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Ong CYT, 2000, BRIT J OBSTET GYNAEC, V107, P1265, DOI 10.1111/j.1471-0528.2000.tb11618.x; Orozco AE, 2006, ANN NY ACAD SCI, V1075, P57, DOI 10.1196/annals.1368.007; Oudejans CBM, 2003, PRENATAL DIAG, V23, P111, DOI 10.1002/pd.539; Ouyang Y, 2014, PLACENTA, V35, pS69, DOI 10.1016/j.placenta.2013.11.002; Pihl K, 2009, PRENATAL DIAG, V29, P1256, DOI 10.1002/pd.2408; Poon LC, 2014, PRENATAL DIAG, V34, P618, DOI 10.1002/pd.4397; Portilho DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116853; Reddy A, 2008, PLACENTA, V29, P942, DOI 10.1016/j.placenta.2008.08.018; Ribeiro-Neto F, 2002, P NATL ACAD SCI USA, V99, P5418, DOI 10.1073/pnas.082122499; Rippe V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009485; Rubin JB, 2009, SEMIN CANCER BIOL, V19, P116, DOI 10.1016/j.semcancer.2008.10.001; Scazzocchio E, 2016, ULTRASOUND OBSTET GY; Sedlackova L, 2011, SCAND J RHEUMATOL, V40, P354, DOI 10.3109/03009742.2011.552522; Sedlackova L, 2011, TUMOR BIOL, V32, P33, DOI 10.1007/s13277-010-0088-7; Smith GCS, 2002, J CLIN ENDOCR METAB, V87, P1762, DOI 10.1210/jc.87.4.1762; Spencer K, 2007, ULTRASOUND OBST GYN, V29, P128, DOI 10.1002/uog.3876; Spencer K, 2008, PRENATAL DIAG, V28, P7, DOI 10.1002/pd.1890; Su CM, 2016, ONCOGENE, V35, P1134, DOI 10.1038/onc.2015.168; Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thompson LP, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.142273; Ura B, 2014, TAIWAN J OBSTET GYNE, V53, P232, DOI 10.1016/j.tjog.2014.03.001; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; VYAS S, 1990, BRIT J OBSTET GYNAEC, V97, P797, DOI 10.1111/j.1471-0528.1990.tb02573.x; Wang D, 2012, AUST NZ J OBSTET GYN, V52, P565, DOI 10.1111/j.1479-828X.2012.01481.x; Wang F, 2010, BRIT J CANCER, V103, P567, DOI 10.1038/sj.bjc.6605724; Whitley GSJ, 2007, AM J PATHOL, V170, P1903, DOI 10.2353/ajpath.2007.070006; Winger EE, 2015, J REPROD IMMUNOL, V110, P22, DOI 10.1016/j.jri.2015.03.005; Winger EE, 2014, AM J REPROD IMMUNOL, V72, P515, DOI 10.1111/aji.12287; Wortelboer EJ, 2010, BJOG-INT J OBSTET GY, V117, P1384, DOI 10.1111/j.1471-0528.2010.02690.x; Xu P, 2014, HYPERTENSION, V63, P1276, DOI 10.1161/HYPERTENSIONAHA.113.02647; Yliniemi A, 2015, CLIN MED INSIGHTS-RE, V9, P13, DOI 10.4137/CMRH.S21865; Zhang MX, 2012, FEBS LETT, V586, P3508, DOI 10.1016/j.febslet.2012.08.007; Zhang R, 2008, MOL BIOL EVOL, V25, P1493, DOI 10.1093/molbev/msn094	89	71	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171756	10.1371/journal.pone.0171756	http://dx.doi.org/10.1371/journal.pone.0171756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182660	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800101
J	Akilimali, PZ; Musumari, PM; Kashala-Abotnes, E; Kayembe, PK; Lepira, FB; Mutombo, PB; Tylleskar, T; Ali, MM				Akilimali, Pierre Zalagile; Musumari, Patou Masika; Kashala-Abotnes, Esperance; Kayembe, Patrick Kalambayi; Lepira, Francois B.; Mutombo, Paulin Beya; Tylleskar, Thorkild; Ali, Mapatano Mala			Disclosure of HIV status and its impact on the loss in the follow-up of HIV-infected patients on potent anti-retroviral therapy programs in a (post-) conflict setting: A retrospective cohort study from Goma, Democratic Republic of Congo	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOUTH-AFRICA; ADHERENCE; CHILDREN; REASONS; CONTEXT; KISUMU; UGANDA; YOUTH; CARE	Background The study aimed to identify the impact of non-disclosure of HIV status on the loss to follow-up (LTFU) of patients receiving anti-retroviral therapy. Methodology A historic cohort of HIV patients from 2 major hospitals in Goma, Democratic Republic of Congo was followed from 2004 to 2012. LTFU was defined as not taking an ART refill for a period of 3 months or longer since the last attendance, and had not yet been classified as 'dead' or 'transferred-out'. Kaplan-Meier plots were used to determine the probability of LTFU as a function of time as inclusive of the cohort. The log-rank test was used to compare survival curves based on determinants. Cox proportional hazard modeling was used to measure predictors of LTFU from the time of treatment induction until December 15th, 2012 (the end-point). Results The median follow-up time was 3.99 years (IQR = 2.33 to 5.59). Seventy percent of patients had shared their HIV status with others (95% CI: 66.3-73.1). The proportion of LTFU was 12% (95% CI: 9.6-14.4). Patients who did not share their HIV status (Adjusted HR 2.28, 95% CI 1.46-2.29), patients who did not live in the city of Goma (Adjusted HR 1.97, 95% CI 1.02-3.77), and those who attained secondary or higher education level (Adjusted HR 1.60, 95% CI 1.02-2.53) had a higher hazard of being LTFU. Conclusion This study shows the relationship between the non-disclosure HIV status and LTFU. Healthcare workers in similar settings should pay more attention to clients who have not disclosed their HIV status, and to those living far from health settings where they receive medication.	[Akilimali, Pierre Zalagile; Kayembe, Patrick Kalambayi; Mutombo, Paulin Beya; Ali, Mapatano Mala] Univ Kinshasa, Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Musumari, Patou Masika] Kyoto Univ, Dept Global Hlth & Socioepidemiol, Sch Publ Hlth, Kyoto, Japan; [Kashala-Abotnes, Esperance; Tylleskar, Thorkild] Univ Bergen, Ctr Int Hlth, Dept Global Hlth & Primary Care, Bergen, Norway; [Lepira, Francois B.] Univ Kinshasa, Dept Internal Med, Kinshasa, DEM REP CONGO	Universite de Kinshasa; Kyoto University; University of Bergen; Universite de Kinshasa	Akilimali, PZ (corresponding author), Univ Kinshasa, Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO.	pierretulanefp@gmail.com	Akilimali, Pierre Z/D-2564-2018; Tylleskär, Thorkild/S-5529-2017	Akilimali, Pierre Z/0000-0002-3828-6214; Tylleskär, Thorkild/0000-0003-4801-4324				Ager A, 2008, J REFUG STUD, V21, P166, DOI 10.1093/jrs/fen016; Alvarez-Uria G, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21682; Aspler A, 2008, INT J TUBERC LUNG D, V12, P928; Berheto TM, 2014, N AM J MED SCI, V6, P453, DOI 10.4103/1947-2714.141636; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Bird K, 2010, J INT DEV, V22, P1183, DOI 10.1002/jid.1754; Bott S, 2013, SAHARA J-J SOC ASP H, V10, pS5, DOI 10.1080/02664763.2012.755319; Daftary A, 2007, AIDS CARE, V19, P572, DOI 10.1080/09540120701203931; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Dessalegn M., 2014, J AIDS HIV RES, V7, P1; Haberer JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018505; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Kenneth Mugisha, 2009, RETENTION HIV POSITI; Kyaddondo D, 2013, SAHARA J-J SOC ASP H, V10, pS37, DOI 10.1080/02664763.2012.755323; Mathews C, 1999, S AFR MED J, V89, P1238; Mberi MN, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0912-2; McIvor Murray S, 2015, J INTERPERS VIOLENCE, P1; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P297; Meloni ST, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu055; Mulanga C, 2004, AIDS, V18, P832, DOI 10.1097/00002030-200403260-00024; Musumari PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085327; Musumari PM, 2013, AIDS CARE PSYCHOL SO; Ndiaye C, 2008, World Health Popul, V10, P43; Ojwang' VO, 2016, AIDS CARE, V28, P500, DOI 10.1080/09540121.2015.1110234; Ojwang VO, 2015, AIDS CARE; Opuni M, 2010, AIDS BEHAV, V14, P807, DOI 10.1007/s10461-009-9584-4; Porter L, 2004, DEMOGRAPHY, V41, P465, DOI 10.1353/dem.2004.0025; [Republique Democratique du congo Ministere de la Sante], 2005, PROGR NAT LUTT CONTR; Seid Mohammed, 2012, Afr J Reprod Health, V16, P97; Simbayi LC, 2007, SEX TRANSM INFECT, V83, P29, DOI 10.1136/sti.2006.019893; Smith R, 2008, AIDS CARE, V20, P1266, DOI 10.1080/09540120801926977; Ssali SN, 2010, AIDS PATIENT CARE ST, V24, P675, DOI 10.1089/apc.2010.0062; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Tadesse K, 2014, J AIDS CLIN RES, V5, P12; Tang WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115691; Wolf HT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1154; World Health Organization, 2006, ANT THER HIV INF AD	37	24	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171407	10.1371/journal.pone.0171407	http://dx.doi.org/10.1371/journal.pone.0171407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1SG	28170410	Green Published, gold, Green Accepted			2022-12-26	WOS:000393705500037
J	Orenstein, EW; Orenstein, LAV; Diarra, K; Djiteye, M; Sidibe, D; Haidara, FC; Doumbia, MF; Diallo, F; Coulibaly, F; Keita, AM; Onwuchekwa, U; Teguete, I; Tapia, MD; Sow, SO; Levine, MM; Rheingans, R				Orenstein, Evan W.; Orenstein, Lauren A. V.; Diarra, Kounandji; Djiteye, Mahamane; Sidibe, Diakaridia; Haidara, Fadima C.; Doumbia, Moussa F.; Diallo, Fatoumata; Coulibaly, Flanon; Keita, Adama M.; Onwuchekwa, Uma; Teguete, Ibrahima; Tapia, Milagritos D.; Sow, Samba O.; Levine, Myron M.; Rheingans, Richard			Cost-effectiveness of maternal influenza immunization in Bamako, Mali: A decision analysis	PLOS ONE			English	Article							SEASONAL INFLUENZA; PREGNANT-WOMEN; OUTPATIENT VISITS; ECONOMIC BURDEN; HOSPITALIZATIONS; VACCINATION; AFRICA; IMPACT	Background Maternal influenza immunization has gained traction as a strategy to diminish maternal and neonatal mortality. However, efforts to vaccinate pregnant women against influenza in developing countries will require substantial investment. We present cost-effectiveness estimates of maternal influenza immunization based on clinical trial data from Bamako, Mali. Methods We parameterized a decision-tree model using prospectively collected trial data on influenza incidence, vaccine efficacy, and direct and indirect influenza-related healthcare expenditures. Since clinical trial participants likely had better access to care than the general Malian population, we also simulated scenarios with poor access to care, including decreased healthcare resource utilization and worse influenza-related outcomes. Results Under base-case assumptions, a maternal influenza immunization program in Mali would cost $857 (95% UI: $188-$2358) per disability-adjusted life year (DALY) saved. Adjusting for poor access to care yielded a cost-effectiveness ratio of $486 (95% UI: $105-$1425) per DALY saved. Cost-effectiveness ratios were most sensitive to changes in the cost of a maternal vaccination program and to the proportion of laboratory-confirmed influenza among infants warranting hospitalization. Mean cost-effectiveness estimates fell below Mali's GDP per capita when the cost per pregnant woman vaccinated was $1.00 or less with no adjustment for access to care or $1.67 for those with poor access to care. Healthcare expenditures for lab-confirmed influenza were not significantly different than the cost of influenza-like illness. Conclusions Maternal influenza immunization in Mali would be cost-effective in most settings if vaccine can be obtained, managed, and administered for <=$1.00 per pregnant woman.	[Orenstein, Evan W.; Orenstein, Lauren A. V.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Orenstein, Evan W.; Orenstein, Lauren A. V.; Diarra, Kounandji; Djiteye, Mahamane; Sidibe, Diakaridia; Haidara, Fadima C.; Doumbia, Moussa F.; Diallo, Fatoumata; Coulibaly, Flanon; Keita, Adama M.; Onwuchekwa, Uma; Sow, Samba O.] Ctr Dev Vaccins Mali CVD Mali, Bamako, Mali; [Teguete, Ibrahima] Gabriel Toure Teaching Hosp, Dept Obstet & Gynecol, Bamako, Mali; [Tapia, Milagritos D.; Sow, Samba O.; Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Rheingans, Richard] Univ Florida, Dept Environm & Global Hlth, Gainesville, FL USA; [Orenstein, Evan W.] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Orenstein, Lauren A. V.] Hosp Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Rheingans, Richard] Appalachian State Univ, Dept Sustainable Dev, Boone, NC 28608 USA	Emory University; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of North Carolina; Appalachian State University	Orenstein, EW (corresponding author), Emory Univ, Sch Med, Atlanta, GA 30322 USA.; Orenstein, EW (corresponding author), Ctr Dev Vaccins Mali CVD Mali, Bamako, Mali.; Orenstein, EW (corresponding author), Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA.	Orenstein.Evan@gmail.com	Rheingans, Richard D/P-1638-2017; Orenstein, Evan/CAH-5618-2022; Orenstein, Evan/ABG-3276-2021	Orenstein, Evan/0000-0003-3756-8575	Bill & Melinda Gates Foundation [OPP1002744]; American Society of Tropical Medicine & Hygiene Benjamin Kean Fellowship; Infectious Diseases Society of America Medical Scholars program; Emory University Global Health Institute Field Scholars program; Alpha Omega Alpha Carolyn Kuckein Student Research Award	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); American Society of Tropical Medicine & Hygiene Benjamin Kean Fellowship; Infectious Diseases Society of America Medical Scholars program; Emory University Global Health Institute Field Scholars program; Alpha Omega Alpha Carolyn Kuckein Student Research Award	The clinical trial and participation of all authors was supported by the Bill & Melinda Gates Foundation (grant OPP1002744). Evan Orenstein's participation was supported by the American Society of Tropical Medicine & Hygiene Benjamin Kean Fellowship, the Infectious Diseases Society of America Medical Scholars program, and the Emory University Global Health Institute Field Scholars program. Lauren Orenstein's participation was supported by the Alpha Omega Alpha Carolyn Kuckein Student Research Award, the Infectious Diseases Society of America Medical Scholars program, and the Emory University Global Health Institute Field Scholars program. The funding sources had no role in data collection, analysis, interpretation, design, or writing of this manuscript.; The authors thank the study and local health center personnel and study participants who made this work possible. In addition to the support of the Bill & Melinda Gates Foundation, Evan Orenstein's participation was supported by the American Society of Tropical Medicine & Hygiene Benjamin Kean Fellowship, the Infectious Diseases Society of America Medical Scholars program, and the Emory University Global Health Institute Field Scholars program. Lauren Orenstein's participation was also supported by the Alpha Omega Alpha Carolyn Kuckein Student Research Award, the Infectious Diseases Society of America Medical Scholars program, and the Emory University Global Health Institute Field Scholars program.	[Anonymous], INFLUENZA OTHER RESP; Beigi RH, 2009, CLIN INFECT DIS, V49, P1784, DOI 10.1086/649013; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Bhuiyan MU, 2014, INFLUENZA OTHER RESP, V8, P406, DOI 10.1111/irv.12254; Cohen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118884; Dao CN, 2010, J INFECT DIS, V202, P881, DOI 10.1086/655904; de Francisco N, 2015, VACCINE, V33, P6537, DOI 10.1016/j.vaccine.2015.10.066; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Eick AA, 2011, ARCH PEDIATR ADOLESC, V165; Fell D, 2016, BJOG INT J OBSTET GY; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Griffiths UK, 2004, B WORLD HEALTH ORGAN, V82, P643; Healy CM, 2007, PEDIATR INFECT DIS J, V26, P945, DOI 10.1097/INF.0b013e318156c18c; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jit M, 2010, VACCINE, V29, P115, DOI 10.1016/j.vaccine.2010.08.078; Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480; Matias G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3128-4; Mosby LG, 2011, AM J OBSTET GYNECOL, V205, P10, DOI 10.1016/j.ajog.2010.12.033; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Myers ER, 2011, AM J OBSTET GYNECOL, V204, pS128, DOI 10.1016/j.ajog.2011.04.009; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nunes MC, 2015, HUM VACC IMMUNOTHER, V11, P2538, DOI 10.1080/21645515.2015.1059976; Omer SB, 2015, VACCINE, V33, P3801, DOI 10.1016/j.vaccine.2015.05.077; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Poehling KA, 2011, AM J OBSTET GYNECOL, V204, pS141, DOI 10.1016/j.ajog.2011.02.042; Roper MH, 2007, LANCET, V370, P1947, DOI 10.1016/S0140-6736(07)61261-6; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034; Tapia MD, 2016, LANCET INFECT DIS; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	34	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171499	10.1371/journal.pone.0171499	http://dx.doi.org/10.1371/journal.pone.0171499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170416	Green Submitted, Green Published, gold			2022-12-26	WOS:000393705500041
J	Clements, CS; Hay, ME				Clements, Cody S.; Hay, Mark E.			Size matters: Predator outbreaks threaten foundation species in small Marine Protected Areas	PLOS ONE			English	Article							OF-THORNS STARFISH; CORAL-REEF MANAGEMENT; ACANTHASTER-PLANCI L; GREAT-BARRIER-REEF; L ECHINODERMATA; RESERVES; CONSERVATION; ASTEROIDEA; AGGREGATIONS; MESOPREDATOR	The unanticipated impacts of consumers in fragmented habitats are frequently a challenge for ecosystem management. On Indo-Pacific coral reefs, crown-of-thorns sea stars (Acanthaster spp.) are coral predators whose outbreaks cause precipitous coral decline. Across large spatial scales, Acanthaster densities are lower in large no-take Marine Protected Areas (MPAs) and reefs subject to limited human exploitation. However, using a combination of observational and manipulative experiments, we found that Acanthaster densities within a network of small, no-take MPAs on reef flats in Fiji were similar to 2-3.4 times greater inside MPAs than in adjacent fished areas an similar to 2-2.5 times greater than the upper threshold density indicative of an outbreak. This appeared to result from selective Acanthaster migration to the coral-rich MPAs from fished areas that are coral-poor and dominated by macroalgae. Small MPAs can dramatically increase the cover of foundation species like corals, but may selectively attract coral predators like Acanthaster due to greater food densities within MPAs or because the MPAs are too small to support Acanthaster enemies. As coral cover increases, their chemical and visual cues may concentrate Acanthasterto outbreak densities that cause coral demise, compromising the value of small MPAs. An understanding of predator dynamics as a function of habitat type, size, and fragmentation needs to be incorporated into MPA design and management.	[Clements, Cody S.; Hay, Mark E.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Hay, ME (corresponding author), Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.	mark.hay@biology.gatech.edu	Hay, Mark E/D-9752-2011	Hay, Mark E/0000-0002-6130-9349	NSF [OCE-0929119]; NIH ICBG [U19TW007401]; Teasley Endowment; FOGARTY INTERNATIONAL CENTER [U19TW007401] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH ICBG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Teasley Endowment; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Financial support provided by NSF grant OCE-0929119, NIH ICBG grant U19TW007401, and the Teasley Endowment to the Georgia Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2015, GLOBAL CHANGE BIOL, V21, P48, DOI 10.1111/gcb.12700; BARNES DS, 1970, NATURE, V228, P342, DOI 10.1038/228342a0; BIRKELAND C, 1990, MAJOR MANAGEMENT PRO; Bonaldo RM, PLOS ONE IN PRESS; Bonaldo RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085786; Bonito V, 2014, NA09NOS4630017 NOAA; Brashares Justin S., 2010, P221; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Christianen M.J.A., 2014, P R SOC B, V281, P1777; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Clements C, 2012, MAR ECOL PROG SER, V449, P233, DOI 10.3354/meps09554; Clements CS, 2015, P ROY SOC B-BIOL SCI, V282, P221, DOI 10.1098/rspb.2015.0714; Costello MJ, 2015, TRENDS ECOL EVOL, V30, P507, DOI 10.1016/j.tree.2015.06.011; Cowan ZL, 2016, CORAL REEFS, V35, P1253, DOI 10.1007/s00338-016-1491-3; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; DANA TF, 1972, PAC SCI, V26, P355; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DUBLIN HT, 1990, J ANIM ECOL, V59, P1147, DOI 10.2307/5037; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Engelhardt U., 1999, 30 CRC REEF RES CTR; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FERLIN V, 1973, HELGOLAND WISS MEER, V24, P151, DOI 10.1007/BF01609507; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18286, DOI 10.1073/pnas.0906473107; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Goodwin BJ, 1999, OIKOS, V84, P160, DOI 10.2307/3546877; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jupiter Stacy D., 2014, Pacific Conservation Biology, V20, P165; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Kenyon JC, 2009, B MAR SCI, V84, P199; Landman M, 2014, ECOL APPL, V24, P2002, DOI 10.1890/14-0080.1; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lubchenco J, 2003, ECOL APPL, V13, pS3; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; MORAN PJ, 1992, MAR BIOL, V113, P509, DOI 10.1007/BF00349178; Moutardier G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137605; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Ohgushi T, 2012, TRAIT MEDIATED INDIR; ORMOND RFG, 1973, NATURE, V246, P167, DOI 10.1038/246167a0; Pratchett MS, 2009, MAR ENVIRON RES, V67, P230, DOI 10.1016/j.marenvres.2009.03.001; Pratchett MS, 2014, OCEANOGR MAR BIOL, V52, P133; Pratchett MS, 2005, CORAL REEFS, V24, P453, DOI 10.1007/s00338-005-0006-4; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Roberts CM, 2003, ECOL APPL, V13, pS199; Rocha JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134639; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Scheffer M, 2015, SCIENCE, V347, P1317, DOI 10.1126/science.aaa3769; SCHEIBLING RE, 1981, J EXP MAR BIOL ECOL, V51, P173, DOI 10.1016/0022-0981(81)90127-1; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Sigl R, 2016, SCI REP-UK, V6, DOI 10.1038/srep30834; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; ZANN L, 1987, B MAR SCI, V41, P561; Zollner PA, 1999, OIKOS, V84, P164, DOI 10.2307/3546878	55	14	14	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171569	10.1371/journal.pone.0171569	http://dx.doi.org/10.1371/journal.pone.0171569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166257	Green Published, Green Submitted, gold			2022-12-26	WOS:000393700100054
J	Tian, ZB; Zheng, BH; Wang, LJ; Li, LQ; Wang, X; Li, H; Norra, S				Tian, Zebin; Zheng, Binghui; Wang, Lijing; Li, Liqiang; Wang, Xing; Li, Hong; Norra, Stefan			Long term (1997-2014) spatial and temporal variations in nitrogen in Dongting Lake, China	PLOS ONE			English	Article							3 GORGES DAM; YANGTZE-RIVER; WATER-QUALITY; POYANG LAKE; PHOSPHORUS; PHYTOPLANKTON; IMPACTS; PROJECT; PERIOD; TAIHU	In order to protect the water quality of Dongting Lake, it is significant to find out its nitrogen pollution characteristics. Using long-term monthly to seasonally data (1997-2014), we investigated the spatial and temporal variations in nitrogen in Dongting Lake, the second largest freshwater lake in China. The average concentrations of total nitrogen (TN) in the eastern, southern, and western parts of the lake were 1.77, 1.56, and 1.35 mg/L, respectively, in 2014. TN pollution was generally worse in the southern area than in the western area. Concentrations showed temporal variation, and were significantly higher during the dry season than during the wet season. Based on the concentration and growth rate of TN, three different stages were identified in the long term lake data, from 1997 to 2002, from 2003 to 2008, and from 2009 to 2014, during which the concentrations and the growth rate ranged from 1.09-1.51 mg/L and 22.09%-40.03%, 1.05-1.57 mg/L and -9.05%-7.74%, and 1.68-2.02 mg/L and 57.99%-60.41%, respectively. The main controls on the lake water TN concentrations were the quality and quantity of the lake inflows, spatial and temporal variations in hydrodynamic conditions within the lake (flow velocity, flow direction), and point and nonpoint inputs from human activities. Diffuse nutrient losses from agricultural land are a significant contributor. As a priority, the local government should aim to control the pollutant inputs from upstream and non-point nutrient losses from land.	[Tian, Zebin; Zheng, Binghui] Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China; [Tian, Zebin; Zheng, Binghui; Wang, Lijing; Wang, Xing; Li, Hong] Chinese Res Inst Environm Sci, State Environm Protect Key Lab Drinking Water Sou, Beijing, Peoples R China; [Li, Liqiang] Ecol & Environm Monitoring Ctr Dongting Lake Huna, Yueyang, Peoples R China; [Norra, Stefan] Karlsruhe Inst Technol, Inst Geog & Geoecol, Karlsruhe, Germany	Beijing Normal University; Chinese Research Academy of Environmental Sciences; Helmholtz Association; Karlsruhe Institute of Technology	Zheng, BH (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China.; Zheng, BH (corresponding author), Chinese Res Inst Environm Sci, State Environm Protect Key Lab Drinking Water Sou, Beijing, Peoples R China.	zhengbh@craes.org.cn	Li, Liqiang/H-9094-2013; Norra, Stefan/G-7867-2012	Li, Liqiang/0000-0001-8399-3957; 	National Science and Technology Pillar Program of China [2014BAC09B02]; National natural Science Foundation of China [51609225]; National Basic Research Program of China [2012CB417004]	National Science and Technology Pillar Program of China; National natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Science and Technology Pillar Program of China (2014BAC09B02), National natural Science Foundation of China (51609225) and National Basic Research Program of China (2012CB417004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaszuk P, 2005, ECOL ENG, V25, P429, DOI 10.1016/j.ecoleng.2005.06.013; Chang JA, 2010, J GEOGR SCI, V20, P771, DOI 10.1007/s11442-010-0810-9; Chen YW, 2003, HYDROBIOLOGIA, V506, P273, DOI 10.1023/B:HYDR.0000008604.09751.01; China Statistic Yearbook Compilation Committee, 1997, CHIN STAT YB; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Du Y, 2001, GEOMORPHOLOGY, V41, P171, DOI 10.1016/S0169-555X(01)00114-3; Fellman JB, 2007, WETLANDS, V27, P44, DOI 10.1672/0277-5212(2007)27[44:NAPMIT]2.0.CO;2; Gao W, 2015, SCI TOTAL ENVIRON, V505, P376, DOI 10.1016/j.scitotenv.2014.10.016; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hayashi S, 2008, J HYDRO-ENVIRON RES, V2, P148, DOI 10.1016/j.jher.2008.10.002; Hong B, 2011, ENVIRON MODELL SOFTW, V26, P623, DOI 10.1016/j.envsoft.2010.11.012; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Hu Q, 2007, J HYDROL, V347, P90, DOI 10.1016/j.jhydrol.2007.09.005; Huang DaiZhong, 2013, Research of Environmental Sciences, V26, P27; Huang Q, 2014, WATER RESOUR MANAG, V28, P5377, DOI 10.1007/s11269-014-0807-8; Ji XH, 2011, PEDOSPHERE, V21, P753, DOI 10.1016/S1002-0160(11)60179-3; Lai XJ, 2014, HYDROL PROCESS, V28, P150, DOI 10.1002/hyp.10077; Li MT, 2007, ESTUAR COAST SHELF S, V71, P3, DOI 10.1016/j.ecss.2006.08.013; Liu SM, 2003, BIOGEOCHEMISTRY, V62, P1, DOI 10.1023/A:1021162214304; Ma X, 2011, SCI TOTAL ENVIRON, V412, P154, DOI 10.1016/j.scitotenv.2011.09.034; Ni ZK, 2015, ECOL ENG, V79, P42, DOI 10.1016/j.ecoleng.2015.03.005; Novotny Vladimir, 2010, Environment Development and Sustainability, V12, P491, DOI 10.1007/s10668-009-9207-2; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419, DOI 10.5194/acp-7-4419-2007; Paerl HW, 2011, WATER RES, V45, P1973, DOI 10.1016/j.watres.2010.09.018; Pan BZ, 2009, FRESEN ENVIRON BULL, V18, P1894; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; Qin DiLan, 2012, Environmental Science & Technology (China), V35, P193; Shen Ruili, 2007, Hupo Kexue, V19, P677; Smith LED, 2015, AGR ECOSYST ENVIRON, V209, P15, DOI 10.1016/j.agee.2015.02.016; Sokal MA, 2010, ECOHYDROLOGY, V3, P41, DOI 10.1002/eco.93; Sun ZD, 2012, WATER RESOUR MANAG, V26, P3367, DOI 10.1007/s11269-012-0076-3; SUTTLE CA, 1988, J PHYCOL, V24, P13; Wang LiJing, 2013, Research of Environmental Sciences, V26, P1; Wang LQ, 2014, AQUAT GEOCHEM, V20, P501, DOI 10.1007/s10498-014-9232-0; Wang Yan, 2014, Research of Environmental Sciences, V27, P484; Wu LH, 2011, PROCEDIA ENVIRON SCI, V10, P1496, DOI 10.1016/j.proenv.2011.09.238; Xie Y, 2012, ECOHYDROLOG IN PRESS; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; Yang SQ, 2010, J GREAT LAKES RES, V36, P150, DOI 10.1016/j.jglr.2009.12.010; Yang Y, 2012, ENVIRON POLLUT, V168, P170, DOI 10.1016/j.envpol.2012.04.017; Yao X, 2015, ENVIRON SCI POLLUT R, V22, P3032, DOI 10.1007/s11356-014-3579-z; Yao ZQ, 2009, APPL GEOCHEM, P2186; Yu T, 2010, ESTUARINE COASTAL SH, V86, P345, DOI DOI 10.1016/J.ECSS.2009.05.014; Yuan YJ, 2015, J HYDROL, V525, P450, DOI 10.1016/j.jhydrol.2015.04.010; Zhang T, 2014, HYDROL EARTH SYST SC, V18, P1493, DOI 10.5194/hess-18-1493-2014	46	15	21	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170993	10.1371/journal.pone.0170993	http://dx.doi.org/10.1371/journal.pone.0170993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166245	Green Submitted, Green Published, gold			2022-12-26	WOS:000393700100018
J	Li, ZG; Zhang, YH; Hedman, AC; Ames, JB; Sacks, DB				Li, Zhigang; Zhang, Yonghong; Hedman, Andrew C.; Ames, James B.; Sacks, David B.			Calmodulin Lobes Facilitate Dimerization and Activation of Estrogen Receptor-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER-CELLS; TRANSCRIPTIONAL ACTIVITY; ANTIESTROGENS; INHIBITION; HADDOCK; IQGAP1; CA2+/CALMODULIN; ANTAGONIST; STABILITY; TAMOXIFEN	Estrogen receptor alpha (ER-alpha) is a nuclear hormone receptor that controls selected genes, thereby regulating proliferation and differentiation of target tissues, such as breast. Gene expression controlled by ER-alpha is modulated by Ca2+ via calmodulin (CaM). Here we present the NMR structure of Ca2+ - CaM bound to two molecules of ER-alpha (residues 287-305). The two lobes of CaM bind to the same site on two separate ER-alpha molecules (residues 292, 296, 299, 302, and 303), which explains why CaM binds two molecules of ER-alpha in a 1: 2 complex and stabilizes ER-alpha dimerization. Exposed glutamate residues in CaM (Glu-11, Glu-14, Glu-84, and Glu-87) form salt bridges with key lysine residues in ER-alpha (Lys-299, Lys-302, and Lys-303), which is likely to prevent ubiquitination at these sites and inhibit degradation of ER-alpha. Transfection of cells with full-length CaM slightly increased the ability of estrogen to enhance transcriptional activation by ER-alpha of endogenous estrogen-responsive genes. By contrast, expression of either the N- or C-lobe of CaM abrogated estrogen-stimulated transcription of the estrogen responsive genes pS2 and progesterone receptor. These data suggest that CaM-induced dimerization of ER-alpha is required for estrogen-stimulated transcriptional activation by the receptor. In light of the critical role of ER-alpha in breast carcinoma, our data suggest that small molecules that selectively disrupt the interaction of ER-alpha with CaM may be useful in the therapy of breast carcinoma.	[Li, Zhigang; Hedman, Andrew C.; Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA; [Zhang, Yonghong] Univ Texas Rio Grande Valley, Dept Chem, Edinburg, TX 78539 USA; [Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	National Institutes of Health (NIH) - USA; University of Texas System; University of Texas Rio Grande Valley; University of California System; University of California Davis	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.; Sacks, DB (corresponding author), 10 Ctr Dr,10-2C306, Bethesda, MD 20892 USA.	jbames@ucdavis.edu; david.sacks2@nih.gov		Sacks, David/0000-0003-3100-0735	Intramural Research Program of the National Institutes of Health; National Institutes of Health [EY012347]; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); CLINICAL CENTER	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health ( to Z. L., A. C. H., and D. B. S.) and an extramural grant from the National Institutes of Health (EY012347) (to J. B. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Biswas DK, 1998, J BIOL CHEM, V273, P33817, DOI 10.1074/jbc.273.50.33817; BOUHOUTE A, 1992, BIOCHEM BIOPH RES CO, V184, P1432, DOI 10.1016/S0006-291X(05)80043-9; Carlier L, 2012, BIOCHEM BIOPH RES CO, V419, P356, DOI 10.1016/j.bbrc.2012.02.028; CASTORIA G, 1988, MOL ENDOCRINOL, V2, P167, DOI 10.1210/mend-2-2-167; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Erdemir HH, 2014, J BIOL CHEM, V289, P9100, DOI 10.1074/jbc.M114.553511; FRANKFURT OS, 1995, CANCER LETT, V97, P149, DOI 10.1016/0304-3835(95)03970-8; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; GULINO A, 1986, CANCER RES, V46, P6274; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Li L, 2005, J BIOL CHEM, V280, P13097, DOI 10.1074/jbc.M410642200; Li L, 2003, J BIOL CHEM, V278, P1195, DOI 10.1074/jbc.M210708200; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Li ZG, 2001, J BIOL CHEM, V276, P17354, DOI 10.1074/jbc.M010238200; Liu R, 2010, J PHARM SCI-US, V99, P3266, DOI 10.1002/jps.22082; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Newton CJ, 2000, J STEROID BIOCHEM, V73, P29, DOI 10.1016/S0960-0760(00)00047-9; Park S, 2011, PROTEIN SCI, V20, P1356, DOI 10.1002/pro.662; Pedrero JMG, 2002, MOL ENDOCRINOL, V16, P947; SACKS DB, 1989, BIOCHEM J, V263, P803, DOI 10.1042/bj2630803; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; Schulltz-Norton JR, 2011, TRENDS ENDOCRIN MET, V22, P124, DOI 10.1016/j.tem.2010.11.005; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; STROBL JS, 1992, J PHARMACOL EXP THER, V263, P186; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; WEI JW, 1983, CANCER CHEMOTH PHARM, V11, P86; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Zhang YH, 2014, EMBO J, V33, P1341, DOI 10.1002/embj.201488126; Zhang YH, 2012, J BIOL CHEM, V287, P9336, DOI 10.1074/jbc.M111.334797; Zhang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023069	39	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4614	4622		10.1074/jbc.M116.754804	http://dx.doi.org/10.1074/jbc.M116.754804			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28174300	hybrid, Green Published			2022-12-26	WOS:000397585100019
J	Liu, XY; Chen, M; Li, L; Gong, LY; Zhou, H; Gao, DM				Liu, Xiangyuan; Chen, Min; Li, Long; Gong, Liyan; Zhou, Hu; Gao, Daming			Extracellular Signal-regulated Kinases (ERKs) Phosphorylate Lin28a Protein to Modulate P19 Cell Proliferation and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; STEM-CELLS; NEURONAL DIFFERENTIATION; SELF-RENEWAL; CYCLIN D1; PLURIPOTENCY; METABOLISM; EXPRESSION; NEUROGENESIS; URIDYLATION	Lin28a, originally discovered in the nematode Caenorhabditis elegans and highly conserved across species, is a well characterized regulator of let-7 microRNA (miRNA) and is implicated in cell proliferation and pluripotency control. However, little is known about how Lin28a function is modulated at the posttranslational level and thereby responds to major signaling pathways. Here we show that Lin28a is directly phosphorylated by ERK1/2 kinases at Ser-200. By editing lin28a gene with the CRISPR/Cas9-based method, we generated P19 mouse embryonic carcinoma stem cells expressing Lin28a-S200A (phosphodeficient) and Lin28a-S200D (phospho-mimetic) mutants, respectively, to study the functional impact of Ser-200 phosphorylation. Lin28a-S200D-expressing cells, but not Lin28a-S200A-expressing or control P19 embryonic carcinoma cells, displayed impaired inhibition of let-7 miRNA and resulted in decreased cyclin D1, whereas Lin28a-S200-A knock-in cells expressed less let-7 miRNA, proliferated faster, and exhibited differentiation defect upon retinoic acid induction. Therefore our results support that ERK kinase-mediated Lin28a phosphorylation may be an important mechanism for pluripotent cells to facilitate the escape from the self-renewal cycle and start the differentiation process.	[Liu, Xiangyuan; Chen, Min; Li, Long; Gong, Liyan; Zhou, Hu; Gao, Daming] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol,CAS Key Lab Sys, CAS Ctr Excellence Mol Cell Sci,Innovat Ctr Cell, 320 Yueyang Rd, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Gao, DM (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol,CAS Key Lab Sys, CAS Ctr Excellence Mol Cell Sci,Innovat Ctr Cell, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	dgao@sibcb.ac.cn		Gao, Daming/0000-0003-4374-1055	Ministry of Science and Technology of China [2015CB964502]; National Science Foundation of China Grant [81372602, 81422033]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China Grant; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Ministry of Science and Technology of China Grant 2015CB964502, National Science Foundation of China Grants 81372602 and 81422033, and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB19000000) (to D.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Choudhury NR, 2014, CELL REP, V9, P1265, DOI 10.1016/j.celrep.2014.10.017; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cremisi F, 2003, CURR OPIN NEUROBIOL, V13, P26, DOI 10.1016/S0959-4388(03)00005-9; Dalton S, 2015, TRENDS CELL BIOL, V25, P592, DOI 10.1016/j.tcb.2015.07.007; EDWARDS MKS, 1983, MOL CELL BIOL, V3, P2280, DOI 10.1128/MCB.3.12.2280; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kim MO, 2012, NAT STRUCT MOL BIOL, V19, P283, DOI 10.1038/nsmb.2217; Kim SK, 2014, CELL STEM CELL, V15, P735, DOI 10.1016/j.stem.2014.10.016; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Leontieva OV, 2013, CELL DEATH DIFFER, V20, P1241, DOI 10.1038/cdd.2013.86; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mayr F, 2013, INT J MOL SCI, V14, P16532, DOI 10.3390/ijms140816532; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Meloche S, 2004, CELL CYCLE, V3, P241; Nowak JS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4687; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pao PC, 2011, CELL DEATH DIFFER, V18, P1791, DOI 10.1038/cdd.2011.52; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Politis PK, 2008, CELL CYCLE, V7, P691, DOI 10.4161/cc.7.6.5550; RAO SS, 1995, J BIOL CHEM, V270, P4093, DOI 10.1074/jbc.270.8.4093; Rehfeld F, 2015, CELL TISSUE RES, V359, P145, DOI 10.1007/s00441-014-1872-2; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Tsanov KM, 2017, NAT CELL BIOL, V19, P60, DOI 10.1038/ncb3453; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wainwright LJ, 2001, P NATL ACAD SCI USA, V98, P9396, DOI 10.1073/pnas.161288698; Wong SCC, 2001, J PATHOL, V194, P35, DOI 10.1002/path.838; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Zhang J, 2016, CELL STEM CELL, V19, P66, DOI 10.1016/j.stem.2016.05.009; Zhou JB, 2013, INT J BIOCHEM CELL B, V45, P973, DOI 10.1016/j.biocel.2013.02.006	42	8	8	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					3970	3976		10.1074/jbc.C117.775122	http://dx.doi.org/10.1074/jbc.C117.775122			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28179426	Green Published, hybrid			2022-12-26	WOS:000395837100002
J	Pujadas-Mestres, L; Lopez-Vilchez, I; Arellano-Rodrigo, E; Reverter, JC; Lopez-Farre, A; Diaz-Ricart, M; Badimon, JJ; Escolar, G				Pujadas-Mestres, Lluis; Lopez-Vilchez, Irene; Arellano-Rodrigo, Eduardo; Carles Reverter, Joan; Lopez-Farre, Antonio; Diaz-Ricart, Maribel; Badimon, Juan Jose; Escolar, Gines			Differential inhibitory action of apixaban on platelet and fibrin components of forming thrombi: Studies with circulating blood and in a platelet-based model of thrombin generation	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; FACTOR-XA INHIBITOR; CELL-BASED MODEL; VENOUS THROMBOEMBOLISM; SYSTEMS-APPROACH; FLOWING BLOOD; TISSUE FACTOR; HEMOSTASIS; RIVAROXABAN; PREVENTION	Introduction Mechanisms of action of direct oral anticoagulants (DOAC) suggest a potential therapeutic use in the prevention of thrombotic complications in arterial territories. However, effects of DOACs on platelet activation and aggregation have not been explored in detail. We have investigated the effects of apixaban on platelet and fibrin components of thrombus formation under static and flow conditions. Methods We assessed the effects of apixaban (10, 40 and 160 ng/mL) on: 1) platelet deposition and fibrin formation onto a thrombogenic surface, with blood circulating at arterial shear-rates; 2) viscoelastic properties of forming clots, and 3) thrombin generation in a cell-model of coagulation primed by platelets. Results In studies with flowing blood, only the highest concentration of apixaban, equivalent to the therapeutic C-max, was capable to significantly reduce thrombus formation, fibrin association and platelet-aggregate formation. Apixaban significantly prolonged thromboelastometry parameters, but did not affect clot firmness. Interestingly, results in a platelet-based model of thrombin generation under more static conditions, revealed a dose dependent persistent inhibitory action by apixaban, with concentrations 4 to 16 times below the therapeutic C-max significantly prolonging kinetic parameters and reducing the total amount of thrombin generated. Conclusions Our studies demonstrate the critical impact of rheological conditions on the antithrombotic effects of apixaban. Studies under flow conditions combined with modified thrombin generation assays could help discriminating concentrations of apixaban that prevent excessive platelet accumulation, from those that deeply impair fibrin formation and may unnecessarily compromise hemostasis.	[Pujadas-Mestres, Lluis; Lopez-Vilchez, Irene; Arellano-Rodrigo, Eduardo; Carles Reverter, Joan; Diaz-Ricart, Maribel; Escolar, Gines] Univ Barcelona, Inst Biomed Res August Pi & Sunyer IDIBAPS, Ctr Biomed Diag CDB, Hosp Clin Barcelona,Dept Hemotherapy & Hemostasis, Barcelona, Spain; [Lopez-Farre, Antonio] Univ Complutense, Sch Med, Dept Med, Madrid, Spain; [Badimon, Juan Jose] Mt Sinai Sch Med, Cardiovasc Inst, Atherothrombosis Res Unit, New York, NY USA; [Pujadas-Mestres, Lluis] Biogen Spain S L, Dept Med, Madrid, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Complutense University of Madrid; Icahn School of Medicine at Mount Sinai	Escolar, G (corresponding author), Univ Barcelona, Inst Biomed Res August Pi & Sunyer IDIBAPS, Ctr Biomed Diag CDB, Hosp Clin Barcelona,Dept Hemotherapy & Hemostasis, Barcelona, Spain.	gescolar@clinic.ub.es	Escolar, Gines/ABF-9003-2021; Albaladejo, Gines Escolar/AAC-9695-2020; Arellano-Rodrigo, Eduardo/H-4094-2015; Arellano-Rodrigo, Eduardo/R-7079-2019; Escolar, Gines/I-1530-2015	Albaladejo, Gines Escolar/0000-0002-6658-0381; Arellano-Rodrigo, Eduardo/0000-0001-6236-7826; Arellano-Rodrigo, Eduardo/0000-0001-6236-7826; Escolar, Gines/0000-0002-6658-0381; LOPEZ FARRE, ANTONIO/0000-0003-0301-067X; Reverter, Joan Carles/0000-0002-1274-4782	Health Institute Carlos III (ISCIII): Health Research Funds [FIS-P113/00517]; Cardiovascular Research Net (RIC) [RD12/0042/0016, RD12/0042/0040]; European Regional Development Funds (FEDER) and Integrated Excellence Project in Health Institutes [PIE15/00027]; Spanish government	Health Institute Carlos III (ISCIII): Health Research Funds; Cardiovascular Research Net (RIC); European Regional Development Funds (FEDER) and Integrated Excellence Project in Health Institutes; Spanish government(Spanish GovernmentEuropean Commission)	This work was partially supported by the Health Institute Carlos III (ISCIII): Health Research Funds (FIS-P113/00517) and Cardiovascular Research Net (RIC) RD12/0042/0016 and RD12/0042/0040 together with the European Regional Development Funds (FEDER) and Integrated Excellence Project in Health Institutes PIE15/00027; from the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JH, 2009, CIRCULATION, V119, P2877, DOI 10.1161/CIRCULATIONAHA.108.832139; Arellano-Rodrigo E, 2015, TRANSFUS MED REV, V29, P242, DOI 10.1016/j.tmrv.2015.08.001; Badimon L, 2014, J INTERN MED, V276, P618, DOI 10.1111/joim.12296; Becker EM, 2012, J THROMB HAEMOST, V10, P2470, DOI 10.1111/jth.12033; Bristol-Myers Squibb, 2016, ELIQUIS AP PROD MON, P32; Caballo C, 2013, BLOOD TRANSFUS-ITALY, V11, P391, DOI 10.2450/2012.0034-12; Carreras ET, 2015, ARTERIOSCL THROM VAS, V35, P520, DOI 10.1161/ATVBAHA.114.303401; Diaz-Ricart M, 1999, THROMB HAEMOSTASIS, V82, P1312; Escolar G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078696; Frost C, 2013, BRIT J CLIN PHARMACO, V76, P776, DOI 10.1111/bcp.12106; Frost C, 2013, BRIT J CLIN PHARMACO, V75, P476, DOI 10.1111/j.1365-2125.2012.04369.x; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Galan AM, 2009, THROMB HAEMOSTASIS, V102, P511, DOI 10.1160/TH08-12-0810; Gibson C.M., 2016, CIRCULATION; GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415; Goldsmith HL, 1999, BIORHEOLOGY, V36, P461; HOFFMAN M, 1992, THROMB HAEMOSTASIS, V68, P74; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Hoffman M, 2015, ANESTHESIOLOGY, V122, P353, DOI 10.1097/ALN.0000000000000540; Jackson SP, 2009, J THROMB HAEMOST, V7, P17, DOI 10.1111/j.1538-7836.2009.03401.x; Lopez-Vilchez I, 2009, CORONARY ARTERY DIS, V20, P392, DOI 10.1097/MCA.0b013e32832cff1f; Lowe GDO, 1999, BEST PRACT RES CL HA, V12, P435, DOI 10.1053/beha.1999.0035; Lowe Gordon D O, 2002, Semin Vasc Med, V2, P429, DOI 10.1055/s-2002-36771; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Muthard RW, 2015, ARTERIOSCL THROM VAS, V35, P645, DOI 10.1161/ATVBAHA.114.305054; Nesbitt WS, 2006, J MOL MED, V84, P989, DOI 10.1007/s00109-006-0101-1; Roberts HR, 2006, SEMIN THROMB HEMOST, V32, P32, DOI 10.1055/s-2006-939552; Stalker TJ, 2014, BLOOD, V124, P1824, DOI 10.1182/blood-2014-01-550319; Stalker TJ, 2013, BLOOD, V121, P1875, DOI 10.1182/blood-2012-09-457739; Tomaiuolo M, 2014, BLOOD, V124, P1816, DOI 10.1182/blood-2014-01-550343; Toschi V, 1997, CIRCULATION, V95, P594, DOI 10.1161/01.CIR.95.3.594; Turitto VT, 1998, THROMB RES, V92, pS25, DOI 10.1016/S0049-3848(98)00157-1; Turpie AGG, 2005, J THROMB HAEMOST, V3, P2479, DOI 10.1111/j.1538-7836.2005.01602.x; Turpie AGG, 2002, BMJ-BRIT MED J, V325, P887, DOI 10.1136/bmj.325.7369.887; Turpie AGG, 2011, THROMB HAEMOSTASIS, V105, P586, DOI 10.1160/TH10-10-0683	36	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171486	10.1371/journal.pone.0171486	http://dx.doi.org/10.1371/journal.pone.0171486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192448	Green Submitted, gold, Green Published			2022-12-26	WOS:000394423800028
J	Quiner, CA; Moses, C; Monroe, BP; Nakazawa, Y; Doty, JB; Hughes, CM; McCollum, AM; Ibata, S; Malekani, J; Okitolonda, E; Carroll, DS; Reynolds, MG				Quiner, Claire A.; Moses, Cynthia; Monroe, Benjamin P.; Nakazawa, Yoshinori; Doty, Jeffrey B.; Hughes, Christine M.; McCollum, Andrea M.; Ibata, Saturnin; Malekani, Jean; Okitolonda, Emile; Carroll, Darin S.; Reynolds, Mary G.			Presumptive risk factors for monkeypox in rural communities in the Democratic Republic of the Congo	PLOS ONE			English	Article							EBOLA-VIRUS DISEASE; SMALLPOX VACCINATION; TRANSMISSION; OUTBREAK	Monkeypox virus (MPXV), a close relative of Variola virus, is a zoonotic virus with an unknown reservoir. Interaction with infected wildlife, bites from peri-domestic animals, and bushmeat hunting are hypothesized routes of infection from wildlife to humans. Using a Risk Questionnaire, performed in monkeypox-affected areas of rural Democratic Republic of the Congo, we describe the lifestyles and demographics associated with presumptive risk factors for MPXV infection. We generated two indices to assess risk: Household Materials Index (HMI), a proxy for socioeconomic status of households and Risk Activity Index (RAI), which describes presumptive risk for animal-to-human transmission of MPXV. Based on participant self-reported activity patterns, we found that people in this population are more likely to visit the forest than a market to fulfill material needs, and that the reported occupation is limited in describing behavior of individuals may participate. Being bitten by rodents in the home was commonly reported, and this was significantly associated with a low HMI. The highest scoring RAI sub-groups were 'hunters' and males aged >= 18 years; however, several activities involving MPXV-implicated animals were distributed across all sub-groups. The current analysis may be useful in identifying at-risk groups and help to direct education, outreach and prevention efforts more efficiently.	[Quiner, Claire A.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA; [Quiner, Claire A.; Monroe, Benjamin P.; Nakazawa, Yoshinori; Doty, Jeffrey B.; Hughes, Christine M.; McCollum, Andrea M.; Reynolds, Mary G.] US Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA USA; [Moses, Cynthia; Ibata, Saturnin; Carroll, Darin S.] Int Conservat Educ Fund, Washington, DC USA; [Malekani, Jean] Univ Kinshasa, Dept Biol, Kinshasa, DEM REP CONGO; [Okitolonda, Emile] Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO	University of California System; University of California Berkeley; Centers for Disease Control & Prevention - USA; Universite de Kinshasa	Reynolds, MG (corresponding author), US Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA USA.	cquiner@berkeley.edu; cynmoses@gmail.com; ihd2@cdc.gov; inp7@cdc.gov; uwb7@cdc.gov; bvp6@cdc.gov; zuz4@cdc.gov; sribata@gmail.com; jean.malekani@unikin.ac.cd; okitow@yahoo.fr; azv4@cdc.gov; nzr6@cdc.gov		Reynolds, Mary/0000-0001-7882-4614; Quiner, Claire/0000-0003-4419-1542	Centers for Disease Control and Prevention; Oakridge Institute for Science and Education, (ORISE)	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Oakridge Institute for Science and Education, (ORISE)	This work was financially supported by the Centers for Disease Control and Prevention, and Oakridge Institute for Science and Education, (ORISE).	Andrews JR, 2015, INT J TUBERC LUNG D, V19, P375, DOI 10.5588/ijtld.14.0423; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; BREMAN JG, 1977, B WORLD HEALTH ORGAN, V55, P605; Fang LQ, 2016, P NATL ACAD SCI USA, V113, P4488, DOI 10.1073/pnas.1518587113; FINE PEM, 1988, INT J EPIDEMIOL, V17, P643, DOI 10.1093/ije/17.3.643; Household transmission of Neisseria meningitidis in the African meningitis belt, 2016, LANCET GLOB HLTH, V4, pe989, DOI 10.1016/S2214-109X(16)30244-3; Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115; Hutin YJF, 2001, EMERG INFECT DIS, V7, P434; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Hutson CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028295; JEZEK Z, 1987, J INFECT DIS, V156, P293, DOI 10.1093/infdis/156.2.293; JEZEK Z, 1988, B WORLD HEALTH ORGAN, V66, P465; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; KHODAKEVICH L, 1986, LANCET, V1, P98; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P115; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Maganga GD, 2014, NEW ENGL J MED, V371, P2083, DOI 10.1056/NEJMoa1411099; Onyango AC, 2009, AJAR-AFR J AIDS RES, V8, P359, DOI 10.2989/AJAR.2009.8.3.12.933; Radonic A, 2014, EMERG INFECT DIS, V20, P1009, DOI 10.3201/eid2006.13-1329; Reynolds MG, 2012, TRENDS MICROBIOL, V20, P80, DOI 10.1016/j.tim.2011.12.001; Reynolds MG, 2010, AM J TROP MED HYG, V82, P746, DOI 10.4269/ajtmh.2010.09-0716; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Tshikuka JG, 1996, ANN TROP MED PARASIT, V90, P277, DOI 10.1080/00034983.1996.11813053	25	16	16	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0168664	10.1371/journal.pone.0168664	http://dx.doi.org/10.1371/journal.pone.0168664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192435	gold, Green Submitted, Green Published			2022-12-26	WOS:000394423800002
J	Li, JY; Liu, B; Zhou, YY; Chen, ZP; Jiang, LL; Yuan, W; Liang, L				Li, Jiyu; Liu, Bin; Zhou, Yingying; Chen, Zhipeng; Jiang, Lelun; Yuan, Wei; Liang, Liang			Fabrication of a Ti porous microneedle array by metal injection molding for transdermal drug delivery	PLOS ONE			English	Article							VIVO FLUORESCENCE MICROSCOPY; PRESSURE WAVE DEVICE; VACCINE DELIVERY; AMINOLEVULINIC ACID; POLYMER MICRONEEDLES; ALZHEIMERS-DISEASE; SKIN; ELECTROPORATION; ENHANCE; MODEL	Microneedle arrays (MA) have been extensively investigated in recent decades for transdermal drug delivery due to their pain-free delivery, minimal skin trauma, and reduced risk of infection. However, porous MA received relatively less attention due to their complex fabrication process and ease of fracturing. Here, we present a titanium porous microneedle array (TPMA) fabricated by modified metal injection molding (MIM) technology. The sintering process is simple and suitable for mass production. TPMA was sintered at a sintering temperature of 1250 degrees C for 2 h. The porosity of TPMA was approximately 30.1% and its average pore diameter was about 1.3 mu m. The elements distributed on the surface of TPMA were only Ti and O, which may guarantee the biocompatibility of TPMA. TPMA could easily penetrate the skin of a human forearm without fracture. TPMA could diffuse dry Rhodamine B stored in micropores into rabbit skin. The cumulative permeated flux of calcein across TPMA with punctured skin was 27 times greater than that across intact skin. Thus, TPMA can continually and efficiently deliver a liquid drug through open micropores in skin.	[Li, Jiyu; Liu, Bin; Zhou, Yingying; Chen, Zhipeng; Jiang, Lelun] Sun Yat Sen Univ, Sch Engn, Guangdong Prov Key Lab Sensor Technol & Biomed In, Guangzhou, Guangdong, Peoples R China; [Yuan, Wei; Liang, Liang] South China Univ Technol, Sch Mech & Automot Engn, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; South China University of Technology	Jiang, LL (corresponding author), Sun Yat Sen Univ, Sch Engn, Guangdong Prov Key Lab Sensor Technol & Biomed In, Guangzhou, Guangdong, Peoples R China.; Liang, L (corresponding author), South China Univ Technol, Sch Mech & Automot Engn, Guangzhou, Guangdong, Peoples R China.	jianglel@mail.sysu.edu.cn; meliang@scut.edu.cn	YUAN, WEI/C-4438-2012	YUAN, WEI/0000-0003-4235-2533; Jiang, Lelun/0000-0002-5530-3266	National Nature Science Foundation of China [51575543]; Natural Science Foundation of Guangdong Province, China [2014A030313211]; Guangdong-Hongkong Technology Cooperation Funding Scheme [2016A050503027]; Science and Technology Planning Project of Guangdong Province, China [20156010125004]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Guangdong-Hongkong Technology Cooperation Funding Scheme; Science and Technology Planning Project of Guangdong Province, China	This research is financially supported by the National Nature Science Foundation of China (Project No. 51575543); Natural Science Foundation of Guangdong Province, China (Project No. 2014A030313211); Guangdong-Hongkong Technology Cooperation Funding Scheme (2016A050503027); and Science and Technology Planning Project of Guangdong Province, China (No. 20156010125004).	Akimoto M, 2014, J AM ACAD DERMATOL, V70, pAB32; Arora A, 2008, INT J PHARMACEUT, V364, P227, DOI 10.1016/j.ijpharm.2008.08.032; Balazs B, 2016, BIOMED OPT EXPRESS, V7, P67, DOI 10.1364/BOE.7.000067; Boks MA, 2015, INT J PHARMACEUT, V491, P375, DOI 10.1016/j.ijpharm.2015.06.025; Bystrova S, 2011, MICROELECTRON ENG, V88, P1681, DOI 10.1016/j.mee.2010.12.067; Caffarel-Salvador E, 2016, CURR PHARM DESIGN, V22, P1105, DOI 10.2174/1381612822666151216145645; Chen BT, 2008, MICROSYST TECHNOL, V14, P1015, DOI 10.1007/s00542-007-0530-y; Chen KY, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091533; Chen LJ, 2009, T NONFERR METAL SOC, V19, P1174, DOI 10.1016/S1003-6326(08)60424-0; Chen QZ, 2015, MAT SCI ENG R, V87, P1, DOI 10.1016/j.mser.2014.10.001; Dardano P, 2015, MATERIALS, V8, P8661, DOI 10.3390/ma8125484; Garland MJ, 2012, J CONTROL RELEASE, V159, P52, DOI 10.1016/j.jconrel.2012.01.003; Hong XY, 2013, DRUG DES DEV THER, V7, P945, DOI 10.2147/DDDT.S44401; Indermun S, 2014, J CONTROL RELEASE, V185, P130, DOI 10.1016/j.jconrel.2014.04.052; Jang HJ, 2014, J BIOMED OPT, V19; Ji J, 2006, J MICROMECH MICROENG, V16, P958, DOI 10.1088/0960-1317/16/5/012; Ji J, 2006, J PHYS CONF SER, V34, P1132, DOI 10.1088/1742-6596/34/1/187; Ji J, 2006, J PHYS CONF SER, V34, P1127, DOI 10.1088/1742-6596/34/1/186; Jiang LL, 2014, T NONFERR METAL SOC, V24, P292, DOI 10.1016/S1003-6326(14)63060-0; Kathuria H, 2015, JOVE-J VIS EXP, DOI 10.3791/52914; Kearney MC, 2016, EUR J PHARM BIOPHARM, V103, P43, DOI 10.1016/j.ejpb.2016.03.026; Kim JY, 2016, EUR J PHARM BIOPHARM, V105, P148, DOI 10.1016/j.ejpb.2016.06.006; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Labala S, 2016, COLLOID SURFACE B, V146, P188, DOI 10.1016/j.colsurfb.2016.05.076; Larraneta E, 2016, MAT SCI ENG R, V104, P1, DOI 10.1016/j.mser.2016.03.001; Larraneta E, 2014, INT J PHARMACEUT, V472, P65, DOI 10.1016/j.ijpharm.2014.05.042; Lee K, 2012, BIOMATERIALS, V33, P7309, DOI 10.1016/j.biomaterials.2012.06.065; Liu LM, 2016, RSC ADV, V6, P48630, DOI 10.1039/c6ra07882f; Liu S, 2014, EUR J PHARM BIOPHARM, V86, P267, DOI 10.1016/j.ejpb.2013.10.001; Martanto W, 2006, J CONTROL RELEASE, V112, P357, DOI 10.1016/j.jconrel.2006.02.017; Mohammed YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101956; Murthy SN, 2010, J CONTROL RELEASE, V148, P197, DOI 10.1016/j.jconrel.2010.08.015; Nguyen HX, 2015, DRUG DELIV TRANSL RE, V5, P407, DOI 10.1007/s13346-015-0241-3; Parhi R, 2016, J ADV RES, V7, P539, DOI 10.1016/j.jare.2015.09.001; Parhi R, 2015, CURR DRUG DELIV, V12, P122, DOI 10.2174/1567201811666140515145329; Park JM, 2016, LASER MED SCI, V31, P113, DOI 10.1007/s10103-015-1835-1; Park JH, 2007, BIOMED MICRODEVICES, V9, P223, DOI 10.1007/s10544-006-9024-4; Park YH, 2016, BIOTECHNOL BIOPROC E, V21, P110, DOI 10.1007/s12257-015-0634-7; Prausnitz MR, 2004, ADV DRUG DELIVER REV, V56, P581, DOI 10.1016/j.addr.2003.10.023; Prausnitz MR, 2004, NAT REV DRUG DISCOV, V3, P115, DOI 10.1038/nrd1304; Rao PR, 2003, EUR J PHARM BIOPHARM, V56, P81, DOI 10.1016/S0939-6411(03)00038-9; Raphael AP, 2016, J CONTROL RELEASE, V225, P40, DOI 10.1016/j.jconrel.2016.01.027; Ren L, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16060908; Roxhed N, 2007, J MICROELECTROMECH S, V16, P1429, DOI 10.1109/JMEMS.2007.907461; Sammeta SM, 2011, DRUG DEV IND PHARM, V37, P1076, DOI 10.3109/03639045.2011.559659; Schoellhammer CM, 2015, J CONTROL RELEASE, V202, P93, DOI 10.1016/j.jconrel.2015.02.002; Schoellhammer CM, 2014, EXPERT OPIN DRUG DEL, V11, P393, DOI 10.1517/17425247.2014.875528; Scott LJ, 2016, CLIN DRUG INVEST, V36, P321, DOI 10.1007/s40261-016-0387-x; Shin SC, 2005, EUR J PHARM BIOPHARM, V61, P14, DOI 10.1016/j.ejpb.2005.03.010; Shirkhanzadeh M, 2005, J MATER SCI-MATER M, V16, P37, DOI 10.1007/s10856-005-6444-2; Sidambe AT, 2014, MATERIALS, V7, P8168, DOI 10.3390/ma7128168; Tokumoto S, 2016, BIOL PHARM BULL, V39, P1206, DOI 10.1248/bpb.b15-00696; Uddin MJ, 2015, INT J PHARMACEUT, V494, P593, DOI 10.1016/j.ijpharm.2015.01.038; van der Maaden K, 2015, DRUG DELIV TRANSL RE, V5, P397, DOI 10.1007/s13346-015-0238-y; van der Maaden K, 2012, J CONTROL RELEASE, V161, P645, DOI 10.1016/j.jconrel.2012.01.042; Vecchione R, 2014, ADV FUNCT MATER, V24, P3515, DOI 10.1002/adfm.201303679; Verhoeven M, 2012, MICROELECTRON ENG, V98, P659, DOI 10.1016/j.mee.2012.07.022; Vinayakumar KB, 2016, J MICROMECH MICROENG, V26, DOI 10.1088/0960-1317/26/6/065013; Waibel J, 2015, J AM ACAD DERMATOL, V72, pAB268; Waibel J, 2015, LASER SURG MED, V47, P31; Waibel JS, 2016, J DRUGS DERMATOL, V15, P14; Wang QL, 2016, MAT SCI ENG C-MATER, V65, P135, DOI 10.1016/j.msec.2016.03.097; Yan GA, 2010, INT J PHARMACEUT, V391, P7, DOI 10.1016/j.ijpharm.2010.02.007; Yan XX, 2013, MICRO NANO LETT, V8, P906, DOI 10.1049/mnl.2013.0630; Yan XX, 2013, MICROELECTRON ENG, V111, P33, DOI 10.1016/j.mee.2013.04.039; Yan XX, 2011, KEY ENG MATER, V483, P443, DOI 10.4028/www.scientific.net/KEM.483.443; Zhang L, 2015, VACUUM, V122, P187, DOI 10.1016/j.vacuum.2015.09.024; Zhou W, 2013, SENSOR ACTUAT A-PHYS, V201, P127, DOI 10.1016/j.sna.2013.06.025; Zorec B, 2013, INT J PHARMACEUT, V457, P214, DOI 10.1016/j.ijpharm.2013.09.020	69	69	70	10	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172043	10.1371/journal.pone.0172043	http://dx.doi.org/10.1371/journal.pone.0172043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187179	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300073
J	Roberts, HL; Schneider, BL; Brown, DR				Roberts, Hazel L.; Schneider, Bernard L.; Brown, David R.			alpha-Synuclein increases beta-amyloid secretion by promoting beta-/gamma-secretase processing of APP	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; RAT MODEL; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MEMBRANE-BINDING; OXIDATIVE STRESS; A-BETA; LEWY BODIES; PHOSPHORYLATION; PROTEIN	alpha-Synuclein misfolding and aggregation is often accompanied by beta-amyloid deposition in some neurodegenerative diseases. We hypothesised that alpha-synuclein promotes beta-amyloid production from APP. beta-Amyloid levels and APP amyloidogenic processing were investigated in neuronal cell lines stably overexpressing wildtype and mutant alpha-synuclein. gamma-Secretase activity and beta-secretase expression were also measured. We show that alpha-synuclein expression induces beta-amyloid secretion and amyloidogenic processing of APP in neuronal cell lines. Certain mutations of a-synuclein potentiate APP amyloidogenic processing. gamma-Secretase activity was not enhanced by wildtype alpha-synuclein expression, however beta-secretase protein levels were induced. Furthermore, a correlation between alpha-synuclein and beta-secretase protein was seen in rat brain striata. Iron chelation abolishes the effect of alpha-synuclein on neuronal cell beta-amyloid secretion, whereas overexpression of the ferrireductase enzyme Steap3 is robustly pro-amyloidogenic. We propose that alpha-synuclein promotes beta-amyloid formation by modulating beta-cleavage of APP, and that this is potentially mediated by the levels of reduced iron and oxidative stress.	[Roberts, Hazel L.; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Schneider, Bernard L.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland	University of Bath; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Brown, DR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, Avon, England.	D.R.Brown@bath.ac.uk	Schneider, Bernard/H-6168-2011	Schneider, Bernard/0000-0001-5485-8748; Hall-Roberts, Hazel/0000-0003-0330-9604	UK Charity, BRACE	UK Charity, BRACE	This work was funded by the UK Charity, BRACE, in the form of a PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alves G, 2014, NEUROLOGY, V82, P1784, DOI 10.1212/WNL.0000000000000425; Atsmon-Raz Y, 2016, ACS CHEM NEUROSCI, V7, P46, DOI 10.1021/acschemneuro.5b00204; Bachhuber T, 2015, NAT MED, V21, P802, DOI 10.1038/nm.3885; Bate C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-55; Bender A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062277; Brown DR, 2013, BIOCHEM SOC T, V41, P1513, DOI 10.1042/BST20130130; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Chami L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-52; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Cho HH, 2010, J BIOL CHEM, V285, P31217, DOI 10.1074/jbc.M110.149161; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cox CJ, 2015, NEUROBIOL AGING, V36, P178, DOI 10.1016/j.neurobiolaging.2014.07.032; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Davies P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015814; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Fanutza T, 2015, ELIFE, V4, DOI 10.7554/eLife.09743; Febbraro F, 2013, NEUROBIOL DIS, V56, P47, DOI 10.1016/j.nbd.2013.03.014; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gaugler MN, 2012, ACTA NEUROPATHOL, V123, P653, DOI 10.1007/s00401-012-0963-y; George S, 2015, J PARKINSON DIS, V5, P413, DOI 10.3233/JPD-150630; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Guo C, 2013, NEUROBIOL AGING, V34, P562, DOI 10.1016/j.neurobiolaging.2012.05.009; Guo LY, 2014, EXP EYE RES, V129, P31, DOI 10.1016/j.exer.2014.10.012; Hall S, 2015, NEUROLOGY, V84, P57, DOI 10.1212/WNL.0000000000001098; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Ill-Raga G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021456; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Jellinger KA, 2003, ACTA NEUROPATHOL, V106, P191, DOI 10.1007/s00401-003-0725-y; Jo DG, 2010, NEUROBIOL AGING, V31, P917, DOI 10.1016/j.neurobiolaging.2008.07.003; Jones SAV, 2014, PSYCHOL MED, V44, P673, DOI 10.1017/S0033291713000494; Kallhoff V, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-6; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kazmierczak A, 2008, NEUROCHEM INT, V53, P263, DOI 10.1016/j.neuint.2008.08.004; Kim CH, 2013, KOREAN J PHYSIOL PHA, V17, P189, DOI 10.4196/kjpp.2013.17.3.189; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Kragh CL, 2009, J BIOL CHEM, V284, P10211, DOI 10.1074/jbc.M809671200; Kuwahara T, 2012, J BIOL CHEM, V287, P7098, DOI 10.1074/jbc.M111.237131; Lashley T, 2008, ACTA NEUROPATHOL, V115, P417, DOI 10.1007/s00401-007-0336-0; Lassek M, 2013, J NEUROCHEM, V127, P48, DOI 10.1111/jnc.12358; Lau KF, 2000, NEUROREPORT, V11, P3607, DOI 10.1097/00001756-200011090-00041; Lazaro DF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004741; Majd S, 2013, NEUROTOX RES, V23, P69, DOI 10.1007/s12640-012-9330-y; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Marsh SE, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt109; Marwarha G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070773; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; McFarland NR, 2009, J NEUROPATH EXP NEUR, V68, P515, DOI 10.1097/NEN.0b013e3181a24b53; McHugh PC, 2012, NEUROCHEM INT, V61, P672, DOI 10.1016/j.neuint.2012.07.002; Mei ZR, 2015, NEUROCHEM RES, V40, P829, DOI 10.1007/s11064-015-1533-1; Mouton-Liger F, 2012, BBA-MOL BASIS DIS, V1822, P885, DOI 10.1016/j.bbadis.2012.01.009; Nakamura K, 2013, NEUROTHERAPEUTICS, V10, P391, DOI 10.1007/s13311-013-0182-9; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oaks AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070872; Oda A, 2010, J NEUROSCI RES, V88, P1137, DOI 10.1002/jnr.22271; Ono K, 2012, J NEUROCHEM, V122, P883, DOI 10.1111/j.1471-4159.2012.07847.x; Oueslati A, 2016, J PARKINSON DIS, V6, P39, DOI 10.3233/JPD-160779; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1; Parkkinen L, 2003, J NEUROPATH EXP NEUR, V62, P363, DOI 10.1093/jnen/62.4.363; Petrou M, 2015, MOVEMENT DISORD, V30, P928, DOI 10.1002/mds.26191; Pino E, 2014, HUM MOL GENET, V23, P1435, DOI 10.1093/hmg/ddt530; Pletnikova O, 2005, NEUROBIOL AGING, V26, P1183, DOI 10.1016/j.neurobiolaging.2004.10.006; Ringman JM, 2016, J NEUROPATH EXP NEUR, V75, P284, DOI 10.1093/jnen/nlv028; Robotta M, 2012, BIOCHEMISTRY-US, V51, P3960, DOI 10.1021/bi300357a; Sambamurti K, 2004, FASEB J, V26, P1; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Sato H, 2011, J NEUROSCI, V31, P16884, DOI 10.1523/JNEUROSCI.3967-11.2011; Schneider JA, 2009, J ALZHEIMERS DIS, V18, P691, DOI 10.3233/JAD-2009-1227; Skogseth RE, 2015, J PARKINSON DIS, V5, P783, DOI 10.3233/JPD-150682; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stav Ane Lovli, 2015, Parkinsonism Relat Disord, V21, P758, DOI 10.1016/j.parkreldis.2015.04.027; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Tan JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051922; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Tenreiro S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004302; Terrelonge M, 2016, J MOL NEUROSCI, V58, P88, DOI 10.1007/s12031-015-0647-x; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Uchikado H, 2006, J NEUROPATH EXP NEUR, V65, P685, DOI 10.1097/01.jnen.0000225908.90052.07; Vamvaca K, 2011, J NEUROCHEM, V119, P389, DOI 10.1111/j.1471-4159.2011.07431.x; Vamvaca K, 2009, J MOL BIOL, V389, P413, DOI 10.1016/j.jmb.2009.03.021; Vranova HP, 2014, J NEUROL SCI, V343, P120, DOI 10.1016/j.jns.2014.05.052; Wang XY, 2010, J NEUROCHEM, V113, P704, DOI 10.1111/j.1471-4159.2010.06638.x; Wright JA, 2013, MOL CELL NEUROSCI, V57, P33, DOI 10.1016/j.mcn.2013.09.002; Yin G, 2014, NEUROBIOL DIS, V70, P149, DOI 10.1016/j.nbd.2014.06.018; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhou XL, 2016, AM J TRANSL RES, V8, P246	93	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171925	10.1371/journal.pone.0171925	http://dx.doi.org/10.1371/journal.pone.0171925			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187176	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300060
J	Faria, SC; Provete, DB; Thurman, CL; McNamara, JC				Faria, Samuel Coelho; Provete, Diogo Borges; Thurman, Carl Leo; McNamara, John Campbell			Phylogenetic patterns and the adaptive evolution of osmoregulation in fiddler crabs (Brachyura, Uca)	PLOS ONE			English	Article							GULF-OF-MEXICO; OSMOTIC REGULATION; NORTH-AMERICA; FRESH-WATER; GENUS UCA; REGRESSION; PHYSIOLOGY; GILLS; ADAPTATIONS; ENVIRONMENT	Salinity is the primary driver of osmoregulatory evolution in decapods, and may have influenced their diversification into different osmotic niches. In semi-terrestrial crabs, hyperosmoregulatory ability favors sojourns into burrows and dilute media, and provides a safeguard against hemolymph dilution; hypo-osmoregulatory ability underlies emersion capability and a life more removed from water sources. However, most comparative studies have neglected the roles of the phylogenetic and environmental components of inter-specific physiological variation, hindering evaluation of phylogenetic patterns and the adaptive nature of osmoregulatory evolution. Semi-terrestrial fiddler crabs (Uca) inhabit fresh to hyper-saline waters, with species from the Americas occupying higher intertidal habitats than Indo-west Pacific species mainly found in the low intertidal zone. Here, we characterize numerous osmoregulatory traits in all ten fiddler crabs found along the Atlantic coast of Brazil, and we employ phylogenetic comparative methods using 24 species to test for: (i) similarities of osmoregulatory ability among closely related species; (ii) salinity as a driver of osmoregulatory evolution; (iii) correlation between salt uptake and secretion; and (iv) adaptive peaks in osmoregulatory ability in the high intertidal American lineages. Our findings reveal that osmoregulation in Uca exhibits strong phylogenetic patterns in salt uptake traits. Salinity does not correlate with hyper/hypo-regulatory abilities, but drives hemolymph osmolality at ambient salinities. Osmoregulatory traits have evolved towards three adaptive peaks, revealing a significant contribution of hyper/hypo-regulatory ability in the American clades. Thus, during the evolutionary history of fiddler crabs, salinity has driven some of the osmoregulatory transformations that underpin habitat diversification, although others are apparently constrained phylogenetically.	[Faria, Samuel Coelho; McNamara, John Campbell] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Ribeirao Preto, SP, Brazil; [Provete, Diogo Borges] Univ Fed Sao Carlos, Dept Ciencias Ambientais, Sorocaba, SP, Brazil; [Provete, Diogo Borges] Gothenburg Global Biodivers Ctr, Gothenburg, Sweden; [Thurman, Carl Leo] Univ Northern Iowa, Dept Biol, Cedar Falls, IA 50614 USA; [McNamara, John Campbell] Univ Sao Paulo, Ctr Biol Marinha, Sao Sebastiao, SP, Brazil; [Faria, Samuel Coelho] Univ Fed Rio Grande FURG, Inst Ciencias Biol, Rio Grande, RS, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Carlos; University of Gothenburg; University of Northern Iowa; Universidade de Sao Paulo; Universidade Federal do Rio Grande	McNamara, JC (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Ribeirao Preto, SP, Brazil.; McNamara, JC (corresponding author), Univ Sao Paulo, Ctr Biol Marinha, Sao Sebastiao, SP, Brazil.	mcnamara@ffclrp.usp.br	Faria, Samuel C/E-6819-2013; McNamara, John Campbell/B-9823-2012; Provete, Diogo B./B-3704-2008	Faria, Samuel C/0000-0003-3143-2191; McNamara, John Campbell/0000-0002-6530-8706; Provete, Diogo B./0000-0002-0097-0651	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/56305-6, 2011/08852-0, 2007/04870-9, 2009/50799-0, 2016/13949-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [450320/2010-3, 300662/2009-2, 203734/2014-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [33002029031P8]; Biology Department, the College of Natural Sciences; Graduate College of the University of Northern Iowa; University of Iowa Global Regional Environmental Research Center (GRERC SA) [1000716062, 1802010001]; Fulbright Foundation;  [2009/06]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Biology Department, the College of Natural Sciences; Graduate College of the University of Northern Iowa; University of Iowa Global Regional Environmental Research Center (GRERC SA); Fulbright Foundation; 	This research was supported in Brazil by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP fellowships #2008/56305-6 and #2011/08852-0 to SCF, and grants #2007/04870-9 to JCM and #2009/50799-0 to JCM and CLT), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq #450320/2010-3 and #300662/2009-2 to JCM) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, 33002029031P8). CLT received funding from the Biology Department, the College of Natural Sciences, and the Graduate College of the University of Northern Iowa, the University of Iowa Global Regional Environmental Research Center (GRERC SA #1000716062, G/P # 1802010001) and the Fulbright Foundation. DBP received post-doctoral fellowships from CNPq (#203734/2014-9) and FAPESP (2016/13949-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are most grateful to the Centro de Biologia Marinha, Universidade de Sao Paulo, for providing laboratory space and facilities (Project #2009/06) and we thank T. Alves, C. Antunes, F. Assis, L. Bezerra, M. Capparelli, R. Faleiros, A. Filhos, J. Hall, M. Hopkins, S. Milograna, F. Penha, L. Perez, E. Ribeiro, H. Silva, C. M. Thurman and J. Vieira for helping with field work. We also thank Dr Hsi-Te Shih for providing the phylogenetic tree, the IBAMA office in Amapa, AP, for supplying the boat, motor and trailer to collect at the mouth of the Amapa River, and M. Sommerlot (Hawkeye Corrugated Box, Cedar Falls, IA) who kindly donated our transportation container. SCF is indebted to Lucas B. Martins and Rafael C. Duarte for fundamental support with the R platform and discussions of phylogenetic comparative methods. Crabs were collected under MMA/ICMBio permits #18559-1, #23976-1, #29594-1 and #29594-3 to JCM. This investigation constitutes part of an M Sc dissertation submitted by SCF to the Graduate Program in Comparative Biology, Departamento de Biologia, FFCLRP, Universidade de Sao Paulo.	Augusto A, 2007, J EXP ZOOL PART A, V307A, P688, DOI 10.1002/jez.a.422; Burggren WW, 1988, BIOL LAND CRABS; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Charmantier Guy, 2009, P165; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; DIAZ H, 1977, BIOL BULL, V153, P485, DOI 10.2307/1540602; Diniz JAF, 2001, EVOLUTION, V55, P1104, DOI 10.1111/j.0014-3820.2001.tb00630.x; Faria SC, 2017, ECOL EVOL, P1; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Finney D.J., 1971, PROBIT ANAL; Freire CA, 2008, COMP BIOCHEM PHYS A, V151, P272, DOI 10.1016/j.cbpa.2007.05.008; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GARLAND T, 1994, ANNU REV PHYSIOL, V56, P579, DOI 10.1146/annurev.ph.56.030194.003051; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Goolsby EW, 2016, METHODS ECOL EVOL; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; GRAY IE, 1957, BIOL BULL, V112, P34, DOI 10.2307/1538877; Greenaway P., 1988, CRUSTACEANS BIODIVER, P823; GROSS WJ, 1964, BIOL BULL, V127, P447, DOI 10.2307/1539247; GROSS WJ, 1955, AM NAT, V89, P205, DOI 10.1086/281884; Hansen TF, 2008, EVOLUTION, V62, P1965, DOI 10.1111/j.1558-5646.2008.00412.x; Hartnoll R.G., 1988, P6, DOI 10.1017/CBO9780511753428.003; Hurman CL, 2005, B MAR SCI, V77, P83; Ingram T, 2013, METHODS ECOL EVOL, V4, P416, DOI 10.1111/2041-210X.12034; Jones LL, 1941, J CELL COMPAR PHYSL, V18, P79, DOI 10.1002/jcp.1030180109; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Levinton J, 1996, J EXP MAR BIOL ECOL, V203, P117, DOI 10.1016/0022-0981(96)02573-7; Lin HC, 2002, ZOOL SCI, V19, P643, DOI 10.2108/zsj.19.643; Little C, 1990, TERRESTRIAL INVASION; Mantel L.H., 1983, P53; Martins E. P., 1996, PHYLOGENIES COMP MET; McNamara JC, 2015, BIOL J LINN SOC, V114, P673, DOI 10.1111/bij.12443; McNamara JC, 2012, J COMP PHYSIOL B, V182, P997, DOI 10.1007/s00360-012-0665-8; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pearse AS., 1929, PAP TORTUGAS LAB, V391, P205; Pequeux A, 1985, J CRUSTACEAN BIOL, V15, P1; Pinheiro J, R PACKAGE VERSION; R Core Team, 2013, R LANG ENV STAT COMP; RABALAIS NN, 1985, BIOL BULL, V168, P135, DOI 10.2307/1541179; Rangel TF, 2015, EVOLUTION, V69, P1301, DOI 10.1111/evo.12644; Revell LJ, 2013, METHODS ECOL EVOL, V4, P754, DOI 10.1111/2041-210X.12066; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Rezende EL, 2012, COMPREHENSIVE PHYSL, V2, P645; Rosenberg MS, 2001, J CRUSTACEAN BIOL, V21, P839, DOI 10.1651/0278-0372(2001)021[0839:TSATOF]2.0.CO;2; Shih HT, 2015, ZOOTAXA, V4034, P471, DOI 10.11646/zootaxa.4034.3.3; SPAARGAREN DH, 1977, NETH J SEA RES, V11, P200, DOI 10.1016/0077-7579(77)90006-0; Sturmbauer C, 1996, P NATL ACAD SCI USA, V93, P10855, DOI 10.1073/pnas.93.20.10855; Takeda S, 1996, J CRUSTACEAN BIOL, V16, P472, DOI 10.2307/1548737; Thurman C, 2003, J EXP MAR BIOL ECOL, V291, P233, DOI 10.1016/S0022-0981(03)00138-2; Thurman C, 2003, MAR BIOL, V142, P77, DOI 10.1007/s00227-002-0920-8; Thurman C, 2010, MAR FRESHW BEHAV PHY, V43, P339, DOI 10.1080/10236244.2010.526407; Thurman Carl L., 2013, Marine Biodiversity Records, V6, pe1, DOI 10.1017/S1755267212000942; Thurman CL, 2002, MAR ECOL-P S Z N I, V23, P269, DOI 10.1046/j.1439-0485.2002.02785.x; Tsai JR, 2007, J EXP BIOL, V210, P620, DOI 10.1242/jeb.02684; Venice System, 1959, ARCHO OCEANOGR LIM S, V11, P243	58	17	17	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171870	10.1371/journal.pone.0171870	http://dx.doi.org/10.1371/journal.pone.0171870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182764	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800128
J	Yanagawa, Y; Kawano, H; Kobayashi, T; Miyahara, H; Okino, A; Mitsuhara, I				Yanagawa, Yuki; Kawano, Hiroaki; Kobayashi, Tomohiro; Miyahara, Hidekazu; Okino, Akitoshi; Mitsuhara, Ichiro			Direct protein introduction into plant cells using a multi-gas plasma jet	PLOS ONE			English	Article							INACTIVATION; BACTERIA; DELIVERY	Protein introduction into cells is more difficult in plants than in mammalian cells, although it was reported that protein introduction was successful in shoot apical meristem and leaves only together with a cell-penetrating peptide. In this study, we tried to introduce superfolder green fluorescent protein (sGFP)-fused to adenylate cyclase as a reporter protein without a cell-penetrating peptide into the cells of tobacco leaves by treatment with atmospheric nonthermal plasmas. For this purpose, CO2 or N-2 plasma was generated using a multi-gas plasma jet. Confocal microscopy indicated that sGFP signals were observed inside of leaf cells after treatment with CO2 or N-2 plasma without substantial damage. In addition, the amount of cyclic adenosine monophosphate (cAMP) formed by the catalytic enzyme adenylate cyclase, which requires cellular calmodulin for its activity, was significantly increased in leaves treated with CO2 or N-2 plasma, also indicating the introduction of sGFP-fused adenylate cyclase into the cells. These results suggested that treatment with CO2 or N-2 plasma could be a useful technique for protein introduction into plant tissues.	[Yanagawa, Yuki; Mitsuhara, Ichiro] NARO, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Kawano, Hiroaki; Kobayashi, Tomohiro; Miyahara, Hidekazu; Okino, Akitoshi] Tokyo Inst Technol, Inst Innovat Res, FIRST, Midori Ku, Yokohama, Kanagawa, Japan	National Agriculture & Food Research Organization - Japan; Tokyo Institute of Technology	Yanagawa, Y; Mitsuhara, I (corresponding author), NARO, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	yyana@affrc.go.jp; mituhara@affrc.go.jp	Yanagawa, Yuki/A-7092-2016; Okino, Akitoshi/O-1804-2013	Okino, Akitoshi/0000-0002-8949-294X	KAKENHI [25440057]; Cabinet Office, Governmental of Japan; Bio-oriented Technology Research Advancement Institution, NARO	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cabinet Office, Governmental of Japan; Bio-oriented Technology Research Advancement Institution, NARO	This work was partly supported by KAKENHI (25440057) and Cabinet Office, Governmental of Japan, Cross-ministerial Strategic Innovation Promotion Program (SIP), Technologies for creating next-generation agriculture, forestry and fisheries (funding agency: Bio-oriented Technology Research Advancement Institution, NARO) to YY and IM, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dobrynin D, 2010, IEEE T PLASMA SCI, V38, P1878, DOI 10.1109/TPS.2010.2041938; Hasadsri L, 2009, J BIOL CHEM, V284, P6972, DOI 10.1074/jbc.M805956200; Hendriks W. T., 2015, CURR PROTOC STEM CEL, V34; Hofmann S, 2013, J PHYS D, V46; Ishaq M, 2015, PHYS PLASMAS, V22, DOI 10.1063/1.4933366; Iwai T, 2014, J ANAL ATOM SPECTROM, V29, P2108, DOI 10.1039/c4ja00205a; Iwai T, 2013, ANAL SCI, V29, P1141, DOI 10.2116/analsci.29.1141; Ji SH, 2015, PLASMA PROCESS POLYM, V12, P1164, DOI 10.1002/ppap.201500021; Jia JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091547; Jokinen V, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3673251; Kaburaki Y, 2013, ANAL SCI, V29, P1147, DOI 10.2116/analsci.29.1147; Kim MC, 2003, SURF COAT TECH, V171, P312, DOI 10.1016/S0257-8972(03)00292-5; Kondo Y, 2008, J IMMUNOL METHODS, V332, P10, DOI 10.1016/j.jim.2007.12.008; Lakshmanan M, 2013, BIOMACROMOLECULES, V14, P10, DOI 10.1021/bm301275g; Liu FX, 2010, PLASMA PROCESS POLYM, V7, P231, DOI 10.1002/ppap.200900070; Lu X, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/3/034005; Nakase I, 2008, ADV DRUG DELIVER REV, V60, P598, DOI 10.1016/j.addr.2007.10.006; Ng KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154081; Numata K, 2014, PLANT BIOTECHNOL J, V12, P1027, DOI 10.1111/pbi.12208; Oshita T, 2015, IEEE T PLASMA SCI, V43, P1987, DOI 10.1109/TPS.2015.2428696; Polak M, 2012, PLASMA PROCESS POLYM, V9, P67, DOI 10.1002/ppap.201000163; Sakakita Hajime, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.S2117; Shigeta K, 2010, IEEJ T FUNDAMENTALS, V130, P955; Shivas JM, 2010, TRENDS CELL BIOL, V20, P445, DOI 10.1016/j.tcb.2010.04.003; Takamatsu T, 2016, CURRENT MICROBIOLOGY, P1; Takamatsu T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135546; Takamatsu T, 2015, AIP ADV, V5, DOI 10.1063/1.4928034; Takamatsu T, 2014, RSC ADV, V4, P39901, DOI 10.1039/c4ra05936k; Takamatsu T, 2014, J TOXICOL SCI, V39, P281, DOI 10.2131/jts.39.281; Takamatsu T, 2013, IEEE T PLASMA SCI, V41, P119, DOI 10.1109/TPS.2012.2227459; Tamura T, 2011, IEEE T PLASMA SCI, V39, P1684, DOI 10.1109/TPS.2011.2155103; Tsuji H, 2013, Japan Patent, Patent No. [2013-053043, 2013053043]; von Keudell A, 2010, PLASMA PROCESS POLYM, V7, P327, DOI 10.1002/ppap.200900121; von Woedtke T, 2014, CONTRIB PLASM PHYS, V54, P104, DOI 10.1002/ctpp.201310068; Wang D, 2010, Japan Patent, Patent No. [2010-119524, 2010119524]	35	21	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171942	10.1371/journal.pone.0171942	http://dx.doi.org/10.1371/journal.pone.0171942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182666	gold, Green Submitted, Green Published			2022-12-26	WOS:000394231800135
J	Yao, YF; Song, XY; Wortley, AH; Wang, YF; Blackmore, S; Li, CS				Yao, Yi-Feng; Song, Xiao-Yan; Wortley, Alexandra H.; Wang, Yu-Fei; Blackmore, Stephen; Li, Cheng-Sen			Pollen-based reconstruction of vegetational and climatic change over the past similar to 30 ka at Shudu Lake in the Hengduan Mountains of Yunnan, southwestern China	PLOS ONE			English	Article							HOLOCENE VEGETATION; ENVIRONMENTAL-CHANGE; PROVINCE; HISTORY; PLEISTOCENE; DYNAMICS; RECORD; ASIA; KYR	The Hengduan Mountains, with a distinct altitudinal differentiation and strong vertical vegetation zonation, occupy an important position in southwestern China as a global hotspot of biodiversity. Pollen analysis of lake sediments sampled along an altitudinal gradient in this region helps us to understand how this vegetation zonation arose and how it has responded to climate change and human impacts through time. Here we present a similar to 30-ka pollen record and interpret it in terms of vegetational and climatic change from a 310 cm-long core from Shudu Lake, located in the Hengduan Mountains region. Our results suggest that from 30 to 22 cal. ka BP, the vegetation was dominated by steppe/grassland (comprising mainly Artemisia, Poaceae and Polygonaceae) and broad-leaved forest (primarily Quercus, Betula and Castanopsis) in the lake catchment, reflecting a relatively warm, wet climate early in this phase and slightly warmer, drier conditions late in the phase. The period between 22 and 13.9 cal. ka BP was marked by a large expansion of needle-and broad-leaved mixed forest (Pinus, Abies and Quercus) and a decline in the extent of steppe/grassland, indicating warming, drying climatic conditions followed by a cold, wet period. Between 13.9 and 3 cal. ka BP, steppe/grassland expanded and the area covered by needle-and broad-leaved mixed forest reduced, implying a fluctuating climate dominated by warm and humid conditions. After 3 cal. ka BP, the vegetation was characterized by an increase in needle-leaved forest and reduction in steppe/grassland, suggesting warming and drying climate. A synthesis of palynological investigations from this and other sites suggests that the vegetation succession patterns seen along an altitudinal gradient in northwestern Yunnan since the Late Pleistocene are comparable, but that each site has its own characteristics probably due to the influences of altitude, topography, microclimate and human impact.	[Yao, Yi-Feng; Wang, Yu-Fei; Li, Cheng-Sen] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Song, Xiao-Yan] Shanxi Agr Univ, Taigu, Shanxi, Peoples R China; [Wortley, Alexandra H.; Blackmore, Stephen] Royal Bot Garden Edinburgh, 20A Inverleith Row, Edinburgh, Midlothian, Scotland	Chinese Academy of Sciences; Institute of Botany, CAS; Shanxi Agricultural University	Yao, YF; Li, CS (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	yaoyf@ibcas.ac.cn; lics@ibcas.ac.cn	Wortley, Alexandra/AAQ-5568-2021		China National Key Basic Research Program [2014CB954201]; National Natural Science Foundation of China [41271222]; China Scholarship Council [201204910043]	China National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This research was supported by the China National Key Basic Research Program (No. 2014CB954201), National Natural Science Foundation of China (No. 41271222), and the visiting scholarship funded by China Scholarship Council (No. 201204910043).	An CB, 2013, J PALEOLIMNOL, V49, P145, DOI 10.1007/s10933-012-9649-7; Boufford DE, 2000, HOTSPOTS EARTHS BIOL; Bronk R, 2005, OXCAL PROGRAM V3 10; Cao XY, 2013, REV PALAEOBOT PALYNO, V194, P21, DOI 10.1016/j.revpalbo.2013.02.003; Chaplin George, 2005, Proceedings of the California Academy of Sciences, V56, P527; Cook CG, 2013, BOREAS, V42, P224, DOI 10.1111/j.1502-3885.2012.00287.x; Cook CG, 2012, QUATERNARY RES, V77, P132, DOI 10.1016/j.yqres.2011.09.011; Cook CG, 2011, QUATERNARY SCI REV, V30, P808, DOI 10.1016/j.quascirev.2011.01.003; ERDTMAN G., 1960, SVENSK BOT TIDSKR, V54, P561; Foster GC, 2008, HOLOCENE, V18, P935, DOI 10.1177/0959683608091799; Grimm EC, 2004, TILIA TILIA GRAPH 2; IBCAS (Institute of Botany Chinese Academy of Sciences), 1976, SPOR PTER SIN; IBSCIBCAS (Institute of Botany and South China Institute of Botany Chinese Academy of Sciences), 1982, ANG POLL FLOR TROP S; Jiang X. Z., 1998, J LAKE SCI, V10, P10; Jones RT, 2012, HYDROBIOLOGIA, V693, P223, DOI 10.1007/s10750-012-1124-y; Li Xi-Wen, 1994, Acta Botanica Yunnanica, V16, P221; Li XQ, 2011, QUATERNARY SCI REV, V30, P3457, DOI 10.1016/j.quascirev.2011.09.010; Li XQ, 1999, ACTA BOT SIN, V41, P782; LIN SM, 1986, J BIOGEOGR, V13, P419; MOOK WG, 1986, RADIOCARBON, V28, P799, DOI 10.1017/S0033822200008043; Moore P.D., 1991, BLACKWELL SCI PUBLI; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Nature Conservancy Council, 2011, CHIN PLAC WE PROT CH; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Shen J, 2006, HOLOCENE, V16, P265, DOI 10.1191/0959683606hl923rp; [石胜强 SHI Shengqiang], 2011, [中国岩溶, Carsologica Sinica], V30, P119; Song XY, 2012, CLIMATIC CHANGE, V113, P841, DOI 10.1007/s10584-011-0364-6; UNESCO, 2011, WORLD HER LIST 3 PAR; Wang FX, 1995, POLLEN FLORA CHINA; WGYV (Writing Group of Yunnan Vegetation), 1987, VEG OF YUNN; Xiao XY, 2014, QUATERNARY SCI REV, V86, P35, DOI 10.1016/j.quascirev.2013.12.023; Yao YF, 2015, BIOGEOSCIENCES, V12, P1525, DOI 10.5194/bg-12-1525-2015; [姚远 Yao Yuan], 2008, [沉积学报, Acta Sedimentologica Sinica], V26, P294; Yao Yuan, 2007, Marine Geology & Quaternary Geology, V27, P115; Yao Yuan, 2008, Hupo Kexue, V20, P486; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; Zhao Y, 2007, REV PALAEOBOT PALYNO, V145, P275, DOI 10.1016/j.revpalbo.2006.12.002	37	7	10	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171967	10.1371/journal.pone.0171967	http://dx.doi.org/10.1371/journal.pone.0171967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182711	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800139
J	Balekouzou, A; Yin, P; Afewerky, HK; Bekolo, C; Pamatika, CM; Nambei, SW; Djeintote, M; Doumgba, AD; Mossoro-Kpinde, CD; Shu, C; Yin, MH; Fu, Z; Qing, TT; Yan, MM; Zhang, JY; Chen, SJ; Li, HY; Xu, ZY; Koffi, B				Balekouzou, Augustin; Yin, Ping; Afewerky, Henok Kessete; Bekolo, Cavin; Pamatika, Christian Maucler; Nambei, Sylvain Wilfrid; Djeintote, Marceline; Doumgba, Antoine Doui; Mossoro-Kpinde, Christian Diamont; Shu, Chang; Yin, Minghui; Fu, Zhen; Qing, Tingting; Yan, Mingming; Zhang, Jianyuan; Chen, Shaojun; Li, Hongyu; Xu, Zhongyu; Koffi, Boniface			Behavioral risk factors of breast cancer in Bangui of Central African Republic: A retrospective case-control study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SOCIOECONOMIC-STATUS; WOMEN; EPIDEMIOLOGY; POPULATION; ALCOHOL; AREAS; URBAN	Breast cancer is recognized as a major public health problem in developing countries; however, there is very little evidence of behavioral factors associated with breast cancer risk. This study was conducted to identify lifestyles as risk factors for breast cancer among Central African women. A case-control study was conducted with 174 cases confirmed histologically by the pathology unit of the National Laboratory and 348 age-matched controls. Data collection tools included a questionnaire with interviews and medical records of patients. Data were analyzed using SPSS software version 20. Odd ratio (OR) and 95% confidence intervals (95% CI) were obtained by unconditional logistic regression. In total, 522 women were studied with a mean age of 45.8 (SD = 13.4) years. By unconditional logistic regression model, women with breast cancer were more likely to have attained illiterate and elementary education level [11.23 (95% CI, 4.65-27.14) and 2.40 (95% CI, 1.15-4.99)], married [2.09 (95% CI, 1.18-3.71)], positive family history [2.31 (95% CI, 1.36-3.91)], radiation exposure [8.21 (95% CI, 5.04-13.38)], consumption charcuterie [10.82 (95% CI, 2.39-48.90)], fresh fish consumption [4.26 (95% CI, 1.56-11.65)], groundnut consumption [6.46 (95% CI, 2.57-16.27)], soybean consumption [16.74 (95% CI, 8.03-39.84)], alcohol [2.53 (95% CI, 1.39-4.60)], habit of keeping money in bras[3.57 (95% CI, 2.24-5.69)], overweight [5.36 (95% CI, 4.46-24.57)] and obesity [3.11(95% CI, 2.39-20.42)]. However, decreased risk of breast cancer was associated with being employed [0.32 (95% CI, 0.19-0.56)], urban residence [0.16 (95% CI, 0.07-0.37)], groundnut oil consumption [0.05 (95% CI, 0.02-0.14)], wine consumption [0.16 (95% CI, 0.09-0.26)], non habit of keeping cell phone in bras [0.56 (95% CI, 0.35-0.89)] and physical activity [0.71(95% CI, 0.14-0.84)]. The study showed that little or no education, marriage, positive family history of cancer, radiation exposure, charcuterie, fresh fish, groundnut, soybean, alcohol, habit of keeping money in bras, overweight and obesity were associated with breast cancer risk among Central African women living in Bangui. Women living in Bangui should be more cautious on the behavioral risk associated with breast cancer.	[Balekouzou, Augustin; Yin, Ping; Shu, Chang; Yin, Minghui; Fu, Zhen; Qing, Tingting; Yan, Mingming; Zhang, Jianyuan; Chen, Shaojun; Li, Hongyu; Xu, Zhongyu] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan, Peoples R China; [Afewerky, Henok Kessete] Huazhong Univ Sci & Technol, Dept Pathol & Pathophysiol, Tongji Med Coll, Wuhan, Peoples R China; [Bekolo, Cavin] Ctr Med Arrondissement Bare, Minist Publ Hlth, Yaounde, Cameroon; [Pamatika, Christian Maucler] Hosp Lab Friendship Bangui, Bangui, Cent Afr Republ; [Nambei, Sylvain Wilfrid; Doumgba, Antoine Doui] Univ Bangui, Fac Hlth Sci, Bangui, Cent Afr Republ; [Djeintote, Marceline; Mossoro-Kpinde, Christian Diamont; Koffi, Boniface] Natl Lab Clin Biol & Publ Hlth, Bangui, Cent Afr Republ	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yin, P (corresponding author), Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan, Peoples R China.	pingyin2000@126.com	Yan, Mingming/ABG-1298-2021; Bekolo, Cavin Epie/HIR-2638-2022; Afewerky, Henok Kessete/AAD-4371-2022	Bekolo, Cavin Epie/0000-0002-9845-9842; Afewerky, Henok Kessete/0000-0001-7030-3224				Ahmed Kawsar, 2015, Asian Pac J Cancer Prev, V16, P7507; Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; [Anonymous], 2014, REP WCRFIAIFCRCUP DI; Ayari I, 2013, MOL MED REP, V7, P280, DOI 10.3892/mmr.2012.1164; Bhadoria AS, 2013, INDIAN J CANCER, V50, P316, DOI 10.4103/0019-509X.123606; Boffetta P, 2014, SPRING CANC RES, P11, DOI 10.1007/978-3-319-05068-3_3; Boice JD, 1996, MED PEDIATR ONCOL, P29; Bratten T, 2004, INT J CANCER, V110, P579, DOI 10.1002/ijc.20141; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Carmichael AR, 2010, EJSO-EUR J SURG ONC, V36, P1139, DOI 10.1016/j.ejso.2010.09.011; Chan SW, 2016, ASIAN J SURG, pS1015; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; COLDITZ GA, 2006, CANC EPIDEMIOLOGY PR, P995; Cunningham R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-674; Ekenga CC, 2015, CANCER CAUSE CONTROL, V26, P1779, DOI 10.1007/s10552-015-0671-8; Elgaili EM, 2010, INT J WOMENS HEALTH, V2, P77; Ferlay J, 2013, IARC CANCERBASE; Galukande M, 2016, ONCOLOGY-BASEL, V90, P356, DOI 10.1159/000445379; Gao CM, 2014, ASIAN PAC J CANCER P, V15, P7879, DOI 10.7314/APJCP.2014.15.18.7879; Gathani T, 2014, BRIT J CANCER, V110, P224, DOI 10.1038/bjc.2013.632; Ghiasvand R, 2011, INT J CANCER, V129, P1443, DOI 10.1002/ijc.25748; Goldberg M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1931-4; Goncalves AK, 2014, J PHYS ACT HEALTH, V11, P445, DOI 10.1123/jpah.2011-0316; Hosseinzadeh M, 2014, J BREAST CANCER, V17, P236, DOI 10.4048/jbc.2014.17.3.236; Jatoi I, 2010, FUTURE ONCOL, V6, P1781, DOI 10.2217/FON.10.139; John CT, 2012, RES NETWORK SOCIOECO; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Koffi B, 2004, MED AFR NOIRE, V1, P112; Krueger J., 2001, INT ENCY SOCIAL BEHA, P14219; Linos E, 2010, CANCER EPIDEM BIOMAR, V19, P689, DOI 10.1158/1055-9965.EPI-09-0802; Liu XO, 2014, ASIAN PAC J CANCER P, V15, P1291, DOI 10.7314/APJCP.2014.15.3.1291; Lowcock EC, 2013, NUTR CANCER, V65, P398, DOI 10.1080/01635581.2013.768348; Ly M, 2011, B CANCER, V98, P797, DOI 10.1684/bdc.2011.1392; Mandal A, 2014, BREAST CANC EPIDEMIO; Sanchez-Zamorano LM, 2011, CANCER EPIDEM BIOMAR, V20, P912, DOI 10.1158/1055-9965.EPI-10-1036; Mayor S., 2011, BRIT J CANCER, V105, P1443; McCormack VA, 2011, ANN ONCOL, V22, P2349, DOI 10.1093/annonc/mdq763; Mohaghegh P, 2015, IRAN J CANCER PREV, V8, P53; Nagrani RT, 2014, INDIAN J CANCER, V51, P277, DOI 10.4103/0019-509X.146793; Neilson HK, 2009, CANCER EPIDEM BIOMAR, V18, P11, DOI 10.1158/1055-9965.EPI-08-0756; Ogundiran TO, 2010, AM J EPIDEMIOL, V172, P682, DOI 10.1093/aje/kwq180; Okobia M, 2006, INT J CANCER, V119, P2179, DOI 10.1002/ijc.22102; Qian F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106908; Sepandi M, 2014, ASIAN PAC J CANCER P, V15, P8499, DOI 10.7314/APJCP.2014.15.19.8499; Serdouma E, 2006, MED AFR NOIRE, V53, P572; Shaukat U, 2013, ASIAN PAC J CANCER P, V14, P5625, DOI 10.7314/APJCP.2013.14.10.5625; Si S, 2015, BREAST CANCER RES TR, V152, P449, DOI 10.1007/s10549-015-3489-x; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; Soriano-Hernandez AD, 2015, GYNECOL OBSTET INVES, V80, P89, DOI 10.1159/000369997; Strand BH, 2007, EUR J CANCER, V43, P1200, DOI 10.1016/j.ejca.2007.01.021; Veisy Afsaneh, 2015, Asian Pac J Cancer Prev, V16, P451; Wang F, 2015, J INT MED RES, V43, P774, DOI 10.1177/0300060515592901; Wierzejska Regina, 2015, Rocz Panstw Zakl Hig, V66, P293; World Health Organization, 2014, COUNTR PROF CANC; Wu YL, 2013, BREAST CANCER RES TR, V137, P869, DOI 10.1007/s10549-012-2396-7; Yang DY, 2003, CANCER, V97, P2565, DOI 10.1002/cncr.11364; Zare N, 2013, J BREAST CANCER, V16, P214, DOI 10.4048/jbc.2013.16.2.214; Zhang CX, 2011, CANCER CAUSE CONTROL, V22, P115, DOI 10.1007/s10552-010-9681-8	58	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171154	10.1371/journal.pone.0171154	http://dx.doi.org/10.1371/journal.pone.0171154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178283	Green Published, Green Submitted, gold			2022-12-26	WOS:000393712500026
J	Ozawa, T; Yamada, K; Ichitani, Y				Ozawa, Takaaki; Yamada, Kazuo; Ichitani, Yukio			Differential requirements of hippocampal de novo protein and mRNA synthesis in two long-term spatial memory tests: Spontaneous place recognition and delay-interposed radial maze performance in rats	PLOS ONE			English	Article							APPETITIVE LEARNING-PARADIGM; WORKING-MEMORY; SYNTHESIS INHIBITOR; DORSAL HIPPOCAMPUS; OBJECT-LOCATION; APIS-MELLIFERA; FEAR MEMORY; RETRIEVAL; RECONSOLIDATION; CONSOLIDATION	Hippocampal de novo mRNA and protein synthesis has been suggested to be critical for long-term spatial memory. However, its requirement in each memory process (i.e. encoding, consolidation and retrieval) and the differences in the roles of de novo mRNA and protein synthesis in different situations where spatial memory is tested have not been thoroughly investigated. To address these questions, we examined the effects of hippocampal administration of the protein synthesis inhibitors, anisomycin (ANI) and emetine (EME), as well as that of an mRNA synthesis inhibitor, 5,6-dichlorobenzimidazole 1-I3-D-ribofuranoside (DRB), on rat performance in two long-term spatial memory tests. In a spontaneous place recognition test with a 6 h delay, ANI, administered either before or immediately after the sample phase, but not before the test phase, eliminated the exploratory preference for the object in a novel place. This amnesic effect was replicated by both EME and DRB. In a 6 h delay-interposed radial maze task, however, administering ANI before the first-half and before the second-half, but not immediately or 2 h after the first-half, impaired performance in the second-half. This disruptive effect of ANI was successfully replicated by EME. However, DRB administered before the first-half performance did not impair the second-half performance, while it did impair it if injected before the second-half. None of these drugs caused amnesic effects during the short (5 min)/non-delayed conditions in either tests. These results suggest that 1) hippocampal protein synthesis is required for the consolidation of spatial memory, while mRNA synthesis is not necessarily required, and 2) hippocampal mRNA and protein synthesis requirement for spatial memory retrieval depends on the types of memory tested, probably because their demands are different.	[Ozawa, Takaaki; Yamada, Kazuo; Ichitani, Yukio] Univ Tsukuba, Inst Psychol & Behav Neurosci, Tsukuba, Ibaraki, Japan; [Ozawa, Takaaki] Univ Geneva, Dept Basic Neurosci, Rue Michel Servet, Geneva, Switzerland	University of Tsukuba; University of Geneva	Ichitani, Y (corresponding author), Univ Tsukuba, Inst Psychol & Behav Neurosci, Tsukuba, Ibaraki, Japan.	y-ichit@human.tsukuba.ac.jp		Ozawa, Takaaki/0000-0003-3633-7062	Japan Society for the Promotion of Science [26590174, 16K04419, 15K04180]; Grants-in-Aid for Scientific Research [15K04180] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Japan Society for the Promotion of Science to Y.I. (26590174,16K04419) and to K.Y. (15K04180).	Bast T, 2005, J NEUROSCI, V25, P5845, DOI 10.1523/JNEUROSCI.0698-05.2005; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Berman DE, 2000, J NEUROSCI, V20, P7017, DOI 10.1523/JNEUROSCI.20-18-07017.2000; Bohbot V, 1996, P NATL ACAD SCI USA, V93, P4016, DOI 10.1073/pnas.93.9.4016; Canal CE, 2007, P NATL ACAD SCI USA, V104, P12500, DOI 10.1073/pnas.0705195104; Da Silva WC, 2008, HIPPOCAMPUS, V18, P29, DOI 10.1002/hipo.20362; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Igaz LM, 2002, J NEUROSCI, V22, P6781; Kraus M, 2002, LEARN MEMORY, V9, P293, DOI 10.1101/lm.47502; Liang K C, 1994, Chin J Physiol, V37, P201; Lima RH, 2009, NEUROBIOL LEARN MEM, V91, P466, DOI 10.1016/j.nlm.2008.12.009; Lin CH, 2003, J NEUROSCI, V23, P8310; Lopez J, 2015, J NEUROSCI, V35, P2465, DOI 10.1523/JNEUROSCI.0735-14.2015; Manahan-Vaughan D, 2000, J NEUROSCI, V20, P8572, DOI 10.1523/JNEUROSCI.20-22-08572.2000; Meiri N, 1998, BRAIN RES, V789, P48, DOI 10.1016/S0006-8993(97)01528-X; MIZUMORI SJY, 1985, BEHAV NEUROSCI, V99, P220, DOI 10.1037/0735-7044.99.2.220; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; OVERTON DA, 1974, FED PROC, V33, P1800; Ozawa T, 2011, NEUROSCI LETT, V497, P37, DOI 10.1016/j.neulet.2011.04.022; Parsons RG, 2006, EUR J NEUROSCI, V23, P1853, DOI 10.1111/j.1460-9568.2006.04723.x; PATTERSON TA, 1988, NEUROCHEM RES, V13, P643, DOI 10.1007/BF00973282; Paxinos G., 1998, RAT BRAIN STEREOTAXI, Vfourth; Qi ZH, 2009, LEARN MEMORY, V16, P308, DOI 10.1101/lm.1333409; Richter K, 2005, LEARN MEMORY, V12, P407, DOI 10.1101/lm.97505; Rodriguez-Ortiz CJ, 2008, NEUROBIOL LEARN MEM, V89, P352, DOI 10.1016/j.nlm.2007.10.004; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Rossato JI, 2015, NEUROBIOL LEARN MEM, V125, P146, DOI 10.1016/j.nlm.2015.09.001; Sajadi AA, 2006, BEHAV BRAIN RES, V173, P158, DOI 10.1016/j.bbr.2006.06.018; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Solntseva S, 2012, BRAIN RES, V1467, P42, DOI 10.1016/j.brainres.2012.05.051; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Stollhoff N, 2005, J NEUROSCI, V25, P4485, DOI 10.1523/JNEUROSCI.0117-05.2005; Stollhoff N, 2008, NEUROBIOL LEARN MEM, V89, P419, DOI 10.1016/j.nlm.2007.10.003; Wanisch K, 2008, BEHAV BRAIN RES, V186, P191, DOI 10.1016/j.bbr.2007.08.008; Yoshihara T, 2004, NEUROSCIENCE, V129, P1, DOI 10.1016/j.neuroscience.2004.07.030	37	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171629	10.1371/journal.pone.0171629	http://dx.doi.org/10.1371/journal.pone.0171629			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178292	Green Published, Green Submitted, gold			2022-12-26	WOS:000393712500055
J	Sapkota, A; Gaire, BP; Cho, KS; Jeon, SJ; Kwon, OW; Jang, DS; Kim, SY; Ryu, JH; Choi, JW				Sapkota, Arjun; Gaire, Bhakta Prasad; Cho, Kyu Suk; Jeon, Se Jin; Kwon, Oh Wook; Jang, Dae Sik; Kim, Sun Yeou; Ryu, Jong Hoon; Choi, Ji Woong			Eupatilin exerts neuroprotective effects in mice with transient focal cerebral ischemia by reducing microglial activation	PLOS ONE			English	Article							NF-KAPPA-B; CELL-DEATH; STROKE; EXPRESSION; NEUROINFLAMMATION; MECHANISMS; EXTRACT; DAMAGE; NEUROTOXICITY; INHIBITION	Microglial activation and its-driven neuroinflammation are characteristic pathogenetic features of neurodiseases, including focal cerebral ischemia. The Artemisia asiatica (Asteraceae) extract and its active component, eupatilin, are well-known to reduce inflammatory responses. But the therapeutic potential of eupatilin against focal cerebral ischemia is not known, along with its anti-inflammatory activities on activated microglia. In this study, we investigated the neuroprotective effect of eupatilin on focal cerebral ischemia through its anti-inflammation, particularly on activated microglia, employing a transient middle cerebral artery occlusion/reperfusion (tMCAO), combined with lipopolysaccharide-stimulated BV2 microglia. Eupatilin exerted anti-inflammatory responses in activated BV2 microglia, in which it reduced secretion of well-known inflammatory markers, including nitrite, IL-6, TNF-alpha, and PGE(2), in a concentration-dependent manner. These observed in vitro effects of eupatilin led to in vivo neuroprotection against focal cerebral ischemia. Oral administration of eupatilin (10 mg/kg) in a therapeutic paradigm significantly reduced brain infarction and improved neurological functions in tMCAO-challenged mice. The same benefit was also observed when eupatilin was given even within 5 hours after MCAO induction. In addition, the neuroprotective effects of a single administration of eupatilin (10 mg/kg) immediately after tMCAO challenge persisted up to 3 days after tMCAO. Eupatilin administration reduced the number of Iba1-immunopositive cells across ischemic brain and induced their morphological changes from amoeboid into ramified in the ischemic core, which was accompanied with reduced microglial proliferation in ischemic brain. Eupatilin suppressed NF-kappa B signaling activities in ischemic brain by reducing IKK alpha/beta phosphorylation, I kappa B alpha phosphorylation, and I kappa B alpha degradation. Overall, these data indicate that eupatilin is a neuroprotective agent against focal cerebral ischemia through the reduction of microglial activation.	[Sapkota, Arjun; Gaire, Bhakta Prasad; Kwon, Oh Wook; Kim, Sun Yeou; Choi, Ji Woong] Gachon Univ, Coll Pharm, Incheon, South Korea; [Sapkota, Arjun; Gaire, Bhakta Prasad; Kwon, Oh Wook; Kim, Sun Yeou; Choi, Ji Woong] Gachon Univ, Gachon Inst Pharmaceut Sci, Incheon, South Korea; [Cho, Kyu Suk; Jeon, Se Jin; Jang, Dae Sik; Ryu, Jong Hoon] Kyung Hee Univ, Dept Oriental Pharmaceut Sci, Coll Pharm, Seoul, South Korea	Gachon University; Gachon University; Kyung Hee University	Choi, JW (corresponding author), Gachon Univ, Coll Pharm, Incheon, South Korea.; Choi, JW (corresponding author), Gachon Univ, Gachon Inst Pharmaceut Sci, Incheon, South Korea.	pharmchoi@gachon.ac.kr	Jang, Dae Sik/AAI-4526-2020; Gaire, Bhakta Prasad/I-7776-2019; Gaire, Bhakta Prasad/AAA-4211-2020; Jeon, Sejin/GWU-7864-2022		National Research Foundation; Ministry of Health and Welfare - Korean government [NRF-2013R1A1A1A05005520, NRF-2014M3A9B6069339, HI13C18200000]	National Research Foundation; Ministry of Health and Welfare - Korean government	This work was supported by grants from the National Research Foundation and Ministry of Health and Welfare funded by the Korean government to JWC (NRF-2013R1A1A1A05005520, NRF-2014M3A9B6069339, and HI13C18200000).	Boscia F, 2009, STROKE, V40, P3608, DOI 10.1161/STROKEAHA.109.557439; Cai M, 2012, EUR J PHARMACOL, V689, P104, DOI 10.1016/j.ejphar.2012.05.042; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Choi EJ, 2008, PHARM RES, V25, P1355, DOI 10.1007/s11095-008-9531-5; Choi EJ, 2011, LIFE SCI, V88, P1121, DOI 10.1016/j.lfs.2011.04.011; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; Gaire BP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120203; Gao SF, 2016, NEUROPHARMACOLOGY, V103, P44, DOI 10.1016/j.neuropharm.2015.12.002; Hahm KB, 1998, PANCREAS, V17, P153, DOI 10.1097/00006676-199808000-00007; Harari OA, 2010, ANN NY ACAD SCI, V1207, P32, DOI 10.1111/j.1749-6632.2010.05735.x; Herrmann O, 2005, NAT MED, V11, P1322, DOI 10.1038/nm1323; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jeon JI, 2015, SCAND J IMMUNOL, V81, P166, DOI 10.1111/sji.12263; Jeong D, 2014, J ETHNOPHARMACOL, V152, P487, DOI 10.1016/j.jep.2014.01.030; Jeong HJ, 2015, ARCH PHARM RES, V38, P1223, DOI 10.1007/s12272-014-0472-8; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Jung J, 2012, IMMUNOLOGY, V137, P98, DOI 10.1111/j.1365-2567.2012.03618.x; Kaushal V, 2008, J NEUROSCI, V28, P2221, DOI 10.1523/JNEUROSCI.5643-07.2008; Kim EK, 2015, J MED FOOD, V18, P921, DOI 10.1089/jmf.2014.3344; Kim JM, 2009, CLIN EXP IMMUNOL, V155, P541, DOI 10.1111/j.1365-2249.2008.03849.x; Lapchak PA, 2010, EXPERT OPIN PHARMACO, V11, P1753, DOI 10.1517/14656566.2010.493558; Lee S, 2008, FOOD CHEM TOXICOL, V46, P2865, DOI 10.1016/j.fct.2008.05.026; Li T, 2013, BRAIN, V136, P3578, DOI 10.1093/brain/awt287; Lim BO, 2008, PHYTOTHER RES, V22, P279, DOI 10.1002/ptr.2304; Min SW, 2009, J ETHNOPHARMACOL, V125, P497, DOI 10.1016/j.jep.2009.06.001; Nam Y, 2013, PHYTOTHER RES, V27, P404, DOI 10.1002/ptr.4737; Nurmi A, 2004, STROKE, V35, P987, DOI 10.1161/01.STR.0000120732.45951.26; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Park JM, 2015, J CLIN BIOCHEM NUTR, V56, P132, DOI 10.3164/jcbn.14-76; Park SW, 2008, J GASTROEN HEPATOL, V23, P976, DOI 10.1111/j.1440-1746.2008.05333.x; Pereira MP, 2006, J CEREBR BLOOD F MET, V26, P218, DOI 10.1038/sj.jcbfm.9600182; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Ryu BK, 1998, ARCH PHARM RES, V21, P508, DOI 10.1007/BF02975366; Ryu Ri, 2013, Prev Nutr Food Sci, V18, P181, DOI 10.3746/pnf.2013.18.3.181; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Shah IM, 2009, CURR MOL MED, V9, P336, DOI 10.2174/156652409787847236; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14	39	42	45	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171479	10.1371/journal.pone.0171479	http://dx.doi.org/10.1371/journal.pone.0171479			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178289	gold, Green Submitted, Green Published			2022-12-26	WOS:000393712500045
J	Eroh, GD; Clayton, FC; Florell, SR; Cassidy, PB; Chirife, A; Maron, CF; Valenzuela, LO; Campbell, MS; Seger, J; Rowntree, VJ; Leachman, SA				Eroh, Guy D.; Clayton, Fred C.; Florell, Scott R.; Cassidy, Pamela B.; Chirife, Andrea; Maron, Carina F.; Valenzuela, Luciano O.; Campbell, Michael S.; Seger, Jon; Rowntree, Victoria J.; Leachman, Sancy A.			Cellular and ultrastructural characterization of the grey-morph phenotype in southern right whales (Eubalaena australis)	PLOS ONE			English	Article							WAARDENBURG-SYNDROME TYPE-2; NEURAL CREST; TRANSCRIPTION FACTOR; HUMAN PIEBALDISM; MITF GENE; EVOLUTIONARY SIGNIFICANCE; ULTRAVIOLET-RADIATION; HIRSCHSPRUNG-DISEASE; HOMOZYGOUS MUTATION; ENDOTHELIN-3 GENE	Southern right whales (SRWs, Eubalena australis) are polymorphic for an X-linked pigmentation pattern known as grey morphism. Most SRWs have completely black skin with white patches on their bellies and occasionally on their backs; these patches remain white as the whale ages. Grey morphs (previously referred to as partial albinos) appear mostly white at birth, with a splattering of rounded black marks; but as the whales age, the white skin gradually changes to a brownish grey color. The cellular and developmental bases of grey morphism are not understood. Here we describe cellular and ultrastructural features of grey-morph skin in relation to that of normal, wild-type skin. Melanocytes were identified histologically and counted, and melanosomes were measured using transmission electron microscopy. Grey-morph skin had fewer melanocytes when compared to wild-type skin, suggesting reduced melanocyte survival, migration, or proliferation in these whales. Grey-morph melanocytes had smaller melanosomes relative to wild-type skin, normal transport of melanosomes to surrounding keratinocytes, and normal localization of melanin granules above the keratinocyte nuclei. These findings indicate that SRW grey-morph pigmentation patterns are caused by reduced numbers of melanocytes in the skin, as well as by reduced amounts of melanin production and/or reduced sizes of mature melanosomes. Grey morphism is distinct from piebaldism and albinism found in other species, which are genetic pigmentation conditions resulting from the local absence of melanocytes, or the inability to synthesize melanin, respectively.	[Eroh, Guy D.; Cassidy, Pamela B.; Leachman, Sancy A.] Huntsman Canc Inst, Salt Lake City, UT 84103 USA; [Eroh, Guy D.] Univ Georgia, Athens, GA 30602 USA; [Clayton, Fred C.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Florell, Scott R.] Univ Utah, Dept Dermatol, Salt Lake City, UT USA; [Cassidy, Pamela B.; Leachman, Sancy A.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Chirife, Andrea] Programa Monitoreo Sanitario Ballena Franca Austr, Puerto Madryn, Chubut, Argentina; [Maron, Carina F.; Valenzuela, Luciano O.; Seger, Jon; Rowntree, Victoria J.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Rowntree, Victoria J.] Inst Conservac Ballenas, Buenos Aires, DF, Argentina; [Valenzuela, Luciano O.] Univ Nacl Ctr Prov Buenos Aires, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Sociales, Buenos Aires, DF, Argentina; [Campbell, Michael S.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Campbell, Michael S.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Rowntree, Victoria J.] Ocean Alliance Whale Conservat Inst, Gloucester, MA USA	Huntsman Cancer Institute; University System of Georgia; University of Georgia; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Oregon Health & Science University; Utah System of Higher Education; University of Utah; Comision Nacional de Energia Atomica (CNEA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Utah System of Higher Education; University of Utah; Cold Spring Harbor Laboratory	Leachman, SA (corresponding author), Huntsman Canc Inst, Salt Lake City, UT 84103 USA.; Leachman, SA (corresponding author), Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA.	leachmas@ohsu.edu		Valenzuela, Luciano/0000-0002-5024-6581	Division Of Environmental Biology [1051491] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; BALDWIN CT, 1995, AM J MED GENET, V58, P115, DOI 10.1002/ajmg.1320580205; Baxter LL, 2013, WIRES DEV BIOL, V2, P379, DOI 10.1002/wdev.72; Baxter LL, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq025; Beadle GW, 1941, P NATL ACAD SCI USA, V27, P499, DOI 10.1073/pnas.27.11.499; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; BEST PB, 1990, S AFR J ZOOL, V25, P114; Bonaventure J, 2013, PIGM CELL MELANOMA R, V26, P316, DOI 10.1111/pcmr.12080; Bondanza S, 2007, J INVEST DERMATOL, V127, P676, DOI 10.1038/sj.jid.5700639; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Bondurand N, 2007, AM J HUM GENET, V81, P1169, DOI 10.1086/522090; BREATHNACH AS, 1965, J INVEST DERMATOL, V45, P28, DOI 10.1038/jid.1965.87; BRUMBAUGH JA, 1971, DEV BIOL, V24, P392, DOI 10.1016/0012-1606(71)90088-1; COMMINGS DE, 1966, J AMER MED ASSOC, V195, P519; DASILVA EO, 1991, AM J MED GENET, V40, P65, DOI 10.1002/ajmg.1320400113; Desmoulins A., 1822, DICT CLASSIQUE HIST, V2, P161; Dessinioti C, 2009, EXP DERMATOL, V18, P741, DOI 10.1111/j.1600-0625.2009.00896.x; Domyan ET, 2014, CURR BIOL, V24, P459, DOI 10.1016/j.cub.2014.01.020; Donoghue PCJ, 2008, BIOESSAYS, V30, P530, DOI 10.1002/bies.20767; Dumaz N, 2014, MELANOMA RES; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Florell SR, 2001, MODERN PATHOL, V14, P116, DOI 10.1038/modpathol.3880267; GIEBEL LB, 1991, P NATL ACAD SCI USA, V88, P8696, DOI 10.1073/pnas.88.19.8696; Gonzalez-Conejero R, 2003, BRIT J HAEMATOL, V123, P132, DOI 10.1046/j.1365-2141.2003.04557.x; Hodgkinson CA, 1998, HUM MOL GENET, V7, P703, DOI 10.1093/hmg/7.4.703; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; HOTH CF, 1993, AM J HUM GENET, V52, P455; INGRAM VM, 1957, NATURE, V180, P326, DOI 10.1038/180326a0; JACKSON IJ, 1988, P NATL ACAD SCI USA, V85, P4392, DOI 10.1073/pnas.85.12.4392; Jin EJ, 2001, DEV BIOL, V233, P22, DOI 10.1006/dbio.2001.0222; Kadekaro AL, 2010, FASEB J, V24, P3850, DOI 10.1096/fj.10-158485; Kaliszewska ZA, 2005, MOL ECOL, V14, P3439, DOI 10.1111/j.1365-294X.2005.02664.x; Kos R, 2001, DEVELOPMENT, V128, P1467; Kronforst MR, 2012, PIGM CELL MELANOMA R, V25, P411, DOI 10.1111/j.1755-148X.2012.01014.x; KUGELMAN TP, 1961, YALE J BIOL MED, V33, P407; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P23033, DOI 10.1074/jbc.273.36.23033; Martinez-Levasseur LM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02386; McAloose D, 2016, DIS AQUAT ORGAN, V119, P17, DOI 10.3354/dao02986; Montoliu L, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12167; Morey Celine, 2010, Ann N Y Acad Sci, V1214, pE18, DOI 10.1111/j.1749-6632.2010.05943.x; Mort RL, 2015, DEVELOPMENT, V142, P620, DOI 10.1242/dev.106567; Nitzan E, 2013, P NATL ACAD SCI USA, V110, P12709, DOI 10.1073/pnas.1306287110; Nitzan E, 2013, DEVELOPMENT, V140, P2269, DOI 10.1242/dev.093294; Payne R., 1986, Reports of the International Whaling Commission Special Issue, P161; Payne R., 1983, COMMUNICATION BEHAV, P371; Pfeiffer CJ, 1996, J SUBMICR CYTOL PATH, V28, P277; Picardo M, 2011, J INVEST DERMATOL, V131, P1182, DOI 10.1038/jid.2011.67; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Plouhinec JL, 2014, DEV BIOL, V386, P461, DOI 10.1016/j.ydbio.2013.12.010; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Reeb D, 2007, ANAT REC, V290, P596, DOI 10.1002/ar.20535; Reissmann M, 2013, SEMIN CELL DEV BIOL, V24, P576, DOI 10.1016/j.semcdb.2013.03.014; Sanchez-Martin M, 2002, HUM MOL GENET, V11, P3231, DOI 10.1093/hmg/11.25.3231; Sanchez-Martin MS, 2003, AM J MED GENET A, V122A, P125, DOI 10.1002/ajmg.a.20345; Schaeff CM, 1999, J HERED, V90, P464, DOI 10.1093/jhered/90.4.464; Schaeff CM, 1999, MAR MAMMAL SCI, V15, P701, DOI 10.1111/j.1748-7692.1999.tb00837.x; Schell DM, 2000, CAN J ZOOL, V78, P721, DOI 10.1139/cjz-78-5-721; Sironi M, 2012, INT WHAL COMM UNPUB; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Tompkins N, 2014, P NATL ACAD SCI USA, V111, P4397, DOI 10.1073/pnas.1322005111; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Verheij JBGM, 2002, AM J MED GENET, V108, P223, DOI 10.1002/ajmg.10172; Watanabe KI, 2002, PIGM CELL RES, V15, P201, DOI 10.1034/j.1600-0749.2002.01080.x; Wei AH, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12051	70	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171449	10.1371/journal.pone.0171449	http://dx.doi.org/10.1371/journal.pone.0171449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170433	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000393705500038
J	Sankpal, NV; Fleming, TP; Sharma, PK; Wiedner, HJ; Gillanders, WE				Sankpal, N. V.; Fleming, T. P.; Sharma, P. K.; Wiedner, H. J.; Gillanders, W. E.			A double-negative feedback loop between EpCAM and ERK contributes to the regulation of epithelial-mesenchymal transition in cancer	ONCOGENE			English	Article							BREAST-CANCER; STEM-CELLS; E-CADHERIN; CLAUDIN-LOW; THERAPEUTIC TARGET; EXPRESSION; METASTASIS; RESISTANCE; PROGNOSIS; ADHESION	Epithelial-mesenchymal transition (EMT) is an important biological process that has been implicated in cancer metastasis. Epithelial cell adhesion molecule (EpCAM) is expressed at the basolateral membrane of most normal epithelial cells but is overexpressed in many epithelial cancers. In our studies on the role of EpCAM in cancer biology, we observed that EpCAM expression is decreased in mesenchymal-like primary cancer specimens in vivo and following induction of EMT in cancer cell lines in vitro. Extracellular signal-related kinase (ERK) is a key regulator of EMT. We observed that EpCAM expression is decreased with activation of the ERK pathway in primary cancer specimens in vivo and in cancer cell lines in vitro. In experimental models, growth factor stimulation and/or oncogene-induced ERK2 activation suppressed EpCAM expression, whereas genetic or pharmacological inhibition of the ERK pathway restored EpCAM expression. In detailed studies of the EpCAM promoter region, we observed that ERK2 suppresses EpCAM transcription directly by binding to a consensus ERK2-binding site in the EpCAM promoter and indirectly through activation of EMT-associated transcription factors SNAI1, SNAI2, TWIST1 and ZEB1, which bind to E-box sites in the EpCAM promoter. Surprisingly, EpCAM appears to modulate ERK activity. Using multiple cell lines, we demonstrated that specific ablation of EpCAM resulted in increased ERK pathway activity and SNAI2 expression, migration and invasion, whereas forced expression of EpCAM resulted in decreased ERK pathway activity and SNAI2 expression, migration and invasion. These observations provide important insights into the regulation of EpCAM expression during EMT, demonstrate an unexpected role for EpCAM in the regulation of ERK and define a novel double-negative feedback loop between EpCAM and ERK that contributes to the regulation of EMT. These studies have important translational implications as both EpCAM and ERK are currently being targeted in human clinical trials.	[Sankpal, N. V.; Fleming, T. P.; Sharma, P. K.; Wiedner, H. J.; Gillanders, W. E.] Washington Univ, Sch Med, Dept Surg, 660 South Euclid Ave,Campus Box 8109, St Louis, MO 63110 USA; [Gillanders, W. E.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Gillanders, WE (corresponding author), Washington Univ, Sch Med, Dept Surg, 660 South Euclid Ave,Campus Box 8109, St Louis, MO 63110 USA.	gillandersw@wustl.edu		Wiedner, Hannah/0000-0002-5919-5944; Sharma, Piyush/0000-0002-6247-3503	Susan G Komen for the Cure [BCTR0707917]; Siteman Cancer Center fund [P30CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER	Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Siteman Cancer Center fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Kerry Kornfeld, Dr Jason Weber and Dr Gregory Longmore for reviewing the manuscript and providing valuable advice. This work was supported by a grant from Susan G Komen for the Cure (BCTR0707917) and Siteman Cancer Center fund (P30CA91842).	Armstrong A, 2003, CANCER BIOL THER, V2, P320, DOI 10.4161/cbt.2.4.451; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Carlson SM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002010; Cheng JC, 2013, ONCOGENE, V32, P1041, DOI 10.1038/onc.2012.127; Courcelles M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.25; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Eberlein C, 2015, ONCOGENE, V34, P704, DOI 10.1038/onc.2013.600; Feldman S, 2011, CANCER-AM CANCER SOC, V117, P2599, DOI 10.1002/cncr.25822; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Gao JJ, 2015, J CELL PHYSIOL, V230, P775, DOI 10.1002/jcp.24802; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Hajra KM, 2002, CANCER RES, V62, P1613; Hook KE, 2012, MOL CANCER THER, V11, P710, DOI 10.1158/1535-7163.MCT-11-0184; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Kusewitt DF, 2009, J INVEST DERMATOL, V129, P491, DOI 10.1038/jid.2008.222; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Lyons JG, 2008, CANCER RES, V68, P4525, DOI 10.1158/1078-0432.CCR-07-6735; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Maghzal N, 2013, DEV CELL, V27, P263, DOI 10.1016/j.devcel.2013.10.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massoner P, 2014, BRIT J CANCER, V111, P955, DOI 10.1038/bjc.2014.366; Munz M, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-44; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Sankpal NV, 2013, MOL CANCER RES, V11, P418, DOI 10.1158/1541-7786.MCR-12-0518; Sankpal NV, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3070; Sankpal NV, 2009, CANCER RES, V69, P753, DOI 10.1158/0008-5472.CAN-08-2708; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Shi L, 2014, CANCER RES, V74, P532, DOI 10.1158/0008-5472.CAN-13-2203; Shin J, 2013, CELL SIGNAL, V25, P2540, DOI 10.1016/j.cellsig.2013.08.014; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Songun I, 2005, BRIT J CANCER, V92, P1767, DOI 10.1038/sj.bjc.6602519; Soysal SD, 2013, BRIT J CANCER, V108, P1480, DOI 10.1038/bjc.2013.80; Spizzo G, 2004, BREAST CANCER RES TR, V86, P207, DOI 10.1023/B:BREA.0000036787.59816.01; Tarcic G, 2012, FASEB J, V26, P1582, DOI 10.1096/fj.11-194654; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vannier C, 2013, J BIOL CHEM, V288, P18643, DOI 10.1074/jbc.M113.467787; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743; Zhang PJ, 2015, CELL CYCLE, V14, P481, DOI 10.1080/15384101.2015.1006048; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	59	41	42	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 29	2017	36	26					3706	3717		10.1038/onc.2016.504	http://dx.doi.org/10.1038/onc.2016.504			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY9WM	28192403	Green Accepted			2022-12-26	WOS:000404349700006
J	ElAzzouny, M; Tom, CTMB; Evans, CR; Olson, LL; Tanga, MJ; Gallagher, KA; Martin, BR; Burant, CF				ElAzzouny, Mahmoud; Tom, Christopher T. M. B.; Evans, Charles R.; Olson, Lori L.; Tanga, Mary J.; Gallagher, Katherine A.; Martin, Brent R.; Burant, Charles F.			Dimethyl Itaconate Is Not Metabolized into Itaconate Intracellularly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUCCINATE-DEHYDROGENASE; INFLAMMATORY MACROPHAGES; INSULIN-SECRETION; GLUCOSE; ACID; METABOLOMICS; IMMUNITY; GENE-1; CELLS; GPR91	Itaconic acid is an important metabolite produced by macrophages after stimulation with LPS. The role of itaconate in the inflammatory cascade is unclear. Here we used [C-13] itaconate and dimethyl [C-13] itaconate ( DMI) to probe itaconate metabolism, and find that [C-13] DMI is not metabolized to itaconate. [C-13] Itaconate in the cell culture medium leads to elevated intracellular levels of unlabeled succinate, with no evidence of intracellular uptake. The goal of this study is to encourage the development of effective pro-drug strategies to increase the intracellular levels of itaconate, which will enable more conclusive analysis of its action on macrophages and other cell and tissue types.	[ElAzzouny, Mahmoud; Evans, Charles R.; Burant, Charles F.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48105 USA; [Tom, Christopher T. M. B.; Martin, Brent R.] Univ Michigan, Dept Chem, Ann Arbor, MI 48105 USA; [Gallagher, Katherine A.] Univ Michigan, Dept Surg, Ann Arbor, MI 48105 USA; [Olson, Lori L.; Tanga, Mary J.] SRI Int, Menlo Pk, CA 94025 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; SRI International	ElAzzouny, M (corresponding author), 6309 Brehm Tower,1000 Wall St, Ann Arbor, MI 48105 USA.	mazzouny@umich.edu	Burant, Charles/GPC-5690-2022; Martin, Brent/B-4370-2012	Burant, Charles/0000-0001-9189-5003; Martin, Brent/0000-0002-7136-2397	National Institutes of Health [P30DK089503, P30DK020572, U24DK097153]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F31EB019320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, K08DK102357, P30DK020572, U24DK097153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM114848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Amrita Joshi for macrophage isolation and Hashim Motiwala for helpful discussions (University of Michigan). The Michigan Nutrition Obesity Research Center is funded by National Institutes of Health Grant P30DK089503, the Michigan Diabetes Research Center is funded by National Institutes of Health Grant P30DK020572, and the Michigan Regional Comprehensive Metabolomics Resource Core is supported by National Institutes of Health Grant U24DK097153.	Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; El Azzouny M, 2016, MOL METAB, V5, P980, DOI 10.1016/j.molmet.2016.07.011; El-Azzouny M, 2014, J BIOL CHEM, V289, P13575, DOI 10.1074/jbc.M113.531970; ElAzzouny MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129029; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Littlewood-Evans A, 2016, J EXP MED, V213, P1655, DOI 10.1084/jem.20160061; Lorenz MA, 2013, J BIOL CHEM, V288, P10923, DOI 10.1074/jbc.M112.414961; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; MACDONALD MJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P400, DOI 10.1016/0003-9861(89)90123-9; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Strelko CL, 2011, J AM CHEM SOC, V133, P16386, DOI 10.1021/ja2070889; Sud M, 2016, NUCLEIC ACIDS RES, V44, pD463, DOI 10.1093/nar/gkv1042; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986	17	49	52	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4766	4769		10.1074/jbc.C117.775270	http://dx.doi.org/10.1074/jbc.C117.775270			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28188288	Green Published, hybrid			2022-12-26	WOS:000397590400001
J	Torres, A; Gubbiotti, MA; Iozzo, RV				Torres, Annabel; Gubbiotti, Maria A.; Iozzo, Renato V.			Decorin-inducible Peg3 Evokes Beclin 1-mediated Autophagy and Thrombospondin 1-mediated Angiostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH PROTEOGLYCANS; IMPRINTED GENE PEG3; HUMAN ENDOTHELIAL-CELLS; RECEPTOR 2; ALPHA-2-BETA-1 INTEGRIN; P53-MEDIATED APOPTOSIS; SIGNAL-TRANSDUCTION; MAMMALIAN AUTOPHAGY; MATERNAL-BEHAVIOR; CANCER GROWTH	We previously discovered that systemic delivery of decorin for treatment of breast carcinoma xenografts induces paternally expressed gene 3 ( Peg3), an imprinted gene encoding a zinc finger transcription factor postulated to function as a tumor suppressor. Here we found that de novo expression of Peg3 increased Beclin 1 promoter activity and protein expression. This process required the full-length Peg3 as truncated mutants lacking either the N-terminal SCAN domain or the zinc fingers failed to translocate to the nucleus and promote Beclin 1 transcription. Importantly, overexpression of Peg3 in endothelial cells stimulated autophagy and concurrently inhibited endothelial cell migration and evasion from a 3D matrix. Mechanistically, we found that Peg3 induced the secretion of the powerful angiostatic glycoprotein Thrombospondin 1 independently of Beclin 1 transcriptional induction. Thus, we provide a new mechanism whereby Peg3 can simultaneously evoke autophagy in endothelial cells and attenuate angiogenesis.	[Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Suite 336 JAH, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Kimmel Canc Ctr, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Suite 336 JAH, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020		National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA164462]; NATIONAL CANCER INSTITUTE [R01CA047282, R01CA164462, R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA164462 (to R. V. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Armstrong LC, 2003, MATRIX BIOL, V22, P63, DOI 10.1016/S0945-053X(03)00005-2; Belloni D, 2010, EXP CELL RES, V316, P1010, DOI 10.1016/j.yexcr.2009.11.005; Besson V, 2011, P NATL ACAD SCI USA, V108, P11470, DOI 10.1073/pnas.1103873108; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441; Botti J, 2006, AUTOPHAGY, V2, P67, DOI 10.4161/auto.2.2.2458; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Champagne FA, 2009, BEHAV NEUROSCI, V123, P469, DOI 10.1037/a0015060; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; Custer SK, 2014, MOL CELL NEUROSCI, V61, P133, DOI 10.1016/j.mcn.2014.06.006; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Deryugina EI, 2015, MATRIX BIOL, V44-46, P94, DOI 10.1016/j.matbio.2015.04.004; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Dunkman AA, 2014, MATRIX BIOL, V35, P232, DOI 10.1016/j.matbio.2013.10.008; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Flisikowski K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015116; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Gaffney J, 2015, MATRIX BIOL, V44-46, P191, DOI 10.1016/j.matbio.2015.01.012; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Gonzalez EM, 2003, J BIOL CHEM, V278, P38113, DOI 10.1074/jbc.C300310200; Goyal A, 2016, J BIOL CHEM, V291, P19245, DOI 10.1074/jbc.M116.740266; Goyal A, 2014, MATRIX BIOL, V34, P46, DOI 10.1016/j.matbio.2013.12.011; Goyal A, 2012, J BIOL CHEM, V287, P43543, DOI 10.1074/jbc.M112.401786; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Green DR, 2016, CELL DEATH DIFFER, V23, P915, DOI 10.1038/cdd.2015.172; Grumati Paolo, 2012, Cells, V1, P325, DOI 10.3390/cells1030325; Gubbiotti MA, 2016, MATRIX BIOL, V55, P7, DOI 10.1016/j.matbio.2016.09.009; Gubbiotti MA, 2015, MATRIX BIOL, V48, P6, DOI 10.1016/j.matbio.2015.10.002; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; Hakkinen L, 2000, LAB INVEST, V80, P1869, DOI 10.1038/labinvest.3780197; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Horvath Z, 2014, MATRIX BIOL, V35, P194, DOI 10.1016/j.matbio.2013.11.004; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Jarvelainen H, 2015, MATRIX BIOL, V43, P15, DOI 10.1016/j.matbio.2015.01.023; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Johnson MD, 2002, J BIOL CHEM, V277, P23000, DOI 10.1074/jbc.M201907200; Kalas W, 2013, ANTICANCER RES, V33, P1429; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kohda T, 2001, GENES CELLS, V6, P237, DOI 10.1046/j.1365-2443.2001.00412.x; Koren I, 2012, SCIENCE, V338, P889, DOI 10.1126/science.1230577; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lee SJ, 2011, AUTOPHAGY, V7, P829, DOI 10.4161/auto.7.8.15598; Lee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145531; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li BX, 2009, AUTOPHAGY, V5, P303, DOI 10.4161/auto.5.3.7491; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lu YC, 2006, J BIOL CHEM, V281, P39081, DOI 10.1074/jbc.M606687200; Maegawa S, 2001, MOL CARCINOGEN, V31, P1, DOI 10.1002/mc.1034; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Morcavallo A, 2014, MATRIX BIOL, V35, P82, DOI 10.1016/j.matbio.2013.12.010; Moresi V, 2008, STEM CELLS, V26, P997, DOI 10.1634/stemcells.2007-0493; Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005; Neill T, 2016, ADV DRUG DELIVER REV, V97, P174, DOI 10.1016/j.addr.2015.10.016; Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653; Neill T, 2013, FEBS J, V280, P2353, DOI 10.1111/febs.12148; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Nguyen TMB, 2009, J CELL MOL MED, V13, P3687, DOI 10.1111/j.1582-4934.2009.00722.x; Nikitovic D, 2012, J BIOL CHEM, V287, P33926, DOI 10.1074/jbc.R112.379602; Nikolovska K, 2014, MATRIX BIOL, V35, P91, DOI 10.1016/j.matbio.2014.01.003; Nye MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056325; O'Doherty AM, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00156; Poluzzi C, 2016, ADV DRUG DELIVER REV, V97, P156, DOI 10.1016/j.addr.2015.10.012; Poluzzi C, 2014, J BIOL CHEM, V289, P16114, DOI 10.1074/jbc.M114.556530; Ramakrishnan S, 2007, AUTOPHAGY, V3, P512; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Rimsa V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069538; Robinson PS, 2004, J BIOMECH ENG-T ASME, V126, P252, DOI 10.1115/1.1695570; Rohani MG, 2015, MATRIX BIOL, V44-46, P113, DOI 10.1016/j.matbio.2015.03.002; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; Ruehland C, 2007, FEBS J, V274, P4246, DOI 10.1111/j.1742-4658.2007.05951.x; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schaefer L, 2012, CURR OPIN GENET DEV, V22, P56, DOI 10.1016/j.gde.2011.12.002; Schonherr E, 2004, J VASC RES, V41, P499, DOI 10.1159/000081806; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Sengle G, 2015, MATRIX BIOL, V47, P3, DOI 10.1016/j.matbio.2015.05.002; Skandalis SS, 2014, MATRIX BIOL, V35, P182, DOI 10.1016/j.matbio.2013.09.002; Song J, 2008, BBA-GENE REGUL MECH, V1779, P134, DOI 10.1016/j.bbagrm.2007.11.002; Soto-Pantoja DR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01038; Soto-Pantoja DR, 2012, AUTOPHAGY, V8, P1628, DOI 10.4161/auto.21562; Stenina-Adognravi O, 2014, MATRIX BIOL, V37, P69, DOI 10.1016/j.matbio.2014.02.001; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Willis CD, 2013, FEBS J, V280, P2271, DOI 10.1111/febs.12164; Wu Z, 2014, MATRIX BIOL, V35, P266, DOI 10.1016/j.matbio.2013.12.006; Yamaguchi A, 2002, J BIOL CHEM, V277, P623, DOI 10.1074/jbc.M107435200; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yao T, 2016, FEBS OPEN BIO, V6, P707, DOI 10.1002/2211-5463.12076; Yoo BH, 2010, J BIOL CHEM, V285, P5438, DOI 10.1074/jbc.M109.046789; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Zhou QY, 2011, ANIM REPROD SCI, V123, P70, DOI 10.1016/j.anireprosci.2010.11.012; Zoeller JJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-7; Zoeller JJ, 2009, J BIOL CHEM, V284, P11728, DOI 10.1074/jbc.M808991200	123	41	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5055	5069		10.1074/jbc.M116.753632	http://dx.doi.org/10.1074/jbc.M116.753632			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28174297	hybrid, Green Published			2022-12-26	WOS:000397590400026
J	Jhee, JH; Kim, H; Park, S; Yun, HR; Jung, SY; Kee, YK; Yoon, CY; Park, JT; Han, SH; Kang, SW; Yoo, TH				Jhee, Jong Hyun; Kim, Hyoungnae; Park, Seohyun; Yun, Hae-Ryong; Jung, Su-Young; Kee, Youn Kyung; Yoon, Chang-Yun; Park, Jung Tak; Han, Seung Hyeok; Kang, Shin-Wook; Yoo, Tae-Hyun			Vitamin D deficiency is significantly associated with depression in patients with chronic kidney disease	PLOS ONE			English	Article							STAGE RENAL-DISEASE; PARATHYROID-HORMONE; 25-HYDROXYVITAMIN D; HYPOVITAMINOSIS-D; MORTALITY; SYMPTOMS; RISK; PREVALENCE; DIALYSIS; HEALTH	Background Depression is reported to be the most common psychological problem in patients with chronic kidney disease (CKD). Several studies have reported that lower levels of serum vitamin D are significantly associated with depression. Both vitamin D deficiency and depression are prevalent in patients with CKD, yet the relationship between these two factors remains poorly understood. This study aimed to investigate the association between vitamin D levels and depression among CKD patients. Methods Totally, 21,257 individuals who participated in the Korean National Health and Nutrition Examination Survey (KNHANES V, VI) from 2010-2014 were screened for the study; 533 CKD patients were included. Vitamin D deficiency was defined as serum 25-hydroxyvitamin D3 [25(OH) D3] <= 10 ng/mL. Patients were divided into vitamin D deficient or sufficient groups. Depression was screened for using the Korean version of the WHO Composite International Diagnostic Interview-Short Form. The association between vitamin D deficiency and depression was evaluated by multivariate logistic regression analysis. Results The mean participant age was 70.1 +/- 9.4 years; 262 patients (49.2%) were male. The median 25(OH) D-3 level was 19.1 +/- 6.9 ng/mL. The prevalence of depression was higher in CKD patients than in the general population (14.3 vs. 11.1%, P = 0.03). Additionally, the prevalence of depression was significantly higher in CKD patients with (vs. without) vitamin D deficiency (32.5% vs. 50.0%, P < 0.001). Multivariate logistic regression analysis showed that vitamin D deficiency was a significant independent predictor of depression after adjusting for confounding factors Conclusion Depression was highly prevalent in CKD patients, in whom vitamin D deficiency was a significant independent predictor of depression. Therefore, management of vitamin D deficiency might help prevent depression in CKD patients.	[Jhee, Jong Hyun; Kim, Hyoungnae; Park, Seohyun; Yun, Hae-Ryong; Jung, Su-Young; Kee, Youn Kyung; Yoon, Chang-Yun; Park, Jung Tak; Han, Seung Hyeok; Kang, Shin-Wook; Yoo, Tae-Hyun] Yonsei Univ, Inst Kidney Dis Res, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Brain Korea PLUS 21, Severance Biomed Sci Inst, Dept Internal Med,Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoo, TH (corresponding author), Yonsei Univ, Inst Kidney Dis Res, Coll Med, Dept Internal Med, Seoul, South Korea.	yoosy0316@yuhs.ac	Han, Seung Hyeok/K-4559-2018; Han, Seung Hyeok/W-8825-2019	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Kang, Shin-Wook/0000-0002-5677-4756; Park, Jung Tak/0000-0002-2325-8982; Yun, Hae-Ryong/0000-0002-7038-0251; Yoo, Tae-Hyun/0000-0002-9183-4507				Anglin RES, 2013, BRIT J PSYCHIAT, V202, P100, DOI 10.1192/bjp.bp.111.106666; Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032; Boulware LE, 2006, CLIN J AM SOC NEPHRO, V1, P496, DOI 10.2215/CJN.00030505; Cawthon PM, 2010, J CLIN ENDOCR METAB, V95, P4625, DOI 10.1210/jc.2010-0638; Chan R, 2011, J PSYCHOSOM RES, V71, P300, DOI 10.1016/j.jpsychores.2011.05.002; Chung HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099185; Cukor D, 2009, KIDNEY INT, V75, P1223, DOI 10.1038/ki.2009.51; de Boer IH, 2009, J AM SOC NEPHROL, V20, P1805, DOI 10.1681/ASN.2008111157; Drechsler C, 2011, NEPHROL DIAL TRANSPL, V26, P1024, DOI 10.1093/ndt/gfq606; Drechsler C, 2010, EUR HEART J, V31, P2253, DOI 10.1093/eurheartj/ehq246; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Eskandari F, 2007, ARCH INTERN MED, V167, P2329, DOI 10.1001/archinte.167.21.2329; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Fernandes de Abreu D A, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS265, DOI 10.1016/j.psyneuen.2009.05.023; Formiga F, 2011, MED CLIN-BARCELONA, V137, P137, DOI 10.1016/j.medcli.2010.01.014; Gahche Jamie, 2011, NCHS Data Brief, P1; Gonzalez EA, 2004, AM J NEPHROL, V24, P503, DOI 10.1159/000081023; Grant WB, 2010, MOL NUTR FOOD RES, V54, P1172, DOI 10.1002/mnfr.200900420; Hedayati SS, 2010, JAMA-J AM MED ASSOC, V303, P1946, DOI 10.1001/jama.2010.619; Hedayati SS, 2009, AM J KIDNEY DIS, V54, P424, DOI 10.1053/j.ajkd.2009.03.017; Hedayati SS, 2006, KIDNEY INT, V69, P1662, DOI 10.1038/sj.ki.5000308; Helgadottir B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115894; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hollis BW, 2008, AM J CLIN NUTR, V88, p507S, DOI 10.1093/ajcn/88.2.507S; Hoogendijk WJG, 2008, ARCH GEN PSYCHIAT, V65, P508, DOI 10.1001/archpsyc.65.5.508; JACOB AI, 1984, J NUTR, V114, P1313, DOI 10.1093/jn/114.7.1313; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Jorde R, 2006, J NEUROL, V253, P464, DOI 10.1007/s00415-005-0027-5; Jorde R, 2009, EUR J NUTR, V48, P349, DOI 10.1007/s00394-009-0020-3; Kesby JP, 2011, MOL CELL ENDOCRINOL, V347, P121, DOI 10.1016/j.mce.2011.05.014; KOENIG KG, 1992, KIDNEY INT, V41, P161, DOI 10.1038/ki.1992.22; LaClair RE, 2005, AM J KIDNEY DIS, V45, P1026, DOI 10.1053/j.ajkd.2005.02.029; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Lopes AA, 2002, KIDNEY INT, V62, P199, DOI 10.1046/j.1523-1755.2002.00411.x; Maddock J, 2013, CLIN NUTR, V32, P758, DOI 10.1016/j.clnu.2013.01.006; Mehrotra R, 2008, CLIN J AM SOC NEPHRO, V3, P1144, DOI 10.2215/CJN.05781207; Mehrotra R, 2009, KIDNEY INT, V76, P977, DOI 10.1038/ki.2009.288; Michelson D, 1996, NEW ENGL J MED, V335, P1176, DOI 10.1056/NEJM199610173351602; Murtagh FEM, 2007, ADV CHRONIC KIDNEY D, V14, P82, DOI 10.1053/j.ackd.2006.10.001; Palmer SC, 2013, AM J KIDNEY DIS, V62, P493, DOI 10.1053/j.ajkd.2013.02.369; Park SJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0645-7; Pilz S, 2008, CANCER EPIDEM BIOMAR, V17, P1228, DOI 10.1158/1055-9965.EPI-08-0002; Pilz S, 2011, AM J KIDNEY DIS, V58, P374, DOI 10.1053/j.ajkd.2011.03.020; Ravani P, 2009, KIDNEY INT, V75, P88, DOI 10.1038/ki.2008.501; REICHEL H, 1991, NEPHROL DIAL TRANSPL, V6, P162, DOI 10.1093/ndt/6.3.162; RICKERS H, 1985, NEPHRON, V39, P267, DOI 10.1159/000183383; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; SATO KA, 1982, J LAB CLIN MED, V99, P325; Schneider B, 2000, J NEURAL TRANSM, V107, P839, DOI 10.1007/s007020070063; Tsai YC, 2012, AM J KIDNEY DIS, V60, P54, DOI 10.1053/j.ajkd.2012.02.325; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; von Kanel R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138550; Wilkins CH, 2006, AM J GERIAT PSYCHIAT, V14, P1032, DOI 10.1097/01.JGP.0000240986.74642.7c; Zittermann A, 2012, AM J CLIN NUTR, V95, P91, DOI 10.3945/ajcn.111.014779	56	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171009	10.1371/journal.pone.0171009	http://dx.doi.org/10.1371/journal.pone.0171009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192445	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423800015
J	Lee, SJ; ter Kuile, FO; Price, RN; Luxemburger, C; Nosten, F				Lee, Sue J.; ter Kuile, Feiko O.; Price, Ric N.; Luxemburger, Christine; Nosten, Francois			Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients	PLOS ONE			English	Article							RESISTANT FALCIPARUM-MALARIA; PLASMODIUM-FALCIPARUM; ARTEMETHER-LUMEFANTRINE; ARTESUNATE-MEFLOQUINE; RANDOMIZED-TRIAL; DIHYDROARTEMISININ-PIPERAQUINE; CLINICAL-TRIAL; DOUBLE-BLIND; COMBINATION; PHARMACOKINETICS	Mefloquine (MQ) has been used for the treatment of malaria since the mid-1980s, first as monotherapy or as fixed combination with sulfadoxine-pyrimethamine (MSP) and since the mid-1990s in combination with artesunate. There is a renewed interested in MQ as part of a triple therapy for the treatment of multi-drug resistance P. falciparum malaria. The widespread use of MQ beyond south-East Asia has been constrained by reports of poor tolerability. Here we present the side effect profile of MQ for the treatment of uncomplicated malaria on the Thai-Myanmar/Cambodia borders. In total 19,850 patients received seven different regimens containing either 15 or 24-25 mg/kg of MQ, the latter given either as a single dose, or split over two or three days. The analysis focused on (predominantly) gastrointestinal and neuropsychiatric events as compared to the new fixed dose combination of MQ plus artesunate given as equal doses of 8 mg/kg MQ per day over three days. Gastrointestinal side effects were dose-dependent and associated with the severity of malaria symptoms. Serious neuropsychiatric side effects associated with MQ use were rare: for a single 25 mg/ kg dose it was 11.9 per 10,000 treatments (95% confidence interval, CI, 4-285) vs. 7.8 (3- 15) for the 15 mg/kg dose. The risk with 25 mg/kg was much higher when it was given as repeat dosing in patients who had failed treatment with 15 mg/kg MQ in the preceding month; (RR 6.57 (95% CI 1.33 to 32.4), p = 0.0077). MQ was best tolerated as 15 mg/kg or as 24 mg/kg when given over three days in combination with artesunate. We conclude that the tolerance of a single dose of MQ in the treatment of uncomplicated malaria is moderate, but can be improved by administering it as a split dose over three days.	[Lee, Sue J.] Mahidol Univ, Mahidol Oxford Res Unit, Bangkok, Thailand; [Lee, Sue J.; Price, Ric N.; Nosten, Francois] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [ter Kuile, Feiko O.] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Price, Ric N.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Price, Ric N.] Charles Darwin Univ, Darwin, NT, Australia; [Luxemburger, Christine; Nosten, Francois] Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Liverpool School of Tropical Medicine; Charles Darwin University; Menzies School of Health Research; Charles Darwin University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Nosten, F (corresponding author), Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England.; Nosten, F (corresponding author), Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand.	francois@tropmedres.ac	Kuile, Feiko ter/ABD-6681-2020; Nosten, Francois/AAC-5509-2019	Kuile, Feiko ter/0000-0003-3663-5617; Nosten, Francois/0000-0002-7951-0745; Price, Richard/0000-0003-2000-2874	Wellcome Trust; Medecins Sans Frontieres (France); Drug for Neglected Diseases Initiative (DNDI); Wellcome Trust of Great Britain	Wellcome Trust(Wellcome TrustEuropean Commission); Medecins Sans Frontieres (France); Drug for Neglected Diseases Initiative (DNDI); Wellcome Trust of Great Britain(Wellcome Trust)	The studies at SMRU were funded by the Wellcome Trust and the work at MSF was funded by Medecins Sans Frontieres (France). The analysis and writing of the manuscript were supported by Drug for Neglected Diseases Initiative (DNDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Shoklo Malaria Research Unit is part of the Mahidol Oxford University Research Unit supported by the Wellcome Trust of Great Britain. We thank the medical staff of the Medecins Sans Frontieres clinics for their assistance in the field work, the staff of the Shoklo Malaria Research Unit, the MSF staff in Mae Sot and Bangkok, Khun Patchari Prakongpan, and Grainne Dolan, Michel Thieren and Charles Woodrow who helped in conducting part of the field work. We thank Dr. Rob Hooft van Huijsduijnen for writing/editorial assistance with the manuscript.	Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Ashley EA, 2005, CLIN INFECT DIS, V41, P425, DOI 10.1086/432011; Ashley EA, 2004, J INFECT DIS, V190, P1773, DOI 10.1086/425015; Ashley E, 2006, TROP MED INT HEALTH, V11, P1898, DOI 10.1111/j.1365-3156.2006.01749_1.x; Barrett PJ, 1996, BRIT MED J, V313, P525, DOI 10.1136/bmj.313.7056.525; BJORKMAN A, 1989, LANCET, V2, P865; Bland JM, 1998, BRIT MED J, V317, P1572, DOI 10.1136/bmj.317.7172.1572; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; CHANTHAVANICH P, 1985, AM J TROP MED HYG, V34, P1028, DOI 10.4269/ajtmh.1985.34.1028; CLYDE DF, 1976, ANTIMICROB AGENTS CH, V9, P384, DOI 10.1128/AAC.9.3.384; D'Alessandro U, 2001, TROP MED INT HEALTH, V6, P845, DOI 10.1046/j.1365-3156.2001.00819.x; EKUE JMK, 1983, B WORLD HEALTH ORGAN, V61, P713; Fusetti M, 1999, Clin Ter, V150, P379; Gonzalez R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-75; Goodman CD, 2016, SCIENCE, V352, P349, DOI 10.1126/science.aad9279; Grabias B, 2016, EXPERT OPIN DRUG SAF, V15, P903, DOI 10.1080/14740338.2016.1175428; Gribble FM, 2000, BRIT J PHARMACOL, V131, P756, DOI 10.1038/sj.bjp.0703638; HARINASUTA T, 1983, B WORLD HEALTH ORGAN, V61, P299; Hutagalung R, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-46; JIANG JB, 1982, LANCET, V2, P285; KARBWANG J, 1994, B WORLD HEALTH ORGAN, V72, P83; LOOAREESUWAN S, 1994, ANN TROP MED PARASIT, V88, P131, DOI 10.1080/00034983.1994.11812850; LOOAREESUWAN S, 1992, LANCET, V339, P821, DOI 10.1016/0140-6736(92)90276-9; LOOAREESUWAN S, 1992, AM J TROP MED HYG, V47, P794, DOI 10.4269/ajtmh.1992.47.794; Looareesuwan Sornchai, 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P230; LUXEMBURGER C, 1994, T ROY SOC TROP MED H, V88, P213, DOI 10.1016/0035-9203(94)90303-4; LUXEMBURGER C, 1991, LANCET, V338, P1268, DOI 10.1016/0140-6736(91)92131-K; MANSOR SM, 1989, BRIT J CLIN PHARMACO, V27, P381, DOI 10.1111/j.1365-2125.1989.tb05381.x; McArdle JJ, 2005, NEUROPHARMACOLOGY, V49, P1132, DOI 10.1016/j.neuropharm.2005.06.011; Milatovic D, 2011, NEUROTOXICOLOGY, V32, P578, DOI 10.1016/j.neuro.2011.01.001; Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23; Nevin RL, 2016, NEUROL THER, V5, P69, DOI 10.1007/s40120-016-0045-5; Nevin RL, 2014, INT J PARASITOL-DRUG, V4, P118, DOI 10.1016/j.ijpddr.2014.03.002; NGIAM TL, 1987, CHEM PHARM BULL, V35, P409; NOSTEN F, 1994, J INFECT DIS, V170, P971, DOI 10.1093/infdis/170.4.971; PHILLIPSHOWARD PA, 1995, DRUG SAFETY, V12, P370, DOI 10.2165/00002018-199512060-00003; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Price RN, 1997, T ROY SOC TROP MED H, V91, P574, DOI 10.1016/S0035-9203(97)90032-8; PRICE RN, 1995, T ROY SOC TROP MED H, V89, P523, DOI 10.1016/0035-9203(95)90094-2; ROGERS JH, 1980, J LARYNGOL OTOL, V94, P1401, DOI 10.1017/S002221510009023X; ROPPER AH, 1985, CAN J NEUROL SCI, V12, P282, DOI 10.1017/S0317167100047193; ROUVEIX B, 1989, ANN INTERN MED, V110, P577, DOI 10.7326/0003-4819-110-7-577; Schlagenhauf P, 1996, TROP MED INT HEALTH, V1, P485, DOI 10.1046/j.1365-3156.1996.d01-85.x; SCHWARTZ DE, 1987, CHEMOTHERAPY, V33, P1; Sirima SB, 2016, LANCET INFECT DIS; SMITHUIS FM, 1993, ANTIMICROB AGENTS CH, V37, P1977, DOI 10.1128/AAC.37.9.1977; STEFFEN R, 1993, LANCET, V341, P1299, DOI 10.1016/0140-6736(93)90814-W; Tansley R, 2010, AM J TROP MED HYG, V83, P1195, DOI 10.4269/ajtmh.2010.10-0228; TERKUILE FO, 1992, J INFECT DIS, V166, P1393, DOI 10.1093/infdis/166.6.1393; terKuile FO, 1995, B WORLD HEALTH ORGAN, V73, P631; TERKUILE FO, 1993, LANCET, V341, P1044, DOI 10.1016/0140-6736(93)92409-M; Toovey S, 2009, TRAVEL MED INFECT DI, V7, P2, DOI 10.1016/j.tmaid.2008.12.004; TRENHOLME GM, 1975, SCIENCE, V190, P792, DOI 10.1126/science.1105787; Tsou TS, 2006, J STAT PLAN INFER, V136, P3173, DOI 10.1016/j.jspi.2004.12.008; van Vugt M, 2000, T ROY SOC TROP MED H, V94, P545, DOI 10.1016/S0035-9203(00)90082-8; van Vugt M, 2002, CLIN INFECT DIS, V35, P1498, DOI 10.1086/344901; van Vugt M, 1998, ANTIMICROB AGENTS CH, V42, P135, DOI 10.1128/AAC.42.1.135; WEINKE T, 1991, AM J TROP MED HYG, V45, P86, DOI 10.4269/ajtmh.1991.45.86; Weiss S. M., 2003, Neurology, V61, pS101; Wells TNC, 2015, NAT REV DRUG DISCOV, V14, P424, DOI 10.1038/nrd4573; *WHO, 1991, WHOMAL911063; World Health Organization, 2015, GUID TREATM MAL, Vthird	62	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0168780	10.1371/journal.pone.0168780	http://dx.doi.org/10.1371/journal.pone.0168780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192434	gold, Green Published, Green Accepted			2022-12-26	WOS:000394423800003
J	Bressa, C; Bailen-Andrino, M; Perez-Santiago, J; Gonzalez-Soltero, R; Perez, M; Montalvo-Lominchar, MG; Mate-Munoz, JL; Dominguez, R; Moreno, D; Larrosa, M				Bressa, Carlo; Bailen-Andrino, Maria; Perez-Santiago, Jennifer; Gonzalez-Soltero, Rocio; Perez, Margarita; Gregoria Montalvo-Lominchar, Maria; Luis Mate-Munoz, Jose; Dominguez, Raul; Moreno, Diego; Larrosa, Mar			Differences in gut microbiota profile between women with active lifestyle and sedentary women	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; DIET; OBESITY; DIVERSITY; BUTYRATE; HEALTH; ASSOCIATIONS; METABOLISM; MODULATION; DISEASE	Physical exercise is a tool to prevent and treat some of the chronic diseases affecting the world's population. A mechanism through which exercise could exert beneficial effects in the body is by provoking alterations to the gut microbiota, an environmental factor that in recent years has been associated with numerous chronic diseases. Here we show that physical exercise performed by women to at least the degree recommended by the World Health Organization can modify the composition of gut microbiota. Using high-throughput sequencing of the 16s rRNA gene, eleven genera were found to be significantly different between active and sedentary women. Quantitative PCR analysis revealed higher abundance of health-promoting bacterial species in active women, including Faecalibacterium prausnitzii, Roseburia hominis and Akkermansia muciniphila. Moreover, body fat percentage, muscular mass and physical activity significantly correlated with several bacterial populations. In summary, we provide the first demonstration of interdependence between some bacterial genera and sedentary behavior parameters, and show that not only does the dose and type of exercise influence the composition of gut microbiota, but also the breaking of sedentary behavior.	[Bressa, Carlo; Bailen-Andrino, Maria; Gonzalez-Soltero, Rocio] European Univ, Dept Basic Sci, Madrid, Spain; [Perez-Santiago, Jennifer; Perez, Margarita; Gregoria Montalvo-Lominchar, Maria; Moreno, Diego; Larrosa, Mar] European Univ, Res Grp Nutr Phys Act & Hlth, Sch Doctorate Studies & Res, Madrid, Spain; [Luis Mate-Munoz, Jose; Dominguez, Raul] Alfonso X El Sabio Univ, Dept Phys Act & Sports Sci, Villanueva De La Canada, Spain	Universidad Alfonso X el Sabio (UAX)	Larrosa, M (corresponding author), European Univ, Res Grp Nutr Phys Act & Hlth, Sch Doctorate Studies & Res, Madrid, Spain.	mar.larrosa@universidadeuropea.es	Bressa, Carlo/P-1131-2019; Domínguez, Raúl/AAX-1068-2021; Gonzalez-Soltero, Rocio/Z-2702-2019; Bailen, Maria/ABF-9684-2020; Bressa, Carlo/AAC-9622-2022; Bailen, Maria/AAD-7198-2022; González-Soltero, Rocío/O-7686-2019; Perez, Margarita/K-8172-2014; LARROSA, MAR/H-6012-2012	Bressa, Carlo/0000-0001-5530-4958; Gonzalez-Soltero, Rocio/0000-0001-9799-0570; Bressa, Carlo/0000-0001-5530-4958; Bailen, Maria/0000-0001-5201-906X; González-Soltero, Rocío/0000-0001-9799-0570; Perez, Margarita/0000-0001-7240-2082; LARROSA, MAR/0000-0002-8863-4686; Mate-Munoz, Jose Luis/0000-0003-3282-1455; Dominguez, Raul/0000-0002-6891-391X	Ministerio de Economia y Competitividad; Ramon y Cajal Grant [2012_11910]; Universidad Europea de Madrid [2015UEM06, 2015UEM24]; Catedra ASISA Grant [2015UEM46]	Ministerio de Economia y Competitividad(Spanish Government); Ramon y Cajal Grant(Spanish Government); Universidad Europea de Madrid; Catedra ASISA Grant	Ministerio de Economia y Competitividad. Ramon y Cajal Grant 2012_11910. www.mineco.gob.es. Universidad Europea de Madrid 2015UEM06, 2015UEM24 and Catedra ASISA Grant 2015UEM46. www.universidadeuropea.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Allen JM, 2015, J APPL PHYSIOL, V118, P1059, DOI 10.1152/japplphysiol.01077.2014; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Baumann S, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0195-3; Bernalier-Donadille A, 2010, GASTROEN CLIN BIOL, V34, pS16, DOI 10.1016/S0399-8320(10)70016-6; Brahe LK, 2016, ADV NUTR, V7, P90, DOI 10.3945/an.115.010587; Brankatschk R, 2012, APPL ENVIRON MICROB, V78, P4481, DOI 10.1128/AEM.07878-11; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Charrad M, 2014, J STAT SOFTW, V61, P1; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; Choi JJ, 2013, ENVIRON HEALTH PERSP, V121, P725, DOI 10.1289/ehp.1306534; Christensen JE, 1999, ANTON LEEUW INT J G, V76, P217, DOI 10.1023/A:1002001919720; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clarke SF, 2014, GUT; Delgado S, 2006, DIGEST DIS SCI, V51, P737, DOI 10.1007/s10620-006-3200-5; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Denou E, 2016, AM J PHYSIOL-ENDOC M, V310, pE982, DOI 10.1152/ajpendo.00537.2015; Derrien M, 2016, MICROBIAL PATHOGENES; Endoh Kaori, 2016, Asian Pac J Cancer Prev, V17, P2007; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Gonzales T, 1996, FEMS MICROBIOL REV, V18, P319, DOI 10.1111/j.1574-6976.1996.tb00247.x; Gorvitovskaia A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0160-7; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Huang CJ, 2013, SCI WORLD J, DOI 10.1155/2013/752071; Huttenhower C, 2014, IMMUNITY, V40, P843, DOI 10.1016/j.immuni.2014.05.013; Queipo-Ortuno MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065465; Kampmann C, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.09.004; Kang SS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-36; Kasai C, 2016, ONCOL REP, V35, P325, DOI 10.3892/or.2015.4398; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Knights D, 2014, CELL HOST MICROBE, V16, P433, DOI 10.1016/j.chom.2014.09.013; Knip M, 2016, NAT REV ENDOCRINOL; Lambert JE, 2015, APPL PHYSIOL NUTR ME, V40, P749, DOI 10.1139/apnm-2014-0452; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Leonel AJ, 2012, CURR OPIN CLIN NUTR, V15, P474, DOI 10.1097/MCO.0b013e32835665fa; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Martinez Alvarez JR, 2010, NUTR CLIN DIETETICA, V30, P4; Mika A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125889; Morotomi M, 2009, INT J SYST EVOL MICR, V59, P1895, DOI 10.1099/ijs.0.008169-0; Nylund L, 2015, ALLERGY, V70, P241, DOI 10.1111/all.12549; Org E, 2015, GENOME RES, V25, P1558, DOI 10.1101/gr.194118.115; Ott SJ, 2006, GUT, V55, P1207; Petriz BA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-511; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Qu WB, 2012, NUCLEIC ACIDS RES, V40, pW205, DOI 10.1093/nar/gks552; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shaw KA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0331-y; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Viitasalo A, 2016, PREV MED, V87, P81, DOI 10.1016/j.ypmed.2016.02.027; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Welly RJ, 2016, MED SCI SPORTS EXERC; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369; Zhong YD, 2015, MOL NUTR FOOD RES, V59, P2066, DOI 10.1002/mnfr.201500187	73	212	237	6	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171352	10.1371/journal.pone.0171352	http://dx.doi.org/10.1371/journal.pone.0171352			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187199	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300020
J	Chang, XY; Xu, B; Bai, YG; Luo, HY; Ma, R; Shi, PJ; Yao, B				Chang, Xiaoyu; Xu, Bo; Bai, Yingguo; Luo, Huiying; Ma, Rui; Shi, Pengjun; Yao, Bin			Role of N-linked glycosylation in the enzymatic properties of a thermophilic GH 10 xylanase from Aspergillus fumigatus expressed in Pichia pastoris	PLOS ONE			English	Article							MICROBIAL XYLANASES; THERMOSTABLE XYLANASE; FUNGUS; ACID; SECRETION; MECHANISM; NIDULANS; CLONING	N-Glycosylation is a posttranslational modification commonly occurred in fungi and plays roles in a variety of enzyme functions. In this study, a xylanase (Af-XYNA) of glycoside hydrolase (GH) family 10 from Aspergillus fumigatus harboring three potential N-glycosylation sites (N87, N124 and N335) was heterologously produced in Pichia pastoris. The N-glycosylated Af-XYNA (WT) exhibited favorable temperature and pH optima (75 degrees C and pH 5.0) and good thermostability (maintaining stable at 60 degrees C). To reveal the role of N-glycosylation on Af-XYNA, the enzyme was deglycosylated by endo-beta-N-acetylglucosaminidase H (DE) or modified by site-directed mutagenesis at N124 (N124T). The deglycosylated DE and mutant N124T showed narrower pH adaptation range, lower specific activity, and worse pH and thermal stability. Further thermodynamic analysis revealed that the enzyme with higher N-glycosylation degree was more thermostable. This study demonstrated that the effects of glycosylation at different degrees and sites were diverse, in which the glycan linked to N124 played a key role in pH and thermal stability of Af-XYNA.	[Chang, Xiaoyu; Xu, Bo] Jiangxi Agr Univ, Coll Biol Sci & Engn, Nanchang, Jiangxi, Peoples R China; [Chang, Xiaoyu; Bai, Yingguo; Luo, Huiying; Ma, Rui; Shi, Pengjun; Yao, Bin] Chinese Acad Agr Sci, Key Lab Feed Biotechnol, Minist Agr, Feed Res Inst, Beijing, Peoples R China	Jiangxi Agricultural University; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Xu, B (corresponding author), Jiangxi Agr Univ, Coll Biol Sci & Engn, Nanchang, Jiangxi, Peoples R China.; Shi, PJ (corresponding author), Chinese Acad Agr Sci, Key Lab Feed Biotechnol, Minist Agr, Feed Res Inst, Beijing, Peoples R China.	xubo583@sina.com; shipengjun@caas.cn			National Natural Science Foundation of China [31372345, 31360372]; National Science Fund for Distinguished Young Scholars [31225026]; China Modern Agriculture Research System [CARS-42]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); China Modern Agriculture Research System	Financial support includes the National Natural Science Foundation of China (grant numbers 31372345 (PS) and 31360372 (BX); [http://www.nsfc.gov.cn/]), the National Science Fund for Distinguished Young Scholars (grant number 31225026 (BY); [http://www.nsfc.gov.cn/]), and the China Modern Agriculture Research System (grant number CARS-42 (BY); [http://www.zgrj.org/]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adav SS, 2015, J PROTEOMICS, V119, P154, DOI 10.1016/j.jprot.2015.02.007; Alvarez C, 2016, MICROB BIOTECHNOL, V9, P149, DOI 10.1111/1751-7915.12346; Anbarasan S, 2010, APPL ENVIRON MICROB, V76, P356, DOI 10.1128/AEM.00357-09; Andersen JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-312; Azhar S, 2015, CARBOHYD POLYM, V117, P19, DOI 10.1016/j.carbpol.2014.09.050; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Berka RM, 2011, NAT BIOTECHNOL, V29, P922, DOI 10.1038/nbt.1976; Chadha BS, 2004, J BIOTECHNOL, V109, P227, DOI 10.1016/j.jbiotec.2003.12.010; Chantasingh D, 2006, PROTEIN EXPRES PURIF, V46, P143, DOI 10.1016/j.pep.2005.09.013; Chavez R, 2006, J BIOTECHNOL, V123, P413, DOI 10.1016/j.jbiotec.2005.12.036; Chen LL, 2009, BIORESOURCE TECHNOL, V100, P5230, DOI 10.1016/j.biortech.2009.05.038; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Davoodi J, 2007, BIOPHYS CHEM, V125, P453, DOI 10.1016/j.bpc.2006.10.006; Decelle B, 2004, CURR GENET, V46, P166, DOI 10.1007/s00294-004-0520-x; Dotsenko AS, 2016, BIOTECHNOL BIOENG, V113, P283, DOI 10.1002/bit.25812; Du YL, 2013, BIORESOURCE TECHNOL, V130, P161, DOI 10.1016/j.biortech.2012.12.067; Ergun BG, 2016, BIOPROC BIOSYST ENG, V39, P1, DOI 10.1007/s00449-015-1476-6; Fan GS, 2012, BIOTECHNOL LETT, V34, P2043, DOI 10.1007/s10529-012-0995-3; Fonseca-Maldonado R, 2013, J BIOL CHEM, V288, P25522, DOI 10.1074/jbc.M113.485953; GRINNELL BW, 1991, J BIOL CHEM, V266, P9778; Juturu V, 2012, BIOTECHNOL ADV, V30, P1219, DOI 10.1016/j.biotechadv.2011.11.006; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luo HY, 2009, EXTREMOPHILES, V13, P849, DOI 10.1007/s00792-009-0272-0; Malsuradze IG, 2011, GENETIKA, V47, P174; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreira LRS, 2016, APPL MICROBIOL BIOT, V100, P5205, DOI 10.1007/s00253-016-7555-z; Oliveira DS, 2010, J FOOD SCI, V75, pC588, DOI 10.1111/j.1750-3841.2010.01740.x; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Ribeiro LFC, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-115; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Skropeta D, 2009, BIOORGAN MED CHEM, V17, P2645, DOI 10.1016/j.bmc.2009.02.037; Subramaniyan S, 2002, CRIT REV BIOTECHNOL, V22, P33, DOI 10.1080/07388550290789450; Taneja K, 2002, BIORESOURCE TECHNOL, V85, P39, DOI 10.1016/S0960-8524(02)00064-0; Tomas-Gamisans M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148031; Ustinov BB, 2008, ENZYME MICROB TECH, V43, P56, DOI 10.1016/j.enzmictec.2008.01.017; Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065; Wei W, 2013, BIOTECHNOL BIOENG, V110, P3075, DOI 10.1002/bit.24990; Wei YD, 2005, BIOCHEM BIOPH RES CO, V329, P331, DOI 10.1016/j.bbrc.2005.01.013; Yang M, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0225-5; Zhang F, 2011, APPL MICROBIOL BIOT, V89, P1851, DOI 10.1007/s00253-010-3016-2; Zou SP, 2012, J BIOTECHNOL, V157, P399, DOI 10.1016/j.jbiotec.2011.12.017	41	25	30	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171111	10.1371/journal.pone.0171111	http://dx.doi.org/10.1371/journal.pone.0171111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187141	Green Published, Green Submitted, gold			2022-12-26	WOS:000394244300012
J	Liu, QQ; Stewart, J; Wang, H; Rashid, A; Zhao, J; Katz, MH; Lee, JE; Fleming, JB; Maitra, A; Wolff, RA; Varadhachary, GR; Krishnan, S; Wang, HM				Liu, Qingqing; Stewart, John; Wang, Hua; Rashid, Asif; Zhao, Jun; Katz, Matthew H.; Lee, Jeffrey E.; Fleming, Jason B.; Maitra, Anirban; Wolff, Robert A.; Varadhachary, Gauri R.; Krishnan, Sunil; Wang, Huamin			Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma	PLOS ONE			English	Article							SINGLE-INSTITUTION EXPERIENCE; ARGININE DEPRIVATION; CANCER; DEIMINASE; RESECTION; SURVIVAL; GEMCITABINE; CARCINOMA; DEFICIENT; HEAD	Argininosuccinate synthetase 1 (ASS1), the rate-limiting enzyme for arginine biosynthesis, is expressed in many types of human malignancies. Recent studies showed that ASS1 may have tumor suppressor function and that ASS1 deficiency is associated with clinical aggressiveness in nasopharyngeal carcinoma, myxofibrosarcomas and bladder cancer. The goal of this study was to evaluate the prognostic impact of ASS1 expression in patients with pancreatic ductal adenocarcinoma (PDAC). Our study included two independent cohorts: untreated cohort, which was comprised of 135 patients with PDAC who underwent pancreatoduodenectomy (PD) without pre-operative neoadjuvant therapy, and treated cohort, which was comprised of 122 patients with PDAC who have completed neoadjuvant therapy and PD. The expression level of ASS1 was evaluated by immunohistochemistry and the results were correlated with clinicopathologic parameters and survival using SPSS statistics. Our study showed that 12% of PDAC in untreated cohort and 15% of PDAC in treated cohort has low expression of ASS1 (ASS1-low). ASS1-low was associated with higher recurrence (p = 0.045), shorter disease-free survival (DFS, 4.8 +/- 1.6 months vs 15.3 +/- 2.2 months, p = 0.001) and shorter overall survival (OS, 14.6 +/- 6.4 months vs 26.5 +/- 3.5 months, p = 0.005) in untreated cohort and shorter OS in treated cohort compared to ASS1-high tumors. In multivariate analysis, ASS1-low (HR: 0.45, 95% CI: 0.26-0.79, p = 0.005) was an independent prognostic factor for DFS in untreated cohort and an independent prognostic factor for OS (HR: 0.56, 95% CI: 0.32-0.97, p = 0.04) in treated cohort. Our results provide supporting evidence for future clinical trial using arginine deprivation agents either alone or in combination with conventional chemotherapy in treating pancreatic cancer.	[Liu, Qingqing; Stewart, John; Rashid, Asif; Zhao, Jun; Maitra, Anirban; Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wang, Hua; Wolff, Robert A.; Varadhachary, Gauri R.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Katz, Matthew H.; Lee, Jeffrey E.; Fleming, Jason B.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Krishnan, Sunil] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wang, HM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	hmwang@mdanderson.org	liu, qingqing/HHD-0360-2022		National Institutes of Health [1R01 CA196941-01A1]; Khalifa Bin Zayed Al Nahyan Foundation Institute for Pancreatic Cancer Research at The University of Texas M. D. Anderson Cancer Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Khalifa Bin Zayed Al Nahyan Foundation Institute for Pancreatic Cancer Research at The University of Texas M. D. Anderson Cancer Center	Support was provided by the National Institutes of Health grant (1R01 CA196941-01A1) [https://www.nih.gov/grants-funding] and the Khalifa Bin Zayed Al Nahyan Foundation Institute for Pancreatic Cancer Research at The University of Texas M. D. Anderson Cancer Center [https://www.mdanderson.org/publications/conquest/fall-2011/khalifa-bin-zayed-al-nahyan-foundation.html].	Allen MD, 2014, CANCER RES, V74, P896, DOI 10.1158/0008-5472.CAN-13-1702; Benassai G, 2000, J SURG ONCOL, V73, P212; Bowles TL, 2008, INT J CANCER, V123, P1950, DOI 10.1002/ijc.23723; Daylami R, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0102-9; Delage B, 2010, INT J CANCER, V126, P2762, DOI 10.1002/ijc.25202; Dillon BJ, 2004, CANCER-AM CANCER SOC, V100, P826, DOI 10.1002/cncr.20057; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Glazer ES, 2010, SURGERY, V148, P310, DOI 10.1016/j.surg.2010.03.022; Huang HY, 2013, CLIN CANCER RES, V19, P2861, DOI 10.1158/1078-0432.CCR-12-2641; Husson A, 2003, EUR J BIOCHEM, V270, P1887, DOI 10.1046/j.1432-1033.2003.03559.x; Kedra B, 2001, HEPATO-GASTROENTEROL, V48, P1762; Lan J, 2014, TUMOR BIOL, V35, P161, DOI 10.1007/s13277-013-1020-8; Liu JB, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-686; Meyer W, 2000, SURG TODAY, V30, P582, DOI 10.1007/s005950070096; Ozaki H, 1999, SURG TODAY, V29, P16; Paniccia A, 2015, CHINESE J CANCER RES, V27, P376, DOI 10.3978/j.issn.1000-9604.2015.05.01; Perera RM, 2015, CANCER DISCOV, V5, P1247, DOI 10.1158/2159-8290.CD-15-0671; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; Sperti C, 1997, WORLD J SURG, V21, P195, DOI 10.1007/s002689900215; Takai S, 2003, PANCREAS, V26, P243, DOI 10.1097/00006676-200304000-00007; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P439, DOI 10.1016/S0753-3322(02)00284-6; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Wolfgang CL, 2013, CA-CANCER J CLIN, V63, P318, DOI 10.3322/caac.21190; Yang H, 2010, ONCOL LETT, V1, P31, DOI 10.3892/ol_00000005; YEO CJ, 1995, ANN SURG, V221, P721, DOI 10.1097/00000658-199506000-00011; Yoon CY, 2007, INT J CANCER, V120, P897, DOI 10.1002/ijc.22322	27	45	46	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171985	10.1371/journal.pone.0171985	http://dx.doi.org/10.1371/journal.pone.0171985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187218	gold, Green Submitted, Green Published			2022-12-26	WOS:000394244300066
J	Sales, G; Deagle, BE; Calura, E; Martini, P; Biscontin, A; De Pitta, C; Kawaguchi, S; Romualdi, C; Meyer, B; Costa, R; Jarman, S				Sales, Gabriele; Deagle, Bruce E.; Calura, Enrica; Martini, Paolo; Biscontin, Alberto; De Pitta, Cristiano; Kawaguchi, So; Romualdi, Chiara; Meyer, Bettina; Costa, Rodolfo; Jarman, Simon			KriIIDB: A de novo transcriptome database for the Antarctic krill (Euphausia superba)	PLOS ONE			English	Article							RNA-SEQ DATA; EXPRESSION; DANA	Antarctic krill (Euphausia superba) is a key species in the Southern Ocean with an estimated biomass between 100 and 500 million tonnes. Changes in krill population viability would have catastrophic effect on the Antarctic ecosystem. One looming threat due to elevated levels of anthropogenic atmospheric carbon dioxide (CO2) is ocean acidification (lowering of sea water pH by CO2 dissolving into the oceans). The genetics of Antarctic krill has long been of scientific interest for both for the analysis of population structure and analysis of functional genetics. However, the genetic resources available for the species are relatively modest. We have developed the most advanced genetic database on Euphausia superba, KriIIDB, which includes comprehensive data sets of former and present transcriptome projects. In particular, we have built a de novo transcriptome assembly using more than 360 million Illumina sequence reads generated from larval krill including individuals subjected to different CO2 levels. The database gives access to: 1) the full list of assembled genes and transcripts; 2) their level of similarity to transcripts and proteins from other species; 3) the predicted protein domains contained within each transcript; 4) their predicted GO terms; 5) the level of expression of each transcript in the different larval stages and CO2 treatments. All references to external entities (sequences, domains, GO terms) are equipped with a link to the appropriate source database. Moreover, the software implements a full-text search engine that makes it possible to submit free-form queries. KriIIDB represents the first largescale attempt at classifying and annotating the full krill transcriptome. For this reason, we believe it will constitute a cornerstone of future approaches devoted to physiological and molecular study of this key species in the Southern Ocean food web.	[Sales, Gabriele; Calura, Enrica; Martini, Paolo; Biscontin, Alberto; De Pitta, Cristiano; Romualdi, Chiara; Costa, Rodolfo] Univ Padua, Dept Biol, Padua, Italy; [Deagle, Bruce E.; Kawaguchi, So; Jarman, Simon] Australian Antarctic Div, Kingston, Tas, Australia; [Meyer, Bettina] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Meyer, Bettina] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Oldenburg, Germany	University of Padua; Australian Antarctic Division; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Carl von Ossietzky Universitat Oldenburg	Costa, R (corresponding author), Univ Padua, Dept Biol, Padua, Italy.; Jarman, S (corresponding author), Australian Antarctic Div, Kingston, Tas, Australia.; Meyer, B (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany.; Meyer, B (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Oldenburg, Germany.	bettina.meyer@awi.de; rodolfo.costa@unipd.it; simon.jarman@gmail.com	De Pitta, Cristiano/AAY-7302-2020; Meyer, Bettina/ABB-5311-2020; Calura, Enrica/AAA-1847-2021; Martini, Paolo/AAG-7398-2020; Deagle, Bruce E/R-2999-2019; Romualdi, Chiara/K-1132-2016; Sales, Gabriele/K-5065-2016	De Pitta, Cristiano/0000-0001-8013-8162; Meyer, Bettina/0000-0001-6804-9896; Calura, Enrica/0000-0001-8463-2432; Martini, Paolo/0000-0002-0146-1031; Deagle, Bruce E/0000-0001-7651-3687; Biscontin, Alberto/0000-0003-1492-7715; Kawaguchi, So/0000-0002-2042-5095; Romualdi, Chiara/0000-0003-4792-9047; Sales, Gabriele/0000-0003-2078-5661	Helmholtz Virtual Institute PolarTime [VH-VI-500]; Italian Programma Nazionale di Ricerche in Antartide - PNRA [2013/C1.05]; Australian Antarctic Science Program (AAS Project) [4015]; Alfred Wegener Institute through the research programme PACES II	Helmholtz Virtual Institute PolarTime; Italian Programma Nazionale di Ricerche in Antartide - PNRA; Australian Antarctic Science Program (AAS Project); Alfred Wegener Institute through the research programme PACES II	This work was supported by the following: * the Helmholtz Virtual Institute PolarTime (VH-VI-500: Biological timing in a changing marine environment - clocks and rhythms in polar pelagic organisms, www.polartime.org), to BM; * the Italian Programma Nazionale di Ricerche in Antartide - PNRA (grant 2013/C1.05, http://www.pnra.it/) to RC; * the Australian Antarctic Science Program (AAS Project 4015, http://www.antarctica.gov.au/science/information-for-scientists/research-guidelines/AASP-guidelines) to SJ; * the Alfred Wegener Institute through the research programme PACES II (topic 1, workpackage 5, https://www.awi.de/en.html) to BM.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Biscontin A, 2016, MAR GENOM, V29, P61, DOI 10.1016/j.margen.2016.04.010; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bortolotto E, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-32; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Chagne D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092644; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; De Pitta C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068652; De Pitta C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-45; Evans JD, 2013, J HERED, V104, P595, DOI 10.1093/jhered/est050; FEVOLDEN SE, 1989, POLAR BIOL, V9, P533, DOI 10.1007/BF00261038; Flores H, 2012, MAR ECOL PROG SER, V458, P1, DOI 10.3354/meps09831; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; IKEDA T, 1984, J EXP MAR BIOL ECOL, V75, P107, DOI 10.1016/0022-0981(84)90175-8; Jarman S, 2016, GENETICS ANTARCTIC K; Jeffery NW, 2012, POLAR BIOL, V35, P959, DOI 10.1007/s00300-011-1137-4; Jia ZN, 2014, POLAR BIOL, V37, P165, DOI 10.1007/s00300-013-1420-7; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kawaguchi S, 2013, NAT CLIM CHANGE, V3, DOI 10.1038/NCLIMATE1937; Kawaguchi S, 2011, BIOL LETTERS, V7, P288, DOI 10.1098/rsbl.2010.0777; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Martins MJF, 2015, MAR GENOM, V23, P45, DOI 10.1016/j.margen.2015.04.008; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; Meyer B, 2015, MOL ECOL RESOUR, V15, P1460, DOI 10.1111/1755-0998.12408; Nakasugi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091776; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; Peng Y, 2013, BIOINFORMATICS, V29, P326, DOI 10.1093/bioinformatics/btt219; Raven J., 2005, OCEAN ACIDIFICATION; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Seear PJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-582; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077	32	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171908	10.1371/journal.pone.0171908	http://dx.doi.org/10.1371/journal.pone.0171908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187156	Green Published, Green Submitted, gold			2022-12-26	WOS:000394244300059
J	Scarano, D; Rao, R; Corrado, G				Scarano, Daria; Rao, Rosa; Corrado, Giandomenico			In Silico identification and annotation of noncoding RNAs by RNA-seq and De Novo assembly of the transcriptome of Tomato Fruits	PLOS ONE			English	Article							GENOME; EXPRESSION; LANDSCAPE; UNCOVERS	The complexity of the tomato (Solanum lycopersicum) transcriptome has not yet been fully elucidated. To gain insights into the diversity and features of coding and non-coding RNA molecules of tomato fruits, we generated strand-specific libraries from berries of two tomato cultivars grown in two open-field conditions with different soil type. Following high-throughput Illumina RNA-sequencing (RNA-seq), more than 90% of the reads (over one billion, derived from twelve dataset) were aligned to the tomato reference genome. We report a comprehensive analysis of the transcriptome, improved with 39,095 transcripts, which reveals previously unannotated novel transcripts, natural antisense transcripts, long noncoding RNAs and alternative splicing variants. In addition, we investigated the sequence variants between the cultivars under investigation to highlight their genetic difference. Our strand-specific analysis allowed us to expand the current tomato transcriptome annotation and it is the first to reveal the complexity of the poly-adenylated RNA world in tomato. Moreover, our work demonstrates the usefulness of strand specific RNA-seq approach for the transcriptome-based genome annotation and provides a resource valuable for further functional studies.	[Scarano, Daria; Rao, Rosa; Corrado, Giandomenico] Univ Napoli Federico II, Dipartimento Agr, Via Univ 100, Portici, NA, Italy	University of Naples Federico II	Corrado, G (corresponding author), Univ Napoli Federico II, Dipartimento Agr, Via Univ 100, Portici, NA, Italy.	giandomenico.corrado@unina.it		Corrado, Giandomenico/0000-0002-8681-6988				Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Argyris JM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1196-3; Bai Y, 2014, MOL GENET GENOMICS, V289, P427, DOI 10.1007/s00438-014-0819-3; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen J, 2008, GENOME RES, V18, P751, DOI 10.1101/gr.068304.107; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Coppola V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-515; Corrado G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-835; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Ietswaart R, 2012, TRENDS GENET, V28, P445, DOI 10.1016/j.tig.2012.06.002; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim JE, 2014, MOL CELLS, V37, P36, DOI 10.14348/molcells.2014.2241; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Kumar R, 2014, J BIOSCIENCES, V39, P917, DOI 10.1007/s12038-014-9480-6; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Loraine AE, 2013, PLANT PHYSIOL, V162, P1092, DOI 10.1104/pp.112.211441; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Olson A., 2013, PLANT GENOME, V10, P3835, DOI DOI 10.3835/PLANTGENOME2013.08.0025; Gallart AP, 2016, NUCLEIC ACIDS RES, V44, pD1161, DOI 10.1093/nar/gkv1215; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Pootakham W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116028; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Scott J.W., 2013, GENETICS GENOMICS BR, P60, DOI [10.1201/b14578-3, DOI 10.1201/B14578-3]; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; SOIL SURVEY STAFF, 2014, KEYS SOIL TAXONOMY, V12th; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r92; Wang J, 2004, NATURE, V431, DOI 10.1038/nature03016; Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wu PY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S8; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yeager M, 2008, HUM GENET, V124, P161, DOI 10.1007/s00439-008-0535-3; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109	55	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171504	10.1371/journal.pone.0171504	http://dx.doi.org/10.1371/journal.pone.0171504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187155	gold, Green Published, Green Submitted			2022-12-26	WOS:000394244300025
J	Hsieh, CC; Chou, MJ; Wang, CH				Hsieh, Chia-Chien; Chou, Mei-Jia; Wang, Chih-Hsuan			Lunasin attenuates obesity-related inflammation in RAW264.7 cells and 3T3-L1 adipocytes by inhibiting inflammatory cytokine production	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; PEPTIDE LUNASIN; LEPTIN; IMMUNE; MACROPHAGES; DYSFUNCTION; MODULATION; ACTIVATION; FOCUS	Obesity has become a major threat to public health and is accompanied by chronic low-grade inflammation, which leads to various pathological developments. Lunasin, a natural seed peptide, exhibits several biological activities, such as anti-carcinogenesis, anti-inflammatory, and antioxidant activities. However, the mechanism of action of lunasin in obesity-related inflammation has not been investigated. The aim of this study was to explore whether lunasin could reduce the inflammation induced by obesity-related mediators in RAW264.7 cells and 3T3-L1 adipocytes and whether it could attenuate the crosstalk between the two cell lines. RAW264.7 cells were cultured in leptin-containing medium, adipocyte-conditioned medium (Ad-CM), or co-cultured with 3T3-L1 cells to mimic the physiology of obesity. The data showed that the secretion of pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) was inhibited by lunasin after leptin activation of RAW264.7 cells. In addition, lunasin decreased monocyte chemoattractant protein-1 (MCP-1) and IL-1 beta secretions in the Ad-CM model. Cytokine MCP-1, IL-6, tumor necrosis factor (TNF)-alpha, and IL-1 beta secretions were significantly decreased by leptin or Ad-CM plus lipopolysaccharide stimulation. Subsequently, the co-culture of the two cells refined the direct relation between them, resulting in apparently increased MCP-1, and decreased IL-6 levels after lunasin treatment. In 3T3-L1 adipocytes, lunasin also exhibited anti-inflammatory property by inhibiting MCP-1, plasminogen activator inhibitor-1, and leptin productions stimulated by (TNF)-alpha, lipopolysaccharide, or RAW264.7 cell-conditioned medium. This result revealed that lunasin acts as a potential anti-inflammatory agent not only in macrophages but also in adipocytes, disrupting the crosstalk between these two cells. Therefore, this study suggests the intake of lunasin from diet or as a supplement, for auxiliary prevention or therapy in obesity-related inflammatory applications.	[Hsieh, Chia-Chien; Chou, Mei-Jia; Wang, Chih-Hsuan] Natl Taiwan Normal Univ, Dept Human Dev & Family Studies, Taipei, Taiwan	National Taiwan Normal University	Hsieh, CC (corresponding author), Natl Taiwan Normal Univ, Dept Human Dev & Family Studies, Taipei, Taiwan.	hsieh@ntnu.edu.tw		Hsieh, Chia-Chien/0000-0003-3993-0144	Ministry of Science and Technology, Taiwan [MOST103-2 320-B-003-003-MY3]; National Taiwan Normal University, Taiwan [T10507000723]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan Normal University, Taiwan	This work was supported by Ministry of Science and Technology, Taiwan (MOST103-2 320-B-003-003-MY3), https://www.most.gov.tw/en/public; and National Taiwan Normal University, T10507000723, Taiwan, http://en.ntnu.edu.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achek A, 2016, ARCH PHARM RES, V39, P1032, DOI 10.1007/s12272-016-0806-9; Andrade-Oliveira V, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/681612; Apostolopoulos V, 2016, MOL NUTR FOOD RES, V60, P43, DOI 10.1002/mnfr.201500272; Aroor AR, 2013, METABOLISM, V62, P1543, DOI 10.1016/j.metabol.2013.07.001; Ballak DB, 2015, CYTOKINE, V75, P280, DOI 10.1016/j.cyto.2015.05.005; Boutagy NE, 2016, BIOCHIMIE, V124, P11, DOI 10.1016/j.biochi.2015.06.020; Bremer AA, 2013, J OBES, V2013, DOI 10.1155/2013/393192; Cam A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072115; Cam A, 2012, MOL NUTR FOOD RES, V56, P1569, DOI 10.1002/mnfr.201200301; Castoldi A, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00637; Collins S, 1996, NATURE, V380, P677, DOI 10.1038/380677a0; Dam V, 2016, OBES REV, V17, P1, DOI 10.1111/obr.12335; Dawson DR, 2014, PERIODONTOL 2000, V64, P161, DOI 10.1111/j.1600-0757.2012.00458.x; de Mejia EG, 2009, PEPTIDES, V30, P2388, DOI 10.1016/j.peptides.2009.08.005; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Delort L, 2015, LIFE SCI, V140, P37, DOI 10.1016/j.lfs.2015.04.012; Dia VP, 2009, FOOD CHEM, V114, P108, DOI 10.1016/j.foodchem.2008.09.023; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Galvez AF, 1999, NAT BIOTECHNOL, V17, P495, DOI 10.1038/8676; Galvez AF, 2013, LUNASIN ENRICHED SOY; Galvez AF, 2012, CIRCULATION, V126; Hall A, 2015, PEERJ, V3, DOI 10.7717/peerj.1428; Hernandez-Ledesma B, 2013, PROTEIN PEPTIDE LETT, V20, P424, DOI 10.2174/092986613805290327; Hernandez-Ledesma B, 2009, BIOCHEM BIOPH RES CO, V390, P803, DOI 10.1016/j.bbrc.2009.10.053; HSIEH CC, 2016, INT J MOL SCI, V17; Hsieh CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147161; Jia SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/346839; Jiang QQ, 2016, ONCOL REP, V36, P253, DOI 10.3892/or.2016.4798; Kalupahana NS, 2012, MOL ASPECTS MED, V33, P26, DOI 10.1016/j.mam.2011.10.011; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Li M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25474; Naylor C, 2016, TRENDS MOL MED, V22, P88, DOI 10.1016/j.molmed.2015.12.001; Onat A, 2008, INT J BIOL SCI, V4, P208; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Patel PS, 2013, J OBES, V2013, DOI 10.1155/2013/616193; Procaccini C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00332; Rose DP, 2015, CANCERS, V7, P2147, DOI 10.3390/cancers7040883; Ruiz-Canela M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081265; Shen J, 2013, MOL ASPECTS MED, V34, P39, DOI 10.1016/j.mam.2012.11.001; Sica A, 2015, CELL MOL LIFE SCI, V72, P4111, DOI 10.1007/s00018-015-1995-y; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011; Strong AL, 2015, STEM CELLS, V33, P318, DOI 10.1002/stem.1857; Tian YF, 2014, LIFE SCI, V116, P51, DOI 10.1016/j.lfs.2014.07.039; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Wensveen FM, 2015, EUR J IMMUNOL, V45, P2446, DOI 10.1002/eji.201545502; World Health Organization (WHO) Media Center Geneva, 2015, OB OV FACTS OV OB; Yang XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115330	48	25	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171969	10.1371/journal.pone.0171969	http://dx.doi.org/10.1371/journal.pone.0171969			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182687	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800140
J	Jiang, DQ; Wang, Y; Zhou, D				Jiang, Da-Quan; Wang, Yue; Zhou, Da			Phenotypic equilibrium as probabilistic convergence in multi-phenotype cell population dynamics	PLOS ONE			English	Article							CANCER STEM-CELLS; LIMIT-THEOREMS; BRANCHING-PROCESS; MODEL; DISTRIBUTIONS; GROWTH	We consider the cell population dynamics with n different phenotypes. Both the Markovian branching process model (stochastic model) and the ordinary differential equation (ODE) system model (deterministic model) are presented, and exploited to investigate the dynamics of the phenotypic proportions. We will prove that in both models, these proportions will tend to constants regardless of initial population states ("phenotypic equilibrium") under weak conditions, which explains the experimental phenomenon in Gupta et al.'s paper. We also prove that Gupta et al.'s explanation is the ODE model under a special assumption. As an application, we will give sufficient and necessary conditions under which the proportion of one phenotype tends to 0 (die out) or 1 (dominate). We also extend our results to non-Markovian cases.	[Jiang, Da-Quan] Peking Univ, Sch Math Sci, LMAM, Beijing 100871, Peoples R China; [Jiang, Da-Quan] Peking Univ, Ctr Stat Sci, Beijing 100871, Peoples R China; [Wang, Yue] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Zhou, Da] Xiamen Univ, Sch Math Sci, Xiamen 361005, Peoples R China	Peking University; Peking University; University of Washington; University of Washington Seattle; Xiamen University	Wang, Y (corresponding author), Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.	yuewang@uw.edu	Wang, Yue/GZG-6184-2022	Wang, Yue/0000-0001-5918-7525; Zhou, Da/0000-0002-0272-6644				Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; ATHREYA KB, 1968, ANN MATH STAT, V39, P347, DOI 10.1214/aoms/1177698395; Athreya KB, 1972, BRANCHING PROCESSES, P199; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Cox DR, 1965, THEORY STOCHASTIC PR, P257; dos Santos RV, 2013, J THEOR BIOL, V335, P79, DOI 10.1016/j.jtbi.2013.06.025; Durrett R, 2010, PROBABILITY THEORY E, P58; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Golubev A, 2010, J THEOR BIOL, V262, P257, DOI 10.1016/j.jtbi.2009.10.005; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; JAGERS P, 1969, J APPL PROBAB, V6, P249, DOI 10.2307/3211996; Karlin S, 1975, 1 COURSE STOCHASTIC, P547; KESTEN H, 1967, J MATH ANAL APPL, V17, P309, DOI 10.1016/0022-247X(67)90155-2; Kimmel M, 2002, BRANCHING PROCESSES, P103; Kimmel M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00089; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Mcdonald TO, 2015, J APPL PROBAB, V52, P864, DOI 10.1017/S002190020011349X; Mode CJ, 1971, MULTITYPE BRANCHING, V34, P138; Murray JW, 2001, MAR MICROPALEONTOL, V41, P1, DOI 10.1016/S0377-8398(00)00057-8; Norris JR, 1997, MARKOV CHAINS, p[11, 122]; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Seneta E, 1981, NONNEGATIVE MATRICES, P22; Smythe RT, 1996, STOCH PROC APPL, V65, P115, DOI 10.1016/S0304-4149(96)00094-4; Yakovlev AY, 2010, STOCH ANAL APPL, V28, P1040, DOI 10.1080/07362994.2010.515486; Yakovlev AY, 2009, ANN APPL PROBAB, V19, P1, DOI 10.1214/08-AAP539; Yakovlev AY, 1998, J MATH BIOL, V37, P49, DOI 10.1007/s002850050119; Yang G, 2012, BRIT J CANCER, V106, P1512, DOI 10.1038/bjc.2012.126; Zhou D, 2014, J THEOR BIOL, V357, P35, DOI 10.1016/j.jtbi.2014.04.039; Zhou DC, 2013, SCI REP-UK, V3, DOI 10.1038/srep03547; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	36	4	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170916	10.1371/journal.pone.0170916	http://dx.doi.org/10.1371/journal.pone.0170916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182672	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800022
J	Kugelman, JR; Wiley, MR; Nagle, ER; Reyes, D; Pfeffer, BP; Kuhn, JH; Sanchez-Lockhart, M; Palacios, GF				Kugelman, Jeffrey R.; Wiley, Michael R.; Nagle, Elyse R.; Reyes, Daniel; Pfeffer, Brad P.; Kuhn, Jens H.; Sanchez-Lockhart, Mariano; Palacios, Gustavo F.			Error baseline rates of five sample preparation methods used to characterize RNA virus populations	PLOS ONE			English	Article							LIBRARY PREPARATION; QUALITY-CONTROL; DNA; REPLICATION; VARIANTS	Individual RNA viruses typically occur as populations of genomes that differ slightly from each other due to mutations introduced by the error-prone viral polymerase. Understanding the variability of RNA virus genome populations is critical for understanding virus evolution because individual mutant genomes may gain evolutionary selective advantages and give rise to dominant sub populations, possibly even leading to the emergence of viruses resistant to medical countermeasures. Reverse transcription of virus genome populations followed by next-generation sequencing is the only available method to characterize variation for RNA viruses. However, both steps may lead to the introduction of artificial mutations, thereby skewing the data. To better understand how such errors are introduced during sample preparation, we determined and compared error baseline rates of five different sample preparation methods by analyzing in vitro transcribed Ebola virus RNA from an artificial plasmid-based system. These methods included: shotgun sequencing from plasmid DNA or in vitro transcribed RNA as a basic "no amplification" method, amplicon sequencing from the plasmid DNA or in vitro transcribed RNA as a "targeted" amplification method, sequenceindependent single-primer amplification (SISPA) as a "random" amplification method, rolling circle reverse transcription sequencing (CirSeq) as an advanced "no amplification" method, and Illumina TruSeq RNA Access as a "targeted" enrichment method. The measured error frequencies indicate that RNA Access offers the best tradeoff between sensitivity and sample preparation error (1.4(-5)) of all compared methods.	[Kugelman, Jeffrey R.; Wiley, Michael R.; Nagle, Elyse R.; Reyes, Daniel; Pfeffer, Brad P.; Sanchez-Lockhart, Mariano; Palacios, Gustavo F.] US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Frederick, MD 21702 USA; [Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick IRF Frederick, NIH, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Palacios, GF (corresponding author), US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Frederick, MD 21702 USA.	gustavo.f.palacios.ctr@mail.mil	Palacios, Gustavo/I-7773-2015; Sanchez-Lockhart, Mariano/H-1321-2019; Kuhn, Jens H./B-7615-2011; Sanchez-Lockhart, Mariano/M-6446-2019	Palacios, Gustavo/0000-0001-5062-1938; Sanchez-Lockhart, Mariano/0000-0001-8009-7540; Kuhn, Jens H./0000-0002-7800-6045; Sanchez-Lockhart, Mariano/0000-0001-8009-7540; Wiley, Michael/0000-0001-6688-007X	Defense Threat Reduction Agency; Battelle Memorial Institute's prime; US National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200700016I]; Tunnell Government Services, Inc.	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Battelle Memorial Institute's prime; US National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Tunnell Government Services, Inc.	This work was supported by Defense Threat Reduction Agency and Battelle Memorial Institute's prime contract with the US National Institute of Allergy and Infectious Diseases (NIAID)under Contract No. HHSN272200700016I (J.H.K.). A subcontractor to Battelle Memorial Institute who performed this work is : J.H.K., an employee of Tunnell Government Services, Inc.	Acevedo A, 2014, NAT PROTOC, V9, P1760, DOI 10.1038/nprot.2014.118; Altmann A, 2011, BIOINFORMATICS, V27, pI77, DOI 10.1093/bioinformatics/btr205; Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; Bull RA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002243; Carneiro MO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-375; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Flaherty P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr861; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Holmes EC, 2009, EVOLUTION EMERGENCES; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Koboldt DC, 2012, METHODS MOL BIOL, V838, P369, DOI 10.1007/978-1-61779-507-7_18; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kugelman JR, 2015, CELL REP, V12, P2111, DOI 10.1016/j.celrep.2015.08.038; Kugelman JR, 2015, MBIO, V6, DOI 10.1128/mBio.02227-14; Kugelman JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050316; Ladner JT, 2016, REV SCI TECH OIE, V35, P43, DOI 10.20506/rst.35.1.2416; Ladner JT, 2014, MBIO, V5, DOI 10.1128/mBio.01360-14; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; Olasagasti F, 2010, NAT NANOTECHNOL, V5, P798, DOI [10.1038/nnano.2010.177, 10.1038/NNANO.2010.177]; Potter J, 2003, FOCUS, V25, P19; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Yang X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-33; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	34	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171333	10.1371/journal.pone.0171333	http://dx.doi.org/10.1371/journal.pone.0171333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182717	gold, Green Submitted, Green Published			2022-12-26	WOS:000394231800055
J	Pichyangkul, S; Spring, MD; Yongvanitchit, K; Kum-Arb, U; Limsalakpetch, A; Im-Erbsin, R; Ubalee, R; Vanachayangkul, P; Remarque, EJ; Angov, E; Smith, PL; Saunders, DL				Pichyangkul, Sathit; Spring, Michele D.; Yongvanitchit, Kosol; Kum-Arb, Utaiwan; Limsalakpetch, Amporn; Im-Erbsin, Rawiwan; Ubalee, Ratawan; Vanachayangkul, Pattaraporn; Remarque, Edmond J.; Angov, Evelina; Smith, Philip L.; Saunders, David L.			Chemoprophylaxis with sporozoite immunization in P-knowlesi rhesus monkeys confers protection and elicits sporozoite-specific memory T cells in the liver	PLOS ONE			English	Article							PLASMODIUM-KNOWLESI; BONE-MARROW; MALARIA; STAGE; LYMPHOCYTES; CHALLENGE; INFECTION; RESPONSES; IMMUNITY; HEPATOCYTES	Whole malaria sporozoite vaccine regimens are promising new strategies, and some candidates have demonstrated high rates of durable clinical protection associated with memory T cell responses. Little is known about the anatomical distribution of memory T cells following whole sporozoite vaccines, and immunization of nonhuman primates can be used as a relevant model for humans. We conducted a chemoprophylaxis with sporozoite (CPS) immunization in P. knowlesi rhesus monkeys and challenged via mosquito bites. Half of CPS immunized animals developed complete protection, with a marked delay in parasitemia demonstrated in the other half. Antibody responses to whole sporozoites, CSP, and AMA1, but not CelTOS were detected. Peripheral blood T cell responses to whole sporozoites, but not CSP and AMA1 peptides were observed. Unlike peripheral blood, there was a high frequency of sporozoite-specific memory T cells observed in the liver and bone marrow. Interestingly, sporozoite-specific CD4(+) and CD8(+) memory T cells in the liver highly expressed chemokine receptors CCR5 and CXCR6, both of which are known for liver sinusoid homing. The majority of liver sporozoite-specific memory T cells expressed CD69, a phenotypic marker of tissue-resident memory (T-RM) cells, which are well positioned to rapidly control liver-stage infection. Vaccine strategies that aim to elicit large number of liver TRM cells may efficiently increase the efficacy and durability of response against pre-erythrocytic parasites.	[Pichyangkul, Sathit; Spring, Michele D.; Yongvanitchit, Kosol; Kum-Arb, Utaiwan; Limsalakpetch, Amporn; Im-Erbsin, Rawiwan; Ubalee, Ratawan; Vanachayangkul, Pattaraporn; Smith, Philip L.; Saunders, David L.] AFRIMS, Bangkok, Thailand; [Remarque, Edmond J.] Biomed Primate Res Ctr, Rijswijk, Netherlands; [Angov, Evelina] Walter Reed Army Inst Res, Silver Spring, MD USA	Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Pichyangkul, S (corresponding author), AFRIMS, Bangkok, Thailand.	sathitp@afrims.org	Remarque, Ed/AAE-8643-2020		Military Infectious Diseases Research Program (MIDRP), Fort Detrick, Maryland, United States of America	Military Infectious Diseases Research Program (MIDRP), Fort Detrick, Maryland, United States of America	This work was supported by the Military Infectious Diseases Research Program (MIDRP), Fort Detrick, Maryland, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar Joao C, 2015, PLoS One, V10, pe0136109, DOI 10.1371/journal.pone.0136109; Alp OS, 2015, EUR J IMMUNOL, V45, P975, DOI 10.1002/eji.201445295; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Antinori S, 2013, ACTA TROP, V125, P191, DOI 10.1016/j.actatropica.2012.10.008; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Bertolino P, 2002, IMMUNOL CELL BIOL, V80, P84, DOI 10.1046/j.0818-9641.2001.01048.x; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Corradin G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00527; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Frevert U, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00482; Frost EL, 2015, J IMMUNOL, V195, P3520, DOI 10.4049/jimmunol.1501521; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Guidotti LG, 2015, CELL, V161, P486, DOI 10.1016/j.cell.2015.03.005; Heesch K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097701; Heydtmann M, 2005, J IMMUNOL, V174, P1055, DOI 10.4049/jimmunol.174.2.1055; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Hudspeth K, 2016, J AUTOIMMUN, V66, P40, DOI 10.1016/j.jaut.2015.08.011; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Liehl P, 2015, INFECT IMMUN, V83, P1172, DOI 10.1128/IAI.02796-14; Liehl P, 2014, NAT MED, V20, P47, DOI 10.1038/nm.3424; McMaster SR, 2015, J IMMUNOL, V195, P203, DOI 10.4049/jimmunol.1402975; Milo I, 2013, BLOOD, V122, P193, DOI 10.1182/blood-2012-01-401265; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Murphy JR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-215; Nahrendorf W, 2015, ELIFE, V4, DOI 10.7554/eLife.05165; Nganou-Makamdop K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036508; Okhrimenko A, 2014, P NATL ACAD SCI USA, V111, P9229, DOI 10.1073/pnas.1318731111; ORJIH AU, 1982, T ROY SOC TROP MED H, V76, P57, DOI 10.1016/0035-9203(82)90019-0; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Pichyangkul S, 2015, J IMMUNOL, V195, P4378, DOI 10.4049/jimmunol.1501702; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Sakai S, 2014, J IMMUNOL, V192, P2965, DOI 10.4049/jimmunol.1400019; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; SEGUIN MC, 1994, J EXP MED, V180, P353, DOI 10.1084/jem.180.1.353; Shin H, 2013, IMMUNOL REV, V255, P165, DOI 10.1111/imr.12087; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Tse SW, 2013, GENES IMMUN, V14, P302, DOI 10.1038/gene.2013.20; Tse SW, 2014, J INFECT DIS, V210, P1508, DOI 10.1093/infdis/jiu281; Tuncer C, 2013, LIVER INT, V33, P852, DOI 10.1111/liv.12182; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; WEISS WR, 1992, J IMMUNOL, V149, P2103; White MT, 2015, LANCET INFECT DIS, V15, P1450, DOI 10.1016/S1473-3099(15)00239-X; White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889; Yilmaz B, 2014, CELL, V159, P1277, DOI 10.1016/j.cell.2014.10.053	54	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171826	10.1371/journal.pone.0171826	http://dx.doi.org/10.1371/journal.pone.0171826			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182750	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800122
J	Place, ES; Smith, JC				Place, Elsie S.; Smith, James C.			Zebrafish atoh8 mutants do not recapitulate morpholino phenotypes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ATOH8; GENE-EXPRESSION; SHEAR-STRESS; DIFFERENTIATION; PROTEINS; EMBRYOS; FAMILY; FRIEND; MATH6; HEMATOPOIESIS	Atoh8 is a bHLH transcription factor expressed in pancreas, skeletal muscle, the nervous system, and cardiovascular tissues during embryological development. Although it has been implicated in the regulation of pancreatic and endothelial cell differentiation, the phenotypic consequences of Atoh8 loss are uncertain. Conclusions from knockout studies in the mouse differ widely depending on the targeting strategy used, while atoh8 knockdown by interfering morpholino oligonucleotides (morpholinos) in zebrafish has led to a range of developmental defects. This study characterised zebrafish embryos homozygous for atoh8(sa1465), a loss-of-function allele of atoh8, in order to provide genetic evidence for the developmental role of Atoh8 in this species. Embryos homozygous for atoh8(sa1465) present normal body morphology, swimbladder inflation, and heart looping, and survive to adulthood. These embryos do not develop pericardial oedema by 72 hpf and are not sensitised to the loss of Fog1 protein, suggesting that this previously described abnormality is not a specific phenotype. Vascular patterning and primitive haematopoiesis are unaffected in atoh8(sa1465/sa1465) mutant embryos. Together, the data suggest that Atoh8 is dispensible for zebrafish development under standard laboratory conditions.	[Place, Elsie S.; Smith, James C.] Francis Crick Inst, Dev Biol Lab, London, England	Francis Crick Institute	Smith, JC (corresponding author), Francis Crick Inst, Dev Biol Lab, London, England.	jim.smith@crick.ac.uk		Smith, Jim/0000-0003-2413-9392	The Francis Crick Institute [10158, 10157] Funding Source: researchfish; Medical Research Council [MC_U117597140] Funding Source: Medline; MRC [MC_U117597140] Funding Source: UKRI	The Francis Crick Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahuja S, 2016, DEV BIOL, V412, P71, DOI 10.1016/j.ydbio.2016.02.003; Amigo JD, 2009, BLOOD, V114, P4654, DOI 10.1182/blood-2008-12-189910; Bagu ET, 2011, J MOL ENDOCRINOL, V47, P299, DOI 10.1530/JME-11-0060; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Benezra R, 2001, ONCOGENE, V20, P8334, DOI 10.1038/sj.onc.1205160; Busch-Nentwich E., 2012, SANGER I ZEBRAFISH M; Cantor AB, 2005, SEMIN CELL DEV BIOL, V16, P117, DOI 10.1016/j.semcdb.2004.10.006; Chen J, 2013, ZEBRAFISH, V10, P389, DOI 10.1089/zeb.2013.0875; Chen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023005; Cooney JD, 2013, DEV BIOL, V373, P431, DOI 10.1016/j.ydbio.2012.08.015; Ejarque M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146273; Ejarque M, 2013, BBA-GENE REGUL MECH, V1829, P1175, DOI 10.1016/j.bbagrm.2013.08.003; Fang F, 2014, J CELL SCI, V127, P1428, DOI 10.1242/jcs.136358; Gao ZG, 2010, EMBO J, V29, P457, DOI 10.1038/emboj.2009.368; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; Inoue C, 2001, GENES CELLS, V6, P977, DOI 10.1046/j.1365-2443.2001.00476.x; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kim J, 2012, CONTEXT DEPENDENT PR, V2, P441; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kubo F, 2010, DEV DYNAM, V239, P2492, DOI 10.1002/dvdy.22381; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lynn FC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002430; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Nishikawa K, 2003, MOL CELL BIOL, V23, P8295, DOI 10.1128/MCB.23.22.8295-8305.2003; Patel N, 2014, BRIT J HAEMATOL, V164, P586, DOI 10.1111/bjh.12649; Rawnsley DR, 2013, J BIOL CHEM, V288, P24429, DOI 10.1074/jbc.M113.463083; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ross MD, 2006, DEV DYNAM, V235, P3102, DOI 10.1002/dvdy.20934; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Stainier DYR, 2015, DEV CELL, V32, P7, DOI 10.1016/j.devcel.2014.12.012; Stevens JD, 2008, DIFFERENTIATION, V76, P1006, DOI 10.1111/j.1432-0436.2008.00285.x; Thisse B., 2001, EXPRESSION ZEBRAFISH; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Walton RZ, 2006, DEV BIOL, V289, P482, DOI 10.1016/j.ydbio.2005.10.040; Wasserman SM, 2002, PHYSIOL GENOMICS, V12, P13, DOI 10.1152/physiolgenomics.00102.2002; Westerfield M., 2007, THE ZEBRAFISH BOOK; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232; Yao JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010945	42	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171143	10.1371/journal.pone.0171143	http://dx.doi.org/10.1371/journal.pone.0171143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182631	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800038
J	Rewell, SSJ; Churilov, L; Sidon, TK; Aleksoska, E; Cox, SF; Macleod, MR; Howells, DW				Rewell, Sarah S. J.; Churilov, Leonid; Sidon, T. Kate; Aleksoska, Elena; Cox, Susan F.; Macleod, Malcolm R.; Howells, David W.			Evolution of ischemic damage and behavioural deficit over 6 months after MCAo in the rat: Selecting the optimal outcomes and statistical power for multi-centre preclinical trials	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; ADHESIVE REMOVAL TEST; MODIFIED RANKIN SCALE; EXPERIMENTAL STROKE; FOCAL ISCHEMIA; FUNCTIONAL RECOVERY; SOCIAL-INTERACTION; NEURONAL DAMAGE; EDEMA FORMATION; BRAIN-DAMAGE	Key disparities between the timing and methods of assessment in animal stroke studies and clinical trial may be part of the reason for the failure to translate promising findings. This study investigates the development of ischemic damage after thread occlusion MCAo in the rat, using histological and behavioural outcomes. Using the adhesive removal test we investigate the longevity of behavioural deficit after ischemic stroke in rats, and examine the practicality of using such measures as the primary outcome for future studies. Ischemic stroke was induced in 132 Spontaneously Hypertensive Rats which were assessed for behavioural and histological deficits at 1, 3, 7, 14, 21, 28 days, 12 and 24 weeks (n> 11 per timepoint). The basic behavioural score confirmed induction of stroke, with deficits specific to stroke animals. Within 7 days, these deficits resolved in 50% of animals. The adhesive removal test revealed contralateral neglect for up to 6 months following stroke. Sample size calculations to facilitate the use of this test as the primary experimental outcome resulted in cohort sizes much larger than are the norm for experimental studies. Histological damage progressed from a necrotic infarct to a hypercellular area that cleared to leave a fluid filled cavity. Whilst absolute volume of damage changed over time, when corrected for changes in hemispheric volume, an equivalent area of damage was lost at all timepoints. Using behavioural measures at chronic timepoints presents significant challenges to the basic science community in terms of the large number of animals required and the practicalities associated with this. Multicentre preclinical randomised controlled trials as advocated by the MultiPART consortium may be the only practical way to deal with this issue.	[Rewell, Sarah S. J.; Churilov, Leonid; Sidon, T. Kate; Aleksoska, Elena; Cox, Susan F.; Howells, David W.] Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Austin Campus, Heidelberg, Vic, Australia; [Macleod, Malcolm R.] Univ Edinburgh, Dept Clin Neurosci, Edinburgh EH8 9YL, Midlothian, Scotland; [Howells, David W.] Univ Tasmania, Sch Med, Fac Hlth, Hobart, Tas, Australia	Florey Institute of Neuroscience & Mental Health; University of Edinburgh; University of Tasmania	Howells, DW (corresponding author), Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Austin Campus, Heidelberg, Vic, Australia.; Howells, DW (corresponding author), Univ Tasmania, Sch Med, Fac Hlth, Hobart, Tas, Australia.	david.howells@utas.edu.au	Macleod, Malcolm Robert/B-2052-2010	Macleod, Malcolm Robert/0000-0001-9187-9839; Rewell, Sarah/0000-0002-4754-6524; Howells, David/0000-0002-2512-7724	National Health & Medical Research Council [GNT1013612]; NHMRC-EU collaborative grant; Victorian State Government; National Centre for the Replacement [NC/L000970/1] Funding Source: researchfish	National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC-EU collaborative grant; Victorian State Government; National Centre for the Replacement	This work was supported by the National Health & Medical Research Council (https://www.nhmrc.gov.au/)) [GNT1013612] (DWH) and an NHMRC-EU collaborative grant (DWH, MRM). The Florey gratefully acknowledges the operational infrastructure support of the Victorian State Government. The Victorian Cancer Biobank is supported by the Victorian State Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaverdashvili M, 2015, J NEUROSCI METH, V247, P58, DOI 10.1016/j.jneumeth.2015.03.029; Aronowski J, 1996, J CEREBR BLOOD F MET, V16, P705, DOI 10.1097/00004647-199607000-00022; Aspey BS, 1998, NEUROPATH APPL NEURO, V24, P487; Balkaya M, 2013, J CEREBR BLOOD F MET, V33, P330, DOI 10.1038/jcbfm.2012.185; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bouet V, 2012, A MASTER KEY TO ASSE; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; BRINT S, 1988, J CEREBR BLOOD F MET, V8, P474, DOI 10.1038/jcbfm.1988.88; Bronnum-Hansen H, 2001, STROKE, V32, P2131, DOI 10.1161/hs0901.094253; CHEN H, 1993, J NEUROL SCI, V118, P109, DOI 10.1016/0022-510X(93)90099-K; Churilov L, 2014, INT J STROKE, V9, P999, DOI 10.1111/ijs.12364; CLARK RK, 1994, BRAIN RES BULL, V35, P387, DOI 10.1016/0361-9230(94)90119-8; CLARK RK, 1993, BRAIN RES BULL, V31, P565, DOI 10.1016/0361-9230(93)90124-T; Corbett D, 1998, PROG NEUROBIOL, V54, P531, DOI 10.1016/S0301-0082(97)00078-6; Craft TKS, 2005, STROKE, V36, P2006, DOI 10.1161/01.STR.0000177538.17687.54; DERESKI MO, 1993, ACTA NEUROPATHOL, V85, P327; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Dirnagl U, 2013, STROKE, V44, P1754, DOI 10.1161/STROKEAHA.113.000734; Dirnagl U, 2012, J CEREBR BLOOD F MET, V32, P933, DOI 10.1038/jcbfm.2012.51; Dittmar M, 2003, STROKE, V34, P2252, DOI 10.1161/01.STR.0000083625.54851.9A; Doeppner TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00338; Dogan A, 1998, NEUROL RES, V20, P265; FARBER JL, 1981, AM J PATHOL, V102, P271; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Freret T, 2006, EUR J NEUROSCI, V23, P1757, DOI 10.1111/j.1460-9568.2006.04699.x; Freret T, 2008, J CEREBR BLOOD F MET, V28, P786, DOI 10.1038/sj.jcbfm.9600575; Freret T, 2006, BEHAV NEUROSCI, V120, P1285, DOI 10.1037/0735-7044.120.6.1285; Freret T, 2009, BEHAV NEUROSCI, V123, P224, DOI 10.1037/a0014157; GARCIA JH, 1994, AM J PATHOL, V144, P188; GARCIA JH, 1993, AM J PATHOL, V142, P623; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Gonzalez CLR, 2003, EUR J NEUROSCI, V18, P1950, DOI 10.1046/j.1460-9568.2003.02928.x; Graham SM, 2004, COMPARATIVE MED, V54, P486; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; Harada H, 2005, BRAIN RES PROTOC, V14, P165, DOI 10.1016/j.brainresprot.2004.12.007; Henninger N, 2006, STROKE, V37, P1283, DOI 10.1161/01.STR.0000217223.72193.98; Ishibashi S, 2003, STROKE, V34, P1501, DOI 10.1161/01.STR.0000074034.32371.13; Justicia C, 2008, STROKE, V39, P1541, DOI 10.1161/STROKEAHA.107.503565; Karelina K, 2011, STROKE, V42, P3606, DOI 10.1161/STROKEAHA.111.628008; Karelina K, 2009, EXP NEUROL, V220, P276, DOI 10.1016/j.expneurol.2009.08.022; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kleikers PWM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13428; KUGE Y, 1995, STROKE, V26, P1655, DOI 10.1161/01.STR.26.9.1655; Lapchak PA, 2013, TRANSL STROKE RES, V4, P279, DOI 10.1007/s12975-012-0209-2; Lees KR, 2012, STROKE, V43, P1163, DOI 10.1161/STROKEAHA.111.641423; Lehrmann E, 1997, J COMP NEUROL, V386, P461; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Li HL, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-58; Li Y, 1998, J NEUROL SCI, V156, P119, DOI 10.1016/S0022-510X(98)00036-7; Lindner MD, 2003, J NEUROSCI, V23, P10913; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lourbopoulos A, 2016, J CEREB BLOOD FLOW M; Macleod M, 2010, NEUROMETHODS, V47, P7, DOI 10.1007/978-1-60761-750-1_2; Mammen E F, 2000, Clin Lab Sci, V13, P239; Matsumoto N, 1973, STROKE, V4, P20, DOI 10.1161/01.STR.4.1.20; Meisel C, 2004, STROKE, V35, P2, DOI 10.1161/01.STR.0000109041.89959.4C; Mergenthaler P, 2012, DIS MODEL MECH, V5, P718, DOI 10.1242/dmm.010033; Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0; Modo M, 2003, NEUROREPORT, V14, P39, DOI 10.1097/00001756-200301200-00007; Modo Michel, 2009, J Exp Stroke Transl Med, V2, P52; Mracsko E, 2014, BRAIN BEHAV IMMUN, V41, P200, DOI 10.1016/j.bbi.2014.05.015; NEDERGAARD M, 1987, ACTA NEUROPATHOL, V73, P267, DOI 10.1007/BF00686621; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; O'Collins VE, 2013, ANIMAL MODELS FOR THE STUDY OF HUMAN DISEASE, P531, DOI 10.1016/B978-0-12-415894-8.00023-3; Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7; Philip M, 2009, STROKE, V40, P577, DOI 10.1161/STROKEAHA.108.524330; Porritt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041090; Rosell A, 2013, TRANSL STROKE RES, V4, P297, DOI 10.1007/s12975-012-0234-1; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Schellinger PD, 2012, INT J STROKE, V7, P227, DOI 10.1111/j.1747-4949.2012.00773.x; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Sicard Kenneth M, 2009, Exp Transl Stroke Med, V1, P7, DOI 10.1186/2040-7378-1-7; Soleman S, 2010, EXP NEUROL, V222, P13, DOI 10.1016/j.expneurol.2009.11.007; Spratt NJ, 2006, J NEUROSCI METH, V155, P285, DOI 10.1016/j.jneumeth.2006.01.020; Stuller KA, 2012, EXP NEUROL, V233, P33, DOI 10.1016/j.expneurol.2011.01.016; Sun LY, 2009, NEUROPATHOLOGY, V29, P45, DOI 10.1111/j.1440-1789.2008.00939.x; Tennant KA, 2009, J NEUROSCI METH, V181, P18, DOI 10.1016/j.jneumeth.2009.04.009; Trueman RC, 2016, J CEREB BLOOD FLOW M; Turner RJ, 2011, TRANSL STROKE RES, V2, P138, DOI 10.1007/s12975-011-0067-3; Veizovic T, 2001, STROKE, V32, P1012, DOI 10.1161/01.STR.32.4.1012; Venna VR, 2011, STROKE, V42, P3329, DOI 10.1161/STROKEAHA.111.632570; Venna VR, 2012, ACTA NEUROPATHOL, V124, P425, DOI 10.1007/s00401-012-0990-8; Virley D, 2000, J CEREB BLOOD FLOW M, V20, P536; Wang MM, 2013, TRANSL STROKE RES, V4, P3, DOI 10.1007/s12975-012-0219-0; Whishaw IQ, 1998, BEHAV BRAIN RES, V96, P79, DOI 10.1016/S0166-4328(97)00200-3; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zhang L, 2000, J NEUROL SCI, V174, P141, DOI 10.1016/S0022-510X(00)00268-9; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129	94	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171688	10.1371/journal.pone.0171688	http://dx.doi.org/10.1371/journal.pone.0171688			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182727	Green Published, gold			2022-12-26	WOS:000394231800090
J	Lonhienne, T; Garcia, MD; Fraser, JA; Williams, CM; Guddat, LW				Lonhienne, Thierry; Garcia, Mario D.; Fraser, James A.; Williams, Craig M.; Guddat, Luke W.			The 2.0 angstrom X-ray structure for yeast acetohydroxyacid synthase provides new insights into its cofactor and quaternary structure requirements	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ACETOLACTATE; FLAVIN; SYSTEM; FORM	Acetohydroxyacid synthase (AHAS) catalyzes the first step of branched-chain amino acid biosynthesis, a pathway essential to the life-cycle of plants and micro-organisms. The catalytic subunit has thiamin diphosphate (ThDP) and flavin adenine dinucleotide (FAD) as indispensable co-factors. A new, high resolution, 2.0 angstrom crystal structure of Saccharomyces cerevisiae AHAS reveals that the dimer is asymmetric, with the catalytic centres having distinct structures where FAD is trapped in two different conformations indicative of different redox states. Two molecules of oxygen (O-2) are bound on the surface of each active site and a tunnel in the polypeptide appears to passage O-2 to the active site independently of the substrate. Thus, O-2 appears to play a novel "co-factor " role in this enzyme. We discuss the functional implications of these features of the enzyme that have not previously been described.	[Lonhienne, Thierry; Garcia, Mario D.; Fraser, James A.; Williams, Craig M.; Guddat, Luke W.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Queensland	Lonhienne, T; Guddat, LW (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	t.lonhienne@uq.edu.au; luke.guddat@uq.edu.au	Guddat, Luke/AAI-2930-2021; Fraser, James A/B-4918-2012; Williams, Craig M./J-2379-2014	Fraser, James A/0000-0001-5724-5285; Williams, Craig M./0000-0002-3834-7398; Garcia, Mario/0000-0001-8378-7475	National Health and Medical Research Council [1008736]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Support was provided by Grant number 1008736 from the National Health and Medical Research Council received by LWG, CW, and JF.; X-ray data were measured at the University of Queensland Remote-Operation Crystallization and X-ray diffraction facility (UQROCX) and using beam line MX1, Australian Synchrotron, Clayton, Victoria. The work was supported by funds Grant number 1008736 from the National Health and Medical Research Council.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baig IA, 2013, ENZYME MICROB TECH, V53, P243, DOI 10.1016/j.enzmictec.2013.05.006; Chipman DM, 2005, CURR OPIN CHEM BIOL, V9, P475, DOI 10.1016/j.cbpa.2005.07.002; Duggleby RG, 2003, EUR J BIOCHEM, V270, P2895, DOI 10.1046/j.1432-1033.2003.03671.x; Duggleby RG, 2000, J BIOCHEM MOL BIOL, V33, P1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Moustafa IM, 2006, J MOL BIOL, V364, P991, DOI 10.1016/j.jmb.2006.09.032; MULLER YA, 1993, SCIENCE, V259, P965, DOI 10.1126/science.8438155; Pang SS, 2002, J MOL BIOL, V317, P249, DOI 10.1006/jmbi.2001.5419; Pang SS, 2001, ACTA CRYSTALLOGR D, V57, P1321, DOI 10.1107/S0907444901011635; STORMER FC, 1964, BIOCHEM BIOPH RES CO, V17, P587, DOI 10.1016/0006-291X(64)90071-3; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Tittmann K, 2004, BIOCHEMISTRY-US, V43, P8652, DOI 10.1021/bi049897t; TSE JMT, 1993, BIOCHEMISTRY-US, V32, P10398, DOI 10.1021/bi00090a015; UKessays, 2015, FLAV ENZ BIOL FUNCT	20	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171443	10.1371/journal.pone.0171443	http://dx.doi.org/10.1371/journal.pone.0171443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178302	Green Published, Green Submitted, gold			2022-12-26	WOS:000393712500042
J	Ewen, M; Zweekhorst, M; Regeer, B; Laing, R				Ewen, Margaret; Zweekhorst, Marjolein; Regeer, Barbara; Laing, Richard			Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases	PLOS ONE			English	Article							ACCESS	Background WHO has set a voluntary target of 80% availability of affordable essential medicines, including generics, to treat major non-communicable diseases (NCDs), in the public and private sectors of countries by 2025. We undertook a secondary analysis of data from 30 surveys in low-and middle-income countries, conducted from 2008-2015 using the World Health Organization (WHO)/Health Action International (HAI) medicine availability and price survey methodology, to establish a baseline for this target. Methods Data for 49 medicines (lowest priced generics and originator brands) to treat cardiovascular diseases (CVD), diabetes, chronic obstructive pulmonary diseases (COPD) and central nervous system (CNS) conditions were analysed to determine their availability in healthcare facilities and pharmacies, their affordability for those on low incomes (based on median patient prices of each medicine), and the percentage of medicines that were both available and affordable. Affordability was expressed as the number of days' wages of the lowest-paid unskilled government worker needed to purchase 30 days' supply using standard treatment regimens. Paying more than 1 days' wages was considered unaffordable. Findings In low-income countries, 15.2% and 18.9% of lowest-priced generics met WHO's target in the public and private sectors, respectively, and 2.6% and 5.2% of originator brands. In lower-middle income countries, 23.8% and 23.2% of lowest priced generics, and 0.8% and 1.4% of originator brands, met the target in the public and private sectors, respectively. In upper-middle income countries, the situation was better for generics but still suboptimal as 36.0% and 39.4% met the target in public and private sectors, respectively. For originator brands in upper-middle income countries, none reached the target in the public sector and 13.7% in the private sector. Across the therapeutic groups for lowest priced generics, CVD medicines in low-income countries (11.9%), and CNS medicines in lower-middle (10.2%) and upper-middle income countries (33.3%), were least available and affordable in the public sector. In the private sector for lowest priced generics, CNS medicines were least available and affordable in all three country income groups (11.4%, 5.8% and 29.3% in low-, lower-middle and upper-middle income countries respectively). Interpretation This data, which can act as a baseline for the WHO target, shows low availability and/or poor affordability is resulting in few essential NCD medicines meeting the target in low-and middle-income countries. In the era of Sustainable Development Goals, and as countries work to achieve Universal Health Coverage, increased commitments are needed by governments to improve the situation through the development of evidence-informed, nationally-contextualised interventions, with regular monitoring of NCD medicine availability, patient prices and affordability.	[Ewen, Margaret] Hlth Act Int, Amsterdam, Netherlands; [Zweekhorst, Marjolein; Regeer, Barbara] Vrije Univ Amsterdam, Athena Inst, Amsterdam, Netherlands; [Laing, Richard] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Laing, Richard] Univ Western Cape, Cape Town, South Africa	Vrije Universiteit Amsterdam; Boston University; University of the Western Cape	Ewen, M (corresponding author), Hlth Act Int, Amsterdam, Netherlands.	marg@haiweb.org	Regeer, Barbara J/M-1207-2018	Regeer, Barbara J/0000-0002-9044-9367				[Anonymous], 2013, PRIC AV AFF PRIC COM; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cameron A, 2011, B WORLD HEALTH ORGAN, V89, P279; Cameron A, 2012, EPILEPSIA, V53, P962, DOI 10.1111/j.1528-1167.2012.03446.x; Gelders S., 2006, PRICE AVAILABILITY A; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; International Diabetes Federation, 2013, INT DIAB FED DIAB AT; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Niens LM, 2012, B WORLD HEALTH ORGAN, V90, P219, DOI 10.2471/BLT.10.084087; UN General Assembly, 2012, 662 UN GEN ASS; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; Volman B, 2008, DIRECT COSTS AVAILAB; Wagner AK, 2011, HEALTH POLICY, V100, P151, DOI 10.1016/j.healthpol.2010.08.004; WHO, 2015, Q AS ON HYP; World Bank/WHO EMRO/HAI, 2013, PRIC AFF MED TREAT N; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization/Health Action International, 2008, MEAS MED PRIC AV AFF	17	73	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171284	10.1371/journal.pone.0171284	http://dx.doi.org/10.1371/journal.pone.0171284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170413	Green Published, gold, Green Submitted			2022-12-26	WOS:000393705500028
J	Llado, S; Baldrian, P				Llado, Salvador; Baldrian, Petr			Community-level physiological profiling analyses show potential to identify the copiotrophic bacteria present in soil environments	PLOS ONE			English	Article							SUBSTRATE UTILIZATION PATTERNS; MICROBIAL COMMUNITIES; RIBOSOMAL-RNA; SP NOV.; FOREST; DIVERSITY; CLASSIFICATION; ABUNDANT	Community-level physiological profiling (CLPP) analyses from very diverse environments are frequently used with the aim of characterizing the metabolic versatility of whole environmental bacterial communities. While the limitations of the methodology for the characterization of whole communities are well known, we propose that CLPP combined with highthroughput sequencing and qPCR can be utilized to identify the copiotrophic, fast-growing fraction of the bacterial community of soil environments, where oligotrophic taxa are usually dominant. In the present work we have used this approach to analyze samples of litter and soil from a coniferous forest in the Czech Republic using BIOLOG GN2 plates. Monosaccharides and amino acids were utilized significantly faster than other C substrates, such as organic acids, in both litter and soil samples. Bacterial biodiversity in CLPP wells was significantly lower than in the original community, independently of the carbon source. Bacterial communities became highly enriched in taxa that typically showed low abundance in the original soil, belonging mostly to the Gammaproteobacteria and the genus Pseudomonas, indicating that the copiotrophic strains, favoured by the high nutrient content, are rare in forest litter and soil. In contrast, taxa abundant in the original samples were rarely found to grow at sufficient rates under the CLPP conditions. Our results show that CLPP is useful to detect copiotrophic bacteria from the soil environments and that bacterial growth is substrate specific.	[Llado, Salvador; Baldrian, Petr] Inst Microbiol CAS, Lab Environm Microbiol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Llado, S (corresponding author), Inst Microbiol CAS, Lab Environm Microbiol, Prague, Czech Republic.	vador21@gmail.com	Baldrian, Petr/A-9170-2009; Lladó, Salvador/ABB-3647-2020	Baldrian, Petr/0000-0002-8983-2721; 	Czech Science Foundation [14-09040P]; Ministry of Education, Youth and Sports of the Czech Republic [LD15086]; Research Concept of the Institute of Microbiology of the CAS [RV061388971]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Research Concept of the Institute of Microbiology of the CAS	This work was supported by the Czech Science Foundation (14-09040P), by the Ministry of Education, Youth and Sports of the Czech Republic (LD15086) and by the Research Concept of the Institute of Microbiology of the CAS (RV061388971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Baldrian P, 2017, FEMS MICROBIOL REV, V41, P109, DOI 10.1093/femsre/fuw040; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Baldrian P, 2010, BIOL FERT SOILS, V46, P717, DOI 10.1007/s00374-010-0478-4; Baldrian P, 2011, PLANT SOIL, V338, P111, DOI 10.1007/s11104-010-0324-3; BOCHNER BR, 1989, NATURE, V339, P157, DOI 10.1038/339157a0; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Carson JK, 2010, APPL ENVIRON MICROB, V76, P3936, DOI 10.1128/AEM.03085-09; Carson JK, 2009, FEMS MICROBIOL ECOL, V67, P381, DOI 10.1111/j.1574-6941.2008.00645.x; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Collins B, 2004, ECOL ENG, V23, P107, DOI 10.1016/j.ecoleng.2004.07.005; Cummings SP, 2010, METHODS MOL BIOL, V599, P1; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ernebjerg M, 2012, APPL ENVIRON MICROB, V78, P1345, DOI 10.1128/AEM.06585-11; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00614; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Gamo M, 1999, APPL ENVIRON MICROB, V65, P4419; Garcia-Fraile P, 2016, APPL ENVIRON MICROB, V82, P560, DOI 10.1128/AEM.03353-15; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Konopka A, 1998, MICROBIAL ECOL, V35, P103, DOI 10.1007/s002489900065; Kuzyakov Y, 2015, SOIL BIOL BIOCHEM, V83, P184, DOI 10.1016/j.soilbio.2015.01.025; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Liu B, 2015, EUR J SOIL BIOL, V68, P69, DOI 10.1016/j.ejsobi.2015.01.002; Llado S, 2016, SYST APPL MICROBIOL, V39, P14, DOI 10.1016/j.syapm.2015.12.005; Llado S, 2016, BIOL FERT SOILS, V52, P251, DOI 10.1007/s00374-015-1072-6; Lyons MM, 2010, AQUAT MICROB ECOL, V60, P1, DOI 10.3354/ame01417; Mangalassery S, 2015, EUR J SOIL BIOL, V68, P9, DOI 10.1016/j.ejsobi.2015.03.001; Mastrogianni A, 2014, APPL SOIL ECOL, V80, P51, DOI 10.1016/j.apsoil.2014.03.009; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Myneni RB, 2001, P NATL ACAD SCI USA, V98, P14784, DOI 10.1073/pnas.261555198; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; Pierce ML, 2014, J MICROBIOL METH, V97, P20, DOI 10.1016/j.mimet.2013.12.002; Preston-Mafham J, 2002, FEMS MICROBIOL ECOL, V42, P1, DOI 10.1111/j.1574-6941.2002.tb00990.x; Sagova-Mareckova M, 2008, APPL ENVIRON MICROB, V74, P2902, DOI 10.1128/AEM.02161-07; Smalla K, 1998, APPL ENVIRON MICROB, V64, P1220; Starke R, 2016, SOIL BIOL BIOCHEM, V96, P30, DOI 10.1016/j.soilbio.2016.01.009; Urbanova M, 2011, FEMS MICROBIOL ECOL, V78, P59, DOI 10.1111/j.1574-6941.2011.01164.x; Vetrovsky T, 2013, BIOL FERT SOILS, V49, P1027, DOI 10.1007/s00374-013-0801-y; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Weber KP, 2008, WATER RES, V42, P180, DOI 10.1016/j.watres.2007.06.055; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; Zifcakova L, 2016, ENVIRON MICROBIOL, V18, P288, DOI 10.1111/1462-2920.13026	47	44	45	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171638	10.1371/journal.pone.0171638	http://dx.doi.org/10.1371/journal.pone.0171638			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170446	Green Published, gold, Green Submitted			2022-12-26	WOS:000393705500049
J	Ruzic-Sabljic, E; Maraspin, V; Stupica, D; Rojko, T; Bogovic, P; Strle, F; Cerar, T				Ruzic-Sabljic, Eva; Maraspin, Vera; Stupica, Dasa; Rojko, Tereza; Bogovic, Petra; Strle, Franc; Cerar, Tjasa			Comparison of MKP and BSK-H media for the cultivation and isolation of Borrelia burgdorferi sensu lato	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; FIELD GEL-ELECTROPHORESIS; LYME-BORRELIOSIS; ERYTHEMA MIGRANS; PLASMID CONTENT; II MEDIUM; DIAGNOSIS; CULTURE; DISEASE; RESTRICTION	The isolation of B. burgdorferi sensu lato requires the use of complex cultivation media. The aim of the study was to compare the usefulness of BSK-H (a commercial medium produced by HiMedia, India) and MKP medium. MKP and BSK-H media were prepared in accordance with the relevant protocols. Borrelia strains and skin culture biopsies were simultaneously inoculated into both media, incubated and checked for growth. Borrelial growth characteristics, isolation rates and characteristics of the isolated borreliae were analysed and compared. Initially, numbers of spirochaetes were higher in BSK-H than in MKP; however, in comparison with MKP, the strains subcultured in BSK-H medium were more frequently irregular, thin and non-motile, and rapidly died. In addition, the borrelial isolation rate from erythema migrans skin samples was higher in MKP than in BSK-H medium (108/171, 63.2% versus 70/171, 40.9%; p < 0.0001). The far most frequently isolated species was Borrelia afzelii (92.9% and 97.2% strains isolated from BSK-H and MKP, respectively). Comparison of strains cultured from individual patients in both media showed differences in plasmid contents in 9/46 (19.6%) strain pairs, and protein profiles differed in 30/43 (69.8%) strain pairs, most often in the expression of OspC (in 27/28 patients OspC was expressed only in strains growing in MKP). BSK-H medium supports the growth of borrelial strains but MKP is superior with regard to the isolation rate, morphology and motility of strains. BSK-H medium supports fast initial growth of borreliae but this is followed by rapid deformation and death of the spirochaetes.	[Ruzic-Sabljic, Eva; Cerar, Tjasa] Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Ljubljana, Slovenia; [Maraspin, Vera; Stupica, Dasa; Rojko, Tereza; Bogovic, Petra; Strle, Franc] Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia	University of Ljubljana; University Medical Centre Ljubljana	Ruzic-Sabljic, E (corresponding author), Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Ljubljana, Slovenia.	eva.ruzic-sabljic@mf.uni-lj.si		Cerar Kisek, Tjasa/0000-0002-4053-5590				Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; Babb K, 2001, INFECT IMMUN, V69, P4146, DOI 10.1128/IAI.69.6.4146-4153.2001; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Biskup UG, 2011, PLASMID, V66, P1, DOI 10.1016/j.plasmid.2011.02.006; BUSCH U, 1995, ELECTROPHORESIS, V16, P744, DOI 10.1002/elps.11501601122; Glinsek U, 2009, WORLD J MICROB BIOT, V25, P1287, DOI 10.1007/s11274-009-0015-5; Iyer R, 2003, INFECT IMMUN, V71, P3699, DOI 10.1128/IAI.71.7.3699-3706.2003; Liveris D, 2002, J CLIN MICROBIOL, V40, P1249, DOI 10.1128/JCM.40.4.1249-1253.2002; Marconi RT, 1996, J BACTERIOL, V178, P3357, DOI 10.1128/jb.178.11.3357-3361.1996; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Nacionalni institut za javno zdravje (NIJZ). [National Institute for Public Health], 2016, EP SPREMLJ NAL BOL S, DOI 10.1016/S0140-6736d1160103-7; Norris DE, 1997, J CLIN MICROBIOL, V35, P2359, DOI 10.1128/JCM.35.9.2359-2364.1997; PACHNER AR, 1993, J CLIN MICROBIOL, V31, P208, DOI 10.1128/JCM.31.2.208-214.1993; Picken MM, 1997, J CLIN PATHOL-MOL PA, V50, P186, DOI 10.1136/mp.50.4.186; Picken MM, 1996, EUR J CLIN MICROBIOL, V15, P489, DOI 10.1007/BF01691317; Piesman J., 2010, BORRELIA MOL BIOL HO, P251; POLLACK RJ, 1993, J CLIN MICROBIOL, V31, P1251, DOI 10.1128/JCM.31.5.1251-1255.1993; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; PREACMURSIC V, 1986, ZBL BAKT-INT J MED M, V263, P112; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Ruzic-Sabljic E, 2014, CLIN MICROBIOL INFEC, V20, P636, DOI 10.1111/1469-0691.12457; Ruzic-Sabljic ER, 2004, INT J MED MICROBIOL, V294, P407, DOI 10.1016/j.ijmm.2004.08.002; Ruzic-Sabljic E, 2008, RES MICROBIOL, V159, P441, DOI 10.1016/j.resmic.2008.05.005; Ruzic-Sabljic E, 2006, INT J MED MICROBIOL, V296, P267, DOI 10.1016/j.ijmm.2006.01.005; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Stupica D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136600; WILSKE B, 1988, ANN NY ACAD SCI, V539, P126, DOI 10.1111/j.1749-6632.1988.tb31846.x; Wilske B, 2007, FEMS IMMUNOL MED MIC, V49, P13, DOI 10.1111/j.1574-695X.2006.00139.x; Wormser GP, 2000, J CLIN MICROBIOL, V38, P1648, DOI 10.1128/JCM.38.4.1648-1650.2000; Yang XF, 2001, INFECT IMMUN, V69, P4159, DOI 10.1128/IAI.69.6.4159-4163.2001; Zore A, 2002, WIEN KLIN WOCHENSCHR, V114, P606	31	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171622	10.1371/journal.pone.0171622	http://dx.doi.org/10.1371/journal.pone.0171622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170447	Green Published, gold, Green Submitted			2022-12-26	WOS:000393705500047
J	Zhang, C; Hua, R; Cui, YY; Wang, SS; Yan, HQ; Li, DM; Zhang, YH; Tu, ZK; Hao, P; Chen, XY; Zhong, J; Niu, JQ; Jin, X				Zhang, Chao; Hua, Rui; Cui, Yuanyuan; Wang, Shasha; Yan, Hongqing; Li, Dongmei; Zhang, Yonghong; Tu, Zhengkun; Hao, Pei; Chen, Xinyue; Zhong, Jin; Niu, Junqi; Jin, Xia			Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance	PLOS ONE			English	Article							IMMUNITY; THERAPY; DETERMINANTS; PERSISTENCE; EXHAUSTION; INDUCTION	Elucidating protective immunity against HCV is important for the development of a preventative vaccine. We hypothesize that spontaneous resolution of acute HCV infection offers clue to protective immune responses, and that DAA therapy affects the quality and quantity of HCV-specific T cell responses. To test these hypotheses, we performed T cell epitope mapping in 111 HCV-infected individuals including 61 chronically HCV-1b (CHC-1b) infected, 24 chronically HCV-2a (CHC-2a) infected and 26 spontaneously recovered (SPR) patients with 376 overlapping peptides covering the entire HCV polyprotein. Selected T cell epitopes were then used to evaluate T cell responses in another 22 chronically HCV-1b infected patients on DAA therapy. Results showed that SPR had better HCV-specific T cell responses than CHC, as manifested by higher response rate, greater magnitude and broader epitope coverage. In addition, SPR recognized novel epitopes in Core, E1, E2, NS4B, NS5A regions that were not present in the CHC. Furthermore, during the first 24 weeks of DAA therapy, there was no functional immune reconstitution of HCV-specific T cells. These results indicate that T cell responses may be a correlate of protection. Therefore, effective preventative vaccines should elicit a robust T cell response. Although various DAA regimens efficiently cleared viruses from the blood of HCV-infected patients, there was no contemporaneous early T cell immune reconstitution, suggesting that early treatment is needed for preserving the functions of HCV-specific T cells.	[Zhang, Chao; Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Unit, Shanghai, Peoples R China; [Hua, Rui; Cui, Yuanyuan; Wang, Shasha; Yan, Hongqing; Li, Dongmei; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun, Jilin, Peoples R China; [Zhang, Yonghong; Chen, Xinyue] Capital Med Univ, Beijing Youan Hosp, Dept Hepatol, Beijing, Peoples R China; [Tu, Zhengkun; Niu, Junqi] Jilin Univ, Hosp 1, Inst Translat Med, Changchun, Jilin, Peoples R China; [Hao, Pei] Chinese Acad Sci, Inst Pasteur Shanghai, Bioinformat Core, Shanghai, Peoples R China; [Zhong, Jin] Chinese Acad Sci, Viral Hepatitis Unit, Inst Pasteur Shanghai, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Jilin University; Capital Medical University; Jilin University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Jin, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Unit, Shanghai, Peoples R China.	xjin@ips.ac.cn	Zhong, Jin/J-4613-2019; chen, xinyue/HHR-9308-2022; Zhong, Jin/M-6859-2018	Zhang, Chao/0000-0001-6292-7651; Zhong, Jin/0000-0002-3554-1275; Tu, Zhengkun/0000-0001-6803-2015; Hao, Pei/0000-0002-1498-7059	Chinese Ministry of Science and Technology 973 Grant [2015CB554304]; National Science and Technology Major Project [2012ZX10002007]; Natural Science Foundation of China of the First Hospital of Jilin University [81373143, 81571535]; Capital Characteristic Clinical Application Research [Z161100000516018]; Capital Health and Development Research Fund of the Beijing You'an Hospital of Capital Medical University [2016-1-2183]	Chinese Ministry of Science and Technology 973 Grant; National Science and Technology Major Project; Natural Science Foundation of China of the First Hospital of Jilin University; Capital Characteristic Clinical Application Research; Capital Health and Development Research Fund of the Beijing You'an Hospital of Capital Medical University	This study was supported by grants from the Chinese Ministry of Science and Technology 973 Grant (#2015CB554304), National Science and Technology Major Project (#2012ZX10002007) and Natural Science Foundation of China (#81373143, #81571535) of the First Hospital of Jilin University, the Capital Characteristic Clinical Application Research (#Z161100000516018) and the Capital Health and Development Research Fund (#2016-1-2183) of the Beijing You'an Hospital of Capital Medical University. The funders have been involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Anthony DD, 2003, METHODS, V29, P260, DOI 10.1016/S1046-2023(02)00348-1; Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Beattie T, 2004, AIDS, V18, P1595, DOI 10.1097/01.aids.0000131362.82951.b2; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Burchill MA, 2015, J VIRAL HEPATITIS, V22, P983, DOI 10.1111/jvh.12465; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Gruner NH, 2000, J INFECT DIS, V181, P1528, DOI 10.1086/315450; Hengst J, 2016, J INFECT DIS, V214, P1965, DOI 10.1093/infdis/jiw457; Humphreys IS, 2012, GUT, V61, P1589, DOI 10.1136/gutjnl-2011-300650; Jin X, 2009, VACCINE, V27, P7080, DOI 10.1016/j.vaccine.2009.09.060; Kelly C, 2016, HEPATOLOGY, V63, P1455, DOI 10.1002/hep.28294; Kurktschiev PD, 2014, J EXP MED, V211, P2047, DOI 10.1084/jem.20131333; Martin B, 2014, J HEPATOL, V61, P538, DOI 10.1016/j.jhep.2014.05.043; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Neumann-Haefelin C, 2008, HEPATOLOGY, V47, P1824, DOI 10.1002/hep.22242; Osburn WO, 2014, HEPATOLOGY, V59, P2140, DOI 10.1002/hep.27013; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Rehermann B, 2015, HEPATOLOGY, V61, P712, DOI 10.1002/hep.27323; Rosen HR, 2013, J CLIN INVEST, V123, P4121, DOI 10.1172/JCI67714; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Urbani S, 2001, HEPATOLOGY, V33, P1533, DOI 10.1053/jhep.2001.25091; Urbani S, 2006, HEPATOLOGY, V44, P126, DOI 10.1002/hep.21242; Webster DP, 2015, LANCET, V385, P1124, DOI [10.1016/S0140-6736(14)62401-6, 10.1016/S0140-6736(14)61932-2]; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wieland D, 2016, HEPATOLOGY, V63, P1411, DOI 10.1002/hep.28388; Xu HQ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2299-8; Zeisel MB, 2008, HEPATOLOGY, V48, P299, DOI 10.1002/hep.22307; Zhang C., 2014, DISCRETE DYN NAT SOC, V2014, P1, DOI DOI 10.1089/CBR.2014.1653	33	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171217	10.1371/journal.pone.0171217	http://dx.doi.org/10.1371/journal.pone.0171217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170421	Green Published, Green Submitted, gold			2022-12-26	WOS:000393705500024
J	Ng, MY; Wang, M; Casey, PJ; Gan, YH; Hagen, T				Ng, Mei Ying; Wang, Mei; Casey, Patrick J.; Gan, Yunn-Hwen; Hagen, Thilo			Activation of MAPK/ERK signaling by Burkholderia pseudomallei cycle inhibiting factor (Cif)	PLOS ONE			English	Article							HOST-CELL CYCLE; NEDD8-ACTIVATING ENZYME; UBIQUITIN LIGASES; EFFECTOR FAMILY; PHOSPHORYLATION; DEGRADATION; P27(KIP1); RAS; DEAMIDATION; COMPLEX	Cycle inhibiting factors (Cifs) are virulence proteins secreted by the type III secretion system of some Gram-negative pathogenic bacteria including Burkholderia pseudomallei. Cif is known to function to deamidate Nedd8, leading to inhibition of Cullin E3 ubiquitin ligases (CRL) and consequently induction of cell cycle arrest. Here we show that Cif can function as a potent activator of MAPK/ERK signaling without significant activation of other signaling pathways downstream of receptor tyrosine kinases. Importantly, we found that the ability of Cif to activate ERK is dependent on its deamidase activity, but independent of Cullin E3 ligase inhibition. This suggests that apart from Nedd8, other cellular targets of Cif dependent deamidation exist. We provide evidence that the mechanism involved in Cif mediated ERK activation is dependent on recruitment of the Grb2-SOS1 complex to the plasma membrane. Further investigation revealed that Cif appears to modify the phosphorylation status of SOS1 in a region containing the CDC25-H and proline-rich domains. It is known that prolonged Cullin E3 ligase inhibition leads to cellular apoptosis. Therefore, we hypothesize that ERK activation is an important mechanism to counter the pro-apoptotic effects of Cif. Indeed, we show that Cif dependent ERK activation promotes phosphorylation of the proapoptotic protein Bim, thereby potentially conferring a pro-survival signal. In summary, we identified a novel deamidation-dependent mechanism of action of the B. pseudomallei virulence factor Cif/CHBP to activate MAPK/ERK signaling. Our study demonstrates that bacterial proteins such as Cif can serve as useful molecular tools to uncover novel aspects of mammalian signaling pathways.	[Ng, Mei Ying; Wang, Mei; Gan, Yunn-Hwen; Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Wang, Mei; Casey, Patrick J.] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore	National University of Singapore; National University of Singapore	Hagen, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.	bchth@nus.edu.sg	Gan, Yunn-Hwen/AAH-8515-2021	Wang, Mei/0000-0001-6887-6840; Casey, Patrick/0000-0002-7366-9309				Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Boh BK, 2011, J MOL BIOL, V413, P430, DOI 10.1016/j.jmb.2011.08.030; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Douville E, 1997, ONCOGENE, V15, P373, DOI 10.1038/sj.onc.1201214; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Gupta RW, 1998, ONCOGENE, V17, P2155, DOI 10.1038/sj.onc.1202158; Hall BE, 2002, FRONT BIOSCI, V7, pD288, DOI 10.2741/hall; Jubelin G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001128; Jubelin G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004855; Kamioka Y, 2010, J BIOL CHEM, V285, P33540, DOI 10.1074/jbc.M110.135517; Kim JH, 1998, ONCOGENE, V16, P2597, DOI 10.1038/sj.onc.1201822; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; McCormack RM, 2015, ELIFE, V4, DOI 10.7554/eLife.06505; Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122; Morikawa H, 2010, BIOCHEM BIOPH RES CO, V401, P268, DOI 10.1016/j.bbrc.2010.09.048; Muangsombut V, 2008, ARCH MICROBIOL, V190, P623, DOI 10.1007/s00203-008-0413-3; Nassar N, 2010, BIOCHEMISTRY-US, V49, P1970, DOI 10.1021/bi9020742; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rojas Jose M, 2011, Genes Cancer, V2, P298, DOI 10.1177/1947601911408078; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Taieb F, 2011, TOXINS, V3, P356, DOI 10.3390/toxins3040356; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Yao Q, 2009, P NATL ACAD SCI USA, V106, P3716, DOI 10.1073/pnas.0900212106; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Yu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10053	32	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171464	10.1371/journal.pone.0171464	http://dx.doi.org/10.1371/journal.pone.0171464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166272	Green Published, gold, Green Submitted			2022-12-26	WOS:000393700100044
J	Papasotiriou, I; Pantopikou, K; Apostolou, P				Papasotiriou, Ioannis; Pantopikou, Katerina; Apostolou, Panagiotis			L1 retrotransposon expression in circulating tumor cells	PLOS ONE			English	Article							LINE-1 RETROTRANSPOSITION	Long interspersed nuclear element 1 (LINE-1 or L1) belongs to the non-long terminal repeat (non-LTR) retrotransposon family, which has been implicated in carcinogenesis and disease progression. Circulating tumor cells (CTCs) are also known to be involved in cancer progression. The present study aimed to compare the L1 expression between circulating tumor cells and non-cancerous samples. Blood samples were collected from 10 healthy individuals and 22 patients with different types of cancer. The whole blood cells were isolated using enrichment protocols and the DNA and RNA were extracted. RT-qPCR was performed for L1-ORF1 (open reading frame 1) and L1-ORF2, using 18S rRNA as the reference gene. The data were analyzed with the Livak method and statistical analyses were carried out with the Mann-Whitney and Kruskal-Wallis tests. In parallel with the above molecular biology experiments, FISH experiments were performed on the interphase nuclei of the cells for the detection of ORF2 RNA. DNA analysis revealed the presence of both ORF1 and ORF2 in all samples. RNA expression experiments demonstrated that ORF1 was not expressed in all samples, while ORF2 was expressed at varying levels in the non-cancer samples and the samples representing the different cancer types. A significant difference in ORF2 expression was observed between the CTCs and non-cancer samples (p = 0,00043), and significant differences were also observed between normal and lung (p = 0,034), pancreatic (p = 0,022), prostate (p = 0,014), and unknown primary of origin (p = 0,0039) cancer samples. Cytogenetic analysis revealed higher levels of ORF2 in the nuclei of CTCs than in normal samples. This study highlights the significant difference in L1-ORF2 expression between CTCs and normal samples. The increased expression levels observed for CTCs may be correlated with the characteristic features of these cells.	[Papasotiriou, Ioannis; Pantopikou, Katerina; Apostolou, Panagiotis] Res Genet Canc Ctr SA, Ind Area, Florina, Greece		Papasotiriou, I (corresponding author), Res Genet Canc Ctr SA, Ind Area, Florina, Greece.	papasotiriou.ioannis@rgcc-genlab.com		PAPASOTIRIOU, IOANNIS/0000-0002-6145-946X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apostolou P, 2015, CELL COMMUN ADHES, V22, P1, DOI 10.3109/15419061.2014.970270; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; Bojang P, 2014, GENOMICS, V104, P96, DOI 10.1016/j.ygeno.2014.07.001; Carreira PE, 2014, FEBS J, V281, P63, DOI 10.1111/febs.12601; Chueh AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000354; De Luca C, 2016, ONCOTARGET, V7, P4048, DOI 10.18632/oncotarget.6767; El-Maarri O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016252; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Freshney RI, 2005, SAFETY BIOETHICS VAL; Garcia-Perez JL, 2010, NATURE, V466, P769, DOI 10.1038/nature09209; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Klawitter S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10286; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Patnala R, 2014, BREAST CANCER RES TR, V143, P239, DOI 10.1007/s10549-013-2812-7; Sciamanna I, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00006; Scott EC, 2016, GENOME RES, V26, P745, DOI 10.1101/gr.201814.115; Theodoropoulos PA, 2010, CANCER LETT, V288, P99, DOI 10.1016/j.canlet.2009.06.027; Vasil'ev S A, 2015, Mol Biol (Mosk), V49, P165; Williams SCP, 2013, P NATL ACAD SCI USA, V110, P4861, DOI 10.1073/pnas.1304186110	23	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171466	10.1371/journal.pone.0171466	http://dx.doi.org/10.1371/journal.pone.0171466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166262	Green Published, Green Submitted, gold			2022-12-26	WOS:000393700100045
J	Seong, KM; Kwon, T; Seo, S; Lee, D; Park, S; Jin, YW; Lee, SS				Seong, Ki Moon; Kwon, TaeWoo; Seo, Songwon; Lee, Dalnim; Park, Sunhoo; Jin, Young Woo; Lee, Seung-Sook			Perception of low dose radiation risks among radiation researchers in Korea	PLOS ONE			English	Article							IONIZING-RADIATION; CANCER; EXPOSURE; PLANT; CONSEQUENCES; BIOLOGY; EXPERTS	Expert's risk evaluation of radiation exposure strongly influences the public's risk perception. Experts can inform laypersons of significant radiation information including health knowledge based on experimental data. However, some experts' radiation risk perception is often based on non-conclusive scientific evidence (i.e., radiation levels below 100 millisievert), which is currently under debate. Examining perception levels among experts is important for communication with the public since these individual's opinions have often exacerbated the public's confusion. We conducted a survey of Korean radiation researchers to investigate their perceptions of the risks associated with radiation exposure below 100 millisievert. A linear regression analysis revealed that having >= 11 years' research experience was a critical factor associated with radiation risk perception, which was inversely correlated with each other. Increased opportunities to understand radiation effects at < 100 millisievert could alter the public's risk perception of radiation exposure. In addition, radiation researchers conceived that more scientific evidence reducing the uncertainty for radiation effects < 100 millisievert is necessary for successful public communication. We concluded that sustained education addressing scientific findings is a critical attribute that will affect the risk perception of radiation exposure.	[Seong, Ki Moon; Kwon, TaeWoo; Seo, Songwon; Lee, Dalnim; Park, Sunhoo; Jin, Young Woo; Lee, Seung-Sook] Korea Inst Radiol & Med Sci, Natl Radiat Emergency Med Ctr, Lab Low Dose Risk Assessment, Seoul, South Korea; [Park, Sunhoo; Lee, Seung-Sook] Korea Inst Radiol & Med Sci, Dept Pathol, Korea Canc Ctr Hosp, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; National Cancer Center - Korea (NCC)	Lee, SS (corresponding author), Korea Inst Radiol & Med Sci, Natl Radiat Emergency Med Ctr, Lab Low Dose Risk Assessment, Seoul, South Korea.; Lee, SS (corresponding author), Korea Inst Radiol & Med Sci, Dept Pathol, Korea Canc Ctr Hosp, Seoul, South Korea.	sslee@kirams.re.kr	Seong, Ki Moon/Y-6083-2019		Nuclear Safety & Security Commission (NSSC) [1501007]; Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea [50586-2016]	Nuclear Safety & Security Commission (NSSC); Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea	This study was financially supported in part by a grant of 1501007 from Nuclear Safety & Security Commission (NSSC), and a grant of 50586-2016 by the Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; [Anonymous], 2012, BIOL MECH RAD ACT LO; [Anonymous], 2005, ANN ICRP, V35, P1; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Brenner DJ, 2011, NATURE; Bromet EJ, 2014, HEALTH PHYS, V106, P206, DOI 10.1097/HP.0000000000000012; Bromet EJ, 2012, J RADIOL PROT, V32, pN71, DOI 10.1088/0952-4746/32/1/N71; Cardis E, 2005, BMJ-BRIT MED J, V331, P77, DOI 10.1136/bmj.38499.599861.E0; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Hendry J. H., 2012, Annals of the ICRP, V41, P64, DOI 10.1016/j.icrp.2012.06.013; Kamiya K, 2015, LANCET, V386, P469, DOI 10.1016/S0140-6736(15)61167-9; Kim Y, 2011, BRIT J PSYCHIAT, V199, P411, DOI 10.1192/bjp.bp.110.085472; Kim Y, 2016, J KOREAN MED SCI, V31, pS88, DOI 10.3346/jkms.2016.31.S1.S88; KRAUS N, 1992, RISK ANAL, V12, P215, DOI 10.1111/j.1539-6924.1992.tb00669.x; Leuraud K, 2015, LANCET HAEMATOL, V2, pE276, DOI 10.1016/S2352-3026(15)00094-0; Mettler FA, 2012, J RADIOL PROT, V32, pN9, DOI 10.1088/0952-4746/32/1/N9; Miura M, 2016, HEALTH PHYS, V110, P558, DOI 10.1097/HP.0000000000000486; Normile D, 2011, SCIENCE, V332, P908, DOI 10.1126/science.332.6032.908; Ozasa K, 2016, J RADIAT RES, V57, pI112, DOI 10.1093/jrr/rrw005; Perko T, 2014, J ENVIRON RADIOACTIV, V133, P86, DOI 10.1016/j.jenvrad.2013.04.005; Sacks Bill, 2016, Biological Theory, V11, P69, DOI 10.1007/s13752-016-0244-4; Siegrist M, 2007, RISK ANAL, V27, P59, DOI 10.1111/j.1539-6924.2006.00859.x; Slovic P, 1996, RADIAT PROT DOSIM, V68, P165, DOI 10.1093/oxfordjournals.rpd.a031860; Slovic P, 2012, B ATOM SCI, V68, P67, DOI 10.1177/0096340212444870; Talbott EO, 2003, ENVIRON HEALTH PERSP, V111, P341, DOI 10.1289/ehp.5662; Visschers VHM, 2013, RISK ANAL, V33, P333, DOI 10.1111/j.1539-6924.2012.01861.x; Wing S, 1997, ENVIRON HEALTH PERSP, V105, P52, DOI 10.2307/3433062; Zeleznik N, 2016, J RADIOL PROT, V36, pS102, DOI 10.1088/0952-4746/36/2/S102; 박방주, 2012, [Journal of Radiation Protection and Research, 방사선방어학회지], V37, P1	29	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171777	10.1371/journal.pone.0171777	http://dx.doi.org/10.1371/journal.pone.0171777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166286	Green Submitted, Green Published, gold			2022-12-26	WOS:000393700100072
J	Varbanov, HP; Kuttler, F; Banfi, D; Turcatti, G; Dyson, PJ				Varbanov, Hristo P.; Kuttler, Fabien; Banfi, Damiano; Turcatti, Gerardo; Dyson, Paul J.			Repositioning approved drugs for the treatment of problematic cancers using a screening approach	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; PANCREATIC-CANCER; SELECTIVE OPTIMIZATION; SIDE ACTIVITIES; CELL-LINES; IN-VITRO; MEBENDAZOLE; VORINOSTAT; CYTOTOXICITY; DOXORUBICIN	Advances in treatment strategies together with an earlier diagnosis have considerably increased the average survival of cancer patients over the last four decades. Nevertheless, despite the growing number of new antineoplastic agents introduced each year, there is still no adequate therapy for problematic malignancies such as pancreatic, lung and stomach cancers. Consequently, it is important to ensure that existing drugs used to treat other types of cancers, and potentially other diseases, are not overlooked when searching for new chemotherapy regimens for these problematic cancer types. We describe a screening approach that identifies chemotherapeutics for the treatment of lung and pancreatic cancers, based on drugs already approved for other applications. Initially, the 1280 chemically and pharmacologically diverse compounds from the Prestwick Chemical Library (R) (PCL) were screened against A549 (lung cancer) and PANC-1 (pancreatic carcinoma) cells using the PrestoBlue fluorescent-based cell viability assay. More than 100 compounds from the PCL were identified as hits in one or both cell lines (80 of them, being drugs used to treat diseases other than cancer). Selected PCL hits were further evaluated in a dose-response manner. Promising candidates for repositioning emanating from this study include antiparasitics, cardiac glycosides, as well as the anticancer drugs vorinostat and topotecan.	[Varbanov, Hristo P.; Dyson, Paul J.] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, Lausanne, Switzerland; [Varbanov, Hristo P.; Kuttler, Fabien; Banfi, Damiano; Turcatti, Gerardo] Ecole Polytech Fed Lausanne, Biomol Screening Facil, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Varbanov, HP; Dyson, PJ (corresponding author), Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, Lausanne, Switzerland.; Varbanov, HP (corresponding author), Ecole Polytech Fed Lausanne, Biomol Screening Facil, Lausanne, Switzerland.	hristo.varbanov@univie.ac.at; paul.dyson@epfl.ch	Dyson, Paul/AAB-9075-2019; Varbanov, Hristo P./O-3973-2017	Dyson, Paul/0000-0003-3117-3249; Varbanov, Hristo P./0000-0003-4450-7332; Kuttler, Fabien/0000-0003-2575-1989	Austrian Science Fund (FWF) [J3577-B13]; BSF-ACCESS screening platform at the EPFL; Austrian Science Fund (FWF) [J 3577] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); BSF-ACCESS screening platform at the EPFL; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	H.V. is indebted to the Austrian Science Fund (FWF) for the financial support (Schrodinger fellowship, Project number: J3577-B13). We acknowledge the Swiss National Center for Competence (NCCR) in Chemical Biology for providing access to the chemical libraries and screening facilities.; We acknowledge the BSF-ACCESS screening platform at the EPFL for support, in particular we are thankful to Julien Bortoli Chapalay for dispensing the PCL with the Echo acoustic liquid handler and to Antoine Gibelin for the quality control with LC-MS.	Arai K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162394; Bai RY, 2011, NEURO-ONCOLOGY, V13, P974, DOI 10.1093/neuonc/nor077; Banuls LMY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-33; Boncler M, 2014, J PHARMACOL TOX MET, V69, P9, DOI 10.1016/j.vascn.2013.09.003; Bray F, GLOBOCAN 2012 V1 0 C; Cancer Research UK, CANC SURV COMM CANC; Cancer Research UK, STER CANC TREATM; Chan E, 2016, RADIOTHER ONCOL, V119, P312, DOI 10.1016/j.radonc.2016.04.013; Chien WW, 2014, MOL CARCINOGEN, V53, P722, DOI 10.1002/mc.22024; DeVita VT, 2012, NEW ENGL J MED, V366, P2207, DOI 10.1056/NEJMra1204479; Doudican N, 2008, MOL CANCER RES, V6, P1308, DOI 10.1158/1541-7786.MCR-07-2159; Elbaz HA, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-4; Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x; Felth J, 2009, J NAT PROD, V72, P1969, DOI 10.1021/np900210m; Herdrich K, 2010, SELECTED SCHEDULES T; Huggett MT, 2014, BRIT J CANCER, V110, P1698, DOI 10.1038/bjc.2014.95; Ishii I, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00137; John R, GLOBAL EC COST CANC; Kenny HA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7220; Kinch MS, 2014, DRUG DISCOV TODAY, V19, P1831, DOI 10.1016/j.drudis.2014.08.007; Kumagai T, 2007, INT J CANCER, V121, P656, DOI 10.1002/ijc.22558; Li H, 2016, ONCOTARGET, V7, P3548, DOI 10.18632/oncotarget.6516; LIEBMANN JE, 1993, BRIT J CANCER, V68, P1104, DOI 10.1038/bjc.1993.488; Lin SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123305; Lopez-Lazaro M, 2007, EXPERT OPIN THER TAR, V11, P1043, DOI 10.1517/14728222.11.8.1043; Meredith AM, 2016, J PHARM PHARMACOL, V68, P729, DOI 10.1111/jphp.12539; Michaelis M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08202; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Miyanaga A, 2008, MOL CANCER THER, V7, P1923, DOI 10.1158/1535-7163.MCT-07-2140; Mukhopadhyay T, 2002, CLIN CANCER RES, V8, P2963; National cancer Institute, WHAT IS CANC; Nosengo N, 2016, NATURE, V534, P314, DOI 10.1038/534314a; Nygren P, 2013, J CANCER RES CLIN, V139, P2133, DOI 10.1007/s00432-013-1539-5; Owonikoko TK, 2010, INT J CANCER, V126, P743, DOI 10.1002/ijc.24759; Pantziarka P, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.443; Petersen GH, 2016, J CONTROL RELEASE, V232, P255, DOI 10.1016/j.jconrel.2016.04.028; Pongrakhananon V., 2013, ANTICANCER PROPERTIE, P65; Prassas I, 2011, MOL CANCER THER, V10, P2083, DOI 10.1158/1535-7163.MCT-11-0421; Price P, 2008, TREATMENT OF CANC; Quaresma M, 2015, LANCET, V385, P1206, DOI 10.1016/S0140-6736(14)61396-9; Roder C, 2015, DRUGS R&D, V15, P13, DOI 10.1007/s40268-015-0083-y; Sasaki J, 2002, MOL CANCER THER, V1, P1201; Slingerland M, 2013, INVEST NEW DRUG, V31, P1087, DOI 10.1007/s10637-013-9984-1; Sweetman, 2009, COMPLETE DRUG REFERE; Traynor AM, 2009, J THORAC ONCOL, V4, P522, DOI 10.1097/JTO.0b013e3181952478; Varghese E, 2014, CANCERS, V6, P2243, DOI 10.3390/cancers6042243; VOGLER WR, 1992, J CLIN ONCOL, V10, P1103, DOI 10.1200/JCO.1992.10.7.1103; Weinberg BA, 2015, ONCOLOGY-NY, V29, P809; Wermuth CG, 2006, DRUG DISCOV TODAY, V11, P160, DOI 10.1016/S1359-6446(05)03686-X; Wermuth CG, 2004, J MED CHEM, V47, P1303, DOI 10.1021/jm030480f; Yang W., 2013, NUCL ACIDS RES, V41; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	52	34	35	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171052	10.1371/journal.pone.0171052	http://dx.doi.org/10.1371/journal.pone.0171052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166232	Green Published, gold, Green Submitted			2022-12-26	WOS:000393700100021
J	Lee, JW; Lee, KE; Park, DJ; Kim, SH; Nah, SS; Lee, JH; Kim, SK; Lee, YA; Hong, SJ; Kim, HS; Lee, HS; Kim, HA; Joung, CI; Kim, SH; Lee, SS				Lee, Jeong-Won; Lee, Kyung-Eun; Park, Dong-Jin; Kim, Seong-Ho; Nah, Seong-Su; Lee, Ji Hyun; Kim, Seong-Kyu; Lee, Yeon-Ah; Hong, Seung-Jae; Kim, Hyun-Sook; Lee, Hye-Soon; Kim, Hyoun Ah; Joung, Chung-Il; Kim, Sang-Hyon; Lee, Shin-Seok			Determinants of quality of life in patients with fibromyalgia: A structural equation modeling approach	PLOS ONE			English	Article							SELF-EFFICACY; RHEUMATOID-ARTHRITIS; HEALTH-STATUS; GENERAL-POPULATION; KOREAN VERSION; ANXIETY; WOMEN; IMPACT; SF-36; CLASSIFICATION	Objective Health-related quality of life (HRQOL) in patients with fibromyalgia (FM) is lower than in patients with other chronic diseases and the general population. Although various factors affect HRQOL, no study has examined a structural equation model of HRQOL as an outcome variable in FM patients. The present study assessed relationships among physical function, social factors, psychological factors, and HRQOL, and the effects of these variables on HRQOL in a hypothesized model using structural equation modeling (SEM). Methods HRQOL was measured using SF-36, and the Fibromyalgia Impact Questionnaire (FIQ) was used to assess physical dysfunction. Social and psychological statuses were assessed using the Beck Depression Inventory (BDI), the State-Trait Anxiety Inventory (STAI), the Arthritis Self-Efficacy Scale (ASES), and the Social Support Scale. SEM analysis was used to test the structural relationships of the model using the AMOS software. Results Of the 336 patients, 301 (89.6%) were women with an average age of 47.9 +/- 10.9 years. The SEM results supported the hypothesized structural model (chi 2 = 2.336, df = 3, p = 0.506). Tfhe final model showed that Physical Component Summary (PCS) was directly related to self-efficacy and inversely related to FIQ, and that Mental Component Summary (MCS) was inversely related to FIQ, BDI, and STAI. Conclusions In our model of FM patients, HRQOL was affected by physical, social, and psychological variables. In these patients, higher levels of physical function and self-efficacy can improve the PCS of HRQOL, while physical function, depression, and anxiety negatively affect the MCS of HRQOL.	[Lee, Jeong-Won; Lee, Kyung-Eun; Park, Dong-Jin; Lee, Shin-Seok] Chonnam Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Gwangju, South Korea; [Lee, Jeong-Won; Lee, Kyung-Eun; Park, Dong-Jin; Lee, Shin-Seok] Sch Med, Gwangju, South Korea; [Kim, Seong-Ho] Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Div Rheumatol, Busan, South Korea; [Nah, Seong-Su] Soonchunhyang Univ, Coll Med, Dept Internal Med, Div Rheumatol, Cheonan, South Korea; [Lee, Ji Hyun] Maryknoll Med Ctr, Dept Internal Med, Div Rheumatol, Busan, South Korea; [Kim, Seong-Kyu] Catholic Univ Daegu, Sch Med, Dept Internal Med, Div Rheumatol, Daegu, South Korea; [Lee, Yeon-Ah; Hong, Seung-Jae] Kyung Hee Univ, Sch Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Kim, Hyun-Sook] Soonchunhyang Univ, Seoul Hosp, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Lee, Hye-Soon] Hanyang Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Lee, Hye-Soon] Hosp Rheumat Dis, Seoul, South Korea; [Kim, Hyoun Ah] Ajou Univ, Sch Med, Ajou Univ Hosp, Div Rheumatol,Dept Internal Med, Suwon, South Korea; [Joung, Chung-Il] Konyang Univ, Sch Med, Dept Internal Med, Div Rheumatol, Daejeon, South Korea; [Kim, Sang-Hyon] Keimyung Univ, Sch Med, Dept Internal Med, Div Rheumatol, Daegu, South Korea	Chonnam National University; Chonnam National University Hospital; Inje University; Soonchunhyang University; Catholic University of Daegu; Kyung Hee University; Soonchunhyang University; Hanyang University; Ajou University; Ajou University Hospital; Konyang University; Konyang University Hospital; Keimyung University	Lee, SS (corresponding author), Chonnam Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Gwangju, South Korea.; Lee, SS (corresponding author), Sch Med, Gwangju, South Korea.	shinseok@chonnam.ac.kr	Lee, Shin-Seok/AAC-6779-2021		Chonnam National University Hospital Biomedical Research Institute [CRI13904-24.3]	Chonnam National University Hospital Biomedical Research Institute	This work was supported by Chonnam National University Hospital Biomedical Research Institute (grant number CRI13904-24.3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alok R, 2014, JCR-J CLIN RHEUMATOL, V20, P314, DOI 10.1097/RHU.0000000000000130; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bernardy K, 2010, J RHEUMATOL, V37, P1991, DOI 10.3899/jrheum.100104; Bernik M, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0358-3; Birtane M, 2007, CLIN RHEUMATOL, V26, P679, DOI 10.1007/s10067-006-0359-2; Borsbo B, 2010, DISABIL REHABIL, V32, P1387, DOI 10.3109/09638280903419269; Buckelew SP, 1996, ARTHRIT CARE RES, V9, P97, DOI 10.1002/1529-0131(199604)9:2<97::AID-ANR1790090205>3.0.CO;2-F; BURCKHARDT CS, 1993, J RHEUMATOL, V20, P475; Campos RP, 2012, CLIN RHEUMATOL, V31, P347, DOI 10.1007/s10067-011-1870-7; Chin YR, 2014, ASIAN NURS RES, V8, P267, DOI 10.1016/j.anr.2014.10.002; Consoli G, 2012, COMPR PSYCHIAT, V53, P962, DOI 10.1016/j.comppsych.2012.03.008; Da Costa D, 2000, J RHEUMATOL, V27, P365; Han CW, 2004, TOHOKU J EXP MED, V203, P189, DOI 10.1620/tjem.203.189; Hoffman DL, 2008, INT J CLIN PRACT, V62, P115, DOI 10.1111/j.1742-1241.2007.01638.x; Jones GT, 2015, ARTHRITIS RHEUMATOL, V67, P568, DOI 10.1002/art.38905; Kaplan RM, 2000, J RHEUMATOL, V27, P785; Kasil O, 2008, J KOREAN ACAD NURS, V38, P881, DOI 10.4040/jkan.2008.38.6.881; Kim JT, 1978, NEW MED J, V21, P69; Kim YA, 2002, J KOREAN MED SCI, V17, P220, DOI 10.3346/jkms.2002.17.2.220; Kurtze N, 1999, BRIT J MED PSYCHOL, V72, P471, DOI 10.1348/000711299160185; LEE HR, 2000, J KOREAN ACAD ADULT, V12, P5; Martinez JE, 2001, DISABIL REHABIL, V23, P64, DOI 10.1080/769983632; Mease P, 2005, J RHEUMATOL, V32, P6; Nuesch E, 2013, ANN RHEUM DIS, V72, P955, DOI 10.1136/annrheumdis-2011-201249; Okifuji A, 1997, J RHEUMATOL, V24, P377; Pae CU, 2008, CURR MED RES OPIN, V24, P2359, DOI 10.1185/03007990802288338; Pagano Tathiana, 2004, Sao Paulo Med. J., V122, P252; Rapaport MH, 2005, AM J PSYCHIAT, V162, P1171, DOI 10.1176/appi.ajp.162.6.1171; Reisine S, 2004, WOMEN HEALTH, V39, P1, DOI 10.1300/J013v39n04_01; Reisine S, 2003, J RHEUMATOL, V30, P2045; Rhee M. K., 1995, KOR J PSYCHOPATHOL, V4, P77; Salaffi F, 2009, CLIN EXP RHEUMATOL, V27, pS67; Salaffi F, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-25; Schoofs Nancy, 2004, Orthop Nurs, V23, P364; Tander B, 2008, RHEUMATOL INT, V28, P859, DOI 10.1007/s00296-008-0551-6; Linares MDU, 2008, CLIN RHEUMATOL, V27, P613, DOI 10.1007/s10067-007-0756-1; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203	38	45	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171186	10.1371/journal.pone.0171186	http://dx.doi.org/10.1371/journal.pone.0171186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158289	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700037
J	Chen, CH; Fong, LWR; Yu, E; Wu, R; Trott, JF; Weiss, RH				Chen, C-H; Fong, L. W. R.; Yu, E.; Wu, R.; Trott, J. F.; Weiss, R. H.			Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target	ONCOGENE			English	Article							RENAL-CELL CARCINOMA; C-KINASE SUBSTRATE; PATHWAY; PHOSPHORYLATION; RESISTANCE; BIOMARKER; GROWTH; REGORAFENIB; INHIBITORS; PROTEOMICS	Targeted therapeutics, such as those abrogating hypoxia inducible factor (HIF)/vascular endothelial growth factor signaling, are initially effective against kidney cancer (or renal cell carcinoma, RCC); however, drug resistance frequently occurs via subsequent activation of alternative pathways. Through genome-scale integrated analysis of the HIF-alpha network, we identified the major protein kinase C substrate MARCKS (myristoylated alanine-rich C kinase substrate) as a potential target molecule for kidney cancer. In a screen of nephrectomy samples from 56 patients with RCC, we found that MARCKS expression and its phosphorylation are increased and positively correlate with tumor grade. Genetic and pharmacologic suppression of MARCKS in high-grade RCC cell lines in vitro led to a decrease in cell proliferation and migration. We further demonstrated that higher MARCKS expression promotes growth and angiogenesis in vivo in an RCC xenograft tumor. MARCKS acted upstream of the AKT/mTOR pathway, activating HIF-target genes, notably vascular endothelial growth factor-A. Following knockdown of MARCKS in RCC cells, the IC50 of the multikinase inhibitor regorafenib was reduced. Surprisingly, attenuation of MARCKS using the MPS (MARCKS phosphorylation site domain) peptide synergistically interacted with regorafenib treatment and decreased survival of kidney cancer cells through inactivation of AKT and mTOR. Our data suggest a major contribution of MARCKS to kidney cancer growth and provide an alternative therapeutic strategy of improving the efficacy of multikinase inhibitors.	[Chen, C-H; Yu, E.; Trott, J. F.; Weiss, R. H.] Univ Calif Davis, Dept Internal Med, Div Nephrol, Davis, CA 95616 USA; [Chen, C-H; Weiss, R. H.] Univ Calif Davis, Comprehens Canc Ctr, Davis, CA 95616 USA; [Fong, L. W. R.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Yu, E.; Wu, R.] Univ Calif Davis, Dept Internal Med, Div Pulm & Crit Care Med, Davis, CA 95616 USA; [Yu, E.; Wu, R.] Univ Calif Davis, Ctr Comparat Resp Biol & Med, Dept Internal Med, Davis, CA 95616 USA; [Weiss, R. H.] Northern Calif Hlth Care Syst, Dept Vet Affairs, Med Serv, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Davis; University of California System; University of California Davis	Chen, CH; Weiss, RH (corresponding author), Univ Calif Davis, Dept Internal Med, Div Nephrol, Davis, CA 95616 USA.	jchchen@ucdavis.edu; rhweiss@ucdavis.edu		Fong, Lon Wolf/0000-0001-6633-3164	NIH [1R01CA135401-01A1, 1R03CA181837-01, 1R01DK082690-01A1]; Medical Service of the US Department of Veterans' Affairs; Dialysis Clinic, Inc.(DCI) [C-3917]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Service of the US Department of Veterans' Affairs; Dialysis Clinic, Inc.(DCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Mr Muhammad S Arif (Department of Public Health Sciences, University of California at Davis, Davis, CA, USA) for assistance with the experiments; Dr Yu-Ching Lin (UNIMED Healthcare Inc., Taiwan) and Ms Wen-Hsin Chang (Institute of Molecular Medicine, National Taiwan University College of Medicine, Taipei, Taiwan) for technological support in ForteBio system; Dr Guan-Chin Tseng (Department of Pathology, China Medical University Hospital, Taiwan) for useful advice; and the UC Davis Comprehensive Cancer Center Biorepository (University of California at Davis, Davis, CA, USA) for pathology support. This work was supported by NIH grants 1R01CA135401-01A1, 1R03CA181837-01 and 1R01DK082690-01A1, the Medical Service of the US Department of Veterans' Affairs (all to RHW), and a research grant from Dialysis Clinic, Inc. (DCI# C-3917 to C-HC).	ADEREM A, 1992, TRENDS BIOCHEM SCI, V17, P438, DOI 10.1016/0968-0004(92)90016-3; Bickeboller M, 2015, ONCOGENE, V34, P1150, DOI 10.1038/onc.2014.40; Brandi J, 2016, J PROTEOMICS, V136, P1, DOI 10.1016/j.jprot.2016.01.017; Brooks G, 1996, CARCINOGENESIS, V17, P683, DOI 10.1093/carcin/17.4.683; Browne BC, 2013, FEBS J, V280, P5237, DOI 10.1111/febs.12441; Chen CH, 2014, ONCOGENE, V33, P3696, DOI 10.1038/onc.2013.336; Chen CH, 2015, ONCOTARGET, V6, P15194, DOI 10.18632/oncotarget.3827; Chen CH, 2014, AM J RESP CRIT CARE, V190, P1127, DOI 10.1164/rccm.201408-1505OC; Chen CH, 2014, AM J RESP CRIT CARE, V189, P1002, DOI 10.1164/rccm.201401-0053LE; Chen XY, 2010, CELL SIGNAL, V22, P1097, DOI 10.1016/j.cellsig.2010.03.003; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Choueiri TK, 2013, CLIN CANCER RES, V19, P5218, DOI 10.1158/1078-0432.CCR-13-0491; Cowey CL, 2009, CURR ONCOL REP, V11, P94, DOI 10.1007/s11912-009-0015-5; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Domblides C, 2013, EXPERT OPIN EMERG DR, V18, P495, DOI 10.1517/14728214.2013.858697; Dorff TB, 2014, EXPERT REV CLIN PHAR, V7, P67, DOI 10.1586/17512433.2014.862496; Eisen T, 2012, LANCET ONCOL, V13, P1055, DOI 10.1016/S1470-2045(12)70364-9; Ferraro D, 2014, THER ADV MED ONCOL, V6, P222, DOI 10.1177/1758834014544892; Greene CS, 2015, NAT GENET, V47, P569, DOI 10.1038/ng.3259; Gross-Goupil M, 2012, CURR UROL REP, V13, P16, DOI 10.1007/s11934-011-0232-y; Gudas LJ, 2014, J MOL MED, V92, P825, DOI 10.1007/s00109-014-1180-z; Han KS, 2015, NEOPLASIA, V17, P805, DOI 10.1016/j.neo.2015.11.001; Hanada S, 2013, CANCER BIOMARK, V13, P289, DOI 10.3233/CBM-130354; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jarboe JS, 2012, CLIN CANCER RES, V18, P3030, DOI 10.1158/1078-0432.CCR-11-3091; Joosten SC, 2015, BBA-REV CANCER, V1855, P1, DOI 10.1016/j.bbcan.2014.11.002; Josic D, 2008, CURR OPIN MOL THER, V10, P116; Kaelin WG, 2004, CLIN CANCER RES, V10, p6290S, DOI 10.1158/1078-0432.CCR-sup-040025; Kalwa H, 2011, J BIOL CHEM, V286, P2320, DOI 10.1074/jbc.M110.196022; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Maroto P, 2014, CLIN CANCER RES, V20, P2060, DOI 10.1158/1078-0432.CCR-13-1351; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; Micallef J, 2009, CANCER RES, V69, P7548, DOI 10.1158/0008-5472.CAN-08-4783; Naboulsi W, 2016, J PROTEOME RES, V15, P38, DOI 10.1021/acs.jproteome.5b00420; Parekh H, 2015, EXPERT REV ANTICANC, V15, P1305, DOI 10.1586/14737140.2015.1090315; Posadas EM, 2013, EXPERT OPIN PHARMACO, V14, P2221, DOI 10.1517/14656566.2013.832202; Rauch ME, 2002, J BIOL CHEM, V277, P14068, DOI 10.1074/jbc.M109572200; Rohrbach TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140870; Rombouts K, 2013, CANCER LETT, V333, P244, DOI 10.1016/j.canlet.2013.01.040; Sajithlal GB, 2013, MOL PHARMACOL, V84, P562, DOI 10.1124/mol.113.088005; Santoni M, 2014, BBA-REV CANCER, V1845, P221, DOI 10.1016/j.bbcan.2014.01.007; Sourbier C, 2006, CANCER RES, V66, P5130, DOI 10.1158/0008-5472.CAN-05-1469; Su D, 2014, CURR OPIN ONCOL, V26, P321, DOI 10.1097/CCO.0000000000000069; von Roemeling CA, 2014, CANCER RES, V74, P4796, DOI 10.1158/0008-5472.CAN-14-0210; Wettersten HI, 2015, CANCER RES, V75, P2541, DOI 10.1158/0008-5472.CAN-14-1703; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Yang Y, 2014, LEUKEMIA, V29, P715; Zaki K, 2013, CURR ONCOL REP, V15, P91, DOI 10.1007/s11912-013-0292-x; Zhou J, 2004, J BIOL CHEM, V279, P13506, DOI 10.1074/jbc.M310164200; Zhou L, 2016, ONCOGENE, V35, P2687, DOI 10.1038/onc.2015.343; Ziemba BP, 2016, BIOPHYS J, V110, P1811, DOI 10.1016/j.bpj.2016.03.001	52	27	27	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 22	2017	36	25					3588	3598		10.1038/onc.2016.510	http://dx.doi.org/10.1038/onc.2016.510			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY3NL	28166200	Green Published, Green Accepted			2022-12-26	WOS:000403878600008
J	Kaludjerovic, J; Komaba, H; Sato, T; Erben, RG; Baron, R; Olauson, H; Larsson, TE; Lanske, B				Kaludjerovic, Jovana; Komaba, Hirotaka; Sato, Tadatoshi; Erben, Reinhold G.; Baron, Roland; Olauson, Hannes; Larsson, Tobias E.; Lanske, Beate			Klotho expression in long bones regulates FGF23 production during renal failure	FASEB JOURNAL			English	Article						bone metabolism; chronic kidney disease; fibroblast growth factor 23	CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR 23; VITAMIN-D METABOLISM; LEFT-VENTRICULAR HYPERTROPHY; SECONDARY HYPERPARATHYROIDISM; HEMODIALYSIS-PATIENTS; KNOCKOUT MICE; ALPHA-KLOTHO; RECEPTOR 1; IN-VIVO	Circulating levels of bone-derived fibroblast growth factor 23 (FGF23) increase early during acute and chronic kidney disease and are associated with adverse outcomes. Membrane-bound Klotho acts as a permissive coreceptor for FGF23, and its expression was recently found in osteoblasts/osteocytes. We hypothesized that Klotho in bone cells is part of an autocrine feedback loop that regulates FGF23 expression during renal failure. Thus, we induced renal failure in mice with targeted deletion of Klotho in long bones. Uremic wild-type (KLfl/fl ) and knockout (Prx1-Cre;KLfl/fl ) mice both responded with reduced body weight, kidney atrophy, hyperphosphatemia, and increased bone turnover. Importantly, long bones of Prx1-Cre;KLfl/fl mice but not their axial skeleton failed to increase FGF23 expression as observed in uremic KLfl/fl mice. Consequently, Prx1-Cre;KLfl/fl mice had significantly lower serum FGF23 and parathyroid hormone levels, and higher renal 1-a-hydroxylase expression, serum 1,25-dihydroxyvitamin D, and calcium levels than KLfl/fl mice. These results were confirmed in two independent models of renal failure, adenine diet induced and 5/6 nephrectomy. Moreover, FGF23-treated bone cells required Klotho to increase FGF23 mRNA and ERK phosphorylation. In summary, our novel findings show that Klotho in bone is crucial for inducing FGF23 production upon renal failure. We propose the presence of an autocrine feedback loop in which Klotho senses the need for FGF23.-Kaludjerovic, J., Komaba, H., Sato, T., Erben, R. G., Baron, R., Olauson, H., Larsson, T. E., Lanske, B. Klotho expression in long bones regulates FGF23 production during renal failure.	[Kaludjerovic, Jovana; Komaba, Hirotaka; Sato, Tadatoshi; Baron, Roland; Lanske, Beate] Harvard Sch Dent Med, Dept Oral Med Infect & Immun, Div Bone & Mineral Res, 188 Longwood Ave, Boston, MA 02115 USA; [Erben, Reinhold G.] Univ Vet Med, Unit Physiol Pathophysiol & Expt Endocrinol, Vienna, Austria; [Baron, Roland; Lanske, Beate] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Baron, Roland; Lanske, Beate] Harvard Med Sch, Boston, MA USA; [Olauson, Hannes; Larsson, Tobias E.] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Renal Med, Stockholm, Sweden	Harvard University; Harvard School of Dental Medicine; University of Veterinary Medicine Vienna; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Karolinska Institutet	Lanske, B (corresponding author), Harvard Sch Dent Med, Dept Oral Med Infect & Immun, Div Bone & Mineral Res, 188 Longwood Ave, Boston, MA 02115 USA.	beate_lanske@hsdm.harvard.edu	Erben, Reinhold/AAG-8007-2020; Komaba, Hirotaka/C-9199-2011	Erben, Reinhold/0000-0003-0801-6958; Komaba, Hirotaka/0000-0002-1704-4507; Lanske, Beate/0000-0003-4638-804X	U.S. Department of Defense [DOD-PR120411]	U.S. Department of Defense(United States Department of Defense)	This work was supported, in part, by a grant from the U.S. Department of Defense (DOD-PR120411 to B.L.). J.K. is a Canadian Institutes of Health Research Fellow. H.K. is a Japan Society for the Promotion of Science Postdoctoral Fellow for Research Abroad. The authors thank H. Wang (Harvard School of Dental Medicine) for assisting with mouse maintenance and genotyping. The authors also thank K. Amano and J.- I. Hanai (both from Harvard Medical School) for assistance with cell culture experiments.	Andrukhova O, 2014, EMBO J, V33, P229, DOI 10.1002/embj.201284188; Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Cejka D, 2016, KIDNEY INT, V90, P828, DOI 10.1016/j.kint.2016.06.019; Christov M, 2014, CURR OPIN NEPHROL HY, V23, P340, DOI 10.1097/01.mnh.0000447021.51722.2f; Christov M, 2013, KIDNEY INT, V84, P776, DOI 10.1038/ki.2013.150; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Durland JL, 2008, J ANAT, V212, P590, DOI 10.1111/j.1469-7580.2008.00879.x; Erben RG, 2005, J BONE MINER RES, V20, P1149, DOI 10.1359/JBMR.050212; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Ferrari GO, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-69; Fried LF, 2007, J AM SOC NEPHROL, V18, P282, DOI 10.1681/ASN.2006050546; Fyfe-Johnson AL, 2016, J HYPERTENS, V34, P1266, DOI 10.1097/HJH.0000000000000936; Galitzer H, 2010, KIDNEY INT, V77, P211, DOI 10.1038/ki.2009.464; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Houston J, 2013, J RENAL NUTR, V23, P12, DOI 10.1053/j.jrn.2011.12.009; Hu MC, 2013, CONTRIB NEPHROL, V180, P47, DOI 10.1159/000346778; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Isakova T, 2011, CLIN J AM SOC NEPHRO, V6, P2688, DOI 10.2215/CJN.04290511; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Isakova T, 2009, J AM SOC NEPHROL, V20, P388, DOI 10.1681/ASN.2008060609; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P2792, DOI 10.1093/ndt/gfp191; Jia T, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-116; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Komaba H, 2010, KIDNEY INT, V77, P232, DOI 10.1038/ki.2009.414; Lanske B, 2014, KIDNEY INT, V86, P1071, DOI 10.1038/ki.2014.316; Lau WL, 2013, NEPHROL DIAL TRANSPL, V28, P62, DOI 10.1093/ndt/gfs333; Lindberg K, 2014, J AM SOC NEPHROL, V25, P2169, DOI 10.1681/ASN.2013111209; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lysaght AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107681; Martin JF, 2000, GENESIS, V26, P225, DOI 10.1002/(SICI)1526-968X(200004)26:4<225::AID-GENE10>3.0.CO;2-F; Moe SM, 2015, CIRCULATION, V132, P27, DOI 10.1161/CIRCULATIONAHA.114.013876; Nasrallah MM, 2010, NEPHROL DIAL TRANSPL, V25, P2679, DOI 10.1093/ndt/gfq089; Nikolov IG, 2010, BONE, V47, P156, DOI 10.1016/j.bone.2010.04.600; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Olauson H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003975; Olauson H, 2012, J AM SOC NEPHROL, V23, P1641, DOI 10.1681/ASN.2012010048; Pereira RC, 2009, BONE, V45, P1161, DOI 10.1016/j.bone.2009.08.008; Pulskens WP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142510; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Raimann A, 2013, CONNECT TISSUE RES, V54, P108, DOI 10.3109/03008207.2012.753879; Rhee Y, 2011, BONE, V49, P636, DOI 10.1016/j.bone.2011.06.025; Shalhoub V, 2012, J CLIN INVEST, V122, P2543, DOI 10.1172/JCI61405; Shigematsu T, 2004, AM J KIDNEY DIS, V44, P250, DOI 10.1053/j.ajkd.2004.04.029; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; Sitara D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000154; Smith K, 2013, AM J KIDNEY DIS, V61, P67, DOI 10.1053/j.ajkd.2012.06.022; Smith RC, 2012, J CLIN INVEST, V122, P4710, DOI 10.1172/JCI64986; Su N, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.3; Suzuki H, 2005, ARCH HISTOL CYTOL, V68, P371, DOI 10.1679/aohc.68.371; Tamagaki K, 2006, NEPHROL DIAL TRANSPL, V21, P651, DOI 10.1093/ndt/gfi273; van Husen M, 2010, KIDNEY INT, V78, P200, DOI 10.1038/ki.2010.107; Walmsley SJ, 2010, AM J PHYSIOL-RENAL, V298, pF1323, DOI 10.1152/ajprenal.00711.2009; Wesseling-Perry K, 2009, J CLIN ENDOCR METAB, V94, P511, DOI 10.1210/jc.2008-0326; Wohrle S, 2011, J BONE MINER RES, V26, P2486, DOI 10.1002/jbmr.478; Wright CB, 2016, STROKE, V47, P923, DOI 10.1161/STROKEAHA.115.012379; Xiao ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101251; Yu XJ, 2005, THER APHER DIAL, V9, P308, DOI 10.1111/j.1744-9987.2005.00287.x; Yuan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002726; Yuan Q, 2011, ENDOCRINOLOGY, V152, P4053, DOI 10.1210/en.2011-1113; Yuan Q, 2011, J BONE MINER RES, V26, P2026, DOI 10.1002/jbmr.433; Zou HW, 2013, BONE, V56, P410, DOI 10.1016/j.bone.2013.07.014	67	25	27	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2050	2064		10.1096/fj.201601036R	http://dx.doi.org/10.1096/fj.201601036R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28183805				2022-12-26	WOS:000399195500025
J	Martinez-Fernandez, L; Gonzalez-Muniesa, P; Laiglesia, LM; Sainz, N; Prieto-Hontoria, PL; Escote, X; Odriozola, L; Corrales, FJ; Arbones-Mainar, JM; Martinez, JA; Moreno-Aliaga, MJ				Martinez-Fernandez, Leyre; Gonzalez-Muniesa, Pedro; Laiglesia, Laura M.; Sainz, Neira; Prieto-Hontoria, Pedro L.; Escote, Xavier; Odriozola, Leticia; Corrales, Fernando J.; Arbones-Mainar, Jose M.; Martinez, Jose A.; Moreno-Aliaga, Maria J.			Maresin 1 improves insulin sensitivity and attenuates adipose tissue inflammation in ob/ob and diet-induced obese mice	FASEB JOURNAL			English	Article						DHA; n-3 PUFAs derivatives; adipokines; macrophages; glucose metabolism	PRORESOLVING LIPID MEDIATORS; POLYUNSATURATED FATTY-ACIDS; RESOLVIN D1; MACROPHAGE POLARIZATION; GLUCOSE-HOMEOSTASIS; RESISTANCE; MUSCLE; LIVER; AMPK; OMEGA-3-FATTY-ACIDS	The beneficial actions of n-3 fatty acids on obesity-induced insulin resistance and inflammation have been related to the synthesis of specialized proresolving lipid mediators (SPMs) like resolvins. The aim of this study was to evaluate the ability of one of these SPMs, maresin 1 (MaR1), to reverse adipose tissue inflammation and/or insulin resistance in two models of obesity: diet-induced obese (DIO) mice and genetic (ob/ob) obese mice. In DIO mice, MaR1 (2 mu g/kg; 10 d) reduced F4/80-positive cells and expression of the proinflammatory M1 macrophage phenotype marker Cd11c in white adipose tissue (WAT). Moreover, MaR1 decreased Mcp-1, Tnf-alpha, and Il-1 beta expression, upregulated adiponectin and Glut-4, and increased Akt phosphorylation in WAT. MaR1 administration (2 mg/kg; 20 d) to ob/ob mice did not modify macrophage recruitment but increased the M2 macrophage markers Cd163 and Il-10. MaR1 reduced Mcp-1, Tnf-alpha, Il-1 beta, and Dpp-4 and increased adiponectin gene expression in WAT. MaR1 treatment also improved the insulin tolerance test of ob/ob mice and increased Akt and AMPK phosphorylation in WAT. These data suggest that treatment with MaR1 can counteract the dysfunctional inflamed WAT and could be useful to improve insulin sensitivity in murine models of obesity.-Martinez-Fernandez, L., Gonzalez-Muniesa, P., Laiglesia, L. M., Sainz, N., Prieto-Hontoria, P. L., Escote, X., Odriozola, L., Corrales, F. J., Arbones-Mainar, J. M., Martinez, J. A., Moreno-Aliaga, M. J. Maresin 1 improves insulin sensitivity and attenuates adipose tissue inflammation in ob/ob and diet-induced obese mice.	[Martinez-Fernandez, Leyre; Gonzalez-Muniesa, Pedro; Prieto-Hontoria, Pedro L.; Martinez, Jose A.; Moreno-Aliaga, Maria J.] Univ Navarra, Dept Nutr Food Sci & Physiol, Pamplona, Spain; [Martinez-Fernandez, Leyre; Gonzalez-Muniesa, Pedro; Laiglesia, Laura M.; Sainz, Neira; Escote, Xavier; Martinez, Jose A.; Moreno-Aliaga, Maria J.] Univ Navarra, Ctr Nutr Res, Sch Pharm & Nutr, Pamplona, Spain; [Odriozola, Leticia; Corrales, Fernando J.] Univ Navarra, Prote & Bioinformat Unit, Pamplona, Spain; [Corrales, Fernando J.] Univ Navarra, Div Hepatol, Ctr Appl Med Res, Pamplona, Spain; [Gonzalez-Muniesa, Pedro; Arbones-Mainar, Jose M.; Martinez, Jose A.; Moreno-Aliaga, Maria J.] Ctr Biomed Res Network Physiopathol Obes & Nutr C, Madrid, Spain; [Gonzalez-Muniesa, Pedro; Martinez, Jose A.; Moreno-Aliaga, Maria J.] Hlth Res Inst Navarra IDISNA, Pamplona, Spain; [Arbones-Mainar, Jose M.] Hosp Univ Miguel Servet, Inst Aragon Ciencias Salud, Inst Invest Sanitaria Aragon, Adipocyte & Fat Biol Lab AdipoFat, Zaragoza, Spain; [Prieto-Hontoria, Pedro L.] Univ SEK, Fac Hlth & Phys Act Sci, Santiago, Chile	University of Navarra; University of Navarra; University of Navarra; University of Navarra; Miguel Servet University Hospital; Universidad Internacional SEK	Moreno-Aliaga, MJ (corresponding author), Univ Navarra, Ctr Nutr Res, Dept Nutr Food Sci & Physiol, Sch Pharm & Nutr, C Irunlarrea 1, Pamplona 31008, Spain.	mjmoreno@unav.es	Sáinz, Neira/AAA-4624-2019; González-Muniesa, Pedro/H-2158-2015; Escote, Xavier/AAC-6335-2019; Moreno-Aliaga, Maria J/M-7015-2018; Escoté, Xavier/AAH-2973-2020; Arbones-Mainar, Jose M/AGL-8624-2022; Martínez, Leyre/H-3463-2015	González-Muniesa, Pedro/0000-0002-3130-2496; Escote, Xavier/0000-0003-1172-3995; Moreno-Aliaga, Maria J/0000-0002-2018-6434; Arbones-Mainar, Jose M/0000-0002-8982-3737; Martínez, Leyre/0000-0002-3048-6131; Laiglesia, Laura/0000-0002-4636-1421; Corrales, Fernando/0000-0002-0231-5159	Spanish Ministry of Economy and Competitiveness [BFU2012-36089, BFU2015-65937-R]; Navarra Department of Health [67-2015]; Physiopathology of Obesity and Nutrition; Carlos III Health Research Institute [CB12/03/30002]; Formacion de Personal Investigador predoctoral fellowship; Asociacion de Amigos	Spanish Ministry of Economy and Competitiveness(Spanish Government); Navarra Department of Health; Physiopathology of Obesity and Nutrition; Carlos III Health Research Institute(Instituto de Salud Carlos III); Formacion de Personal Investigador predoctoral fellowship; Asociacion de Amigos	This work was supported by the Spanish Ministry of Economy and Competitiveness (Grants BFU2012-36089 and BFU2015-65937-R), the Navarra Department of Health (Grant 67-2015), Physiopathology of Obesity and Nutrition, and the Carlos III Health Research Institute (Grant CB12/03/30002). L.M.-F. is supported by a Formacion de Personal Investigador predoctoral fellowship, and by a predoctoral fellowship from Asociacion de Amigos (to L.M.L.). The authors thank Asuncion Redin, Maria Zabala, David Garcia, and Javier Garcia (all from the University of Navarra) for their valuable technical support on this project. The authors declare no conflicts of interest.	Abraham NG, 2006, CIRC RES, V99, P911, DOI 10.1161/01.RES.0000249616.10603.d6; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Borgeson E, 2015, CELL METAB, V22, P125, DOI 10.1016/j.cmet.2015.05.003; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Claria J, 2013, AM J PHYSIOL-CELL PH, V304, pC1141, DOI 10.1152/ajpcell.00351.2012; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Favero G, 2015, NUTR RES, V35, P891, DOI 10.1016/j.nutres.2015.07.001; Ferrante CJ, 2012, ADV WOUND CARE, V1, P10, DOI 10.1089/wound.2011.0307; Flachs P, 2014, PHYSIOL RES, V63, pS93, DOI 10.33549/physiolres.932715; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Iglesias MA, 2002, DIABETES, V51, P2886, DOI 10.2337/diabetes.51.10.2886; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Leon-Cabrera S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/493409; Liong S, 2015, J PHYSIOL BIOCHEM, V71, P703, DOI 10.1007/s13105-015-0435-7; Lopategi A, 2016, MOL CELL ENDOCRINOL, V419, P44, DOI 10.1016/j.mce.2015.09.033; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Martinez-Fernandez L, 2015, PROSTAG OTH LIPID M, V121, P24, DOI 10.1016/j.prostaglandins.2015.07.003; Masoodi M, 2015, BBA-MOL CELL BIOL L, V1851, P503, DOI 10.1016/j.bbalip.2014.09.023; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Nakata M, 2016, INT J OBESITY, V40, P425, DOI 10.1038/ijo.2015.201; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Perez-Diaz S, 2017, AM J PHYSIOL-CELL PH, V312, pC83, DOI 10.1152/ajpcell.00246.2016; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sell H, 2013, DIABETES CARE, V36, P4083, DOI 10.2337/dc13-0496; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Titos E, 2016, J IMMUNOL, V197, P3360, DOI 10.4049/jimmunol.1502522; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Torres-Perez E, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0203-6; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Welty FK, 2016, TRANSL RES, V167, P257, DOI 10.1016/j.trsl.2015.06.017; White PJ, 2014, NAT MED, V20, P664, DOI 10.1038/nm.3549; Wu H, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1943918; Yates CM, 2014, PHARMACOL THERAPEUT, V141, P272, DOI 10.1016/j.pharmthera.2013.10.010; Yu X, 2004, DIABETOLOGIA, V47, P2012, DOI 10.1007/s00125-004-1570-9	50	61	62	1	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2135	2145		10.1096/fj.201600859R	http://dx.doi.org/10.1096/fj.201600859R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28188173				2022-12-26	WOS:000399195500032
J	Li, W; Reeb, AN; Lin, BY; Subramanian, P; Fey, EE; Knoverek, CR; French, RL; Bigio, EH; Ayala, YM				Li, Wen; Reeb, Ashley N.; Lin, Binyan; Subramanian, Praveen; Fey, Erin E.; Knoverek, Catherine R.; French, Rachel L.; Bigio, Eileen H.; Ayala, Yuna M.			Heat Shock-induced Phosphorylation of TAR DNA-binding Protein 43 (TDP-43) by MAPK/ERK Kinase Regulates TDP-43 Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; HEXANUCLEOTIDE REPEAT; CFTR EXON-9; ANTISENSE TRANSCRIPTS; ALZHEIMER-DISEASE; STRESS GRANULES; RNA FOCI; IN-VIVO	TAR DNA-binding protein (TDP-43) is a highly conserved and essential DNA-and RNA-binding protein that controls gene expression through RNA processing, in particular, regulation of splicing. Intracellular aggregation of TDP-43 is a hallmark of amyotrophic lateral sclerosis and ubiquitin-positive frontotemporal lobar degeneration. This TDP-43 pathology is also present in other types of neurodegeneration including Alzheimer's disease. We report here that TDP-43 is a substrate of MEK, a central kinase in the MAPK/ERK signaling pathway. TDP-43 dual phosphorylation by MEK, at threonine 153 and tyrosine 155 ( p-T153/Y155), was dramatically increased by the heat shock response (HSR) in human cells. HSR promotes cell survival under proteotoxic conditions by maintaining protein homeostasis and preventing protein misfolding. MEK is activated by HSR and contributes to the regulation of proteome stability. Phosphorylated TDP-43 was not associated with TDP-43 aggregation, and p-T153/Y155 remained soluble under conditions that promote protein misfolding. We found that active MEK significantly alters TDP-43-regulated splicing and that phosphomimetic substitutions at these two residues reduce binding to GU-rich RNA. Cellular imaging using a phospho-specific p-T153/Y155 antibody showed that phosphorylated TDP-43 was specifically recruited to the nucleoli, suggesting that p-T153/Y155 regulates a previously unappreciated function of TDP-43 in the processing of nucleolarassociated RNA. These findings highlight a new mechanism that regulates TDP-43 function and homeostasis through phosphorylation and, therefore, may contribute to the development of strategies to prevent TDP-43 aggregation and to uncover previously unexplored roles of TDP-43 in cell metabolism.	[Li, Wen; Reeb, Ashley N.; Lin, Binyan; Subramanian, Praveen; Fey, Erin E.; Knoverek, Catherine R.; French, Rachel L.; Ayala, Yuna M.] St Louis Univ, Sch Med, Edward Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Bigio, Eileen H.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Subramanian, Praveen] AT Still Univ Kirksville, Coll Osteopath Med, Kirksville, MO 63501 USA; [Fey, Erin E.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Knoverek, Catherine R.] Washington Univ, Dept Computat & Mol Biophys, St Louis, MO 63110 USA	Saint Louis University; Northwestern University; Feinberg School of Medicine; A.T. Still University of Health Sciences; Vanderbilt University; Washington University (WUSTL)	Ayala, YM (corresponding author), St Louis Univ, Sch Med, Edward Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	yayala@slu.edu			National Institutes of Health, NINDS [K01 NS082391]; St. Louis University Presidential Research Fund [230175]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K01NS082391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013854] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); St. Louis University Presidential Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the National Institutes of Health, NINDS Grant K01 NS082391 and St. Louis University Presidential Research Fund Grant 230175. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2006, FEBS LETT, V580, P1339, DOI 10.1016/j.febslet.2006.01.052; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; Bigio EH, 2010, ACTA NEUROPATHOL, V120, P43, DOI 10.1007/s00401-010-0681-2; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.011429; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2015, ADV GENET, V91, P1, DOI 10.1016/bs.adgen.2015.07.001; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Butch ER, 1996, J BIOL CHEM, V271, P4230; Chen HJ, 2016, BRAIN, V139, P1417, DOI 10.1093/brain/aww028; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Huang CC, 2014, J CELL SCI, V127, P3024, DOI 10.1242/jcs.136150; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Kalmar B, 2014, PHARMACOL THERAPEUT, V141, P40, DOI 10.1016/j.pharmthera.2013.08.003; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lin PY, 2016, J NEUROSCI RES, V94, P671, DOI 10.1002/jnr.23725; Lin Y, 2016, CELL, V167, P789, DOI 10.1016/j.cell.2016.10.003; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Ling JP, 2015, SCIENCE, V349, P650, DOI 10.1126/science.aab0983; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Morimoto RI, 2011, COLD SPRING HARB SYM, V76, P91, DOI DOI 10.1101/SQB.2012.76.010637; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Schmid B, 2013, P NATL ACAD SCI USA, V110, P4986, DOI 10.1073/pnas.1218311110; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shalgi R, 2014, CELL REP, V7, P1362, DOI 10.1016/j.celrep.2014.04.044; Tang ZJ, 2015, CELL, V160, P729, DOI 10.1016/j.cell.2015.01.028; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tsuiji H, 2013, EMBO MOL MED, V5, P221, DOI 10.1002/emmm.201202303; Udan-Johns M, 2014, HUM MOL GENET, V23, P157, DOI 10.1093/hmg/ddt408; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yunus Ali A., 2009, V497, P167, DOI 10.1007/978-1-59745-566-4_11; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	55	33	34	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5089	5100		10.1074/jbc.M116.753913	http://dx.doi.org/10.1074/jbc.M116.753913			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28167528	Green Published, hybrid			2022-12-26	WOS:000397590400028
J	Boonma, S; Romsang, A; Duang-nkern, J; Atichartpongkul, S; Trinachartvanit, W; Vattanaviboon, P; Mongkolsuk, S				Boonma, Siriwan; Romsang, Adisak; Duang-nkern, Jintana; Atichartpongkul, Sopapan; Trinachartvanit, Wachareeporn; Vattanaviboon, Paiboon; Mongkolsuk, Skorn			The FinR-regulated essential gene fprA, encoding ferredoxin NADP(+) reductase: Roles in superoxide-mediated stress protection and virulence of Pseudomonas aeruginosa	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; TRANSCRIPTIONAL REGULATOR; OXIDATIVE STRESS; ESCHERICHIA-COLI; RHODOCOCCUS-EQUI; PUTIDA KT2440; EXPRESSION; BIOSYNTHESIS; HOST; RESISTANCE	Pseudomonas aeruginosa has two genes encoding ferredoxin NADP(+) reductases, denoted fprA and fprB. We show here that P. aeruginosa fprA is an essential gene. However, the Delta fprA mutant could only be successfully constructed in PAO1 strains containing an extra copy of fprA on a mini-Tn7 vector integrated into the chromosome or carrying it on a temperature-sensitive plasmid. The strain containing an extra copy of the ferredoxin gene (fdx1) could suppress the essentiality of FprA. Other ferredoxin genes could not suppress the requirement for FprA, suggesting that Fdx1 mediates the essentiality of FprA. The expression of fprA was highly induced in response to treatments with a superoxide generator, paraquat, or sodium hypochlorite (NaOCl). The induction of fprA by these treatments depended on FinR, a LysR-family transcription regulator. In vivo and in vitro analysis suggested that oxidized FinR acted as a transcriptional activator of fprA expression by binding to its regulatory box, located 20 bases upstream of the fprA -35 promoter motif. This location of the FinR box also placed it between the -35 and -10 motifs of the finR promoter, where the reduced regulator functions as a repressor. Under uninduced conditions, binding of FinR repressed its own transcription but had no effect on fprA expression. Exposure to paraquat or NaOCl converted FinR to a transcriptional activator, leading to the expression of both fprA and finR. The Delta finR mutant showed an increased paraquat sensitivity phenotype and attenuated virulence in the Drosophila melanogaster host model. These phenotypes could be complemented by high expression of fprA, indicating that the observed phenotypes of the Delta finR mutant arose from the inability to up-regulate fprA expression. In addition, increased expression of fprB was unable to rescue essentiality of fprA or the superoxide-sensitive phenotype of the.finR mutant, suggesting distinct mechanisms of the FprA and FprB enzymes.	[Boonma, Siriwan; Romsang, Adisak; Mongkolsuk, Skorn] Mahidol Univ, Dept Biotechnol, Fac Sci, Bangkok, Thailand; [Duang-nkern, Jintana; Atichartpongkul, Sopapan; Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Chulabhorn Res Inst, Biotechnol Lab, Bangkok, Thailand; [Trinachartvanit, Wachareeporn] Mahidol Univ, Dept Biol, Fac Sci, Bangkok, Thailand; [Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Minist Educ, CHE, Ctr Excellence Environm Hlth & Toxicol, Bangkok, Thailand; [Vattanaviboon, Paiboon] Chulabhorn Grad Inst, Program Appl Biol Sci Environm Hlth, Bangkok, Thailand; [Mongkolsuk, Skorn] Mahidol Univ, Ctr Emerging Bacterial Infect, Fac Sci, Bangkok, Thailand	Mahidol University; Chulabhorn Research Institute; Mahidol University; Chulabhorn Graduate Institute; Mahidol University	Mongkolsuk, S (corresponding author), Mahidol Univ, Dept Biotechnol, Fac Sci, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Chulabhorn Res Inst, Biotechnol Lab, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Minist Educ, CHE, Ctr Excellence Environm Hlth & Toxicol, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Mahidol Univ, Ctr Emerging Bacterial Infect, Fac Sci, Bangkok, Thailand.	skorn.mon@mahidol.ac.th	Romsang, Adisak/K-2630-2019; Vattanaviboon, Paiboon/V-1380-2019; Romsang, Adisak/H-7142-2014	Romsang, Adisak/0000-0002-5339-5443; Romsang, Adisak/0000-0002-5339-5443	Chulabhorn Research Institute; Faculty of Science; Mahidol University; Office of the Higher Education Commission; Thailand Research Fund [MRG5980047]; Royal Thai Government Scholarship under the Development and Promotion of Science and Technology Talents Project (DPST), Thailand	Chulabhorn Research Institute; Faculty of Science; Mahidol University; Office of the Higher Education Commission; Thailand Research Fund(Thailand Research Fund (TRF)); Royal Thai Government Scholarship under the Development and Promotion of Science and Technology Talents Project (DPST), Thailand	This work was supported by grants from the Chulabhorn Research Institute (http://www.cri.or.th/en/index.php), the Faculty of Science (http://science.mahidotac.th/), and the Mahidol University (https://www.manidolac.th). AR was supported by the grant from the joint funding of Office of the Higher Education Commission and Thailand Research Fund (MRG5980047) with SM as his mentor. SB was supported by the Royal Thai Government Scholarship under the Development and Promotion of Science and Technology Talents Project (DPST), Thailand (www.dpstenter.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Apidianakis Y, 2009, NAT PROTOC, V4, P1285, DOI 10.1038/nprot.2009.124; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Braz VS, 2010, J BACTERIOL, V192, P5480, DOI 10.1128/JB.00496-10; Byrne GA, 2007, J BACTERIOL, V189, P5082, DOI 10.1128/JB.00431-07; Cao H, 2001, P NATL ACAD SCI USA, V98, P14613, DOI 10.1073/pnas.251465298; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Deghmane AE, 2000, EMBO J, V19, P1068, DOI 10.1093/emboj/19.5.1068; Dietrich LEP, 2011, MOL MICROBIOL, V79, P1119, DOI 10.1111/j.1365-2958.2011.07552.x; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Elsen S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-271; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Fuangthong M, 2015, MICROBIOL RES, V170, P139, DOI 10.1016/j.micres.2014.08.004; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; HASSETT DJ, 1995, J BACTERIOL, V177, P6330, DOI 10.1128/jb.177.22.6330-6337.1995; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Imlay JA, 2015, ANNU REV MICROBIOL, V69, P93, DOI 10.1146/annurev-micro-091014-104322; ISAS JM, 1995, J BIOL CHEM, V270, P21258, DOI 10.1074/jbc.270.36.21258; Kang IH, 2007, J MICROBIOL BIOTECHN, V17, P176; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Kim SH, 2009, J MICROBIOL BIOTECHN, V19, P1520, DOI 10.4014/jmb.0906.06028; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kovacikova G, 1999, J BACTERIOL, V181, P4250, DOI 10.1128/JB.181.14.4250-4256.1999; Lee, 2007, J MICROBIOL BIOTECHN, V17, P1504; Lee SA, 2015, P NATL ACAD SCI USA, V112, P5189, DOI 10.1073/pnas.1422186112; Lee Y, 2006, BIOCHEM BIOPH RES CO, V339, P1246, DOI 10.1016/j.bbrc.2005.11.135; Lewis TA, 2013, J BACTERIOL, V195, P3876, DOI 10.1128/JB.00528-13; LINDQUIST S, 1989, J BACTERIOL, V171, P3746, DOI 10.1128/jb.171.7.3746-3753.1989; Lu Z, 2007, J BACTERIOL, V189, P5642, DOI 10.1128/JB.00467-07; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Oliver A, 2015, DRUG RESIST UPDATE, V21-22, P41, DOI 10.1016/j.drup.2015.08.002; Park W, 2006, BIOCHEM BIOPH RES CO, V341, P51, DOI 10.1016/j.bbrc.2005.12.142; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Romsang A, 2016, STRESS ENV CONTROL G, V2, P1090; Romsang A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134374; Romsang A, 2015, INT J ANTIMICROB AG, V45, P314, DOI 10.1016/j.ijantimicag.2014.10.024; Romsang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086763; Romsang A, 2013, J BACTERIOL, V195, P3299, DOI 10.1128/JB.00167-13; Runyen-Janecky L, 2008, INFECT IMMUN, V76, P1083, DOI 10.1128/IAI.01211-07; Russell DA, 2004, J BACTERIOL, V186, P5576, DOI 10.1128/JB.186.17.5576-5584.2004; Saenkham P, 2007, J BACTERIOL, V189, P8807, DOI 10.1128/JB.00960-07; Sambrook J., 2012, MOL CLONING LAB MANU, V4th, DOI DOI 10.1016/0003-2697(90)90595-Z; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Silo-Suh LA, 2009, J MICROBIOL METH, V78, P319, DOI 10.1016/j.mimet.2009.07.002; Somprasong N, 2012, J BACTERIOL, V194, P3904, DOI 10.1128/JB.00347-12; Sperandio B, 2007, J BACTERIOL, V189, P7032, DOI 10.1128/JB.00703-07; Srijaruskul K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123699; STORZ G, 1992, J NUTR, V122, P627, DOI 10.1093/jn/122.suppl_3.627; Stover C. K., 2000, NATURE, V406, P1, DOI DOI 10.1038/35023203; Suwantarat N, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0115-6; Takeda K, 2010, BIOMETALS, V23, P727, DOI 10.1007/s10534-010-9339-8; Velayudhan J, 2014, INFECT IMMUN, V82, P1390, DOI 10.1128/IAI.01022-13; Vollack KU, 1998, MICROBIOL-SGM, V144, P441, DOI 10.1099/00221287-144-2-441; Weeratunga SK, 2010, BIOCHEMISTRY-US, V49, P1160, DOI 10.1021/bi9015204; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Yeom J, 2012, BMB REP, V45, P476, DOI 10.5483/BMBRep.2012.45.8.071; Yeom J, 2009, J BIOCHEM, V145, P481, DOI 10.1093/jb/mvn185; Yeom J, 2009, J BACTERIOL, V191, P1472, DOI 10.1128/JB.01473-08; Yeom S, 2010, MICROBIOL-SGM, V156, P1487, DOI 10.1099/mic.0.034181-0; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105	63	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172071	10.1371/journal.pone.0172071	http://dx.doi.org/10.1371/journal.pone.0172071			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187184	Green Submitted, Green Published, gold			2022-12-26	WOS:000394244300079
J	Murray, JM; Maher, S; Mota, T; Suzuki, K; Kelleher, AD; Center, RJ; Purcell, D				Murray, John M.; Maher, Stephen; Mota, Talia; Suzuki, Kazuo; Kelleher, Anthony D.; Center, Rob J.; Purcell, Damian			Differentiating founder and chronic HIV envelope sequences	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INTEGRIN ALPHA(4)BETA(7); HETEROSEXUAL TRANSMISSION; GLYCOPROTEIN GP120; DEPENDENT EPITOPE; HUMAN-ANTIBODY; INFECTION; NEUTRALIZATION; DOMAINS; GP41	Significant progress has been made in characterizing broadly neutralizing antibodies against the HIV envelope glycoprotein Env, but an effective vaccine has proven elusive. Vaccine development would be facilitated if common features of early founder virus required for transmission could be identified. Here we employ a combination of bioinformatic and operations research methods to determine the most prevalent features that distinguish 78 subtype B and 55 subtype C founder Env sequences from an equal number of chronic sequences. There were a number of equivalent optimal networks (based on the fewest covarying amino acid (AA) pairs or a measure of maximal covariance) that separated founders from chronics: 13 pairs for subtype B and 75 for subtype C. Every subtype B optimal solution contained the founder pairs 178-346 Asn-Val, 232-236 Thr-Ser, 240-340 Lys-Lys, 279-315 Asp-Lys, 291-792 Ala-Ile, 322-347 Asp-Thr, 535-620 Leu-Asp, 742-837 Arg-Phe, and 750-836 Asp-Ile; the most common optimal pairs for subtype C were 644-781 Lys-Ala (74 of 75 networks), 133-287 Ala-Gln (73/75) and 307-337 Ile-Gln (73/75). No pair was present in all optimal subtype C solutions highlighting the difficulty in targeting transmission with a single vaccine strain. Relative to the size of its domain (0.35% of Env), the alpha(4)beta(7) binding site occurred most frequently among optimal pairs, especially for subtype C: 4.2% of optimal pairs (1.2% for subtype B). Early sequences from 5 subtype B pre-seroconverters each exhibited at least one clone containing an optimal feature 553-624 (Ser-Asn), 724-747 (Arg-Arg), or 46-293 (Arg-Glu).	[Murray, John M.; Maher, Stephen] UNSW Sydney, Sch Math & Stat, Sydney, NSW, Australia; [Maher, Stephen] Zuse Inst Berlin, Berlin, Germany; [Mota, Talia; Center, Rob J.; Purcell, Damian] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Suzuki, Kazuo; Kelleher, Anthony D.] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia; [Center, Rob J.] Ctr Biomed Res, Burnet Inst, Melbourne, Vic, Australia	University of New South Wales Sydney; Zuse Institute Berlin; University of Melbourne; University of New South Wales Sydney; Kirby Institute; Burnet Institute	Murray, JM (corresponding author), UNSW Sydney, Sch Math & Stat, Sydney, NSW, Australia.	J.Murray@unsw.edu.au	Murray, John/B-5481-2009; Purcell, Damian F/G-5068-2011	Murray, John/0000-0001-9314-2283; Kelleher, Anthony/0000-0002-0009-3337; Mota, Talia/0000-0002-8925-0158; Suzuki, Kazuo/0000-0002-2531-794X	UNSW Goldstar grant [RG134772]	UNSW Goldstar grant	JM was funded by a UNSW Goldstar grant (RG134772, https://research.unsw.edu.au/ unsw-internal-funding-opportunities). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; [Anonymous], SCIENCE; [Anonymous], SCIENCE; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Asmal M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023673; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Byrareddy SN, 2014, NAT MED, V20, P1397, DOI 10.1038/nm.3715; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Cocchi F, 1996, NAT MED, P2; Costin JM, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-123; Day TA, 2013, CURR HIV RES, V11, P441, DOI 10.2174/1570162X113116660051; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Eyal E, 2007, PROTEINS, V67, P142, DOI 10.1002/prot.21223; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Geretti AM, 2006, CURR OPIN INFECT DIS, V19, P1, DOI 10.1097/01.qco.0000200293.45532.68; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Go EP, 2011, J VIROL, V85, P8270, DOI 10.1128/JVI.05053-11; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gorny MK, 1993, J IMMUNOL, P150; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2010, CURR OPIN HIV AIDS, V5, P327, DOI 10.1097/COH.0b013e32833a0b9b; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; KENNEDY RC, 1986, SCIENCE, V231, P1556, DOI 10.1126/science.3006246; Korazim O, 2006, J MOL BIOL, V364, P1103, DOI 10.1016/j.jmb.2006.08.091; Korber B., 1998, HUMAN RETROVIRUSES A, V3, P102; Kuhlmann AS, 2014, J BIOL CHEM, V289, P7630, DOI 10.1074/jbc.M113.529339; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lee BC, 2008, PROTEINS, V72, P863, DOI 10.1002/prot.21972; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Liao H-X, 2013, NATURE; Maher SJ, 2016, EUR J OPER RES, V248, P668, DOI 10.1016/j.ejor.2015.07.011; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; MOORE JP, 1994, J VIROL, V68, P6836, DOI 10.1128/JVI.68.11.6836-6847.1994; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Mota TM, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-54; Murray JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067254; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Parrish NF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002686; Perez LG, 2014, J VIROL, V88, P10767, DOI 10.1128/JVI.03296-13; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rong R, 2007, J VIROL, V81, P5658, DOI 10.1128/JVI.00257-07; Sagar M, 2009, J INFECT DIS, V199, P580, DOI 10.1086/596557; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Wang WK, 1996, J VIROL, V70, P607, DOI 10.1128/JVI.70.1.607-611.1996; Wang X, 2009, MUCOSAL IMMUNOL, V2, P518, DOI 10.1038/mi.2009.104; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	55	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171572	10.1371/journal.pone.0171572	http://dx.doi.org/10.1371/journal.pone.0171572			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187204	Green Published, gold			2022-12-26	WOS:000394244300031
J	Oles, V; Panchenko, A; Smertenko, A				Oles, Vladyslav; Panchenko, Alexander; Smertenko, Andrei			Modeling hormonal control of cambium proliferation	PLOS ONE			English	Article							GENE REGULATORY NETWORK; CYTOKININ BIOSYNTHESIS; ARABIDOPSIS HYPOCOTYL; TRANSCRIPTION FACTOR; VASCULAR PATTERN; RECEPTOR KINASE; HOMEOBOX GENE; POLAR AUXIN; CELL FATE; GROWTH	Rise of atmospheric CO2 is one of the main causes of global warming. Catastrophic climate change can be avoided by reducing emissions and increasing sequestration of CO2. Trees are known to sequester CO2 during photosynthesis, and then store it as wood biomass. Thus, breeding of trees with higher wood yield would mitigate global warming as well as augment production of renewable construction materials, energy, and industrial feedstock. Wood is made of cellulose-rich xylem cells produced through proliferation of a specialized stem cell niche called cambium. Importance of cambium in xylem cells production makes it an ideal target for the tree breeding programs; however our knowledge about control of cambium proliferation remains limited. The morphology and regulation of cambium are different from those of stem cell niches that control axial growth. For this reason, translating the knowledge about axial growth to radial growth has limited use. Furthermore, genetic approaches cannot be easily applied because overlaying tissues conceal cambium from direct observation and complicate identification of mutants. To overcome the paucity of experimental tools in cambium biology, we constructed a Boolean network CARENET (CAmbium REgulation gene NETwork) for modelling cambium activity, which includes the key transcription factors WOX4 and HD-ZIP III as well as their potential regulators. Our simulations predict that: (1) auxin, cytokinin, gibberellin, and brassinosteroids act cooperatively in promoting transcription of WOX4 and HD-ZIP III; (2) auxin and cytokinin pathways negatively regulate each other; (3) hormonal pathways act redundantly in sustaining cambium activity; (4) individual cambium cells can have diverse molecular identities. CARENET can be extended to include components of other signalling pathways and be integrated with models of xylem and phloem differentiation. Such extended models would facilitate breeding trees with higher wood yield.	[Oles, Vladyslav; Panchenko, Alexander] Washington State Univ, Dept Math, Pullman, WA 99164 USA; [Smertenko, Andrei] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Washington State University; Washington State University	Panchenko, A (corresponding author), Washington State Univ, Dept Math, Pullman, WA 99164 USA.; Smertenko, A (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	panchenko@math.wsu.edu; andrei.smertenko@wsu.edu		Smertenko, Andrei/0000-0002-5078-4881	NIFA hatch project [WNP00826]	NIFA hatch project	This project was supported by NIFA hatch project WNP00826 (to AS).	Agusti J, 2013, MECH DEVELOP, V130, P34, DOI 10.1016/j.mod.2012.05.011; Agusti J, 2011, P NATL ACAD SCI USA, V108, P20242, DOI 10.1073/pnas.1111902108; Agusti J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001312; Baima S, 1995, DEVELOPMENT, V121, P4171; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Benitez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063108; Bhalerao RP, 2014, PHYSIOL PLANTARUM, V151, P43, DOI 10.1111/ppl.12134; Bishopp A, 2011, CURR BIOL, V21, P927, DOI 10.1016/j.cub.2011.04.049; Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; Bjorklund S, 2007, PLANT J, V52, P499, DOI 10.1111/j.1365-313X.2007.03250.x; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Ckurshumova W, 2014, NEW PHYTOL, V204, P556, DOI 10.1111/nph.13014; De Rybel B, 2014, SCIENCE, V345, DOI 10.1126/science.1255215; De Rybel B, 2013, DEV CELL, V24, P426, DOI 10.1016/j.devcel.2012.12.013; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Ding ZJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1941; Donner TJ, 2009, DEVELOPMENT, V136, P3235, DOI 10.1242/dev.037028; Eriksson ME, 2000, NAT BIOTECHNOL, V18, P784, DOI 10.1038/77355; Etchells JP, 2015, CURR BIOL, V25, P1050, DOI 10.1016/j.cub.2015.02.023; Etchells JP, 2013, DEVELOPMENT, V140, P2224, DOI 10.1242/dev.091314; Etchells JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002997; Etchells JP, 2010, DEVELOPMENT, V137, P767, DOI 10.1242/dev.044941; Fisher K, 2007, CURR BIOL, V17, P1061, DOI 10.1016/j.cub.2007.05.049; Furuta KM, 2014, ANNU REV PLANT BIOL, V65, P607, DOI 10.1146/annurev-arplant-050213-040306; Gerttula S, 2015, PLANT CELL, V27, P2800, DOI 10.1105/tpc.15.00531; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; Hejatko J, 2009, PLANT CELL, V21, P2008, DOI 10.1105/tpc.109.066696; Hirakawa Y, 2008, P NATL ACAD SCI USA, V105, P15208, DOI 10.1073/pnas.0808444105; Hirakawa Y, 2010, PLANT CELL, V22, P2618, DOI 10.1105/tpc.110.076083; Hirose N, 2008, J EXP BOT, V59, P75, DOI 10.1093/jxb/erm157; Ji JB, 2010, PLANT PHYSIOL, V152, P1346, DOI 10.1104/pp.109.149641; Jouannet V, 2015, CURR OPIN PLANT BIOL, V23, P54, DOI 10.1016/j.pbi.2014.10.010; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; KAUFFMAN S, 1974, J THEOR BIOL, V44, P167, DOI 10.1016/S0022-5193(74)80037-8; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kondo Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4504; Krawitz P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158701; Lavenus J, 2015, PLANT CELL, V27, P1368, DOI 10.1105/tpc.114.132993; Liebsch D, 2014, DEVELOPMENT, V141, P4311, DOI 10.1242/dev.111369; Little CHA, 2002, INT J PLANT SCI, V163, P519, DOI 10.1086/339642; Liu LJ, 2015, NEW PHYTOL, V205, P682, DOI 10.1111/nph.13151; Love J, 2009, P NATL ACAD SCI USA, V106, P5984, DOI 10.1073/pnas.0811660106; Lucas WJ, 2013, J INTEGR PLANT BIOL, V55, P294, DOI 10.1111/jipb.12041; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Matsumoto-Kitano M, 2008, P NATL ACAD SCI USA, V105, P20027, DOI 10.1073/pnas.0805619105; Milhinhos A, 2013, PLANT CELL REP, V32, P867, DOI 10.1007/s00299-013-1420-7; Nordstrom A, 2004, P NATL ACAD SCI USA, V101, P8039, DOI 10.1073/pnas.0402504101; Oh MH, 2011, PLANT PHYSIOL, V157, P120, DOI 10.1104/pp.111.182741; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Ohashi-Ito K, 2003, PLANT CELL PHYSIOL, V44, P1350, DOI 10.1093/pcp/pcg164; Peer WA, 2013, CURR OPIN PLANT BIOL, V16, P561, DOI 10.1016/j.pbi.2013.08.003; Pernisova M, 2009, P NATL ACAD SCI USA, V106, P3609, DOI 10.1073/pnas.0811539106; Ragni L, 2014, PHYSIOL PLANTARUM, V151, P164, DOI 10.1111/ppl.12118; Ragni L, 2011, PLANT CELL, V23, P1322, DOI 10.1105/tpc.111.084020; Ruzicka K, 2009, P NATL ACAD SCI USA, V106, P4284, DOI 10.1073/pnas.0900060106; Sanio K., 1872, JB WISS BOT, V8, P401; Sankar M, 2011, BIOINFORMATICS, V27, P1404, DOI 10.1093/bioinformatics/btr158; Sawchuk MG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003294; Schlereth A, 2010, NATURE, V464, P913, DOI 10.1038/nature08836; Shmulevich I., 2014, GENOMIC SIGNAL PROCE; Shmulevich I., 2010, PROB BOOL NETW; Suer S, 2011, PLANT CELL, V23, P3247, DOI 10.1105/tpc.111.087874; Tanaka M, 2006, PLANT J, V45, P1028, DOI 10.1111/j.1365-313X.2006.02656.x; Taylor-Teeples M, 2015, NATURE, V517, P571, DOI 10.1038/nature14099; Veliz-Cuba A, 2015, ELECTRON NOTES THEOR, V316, P83, DOI 10.1016/j.entcs.2015.06.012; Voss U, 2014, TRENDS PLANT SCI, V19, P311, DOI 10.1016/j.tplants.2014.02.004; Wang HZ, 2010, P NATL ACAD SCI USA, V107, P22338, DOI 10.1073/pnas.1016436107; Wang JH, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-94; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Whitford R, 2008, P NATL ACAD SCI USA, V105, P18625, DOI 10.1073/pnas.0809395105; Wittmann DM, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-98; Zazimalova E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001552	76	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171927	10.1371/journal.pone.0171927	http://dx.doi.org/10.1371/journal.pone.0171927			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187161	Green Submitted, gold, Green Published			2022-12-26	WOS:000394244300061
J	Dutra, LM; Glantz, SA; Lisha, NE; Song, AV				Dutra, Lauren M.; Glantz, Stanton A.; Lisha, Nadra E.; Song, Anna V.			Beyond experimentation: Five trajectories of cigarette smoking in a longitudinal sample of youth	PLOS ONE			English	Article							GROWTH MIXTURE-MODELS; DEVELOPMENTAL TRAJECTORIES; YOUNG ADULTHOOD; HIGH-SCHOOL; EMERGING ADULTHOOD; EARLY ADOLESCENCE; COLLEGE-STUDENTS; PREDICT INSOMNIA; NATURAL-HISTORY; TOBACCO-CONTROL	The first goal of this study was to identify the most appropriate measure of cigarette smoking for identifying unique smoking trajectories among adolescents; the second goal was to describe the resulting trajectories and their characteristics. Using 15 annual waves of smoking data in the National Longitudinal Survey of Youth 1997 (NLSY97), we conducted an exploratory latent class growth analysis to determine the best of four outcome variables for yearly smoking (cigarettes per day on days smoked, days smoked per month, mean cigarettes per day, and total cigarettes per month) among individuals aged 12 to 30 (n = 8,791). Days smoked per month was the best outcome variable for identifying unique longitudinal trajectories of smoking and characteristics of these trajectories that could be used to target different types of smokers for prevention and cessation. Objective statistics were used to identify four trajectories in addition to never smokers (34.1%): experimenters (13.6%), quitters (8.1%), early established smokers (39.0%), and late escalators (5.2%). We identified a quitter and late escalator class not identified in the only other comparable latent class growth analysis. Logistic regressions were used to identify the characteristics of individuals in each trajectory. Compared with never smokers, all trajectories except late escalators were less likely to be black; experimenters were more likely to be out of school and unemployed and drink alcohol in adolescence; quitters were more likely to have a mother with a high school degree/GED or higher (versus none) and to use substances in adolescence and less likely to have ever married as a young adult; early established smokers were more likely to have a mother with a high school diploma or GED, be out of school and unemployed, not live with both parents, have used substances, be depressed, and have peers who smoked in adolescence and to have children as young adults and less likely to be Hispanic and to have ever married as young adults; and late escalators were more likely to be Hispanic, drink alcohol, and break rules in adolescence and less likely to have ever married as young adults. Because of the number of waves of data analyzed, this analysis provided a clearer temporal depiction of smoking behavior and more easily distinguishable smoking trajectories than previous analyses. Tobacco control interventions need to move beyond youth-focused approaches to reach all smokers.	[Dutra, Lauren M.; Glantz, Stanton A.; Lisha, Nadra E.] Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA; [Dutra, Lauren M.] RTI Int, Ctr Hlth Policy Sci & Tobacco Res, Berkeley, CA USA; [Glantz, Stanton A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Song, Anna V.] Univ Calif Merced, Psychol Sci Hlth Sci Res Inst, Merced, CA USA	University of California System; University of California San Francisco; Research Triangle Institute; University of California System; University of California San Francisco; University of California System; University of California Merced	Glantz, SA (corresponding author), Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA.; Glantz, SA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	glantz@medicine.ucsf.edu		Dutra, Lauren/0000-0001-8505-7994; Glantz, Stanton/0000-0003-4620-6672	National Institutes of Health and Food and Drug Administration Center for Tobacco Products [R01 CA-060121, R25CA-113710, P50CA180890, 1U01CA154240]; NATIONAL CANCER INSTITUTE [R25CA113710, P50CA180890, T32CA113710, R01CA061021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA043950] Funding Source: NIH RePORTER	National Institutes of Health and Food and Drug Administration Center for Tobacco Products; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by R01 CA-060121 (Drs. Glantz and Song), R25CA-113710 and P50CA180890 (Dr. Dutra), 1U01CA154240 (Dr. Lisha) from the National Institutes of Health and Food and Drug Administration Center for Tobacco Products. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the US FDA. This research was conducted with Bureau of Labor Statistics data. The views expressed here do not necessarily reflect the views of the Bureau of Labor Statistics.	Abroms L, 2005, ADDICTION, V100, P852, DOI 10.1111/j.1360-0443.2005.01090.x; Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; Akhtar-Khaleel WZ, 2016, AIDS BEHAV; Amstadter AB, 2009, J TRAUMA STRESS, V22, P113, DOI 10.1002/jts.20398; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Bauer DJ, 2003, PSYCHOL METHODS, V8, P338, DOI 10.1037/1082-989X.8.3.338; Berlin KS, 2014, J PEDIATR PSYCHOL, V39, P188, DOI 10.1093/jpepsy/jst085; Bernat DH, 2008, J ADOLESCENT HEALTH, V43, P334, DOI 10.1016/j.jadohealth.2008.02.014; BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Brook DW, 2012, SLEEP MED, V13, P1130, DOI 10.1016/j.sleep.2012.05.008; Brook JS, 2006, NICOTINE TOB RES, V8, P639, DOI 10.1080/14622200600789627; Brook JS, 2014, NICOTINE TOB RES, V16, P1559, DOI 10.1093/ntr/ntu107; Brown AE, 2011, ADDICT BEHAV, V36, P1199, DOI 10.1016/j.addbeh.2011.07.024; Caldeira KM, 2012, NICOTINE TOB RES, V14, P777, DOI 10.1093/ntr/nts131; Centers for Disease Control and Prevention, 2015, CAMP OV; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1434; Chassin L, 2000, HEALTH PSYCHOL, V19, P223, DOI 10.1037//0278-6133.19.3.223; CHEN K, 1995, AM J PUBLIC HEALTH, V85, P41, DOI 10.2105/AJPH.85.1.41; Cheng KW, 2015, TOB CONTROL, V24, P168, DOI 10.1136/tobaccocontrol-2013-051121; Cheng KW, 2011, AM J PREV MED, V41, P566, DOI 10.1016/j.amepre.2011.08.014; Colder CR, 2008, ADDICTION, V103, P1534, DOI 10.1111/j.1360-0443.2008.02280.x; Costello DM, 2008, HEALTH PSYCHOL, V27, P811, DOI 10.1037/0278-6133.27.6.811; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Etzel RA, 2015, PEDIATRICS, V136, P998, DOI 10.1542/peds.2015-3109; Frosch ZAK, 2009, ADDICT BEHAV, V34, P701, DOI 10.1016/j.addbeh.2009.04.007; Fuemmeler B, 2013, DRUG ALCOHOL DEPEN, V132, P301, DOI 10.1016/j.drugalcdep.2013.02.021; Glantz SA, 2012, PRIMER BIOSTATISTICS; Glenn N, 2009, IS APPARENT U SHAPE, V66, P1733; Glenn N, 2009, SOC SCI MED, V69, P481, DOI 10.1016/j.socscimed.2009.05.038; Hampson SE, 2013, NICOTINE TOB RES, V15, P1400, DOI 10.1093/ntr/nts338; Husten CG, 2009, NICOTINE TOB RES, V11, P111, DOI 10.1093/ntr/ntp010; Hyland A, 2009, NICOTINE TOB RES, V11, P614, DOI 10.1093/ntr/ntp022; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Karp I, 2005, ANN EPIDEMIOL, V15, P445, DOI 10.1016/j.annepidem.2004.10.002; Landman A, 2002, AM J PUBLIC HEALTH, V92, P917, DOI 10.2105/AJPH.92.6.917; Lee JY, 2016, SUBST USE MISUSE, V51, P616, DOI 10.3109/10826084.2015.1126747; Lessov-Schlaggar CN, 2012, ADDICTION, V107, P1696, DOI 10.1111/j.1360-0443.2012.03871.x; Ling PM, 2014, AM J PUBLIC HEALTH, V104, P751, DOI 10.2105/AJPH.2013.301666; Ling PM, 2002, JAMA-J AM MED ASSOC, V287, P2983, DOI 10.1001/jama.287.22.2983; Long J.S., 2006, REGRESSION MODELS CA; Mays D, 2014, PEDIATRICS, V133, P983, DOI 10.1542/peds.2013-3003; Morgan GB, 2014, STRUCTURAL EQUATION, V22, P76; Munafo M, 2008, NICOTINE TOB RES, V10, P1609, DOI 10.1080/14622200802412895; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x; Muthen B, 2003, PSYCHOL METHODS, V8, P369, DOI 10.1037/1082-989X.8.3.369; Muthen B, 2016, COMMUNICATION; Muthen L.K., 2010, MPLUS USERS GUIDE; Muthen LK, GOODNESS FIT STAT MI; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Orlando M, 2004, J CONSULT CLIN PSYCH, V72, P400, DOI 10.1037/0022-006X.72.3.400; Orpinas P, 2016, NICOTINE TOB RES, V18, P156, DOI 10.1093/ntr/ntv040; Pollard MS, 2010, ADDICT BEHAV, V35, P678, DOI 10.1016/j.addbeh.2010.02.013; Riggs NR, 2007, NICOTINE TOB RES, V9, P1147, DOI 10.1080/14622200701648359; Schane RE, 2009, ARCH INTERN MED, V169, P1742, DOI 10.1001/archinternmed.2009.315; Scott-Sheldon LAJ, 2010, NICOTINE TOB RES, V12, P1019, DOI 10.1093/ntr/ntq142; Shmueli D, 2010, AM J PREV MED, V38, P351, DOI 10.1016/j.amepre.2009.12.025; Song AV, 2007, AM J PREV MED, V33, P396, DOI 10.1016/j.amepre.2007.07.026; Song AV, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.2285; Stanton WR, 2004, NICOTINE TOB RES, V6, P843, DOI 10.1080/14622200410001734076; Tucker JS, 2006, WOMEN HEALTH ISS, V16, P30, DOI 10.1016/j.whi.2005.08.004; TUKEY JW, 1962, ANN MATH STAT, V33, P1, DOI 10.1214/aoms/1177704711; Tukey JW, 1977, EXPLORATORY DATA ANA; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; Vijayaraghavan M, 2013, AM J PUBLIC HEALTH, V103, P2276, DOI 10.2105/AJPH.2013.301300; White HR, 2002, DRUG ALCOHOL DEPEN, V65, P167, DOI 10.1016/S0376-8716(01)00159-4	66	46	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171808	10.1371/journal.pone.0171808	http://dx.doi.org/10.1371/journal.pone.0171808			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182748	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800116
J	Liang, WC; Tian, X; Yuo, CY; Chen, WZ; Kan, TM; Su, YN; Nishino, I; Wong, LJC; Jong, YJ				Liang, Wen-Chen; Tian, Xia; Yuo, Chung-Yee; Chen, Wan-Zi; Kan, Tsu-Min; Su, Yi-Ning; Nishino, Ichizo; Wong, Lee-Jun C.; Jong, Yuh-Jyh			Comprehensive target capture/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in Taiwan	PLOS ONE			English	Article							WALKER-WARBURG SYNDROME; COLLAGEN VI MYOPATHIES; ALPHA-DYSTROGLYCAN; BETHLEM MYOPATHY; MUTATIONS CAUSE; MUSCLE; DEFICIENCY; PHENOTYPE; GLYCOSYLATION; SPECTRUM	Purpose Congenital muscular dystrophy (CMD) is a heterogeneous disease entity. The detailed clinical manifestation and causative gene for each subgroup of CMD are quite variable. This study aims to analyze the phenotypes and genotypes of Taiwanese patients with CMD as the epidemiology of CMD varies among populations and has been scantly described in Asia. Methods A total of 48 patients suspected to have CMD were screened and categorized by histochemistry and immunohistochemistry studies. Different genetic analyses, including next-generation sequencing (NGS), were selected, based on the clinical and pathological findings. Results We identified 17 patients with sarcolemma-specific collagen VI deficiency (SSCD), 6 patients with merosin deficiency, two with reduced alpha-dystroglycan staining, and two with striking lymphocyte infiltration in addition to dystrophic change on muscle pathology. Fourteen in 15 patients with SSCD, were shown to have COL6A1, COL6A2 or COL6A3 mutations by NGS analysis; all showed marked distal hyperlaxity and normal intelligence but the overall severity was less than in previously reported patients from other populations. All six patients with merosin deficiency had mutations in LAMA2. They showed relatively uniform phenotype that were compatible with previous studies, except for higher proportion of mental retardation with epilepsy. With reduced alpha-dystroglycan staining, one patient was found to carry mutations in POMT1 while another patient carried mutations in TRAPPC11. LMNA mutations were found in the two patients with inflammatory change on muscle pathology. They were clinically characterized by neck flexion limitation and early joint contracture, but no cardiac problem had developed yet. Conclusion Muscle pathology remains helpful in guiding further molecular analyses by direct sequencing of certain genes or by target capture/NGS as a second-tier diagnostic tool, and is crucial for establishing the genotype-phenotype correlation. We also determined the frequencies of the different types of CMD in our cohort which is important for the development of a specific care system for each disease.	[Liang, Wen-Chen; Kan, Tsu-Min; Jong, Yuh-Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Liang, Wen-Chen] Kaohsiung Med Univ, Coll Med, Dept Pediat Sch Med, Kaohsiung, Taiwan; [Tian, Xia; Wong, Lee-Jun C.] Baylor Genet, Houston, TX USA; [Tian, Xia; Wong, Lee-Jun C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX USA; [Yuo, Chung-Yee] Kaohsiung Med Univ, Coll Life Sci, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Chen, Wan-Zi] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Su, Yi-Ning] Sofiva Genom Co Ltd, Taipei, Taiwan; [Su, Yi-Ning] Dianthus Maternal Fetal Med Clin, Taipei, Taiwan; [Su, Yi-Ning] Taipei Med Univ, Coll Med, Sch Med, Dept Obstet & Gynecol, Taipei, Taiwan; [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan; [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Dept Genome Med Dev, Tokyo, Japan; [Jong, Yuh-Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Jong, Yuh-Jyh] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Jong, Yuh-Jyh] Natl Chiao Tung Univ, Coll Biol Sci & Technol, Dept Biol Sci & Technol, Hsinchu, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Baylor College of Medicine; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Medical University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Yang Ming Chiao Tung University	Jong, YJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan.; Jong, YJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan.; Jong, YJ (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan.; Jong, YJ (corresponding author), Natl Chiao Tung Univ, Coll Biol Sci & Technol, Dept Biol Sci & Technol, Hsinchu, Taiwan.	yjjong@gap.kmu.edu.tw	Nishino, Ichizo/G-2676-2010	Nishino, Ichizo/0000-0001-9452-112X; Jong, Yuh-Jyh/0000-0002-1735-1101				Ball S, 2003, J BIOL CHEM, V278, P15326, DOI 10.1074/jbc.M209977200; Bogershausen N, 2013, AM J HUM GENET, V93, P181, DOI 10.1016/j.ajhg.2013.05.028; Bonnemann CG, 2014, NEUROMUSCULAR DISORD, V24, P289, DOI 10.1016/j.nmd.2013.12.011; Brinas L, 2010, ANN NEUROL, V68, P511, DOI 10.1002/ana.22087; Butterfield RJ, 2013, HUM MUTAT, V34, P1558, DOI 10.1002/humu.22429; Buysse K, 2013, HUM MOL GENET, V22, P1746, DOI 10.1093/hmg/ddt021; Carboni Nicola, 2013, Acta Myol, V32, P7; Carss KJ, 2013, AM J HUM GENET, V93, P29, DOI 10.1016/j.ajhg.2013.05.009; CHU ML, 1988, J BIOL CHEM, V263, P18601; Clement EM, 2012, NEUROMUSCULAR DISORD, V22, P522, DOI 10.1016/j.nmd.2012.01.010; Collins J, 2012, NEUROLOGY, V79, P2158, DOI 10.1212/WNL.0b013e3182752ebc; Di Costanzo S, 2014, HUM MOL GENET, V23, P5781, DOI 10.1093/hmg/ddu296; Geranmayeh F, 2010, NEUROMUSCULAR DISORD, V20, P241, DOI 10.1016/j.nmd.2010.02.001; HAYASHI YK, 1995, MUSCLE NERVE, V18, P1027, DOI 10.1002/mus.880180918; Kaplan JC, 2014, NEUROMUSCULAR DISORD, V24, P1123, DOI 10.1016/j.nmd.2014.11.001; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Komaki H, 2011, NEUROMUSCULAR DISORD, V21, P563, DOI 10.1016/j.nmd.2011.04.010; Liang WC, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0056-4; Liang WC, 2013, NEUROMUSCULAR DISORD, V23, P675, DOI 10.1016/j.nmd.2013.05.010; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Matalonga L, HUM MUTAT; Mercuri E, 2005, NEUROMUSCULAR DISORD, V15, P303, DOI 10.1016/j.nmd.2005.01.004; Muntoni F, 2004, NEUROMUSCULAR DISORD, V14, P635, DOI 10.1016/j.nmd.2004.06.009; Muntoni F, 2011, CURR OPIN NEUROL, V24, P437, DOI 10.1097/WCO.0b013e32834a95e3; Nishikawa A, 2016, J MED GENET; Okada M, 2007, NEUROLOGY, V69, P1035, DOI 10.1212/01.wnl.0000271387.10404.4e; Pane M, 2012, NEUROMUSCULAR DISORD, V22, P685, DOI 10.1016/j.nmd.2012.05.006; Peat RA, 2008, NEUROLOGY, V71, P312, DOI 10.1212/01.wnl.0000284605.27654.5a; PHILPOT J, 1995, NEUROMUSCULAR DISORD, V5, P301, DOI 10.1016/0960-8966(94)00069-L; Qin L, 2016, J MOL DIAGN, V18, P446, DOI 10.1016/j.jmoldx.2016.01.002; Quijano-Roy S, 2008, ANN NEUROL, V64, P177, DOI 10.1002/ana.21417; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; Shaheen R, 2013, NEUROGENETICS, V14, P243, DOI 10.1007/s10048-013-0367-8; Su YN, 2005, HUM MUTAT, V25, P460, DOI 10.1002/humu.20160; Tian X, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000015; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Xiong H, 2015, CLIN GENET, V87, P233, DOI 10.1111/cge.12366; Yonekawa T, 2013, J NEUROL NEUROSUR PS, V84, P982, DOI 10.1136/jnnp-2012-304710; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951	39	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170517	10.1371/journal.pone.0170517	http://dx.doi.org/10.1371/journal.pone.0170517			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182637	gold, Green Published			2022-12-26	WOS:000394231800012
J	Shao, LY; Zhang, LJ; Zhen, Z				Shao, Liyang; Zhang, Lianjun; Zhen, Zhen			Interrupted time series analysis of children's blood lead levels: A case study of lead hazard control program in Syracuse, New York	PLOS ONE			English	Article							INTELLECTUAL IMPAIRMENT; EXPOSURE	Children's blood lead concentrations have been closely monitored over the last two decades in the United States. The bio-monitoring surveillance data collected in local agencies reflected the local temporal trends of children's blood lead levels (BLLs). However, the analysis and modeling of the long-term time series of BLLs have rarely been reported. We attempted to quantify the long-term trends of children's BLLs in the city of Syracuse, New York and evaluate the impacts of local lead poisoning prevention programs and Lead Hazard Control Program on reducing the children's BLLs. We applied interrupted time series analysis on the monthly time series of BLLs surveillance data and used ARMA (autoregressive and moving average) models to measure the average children's blood lead level shift and detect the seasonal pattern change. Our results showed that there were three intervention stages over the past 20 years to reduce children's BLLs in the city of Syracuse, NY. The average of children's BLLs was significantly decreased after the interventions, declining from 8.77 mu g/dL to 3.94 mu g/dL during1992 to 2011. The seasonal variation diminished over the past decade, but more short term influences were in the variation. The lead hazard control treatment intervention proved effective in reducing the children's blood lead levels in Syracuse, NY. Also, the reduction of the seasonal variation of children's BLLs reflected the impacts of the local lead-based paint mitigation program. The replacement of window and door was the major cost of lead house abatement. However, soil lead was not considered a major source of lead hazard in our analysis.	[Shao, Liyang; Zhang, Lianjun] SUNY Coll Environm Sci & Forestry, Dept Forest & Nat Resources Management, Syracuse, NY 13210 USA; [Zhen, Zhen] Northeast Forestry Univ, Sch Forestry, Harbin, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Northeast Forestry University - China	Zhen, Z (corresponding author), Northeast Forestry Univ, Sch Forestry, Harbin, Peoples R China.	zhzhen@syr.edu	Shao, Liyang/B-2921-2009	Shao, Liyang/0000-0003-1272-1959	National Natural Science Foundation of China [31400491]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by National Natural Science Foundation of China, Project "Three-dimensional individual tree crown delineation based on mutiple remotely sensed data sources and tree competition mechanism (31400491)".	Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P513; BOX GEP, 1975, J AM STAT ASSOC, V70, P70, DOI 10.2307/2285379; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Center for Disease Control and Prevention (CDC), 2013, CDC UPD GUID CHILDR; Dixon SL, 2012, ENVIRON RES, V113, P14, DOI 10.1016/j.envres.2012.01.005; Griffith DA, 1998, ANN ASSOC AM GEOGR, V88, P640, DOI 10.1111/0004-5608.00116; Haley Valerie B, 2004, BMC Pediatr, V4, P8, DOI 10.1186/1471-2431-4-8; HARTMANN DP, 1980, J APPL BEHAV ANAL, V13, P543, DOI 10.1901/jaba.1980.13-543; Johnston J., 1997, ECONOMETRICS METHODS, V4th ed.; Jones RL, 2009, PEDIATRICS, V123, pe376, DOI 10.1542/peds.2007-3608; Jusko TA, 2008, ENVIRON HEALTH PERSP, V116, P243, DOI 10.1289/ehp.10424; Koller K, 2004, ENVIRON HEALTH PERSP, V112, P987, DOI 10.1289/ehp.6941; Laidlaw MAS, 2005, ENVIRON HEALTH PERSP, V113, P793, DOI 10.1289/ehp.7759; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Liu L-M, 2006, TIME SERIES ANAL FOR; Meyer Pamela A, 2003, MMWR Surveill Summ, V52, P1; SAS Institute Inc, 2011, SAS 9 3 HELP DOC; Strauss W, 2005, ENVIRON RES, V99, P214, DOI 10.1016/j.envres.2005.02.005; Surkan PJ, 2007, NEUROTOXICOLOGY, V28, P1170, DOI 10.1016/j.neuro.2007.07.007; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Yiin LM, 2000, ENVIRON HEALTH PERSP, V108, P177, DOI 10.2307/3454518	21	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171778	10.1371/journal.pone.0171778	http://dx.doi.org/10.1371/journal.pone.0171778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182688	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800107
J	Yuan, Y; Sun, Z; Chen, Y; Zheng, YX; Xie, KL; He, Y; Wang, ZF; Wang, GL; Yu, YH				Yuan, Yuan; Sun, Zhe; Chen, Yi; Zheng, Yuxin; Xie, Ke-liang; He, Ying; Wang, Zhifen; Wang, Guo-lin; Yu, Yong-hao			Prevention of Remifentanil Induced Postoperative Hyperalgesia by Dexmedetomidine via Regulating the Trafficking and Function of Spinal NMDA Receptors as well as PKC and CaMKII Level In Vivo and In Vitro	PLOS ONE			English	Article							PROTEIN-KINASE-C; OPIOID-INDUCED HYPERALGESIA; D-ASPARTATE RECEPTOR; SYNAPTIC-TRANSMISSION; PAIN; RAT; CALCIUM/CALMODULIN; ACTIVATION; MECHANISMS; ANALGESIA	Remifentanil-induced secondary hyperalgesia has been demonstrated in both animal experiments and clinical trials. Enhancement of N-methyl-D-aspartate (NMDA) receptor trafficking as well as protein kinase C (PKC) and calmodulin- dependent protein kinase II (CaMKII) have been reported to be involved in the induction and maintenance of central sensitization. In the current study, it was demonstrated that dexmedetomidine could prevent remifentanilinduced hyperalgesia (RIH) via regulating spinal NMDAR-PKC-Ca2+/CaMKII pathway in vivo and in vitro. We firstly investigated the effect of dexmedetomidine, a highly selective a2-adrenergic receptor agonist, on mechanical and thermal hyperalgesia using a rat model of RIH. NMDA receptor subunits (NR1, NR2A and NR2B) expression and membrane trafficking as well as PKC and CaMKII expression in spinal cord L4-L5 segments were measured by Western blot analysis. The expression of NMDA receptor subunits (NR1, NR2A and NR2B) were also detected by immunohistochemistry. Further more, the effect of dexmedetomidine on NMDA receptor current amplitude and frequency in spinal cord slices were investigated by whole-cell patch-clamp recording. We found that remifentail infusion at 1.2 mu g. kg(-1). min(-1) for 90 min caused mechanical and thermal hyperalgesia, up-regulated NMDA receptor subunits NR1 and NR2B expression in both membrane fraction and total lysate as well as increased PKC and CaMKII expression in spinal cord dorsal horn. Subcutaneously injection of dexmedetomidine at the dose of 50 mu g/kg at 30 min before plantar incision significantly attenuated remifentanil-induced mechanical and thermal hyperalgesia from 2 h to 48 h after infusion, and this was associated with reversal of up-regulated NR1 and NR2B subunits in both membrane fraction and total lysate as well as increased PKC and CaMKII expression in spinal cord dorsal horn. Furthermore, remifentanil incubation increased amplitude and frequency of NMDA receptor-induced current in dorsal horn neurons, which was dose-dependently attenuated by dexmedetomidine. These results suggest that dexmedetomidine can significantly ameliorate RIH via modulating the expression, membrane trafficking and function of NMDA receptors as well as PKC and CaMKII level in spinal dorsal horn, which present useful insights into the mechanistic action of dexmedetomidine as a potential anti-hyperalgesic agents for treating RIH. increased amplitude and frequency of NMDA receptor-induced current in dorsal horn neurons, which was dose-dependently attenuated by dexmedetomidine. These results suggest that dexmedetomidine can significantly ameliorate RIH via modulating the expression, membrane trafficking and function of NMDA receptors as well as PKC and CaMKII level in spinal dorsal horn, which present useful insights into the mechanistic action of dexmedetomidine as a potential anti-hyperalgesic agents for treating RIH.	[Yuan, Yuan; Sun, Zhe; Chen, Yi; Zheng, Yuxin; Xie, Ke-liang; He, Ying; Wang, Zhifen; Wang, Guo-lin; Yu, Yong-hao] Tianjin Med Univ, Gen Hosp, Dept Anesthesiol, Tianjin, Peoples R China; [Yuan, Yuan; Sun, Zhe; Chen, Yi; Zheng, Yuxin; Xie, Ke-liang; He, Ying; Wang, Zhifen; Wang, Guo-lin; Yu, Yong-hao] Tianjin Res Inst Anesthesiol, Tianjin, Peoples R China	Tianjin Medical University	Yu, YH (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Anesthesiol, Tianjin, Peoples R China.; Yu, YH (corresponding author), Tianjin Res Inst Anesthesiol, Tianjin, Peoples R China.	family2480@126.com			National Natural Science Foundation of China [81300960]; Application foundation and advanced technology research program of Tianjin [14JCQNJC12800]; science foundation of Tianjin Health Bureau [2012KZ102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Application foundation and advanced technology research program of Tianjin; science foundation of Tianjin Health Bureau	National Natural Science Foundation of China (81300960), Yuan Yuan; Application foundation and advanced technology research program of Tianjin (14JCQNJC12800), Yuan Yuan; The science foundation of Tianjin Health Bureau (2012KZ102), Yi Chen. 2. Yuan Yuan : This author helped design the study, analyze the data, and write the manuscript; Yi Chen : This author helped design the study and analyze the data.	Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Banks MI, 1999, ANESTHESIOLOGY, V90, P120, DOI 10.1097/00000542-199901000-00018; Belgrade M, 2010, PAIN MED, V11, P1819, DOI 10.1111/j.1526-4637.2010.00973.x; Bongha H, 2014, KOREAN J ANESTHESIOL, V66, P39, DOI [10.4097/kjae.2014.66.1.39, DOI 10.4097/KJAE.2014.66.1.39]; Brennan Timothy J, 2005, Anesthesiol Clin North Am, V23, P1, DOI 10.1016/j.atc.2004.11.009; Bruggemann I, 2000, MOL BRAIN RES, V85, P239, DOI 10.1016/S0169-328X(00)00265-5; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Chen Y, 2010, J NEUROSCI, V30, P38, DOI 10.1523/JNEUROSCI.4346-09.2010; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Evelyne C, 2004, NEUROPHARMACOLOGY, V46, P264; Faber ESL, 1998, BRIT J PHARMACOL, V124, P507, DOI 10.1038/sj.bjp.0701873; Ferreira J, 2005, PAIN, V117, P171, DOI 10.1016/j.pain.2005.06.001; Gu XP, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-76; Guo H, 2001, J PHYSIOL-LONDON, V537, P115, DOI 10.1111/j.1469-7793.2001.0115k.x; Hahnenkamp K, 2006, BRIT J ANAESTH, V96, P77, DOI 10.1093/bja/aei271; Harald L, 2011, PAIN, V152, P1289, DOI [10.1016/j.pain.2011.02.007, DOI 10.1016/J.PAIN.2011.02.007]; Huang KP, 2004, J NEUROSCI, V24, P10660, DOI 10.1523/JNEUROSCI.2213-04.2004; Hughes AS, 2008, NEUROSCIENCE, V153, P507, DOI 10.1016/j.neuroscience.2008.01.082; Hwang W, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0004-1; Diez-Guerra FJ, 2010, IUBMB LIFE, V62, P597, DOI 10.1002/iub.357; Joly V, 2005, ANESTHESIOLOGY, V103, P147, DOI 10.1097/00000542-200507000-00022; Koppert W, 2007, BEST PRACT RES-CLIN, V21, P65, DOI 10.1016/j.bpa.2006.12.004; Lee M, 2011, PAIN PHYSICIAN, V14, P145; Lei T, 2007, BRAIN RES, V1143, P78, DOI [10.1016/j.brainres.2007.01.058, DOI 10.1016/J.BRAINRES.2007.01.058]; Li YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077790; Liao GY, 2001, MOL PHARMACOL, V59, P960, DOI 10.1124/mol.59.5.960; Liao GY, 2000, J NEUROCHEM, V75, P282, DOI 10.1046/j.1471-4159.2000.0750282.x; Lin TF, 2009, BRIT J ANAESTH, V102, P117, DOI 10.1093/bja/aen320; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Malcangio M, 1998, BRIT J PHARMACOL, V125, P1625, DOI 10.1038/sj.bjp.0702260; Mayer DJ, 1999, P NATL ACAD SCI USA, V96, P7731, DOI 10.1073/pnas.96.14.7731; McQueen-Shadfar LA, 2011, CURR MED RES OPIN, V27, P2091, DOI 10.1185/03007995.2011.618491; Patel A, 2010, ANESTH ANALG, V111, P1004, DOI 10.1213/ANE.0b013e3181ee82fa; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Tian YT, 2010, NEUROSCI RES, V68, P167, DOI 10.1016/j.neures.2010.07.2030; Tufanogullari B, 2008, ANESTH ANALG, V106, P1741, DOI 10.1213/ane.0b013e318172c47c; Velazquez KT, 2007, PHARMACOL RES, V55, P578, DOI 10.1016/j.phrs.2007.04.006; Wang CY, 2015, BRAIN RES BULL, V110, P30, DOI 10.1016/j.brainresbull.2014.12.001; Yang QA, 2011, BRAIN RES BULL, V84, P137, DOI 10.1016/j.brainresbull.2010.12.009; Yuan Y, 2013, ANESTH ANALG, V116, P473, DOI 10.1213/ANE.0b013e318274e3f1	40	18	21	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171348	10.1371/journal.pone.0171348	http://dx.doi.org/10.1371/journal.pone.0171348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182698	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800056
J	Xu, K; Kuntz, LA; Foehr, P; Kuempel, K; Wagner, A; Tuebel, J; Deimling, CV; Burgkart, RH				Xu, Kai; Kuntz, Lara A.; Foehr, Peter; Kuempel, Katharina; Wagner, Alexandra; Tuebel, Jutta; Deimling, Constantin V.; Burgkart, Rainer H.			Efficient decellularization for tissue engineering of the tendon-bone interface with preservation of biomechanics	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX SCAFFOLDS; EXTRACTION TECHNIQUES; ATTACHMENT SITES; PATELLAR TENDON; RAT MODEL; ENTHESES; REPAIR; RECONSTRUCTION; REGENERATION	Interfaces between tendon/ligament and bone ("entheses") are highly specialized tissues that allow for stress transfer between mechanically dissimilar materials. Entheses show very low regenerative capacity resulting in high incidences of failure after surgical repair. Tissue engineering is a promising approach to recover functionality of entheses. Here, we established a protocol to decellularize porcine entheses as scaffolds for enthesis tissue engineering. Chemical detergents as well as physical treatments were investigated with regard to their efficiency to decellularize 2 mm thick porcine Achilles tendon entheses. A two-phase approach was employed: study 1 investigated the effect of various concentrations of sodium dodecyl sulfate (SDS) and t-octylphenoxypolyethoxy-ethanol (Triton X-100) as decellularization agents. The most efficient combination of SDS and Triton was then carried forward into study 2, where different physical methods, including freeze-thaw cycles, ultrasound, perfusion, and hydrostatic washing were used to enhance the decellularization effect. Cell counts, DNA quantification, and histology showed that washing with 0.5% SDS + 1% Triton X-100 for 72 h at room temperature could remove similar to 98% cells from the interface. Further investigation of physical methods proved that washing under 200 mmHg hydrostatic pressure shortened the detergent exposing time from 72 h to 48 h. Biomechanical tensile testing showed that the biomechanical features of treated samples were preserved. Washing under 200 mmHg hydrostatic pressure with 0.5% SDS + 1% Triton X-100 for 48 h efficiently decellularized entheses with preservation of matrix structure and biomechanical features. This protocol can be used to efficiently decellularize entheses as scaffolds for tissue engineering.	[Xu, Kai; Kuntz, Lara A.; Foehr, Peter; Kuempel, Katharina; Wagner, Alexandra; Tuebel, Jutta; Deimling, Constantin V.; Burgkart, Rainer H.] Tech Univ Munich, Dept Orthopaed & Sportsorthopaed, Klinikum Rechts Isar, Munich, Germany; [Xu, Kai] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Orthoped, Wuhan, Peoples R China	Technical University of Munich; Huazhong University of Science & Technology	Kuntz, LA; Burgkart, RH (corresponding author), Tech Univ Munich, Dept Orthopaed & Sportsorthopaed, Klinikum Rechts Isar, Munich, Germany.	kuntz@tum.de; burgkart@tum.de		Foehr, Peter/0000-0003-1042-546X; Tuebel, Jutta/0000-0001-5033-2191	International Graduate School of Science and Engineering; German Research Foundation (DFG); Technical University of Munich (TUM) in the framework of the Open Access Publishing Program	International Graduate School of Science and Engineering; German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM) in the framework of the Open Access Publishing Program	Research was supported by the International Graduate School of Science and Engineering. This work was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research was supported by the International Graduate School of Science and Engineering. The authors acknowledge the continuous support of the German Research Foundation (DFG). This work was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. Further, the authors thank Carmen Marthen for support with histological analyses and the Chinese oversea training foundation, Prof. Anmin Chen and Prof. Feng Li for support of Dr. Kai Xu.	Angeline ME, 2012, CLIN SPORT MED, V31, P645, DOI 10.1016/j.csm.2012.07.003; ARNOCZKY SP, 1982, J BONE JOINT SURG AM, V64, P217, DOI 10.2106/00004623-198264020-00011; Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Bedi A, 2012, J SHOULDER ELB SURG, V21, P218, DOI 10.1016/j.jse.2011.09.020; Benjamin M, 2006, J ANAT, V208, P471, DOI 10.1111/j.1469-7580.2006.00540.x; Benjamin M, 2002, COMP BIOCHEM PHYS A, V133, P931, DOI 10.1016/S1095-6433(02)00138-1; Benjamin M, 2009, SCAND J MED SCI SPOR, V19, P520, DOI 10.1111/j.1600-0838.2009.00906.x; BISSELL DM, 1986, EUR J CELL BIOL, V40, P72; Bronstein JA, 2013, PLAST RECONSTR SURG, V132, P94, DOI 10.1097/PRS.0b013e318290f5fc; Burgkart R, 2014, TISSUE ENG PART C-ME, V20, P553, DOI [10.1089/ten.tec.2013.0270, 10.1089/ten.TEC.2013.0270]; Burk J, 2014, TISSUE ENG PART C-ME, V20, P276, DOI [10.1089/ten.tec.2012.0760, 10.1089/ten.TEC.2012.0760]; Cartmell JS, 2004, TISSUE ENG, V10, P1065, DOI 10.1089/1076327041887682; Chan LKY, 2013, ACTA BIOMATER, V9, P5262, DOI 10.1016/j.actbio.2012.09.005; Chen KL, 2016, J TISSUE ENG REGEN M, V10, P294, DOI 10.1002/term.1716; Cheng CW, 2014, BIOTECHNOL ADV, V32, P462, DOI 10.1016/j.biotechadv.2013.12.012; Dohmen PM, 2011, ANN THORAC SURG, V92, P1308, DOI 10.1016/j.athoracsur.2011.06.009; Dong SW, 2009, BIOSCI BIOTECH BIOCH, V73, P2226, DOI 10.1271/bbb.90329; Dong XC, 2009, J MATER SCI-MATER M, V20, P2327, DOI 10.1007/s10856-009-3791-4; Du LQ, 2011, ARTIF ORGANS, V35, P691, DOI 10.1111/j.1525-1594.2010.01174.x; Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050; Fan Heng-hua, 2005, Zhonghua Wai Ke Za Zhi, V43, P870; Ghanavi P, 2012, CELL TISSUE RES, V347, P643, DOI 10.1007/s00441-012-1323-x; Gilbert TW, 2012, J CELL BIOCHEM, V113, P2217, DOI 10.1002/jcb.24130; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078; Gulotta LV, 2011, AM J SPORT MED, V39, P1282, DOI 10.1177/0363546510395485; Gulotta LV, 2009, AM J SPORT MED, V37, P2126, DOI 10.1177/0363546509339582; Guo LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144240; Hjorthaug GA, 2015, J ORTHOP RES, V33, P216, DOI 10.1002/jor.22756; Ingavle GC, 2013, TISSUE ENG PT A, V19, P1349, DOI [10.1089/ten.tea.2012.0160, 10.1089/ten.TEA.2012.0160]; Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171; Kutten JC, 2015, TISSUE ENG PT A, V21, P75, DOI [10.1089/ten.tea.2014.0089, 10.1089/ten.TEA.2014.0089]; LIVESEY SA, 1995, TRANSPLANTATION, V60, P1, DOI 10.1097/00007890-199507150-00001; Lu HH, 2013, ANNU REV BIOMED ENG, V15, P201, DOI 10.1146/annurev-bioeng-071910-124656; Lu HX, 2011, BIOMATERIALS, V32, P9658, DOI 10.1016/j.biomaterials.2011.08.091; Macfelda K, 2007, ARTIF ORGANS, V31, P4, DOI 10.1111/j.1525-1594.2007.00334.x; Mohan N, 2014, BIOTECHNOL BIOENG, V111, P829, DOI 10.1002/bit.25145; Oguma H, 2001, J ORTHOP RES, V19, P873, DOI 10.1016/S0736-0266(01)00021-3; Ohtera K, 2000, CRIT REV BIOMED ENG, V28, P115, DOI 10.1615/CritRevBiomedEng.v28.i12.190; Paxton J.Z., 2012, ORTHOPEDIC MUSCUL S, VS1; Paxton JZ, 2009, TISSUE ENG PT A, V15, P1201, DOI 10.1089/ten.tea.2008.0105; Phillips JE, 2008, P NATL ACAD SCI USA, V105, P12170, DOI 10.1073/pnas.0B019BB105; Saccomanni Bernardino, 2011, Musculoskelet Surg, V95, P183, DOI 10.1007/s12306-011-0137-4; Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]; Sellaro TL, 2007, TISSUE ENG, V13, P2301, DOI 10.1089/ten.2006.0437; Spalazzi JP, 2008, J BIOMED MATER RES A, V86A, P1, DOI 10.1002/jbm.a.32073; Spalazzi Jeffrey P, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P525; Stapleton TW, 2011, TISSUE ENG PT A, V17, P231, DOI [10.1089/ten.tea.2009.0807, 10.1089/ten.TEA.2009.0807]; Sun XH, 2009, CELL MOL NEUROBIOL, V29, P347, DOI 10.1007/s10571-008-9326-6; Sutherland AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121966; Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0; Wang INE, 2007, J ORTHOP RES, V25, P1609, DOI 10.1002/jor.20475; Weeks Kenneth D 3rd, 2014, Instr Course Lect, V63, P443; Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066; Wu LC, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0118-z; Xing SX, 2014, EXP THER MED, V8, P628, DOI 10.3892/etm.2014.1742; Xu HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086723; Xu Y, 2015, J BIOMED MATER RES B, V103, P670, DOI 10.1002/jbm.b.33231; Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037; Zhang YY, 2009, BIOMATERIALS, V30, P4021, DOI 10.1016/j.biomaterials.2009.04.005	60	33	33	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171577	10.1371/journal.pone.0171577	http://dx.doi.org/10.1371/journal.pone.0171577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170430	Green Published, Green Submitted, gold			2022-12-26	WOS:000393705500044
J	Al-Kindi, KM; Kwan, P; Andrew, NR; Welch, M				Al-Kindi, Khalifa M.; Kwan, Paul; Andrew, Nigel R.; Welch, Mitchell			Impacts of human-related practices on Ommatissus lybicus infestations of date palm in Oman	PLOS ONE			English	Article							DUBAS BUG	Date palm cultivation is economically important in the Sultanate of Oman, with significant financial investments coming from both the government and private individuals. However, a widespread Dubas bug (DB) (Ommatissus lybicus Bergevin) infestation has impacted regions including the Middle East, North Africa, Southeast Russia, and Spain, resulting in widespread damages to date palms. In this study, techniques in spatial statistics including ordinary least squares (OLS), geographically weighted regression (GRW), and exploratory regression (ER) were applied to (a) model the correlation between DB infestations and human-related practices that include irrigation methods, row spacing, palm tree density, and management of undercover and intercropped vegetation, and (b) predict the locations of future DB infestations in northern Oman. Firstly, we extracted row spacing and palm tree density information from remote sensed satellite images. Secondly, we collected data on irrigation practices and management by using a simple questionnaire, augmented with spatial data. Thirdly, we conducted our statistical analyses using all possible combinations of values over a given set of candidate variables using the chosen predictive modelling and regression techniques. Lastly, we identified the combination of human-related practices that are most conducive to the survival and spread of DB. Our results show that there was a strong correlation between DB infestations and several human-related practices parameters (R-2 = 0.70). Variables including palm tree density, spacing between trees (less than 5 x 5 m), insecticide application, date palm and farm service (pruning, dethroning, remove weeds, and thinning), irrigation systems, offshoots removal, fertilisation and labour (non-educated) issues, were all found to significantly influence the degree of DB infestations. This study is expected to help reduce the extent and cost of aerial and ground sprayings, while facilitating the allocation of date palm plantations. An integrated pest management (IPM) system monitoring DB infestations, driven by GIS and remote sensed data collections and spatial statistical models, will allow for an effective DB management program in Oman. This will in turn ensure the competitiveness of Oman in the global date fruits market and help preserve national yields.	[Al-Kindi, Khalifa M.; Kwan, Paul; Welch, Mitchell] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Andrew, Nigel R.] Univ New England, Zool, Ctr Behav & Physiol Ecol, Armidale, NSW, Australia	University of New England; University of New England	Al-Kindi, KM (corresponding author), Univ New England, Sch Sci & Technol, Armidale, NSW, Australia.	kalkindi@myune.edu.au	Andrew, Nigel/B-7162-2008; Alkindi, Khalifa/AAK-4998-2020	Andrew, Nigel/0000-0002-2850-2307; Welch, Mitchell/0000-0003-4220-8734; Kwan, Paul Wing Hing/0000-0002-4959-5274				ABDULLAH S.K, 2010, BASRAH J DATE PALM R, V9, P40; AI-Khatri S. A., 2004, P DAT PALM REG WORKS, P84; Al Sarai Al Alawi M, 2015, STUDIES CONTROL DUBA; Al-Farsi M, 2007, FOOD CHEM, V104, P943, DOI 10.1016/j.foodchem.2006.12.051; Al-Kharusi LM, 2009, INT J AGRIC BIOL, V11, P290; Al-Kindi K, 2016, REV ANAL TECHN UNPUB; Al-Kindi K, 2016, IMPACT ENV VAR UNPUB; Al-Kindi KM, 2017, CROP PROT, V93, P113, DOI 10.1016/j.cropro.2016.11.033; Al-Marshudi A. S., 2002, Tropicultura, V20, P203; Al-Rumaihi M, 1975, J GULF ARABIAN PENIN, V1; Al-Samarrie AI, 2011, AGRIC BIOL JN AM, V12, P1416; Al-Yahyai R., 2015, DATE PALM GENETIC RE, P207, DOI [10.1007/978-94-017-9707-8_6, DOI 10.1007/978-94-017-9707-8_6]; Al-Yahyai R, 2008, AFR J AGR RES, V3, P389; Al-Zadjali T. S., 2006, Egyptian Journal of Agricultural Research, V84, P51; Ali A-S, 2010, FUTURE VISIONS INFLU, P929; Ali HG, 2010, DEV DATE PALM CULTIV, P29; [Anonymous], 2016, OUTLOOKS PEST MANAG; Carlson TN, 1997, REMOTE SENS ENVIRON, V62, P241, DOI 10.1016/S0034-4257(97)00104-1; El-Hadrami A., 2012, Emirates Journal of Food and Agriculture, V24, P371; El-Shafie HAF, 2015, SUST PLANT CROP PRO, P169, DOI 10.1007/978-3-319-24397-9_7; Elwan A. S. A., 1999, Egyptian Journal of Agricultural Research, V77, P1547; Hill D, 1990, PEST DIS TROPICAL CR, V2; Howard F. W., 2001, Pesticide Outlook, V12, P240, DOI 10.1039/b110547g; Hunter-Jones P. J. T, 1972, AGR OMAN CTR OVERS P; HUSSAIN A. A., 1963, Bulletin of Entomological Research, V53, P737, DOI 10.1017/S0007485300048458; Jasim H, 2010, EGGS DISTRIBUTION OL, P465; Johnson G, 1996, PRECIS AGRIC, P589; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Khalaf M. Z., 2015, J ENTOMOL RES, V3, P9; Khan A, 2001, P 2 INT C DAT PALMS, P211; KLEIN M, 1985, PHYTOPARASITICA, V13, P95, DOI 10.1007/BF02980886; Liao D, 2012, SURV METHODOL, V38, P53; Lyon JD, 1996, J ROY STAT SOC D-STA, V45, P337; Mahmoudi M, 2015, J AGR SCI TECH-IRAN, V17, P263; Manickavasagan A, 2012, OVERVIEW DATE PALM P, P3; Mokhtar AM, 2010, EUR J ENTOMOL, V107, P681, DOI 10.14411/eje.2010.076; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Robertson C, 2008, FOREST ECOL MANAG, V256, P900, DOI 10.1016/j.foreco.2008.05.054; Rosenshein L., 2011, EXPLORATORY REGRESSI, V1; Shah A, 2013, J INSECT BEHAV, V26, P371, DOI 10.1007/s10905-012-9354-4; STINE RA, 1995, AM STAT, V49, P53, DOI 10.2307/2684812; Thacker JRM, 2003, BCPC INTERNATIONAL CONGRESS CROP SCIENCE & TECHNOLOGY 2003, VOL 1 AND 2, CONGRESS PROCEEDINGS, P987; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; Wang Q, 2005, GLOBAL ECOL BIOGEOGR, V14, P379, DOI 10.1111/j.1466-822x.2005.00153.x; Wheeler D., 2005, J GEOGRAPHICAL SYSTE, V7, P161, DOI [DOI 10.1007/S10109-005-0155-6, 10.1007/s10109-005-0155-6]	45	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171103	10.1371/journal.pone.0171103	http://dx.doi.org/10.1371/journal.pone.0171103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166300	gold, Green Published, Green Submitted			2022-12-26	WOS:000393700100023
J	d'Almeida, TC; Sadissou, I; Milet, J; Cottrell, G; Mondiere, A; Avokpaho, E; Gineau, L; Sabbagh, A; Massougbodji, A; Moutairou, K; Donadi, EA; Favier, B; Carosella, E; Moreau, P; Rouas-Freiss, N; Courtin, D; Garcia, A				d'Almeida, Tania C.; Sadissou, Ibrahim; Milet, Jacqueline; Cottrell, Gilles; Mondiere, Amandine; Avokpaho, Euripide; Gineau, Laure; Sabbagh, Audrey; Massougbodji, Achille; Moutairou, Kabirou; Donadi, Eduardo A.; Favier, Benoit; Carosella, Edgardo; Moreau, Philippe; Rouas-Freiss, Nathalie; Courtin, David; Garcia, Andre			Soluble human leukocyte antigen -G during pregnancy and infancy in Benin: Mother/child resemblance and association with the risk of malaria infection and low birth weight	PLOS ONE			English	Article							HLA-G; PLASMODIUM-FALCIPARUM; PLACENTAL MALARIA; MATERNAL BLOOD; G MOLECULES; IN-VITRO; RECEPTOR; CELLS; PROGRESSION; INHIBITION	Human leukocyte antigen (HLA) G is a tolerogenic molecule involved in the maternal-fetal immune tolerance phenomenon. Its expression during some infectious diseases leading to immune evasion has been established. A first study conducted in Benin has shown that the production of soluble HLA-G (sHLA-G) during the first months of life is strongly correlated with the maternal level at delivery and associated with low birth weight and malaria. However sHLA-G measurements during pregnancy were not available for mothers and furthermore, to date the evolution of sHLA-G in pregnancy is not documented in African populations. To extend these previous findings, between January 2010 and June 2013, 400 pregnant women of a malaria preventive trial and their newborns were followed up in Benin until the age of 2 years. Soluble HLA-G was measured 3 times during pregnancy and repeatedly during the 2 years follow-up to explore how sHLA-G evolved and the factors associated. During pregnancy, plasma levels of sHLA-G remained stable and increased significantly at delivery (p<0.001). Multigravid women seemed to have the highest levels (p = 0.039). In infants, the level was highest in cord blood and decreased before stabilizing after 18 months (p<0.001). For children, a high level of sHLA-G was associated with malaria infection during the follow-up (p = 0.02) and low birth weight (p = 0.06). The mean level of sHLA-G during infancy was strongly correlated with the mother's level during pregnancy (<0.001), and not only at delivery. Moreover, mothers with placental malaria infection had a higher probability of giving birth to a child with a high level of sHLA-g (p = 0.006). High sHLA-G levels during pregnancy might be associated with immune tolerance related to placental malaria. Further studies are needed but this study provides a first insight concerning the potential role of sHLA-G as a biomarker of weakness for newborns and infants.	[d'Almeida, Tania C.; Garcia, Andre] Univ Paris 06, Paris, France; [d'Almeida, Tania C.; Sadissou, Ibrahim; Milet, Jacqueline; Cottrell, Gilles; Gineau, Laure; Sabbagh, Audrey; Courtin, David; Garcia, Andre] Univ Paris 05, Sorbonne Paris Cite, Inst Rech Dev, Fac Pharm,UMR MERIT 216, Paris, France; [Sadissou, Ibrahim; Garcia, Andre] Fac Sci Sante, Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin; [Sadissou, Ibrahim; Massougbodji, Achille; Moutairou, Kabirou] Univ Abomey Calavi, Cotonou, Benin; [Sadissou, Ibrahim] Univ Sao Paulo, Sch Med Ribeirao Preto, Div Clin Immunol, BR-05508 Sao Paulo, Brazil; [Milet, Jacqueline; Cottrell, Gilles; Courtin, David] Univ Paris 05, Sorbonne Paris Cite, Paris, Benin; [Mondiere, Amandine] ISBA, Campus Fac Sci Sante FSS, UMR MERIT 216, Inst Rech Dev, Cotonou, Benin; [Avokpaho, Euripide] Ecole Pasteur, CNAM Sante Publ, Paris, France; [Favier, Benoit; Carosella, Edgardo; Moreau, Philippe; Rouas-Freiss, Nathalie] Hop St Louis, IUH, SRHI, IMETI,CEA, Paris, France; [Favier, Benoit; Carosella, Edgardo; Moreau, Philippe; Rouas-Freiss, Nathalie] Univ Paris Diderot, Sorbonne Paris Cite, Hop St Louis, UMR E5,IUH, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi; Universidade de Sao Paulo; Institut de Recherche pour le Developpement (IRD); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; CEA; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	d'Almeida, TC (corresponding author), Univ Paris 06, Paris, France.; d'Almeida, TC (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Inst Rech Dev, Fac Pharm,UMR MERIT 216, Paris, France.	carennedalmeida@gmail.com	donadi, eduardo A/H-7080-2013; Sadissou, IBRAHIM/AAT-2692-2020; Garcia, Andre/ABA-1820-2020; Gineau, Laure/G-2446-2016; courtin, david/A-1584-2017; FAVIER, Benoit/W-7379-2019; Garcia, Andre/S-2959-2016	donadi, eduardo A/0000-0002-9457-9601; Sadissou, IBRAHIM/0000-0001-7300-3753; Garcia, Andre/0000-0002-1808-472X; courtin, david/0000-0002-5263-4430; Garcia, Andre/0000-0002-1808-472X; Cottrell, Gilles/0000-0002-7964-8963; SABBAGH, Audrey/0000-0003-0283-8803; Gineau, Laure/0000-0002-3863-1671; MILET, Jacqueline/0000-0003-2710-1517; Moreau, Philippe/0000-0002-2868-7401	Agence Nationale de la Recherche (ANR) [project 2006/040/001]; Programa Cienca sem Fronteiras Pesquisador Visitante Especial [406594/2013-9]; iDEX Sorbonne Paris Cite mobilite internationale Bresil; Fondation pour la Recherche Medicale [FDM20130727043]; Institut de Recherche pour le Developpement (IRD); European Developing Countries Clinical Trials Partnership (EDCTP) the Malaria in Pregnancy Consortium [IP.2007.31080.002]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Programa Cienca sem Fronteiras Pesquisador Visitante Especial; iDEX Sorbonne Paris Cite mobilite internationale Bresil; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut de Recherche pour le Developpement (IRD); European Developing Countries Clinical Trials Partnership (EDCTP) the Malaria in Pregnancy Consortium	This study was supported by the Agence Nationale de la Recherche (ANR) (project 2006/ 040/001), Programa Cienca sem Fronteiras << Pesquisador Visitante Especial >> (grant 406594/2013-9) and iDEX Sorbonne Paris Cite << mobilite internationale Bresil 2015 >>. Tania C d'Almeida was partly supported by grants from << Fondation pour la Recherche Medicale >> (Grant FDM20130727043) and by Institut de Recherche pour le Developpement (IRD). The clinical trial in which the study was nested was funded by the European Developing Countries Clinical Trials Partnership (EDCTP; IP.2007.31080.002), the Malaria in Pregnancy Consortium.	Alegre E, 2007, HUM IMMUNOL, V68, P661, DOI 10.1016/j.humimm.2007.04.007; AMEMIYA T, 1973, ECONOMETRICA, V41, P997, DOI 10.2307/1914031; Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331; Baudhuin J, 2013, P NATL ACAD SCI USA, V110, P17957, DOI 10.1073/pnas.1221535110; Baudhuin J, 2012, EUR J IMMUNOL, V42, P700, DOI 10.1002/eji.201141930; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Buzzi M, 2012, HUM IMMUNOL, V73, P150, DOI 10.1016/j.humimm.2011.12.003; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Carosella ED, 2015, ADV IMMUNOL, V127, P33, DOI 10.1016/bs.ai.2015.04.001; Carosella ED, 2011, CELL MOL LIFE SCI, V68, P353, DOI 10.1007/s00018-010-0579-0; Celsi F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/693643; d'Almeida T. C., 2016, Malaria Journal, V15; Dahl M, 2015, HUM IMMUNOL, V76, P260, DOI 10.1016/j.humimm.2015.01.015; Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7; Favier B, 2016, IMMUNOL REV, V273, P140, DOI 10.1111/imr.12457; Gineau L, 2015, GENES IMMUN, V16, P57, DOI 10.1038/gene.2014.63; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; He Y, 2015, J PERINAT MED; He YD, 2016, J PERINAT MED, V44, P283, DOI 10.1515/jpm-2015-0062; Hunt JS, 2000, AM J OBSTET GYNECOL, V183, P682, DOI 10.1067/mob.2000.106762; Klitkou L, 2015, HUM IMMUNOL, V76, P254, DOI 10.1016/j.humimm.2015.01.013; Knafel A, 2009, NEUROENDOCRINOL LETT, V30, P67; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Lesport E, 2009, HUM IMMUNOL, V70, P1000, DOI 10.1016/j.humimm.2009.07.019; Martelli-Palomino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071742; McCulloch CE, 2003, C BOARD MATH SCI NAT, Vviii; Menier C, 2003, HUM IMMUNOL, V64, P315, DOI 10.1016/S0198-8859(02)00821-2; Moreau P, 1998, AM J REPROD IMMUNOL, V40, P136; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Naji A, 2014, J IMMUNOL, V192, P1536, DOI 10.4049/jimmunol.1300438; Ntuli Sam Thembelihle, 2013, Glob J Health Sci, V5, P95, DOI 10.5539/gjhs.v5n3p95; Ouedraogo S, 2013, AM J TROP MED HYG, V88, P292, DOI 10.4269/ajtmh.12-0195; Porto IOP, 2015, MOL IMMUNOL, V65, P230, DOI 10.1016/j.molimm.2015.01.030; Rachas A, 2012, CLIN INFECT DIS, V55, P672, DOI 10.1093/cid/cis490; Rajagopalan S, 2006, PLOS BIOL, V4, P70, DOI 10.1371/journal.pbio.0040009; Rajagopalan S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00258; Rebmann V, 2005, HUM IMMUNOL, V66, P853, DOI 10.1016/j.humimm.2005.05.003; Rebmann V, 2007, HUM IMMUNOL, V68, P251, DOI 10.1016/j.humimm.2006.11.003; Ristich V, 2005, EUR J IMMUNOL, V35, P1133, DOI 10.1002/eji.200425741; Rizzo R, 2007, J REPROD IMMUNOL, V74, P133, DOI 10.1016/j.jri.2007.02.005; Rizzo R, 2009, AM J REPROD IMMUNOL, V61, P368, DOI 10.1111/j.1600-0897.2009.00703.x; Sadissou I, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-312; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tilburgs T, 2015, P NATL ACAD SCI USA, V112, P13312, DOI 10.1073/pnas.1517724112; Wang W, 2015, STAT METHODS MED RES; Weng PJ, 2011, HUM IMMUNOL, V72, P406, DOI 10.1016/j.humimm.2011.02.008; Yie SM, 2005, AM J OBSTET GYNECOL, V193, P204, DOI 10.1016/j.ajog.2004.11.062	50	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171117	10.1371/journal.pone.0171117	http://dx.doi.org/10.1371/journal.pone.0171117			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166246	Green Published, gold			2022-12-26	WOS:000393700100024
J	Koutroumani, M; Papadopoulos, GE; Vlassi, M; Nikolakaki, E; Giannakouros, T				Koutroumani, Maria; Papadopoulos, Georgios E.; Vlassi, Metaxia; Nikolakaki, Eleni; Giannakouros, Thomas			Evidence for disulfide bonds in SR Protein Kinase 1 (SRPK1) that are required for activity and nuclear localization	PLOS ONE			English	Article							ESCHERICHIA-COLI CYTOPLASM; SUBSTRATE SPECIFICITIES; MOLECULAR-DYNAMICS; SPLICING FACTORS; PHOSPHORYLATION; CYSTEINE; PREDICTION; MECHANISM; SWITCHES; BRIDGES	Serine/arginine protein kinases (SRPKs) phosphorylate Arg/Ser dipeptide-containing proteins that play crucial roles in a broad spectrum of basic cellular processes. The existence of a large internal spacer sequence that separates the bipartite kinase catalytic core is a unique structural feature of SRPKs. Previous structural studies on a catalytically active fragment of SRPK1, which lacks the main part of the spacer domain, revealed that SRPK1 remains in an active state without any post-translational modifications or specific intra-protein interactions, while the spacer domain is depicted as a loop structure, outside the kinase core. Using systematic mutagenesis we now provide evidence that replacement of any individual cysteine residue in the spacer, apart from Cys414, or in its proximal flaking ends of the two kinase catalytic domains has an impact on kinase activity. Furthermore, the cysteine residues are critical for nuclear translocation of SRPK1 in response to genotoxic stress and SRPK1-dependent splicing of a reporter gene. While replacement of Cys207, Cys502 and Cys539 of the catalytic domains is predicted to distort the kinase active structure, our findings suggest that Cys356, Cys386, Cys427 and Cys455 of the spacer domain and Cys188 of the first catalytic domain are engaged in disulfide bridging. We propose that such a network of intramolecular disulfide bonds mediates the bending of the spacer region thus allowing the proximal positioning of the two catalytic subunits which is a prerequisite for SRPK1 activity.	[Koutroumani, Maria; Nikolakaki, Eleni; Giannakouros, Thomas] Aristotle Univ Thessaloniki, Dept Chem, Biochem Lab, Thessaloniki, Greece; [Papadopoulos, Georgios E.] Univ Thessaly, Dept Biochem & Biotechnol, Mezourlo, Larisa, Greece; [Vlassi, Metaxia] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece	Aristotle University of Thessaloniki; University of Thessaly; National Centre of Scientific Research "Demokritos"	Nikolakaki, E; Giannakouros, T (corresponding author), Aristotle Univ Thessaloniki, Dept Chem, Biochem Lab, Thessaloniki, Greece.	nikol@chem.auth.gr; giannako@chem.auth.gr	GIANNAKOUROS, THOMAS/R-3204-2019; Vlassi, Metaxia/B-8692-2013	Papadopoulos, Georgios/0000-0002-2742-8467; Vlassi, Metaxia/0000-0003-0931-2660	THALES Programme [379440]; European Union (European Social Fund ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)	THALES Programme(Thales Group); European Union (European Social Fund ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)	Thomas Giannakouros was funded by the THALES Programme (http//excellence.minedu.gov.gr/thales; grant number 379440), co-financed by the European Union (European Social Fund ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF). Maria Koutroumani received a salary from this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREADIS A, 1995, NUCLEIC ACIDS RES, V23, P3585, DOI 10.1093/nar/23.17.3585; Aubol BE, 2012, BIOCHEMISTRY-US, V51, P6584, DOI 10.1021/bi300876h; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Ceroni A, 2006, NUCLEIC ACIDS RES, V34, pW177, DOI 10.1093/nar/gkl266; Cheng JL, 2006, PROTEINS, V62, P617, DOI 10.1002/prot.20787; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; Fariselli P, 1999, PROTEINS, V36, P340; Ferre F, 2006, NUCLEIC ACIDS RES, V34, pW182, DOI 10.1093/nar/gkl189; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Giannakouros T, 2011, FEBS J, V278, P570, DOI 10.1111/j.1742-4658.2010.07987.x; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Mylonis I, 2003, BIOCHEM BIOPH RES CO, V301, P650, DOI 10.1016/S0006-291X(02)03055-3; Ngo JCK, 2007, STRUCTURE, V15, P123, DOI 10.1016/j.str.2006.11.011; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Nikolakaki E, 2001, J BIOL CHEM, V276, P40175, DOI 10.1074/jbc.M104755200; Nolen B, 2001, NAT STRUCT BIOL, V8, P176, DOI 10.1038/84178; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Papoutsopoulou S, 1999, BIOCHEM BIOPH RES CO, V255, P602, DOI 10.1006/bbrc.1999.0249; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plocinik RM, 2011, J MOL BIOL, V410, P131, DOI 10.1016/j.jmb.2011.04.077; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Sanchez R, 2008, PROTEIN SCI, V17, P473, DOI 10.1110/ps.073252408; Sanidas I, 2010, BBA-MOL CELL RES, V1803, P1319, DOI 10.1016/j.bbamcr.2010.07.008; Sellis D, 2012, BBA-GEN SUBJECTS, V1820, P44, DOI 10.1016/j.bbagen.2011.10.010; Siebel CW, 1999, P NATL ACAD SCI USA, V96, P5440, DOI 10.1073/pnas.96.10.5440; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Tsianou D, 2009, FEBS J, V276, P5212, DOI 10.1111/j.1742-4658.2009.07217.x; Voukkalis N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154198; Wang PP, 2014, MOL CELL, V54, P378, DOI 10.1016/j.molcel.2014.03.007; WETZEL R, 1987, TRENDS BIOCHEM SCI, V12, P478, DOI 10.1016/0968-0004(87)90234-9; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	41	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171328	10.1371/journal.pone.0171328	http://dx.doi.org/10.1371/journal.pone.0171328			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166275	Green Published, gold, Green Submitted			2022-12-26	WOS:000393700100035
J	Schmithals, A; Kuhn, N				Schmithals, Anja; Kuehn, Norbert			To mulch or not to mulch? Effects of gravel mulch toppings on plant establishment and development in ornamental prairie plantings	PLOS ONE			English	Article							ECOSYSTEM	In recent years, North American prairie vegetation has served as a design model for highly attractive, low-cost and low-maintenance plantings in German urban green spaces. Where mixed-planting techniques, gravel mulch toppings and non-selective maintenance techniques such as mowing are used, prairie plantings are considered to be cost-effective alternative design concepts for public green space management. In this study, we investigated the establishment success of different mixtures of prairie species plantings on two sites with different soil conditions: topsoil and topsoil with graywacke gravel topping. We documented significantly higher average mortality rates on gravel mulch sites in the first year after establishment. Further development of mortality was not significantly different between sites. Weed species were always more numerous on topsoil sites and had an obvious effect on the visual impact of the plantings. The mulch created an effective barrier for wind-dispersed germinators. Soil temperatures down to 30 cm were significantly higher on gravel mulch sites throughout the year, stimulating more vital plant growth and a prolonged growing season. Our results emphasize the importance of considering these kinds of practical issues during the planning process as they are critical to the success or failure of the design.	[Schmithals, Anja; Kuehn, Norbert] Tech Univ Berlin, Dept Landscape Architecture & Environm Planning, Berlin, Germany	Technical University of Berlin	Schmithals, A (corresponding author), Tech Univ Berlin, Dept Landscape Architecture & Environm Planning, Berlin, Germany.	anja.schmithals@tu-berlin.de			Deutsche Forschungsgemeinschaft [KU 1462/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft, http://kmv.dfg.de/, grant number KU 1462/4-1 (NK).	Albert KR, 2011, PLANT CELL ENVIRON, V34, P1207, DOI 10.1111/j.1365-3040.2011.02320.x; Bullock JM, 2001, SEEDS ECOLOGY REGENE, P375; Busse N., 2005, GARTENPRAXIS, V10, P55; CURTIS JT, 1971, VEGETATION WISCONSIN; de la Fleur M, 2001, GARTENPRAXIS, V10, P29; Ellenberg H., 1992, SCRIPTA GEOBOTANICA, V18, P1; Elsner AK, 2007, GARTEN LANDSCHAFT, V5, P16; Eppel-Hotz A, 1997, LA LANDSCHAFTSARCHIT, V10, P12; Eppel-Hotz A., 2010, NEUE LANDSCHAFT, V10, P35; Gardner HW, 2011, TALLGRASS PRAIRIE RESTORATION IN THE MIDWESTERN AND EASTERN UNITED STATES: A HANDS-ON GUIDE, P3, DOI 10.1007/978-1-4419-7427-3_1; Hansen R., 1981, STAUDEN IHRE LEBENSB; Hertle B., 1995, THESIS; Hertlein-Rieder V, 2006, GARTEN LANDSCHAFT, V1, P10; Kircher W, 2002, GARTEN LANDSCHAFT, V5, P24; Kircher W., 2005, PFLANZEN EXTREME STA, P92; Kircher W., 2001, STADT GRUN, V5, P355; Kunick W., 1999, NEUE LANDSCHAFT, V3, P164; Kuntze H., 1994, BODENKUNDE; Luz H., 2005, GARTEN LANDSCHAFT, V5, P16; Luz H., 2004, GRUNFORUMLA, V11, P24; Menhusen BR, 1963, T KANSAS ACAD SCI, V661, P107; Messer U., 2003, STADT GRUN, V12, P44; Messer UJ, 2004, ACTA HORTIC, P157, DOI 10.17660/ActaHortic.2004.643.19; Missouri Botanical Garden. Asclepias tuberosa, 2016, ASCL TUB; Missouri Botanical Garden. Bouteloua curtipendula, 2016, BOUT CURT; Oehmichen F, 2000, GARTENPRAXIS, V4, P39; Palm M., 1993, GARTENPRAXIS, V5, P16; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; R Core Team, 2021, R LANGUAGE ENV STAT; ROBER R. UND H. SCHACHT, 2008, PFLANZENERNAHRUNG GA, V4; Rothmund S, 2000, GARTENPRAXIS, V12, P31; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Scheffer P., 1998, LEHRBUCH BODENKUNDE, V14; Schmidt C, 2004, GARTENPRAXIS, V5, P32; Schmidt C, 2004, GARTENPRAXIS, V7, P17; Schmidt C, 2004, DEGA, V11, P12; Schmidt C, 2003, GRUNFORUMLA, V3, P18; Schmidt C., 2009, GARTENPRAXIS, V6, P22; Schmithals A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108588; Schonfeld P., 2001, CAMPOS, V3, P20; Sharon Y., 2014, WHORLED MILKWEED ASC; Simon H., 1991, GARTENPRAXIS, V5, P19; Sullivan AT, 2011, OECOLOGIA, V165, P1007, DOI 10.1007/s00442-010-1815-x; University of Wisconsin-Madison Arboretum. Plants of Southern Wisconsin, 2013, PLANTS SO WISC; USDA  NRCS, 2016, PLANTS DAT; Wan SQ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002315; WEAVER J. E., 1934, ECOL MONOGR, V4, P109, DOI 10.2307/1943575	48	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171533	10.1371/journal.pone.0171533	http://dx.doi.org/10.1371/journal.pone.0171533			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166269	Green Submitted, Green Published, gold			2022-12-26	WOS:000393700100052
J	Lin, Y; Yang, X; Liu, W; Li, B; Yin, W; Shi, Y; He, R				Lin, Y.; Yang, X.; Liu, W.; Li, B.; Yin, W.; Shi, Y.; He, R.			Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation	ONCOGENE			English	Article							NATURAL-KILLER-CELLS; NF-KAPPA-B; SUPPRESSOR-CELLS; ENDOTHELIAL-CELLS; CANCER-CELLS; TUMOR MICROENVIRONMENT; DENDRITIC CELLS; RECEPTOR CCRL2; POOR-PROGNOSIS; T-CELLS	Hepatocellular carcinoma (HCC) is linked to inflammation and immunosuppression. Chemerin is highly expressed in the liver and implicated in the regulation of inflammation. However, the role of chemerin in HCC remains unclear. In this study, we aimed to investigate whether chemerin is able to influence HCC progression by regulating tumor-associated inflammation. Here we demonstrated that chemerin significantly decreased in blood and tumor tissues of HCC patients, and tumor chemerin levels were inversely associated with the prognosis. In an orthotopic mouse model of HCC, Rarres2(-/-)mice exhibited aggressive tumor growth and lung metastasis, whereas chemerin overexpression greatly inhibited tumor growth. The tumor-inhibitory effect of chemerin was accompanied by a shift in tumor-infiltrating immune cells from myeloid-derived suppressive cells (MDSCs) to interferon-gamma'T cells and decreased tumor angiogenesis. Furthermore, we demonstrated that the tumor-inhibitory effect of chemerin was partly dependent on T cells, as chemerin overexpression could inhibit tumor growth, albeit to a lesser extent, in Rag1(-/-) mice when compared with wild-type controls. Mechanistically, chemerin inhibited nuclear factor-.B activation and the expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-2 (IL-6) by tumor cells and tumor-associated endothelial cell, respectively, via its receptors, and consequently, MDSC induction was impaired, leading to restoration of antitumor T-cell response and decreased tumor angiogenesis. Clinically, systemic and tumor levels of chemerin were found to inversely correlate with circulating concentrations of GM-CSF or IL-6 and tumor-infiltrating myeloid cells, respectively, in HCC patients. Moreover, neutralization of GM-CSF and IL-6 abrogated HCC progression and MDSC accumulation in Rarres2(-/-) mice. In conclusion, our study reveals the tumor-inhibitory effect of chemerin by suppressing inflammatory tumor microenvironment with therapeutic implications for inflammation-associated cancer-like HCC.	[Lin, Y.; Yang, X.; Li, B.; Yin, W.; He, R.] Minist Educ, Dept Immunol, Sch Basic Med Sci, Shanghai, Peoples R China; [Lin, Y.; Yang, X.; Li, B.; Yin, W.; He, R.] Minist Educ, Key Lab Med Mol Virol, Sch Basic Med Sci, Shanghai, Peoples R China; [Lin, Y.; Yang, X.; Li, B.; Yin, W.; He, R.] Minist Hlth, Dept Immunol, Sch Basic Med Sci, Shanghai, Peoples R China; [Lin, Y.; Yang, X.; Li, B.; Yin, W.; He, R.] Minist Hlth, Key Lab Med Mol Virol, Sch Basic Med Sci, Shanghai, Peoples R China; [Liu, W.; Shi, Y.] Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg, Key Lab Carcinogenesis & Canc Invas,Minist Educ, 180 FengLin Rd, Shanghai 200032, Peoples R China; [He, R.] Fudan Univ, Biotherapy Res Ctr, Dept Immunol, Shanghai, Peoples R China	Fudan University; Fudan University	Shi, Y (corresponding author), Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg, Key Lab Carcinogenesis & Canc Invas,Minist Educ, 180 FengLin Rd, Shanghai 200032, Peoples R China.; He, R (corresponding author), Fudan Univ, Shanghai Med Sch, Dept Immunol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China.	shi.yinghong@zs-hospital.sh.cn; ruihe@fudan.edu.cn	He, Rui/P-7302-2019; Lin, Yuli/GNP-4999-2022; Yang, Xuguang/GNP-2847-2022	He, Rui/0000-0001-5288-9786; Lin, Yuli/0000-0002-8779-2471; Yang, Xuguang/0000-0002-6198-6008	National Natural Science Foundation of China [813220437, 81471555, 31600715, 81272389, 81472674]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Dr Yongjun Dang (Department of Biochemistry and Molecular Biology, Fudan University) for the assistance with pulldown assay. This work is supported by National Natural Science Foundation of China grant 813220437, 81471555 (to RH), 31600715 (to YL) and 81272389, 81472674 (to YS).	Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Arihara F, 2013, CANCER IMMUNOL IMMUN, V62, P1421, DOI 10.1007/s00262-013-1447-1; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; Bondue B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002358; Chen MF, 2014, ONCOTARGET, V5, P8716, DOI 10.18632/oncotarget.2368; Condamine T, 2015, ANNU REV MED, V66, P97, DOI 10.1146/annurev-med-051013-052304; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Fisher DT, 2014, SEMIN IMMUNOL, V26, P38, DOI 10.1016/j.smim.2014.01.008; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Hoechst B, 2009, HEPATOLOGY, V50, P799, DOI 10.1002/hep.23054; Imai K, 2014, INT J MOL SCI, V15, P11294, DOI 10.3390/ijms150711294; Kaur J, 2010, BIOCHEM BIOPH RES CO, V391, P1762, DOI 10.1016/j.bbrc.2009.12.150; Lin W, 2011, CLIN LAB, V57, P879; Lin YL, 2014, CELL MOL IMMUNOL, V11, P355, DOI 10.1038/cmi.2014.15; Makarova-Rusher OV, 2015, J HEPATOL, V62, P1420, DOI 10.1016/j.jhep.2015.02.038; Monnier J, 2012, J IMMUNOL, V189, P956, DOI 10.4049/jimmunol.1102871; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pachynski RK, 2012, J EXP MED, V209, P1427, DOI 10.1084/jem.20112124; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Tian ZG, 2013, HEPATOLOGY, V57, P1654, DOI 10.1002/hep.26115; Tsuyada A, 2012, CANCER RES, V72, P2768, DOI 10.1158/0008-5472.CAN-11-3567; Wanninger J, 2012, MOL CELL ENDOCRINOL, V349, P248, DOI 10.1016/j.mce.2011.10.032; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281; Yang S, 2014, IMMUNITY, V41, P973, DOI 10.1016/j.immuni.2014.11.013; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhao L, 2014, ALLERGY, V69, P763, DOI 10.1111/all.12408; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521	42	83	86	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 22	2017	36	25					3599	3608		10.1038/onc.2016.516	http://dx.doi.org/10.1038/onc.2016.516			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY3NL	28166197				2022-12-26	WOS:000403878600009
J	Woldetsadik, AD; Vogel, MC; Rabeh, WM; Magzoub, M				Woldetsadik, Abiy D.; Vogel, Maria C.; Rabeh, Wael M.; Magzoub, Mazin			Hexokinase II-derived cell-penetrating peptide targets mitochondria and triggers apoptosis in cancer cells	FASEB JOURNAL			English	Article						ATP; cytochrome c; cytotoxicity; glycolysis; oxidative phosphorylation	PERMEABILITY TRANSITION PORE; ARGININE-RICH PEPTIDES; CARBON NANOTUBES; SUBCELLULAR-LOCALIZATION; MAMMALIAN HEXOKINASE; BROMIDE MTT; ANNEXIN-V; GLUCOSE; BINDING; INVOLVEMENT	Overexpression of mitochondria-bound hexokinase II (HKII) in cancer cells plays an important role in their metabolic reprogramming and protects them against apoptosis, thereby facilitating their growth and proliferation. Here, we show that covalently coupling a peptide that corresponds to the mitochondrial membrane-binding N-terminal domain of HKII (pHK) to a short, penetration-accelerating sequence (PAS) enhances the cellular uptake, mitochondrial localization, and cytotoxicity of the peptide in HeLa cells. Further analysis revealed that pHK-PAS depolarized mitochondrial membrane potential, inhibited mitochondrial respiration and glycolysis, and depleted intracellular ATP levels. The effects of pHK-PAS were correlated with dissociation of endogenous full-length HKII from mitochondria and release of cytochrome c Of significance, pHK-PAS treatment of noncancerous HEK293 cells resulted in substantially lower cytotoxicity. Thus, pHK-PAS effectively disrupted the mitochondria-HKII association in cancer cells, which led to mitochondrial dysfunction and, finally, apoptosis. Our results demonstrate the potential of the pHK-PAS cell-penetrating peptide as a novel therapeutic strategy in cancer.-Woldetsadik, A. D., Vogel, M. C., Rabeh, W. M., Magzoub, M. Hexokinase II-derived cell-penetrating peptide targets mitochondria and triggers apoptosis in cancer cells.	[Woldetsadik, Abiy D.; Vogel, Maria C.; Rabeh, Wael M.; Magzoub, Mazin] New York Univ Abu Dhabi, Div Sci, Abu Dhabi, U Arab Emirates		Magzoub, M (corresponding author), New York Univ Abu Dhabi, Biol Program, POB 129188,Saadiyat Isl Campus, Abu Dhabi, U Arab Emirates.	mazin.magzoub@nyu.edu	Rabeh, Wael/AAO-4647-2020	Rabeh, Wael/0000-0001-6071-8581	NYU Abu Dhabi	NYU Abu Dhabi	The authors thank Khulood Alawadi [Department of Laboratories, New York University (NYU) Abu Dhabi] for preparing the graphic illustration (Fig. 9). Confocal imaging experiments were carried out by using the Core Technology Platform resources at NYU Abu Dhabi. This work was supported by a start-up fund from NYU Abu Dhabi (to M. M.). The authors declare no competing financial interests.	Ahn KJ, 2009, BMB REP, V42, P350, DOI 10.5483/BMBRep.2009.42.6.350; Alshehri R, 2016, J MED CHEM, V59, P8149, DOI 10.1021/acs.jmedchem.5b01770; Amand HL, 2012, BBA-BIOMEMBRANES, V1818, P2669, DOI 10.1016/j.bbamem.2012.06.006; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; ARORA KK, 1988, J BIOL CHEM, V263, P17422; BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Botzer LE, 2016, BRIT J CANCER, V114, P759, DOI 10.1038/bjc.2016.26; Calmettes G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081988; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Dupont E, 2011, METHODS MOL BIOL, V683, P21, DOI 10.1007/978-1-60761-919-2_2; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Flescher E, 2007, CANCER LETT, V245, P1, DOI 10.1016/j.canlet.2006.03.001; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Ganapathy-Kanniappan S, 2010, CURR PHARM BIOTECHNO, V11, P510, DOI 10.2174/138920110791591427; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; KAPLAN O, 1990, CANCER RES, V50, P544; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Levy AG, 2012, INVEST NEW DRUG, V30, P191, DOI 10.1007/s10637-010-9551-y; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; LYON RC, 1988, CANCER RES, V48, P870; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Magzoub M, 2004, Q REV BIOPHYS, V37, P147, DOI 10.1017/S0033583505004014; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Manceur AP, 2009, MOL THER, V17, P500, DOI 10.1038/mt.2008.271; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Mathupala SP, 2001, J BIOL CHEM, V276, P43407, DOI 10.1074/jbc.M108181200; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; NAKASHIMA RA, 1986, BIOCHEMISTRY-US, V25, P1015, DOI 10.1021/bi00353a010; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Pan R, 2016, MOL PHARMACEUT, V13, P1366, DOI 10.1021/acs.molpharmaceut.6b00030; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Pedersen PL, 2008, J BIOENERG BIOMEMBR, V40, P123, DOI 10.1007/s10863-008-9165-7; Pedersen PL, 2002, BBA-BIOENERGETICS, V1555, P14, DOI 10.1016/S0005-2728(02)00248-7; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rezgui R, 2016, BBA-BIOMEMBRANES, V1858, P1499, DOI 10.1016/j.bbamem.2016.03.023; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Sajid MI, 2016, INT J PHARMACEUT, V501, P278, DOI 10.1016/j.ijpharm.2016.01.064; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; Sui DX, 1997, ARCH BIOCHEM BIOPHYS, V345, P111, DOI 10.1006/abbi.1997.0241; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Takayama K, 2012, MOL PHARMACEUT, V9, P1222, DOI 10.1021/mp200518n; Takayama K, 2009, J CONTROL RELEASE, V138, P128, DOI 10.1016/j.jconrel.2009.05.019; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yoong SL, 2015, NANOSCALE, V7, P13907, DOI 10.1039/c5nr00980d; Zhou J, 2012, AMINO ACIDS, V42, P1253, DOI 10.1007/s00726-010-0817-7	72	44	45	2	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2168	2184		10.1096/fj.201601173R	http://dx.doi.org/10.1096/fj.201601173R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28183803	hybrid, Green Published			2022-12-26	WOS:000399195500035
J	Alajajian, SE; Williams, JR; Reagan, AJ; Alajajian, SC; Frank, MR; Mitchell, L; Lahne, J; Danforth, CM; Dodds, PS				Alajajian, Sharon E.; Williams, Jake Ryland; Reagan, Andrew J.; Alajajian, Stephen C.; Frank, Morgan R.; Mitchell, Lewis; Lahne, Jacob; Danforth, Christopher M.; Dodds, Peter Sheridan			The Lexicocalorimeter: Gauging public health through caloric input and output on social media	PLOS ONE			English	Article								We propose and develop a Lexicocalorimeter: an online, interactive instrument for measuring the "caloric content" of social media and other large-scale texts. We do so by constructing extensive yet improvable tables of food and activity related phrases, and respectively assigning them with sourced estimates of caloric intake and expenditure. We show that for Twitter, our naive measures of "caloric input", "caloric output", and the ratio of these measures are all strong correlates with health and well-being measures for the contiguous United States. Our caloric balance measure in many cases outperforms both its constituent quantities; is tunable to specific health and well-being measures such as diabetes rates; has the capability of providing a real-time signal reflecting a population's health; and has the potential to be used alongside traditional survey data in the development of public policy and collective self-awareness. Because our Lexicocalorimeter is a linear superposition of principled phrase scores, we also show we can move beyond correlations to explore what people talk about in collective detail, and assist in the understanding and explanation of how population -scale conditions vary, a capacity unavailable to black -box type methods.	[Alajajian, Sharon E.; Williams, Jake Ryland; Reagan, Andrew J.; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, Dept Math & Stat, Burlington, VT 05401 USA; [Alajajian, Sharon E.; Williams, Jake Ryland; Reagan, Andrew J.; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, Vermont Ctr Complex Syst, Burlington, VT 05401 USA; [Alajajian, Sharon E.; Williams, Jake Ryland; Reagan, Andrew J.; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, Computat Story Lab, Burlington, VT 05401 USA; [Alajajian, Sharon E.; Williams, Jake Ryland; Reagan, Andrew J.; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, Vermont Adv Comp Core, Burlington, VT 05401 USA; [Williams, Jake Ryland] Univ Calif Berkeley, Sch Informat, 102 South Hall 4600, Berkeley, CA 94720 USA; [Alajajian, Stephen C.] Women Infants & Children, East Boston, MA 02128 USA; [Frank, Morgan R.] MIT, Media Lab, Cambridge, MA 02139 USA; [Mitchell, Lewis] Univ Adelaide, Sch Math Sci, North Terrace Campus, Adelaide, SA 5005, Australia; [Lahne, Jacob] Drexel Univ, Culinary Arts & Food Sci, 3141 Chestnut St, Philadelphia, PA 19104 USA	University of Vermont; University of Vermont; University of Vermont; University of Vermont; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); University of Adelaide; Drexel University	Alajajian, SE; Dodds, PS (corresponding author), Univ Vermont, Dept Math & Stat, Burlington, VT 05401 USA.; Alajajian, SE; Dodds, PS (corresponding author), Univ Vermont, Vermont Ctr Complex Syst, Burlington, VT 05401 USA.; Alajajian, SE; Dodds, PS (corresponding author), Univ Vermont, Computat Story Lab, Burlington, VT 05401 USA.; Alajajian, SE; Dodds, PS (corresponding author), Univ Vermont, Vermont Adv Comp Core, Burlington, VT 05401 USA.	salajajian@asc.upenn.edu; peter.dodds@uvm.edu	Mitchell, Lewis/W-1312-2018; Mitchell, Lewis/U-8250-2019; Frank, Morgan R/L-3124-2016; Dodds, Peter/C-9119-2014	Mitchell, Lewis/0000-0001-8191-1997; Mitchell, Lewis/0000-0001-8191-1997; /0000-0001-9487-9359; Dodds, Peter/0000-0003-1973-8614; Lahne, Jacob/0000-0002-2344-1816	NSF CA-REER [0846668]; NSF BIGDATA [1447634]; Women, Infants and Children, East Boston	NSF CA-REER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF BIGDATA; Women, Infants and Children, East Boston	PSD was supported by NSF CA-REER Grant No. 0846668. CM D and PSD were supported by NSF BIGDATA Grant No.1447634. The funder Women, Infants and Children, East Boston provided support in the form of salary for author SCA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abbar S, 2015, YOU TWEET WHAT YOU E; Ainsworth B, 2013, COMPENDIUM PHYS ACTI; [Anonymous], 2013, USDA NAT NUTR DAT ST; [Anonymous], 2013, HLTH RELATED QUALITY; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Chunara R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061373; Culotta A, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P1335, DOI 10.1145/2556288.2557139; DIENER E, 1995, J PERS SOC PSYCHOL, V69, P851, DOI 10.1037/0022-3514.69.5.851; Dodds PS, 2015, P NATL ACAD SCI USA, V112, P2389, DOI 10.1073/pnas.1411678112; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Duggan M, 2013, DEMOGRAPHICS SOCIAL; Eichstaedt J. C., 2015, PSYCHOL SCI; French MT, 2009, AM J HEALTH PROMOT, V24, P2, DOI 10.4278/ajhp.0801104; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Mitchell L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064417; National Center for Chronic Disease Prevention and Health Promo- tion. Division of Nutrition Physical Activity and Centers for Disease Control and Prevention, 2013, STAT IND REP FRUITS; Paul M.J., 2011, P 5 INT AAAI C WEBL, P265; Pesta BJ, 2012, INTELLIGENCE, V40, P107, DOI 10.1016/j.intell.2012.01.011; Prieto VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086191; Rentfrow PJ, 2013, J PERS SOC PSYCHOL, V105, P996, DOI 10.1037/a0034434; Siebens J., 2013, EXTENDED MEASURES WE; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Walpole SC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-439; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; West R., 2013, WWW, P1399; Williams JR, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.042808; Williams JR, 2015, SCI REP-UK, V5, DOI 10.1038/srep12209	28	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0168893	10.1371/journal.pone.0168893	http://dx.doi.org/10.1371/journal.pone.0168893			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187216	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300002
J	Atkinson, RJ; Fulham, WR; Michie, PT; Ward, PB; Todd, J; Stain, H; Langdon, R; Thienel, R; Paulik, G; Cooper, G; Consortium, M; Schall, U				Atkinson, Rebbekah J.; Fulham, W. Ross; Michie, Patricia T.; Ward, Philip B.; Todd, Juanita; Stain, Helen; Langdon, Robyn; Thienel, Renate; Paulik, Georgie; Cooper, Gavin; Consortium, MinT; Schall, Ulrich			Electrophysiological, cognitive and clinical profiles of at-risk mental state: The longitudinal Minds in Transition (MinT) study	PLOS ONE			English	Article							ULTRA-HIGH-RISK; MISMATCH NEGATIVITY MMN; INFORMATION-PROCESSING DEFICITS; 1ST-EPISODE PSYCHOSIS; INVOLUNTARY ATTENTION; FORECASTING PSYCHOSIS; AUDITORY DYSFUNCTION; IDENTIFICATION TEST; REVISED VERSION; PRODROMAL PHASE	The onset of schizophrenia is typically preceded by a prodromal period lasting several years during which sub-threshold symptoms may be identified retrospectively. Clinical interviews are currently used to identify individuals who have an ultra-high risk (UHR) of developing a psychotic illness with a view to provision of interventions that prevent, delay or reduce severity of future mental health issues. The utility of bio-markers as an adjunct in the identification of UHR individuals is not yet established. Several event-related potential measures, especially mismatch-negativity (MMN), have been identified as potential biomarkers for schizophrenia. In this 12-month longitudinal study, demographic, clinical and neuropsychological data were acquired from 102 anti-psychotic naive UHR and 61 healthy controls, of whom 80 UHR and 58 controls provided valid EEG data during a passive auditory task at baseline. Despite widespread differences between UHR and controls on demographic, clinical and neuropsychological measures, MMN and P3a did not differ between these groups. Of 67 UHR at the 12-month follow-up, 7 (10%) had transitioned to a psychotic illness. The statistical power to detect differences between those who did or did not transition was limited by the lower than expected transition rate. ERPs did not predict transition, with trends in the opposite direction to that predicted. In exploratory analysis, the strongest predictors of transition were measures of verbal memory and subjective emotional disturbance.	[Atkinson, Rebbekah J.; Fulham, W. Ross; Michie, Patricia T.; Todd, Juanita; Thienel, Renate; Cooper, Gavin; Schall, Ulrich] Univ Newcastle, Ctr Brain & Mental Hlth Res, Newcastle, NSW, Australia; [Atkinson, Rebbekah J.; Fulham, W. Ross; Michie, Patricia T.; Thienel, Renate; Schall, Ulrich] Hunter Med Res Inst, Newcastle, NSW, Australia; [Atkinson, Rebbekah J.; Fulham, W. Ross; Michie, Patricia T.; Todd, Juanita; Langdon, Robyn; Thienel, Renate; Paulik, Georgie; Cooper, Gavin; Schall, Ulrich] Schizophrenia Res Inst, Darlinghurst, NSW, Australia; [Michie, Patricia T.; Todd, Juanita] Univ Newcastle, Sch Psychol, Newcastle, NSW, Australia; [Ward, Philip B.] Univ New South Wales, Sch Med & Populat Hlth Univ, Sydney, NSW, Australia; [Ward, Philip B.] Schizophrenia Res Unit, South Western Sydney Local Hlth, Sydney, NSW, Australia; [Stain, Helen] Bloomfield Hosp, Ctr Rural & Remote Mental Hlth, Orange, NSW, Australia; [Stain, Helen] Leeds Trin Univ, Sch Social & Hlth Sci, Leeds, W Yorkshire, England; [Langdon, Robyn] Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Langdon, Robyn] Macquarie Univ, Dept Cognit Sci, Sydney, NSW, Australia; [Thienel, Renate] Hunter Inst Mental Hlth, Newcastle, NSW, Australia; [Paulik, Georgie] Univ Western Australia, Sch Psychol, Nedlands, WA, Australia; [Paulik, Georgie] Murdoch Univ, Sch Psychol & Exercise Sci, Murdoch, WA, Australia; [Schall, Ulrich] Hunter New England Hlth, Newcastle, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of New South Wales Sydney; Macquarie University; Macquarie University; University of Western Australia; Murdoch University	Fulham, WR (corresponding author), Univ Newcastle, Ctr Brain & Mental Hlth Res, Newcastle, NSW, Australia.; Fulham, WR (corresponding author), Hunter Med Res Inst, Newcastle, NSW, Australia.; Fulham, WR (corresponding author), Schizophrenia Res Inst, Darlinghurst, NSW, Australia.	ross.fulham@newcastle.edu.au	Weickert, Thomas/AFS-7669-2022; SCHALL, ULRICH ANDREAS/G-7452-2013; Ward, Philip/E-3959-2010; Thienel, Renate/H-8813-2012; , Juanita/B-6191-2013; Cooper, Gavin/G-7458-2013; Fulham, Ross/G-7266-2013	Weickert, Thomas/0000-0002-6408-718X; SCHALL, ULRICH ANDREAS/0000-0001-9041-4562; Ward, Philip/0000-0002-5779-7722; Curtis, Jackie/0000-0001-6884-0098; Thienel, Renate/0000-0003-0381-7828; , Juanita/0000-0002-0443-600X; Mathersul, Danielle/0000-0003-2372-8654; Langdon, Robyn/0000-0002-1044-7194; Cooper, Gavin/0000-0002-7186-5293; Fulham, Ross/0000-0001-8828-1588; Tooney, Paul/0000-0003-3745-4367; Seal, Marc/0000-0002-8396-140X; Paulik-White, Georgie/0000-0001-8973-8922	National Health & Medical Research Council of Australia [569259]; University of Newcastle Post-doctoral Fellowship; Schizophrenia Research Institute utilizining frastructure from the New South Wales Ministry of Health and New South Wales Ministry of Trade and Investment (Australia); Australia Research Council Future Fellowship [FT110100631]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Newcastle Post-doctoral Fellowship; Schizophrenia Research Institute utilizining frastructure from the New South Wales Ministry of Health and New South Wales Ministry of Trade and Investment (Australia); Australia Research Council Future Fellowship(Australian Research Council)	The MinT study was supported by the National Health & Medical Research Council of Australia (Project 569259). RT was supported by a University of Newcastle Post-doctoral Fellowship. US and GC were supported by the Schizophrenia Research Institute utilizining frastructure funding from the New South Wales Ministry of Health and New South Wales Ministry of Trade and Investment (Australia). RL was supported by an Australia Research Council Future Fellowship (FT110100631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SJ, 2003, DRUG ALCOHOL REV, V22, P309, DOI 10.1080/0959523031000154454; Atkinson RJ, 2012, BIOL PSYCHIAT, V71, P98, DOI 10.1016/j.biopsych.2011.08.023; Babor T. F, 2001, GUIDELINES USE PRIMA; Baldeweg T, 2015, INT J PSYCHOPHYSIOL, V95, P145, DOI 10.1016/j.ijpsycho.2014.03.008; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bishop DVM, 2011, DEVELOPMENTAL SCI, V14, P402, DOI 10.1111/j.1467-7687.2010.00990.x; Bodatsch M, 2015, BIOL PSYCHIAT, V77, P951, DOI 10.1016/j.biopsych.2014.09.025; Bodatsch M, 2011, BIOL PSYCHIAT, V69, P959, DOI 10.1016/j.biopsych.2010.09.057; Bowie Christopher R, 2006, Neuropsychiatr Dis Treat, V2, P531, DOI 10.2147/nedt.2006.2.4.531; Brewer WJ, 2006, SCHIZOPHRENIA BULL, V32, P538, DOI 10.1093/schbul/sbj077; Brewer WJ, 2003, AM J PSYCHIAT, V160, P1790, DOI 10.1176/appi.ajp.160.10.1790; Brockhaus-Dumke A, 2005, SCHIZOPHR RES, V73, P297, DOI 10.1016/j.schres.2004.05.016; Brune M, 2007, SCHIZOPHR RES, V92, P151, DOI 10.1016/J.SCHRES.2007.01.006; Bruggemann JM, 2013, INT J PSYCHOPHYSIOL, V89, P374, DOI 10.1016/j.ijpsycho.2013.05.008; Buysse D J, 1989, Psychiatry Res, V28, P193; Carlozzi NE, 2011, CLIN NEUROPSYCHOL, V25, P757, DOI 10.1080/13854046.2011.577811; Carlsson ML, 2004, CURR MED CHEM, V11, P267, DOI 10.2174/0929867043456034; Carrion RE, 2015, SCHIZOPHR RES, V164, P1, DOI 10.1016/j.schres.2015.01.030; Clark S, 2015, J NEURAL TRANSM, V122, P155, DOI 10.1007/s00702-014-1325-9; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Cornblatt BA, 2007, SCHIZOPHRENIA BULL, V33, P688, DOI 10.1093/schbul/sbm029; Cullen AE, 2013, SCHIZOPHRENIA BULL, V39, P1318, DOI 10.1093/schbul/sbs128; Daneault JG, 2013, FRONT PSYCHIAT, V4; Darke S., 1991, 11 NAT DRUG ALC RES; Delis D. C., 1994, CALIFORNIA VERBAL LE; Delis DC, 2001, DELIS KAPLAN EXECUTI; Della Sala S, 1999, NEUROPSYCHOLOGIA, V37, P1189, DOI 10.1016/S0028-3932(98)00159-6; Demjaha A, 2012, SCHIZOPHRENIA BULL, V38, P351, DOI 10.1093/schbul/sbq088; Dien J, 2004, PSYCHOPHYSIOLOGY, V41, P665, DOI 10.1111/j.1469-8986.2004.00193.x; Dittmann-Balcar A, 1999, NEUROREPORT, V10, P3749, DOI 10.1097/00001756-199912160-00005; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Erickson MA, 2016, BIOL PSYCHIAT, V79, P980, DOI 10.1016/j.biopsych.2015.08.025; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P21, DOI 10.1016/0191-8869(85)90026-1; First M.B., 2014, STRUCTURED CLIN INTE; Fulham WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100221; Fusar-Poli P, 2013, SCHIZOPHRENIA BULL, V39, P923, DOI 10.1093/schbul/sbs060; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P562, DOI 10.1001/archgenpsychiatry.2011.1592; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Gross G., 2010, ACTA CLIN CROAT, V49, P47; Harmony T, 2000, COGNITIVE BRAIN RES, V9, P53, DOI 10.1016/S0926-6410(99)00044-0; Hay RA, 2015, BIOL PSYCHOL, V105, P130, DOI 10.1016/j.biopsycho.2015.01.004; Heinrichs RW, 2005, AM PSYCHOL, V60, P229, DOI 10.1037/0003-066X.60.3.229; Hermens DF, 2010, PROG NEURO-PSYCHOPH, V34, P822, DOI 10.1016/j.pnpbp.2010.03.019; Higuchi Y, 2014, FRONT BEHAV NEUROSCI, P8; Hill SK, 2004, SCHIZOPHR RES, V68, P127, DOI 10.1016/S0920-9964(03)00125-7; Hoff AL, 2005, SCHIZOPHR RES, V78, P27, DOI 10.1016/j.schres.2005.05.010; Horvath J, 2008, BIOL PSYCHOL, V79, P139, DOI 10.1016/j.biopsycho.2008.04.001; Hsieh MH, 2012, SCHIZOPHR RES, V140, P243, DOI 10.1016/j.schres.2012.06.021; Jahshan C, 2012, PSYCHOL MED, V42, P85, DOI 10.1017/S0033291711001061; Javitt DC, 2015, NAT REV NEUROSCI, V16, P535, DOI 10.1038/nrn4002; Javitt DC, 2012, SCHIZOPHRENIA BULL, V38, P958, DOI 10.1093/schbul/sbs069; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Jobe TH, 2005, CAN J PSYCHIAT, V50, P892, DOI 10.1177/070674370505001403; Kahkonen S, 2002, CLIN NEUROPHYSIOL, V113, P1894, DOI 10.1016/S1388-2457(02)00305-X; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kaur M, 2013, PROG NEURO-PSYCHOPH, V46, P161, DOI 10.1016/j.pnpbp.2013.07.002; Kenemans JL, 2011, NEUROPSYCHOPHARMACOL, V36, P26, DOI 10.1038/npp.2010.157; Kettle JWL, 2008, SCHIZOPHR RES, V99, P96, DOI 10.1016/j.schres.2007.11.011; Kiang M, 2007, J INT NEUROPSYCH SOC, V13, P653, DOI 10.1017/S1355617707070816; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; Kirkbride JB, 2006, ARCH GEN PSYCHIAT, V63, P250, DOI 10.1001/archpsyc.63.3.250; Klosterkotter J, 2001, ARCH GEN PSYCHIAT, V58, P158, DOI 10.1001/archpsyc.58.2.158; KOEHLER K, 1984, COMPR PSYCHIAT, V25, P174, DOI 10.1016/0010-440X(84)90006-3; Kumarasinghe N, 2014, NEUROL PSYCHIAT BR, V20, P29; Langdon R, 1999, COGNITION, V71, P43, DOI 10.1016/S0010-0277(99)00018-9; Langdon R., 2003, INDIVIDUAL DIFFERENC, P241; Langdon R., 2005, OTHER MINDS HUMANS B, P333; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Light GA, 2007, J COGNITIVE NEUROSCI, V19, P1624, DOI 10.1162/jocn.2007.19.10.1624; Light GA, 2015, ANN NY ACAD SCI, V1344, P105, DOI 10.1111/nyas.12730; Light GA, 2015, SCHIZOPHR RES, V163, P63, DOI 10.1016/j.schres.2014.09.042; Lin A, 2015, SCHIZOPHR RES, V161, P156, DOI 10.1016/j.schres.2014.10.051; Marco-Pallares J, 2010, NEUROIMAGE, V53, P962, DOI 10.1016/j.neuroimage.2010.02.012; McGorry PD, 2003, SCHIZOPHRENIA BULL, V29, P771, DOI 10.1093/oxfordjournals.schbul.a007046; Michie PT, 2000, CLIN NEUROPHYSIOL, V111, P1054, DOI 10.1016/S1388-2457(00)00275-3; Michie PT, 2001, INT J PSYCHOPHYSIOL, V42, P177, DOI 10.1016/S0167-8760(01)00166-0; Mondragon-Maya A, 2013, J PSYCHIATR RES, V47, P755, DOI 10.1016/j.jpsychires.2012.12.017; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; Naatanen R, 2016, BIOL PSYCHOL; Naatanen R, 2015, INT J PSYCHOPHYSIOL, V95, P338, DOI 10.1016/j.ijpsycho.2014.12.012; Naatanen R, 2011, BRAIN, V134, P3432, DOI 10.1093/brain/awr064; Naatanen R, 2009, INT J NEUROPSYCHOPH, V12, P125, DOI 10.1017/S1461145708009322; Naatanen R, 2014, BRAIN TOPOGR, V27, P451, DOI 10.1007/s10548-014-0374-6; Nagai T, 2013, FRONT PSYCHIAT, V4; Nagai T, 2013, SCHIZOPHR RES, V150, P547, DOI 10.1016/j.schres.2013.08.005; Nelson B, 2008, SCHIZOPHRENIA BULL, V34, P381, DOI 10.1093/schbul/sbm094; Oades RD, 1997, PSYCHOPHYSIOLOGY, V34, P677, DOI 10.1111/j.1469-8986.1997.tb02143.x; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Perez VB, 2014, BIOL PSYCHIAT, V75, P459, DOI 10.1016/j.biopsych.2013.07.038; Phillips LJ, 2005, BRIT J PSYCHIAT, V187, pS33, DOI 10.1192/bjp.187.48.s33; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Raballo A, 2011, SCHIZOPHR RES, V127, P107, DOI 10.1016/j.schres.2010.12.021; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Rasser PE, 2011, SCHIZOPHRENIA BULL, V37, P131, DOI 10.1093/schbul/sbp060; Rinne T, 2006, BRAIN RES, V1077, P135, DOI 10.1016/j.brainres.2006.01.043; Rissling AJ, 2012, CLIN NEUROPHYSIOL, V123, P1942, DOI 10.1016/j.clinph.2012.02.079; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Salisbury DF, 2007, ARCH GEN PSYCHIAT, V64, P521, DOI 10.1001/archpsyc.64.5.521; Schall U, 2016, BIOL PSYCHOL, V116, P41, DOI 10.1016/j.biopsycho.2015.09.001; Schmidt SJ, 2015, EUR PSYCHIAT, V30, P388, DOI 10.1016/j.eurpsy.2015.01.013; Schroger E, 1997, PSYCHOPHYSIOLOGY, V34, P245, DOI 10.1111/j.1469-8986.1997.tb02395.x; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shaikh M, 2012, SCHIZOPHR RES, V134, P42, DOI 10.1016/j.schres.2011.09.022; Shin KS, 2012, SCHIZOPHRENIA BULL, V38, P1258, DOI 10.1093/schbul/sbr138; Shin KS, 2009, BIOL PSYCHIAT, V65, P1071, DOI 10.1016/j.biopsych.2008.12.024; Solis-Vivanco R, 2014, SCHIZOPHR RES, V158, P58, DOI 10.1016/j.schres.2014.07.009; Solowij N, 2007, J PSYCHIATR NEUROSCI, V32, P30; Solowij N, 2011, PSYCHOPHARMACOLOGY, V216, P131, DOI 10.1007/s00213-011-2203-x; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Todd J, 2013, FRONT PSYCHIATRY, V4, P1; Todd J, 2008, BIOL PSYCHIAT, V63, P58, DOI 10.1016/j.biopsych.2007.02.016; Todd J, 2012, INT J PSYCHOPHYSIOL, V83, P222, DOI 10.1016/j.ijpsycho.2011.10.003; Turetsky BI, 2009, PSYCHIAT RES, V165, P27, DOI 10.1016/j.psychres.2008.04.013; Umbricht D, 2000, ARCH GEN PSYCHIAT, V57, P1139, DOI 10.1001/archpsyc.57.12.1139; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Umbricht D, 2003, BIOL PSYCHIAT, V53, P1120, DOI 10.1016/S0006-3223(02)01642-6; Valkonen-Korhonen M, 2003, COGNITIVE BRAIN RES, V17, P747, DOI 10.1016/S0926-6410(03)00199-X; van der Gaag M, 2013, SCHIZOPHR RES, V149, P56, DOI 10.1016/j.schres.2013.07.004; Wechsler D, 1997, WMS 3 ADM SCORING MA; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 2004, WISC 4 WECHSLER INTE, DOI 10.1037/t15174-000; Wiltink S, 2015, EARLY INTERV PSYCHIA, V9, P200, DOI 10.1111/eip.12105; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002; Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x	129	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171657	10.1371/journal.pone.0171657	http://dx.doi.org/10.1371/journal.pone.0171657			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187217	Green Published, gold			2022-12-26	WOS:000394244300034
J	Kirichenko, N; Triberti, P; Ohshima, I; Haran, J; Byun, BK; Li, HH; Augustin, S; Roques, A; Lopez-Vaamonde, C				Kirichenko, Natalia; Triberti, Paolo; Ohshima, Issei; Haran, Julien; Byun, Bong-Kyu; Li, Houhun; Augustin, Sylvie; Roques, Alain; Lopez-Vaamonde, Carlos			From east to west across the Palearctic: Phylogeography of the invasive lime leaf miner Phyllonorycter issikii (Lepidoptera: Gracillariidae) and discovery of a putative new cryptic species in East Asia	PLOS ONE			English	Article							DNA BARCODES; MITOCHONDRIAL; POPULATION; TAXONOMY; SUCCESS; REVEAL; MOTH	Knowing the phylogeographic structure of invasive species is important for understanding the underlying processes of invasion. The micromoth Phyllonorycter issikii, whose larvae damage leaves of lime trees Tilia spp., was only known from East Asia. In the last three decades, it has been recorded in most of Europe, Western Russia and Siberia. We used the mitochondrial cytochrome c oxidase subunit I (COI) gene region to compare the genetic variability of P. issikii populations between these different regions. Additionally, we sequenced two nuclear genes (28S rRNA and Histone 3) and run morphometric analysis of male genitalia to probe for the existence of cryptic species. The analysis of COI data of 377 insect specimens collected in 16 countries across the Palearctic revealed the presence of two different lineages: P. issikiiand a putative new cryptic Phyllonorycterspecies distributed in the Russian Far East and Japan. In P. issikii, we identified 31 haplotypes among which 23 were detected in the invaded area (Europe) and 10 were found in its putative native range in East Asia (Russian Far East, Japan, South Korea and China), with only two common haplotypes. The high number of haplotypes found in the invaded area suggest a possible scenario of multiple introductions. One haplotype H1 was dominant (119 individuals, 67.2%), not only throughout its expanding range in Europe and Siberia but, intriguingly, also in 96% of individuals originating from Japan. We detected eight unique haplotypes of P. issikii in East Asia. Five of them were exclusively found in the Russian Far East representing 95% of individuals from that area. The putative new cryptic Phyllonorycterspecies showed differences from P. issikii for the three studied genes. However, both species are morphologically undistinguishable. They occur in sympatry on the same host plants in Japan (Sendai) and the Russian Far East (Primorsky krai) without evidence of admixture.	[Kirichenko, Natalia] Krasnoyarsk Sci Ctr SB RAS, Fed Res Ctr, Sukachev Inst Forest SB RAS, Krasnoyarsk, Russia; [Kirichenko, Natalia] Siberian Fed Univ, Krasnoyarsk, Russia; [Kirichenko, Natalia; Haran, Julien; Augustin, Sylvie; Roques, Alain; Lopez-Vaamonde, Carlos] INRA, Zool Forestiere UR0633, Orleans, France; [Triberti, Paolo] Museo Civ Storia Nat, Verona, Italy; [Ohshima, Issei] Kyoto Prefectural Univ, Dept Life & Environm Sci, Kyoto, Japan; [Haran, Julien] IRD, CIRAD, INRA, UMR CBGP,SupAgro, Montpellier, France; [Byun, Bong-Kyu] Hannam Univ, Dept Biol Sci & Biotechnol, Daejeon, South Korea; [Li, Houhun] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China; [Lopez-Vaamonde, Carlos] Univ Francois Rabelais Tours, Inst Rech Biol Insecte, CNRS UMR 7261, UFR Sci & Tech, Tours, France	Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Sukachev Institute of Forest, Siberian Branch, Russian Academy of Sciences; Siberian Federal University; INRAE; Kyoto Prefectural University; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Hannam University; Nankai University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Kirichenko, N (corresponding author), Krasnoyarsk Sci Ctr SB RAS, Fed Res Ctr, Sukachev Inst Forest SB RAS, Krasnoyarsk, Russia.; Kirichenko, N (corresponding author), Siberian Fed Univ, Krasnoyarsk, Russia.; Kirichenko, N (corresponding author), INRA, Zool Forestiere UR0633, Orleans, France.		Vaamonde, Carlos Lopez/A-5548-2009; Byun, Bong-Kyu/G-1520-2010	Vaamonde, Carlos Lopez/0000-0003-2278-2368; Byun, Bong-Kyu/0000-0003-0393-6464; Kirichenko, Natalia/0000-0002-7362-6464	LE STUDIUM Loire Valley Institute for Advanced Studies, France [INRA-URZF-007]; Russian Foundation for Basic Research, Russia [15-29-02645]	LE STUDIUM Loire Valley Institute for Advanced Studies, France; Russian Foundation for Basic Research, Russia(Russian Foundation for Basic Research (RFBR))	NK was supported by a fellowship of LE STUDIUM Loire Valley Institute for Advanced Studies, France, http://www.lestudium-ias.com/ (grant No INRA-URZF-007) and the Russian Foundation for Basic Research, Russia, http.//www.rfbr.ru/rffi/eng (grant No 15-29-02645). The role of LE STUDIUM Loire Valley Institute for Advanced Studies: study design, data collection and analysis, decision to publish. The role of the Russian Foundation for Basic Research: data collection and analysis, preparation of the manuscript.	[Anonymous], 2015, DATABASE; [Anonymous], 2015, DATABASE; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Baranova AL, 2015, RED BOOK TOMSK OBLAS; Beguinot J, 2016, PHYLLONORYCTER ISSIK; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DeWaard Jeremy R., 2008, V410, P275; Ellis WN, 2016, LEAFMINERS PLANT GAL; Ermolaev IV, 2014, CONTEMP PROBL ECOL+, V7, P324, DOI 10.1134/S1995425514030032; Ermolaev I.V., 2011, ENTOMOL REV, V91, P592, DOI [10.1134/S0013873811050046, DOI 10.1134/S0013873811050046]; Ermolaev V. P., 1977, Trudy zool Inst Leningr, V70, P98; ESRI, 2008, ARCGIS DESKT REL 9 3; EXCOFFIER L, 1992, GENETICS, V131, P479; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gerasimov AM, 1952, FAUNA USSR; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Glavendekic M, 2014, INVASIVE INSECTS CHA, P15; Gurzenkov NN, 1967, THESIS; Gusev VI, 1984, KEY DAMAGE FOREST OR; Gutzwiller F, 2015, ECOL EVOL, V5, P4049, DOI 10.1002/ece3.1580; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2; Hayashi Y, 1969, YU YO JUMOKU ZUSETSU; Hellrigl Klaus, 2012, Forest Observer, V6, P99; Hering EM, 1957, BESTIMMUNGSTABELLEN; Hespenheide Henry A., 2011, Zootaxa, V2805, P36; Kazantseva M.N, 2015, RED BOOK TYUMEN OBLA; Kenis M., 2013, Aliens: The Invasive Species Bulletin, P38; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; Khlonov YP, 1965, LIME TREES LIME GROV; Kirichenko NI, 2014, CONTEMP PROBL ECOL+, V7, P114, DOI 10.1134/S1995425514010077; Kirichenko N, 2016, ZOOKEYS, P99, DOI 10.3897/zookeys.579.7166; Kirichenko N, 2015, ZOOKEYS, P157, DOI 10.3897/zookeys.473.8543; Kirichenko NI, 2009, T SAINT PETERSBURG F, V187, P140; Kirichenko NI, 2013, PESTS DIS WOODY PLAN, P47; Kozlov M.V., 1991, PLANT PROT QUAR, V4, P46; Krapivkina ED, 1996, GREEN BOOK SIBERIA, P58; Krylov PN, 1894, P IMP TOMSK U TOMSK, P1; Kullberg J., 2002, SAHLBERGIA, V6, P45; Kumata T., 1983, Korean Journal of Plant Protection, V22, P213; Kumata T, 1963, INSECTA MATSUMURANA, V25, P53; Kumata T, 2013, STANDARD MOTHS JAPAN; Kuznetzov VI, 1999, INSECTS MITES PESTS, P9; Lastuvka Z, 2013, SHILAP-REV LEPIDOPT, V41, P251; Lees DC, 2011, FRONT ECOL ENVIRON, V9, P322, DOI 10.1890/100098; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez VM, 2014, BIOL INVASIONS, V16, P2393, DOI 10.1007/s10530-014-0672-7; Lopez-Vaamonde C, 2006, J EVOLUTION BIOL, V19, P1314, DOI 10.1111/j.1420-9101.2005.01070.x; Lopez-Vaamonde C, 2003, EVOLUTION, V57, P1804, DOI 10.1111/j.0014-3820.2003.tb00588.x; Lopez-Vaamonde Carlos, 2010, BioRisk, V4, P603; Matosevic D., 2007, RAD SUMAR I JASTREBA, V42, P127; McLachlan G.J., 2004, DISCRIMINANT ANAL ST; Meng PS, 2015, J INTEGR PEST MANAG, V6, DOI 10.1093/jipm/pmv003; Noreika Remigijus, 1998, Acta Zoologica Lituanica, V8, P34; Pigott D, 2012, BIOL MONOGRAPH GENUS; Polozhiy AV, 1985, TERTIARY RELIC BROAD, P1; Puillandre N, 2008, BIOL INVASIONS, V10, P319, DOI 10.1007/s10530-007-9132-y; Rennwald E., 2008, ENTOMOL NACHR BER, V51, P233; Revyakina NV, 1998, RED BOOK ALTAI TERRI; Rewicz T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118121; ROBINSON G S, 1976, Entomologist's Gazette, V27, P127; Roques Alain, 2010, BioRisk, V4, P11; Schmid-Hempel P, 2007, HEREDITY, V99, P414, DOI 10.1038/sj.hdy.6801017; Schreurs A, 2007, DATABASE; Sefrova H., 2002, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V50, P99; Shigesada N., 1997, BIOL INVASIONS THEOR; Stepanov NV, 1993, BOT J, V78, P142; Svejgaard JJ, 2003, EUFORGEN TECHNICAL G; Szocs L, 2015, EUR J ENTOMOL, V112, P591, DOI 10.14411/eje.2015.101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timofeeva YA, 2014, T SAINT PETERSBURG S, V207, P133; Tomov R., 2009, P 6 C PLANT PROTECTI, P83; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Urusov VM, 1993, STRUCTURE DIVERSITY; Valade R, 2009, MOL ECOL, V18, P3458, DOI 10.1111/j.1365-294X.2009.04290.x; van Nieukerken EJ, 2012, ZOOKEYS, P29, DOI 10.3897/zookeys.170.2617; Wullaert S, 2012, PHEGEA, V40, P63; Zhuravlev BB, 2009, MAP AREAS MAIN TYPES	79	21	25	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171104	10.1371/journal.pone.0171104	http://dx.doi.org/10.1371/journal.pone.0171104			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187126	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300011
J	Wang, HL; Zhang, H; Wu, SL; Liao, GC; Fang, AP; Zhu, MF; Zhu, HL				Wang, Hai-lin; Zhang, Hui; Wu, Shang-ling; Liao, Gong-cheng; Fang, Ai-ping; Zhu, Ming-fan; Zhu, Hui-lian			Red blood cell count has an independent contribution to the prediction of ultrasonography-diagnosed fatty liver disease	PLOS ONE			English	Article							METABOLIC SYNDROME; HEMATOLOGICAL PARAMETERS; INSULIN-RESISTANCE; ASSOCIATION; CHINESE; INFLAMMATION; PREVALENCE; COMPONENTS; FERRITIN; RISK	Background & aims Red blood cell (RBC) indices have been demonstrated to be associated with fatty liver disease (FLD) and metabolic syndrome. However, controversy exists regarding the relationship of RBC indices with FLD to date and few has focused on RBC count. This study aimed to explore the association between RBC count and risk of FLD in Southern Chinese adults. Methods A hospital-based cross-sectional study was performed in two hospital health examination centers, including information on ultrasonography-diagnosed FLD, anthropometric indices and biochemical measurements. Covariance analysis was used to evaluate group differences. After quintile classification of RBC counts, logistic regression analysis was conducted to evaluate the odds ratios (ORs) of FLD. Results This study consisted of 8618 subjects (4137 men and 4481 women) aged between 20 and 89 years. FLD cases had higher RBC counts than non-FLD cases in both genders (P<0.001). The prevalence rates of FLD increased with the RBC quintiles in both genders (all P trend<0.001), and were higher in men than women. Binary logistic regression analysis showed positive association between RBC count and FLD, and the OR (95% confidence interval (CI)) were 2.56 (2.06-3.18) in men and 3.69 (2.74-4.98) in women, respectively, when comparing Q5 with Q1. Stratified analyses showed similar trends among subjects with and without FLD risk factors. Gender independent results were similar to gender dependent results. Conclusions Elevated RBC count is independently associated with high risk of FLD, suggesting that the RBC count may be a potential risk predictor for FLD.	[Wang, Hai-lin; Wu, Shang-ling; Liao, Gong-cheng; Fang, Ai-ping; Zhu, Hui-lian] Sun Yat Sen Univ, Sch Publ Hlth, Fac Nutr, Guangzhou, Guangdong, Peoples R China; [Zhang, Hui] Shenzhen Luohu Peoples Hosp, Hlth Examinat Ctr, Shenzhen, Guangdong, Peoples R China; [Zhu, Ming-fan] Sun Yat Sen Univ, Affiliated Hosp 1, Hlth Examinat Ctr, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhu, HL (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Nutr, Guangzhou, Guangdong, Peoples R China.	zhuhl@mail.sysu.edu.cn	Zhu, Huilian/V-1040-2019; Fang, Aiping/V-1792-2019	Fang, Aiping/0000-0001-9139-3898; Wu, Shang-ling/0000-0002-2816-3755	National Natural Science Foundation of China [81273050]; Key Program of National Natural Science Foundation of Guangdong, China [2015A030311035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of National Natural Science Foundation of Guangdong, China	This work was funded by the National Natural Science Foundation of China, http://www.nsfc.gov.cn/publish/portal1/, (NO. 81273050), recipient: HLZ; and Key Program of National Natural Science Foundation of Guangdong, China, http://www.gdstc.gov.cn/, (NO. 2015A030311035), recipient: HLZ.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Association AD, 2005, DIABETES CARE S1, V28, pS42; Barbieri M, 2001, DIABETOLOGIA, V44, P1232, DOI 10.1007/s001250100634; Buttari B, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/616834; Crawford JH, 2004, ANTIOXID REDOX SIGN, V6, P992, DOI 10.1089/ars.2004.6.992; Das SK, 2011, SINGAP MED J, V52, P175; Day CP, 2006, GASTROENTEROLOGY, V130, P207, DOI 10.1053/j.gastro.2005.11.017; de Back DZ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00009; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042; Feng RN, 2014, WORLD J GASTROENTERO, V20, P17932, DOI 10.3748/wjg.v20.i47.17932; Giovannetti A, 2012, CELL PHYSIOL BIOCHEM, V30, P418, DOI 10.1159/000339035; Graif M, 2000, INVEST RADIOL, V35, P319, DOI 10.1097/00004424-200005000-00006; Haukeland JW, 2006, J HEPATOL, P44; Issa D, 2014, EUR J GASTROEN HEPAT, V26, P363, DOI 10.1097/MEG.0000000000000031; Jiang YZ, 2014, J GASTROEN HEPATOL, V29, P1508, DOI 10.1111/jgh.12580; Kawamoto R, 2013, ENDOCRINE, V43, P334, DOI 10.1007/s12020-012-9662-7; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Li ZZ, 2014, J GASTROEN HEPATOL, V29, P42, DOI 10.1111/jgh.12428; Lohsoonthorn V, 2007, DIABETES METAB SYND, V1, P143, DOI 10.1016/j.dsx.2007.05.002; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Manousou P, 2011, LIVER INT, V31, P730, DOI 10.1111/j.1478-3231.2011.02488.x; Minetti M, 2007, CARDIOVASC RES, V75, P21, DOI 10.1016/j.cardiores.2007.03.007; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Sanchez-Chaparro Miguel Angel, 2010, Diabetes Care, V33, pe40, DOI 10.2337/dc09-1707; Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204; Straface Elisabetta, 2011, Int J Cell Biol, V2011, P204157, DOI 10.1155/2011/204157; Tabara Y, 2013, CLIN HEMORHEOL MICRO, V55, P297, DOI 10.3233/CH-2012-1634; Wang YY, 2004, J DIABETES COMPLICAT, V18, P322, DOI 10.1016/S1056-8727(04)00003-0; Wu S, 2013, BMC PUBLIC HEALTH, P13; Wu S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-989; Zeng MD, 2008, J DIGEST DIS, V9, P108, DOI 10.1111/j.1751-2980.2008.00331.x; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172027	10.1371/journal.pone.0172027	http://dx.doi.org/10.1371/journal.pone.0172027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187211	Green Submitted, gold, Green Published			2022-12-26	WOS:000394244300069
J	Adams, EJ; Esliger, DW; Taylor, IM; Sherar, LB				Adams, Emma J.; Esliger, Dale W.; Taylor, Ian M.; Sherar, Lauren B.			Individual, employment and psychosocial factors influencing walking to work: Implications for intervention design	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; ACTIVE TRAVEL; HEALTH-PROMOTION; PLANNED BEHAVIOR; WORKPLACE TRAVEL; BLOOD-PRESSURE; RISK-FACTORS; ILL HEALTH; ADULTS; METAANALYSIS	Background Promoting walking for the journey to and from work (commuter walking) is a potential strategy for increasing physical activity. Understanding the factors influencing commuter walking is important for identifying target groups and designing effective interventions. This study aimed to examine individual, employment-related and psychosocial factors associated with commuter walking and to discuss the implications for targeting and future design of interventions. Methods 1,544 employees completed a baseline survey as part of the 'Walking Works' intervention project (33.4% male; 36.3% aged < 30 years). Multivariate logistic regression was used to examine the associations of individual (age, ethnic group, educational qualifications, number of children < 16 and car ownership), employment-related (distance lived from work, free car parking at work, working hours, working pattern and occupation) and psychosocial factors (perceived behavioural control, intention, social norms and social support from work colleagues) with commuter walking. Results Almost half of respondents (n = 587, 49%) were classified as commuter walkers. Those who were aged < 30 years, did not have a car, had no free car parking at work, were confident of including some walking or intended to walk to or from work on a regular basis, and had support from colleagues for walking were more likely to be commuter walkers. Those who perceived they lived too far away from work to walk, thought walking was less convenient than using a car for commuting, did not have time to walk, needed a car for work or had always travelled the same way were less likely to be commuter walkers. Conclusions A number of individual, employment-related and psychosocial factors were associated with commuter walking. Target groups for interventions to promote walking to and from work may include those in older age groups and those who own or have access to a car. Multilevel interventions targeting individual level behaviour change, social support within the workplace and organisational level travel policies may be required in order to promote commuter walking.	[Adams, Emma J.; Esliger, Dale W.; Taylor, Ian M.; Sherar, Lauren B.] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Natl Ctr Sport & Exercise Med, Loughborough, Leics, England	Loughborough University	Adams, EJ (corresponding author), Univ Loughborough, Sch Sport Exercise & Hlth Sci, Natl Ctr Sport & Exercise Med, Loughborough, Leics, England.	e.j.adams@lboro.ac.uk		Adams, Emma J/0000-0002-5444-6951	Big Lottery Fund's Wellbeing Programme [WB/2/010250147]	Big Lottery Fund's Wellbeing Programme	EA was commissioned by Living Streets (www.livingstreets.org.uk) to undertake an independent evaluation of the Walking Works Pathfinder Employers Scheme. The Walking Works project was managed and delivered by Living Streets as part of a portfolio of projects being delivered by a consortium of the leading walking, cycling and health organisations in England and funded through the Big Lottery Fund's Wellbeing Programme (www.biglotteryfund.org.uk) (Grant number WB/2/010250147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2012, EVALUATION LIVING ST; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Allender S, 2007, J EPIDEMIOL COMMUN H, V61, P344, DOI 10.1136/jech.2006.050807; Altman DG., 1999, PRACTICAL STAT MED R; Arnott B, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0133-9; Audrey S, 2015, PUBLIC HEALTH RESEAR, V3, DOI [10.3310/phr03040, DOI 10.3310/phr03040]; Audrey S, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-37; Bird EL, 2013, HEALTH PSYCHOL, V32, P829, DOI 10.1037/a0032078; Bopp M, 2014, J AGING PHYS ACTIV, V22, P199, DOI [10.1123/JAPA.2012-0236, 10.1123/japa.2012-0236]; Bopp M, 2013, AM J HEALTH BEHAV, V37, P543, DOI 10.5993/AJHB.37.4.12; Bopp M, 2012, PREV MED, V54, P237, DOI 10.1016/j.ypmed.2012.01.016; Breslow L, 1996, AM J HEALTH PROMOT, V10, P253, DOI 10.4278/0890-1171-10.4.253; Brockman R, 2011, PUBLIC HEALTH, V125, P210, DOI 10.1016/j.puhe.2011.01.005; Cairns S, 2010, TRANSPORT RES A-POL, V44, P473, DOI 10.1016/j.tra.2010.03.010; Campbell ME, 2013, J PUBLIC HEALTH MAN, V19, P521, DOI 10.1097/PHH.0b013e31828a83e6; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Craig R, 2013, HLTH SURVEY ENGLAND; Dalton AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067575; de Bruijn GJ, 2009, AM J PREV MED, V36, P189, DOI 10.1016/j.amepre.2008.10.019; Department for Transport, 2015, NAT TRAV SURV ENGL 2; Department for Transport, 2004, WALK CYCL ACT PLAN; Department of Health, 2011, START ACT STAY ACT R; Flint E, 2016, LANCET DIABETES ENDO, V4, P420, DOI 10.1016/S2213-8587(16)00053-X; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; Kelly P, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0132-x; Krizek KJ, 2009, ENVIRON PLANN B, V36, P725, DOI 10.1068/b34023; Kwasniewska M, 2010, PREV MED, V50, P257, DOI 10.1016/j.ypmed.2010.02.011; Laverty AA, 2013, AM J PREV MED, V45, P282, DOI 10.1016/j.amepre.2013.04.012; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee LL, 2010, INT J NURS STUD, V47, P1545, DOI 10.1016/j.ijnurstu.2010.08.008; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Lemieux M, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-12; Lindstrom M, 2008, PREV MED, V46, P22, DOI 10.1016/j.ypmed.2007.07.012; Martin A, 2014, PREV MED, V69, P296, DOI 10.1016/j.ypmed.2014.08.023; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Morris JN, 1997, SPORTS MED, V23, P306, DOI 10.2165/00007256-199723050-00004; Murphy MH, 2007, PREV MED, V44, P377, DOI 10.1016/j.ypmed.2006.12.008; Murtagh EM, 2015, PREV MED, V72, P34, DOI 10.1016/j.ypmed.2014.12.041; Office for National Statistics, 2011, METH TRAV WORK ENGL; Office for National Statistics, 2016, LAB MARK STAT; Oja P, 1998, PATIENT EDUC COUNS, V33, pS87, DOI 10.1016/S0738-3991(98)00013-5; Panter J, 2013, PREV MED, V57, P776, DOI 10.1016/j.ypmed.2013.07.020; Panter J, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-124; Panter JR, 2010, J PHYS ACT HEALTH, V7, P551, DOI 10.1123/jpah.7.4.551; Petrunoff N, 2015, J TRANSP HEALTH, V2, P563, DOI 10.1016/j.jth.2015.06.007; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Robertson R., 2012, MENT HEALTH PHYS ACT, V5, P66, DOI DOI 10.1016/J.MHPA.2012.03.002; Sahlqvist S, 2012, PREV MED, V55, P206, DOI 10.1016/j.ypmed.2012.06.028; Sallis JF, 1998, AM J PREV MED, V15, P379, DOI 10.1016/S0749-3797(98)00076-2; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; STOKOLS D, 1992, AM PSYCHOL, V47, P6, DOI 10.1037/0003-066X.47.1.6; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Yang L, 2012, PREV MED, V55, P453, DOI 10.1016/j.ypmed.2012.08.019	55	16	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171374	10.1371/journal.pone.0171374	http://dx.doi.org/10.1371/journal.pone.0171374			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182714	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800057
J	Haft, DR; Haft, DH				Haft, David Renfrew; Haft, Daniel H.			A comprehensive software suite for protein family construction and functional site prediction	PLOS ONE			English	Article							COMPARATIVE GENOMICS; MICROBIOLOGY; ANNOTATION	In functionally diverse protein families, conservation in short signature regions may outperform full-length sequence comparisons for identifying proteins that belong to a subgroup within which one specific aspect of their function is conserved. The SIMBAL workflow (Sites Inferred by Metabolic Background Assertion Labeling) is a data-mining procedure for finding such signature regions. It begins by using clues from genomic context, such as co-occurrence or conserved gene neighborhoods, to build a useful training set from a large number of uncharacterized but mutually homologous proteins. When training set construction is successful, the YES partition is enriched in proteins that share function with the user's query sequence, while the NO partition is depleted. A selected query sequence is then mined for short signature regions whose closest matches overwhelmingly favor proteins from the YES partition. High-scoring signature regions typically contain key residues critical to functional specificity, so proteins with the highest sequence similarity across these regions tend to share the same function. The SIMBAL algorithm was described previously, but significant manual effort, expertise, and a supporting software infrastructure were required to prepare the requisite training sets. Here, we describe a new, distributable software suite that speeds up and simplifies the process for using SIMBAL, most notably by providing tools that automate training set construction. These tools have broad utility for comparative genomics, allowing for flexible collection of proteins or protein domains based on genomic context as well as homology, a capability that can greatly assist in protein family construction. Armed with this new software suite, SIMBAL can serve as a fast and powerful in silico alternative to direct experimentation for characterizing proteins and their functional interactions.	[Haft, David Renfrew] J Craig Venter Inst, Rockville, MD USA; [Haft, Daniel H.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	J. Craig Venter Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Haft, DH (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	daniel.haft@nih.gov			National Science Foundationunder [1458808]; Div Of Biological Infrastructure [1458808] Funding Source: National Science Foundation	National Science Foundationunder(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundationunder Grant No.1458808 to the J.Craig Venter Institute and by the Intramural Research Program of the NIH, National Library of Medicine. The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Basu MK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-434; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2122, DOI 10.1021/acs.biochem.6b00145; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Graille M, 2005, MOL CELL, V20, P917, DOI 10.1016/j.molcel.2005.10.025; Haft DH, 2015, CURR OPIN MICROBIOL, V23, P189, DOI 10.1016/j.mib.2014.11.017; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; Haft DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028886; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Haft DH, 2005, BIOINFORMATICS, V21, P293, DOI 10.1093/bioinformatics/bti015; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Selengut JD, 2010, J BACTERIOL, V192, P5788, DOI 10.1128/JB.00425-10; Selengut JD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-52; Sikic K, 2010, BIOINFORMATION, V5, P234, DOI 10.6026/97320630005234; Szklarczyk D., 2016, NUCL ACIDS RES	22	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171758	10.1371/journal.pone.0171758	http://dx.doi.org/10.1371/journal.pone.0171758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182651	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800102
J	Kamei, J; Hayashi, S; Sakai, A; Nakanishi, Y; Kai, M; Ikegami, M; Ikeda, H				Kamei, Junzo; Hayashi, Shunsuke; Sakai, Akane; Nakanishi, Yuki; Kai, Misa; Ikegami, Megumi; Ikeda, Hiroko			Rikkunshito prevents paclitaxel-induced peripheral neuropathy through the suppression of the nuclear factor kappa B (NF kappa B) phosphorylation in spinal cord of mice	PLOS ONE			English	Article							CHRONIC CONSTRICTION INJURY; METASTATIC BREAST-CANCER; ACETYL-L-CARNITINE; LEUKEMIA GROUP-B; MECHANICAL ALLODYNIA; CYTOKINE EXPRESSION; INFLAMMATORY PAIN; INDUCED APOPTOSIS; DOSE PACLITAXEL; RATS	Peripheral neuropathy is the major side effect caused by paclitaxel, a microtubule-binding antineoplastic drug. Paclitaxel-induced peripheral neuropathy causes a long-term negative impact on the patient's quality of life. However, the mechanism underlying paclitaxel-induced peripheral neuropathy is still unknown, and there is no established treatment. Ghrelin is known to attenuate thermal hyperalgesia and mechanical allodynia in chronic constriction injury of the sciatic nerve, and inhibit the activation of nuclear factor kappa B (NF kappa B) in the spinal dorsal horn. Rikkunshito (RKT), a kampo medicine, increases the secretion of ghrelin in rodents and humans. Thus, RKT may attenuate paclitaxel-induced peripheral neuropathy by inhibiting phosphorylated NF kappa B (pNF kappa B) in the spinal cord. We found that paclitaxel dose-dependently induced mechanical hyperalgesia in mice. Paclitaxel increased the protein levels of spinal pNF kappa B, but not those of spinal NF kappa B. NF kappa B inhibitor attenuated paclitaxel-induced mechanical hyperalgesia suggesting that the activation of NF kappa B mediates paclitaxel-induced hyperalgesia. RKT dose-dependently attenuated paclitaxel-induced mechanical hyperalgesia. Ghrelin receptor antagonist reversed the RKT-induced attenuation of paclitaxel-induced mechanical hyperalgesia. RKT inhibited the paclitaxel-induced increase in the protein levels of spinal pNF kappa B. Taken together, the present study indicates that RKT exerts an antihyperalgesic effect in paclitaxel-induced neuropathic pain by suppressing the activation of spinal NF kappa B.	[Kamei, Junzo; Hayashi, Shunsuke; Sakai, Akane; Nakanishi, Yuki; Kai, Misa; Ikegami, Megumi; Ikeda, Hiroko] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pathophysiol & Therapeut, Shinagawa Ku, Tokyo, Japan	Hoshi University	Kamei, J (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pathophysiol & Therapeut, Shinagawa Ku, Tokyo, Japan.	kamei@hoshi.ac.jp						Akerley W, 2003, CANCER, V97, P2480, DOI 10.1002/cncr.11375; Argyriou AA, 2008, CRIT REV ONCOL HEMAT, V66, P218, DOI 10.1016/j.critrevonc.2008.01.008; Bames P.J., 1997, NEW ENGL J MED, V336, P1066; Bava SV, 2005, J BIOL CHEM, V280, P6301, DOI 10.1074/jbc.M410647200; Boyette-Davis J, 2011, PAIN, V152, P308, DOI 10.1016/j.pain.2010.10.030; Cata JP, 2008, BRAIN RES, V1229, P100, DOI 10.1016/j.brainres.2008.07.001; Dougherty PM, 2004, PAIN, V109, P132, DOI 10.1016/j.pain.2004.01.021; Esin E, 2014, ONCOTARGETS THER, V7, P599, DOI 10.2147/OTT.S60995; Ferrini F, 2009, CURR NEUROPHARMACOL, V7, P37, DOI 10.2174/157015909787602779; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Flatters SJL, 2006, NEUROSCI LETT, V397, P219, DOI 10.1016/j.neulet.2005.12.013; Forsyth PA, 1997, J NEURO-ONCOL, V35, P47, DOI 10.1023/A:1005805907311; Gahete MD, 2011, PEPTIDES, V32, P2225, DOI 10.1016/j.peptides.2011.09.019; Garcia JM, 2008, ENDOCRINOLOGY, V149, P455, DOI 10.1210/en.2007-0828; Gogas H, 1996, GYNECOL ONCOL, V61, P22, DOI 10.1006/gyno.1996.0090; Guneli E, 2010, NEUROSCI LETT, V479, P226, DOI 10.1016/j.neulet.2010.05.066; Guo CJ, 2004, GLIA, V48, P259, DOI 10.1002/glia.20079; Hatton T., 2010, INT J PEPT; Hiyama T, 2008, WORLD J GASTROENTERO, V14, P3123, DOI 10.3748/wjg.14.3123; Huang Y, 2002, MOL PHARMACOL, V61, P105, DOI 10.1124/mol.61.1.105; Ito S, 2012, J PHARMACOL EXP THER, V342, P53, DOI 10.1124/jpet.111.187401; Jin HW, 2008, EXP NEUROL, V210, P229, DOI 10.1016/j.expneurol.2007.11.001; Kawahara H, 2007, PEDIATR SURG INT, V23, P1001, DOI 10.1007/s00383-007-1986-7; Kim HK, 2010, ANESTHESIOLOGY, V112, P432, DOI 10.1097/ALN.0b013e3181ca31bd; Ledeboer A, 2007, BRAIN BEHAV IMMUN, V21, P686, DOI 10.1016/j.bbi.2006.10.012; Lee HL, 2004, NEUROREPORT, V15, P2807; Lee JJ, 2006, J CLIN ONCOL, V24, P1633, DOI 10.1200/JCO.2005.04.0543; Li WG, 2004, CIRCULATION, V109, P2221, DOI 10.1161/01.CIR.0000127956.43874.F2; LIPTON RB, 1989, NEUROLOGY, V39, P368, DOI 10.1212/WNL.39.3.368; Ma VY, 1998, BRAIN RES, V797, P243, DOI 10.1016/S0006-8993(98)00380-1; Matsumoto M, 2006, J PHARMACOL EXP THER, V318, P735, DOI 10.1124/jpet.106.103614; Matsumura T, 2010, J GASTROENTEROL, V45, P300, DOI 10.1007/s00535-009-0166-z; Nabholtz JM, 1996, J CLIN ONCOL, V14, P1858, DOI 10.1200/JCO.1996.14.6.1858; Pan YD, 2010, REGION ANESTH PAIN M, V35, P231, DOI 10.1097/AAP.0b013e3181df245b; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; Rowinsky E K, 1993, J Natl Cancer Inst Monogr, P107; ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1; Sakaue G, 2001, NEUROREPORT, V12, P2079, DOI 10.1097/00001756-200107200-00008; Scripture CD, 2006, CURR NEUROPHARMACOL, V4, P165, DOI 10.2174/157015906776359568; Sibilia V, 2006, NEUROPHARMACOLOGY, V51, P497, DOI 10.1016/j.neuropharm.2006.04.009; Sibilia V, 2012, AMINO ACIDS, V43, P1751, DOI 10.1007/s00726-012-1260-8; Sun T, 2012, EUR J PHARMACOL, V682, P79, DOI 10.1016/j.ejphar.2012.02.017; Takeda H, 2008, GASTROENTEROLOGY, V134, P2004, DOI 10.1053/j.gastro.2008.02.078; Tanabe Y, 2013, INT J CLIN ONCOL, V18, P132, DOI 10.1007/s10147-011-0352-x; TATSUTA M, 1993, ALIMENT PHARM THERAP, V7, P459; Tegeder I, 2004, J NEUROSCI, V24, P1637, DOI 10.1523/JNEUROSCI.3118-03.2004; Tominaga K, 2013, J GASTROENTEROL, V48, P452, DOI 10.1007/s00535-013-0788-z; Tominaga K, 2012, J GASTROENTEROL, V47, P284, DOI 10.1007/s00535-011-0488-5; Vergnano AM, 2008, ENDOCRINOLOGY, V149, P2306, DOI 10.1210/en.2007-1164; Wang W, 2009, AM J PHYSIOL-RENAL, V297, pF1032, DOI 10.1152/ajprenal.00044.2009; WIERNIK PH, 1987, CANCER RES, V47, P2486; Winer EP, 2004, J CLIN ONCOL, V22, P2061, DOI 10.1200/JCO.2004.08.048; Wolf S, 2008, EUR J CANCER, V44, P1507, DOI 10.1016/j.ejca.2008.04.018; Xiao W, 2007, NEUROSCIENCE, V144, P714, DOI 10.1016/j.neuroscience.2006.09.044; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yanai M, 2013, J GASTROENTEROL, V48, P611, DOI 10.1007/s00535-012-0687-8; Zhou CH, 2014, REGION ANESTH PAIN M, V39, P137, DOI 10.1097/AAP.0000000000000050	57	6	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171819	10.1371/journal.pone.0171819	http://dx.doi.org/10.1371/journal.pone.0171819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182729	Green Submitted, Green Published, gold			2022-12-26	WOS:000394231800120
J	Gucluler, G; Adiguzel, E; Gungor, B; Kahraman, T; Gursel, M; Yilmaz, B; Gursel, I				Gucluler, Gozde; Adiguzel, Emre; Gungor, Bilgi; Kahraman, Tamer; Gursel, Mayda; Yilmaz, Bilge; Gursel, Ihsan			Impaired toll like receptor-7 and 9 induced immune activation in chronic spinal cord injured patients contributes to immune dysfunction	PLOS ONE			English	Article							C-REACTIVE PROTEIN; OXIDATIVE STRESS; CHRONIC INFLAMMATION; PATTERN-RECOGNITION; INNATE IMMUNITY; SYSTEM FUNCTION; MORTALITY; SCI	Reduced immune activation or immunosuppression is seen in patients withneurological diseases. Urinary and respiratory infections mainly manifested as septicemia and pneumonia are the most frequent complications following spinal cord injuries and they account for the majority of deaths. The underlying reason of these losses is believed to arise due to impaired immune responses to pathogens. Here, we hypothesized that susceptibility to infections of chronic spinal cord injured (SCI) patients might be due to impairment in recognition of pathogen associated molecular patterns and subsequently declining innate and adaptive immune responses that lead to immune dysfunction. We tested our hypothesis on healthy and chronic SCI patients with a level of injury above T-6. Donor PBMCs were isolated and stimulated with different toll like receptor ligands and T-cell inducers aiming to investigate whether chronic SCI patients display differential immune activation to multiple innate and adaptive immune cell stimulants. We demonstrate that SCI patients' B-cell and plasmacytoid dendritic cells retain their functionality in response to TLR7 and TLR9 ligand stimulation as they secreted similar levels of IL6 and IFN alpha. The immune dysfunction is not probably due to impaired T-cell function, since neither CD4(+) T-cell dependent IFN. producing cell number nor IL10 producing regulatory T-cells resulted different outcomes in response to PMA-Ionomycin and PHA-LPS stimulation, respectively. We showed that TLR7 dependent IFN gamma and IP10 levels and TLR9 mediated APC function reduced substantially in SCI patients compared to healthy subjects. More importantly, IP10 producing monocytes were significantly fewer compared to healthy subjects in response to TLR7 and TLR9 stimulation of SCI PBMCs. When taken together this work implicated that these defects could contribute to persistent complications due to increased susceptibility to infections of chronic SCI patients.	[Gucluler, Gozde; Kahraman, Tamer; Gursel, Ihsan] Bilkent Univ, Dept Mol Biol & Genet, THORLAB, Ankara, Turkey; [Adiguzel, Emre; Yilmaz, Bilge] Gaziler Phys Med & Rehabil Educ & Res Hosp, Ankara, Turkey; [Gungor, Bilgi; Gursel, Mayda] Middle East Tech Univ, Dept Mol Biol & Genet, Ankara, Turkey; [Yilmaz, Bilge] Univ Hlth Sci, Gaziler Phys Med & Rehabil Educ & Res Hosp, Dept Phys Med & Rehabil, Gulhane Med Sch, Ankara, Turkey	Ihsan Dogramaci Bilkent University; Gaziler Physical Therapy & Research Hospital; Middle East Technical University; Gaziler Physical Therapy & Research Hospital; University of Health Sciences Turkey	Gursel, I (corresponding author), Bilkent Univ, Dept Mol Biol & Genet, THORLAB, Ankara, Turkey.; Yilmaz, B (corresponding author), Gaziler Phys Med & Rehabil Educ & Res Hosp, Ankara, Turkey.; Yilmaz, B (corresponding author), Univ Hlth Sci, Gaziler Phys Med & Rehabil Educ & Res Hosp, Dept Phys Med & Rehabil, Gulhane Med Sch, Ankara, Turkey.	biyilmaz@gata.edu.tr; ihsangursel@bilkent.edu.tr	YILMAZ, Bilge/A-7428-2013; Gursel, Ihsan/AAT-7168-2021; YILMAZ, Bilge/W-6481-2019; Gursel, M/H-1812-2012; Adiguzel, Emre/G-9138-2015	YILMAZ, Bilge/0000-0003-1173-9399; YILMAZ, Bilge/0000-0003-1173-9399; Gursel, M/0000-0003-0044-9054; Kahraman, Tamer/0000-0002-5527-7336; Gursel, Ihsan/0000-0003-3761-1166; Adiguzel, Emre/0000-0002-2447-5065	Bilkent University	Bilkent University(Ihsan Dogramaci Bilkent University)	This study is partly supported by Bilkent University account to IG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DJ, 2015, SPINAL CORD, V53, P14, DOI 10.1038/sc.2014.184; Campagnolo DI, 2008, SPINAL CORD, V46, P477, DOI 10.1038/sc.2008.4; Campagnolo D I, 2000, J Spinal Cord Med, V23, P121; CAMPAGNOLO DI, 1994, AM J PHYS MED REHAB, V73, P387, DOI 10.1097/00002060-199411000-00003; CRUSE JM, 1992, IMMUNOL RES, V11, P104, DOI 10.1007/BF02918615; Davies AL, 2007, ARCH PHYS MED REHAB, V88, P1384, DOI 10.1016/j.apmr.2007.08.004; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; Fallarino F, 2016, METHODS MOL BIOL, V1390, P383, DOI 10.1007/978-1-4939-3335-8_23; Gibson AE, 2008, SPINAL CORD, V46, P616, DOI 10.1038/sc.2008.32; Held KS, 2010, EXP NEUROL, V226, P242, DOI 10.1016/j.expneurol.2010.08.036; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Leszek J, 2016, CNS NEUROL DISORD-DR, V15, P329, DOI 10.2174/1871527315666160202125914; Liang HF, 2008, ARCH PHYS MED REHAB, V89, P36, DOI 10.1016/j.apmr.2007.08.121; Lidal IB, 2007, J REHABIL MED, V39, P145, DOI 10.2340/16501977-0017; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Riegger T, 2009, NEUROSCIENCE, V158, P1194, DOI 10.1016/j.neuroscience.2008.08.021; Riegger T, 2007, EUR J NEUROSCI, V25, P1743, DOI 10.1111/j.1460-9568.2007.05447.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421	24	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171003	10.1371/journal.pone.0171003	http://dx.doi.org/10.1371/journal.pone.0171003			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170444	Green Published, Green Submitted, gold			2022-12-26	WOS:000393705500018
J	Vaze, ND; Park, S; Brooks, AD; Fridman, A; Joshi, SG				Vaze, Nachiket D.; Park, Sin; Brooks, Ari D.; Fridman, Alexander; Joshi, Suresh G.			Involvement of multiple stressors induced by non-thermal plasma-charged aerosols during inactivation of airborne bacteria	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BARRIER DISCHARGE PLASMA; ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; SUPEROXIDE-DISMUTASE; OXIDATIVE DAMAGE; MOLECULAR EPIDEMIOLOGY; RAPID INACTIVATION; HYPOCHLOROUS ACID; OXYR	A lab-scale, tunable, single-filament, point-to-point nonthermal dieletric-barrier discharge (DBD) plasma device was built to study the mechanisms of inactivation of aerosolized bacterial pathogens. The system inactivates airborne antibiotic-resistant pathogens efficiently. Nebulization mediated pre-optimized (4 log and 7 log) bacterial loads were challenged to plasma-charged aerosols, and lethal and sublethal doses determined using colony assay, and cell viability assay; and the loss of membrane potential and cellular respiration were determined using cell membrane potential assay and XTT assay. Using the strategies of Escherichia coli wildtype, over-expression mutant, deletion mutants, and peroxide and heat stress scavenging, we analyzed activation of intracellular reactive oxygen species (ROS) and heat shock protein (hsp) chaperons. Superoxide dismutase deletion mutants (Delta sodA, Delta sodB, Delta sodA Delta sodB) and catalase mutants Delta katG and Delta katE Delta katG did not show significant difference from wildtype strain, and Delta katE and Delta ahpC was found significantly more susceptible to cell death than wildtype. The oxyR regulon was found to mediate plasma-charged aerosol-induced oxidative stress in bacteria. Hsp deficient E. coli (Delta htpG, Delta groEL, Delta cIpX, Delta grpE) showed complete inactivation of cells at ambient temperature, and the treatment at cold temperature (4 degrees C) significantly protected hsp deletion mutants and wildtype cells, and indicate a direct involvement of hsp in plasma-charged aerosol mediated E. coli cell death.	[Vaze, Nachiket D.; Brooks, Ari D.; Fridman, Alexander; Joshi, Suresh G.] Drexel Univ, Coll Med, Ctr Surg Infect & Biofilm, Philadelphia, PA 19104 USA; [Vaze, Nachiket D.; Joshi, Suresh G.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Park, Sin; Fridman, Alexander; Joshi, Suresh G.] Drexel Univ, AJ Drexel Plasma Inst, Philadelphia, PA 19104 USA; [Vaze, Nachiket D.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Brooks, Ari D.] Univ Penn Hlth Syst, Dept Surg, Philadelphia, PA USA	Drexel University; Drexel University; Drexel University; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania	Joshi, SG (corresponding author), Drexel Univ, Coll Med, Ctr Surg Infect & Biofilm, Philadelphia, PA 19104 USA.; Joshi, SG (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.; Joshi, SG (corresponding author), Drexel Univ, AJ Drexel Plasma Inst, Philadelphia, PA 19104 USA.	suresh.joshi@drexelmed.edu	Joshi, Suresh G./AAT-1354-2021	Joshi, Suresh G./0000-0002-7838-4898	Drexel University College of Medicine for Surgical Infection Control Research	Drexel University College of Medicine for Surgical Infection Control Research	This research was carried out through intramural research support from the Drexel University College of Medicine for Surgical Infection Control Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos J, 2013, MOL MICROBIOL, V90, P167, DOI 10.1111/mmi.12356; AMBROSIO G, 1992, CARDIOVASC DRUG THER, V6, P623, DOI 10.1007/BF00052564; Arjunan KP, 2011, IEEE ENG MED BIO, P2447, DOI 10.1109/IEMBS.2011.6090680; Asad NR, 1998, MUTAT RES-DNA REPAIR, V407, P253, DOI 10.1016/S0921-8777(98)00010-X; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baharoglu Z, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003421; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; BUKAU B, 1993, MOL MICROBIOL, V9, P671, DOI 10.1111/j.1365-2958.1993.tb01727.x; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; COOMBS AML, 1987, INT J RADIAT BIOL, V51, P493, DOI 10.1080/09553008714550971; Cooper M, 2010, J APPL MICROBIOL, V109, P2039, DOI 10.1111/j.1365-2672.2010.04834.x; D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844; Dukan S, 1996, J BACTERIOL, V178, P6145, DOI 10.1128/jb.178.21.6145-6150.1996; Eduard W, 1998, AM IND HYG ASSOC J, V59, P113, DOI 10.1080/15428119891010370; Gallagher MJ, 2007, IEEE T PLASMA SCI, V35, P1501, DOI 10.1109/TPS.2007.905209; Genest O, 2011, P NATL ACAD SCI USA, V108, P8206, DOI 10.1073/pnas.1104703108; Goswami M, 2006, ANTIMICROB AGENTS CH, V50, P949, DOI 10.1128/AAC.50.3.949-954.2006; Guan TJ, 2010, J AEROSOL SCI, V41, P611, DOI 10.1016/j.jaerosci.2010.03.002; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Hwang D, 2015, SCI REP-UK, V5, DOI 10.1038/srep10029; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002; JUOZAITIS A, 1994, APPL ENVIRON MICROB, V60, P861, DOI 10.1128/AEM.60.3.861-870.1994; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kim NH, 2006, J BIOCHEM MOL BIOL, V39, P452; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kvam E, 2012, ANTIMICROB AGENTS CH, V56, P2028, DOI 10.1128/AAC.05642-11; Liang JL, 2012, J AEROSOL SCI, V54, P103, DOI 10.1016/j.jaerosci.2012.07.009; Liang YD, 2012, ENVIRON SCI TECHNOL, V46, P3360, DOI 10.1021/es203770q; McCormick ML, 1998, J BACTERIOL, V180, P622, DOI 10.1128/JB.180.3.622-625.1998; McDonald KF, 2002, IEEE T PLASMA SCI, V30, P1986, DOI 10.1109/TPS.2002.805378; Moreau M, 2008, BIOTECHNOL ADV, V26, P610, DOI 10.1016/j.biotechadv.2008.08.001; Moritz M, 2001, INT J HYG ENVIR HEAL, V203, P401, DOI 10.1078/1438-4639-00054; Nair N, 2011, INFECT CONT HOSP EP, V32, P1057, DOI 10.1086/662178; Noor R, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1415-7; OGG JE, 1956, J BACTERIOL, V72, P494, DOI 10.1128/JB.72.4.494-496.1956; Panek HR, 2004, J BACTERIOL, V186, P7874, DOI 10.1128/JB.186.23.7874-7880.2004; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Schmid S, 2013, J HAZARD MATER, V256, P76, DOI 10.1016/j.jhazmat.2013.04.021; SCHWARTZ CE, 1983, J BIOL CHEM, V258, P6277; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Shi Xing-min, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P2033; Theodore A, 2013, GENETICS; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Uhlich GA, 2009, MICROBIOL-SGM, V155, P3589, DOI 10.1099/mic.0.031435-0; Van Droogenbroeck C, 2009, VET MICROBIOL, V135, P31, DOI 10.1016/j.vetmic.2008.09.042; VANDERHEIDE RS, 1987, J MOL CELL CARDIOL, V19, P615, DOI 10.1016/S0022-2828(87)80367-X; Vaze ND, 2010, IEEE T PLASMA SCI, V38, P3234, DOI 10.1109/TPS.2010.2072788; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Warnes SL, 2012, ENVIRON MICROBIOL, V14, P1730, DOI 10.1111/j.1462-2920.2011.02677.x; WASIL M, 1987, BIOCHEM J, V243, P867, DOI 10.1042/bj2430867; Weir SK, 2012, J CLIN MICROBIOL, V50, P3283, DOI 10.1128/JCM.01143-12; Yamazaki H, 2011, DENT MATER J, V30, P384, DOI 10.4012/dmj.2010-190; Yao M, 2005, ENVIRON SCI TECHNOL, V39, P3338, DOI 10.1021/es048808x; Yoon SJ, 2002, J BIOCHEM MOL BIOL, V35, P297; Yost AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139903; Zerrouki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116083; Zhang Q, 2010, J AEROSOL SCI, V41, P880, DOI 10.1016/j.jaerosci.2010.06.001	59	19	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171434	10.1371/journal.pone.0171434	http://dx.doi.org/10.1371/journal.pone.0171434			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166240	gold, Green Submitted, Green Published			2022-12-26	WOS:000393700100042
J	Ji, JP; Zhang, YP; Redon, CE; Reinhold, WC; Chen, AP; Fogli, LK; Holbeck, SL; Parchment, RE; Hollingshead, M; Tomaszewski, JE; Dudon, Q; Pommier, Y; Doroshow, JH; Bonner, WM				Ji, Jiuping; Zhang, Yiping; Redon, Christophe E.; Reinhold, William C.; Chen, Alice P.; Fogli, Laura K.; Holbeck, Susan L.; Parchment, Ralph E.; Hollingshead, Melinda; Tomaszewski, Joseph E.; Dudon, Quentin; Pommier, Yves; Doroshow, James H.; Bonner, William M.			Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; HISTONE VARIANTS; STRAND BREAKS; LINE SET; PHASE-I; GAMMA-H2AX; REPAIR; INHIBITOR; XENOGRAFTS; OLAPARIB	Phosphorylated H2AX (gamma-H2AX) is a sensitive marker for DNA double-strand breaks (DSBs), but the variability of H2AX expression in different cell and tissue types makes it difficult to interpret the meaning of the gamma-H2AX level. Furthermore, the assays commonly used for gamma-H2AX detection utilize laborious and low-throughput microscopy-based methods. We describe here an ELISA assay that measures both phosphorylated H2AX and total H2AX absolute amounts to determine the percentage of gamma-H2AX, providing a normalized value representative of the amount of DNA damage. We demonstrate the utility of the assay to measure DSBs introduced by either ionizing radiation or DNA-damaging agents in cultured cells and in xenograft models. Furthermore, utilizing the NCI-60 cancer cell line panel, we show a correlation between the basal fraction of gamma-H2AX and cellular mutation levels. This additional application highlights the ability of the assay to measure gamma-H2AX levels in many extracts at once, making it possible to correlate findings with other cellular characteristics. Overall, the gamma-H2AX ELISA represents a novel approach to quantifying DNA damage, which may lead to a better understanding of mutagenic pathways in cancer and provide a useful biomarker for monitoring the effectiveness of DNA-damaging anticancer agents.	[Ji, Jiuping; Zhang, Yiping; Parchment, Ralph E.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Appl Dev Res Directorate, Frederick, MD 21701 USA; [Redon, Christophe E.; Reinhold, William C.; Dudon, Quentin; Pommier, Yves; Doroshow, James H.; Bonner, William M.] NCI, Dev Therapeut Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Chen, Alice P.] NCI, Early Clin Trials Dev Program, Div Canc Treatment & Diag, Bethesda, MD 20892 USA; [Fogli, Laura K.; Holbeck, Susan L.; Hollingshead, Melinda; Tomaszewski, Joseph E.; Doroshow, James H.] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ji, JP (corresponding author), Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Appl Dev Res Directorate, Frederick, MD 21701 USA.	jijiupi@mail.nih.gov	Chen, Alice/AAG-9400-2020; Reinhold, William/J-6704-2017	Chen, Alice/0000-0002-1426-853X; Reinhold, William/0000-0001-5513-9323	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Intramural Research Program at the Center for Cancer Research at National Cancer Institute [Z01BC006150]; Radiation and Nuclear Countermeasures Program at the National Institute of Allergy and Infectious Diseases; federal government; Kelly Government Solutions, a division of Kelly Services; NATIONAL CANCER INSTITUTE [ZIABC011078] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program at the Center for Cancer Research at National Cancer Institute; Radiation and Nuclear Countermeasures Program at the National Institute of Allergy and Infectious Diseases; federal government; Kelly Government Solutions, a division of Kelly Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was also supported by the Intramural Research Program at the Center for Cancer Research at National Cancer Institute [Z01BC006150] and by the Radiation and Nuclear Countermeasures Program at the National Institute of Allergy and Infectious Diseases. The Frederick National Laboratory for Cancer Research, which is funded by the federal government and operated by Leidos Biomedical Research, Inc., provided support in the form of salaries for authors J.J., Y.Z., and R.E.P. Leidos Biomedical Research, Inc., is prime contractor for the operation of Frederick National Laboratory and is therefore precluded from conducting any business that represents a conflict of interest with this contract. L.K.F., who is a government contractor at the National Cancer Institute, received support in the form of a salary from Kelly Government Solutions, a division of Kelly Services. The specific roles of all authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Antony S, 2005, MOL PHARMACOL, V67, P523, DOI 10.1124/mol.104.003889; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Belin BJ, 2015, ELIFE, V4, DOI [10.7554/eLife.07735, 10.7554/eLife.11935]; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bourton EC, 2012, CYTOM PART A, V81A, P130, DOI 10.1002/cyto.a.21171; Chen EX, 2016, INVEST NEW DRUG, V34, P450, DOI 10.1007/s10637-016-0351-x; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; DINCALCI M, 1986, EUR J BIOCHEM, V154, P273, DOI 10.1111/j.1432-1033.1986.tb09393.x; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Ferry-Galow KV, 2016, SEMIN ONCOL, V43, P492, DOI 10.1053/j.seminoncol.2016.06.007; Hassan M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/150845; Hehlgans S, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0507-4; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Jeggo PA, 2016, NAT REV CANCER, V16, P35, DOI 10.1038/nrc.2015.4; Ji JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026152; Kinders RJ, 2008, CLIN CANCER RES, V14, P6877, DOI 10.1158/1078-0432.CCR-08-0214; Kinders RJ, 2010, CLIN CANCER RES, V16, P5447, DOI 10.1158/1078-0432.CCR-09-3076; Kummar S, 2011, CANCER RES, V71, P5626, DOI 10.1158/0008-5472.CAN-11-1227; Matsuzaki K, 2010, MUTAT RES-GEN TOX EN, V700, P71, DOI 10.1016/j.mrgentox.2010.05.009; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Redon CE, 2012, BBA-GENE REGUL MECH, V1819, P743, DOI 10.1016/j.bbagrm.2012.02.021; Redon CE, 2011, AGING-US, V3, P168, DOI 10.18632/aging.100284; Redon CE, 2011, METHODS MOL BIOL, V682, P249, DOI 10.1007/978-1-60327-409-8_18; Reinhold WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101670; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Samol J, 2012, INVEST NEW DRUG, V30, P1493, DOI 10.1007/s10637-011-9682-9; Schettino Clorinda, 2008, Expert Rev Respir Med, V2, P167, DOI 10.1586/17476348.2.2.167; Sedelnikova OA, 2006, CELL CYCLE, V5, P2909, DOI 10.4161/cc.5.24.3569; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shinagawa T, 2014, CELL STEM CELL, V14, P217, DOI 10.1016/j.stem.2013.12.015; Singh R, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9095-4; Skene PJ, 2013, DEVELOPMENT, V140, P2513, DOI 10.1242/dev.091439; Smith LM, 2005, CLIN CANCER RES, V11, P8449, DOI 10.1158/1078-0432.CCR-05-1224; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Tahara M, 2014, MOL CANCER THER, V13, P1170, DOI 10.1158/1535-7163.MCT-13-0683; Tsuruo T, 2003, CANCER SCI, V94, P15, DOI 10.1111/j.1349-7006.2003.tb01345.x; Varma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092047; Voigt W, 1998, ANTICANCER RES, V18, P3499; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; WU RS, 1983, BIOCHEMISTRY-US, V22, P3868, DOI 10.1021/bi00285a023; Wu Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7593787; Xu Y, 2015, BIOMOLECULES, V5, P1652, DOI 10.3390/biom5031652; Zhang YW, 2011, NUCLEIC ACIDS RES, V39, P3607, DOI 10.1093/nar/gkq1304	52	56	60	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171582	10.1371/journal.pone.0171582	http://dx.doi.org/10.1371/journal.pone.0171582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158293	gold, Green Submitted, Green Published			2022-12-26	WOS:000396161700102
J	van Rijnberk, LM; van der Horst, SEM; van den Heuvel, S; Ruijtenberg, S				van Rijnberk, Lotte M.; van der Horst, Suzanne E. M.; van den Heuvel, Sander; Ruijtenberg, Suzan			A dual transcriptional reporter and CDK-activity sensor marks cell cycle entry and progression in C-elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; DEVELOPMENTAL REGULATION; DEPENDENT KINASE; GENE-EXPRESSION; S-PHASE; PROLIFERATION; INHIBITION; UNDERLIES; PROTEIN; POINT	Development, tissue homeostasis and tumor suppression depend critically on the correct regulation of cell division. Central in the cell division process is the decision whether to enter the next cell cycle and commit to going through the S and M phases, or to remain temporarily or permanently arrested. Cell cycle studies in genetic model systems could greatly benefit from visualizing cell cycle commitment in individual cells without the need of fixation. Here, we report the development and characterization of a reporter to monitor cell cycle entry in the nematode C. elegans. This reporter combines the mcm-4 promoter, to reveal Rb/E2F-mediated transcriptional control, and a live-cell sensor for CDK-activity. The CDK sensor was recently developed for use in human cells and consists of a DNA Helicase fragment fused to eGFP. Upon phosphorylation by CDKs, this fusion protein changes in localization from the nucleus to the cytoplasm. The combined regulation of transcription and subcellular localization enabled us to visualize the moment of cell cycle entry in dividing seam cells during C. elegans larval development. This reporter is the first to reflect cell cycle commitment in C. elegans and will help further genetic studies of the mechanisms that underlie cell cycle entry and exit.	[van Rijnberk, Lotte M.; van der Horst, Suzanne E. M.; van den Heuvel, Sander; Ruijtenberg, Suzan] Univ Utrecht, Fac Sci, Dept Biol, Dev Biol, Padualaan 8, Utrecht, Netherlands; [van Rijnberk, Lotte M.; Ruijtenberg, Suzan] Hubrecht Inst, Uppsalalaan 8, Utrecht, Netherlands	Utrecht University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	van den Heuvel, S; Ruijtenberg, S (corresponding author), Univ Utrecht, Fac Sci, Dept Biol, Dev Biol, Padualaan 8, Utrecht, Netherlands.; Ruijtenberg, S (corresponding author), Hubrecht Inst, Uppsalalaan 8, Utrecht, Netherlands.	s.j.l.vandenheuvel@uu.nl; s.ruijtenberg@hubrecht.eu	van den Heuvel, Sander J.L./B-8892-2011	van den Heuvel, Sander J.L./0000-0001-9015-7463; van der Horst, Suzanne/0000-0001-6495-3482	CW ECHO grant - Netherlands Organization for Scientific Research (NWO) [711.011.010]; NIH Office of Research Infrastructure Programs [P40 OD010440]	CW ECHO grant - Netherlands Organization for Scientific Research (NWO); NIH Office of Research Infrastructure Programs	This research was part of CW ECHO grant 711.011.010 (SvdH) financed by the Netherlands Organization for Scientific Research (NWO). Some strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr AR, 2016, CELL SYST, V2, P27, DOI 10.1016/j.cels.2016.01.001; Boxem M, 1999, DEVELOPMENT, V126, P2227; Boxem M, 2001, DEVELOPMENT, V128, P4349; Brodigan TM, 2003, DEV BIOL, V254, P102, DOI 10.1016/S0012-1606(02)00032-5; Cappell SD, 2016, CELL, V166, P167, DOI 10.1016/j.cell.2016.05.077; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Euling S, 1996, CELL, V84, P667, DOI 10.1016/S0092-8674(00)81045-4; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; Hahn AT, 2009, CELL CYCLE, V8, P1044, DOI 10.4161/cc.8.7.8042; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; Hong Y, 1998, DEVELOPMENT, V125, P3585; Karnani N, 2011, GENE DEV, V25, P621, DOI 10.1101/gad.2029711; Kim J, 2007, CURR BIOL, V17, P966, DOI 10.1016/j.cub.2007.04.055; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Korzelius J, 2011, DEV BIOL, V350, P358, DOI 10.1016/j.ydbio.2010.12.009; Park M, 1999, DEVELOPMENT, V126, P4849; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Redemann S, 2011, NAT METHODS, V8, P250, DOI [10.1038/nmeth.1565, 10.1038/NMETH.1565]; Regot S, 2014, CELL, V157, P1724, DOI 10.1016/j.cell.2014.04.039; Ruijtenberg S, 2016, CELL CYCLE, V15, P196, DOI 10.1080/15384101.2015.1120925; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Sulston J. E., 1977, CAENORHABDITIS ELEGA, V156, P110; The I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6906; van den Heuvel S, 2012, METHOD CELL BIOL, V107, P265, DOI 10.1016/B978-0-12-394620-1.00009-6; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711	28	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171600	10.1371/journal.pone.0171600	http://dx.doi.org/10.1371/journal.pone.0171600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158315	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700107
J	Xian, Y; Zhu, BW; Zhang, X; Ma, P; Wei, Y; Xia, HL; Jiang, WJ; Yang, CQ; Meng, XJ; Peng, P; Yang, Y; Jiang, LY; Chu, MJ; Zhuang, X				Xian, Yun; Zhu, Bowen; Zhang, Xuan; Ma, Ping; Wei, Ye; Xia, Hongli; Jiang, Wenjie; Yang, Changqing; Meng, Xiaojun; Peng, Peng; Yang, Yue; Jiang, Liying; Chu, Minjie; Zhuang, Xun			Risk factors associated with sexually transmitted infections among HIV infected men who have sex with men	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; PREVENTION; CHINA; EPIDEMIOLOGY; MUTATIONS	To investigate the factors associated with sexually transmitted infection and Human Immunodeficiency Virus (STI-HIV) co-infection among men who have sex with men (MSM). A total of 357 HIV-infected participants (84 STI-HIV co-infection and 273 HIV infections only) were recruited from Jiangsu, China. Logistic regression analyses were used to estimate the related factors associated with STI-HIV co-infection. Marginal structural models were adopted to estimate the effect of transmission drug resistance (TDR) on STI-HIV co-infection. For all participants, logistic regression analyses revealed that those who diagnosed with HIV-1 for longer duration (>= 1.8 years) were significantly associated with reduced STI-HIV co-infection risk (OR = 0.55, 95% CI: 0.32-0.96, P = 0.036). In further stratification analysis by antiretroviral therapy (ART), individuals with longer duration showed consistent significant associations with STI-HIV co-infection risk (OR = 0.46, 95% CI: 0.26-0.83, P = 0.010) among MSM with ART-naive status. In addition, significant reduced risk for STI-HIV co-infection (OR = 0.98, 95% CI: 0.96-0.99, P = 0.010) were observed in younger (under the average age of 31.03) MSM of the same group. Interestingly, we also found TDR was significantly associated with an increased risk of STI-HIV co-infection risk (OR = 3.84, 95% CI: 1.05-14.03, P = 0.042) in ART-naive group. Our study highlights a pattern of STI-HIV coinfection among MSM in China and indicates that targeted interventions aimed at encouraging TDR monitoring in MSM with early HIV infection are warranted.	[Xian, Yun; Zhu, Bowen; Peng, Peng; Yang, Yue; Jiang, Liying; Chu, Minjie; Zhuang, Xun] Nantong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nantong City, Jiangsu, Peoples R China; [Zhang, Xuan; Meng, Xiaojun] Wuxi Ctr Dis Control & Prevent, Wuxi City, Jiangsu, Peoples R China; [Ma, Ping; Wei, Ye; Xia, Hongli] Nantong Ctr Dis Control & Prevent, Nantong City, Jiangsu, Peoples R China; [Jiang, Wenjie] Univ Bath, Dept Management Studies, Bath, Avon, England; [Yang, Changqing] Yancheng Ctr Dis Control & Prevent, Yancheng City, Jiangsu, Peoples R China; [Zhuang, Xun] Nantong Univ, Sch Publ Hlth, Dept Epidemiol, Nantong, Peoples R China	Nantong University; University of Bath; Nantong University	Zhuang, X (corresponding author), Nantong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nantong City, Jiangsu, Peoples R China.; Zhuang, X (corresponding author), Nantong Univ, Sch Publ Hlth, Dept Epidemiol, Nantong, Peoples R China.	xzhuang@ntu.edu.cn						Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Bruner KM, 2016, NATURE MED; Castillo JJ, 2015, CANCER; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Silva MCF, 2009, REV INST MED TROP SP, V51, P135, DOI 10.1590/S0036-46652009000300003; Frentz D, 2012, AIDS REV, V14, P17; Gulov K, 2016, AIDS BEHAV; He Q, 2006, AIDS BEHAV, V10, pS17, DOI 10.1007/s10461-006-9125-3; He X., 2012, INT J ANTENN PROPAG, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0047289; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Jensen A K, 2016, STAT MED; Kalichman SC, 2011, SEX TRANSM INFECT, V87, P183, DOI 10.1136/sti.2010.047514; Li ZP, 2013, J ANTIMICROB CHEMOTH, V68, P2521, DOI 10.1093/jac/dkt228; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Manosuthi W, 2013, J MED VIROL, V85, P194, DOI 10.1002/jmv.23452; Mendoza Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154317; Ostrowski M, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv138; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; Schiffer JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155124; Schnarrs PW, 2016, J HOMOSEXUAL, P1; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Tang W, 2016, SEXUALLY TRANSMITTED; Tang ZZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000902; Vermund SH, 2013, CURR HIV-AIDS REP, V10, P169, DOI 10.1007/s11904-013-0155-y; White MK, 2006, VIROLOGY, V352, P1, DOI 10.1016/j.virol.2006.04.006; Winand R, 2015, AIDS, V29, P2045, DOI 10.1097/QAD.0000000000000811; Zheng WJ, 2016, INT J BIOSTAT, V12, P233, DOI 10.1515/ijb-2015-0036; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196; Zhou Q, 2016, AIDS CARE, V21, P1	31	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170635	10.1371/journal.pone.0170635	http://dx.doi.org/10.1371/journal.pone.0170635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158317	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161700016
J	Dozier, C; Mazzolini, L; Cenac, C; Froment, C; Burlet-Schiltz, O; Besson, A; Manenti, S				Dozier, C.; Mazzolini, L.; Cenac, C.; Froment, C.; Burlet-Schiltz, O.; Besson, A.; Manenti, S.			CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability	ONCOGENE			English	Article							CELL-CYCLE ARREST; BETA-TRCP; DEPENDENT KINASES; MAMMARY TUMORIGENESIS; G(1)/S TRANSITION; PHOSPHATASES; ACTIVATION; DEGRADATION; EXPRESSION; TARGETS	The phosphatase CDC25A is a key regulator of cell cycle progression by dephosphorylating and activating cyclin-CDK complexes. CDC25A is an unstable protein expressed from G1 until mitosis. CDC25A overexpression, which can be caused by stabilization of the protein, accelerates the G1/S and G2/M transitions, leading to genomic instability and promoting tumorigenesis. Thus, controlling CDC25A protein levels by regulating its stability is a critical mechanism for timing cell cycle progression and to maintain genomic integrity. Herein, we show that CDC25A is phosphorylated on Ser40 throughout the cell cycle and that this phosphorylation is established during the progression from G1 to S phase. We demonstrate that CyclinD-CDK4/CDK6 complexes mediate the phosphorylation of CDC25A on Ser40 during G1 and that these complexes directly phosphorylate this residue in vitro. Importantly, we also find that CyclinD1-CDK4 decreases CDC25A stability in a beta TrCP-dependent manner and that Ser40 and Ser88 phosphorylations contribute to this regulation. Thus our results identify cyclinD-CDK4/6 complexes as novel regulators of CDC25A stability during G1 phase, generating a negative feedback loop allowing control of the G1/S transition.	[Dozier, C.; Mazzolini, L.; Cenac, C.; Besson, A.; Manenti, S.] Univ Toulouse III Paul Sabatier, INSERM UMR1037, Canc Res Ctr Toulouse, Toulouse, France; [Dozier, C.; Mazzolini, L.; Manenti, S.] CNRS ERL5294, Equipe Labellisee Ligue Canc, Toulouse, France; [Froment, C.; Burlet-Schiltz, O.] Univ Toulouse, CNRS UMR5089, Inst Pharmacol & Biol Struct, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Dozier, C (corresponding author), Univ Toulouse III Paul Sabatier, INSERM UMR1037, Canc Res Ctr Toulouse, CNRS ERL5294, Toulouse, France.	christine.dozier@inserm.fr	Besson, Arnaud/J-6254-2014; manenti, stephane/P-1518-2014	Besson, Arnaud/0000-0002-9599-3943; manenti, stephane/0000-0002-4793-3196; CENAC, Claire/0000-0001-6641-7851; Schiltz, Odile/0000-0002-3606-2356	Region Midi-Pyrenees; Toulouse Metropole; European funds FEDER (Fonds Europeens de Developpement Regional)	Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur); Toulouse Metropole; European funds FEDER (Fonds Europeens de Developpement Regional)	We thank H. Piwnica-Worms for providing phospho-Ser76, 82 and 88 CDC25A antibodies, V. Dulic for providing BJ-hTert cells and M. Gotanegre for technical assistance. This work was supported in part by grants to OBS from the Region Midi-Pyrenees, Toulouse Metropole and European funds FEDER (Fonds Europeens de Developpement Regional) for mass spectrometry.	Bertero T, 2013, CELL DEATH DIFFER, V20, P800, DOI 10.1038/cdd.2013.5; Bhowmick NA, 2003, P NATL ACAD SCI USA, V100, P15548, DOI 10.1073/pnas.2536483100; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Chang KH, 2012, J CELL SCI, V125, P5124, DOI 10.1242/jcs.108183; Chung JH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000863; Clucas C, 2002, EMBO J, V21, P665, DOI 10.1093/emboj/21.4.665; Ducruet AP, 2003, J BIOL CHEM, V278, P31838, DOI 10.1074/jbc.M303604200; Fernandez-Vidal A, 2006, CANCER RES, V66, P7128, DOI 10.1158/0008-5472.CAN-05-2552; Fernandez-Vidal A, 2008, ANTI-CANCER AGENT ME, V8, P825, DOI 10.2174/187152008786847684; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gubanova E, 2013, CELL CYCLE, V12, P3770, DOI 10.4161/cc.26660; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; Honaker Y, 2010, ONCOGENE, V29, P3324, DOI 10.1038/onc.2010.96; Hutchins JRA, 2004, CELL CYCLE, V3, P41; Isoda M, 2009, MOL BIOL CELL, V20, P2186, DOI 10.1091/mbc.E09-01-0008; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Karagoz ID, 2010, TUMOR BIOL, V31, P597, DOI 10.1007/s13277-010-0075-z; Khaled AR, 2005, J CELL BIOL, V169, P755, DOI 10.1083/jcb.200409099; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Kittipatarin C, 2006, CELL CYCLE, V5, P907, DOI 10.4161/cc.5.9.2693; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Ray D, 2007, CANCER RES, V67, P6605, DOI 10.1158/0008-5472.CAN-06-4815; Ray D, 2007, CANCER RES, V67, P984, DOI 10.1158/0008-5472.CAN-06-3927; Shen T, 2012, ANTI-CANCER AGENT ME, V12, P631, DOI 10.2174/187152012800617678; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Tumurbaatar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014711; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Watanabe H, 1998, P NATL ACAD SCI USA, V95, P1392, DOI 10.1073/pnas.95.4.1392; Yin M, 2011, CELL DIV, V6, P4	37	29	32	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 29	2017	36	26					3781	3788		10.1038/onc.2016.506	http://dx.doi.org/10.1038/onc.2016.506			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY9WM	28192398				2022-12-26	WOS:000404349700013
J	Lupu, DS; Orozco, LD; Wang, Y; Cullen, JM; Pellegrini, M; Zeisel, SH				Lupu, Daniel S.; Orozco, Luz D.; Wang, Ying; Cullen, John M.; Pellegrini, Matteo; Zeisel, Steven H.			Altered methylation of specific DNA loci in the liver of Bhmt-null mice results in repression of Iqgap2 and F2rl2 and is associated with development of preneoplastic foci	FASEB JOURNAL			English	Article						betaine; folate; epigenetics; methylome	HEPATOCELLULAR-CARCINOMA; GST-P; EPIGENETIC ALTERATIONS; S-ADENOSYLMETHIONINE; MASS-SPECTROMETRY; DEFICIENT DIET; IN-VITRO; HOMOCYSTEINE; CANCER; CELLS	Folate B-12-dependent remethylation of homocysteine is important, but less is understood about the importance of the alternative betaine-dependent methylation pathway-catalyzed by betaine-homocysteine methyltransferase (BHMT)-for establishing and maintaining adequate DNA methylation across the genome. We studied C57Bl/6J Bhmt (betaine-homocysteine methyltransferase)-null mice at age 4, 12, 24, and 52 wk (N = 8) and observed elevation of S-adenosylhomocysteine concentrations and development of preneoplastic foci in the liver (increased placental glutathione S-transferase and cytokeratin 8-18 activity; starting at 12 wk). At 4 wk, we identified 63 differentially methylated CpGs (DMCs; false discovery rate < 5%) proximal to 81 genes (across 14 chromosomes), of which 18 were differentially expressed. Of these DMCs, 52% were located in one 15.5-Mb locus on chromosome 13, which encompassed the Bhmt gene and defined a potentially sensitive region with mostly decreased methylation. Analyzing Hybrid Mouse Diversity Panel data, which consisted of 100 inbred strains of mice, we identified 97 DMCs that were affected by Bhmt genetic variation in the same region, with 7 overlapping those found in Bhmt-null mice (P < 0.001). At all time points, we found a hypomethylated region mapping to Iqgap2 (IQ motif-containing GTPase activating protein 2) and F2rl2 (proteinase-activated receptor-3), 2 genes that were also silenced and underexpressed, respectively.-Lupu, D. S., Orozco, L. D., Wang, Y., Cullen, J. M., Pellegrini, M., Zeisel, S. H. Altered methylation of specific DNA loci in the liver of Bhmt-null mice results in repression of Iqgap2 and F2rl2 and is associated with development of preneoplastic foci.	[Lupu, Daniel S.; Zeisel, Steven H.] Univ N Carolina, Inst Nutr Res, Dept Nutr, Kannapolis, NC USA; [Orozco, Luz D.; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Wang, Ying; Cullen, John M.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Shanghai, Peoples R China	University of North Carolina; University of California System; University of California Los Angeles	Zeisel, SH (corresponding author), Univ N Carolina, 500 Laureate Way, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu	LUPU, DANIEL/A-6004-2011; Cullen, John M/I-2051-2019; LUPU, DANIEL/K-1990-2014	Pellegrini, Matteo/0000-0001-9355-9564; LUPU, DANIEL/0000-0001-8174-5482	University of North Carolina Nutrition Research Institute; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK56350]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	University of North Carolina Nutrition Research Institute; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the University of North Carolina Nutrition Research Institute and by a U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK56350. The authors thank Jennifer Owen, for assisting with blinded analysis of GSTP-positive cells in liver, and Scott Jaworski, for help with figure editing (both from University of North Carolina at Chapel Hill).	Avila MA, 2002, ALCOHOL, V27, P163, DOI 10.1016/S0741-8329(02)00228-8; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Clarke S, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P63; Ducros V, 2006, CLIN CHEM LAB MED, V44, P987, DOI 10.1515/CCLM.2006.178; Fernandez AF, 2015, GENOME RES, V25, P27, DOI 10.1101/gr.169011.113; FINKELSTEIN JD, 1984, J BIOL CHEM, V259, P9508; Gnatenko DV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071826; Guo XJ, 2016, CLIN EXP MED, V16, P357, DOI 10.1007/s10238-015-0365-2; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Ittrich C, 2003, TOXICOL PATHOL, V31, P60, DOI 10.1080/01926230390173888; Jiang SM, 2015, J HEPATOL, V62, P371, DOI 10.1016/j.jhep.2014.09.026; Kakehashi A, 2010, TOXICOL APPL PHARM, V242, P47, DOI 10.1016/j.taap.2009.09.013; Kakehashi A, 2009, TOXICOL APPL PHARM, V238, P71, DOI 10.1016/j.taap.2009.04.018; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Koc H, 2002, ANAL CHEM, V74, P4734, DOI 10.1021/ac025624x; Kok DEG, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0154-5; Koushik A, 2006, CANCER EPIDEM BIOMAR, V15, P2408, DOI 10.1158/1055-9965.EPI-06-0624; Kushida M, 2011, TOXICOL PATHOL, V39, P776, DOI 10.1177/0192623311409596; Lin NN, 2014, FEBS J, V281, P2088, DOI 10.1111/febs.12764; Ly A, 2012, ANTIOXID REDOX SIGN, V17, P302, DOI 10.1089/ars.2012.4554; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Megger DA, 2013, MOL CELL PROTEOMICS, V12, P2006, DOI 10.1074/mcp.M113.028027; MOLLOY AM, 1990, BIOMED CHROMATOGR, V4, P257, DOI 10.1002/bmc.1130040611; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; National Research Council, 1995, NUTR REQ LAB AN; Ni M, 2013, GENE DEV, V27, P734, DOI 10.1101/gad.209569.112; Niculescu MD, 2013, FASEB J, V27, P350, DOI 10.1096/fj.12-210724; Nilsson E, 2015, J CLIN ENDOCR METAB, V100, pE1491, DOI 10.1210/jc.2015-3204; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Orozco LD, 2015, CELL METAB, V21, P905, DOI 10.1016/j.cmet.2015.04.025; Orozco LD, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r68; Pellanda H, 2012, INT J BIOCHEM CELL B, V44, P385, DOI 10.1016/j.biocel.2011.11.014; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Pogribny IP, 2009, MUTAT RES-FUND MOL M, V669, P56, DOI 10.1016/j.mrfmmm.2009.05.003; Pogribny IP, 2008, BRAIN RES, V1237, P25, DOI 10.1016/j.brainres.2008.07.077; Salbaum JM, 2012, PROG MOL BIOL TRANSL, V108, P129, DOI 10.1016/B978-0-12-398397-8.00006-X; Satoh K, 2002, CARCINOGENESIS, V23, P1193, DOI 10.1093/carcin/23.7.1193; Saw SM, 2001, AM J CLIN NUTR, V73, P232; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Segal L, 2014, PANCREAS, V43, P103, DOI 10.1097/MPA.0b013e31829f0b81; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Takumi S, 2015, J APPL TOXICOL, V35, P1550, DOI 10.1002/jat.3117; TATEMATSU M, 1987, TOXICOL PATHOL, V15, P60, DOI 10.1177/019262338701500107; Tehlivets O, 2013, BBA-MOL BASIS DIS, V1832, P204, DOI 10.1016/j.bbadis.2012.09.007; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Tsuda H, 2003, TOXICOL PATHOL, V31, P80, DOI 10.1080/01926230390173879; Vaitheesvaran B, 2014, METABOLOMICS, V10, P920, DOI 10.1007/s11306-014-0639-9; Warner DR, 2003, FEBS LETT, V539, P167, DOI 10.1016/S0014-5793(03)00155-8; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	53	6	6	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2090	2103		10.1096/fj.201601169R	http://dx.doi.org/10.1096/fj.201601169R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28179424	Green Published, Green Submitted			2022-12-26	WOS:000399195500028
J	Thangaraj, MP; Furber, KL; Gan, JK; Ji, SP; Sobchishin, L; Doucette, JR; Nazarali, AJ				Thangaraj, Merlin P.; Furber, Kendra L.; Gan, Jotham K.; Ji, Shaoping; Sobchishin, Larhonda; Doucette, J. Ronald; Nazarali, Adil J.			RNA-binding Protein Quaking Stabilizes Sirt2 mRNA during Oligodendroglial Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; BASIC-PROTEIN; NERVOUS-SYSTEM; MUTANT MICE; CELL-DIFFERENTIATION; PROTEOLIPID PROTEIN; GENE-EXPRESSION; PRECURSOR CELLS; CNS MYELIN; QKI	Myelination is controlled by timely expression of genes involved in the differentiation of oligodendrocyte precursor cells (OPCs) into myelinating oligodendrocytes (OLs). Sirtuin 2 (SIRT2), a NAD(+)-dependent deacetylase, plays a critical role in OL differentiation by promoting both arborization and downstream expression of myelin-specific genes. However, the mechanisms involved in regulating SIRT2 expression during OL development are largely unknown. The RNA-binding protein quaking (QKI) plays an important role in myelination by post-transcriptionally regulating the expression of several myelin specific genes. In quaking viable (qk(v)/qk(v)) mutant mice, SIRT2 protein is severely reduced; however, it is not known whether these genes interact to regulate OL differentiation. Here, we report for the first time that QKI directly binds to Sirt2 mRNA via a common quaking response element (QRE) located in the 3' untranslated region (UTR) to control SIRT2 expression in OL lineage cells. This interaction is associated with increased stability and longer half-lives of Sirt2.1 and Sirt2.2 transcripts leading to increased accumulation of Sirt2 transcripts. Consistent with this, overexpression of qkI promoted the expression of Sirt2 mRNA and protein. However, overexpression of the nuclear isoform qkI-5 promoted the expression of Sirt2mRNA, but not SIRT2 protein, and delayed OL differentiation. These results suggest that the balance in the subcellular distribution and temporal expression of QKI isoforms control the availability of Sirt2 mRNA for translation. Collectively, our study demonstrates that QKI directly plays a crucial role in the post-transcriptional regulation and expression of Sirt2 to facilitate OL differentiation.	[Thangaraj, Merlin P.; Furber, Kendra L.; Gan, Jotham K.; Ji, Shaoping; Sobchishin, Larhonda; Nazarali, Adil J.] Univ Saskatchewan, Coll Pharm & Nutr, Mol Cell Biol Lab, Saskatoon, SK S7N 5E5, Canada; [Doucette, J. Ronald] Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, Saskatoon, SK S7N 5E5, Canada; [Thangaraj, Merlin P.; Furber, Kendra L.; Gan, Jotham K.; Ji, Shaoping; Sobchishin, Larhonda; Doucette, J. Ronald; Nazarali, Adil J.] Univ Saskatchewan, Neurosci Res Cluster, Saskatoon, SK S7N 5E5, Canada; [Doucette, J. Ronald; Nazarali, Adil J.] City Hosp, Cameco Multiple Sclerosis Neurosci Res Ctr, Saskatoon, SK S7K 0M7, Canada; [Ji, Shaoping] Henan Univ, Sch Med, Dept Biochem & Mol Biol, Kaifeng 475004, Peoples R China	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; Henan University	Nazarali, AJ (corresponding author), Univ Saskatchewan, Coll Pharm & Nutr, Mol Cell Biol Lab, Saskatoon, SK S7N 5E5, Canada.; Nazarali, AJ (corresponding author), Univ Saskatchewan, Neurosci Res Cluster, Saskatoon, SK S7N 5E5, Canada.; Nazarali, AJ (corresponding author), City Hosp, Cameco Multiple Sclerosis Neurosci Res Ctr, Saskatoon, SK S7K 0M7, Canada.	aj.nazarali@usask.ca		Thangaraj, Merlin Premalatha/0000-0002-5407-0069	Canadian Institutes of Health Research (CIHR Institute of Aging); Saskatchewan Health Research Foundation (SHRF); Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR Institute of Aging)(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation (SHRF); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by an operating grant from the Canadian Institutes of Health Research (CIHR Institute of Aging), the Saskatchewan Health Research Foundation (SHRF) (to A.J.N. and J.R.D.) and the Natural Sciences and Engineering Research Council of Canada (NSERC) (to A.J.N.). The authors declare that they have no conflicts of interest with the contents of this article.	Baudouin-Legros M, 2005, AM J PHYSIOL-CELL PH, V289, pC1240, DOI 10.1152/ajpcell.00595.2004; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Beuck C, 2012, J MOL BIOL, V423, P766, DOI 10.1016/j.jmb.2012.08.027; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Chen YT, 2007, J BIOL CHEM, V282, P23553, DOI 10.1074/jbc.M702045200; Cox RD, 1999, GENOMICS, V57, P333, DOI 10.1006/geno.1999.5804; Doucette JR, 2010, CELL MOL NEUROBIOL, V30, P607, DOI 10.1007/s10571-009-9486-z; Doukhanine E, 2010, MOL BIOL CELL, V21, P3029, DOI 10.1091/mbc.E10-04-0305; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Emery B, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020461; FOKSEANG J, 1994, J NEUROSCI RES, V37, P219, DOI 10.1002/jnr.490370208; FUJITA N, 1988, FEBS LETT, V232, P323, DOI 10.1016/0014-5793(88)80762-2; FUJITA N, 1990, J NEUROCHEM, V55, P1056, DOI 10.1111/j.1471-4159.1990.tb04596.x; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Hardy RJ, 1998, J NEUROSCI RES, V54, P46, DOI 10.1002/(SICI)1097-4547(19981001)54:1<46::AID-JNR6>3.0.CO;2-H; Inoue T, 2007, CELL CYCLE, V6, P1011, DOI 10.4161/cc.6.9.4219; Ji SP, 2011, J MOL CELL BIOL, V3, P351, DOI 10.1093/jmcb/mjr009; Kondo T, 1999, MAMM GENOME, V10, P662; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Li WB, 2007, J NEUROSCI, V27, P2606, DOI 10.1523/JNEUROSCI.4181-06.2007; Li ZZ, 2000, J NEUROSCI, V20, P4944; LOUIS JC, 1992, GLIA, V6, P30, DOI 10.1002/glia.440060105; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; Lu ZF, 2003, NUCLEIC ACIDS RES, V31, P4616, DOI 10.1093/nar/gkg635; Maxwell MM, 2011, HUM MOL GENET, V20, P3986, DOI 10.1093/hmg/ddr326; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Nicoilay DJ, 2007, GLIA, V55, P1287, DOI 10.1002/glia.20540; Niu JQ, 2012, J NEUROSCI METH, V209, P241, DOI 10.1016/j.jneumeth.2012.05.032; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; ROTH HJ, 1985, J NEUROCHEM, V45, P572, DOI 10.1111/j.1471-4159.1985.tb04025.x; Ryder SP, 2004, RNA, V10, P1449, DOI 10.1261/rna.7780504; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; SORG BJA, 1986, J NEUROCHEM, V46, P379, DOI 10.1111/j.1471-4159.1986.tb12979.x; Southwood CM, 2007, NEUROCHEM RES, V32, P187, DOI 10.1007/s11064-006-9127-6; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Wang M, 2011, CELL MOL NEUROBIOL, V31, P875, DOI 10.1007/s10571-011-9685-2; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Zearfoss NR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001269; Zhang YY, 2003, EMBO J, V22, P1801, DOI 10.1093/emboj/cdg171; Zhao LX, 2006, J NEUROSCI, V26, P11278, DOI 10.1523/JNEUROSCI.2677-06.2006; Zhao LX, 2006, MOL BIOL CELL, V17, P4179, DOI 10.1091/mbc.E06-04-0355; Zhao LX, 2010, P NATL ACAD SCI USA, V107, P19061, DOI 10.1073/pnas.1007487107; Zhu H, 2012, GLIA, V60, P69, DOI 10.1002/glia.21248	55	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5166	5182		10.1074/jbc.M117.775544	http://dx.doi.org/10.1074/jbc.M117.775544			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28188285	hybrid, Green Published			2022-12-26	WOS:000397875500002
J	Lonhienne, T; Garcia, MD; Guddat, LW				Lonhienne, Thierry; Garcia, Mario D.; Guddat, Luke W.			The Role of a FAD Cofactor in the Regulation of Acetohydroxyacid Synthase by Redox Signaling Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETOLACTATE SYNTHASE; ACID SYNTHASE; PURIFICATION	Acetohydroxyacid synthase (AHAS) catalyzes the first step of branched-chain amino acid (BCAA) biosynthesis, a pathway essential to the lifecycle of plants and microorganisms. This enzyme is of high interest because its inhibition is at the base of the exceptional potency of herbicides and potentially a target for the discovery of new antimicrobial drugs. The enzyme has conserved attributes from its predicted ancestor, pyruvate oxidase, such as a ubiquinone-binding site and the requirement for FAD as cofactor. Here, we show that these requirements are linked to the regulation of AHAS, in relationship to its anabolic function. Using various soluble quinone derivatives (e.g. ubiquinones), we reveal a new path of down- regulation of AHAS activity involving inhibition by oxidized redox-signaling molecules. The inhibition process relies on two factors specific to AHAS: (i) the requirement of a reduced FAD cofactor for the enzyme to be active and (ii) a characteristic slow rate of FAD reduction by the pyruvate oxidase side reaction of the enzyme. The mechanism of inhibition involves the oxidation of the FAD cofactor, leading to a time-dependent inhibition of AHAS correlated with the slow process of FAD re-reduction. The existence and conservation of such a complex mechanism suggests that the redox level of the environment regulates the BCAA biosynthesis pathway. This mode of regulation appears to be the foundation of the inhibitory activity of many of the commercial herbicides that target AHAS.	[Lonhienne, Thierry; Garcia, Mario D.; Guddat, Luke W.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland	Lonhienne, T (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.; Guddat, LW (corresponding author), Univ Queensland, Dept Biosci, Sch Chem & Mol Biol, Bldg 76,Cooper Rd, St Lucia, Qld 4072, Australia.	t.lonhienne@uq.edu.au; luke.guddat@uq.edu.au	Guddat, Luke/AAI-2930-2021	Garcia, Mario/0000-0001-8378-7475	National Health and Medical Research Council [1008736]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by Grant 1008736 from the National Health and Medical Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Hwang J, 2003, B KOREAN CHEM SOC, V24, P1856; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lonhienne T, 2016, ANGEW CHEM INT EDIT, V55, P4247, DOI 10.1002/anie.201511985; McCourt JA, 2006, P NATL ACAD SCI USA, V103, P569, DOI 10.1073/pnas.0508701103; MULLER YA, 1993, SCIENCE, V259, P965, DOI 10.1126/science.8438155; Pang SS, 2002, J MOL BIOL, V317, P249, DOI 10.1006/jmbi.2001.5419; Pang SS, 1999, BIOCHEMISTRY-US, V38, P5222, DOI 10.1021/bi983013m; Pang SS, 2001, BIOCHEM J, V357, P749, DOI 10.1042/0264-6021:3570749; Pang SS, 2001, ACTA CRYSTALLOGR D, V57, P1321, DOI 10.1107/S0907444901011635; Schloss J. V., 1991, CHEM BIOCH FLAVOENZY, VIII, P531; SCHLOSS JV, 1985, BIOCHEMISTRY-US, V24, P4952, DOI 10.1021/bi00339a034; SCHLOSS JV, 1988, NATURE, V331, P360, DOI 10.1038/331360a0; SINGH BK, 1988, ANAL BIOCHEM, V171, P173, DOI 10.1016/0003-2697(88)90139-X; Tittmann K, 2004, BIOCHEMISTRY-US, V43, P8652, DOI 10.1021/bi049897t	16	8	8	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5101	5109		10.1074/jbc.M116.773242	http://dx.doi.org/10.1074/jbc.M116.773242			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28159840	Green Published, hybrid			2022-12-26	WOS:000397590400029
J	O'Hara, SP; Splinter, PL; Trussoni, CE; Pisarello, MJL; Loarca, L; Splinter, NS; Schutte, BF; LaRusso, NF				O'Hara, Steven P.; Splinter, Patrick L.; Trussoni, Christy E.; Pisarello, Maria J. Lorenzo; Loarca, Lorena; Splinter, Noah S.; Schutte, Bryce F.; LaRusso, Nicholas F.			ETS Proto-oncogene 1 Transcriptionally Up-regulates the Cholangiocyte Senescence- associated Protein Cyclin-dependent Kinase Inhibitor 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY SCLEROSING CHOLANGITIS; ONCOGENE-INDUCED SENESCENCE; BILIARY EPITHELIAL-CELLS; CELLULAR SENESCENCE; GENOME BROWSER; LIPOPOLYSACCHARIDE; INACTIVATION; EXPRESSION; UPDATE; CANCER	Primary sclerosing cholangitis (PSC) is a chronic, fibroinflammatory cholangiopathy (disease of the bile ducts) of unknown pathogenesis. We reported that cholangiocyte senescence features prominently in PSC and that neuroblastoma RAS viral oncogene homolog (NRAS) is activated in PSC cholangiocytes. Additionally, persistent microbial insult (e.g. LPSs) induces cyclin-dependent kinase inhibitor 2A (CDKN2A/ p16(INK4a)) expression and senescence in cultured cholangiocytes in an NRAS-dependent manner. However, the molecular mechanisms involved in LPS-induced cholangiocyte senescence and NRAS-dependent regulation of CDKN2A remain unclear. Using our in vitro senescence model, we found that LPSinduced CDKN2A expression coincided with a 4.5-fold increase in ETS1 (ETS proto-oncogene 1) mRNA, suggesting that ETS1 is involved in regulating CDKN2A. This idea was confirmed by RNAi-mediated suppression or genetic deletion of ETS1, which blocked CDKN2A expression and reduced cholangiocyte senescence. Furthermore, site-directed mutagenesis of a predicted ETS-binding site within the CDKN2A promoter abolished luciferase reporter activity. Pharmacological inhibition of RAS/ MAPK reduced ETS1 and CDKN2A protein expression and CDKN2A promoter-driven luciferase activity by similar to 50%. In contrast, constitutively active NRAS expression induced ETS1 and CDKN2A protein expression, whereas ETS1 RNAi blocked this increase. Chromatin immunoprecipitation-PCR detected increased ETS1 and histone 3 lysine 4 trimethylation (H3K4Me3) at the CDKN2A promoter following LPS-induced senescence. Additionally, phospho-ETS1 expression was increased in cholangiocytes of human PSC livers and in the Abcb4 (Mdr2)(-/-) mouse model of PSC. These data pinpoint ETS1 and H3K4Me3 as key transcriptional regulators in NRAS-induced expression of CDKN2A, and this regulatory axis may therefore represent a potential therapeutic target for PSC treatment.	Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; Mayo Clin, Ctr Cell Signaling Gastroenterol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	LaRusso, NF (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	larusso.nicholas@mayo.edu		Trussoni, Christy/0000-0002-4247-076X; LORENZO PISARELLO, MARIA JOSE/0000-0001-6639-2965	National Institutes of Health [AI089713, DK057993]; Mayo Foundation, Clinical and Optical Microscopy Cores of the Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; Chris M. Carlos and Catharine Nicole Jockisch Carlos Endowment Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R01DK057993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation, Clinical and Optical Microscopy Cores of the Mayo Clinic Center for Cell Signaling in Gastroenterology; Chris M. Carlos and Catharine Nicole Jockisch Carlos Endowment Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants AI089713 (to S. P. O.), DK057993 (to N. F. L), the Mayo Foundation, Clinical and Optical Microscopy Cores of the Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30DK084567, and the Chris M. Carlos and Catharine Nicole Jockisch Carlos Endowment Fund in Primary Sclerosing Cholangitis. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahrendt SA, 1999, J SURG RES, V84, P88, DOI 10.1006/jsre.1999.5615; Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Bangarulingam SY, 2010, HEPATOLOGY, V51, P174, DOI 10.1002/hep.23277; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Burton DGA, 2009, AGE, V31, P1, DOI 10.1007/s11357-008-9075-y; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cho MC, 2008, BIOCHEM BIOPH RES CO, V377, P832, DOI 10.1016/j.bbrc.2008.10.053; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; de Planell-Saguer M, 2010, NAT PROTOC, V5, P1061, DOI 10.1038/nprot.2010.62; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Esteller M, 2001, CANCER RES, V61, P3225; FARRANT JM, 1991, GASTROENTEROLOGY, V100, P1710, DOI 10.1016/0016-5085(91)90673-9; Gonzalez S, 2006, CELL CYCLE, V5, P1382, DOI 10.4161/cc.5.13.2901; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hollenhorst Peter C, 2012, Small GTPases, V3, P154, DOI 10.4161/sgtp.19630; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; JOPLIN R, 1989, IN VITRO CELL DEV B, V25, P1189; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kotake Y, 2009, CANCER RES, V69, P1809, DOI 10.1158/0008-5472.CAN-08-2739; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Mao Zhiyong, 2012, Aging (Albany NY), V4, P431; MIMURA Y, 1995, GASTROENTEROLOGY, V109, P1969, DOI 10.1016/0016-5085(95)90765-3; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; O'Hara SP, 2011, J BIOL CHEM, V286, P30352, DOI 10.1074/jbc.M111.269464; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Plotnik JP, 2014, NUCLEIC ACIDS RES, V42, P11928, DOI 10.1093/nar/gku929; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Ruas M, 1999, ONCOGENE, V18, P5423, DOI 10.1038/sj.onc.1202918; Sasatomi K, 1998, J HEPATOL, V29, P409, DOI 10.1016/S0168-8278(98)80058-5; Shin J, 2013, CANC LETT, V1, P1; Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993; Tabibian James H, 2012, J Anal Oncol, V1, P50, DOI 10.6000/1927-7229.2012.01.01.7; Tabibian JH, 2013, EXPERT REV GASTROENT, V7, P103, DOI [10.1586/egh.12.80, 10.1586/EGH.12.80]; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Trussoni CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125793; Weismueller TJ, 2008, J HEPATOL, V48, pS38, DOI 10.1016/j.jhep.2008.01.020; Wu PK, 2015, FEBS J, V282, P1017, DOI 10.1111/febs.13197; Zook EC, 2016, J EXP MED, V213, P687, DOI 10.1084/jem.20150851	45	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4833	4846		10.1074/jbc.M117.777409	http://dx.doi.org/10.1074/jbc.M117.777409			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28184004	Green Published, hybrid			2022-12-26	WOS:000397590400008
J	Palma, A; Tinti, M; Paoluzi, S; Santonico, E; Brandt, BW; van Huijsduijnen, RH; Masch, A; Heringa, J; Schutkowski, M; Castagnoli, L; Cesareni, G				Palma, Anita; Tinti, Michele; Paoluzi, Serena; Santonico, Elena; Brandt, Bernd Willem; van Huijsduijnen, Rob Hooft; Masch, Antonia; Heringa, Jaap; Schutkowski, Mike; Castagnoli, Luisa; Cesareni, Gianni			Both Intrinsic Substrate Preference and Network Context Contribute to Substrate Selection of Classical Tyrosine Phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; SEQUENCE ALIGNMENTS; TRAPPING MUTANTS; RPTP-ALPHA; SH2 DOMAIN; PTP-PEST; IN-VIVO; PROTEIN; SPECIFICITY; PHOSPHORYLATION	Reversible tyrosine phosphorylation is a widespread post-translational modification mechanism underlying cell physiology. Thus, understanding the mechanisms responsible for substrate selection by kinases and phosphatases is central to our ability to model signal transduction at a system level. Classical protein- tyrosine phosphatases can exhibit substrate specificity in vivo by combining intrinsic enzymatic specificity with the network of protein-protein interactions, which positions the enzymes in close proximity to their substrates. Here we use a high throughput approach, based on high density phosphopep-tide chips, to determine the in vitro substrate preference of 16 members of the protein-tyrosine phosphatase family. This approach helped identify one residue in the substrate binding pocket of the phosphatase domain that confers specificity for phosphopeptides in a specific sequence context. We also present a Bayesian model that combines intrinsic enzymatic specificity and interaction information in the context of the human protein interaction network to infer new phosphatase substrates at the proteome level.	[Palma, Anita; Tinti, Michele; Paoluzi, Serena; Santonico, Elena; Castagnoli, Luisa; Cesareni, Gianni] Univ Roma Tor Vergata, Dept Biol, Via Ric Scientifica, I-00133 Rome, Italy; [Masch, Antonia; Schutkowski, Mike] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06108 Halle, Germany; [Brandt, Bernd Willem; Heringa, Jaap] Vrije Univ, Ctr Integrat Bioinformat, NL-1081 HV Amsterdam, Netherlands; [van Huijsduijnen, Rob Hooft] Merck Serono Int, Geneva Res Ctr, CH-1202 Geneva, Switzerland; [van Huijsduijnen, Rob Hooft] Hooft Pharma Serv Sarl, Chemin Lechaire 27, CH-1233 Bernex, Switzerland	University of Rome Tor Vergata; Martin Luther University Halle Wittenberg; Vrije Universiteit Amsterdam; Merck KGaA; EMD Serono Inc.	Cesareni, G (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Scientifica, I-00133 Rome, Italy.	cesareni@uniroma2.it	van Huijsduijnen, Rob A.M. Hooft/B-3653-2009; Santonico, Elena/ABB-8919-2020; Cesareni, Gianni/AAW-1382-2020; Palma, Anita/K-7656-2016	van Huijsduijnen, Rob A.M. Hooft/0000-0002-2261-9424; Santonico, Elena/0000-0002-3897-8990; Brandt, Bernd/0000-0002-1155-1989; Palma, Anita/0000-0002-5971-3676; Tinti, Michele/0000-0002-0051-017X; Castagnoli, Luisa/0000-0001-5283-8671; Schutkowski, MIke/0000-0003-0919-7076	DEPTH project of the European Research Council [322749]; Italian Association for Cancer Research [14135]; Telethon Grant [GGP09243]	DEPTH project of the European Research Council; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon Grant(Fondazione Telethon)	This work was supported by the DEPTH project of the European Research Council under Grant Agreement 322749, by Italian Association for Cancer Research Grant IG 2013 N. 14135, and by Telethon Grant GGP09243 (to G. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barker WC, 2001, NUCLEIC ACIDS RES, V29, P29, DOI 10.1093/nar/29.1.29; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Brandt BW, 2010, NUCLEIC ACIDS RES, V38, pW35, DOI 10.1093/nar/gkq415; Calderone A, 2013, NAT METHODS, V10, P690, DOI 10.1038/nmeth.2561; Carducci M, 2012, BIOTECHNOL ADV, V30, P4, DOI 10.1016/j.biotechadv.2011.06.012; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Cote JF, 1998, BIOCHEMISTRY-US, V37, P13128, DOI 10.1021/bi981259l; Critton DA, 2008, BIOCHEMISTRY-US, V47, P13336, DOI 10.1021/bi801724n; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Espanel X, 2002, PROTEIN SCI, V11, P2326, DOI 10.1110/ps.0213402; Feenstra KA, 2007, NUCLEIC ACIDS RES, V35, pW495, DOI 10.1093/nar/gkm406; Ferrari E, 2011, J BIOL CHEM, V286, P4173, DOI 10.1074/jbc.M110.157420; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fundel K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-372; Garaud M, 2007, J AM CHEM SOC, V129, P5366, DOI 10.1021/ja071275i; Garton AJ, 1997, ONCOGENE, V15, P877, DOI 10.1038/sj.onc.1201279; Gross S, 2002, J BIOL CHEM, V277, P48139, DOI 10.1074/jbc.M208228200; He Z, 2013, P NATL ACAD SCI USA, V110, pE79, DOI 10.1073/pnas.1213000110; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kohn M, 2007, ANGEW CHEM INT EDIT, V46, P7700, DOI 10.1002/anie.200701601; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Liberti S, 2013, FEBS J, V280, P379, DOI 10.1111/j.1742-4658.2012.08712.x; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lizcano JM, 2002, J BIOL CHEM, V277, P27839, DOI 10.1074/jbc.M202042200; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; RUZZENE M, 1993, EUR J BIOCHEM, V211, P289, DOI 10.1111/j.1432-1033.1993.tb19897.x; Sacco F, 2012, FEBS LETT, V586, P2732, DOI 10.1016/j.febslet.2012.05.008; Sacco F, 2009, J BIOL CHEM, V284, P22048, DOI 10.1074/jbc.M109.002758; Sarmiento M, 2000, BIOCHEMISTRY-US, V39, P8171, DOI 10.1021/bi000319w; Sonego P, 2008, BRIEF BIOINFORM, V9, P198, DOI 10.1093/bib/bbm064; Sun HY, 2009, CHEM COMMUN, P677, DOI 10.1039/b817853d; Taddei ML, 2000, BIOCHEM BIOPH RES CO, V270, P564, DOI 10.1006/bbrc.2000.2456; Thiele A, 2009, METHODS MOL BIOL, V570, P19, DOI 10.1007/978-1-60327-394-7_2; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tinti M, 2013, CELL REP, V3, P1293, DOI 10.1016/j.celrep.2013.03.001; Tinti M, 2012, NEW BIOTECHNOL, V29, P571, DOI 10.1016/j.nbt.2011.12.001; Tomizaki K, 2010, FEBS J, V277, P1996, DOI 10.1111/j.1742-4658.2010.07626.x; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Vacaresse N, 2008, J BIOL CHEM, V283, P35815, DOI 10.1074/jbc.M807964200; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Walchli S, 2004, J BIOL CHEM, V279, P311, DOI 10.1074/jbc.M307617200; Walchli S, 2000, J BIOL CHEM, V275, P9792, DOI 10.1074/jbc.275.13.9792; Wavreille AS, 2007, METHODS, V42, P207, DOI 10.1016/j.ymeth.2007.02.010; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Yang J, 2000, J BIOL CHEM, V275, P4066, DOI 10.1074/jbc.275.6.4066; Ye K, 2008, BIOINFORMATICS, V24, P18, DOI 10.1093/bioinformatics/btm537; Zhao BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134984	58	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4942	4952		10.1074/jbc.M116.757518	http://dx.doi.org/10.1074/jbc.M116.757518			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28159843	Green Published, hybrid			2022-12-26	WOS:000397590400016
J	de Carvalho, DL; Sousa-Neves, T; Cerqueira, PV; Gonsioroski, G; Silva, SM; Silva, DP; Santos, MPD				de Carvalho, Dorinny Lisboa; Sousa-Neves, Tiago; Cerqueira, Pablo Vieira; Gonsioroski, Gustavo; Silva, Sofia Marques; Silva, Daniel Paiva; Dantas Santos, Marcos Persio			Delimiting priority areas for the conservation of endemic and threatened Neotropical birds using a niche-based gap analysis	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BIODIVERSITY HOTSPOTS; PREDICTIVE MODELS; PROTECTED AREAS; CERRADO REGION; SAMPLE-SIZE; DISTRIBUTIONS; ACCURACY; PATTERNS; ENVIRONMENT	Knowledge of spatiotemporal distribution of biodiversity is still very incomplete in the tropics. This is one of the major problems preventing the assessment and effectiveness of conservation actions. Mega-diverse tropical regions are being exposed to fast and profound environmental changes, and the amount of resources available to describe the distribution of species is generally limited. Thus, the tropics is losing species at unprecedented rates, without a proper assessment of its biodiversity. Species distribution models (SDMs) can be used to fill such biogeographic gaps within a species' range and, when allied with systematic conservation planning (e.g. analyses of representativeness, gap analysis), help transcend such data shortage and support practical conservation actions. Within the Neotropics, eastern Amazon and northern Cerrado present a high variety of environments and are some of the most interesting ecotonal areas within South America, but are also among the most threatened biogeographic provinces in the world. Here, we test the effectiveness of the current system of Protected Areas (PAs), in protecting 24 threatened and endemic bird species using SDMs. We found that taxa with wider distributions are potentially as protected as taxa with smaller ranges, and larger PAs were more efficient than smaller PAs, while protecting these bird species. Nonetheless, Cerrado PAs are mostly misallocated. We suggest six priority areas for conservation of Neotropical birds. Finally, we highlight the importance of indigenous lands in the conservation of Neotropical biodiversity, and recommend the development of community management plans to conserve the biological resources of the region.	[de Carvalho, Dorinny Lisboa; Sousa-Neves, Tiago; Cerqueira, Pablo Vieira; Silva, Sofia Marques; Dantas Santos, Marcos Persio] Fed Univ Para, Museu Paraense Emilio Goeldi, Programa Posgrad Zool, Av Perimetral 1901, Belem, Para, Brazil; [Sousa-Neves, Tiago; Silva, Sofia Marques] Res Ctr Biodivers & Genet Resources, InBIO Associate Lab, Campus Agr Vairao, Vairao, Portugal; [Gonsioroski, Gustavo] Eudocimus Consultoria Ambiental, R 31,28b, Sao Luis, Maranhao, Brazil; [Silva, Daniel Paiva] Inst Fed Goiano, Dept Biol, Rodovia Geraldo Silva Nascimento, Urutai, Go, Brazil	Museu Paraense Emilio Goeldi; Universidade Federal do Para; Universidade do Porto; Instituto Federal Goiano	de Carvalho, DL (corresponding author), Fed Univ Para, Museu Paraense Emilio Goeldi, Programa Posgrad Zool, Av Perimetral 1901, Belem, Para, Brazil.	dorinny.lisboa@gmail.com	Cerqueira, Pablo Vieira/D-9268-2013; Gonsioroski, Gustavo/AAR-4331-2021; Silva, Daniel Paiva/F-8052-2010; Silva, Sofia Marques/Z-4854-2019; Pérsio, Marcos/B-8653-2016	Silva, Daniel Paiva/0000-0002-2457-6245; Pérsio, Marcos/0000-0001-8819-867X; Gonsioroski, Gustavo/0000-0002-5323-3794; Silva, Sofia/0000-0002-0502-3071	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA) doctoral fellowship; Programa de Pos-Graduacao em Zoologia Museu Paraense Emilio Goeldi / Universidade Federal do Para (PPGZOO MPEG/UFPA) Programa Nacional de Pos-Doutorado (PNPD) / Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship; Eudocimus Consultoria Ambiental	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA) doctoral fellowship(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Programa de Pos-Graduacao em Zoologia Museu Paraense Emilio Goeldi / Universidade Federal do Para (PPGZOO MPEG/UFPA) Programa Nacional de Pos-Doutorado (PNPD) / Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship; Eudocimus Consultoria Ambiental	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) doctoral fellowships: DLC and PVC. Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA) doctoral fellowship: TSN. Programa de Pos-Graduacao em Zoologia Museu Paraense Emilio Goeldi / Universidade Federal do Para (PPGZOO MPEG/UFPA) Programa Nacional de Pos-Doutorado (PNPD) / Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship: SMS. Eudocimus Consultoria Ambiental provided support in the form of salaries for GG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Thus, I assure that GG's commercial affiliation did not play a role in our study. The specific roles of all the authors are shown in the author contributions section.	AbSaber A. N., 1977, ESPACOS OCUPADOS PEL; Ahmed SE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1742; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo Miguel B., 1999, Diversity and Distributions, V5, P151, DOI 10.1046/j.1472-4642.1999.00052.x; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Bawa KS, 2004, BIOTROPICA, V36, P437, DOI 10.1111/j.1744-7429.2004.tb00341.x; Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; Borges SH, 2007, POLITICA AMBIENTAL, V4, P1; Brasileiro de Ornitologia, 2014, LIST AV BRAS; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Camm JD, 1994, BIOL CONSERV; Carvalho FMV, 2009, BIOL CONSERV, V142, P1392, DOI 10.1016/j.biocon.2009.01.031; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Couto RG, 2004, ATLAS CONSERVACAO NA; Da Silva JMC, 2005, CONSERV BIOL, V19, P689, DOI 10.1111/j.1523-1739.2005.00705.x; Da Silva JMC, 2002, BIOSCIENCE, V52, P225, DOI 10.1641/0006-3568(2002)052[0225:BPACIT]2.0.CO;2; DaSilva JMC, 1997, BIODIVERS CONSERV, V6, P435, DOI 10.1023/A:1018368809116; De Luca AC, 2009, AREAS IMPORTANTES CO; de Siqueira MF, 2009, J NAT CONSERV, V17, P25, DOI 10.1016/j.jnc.2008.11.001; del Hoyo J., 2003, HDB BIRDS WORLD, V8; Diniz JAF, 2004, AMPHIBIA-REPTILIA, V25, P63, DOI 10.1163/156853804322992841; Dobrovolski R, 2011, BIODIVERS CONSERV, V20, P2445, DOI 10.1007/s10531-011-9997-z; DORNAS T, 2012, REV BRAS ORNITOL, V20, P119; Dutra RCD, 2006, POLITICA AMBIENT, V1, P3; Elith J, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P303; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fagundes CK, 2016, DIVERS DISTRIB, V22, P123, DOI 10.1111/ddi.12396; Fearnside PM, 2001, ENVIRON CONSERV, V28, P23, DOI 10.1017/S0376892901000030; Diniz JAF, 2008, ORYX, V42, P567, DOI 10.1017/S0030605308001129; FIEMA, 2009, PLAN ESTR DES IND MA; Fuller T, 2006, BIOL CONSERV, V133, P131, DOI 10.1016/j.biocon.2006.04.040; Galetti M, 2009, BIOL CONSERV, V142, P1229, DOI 10.1016/j.biocon.2009.01.023; Girardello M, 2009, ANIM CONSERV, V12, P20, DOI 10.1111/j.1469-1795.2008.00216.x; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hong SK, 2006, ECOL RES, V21, P783, DOI 10.1007/s11284-006-0032-x; Hurlbert AH, 2005, ECOL LETT, V8, P319, DOI 10.1111/j.1461-0248.2005.00726.x; Instituto Brasileiro de Geografia e Estatstica, 2013, MAP TEM BRAS; Instituto Brasileiro do Meio Ambiente Ministerio do Meio Ambiente, 2014, LIST ESP FAUN BRAS A; Instituto Nacional de Pesquisa Espacial, 2014, TAX EST DESM AM LEG; Instituto Socioambiental Instituto do Homem e Meio Ambiente da Amazonia Instituto de Pesquisa Ambiental da Amazonia Instituto Sociedade Populacao e Natureza Grupo de Trabalho Amazonico Conservation International, 1999, SEM CONS MAC 99; International Union for Conservation of Nature, 2012, IUCN RED LIST THREAT; Jennings MD, 2000, LANDSCAPE ECOL, V15, P5, DOI 10.1023/A:1008184408300; Jimenez ALM, 2005, AM J PRIMATOL, V66, P131; Kamino LHY, 2012, BIOL LETTERS, V8, P324, DOI 10.1098/rsbl.2011.0942; Klink C.A., 2002, CERRADOS BRAZIL ECOL, P69, DOI DOI 10.7312/0LIV12042; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Ko CY, 2009, ZOOL STUD, V48, P418; Laurance WF, 2005, TRENDS ECOL EVOL, V20, P645, DOI 10.1016/j.tree.2005.10.009; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Lees AC, 2015, CURR BIOL, V25, pR177, DOI 10.1016/j.cub.2014.12.017; Lees AC, 2012, REV BRAS ORNITOL, V20, P93; Leite LO, 2006, ANALISE ENDEMISMO VA, P187; Lima-Ribeiro MD, 2012, REV BRAS PALEONTOLOG, V15, P371, DOI 10.4072/rbp.2012.3.12; Liu CR, 2011, ECOGRAPHY, V34, P232, DOI 10.1111/j.1600-0587.2010.06354.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Machado R.B, 2004, ESTIMATIVAS PERDA AR; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marini MA, 2010, J ORNITHOL, V151, P857, DOI 10.1007/s10336-010-0523-y; Marini MA, 2009, CONSERV BIOL, V23, P1558, DOI 10.1111/j.1523-1739.2009.01258.x; Marini MA, 2009, BIOL CONSERV, V142, P3039, DOI 10.1016/j.biocon.2009.08.002; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Martinez I, 2006, BIOL CONSERV, V133, P500, DOI 10.1016/j.biocon.2006.08.003; Martinez-Meyer E, 2006, ORYX, V40, P411, DOI 10.1017/S0030605306001360; Mello CF, 2000, IBAMA DIAGNOSTICO AV; Miller MP, 2013, CONSERV GENET, V14, P333, DOI 10.1007/s10592-012-0420-4; Ministerio do Meio Ambiente, 2008, MON DES BIOM BRAS; Ministerio do Meio Ambiente, 2003, AR PRIOR CONS UT SUS; Moura NG, 2014, CONSERV BIOL, V28, P1271, DOI 10.1111/cobi.12300; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nantel P, 1998, BIOL CONSERV, V84, P223, DOI 10.1016/S0006-3207(97)00133-X; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Nitta R, 2009, BUDGET STAFF ANAL MA; Nobrega CC, 2011, DIVERS DISTRIB, V17, P491, DOI 10.1111/j.1472-4642.2011.00749.x; Noss RF, 2001, CONSERV BIOL, V15, P578, DOI 10.1046/j.1523-1739.2001.015003578.x; OREN D. C., 2011, AMAZONIA MARANHENSE, P221; Oren DC., 1991, AVES ESTADO MARANHAO; Payne R. B., 1997, HDB BIRDS WORLD, V4, P508; Paynter Jr R. A., 1991, ORNITHOLOGICAL GAZET; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peres CA, 2005, CONSERV BIOL, V19, P728, DOI 10.1111/j.1523-1739.2005.00691.x; Peterson AT, 2003, CONSERV BIOL, V17, P1161, DOI 10.1046/j.1523-1739.2003.02206.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pinheiro Renato Torres, 2009, Biota Neotropica, V9, P187; Portes CEB, 2013, BRAZILIAN J ORNITHOL, V19, P19; Prado D.E., 2003, ECOLOGIA CONSERVACA; Pressey RL, 2009, SPATIAL CONSERVATION, P211; Ramos-Fernandez G, 2008, CAM S BIO EVOL ANTHR, V55, P351; Rangel TF, 2012, NAT CONSERVACAO, V10, P119, DOI 10.4322/natcon.2012.030; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; REDFORD KH, 1993, CONSERV BIOL, V7, P248, DOI 10.1046/j.1523-1739.1993.07020248.x; Rego MA, 2011, BIOTA NEOTROP, V11, P283, DOI 10.1590/S1676-06032011000100027; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rylands AB., 1991, STATUS CONSERVATION; Rylands AB, 1998, CONSERVACAO BIODIVER; Santos MPD, 2005, IMPORTANCIA RELATIVA; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Secretaria do Meio Ambiente e Recursos Hidricos (SEMA), 2011, PLANO ACAO PREVENCAO; Silva DP, 2015, J INSECT CONSERV, V19, P901, DOI 10.1007/s10841-015-9807-0; Silva DP, 2014, ECOL MODEL, V273, P200, DOI 10.1016/j.ecolmodel.2013.11.016; Silva DP, 2013, APIDOLOGIE, V44, P673, DOI 10.1007/s13592-013-0216-7; Silva Jose Maria Cardoso Da, 1995, Steenstrupia, V21, P69; Silveira LF., 2008, LIVRO VERMELHO FAUNA; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tarroso P, 2014, MOL ECOL, V23, P1108, DOI 10.1111/mec.12671; THUILLER W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI DOI 10.1111/J.1365-2486.2005.01018.X; Peterson AT, 2006, J MAMMAL, V87, P427, DOI 10.1644/05-MAMM-A-133R3.1; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Vale CG, 2014, DIVERS DISTRIB, V20, P20, DOI 10.1111/ddi.12115; Verissimo A, 2002, CONSERV ECOL, V6; Vieira ICG, 2008, BRAZ J BIOL, V68, P949, DOI 10.1590/S1519-69842008000500004; White C.M., 1994, NEW WORLD VULTURES G; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; WILSON JA, 1994, MAR POLICY, V18, P291, DOI 10.1016/0308-597X(94)90044-2; Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Zhao L, 2016, BOTANY, V94, DOI 10.1139/cjb-2015-0232	131	25	26	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171838	10.1371/journal.pone.0171838	http://dx.doi.org/10.1371/journal.pone.0171838			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187182	Green Submitted, Green Published, gold			2022-12-26	WOS:000394244300049
J	Rath, H; Stumpp, SN; Stiesch, M				Rath, Henryke; Stumpp, Sascha Nico; Stiesch, Meike			Development of a flow chamber system for the reproducible in vitro analysis of biofilm formation on implant materials	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS; VIRIDANS STREPTOCOCCI; PORPHYROMONAS-GINGIVALIS; ANTIBIOTIC-RESISTANCE; ORAL STREPTOCOCCI; DENTAL IMPLANT; GROWTH; ADHESION; IDENTIFICATION; CELLS	Since the introduction of modern dental implants in the 1980s, the number of inserted implants has steadily increased. Implant systems have become more sophisticated and have enormously enhanced patients' quality of life. Although there has been tremendous development in implant materials and clinical methods, bacterial infections are still one of the major causes of implant failure. These infections involve the formation of sessile microbial communities, called biofilms. Biofilms possess unique physical and biochemical properties and are hard to treat conventionally. There is a great demand for innovative methods to functionalize surfaces antibacterially, which could be used as the basis of new implant technologies. Present, there are few test systems to evaluate bacterial growth on these surfaces under physiological flow conditions. We developed a flow chamber model optimized for the assessment of dental implant materials. As a result it could be shown that biofilms of the five important oral bacteria Streptococcus gordonii, Streptococcus oralis, Streptococcus salivarius, Porphyromonas gingivalis, and Aggregatibacter actinomycetemcomitans, can be reproducibly formed on the surface of titanium, a frequent implant material. This system can be run automatically in combination with an appropriate microscopic device and is a promising approach for testing the antibacterial effect of innovative dental materials.	[Rath, Henryke; Stumpp, Sascha Nico; Stiesch, Meike] Hannover Med Sch, Dept Prosthet Dent & Biomed Mat Sci, Hannover, Germany	Hannover Medical School	Rath, H (corresponding author), Hannover Med Sch, Dept Prosthet Dent & Biomed Mat Sci, Hannover, Germany.	henryke.rath@ibnm.uni-hannover.de			Multifunktionale aktive und reaktive Interfaces und Oberflachen; Ministry of Science and Culture of Lower Saxony	Multifunktionale aktive und reaktive Interfaces und Oberflachen; Ministry of Science and Culture of Lower Saxony	Henryke Rath was funded by Multifunktionale aktive und reaktive Interfaces und Oberflachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Henryke Rath was financially supported provided by the Ministry of Science and Culture of Lower Saxony, within the framework of the Doctoral Program MARIO (Multifunctional Active and Reactive Interfaces and Surfaces). Additionally, we thank Dr. Andeas Winkel, Dr. Sebastian Grade and Manly Felicia Dalton for statistical and technical support. The authors declare no conflicts of interest related to this study.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Alam S, 2000, APPL ENVIRON MICROB, V66, P3330, DOI 10.1128/AEM.66.8.3330-3336.2000; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; BEIGHTON D, 1994, J MED MICROBIOL, V40, P202, DOI 10.1099/00222615-40-3-202; Besemer K, 2007, APPL ENVIRON MICROB, V73, P4966, DOI 10.1128/AEM.00588-07; Byers HL, 2000, J MED MICROBIOL, V49, P235, DOI 10.1099/0022-1317-49-3-235; Chalmers NI, 2008, MULTISPECIES ORAL BI; Chin MYH, 2006, EUR J ORTHODONT, V28, P1, DOI 10.1093/ejo/cji094; Christensen BB, 1998, APPL ENVIRON MICROB, V64, P2247; Cook GS, 1998, J PERIODONTAL RES, V33, P323, DOI 10.1111/j.1600-0765.1998.tb02206.x; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Cuadra-Saenz G, 2012, MICROBIOL-SGM, V158, P1783, DOI 10.1099/mic.0.057182-0; Davey ME, 2006, PERIODONTOL 2000, V42, P27, DOI 10.1111/j.1600-0757.2006.00183.x; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; DEBEER D, 1994, BIOTECHNOL BIOENG, V44, P636, DOI 10.1002/bit.260440510; Diaz PI, 2012, INFECT IMMUN, V80, P620, DOI 10.1128/IAI.05896-11; Domingues JFD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070046; Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; DUGUID IG, 1992, J ANTIMICROB CHEMOTH, V30, P803, DOI 10.1093/jac/30.6.803; DUGUID IG, 1992, J ANTIMICROB CHEMOTH, V30, P791, DOI 10.1093/jac/30.6.791; Duran-Pinedo AE, 2014, ISME J, V8, P1659, DOI 10.1038/ismej.2014.23; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Gashti MP, 2016, LAB CHIP, V16, P1412, DOI 10.1039/c5lc01540e; Gilmore KS, 2003, INFECT IMMUN, V71, P4759, DOI 10.1128/IAI.71.8.4759-4766.2003; Gowrishankar S, 2015, RSC ADV, V5, P95788, DOI 10.1039/c5ra11641d; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Hardie JM, 1994, REV MED MICROBIOL, P151; Hauser-Gerspach I, 2007, DENT MATER J, V26, P361, DOI 10.4012/dmj.26.361; Henderson B, 2003, ANNU REV MICROBIOL, V57, P29, DOI 10.1146/annurev.micro.57.030502.090908; HOLT SC, 1988, SCIENCE, V239, P55, DOI 10.1126/science.3336774; HOYLE BD, 1992, CAN J MICROBIOL, V38, P1214, DOI 10.1139/m92-201; Islam N, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-21; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; Kim J, 2012, MOLECULES, V17, P9818, DOI 10.3390/molecules17089818; Kroukamp O, 2010, APPL ENVIRON MICROB, V76, P6025, DOI 10.1128/AEM.00070-10; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Meier R, 2008, J MATER SCI-MATER M, V19, P3249, DOI 10.1007/s10856-008-3457-7; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Paquette David W, 2006, Dent Clin North Am, V50, P361, DOI 10.1016/j.cden.2006.05.002; Paramonova E, 2009, J DENT RES, V88, P922, DOI 10.1177/0022034509344569; Park A, 2011, BIOCHIP J, V5, P236, DOI 10.1007/s13206-011-5307-9; Purevdorj B, 2002, APPL ENVIRON MICROB, V68, P4457, DOI 10.1128/AEM.68.9.4457-4464.2002; Raj M, 2014, J CLIN DIAGN RES, V8, DOI 10.7860/JCDR/2014/10067.5133; RIJNAARTS HHM, 1993, APPL ENVIRON MICROB, V59, P3255, DOI 10.1128/AEM.59.10.3255-3265.1993; Roberts AP, 1999, FEMS MICROBIOL LETT, V177, P63; ROTHE B, 1991, MOL GEN GENET, V226, P190, DOI 10.1007/BF00273603; Schonfeld ES, 1992, CONT ORAL MICROBIOLO, P267; Shemesh J, 2015, LAB CHIP, V15, P4114, DOI 10.1039/c5lc00633c; Sliepen I, 2008, ORAL MICROBIOL IMMUN, V23, P520, DOI 10.1111/j.1399-302X.2008.00456.x; Sterer N, 2006, J DENT RES, V85, P910, DOI 10.1177/154405910608501007; Sternberg C, 1999, APPL ENVIRON MICROB, V65, P4108; Stewart PS, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0010-2014; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Stoodley P, 1999, J APPL MICROBIOL, V85, p19S, DOI 10.1111/j.1365-2672.1998.tb05279.x; Waters EM, 2014, METHODS MOL BIOL, V1106, P157, DOI 10.1007/978-1-62703-736-5_14; Weiger R, 1999, ARCH ORAL BIOL, V44, P621, DOI 10.1016/S0003-9969(99)00061-8; West PWJ, 1998, J MED MICROBIOL, V47, P923, DOI 10.1099/00222615-47-10-923; WOLFAARDT GM, 1994, APPL ENVIRON MICROB, V60, P434, DOI 10.1128/AEM.60.2.434-446.1994; ZAMBON JJ, 1985, J CLIN PERIODONTOL, V12, P1, DOI 10.1111/j.1600-051X.1985.tb01348.x; Zhang W, 2011, BIOTECHNOL BIOENG, V108, P2571, DOI 10.1002/bit.23234; Zhao B, 2014, DENT MATER, V30, P716, DOI 10.1016/j.dental.2014.04.001	66	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172095	10.1371/journal.pone.0172095	http://dx.doi.org/10.1371/journal.pone.0172095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187188	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300080
J	Chua, CL; Sam, IC; Chiam, CW; Chan, YF				Chua, Chong-Long; Sam, I-Ching; Chiam, Chun-Wei; Chan, Yoke-Fun			The neutralizing role of IgM during early Chikungunya virus infection	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; DIAGNOSIS; E2; DISEASE; RESPONSES; EPITOPE; ASSAY; SERODIAGNOSIS; PROTECTION; CLEARANCE	The antibody isotype IgM appears earlier than IgG, within days of onset of symptoms, and is important during the early stages of the adaptive immune response. Little is known about the functional role of IgM during infection with chikungunya virus (CHIKV), a recently reemerging arbovirus that has caused large global outbreaks. In this study, we studied antibody responses in 102 serum samples collected during CHIKV outbreaks in Malaysia. We described the neutralizing role of IgM at different times post-infection and examined the independent contributions of IgM and IgG towards the neutralizing capacity of human immune sera during the early phase of infection, including the differences in targets of neutralizing epitopes. Neutralizing IgM starts to appear as early as day 4 of symptoms, and their appearance from day 6 is associated with a reduction in viremia. IgM acts in a complementary manner with the early IgG, but plays the main neutralizing role up to a point between days 4 and 10 which varies between individuals. After this point, total neutralizing capacity is attributable almost entirely to the robust neutralizing IgG response. IgM preferentially binds and targets epitopes on the CHIKV surface E1-E2 glycoproteins, rather than individual E1 or E2. These findings provide insight into the early antibody responses to CHIKV, and have implications for design of diagnostic serological assays.	[Chua, Chong-Long; Sam, I-Ching; Chiam, Chun-Wei; Chan, Yoke-Fun] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Malaya	Sam, IC; Chan, YF (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	jicsam@ummc.edu.my; chanyf@ummc.edu.my	Chua, Chong Long/J-3028-2016; Sam, Jamal I-Ching/B-8688-2010; Chan, Yoke Fun/B-5351-2010	Chua, Chong Long/0000-0002-8854-4955; Sam, Jamal I-Ching/0000-0002-1296-7898; Chan, Yoke Fun/0000-0001-7089-0510	University of Malaya High Impact Research grant [E000013-20001]; Fundamental Research Grant Scheme of the Ministry of Higher Education, Malaysia [FP035-2015A]; MyBrain15 (MyPhD) scheme of the Ministry of Higher Education, Malaysia	University of Malaya High Impact Research grant; Fundamental Research Grant Scheme of the Ministry of Higher Education, Malaysia; MyBrain15 (MyPhD) scheme of the Ministry of Higher Education, Malaysia	This study was funded by grants from University of Malaya High Impact Research grant E000013-20001 and Fundamental Research Grant Scheme FP035-2015A of the Ministry of Higher Education, Malaysia. CLC was supported by the MyBrain15 (MyPhD) scheme of the Ministry of Higher Education, Malaysia. The funders had no role in study design,data collection and analysis, decision to publish,or preparation of the manuscript.	Amor S, 1996, J GEN VIROL, V77, P281, DOI 10.1099/0022-1317-77-2-281; Ayu SM, 2010, AM J TROP MED HYG, V83, P1245, DOI 10.4269/ajtmh.2010.10-0279; Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P1773, DOI 10.1128/CVI.05288-11; Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003; Burdino E, 2016, EMERG INFECT DIS, V22, P1837, DOI 10.3201/eid2210.151784; Chiam CW, 2013, DIAGN MICR INFEC DIS, V77, P133, DOI 10.1016/j.diagmicrobio.2013.06.018; Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042; Chua CL, 2016, METHODS MOL BIOL, V1426, P51, DOI 10.1007/978-1-4939-3618-2_5; Chua CL, 2014, J VIROL METHODS, V195, P126, DOI 10.1016/j.jviromet.2013.10.015; Chua CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004960; Chusri S, 2011, AM J TROP MED HYG, V85, P386, DOI 10.4269/ajtmh.2011.10-0725; Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Dorfmeier CL, 2013, J VIROL, V87, P9217, DOI 10.1128/JVI.00995-13; Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167; Erasmus JH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004119; Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050; Fric J, 2013, J INFECT DIS, V207, P319, DOI 10.1093/infdis/jis674; Gauri L A, 2012, J Assoc Physicians India, V60, P68; Grivard P, 2007, PATHOL BIOL, V55, P490, DOI 10.1016/j.patbio.2007.07.002; Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085; Hawman DW, 2016, CELL REP, V16, P1326, DOI 10.1016/j.celrep.2016.06.076; Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13; Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255; Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013; Kam YW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003445; Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12; Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213; Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033; Kashyap Rajpal S, 2010, Cerebrospinal Fluid Res, V7, P12, DOI 10.1186/1743-8454-7-12; Kosasih H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002483; Kosasih H, 2012, SE ASIAN J TROP MED, V43, P55; Kumar P, 2014, J VIROL METHODS, V206, P67, DOI 10.1016/j.jviromet.2014.05.014; Lam S K, 2001, Southeast Asian J Trop Med Public Health, V32, P447; Lam S, 2015, MABS-AUSTIN, V7, P1178, DOI 10.1080/19420862.2015.1083664; Laurent P, 2007, CLIN CHEM, V53, P1408, DOI 10.1373/clinchem.2007.086595; Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304; Malvy D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-200; Miner JJ, 2015, ARTHRITIS RHEUMATOL, V67, P1214, DOI 10.1002/art.39027; Moyron-Quiroz JE, 2009, VACCINE, V28, P140, DOI 10.1016/j.vaccine.2009.09.086; Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Nitatpattana N, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-183; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Oliver M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000374; Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354; Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269; Prince HE, 2016, CLIN VACCINE IMMUNOL, V23, P825, DOI 10.1128/CVI.00330-16; Racine R, 2009, IMMUNOL LETT, V125, P79, DOI 10.1016/j.imlet.2009.06.003; Rianthavorn P, 2010, SE ASIAN J TROP MED, V41, P92; Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032; Sam I-C, 2006, Med J Malaysia, V61, P264; Sam IC, 2015, EMERG INFECT DIS, V21, P1683, DOI 10.3201/eid2109.150439; Sam IC, 2015, VECTOR-BORNE ZOONOT, V15, P223, DOI 10.1089/vbz.2014.1680; Sam IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050476; Sam IC, 2011, EXPERT REV ANTI-INFE, V9, P1089, DOI [10.1586/eri.11.132, 10.1586/ERI.11.132]; Sam IC, 2009, J CLIN VIROL, V46, P180, DOI 10.1016/j.jcv.2009.07.016; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Selvarajah S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002423; Simarmata D, 2016, SCI REP-UK, V6, DOI 10.1038/srep26097; Skountzou I, 2014, CLIN VACCINE IMMUNOL, V21, P1481, DOI 10.1128/CVI.00374-14; Smith SA, 2015, CELL HOST MICROBE, V18, P86, DOI 10.1016/j.chom.2015.06.009; Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64; Teo TH, 2013, J IMMUNOL, V190, P259, DOI 10.4049/jimmunol.1202177; Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753; Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764; Zim MAM, 2013, J CLIN VIROL, V56, P141, DOI 10.1016/j.jcv.2012.10.019	74	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171989	10.1371/journal.pone.0171989	http://dx.doi.org/10.1371/journal.pone.0171989			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182795	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800141
J	Ma, X; Yan, L; Zhu, Q; Shao, FM				Ma, Xu; Yan, Lei; Zhu, Qing; Shao, Fengmin			Puerarin attenuates cisplatin-induced rat nephrotoxicity: The involvement of TLR4/NF-kappa B signaling pathway	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; RENAL INJURY; LUNG-CANCER; IN-VITRO; INDUCED TOXICITY; APOPTOSIS; CELLS; INFLAMMATION; EXPRESSION	Puerarin was a major isoflavonoid derived from the Chinese medical herb radix puerariae (Gegen). In present study effect of puerarin on cisplatin nephrotoxicity was evaluated. Rat model of nephrotoxicity was established by a single intraperitoneal injection of cisplatin (7mg/kg). Puerarin was administrated through caudal vein injection once per day at the dose of 10mg/kg, 30mg/kg and 50mg/kg. Biochemical assays showed that after cisplatin treatment the serum urea and creatinine increased significantly compared with control (P<0.05). Cisplatin treatment significantly increased xanthine oxidase (XO) activity and malondialdehyde (MDA) formation, and significantly decreased the levels and /or activities of enzymatic and non-enzymatic antioxidants (GSH, GPx, GST, GR, SOD, CAT), in the kidney tissues. Renal levels of TNF-alpha and IL-6, two important inflammatory cytokines, were also upregulated by cisplatin. Histopathological examination indicated that cisplatin treatment resulted in severe necrosis and degeneration, hyaline casts in the tubules, intertubular hemorrhage, congestion and swelling in glomerulus and leukocytes infiltration in the kidney tissues. Western blot results demonstrated that cisplatin increased TLR4 and NF-kappa B protein expression in the kidney tissues. However, all these changes induced by cisplatin were significantly attenuated by puerarin treatment in dose-dependent manner, which indicated the renal protective effect of puerarin. Cell culture experiments illustrated that puerarin alone treatment concentration-dependently inhibited COLO205 and HeLa tumor cell growth and dose-dependently promoted the antitumor activity of cisplatin in COLO205 and HeLa tumor cells. The promotion effects might be attributed to suppression of cisplatin-increased NF-kappa B p65 expression by puerarin. Taken together, findings in this study suggested that puerarin exhibited renal protection against cisplatin nephrotoxicity via inhibiting TLR4/NF-kappa B signaling, with no inhibition but promotion effect on the antitumor activity of cisplatin. Puerarin might be a promising adjuvant agent for cisplatin chemotherapy.	[Ma, Xu; Yan, Lei; Zhu, Qing; Shao, Fengmin] Zhengzhou Univ, Peoples Hosp, Dept Nephrol, Zhengzhou, Peoples R China	Zhengzhou University	Shao, FM (corresponding author), Zhengzhou Univ, Peoples Hosp, Dept Nephrol, Zhengzhou, Peoples R China.	shaofengmin98@sina.com		Shao, Fengmin/0000-0003-2905-4312				Bai JX, 2001, BIOL SIGNAL RECEPT, V10, P189; Cetin R, 2006, J APPL TOXICOL, V26, P42, DOI 10.1002/jat.1103; Chen T, 2016, PHARM BIOL, V54, P1793, DOI 10.3109/13880209.2015.1127980; Chen YZ, 2014, ANTI-CANCER DRUG, V25, P983, DOI 10.1097/CAD.0000000000000127; Eichholtz-Wirth H, 2000, APOPTOSIS, V5, P255, DOI 10.1023/A:1009656513307; Erstad DJ, 2013, SURG ONCOL CLIN N AM, V22, P705, DOI 10.1016/j.soc.2013.06.011; Godwin P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00120; Hagar H, 2015, EXP TOXICOL PATHOL, V67, P133, DOI 10.1016/j.etp.2014.11.001; Hermenean A, 2013, CHEM-BIOL INTERACT, V205, P138, DOI 10.1016/j.cbi.2013.06.016; Hu WZ, 2011, PHARMACOL REP, V63, P781, DOI 10.1016/S1734-1140(11)70590-4; Jariyawat S, 2009, J NAT MED-TOKYO, V63, P430, DOI 10.1007/s11418-009-0345-5; Jiang L, 2012, INTERN MED J, V42, P1297, DOI 10.1111/j.1445-5994.2012.02821.x; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; Kandemir FM, 2015, RENAL FAILURE, V37, P518, DOI 10.3109/0886022X.2015.1006100; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kuper C, 2012, AM J PHYSIOL-RENAL, V302, pF38, DOI 10.1152/ajprenal.00590.2010; Li GM, 2002, LAB INVEST, V82, P585, DOI 10.1038/labinvest.3780453; Lin L, 2015, CELL BIOCHEM BIOPHYS, V71, P535, DOI 10.1007/s12013-014-0231-y; Liu CM, 2012, TOXICOL APPL PHARM, V258, P330, DOI 10.1016/j.taap.2011.11.015; Liu G, 2014, HUM EXP TOXICOL, V33, P1071, DOI 10.1177/0960327114521048; Liu H, 2003, KIDNEY INT, V63, P1687, DOI 10.1046/j.1523-1755.2003.00908.x; Liu XJ, 2013, NEURAL REGEN RES, V8, P3203, DOI 10.3969/j.issn.1673-5374.2013.34.004; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Nair A, 2003, ONCOGENE, V22, P50, DOI 10.1038/sj.onc.1206043; Oh GS, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4048390; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Park BH, 2016, ONCOTARGET, V7, P63870, DOI 10.18632/oncotarget.11563; Petrelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083022; Ramesh G, 2004, KIDNEY INT, V65, P490, DOI 10.1111/j.1523-1755.2004.00413.x; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Ramesh G, 2007, AM J PHYSIOL-RENAL, V292, pF812, DOI 10.1152/ajprenal.00277.2006; Sahu BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105070; Sahu BD, 2014, TOXICOL APPL PHARM, V277, P8, DOI 10.1016/j.taap.2014.02.022; Sahu BD, 2013, PHYTOMEDICINE, V20, P453, DOI 10.1016/j.phymed.2012.12.001; Sahu BD, 2011, FOOD CHEM TOXICOL, V49, P3090, DOI 10.1016/j.fct.2011.08.018; Sanatani MS, 2013, CASE REP ONCOL MED, V2013, DOI 10.1155/2013/594787; Sanchez-Gonzalez PD, 2011, CRIT REV TOXICOL, V41, P803, DOI 10.3109/10408444.2011.602662; Santos NAG, 2007, ARCH TOXICOL, V81, P495, DOI 10.1007/s00204-006-0173-2; Song X, 2016, J AM COLL NUTR, P1; Sultana S, 2012, J PHARM PHARMACOL, V64, P872, DOI 10.1111/j.2042-7158.2012.01470.x; Tarang S, 2007, INT IMMUNOL, V19, P635, DOI 10.1093/intimm/dxm029; Topcu-Tarladacalisir Y, 2016, REN FAIL, P1; Ugur S, 2015, RENAL FAILURE, V37, P332, DOI 10.3109/0886022X.2014.986005; UTLEY HG, 1967, ARCH BIOCHEM BIOPHYS, V118, P29, DOI 10.1016/0003-9861(67)90273-1; Wang CY, 2014, AM J CHINESE MED, V42, P543, DOI 10.1142/S0192415X14500359; Wang L, 2013, HUM EXP TOXICOL, V32, P172, DOI 10.1177/0960327112462729; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Wang YC, 2013, INT J PHARMACEUT, V441, P728, DOI 10.1016/j.ijpharm.2012.10.021; Wangpaichitr M, 2012, MOL CANCER THER, V11, P604, DOI 10.1158/1535-7163.MCT-11-0599; Yuan Y, 2016, EXP THER MED, V11, P415, DOI 10.3892/etm.2015.2910; Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982; Zhang GY, 2012, INT J GYNECOL CANCER, V22, P1220, DOI 10.1097/IGC.0b013e3182643b7c; Zhang WG, 2014, MOL MED REP, V10, P2752, DOI 10.3892/mmr.2014.2512; Zhou YX, 2014, PHYTOTHER RES, V28, P961, DOI 10.1002/ptr.5083	54	47	47	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171612	10.1371/journal.pone.0171612	http://dx.doi.org/10.1371/journal.pone.0171612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182789	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800078
J	Toffoli, B; Gilardi, F; Winkler, C; Soderberg, M; Kowalczuk, L; Arsenijevic, Y; Bamberg, K; Bonny, O; Desvergne, B				Toffoli, Barbara; Gilardi, Federica; Winkler, Carine; Soderberg, Magnus; Kowalczuk, Laura; Arsenijevic, Yvan; Bamberg, Krister; Bonny, Olivier; Desvergne, Beatrice			Nephropathy in Pparg-null mice highlights PPAR gamma systemic activities in metabolism and in the immune system	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; LUPUS-ERYTHEMATOSUS; ANTIPHOSPHOLIPID SYNDROME; MOUSE MODEL; DIABETIC COMPLICATIONS; MECHANISMS; ANTIBODIES; DISEASE; LIPODYSTROPHY; INFLAMMATION	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a ligand-dependent transcription factor involved in many aspects of metabolism, immune response, and development. Totalbody deletion of the two Pparg alleles provoked generalized lipoatrophy along with severe type 2 diabetes. Herein, we explore the appearance and development of structural and functional alterations of the kidney, comparing Pparg null-mice to their littermate controls (carrying Pparg floxed alleles). We show that renal hypertrophy and functional alterations with increased glucosuria and albuminuria are already present in 3 weeks-old Pparg null-mice. Renal insufficiency with decreased creatinine clearance progress at 7 weeks of age, with the advance of the type 2 diabetes. At 52 weeks of age, these alterations are accompanied by signs of fibrosis and mesangial expansion. More intriguingly, aged Pparg null-mice concomitantly present an anti-phospholipid syndrome (APS), characterized by the late appearance of microthrombi and a mesangioproliferative pattern of glomerular injury, associated with significant plasmatic levels of anti-beta(2)-glycoprotein1 antibodies and renal deposition of IgG, IgM, and C3. Thus, in line with the role of PPAR gamma in metabolic homeostasis, Pparg nullmice first represent a potent model for studying the initiation and the development of diabetic nephropathy. Second, and in relation with the important PPAR gamma activity in inflammation and in immune system, these mice also highlight a new role for PPAR gamma signaling in the promotion of APS, a syndrome whose pathogenesis is poorly known and whose current treatment is limited to prevention of thrombosis events.	[Toffoli, Barbara; Gilardi, Federica; Winkler, Carine; Desvergne, Beatrice] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, Lausanne, Switzerland; [Soderberg, Magnus; Bamberg, Krister] AstraZeneca R&D, Pepparredsleden 1, Molndal, Sweden; [Kowalczuk, Laura; Arsenijevic, Yvan] Univ Lausanne, Jules Gonin Eye Hosp, Fdn Asile Des Aveugles, Dept Ophthalmol,Unit Gene Therapy & Stem Cell Bio, Lausanne, Switzerland; [Bonny, Olivier] Univ Lausanne, Univ Lausanne Hosp, Serv Nephrol, Lausanne, Switzerland; [Bonny, Olivier] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland; [Toffoli, Barbara] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy	University of Lausanne; AstraZeneca; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Trieste	Desvergne, B (corresponding author), Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, Lausanne, Switzerland.	Beatrice.Desvergne@unil.ch	Toffoli, Barbara/AAT-1101-2021; Kowalczuk, Laura/AAF-6230-2020; Desvergne, Beatrice/C-8892-2016	Desvergne, Beatrice/0000-0001-5483-288X; Toffoli, Barbara/0000-0002-6854-5782; Arsenijevic, Yvan/0000-0001-6960-1291; Gilardi, Federica/0000-0001-5421-2779; bonny, olivier/0000-0003-4123-4279	Swiss National Science Foundation [3100AO-120633/1]; Etat de Vaud, Faculte de Biologie et Medecine of University of Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Etat de Vaud, Faculte de Biologie et Medecine of University of Lausanne	This work was supported by grants from the Swiss National Science Foundation (3100AO-120633/1) to BD and the Etat de Vaud, Faculte de Biologie et Medecine of University of Lausanne (no speicifc grant numbers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprahamian TR, 2014, IMMUNOLOGY, V142, P363, DOI 10.1111/imm.12256; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Becarevic M, 2016, CLIN RHEUMATOL, V35, P2477, DOI 10.1007/s10067-016-3345-3; Bertolaccini ML, 2014, AUTOIMMUN REV, V13, P917, DOI 10.1016/j.autrev.2014.05.001; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Caballero CR, 2003, J AM ACAD DERMATOL, V49, P768, DOI 10.1067/S0190-9622(03)00789-8; Cortes S, 2008, LUPUS, V17, P977, DOI 10.1177/0961203308091539; De Angelis V, 2009, J AUTOIMMUN, V32, P60, DOI 10.1016/j.jaut.2008.11.002; de Groot PG, 2012, LUPUS, V21, P704, DOI 10.1177/0961203312438631; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Gabriel CL, 2012, AM J PHYSIOL-ENDOC M, V303, pE1313, DOI 10.1152/ajpendo.00665.2011; Horita S, 2015, PPAR RES, V2015, DOI 10.1155/2015/646423; Hu C, 2015, CURR MED CHEM, V22, P2858, DOI 10.2174/0929867322666150625095407; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Kim JH, 2015, ARCH PHARM RES, V38, P302, DOI 10.1007/s12272-015-0559-x; Kiremitci Saba, 2014, ScientificWorldJournal, V2014, P580620, DOI 10.1155/2014/580620; Martinez-Garcia C, 2012, DIS MODEL MECH, V5, P636, DOI 10.1242/dmm.009266; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Nadra K, 2010, ENDOCRINOLOGY, V151, P4969, DOI 10.1210/en.2010-0131; Naito M, 2011, DIABETES, V60, P2265, DOI 10.2337/db10-1795; Necela BM, 2008, IMMUNOLOGY, V125, P344, DOI 10.1111/j.1365-2567.2008.02849.x; Parker B, 2015, ANN RHEUM DIS, V74, P1530, DOI 10.1136/annrheumdis-2013-203933; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Rovin BH, 2014, AM J KIDNEY DIS, V63, P677, DOI 10.1053/j.ajkd.2013.11.023; Sciascia S, 2014, NAT REV NEPHROL, V10, P279, DOI 10.1038/nrneph.2014.38; Suganami T, 2004, FASEB J, V18, P127, DOI 10.1096/fj.04-2183fje; Szeles L, 2007, BBA-MOL CELL BIOL L, V1771, P1014, DOI 10.1016/j.bbalip.2007.02.005; Unlu O, 2016, EUR J RHEUMATOL, V3, P75, DOI 10.5152/eurjrheum.2015.0085; Venegas-Pont M, 2009, AM J PHYSIOL-REG I, V296, pR1282, DOI 10.1152/ajpregu.90992.2008; Xia LF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147958; Yang JC, 2012, CURR OPIN NEPHROL HY, V21, P97, DOI 10.1097/MNH.0b013e32834de526; Yang JC, 2009, CLIN SCI, V116, P17, DOI 10.1042/CS20070462; Yavuz S, 2010, PEDIATR DERMATOL, V27, P504, DOI 10.1111/j.1525-1470.2010.01255.x; Zhao WP, 2009, J IMMUNOL, V183, P2729, DOI 10.4049/jimmunol.0804341	34	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171474	10.1371/journal.pone.0171474	http://dx.doi.org/10.1371/journal.pone.0171474			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182703	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800062
J	Zimmermann, MT; Urrutia, R; Oliver, GR; Blackburn, PR; Cousin, MA; Bozeck, NJ; Klee, EW				Zimmermann, Michael T.; Urrutia, Raul; Oliver, Gavin R.; Blackburn, Patrick R.; Cousin, Margot A.; Bozeck, Nicole J.; Klee, Eric W.			Molecular modeling and molecular dynamic simulation of the effects of variants in the TGFBR2 kinase domain as a paradigm for interpretation of variants obtained by next generation sequencing	PLOS ONE			English	Article							MARFAN-SYNDROME; SRC KINASE; WEB SERVER; BETA; PROTEINS; NETWORK; FLEXIBILITY; QUALITY; MOTION; COOPERATIVITY	Variants in the TGFBR2 kinase domain cause several human diseases and can increase propensity for cancer. The widespread application of next generation sequencing within the setting of Individualized Medicine (IM) is increasing the rate at which TGFBR2 kinase domain variants are being identified. However, their clinical relevance is often uncertain. Consequently, we sought to evaluate the use of molecular modeling and molecular dynamics (MD) simulations for assessing the potential impact of variants within this domain. We documented the structural differences revealed by these models across 57 variants using independent MD simulations for each. Our simulations revealed various mechanisms by which variants may lead to functional alteration; some are revealed energetically, while others structurally or dynamically. We found that the ATP binding site and activation loop dynamics may be affected by variants at positions throughout the structure. This prediction cannot be made from the linear sequence alone. We present our structure-based analyses alongside those obtained using several commonly used genomics-based predictive algorithms. We believe the further mechanistic information revealed by molecular modeling will be useful in guiding the examination of clinically observed variants throughout the exome, as well as those likely to be discovered in the near future by clinical tests leveraging nextgeneration sequencing through IM efforts.	[Zimmermann, Michael T.; Oliver, Gavin R.; Cousin, Margot A.; Klee, Eric W.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Urrutia, Raul] Mayo Clin, Lab Epigenet & Chromatin Dynam, Gastroenterol Res Unit, Rochester, MN 55905 USA; [Urrutia, Raul] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Urrutia, Raul] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Oliver, Gavin R.; Cousin, Margot A.; Bozeck, Nicole J.; Klee, Eric W.] Mayo Clin, Ctr Individualized Med, Rochester, MN 55905 USA; [Blackburn, Patrick R.] Mayo Clin, Ctr Individualized Med, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Klee, EW (corresponding author), Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA.; Urrutia, R (corresponding author), Mayo Clin, Lab Epigenet & Chromatin Dynam, Gastroenterol Res Unit, Rochester, MN 55905 USA.; Urrutia, R (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.; Urrutia, R (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.; Klee, EW (corresponding author), Mayo Clin, Ctr Individualized Med, Rochester, MN 55905 USA.	urrutia.raul@mayo.edu; klee.eric@mayo.edu	Cousin, Margot/AAD-4591-2019	Cousin, Margot/0000-0002-6119-9346; Oliver, Gavin/0000-0002-9948-3799; Zimmermann, Michael/0000-0001-7073-0525	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK052913] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; [Anonymous], 2013, CANCER DISCOV, V3, P1320, DOI 10.1158/2159-8290.CD-NB2013-153; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1999, J MOL BIOL, V285, P1023, DOI 10.1006/jmbi.1998.2371; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIOVIA, 2015, DASS SYST BIOVIA DIS; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Boyken SE, 2014, J MOL BIOL, V426, P3656, DOI 10.1016/j.jmb.2014.08.018; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Edwards A, 2009, ANNU REV BIOCHEM, V78, P541, DOI 10.1146/annurev.biochem.78.070907.103305; Foda ZH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6939; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gao M., CRYSTAL STRUCTURES O; Han S, 2007, PROTEIN SCI, V16, P2272, DOI 10.1110/ps.073068407; Hilser VJ, 2010, SCIENCE, V327, P653, DOI 10.1126/science.1186121; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; HUBER R, 1983, BIOPOLYMERS, V22, P261, DOI 10.1002/bip.360220136; Janin J, ASSESSING STRUCTURAL; Joseph RE, 2010, J MOL BIOL, V403, P231, DOI 10.1016/j.jmb.2010.08.035; Keskin O, 2002, BIOPHYS J, V83, P663, DOI 10.1016/S0006-3495(02)75199-0; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu X, 2015, HUM MUTAT; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Matyas G, 2006, HUM MUTAT, V27, P760, DOI 10.1002/humu.20353; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meng YL, 2014, J MOL BIOL, V426, P423, DOI 10.1016/j.jmb.2013.10.001; Mistry J, 2013, ACTA CRYSTALLOGR D, V69, P2186, DOI 10.1107/S0907444913027157; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Moult J, 2016, PROTEINS; Muller A, 2002, GENOME RES, V12, P1625, DOI 10.1101/gr.221202; Niu B, 2016, NAT GENET; Ozkirimli E, 2006, PROTEIN SCI, V15, P1051, DOI 10.1110/ps.051999206; Ozkirimli E, 2008, PROTEIN SCI, V17, P1871, DOI 10.1110/ps.037457.108; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Potestio R, 2009, BIOPHYS J, V96, P4993, DOI 10.1016/j.bpj.2009.03.051; Preller M, 2013, STRUCTURE, V21, P1911, DOI 10.1016/j.str.2013.09.015; Pucheta-Martinez E, 2016, SCI REP-UK, V6, DOI 10.1038/srep24235; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ryadnov MG, 2010, FUTURE MED CHEM, V2, P1633, DOI 10.4155/FMC.10.256; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saunders CT, 2002, J MOL BIOL, V322, P891, DOI 10.1016/S0022-2836(02)00813-6; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shen QC, 2016, NUCLEIC ACIDS RES, V44, pD527, DOI 10.1093/nar/gkv902; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stavropoulos DJ, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2015.12; Stenson Peter D, 2012, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0113s39; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Verstraeten A, 2016, HUM MUTAT, V37, P524, DOI 10.1002/humu.22977; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Woods NT, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.1; Xie L, 2005, PLOS COMPUT BIOL, V1, P222, DOI 10.1371/journal.pcbi.0010031; Yang L, 2009, P NATL ACAD SCI USA, V106, P12347, DOI 10.1073/pnas.0902159106; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zimmermann MT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-264	76	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170822	10.1371/journal.pone.0170822	http://dx.doi.org/10.1371/journal.pone.0170822			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182693	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800019
J	Lykens, NM; Coughlin, DJ; Reddi, JM; Lutz, GJ; Tallent, MK				Lykens, Nicole M.; Coughlin, David J.; Reddi, Jyoti M.; Lutz, Gordon J.; Tallent, Melanie K.			AMPA GluA1-flip targeted oligonucleotide therapy reduces neonatal seizures and hyperexcitability	PLOS ONE			English	Article							LONG-TERM POTENTIATION; GLUTAMATE-OPERATED CHANNELS; CALCIUM-PERMEABLE AMPA; SYNAPTIC PLASTICITY; MESSENGER-RNAS; RECEPTOR SUBUNIT; MOUSE MODEL; EPILEPSY; EXPRESSION; GLUR1	Glutamate-activated alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPA-Rs) mediate the majority of excitatory neurotransmission in brain and thus are major drug targets for diseases associated with hyperexcitability or neurotoxicity. Due to the critical nature of AMPA-Rs in normal brain function, typical AMPA-R antagonists have deleterious effects on cognition and motor function, highlighting the need for more precise modulators. A dramatic increase in the flip isoform of alternatively spliced AMPA-R GluA1 subunits occurs post-seizure in humans and animal models. GluA1-flip produces higher gain AMPA channels than GluA1-flop, increasing network excitability and seizure susceptibility. Splice modulating oligonucleotides (SMOs) bind to pre-mRNA to influence alternative splicing, a strategy that can be exploited to develop more selective drugs across therapeutic areas. We developed a novel SMO, GR1, which potently and specifically decreased GluA1flip expression throughout the brain of neonatal mice lasting at least 60 days after single intracerebroventricular injection. GR1 treatment reduced AMPA-R mediated excitatory postsynaptic currents at hippocampal CA1 synapses, without affecting long-term potentiation or long-term depression, cellular models of memory, or impairing GluA1-dependent cognition or motor function in mice. Importantly, GR1 demonstrated anti-seizure properties and reduced post-seizure hyperexcitability in neonatal mice, highlighting its drug candidate potential for treating epilepsies and other neurological diseases involving network hyperexcitability.	[Lykens, Nicole M.] Drexel Univ, Coll Med, Grad Program Pharmacol & Physiol, Philadelphia, PA 19104 USA; [Lykens, Nicole M.; Lutz, Gordon J.; Tallent, Melanie K.] LifeSplice Pharma, Malvern, PA 19355 USA; [Coughlin, David J.] Widener Univ, Dept Biol, Chester, PA 19013 USA; [Reddi, Jyoti M.; Tallent, Melanie K.] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA; [Lutz, Gordon J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA	Drexel University; Widener University; Drexel University; Drexel University	Tallent, MK (corresponding author), LifeSplice Pharma, Malvern, PA 19355 USA.; Tallent, MK (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA.	melanie.tallent@lifesplicepharma.com			Citizens United for Research in Epilepsy (CURE) Pediatric Epilepsy Multidisciplinary Grant; NIH [1R21NS064223]; Pennsylvania Department of Health DrexelMed Translational Tobacco Funds Grant; Epilepsy Foundation/American Epilepsy Society	Citizens United for Research in Epilepsy (CURE) Pediatric Epilepsy Multidisciplinary Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health DrexelMed Translational Tobacco Funds Grant; Epilepsy Foundation/American Epilepsy Society	This work was supported by Citizens United for Research in Epilepsy (CURE) Pediatric Epilepsy Multidisciplinary Grant (MKT and GJL), NIH 1R21NS064223 (GJL), Pennsylvania Department of Health DrexelMed Translational Tobacco Funds Grant (GJL), and an Epilepsy Foundation/American Epilepsy Society predoctoral fellowship (NML). Dr. Tallent left Drexel University to found LifeSplice Pharma prior to the completion of the presented work, but the company was virtual and did not provide any support in the form of funding for author salaries or funding of the experimental work presented in this manuscript. LifeSplice did not have any role in study design, data collection, or decision to publish. However, Dr. Tallent and Dr. Lutz were both affiliated with LifeSplice while supervising and performing some of the data analysis, figure making, and writing of the manuscript.	Andrasfalvy BK, 2003, J PHYSIOL-LONDON, V552, P35, DOI 10.1113/jphysiol.2003.045575; Baratta MV, 2002, J NEUROPHYSIOL, V88, P3078, DOI 10.1152/jn.00398.2002; Bolshakov K V, 2001, Neurosci Behav Physiol, V31, P219, DOI 10.1023/A:1005276627192; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Catarzi D, 2007, MED RES REV, V27, P239, DOI 10.1002/med.20084; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Coleman SK, 2010, J BIOL CHEM, V285, P36032, DOI 10.1074/jbc.M110.156943; Coyle H, 2014, EPILEPSY BEHAV, V41, P193, DOI 10.1016/j.yebeh.2014.09.072; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; de Lanerolle NC, 1998, EUR J NEUROSCI, V10, P1687, DOI 10.1046/j.1460-9568.1998.00171.x; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; EASTWOOD SL, 1994, NEUROREPORT, V5, P1325, DOI 10.1097/00001756-199406270-00007; Einstein EB, 2010, J NEUROSCI, V30, P4306, DOI 10.1523/JNEUROSCI.5295-09.2010; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Faravelli I, 2015, NAT REV NEUROL, V11, P351, DOI 10.1038/nrneurol.2015.77; Finkel R. S, 2016, LANCET; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Granger Adam J, 2014, Front Synaptic Neurosci, V6, P15, DOI 10.3389/fnsyn.2014.00015; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Grosskreutz J, 2003, EUR J NEUROSCI, V17, P1173, DOI 10.1046/j.1460-9568.2003.02531.x; Hache M, 2016, J CHILD NEUROL; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Ihara Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150095; Jensen FE, 2006, EPILEPSY RES, V68, P28, DOI 10.1016/j.eplepsyres.2005.09.013; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KAMPHUIS W, 1994, EUR J NEUROSCI, V6, P1119, DOI 10.1111/j.1460-9568.1994.tb00609.x; KAMPHUIS W, 1992, NEUROSCI LETT, V148, P51, DOI 10.1016/0304-3940(92)90802-E; Kemp A, 2007, TRENDS NEUROSCI, V30, P111, DOI 10.1016/j.tins.2007.01.002; Koike-Tani M, 2005, J NEUROSCI, V25, P199, DOI 10.1523/JNEUROSCI.3861-04.2005; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Lambolez B, 1996, P NATL ACAD SCI USA, V93, P1797, DOI 10.1073/pnas.93.5.1797; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; Langan YM, 2003, EPILEPSIA, V44, P46, DOI 10.1046/j.1528-1157.2003.128902.x; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOSCHER W, 1994, BRIT J PHARMACOL, V113, P1349; Lu QL, 2011, MOL THER, V19, P9, DOI 10.1038/mt.2010.219; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Martin MS, 2007, HUM MOL GENET, V16, P2892, DOI 10.1093/hmg/ddm248; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; PARTIN KM, 1995, NEURON, V14, P833, DOI 10.1016/0896-6273(95)90227-9; Penn AC, 2009, RNA BIOL, V6, P517, DOI 10.4161/rna.6.5.9552; Qiu C, 2008, J NEUROSCI, V28, P3567, DOI 10.1523/JNEUROSCI.4679-07.2008; Rakhade SN, 2008, J NEUROSCI, V28, P7979, DOI 10.1523/JNEUROSCI.1734-08.2008; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Rennie JM, 2003, CURR OPIN NEUROL, V16, P177, DOI 10.1097/00019052-200304000-00010; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Rosa MLNM, 1999, EPILEPSY RES, V36, P243, DOI 10.1016/S0920-1211(99)00055-8; Sanderson DJ, 2008, PROG BRAIN RES, V169, P159, DOI 10.1016/S0079-6123(07)00009-X; Sarkisian MR, 2001, EPILEPSY BEHAV, V2, P201, DOI 10.1006/ebeh.2001.0193; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; Selcher JC, 2012, BRAIN RES, V1435, P8, DOI 10.1016/j.brainres.2011.11.029; Shababi M., DRUG NEWS PERSPECTIV, V23, P475; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Silverstein FS, 2007, ANN NEUROL, V62, P112, DOI 10.1002/ana.21167; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Tang B, 2009, NEUROBIOL DIS, V35, P91, DOI 10.1016/j.nbd.2009.04.007; Tekgul H, 2006, PEDIATRICS, V117, P1270, DOI 10.1542/peds.2005-1178; Traa BS, 2008, PEDIATR RES, V64, P81, DOI 10.1203/PDR.0b013e318174e70e; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Williams JH, 2009, J NEUROSCI, V29, P7633, DOI 10.1523/JNEUROSCI.0950-09.2009; YAMAGUCHI S, 1993, EPILEPSY RES, V15, P179, DOI 10.1016/0920-1211(93)90054-B; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zaccara G, 2013, EUR J NEUROL, V20, P1204, DOI 10.1111/ene.12170; Zaccara G, 2013, EXPERT REV NEUROTHER, V13, P647, DOI [10.1586/ern.13.46, 10.1586/ERN.13.46]; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304	76	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171538	10.1371/journal.pone.0171538	http://dx.doi.org/10.1371/journal.pone.0171538			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178321	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500049
J	Farrell, JJ; Wang, H; Sampath, R; Lowery, KS; Bonomo, RA				Farrell, John Joseph; Wang, Huaping; Sampath, Rangarajan; Lowery, Kristin S.; Bonomo, Robert A.			The effect of empiric antimicrobial treatment duration on detection of bacterial DNA in sterile surgical specimens	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; SEVERE SEPSIS; SEPTIC SHOCK; PATHOGENS; OUTCOMES; PCR	Initial antimicrobial treatment of patients with deep seated or invasive infections is typically empiric. Usually, cultures of specimens obtained from the suspected source of infection are performed to identify pathogens and guide continued antimicrobial treatment. When patients present with signs and symptoms of infection, but sterile body fluid or tissue specimens cannot be obtained in a timely fashion, growth of bacterial pathogens in culture may be inhibited following initiation of empiric antibiotic treatment. To address this clinical dilemma, we performed a prospective evaluation of conventional culture vs. PCR coupled to electrospray ionization mass spectrometry (PCR/ESI-MS) on sterile body fluids and tissues submitted to the diagnostic microbiology lab following initiation of empiric antibiotic treatment for patients with suspected infection. In this series of surgical samples, PCR/ESI-MS identified bacterial pathogen(s) in 56% (49/87) of patients with non-diagnostic cultures. Examination of patients stratified by antibiotic treatment duration demonstrated that PCR/ESI-MS sustains high rates of bacterial DNA detection over time by generalized estimating equation models (p<0.0001).	[Farrell, John Joseph; Wang, Huaping] Univ Illinois, Coll Med, Dept Med, Peoria, IL 61656 USA; [Farrell, John Joseph] OSF Syst Lab, Div Clin Microbiol & Serol, Dept Lab Med, Peoria, IL 61603 USA; [Sampath, Rangarajan; Lowery, Kristin S.] Ibis Biosci, Carlsbad, CA USA; [Bonomo, Robert A.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	University of Illinois System; University of Illinois Peoria; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Farrell, JJ (corresponding author), Univ Illinois, Coll Med, Dept Med, Peoria, IL 61656 USA.; Farrell, JJ (corresponding author), OSF Syst Lab, Div Clin Microbiol & Serol, Dept Lab Med, Peoria, IL 61603 USA.	jjf@uic.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI063517, R01AI100560]; Antibiotic Resistance Leadership Group under National Institutes of Health [UM1AI104681]; NIH [R01AI072219]; Ibis Biosciences; Geriatric Research Education and Clinical Center VISN	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Antibiotic Resistance Leadership Group under National Institutes of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ibis Biosciences; Geriatric Research Education and Clinical Center VISN	This work was funded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01AI063517 and R01AI100560 to RAB, as well as funds from the Antibiotic Resistance Leadership Group under National Institutes of Health award number UM1AI104681, and NIH award number R01AI072219. The specific roles of all of the authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The manuscript content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Veterans Affairs. Ibis Biosciences provided support for RS strictly in the form of salary, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the staff at Ibis Biosciences for their assistance with PCR/ESI-MS, particularly Jenna Cromwell, as well as the staff of the OSF system lab and research department; particularly Lindsay O'Rourke, Ross Barton, Joshua Larson and Gwenn Selby, for their assistance with specimen processing and aerobic and anaerobic bacterial cultures, and Anna Bogner for her help generating figures for publication. We also acknowledge the staff of the research service of the Louis Stokes Cleveland Department of Veterans Affairs Medical Center for their assistance with manuscript review, especially Andrea M. Hujer. Funds provided by the Geriatric Research Education and Clinical Center VISN to RAB facilitated this work. This work was also supported by funds from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01AI063517 and R01AI100560 to RAB, and through the Antibiotic Resistance Leadership Group under National Institutes of Health award number UM1AI104681, and NIH award number R01AI072219. Funding organizations were not involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Veterans Affairs. RS is employed by Ibis Biosciences, and KSL was formerly employed by Ibis Biosciences. Ibis Biosciences did not play a role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials.	BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Davey P, 2013, COCHRANE DB SYST REV, V4, P1; Farrell JJ, 2013, J CLIN MICROBIOL, V51, P3464, DOI 10.1128/JCM.01343-13; Farrell JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066349; Flayhart D, 2007, J CLIN MICROBIOL, V45, P816, DOI 10.1128/JCM.02064-06; Hardin JW, 2012, GEN ESTIMATING EQUAT; Kaleta EJ, 2011, J CLIN MICROBIOL, V49, P345, DOI 10.1128/JCM.00936-10; Levy MM, 2015, CRIT CARE MED, V43, P3, DOI [10.1097/CCM.0000000000000723, 10.1007/s00134-014-3496-0]; Previsdomini M, 2012, CROAT MED J, V53, P30, DOI 10.3325/cmj.2012.53.30; Vazquez-Guillamet C, 2014, CRIT CARE MED, V42, P2342, DOI 10.1097/CCM.0000000000000516; Zahar JR, 2011, CRIT CARE MED, V39, P1886, DOI 10.1097/CCM.0b013e31821b827c	11	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171074	10.1371/journal.pone.0171074	http://dx.doi.org/10.1371/journal.pone.0171074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170436	Green Submitted, Green Published, gold			2022-12-26	WOS:000393705500021
J	Prajapati, HJ; Kim, HS				Prajapati, Hasmukh J.; Kim, Hyun S.			Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization	PLOS ONE			English	Article							DRUG-ELUTING BEADS; CONCURRENT TRANSARTERIAL CHEMOEMBOLIZATION; PROGNOSTIC-FACTORS; PREDICT SURVIVAL; LIVER-CANCER; PHASE-II; SORAFENIB; EFFICACY; SAFETY; COHORT	Purpose To develop the treatment algorithm from multivariate survival analyses (MVA) in patients with Barcelona clinic liver cancer (BCLC) C (advanced) Hepatocellular carcinoma (HCC) patients treated with Trans-arterial Chemoembolization (TACE). Methods Consecutive unresectable and non-tranplantable patients with advanced HCC, who received DEB TACE were studied. A total of 238 patients (mean age, 62.4yrs) was included in the study. Survivals were analyzed according to different parameters from the time of the 1st DEB TACE. Kaplan Meier and Cox Proportional Hazard model were used for survival analysis. The SS was constructed from MVA and named BCLC C HCC Prognostic (BCHP) staging system (SS). Results Overall median survival (OS) was 16.2 months. In HCC patients with venous thrombosis (VT) of large vein [main portal vein (PV), right or left PV, hepatic vein, inferior vena cava] (22.7%) versus small vein (segmental/subsegmental PV) (9.7%) versus no VT had OSs of 6.4 months versus 20 months versus 22.8 months respectively (p<0.001). On MVA, the significant independent prognostic factors (PFs) of survival were CP class, eastern cooperative oncology group (ECOG) performance status (PS), single HCC<5 cm, site of VT, metastases, serum creatinine and serum alpha-feto protein. Based on these PFs, the BCHP staging system was constructed. The OSs of stages I, II and III were 28.4 months, 11.8 months and 2.4 months accordingly (p<0.001). The treatment plan was proposed according to the different stages. Conclusion On MVA of patients with advanced HCC treated with TACE, significant independent prognostic factors (PFs) of survival were CP class, ECOG PS, single HCC<5 cm or others, site of VT, metastases, serum creatinine and serum alpha-feto protein. New BCHP SS was proposed based on MVA data to identify the suitable advanced HCC patients for TACE treatments.	[Prajapati, Hasmukh J.] Univ Tennessee, Hlth Sci Ctr, Div Pediat Intervent Radiol, Dept Radiol, Memphis, TN USA; [Kim, Hyun S.] Yale Univ, Dept Radiol & Biomed Imaging, Div Intervent Radiol, New Haven, CT 06520 USA; [Kim, Hyun S.] Yale Univ, Yale Canc Ctr, New Haven, CT 06520 USA	University of Tennessee System; University of Tennessee Health Science Center; Yale University; Yale University	Kim, HS (corresponding author), Yale Univ, Dept Radiol & Biomed Imaging, Div Intervent Radiol, New Haven, CT 06520 USA.; Kim, HS (corresponding author), Yale Univ, Yale Canc Ctr, New Haven, CT 06520 USA.	kevin.kim@yale.edu		Kim, Hyun/0000-0002-3077-9989				Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Brown DB, 2004, J VASC INTERV RADIOL, V15, P1209, DOI 10.1097/01.RVI.0000128123.04554.C1; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Chung YE, 2009, AM J ROENTGENOL, V193, pW7, DOI 10.2214/AJR.07.3947; Dhanasekaran R, 2010, HPB, V12, P174, DOI 10.1111/j.1477-2574.2009.00138.x; Hiraoka A, 2009, HEPATO-GASTROENTEROL, V56, P213; Hu HT, 2011, J VASC INTERV RADIOL, V22, P917, DOI 10.1016/j.jvir.2011.03.005; Hung H, 2005, CURR CANCER DRUG TAR, V5, P131, DOI 10.2174/1568009053202063; Huo TI, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-146; Jin B, 2011, AM J ROENTGENOL, V196, P919, DOI 10.2214/AJR.10.4770; Kalva SP, 2013, J VASC INTERV RADIOL, V24, P257, DOI 10.1016/j.jvir.2012.10.021; Kalva SP, 2013, CARDIOVASCULAR INTER, P1; Lance C, 2011, J VASC INTERV RADIOL, V22, P1697, DOI 10.1016/j.jvir.2011.08.013; Lewandowski RJ, 2010, RADIOLOGY, V255, P955, DOI 10.1148/radiol.10091473; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Malagari K, 2012, CARDIOVASC INTER RAD, V35, P1119, DOI 10.1007/s00270-012-0394-0; Olivo M, 2010, DIGEST LIVER DIS, V42, P515, DOI 10.1016/j.dld.2009.09.012; Park JW, 2012, J HEPATOL, V56, P1336, DOI 10.1016/j.jhep.2012.01.006; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pawlik TM, 2011, J CLIN ONCOL, V29, P3960, DOI 10.1200/JCO.2011.37.1021; Pinter M, 2012, RADIOLOGY, V263, P590, DOI 10.1148/radiol.12111550; Prajapati HJ, 2013, ANN ONCOL, V24, P965, DOI 10.1093/annonc/mds605; Prajapati HJ, 2013, J VASC INTERV RADIOL, V24, P307, DOI 10.1016/j.jvir.2012.11.026; Sellers MT, 2013, J VASC INTERV RADIOL, V24, P647, DOI 10.1016/j.jvir.2012.12.003; Shin BS, 2011, ACTA RADIOL, V52, P331, DOI 10.1258/ar.2010.100369; Uraki J, 2004, EUR J RADIOL, V51, P12, DOI 10.1016/S0720-048X(03)00219-5; Yau T, 2014, GASTROENTEROLOGY, V146, P1691, DOI 10.1053/j.gastro.2014.02.032	28	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170750	10.1371/journal.pone.0170750	http://dx.doi.org/10.1371/journal.pone.0170750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170405	Green Published, Green Submitted, gold			2022-12-26	WOS:000393705500010
J	Zhang, YL; Xu, WJ; Duan, PP; Cong, YH; An, TT; Yu, N; Zou, HT; Dang, XL; An, J; Fan, QF; Zhang, YL				Zhang, Yuling; Xu, Wenjing; Duan, Pengpeng; Cong, Yaohui; An, Tingting; Yu, Na; Zou, Hongtao; Dang, Xiuli; An, Jing; Fan, Qingfeng; Zhang, Yulong			Evaluation and simulation of nitrogen mineralization of paddy soils in Mollisols area of Northeast China under waterlogged incubation	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; SUBMERGED RICE SOILS; AMMONIUM PRODUCTION; N MINERALIZATION; COMMUNITY STRUCTURE; MICROBIAL BIOMASS; REDUCIBLE IRON; ARABLE SOIL; PH; PLANTS	Background Understanding the nitrogen (N) mineralization process and applying appropriate model simulation are key factors in evaluating N mineralization. However, there are few studies of the N mineralization characteristics of paddy soils in Mollisols area of Northeast China. Materials and methods The soils were sampled from the counties of Qingan and Huachuan, which were located in Mollisols area of Northeast China. The sample soil was incubated under waterlogged at 30 E C in a controlled temperature cabinet for 161 days (a 2: 1 water: soil ratio was maintained during incubation). Three models, i.e. the single first-order kinetics model, the double firstorder kinetics model and the mixed first-order and zero-order kinetics model were used to simulate the cumulative mineralised N (NH4+-N and TSN) in the laboratory and waterlogged incubation. Principal results During 161 days of waterlogged incubation, the average cumulative total soluble N (TSN), ammonium N (NH4+-N), and soluble organic N (SON) was 122.2 mg kg(-1), 85.9 mg kg(-1), and 36.3 mg kg(-1), respectively. Cumulative NH4+-N was significantly (P < 0.05) positively correlated with organic carbon (OC), total N (TN), pH, and exchangeable calcium (Ca), and cumulative TSN was significantly (P < 0.05) positively correlated with OC, TN, and exchangeable Ca, but was not significantly (P > 0.05) correlated with C/ N ratio, cation exchange capacity (CEC), extractable iron (Fe), clay, and sand. When the cumulative NH4+-N and TSN were simulated, the single first-order kinetics model provided the least accurate simulation. The parameter of the double first-order kinetics model also did not represent the actual data well, but the mixed first-order and zero-order kinetics model provided the most accurate simulation, as demonstrated by the estimated standard error, F statistic values, parameter accuracy, and fitting effect. Conclusions Overall, the results showed that SON was involved with N mineralization process, and the mixed first-order and zero-order kinetics model accurately simulates the N mineralization process of paddy soil in Mollisols area of Northeast China under waterlogged incubation.	[Zhang, Yuling; Xu, Wenjing; Duan, Pengpeng; Cong, Yaohui; An, Tingting; Yu, Na; Zou, Hongtao; Dang, Xiuli; An, Jing; Fan, Qingfeng; Zhang, Yulong] Shenyang Agr Univ, Coll Land & Environm Sci, Shenyang, Peoples R China; [Zhang, Yuling; Xu, Wenjing; Duan, Pengpeng; Cong, Yaohui; An, Tingting; Yu, Na; Zou, Hongtao; Dang, Xiuli; An, Jing; Fan, Qingfeng; Zhang, Yulong] Key Lab Northeast Arable Land Conservat Northest, Shenyang, Peoples R China	Shenyang Agricultural University	Zhang, YL (corresponding author), Shenyang Agr Univ, Coll Land & Environm Sci, Shenyang, Peoples R China.; Zhang, YL (corresponding author), Key Lab Northeast Arable Land Conservat Northest, Shenyang, Peoples R China.	ylzsau@163.com	An, Tingting/M-2186-2017; An, Tingting/V-9666-2017; dang, xiuli/ABG-4716-2021; Yu, Na/L-3811-2017	An, Tingting/0000-0002-5263-7375; An, Tingting/0000-0002-5263-7375; dang, xiuli/0000-0002-1702-9745; /0000-0001-6772-5338	National Natural Science Foundation of China [41571280, 41101276]; Agriculture Research and Achievements Industrialization Foundation of Science and Technology Department of Liaoning Province in China [2014213004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture Research and Achievements Industrialization Foundation of Science and Technology Department of Liaoning Province in China	This study was financially supported by the National Natural Science Foundation of China (41571280, 41101276) and the Agriculture Research and Achievements Industrialization Foundation of Science and Technology Department of Liaoning Province in China (2014213004).	Abadin J, 2011, PLANT SOIL, V339, P193, DOI 10.1007/s11104-010-0568-y; Pietri JCA, 2009, SOIL BIOL BIOCHEM, V41, P1396, DOI 10.1016/j.soilbio.2009.03.017; Bird JA, 2006, BIOGEOCHEMISTRY, V79, P361, DOI 10.1007/s10533-005-5632-y; Bregliani MM, 2010, COMMUN SOIL SCI PLAN, V41, P1383, DOI 10.1080/00103621003759387; BREMNER JM, 1966, SOIL SCI SOC AM PRO, V30, P577, DOI 10.2136/sssaj1966.03615995003000050015x; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P63, DOI 10.2136/sssaj1993.03615995005700010012x; Cassman KG, 1996, PLANT SOIL, V182, P267, DOI 10.1007/BF00029058; Chen CR, 2005, PLANT SOIL, V277, P285, DOI 10.1007/s11104-005-7530-4; Colberg PJ, 1988, ANAEROBIC MICROBIAL; Cookson WR, 2004, SOIL BIOL BIOCHEM, V36, P2097, DOI 10.1016/j.soilbio.2004.05.013; Cui J, 2012, SOIL TILL RES, V123, P50, DOI 10.1016/j.still.2012.03.009; Dessureault-Rompre J, 2010, GEODERMA, V157, P97, DOI 10.1016/j.geoderma.2010.04.001; Dessureault-Rompre J, 2010, SOIL SCI SOC AM J, V74, P1218, DOI 10.2136/sssaj2009.0213; Devevre OC, 2001, SOIL SCI SOC AM J, V65, P499, DOI 10.2136/sssaj2001.652499x; Gil MV, 2011, BIORESOURCE TECHNOL, V102, P863, DOI 10.1016/j.biortech.2010.09.010; GONZALEZPRIETO SJ, 1992, PLANT SOIL, V144, P31, DOI 10.1007/BF00018842; Groffman PM, 1996, PLANT SOIL, V183, P61, DOI 10.1007/BF02185565; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Jones DL, 2005, SOIL BIOL BIOCHEM, V37, P413, DOI 10.1016/j.soilbio.2004.08.008; Ju X, 2000, PLANT NUTR FERTILIZE, V6, P251; Kalbitz K, 2005, SOIL BIOL BIOCHEM, V37, P1319, DOI 10.1016/j.soilbio.2004.11.028; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li HL, 2003, GEODERMA, V115, P161, DOI 10.1016/S0016-7061(02)00358-0; Li S., 1999, ACTA U AGR BOREALI O, V27, P1; Li ZP, 2010, GEODERMA, V157, P206, DOI 10.1016/j.geoderma.2010.04.015; Lipson D, 2001, OECOLOGIA, V128, P305, DOI 10.1007/s004420100693; Liu XY, 2013, PLANT SOIL, V373, P583, DOI 10.1007/s11104-013-1806-x; Lu HL, 2008, SCI AGR SINICA, V10; Lu HongLing, 2008, Plant Nutrition and Fertilizer Science, V14, P1083; Lu HongLing, 2008, Agricultural Sciences in China, V7, P860, DOI 10.1016/S1671-2927(08)60124-8; Lu SB, 2012, GEODERMA, V170, P136, DOI 10.1016/j.geoderma.2011.11.023; Minick KJ, 2011, SOIL BIOL BIOCHEM, V43, P271, DOI 10.1016/j.soilbio.2010.10.009; Murphy DV, 2000, BIOL FERT SOILS, V30, P374, DOI 10.1007/s003740050018; Narteh LT, 1997, GEODERMA, V76, P145, DOI 10.1016/S0016-7061(96)00097-3; Nasholm T, 1998, NATURE, V392, P914, DOI 10.1038/31921; Olk DC, 1996, EUR J SOIL SCI, V47, P293, DOI 10.1111/j.1365-2389.1996.tb01403.x; Peng YY, 2012, J SOIL WATER CONSERV, V5; Pietri JCA, 2008, SOIL BIOL BIOCHEM, V40, P1856, DOI [10.1016/j.soilbio.2008.03.020, 10.1016/i.soilbio.2008.03.020]; Pietri JCA, 2008, SOIL BIOL BIOCHEM, V40, P797, DOI 10.1016/j.soilbio.2007.10.014; RICHTER J, 1980, PLANT SOIL, V54, P329, DOI 10.1007/BF02181829; Roden EE, 2002, LIMNOL OCEANOGR, V47, P198, DOI 10.4319/lo.2002.47.1.0198; Ros GH, 2011, SOIL BIOL BIOCHEM, V43, P1714, DOI 10.1016/j.soilbio.2011.04.017; Sahrawat KL, 2002, COMMUN SOIL SCI PLAN, V33, P229, DOI 10.1081/CSS-120002389; Sahrawat KL, 2004, COMMUN SOIL SCI PLAN, V35, P399, DOI 10.1081/CSS-120029721; Sahrawat KL, 2003, COMMUN SOIL SCI PLAN, V34, P1013, DOI 10.1081/CSS-120019106; Sahrawat KL, 2001, COMMUN SOIL SCI PLAN, V32, P1543, DOI 10.1081/CSS-100104211; SCHNITZER M, 1966, SOIL SCI, V102, P361, DOI 10.1097/00010694-196612000-00002; Schulten HR, 1997, BIOL FERT SOILS, V26, P1, DOI 10.1007/s003740050335; SMITH JL, 1980, SOIL SCI SOC AM J, V44, P996, DOI 10.2136/sssaj1980.03615995004400050025x; SMITH SJ, 1987, SOIL SCI SOC AM J, V51, P1191, DOI 10.2136/sssaj1987.03615995005100050018x; STANFORD G, 1972, SOIL SCI SOC AM PRO, V36, P465, DOI 10.2136/sssaj1972.03615995003600030029x; Turrion MB, 2012, J ENVIRON MANAGE, V95, pS245, DOI 10.1016/j.jenvman.2010.10.020; Xu HJ, 2014, ENVIRON SCI TECHNOL, V48, P9391, DOI 10.1021/es5021058; Yamamoto T, 1986, JAPANESE J SOIL SCI; Zhang YL, 2008, CHINESE J SOIL SCI, V4; Zhao W, 2007, PLANT SOIL, V297, P213, DOI 10.1007/s11104-007-9334-1; Zhu Z.L., 1985, SOIL-GERMANY, V17, P2	57	14	17	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171022	10.1371/journal.pone.0171022	http://dx.doi.org/10.1371/journal.pone.0171022			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170409	gold, Green Submitted, Green Published			2022-12-26	WOS:000393705500020
J	Desyibelew, HD; Fekadu, A; Woldie, H				Desyibelew, Hanna Demelash; Fekadu, Abel; Woldie, Haile			Recovery rate and associated factors of children age 6 to 59 months admitted with severe acute malnutrition at inpatient unit of Bahir Dar Felege Hiwot Referral hospital therapeutic feeding unite, northwest Ethiopia	PLOS ONE			English	Article							MALNOURISHED CHILDREN; MANAGEMENT; EXPERIENCE; NUTRITION	Background Despite numerous advances made in improving child health and the clinical management protocols for treating severe acute malnutrition at treatment centers, evidences concerning the treatment outcomes are scarce. Therefore, this study was conducted to assess the recovery rate and associated factors of severely acute malnourished children of age 6 to 59 months admitted to inpatient therapeutic feeding unit at Felege Hiwot Referral Hospital. Methods We conducted a hospital-based cross-sectional study including 401 severely malnourished children who were admitted from September 2012 to January 2016. Bivariable and a Multi variable logistic regression model were fitted to identify factors associated with recovery rate. Adjusted Odds ratio with its 95% CI was reported and P-value less than 0.05 was considered as significant. Results Fifty eight percent (58.4%) (95%Cl: 53.1-64.1) of admitted children were recovered with a mean recovery time of 18 ( 6.3) days. Being female, children who were fully and partially vaccinated, who had better MUAC measurement, who stayed longer in the hospital, and children who took routine vitamin-A supplementation had better recovery rate. However, children who had co-morbidity at admission, had human immune virus (HIV) and Tuberculosis (TB) infection, and who had edema were less likely to recover. Interpretation Recovery rate was low as compared to international SPHERE cutoff points (> 75% recovery rate). Interventions that could address the outlined factors would be helpful to improve treatment recovery rate of admitted children.	[Desyibelew, Hanna Demelash] Woldia Univ, Dept Publ Hlth, Fac Hlth Sci, Woldia, Ethiopia; [Fekadu, Abel] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Woldie, Haile] Univ Gondar, Inst Publ Hlth, Dept Human Nutr, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar	Fekadu, A (corresponding author), Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Dept Epidemiol & Biostat, Gondar, Ethiopia.	Fekten@yahoo.com	Dadi, Abel Fekadu/AAU-3433-2020	Dadi, Abel Fekadu/0000-0001-9967-7713	University of Gondar	University of Gondar	University of Gondar funded the project.	AHMED AU, 2013, BANGLADESH J CHILD H, V37, P5, DOI DOI 10.3329/bjch.v37i1.15345; Ahmed S, 2014, JCPSP-J COLL PHYSICI, V24, P493, DOI 07.2014/JCPSP.493497; Amsalu Solomon, 2006, Ethiop Med J, V44, P151; [Anonymous], 2009, WHO CHILD GROWTH STA; Briend A, 2010, INDIAN PEDIATR, V47, P655, DOI 10.1007/s13312-010-0094-2; Central Stastics Agency, 2014, ETH MIN DEM HLTH SUR; Chane T, 2014, J NUTR FOOD SCI, V2014; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Dereje N, 2014, J NUTR FOOD SCI, V2014; Gebremichael DY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2593-5; Hamill PV, 1977, VITAL HLTH STAT, V11, p[1, i]; Irena AH, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-110; Jarso H, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0398-4; Layton R, 2001, SPHER PROJ HUM CHART; Mekonnen L, 2013, SEVERITY MALNUTRITIO; Munthali T, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0072-1; Puoane T, 2001, S AFR MED J, V91, P137; Shanka NA, 2015, J NUTR DISORDERS THE, V2015; Singh K, 2014, INDIAN PEDIATR, V51, P21, DOI 10.1007/s13312-014-0328-9; Union African, 2015, SOC EC IMP CHILD NUT; WHO WFP, 2007, COMM BAS MANG SEV AC	21	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171020	10.1371/journal.pone.0171020	http://dx.doi.org/10.1371/journal.pone.0171020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166247	Green Published, Green Submitted, gold			2022-12-26	WOS:000393700100019
J	Herrero, O; Morcillo, G; Planello, R				Herrero, Oscar; Morcillo, Gloria; Planello, Rosario			Transcriptional deregulation of genetic biomarkers in Chironomus riparius larvae exposed to ecologically relevant concentrations of di(2-ethylhexyl) phthalate (DEHP)	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FRESH-WATER BENTHOS; HEAT-SHOCK-PROTEIN; DAPHNIA-MAGNA; DI-2-ETHYLHEXYL PHTHALATE; AQUATIC ENVIRONMENT; HSP70 CHAPERONES; HEMOGLOBIN GENES; MESSENGER-RNA; EXPRESSION	Di(2-ethylhexyl) phthalate (DEHP) is a ubiquitous environmental pollutant used worldwide as a plasticizer and solvent in many formulations. Based on available toxicological data, it has been classified as toxic for reproduction and as an endocrine disruptor. Despite this, ecotoxicological studies in aquatic wildlife organisms are still scarce. In the present work, the toxic molecular alterations caused by DEHP in aquatic larvae of the midge Chironomus riparius have been studied, by analyzing the transcriptional activity of genes related to some vital cellular pathways, such as the ribosomal machinery (rpL4, rpL13), the cell stress response (hsc70, hsp70, hsp40, hsp27), the ecdysone hormone pathway (EcR), the energy metabolism (GAPDH), and detoxication processes (CYP4G). Environmentally relevant concentrations (10(-3) to 10(5) mu g/L) and exposure conditions (24 to 96 h) have been tested, as well as the toxic effects after DEHP withdrawal. Although the compound caused no mortality, significant changes were detected in almost all the studied biomarkers: e.g. strong repression of hsp70; general inhibition of EcR; GAPDH activity loss in long exposures; among others. Our data show a general transcriptional downregulation that could be associated with an adaptive response to cell damage. Besides, the activity of the compound as an ecdysone antagonist and its delayed effects over almost all the biomarkers analyzed are described as novel toxic targets in insects.	[Herrero, Oscar; Morcillo, Gloria; Planello, Rosario] Univ Nacl Educ Distancia, Fac Ciencias, Grp Biol & Toxicol Ambiental, Paseo Senda del Rey 9, Madrid, Spain	Universidad Nacional de Educacion a Distancia (UNED)	Herrero, O (corresponding author), Univ Nacl Educ Distancia, Fac Ciencias, Grp Biol & Toxicol Ambiental, Paseo Senda del Rey 9, Madrid, Spain.	oscar.herrero@ccia.uned.es	Herrero, Óscar/B-3782-2012; Planelló, Rosario/AAQ-5881-2020; Planello, Rosario/V-1462-2019; Planelló, Rosario/E-9975-2015	Herrero, Óscar/0000-0002-1410-368X; Planelló, Rosario/0000-0003-3730-9549; Planelló, Rosario/0000-0003-3730-9549	Ministerio de Economia y Competitividad (Spain) [CTM2015-64913-R]	Ministerio de Economia y Competitividad (Spain)	This research was supported by Ministerio de Economia y Competitividad (Spain) contract grant number CTM2015-64913-R (http://www.idi.mineco.gob.es).; This research was supported by Ministerio de Economia y Competitividad (Spain) contract grant number CTM2015-64913-R. The authors thank Dr. A. Hidalgo and Dr. M. Casanova (CNIC, Madrid, Spain) for their help with spectrophotometry equipment used in enzyme activity tests.	Adams WJ, 1985, AQUATIC TOXICOLOGY H, P87; Anderson TD, 2008, AQUAT TOXICOL, V86, P148, DOI 10.1016/j.aquatox.2007.10.015; Aquilino M., 2014, REV TOXICOL; Aquilino M, 2016, AQUAT TOXICOL, V174, P179, DOI 10.1016/j.aquatox.2016.03.001; ATSDR, 2014, SUPP DOC 2013 PRIOR; ATSDR(AgencyforToxicSubstancesandDiseaseRegistry), 2002, TOX PROF DI 2 ETH PH; Brown D, 1998, CHEMOSPHERE, V36, P1367, DOI 10.1016/S0045-6535(97)10018-2; BROWN D, 1982, CHEMOSPHERE, V11, P427, DOI 10.1016/0045-6535(82)90046-7; BROWN D, 1982, CHEMOSPHERE, V11, P417, DOI 10.1016/0045-6535(82)90045-5; Bryantsev AL, 2007, BIOCHEM J, V407, P407, DOI 10.1042/BJ20070195; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Cadogan D. F., 1993, PROGR RUBBER PLASTIC, V10, P1; Call DJ, 2001, ENVIRON TOXICOL CHEM, V20, P1805, DOI 10.1897/1551-5028(2001)020&lt;1805:AAOTTO&gt;2.0.CO;2; Call DJ, 2001, ENVIRON TOXICOL CHEM, V20, P1798, DOI [10.1002/etc.5620200825, 10.1897/1551-5028(2001)020&lt;1798:AAOTTO&gt;2.0.CO;2]; Che-Mendoza A, 2009, AFR J BIOTECHNOL, V8, P1386; Clark K, 2003, HANDB ENVIRON CHEM, V3, P125; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; *EC, 2000, EST PRIOR LIST SUBST; ECB, 2008, EUR UN RISK ASS REP; ECHA-European Chemicals Agency (EChA), 2013, COMM RISK ASS RAC OP; EPA, 2012, 2012 ED DRINK WAT ST; EPA, 1994, WAT QUAL STAND HDB 2; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Gao DW, 2016, SCI TOTAL ENVIRON, V541, P986, DOI 10.1016/j.scitotenv.2015.09.148; Gillesby BE, 1998, ENVIRON TOXICOL CHEM, V17, P3, DOI 10.1002/etc.5620170102; Halden RU, 2010, ANNU REV PUBL HEALTH, V31, P179, DOI 10.1146/annurev.publhealth.012809.103714; Herrero O, 2012, MUTAT RES-GEN TOX EN, V743, P20, DOI 10.1016/j.mrgentox.2011.12.028; Herrero O, 2016, CHEMOSPHERE, V144, P1874, DOI 10.1016/j.chemosphere.2015.10.051; Herrero O, 2015, CHEMOSPHERE, V128, P266, DOI 10.1016/j.chemosphere.2015.01.059; International Agency for Research on Cancer, 2012, IARC MONOGRAPHS EVAL, V101; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; KNOWLES CO, 1987, ENVIRON TOXICOL CHEM, V6, P201, DOI 10.1897/1552-8618(1987)6[201:CEODPO]2.0.CO;2; Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x; LAUGHLIN RB, 1978, WATER AIR SOIL POLL, V9, P323; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; Lee SB, 2006, ENVIRON TOXICOL CHEM, V25, P3006, DOI 10.1897/05-601R1.1; Lee SW, 2008, ENVIRON TOXICOL CHEM, V27, P1118, DOI 10.1897/07-219.1; Lee SW, 2009, ENVIRON TOXICOL PHAR, V28, P269, DOI 10.1016/j.etap.2009.05.004; Lee SM, 2006, CHEMOSPHERE, V65, P1074, DOI 10.1016/j.chemosphere.2006.02.042; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; MacDonald MM, 2004, ENVIRON TOXICOL CHEM, V23, P2116, DOI 10.1897/03-449; Majumdar TN, 2012, J ENVIRON BIOL, V33, P139; Marinkovic M, 2012, ENVIRON SCI TECHNOL, V46, P12679, DOI 10.1021/es3033617; Martin-Folgar R, 2017, CHEMOSPHERE, V169, P485, DOI 10.1016/j.chemosphere.2016.11.067; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Morales M, 2011, COMP BIOCHEM PHYS C, V153, P150, DOI 10.1016/j.cbpc.2010.10.003; Nair PMG, 2015, COMP BIOCHEM PHYS B, V190, P1, DOI 10.1016/j.cbpb.2015.08.004; Nair PMG, 2012, ENVIRON TOXICOL PHAR, V33, P98, DOI 10.1016/j.etap.2011.09.006; Net S, 2015, ENVIRON SCI TECHNOL, V49, P4019, DOI 10.1021/es505233b; *NTP CERHR, 2006, NTP CERHR MON POT HU; OECD, 2006, OECD SER TEST ASS, V55, P125; OECD, 2011, 40 YEARS CHEM SAF OE; OECD, 2008, SURF WAT QUAL REG EE; *OECD, 2004, TEST NO 219 SED WAT; OECD, 2010, TEST NO 233 SED WAT; OECD, 2011, TEST NO 235 CHIR AC; OECD, 2004, TEST NO 218 SED WAT; OEHHA, 2009, TOX PROF DI 2 ETH PH; Oehlmann J, 2003, PURE APPL CHEM, V75, P2207, DOI 10.1351/pac200375112207; Oehlmann J, 2009, PHILOS T R SOC B, V364, P2047, DOI 10.1098/rstb.2008.0242; Ozaez I, 2016, SCI TOTAL ENVIRON, V557, P240, DOI 10.1016/j.scitotenv.2016.03.078; Ozaez I, 2014, ENVIRON POLLUT, V192, P19, DOI 10.1016/j.envpol.2014.04.038; Park K, 2014, SCI TOTAL ENVIRON, V470, P1003, DOI 10.1016/j.scitotenv.2013.10.052; Park K, 2012, COMP BIOCHEM PHYS C, V156, P113, DOI 10.1016/j.cbpc.2012.05.002; Park K, 2010, CHEMOSPHERE, V79, P934, DOI 10.1016/j.chemosphere.2010.03.002; Park K, 2008, CHEMOSPHERE, V74, P89, DOI 10.1016/j.chemosphere.2008.09.041; Peropadre A, 2015, TOXICOL IN VITRO, V30, P281, DOI 10.1016/j.tiv.2015.10.009; Peterson JSK, 2004, AQUAT TOXICOL, V66, P345, DOI 10.1016/j.aquatox.2003.10.005; Planello R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140239; Planello R, 2011, AQUAT TOXICOL, V105, P62, DOI 10.1016/j.aquatox.2011.05.011; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x; Servia MJ, 2006, ECOTOXICOLOGY, V15, P229, DOI 10.1007/s10646-005-0054-0; Shi YJ, 2015, COMP BIOCHEM PHYS C, V174, P32, DOI 10.1016/j.cbpc.2015.06.005; Soldatenkov VA, 1997, CANCER RES, V57, P3881; Somparn A, 2015, J ENVIRON BIOL, V36, P1355; Staples C., 2003, PHTHALATE ESTERS; Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1; STREUFERT J M, 1980, Transactions of the Missouri Academy of Science, V14, P33; Sun X, 2015, J CELL MOL MED, V19, P581, DOI 10.1111/jcmm.12409; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; US EPA (United States Environmental Protection Agency), 1996, EC EFF TEST GUID OPP; US Food and Drug Administration, 2001, SAF ASS DI 2 ETH PHT; US-EPA, 2000, METH MEAS TOX BIOACC; World Health Organization, 2003, DI 2 ETH PHTHAL DRIN	89	28	29	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171719	10.1371/journal.pone.0171719	http://dx.doi.org/10.1371/journal.pone.0171719			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166271	gold, Green Published, Green Submitted			2022-12-26	WOS:000393700100064
J	Monti, M; Iommelli, F; De Rosa, V; Carriero, MV; Miceli, R; Camerlingo, R; Di Minno, G; Del Vecchio, S				Monti, Marcello; Iommelli, Francesca; De Rosa, Viviana; Carriero, Maria Vincenza; Miceli, Roberta; Camerlingo, Rosa; Di Minno, Giovanni; Del Vecchio, Silvana			Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells	PLOS ONE			English	Article							BREAST-CANCER; PROMOTE; ALPHA(V)BETA(3); EXPRESSION; RECEPTOR; METASTASIS; ACTIVATION; MIGRATION; PAD4	Neutrophil extracellular traps (NETs), originally recognized as a host defense mechanism, were reported to promote thrombosis and metastatic dissemination of cancer cells. Here we tested the role of integrins alpha 5 beta 1 and alpha v beta 3 in the adhesion of cancer cells to NETs. Neutrophil-like cells stimulated with calcium ionophore (A23187) were used as a stable source of cell-free NETs-enriched suspensions. Using NETs as an adhesion substrate, two human K562 cell lines, differentially expressing alpha 5 beta 1 and alpha v beta 3 integrins, were subjected to adhesion assays in the presence or absence of DNAse 1, blocking antibodies against alpha 5 beta 1 or alpha v beta 3 alone or in combination with DNAse 1, and Proteinase K. As expected DNAse 1 treatment strongly inhibited adhesion of both cell lines to NETs. An equivalent significant reduction of cell adhesion to NETs was obtained after treatment of cells with blocking antibodies against alpha 5 beta 1 or alpha v beta 3 indicating that both integrins were able to mediate cell adhesion to NETs. Furthermore, the combination of DNAse 1 and anti-integrin antibody treatment almost completely blocked cell adhesion. Western blot analysis and immunoprecipitation experiments showed a dose-dependent increase of fibronectin levels in samples from stimulated neutrophil-like cells and a direct or indirect interaction of fibronectin with histone H3. Finally, co-immunolocalization studies with confocal microscopy showed that fibronectin and citrullinated histone H3 co-localize inside the web-structure of NETs. In conclusion, our study showed that alpha 5 beta 1 and alpha v beta 3 integrins mediate cell adhesion to NETs by binding to their common substrate fibronectin. Therefore, in addition to mechanical trapping and aspecific adsorption of different cell types driven by DNA/histone complexes, NETs may provide specific binding sites for integrin-mediated cell adhesion of neutrophils, platelets, endothelial and cancer cells thus promoting intimate interactions among these cells.	[Monti, Marcello; Di Minno, Giovanni] Univ Napoli Federico II, Dipartimento Med Clin & Chirurg, Naples, Italy; [Iommelli, Francesca; De Rosa, Viviana; Del Vecchio, Silvana] CNR, Ist Biostrutture & Bioimmagini, Naples, Italy; [Carriero, Maria Vincenza; Miceli, Roberta; Camerlingo, Rosa] Fdn G Pascale, Ist Nazl Tumori, IRCCS, Dipartimento Oncol Sperimentale, Naples, Italy; [Del Vecchio, Silvana] Univ Napoli Federico II, Dipartimento Sci Biomed Avanzate, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; University of Naples Federico II	Del Vecchio, S (corresponding author), CNR, Ist Biostrutture & Bioimmagini, Naples, Italy.; Del Vecchio, S (corresponding author), Univ Napoli Federico II, Dipartimento Sci Biomed Avanzate, Naples, Italy.	delvecc@unina.it	Iommelli, Francesca/ABG-7721-2020; De Rosa, Viviana/AAC-3427-2022; Carriero, Maria Vincenza/K-1240-2018; Iommelli, Francesca/ABF-3573-2020; Camerlingo, Rosa/AAB-8349-2022	De Rosa, Viviana/0000-0002-0430-5608; Carriero, Maria Vincenza/0000-0002-9768-2997; Iommelli, Francesca/0000-0002-5132-3593; Camerlingo, Rosa/0000-0001-6488-9740; DEL VECCHIO, Silvana/0000-0002-5466-1213	Associazione Italiana per la Ricerca sul Cancro (AIRC project) [IG-17249]; Programma Operativo Regionale POR Campania, Fondo Europeo Sviluppo Regionale, Rete delle Biotecnologie Campane	Associazione Italiana per la Ricerca sul Cancro (AIRC project)(Fondazione AIRC per la ricerca sul cancro); Programma Operativo Regionale POR Campania, Fondo Europeo Sviluppo Regionale, Rete delle Biotecnologie Campane	This work was partly supported by no profit association and public governmental institution: Associazione Italiana per la Ricerca sul Cancro (AIRC project No. IG-17249); Programma Operativo Regionale POR Campania, Fondo Europeo Sviluppo Regionale 2007/2013, Rete delle Biotecnologie Campane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Gioconda Di Carluccio for her technical assistance in coimmunolocalization studies. This work was partly supported by Associazione Italiana per la Ricerca sul Cancro (AIRC, project No. IG-17249) and Programma Operativo Regionale POR Campania, Fondo Europeo Sviluppo Regionale 2007/2013, Rete delle Biotecnologie Campane.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; [Anonymous], 2012, NATL ACAD SCI US, V109, P13076, DOI [10.1073/pnas.1200419109, DOI 10.1073/PNAS.1200419109]; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Barrientos L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00166; BLYSTONE SD, 1995, J CELL BIOL, V130, P745, DOI 10.1083/jcb.130.3.745; BLYSTONE SD, 1994, J CELL BIOL, V127, P1129, DOI 10.1083/jcb.127.4.1129; Brandau S, 2013, SEMIN IMMUNOPATHOL, V35, P163, DOI 10.1007/s00281-012-0344-6; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Butler B, 2003, J BIOL CHEM, V278, P5264, DOI 10.1074/jbc.M206997200; Carriero MV, 1999, CANCER RES, V59, P5307; Chiaradonna F, 1999, EMBO J, V18, P3013, DOI 10.1093/emboj/18.11.3013; Chiron D, 2008, BLOOD, V112, P2205, DOI 10.1182/blood-2008-02-140673; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Douda DN, 2015, P NATL ACAD SCI USA, V112, P2817, DOI 10.1073/pnas.1414055112; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; HOFFSTEIN ST, 1981, J CELL SCI, V50, P315; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; LAFLEUR M, 1987, J BIOL CHEM, V262, P2111; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Millius A, 2009, METHODS MOL BIOL, V571, P167, DOI 10.1007/978-1-60761-198-1_11; Najmeh S, 2015, JOVE-J VIS EXP, DOI 10.3791/52687; Ojo OO, 2015, AM J PHYSIOL-LUNG C, V309, pL1354, DOI 10.1152/ajplung.00054.2015; PANDE H, 1985, J BIOL CHEM, V260, P2301; POMMIER CG, 1984, BLOOD, V64, P858; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Rolli M, 2003, P NATL ACAD SCI USA, V100, P9482, DOI 10.1073/pnas.1633689100; Sloan EK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1398; Tohme S, 2016, CANCER RES, V76, P1367, DOI 10.1158/0008-5472.CAN-15-1591; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Weber MR, 2016, THROMB RES, V140, pS27, DOI 10.1016/S0049-3848(16)30095-0; Zannetti A, 2009, CLIN CANCER RES, V15, P5224, DOI 10.1158/1078-0432.CCR-08-3270	37	35	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171362	10.1371/journal.pone.0171362	http://dx.doi.org/10.1371/journal.pone.0171362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166238	Green Submitted, Green Published, gold			2022-12-26	WOS:000393700100036
J	Tormos, AM; Rius-Perez, S; Jorques, M; Rada, P; Ramirez, L; Valverde, AM; Nebreda, AR; Sastre, J; Talens-Visconti, R				Tormos, Ana M.; Rius-Perez, Sergio; Jorques, Maria; Rada, Patricia; Ramirez, Lorena; Valverde, Angela M.; Nebreda, Angel R.; Sastre, Juan; Talens-Visconti, Raquel			p38 alpha regulates actin cytoskeleton and cytokinesis in hepatocytes during development and aging	PLOS ONE			English	Article							ACTIVATED-PROTEIN-KINASE; P38 MAPK; NUCLEAR ACTIN; CELL-PROLIFERATION; INDUCED ASSOCIATION; ANIMAL CYTOKINESIS; DOUBLE-BLIND; RHO-GTPASES; GROWTH; PHOSPHORYLATION	Background Hepatocyte poliploidization is an age-dependent process, being cytokinesis failure the main mechanism of polyploid hepatocyte formation. Our aim was to study the role of p38 alpha MAPK in the regulation of actin cytoskeleton and cytokinesis in hepatocytes during development and aging. Methods Wild type and p38 alpha liver-specific knock out mice at different ages (after weaning, adults and old) were used. Results We show that p38 alpha MAPK deficiency induces actin disassembly upon aging and also cytokinesis failure leading to enhanced binucleation. Although the steady state levels of cyclin D1 in wild type and p38 alpha knock out old livers remained unaffected, cyclin B1-alpha marker for G2/M transition-was significantly overexpressed in p38a knock out mice. Our findings suggest that hepatocytes do enter into S phase but they do not complete cell division upon p38 alpha a deficiency leading to cytokinesis failure and binucleation. Moreover, old liver-specific p38 alpha MAPK knock out mice exhibited reduced F-actin polymerization and a dramatic loss of actin cytoskeleton. This was associated with abnormal hyperactivation of RhoA and Cdc42 GTPases. Long-term p38 alpha deficiency drives to inactivation of HSP27, which seems to account for the impairment in actin cytoskeleton as Hsp27-silencing decreased the number and length of actin filaments in isolated hepatocytes. Conclusions p38 alpha MAPK is essential for actin dynamics with age in hepatocytes.	[Tormos, Ana M.; Rius-Perez, Sergio; Jorques, Maria; Sastre, Juan] Univ Valencia Burjassot, Dept Physiol, Valencia, Spain; [Rada, Patricia; Valverde, Angela M.] Ctr Mixto CSIC UAM, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid, Spain; [Rada, Patricia; Valverde, Angela M.] ISCIII, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Ramirez, Lorena; Nebreda, Angel R.] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Nebreda, Angel R.] ICREA, Barcelona, Spain; [Talens-Visconti, Raquel] Univ Valencia Burjassot, Dept Pharm & Pharmaceut Technol & Parasitol, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Talens-Visconti, R (corresponding author), Univ Valencia Burjassot, Dept Pharm & Pharmaceut Technol & Parasitol, Valencia, Spain.	raquel.talens@uv.es	Taléns-Visconti, Raquel/P-6621-2019; PEREZ, SERGIO RIUS/T-7766-2017; Rada, Patricia/G-7300-2015; Nebreda, Angel Rodriguez/R-9594-2019; Taléns-Visconti, Raquel/A-9162-2018	Taléns-Visconti, Raquel/0000-0002-9816-9693; Rada, Patricia/0000-0002-6731-2098; Taléns-Visconti, Raquel/0000-0002-9816-9693; Martinez Valverde, Angela/0000-0003-1192-9045	Ministry of Economy and Competitiveness; postdoctoral contract Juan de la Cierva (MINECO, Spain); FEDER [SAF 2015-71208-R]; Spanish Ministry of Economy and Competitiveness (MINECO, Spain) [CSD-2007-00020]; Generalitat Valenciana [GV PROMETEO II 2014-056]; MINECO/FEDER; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM, ISCIII, Spain); MI NECO [BFU2010-17850]; European Commission [ERC 294665]; ICREA Funding Source: Custom	Ministry of Economy and Competitiveness; postdoctoral contract Juan de la Cierva (MINECO, Spain); FEDER(European Commission); Spanish Ministry of Economy and Competitiveness (MINECO, Spain)(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); MINECO/FEDER(Spanish Government); Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM, ISCIII, Spain); MI NECO(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); ICREA(ICREA)	AMT was recipient of a fellowship from the Ministry of Economy and Competitiveness. PR was recipient of a postdoctoral contract Juan de la Cierva (MINECO, Spain). This work was supported by Grants SAF 2015-71208-R with FEDER funds and CSD-2007-00020 from the Spanish Ministry of Economy and Competitiveness (MINECO, Spain, http://www.mineco.gob.es/portal/site/mineco/) and GV PROMETEO II 2014-056 from Generalitat Valenciana to JS and RTV, and by Grant SAF 2015-65267-R (MINECO/FEDER) and by Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM, ISCIII, Spain) to AMV. ARN was funded by grants from MI NECO (BFU2010-17850) and the European Commission (ERC 294665).	Ambrosino C, 2001, BIOL CELL, V93, P47, DOI 10.1016/S0248-4900(01)01124-8; Atkins BD, 2013, J CELL BIOL, V202, P231, DOI 10.1083/jcb.201301090; Awad MM, 2000, J BIOL CHEM, V275, P38716, DOI 10.1074/jbc.M008040200; Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; BENVENISTE R, 1988, CELL BIOCHEM FUNCT, V6, P231, DOI 10.1002/cbf.290060403; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Bitar KN, 2002, J APPL PHYSIOL, V92, P41, DOI 10.1152/jappl.2002.92.1.41; Bitar KN, 2002, AM J PHYSIOL-GASTR L, V282, pG894, DOI 10.1152/ajpgi.00141.2001; Buttrick GJ, 2008, CELL CYCLE, V7, P2621, DOI 10.4161/cc.7.17.6514; Campbell JS, 2011, INT J BIOCHEM CELL B, V43, P180, DOI 10.1016/j.biocel.2010.08.002; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Chevalier D, 2000, BIOCHEMISTRY-US, V39, P6145, DOI 10.1021/bi9928389; Coleman ML, 2006, ONCOGENE, V25, P2708, DOI 10.1038/sj.onc.1209322; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; Damjanov N, 2009, ARTHRITIS RHEUM-US, V60, P1232, DOI 10.1002/art.24485; Danese S, 2006, WORLD J GASTROENTERO, V12, P4807; Davies T, 2012, J CELL BIOL, V198, P769, DOI 10.1083/jcb.201207197; Dubroca C, 2005, HYPERTENSION, V45, P974, DOI 10.1161/01.HYP.0000164582.63421.2d; Duffy JP, 2011, ACS MED CHEM LETT, V2, P758, DOI 10.1021/ml2001455; Duncan AW, 2013, SEMIN CELL DEV BIOL, V24, P347, DOI 10.1016/j.semcdb.2013.01.003; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Fisk M, 2014, AM J CARDIOVASC DRUG, V14, P155, DOI 10.1007/s40256-014-0063-6; Gaffey K, 2013, EUR RESPIR J, V42, P28, DOI 10.1183/09031936.00170711; Genovese MC, 2011, J RHEUMATOL, V38, P846, DOI 10.3899/jrheum.100602; Gentric G, 2012, CLIN RES HEPATOL GAS, V36, P29, DOI 10.1016/j.clinre.2011.05.011; Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430; Gentric G, 2014, AM J PATHOL, V184, P322, DOI 10.1016/j.ajpath.2013.06.035; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0303s04, 10.1002/0471143030.cb0305s06, 10.1002/0471143030.cb0304s04]; Guay J, 1997, J CELL SCI, V110, P357; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Guo K, 2008, CANCER SCI, V99, P486, DOI 10.1111/j.1349-7006.2007.00702.x; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Gurgis FMS, 2014, MOL PHARMACOL, V85, P345, DOI 10.1124/mol.113.090365; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Hill RJ, 2008, J PHARMACOL EXP THER, V327, P610, DOI 10.1124/jpet.108.139006; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Iyoda K, 2003, CANCER-AM CANCER SOC, V97, P3017, DOI 10.1002/cncr.11425; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kalendova A, 2014, HISTOCHEM CELL BIOL, V142, P139, DOI 10.1007/s00418-014-1243-9; Kato K, 2010, EXP THER MED, V1, P579, DOI 10.3892/etm_00000091; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Korb A, 2006, ARTHRITIS RHEUM, V54, P2745, DOI 10.1002/art.22080; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Lavoie J N, 1996, Prog Cell Cycle Res, V2, P49; Lee SH, 2001, J BIOL CHEM, V276, P25066, DOI 10.1074/jbc.M010892200; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; Martin ED, 2015, BRIT J PHARMACOL, V172, P2101, DOI 10.1111/bph.12901; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MOSSIN L, 1994, EXP CELL RES, V214, P551, DOI 10.1006/excr.1994.1293; Munsie LN, 2012, J CELL SCI, V125, P3977, DOI 10.1242/jcs.097667; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Navas TA, 2006, LEUKEMIA, V20, P1017, DOI 10.1038/sj.leu.2404200; Newby LK, 2014, LANCET, V384, P1187, DOI 10.1016/S0140-6736(14)60417-7; Normand G, 2010, ADV EXP MED BIOL, V676, P27; Nunez F, 2000, FASEB J, V14, P1073, DOI 10.1096/fasebj.14.9.1073; Patil SB, 2004, AM J PHYSIOL-GASTR L, V286, pG635, DOI 10.1152/ajpgi.00261.2003; Pederson T, 2008, J CELL BIOL, V180, P1061, DOI 10.1083/jcb.200709082; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Pongratz G, 2006, J IMMUNOL, V177, P2926, DOI 10.4049/jimmunol.177.5.2926; Rannou Y, 2012, J CELL SCI, V125, P2844, DOI 10.1242/jcs.058081; Sagona AP, 2010, FEBS LETT, V584, P2652, DOI 10.1016/j.febslet.2010.03.044; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schafer C, 1998, J BIOL CHEM, V273, P24173, DOI 10.1074/jbc.273.37.24173; Schiel JA, 2010, THESCIENTIFICWORLDJO, V10, P1424, DOI 10.1100/tsw.2010.129; Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Svensson CI, 2005, NEUROSCI LETT, V379, P209, DOI 10.1016/j.neulet.2004.12.064; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Tong SE, 2012, J CLIN PHARMACOL, V52, P717, DOI 10.1177/0091270011405496; Tormos AM, 2013, HEPATOLOGY, V57, P1950, DOI 10.1002/hep.26174; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Xu JT, 2007, EXP NEUROL, V204, P355, DOI 10.1016/j.expneurol.2006.11.016; Yang F, 2010, HEPATOLOGY, V51, P1614, DOI 10.1002/hep.23566; Yoshida S, 2009, GENE DEV, V23, P810, DOI 10.1101/gad.1785209; Zeitlin SG, 2001, CURR BIOL, V11, pR514, DOI 10.1016/S0960-9822(01)00307-4; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	90	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171738	10.1371/journal.pone.0171738	http://dx.doi.org/10.1371/journal.pone.0171738			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166285	Green Published, Green Submitted, gold			2022-12-26	WOS:000393700100067
J	Escoll, M; Gargini, R; Cuadrado, A; Anton, IM; Wandosell, F				Escoll, M.; Gargini, R.; Cuadrado, A.; Anton, I. M.; Wandosell, F.			Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ	ONCOGENE			English	Article							WASP-INTERACTING PROTEIN; HIPPO PATHWAY; T-CELL; ACTIN ORGANIZATION; TISSUE-GROWTH; ORGAN GROWTH; F-ACTIN; TAZ; YAP; INVASION	Wild-type p53 (wtp53) is described as a tumour suppressor gene; mutations in this gene occur in many human cancers and promote oncogenic capacity. Here, we establish that the oncogenic activity of mutant p53 (mtp53) is driven by the WASP-interacting protein (WIP). WIP knockdown from mtp53-expressing glioblastoma and breast cancer cells (BCC) greatly reduced proliferation and growth capacity of cancer stem cell (CSC)-like cells and decreased CSC-like markers (CD133, CD44 or YAP/TAZ). mtp53 overexpression in human astrocytes enhanced their proliferative capacity in suspension culture and increased expression of CSC markers and WIP. WIP knockdown compromised tumour glioblastoma and BCC growth capacity in vivo. We show that WIP is phosphorylated by AKT2 and is regulated by mtp53/p63 through enhancement of PI3K/AKT2-mediated integrin/receptor recycling pathways. WIP regulates this oncogenic pathway by controlling YAP/TAZ stability. We thus establish a new CSC signalling pathway downstream of mtp53 in which AKT2 regulates WIP and controls YAP/TAZ stability.	[Escoll, M.; Wandosell, F.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Nicolas Cabrera 1, E-28049 Madrid, Spain; [Escoll, M.; Cuadrado, A.; Anton, I. M.; Wandosell, F.] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Valderrebollo 5, Madrid, Spain; [Gargini, R.; Anton, I. M.] Ctr Nacl Biotecnol CNB CSIC, Dept Mol & Cellular Biol, Darwin 3, Madrid 28049, Spain; [Cuadrado, A.] Inst Invest Biomed Alberto Sols CSIC UAM, Inst Invest Sanitaria La Paz IdiPaz, Madrid, Spain; [Cuadrado, A.] Univ Autonoma Madrid, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid	Wandosell, F (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Nicolas Cabrera 1, E-28049 Madrid, Spain.; Anton, IM (corresponding author), Ctr Nacl Biotecnol CNB CSIC, Dept Mol & Cellular Biol, Darwin 3, Madrid 28049, Spain.	ianton@cnb.csic.es; fwandosell@cbm.csic.es	Wandosell, Francisco/AAV-6391-2020; Gargini, Ricardo/AAA-3542-2020; Anton, Ines M/G-6090-2015; Wandosell, Francisco/G-6105-2015	Anton, Ines M/0000-0002-2935-5919; Wandosell, Francisco/0000-0001-6537-2321; Cuadrado, Antonio/0000-0002-4039-7140; Escoll, Maribel/0000-0003-0043-6878	MICINN; Plan Nacional of the Direccio General de Ciencia y Tecnologia [SAF2012-39148-C03-01, SAF2013-45937-R, SAF2015-70368-R, SAF2013-43271-R]; European Union [EU-FP7-2009-CT222887]; Instituto de Salud Carlos III Centro de Investigacion Biomedica en Red (CIBERNED)	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Plan Nacional of the Direccio General de Ciencia y Tecnologia; European Union(European Commission); Instituto de Salud Carlos III Centro de Investigacion Biomedica en Red (CIBERNED)	We thank Catherine Mark for editorial assistance. The proteomic analysis was performed in the proteomics facility of Centro Nacional de Biotecnolog~a that belongs to ProteoRed, PRB2-ISCIII; we particularly acknowledge the exceptional work of Rosana Navajas. This work was supported by grants from the MICINN, the Plan Nacional of the Direccio General de Ciencia y Tecnologia (SAF2012-39148-C03-01 to FW, SAF2013-45937-R to IMA and SAF2015-70368-R to both and SAF2013-43271-R to AC), the European Union (EU-FP7-2009-CT222887 to FW) and the Instituto de Salud Carlos III Centro de Investigacion Biomedica en Red (CIBERNED).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anton IM, 2002, IMMUNITY, V16, P193, DOI 10.1016/S1074-7613(02)00268-6; Anton IM, 2007, TRENDS CELL BIOL, V17, P555, DOI 10.1016/j.tcb.2007.08.005; Aspenstrom P, 2005, FEBS LETT, V579, P5253, DOI 10.1016/j.febslet.2005.08.053; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Banon-Rodriguez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070364; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Franco A, 2012, CEREB CORTEX, V22, P1191, DOI 10.1093/cercor/bhr199; Gallego MD, 2006, INT IMMUNOL, V18, P221, DOI 10.1093/intimm/dxh310; Garcia E, 2014, EUR J CELL BIOL, V93, P413, DOI 10.1016/j.ejcb.2014.07.008; Garcia E, 2012, EUR J CELL BIOL, V91, P869, DOI 10.1016/j.ejcb.2012.06.002; Gargini R, 2016, CELL REP, V17, P1962, DOI 10.1016/j.celrep.2016.10.064; Gargini R, 2015, STEM CELLS, V33, P646, DOI 10.1002/stem.1904; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hiemer SE, 2013, BBA-GEN SUBJECTS, V1830, P2323, DOI 10.1016/j.bbagen.2012.07.005; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Imajo M, 2015, NAT CELL BIOL, V17, P7, DOI 10.1038/ncb3084; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Lanzardo S, 2007, INT J BIOCHEM CELL B, V39, P262, DOI 10.1016/j.biocel.2006.08.011; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Le Bras S, 2009, P NATL ACAD SCI USA, V106, P7519, DOI 10.1073/pnas.0806410106; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Lucas EP, 2013, J CELL BIOL, V201, P875, DOI 10.1083/jcb.201210073; Mizuarai S, 2006, CANCER RES, V66, P6319, DOI 10.1158/0008-5472.CAN-05-4629; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nagpal J, 2006, ANTICANCER RES, V26, P4633; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Piccolo S, 2013, CLIN CANCER RES, V19, P4925, DOI 10.1158/1078-0432.CCR-12-3172; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Powell E, 2014, CANCER DISCOV, V4, P405, DOI 10.1158/2159-8290.CD-13-0136; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Rainero E, 2012, J CELL BIOL, V196, P277, DOI 10.1083/jcb.201109112; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Shiraishi S, 2002, CANCER-AM CANCER SOC, V95, P249, DOI 10.1002/cncr.10677; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Staub E, 2009, J MOL MED, V87, P633, DOI 10.1007/s00109-009-0467-y; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Suh YA, 2011, CANCER RES, V71, P7168, DOI 10.1158/0008-5472.CAN-11-0459; Thanabalu T, 2007, FEBS J, V274, P4103, DOI 10.1111/j.1742-4658.2007.05936.x; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Werbowetski-Ogilvie TE, 2006, CANCER RES, V66, P1464, DOI 10.1158/0008-5472.CAN-05-1913; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	65	52	53	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 22	2017	36	25					3515	3527		10.1038/onc.2016.518	http://dx.doi.org/10.1038/onc.2016.518			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY3NL	28166194				2022-12-26	WOS:000403878600002
J	Thannesberger, J; Hellinger, HJ; Klymiuk, I; Kastner, MT; Rieder, FJJ; Schneider, M; Fister, S; Lion, T; Kosulin, K; Laengle, J; Bergmann, M; Rattei, T; Steininger, C				Thannesberger, Jakob; Hellinger, Hans-Joerg; Klymiuk, Ingeborg; Kastner, Marie-Theres; Rieder, Franz J. J.; Schneider, Martina; Fister, Susanne; Lion, Thomas; Kosulin, Karin; Laengle, Johannes; Bergmann, Michael; Rattei, Thomas; Steininger, Christoph			Viruses comprise an extensive pool of mobile genetic elements in eukaryote cell cultures and human clinical samples	FASEB JOURNAL			English	Article						viral microbiome; next-generation sequencing; viral dark matter; bacteriophages	OUTER-MEMBRANE VESICLES; HUMAN GUT VIROME; CYTOMEGALOVIRUS-INFECTION; SEQUENCING DATA; TRANSPLANT RECIPIENTS; REVERSE TRANSCRIPTION; METAGENOMIC ANALYSIS; VIRAL METAGENOMICS; DNA VIRUSES; PCR METHOD	Viruses shape a diversity of ecosystems by modulating their microbial, eukaryotic, or plant host metabolism. The complexity of virus-host interaction networks is progressively fathomed by novel metagenomic approaches. By using a novel metagenomic method, we explored the virome in mammalian cell cultures and clinical samples to identify an extensive pool of mobile genetic elements in all of these ecosystems. Despite aseptic treatment, cell cultures harbored extensive and diverse phage populations with a high abundance of as yet unknown and uncharacterized viruses (viral dark matter). Unknown phages also predominated in the oropharynx and urine of healthy individuals and patients infected with cytomegalovirus despite demonstration of active cytomegalovirus replication. The novelty of viral sequences correlated primarily with the individual evaluated, whereas relative abundance of encoded protein functions was associated with the ecologic niches probed. Together, these observations demonstrate the extensive presence of viral dark matter in human and artificial ecosystems.-Thannesberger, J., Hellinger, H.-J., Klymiuk, I., Kastner, M.-T., Rieder, F. J. J., Schneider, M., Fister, S., Lion, T., Kosulin, K., Laengle, J., Bergmann, M., Rattei, T., Steininger, C. Viruses comprise an extensive pool of mobile genetic elements in eukaryote cell cultures and human clinical samples.	[Thannesberger, Jakob; Kastner, Marie-Theres; Rieder, Franz J. J.; Schneider, Martina; Steininger, Christoph] Med Univ Vienna, Div Infect Dis, Dept Med 1, Vienna, Austria; [Laengle, Johannes; Bergmann, Michael] Med Univ Vienna, Dept Surg, Vienna, Austria; [Hellinger, Hans-Joerg; Rattei, Thomas] Univ Vienna, CUBE Div Computat Syst Biol, Dept Microbiol & Ecosyst Sci, Vienna, Austria; [Klymiuk, Ingeborg] Med Univ Graz, Ctr Med Res, Core Facil Mol Biol, Graz, Austria; [Fister, Susanne] Univ Vet Med, Christian Doppler Lab Monitoring Microbial Contam, Vienna, Austria; [Lion, Thomas; Kosulin, Karin] Childrens Canc Res Inst, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Vienna; Medical University of Graz; University of Veterinary Medicine Vienna; Saint Anna Children's Hospital	Steininger, C (corresponding author), Med Univ Vienna, Dept Med 1, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	christoph.steininger@meduniwien.ac.at	Laengle, Johannes/D-5794-2019; Rattei, Thomas/F-1366-2011; Steininger, Christoph/U-8815-2019; Kosulin, Karin/AAB-2471-2019; Bergmann, Michael/GZK-7700-2022; Klymiuk, Ingeborg/ABG-9952-2021; Lion, MD, PhD, Professor, Thomas/C-3241-2016	Laengle, Johannes/0000-0003-4771-1398; Rattei, Thomas/0000-0002-0592-7791; Steininger, Christoph/0000-0003-3500-7205; Kosulin, Karin/0000-0001-7397-9692; Thannesberger, Jakob/0000-0002-3738-0356; Klymiuk, Ingeborg/0000-0001-8755-0037; Lion, MD, PhD, Professor, Thomas/0000-0001-9346-0994; Bergmann, Michael/0000-0001-8529-1166	Austrian Science Fund [P25353-B21]; Austrian Federal Ministry of Science, Research, and Economy; National Foundation of Research, Technology, and Development; Austrian Science Fund (FWF) [P 25353] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science, Research, and Economy; National Foundation of Research, Technology, and Development; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a research grant from the Austrian Science Fund P25353-B21. Financial support by the Austrian Federal Ministry of Science, Research, and Economy and the National Foundation of Research, Technology, and Development is gratefully acknowledged. The authors declare no conflicts of interest.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bachrach G, 2003, LETT APPL MICROBIOL, V36, P50, DOI 10.1046/j.1472-765X.2003.01262.x; Barr JJ, 2013, P NATL ACAD SCI USA, V110, P10771, DOI 10.1073/pnas.1305923110; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Binetti AG, 2008, INT J FOOD MICROBIOL, V124, P147, DOI 10.1016/j.ijfoodmicro.2008.03.006; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Britt William J, 2010, Curr Protoc Microbiol, VChapter 14, DOI 10.1002/9780471729259.mc14e03s18; Brum JR, 2015, NAT REV MICROBIOL, V13, P147, DOI 10.1038/nrmicro3404; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Daly GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028879; de Vries M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016118; Do Anh Ha Lien, 2011, PLoS One, V6, pe18176, DOI 10.1371/journal.pone.0018176; DORWARD DW, 1989, J BACTERIOL, V171, P2499, DOI 10.1128/jb.171.5.2499-2505.1989; Dreier J, 2005, J CLIN MICROBIOL, V43, P4551, DOI 10.1128/JCM.43.9.4551-4557.2005; Ebner K, 2005, J CLIN MICROBIOL, V43, P3049, DOI 10.1128/JCM.43.7.3049-3053.2005; Edlund A, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.27423; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Endoh D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni064; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Fister S, 2015, SEP PURIF TECHNOL, V155, P38, DOI 10.1016/j.seppur.2015.03.035; Forterre P, 2013, CURR OPIN VIROL, V3, P558, DOI 10.1016/j.coviro.2013.06.013; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Geetha V, 2012, J CYTOL, V29, P133, DOI 10.4103/0970-9371.97157; George MJ, 1997, AM J MED, V103, P106, DOI 10.1016/S0002-9343(97)80021-6; Gorski A, 2005, CELL MOL LIFE SCI, V62, P511, DOI 10.1007/s00018-004-4403-6; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Hurwitz BL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r123; Kim KH, 2011, APPL ENVIRON MICROB, V77, P7663, DOI 10.1128/AEM.00289-11; Kleiner M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1207-4; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kristensen DM, 2013, J BACTERIOL, V195, P941, DOI 10.1128/JB.01801-12; Kropinski Andrew M., 2009, V501, P69, DOI 10.1007/978-1-60327-164-6_7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ly M, 2014, MBIO, V5, DOI 10.1128/mBio.01133-14; Machida U, 2000, J CLIN MICROBIOL, V38, P2536, DOI 10.1128/JCM.38.7.2536-2542.2000; Mangul S, 2014, BIOINFORMATICS, V30, P329, DOI 10.1093/bioinformatics/btu295; Manning AJ, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-258; Marine R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-3; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Minot S, 2012, P NATL ACAD SCI USA, V109, P3962, DOI 10.1073/pnas.1119061109; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Naidu M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-175; Ng TFF, 2009, J VIROL, V83, P2500, DOI 10.1128/JVI.01946-08; Nogusa S, 2008, MECH AGEING DEV, V129, P223, DOI 10.1016/j.mad.2008.01.003; Norman JM, 2014, GASTROENTEROLOGY, V146, P1459, DOI 10.1053/j.gastro.2014.02.001; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Park EJ, 2011, APPL ENVIRON MICROB, V77, P1284, DOI 10.1128/AEM.01859-10; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Rosario K, 2009, ENVIRON MICROBIOL, V11, P2806, DOI 10.1111/j.1462-2920.2009.01964.x; Rossmanith P, 2006, RES MICROBIOL, V157, P763, DOI 10.1016/j.resmic.2006.03.003; Roux S, 2015, ELIFE, V4, DOI 10.7554/eLife.08490; Rumbo C, 2011, ANTIMICROB AGENTS CH, V55, P3084, DOI 10.1128/AAC.00929-10; Sagar K, 2014, J MICROBIOL METH, V97, P68, DOI 10.1016/j.mimet.2013.11.008; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shaukat S, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-146; Sia IG, 2000, CLIN MICROBIOL REV, V13, P83, DOI 10.1128/CMR.13.1.83-121.2000; Silander OK, 2005, P NATL ACAD SCI USA, V102, P19009, DOI 10.1073/pnas.0503074102; Steininger C, 2007, CLIN MICROBIOL INFEC, V13, P953, DOI 10.1111/j.1469-0691.2007.01781.x; STEVENS RH, 1994, FEMS MICROBIOL LETT, V119, P329; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Theze J, 2013, J VIROL, V87, P7992, DOI 10.1128/JVI.00453-13; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Tsumoto K, 2003, BIOCHEM BIOPH RES CO, V312, P1383, DOI 10.1016/j.bbrc.2003.11.055; van der Hoek L, 2006, FEMS MICROBIOL REV, V30, P760, DOI 10.1111/j.1574-6976.2006.00032.x; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Yan Qing-guo, 2003, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V17, P262; Yaron S, 2000, APPL ENVIRON MICROB, V66, P4414, DOI 10.1128/AEM.66.10.4414-4420.2000; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	84	25	26	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1987	2000		10.1096/fj.201601168R	http://dx.doi.org/10.1096/fj.201601168R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28179422				2022-12-26	WOS:000399195500020
J	Fasterius, E; Raso, C; Kennedy, S; Rauch, N; Lundin, P; Kolch, W; Uhlen, M; Szigyarto, CA				Fasterius, Erik; Raso, Cinzia; Kennedy, Susan; Rauch, Nora; Lundin, Par; Kolch, Walter; Uhlen, Mathias; Szigyarto, Cristina Al-Khalili			A novel RNA sequencing data analysis method for cell line authentication	PLOS ONE			English	Article							COLON; CARCINOMA; CULTURE; IDENTIFICATION; CONTAMINATION; EXPRESSION; PROGRAM; GENOME; HCT-15; GROWTH	We have developed a novel analysis method that can interrogate the authenticity of biological samples used for generation of transcriptome profiles in public data repositories. The method uses RNA sequencing information to reveal mutations in expressed transcripts and subsequently confirms the identity of analysed cells by comparison with publicly available cell-specific mutational profiles. Cell lines constitute key model systems widely used within cancer research, but their identity needs to be confirmed in order to minimise the influence of cell contaminations and genetic drift on the analysis. Using both public and novel data, we demonstrate the use of RNA-sequencing data analysis for cell line authentication by examining the validity of COLO205, DLD1, HCT15, HCT116, HKE3, HT29 and RKO colorectal cancer cell lines. We successfully authenticate the studied cell lines and validate previous reports indicating that DLD1 and HCT15 are synonymous. We also show that the analysed HKE3 cells harbour an unexpected KRAS-G13D mutation and confirm that this cell line is a genuine KRAS dosage mutant, rather than a true isogenic derivative of HCT116 expressing only the wild type KRAS. This authentication method could be used to revisit the numerous cell line based RNA sequencing experiments available in public data repositories, analyse new experiments where whole genome sequencing is not available, as well as facilitate comparisons of data from different experiments, platforms and laboratories.	[Fasterius, Erik; Uhlen, Mathias; Szigyarto, Cristina Al-Khalili] Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden; [Raso, Cinzia; Kennedy, Susan; Rauch, Nora; Kolch, Walter] Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland; [Lundin, Par] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Stockholm, Sweden; [Kolch, Walter] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Kolch, Walter] Univ Coll Dublin, Sch Med, Dublin 4, Ireland; [Uhlen, Mathias] Sci Life Lab, Stockholm, Sweden	Royal Institute of Technology; University College Dublin; Stockholm University; University College Dublin; University College Dublin	Szigyarto, CA (corresponding author), Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden.	caks@kth.se	Uhlen, Mathias/AAV-8746-2021; Admin, SBI/HGB-2738-2022; Kolch, Walter/ABF-2102-2021; Uhlen, Mathias/B-3262-2016	Uhlen, Mathias/0000-0002-4858-8056; Al-Khalili Szigyarto, Cristina/0000-0001-6990-1905; Kennedy, Susan/0000-0002-5898-8993; Rauch, Nora/0000-0001-6009-5177; Fasterius, Erik/0000-0003-0492-9960	European Community [278568]; Science for Life Laboratory, the National Genomics Infrastructure, NGI; Uppmax	European Community(European Commission); Science for Life Laboratory, the National Genomics Infrastructure, NGI; Uppmax	This work was supported by the European Community 7'th Framework Program under grant agreement no. 278568 "PRIMES" (https://ec.europa.eu/research/fp7/index_en.cfrn).; We would like to thank Ola Soderberg (Uppsala University, Sweden) for providing the RKO cell line, and Senji Shirasawa (Fukuoka University, Tokyo) for the HCT116 and HKE3 cell lines used in this study. Additional thanks also go to Bjorn Hallstrom for valuable guidance at the beginning of the project, as well as to Olof Emanuelsson for fruitful discussions on data analysis (Science for Life Laboratory, Stockholm, Sweden). We also acknowledge support from Science for Life Laboratory, the National Genomics Infrastructure, NGI, and Uppmax for providing assistance in massive parallel sequencing and computational infrastructure, as well as assistance from the UCD Conway Mass Spectrometry Core Facility. This work was supported by the European Community 7'th Framework Program under grant agreement no. 278568 "PRIMES".	Almeida JL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002476; Barallon R, 2010, IN VITRO CELL DEV-AN, V46, P727, DOI 10.1007/s11626-010-9333-z; BOYD D, 1988, CANCER RES, V48, P3112; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Capes-Davis A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002477; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; CHEN TR, 1995, CANCER GENET CYTOGEN, V81, P103, DOI 10.1016/0165-4608(94)00225-Z; Cingolani P, 2011, FRONT GENET, V3, P35; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cirulli ET, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r57; Cooper JK, 2007, IN VITRO CELL DEV-AN, V43, P344, DOI 10.1007/s11626-007-9060-2; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; FORGUELAFITTE ME, 1989, CANCER RES, V49, P6566; Freedman LP, 2015, NAT METHODS, V12, P493, DOI 10.1038/nmeth.3403; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hwang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17875; Liang-Chu MMY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116218; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; McCleland ML, 2016, J CLIN INVEST, V126, P639, DOI 10.1172/JCI83265; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Olarerin-George AO, 2015, NUCLEIC ACIDS RES, V43, P2535, DOI 10.1093/nar/gkv136; Piskol R, 2013, AM J HUM GENET, V93, P641, DOI 10.1016/j.ajhg.2013.08.008; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058815; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; SEMPLE TU, 1978, CANCER RES, V38, P1345; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Strong MJ, 2014, J VIROL, V88, P10696, DOI 10.1128/JVI.01457-14; TIBBETTS LM, 1977, CANCER, V40, P2651, DOI 10.1002/1097-0142(197711)40:5+<2651::AID-CNCR2820400939>3.0.CO;2-V; Torsvik A, 2014, CANCER MED-US, V3, P812, DOI 10.1002/cam4.219; Turriziani Benedetta, 2014, Biology (Basel), V3, P320, DOI 10.3390/biology3020320; Vermeulen SJ, 1998, CANCER GENET CYTOGEN, V107, P76, DOI 10.1016/S0165-4608(98)00081-8; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Xu GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089445; Yu M, 2015, NATURE, V520, P307, DOI 10.1038/nature14397	40	12	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171435	10.1371/journal.pone.0171435	http://dx.doi.org/10.1371/journal.pone.0171435			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192450	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800024
J	Bazin, M; Purohit, NK; Shah, GM				Bazin, Marc; Purohit, Nupur K.; Shah, Girish M.			Comprehensive measurement of UVB-induced non-melanoma skin cancer burden in mice using photographic images as a substitute for the caliper method	PLOS ONE			English	Article							HAIRLESS MICE; TUMORS; CARCINOGENESIS; RADIATION; MECHANISM	The vernier caliper has been used as a gold standard to measure the length, width and height of skin tumors to calculate their total area and volume. It is a simple method for collecting data on a few tumors at a time, but becomes tedious, time-consuming and stressful for the animals and the operator when used for measuring multiple tumors in a large number of animals in protocols such as UVB-induced non-melanoma skin cancer (NMSC) in SKH-1 mice. Here, we show that photographic images of these mice taken within a few minutes under optimized conditions can be subjected to computerized analyses to determine tumor volume and area as accurately and precisely as the caliper method. Unlike the caliper method, the photographic method also records the incidence and multiplicity of tumors, thus permitting comprehensive measurement of tumor burden in the animal. The simplicity and ease of this method will permit more frequent monitoring of tumor burden in long protocols, resulting in the creation of additional data about dynamic changes in progression of cancer or the efficacy of therapeutic intervention. The photographic method can broadly substitute the caliper method for quantifying other skin pathologies.	[Bazin, Marc; Purohit, Nupur K.; Shah, Girish M.] Univ Laval, Lab Skin Canc Res, CHU Q CHUL, Quebec Univ Hosp,Res Ctr, Quebec City, PQ, Canada	Laval University	Shah, GM (corresponding author), Univ Laval, Lab Skin Canc Res, CHU Q CHUL, Quebec Univ Hosp,Res Ctr, Quebec City, PQ, Canada.	girish.shah@crchul.ulaval.ca		Shah, Girish/0000-0002-9291-1164	Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-05868, RGPAS-492875-2016]; Quebec Government; Shastri Indo-Canadian Institute; Neuroscience Axis of CR-CHU-Q	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Quebec Government; Shastri Indo-Canadian Institute; Neuroscience Axis of CR-CHU-Q	This work was supported by the grants to GMS from Natural Sciences and Engineering Research Council of Canada (Discovery Grants # RGPIN-2016-05868 and Discovery Accelerator Grant # RGPAS-492875-2016). NKP received a foreign student fee-waiver scholarship from Quebec Government and Shastri Indo-Canadian Institute. NKP was also a recipient of the graduate scholarships from the Neuroscience Axis of CR-CHU-Q. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers GD, 2010, J ULTRAS MED, V29, P891, DOI 10.7863/jum.2010.29.6.891; Chang Angela Christine, 2011, Eplasty, V11, pe18; Chilampalli C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-456; Gaddameedhi S, 2011, P NATL ACAD SCI USA, V108, P18790, DOI 10.1073/pnas.1115249108; Gilman Thomas, 2004, Int J Low Extrem Wounds, V3, P125; GRIFFIN JW, 1993, PHYS THER, V73, P117, DOI 10.1093/ptj/73.2.117; Katiyar SK, 1997, JNCI-J NATL CANCER I, V89, P556, DOI 10.1093/jnci/89.8.556; Lou YR, 2011, CARCINOGENESIS, V32, P1078, DOI 10.1093/carcin/bgr074; Lu YP, 2002, P NATL ACAD SCI USA, V99, P12455, DOI 10.1073/pnas.182429899; Pentland AP, 1999, CARCINOGENESIS, V20, P1939, DOI 10.1093/carcin/20.10.1939; Sapi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142190; Singh A, 2015, J INVEST DERMATOL, V135, P1098, DOI 10.1038/jid.2014.460; Thomas-Ahner JM, 2007, CANCER RES, V67, P3468, DOI 10.1158/0008-5472.CAN-06-3798; Tsai KD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/593952; Vaid M, 2014, TOXICOL APPL PHARM, V274, P147, DOI 10.1016/j.taap.2013.10.030; Vodenicharov MD, 2005, J CELL SCI, V118, P589, DOI 10.1242/jcs.01636; Wysocki AB, 1996, INT J DERMATOL, V35, P82, DOI 10.1111/j.1365-4362.1996.tb03266.x	17	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171875	10.1371/journal.pone.0171875	http://dx.doi.org/10.1371/journal.pone.0171875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187193	gold, Green Published, Green Submitted			2022-12-26	WOS:000394244300056
J	Chetri, M; Odden, M; Wegge, P				Chetri, Madhu; Odden, Morten; Wegge, Per			Snow Leopard and Himalayan Wolf: Food Habits and Prey Selection in the Central Himalayas, Nepal	PLOS ONE			English	Article							LIVESTOCK DEPREDATION; UNGULATE COMMUNITIES; LARGE CARNIVORES; PANTHERA-UNCIA; WILD PREY; DIET; PERCEPTIONS; CONFLICT; PATTERNS; PREDATOR	Top carnivores play an important role in maintaining energy flow and functioning of the ecosystem, and a clear understanding of their diets and foraging strategies is essential for developing effective conservation strategies. In this paper, we compared diets and prey selection of snow leopards and wolves based on analyses of genotyped scats (snow leopards n = 182, wolves n = 57), collected within 26 sampling grid cells (5x5 km) that were distributed across a vast landscape of ca 5000 km(2) in the Central Himalayas, Nepal. Within the grid cells, we sampled prey abundances using the double observer method. We found that interspecific differences in diet composition and prey selection reflected their respective habitat preferences, i.e. snow leopards significantly preferred cliff-dwelling wild ungulates (mainly bharal, 57% of identified material in scat samples), whereas wolves preferred typically plain-dwellers (Tibetan gazelle, kiang and argali, 31%). Livestock was consumed less frequently than their proportional availability by both predators (snow leopard = 27%; wolf = 24%), but significant avoidance was only detected among snow leopards. Among livestock species, snow leopards significantly preferred horses and goats, avoided yaks, and used sheep as available. We identified factors influencing diet composition using Generalized Linear Mixed Models. Wolves showed seasonal differences in the occurrence of small mammals/birds, probably due to the winter hibernation of an important prey, marmots. For snow leopard, occurrence of both wild ungulates and livestock in scats depended on sex and latitude. Wild ungulates occurrence increased while livestock decreased from south to north, probably due to a latitudinal gradient in prey availability. Livestock occurred more frequently in scats from male snow leopards (males: 47%, females: 21%), and wild ungulates more frequently in scats from females (males: 48%, females: 70%). The sexual difference agrees with previous telemetry studies on snow leopards and other large carnivores, and may reflect a high-risk high-gain strategy among males.	[Chetri, Madhu; Odden, Morten] Inland Norway Univ Appl Sci, Fac Appl Ecol & Agr Sci, Campus Evenstad, Evenstad, Norway; [Chetri, Madhu] Natl Trust Nat Conservat, Khumaltar, Lalitpur, Nepal; [Wegge, Per] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Nepal	Inland Norway University of Applied Sciences	Chetri, M (corresponding author), Inland Norway Univ Appl Sci, Fac Appl Ecol & Agr Sci, Campus Evenstad, Evenstad, Norway.; Chetri, M (corresponding author), Natl Trust Nat Conservat, Khumaltar, Lalitpur, Nepal.	mchetri@gmail.com	Chetri, Madhu/AAI-6147-2020	Chetri, Madhu/0000-0003-4355-9640	United States Agency for International Development; Inland Norway University of Applied Sciences; Zoological Society of London (Nepal Program Office)	United States Agency for International Development(United States Agency for International Development (USAID)); Inland Norway University of Applied Sciences; Zoological Society of London (Nepal Program Office)	The United States Agency for International Development funded Hariyo Ban Program, Panthera-Kaplan Graduate Awards and National Trust for Nature Conservation supported logistic cost for the field work to MC. Inland Norway University of Applied Sciences and the Zoological Society of London (Nepal Program Office) funded the laboratory cost for the genetic part. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN BB, 1984, J WILDLIFE MANAGE, V48, P147, DOI 10.2307/3808462; Angerbjorn A, 1999, J ANIM ECOL, V68, P34, DOI 10.1046/j.1365-2656.1999.00258.x; Bahuguna A., 2010, SPECIES IDENTIFICATI; Bailey I, 2013, BEHAV ECOL SOCIOBIOL, V67, P1, DOI 10.1007/s00265-012-1423-3; Brunner H., 1974, IDENTIFICATION MAMMA, DOI [10.1017/S0030605300014253, DOI 10.1017/S0030605300014253]; Buckland S.T., 2001, pi; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chetri M, 2004, P INT C YAK; Chetri M, 2016, ZOOKEYS, P143, DOI 10.3897/zookeys.582.5966; Ciucci P, 2004, WILDLIFE BIOL, V10, P149, DOI 10.2981/wlb.2004.020; FANSHAWE JH, 1993, ANIM BEHAV, V45, P479, DOI 10.1006/anbe.1993.1059; Forsyth DM, 1997, NEW ZEAL J ECOL, V21, P97; Habib B., 2013, TR201301 WILDL I IND, P46; Hines JE, 1994, SCATMAN USGS PATUXAN; Jackson R., 2008, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2008.RLTS.T22732A9381126.en; Jackson R. M., 1996, THESIS U LONDON, P233; Jackson Rodney M., 2010, P417; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Janecka JE, 2008, ANIM CONSERV, V11, P401, DOI 10.1111/j.1469-1795.2008.00195.x; Jedrzejewski W, 2012, J MAMMAL, V93, P1480, DOI 10.1644/10-MAMM-A-132.1; Johansson O, 2016, BIOL CONSERV, V203, P1, DOI 10.1016/j.biocon.2016.08.034; Johansson O, 2015, BIOL CONSERV, V184, P251, DOI 10.1016/j.biocon.2015.02.003; Jumabay-Uulu K, 2014, ORYX, V48, P529, DOI 10.1017/S0030605313000306; Karmacharya Dibesh B., 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-516; Khorozyan I, 2015, BIOL CONSERV, V192, P268, DOI 10.1016/j.biocon.2015.09.031; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; LINK WA, 1994, ECOLOGY, V75, P2456, DOI 10.2307/1940899; Linnell JDC, 1999, WILDLIFE SOC B, V27, P698; Lovari S, 2009, ANIM CONSERV, V12, P559, DOI 10.1111/j.1469-1795.2009.00285.x; Lyngdoh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088349; McCarthy T, 2003, SNOW LEOPARD SURVIVA; McCarthy TM, 2005, BIOL CONSERV, V124, P527, DOI 10.1016/j.biocon.2005.03.003; Meriggi A, 1996, J APPL ECOL, V33, P1561, DOI 10.2307/2404794; Mishra C, 1997, ENVIRON CONSERV, V24, P338, DOI 10.1017/S0376892997000441; Newsome TM, 2016, MAMMAL REV, V46, P255, DOI 10.1111/mam.12067; Odden J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079261; Odden M, 2005, WILDLIFE BIOL, V11, P145, DOI 10.2981/0909-6396(2005)11[145:SAAPOL]2.0.CO;2; Okarma H, 1995, ACTA THERIOL, V40, P335, DOI 10.4098/AT.arch.95-35; Oli MK, 1997, MAMMALIA, V61, P355; OLI MK, 1993, J ZOOL, V231, P365, DOI 10.1111/j.1469-7998.1993.tb01924.x; Pandey MR, 2005, OUR NATURE, V3, P42; Pereira P, 2012, ECOL RES, V27, P745, DOI 10.1007/s11284-012-0949-1; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Pokharel A., 2006, OUR NAT, V4, P29, DOI [10.3126/on.v4i1.500, DOI 10.3126/ON.V4I1.500]; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Singh NJ, 2011, ORYX, V45, P38, DOI 10.1017/S0030605310000839; STEWART DRM, 1967, J APPL ECOL, V4, P83, DOI 10.2307/2401411; SUKUMAR R, 1991, BIOL CONSERV, V55, P93, DOI 10.1016/0006-3207(91)90007-V; Suryawanshi KR, 2013, J APPL ECOL, V50, P550, DOI 10.1111/1365-2664.12061; Suryawanshi KR, 2012, OECOLOGIA, V169, P581, DOI 10.1007/s00442-011-2237-0; Wang J, 2014, CHINESE SCI BULL, V59, P3162, DOI 10.1007/s11434-014-0370-y; WEAVER JL, 1993, J WILDLIFE MANAGE, V57, P534, DOI 10.2307/3809278; Wegge P, 2012, WILDLIFE BIOL, V18, P131, DOI 10.2981/11-049; Wingard GJ, 2011, WILDLIFE BIOL, V17, P93, DOI 10.2981/10-046; Yachi S, 2000, EVOL ECOL RES, V2, P957; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	58	57	60	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170549	10.1371/journal.pone.0170549	http://dx.doi.org/10.1371/journal.pone.0170549			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178279	gold, Green Published, Green Accepted			2022-12-26	WOS:000393712500009
J	Voronova, V; Zhudenkov, K; Helmlinger, G; Peskov, K				Voronova, Veronika; Zhudenkov, Kirill; Helmlinger, Gabriel; Peskov, Kirill			Interpretation of metabolic memory phenomenon using a physiological systems model: What drives oxidative stress following glucose normalization?	PLOS ONE			English	Article							VEIN ENDOTHELIAL-CELLS; PROTEIN-KINASE-C; INDUCED APOPTOSIS; EXPRESSION; ACTIVATION	Hyperglycemia is generally associated with oxidative stress, which plays a key role in diabetes -related complications. A complex, quantitative relationship has been established between glucose levels and oxidative stress, both in vitro and in vivo. For example, oxidative stress is known to persist after glucose normalization, a phenomenon described as metabolic memory. Also, uncontrolled glucose levels appear to be more detrimental to patients with diabetes (non-constant glucose levels) vs. patients with high, constant glucose levels. The objective of the current study was to delineate the mechanisms underlying such behaviors, using a mechanistic physiological systems modeling approach that captures and integrates essential underlying pathophysiological processes. The proposed model was based on a system of ordinary differential equations. It describes the interplay between reactive oxygen species production potential (ROS), ROS-induced cell alterations, and subsequent adaptation mechanisms. Model parameters were calibrated using different sources of experimental information, including ROS production in cell cultures exposed to various concentration profiles of constant and oscillating glucose levels. The model adequately reproduced the ROS excess generation after glucose normalization. Such behavior appeared to be driven by positive feedback regulations between ROS and ROS-induced cell alterations. The further oxidative stress-related detrimental effect as induced by unstable glucose levels can be explained by inability of cells to adapt to dynamic environment. Cell adaptation to instable high glucose declines during glucose normalization phases, and further glucose increase promotes similar or higher oxidative stress. In contrast, gradual ROS production potential decrease, driven by adaptation, is observed in cells exposed to constant high glucose.	[Voronova, Veronika; Zhudenkov, Kirill; Peskov, Kirill] M&S Decis LLC, Moscow, Russia; [Helmlinger, Gabriel] AstraZeneca, Quantitat Clin Pharmacol, Early Clin Dev, Innovat Med, Boston, MA USA	AstraZeneca	Voronova, V (corresponding author), M&S Decis LLC, Moscow, Russia.	veronika.voronova@msdecisions.ru	Voronova, Veronika/GSI-5604-2022; Zhudenkov, Kirill/AGG-2014-2022	Zhudenkov, Kirill/0000-0003-2991-6189; Peskov, Kirill/0000-0003-0678-5729	MS Decisions LLC; AstraZeneca	MS Decisions LLC; AstraZeneca(AstraZeneca)	V.V., K.Z. and K.P. are employed by M&S Decisions LLC, and G.H. is employed by AstraZeneca. The funders provided support in the form of salaries for authors V.V., K.Z., K.P. and G. H., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkoshi S, 2014, LIBYAN J MED, V9, DOI 10.3402/ljm.v9.26236; Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS39, DOI 10.2337/dc16-S008; Ceriello A, 2012, VASC PHARMACOL, V57, P133, DOI 10.1016/j.vph.2012.05.005; Ceriello A, 2009, J CLIN ENDOCR METAB, V94, P410, DOI 10.1210/jc.2008-1824; Di Wu Q, 1999, AM J PHYSIOL-CELL PH, V277, pC1229, DOI 10.1152/ajpcell.1999.277.6.C1229; Girach A, 2006, INT J CLIN PRACT, V60, P1471, DOI 10.1111/j.1742-1241.2006.01175.x; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; Hou Q, 2015, CARDIOVASC TOXICOL, V15, P140, DOI 10.1007/s12012-014-9276-9; Hovorka R, 1998, J CLIN ENDOCR METAB, V83, P744, DOI 10.1210/jc.83.3.744; Ihnat MA, 2007, DIABETOLOGIA, V50, P1523, DOI 10.1007/s00125-007-0684-2; Kowluru RA, 2004, ACTA DIABETOL, V41, P194, DOI 10.1007/s00592-004-0165-8; Kowluru RA, 2003, DIABETES, V52, P818, DOI 10.2337/diabetes.52.3.818; La Sala L, 2015, ACTA DIABETOL, V52, P505, DOI 10.1007/s00592-014-0670-3; Landgraf R, 2004, DIABETES-METAB RES, V20, pS9, DOI 10.1002/dmrr.517; LIPSKY NG, 1981, J BIOL CHEM, V256, P8652; Meng X, 2008, CLIN EXP MED, V8, P43, DOI 10.1007/s10238-008-0155-1; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel H, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-142; Quagliaro L, 2005, ATHEROSCLEROSIS, V183, P259, DOI 10.1016/j.atherosclerosis.2005.03.015; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Schisano B, 2011, DIABETOLOGIA, V54, P1219, DOI 10.1007/s00125-011-2049-0; Sun JZ, 2010, MOL CELL BIOCHEM, V343, P27, DOI 10.1007/s11010-010-0495-5; Sun JZ, 2009, CELL BIOCHEM BIOPHYS, V55, P173, DOI 10.1007/s12013-009-9066-3; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wang Lei, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P1253, DOI 10.11817/j.issn.1672-7347.2014.12.006; Zhu MM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-13	28	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171781	10.1371/journal.pone.0171781	http://dx.doi.org/10.1371/journal.pone.0171781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178319	gold, Green Published, Green Submitted			2022-12-26	WOS:000393712500071
J	Haliburton, JR; Shao, WJ; Deutschbauer, A; Arkin, A; Abate, AR				Haliburton, John R.; Shao, Wenjun; Deutschbauer, Adam; Arkin, Adam; Abate, Adam R.			Genetic interaction mapping with microfluidic-based single cell sequencing	PLOS ONE			English	Article							HIGH-THROUGHPUT; INTERACTION NETWORKS; SYSTEMS BIOLOGY; E. COLI; MICROORGANISMS; EPISTASIS	Genetic interaction mapping is useful for understanding the molecular basis of cellular decision making, but elucidating interactions genome-wide is challenging due to the massive number of gene combinations that must be tested. Here, we demonstrate a simple approach to thoroughly map genetic interactions in bacteria using microfluidic-based single cell sequencing. Using single cell PCR in droplets, we link distinct genetic information into single DNA sequences that can be decoded by next generation sequencing. Our approach is scalable and theoretically enables the pooling of entire interaction libraries to interrogate multiple pairwise genetic interactions in a single culture. The speed, ease, and low-cost of our approach makes genetic interaction mapping viable for routine characterization, allowing the interaction network to be used as a universal read out for a variety of biology experiments, and for the elucidation of interaction networks in non-model organisms.	[Haliburton, John R.; Abate, Adam R.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Shao, Wenjun; Deutschbauer, Adam; Arkin, Adam] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Deutschbauer, Adam; Arkin, Adam] EO Lawrence Berkeley Natl Lab, Berkeley, CA USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Abate, AR (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	adam.abate@ucsf.edu	Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008	Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931	National Science Foundation through a CAREER Award [DBI-1253293]; National Institutes of Health (NIH) [HG007233-01, R01-EB019453-01, DP2-AR068129-01]; Defense Advanced Research Projects Agency Living Foundries Program [HR0011-12-C-0065, N66001-12-C-4211, HR0011-12-C-0066]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP2AR068129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383, R01EB019453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284] Funding Source: NIH RePORTER	National Science Foundation through a CAREER Award(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency Living Foundries Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation through a CAREER Award [DBI-1253293]; National Institutes of Health (NIH) [HG007233-01, R01-EB019453-01, DP2-AR068129-01]; Defense Advanced Research Projects Agency Living Foundries Program [contract numbers HR0011-12-C-0065, N66001-12-C-4211, HR0011-12-C-0066]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appling DR, 1999, METHODS, V19, P338, DOI 10.1006/meth.1999.0861; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; BABA T, 2006, MOL SYSTEMS BIOL, V2, P2006, DOI DOI 10.1038/MSB4100050; Babu M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004120; Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Baryshnikova A, 2013, ANNU REV GENOM HUM G, V14, P111, DOI 10.1146/annurev-genom-082509-141730; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; CHEVERUD JM, 1995, GENETICS, V139, P1455; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Giaever G, 2014, GENETICS, V197, P451, DOI 10.1534/genetics.114.161620; Kumar A, 2016, CELL REP, V14, P648, DOI 10.1016/j.celrep.2015.12.060; Li P, 2015, BRIEF FUNCT GENOMICS, V14, P143, DOI 10.1093/bfgp/elu036; Mordukhova EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110504; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Pritchard JR, 2014, ARTIST HIGH RESOLUTI; Regev A, 2002, NATURE, V419, P343, DOI 10.1038/419343a; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Zeitoun RT, 2015, NATURE BIOTECHNOLOGY	29	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171302	10.1371/journal.pone.0171302	http://dx.doi.org/10.1371/journal.pone.0171302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170417	Green Submitted, Green Published, gold			2022-12-26	WOS:000393705500030
J	El Moujahid, L; Le Roux, X; Michalet, S; Bellvert, F; Weigelt, A; Poly, F				El Moujahid, Lamiae; Le Roux, Xavier; Michalet, Serge; Bellvert, Florian; Weigelt, Alexandra; Poly, Franck			Effect of plant diversity on the diversity of soil organic compounds	PLOS ONE			English	Article							SPECIES-DIVERSITY; PHENOLIC-COMPOUNDS; PRODUCTIVITY RELATIONSHIPS; MICROBIAL COMMUNITIES; CARBON; BIODIVERSITY; RHIZOSPHERE; SELECTION; GRADIENT; FOREST	The effect of plant diversity on aboveground organisms and processes was largely studied but there is still a lack of knowledge regarding the link between plant diversity and soil characteristics. Here, we analyzed the effect of plant identity and diversity on the diversity of extractible soil organic compounds (ESOC) using 87 experimental grassland plots with different levels of plant diversity and based on a pool of over 50 plant species. Two pools of low molecular weight organic compounds, LMW1 and LMW2, were characterized by GC-MS and HPLC-DAD, respectively. These pools include specific organic acids, fatty acids and phenolics, with more organic acids in LMW1 and more phenolics in LMW2. Plant effect on the diversity of LMW1 and LMW2 compounds was strong and weak, respectively. LMW1 richness observed for bare soil was lower than that observed for all planted soils; and the richness of these soil compounds increased twofold when dominant plant species richness increased from 1 to 6. Comparing the richness of LMW1 compounds observed for a range of plant mixtures and for plant monocultures of species present in these mixtures, we showed that plant species richness increases the richness of these ESOC mainly through complementarity effects among plant species associated with contrasted spectra of soil compounds. This could explain previously reported effects of plant diversity on the diversity of soil heterotrophic microorganisms.	[El Moujahid, Lamiae; Le Roux, Xavier; Michalet, Serge; Bellvert, Florian; Poly, Franck] Univ Lyon 1, CNRS, INRA, Lab Ecol Microbienne,UMR 5557,UMR 1418, Villeurbanne, France; [Michalet, Serge; Bellvert, Florian] Univ Lyon 1, CNRS, INRA, UMR5557,UMR 1418,Ctr Etud Subst Nat, Villeurbanne, France; [Weigelt, Alexandra] Univ Leipzig, Dept Systemat Bot & Funct Biodivers, Inst Biol, Leipzig, Germany; [Weigelt, Alexandra] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; Leipzig University	Le Roux, X (corresponding author), Univ Lyon 1, CNRS, INRA, Lab Ecol Microbienne,UMR 5557,UMR 1418, Villeurbanne, France.	xavier.le-roux@univ-lyon1.fr	; MICHALET, Serge/N-6899-2013	LE ROUX, Xavier/0000-0001-9695-0825; MICHALET, Serge/0000-0001-8393-3639	Agence Nationale de la Recherche ANR [ANR-05-BDIV-010-01]; Ecology Department of the National Research Institute for Agronomy Research (INRA EFPA); Ecology Institute of CNRS (CNRS INEE)	Agence Nationale de la Recherche ANR(French National Research Agency (ANR)); Ecology Department of the National Research Institute for Agronomy Research (INRA EFPA); Ecology Institute of CNRS (CNRS INEE)	This work was funded by the Agence Nationale de la Recherche ANR, part of the "Discover project (ANR-05-BDIV-010-01) and by the Ecology Department of the National Research Institute for Agronomy Research (INRA EFPA) and Ecology Institute of CNRS (CNRS INEE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abalos D, 2014, GLOBAL CHANGE BIOL, V20, P265, DOI 10.1111/gcb.12350; Achkar J, 2005, J AM CHEM SOC, V127, P5332, DOI 10.1021/ja042340g; Allan E, 2013, OECOLOGIA, V173, P223, DOI 10.1007/s00442-012-2589-0; Attard E, 2016, SOIL BIOL BIOCHEM, V97, P31, DOI 10.1016/j.soilbio.2016.02.016; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bardon C, 2014, NEW PHYTOL, V204, P620, DOI 10.1111/nph.12944; Basu A, 2006, APPL ENVIRON MICROB, V72, P2226, DOI 10.1128/AEM.72.3.2226-2230.2006; Beck JJ, 2007, J NAT PROD, V70, P891, DOI 10.1021/np0605586; Broughton LC, 2000, OECOLOGIA, V125, P420, DOI 10.1007/s004420000456; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Chacon ID, 2013, PHYTOCHEM REV, V12, P47, DOI 10.1007/s11101-012-9250-8; DeRito CM, 2005, APPL ENVIRON MICROB, V71, P7858, DOI 10.1128/AEM.71.12.7858-7865.2005; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Gruter D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-68; Gubsch M, 2011, PLANT CELL ENVIRON, V34, P895, DOI 10.1111/j.1365-3040.2011.02287.x; Gunina A, 2015, SOIL BIOL BIOCHEM, V90, P87, DOI 10.1016/j.soilbio.2015.07.021; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Hayes MHB, 2001, SOIL SCI, V166, P723, DOI 10.1097/00010694-200111000-00002; Henry S, 2008, ENVIRON MICROBIOL, V10, P3082, DOI 10.1111/j.1462-2920.2008.01599.x; HINTEREGGER C, 1992, APPL MICROBIOL BIOT, V37, P252, DOI 10.1007/BF00178180; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Iyer B, 2016, MICROBIOL RES, V192, P211, DOI 10.1016/j.micres.2016.07.006; Jones DL, 2003, PLANT SOIL, V248, P31, DOI 10.1023/A:1022304332313; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Kanani MR, 2011, CHEM BIODIVERS, V8, P503, DOI 10.1002/cbdv.201000148; Le Roux X, 2003, OECOLOGIA, V137, P417, DOI 10.1007/s00442-003-1367-4; Le Roux X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061069; Liu ZF, 2008, ECOL RES, V23, P511, DOI 10.1007/s11284-007-0405-9; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2010, PHILOS T R SOC B, V365, P49, DOI 10.1098/rstb.2009.0155; Makoi JHJR, 2007, AFR J BIOTECHNOL, V6, P1358; Martens DA, 2004, GLOBAL CHANGE BIOL, V10, P65, DOI 10.1046/j.1529-8817.2003.00722.x; Meier CL, 2008, OECOLOGIA, V158, P95, DOI 10.1007/s00442-008-1124-9; Meier CL, 2008, J ECOL, V96, P421, DOI 10.1111/j.1365-2745.2008.01356.x; Michalet S, 2013, PLANT PHYSIOL BIOCH, V72, P169, DOI 10.1016/j.plaphy.2013.05.003; Morley NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108144; NAEEM S, 1995, PHILOS T R SOC B, V347, P249, DOI 10.1098/rstb.1995.0025; Niklaus PA, 2007, ECOLOGY, V88, P3153, DOI 10.1890/06-2100.1; Niklaus PA, 2016, OECOLOGIA, V181, P919, DOI 10.1007/s00442-016-3611-8; Patra AK, 2006, ENVIRON MICROBIOL, V8, P1005, DOI 10.1111/j.1462-2920.2006.00992.x; Pelz O, 2005, BIOL FERT SOILS, V41, P153, DOI 10.1007/s00374-004-0826-3; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rovira P, 2010, BIOL FERT SOILS, V46, P355, DOI 10.1007/s00374-009-0437-0; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; Sandnes A, 2005, SOIL BIOL BIOCHEM, V37, P259, DOI 10.1016/j.soilbio.2004.07.036; Sauheitl L, 2010, PLANT SOIL, V334, P353, DOI 10.1007/s11104-010-0387-1; Schmid B, 2008, J PLANT ECOL, V1, P95, DOI 10.1093/jpe/rtn011; Shrivastava R, 2011, MICROBIOL-SGM, V157, P1531, DOI 10.1099/mic.0.047191-0; Sonnleitner E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004440; Souto XC, 2000, J CHEM ECOL, V26, P2025, DOI 10.1023/A:1005504029243; Trenbath B. R., 1974, Advances in Agronomy, V26, P177, DOI 10.1016/S0065-2113(08)60871-8; van Hees PAW, 2005, SOIL BIOL BIOCHEM, V37, P1, DOI 10.1016/j.soilbio.2004.06.010; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Wardle DA, 1996, FUNCT ECOL, V10, P410, DOI 10.2307/2390291; Warembourg FR, 2003, PLANT SOIL, V256, P347, DOI 10.1023/A:1026147622800; Weigelt A., 2010, ECOLOGY, V91, P930, DOI DOI 10.1890/09-0863.1; Weston LA, 2013, J CHEM ECOL, V39, P283, DOI 10.1007/s10886-013-0248-5; WHITEHEAD DC, 1982, J APPL ECOL, V19, P579, DOI 10.2307/2403490; Williams AC, 2001, ECOL RES, V16, P29, DOI 10.1046/j.1440-1703.2001.00368.x; Wright JP, 2006, ECOL LETT, V9, P111, DOI 10.1111/j.1461-0248.2005.00850.x; Xie Z, 2014, SOIL BIOL BIOCHEM, V77, P89, DOI 10.1016/j.soilbio.2014.06.024; Zhang YB, 2011, FOREST ECOL MANAG, V262, P361, DOI 10.1016/j.foreco.2011.03.042	62	20	20	8	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170494	10.1371/journal.pone.0170494	http://dx.doi.org/10.1371/journal.pone.0170494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166250	Green Published, gold, Green Submitted			2022-12-26	WOS:000393700100010
J	Obata, Y; Horikawa, K; Takahashi, T; Akieda, Y; Tsujimoto, M; Fletcher, JA; Esumi, H; Nishida, T; Abe, R				Obata, Y.; Horikawa, K.; Takahashi, T.; Akieda, Y.; Tsujimoto, M.; Fletcher, J. A.; Esumi, H.; Nishida, T.; Abe, R.			Oncogenic signaling by Kit tyrosine kinase occurs selectively on the Golgi apparatus in gastrointestinal stromal tumors	ONCOGENE			English	Article							C-KIT; ENDOPLASMIC-RETICULUM; INHIBITOR STI571; PI 3-KINASE; IMATINIB; MUTATIONS; ACTIVATION; MECHANISMS; RESISTANT; MEMBRANE	Gastrointestinal stromal tumors (GISTs) are caused by gain-of-function mutations in the Kit receptor tyrosine kinase. Most primary GIST patients respond to the Kit inhibitor imatinib, but this drug often becomes ineffective because of secondary mutations in the Kit kinase domain. The characteristic intracellular accumulation of imatinib-sensitive and - resistant Kit protein is well documented, but its relationship to oncogenic signaling remains unknown. Here, we show that in cancer tissue from primary GIST patients as well as in cell lines, mutant Kit accumulates on the Golgi apparatus, whereas normal Kit localizes to the plasma membrane (PM). In imatinib-resistant GIST with a secondary Kit mutation, Kit localizes predominantly on the Golgi apparatus. Both imatinib-sensitive and imatinib-resistant Kit (Kit(mut)) become fully auto-phosphorylated only on the Golgi and only if in a complex-glycosylated form. Kit(mut) accumulates on the Golgi during the early secretory pathway, but not after endocytosis. The aberrant kinase activity of Kit(mut) prevents its export from the Golgi to the PM. Furthermore, Kit(mut) on the Golgi signals and activates the phosphatidylinositol 3-kinase-Akt (PI3K-Akt) pathway, signal transducer and activator of transcription 5 (STAT5), and the Mek-Erk pathway. Blocking the biosynthetic transport of Kit(mut) to the Golgi from the endoplasmic reticulum inhibits oncogenic signaling. PM localization of Kit(mut) is not required for its signaling. Activation of Src-family tyrosine kinases on the Golgi is essential for oncogenic Kit signaling. These results suggest that the Golgi apparatus serves as a platform for oncogenic Kit signaling. Our study demonstrates that Kit(mut)'s pathogenicity is related to its mislocalization, and may offer a new strategy for treating imatinib-resistant GISTs.	[Obata, Y.; Horikawa, K.; Akieda, Y.; Abe, R.] Tokyo Univ Sci, Res Inst Biomed Sci, Div Immunobiol, Yamazaki 2669, Noda, Chiba 2780022, Japan; [Takahashi, T.] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka, Japan; [Tsujimoto, M.] Osaka Police Hosp, Dept Diagnost Pathol, Osaka, Osaka, Japan; [Fletcher, J. A.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Fletcher, J. A.] Harvard Med Sch, Boston, MA USA; [Esumi, H.] Tokyo Univ Sci, Res Inst Biomed Sci, Div Clin Res, Noda, Chiba, Japan; [Nishida, T.] Natl Canc Ctr, Chuo Ku, Tokyo, Japan	Tokyo University of Science; Osaka University; Osaka Police Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Tokyo University of Science; National Cancer Center - Japan	Abe, R (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci, Div Immunobiol, Yamazaki 2669, Noda, Chiba 2780022, Japan.	rabe@rs.noda.tus.ac.jp		Akieda, Yuki/0000-0001-7899-3186	Japanese Ministry of Education, Culture, Sports, Science and Technology [16K18427, 16H05419, 15K06843]; Uehara Memorial Foundation; NOVARTIS FOUNDATION (Japan) for the Promotion of Science; Grants-in-Aid for Scientific Research [16K18427] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); NOVARTIS FOUNDATION (Japan) for the Promotion of Science(Novartis); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr Eiji Miyoshi (Osaka University), Satoshi Owada (Tokai University), Dr Kazuo Kurokawa, and Dr Akihiko Nakano (RIKEN) for their helpful advice. We are grateful to Dr Rie Nakatsuka (Osaka University), Dr Shota Toyoshima, Dr Yasushi Hara, and Dr Isamu Shiina (Tokyo University of Science) for their helpful advice and sharing of materials throughout this study. This work was supported by a grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (16K18427 to YO, 16H05419 to TN, and 15K06843 to RA), a research grant from the Uehara Memorial Foundation (to YO and TN) and from the NOVARTIS FOUNDATION (Japan) for the Promotion of Science (to YO).	Agaimy A, 2013, INT J CLIN EXP PATHO, V6, P1839; Bahlawane C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0096-8; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; BESMER P, 1986, NATURE, V320, P415, DOI 10.1038/320415a0; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boissan M, 2000, J LEUKOCYTE BIOL, V67, P135, DOI 10.1002/jlb.67.2.135; Bosbach B, 2012, P NATL ACAD SCI USA, V109, pE2276, DOI 10.1073/pnas.1115240109; Bougherara H, 2009, MOL CANCER RES, V7, P1525, DOI 10.1158/1541-7786.MCR-09-0138; Burger H, 2015, MOL PHARMACOL, V88, P477, DOI 10.1124/mol.114.097451; Chaix A, 2014, ONCOGENE, V33, P872, DOI 10.1038/onc.2013.12; Chen H, 2003, INT J CANCER, V105, P130, DOI 10.1002/ijc.11025; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Chung BM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-84; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; Debiec-Rychter M, 2005, GASTROENTEROLOGY, V128, P270, DOI 10.1053/j.gastro.2004.11.020; Debiec-Rychter M, 2006, EUR J CANCER, V42, P1093, DOI 10.1016/j.ejca.2006.01.030; Duensing A, 2004, ONCOGENE, V23, P3999, DOI 10.1038/sj.onc.1207525; Edris B, 2013, P NATL ACAD SCI USA, V110, P3501, DOI 10.1073/pnas.1222893110; Emile JF, 2009, AM J SURG PATHOL, V33, P157, DOI 10.1097/PAS.0b013e3181883765; Fu D, 2014, NAT CHEM, V6, P615, DOI [10.1038/nchem.1961, 10.1038/NCHEM.1961]; Gibbs L, 2007, BBA-MOL CELL RES, V1773, P502, DOI 10.1016/j.bbamcr.2006.12.010; Gonzalez-Campora R, 2011, ANAL QUANT CYTOL, V33, P1; Gordon PM, 2010, J BIOL CHEM, V285, P14109, DOI 10.1074/jbc.M109.078592; Goss PE, 1995, CLIN CANCER RES, V1, P935; GRIFFITHS G, 1983, J CELL BIOL, V96, P835, DOI 10.1083/jcb.96.3.835; Growney JD, 2005, BLOOD, V106, P721, DOI 10.1182/blood-2004-12-4617; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hirota S, 2001, J PATHOL, V193, P505, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH818>3.0.CO;2-E; Jaramillo S, 2012, REV ESP ENFERM DIG, V104, P128, DOI 10.4321/s1130-01082012000300005; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Joffre C, 2011, NAT CELL BIOL, V13, P827, DOI 10.1038/ncb2257; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kon S, 2013, J CLIN INVEST, V123, P1123, DOI 10.1172/JCI63711; Lasota J, 2008, HISTOPATHOLOGY, V53, P245, DOI 10.1111/j.1365-2559.2008.02977.x; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Ma PL, 2011, MOL CELL BIOL, V31, P4052, DOI 10.1128/MCB.05750-11; MAEDA H, 1992, DEVELOPMENT, V116, P369; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Nishida T, 1998, NAT GENET, V19, P323, DOI 10.1038/1209; Nishida T, 2008, CANCER SCI, V99, P799, DOI 10.1111/j.1349-7006.2008.00727.x; Obata Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6715; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Peterson MR, 2006, APPL IMMUNOHISTO M M, V14, P390, DOI 10.1097/01.pai.0000203038.33414.a3; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Ran LL, 2015, CANCER DISCOV, V5, P304, DOI 10.1158/2159-8290.CD-14-0985; Ronchetti D, 2001, ONCOGENE, V20, P3553, DOI 10.1038/sj.onc.1204465; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V338, P1307, DOI 10.1016/j.bbrc.2005.09.150; Rossi F, 2006, P NATL ACAD SCI USA, V103, P12843, DOI 10.1073/pnas.0511076103; Rubin BP, 2006, LAB INVEST, V86, P981, DOI 10.1038/labinvest.3700466; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Schmidt-Arras D, 2014, J CELL SCI, V127, P341, DOI 10.1242/jcs.130294; SUCHY SF, 1995, HUM MOL GENET, V4, P2245, DOI 10.1093/hmg/4.12.2245; Tabone-Eglinger S, 2008, CLIN CANCER RES, V14, P2285, DOI 10.1158/1078-0432.CCR-07-4102; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; Takahashi T, 2013, INT J CANCER, V133, P2737, DOI 10.1002/ijc.28282; Thomsen L, 1998, NAT MED, V4, P848, DOI 10.1038/nm0798-848; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Toffalini F, 2010, BLOOD, V116, P2429, DOI 10.1182/blood-2010-04-279752; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Vanderwinden JM, 2006, CELL SIGNAL, V18, P661, DOI 10.1016/j.cellsig.2005.06.008; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Watanuki Z, 2014, BIOCHEM BIOPH RES CO, V455, P269, DOI 10.1016/j.bbrc.2014.11.003; Xiang ZF, 2007, MOL CELL BIOL, V27, P267, DOI 10.1128/MCB.01153-06; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; Zermati Y, 2003, ONCOGENE, V22, P660, DOI 10.1038/sj.onc.1206120; Zhu MJ, 2007, ONCOGENE, V26, P6386, DOI 10.1038/sj.onc.1210464	72	19	21	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 29	2017	36	26					3661	3672		10.1038/onc.2016.519	http://dx.doi.org/10.1038/onc.2016.519			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY9WM	28192400	Green Published, hybrid			2022-12-26	WOS:000404349700002
J	Cabrita, I; Benedetto, R; Fonseca, A; Wanitchakool, P; Sirianant, L; Skryabin, BV; Schenk, LK; Pavenstadt, H; Schreiber, R; Kunzelmann, K				Cabrita, Ines; Benedetto, Roberta; Fonseca, Ana; Wanitchakool, Podchanart; Sirianant, Lalida; Skryabin, Boris V.; Schenk, Laura K.; Pavenstaedt, Hermann; Schreiber, Rainer; Kunzelmann, Karl			Differential effects of anoctamins on intracellular calcium signals	FASEB JOURNAL			English	Article						TMEM16A; TMEM16D; TMEM16F; anoctamin; Ca2+ signaling	CA2+-ACTIVATED CL-CHANNEL; OPERATED CA2+ ENTRY; ACTIVATED CHLORIDE CHANNELS; RAT SENSORY NEURONS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INTERSTITIAL-CELLS; LIPID RAFTS; SECRETION; CURRENTS; TMEM16	The Ca2+-activated Cl- channel TMEM16A[anoctamin(ANO)1] is homologous to yeast Ist2 and has been shown to tether the cortical endoplasmic reticulum(ER) to the plasma membrane. We therefore examined whether ANO1 and other members of the ANO family affect intracellular Ca2+ ([Ca2+](i)) signals. It is shown that expression of ANO1 augments Ca2+ store release upon stimulation of GPCRs, whereas knockdown of ANO1, or lack of Ano1 expression in Ano1(-/-) animals, as shown in an earlier report, inhibits Ca2+ release. ANO6, and -10 show similar effects, whereas expression of ANO4, -8, and -9 attenuate filling of the ER store. The impact of ANO1 and -4 were examined in more detail. ANO1 colocalized and interacted with IP3R, where as ANO4 colocalized with SERCA Ca2+ pumps and interacted with ORAI-1 channels, respectively. ANO1 Cl currents were rapidly activated exclusively through Ca2+ store release, and remained untouched by influx of extracellular Ca2+. In contrast expression of ANO4 caused a delayed activation of membrane-localized ANO6 channels, solely through store-operated Ca2+ entry via ORAI. Ca2+ signals were inhibited by knocking down expression of endogenous ANO1, -5, -6, and -10 and were also reduced in epithelial cells from Ano10(-/-) mice. The data suggest that ANOs affect compartmentalized [Ca2+](i) signals, which may explain some of the cellular defects related to ANO mutations.-Cabrita, I., Benedetto, R., Fonseca, A., Wanitchakool, P., Sirianant, L., Skryabin, B. V., Schenk, L. K., Pavenstadt, H., Schreiber, R., Kunzelmann, K. Differential effects of anoctamins on intracellular calcium signals.	[Cabrita, Ines; Benedetto, Roberta; Fonseca, Ana; Wanitchakool, Podchanart; Sirianant, Lalida; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Physiol Inst, Univ Str 31, D-93053 Regensburg, Germany; [Skryabin, Boris V.] Univ Munster, Dept Med TRAM, Munster, Germany; [Schenk, Laura K.; Pavenstaedt, Hermann] Univ Klinikum Munster, Dept Internal Med D, Albert Schweitzer Campus, Munster, Germany	University of Regensburg; University of Munster; University of Munster	Cabrita, I; Kunzelmann, K (corresponding author), Univ Regensburg, Physiol Inst, Univ Str 31, D-93053 Regensburg, Germany.	karl.kunzelmann@ur.de	Skryabin, Boris/AAL-3100-2020	Skryabin, Boris/0000-0002-4392-185X; Fonseca, Ana/0000-0002-7920-9477; Sievers, Laura Katharina/0000-0002-4677-5181; Cabrita, Ines/0000-0002-1349-7605	Deutsche Forschungsgemeinschaft (DFG) [SFB699-A7/A12, KU756/12-1]; Cystic Fibrosis Trust SRC, INOVCF [003]; Cystic Fibrosis Trust [SRC003] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cystic Fibrosis Trust SRC, INOVCF; Cystic Fibrosis Trust	The authors thank B.Wild, P.Seeberger, and E.Tartler (Physiological Institute, University of Regensburg) for excellent technical assistance. This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants SFB699-A7/A12 (to K.K. and R.S.) and KU756/12-1 (to K.K.), and Cystic Fibrosis Trust SRC 003, INOVCF (to K.K.).I.C.and R.B.are co-first authors. R.S. and K.K. are co-senior authors. The authors declare no conflicts of interest.	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Balreira A, 2014, J NEUROL, V261, P2192, DOI 10.1007/s00415-014-7476-7; Barro-Soria R, 2010, PFLUG ARCH EUR J PHY, V459, P485, DOI 10.1007/s00424-009-0745-0; Billet A, 2013, J PHYSIOL-LONDON, V591, P5273, DOI 10.1113/jphysiol.2013.261909; Concepcion AR, 2016, J CLIN INVEST, V126, P4303, DOI 10.1172/JCI89056; Courjaret R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4916; Derler I, 2013, CELL CALCIUM, V53, P139, DOI 10.1016/j.ceca.2012.11.005; Diaz O, 2005, J IMMUNOL, V175, P8077, DOI 10.4049/jimmunol.175.12.8077; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Ehlen HWA, 2013, J BONE MINER RES, V28, P246, DOI 10.1002/jbmr.1751; Fischer KG, 1996, PFLUG ARCH EUR J PHY, V432, P735, DOI 10.1007/s004240050192; Fischer MA, 2009, TRAFFIC, V10, P1084, DOI 10.1111/j.1600-0854.2009.00926.x; Griffin DA, 2016, HUM MOL GENET, V25, P1900, DOI 10.1093/hmg/ddw063; Grubb S, 2013, J GEN PHYSIOL, V141, P585, DOI 10.1085/jgp.201210861; Hammer C, 2015, MOL MED, V21, DOI 10.2119/molmed.2014.00219; Heinze C, 2014, J CLIN INVEST, V124, P675, DOI 10.1172/JCI70025; Huang F, 2013, NAT NEUROSCI, V16, P1284, DOI 10.1038/nn.3468; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Jin X, 2016, J PHYSIOL-LONDON, V594, P19, DOI 10.1113/jphysiol.2014.275107; Jin X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004184; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kunzelmann K, 2016, PFLUG ARCH EUR J PHY, V468, P475, DOI 10.1007/s00424-015-1767-4; Kunzelmann K, 2012, EXP PHYSIOL, V97, P184, DOI 10.1113/expphysiol.2011.058206; Lee MY, 2006, P NATL ACAD SCI USA, V103, P13232, DOI 10.1073/pnas.0605757103; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Maass K, 2009, J CELL SCI, V122, P625, DOI 10.1242/jcs.036012; Maniero C, 2015, LANCET, V385, P62; Namkung W, 2010, MOL BIOL CELL, V21, P2639, DOI 10.1091/mbc.E09-12-1004; Ohga K, 2008, INT IMMUNOPHARMACOL, V8, P1787, DOI 10.1016/j.intimp.2008.08.016; Ousingsawat J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7245; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Pritchard HAT, 2014, BRIT J PHARMACOL, V171, P4311, DOI 10.1111/bph.12778; Ruppersburg CC, 2014, MOL BIOL CELL, V25, P1793, DOI 10.1091/mbc.E13-10-0599; Schreiber R, 2015, PFLUG ARCH EUR J PHY, V467, P1203, DOI 10.1007/s00424-014-1559-2; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Singh RD, 2014, J PHYSIOL-LONDON, V592, P4051, DOI 10.1113/jphysiol.2014.277152; Sirianant L, 2016, PFLUG ARCH EUR J PHY, V468, P335, DOI 10.1007/s00424-015-1739-8; Sirianant L, 2014, CELL SIGNAL, V26, P2826, DOI 10.1016/j.cellsig.2014.09.001; Sones WR, 2010, CARDIOVASC RES, V87, P476, DOI 10.1093/cvr/cvq057; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Takayama Y, 2015, P NATL ACAD SCI USA, V112, P5213, DOI 10.1073/pnas.1421507112; Takayama Y, 2014, FASEB J, V28, P2238, DOI 10.1096/fj.13-243436; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; TONES MA, 1989, FEBS LETT, V252, P105, DOI 10.1016/0014-5793(89)80898-1; Vocke K, 2013, J GEN PHYSIOL, V142, P381, DOI 10.1085/jgp.201311015; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Wanitchakool P, 2017, CELL SIGNAL, V30, P41, DOI 10.1016/j.cellsig.2016.11.006; Watts SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035373; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang CH, 2013, AM J RESP CRIT CARE, V187, P374, DOI 10.1164/rccm.201207-1303OC; Zhang WM, 2003, AM J PHYSIOL-LUNG C, V285, pL680, DOI 10.1152/ajplung.00067.2003; Zhu MH, 2015, AM J PHYSIOL-CELL PH, V308, pC608, DOI 10.1152/ajpcell.00360.2014	56	59	59	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2123	2134		10.1096/fj.201600797RR	http://dx.doi.org/10.1096/fj.201600797RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28183802				2022-12-26	WOS:000399195500031
J	Sood, C; Marin, M; Chande, A; Pizzato, M; Melikyan, GB				Sood, Chetan; Marin, Mariana; Chande, Ajit; Pizzato, Massimo; Melikyan, Gregory B.			SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence; host defense; membrane fusion; peptides; virus entry; Env inactivation; HIV neutralization; conformational changes; hemifusion; membrane-proximal extracellular domain	IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; MEDIATED MEMBRANE-FUSION; NEUTRALIZING ANTIBODIES; HEPTAD REPEAT; COILED-COIL; CELL-FUSION; NEF; GP41; INFECTIVITY	The host proteins, SERINC3 and SERINC5, have been recently shown to incorporate into HIV-1 particles and compromise their ability to fuse with target cells, an effect that is antagonized by the viral Nef protein. Envelope (Env) glycoproteins from different HIV-1 isolates exhibit a broad range of sensitivity to SERINC-mediated restriction, and the mechanism by which SERINCs interfere with HIV-1 fusion remains unclear. Here, we show that incorporation of SERINC5 into virions in the absence of Nef inhibits the formation of small fusion pores between viruses and cells. Strikingly, we found that SERINC5 promotes spontaneous functional inactivation of sensitive but not resistant Env glycoproteins. Although SERINC5-Env interaction was not detected by co-immunoprecipitation, incorporation of this protein enhanced the exposure of the conserved gp41 domains and sensitized the virus to neutralizing antibodies and gp41-derived inhibitory peptides. These results imply that SERINC5 restricts HIV-1 fusion at a step prior to small pore formation by selectively inactivating sensitive Env glycoproteins, likely through altering their conformation. The increased HIV-1 sensitivity to anti-gp41 antibodies and peptides suggests that SER5 also delays refolding of the remaining fusion-competent Env trimers.	[Sood, Chetan; Marin, Mariana; Melikyan, Gregory B.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Chande, Ajit; Pizzato, Massimo] Univ Trento, Ctr Integrat Biol, I-38123 Trento, Italy	Emory University; University of Trento	Melikyan, GB (corresponding author), Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.	gmeliki@emory.edu	Pizzato, Massimo/AFL-0051-2022; Chande, Ajit/K-5031-2014	Pizzato, Massimo/0000-0002-9491-1483; Chande, Ajit/0000-0003-2210-5180	National Institutes of Health [R01 GM054787]; FP7 Marie Curie Career Integration Grant [322130]; Caritro "Ricerca Biomedica" [2013.0248]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FP7 Marie Curie Career Integration Grant; Caritro "Ricerca Biomedica"; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM054787 (to G. B. M.), FP7 Marie Curie Career Integration Grant 322130, and Caritro "Ricerca Biomedica" Grant 2013.0248 (to M. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021339; Ahi YS, 2016, MBIO, V7, DOI 10.1128/mBio.01985-16; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Beitari S, 2017, J VIROL, V91, DOI 10.1128/JVI.02214-16; Brandenberg OF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004595; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Cavrois M, 2004, VIROLOGY, V328, P36, DOI 10.1016/j.virol.2004.07.015; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Day JR, 2004, J VIROL, V78, P1069, DOI 10.1128/JVI.78.3.1069-1079.2004; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; de Rosny E, 2004, J VIROL, V78, P2627, DOI 10.1128/JVI.78.5.2627-2631.2004; Demirkhanyan L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003431; Desai TM, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0215-z; Dimitrov AS, 2007, BIOCHEMISTRY-US, V46, P1398, DOI 10.1021/bi062245f; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Gustchina E, 2005, J MED CHEM, V48, P3036, DOI 10.1021/jm049026h; Gustchina E, 2006, J MOL BIOL, V364, P283, DOI 10.1016/j.jmb.2006.09.017; Haim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002101; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Heigele A, 2016, CELL HOST MICROBE, V20, P381, DOI 10.1016/j.chom.2016.08.004; Inuzuka M, 2005, J BIOL CHEM, V280, P35776, DOI 10.1074/jbc.M505712200; Jeetendra E, 2002, J VIROL, V76, P12300, DOI 10.1128/JVI.76.23.12300-12311.2002; Kang M, 2012, TRAFFIC, V13, P1589, DOI 10.1111/tra.12008; Kondo N, 2015, J BIOL CHEM, V290, P6558, DOI 10.1074/jbc.M114.623181; Kondo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044827; Lai RPJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002442; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 1997, J CELL BIOL, V136, P995, DOI 10.1083/jcb.136.5.995; Miyauchi K, 2011, BIOCHEM J, V434, P559, DOI 10.1042/BJ20101588; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Nelson JD, 2008, VIROLOGY, V377, P170, DOI 10.1016/j.virol.2008.04.005; Padilla-Parra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071002; Peachman KK, 2010, VIROLOGY, V408, P213, DOI 10.1016/j.virol.2010.09.029; Pizzato M, 2008, J VIROL, V82, P10811, DOI 10.1128/JVI.01150-08; Rathinakumar R, 2012, J VIROL, V86, P1820, DOI 10.1128/JVI.05489-11; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Schaeffer E, 2001, J VIROL, V75, P2993, DOI 10.1128/JVI.75.6.2993-3000.2001; SCHWARTZ O, 1995, J VIROL, V69, P4053, DOI 10.1128/JVI.69.7.4053-4059.1995; Sood C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148944; Steger HK, 2006, J BIOL CHEM, V281, P25813, DOI 10.1074/jbc.M601457200; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Tobiume M, 2001, ARCH VIROL, V146, P1739, DOI 10.1007/s007050170060; Trautz B, 2016, J VIROL, V90, P10915, DOI 10.1128/JVI.01246-16; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Usami Y, 2013, CELL REP, V5, P802, DOI 10.1016/j.celrep.2013.09.028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang JQ, 2009, J VIROL METHODS, V161, P216, DOI 10.1016/j.jviromet.2009.06.017; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002	64	79	82	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					6014	6026		10.1074/jbc.M117.777714	http://dx.doi.org/10.1074/jbc.M117.777714			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28179429	Green Published, hybrid			2022-12-26	WOS:000398813200034
J	Gormley, M; Aspray, TJ; Kelly, DA; Rodriguez-Gil, C				Gormley, Michael; Aspray, Thomas J.; Kelly, David A.; Rodriguez-Gil, Cristina			Pathogen cross-transmission via building sanitary plumbing systems in a full scale pilot test-rig	PLOS ONE			English	Article							HONG-KONG; CONTAMINATION; BIOFILM; TOILET; IMPACT; SARS	The WHO Consensus Document on the epidemiology of the SARS epidemic in 2003, included a report on a concentrated outbreak in one Hong Kong housing block which was considered a 'super-spreading event'. The WHO report conjectured that the sanitary plumbing system was one transmission route for the virus. Empty U-traps allowed the aerosolised virus to enter households from the sewerage system. No biological evidence was presented. This research reports evidence that pathogens can be aerosolised and transported on airstreams within sanitary plumbing systems and enter buildings via empty U-traps. A sanitary plumbing system was built, representing two floors of a building, with simulated toilet flushes on the lower floor and a sterile chamber with extractor fan on the floor above. Cultures of a model organism, Pseudomonas putida at 10(6) - 10(9) cfu ml(-1) in 0.85% NaCl were flushed into the system in volumes of 6 to 20 litres to represent single or multiple toilet flushes. Air and surface samples were cultured on agar plates and assessed qualitatively and semi-quantitatively. Flushing from a toilet into a sanitary plumbing system generated enough turbulence to aerosolise pathogens. Typical sanitary plumbing system airflows (between 20-30 ls(-1)) were sufficient to carry aerosolised pathogens between different floors of a building. Empty U-traps allowed aerosolised pathogens to enter the chamber, encouraging cross-transmission. All parts of the system were found to be contaminated post-flush. Empty U-traps have been observed in many buildings and a risk assessment indicates the potential for high risk cross-transmission under defect conditions in buildings with high pathogen loading such as hospitals. Under defective conditions (which are not uncommon) aerosolised pathogens can be carried on the airflows within sanitary plumbing systems. Our findings show that greater consideration should be given to this mode of pathogen transmission.	[Gormley, Michael; Aspray, Thomas J.; Kelly, David A.; Rodriguez-Gil, Cristina] Heriot Watt Univ, Sch Energy Geosci Infrastruct & Soc, Riccarton Campus, Edinburgh, Midlothian, Scotland	Heriot Watt University	Gormley, M (corresponding author), Heriot Watt Univ, Sch Energy Geosci Infrastruct & Soc, Riccarton Campus, Edinburgh, Midlothian, Scotland.	m.gormley@hw.ac.uk		Kelly, David/0000-0003-4230-8823; Gormley, Michael/0000-0003-3418-4621; Aspray, Thomas/0000-0001-7087-1846	Dyteqta Ltd. [D13R10169]	Dyteqta Ltd.	A small Funding grant ((sic)15k) was obtained from Dyteqta Ltd., Funding No. D13R10169. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had final responsibility for the decision to submit for publication.	[Anonymous], 1882015 ANSI ASHRAE; [Anonymous], 2013, WHOCDSCSRGAR2003; Aspray TJ, 2005, FEMS MICROBIOL ECOL, V54, P317, DOI 10.1016/j.femsec.2005.04.007; Barker J, 2000, J APPL MICROBIOL, V89, P137, DOI 10.1046/j.1365-2672.2000.01091.x; Barker J, 2005, J APPL MICROBIOL, V99, P339, DOI 10.1111/j.1365-2672.2005.02610.x; British Standards Institute, 2003, 1469812003 BS EN ISO; British Standards Institution, 2000, 120562 BS EN; CHANG CW, 1994, APPL ENVIRON MICROB, V60, P3732, DOI 10.1128/AEM.60.10.3732-3738.1994; CIBSE, 2013, TM13 MIN RISK LEG DI; Gebra CP, 1975, APPL ENVIRON MICROB, V30, P229; Gormley M, 2007, BUILD SERV ENG RES T, V28, P55, DOI 10.1177/0143624406071980; Gormley M, 2014, BUILD SERV ENG RES T, V35, P244, DOI 10.1177/0143624413485080; Gormley M, 2012, BUILD SERV ENG RES T, V33, P203, DOI 10.1177/0143624411410619; Gormley M, IND AIR 2014 13 INT, P132; Hathway EA, 2011, BUILD ENVIRON, V46, P2500, DOI 10.1016/j.buildenv.2011.06.001; Hung HCK, 2006, BUILD SERV ENG RES T, V27, P91, DOI 10.1191/0143624406bt145oa; Moore G, 2013, BIOFILMS INFECT PREV; Moore G, 2015, BIOFOULING, V31, P677, DOI 10.1080/08927014.2015.1089986; OECD, 2005, LESS DANG SCH SAF SE; Pitts B, 1998, BIOFOULING, V13, P19, DOI 10.1080/08927019809378368; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; STEWART SL, 1995, APPL ENVIRON MICROB, V61, P1232, DOI 10.1128/AEM.61.4.1232-1239.1995; Swaffield, 2015, TRANSIENT FREE SURFA; Swaffield J., 2010, TRANSIENT AIRFLOWS B; Swaffield J. A., 2005, Building Services Engineering Research & Technology, V26, P195, DOI 10.1191/0143624405bt120oa; Swaffield JA, 2005, PRESSURE TRANSIENT I, V26, P99; Tang JW, 2011, J HOSP INFECT, V77, P213, DOI 10.1016/j.jhin.2010.09.037; Walker J, 2015, J HOSP INFECT, V89, P324, DOI 10.1016/j.jhin.2014.11.019; Wise AFE, 1995, WATER SANITARY WASTE	29	42	42	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171556	10.1371/journal.pone.0171556	http://dx.doi.org/10.1371/journal.pone.0171556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187135	Green Published, Green Submitted, gold			2022-12-26	WOS:000394244300030
J	Palidis, DJ; Wyder-Hodge, PA; Fooken, J; Spering, M				Palidis, Dimitrios J.; Wyder-Hodge, Pearson A.; Fooken, Jolande; Spering, Miriam			Distinct eye movement patterns enhance dynamic visual acuity	PLOS ONE			English	Article							BASEBALL PLAYERS; MOVING TARGETS; TRACKING; PERFORMANCE; RESOLUTION; MOTION; BALL; PERCEPTION; SACCADES; VISION	Dynamic visual acuity (DVA) is the ability to resolve fine spatial detail in dynamic objects during head fixation, or in static objects during head or body rotation. This ability is important for many activities such as ball sports, and a close relation has been shown between DVA and sports expertise. DVA tasks involve eye movements, yet, it is unclear which aspects of eye movements contribute to successful performance. Here we examined the relation between DVA and the kinematics of smooth pursuit and saccadic eye movements in a cohort of 23 varsity baseball players. In a computerized dynamic-object DVA test, observers reported the location of the gap in a small Landolt-C ring moving at various speeds while eye movements were recorded. Smooth pursuit kinematics-eye latency, acceleration, velocity gain, position error-and the direction and amplitude of saccadic eye movements were linked to perceptual performance. Results reveal that distinct eye movement patterns-minimizing eye position error, tracking smoothly, and inhibiting reverse saccades-were related to dynamic visual acuity. The close link between eye movement quality and DVA performance has important implications for the development of perceptual training programs to improve DVA.	[Palidis, Dimitrios J.; Wyder-Hodge, Pearson A.; Fooken, Jolande; Spering, Miriam] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC, Canada; [Palidis, Dimitrios J.; Fooken, Jolande; Spering, Miriam] Univ British Columbia, Grad Program Neurosci, Vancouver, BC, Canada; [Spering, Miriam] Univ British Columbia, Ctr Brain Hlth, Vancouver, BC, Canada; [Spering, Miriam] Univ British Columbia, Inst Comp Informat & Cognit Syst, Vancouver, BC, Canada; [Spering, Miriam] Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Spering, M (corresponding author), Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC, Canada.; Spering, M (corresponding author), Univ British Columbia, Grad Program Neurosci, Vancouver, BC, Canada.; Spering, M (corresponding author), Univ British Columbia, Ctr Brain Hlth, Vancouver, BC, Canada.; Spering, M (corresponding author), Univ British Columbia, Inst Comp Informat & Cognit Syst, Vancouver, BC, Canada.; Spering, M (corresponding author), Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC, Canada.	mspering@mail.ubc.ca			Discovery Grant from the Natural Sciences and Engineering Research Council Canada (NSERC) [RGPIN 418493]; Canada Foundation for Innovation (CFI) John R. Evans Leaders Fund	Discovery Grant from the Natural Sciences and Engineering Research Council Canada (NSERC); Canada Foundation for Innovation (CFI) John R. Evans Leaders Fund	This study was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council Canada (NSERC RGPIN 418493) and Canada Foundation for Innovation (CFI) John R. Evans Leaders Fund to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHILL AT, 1984, AM SCI, V72, P249; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BROWN B, 1972, VISION RES, V12, P293, DOI 10.1016/0042-6989(72)90119-8; BROWN B, 1972, VISION RES, V12, P305, DOI 10.1016/0042-6989(72)90120-4; Chen-Harris H, 2008, J NEUROSCI, V28, P2804, DOI 10.1523/JNEUROSCI.5300-07.2008; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; de Brouwer S, 2002, J NEUROPHYSIOL, V87, P1646, DOI 10.1152/jn.00432.2001; Demer JL, 2001, ANN NY ACAD SCI, V942, P428; Deveau J, 2014, CURR BIOL, V24, pR146, DOI 10.1016/j.cub.2014.01.004; Diaz G, 2013, J VISION, V13, DOI 10.1167/13.12.5; Faubert J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01154; Faubert J, 2012, J CLIN SPORT PSYCHOL, V6, P85, DOI 10.1123/jcsp.6.1.85; Fooken J, 2016, J VISION, V16, DOI 10.1167/16.14.1; HIRSCH J, 1989, VISION RES, V29, P1095, DOI 10.1016/0042-6989(89)90058-8; Holladay JT, 1997, J REFRACT SURG, V13, P388; Hughes PK, 1993, CLIN EXP OPTOM, V76, P51, DOI DOI 10.1111/J.1444-0938.1993.TB05090.X; Ilg UJ, 1997, PROG NEUROBIOL, V53, P293, DOI 10.1016/S0301-0082(97)00039-7; ISHIGAKI H, 1993, PERCEPT MOTOR SKILL, V77, P835, DOI 10.2466/pms.1993.77.3.835; Jacob R, 2005, OPTOMETRY VISION SCI, V82, P1060, DOI 10.1097/01.opx.0000192346.84549.6a; JACOBS RJ, 1979, VISION RES, V19, P1187, DOI 10.1016/0042-6989(79)90183-4; Laby DM, 1996, AM J OPHTHALMOL, V122, P476, DOI 10.1016/S0002-9394(14)72106-3; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; Mangine GT, 2014, J STRENGTH COND RES, V28, P2406, DOI 10.1519/JSC.0000000000000550; Millslagle DG, 2000, PERCEPT MOTOR SKILL, V90, P498, DOI 10.2466/PMS.90.2.498-504; MORRIS GSD, 1977, RES QUART, V48, P480; Moulder MJ, 2013, VISION RES, V81, P6, DOI 10.1016/j.visres.2013.01.004; Poltavski D, 2015, J SPORT SCI, V33, P597, DOI 10.1080/02640414.2014.951952; Quevedo-Junyent L, 2011, RES Q EXERCISE SPORT, V82, P644, DOI 10.1080/02701367.2011.10599801; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Rouse M W, 1988, J Am Optom Assoc, V59, P946; Schutz AC, 2011, J VISION, V11, DOI 10.1167/11.5.9; Spering M, 2011, J NEUROPHYSIOL, V105, P1756, DOI 10.1152/jn.00344.2010; Spering M, 2011, VISION RES, V51, P836, DOI 10.1016/j.visres.2010.10.017; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Tong JL, 2007, VISION RES, V47, P1011, DOI 10.1016/j.visres.2006.12.002; Uchida Y, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/JOURNAL.PONE.0031530; Uchida Y, 2013, MED SCI SPORT EXER, V45, P319, DOI 10.1249/MSS.0b013e31826fec97; Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93	39	23	25	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172061	10.1371/journal.pone.0172061	http://dx.doi.org/10.1371/journal.pone.0172061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187157	Green Published, Green Submitted, gold			2022-12-26	WOS:000394244300075
J	Shea, AA; Bernhards, RC; Cote, CK; Chase, CJ; Koehler, JW; Klimko, CP; Ladner, JT; Rozak, DA; Wolcott, MJ; Fetterer, DP; Kern, SJ; Koroleva, GI; Lovett, SP; Palacios, GF; Toothman, RG; Bozue, JA; Worsham, PL; Welkos, SL				Shea, A. A.; Bernhards, R. C.; Cote, C. K.; Chase, C. J.; Koehler, J. W.; Klimko, C. P.; Ladner, J. T.; Rozak, D. A.; Wolcott, M. J.; Fetterer, D. P.; Kern, S. J.; Koroleva, G. I.; Lovett, S. P.; Palacios, G. F.; Toothman, R. G.; Bozue, J. A.; Worsham, P. L.; Welkos, S. L.			Two stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences	PLOS ONE			English	Article							COLONY MORPHOLOGY VARIATION; ANTIGENIC VARIATION; PSEUDOMONAS-PSEUDOMALLEI; CAPSULAR POLYSACCHARIDE; OXIDATIVE STRESS; ANTIMICROBIAL PEPTIDES; CYSTIC-FIBROSIS; MICROARRAY DATA; D-SERINE; MELIOIDOSIS	Burkholderia pseudomallei (Bp), the agent of melioidosis, causes disease ranging from acute and rapidly fatal to protracted and chronic. Bp is highly infectious by aerosol, can cause severe disease with nonspecific symptoms, and is naturally resistant to multiple antibiotics. However, no vaccine exists. Unlike many Bp strains, which exhibit random variability in traits such as colony morphology, Bp strain MSHR5848 exhibited two distinct and relatively stable colony morphologies on sheep blood agar plates: a smooth, glossy, pale yellow colony and a flat, rough, white colony. Passage of the two variants, designated "Smooth" and "Rough", under standard laboratory conditions produced cultures composed of > 99.9% of the single corresponding type; however, both could switch to the other type at different frequencies when incubated in certain nutritionally stringent or stressful growth conditions. These MSHR5848 derivatives were extensively characterized to identify variant-associated differences. Microscopic and colony morphology differences on six differential media were observed and only the Rough variant metabolized sugars in selective agar. Antimicrobial susceptibilities and lipopolysaccharide (LPS) features were characterized and phenotype microarray profiles revealed distinct metabolic and susceptibility disparities between the variants. Results using the phenotype microarray system narrowed the 1,920 substrates to a subset which differentiated the two variants. Smooth grew more rapidly in vitro than Rough, yet the latter exhibited a nearly 10-fold lower lethal dose for mice than Smooth. Finally, the Smooth variant was phagocytosed and replicated to a greater extent and was more cytotoxic than Rough in macrophages. In contrast, multiple locus sequence type (MLST) analysis, ribotyping, and whole genome sequence analysis demonstrated the variants' genetic conservation; only a single consistent genetic difference between the two was identified for further study. These distinct differences shown by two variants of a Bp strain will be leveraged to better understand the mechanism of Bp phenotypic variability and to possibly identify in vitro markers of infection.	[Shea, A. A.; Chase, C. J.; Koehler, J. W.; Rozak, D. A.; Wolcott, M. J.] USAMRIID, Diagnost Syst Div, Frederick, MD USA; [Bernhards, R. C.; Cote, C. K.; Klimko, C. P.; Toothman, R. G.; Bozue, J. A.; Worsham, P. L.; Welkos, S. L.] USAMRIID, Bacteriol Div, Frederick, MD 21702 USA; [Ladner, J. T.; Koroleva, G. I.; Lovett, S. P.; Palacios, G. F.] USAMRIID, Ctr Genome Sci, Frederick, MD USA; [Fetterer, D. P.; Kern, S. J.] USAMRIID, Biostat Serv Div, Frederick, MD USA; [Bernhards, R. C.] Edgewood Chem Biol Ctr, Aberdeen Proving Ground, MD USA; [Kern, S. J.] NIH, Bldg 10, Bethesda, MD 20892 USA	United States Army Medical Research Institute of Infectious Diseases; United States Army Medical Research Institute of Infectious Diseases; United States Army Medical Research Institute of Infectious Diseases; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); National Institutes of Health (NIH) - USA	Welkos, SL (corresponding author), USAMRIID, Bacteriol Div, Frederick, MD 21702 USA.	susan.l.welkos.civ@mail.mil	Bozue, Joel/AAE-4363-2022; Palacios, Gustavo/I-7773-2015; Bozue, Joel/AAE-4357-2022; Ladner, Jason/G-3486-2011	Bozue, Joel/0000-0001-6959-8176; Palacios, Gustavo/0000-0001-5062-1938; Bozue, Joel/0000-0001-6959-8176; Ladner, Jason/0000-0001-7751-4366; Koehler, Jeffrey/0000-0003-3225-6599	Joint Science & Technology Office for Chemical & Biological Defense (JSTO-CBD), Defense Threat Reduction Agency (DTRA) [CB3846PPE-1, CB10246]	Joint Science & Technology Office for Chemical & Biological Defense (JSTO-CBD), Defense Threat Reduction Agency (DTRA)	This research was funded by the Joint Science & Technology Office for Chemical & Biological Defense (JSTO-CBD), Defense Threat Reduction Agency (DTRA) - (1) Project CCAR# CB3846PPE-1 Burkholderia (PatriciaWorsham). (2) Project CB10246: High Speed Sequencing for Rapid Response and Countermeasure Development (GustavoPalacios) http://www.dtra. mil/Research/Chemical-Biological-TechnologyD epartment/.	Abu Kwaik Y, 2013, CELL MICROBIOL, V15, P882, DOI 10.1111/cmi.12138; Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005; Alice AF, 2006, J BACTERIOL, V188, P1551, DOI 10.1128/JB.188.4.1551-1566.2006; Alkhuder K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000284; Atkins T, 2002, INFECT IMMUN, V70, P5290, DOI 10.1128/IAI.70.9.5290-5294.2002; Austin CR, 2015, MBIO, V6, DOI 10.1128/mBio.02462-14; Biggins JB, 2012, J AM CHEM SOC, V134, P13192, DOI 10.1021/ja3052156; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BRAUN V, 1995, FEMS MICROBIOL REV, V16, P295, DOI 10.1111/j.1574-6976.1995.tb00177.x; Butt A, 2014, BIOCHEM J, V459, P333, DOI 10.1042/BJ20140073; Caballero JD, 2015, MBIO, V6, DOI 10.1128/mBio.00981-15; Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06; Chantratita N, 2012, J PROTEOMICS, V75, P1031, DOI 10.1016/j.jprot.2011.10.015; Chasteen TG, 2009, FEMS MICROBIOL REV, V33, P820, DOI 10.1111/j.1574-6976.2009.00177.x; Chieng S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-328; Chin CY, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00085; Conerly O, 2009, TOXICOLOGICAL REV TH; Conway T, 2015, METABOLISM BACTERIAL; Cuccui J, 2012, INFECT IMMUN, V80, P1209, DOI 10.1128/IAI.05805-11; Cullen L, 2015, PATHOGENS, V4, P66, DOI 10.3390/pathogens4010066; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; Daligault HE, 2014, GENOME ANNOUNCE, V2; DANCE DAB, 1991, J ANTIMICROB CHEMOTH, V28, P321, DOI 10.1093/jac/28.2.321; Dance D, 2014, INT J ANTIMICROB AG, V43, P310, DOI 10.1016/j.ijantimicag.2014.01.005; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Dowling AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015693; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Fazeli M, 2011, HUM EXP TOXICOL, V30, P152, DOI 10.1177/0960327110369821; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; Fox MA, 2012, PEPTIDES, V33, P197, DOI 10.1016/j.peptides.2012.01.013; Fuentes DE, 2007, J BACTERIOL, V189, P8953, DOI 10.1128/JB.01252-07; Galardini M, 2014, GENOMICS, V103, P1, DOI 10.1016/j.ygeno.2013.11.005; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gierok P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004483; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; GRULA EA, 1963, BIOCHIM BIOPHYS ACTA, V74, P776, DOI 10.1016/0006-3002(63)91430-6; HANCOCK REW, 1983, INFECT IMMUN, V42, P170, DOI 10.1128/IAI.42.1.170-177.1983; Harland DN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-83; Hayden HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036507; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Kanthawong S, 2009, INT J ANTIMICROB AG, V34, P309, DOI 10.1016/j.ijantimicag.2009.05.012; Kleber HP, 1997, FEMS MICROBIOL LETT, V147, P1; Korte-Berwanger M, 2013, INFECT IMMUN, V81, P4525, DOI 10.1128/IAI.00599-13; Kvitko BH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001715; Li KY, 2004, J BACTERIOL, V186, P6800, DOI 10.1128/JB.186.20.6800-6808.2004; Li Y, 2003, APPL ENVIRON MICROB, V69, P5739, DOI 10.1128/AEM.69.10.5739-5745.2003; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Loprasert S, 2003, ARCH MICROBIOL, V180, P498, DOI 10.1007/s00203-003-0621-9; Madhongsa K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002267; MATTHEWS DM, 1980, CURR TOP MEMBR TRANS, V14, P331; Meadows JA, 2015, MICROBIOL-SGM, V161, P1161, DOI 10.1099/mic.0.000080; Meibom KL, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00140; Mott TM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003863; Mulye M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002988; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; Nicholls L, 1930, BRIT J EXP PATHOL, V11, P393; Niu H, 2008, CELL MICROBIOL, V10, P593, DOI 10.1111/j.1462-5822.2007.01068.x; Niu H, 2012, P NATL ACAD SCI USA, V109, P20800, DOI 10.1073/pnas.1218674109; Ouellette SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016783; Palmer GC, 2015, METABOLISM BACTERIAL, P185; Pletzer D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111311; Price EP, 2013, MBIO, V4, DOI 10.1128/mBio.00388-13; Reckseidler-Zenteno SL, 2005, INFECT IMMUN, V73, P1106, DOI 10.1128/IAI.73.2.1106-1115.2005; ROGUL M, 1972, J BACTERIOL, V112, P372, DOI 10.1128/JB.112.1.372-380.1972; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Ronning CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-202; Sarkar-Tyson M, 2007, J MED MICROBIOL, V56, P1005, DOI 10.1099/jmm.0.47043-0; Senior NJ, J CYSTIC FIBROSIS; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; Sperandio V, 2015, CELL HOST MICROBE, V18, P7, DOI 10.1016/j.chom.2015.06.010; Stanton AT, 1924, J HYG-CAMBRIDGE, V23, P268, DOI 10.1017/S0022172400034197; Tandhavanant S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-303; Tatusova T., 2013, NCBI HDB; Telford JR, 1997, J BIOL INORG CHEM, V2, P750, DOI 10.1007/s007750050191; Traverse CC, 2013, P NATL ACAD SCI USA, V110, pE250, DOI 10.1073/pnas.1207025110; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Utaisincharoen P, 2001, MICROBIOL IMMUNOL, V45, P307, DOI 10.1111/j.1348-0421.2001.tb02623.x; Vaas LAI, 2013, BIOINFORMATICS, V29, P1823, DOI 10.1093/bioinformatics/btt291; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; Valvano MA, 2005, CURR OPIN MICROBIOL, V8, P99, DOI 10.1016/j.mib.2004.12.002; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Vehkala M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118392; Velapatino B, 2012, MICROBES INFECT, V14, P335, DOI 10.1016/j.micinf.2011.11.011; Vial L, 2010, ISME J, V4, P49, DOI 10.1038/ismej.2009.95; Welkos SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124667; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wikraiphat C, 2015, INFECT IMMUN, V83, P2127, DOI 10.1128/IAI.02785-14; Wisniewski-Dye F, 2008, ANTON LEEUW INT J G, V94, P493, DOI 10.1007/s10482-008-9267-6; Wong J, 2015, CELL HOST MICROBE, V18, P38, DOI 10.1016/j.chom.2015.06.002; Woodman ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052276; YANG HM, 1993, INFECT IMMUN, V61, P656, DOI 10.1128/IAI.61.2.656-662.1993; Yi EC, 2000, ANALYST, V125, P651, DOI 10.1039/b000368i; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003	98	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171363	10.1371/journal.pone.0171363	http://dx.doi.org/10.1371/journal.pone.0171363			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187198	Green Submitted, Green Published, gold			2022-12-26	WOS:000394244300022
J	Zhang, FD; Liu, L; Sun, MY; Sun, JJ; Lu, HZ				Zhang, Fengdi; Liu, Li; Sun, Meiyan; Sun, Jianjun; Lu, Hongzhou			An analysis of drug resistance among people living with HIV/AIDS in Shanghai, China	PLOS ONE			English	Article							1ST-LINE ANTIRETROVIRAL THERAPY; NAIVE HIV-1-INFECTED PATIENTS; HIV-INFECTED PATIENTS; REVERSE-TRANSCRIPTASE; VIROLOGICAL FAILURE; EFAVIRENZ; TENOFOVIR; METAANALYSIS; LAMIVUDINE; SAFETY	Background Understanding the mechanisms of drug resistance can facilitate better management of antiretroviral therapy, helping to prevent transmission and decrease the morbidity and mortality of people living with HIV/AIDS. However, there is little data about transmitted drug resistance and acquired drug resistance for HIV/AIDS patients in Shanghai. Methods A retrospective cohort study of HIV-infected patients who visited the Department of Infectious Disease from June 2008 to June 2015 was conducted in Shanghai, China. Logistic regression analysis was performed to analyze risk factors for drug resistance among HIV infected people with virological failure. The related collected factors included patient age, gender, marital status, infection route, baseline CD4 count, antiretroviral therapy regimens, time between HIV diagnosis and initiating antiretroviral therapy. Factors with p<0.1 in the univariate logistic regression test were analyzed by multivariate logistic regression test. Results There were 575 subjects selected for this study and 369 participated in this research. For the antiretroviral therapy drugs, the rates of transmitted drug resistance and acquired drug resistance were significantly different. The non -nucleoside reverse transcriptase inhibitor (NNRTI) had the highest drug resistance rate (transmitted drug resistance, 10.9%; acquired drug resistance, 53.3%) and protease inhibitors (Pis) had the lowest drug resistance rate (transmitted drug resistance, 1.7%; acquired drug resistance, 2.7%). Logistic regression analysis found no factors that were related to drug resistance except marital status (married status for tenofovir: odds ratio = 6.345, 95% confidence interval = 1.553-25.921, P = 0.010) and the time span between HIV diagnosis and initiating antiretroviral therapy (<6M for stavudine: odds ratio = 0.271, 95% confidence interval = 0.086-0.850, P = 0.025; <6M for didanosine: odds ratio = 0.284, 95% confidence interval = 0.096-0.842, P = 0.023; <6M for tenofovir: odds ratio = 0.079, 95% confidence interval = 0.018-0.350,P<0.001). Conclusion NNRTI had a higher DR rate compared with nucleoside reverse transcriptase inhibitor (NRTI) and Pls, consequently, LPV/r was a reasonable choice for patients with NNRTI drugs resistance in China. Only married status and a time span <= 6 month between the HIV confirmed date and the time initiating antiretroviral therapy were risk factors for TDF drug resistance. Both baseline HIV-RNA load and resistance test is crucial for TDR diagnosis, and frequent monitoring of HIV-RNA load is crucial for ADR identification and intervention. Treatment adherence still plays a positive role on the outcome of ART.	[Zhang, Fengdi; Liu, Li; Sun, Meiyan; Sun, Jianjun; Lu, Hongzhou] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai, Peoples R China; [Lu, Hongzhou] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China; [Lu, Hongzhou] Fudan Univ, Dept Internal Med, Shanghai Med Coll, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Lu, HZ (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai, Peoples R China.; Lu, HZ (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China.; Lu, HZ (corresponding author), Fudan Univ, Dept Internal Med, Shanghai Med Coll, Shanghai, Peoples R China.	luhongzhou@fudan.edu.cn			Natural Science Foundation of China [81571977]; National High Technology Research and Development Program (863 Program) [2014AA021403]; fourth round of three-year public health active plan [15GWZK0103]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); fourth round of three-year public health active plan	HZL received the grant of Natural Science Foundation of China (grant 81571977), The National High Technology Research and Development Program (863 Program) (grant 2014AA021403), and the fourth round of three-year public health active plan (grant 15GWZK0103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain N, 2011, AIDS, V25, P1481, DOI 10.1097/QAD.0b013e328348dab0; Mata-Marin JA, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0072-9; Barbour JD, 2002, J VIROL, V76, P11104, DOI 10.1128/JVI.76.21.11104-11112.2002; Bartolo I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113626; Bastos MM, 2016, EUR J MED CHEM, V108, P455, DOI 10.1016/j.ejmech.2015.11.025; Bennett DE, 2012, CLIN INFECT DIS, V54, pS280, DOI 10.1093/cid/cis207; Boyer PL, 2015, ANTIMICROB AGENTS CH, V59, P7184, DOI 10.1128/AAC.05069-14; Bulteel N, 2014, J INFECTION, V68, P77, DOI 10.1016/j.jinf.2013.09.005; Cassetti I, 2007, HIV CLIN TRIALS, V8, P164, DOI 10.1310/hct0803-164; Chung MH, 2016, AIDS; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Etiebet MAA, 2013, AIDS, V27, P553, DOI 10.1097/QAD.0b013e32835b0f59; Ford N, 2010, AIDS, V24, P1461, DOI 10.1097/QAD.0b013e32833a2a14; Gupta RK, 2014, CLIN INFECT DIS, V58, P1023, DOI 10.1093/cid/cit933; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Health NIo, GUIDELINES USE ANTIR; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Lai MT, 2010, ANTIMICROB AGENTS CH, V54, P4812, DOI 10.1128/AAC.00829-10; Larru B, 2014, PEDIATR HEALTH MED T, V5, P29, DOI 10.2147/PHMT.S47794; Liu L, 2007, J MED VIROL, V79, P1593, DOI 10.1002/jmv.20998; Margot NA, 2006, HIV MED, V7, P442, DOI 10.1111/j.1468-1293.2006.00404.x; Muri L, 2017, AIDS, V31, P61, DOI 10.1097/QAD.0000000000001273; Mutenda N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166649; Ndahimana JD, 2016, TROPICAL MED INT HLT; O'Connor JL, 2013, J INFECT DIS, V208, P40, DOI 10.1093/infdis/jis731; Rodriguez-French A, 2004, JAIDS-J ACQ IMM DEF, V35, P22, DOI 10.1097/00126334-200401010-00003; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; TenoRes Study G, 2016, LANCET INFECT DIS; Xing YF, 2013, SCI WORLD J, DOI [10.1155/2013/381219, 10.1155/2013/630654]; Zhang XZ, 2016, PROCEEDINGS 2016 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P2016, DOI 10.1109/ICIT.2016.7475077	30	19	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0165110	10.1371/journal.pone.0165110	http://dx.doi.org/10.1371/journal.pone.0165110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187212	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300001
J	Hocevar, T; Demsar, J				Hocevar, Tomaz; Demsar, Janez			Combinatorial algorithm for counting small induced graphs and orbits	PLOS ONE			English	Article							SUBGRAPHS; NETWORKS	Graphlet analysis is an approach to network analysis that is particularly popular in bioinformatics. We show how to set up a system of linear equations that relate the orbit counts and can be used in an algorithm that is significantly faster than the existing approaches based on direct enumeration of graphlets. The approach presented in this paper presents a generalization of the currently fastest method for counting 5-node graphlets in bioinformatics. The algorithm requires existence of a vertex with certain properties; we show that such vertex exists for graphlets of arbitrary size, except for complete graphs and a cycle with four nodes, which are treated separately. Empirical analysis of running time agrees with the theoretical results.	[Hocevar, Tomaz; Demsar, Janez] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia	University of Ljubljana	Hocevar, T (corresponding author), Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia.	tomaz.hocevar@fri.uni-lj.si	Demšar, Janez/AAS-2762-2020; Hočevar, Tomaž/GWM-8593-2022	Hocevar, Tomaz/0000-0002-7998-2638	Slovenian research agency [J2-5480, P2-0209]	Slovenian research agency(Slovenian Research Agency - Slovenia)	This work has been funded by the Slovenian research agency (https://www.arrs.gov.si/en/) grants J2-5480 and P2-0209. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON N, 1995, J ASSOC COMPUT MACH, V42, P844, DOI 10.1145/210332.210337; Alon N, 1997, ALGORITHMICA, V17, P209, DOI 10.1007/BF02523189; Alon N, 2008, BIOINFORMATICS, V24, pI241, DOI 10.1093/bioinformatics/btn163; Backstrom L, 2011, P 4 ACM INT C WEB SE, V11, P635; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Eppstein D, 2010, LECT NOTES COMPUT SC, V6506, P403, DOI 10.1007/978-3-642-17517-6_36; Floderus P, 2012, 18 ANN INT COMP COMB, P37; Hocevar T, 2014, BIOINFORMATICS, V30, P559, DOI 10.1093/bioinformatics/btt717; ITAI A, 1978, SIAM J COMPUT, V7, P413, DOI 10.1137/0207033; Kloks T, 2000, INFORM PROCESS LETT, V74, P115, DOI 10.1016/S0020-0190(00)00047-8; Kowaluk M, 2013, SIAM J DISCRETE MATH, V27, P892, DOI 10.1137/110859798; Kuramochi M, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P313, DOI 10.1109/ICDM.2001.989534; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Marcus D, 2012, COMPUT NETW, V56, P810, DOI 10.1016/j.comnet.2011.08.019; Melckenbeeck I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147078; Milenkovic T, 2008, CANCER INFORM, V6, P257; Milenkovic T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-70; Nesetril Jaroslav, 1985, COMMENT MATH UNIV CA, V26, P415; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Ralaivola L, 2005, NEURAL NETWORKS, V18, P1093, DOI 10.1016/j.neunet.2005.07.009; Vassilevska V, 2009, ACM S THEORY COMPUT, P455	22	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171428	10.1371/journal.pone.0171428	http://dx.doi.org/10.1371/journal.pone.0171428			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182743	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800059
J	Quaglia, D; Ebert, MCCJC; Mugford, PF; Pelletier, JN				Quaglia, Daniela; Ebert, Maximilian C. C. J. C.; Mugford, Paul F.; Pelletier, Joelle N.			Enzyme engineering: A synthetic biology approach for more effective library generation and automated high-throughput screening	PLOS ONE			English	Article							ANTARCTICA LIPASE; DIRECTED EVOLUTION; ACTIVE-SITE; PROTEIN; STRATEGIES; MUTATIONS; DIVERSITY; DESIGN; TOOL	The Golden Gate strategy entails the use of type IIS restriction enzymes, which cut outside of their recognition sequence. It enables unrestricted design of unique DNA fragments that can be readily and seamlessly recombined. Successfully employed in other synthetic biology applications, we demonstrate its advantageous use to engineer a biocatalyst. Hot-spots for mutations were individuated in three distinct regions of Candida antarctica lipase A (CalA), the biocatalyst chosen as a target to demonstrate the versatility of this recombination method. The three corresponding gene segments were subjected to the most appropriate method of mutagenesis (targeted or random). Their straightforward reassembly allowed combining products of different mutagenesis methods in a single round for rapid production of a series of diverse libraries, thus facilitating directed evolution. Screening to improve discrimination of short-chain versus long-chain fatty acid substrates was aided by development of a general, automated method for visual discrimination of the hydrolysis of varied substrates by whole cells.	[Quaglia, Daniela; Pelletier, Joelle N.] Univ Montreal, Dept Chim, Montreal, PQ, Canada; [Quaglia, Daniela; Ebert, Maximilian C. C. J. C.; Pelletier, Joelle N.] Univ Montreal, CGCC, Montreal, PQ, Canada; [Quaglia, Daniela; Ebert, Maximilian C. C. J. C.; Pelletier, Joelle N.] PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada; [Ebert, Maximilian C. C. J. C.; Pelletier, Joelle N.] Univ Montreal, Dept Biochim, Montreal, PQ, Canada; [Mugford, Paul F.] DSM Nutr Prod, 101 Res Dr, Dartmouth, NS, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; DSM NV	Pelletier, JN (corresponding author), Univ Montreal, Dept Chim, Montreal, PQ, Canada.; Pelletier, JN (corresponding author), Univ Montreal, CGCC, Montreal, PQ, Canada.; Pelletier, JN (corresponding author), PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada.; Pelletier, JN (corresponding author), Univ Montreal, Dept Biochim, Montreal, PQ, Canada.	joelle.pelletier@umontreal.ca		Quaglia, Daniela/0000-0003-3756-3782; Ebert, Maximilian/0000-0002-8055-8404	Natural Sciences and Engineering Research Council of Canada [227853, 476466, 490749]; DSM Nutritional Supplements	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); DSM Nutritional Supplements	This work was supported by Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) grants 227853 to J. N. P and 476466 and 490749 to J. N. P and P. F. M., and DSM Nutritional Supplements (www.dsm.corn). The funders provided support in the form of salaries for authors [D.Q., P.F.M.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acevedo-Rocha CG, 2015, SCI REP, V5, P1; Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; Bendl J, 2016, NUCLEIC ACIDS RES, V44, pW479, DOI 10.1093/nar/gkw416; Brundiek HB, 2012, ANGEW CHEM INT EDIT, V51, P412, DOI 10.1002/anie.201106126; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chica RA, 2005, CURR OPIN BIOTECH, V16, P378, DOI 10.1016/j.copbio.2005.06.004; Davids T, 2013, CURR OPIN CHEM BIOL, V17, P215, DOI 10.1016/j.cbpa.2013.02.022; de Maria PD, 2005, J MOL CATAL B-ENZYM, V37, P36, DOI 10.1016/j.molcatb.2005.09.001; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Ericsson DJ, 2008, J MOL BIOL, V376, P109, DOI 10.1016/j.jmb.2007.10.079; Ferla MP, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0996-7; Firth AE, 2008, NUCLEIC ACIDS RES, V36, pW281, DOI 10.1093/nar/gkn226; Gao XZ, 2013, ANAL BIOCHEM, V437, P172, DOI 10.1016/j.ab.2013.02.028; Gillam EMJ, 2014, METHODS MOL BIOL, V1179, P1, DOI 10.1007/978-1-4939-1053-3; Goldsmith M, 2012, CURR OPIN STRUC BIOL, V22, P406, DOI 10.1016/j.sbi.2012.03.010; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Hiraga K, 2003, J MOL BIOL, V330, P287, DOI 10.1016/S0022-2836(03)00590-4; JETTE JF, 1994, ANAL BIOCHEM, V219, P256, DOI 10.1006/abio.1994.1265; Kazlauskas RJ, 2009, NAT CHEM BIOL, V5, P526, DOI 10.1038/nchembio0809-526; Kille S, 2013, ACS SYNTH BIOL, V2, P83, DOI 10.1021/sb300037w; Kirchner SM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071030, 10.1371/journal.pone.0076117]; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; LAWRENCE RC, 1967, NATURE, V213, P1264, DOI 10.1038/2131264a0; Nyyssola A, 2015, INT DAIRY J, V41, P16, DOI 10.1016/j.idairyj.2014.09.003; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; Reetz MT, 2013, ANGEW CHEM INT EDIT, V52, P2658, DOI 10.1002/anie.201207842; Rosenfeld L, 2016, TRENDS BIOCHEM SCI, V41, P421, DOI 10.1016/j.tibs.2016.03.002; Ruff AJ, 2013, FEBS J, V280, P2961, DOI 10.1111/febs.12325; Shivange AV, 2009, CURR OPIN CHEM BIOL, V13, P19, DOI 10.1016/j.cbpa.2009.01.019; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Volpato JP, 2007, J MOL BIOL, V373, P599, DOI 10.1016/j.jmb.2007.07.076; Volpato JP, 2009, J BIOL CHEM, V284, P20079, DOI 10.1074/jbc.M109.018010; Wong TS, 2007, ENVIRON MICROBIOL, V9, P2645, DOI 10.1111/j.1462-2920.2007.01411.x; Yan P, 2012, ANAL BIOCHEM, V430, P65, DOI 10.1016/j.ab.2012.07.029; Zhou LB, 2013, GENE, V523, P122, DOI 10.1016/j.gene.2013.03.140	36	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171741	10.1371/journal.pone.0171741	http://dx.doi.org/10.1371/journal.pone.0171741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178357	Green Published, Green Submitted, gold			2022-12-26	WOS:000393712500065
J	Rainwater-Lovett, K; Ziemniak, C; Watson, D; Luzuriaga, K; Siberry, G; Petru, A; Chen, YH; Uprety, P; McManus, M; Ho, YC; Lamers, SL; Persaud, D				Rainwater-Lovett, Kaitlin; Ziemniak, Carrie; Watson, Douglas; Luzuriaga, Katherine; Siberry, George; Petru, Ann; Chen, YaHui; Uprety, Priyanka; McManus, Margaret; Ho, Ya-Chi; Lamers, Susanna L.; Persaud, Deborah			Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection	PLOS ONE			English	Article							VIRUS TYPE-1 RECOMBINATION; CD4(+) T-CELLS; LATENT RESERVOIR; HIV-1-INFECTED CHILDREN; VIROLOGICAL CONTROL; PERIPHERAL-BLOOD; IMMUNE-RESPONSES; REPLICATION; SUPPRESSION; CURE	The latent reservoir is a major barrier to HIV eradication. Reservoir size is emerging as an important biomarker to assess the likelihood of HIV remission in the absence of antiretroviral therapy (ART) and may be reduced by earlier initiation of ART that restricts HIV spread into CD4+ T cells. Reservoir size is traditionally measured with a quantitative viral outgrowth assay (QVOA) that induces replication-competent HIV production through in vitro stimulation of resting CD4+ T cells. However, the recent identification of replication-intact, non-induced proviral genomes (NIPG) suggests the QVOA significantly underestimates (by 62-fold) latent reservoir size in chronically-infected adults. Whether formation and persistence of Intact, NIPG is thwarted by early ART initiation and long-term virologic suppression in perinatal infection is unclear. Here, we show that the latent reservoir in 11 early treated, long-term suppressed perinatally infected children and adolescents was not inducible by QVOA and dominated by defective, NIPG. Single genome analysis of 164 NIPG from 232 million cultured resting CD4+ T cells revealed no replication-intact, near-full length sequences. Forty-three (26%) NIPG contained APOBEC3G-mediated hypermutation, 115 (70%) NIPG contained large internal deletions, one NIPG contained nonsense mutations and indels, and 5 (3%) NIPG were assigned as "Not Evaluable" due to multiple failed sequencing attempts that precluded further classification. The lack of replication competent inducible provirus and intact NIPG in this cohort indicate early, long-term ART of perinatal infection leads to marked diminution of replication-competent HIV-1 reservoirs, creating a favorable state towards interventions aimed at virologic remission.	[Rainwater-Lovett, Kaitlin; Ziemniak, Carrie; Chen, YaHui; Uprety, Priyanka; Persaud, Deborah] Johns Hopkins Univ, Sch Med, Dept Pediat Infect Dis, Baltimore, MD 21218 USA; [Watson, Douglas] Univ Maryland, Dept Pediat, Baltimore, MD 21201 USA; [Luzuriaga, Katherine; McManus, Margaret] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Siberry, George] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Maternal & Pediat Infect Dis Branch, Rockville, MD USA; [Petru, Ann] Childrens Hosp & Res Ctr Oakland, Dept Pediat Infect Dis, Oakland, CA USA; [Ho, Ya-Chi] Johns Hopkins Univ, Sch Med, Dept Med Infect Dis, Baltimore, MD USA; [Lamers, Susanna L.] Bioinfoexperts LLC, Thibodaux, LA USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Johns Hopkins University	Persaud, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat Infect Dis, Baltimore, MD 21218 USA.	dpers@jhmi.edu		Ho, Ya-Chi/0000-0002-7046-0147; Rainwater-Lovett, Kaitlin/0000-0002-8707-7339	NIAID; NICHD [R01 HD080474]; Johns Hopkins Center for AIDS Research [P30 A1094189]; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network; NIAID [UM1 Al068632, UM1 Al068616, UM1 Al106716]; NICHD; NIMH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD080474] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068616, P30AI094189, UM1AI106716, UM1AI068632] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Johns Hopkins Center for AIDS Research; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the NIAID and NICHD (R01 HD080474 to DP), the Johns Hopkins Center for AIDS Research (P30 A1094189), and subspecialty laboratory funding to DP from the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network. Overall support for IMPAACT was provided by NIAID (UM1 Al068632, UM1 Al068616, and UM1 Al106716) with co-funding from NICHD and NIMH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funder provided support in the form of salaries for authors [SL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ananworanich J, 2015, CURR OPIN HIV AIDS, V10, P18, DOI 10.1097/COH.0000000000000122; Ananworanich J, 2014, AIDS, V28, P1015, DOI 10.1097/QAD.0000000000000178; Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Bitnun A, 2014, CLIN INFECT DIS, V59, P1012, DOI 10.1093/cid/ciu432; Bruner KM, 2016, NAT MED, P10; Chun TW, 2015, NAT IMMUNOL, V16, P584, DOI 10.1038/ni.3152; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Deepayan S., 2008, LATTICE MULTIVARIATE; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Galli A, 2010, J VIROL, V84, P7651, DOI 10.1128/JVI.00276-10; Golden M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100400; Henrich TJ, 2014, ANN INTERN MED; Hill AL, 2014, P NATL ACAD SCI USA, V111, P13475, DOI 10.1073/pnas.1406663111; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hocqueloux L, 2010, AIDS, V24, P1598, DOI 10.1097/QAD.0b013e32833b61ba; Imamichi H, 2016, P NATL ACAD SCI USA, V113, P8783, DOI 10.1073/pnas.1609057113; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Luzuriaga K, 2000, J VIROL, V74, P6984, DOI 10.1128/JVI.74.15.6984-6991.2000; Luzuriaga K, 2015, NEW ENGL J MED, V372, P786, DOI 10.1056/NEJMc1413931; Luzuriaga K, 2014, J INFECT DIS, V210, P1529, DOI 10.1093/infdis/jiu297; Onafuwa A, 2003, J VIROL, V77, P4577, DOI 10.1128/JVI.77.8.4577-4587.2003; Pace MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002818; Payne H, 2015, LANCET INFECT DIS, V15, P803, DOI 10.1016/S1473-3099(15)00087-0; Persaud D, 2000, J CLIN INVEST, V105, P995, DOI 10.1172/JCI9006; Persaud D, 2014, JAMA PEDIATR, V168, P1138, DOI 10.1001/jamapediatrics.2014.1560; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Persaud D, 2012, AIDS, V26, P1483, DOI 10.1097/QAD.0b013e3283553638; Pinkevych M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005000; Rainwater-Lovett K, 2015, CURR OPIN HIV AIDS, V10, P4, DOI 10.1097/COH.0000000000000127; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Schuetz A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004543; Siliciano Janet D, 2005, Methods Mol Biol, V304, P3; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; TEMIN HM, 1993, P NATL ACAD SCI USA, V90, P6900, DOI 10.1073/pnas.90.15.6900; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; Uprety P, 2015, CLIN INFECT DIS; van Zyl GU, 2015, J INFECT DIS, V212, P39, DOI 10.1093/infdis/jiu827; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zanchetta M, 2006, J INFECT DIS, V193, P1718, DOI 10.1086/504264; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002	45	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170548	10.1371/journal.pone.0170548	http://dx.doi.org/10.1371/journal.pone.0170548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178277	Green Published, gold			2022-12-26	WOS:000393712500008
J	Rodriguez, JD; Haq, S; Bachvaroff, T; Nowak, KF; Nowak, SJ; Morgan, D; Cherny, VV; Sapp, MM; Bernstein, S; Bolt, A; DeCoursey, TE; Place, AR; Smith, SME				Rodriguez, Juan D.; Haq, Saddef; Bachvaroff, Tsvetan; Nowak, Kristine F.; Nowak, Scott J.; Morgan, Deri; Cherny, Vladimir V.; Sapp, Maredith M.; Bernstein, Steven; Bolt, Andrew; DeCoursey, Thomas E.; Place, Allen R.; Smith, Susan M. E.			Identification of a vacuolar proton channel that triggers the bioluminescent flash in dinoflagellates	PLOS ONE			English	Article							HYDROGEN-ION CURRENTS; ALVEOLAR EPITHELIAL-CELLS; GATED H+ CURRENTS; BINDING PROTEIN; NADPH OXIDASE; VOLTAGE; PH; GONYAULAX; NOCTILUCA; SCINTILLONS	In 1972, J. Woodland Hastings and colleagues predicted the existence of a proton selective channel (H(v)1) that opens in response to depolarizing voltage across the vacuole membrane of bioluminescent dinoflagellates and conducts protons into specialized luminescence compartments (scintillons), thereby causing a pH drop that triggers light emission. H(v)1 channels were subsequently identified and demonstrated to have important functions in a multitude of eukaryotic cells. Here we report a predicted protein from Lingulodinium polyedrum that displays hallmark properties of bona fide H(v)1, including time-dependent opening with depolarization, perfect proton selectivity, and characteristic Delta pH dependent gating. Western blotting and fluorescence confocal microscopy of isolated L. polyedrum scintillons immunostained with antibody to LpH(v)1 confirm LpHvi's predicted organellar location. Proteomics analysis demonstrates that isolated scintillon preparations contain peptides that map to LpH(v)1. Finally, Zn2+ inhibits both LpH(v)1 proton current and the acid-induced flash in isolated scintillons. These results implicate LpH(v)1 as the voltage gated proton channel that triggers bioluminescence in L. polyedrum, confirming Hastings' hypothesis. The same channel likely mediates the action potential that communicates the signal along the tonoplast to the scintillon.	[Rodriguez, Juan D.; Nowak, Kristine F.; Nowak, Scott J.; Sapp, Maredith M.; Bernstein, Steven; Bolt, Andrew; Smith, Susan M. E.] Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA 30144 USA; [Haq, Saddef; Bachvaroff, Tsvetan; Place, Allen R.] Univ Maryland, Ctr Environm Sci, Inst Marine & Environm Technol, Baltimore, MD 21201 USA; [Morgan, Deri; Cherny, Vladimir V.; DeCoursey, Thomas E.] Rush Univ, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA	University System of Georgia; Kennesaw State University; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; Rush University	Smith, SME (corresponding author), Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA 30144 USA.	susan.m.e.smith@kennesaw.edu	Nowak, Scott J/H-2974-2012; Place, Allen R/F-9267-2013; Nowak, Kristine F/A-8300-2013; DeCoursey, Thomas/A-6820-2009	Nowak, Scott J/0000-0001-8548-8356; DeCoursey, Thomas/0000-0002-4263-180X; Nowak, Kristine/0000-0001-7782-7813	NIH [GM102336, GM102826]; NSF [MCB-1242985, DBI-1229237]; Kennesaw State University Office of the Vice President for Research; a Birla Carbon Scholarship; OHH NIH [R01ES021949-01/NSFOCE1313888, NOAA-NOS-NCCOS-2012-2002987]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM102826, R01GM102336] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1242985] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Kennesaw State University Office of the Vice President for Research; a Birla Carbon Scholarship; OHH NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NIH grant GM102336 (https://grants.nih.gov/funding/index.htm) to TED and SMES, NSF grant MCB-1242985 (http://www.nsf.gov./funding/)to TED and SMES; a grant from the Kennesaw State University Office of the Vice President for Research (https://www.kennesaw.edu/research/ovprgrants.html) to SMES; a Birla Carbon Scholarship (http://csm.kennesaw.edu/research/birla-carbon-scholars.php) to MS; NIH grant GM102826 (https://grants.nih.gov/funding/index.htm) and NSF grant DBI-1229237 (http://www.nsf.gov/funding/) to SJN; and was funded in part by grants from OHH NIH R01ES021949-01/NSFOCE1313888 (https://grants.nih.gov/funding/index.htm) and NOAA-NOS-NCCOS-2012-2002987 (https://coastalscience.noaa.gov/funding) to ARP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvaroff TR, 2014, MOL PHYLOGENET EVOL, V70, P314, DOI 10.1016/j.ympev.2013.10.007; BARISH ME, 1984, J PHYSIOL-LONDON, V352, P243, DOI 10.1113/jphysiol.1984.sp015289; Beauchemin M, 2012, P NATL ACAD SCI USA, V109, P15793, DOI 10.1073/pnas.1206683109; Bezanilla F., 2014, PNAS, V111, P1950, DOI DOI 10.1073/PNAS; Brunelle SA, 2007, J PHYCOL, V43, P509, DOI 10.1111/j.1529-8817.2007.00339.x; BYERLY L, 1984, J PHYSIOL-LONDON, V351, P199, DOI 10.1113/jphysiol.1984.sp015241; Chaves G, 2016, FEBS J, V283, P1453, DOI 10.1111/febs.13680; Chen AK, 2007, AM J PHYSIOL-REG I, V292, pR2020, DOI 10.1152/ajpregu.00649.2006; Cherny VV, 2015, J GEN PHYSIOL, V146, P343, DOI 10.1085/jgp.201511456; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; Cherny VV, 2003, J GEN PHYSIOL, V121, P615, DOI 10.1085/jgp.200308813; Cherny VV, 2001, BIOL MEMBRANY, V18, P458; CHERNY VV, 1995, J GEN PHYSIOL, V105, P861, DOI 10.1085/jgp.105.6.861; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DECOURSEY TE, 1991, BIOPHYS J, V60, P1243, DOI 10.1016/S0006-3495(91)82158-0; DECOURSEY TE, 1993, BIOPHYS J, V65, P1590, DOI 10.1016/S0006-3495(93)81198-6; DeCoursey TE, 2001, J PHYSIOL-LONDON, V535, P767, DOI 10.1111/j.1469-7793.2001.00767.x; DeCoursey TE, 1998, J GEN PHYSIOL, V112, P503, DOI 10.1085/jgp.112.4.503; DeCoursey TE, 1996, J MEMBRANE BIOL, V152, P131, DOI 10.1007/s002329900092; DeCoursey TE, 2016, J GEN PHYSIOL, V148, P97, DOI 10.1085/jgp.201611619; DeCoursey TE, 2015, P NATL ACAD SCI USA, V112, P13430, DOI 10.1073/pnas.1518486112; DeCoursey TE, 2013, PHYSIOL REV, V93, P599, DOI 10.1152/physrev.00011.2012; DESJARDINS M, 1993, BIOCHEM CELL BIOL, V71, P176, DOI 10.1139/o93-028; Dudev T, 2015, SCI REP, V5; DUNLAP JC, 1981, BIOCHEMISTRY-US, V20, P983, DOI 10.1021/bi00507a052; ECKERT R, 1967, J GEN PHYSIOL, V50, P1429, DOI 10.1085/jgp.50.5.1429; ECKERT R, 1968, J GEN PHYSIOL, V52, P258, DOI 10.1085/jgp.52.2.258; FOGEL M, 1971, ARCH BIOCHEM BIOPHYS, V142, P310, DOI 10.1016/0003-9861(71)90289-X; FOGEL M, 1972, J CELL SCI, V11, P305; FOGEL M, 1972, P NATL ACAD SCI USA, V69, P690, DOI 10.1073/pnas.69.3.690; FRITZ L, 1990, J CELL SCI, V95, P321; Fujiwara Y, 2014, J GEN PHYSIOL, V143, P377, DOI 10.1085/jgp.201311082; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; HAMMAN JP, 1972, J CELL PHYSIOL, V80, P397, DOI 10.1002/jcp.1040800310; HASTINGS JW, 1986, METHOD ENZYMOL, V133, P307; Jin K, 2013, J PHYCOL, V49, P733, DOI 10.1111/jpy.12084; JOHNSON CH, 1985, J CELL BIOL, V100, P1435, DOI 10.1083/jcb.100.5.1435; KAPUS A, 1993, J GEN PHYSIOL, V102, P729, DOI 10.1085/jgp.102.4.729; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; KRAUSE RM, 1993, NEUROMUSCULAR DISORD, V3, P407, DOI 10.1016/0960-8966(93)90086-Y; KRIEGER N, 1968, SCIENCE, V161, P586, DOI 10.1126/science.161.3841.586; Kulleperuma K, 2013, J GEN PHYSIOL, V141, P445, DOI 10.1085/jgp.201210856; Latz MI, 1999, LIMNOL OCEANOGR, V44, P1423, DOI 10.4319/lo.1999.44.6.1423; LATZ MI, 1994, LIMNOL OCEANOGR, V39, P1424, DOI 10.4319/lo.1994.39.6.1424; Latz MI, 2008, J EXP BIOL, V211, P2865, DOI 10.1242/jeb.011890; LECUYER B, 1979, ARCH BIOCHEM BIOPHYS, V196, P371, DOI 10.1016/0003-9861(79)90288-1; Lee S-Y, 2010, J MOL BIOL, V387, P1055; Li Q, 2014, NAT STRUCT MOL BIOL; Li QF, 2015, P NATL ACAD SCI USA, V112, pE5926, DOI 10.1073/pnas.1515043112; Liu YC, 2010, BIOINFORMATICS, V26, P1958, DOI 10.1093/bioinformatics/btq338; MAHAUTSMITH MP, 1989, J EXP BIOL, V145, P455; Morgan D, 2005, J PHYSIOL-LONDON, V569, P419, DOI 10.1113/jphysiol.2005.094748; MORSE D, 1989, J BIOL CHEM, V264, P11822; Musset B, 2011, NATURE, V480, P273, DOI 10.1038/nature10557; NAWATA T, 1976, PLANT CELL PHYSIOL, V17, P265; NAWATA T, 1979, J COMP PHYSIOL, V134, P137, DOI 10.1007/BF00610472; NICOLAS MT, 1987, J CELL BIOL, V105, P723, DOI 10.1083/jcb.105.2.723; NICOLAS MT, 1987, J CELL SCI, V87, P189; OAMI K, 1995, J COMP PHYSIOL A, V176, P625, DOI 10.1007/BF01021582; Orr RJS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050004; Pozdnyakov I A, 2015, Tsitologiia, V57, P533; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; SCHMITTER RE, 1976, J CELL PHYSIOL, V87, P123, DOI 10.1002/jcp.1040870115; Smith SME, 2013, PROG MOL BIOL TRANSL, V117, P335, DOI 10.1016/B978-0-12-386931-9.00012-X; Smith SME, 2011, P NATL ACAD SCI USA, V108, P18162, DOI 10.1073/pnas.1115405108; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Taylor AR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001085; Tesson B, 2015, BIOPHYS J, V108, P1341, DOI 10.1016/j.bpj.2015.02.009; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Topalov G, 2001, ANGEW CHEM INT EDIT, V40, P3892, DOI 10.1002/1521-3773(20011015)40:20<3892::AID-ANIE3892>3.0.CO;2-H; Villalba-Galea CA, 2014, BIOPHYS J, V107, P1564, DOI 10.1016/j.bpj.2014.08.017; von Dassow P, 2002, J EXP BIOL, V205, P2971	76	22	23	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171594	10.1371/journal.pone.0171594	http://dx.doi.org/10.1371/journal.pone.0171594			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178296	gold, Green Published			2022-12-26	WOS:000393712500052
J	Saha, D; Koli, S; Patgaonkar, M; Reddy, KVR				Saha, Debarchana; Koli, Swanand; Patgaonkar, Mandar; Reddy, Kudumula Venkata Rami			Expression of hemoglobin-alpha and beta subunits in human vaginal epithelial cells and their functional significance	PLOS ONE			English	Article							FEMALE GENITAL-TRACT; INNATE; GLOBIN; DIFFERENTIATION; TRANSCRIPTION; SECRETION; EVOLUTION; PEPTIDES; PATTERNS; IMMUNITY	Hemoglobin (Hb) is a major protein involved in transport of oxygen (O-2). It consists of Hb-alpha and Hb-beta subunits, which are normally expressed by cells of erythroid lineage. However, till recently, it was not known whether non-erythroid cells like vaginal cells synthesize Hb and whether it has any functional significance. Therefore, we designed the following objectives: (1) to establish in-vitro culture system of human primary vaginal epithelial cells (hPVECs), (2) to determine whether Hb-alpha and Hb-beta proteins are truly synthesized by hPVECs, (3) to evaluate the effect of LPS (lipopolysaccharide) on the expression of Hb-alpha and Hb-beta proteins (4) to decipher the significance of the Hb-alpha and Hb-beta expression in hPVECs and (5) to determine the molecular mechanism regulating the expression of Hb-alpha in hPVECs. To accomplish these studies, we applied a battery of assays such as RT-PCR, qRT-PCR, Flow cytometry, western blot, and immunofluorescence, Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP). The results revealed the expression of Hb-alpha and Hb-beta at both mRNA and protein level in hPVECs. The expression was significantly upregulated following LPS treatment (10 mu g/m1 for 6 hrs) and these results are comparable with the expression induced by LPS in human vaginal epithelial cell line (VK2/E6E7). These cells constitutively produced low levels of pro-inflammatory (IL-6) and anti-inflammatory (IL-10) cytokines. Also, the response of phosphorylated (p65)-NF-kappa B to LPS was upregulated with increased expression of IL-6, Toll-like receptor-4 (TLR4) and human beta defensin-1 (hBD-1) in hPVECs and VK2/E6E7 cells. However, Bay 11-7082 treatment (5 mu M for 24 hrs) could neutralize the effect of LPS-induced p65-NF-kappa B activity and represses the production'of Hb-alpha and Hb-beta. The results of EMSA revealed the presence of putative binding sites of NF-kappa B in the human Hb-alpha promoter region (nt-115 to-106). ChIP analysis confirmed the binding of NF-kappa B to Hb-alpha promoter. In conclusion, the present findings revealed for the first time that hPVECs synthesized Hb-alpha and Hb-beta and the expression is comparable with the expression of VK2/E6E7 cells. The identification of NF-KB regulatory sequences in Hb-alpha promoter, whose activation is associated with immune response of hPVECs, indicating Hb-alpha and Hb-beta may act as an endogenous antimicrobial defense protein against vaginal inflammation/infections.	[Saha, Debarchana; Koli, Swanand; Patgaonkar, Mandar; Reddy, Kudumula Venkata Rami] NIRRH, Div Mol Immunol & Microbiol MIM, Mumbai, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH)	Reddy, KVR (corresponding author), NIRRH, Div Mol Immunol & Microbiol MIM, Mumbai, Maharashtra, India.	reddyk@nirrh.res.in		KOLI, SWANAND/0000-0002-4742-4439	NIRRH [NIRRH/MS/417/2016]; University Grant Commission (UGC), New Delhi	NIRRH; University Grant Commission (UGC), New Delhi(University Grants Commission, India)	The authors acknowledge NIRRH for providing necessary support (NIRRH/MS/417/2016). DS is grateful to the University Grant Commission (UGC), New Delhi for providing Senior Research Fellowship. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranha CC, 2008, CYTOKINE, V43, P63, DOI 10.1016/j.cyto.2008.04.005; Baron MH, 1997, BBA-GENE STRUCT EXPR, V1351, P51, DOI 10.1016/S0167-4781(96)00195-9; Bashir T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124839; Bhaskaran M, 2005, BIOCHEM BIOPH RES CO, V333, P1348, DOI 10.1016/j.bbrc.2005.06.042; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Carter AM, 2012, PHYSIOL REV, V92, P1543, DOI 10.1152/physrev.00040.2011; Chou SF, 2003, EUR J BIOCHEM, V270, P1855, DOI 10.1046/j.1432-1033.2003.03551.x; Cole AM, 2006, CURR TOP MICROBIOL, V306, P199; Dassen H, 2008, HUM REPROD, V23, P635, DOI 10.1093/humrep/dem430; Deng LX, 2009, HUM REPROD, V24, P211, DOI 10.1093/humrep/den318; Du RJ, 2010, EMBO J, V29, P632, DOI 10.1038/emboj.2009.380; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Grek CL, 2011, AM J RESP CELL MOL, V44, P439, DOI 10.1165/rcmb.2009-0307OC; Haase VH, 2008, J AM SOC NEPHROL, V19, P1440, DOI 10.1681/ASN.2008060594; Hardison R, 1998, J EXP BIOL, V201, P1099; Ishikawa N, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-123; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; Li XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054342; Liu LM, 1999, P NATL ACAD SCI USA, V96, P6643, DOI 10.1073/pnas.96.12.6643; Liu WS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024363, 10.1371/journal.pone.0024406]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mak P, 2004, PEPTIDES, V25, P1839, DOI 10.1016/j.peptides.2004.06.015; Mak P, 2008, FRONT BIOSCI-LANDMRK, V13, P6859, DOI 10.2741/3194; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; PASSOW H, 1986, REV PHYSIOL BIOCH P, V103, P61; Patgaonkar MS, 2011, CLIN VACCINE IMMUNOL, V18, P1632, DOI 10.1128/CVI.00411-10; Quayle AJ, 2002, J REPROD IMMUNOL, V57, P61, DOI 10.1016/S0165-0378(02)00019-0; Rifkind JM, 2013, ANTIOXID REDOX SIGN, V18, P2274, DOI 10.1089/ars.2012.4867; Saha D, 2014, INT J INFLAMM, V2014, DOI 10.1155/2014/803237; Sathe A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083882; Sathe A, 2014, AM J REPROD IMMUNOL, V71, P137, DOI 10.1111/aji.12165; Schulte W, 2012, MEDIAT INFLAMM; Setton-Avruj CP, 2007, EXP NEUROL, V203, P568, DOI 10.1016/j.expneurol.2006.09.024; Taylor BN, 2000, MED MYCOL, V38, P419, DOI 10.1080/714030969; Tezel TH, 2009, INVEST OPHTH VIS SCI, V50, P1911, DOI 10.1167/iovs.07-1372; Tommila M, 2011, J MOL CELL BIOL, V3, P190, DOI 10.1093/jmcb/mjq036; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wicherek L, 2007, EUR J OBSTET GYN R B, V131, P97, DOI 10.1016/j.ejogrb.2006.03.012; Wira CR, 2011, MUCOSAL IMMUNOL, V4, P335, DOI 10.1038/mi.2010.72; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wride MA, 2003, MOL VIS, V9, P360	44	9	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171084	10.1371/journal.pone.0171084	http://dx.doi.org/10.1371/journal.pone.0171084			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178273	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500022
J	Geng, PY; Zhang, Y; Liu, XQ; Zhang, N; Liu, YQ; Liu, X; Lin, C; Yan, X; Li, ZW; Wang, GN; Li, YX; Tan, J; Liu, DX; Huang, BQ; Lu, J				Geng, Pengyu; Zhang, Yu; Liu, Xiaoqing; Zhang, Na; Liu, Yingqi; Liu, Xin; Lin, Cong; Yan, Xu; Li, Zhongwei; Wang, Guannan; Li, Yuxin; Tan, Jiang; Liu, Dong-Xu; Huang, Baiqu; Lu, Jun			Automethylation of protein arginine methyltransferase 7 and its impact on breast cancer progression	FASEB JOURNAL			English	Article						migration; invasion; E-cadherin; YY1	TO-MESENCHYMAL TRANSITION; MASS-SPECTROMETRY; METHYLATION; PRMT7; TRANSCRIPTION; METASTASIS; EXPRESSION; YY1; CONTRIBUTES; SPECIFICITY	Protein arginine methyltransferases (PRMTs) catalyze protein arginine methylation and are linked to carcinogenesis and metastasis. Some members of PRMTs have been found to undergo automethylation; however, the biologic significance of this self-modification is not entirely clear. In this report, we demonstrate that R531 of PRMT7 is self-methylated, both in vitro and in vivo. Automethylation of PRMT7 plays a key role in inducing the epithelial-mesenchymal transition (EMT) program and in promoting the migratory and invasive behavior of breast cancer cells. We also prove in a nude mouse model that expression of wild-type PRMT7 in MCF7 breast cancer cells promotes metastasis in vivo, in contrast to the PRMT7 R531K mutant (a mimic of the unmethylated status). Moreover, our immunohistochemical data unravel a close link between PRMT7 automethylation and the clinical outcome of breast carcinomas. Mechanistically, we determine that loss of PRMT7 automethylation leads to the reduction of its recruitment to the E-cadherin promoter by YY1, which consequently derepresses the E-cadherin expression through decreasing the H4R3me2s level. The findings in this work define a novel post-translational modification of PRMT7 that has a promoting impacton breast cancer metastasis.	[Geng, Pengyu; Zhang, Yu; Zhang, Na; Liu, Xin; Tan, Jiang; Lu, Jun] Northeast Normal Univ, Inst Genet & Cytol, 5268 Renmin St, Changchun 130024, Peoples R China; [Liu, Xiaoqing; Liu, Yingqi; Lin, Cong; Li, Zhongwei; Huang, Baiqu] Northeast Normal Univ, Key Lab Mol Epigenet, Minist Educ, Changchun, Peoples R China; [Wang, Guannan; Li, Yuxin] Northeast Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China; [Yan, Xu] Jilin Univ, Hosp 1, Pathol Diagnost Ctr, Changchun, Peoples R China; [Liu, Dong-Xu] Auckland Univ Technol, Sch Sci, Fac Hlth & Environm Sci, Auckland, New Zealand	Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China; Jilin University; Auckland University of Technology	Lu, J (corresponding author), Northeast Normal Univ, Inst Genet & Cytol, 5268 Renmin St, Changchun 130024, Peoples R China.; Huang, BQ (corresponding author), Normal Univ, Key Lab Mol Epigenet, Minist Educ, Beijing, Peoples R China.	huangbq705@nenu.edu.cn; luj809@nenu.edu.cn	li, Yu/HCI-9086-2022; Li, yu/HHZ-5236-2022; Li, yuxin/GSD-1668-2022; li, yu/HGL-9518-2022	Li, Zhongwei/0000-0003-1014-4238	Natural Science Foundation of China [31570718, 31571317, 31571478, 31401105, 31371294]; Jilin Scientific and Technological Development Program [20140520003JH]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Scientific and Technological Development Program	The authors thank Dr. Graydon B. Gonsalvez (Case Western Reserve University, Cleveland, OH, USA) for providing the plasmids. This work was supported in part by Natural Science Foundation of China Grants 31570718, 31571317, 31571478, 31401105, and 31371294; and Jilin Scientific and Technological Development Program Grant 20140520003JH. The authors declare no conflicts of interest.	Baldwin RM, 2015, ONCOTARGET, V6, P3013, DOI 10.18632/oncotarget.3072; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Blanc RS, 2016, CELL REP, V14, P1528, DOI 10.1016/j.celrep.2016.01.022; Blanchet F, 2005, J EXP MED, V202, P371, DOI 10.1084/jem.20050176; Boisvert Francois-Michel, 2005, Sci STKE, V2005, pre2, DOI 10.1126/stke.2712005re2; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Debler EW, 2016, P NATL ACAD SCI USA, V113, P2068, DOI 10.1073/pnas.1525783113; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; Dillon MBC, 2013, J BIOL CHEM, V288, P27872, DOI 10.1074/jbc.M113.491092; Fang Y., 2014, COMPLEXITY, V2014, P1, DOI DOI 10.1016/J.CELREP.2014.03.032; Feng Y, 2013, J BIOL CHEM, V288, P37010, DOI 10.1074/jbc.M113.525345; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Hasegawa M, 2014, FEBS LETT, V588, P1942, DOI 10.1016/j.febslet.2014.03.053; Hou P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.249; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Karkhanis V, 2012, J BIOL CHEM, V287, P29801, DOI 10.1074/jbc.M112.378281; Kuhn P, 2011, NUCLEIC ACIDS RES, V39, P2717, DOI 10.1093/nar/gkq1246; Kuhn P, 2009, PROTEIN SCI, V18, P1272, DOI 10.1002/pro.139; Lee SH, 2016, NUCLEIC ACIDS RES, V44, P10603, DOI 10.1093/nar/gkw788; Liu X, 2016, BBA-MOL CELL RES, V1863, P2093, DOI 10.1016/j.bbamcr.2016.05.009; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; Niu LF, 2012, PROTEIN CELL, V3, P450, DOI 10.1007/s13238-012-2935-3; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; Shi JM, 2015, CURR CANCER DRUG TAR, V15, P145, DOI 10.2174/1568009615666150131124200; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Singhroy DN, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-73; Trask MC, 2012, DEV BIOL, V368, P273, DOI 10.1016/j.ydbio.2012.05.031; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X; Yao RS, 2014, CANCER RES, V74, P5656, DOI 10.1158/0008-5472.CAN-14-0800; Ying ZZ, 2015, J IMMUNOL, V195, P1538, DOI 10.4049/jimmunol.1500224; Zhang JC, 2012, CANCER RES, V72, P4597, DOI 10.1158/0008-5472.CAN-12-1045; Zhang WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21718; Zhao L, 2015, CELL DEATH DIFFER, V22, P1630, DOI 10.1038/cdd.2015.6; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	41	35	36	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2287	2300		10.1096/fj.201601196R	http://dx.doi.org/10.1096/fj.201601196R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28188177				2022-12-26	WOS:000401553400007
J	Gaviglio, AL; Knelson, EH; Blobe, GC				Gaviglio, Angela L.; Knelson, Erik H.; Blobe, Gerard C.			Heparin-binding epidermal growth factor-like growth factor promotes neuroblastoma differentiation	FASEB JOURNAL			English	Article						HBEGF; heparan sulfate; cancer; signaling; stroma	GENE-EXPRESSION; NEURONAL DIFFERENTIATION; NEUROTROPHIC FACTOR; SCHWANNIAN STROMA; MICROARRAY DATA; RETINOIC ACID; AURORA KINASE; IN-VITRO; RNA-SEQ; HB-EGF	High-risk neuroblastoma is characterized by undifferentiated neuroblasts and low schwannian stroma content. The tumor stroma contributes to the suppression of tumor growth by releasing soluble factors that promote neuroblast differentiation. Here we identify heparin-binding epidermal growth factor-like growth factor (HBEGF) as a potent prodifferentiating factor in neuroblastoma. HBEGF mRNA expression is decreased in human neuroblastoma tumors compared with benign tumors, with loss correlating with decreased survival. HBEGF protein is expressed only in stromal compartments of human neuroblastoma specimens, with tissue from high-stage disease containing very little stroma orHBEGF expression. In 3 human neuroblastoma cell lines (SK-N-AS, SK-N-BE2, and SH-SY5Y), soluble HBEGF is sufficient to promote neuroblast differentiation and decrease proliferation. Heparan sulfate proteoglycans and heparin derivatives further enhance HBEGF-induced differentiation by forming a complex with the epidermal growth factor receptor, leading to activation of the ERK1/2 and STAT3 pathways and up-regulation of the inhibitor of DNA binding transcription factor. These data support a role for loss of HBEGF in the neuroblastoma tumor microenvironment in neuroblastoma pathogenesis.-Gaviglio, A. L., Knelson, E. H., Blobe, G. C. Heparin-binding epidermal growth factor-like growth factor promotes neuroblastoma differentiation.	[Gaviglio, Angela L.; Blobe, Gerard C.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Knelson, Erik H.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Harvard University; Brigham & Women's Hospital; Duke University	Blobe, GC (corresponding author), Duke Univ, Med Ctr, Box 91004, Durham, NC 27708 USA.	gerard.blobe@duke.edu	Blobe, Gerard/AAJ-5945-2020	Blobe, Gerard/0000-0002-4274-8901; Knelson, Erik/0000-0003-4087-2017	U.S. National Institutes of Health, National Cancer Institute [F31CA192558]; Alex's Lemonade Stand Foundation Reach and Innovation; NATIONAL CANCER INSTITUTE [F31CA192558] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alex's Lemonade Stand Foundation Reach and Innovation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by U.S. National Institutes of Health, National Cancer Institute Grant F31CA192558 (to A.L.G.), and by a grant from the Alex's Lemonade Stand Foundation Reach and Innovation Grants (to G.C.B.). The authors thank Michael Armstrong (Duke University), the Children's Oncology Group Neuroblastoma Biology Subcommittee, Wendy London, and Evan Plunkett (both from the Children's Oncology Group) for assistance in obtaining patient tissue samples; Jennifer Huang for technical help with the animal experiment; David MacAlpine, Donald McDonnell, Ann Marie Pendergast, and Daniel Wechsler for crucial mentoring throughout this project; Elaine Justice for technical assistance; and Cheryl Alles (all from Duke University) for clerical assistance. The authors declare no conflicts of interest.	Albino D, 2008, CANCER-AM CANCER SOC, V113, P1412, DOI 10.1002/cncr.23720; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; AVIEZER D, 1994, P NATL ACAD SCI USA, V91, P12173, DOI 10.1073/pnas.91.25.12173; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; BROWN TA, 1991, J CELL BIOL, V113, P207, DOI 10.1083/jcb.113.1.207; Celie JWAM, 2012, KIDNEY INT, V81, P651, DOI 10.1038/ki.2011.425; Chu CL, 2005, BIOCHEMISTRY-US, V44, P12203, DOI 10.1021/bi050241p; Ciana P, 2003, J BIOL CHEM, V278, P31737, DOI 10.1074/jbc.M301525200; Cole CL, 2014, J BIOL CHEM, V289, P10488, DOI 10.1074/jbc.M113.534263; COOK PW, 1991, MOL CELL BIOL, V11, P2547, DOI 10.1128/MCB.11.5.2547; David M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097771; Du WL, 2008, AM J PATHOL, V173, P1153, DOI 10.2353/ajpath.2008.070309; Edsjo A, 2007, SEMIN CANCER BIOL, V17, P248, DOI 10.1016/j.semcancer.2006.04.005; Edwards JP, 2009, J IMMUNOL, V182, P1929, DOI 10.4049/jimmunol.0802703; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Evangelopoulos ME, 2009, J NEUROSCI RES, V87, P2138, DOI 10.1002/jnr.22025; Evangelopoulos ME, 2005, ONCOGENE, V24, P3309, DOI 10.1038/sj.onc.1208494; Gershon TR, 2005, NEOPLASIA, V7, P575, DOI 10.1593/neo.04637; Hahn CK, 2008, P NATL ACAD SCI USA, V105, P9751, DOI 10.1073/pnas.0710413105; Hanks BA, 2013, J CLIN INVEST, V123, P3925, DOI 10.1172/JCI65745; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Hienola A, 2006, J CELL BIOL, V174, P569, DOI 10.1083/jcb.200602043; HIGASHIYAMA S, 1993, J CELL BIOL, V122, P933, DOI 10.1083/jcb.122.4.933; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; Ho R, 2005, CANCER RES, V65, P9868, DOI 10.1158/0008-5472.CAN-04-2426; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; Kaneko M, 2006, EXP CELL RES, V312, P2028, DOI 10.1016/j.yexcr.2006.03.005; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Kleeff J, 1998, J CLIN INVEST, V102, P1662, DOI 10.1172/JCI4105; Knelson EH, 2014, J CLIN INVEST, V124, P3016, DOI 10.1172/JCI74270; Knelson EH, 2013, J CLIN INVEST, V123, P4786, DOI 10.1172/JCI69657; Kwiatkowski JL, 1998, CANCER RES, V58, P4602; LELI U, 1992, J NEUROCHEM, V58, P1191, DOI 10.1111/j.1471-4159.1992.tb11328.x; Liu SQ, 2005, CANCER LETT, V228, P125, DOI 10.1016/j.canlet.2005.01.056; LOEB JA, 1995, J CELL BIOL, V130, P127, DOI 10.1083/jcb.130.1.127; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Maris JM, 2010, PEDIATR BLOOD CANCER, V55, P26, DOI 10.1002/pbc.22430; Matsuda K, 2001, CANCER RES, V61, P5562; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Meier T, 1998, J CELL BIOL, V141, P715, DOI 10.1083/jcb.141.3.715; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miyata K, 2014, CANCER MED-US, V3, P1159, DOI 10.1002/cam4.301; Monaghan TK, 2008, J NEUROCHEM, V104, P74, DOI 10.1111/j.1471-4159.2007.05018.x; Mosse YP, 2012, CLIN CANCER RES, V18, P6058, DOI 10.1158/1078-0432.CCR-11-3251; Mullassery D, 2009, ARCH DIS CHILDHOOD-E, V94, P177, DOI 10.1136/adc.2008.143909; Munro SA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6125; Mythreye K, 2013, ONCOGENE, V32, P1416, DOI 10.1038/onc.2012.157; Nam SO, 2015, ANTICANCER RES, V35, P4433; Passiatore G, 2011, J CELL PHYSIOL, V226, P1763, DOI 10.1002/jcp.22505; Qiao JB, 2012, BIOCHEM BIOPH RES CO, V424, P421, DOI 10.1016/j.bbrc.2012.06.125; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Richards KN, 2010, CANCER-AM CANCER SOC, V116, P3233, DOI 10.1002/cncr.25073; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Ross RA, 2003, CANCER LETT, V197, P35, DOI 10.1016/S0304-3835(03)00079-X; Scarpa S, 1996, EXP CELL RES, V229, P147, DOI 10.1006/excr.1996.0352; SHISHIDO Y, 1995, J BIOL CHEM, V270, P29578, DOI 10.1074/jbc.270.49.29578; Su ZQ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0523-y; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Tamura S, 2007, BIOCHEM BIOPH RES CO, V358, P226, DOI 10.1016/j.bbrc.2007.04.124; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Wang XH, 2011, BBA-MOL CELL RES, V1813, P827, DOI 10.1016/j.bbamcr.2011.01.027; Wei JS, 2004, CANCER RES, V64, P6883, DOI 10.1158/0008-5472.CAN-04-0695; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Yan S, 2013, ONCOTARGET, V4, P433, DOI 10.18632/oncotarget.930; Yu HY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6218; Zhou Y, 2010, NEUROSIGNALS, V18, P141, DOI 10.1159/000319823	67	11	11	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1903	1915		10.1096/fj.201600828R	http://dx.doi.org/10.1096/fj.201600828R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28174207	Green Published			2022-12-26	WOS:000399195500013
J	Liu, TQ; Wang, Q; Li, WQ; Mao, FY; Yue, SS; Liu, S; Liu, XN; Xiao, S; Xia, LX				Liu, Tianqi; Wang, Qi; Li, Wenqing; Mao, Feiyu; Yue, Shanshan; Liu, Sun; Liu, Xiaona; Xiao, Shan; Xia, Laixin			Gcn5 determines the fate of Drosophila germline stem cells through degradation of Cyclin A	FASEB JOURNAL			English	Article						gametogenesis; development; cell cycle; ubiquitination	ANAPHASE-PROMOTING COMPLEX; BAG-OF-MARBLES; FEMALE GERMLINE; OVARIAN GERMLINE; DIVISION; NICHE; MAINTENANCE; GENE; TRANSCRIPTION; ACETYLATION	The fluctuating CDK-CYCLIN complex plays a general role in cell-cycle control. Many types of stem cells use unique features of the cell cycle to facilitate asymmetric division. However, the manner in which these features are established remains poorly understood. The cell cycle of Drosophila female germline stem cells (GSCs) is characterized by short G(1) and very long G(2) phases, making it an excellent model for the study of cell cycle control in stem cell fate determination. Using a Drosophila female GSCs model, we found Gcn5, the first discovered histone acetyltransferase, to maintain germline stem cells in Drosophila ovaries. Results showed that Gcn5 is dispensable for the transcriptional silencing of bam, but interacts with Cyclin A to facilitate proper turnover in GSCs. Results also showed that Gcn5 promotes Cyclin A ubiquitination, which is dependent on its acetylating activity. Finally, results showed that knockdown of Cyclin A rescued the GSC-loss phenotype caused by lack of Gcn5. Collectively, these findings support the conclusion that Gcn5 acts through acetylation to facilitate Cyclin A ubiquitination and proper turnover, thereby determining the fate of GSCs.-Liu, T., Wang, Q., Li, W., Mao, F., Yue, S., Liu, S., Liu, X., Xiao, S., Xia, L. Gcn5 determines the fate of Drosophila germline stem cells through degradation of Cyclin A.	[Liu, Tianqi; Wang, Qi; Li, Wenqing; Mao, Feiyu; Yue, Shanshan] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [Liu, Tianqi; Liu, Sun; Liu, Xiaona; Xiao, Shan; Xia, Laixin] Southern Med Univ, Sch Basic Med Sci, Dept Dev Biol, 1023 Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Southern Medical University - China	Xiao, S; Xia, LX (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Dev Biol, 1023 Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.	asdfg@smu.edu.cn; xialx@smu.edu.cn		Xia, Laixin/0000-0003-2735-9518	National Basic Research Program of China [2014CB943202]; Natural Science Foundation of China [31371494, 31500660, 31571485]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Dr. Dahua Chen (Institute of Zoology, Chinese Academy of Sciences, Beijing, China) for critical reading of the manuscript and for help with its preparation. This work was supported by the National Basic Research Program of China (Grant 2014CB943202 to L. Xia) and the Natural Science Foundation of China (Grants 31371494 to L. X., 31500660 to S. X., and 31571485 to L. X.). The authors declare no conflicts of interest.	Ables ET, 2013, DEVELOPMENT, V140, P530, DOI 10.1242/dev.088583; Ables ET, 2010, CELL STEM CELL, V7, P581, DOI 10.1016/j.stem.2010.10.001; Bu P, 2007, MOL CELL BIOL, V27, P3405, DOI 10.1128/MCB.00066-07; Carre C, 2005, MOL CELL BIOL, V25, P8228, DOI 10.1128/MCB.25.18.8228-8238.2005; Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DS, 2009, DEVELOPMENT, V136, P4133, DOI 10.1242/dev.039032; Cox DN, 2000, DEVELOPMENT, V127, P503; DAWSON IA, 1995, J CELL BIOL, V129, P725, DOI 10.1083/jcb.129.3.725; Forbes A, 1998, DEVELOPMENT, V125, P679; Fox PM, 2011, DEVELOPMENT, V138, P2223, DOI 10.1242/dev.059535; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Guo Z, 2009, DEVELOPMENT, V136, P3627, DOI 10.1242/dev.036939; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Huang HD, 2014, J CELL BIOL, V206, P217, DOI 10.1083/jcb.201401002; Huang SJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001721; Jin ZG, 2007, CURR BIOL, V17, P539, DOI 10.1016/j.cub.2007.01.050; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Kapinas K, 2013, J CELL PHYSIOL, V228, P9, DOI 10.1002/jcp.24104; Kashevsky H, 2002, P NATL ACAD SCI USA, V99, P11217, DOI 10.1073/pnas.172391099; Li Y, 2012, DEVELOPMENT, V139, P1547, DOI 10.1242/dev.077412; Lin HF, 1997, DEVELOPMENT, V124, P2463; Mateo F, 2009, ONCOGENE, V28, P2654, DOI 10.1038/onc.2009.127; Mateo F, 2010, BIOCHEM SOC T, V38, P83, DOI 10.1042/BST0380083; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Orpinell M, 2010, EMBO J, V29, P2381, DOI 10.1038/emboj.2010.125; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Wang HL, 2011, CELL RES, V21, P700, DOI 10.1038/cr.2011.44; Wang Z, 2005, CURR BIOL, V15, P328, DOI 10.1016/j.cub.2005.02.016; Xia LX, 2012, CURR BIOL, V22, P515, DOI 10.1016/j.cub.2012.01.056; Xia LX, 2010, CELL, V143, P978, DOI 10.1016/j.cell.2010.11.022; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; XU T, 1993, DEVELOPMENT, V117, P1223; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang GQ, 2015, CELL, V161, P893, DOI 10.1016/j.cell.2015.04.018	45	19	20	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2185	2194		10.1096/fj.201601217R	http://dx.doi.org/10.1096/fj.201601217R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28188175				2022-12-26	WOS:000399195500036
J	Yang, CC; Zheng, ST; Liu, T; Liu, Q; Dai, F; Zhou, J; Chen, YM; Sheyhidin, I; Lu, XM				Yang, Chenchen; Zheng, Shutao; Liu, Tao; Liu, Qing; Dai, Fang; Zhou, Jian; Chen, Yumei; Sheyhidin, Ilyar; Lu, Xiaomei			Down-regulated miR-26a promotes proliferation, migration, and invasion via negative regulation of MTDH in esophageal squamous cell carcinoma	FASEB JOURNAL			English	Article						ESCC; malignant phenotype; regulatory mechanism	TUMOR-SUPPRESSING FUNCTIONS; CANCER PROGRESSION; METASTASIS; MICRORNA; METADHERIN	Numerous studies have reported that the role played by miR-26a in cancer is controversial, but whether miR-26a regulates metadherin (MTDH) expression in esophageal squamous cell carcinoma (ESCC) is unclear. We performed this study to investigate the clinical relevance of miR-26a expression in ESCC. miR-26a was detected by using the in situ hybridization method. To functionally analyze the role of miR-26a in ESCC cell lines in vitro, KYSE-450 and Eca109 cells were employed, whose endogenous miR-26a was artificially down- or up-regulated, respectively, by using lentiviral-based transfection. There was significant association between miR-26a expression and clinical stage (P = 0.049), lymph node metastasis (P = 0.023), tumor volume (P = 0.003), and poor overall prognosis (P = 0.026). miR-26a was able to suppress proliferation and migration of ESCC cells in vitro Moreover, we have confirmed that miR-26a can negatively regulate MTDH in ESCC cells by using luciferase reporter assay. In addition, to investigate the role miR-26a plays in cell proliferation, we nude mice were xenografted with ESCC cells whose miR-26a was stably down- and up-regulated. Together, our results show that miR-26a is capable of suppressing the proliferation and migration of ESCC cells via negative regulation of MTDH. Moreover, miR-26a expression was clinically relevant in cancer progression and poor prognosis, which supports the idea that miR-26a acts as a tumor suppressor in ESCC.-Yang, C., Zheng, S., Liu, T., Liu, Q., Dai, F., Zhou, J., Chen, Y., Sheyhidin, I., Lu, X. Down-regulated miR-26a promotes proliferation, migration, and invasion via negative regulation of MTDH in esophageal squamous cell carcinoma.	[Yang, Chenchen; Zheng, Shutao; Liu, Tao; Liu, Qing; Dai, Fang; Zhou, Jian; Chen, Yumei; Lu, Xiaomei] Xinjiang Med Univ, Affiliated Hosp 1, Clin Med Res Inst, Urumqi, Peoples R China; [Yang, Chenchen; Zheng, Shutao; Liu, Tao; Liu, Qing; Dai, Fang; Zhou, Jian; Chen, Yumei; Sheyhidin, Ilyar; Lu, Xiaomei] Xinjiang Med Univ, Affiliated Hosp 1, State Key Lab Incubat Base Xinjiang Major Dis Res, Urumqi, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Lu, XM (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, State Key Lab Breeding Base Xinjiang Major Dis Re, Clin Med Res Inst, Urumqi 830054, Xinjiang, Peoples R China.	luxiaomei88@163.com	Zheng, Shutao/GRX-1737-2022	Zheng, Shutao/0000-0002-9000-0148	Natural Science Foundation of China [81160303, 81260359, U1303321]; Major Science and Technology Projects of the Xinjiang Uygur Autonomous Region [201430123-1]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Projects of the Xinjiang Uygur Autonomous Region	This work was supported by grants from the Natural Science Foundation of China (81160303, 81260359, U1303321), and from the Major Science and Technology Projects of the Xinjiang Uygur Autonomous Region (Grant 201430123-1). The authors thank Prof. Qian Zhao (State Key Laboratory for Oncogenes and Related Genes, Shanghai Jiao-Tong University School of Medicine) for plasmid presentation.	Acunzo M, 2015, J INFECT DIS, V212, pS74, DOI 10.1093/infdis/jiv197; Borno ST, 2012, CANCER DISCOV, V2, P1024, DOI 10.1158/2159-8290.CD-12-0041; Chen B, 2015, BIOMED PHARMACOTHER, V75, P1, DOI 10.1016/j.biopha.2015.08.012; Chen J, 2016, TUMOR BIOL, V37, P7095, DOI 10.1007/s13277-016-5017-y; Chen XB, 2015, GYNECOL ONCOL, V139, P513, DOI 10.1016/j.ygyno.2015.10.008; Deng M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072662; Arnal MJD, 2015, WORLD J GASTROENTERO, V21, P7933, DOI 10.3748/wjg.v21.i26.7933; Fukumoto I, 2016, J HUM GENET, V61, P109, DOI 10.1038/jhg.2015.120; Gong C, 2015, ONCOGENE, V34, P84, DOI 10.1038/onc.2013.525; Huang QY, 2016, J THORAC ONCOL, V11, P583, DOI 10.1016/j.jtho.2015.12.109; Lin RK, 2014, BIOMED PHARMACOTHER, V68, P929, DOI 10.1016/j.biopha.2014.10.003; Liu BN, 2012, BBA-MOL BASIS DIS, V1822, P1692, DOI 10.1016/j.bbadis.2012.07.019; Liu P, 2015, CANCER LETT, V357, P384, DOI 10.1016/j.canlet.2014.11.050; Ma J, 2014, ONCOL REP, V32, P2744, DOI 10.3892/or.2014.3517; Mallick R, 2016, DIGEST DIS SCI, V61, P1039, DOI 10.1007/s10620-015-3959-3; Okada N, 2016, SURGERY, V159, P441, DOI 10.1016/j.surg.2015.06.044; Sandhu R, 2014, INT J ONCOL, V44, P563, DOI 10.3892/ijo.2013.2197; Shao Y, 2016, ONCOTARGET, V7, P15173, DOI 10.18632/oncotarget.7908; Shen WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086871; Tang WR, 2015, INT J HYG ENVIR HEAL, V218, P12, DOI 10.1016/j.ijheh.2014.10.004; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang G, 2015, GENET TEST MOL BIOMA, V19, P30, DOI 10.1089/gtmb.2014.0245; Yang CC, 2015, TRANSL RES, V166, P614, DOI 10.1016/j.trsl.2015.05.004; Yu L, 2013, ONCOL LETT, V5, P1223, DOI 10.3892/ol.2013.1173; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhang JQ, 2012, GASTROENTEROLOGY, V143, P246, DOI 10.1053/j.gastro.2012.03.045; Zhao SJ, 2014, TUMOR BIOL, V35, P9725, DOI 10.1007/s13277-014-2206-4; Zhao XX, 2015, INT J CLIN EXP PATHO, V8, P368	28	22	23	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2114	2122		10.1096/fj.201601237	http://dx.doi.org/10.1096/fj.201601237			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28174206				2022-12-26	WOS:000399195500030
J	Jokela, T; Karna, R; Rauhala, L; Bart, G; Pasonen-Seppanen, S; Oikari, S; Tammi, MI; Tammi, RH				Jokela, Tiina; Karna, Riikka; Rauhala, Leena; Bart, Genevieve; Pasonen-Seppanen, Sanna; Oikari, Sanna; Tammi, Markku I.; Tammi, Raija H.			Human Keratinocytes Respond to Extracellular UTP by Induction of Hyaluronan Synthase 2 Expression and Increased Hyaluronan Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT HYALURONAN; ELEMENT-BINDING PROTEIN; PURINERGIC RECEPTORS; EPIDERMAL-KERATINOCYTES; P2Y(14) RECEPTOR; O-GLCNACYLATION; DOWN-REGULATION; CELL-MIGRATION; RETINOIC ACID; ATP	The release of nucleotides into extracellular space is triggered by insults like wounding and ultraviolet radiation, resulting in stimulatory or inhibitory signals via plasma membrane nucleotide receptors. As similar insults are known to activate hyaluronan synthesis we explored the possibility that extracellular UTP or its breakdown products UDP and UMP act as mediators for hyaluronan synthase (HAS) activation in human epidermal keratinocytes. UTP increased hyaluronan both in the pericellular matrix and in the culture medium of HaCaT cells. 10-100 mu M UTP strongly up-regulated HAS2 expression, although the other hyaluronan synthases (HAS1, HAS3) and hyaluronidases (HYAL1, HYAL2) were not affected. The HAS2 response was rapid and transient, with the maximum stimulation at 1.5 h. UDP exerted a similar effect, but higher concentrations were required for the response, and UMP showed no stimulation at all. Specific siRNAs against the UTP receptor P2Y(2),and inhibitors of UDP receptors P2Y(6) and P2Y(14), indicated that the response to UTP was mediated mainly through P2Y(2) and to a lesser extent via UDP receptors. UTP increased the phosphorylation of p38, ERK, CREB, and Ser-727 of STAT3 and induced nuclear translocation of pCaMKII. Inhibitors of PKC, p38, ERK, CaMKII, STAT3, and CREB partially blocked the activation of HAS2 expression, confirming the involvement of these pathways in the UTP-induced HAS2 response. The present data reveal a selective up-regulation of HAS2 expression by extracellular UTP, which is likely to contribute to the previously reported rapid activation of hyaluronan metabolism in response to tissue trauma or ultraviolet radiation.	[Jokela, Tiina; Karna, Riikka; Rauhala, Leena; Bart, Genevieve; Pasonen-Seppanen, Sanna; Oikari, Sanna; Tammi, Markku I.; Tammi, Raija H.] Univ Eastern Finland, Inst Biomed, Kuopio 70211, Finland	University of Eastern Finland	Tammi, RH (corresponding author), Univ Eastern Finland, Inst Biomed, Kuopio 70211, Finland.	tammi@uef.fi	Jokela, Tiina/O-9206-2015; Tammi, Markku/AAQ-7878-2021	Jokela, Tiina/0000-0002-7521-3866; Bart, Genevieve/0000-0001-9809-150X	Sigrid Juselius Foundation; Kuopio University Hospital; University of Eastern Finland/Cancer Center of Eastern Finland; Cancer Foundation of Northern Savo	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Kuopio University Hospital; University of Eastern Finland/Cancer Center of Eastern Finland; Cancer Foundation of Northern Savo	This work was supported by grants from the Sigrid Juselius Foundation (to R. H. T., M. I. T., and S. P. S.), the Special Government Funding of Kuopio University Hospital (to M. I. T.), The Spearhead Funds of the University of Eastern Finland/Cancer Center of Eastern Finland (to M. I. T. and R. H. T.), and the Cancer Foundation of Northern Savo (to L. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Austin JW, 2012, J NEUROCHEM, V122, P344, DOI 10.1111/j.1471-4159.2012.07789.x; Azorin N, 2011, EXP DERMATOL, V20, P401, DOI 10.1111/j.1600-0625.2010.01219.x; Boarder MR, 1998, TRENDS PHARMACOL SCI, V19, P99, DOI 10.1016/S0165-6147(98)01170-5; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brinck J, 1999, EXP CELL RES, V252, P342, DOI 10.1006/excr.1999.4645; Bromberg J, 2001, METHOD ENZYMOL, V333, P138; Burnstock G, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.11; Burnstock G, 2012, BIOESSAYS, V34, P218, DOI 10.1002/bies.201100130; Burrell HE, 2005, J BIOL CHEM, V280, P29667, DOI 10.1074/jbc.M505381200; Burrell HE, 2003, J INVEST DERMATOL, V120, P440, DOI 10.1046/j.1523-1747.2003.12050.x; Cheng SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054125; Deen AJ, 2016, CELL MOL LIFE SCI, V73, P3183, DOI 10.1007/s00018-016-2158-5; Dixon CJ, 1999, BRIT J PHARMACOL, V127, P1680, DOI 10.1038/sj.bjp.0702653; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Falzoni S, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0101; Faure E, 2012, J CELL SCI, V125, P4264, DOI 10.1242/jcs.097600; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; Fricks IP, 2009, J PHARMACOL EXP THER, V330, P162, DOI 10.1124/jpet.109.150730; Gendaszewska-Darmach E, 2011, PURINERG SIGNAL, V7, P193, DOI 10.1007/s11302-011-9233-z; Giltaire S, 2011, J CELL PHYSIOL, V226, P1651, DOI 10.1002/jcp.22496; Glaser T, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-12; Grandoch M, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0340-6; Greig AVH, 2003, J INVEST DERMATOL, V121, P1145, DOI 10.1046/j.1523-1747.2003.12567.x; Grimm I, 2009, J CELL SCI, V122, P2524, DOI 10.1242/jcs.044891; Hiltunen ELJ, 2002, CANCER RES, V62, P6410; Ho CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057666; Holzer AM, 2004, J CUTAN MED SURG, V8, P90, DOI 10.1177/120347540400800203; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Ichiki T, 2006, ARTERIOSCL THROM VAS, V26, P449, DOI 10.1161/01.ATV.0000196747.79349.d1; Inoue K, 2007, J INVEST DERMATOL, V127, P362, DOI 10.1038/sj.jid.5700526; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jiang QS, 1998, J CELL BIOL, V143, P645, DOI 10.1083/jcb.143.3.645; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Jokela TA, 2014, J BIOL CHEM, V289, P18569, DOI 10.1074/jbc.M114.551804; Kaczmarek E, 2005, THROMB HAEMOSTASIS, V93, P735, DOI 10.1160/TH04-09-0576; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; Kobayashi D, 2006, J PHARMACOL SCI, V102, P368, DOI 10.1254/jphs.FP0060669; KOPF GS, 1991, METHOD ENZYMOL, V195, P257; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Lamarca A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098998; Le Goff W, 2006, ARTERIOSCL THROM VAS, V26, P527, DOI 10.1161/01.ATV.0000201042.00725.84; Lee JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122628; Lee-Sayer SSM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00150; Li WH, 2013, BRIT J CANCER, V109, P1666, DOI 10.1038/bjc.2013.484; Li W, 2015, FOR ECOSYST, V2, DOI 10.1186/s40663-015-0046-3; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Maytin EV, 2004, AM J PATHOL, V165, P1331, DOI 10.1016/S0002-9440(10)63391-3; Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201; Monslow J, 2009, J INVEST DERMATOL, V129, P2046, DOI 10.1038/jid.2009.9; Murakami S, 2001, INT IMMUNOL, V13, P1533, DOI 10.1093/intimm/13.12.1533; Nagakura C, 2014, TOXICOLOGY, V322, P61, DOI 10.1016/j.tox.2014.03.010; Oikari S, 2016, GLYCOBIOLOGY, V26, P710, DOI 10.1093/glycob/cww019; Oikari S, 2014, J CHROMATOGR A, V1323, P82, DOI 10.1016/j.chroma.2013.11.004; Oikari S, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P39; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pasonen-Seppanen SM, 2008, J INVEST DERMATOL, V128, P797, DOI 10.1038/sj.jid.5701098; Pastore S, 2007, J INVEST DERMATOL, V127, P660, DOI 10.1038/sj.jid.5700591; Pauloin T, 2009, MOL VIS, V15, P577; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; Pillois X, 2002, CIRC RES, V90, P678, DOI 10.1161/01.RES.0000013700.98464.8E; Qi Qian-Rong, 2014, World J Biol Chem, V5, P231, DOI 10.4331/wjbc.v5.i2.231; Rauhala L, 2013, J BIOL CHEM, V288, P17999, DOI 10.1074/jbc.M113.472530; RCore Team R, 2015, R LANG ENV STAT COMP; Rilla K, 2013, J BIOL CHEM, V288, P5973, DOI 10.1074/jbc.M112.443879; Rooney P, 2015, ACTA BIOMATER, V19, P66, DOI 10.1016/j.actbio.2015.02.030; Ruppert SM, 2014, IMMUNOL RES, V58, P186, DOI 10.1007/s12026-014-8495-2; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Seo M, 2010, BIOCHEM BIOPH RES CO, V393, P190, DOI 10.1016/j.bbrc.2010.01.085; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; Takabe P, 2015, EXP CELL RES, V337, P1, DOI 10.1016/j.yexcr.2015.07.026; Takai E, 2011, RADIAT RES, V175, P358, DOI 10.1667/RR2375.1; Tammi R, 1998, J BIOL CHEM, V273, P28878, DOI 10.1074/jbc.273.44.28878; Tammi R, 2005, J INVEST DERMATOL, V124, P898, DOI 10.1111/j.0022-202X.2005.23697.x; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tsutsumi M, 2009, CELL TISSUE RES, V338, P99, DOI 10.1007/s00441-009-0848-0; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vistejnova L, 2014, CYTOKINE, V70, P97, DOI 10.1016/j.cyto.2014.07.006; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; WANG D, 1990, BIOCHEM BIOPH RES CO, V166, P251, DOI 10.1016/0006-291X(90)91938-O; Wang Y, 2014, J BIOL CHEM, V289, P32253, DOI 10.1074/jbc.M114.578377; Wang ZX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010095; Washburn KB, 2006, NEUROSCIENCE, V142, P411, DOI 10.1016/j.neuroscience.2006.06.034; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Wood MW, 2011, INFECT IMMUN, V79, P708, DOI 10.1128/IAI.01102-10; Ye J, 2012, EYE, V26, P1012, DOI 10.1038/eye.2012.89; Yoshida H, 2006, EUR J PHARMACOL, V540, P1, DOI 10.1016/j.ejphar.2006.04.008; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	98	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4861	4872		10.1074/jbc.M116.760322	http://dx.doi.org/10.1074/jbc.M116.760322			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28188289	Green Published, hybrid			2022-12-26	WOS:000397590400010
J	Lindner, M; Bell, T; Iqbal, S; Mullins, PG; Christakou, A				Lindner, Michael; Bell, Tiffany; Iqbal, Somya; Mullins, Paul Gerald; Christakou, Anastasia			In vivo functional neurochemistry of human cortical cholinergic function during visuospatial attention	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; VISUAL-SPATIAL ATTENTION; SIGNAL INTENSITY; TRANSPORTER CHT; BRAIN-REGIONS; PARIETAL; ACETYLCHOLINE; QUANTITATION; CORTEX; MRS	Cortical acetylcholine is involved in key cognitive processes such as visuospatial attention. Dysfunction in the cholinergic system has been described in a number of neuropsychiatric disorders. Levels of brain acetylcholine can be pharmacologically manipulated, but it is not possible to directly measure it in vivo in humans. However, key parts of its biochemical cascade in neural tissue, such as choline, can be measured using magnetic resonance spectroscopy (MRS). There is evidence that levels of choline may be an indirect but proportional measure of acetylcholine availability in brain tissue. In this study, we measured relative choline levels in the parietal cortex using functional (event-related) MRS (fMRS) during performance of a visuospatial attention task, with a modelling approach verified using simulated data. We describe a task-driven interaction effect on choline concentration, specifically driven by contralateral attention shifts. Our results suggest that choline MRS has the potential to serve as a proxy of brain acetylcholine function in humans.	[Lindner, Michael; Bell, Tiffany; Iqbal, Somya; Christakou, Anastasia] Univ Reading, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England; [Lindner, Michael; Bell, Tiffany; Iqbal, Somya; Christakou, Anastasia] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Mullins, Paul Gerald] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales	University of Reading; University of Reading; Bangor University	Christakou, A (corresponding author), Univ Reading, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England.; Christakou, A (corresponding author), Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England.	anastasia.christakou@reading.ac.uk	Bell, Tiffany/AAB-4896-2019; Christakou, Anastasia/B-7838-2008	Bell, Tiffany/0000-0002-9591-706X; Mullins, Paul/0000-0002-1339-6361; Christakou, Anastasia/0000-0002-4267-3436	Human Frontier Science Program [RGP0048/2012]; Engineering and Physical Sciences Research Council [1374682] Funding Source: researchfish	Human Frontier Science Program(Human Frontier Science Program); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The study was supported by a Human Frontier Science Program (Navw.hfsp.org) grant to AC (RGP0048/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apsvalka D, 2015, NEUROIMAGE; Bauer M, 2012, CURR BIOL, V22, P397, DOI 10.1016/j.cub.2012.01.022; Beane M, 2002, 13 ABSTR VIEWER ITER; Berry AS, 2015, NEUROIMAGE, V108, P386, DOI 10.1016/j.neuroimage.2014.12.036; Bidulescu A, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-14; Black Stefanie A. G., 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P114; Boulanger Y, 2000, BRAIN RES REV, V33, P380, DOI 10.1016/S0165-0173(00)00037-0; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Ennis EA, 2015, ACS CHEM NEUROSCI, V6, P417, DOI 10.1021/cn5001809; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; Gates J, 2004, J PHARMACOL EXP THER, V310, P536, DOI 10.1124/jpet.104.066795; Graveron-Demilly D, 2014, MAGN RESON MATER PHY, V27, P113, DOI 10.1007/s10334-013-0393-4; Gussew A, 2010, NEUROIMAGE, V49, P1895, DOI 10.1016/j.neuroimage.2009.09.007; Harris JL, 2014, NEUROBIOL AGING, V35, P1686, DOI 10.1016/j.neurobiolaging.2014.01.018; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; Henry ME, 2011, J MAGN RESON, V208, P210, DOI 10.1016/j.jmr.2010.11.003; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Holt DJ, 2005, BIOL PSYCHIAT, V58, P408, DOI 10.1016/j.biopsych.2005.04.007; Huang Z, 2015, HUM BRAIN MAPP; Katz-Brull R, 2005, BRAIN RES, V1048, P202, DOI 10.1016/j.brainres.2005.04.080; KLATSKIN G, 1954, J EXP MED, V100, P605, DOI 10.1084/jem.100.6.605; KUHAR MJ, 1978, J NEUROCHEM, V30, P15, DOI 10.1111/j.1471-4159.1978.tb07029.x; Kus L, 2003, J COMP NEUROL, V463, P341, DOI 10.1002/cne.10759; Lally N, 2014, NEUROIMAGE, V85, P823, DOI 10.1016/j.neuroimage.2013.07.049; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Lin Y, 2012, J CEREBR BLOOD F MET, V32, P1484, DOI 10.1038/jcbfm.2012.33; Lockman PR, 2002, DRUG DEV IND PHARM, V28, P749, DOI 10.1081/DDC-120005622; Mangia S, 2006, MAGN RESON IMAGING, V24, P343, DOI 10.1016/j.mri.2005.12.023; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Miller BL, 1996, LIFE SCI, V58, P1929, DOI 10.1016/0024-3205(96)00182-8; Minati L, 2010, J MED PHYS, V35, P154, DOI 10.4103/0971-6203.62128; Mullins PG, 2005, NEUROIMAGE, V26, P642, DOI 10.1016/j.neuroimage.2005.02.001; Mullins PG, 2012, CURRENT PRACTICE USE; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Nelson CL, 2005, NEUROSCIENCE, V132, P347, DOI 10.1016/j.neuroscience.2004.12.007; Nishitani N, 2003, NEUROIMAGE, V20, P561, DOI 10.1016/S1053-8119(03)00280-5; Okuda T, 2011, J NEUROSCI, V31, P14989, DOI 10.1523/JNEUROSCI.2983-11.2011; Osipova D, 2005, NEUROIMAGE, V27, P835, DOI 10.1016/j.neuroimage.2005.05.011; Osipova D, 2003, CLIN NEUROPHYSIOL, V114, P1902, DOI 10.1016/S1388-2457(03)00165-2; Parikh V, 2006, J NEUROCHEM, V97, P488, DOI 10.1111/j.1471-4159.2006.03766.x; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; Pinthong M, 2008, MOL PHARMACOL, V73, P801, DOI 10.1124/mol.107.040881; Posse S, 2007, MAGN RESON MED, V58, P236, DOI 10.1002/mrm.21287; Poullet JB, 2007, NMR BIOMED, V20, P493, DOI 10.1002/nbm.1112; Ross AJ, 2004, BRAIN RES REV, V44, P83, DOI 10.1016/j.brainresrev.2003.11.001; SALTARELLI MD, 1990, J NEUROSCI, V10, P62; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; St Peters M, 2011, J NEUROSCI, V31, P9760, DOI 10.1523/JNEUROSCI.1902-11.2011; Taylor R, 2015, NEUROREPORT, V26, P107, DOI 10.1097/WNR.0000000000000309; VONALLWORDEN HN, 1993, EUR J APPL PHYSIOL O, V67, P87, DOI 10.1007/BF00377711; Wang XC, 2008, NEUROCHEM RES, V33, P814, DOI 10.1007/s11064-007-9509-4; Wauschkuhn B, 1998, J NEUROPHYSIOL, V80, P2900, DOI 10.1152/jn.1998.80.6.2900; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Zhu H, 2011, METHODS MOL BIOL, V711, P203, DOI 10.1007/978-1-61737-992-5_9	57	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171338	10.1371/journal.pone.0171338	http://dx.doi.org/10.1371/journal.pone.0171338			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192451	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000394423800022
J	Dong, W; Farooqui, A; Leon, AJ; Kelvin, DJ				Dong, Wei; Farooqui, Amber; Leon, Alberto J.; Kelvin, David J.			Inhibition of influenza A virus infection by ginsenosides	PLOS ONE			English	Article							RECEPTOR-BINDING; PHASE-II; HEMAGGLUTININ; MICE	Influenza viruses cause mild to severe respiratory infections in humans. Due to efficient means of transmission, the viruses infect human population on a large scale. Apart from vaccines, antiviral drugs are used to control infection; neuraminidase inhibitors are thought to be the first choice of treatment, particularly for severe cases. Rapidly evolving and emerging influenza viruses with increased frequency of viral resistance to these drugs stress the need to explore novel antiviral compounds. In this study, we investigated antiviral activity of ginseng extract and ginsenosides, the ginseng-derived triterpene and saponin compounds, against 2009 pandemic H1 N1 virus in vitro and in vivo. Our data showed that treatment of mice with ginsenosides protected the animals from lethal 2009 pandemic H1N1 infection and lowered viral titers in animal lungs. Mechanistic studies revealed that ginsenosides interact with viral hemagglutinin protein and prevent the attachment of virus with a 2-3' sialic acid receptors present on host cell surfaces. The interference in the viral attachment process subsequently minimizes viral entry into the cells and decreases the severity of the viral infection. We also describe that sugar moieties present in ginsenosides are indispensible for their attachment with viral HA protein. On the basis of our observations, we can say that ginsenosides are promising candidates for the development of antiviral drugs for influenza viruses.	[Dong, Wei; Farooqui, Amber; Leon, Alberto J.; Kelvin, David J.] Univ Hlth Network, Int Inst Infect & Immun, Div Immunol, Shantou, Peoples R China; [Dong, Wei; Farooqui, Amber; Leon, Alberto J.; Kelvin, David J.] Shantou Univ, Coll Med, Shantou, Peoples R China; [Farooqui, Amber; Leon, Alberto J.; Kelvin, David J.] Univ Hlth Network, Div Expt Therapeut, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Farooqui, Amber; Kelvin, David J.] Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Peoples R China; [Kelvin, David J.] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada; [Kelvin, David J.] Univ Toronto, Deptartment Immunol, Fac Med, Toronto, ON, Canada	Shantou University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Kelvin, DJ (corresponding author), Univ Hlth Network, Int Inst Infect & Immun, Div Immunol, Shantou, Peoples R China.; Kelvin, DJ (corresponding author), Shantou Univ, Coll Med, Shantou, Peoples R China.; Kelvin, DJ (corresponding author), Univ Hlth Network, Div Expt Therapeut, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada.; Kelvin, DJ (corresponding author), Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Peoples R China.; Kelvin, DJ (corresponding author), Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada.; Kelvin, DJ (corresponding author), Univ Toronto, Deptartment Immunol, Fac Med, Toronto, ON, Canada.	dkelvin@jidc.org	Ohba, Yusuke/E-7944-2011	Farooqui, Amber/0000-0002-6031-9561	Li Ka Shing Foundation	Li Ka Shing Foundation	This work was financially supported by the Li Ka Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Farooqui A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-104; Farooqui A, 2011, J INFECT DEV COUNTR, V5, P700, DOI 10.3855/jidc.2251; Guan Y, 2013, J INFECT DEV COUNTR, V7, P302, DOI 10.3855/jidc.3675; Hoffmann J, 2014, ANTIVIR RES, V104, P23, DOI 10.1016/j.antiviral.2014.01.015; Kelvin AA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001279; Leung KW, 2009, BRIT J PHARMACOL, V156, P626, DOI 10.1111/j.1476-5381.2008.00066.x; Lu JM, 2009, CURR VASC PHARMACOL, V7, P293, DOI 10.2174/157016109788340767; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Moss RB, 2012, J INFECT DIS, V206, P1844, DOI 10.1093/infdis/jis622; Qi LW, 2010, BIOCHEM PHARMACOL, V80, P947, DOI 10.1016/j.bcp.2010.06.023; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Rowe T, 2010, J GEN VIROL, V91, P2898, DOI 10.1099/vir.0.024323-0; Seida JK, 2011, ECAM, V2011, DOI 10.1542/peds.2007-2186; Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; Vanderlinden E, 2010, J VIROL, V84, P4277, DOI 10.1128/JVI.02325-09; Vohra S, 2008, PEDIATRICS, V122, pE402, DOI 10.1542/peds.2007-2186; Wang MX, 2012, J VIROL, V86, P4455, DOI 10.1128/JVI.07187-11; World Health Organization, 2012, DENG SEV DENG; Yoo DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033678; Zhao HF, 2009, BRAIN RES, V1256, P111, DOI 10.1016/j.brainres.2008.12.031	24	23	24	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171936	10.1371/journal.pone.0171936	http://dx.doi.org/10.1371/journal.pone.0171936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187149	gold, Green Published, Green Submitted			2022-12-26	WOS:000394244300062
J	Pereira, S; Katzmarzyk, PT; Gomes, TN; Souza, M; Chaves, RN; dos Santos, FK; Santos, D; Hedeker, D; Maia, J				Pereira, Sara; Katzmarzyk, Peter Todd; Gomes, Thayse Natacha; Souza, Michele; Chaves, Raquel Nichele; dos Santos, Fernanda Karina; Santos, Daniel; Hedeker, Donald; Maia, Jose			A multilevel analysis of health-related physical fitness. The Portuguese sibling study on growth, fitness, lifestyle and health	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; HEART-DISEASE RISK; FAMILIAL RESEMBLANCE; CARDIORESPIRATORY FITNESS; PRO12ALA POLYMORPHISM; SOCIOECONOMIC-STATUS; SEXUAL-DIMORPHISM; AEROBIC FITNESS; SEDENTARY TIME; SCREEN TIME	This study investigates biological, behavioural and sociodemographic correlates of intrapair similarities, and estimates sibling resemblance in health-related physical fitness (PF). The sample comprises 1101 biological siblings (525 females) aged 9-20 years. PF components and markers were: morphological [waist circumference (WC) and %body fat (%BF)], muscular [handgrip strength (GS) and standing long jump (SLJ)], motor [50-yard dash (50YD) and shuttle run (SR)], and cardiorespiratory (1-mile run). Biological maturation was assessed; physical activity (PA), TV viewing and socioeconomic status (SES) information was obtained. On average, older and more mature subjects are better performers in all PF components; PA was negatively associated with SR, while SES was negatively associated with SLJ and SR. A pattern was observed in the intraclass correlations (rho) wherein same sex siblings demonstrate greater resemblance for most PF components (sister-sister: 0.35 <= p <= 0.55; brother-brother: (0.25 <=rho <= 0.60) than brother-sister pairs (BS) (0<rho<0.15), except for %BF (rho BB>rho SS>rho BS), and the 1-mile run (pSS>pBS>pBB). In conclusion, behavioural and sociodemographic correlates play different roles in siblings PF expression. Further, a significant familial PF resemblance was observed with different trends in different sibling types, probably due to variations in shared genetic factors and sociodemographic conditions.	[Pereira, Sara; Gomes, Thayse Natacha; Souza, Michele; Chaves, Raquel Nichele; dos Santos, Fernanda Karina; Santos, Daniel; Maia, Jose] Univ Porto, CIFI2D, Fac Sport, Porto, Portugal; [Katzmarzyk, Peter Todd] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA; [Souza, Michele] Univ Fed Santa Catarina, Dept Phys Educ, Florianopolis, SC, Brazil; [Chaves, Raquel Nichele] Fed Univ Technol Parana UTFPR, Campus Curitiba, Curitiba, Parana, Brazil; [dos Santos, Fernanda Karina] Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil; [Hedeker, Donald] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA	Universidade do Porto; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Universidade Federal de Santa Catarina (UFSC); Universidade Tecnologica Federal do Parana; Universidade Federal de Vicosa; University of Chicago	Maia, J (corresponding author), Univ Porto, CIFI2D, Fac Sport, Porto, Portugal.	jmaia@fade.up.pt	Hedeker, Donald/R-7055-2019; Gomes, Thayse Natacha Queiroz Ferreira/AAL-5002-2020; Pereira, Sara/V-1516-2019; Katzmarzyk, Peter T/N-1974-2017; de Souza Ribas, Michele/AAG-5110-2021	Pereira, Sara/0000-0002-4661-3879; Katzmarzyk, Peter T/0000-0002-9280-6022; Queiroz Ferreira Gomes, Thayse Natacha/0000-0003-4991-1238				Antunes AM, 2015, AM J HUM BIOL, V27, P681, DOI 10.1002/ajhb.22715; Ara I, 2004, INT J OBESITY, V28, P1585, DOI 10.1038/sj.ijo.0802754; Arango CM, 2014, J SCI MED SPORT, V17, P491, DOI 10.1016/j.jsams.2013.09.010; Asmussen E, 1973, PHYSICAL ACTIVITY HU, P60; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bai Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148038; Bohr AD, 2013, J SCHOOL HEALTH, V83, P542, DOI 10.1111/josh.12063; Boreham C, 2001, MED SCI SPORT EXER, V33, P270; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179; Chan JPL, 2015, AGE, V37, DOI 10.1007/s11357-015-9745-5; de Chaves RN, 2014, ANN HUM BIOL, V41, P157, DOI 10.3109/03014460.2013.838303; Dencker M, 2006, EUR J APPL PHYSIOL, V96, P587, DOI 10.1007/s00421-005-0117-1; Ekelund U, 2001, EUR J APPL PHYSIOL, V85, P195, DOI 10.1007/s004210100460; Erikssen G, 2001, SPORTS MED, V31, P571, DOI 10.2165/00007256-200131080-00001; Falconer D. S., 1996, Introduction to quantitative genetics.; Ferreira J, 2002, PHYS FITNESS PHYS AC; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Fornage M, 2005, METABOLISM, V54, P910, DOI 10.1016/j.metabol.2005.02.005; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Greca João Paulo de Aguiar, 2016, Rev. paul. pediatr., V34, P316, DOI [10.1016/j.rppede.2016.01.001, 10.1016/j.rpped.2015.11.001]; Guedes DP, 2012, J PHYS ACT HEALTH, V9, P473, DOI 10.1123/jpah.9.4.473; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hedeker D, 2012, STAT MED, V31, P3328, DOI 10.1002/sim.5338; Herman KM, 2014, PEDIATR EXERC SCI, V26, P76, DOI 10.1123/pes.2012-0128; Hox JJ, 2010, MULTILEVEL ANAL TECH, V2nd; Hubal M, 2011, EXERCISE GENOMIC; Pavon DJ, 2010, NUTR HOSP, V25, P311, DOI 10.3305/nh.2010.25.2.4596; Jones MA, 2000, ANN HUM BIOL, V27, P57, DOI 10.1080/030144600282389; Katzmarzyk PT, 2000, AM J HUM BIOL, V12, P395, DOI 10.1002/(SICI)1520-6300(200005/06)12:3<395::AID-AJHB10>3.0.CO;2-J; Kenny D.A., 2006, DYADIC DATA ANAL MET; Kim HT, 2014, INT CONF UBIQ FUTUR, P3, DOI 10.1109/ICUFN.2014.6876736; Kim KS, 2004, METABOLISM, V53, P1538, DOI 10.1016/j.metabol.2004.06.019; Kovar R, 1976, J Sports Med Phys Fitness, V16, P205; Lloyd RS, 2014, BRIT J SPORT MED, V48, P498, DOI 10.1136/bjsports-2013-092952; Loos RJF, 2015, MED SCI SPORT EXER, V47, P1105, DOI 10.1249/MSS.0000000000000645; LORTIE G, 1982, HUM BIOL, V54, P801; Lu YC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10495; Maes HHM, 1996, MED SCI SPORT EXER, V28, P1479, DOI 10.1097/00005768-199612000-00007; Maia J, 2014, J SCI MED SPORT, V17, P381, DOI 10.1016/j.jsams.2013.09.004; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; MALINA RM, 1981, HUM BIOL, V53, P163; Matton L, 2007, J SPORT SCI, V25, P1011, DOI 10.1080/02640410600951563; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Moliner-Urdiales D, 2011, BRIT J SPORT MED, V45, P101, DOI 10.1136/bjsm.2009.062430; Mutunga M, 2006, INT J PEDIATR OBES, V1, P114, DOI 10.1080/17477160600569560; NEVILL AM, 1992, EUR J APPL PHYSIOL, V65, P110, DOI 10.1007/BF00705066; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Ortega FB, 2011, BRIT J SPORT MED, V45, P20, DOI 10.1136/bjsm.2009.062679; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Pawlak K., 1984, GENETICS PSYCHOMOTOR; Pereira S, 2015, NUTRIENTS, V7, P4345, DOI 10.3390/nu7064345; PERUSSE L, 1987, PREV MED, V16, P607, DOI 10.1016/0091-7435(87)90044-2; Philippaerts RM, 1999, INT J SPORTS MED, V20, P284, DOI 10.1055/s-2007-971132; Puthucheary Z, 2011, SPORTS MED, V41, P433, DOI 10.2165/11588720-000000000-00000; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rice T, 1997, OBES RES, V5, P557; Rigby N, 2015, J CELL PHYSIOL, V230, P2304, DOI 10.1002/jcp.24979; Robitaille J, 2003, CLIN GENET, V63, P109, DOI 10.1034/j.1399-0004.2003.00026.x; Ross D., 1986, INANTHROPOMETRY 3 CO; Safrit MJ, 1990, PEDIATRIC EXERCISE S, V2, P9, DOI DOI 10.1123/PES.2.1.9; Santiago C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016323; Santos DMV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110025; Saranga S, REV BRASILEIRA EDUCA; Schutte NM, 2016, BEHAV GENET, V46, P217, DOI 10.1007/s10519-015-9754-2; Seabra Andre F, 2007, J Phys Act Health, V4, P370; Shang Lei, 2015, Prev Med Rep, V2, P265, DOI 10.1016/j.pmedr.2015.04.003; Starc G., 2013, ANNALES KINESIOLOGIA, V4, P95; Stephens, 1994, PHYS ACTIVITY FITNES, P77, DOI DOI 10.1249/00005768-199401000-00024; Taylor RW, 2010, OBESITY, V18, P1410, DOI 10.1038/oby.2009.399; Thomis M, 2011, GENETIC MOL ASPECTS, P159; Tomkinson GR., 2007, MED SPORT SCI BASEL, V50, P46; Vallance JK, 2015, AM J HEALTH BEHAV, V39, P62, DOI 10.5993/AJHB.39.1.7; Vasconcelos M. A., 2001, PORTUGUESE J SPORTS, V1, P44; Vasques C, 2007, REV PORTUGUESA CIENC, V9; Welk GJ, 2015, RES Q EXERCISE SPORT, V86, pS45, DOI 10.1080/02701367.2015.1043231; Wolfarth B, 2011, GENETIC MOL ASPECTS; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	78	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172013	10.1371/journal.pone.0172013	http://dx.doi.org/10.1371/journal.pone.0172013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187195	Green Submitted, Green Published, gold			2022-12-26	WOS:000394244300068
J	Bruffaerts, N; Vluggen, C; Roupie, V; Duytschaever, L; Van den Poel, C; Denoel, J; Wattiez, R; Letesson, JJ; Fretin, D; Rigouts, L; Chapeira, O; Mathys, V; Saegerman, C; Huygen, K				Bruffaerts, Nicolas; Vluggen, Christelle; Roupie, Virginie; Duytschaever, Lucille; Van den Poel, Christophe; Denoel, Joseph; Wattiez, Ruddy; Letesson, Jean-Jacques; Fretin, David; Rigouts, Leen; Chapeira, Ophelie; Mathys, Vanessa; Saegerman, Claude; Huygen, Kris			Virulence and immunogenicity of genetically defined human and porcine isolates of M. avium subsp hominissuis in an experimental mouse infection	PLOS ONE			English	Article							MYCOBACTERIUM-AVIUM; NONTUBERCULOUS MYCOBACTERIA; PROTECTIVE EFFICACY; PARATUBERCULOSIS; TUBERCULOSIS; DISEASE; COMPLEX; MICE; PIGS; ORGANISMS	Mycobacterium avium subsp. hominissuis (Mah) represents a health concern for humans and to a lesser extent for pigs, but its zoonotic potential remains elusive. Using multispacer sequence typing (MST) we previously identified 49 different genotypes of Mah among Belgian clinical and porcine isolates, with 5 MSTs shared by both hosts. Using experimental intranasal infection of BALB/ c mice, we compared the virulence and immunogenicity of porcine and clinical human isolates with shared genotype or with a genotype only found in humans or pigs. Bacterial replication was monitored for 20 weeks in lungs, spleen and liver and mycobacteria specific spleen cell IFN-gamma , IL-10 and IL-17 production as well as serum antibody responses were analyzed. Isolates varied in virulence, with human and porcine isolates sharing MST22 genotype showing a thousand fold higher bacterial replication in lungs and more dissemination to spleen and liver than the human and porcine MST91 isolates. Virulent MST22 type was also associated with progressive suppression of IFN-gamma and IL-17 responses, and increased IL-10 production. Whole genome sequencing of the two virulent isolates with MST22 genotype and two avirulent isolates of genotype MST91 and comparison with two well-studied M. avium subsp. hominissuis reference strains i.e. Mah 104 and Mah TH135, identified in the two MST22 isolates nine specific virulence factors of the mammalian cell entry family, that were identical with Mah 104 strain. Despite the obvious limitations of the mouse model, a striking link of virulence and identity at the genome level of porcine and human isolates with the same multisequence type, for which no correlation of place of residence (humans) or farm of origin (pigs) was observed, seems to point to the existence in the environment of certain genotypes of Mah which may be more infectious both for humans and pigs than other genotypes.	[Bruffaerts, Nicolas; Van den Poel, Christophe; Huygen, Kris] Sci Inst Publ Hlth, Serv Immunol, Operat Direct Communicable & Infect Dis, Brussels, Belgium; [Vluggen, Christelle; Mathys, Vanessa] Sci Inst Publ Hlth, Serv Bacterial Dis, Operat Direct Communicable & Infect Dis, Brussels, Belgium; [Roupie, Virginie; Duytschaever, Lucille; Fretin, David] Vet & Agrochem Res Ctr, Unit Bacterial Zoonoses Livestock, Operat Direct Bacterial Dis, Brussels, Belgium; [Duytschaever, Lucille; Denoel, Joseph; Saegerman, Claude] Univ Liege, Res Unit Epidemiol & Risk Anal Appl Vet Sci, Fundamental & Appl Res Anim & Hlth, Liege, Belgium; [Wattiez, Ruddy] Univ Mons, Serv Prote & Microbiol, Mons, Belgium; [Letesson, Jean-Jacques] Univ Namur, Unite Rech Biol Microorganismes, Namur, Belgium; [Rigouts, Leen] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Rigouts, Leen] Inst Trop Med, Unit Mycobacteriol, Antwerp, Belgium; [Chapeira, Ophelie] Genoscreen, Serv Bioinformat, Lille, France; [Bruffaerts, Nicolas] Sci Inst Publ Hlth, Serv Mycol & Aerobiol, Operat Direct Communicable & Infect Dis, Brussels, Belgium	University of Liege; University of Mons; University of Namur; University of Antwerp; Institute of Tropical Medicine (ITM)	Bruffaerts, N; Huygen, K (corresponding author), Sci Inst Publ Hlth, Serv Immunol, Operat Direct Communicable & Infect Dis, Brussels, Belgium.	nicolas.bruffaerts@wiv-isp.be; kris.huygen@wiv-isp.be	Bruffaerts, Nicolas/AAQ-2647-2020; Jean-Jacques, LETESSON/AHB-6921-2022	Bruffaerts, Nicolas/0000-0001-6310-9140; Huygen, Kris/0000-0001-7808-0512; wattiez, ruddy/0000-0003-2071-4310; Saegerman, Claude/0000-0001-9087-7436; LETESSON, Jean-Jacques/0000-0002-5838-0224	Federal Public Service of Public Health, Safety of the Food Chain and Environment [RT-07/6, RT12/5]; Walloon Region; Belgian Ministry of Social Affairs through Health Insurance System; Genoscreen	Federal Public Service of Public Health, Safety of the Food Chain and Environment; Walloon Region; Belgian Ministry of Social Affairs through Health Insurance System; Genoscreen	This work was partially financed by the Federal Public Service of Public Health, Safety of the Food Chain and Environment (Convention RT-07/6 PARATUB, 2008-2012 and RT12/5 LYMPHINDIC 1, 2012-2015). This work was also funded through a grant from the Walloon Region (J-JL and RW). The National Reference Centre for Tuberculosis & Mycobacteria is partially supported by the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genoscreen provided support in the form of salaries for author OC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agdestein A, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-46; Agdestein A, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-11; Borsutzky S, 2005, J IMMUNOL, V174, P6308, DOI 10.4049/jimmunol.174.10.6308; Bruffaerts N, 2016, GENOME ANNOUNC, V4; Cayrou C, 2010, MICROBIOL-SGM, V156, P687, DOI 10.1099/mic.0.033522-0; Cook JL, 2010, BRIT MED BULL, V96, P45, DOI 10.1093/bmb/ldq035; Despierres L, 2012, EUR J CLIN MICROBIOL, V31, P1373, DOI 10.1007/s10096-011-1452-2; Falkinham JO, 2015, CLIN CHEST MED, V36, P35, DOI 10.1016/j.ccm.2014.10.003; Feller M, 2007, LANCET INFECT DIS, V7, P607, DOI 10.1016/S1473-3099(07)70211-6; GANGADHARAM PRJ, 1995, ANTIMICROB AGENTS CH, V39, P1647, DOI 10.1128/AAC.39.8.1647; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Horan KL, 2006, J CLIN MICROBIOL, V44, P783, DOI 10.1128/JCM.44.3.783-789.2006; HUYGEN K, 1993, INFECT IMMUN, V61, P2687, DOI 10.1128/IAI.61.6.2687-2693.1993; Huygen K, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00321; Ichikawa K, 2015, INFECT GENET EVOL, V36, P250, DOI 10.1016/j.meegid.2015.09.029; Johansen TB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/189649; KIRSCHNER P, 1993, J CLIN MICROBIOL, V31, P2882, DOI 10.1128/JCM.31.11.2882-2889.1993; Komijn RE, 1999, J CLIN MICROBIOL, V37, P1254, DOI 10.1128/JCM.37.5.1254-1259.1999; Leroy B, 2009, VET MICROBIOL, V135, P313, DOI 10.1016/j.vetmic.2008.09.065; Leroy B, 2007, PROTEOMICS, V7, P1164, DOI 10.1002/pmic.200600988; Lim A, 2010, CLIN IMMUNOL, V137, P296, DOI 10.1016/j.clim.2010.07.011; Mijs W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI [10.1099/ijs.0.02037-0, 10.1099/00207713-52-5-1505]; Moriyama Makoto, 2016, Kekkaku, V91, P9; Prevots DR, 2015, CLIN CHEST MED, V36, P13, DOI 10.1016/j.ccm.2014.10.002; Roque S, 2007, J IMMUNOL, V178, P8028, DOI 10.4049/jimmunol.178.12.8028; Roupie V, 2008, VACCINE, V26, P4783, DOI 10.1016/j.vaccine.2008.07.009; Roupie V, 2008, INFECT IMMUN, V76, P2099, DOI 10.1128/IAI.01137-07; Roupie V, 2012, VET IMMUNOL IMMUNOP, V145, P74, DOI 10.1016/j.vetimm.2011.10.012; Slany M, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4387461; Tanghe A, 1999, J IMMUNOL, V162, P1113; Tirkkonen T, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-21; Turenne CY, 2008, J BACTERIOL, V190, P2479, DOI 10.1128/JB.01691-07; Turenne CY, 2007, CLIN MICROBIOL REV, V20, P205, DOI 10.1128/CMR.00036-06; Uchiya K, 2017, SCI REP-UK, V7, DOI 10.1038/srep39750; Uchiya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071831; Vluggen Christelle, 2016, Euro Surveill, V21, P30111, DOI 10.2807/1560-7917.ES.2016.21.3.30111; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Weiss CH, 2012, EXPERT REV RESP MED, V6, P597, DOI [10.1586/ERS.12.58, 10.1586/ers.12.58]; Wilkinson RJ, 1997, J CLIN MICROBIOL, V35, P553, DOI 10.1128/JCM.35.3.553-557.1997; Winthrop K, 2016, AM J RESP CELL MOL, V54, P170, DOI 10.1165/rcmb.2015-0256RC	40	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171895	10.1371/journal.pone.0171895	http://dx.doi.org/10.1371/journal.pone.0171895			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182785	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800130
J	Bubici, G; Carluccio, AV; Stavolone, L; Cillo, F				Bubici, Giovanni; Carluccio, Anna Vittoria; Stavolone, Livia; Cillo, Fabrizio			Prosystemin overexpression induces transcriptional modifications of defense-related and receptor-like kinase genes and reduces the susceptibility to Cucumber mosaic virus and its satellite RNAs in transgenic tomato plants	PLOS ONE			English	Article							SALICYLIC-ACID; CELL-DEATH; SIGNALING PATHWAY; BOTRYTIS-CINEREA; SYSTEMIN; RESISTANCE; EXPRESSION; DISEASE; ARABIDOPSIS; RESPONSES	Systemin is a plant signal peptide hormone involved in the responses to wounding and insect damage in the Solanaceae family. It works in the same signaling pathway of jasmonic acid (JA) and enhances the expression of proteinase inhibitors. With the aim of studying a role for systemin in plant antiviral responses, a tomato ( Solanum lycopersicum) transgenic line overexpressing the prosystemin cDNA, i.e. the systemin precursor, was inoculated with Cucumber mosaic virus (CMV) strain Fny supporting either a necrogenic or a non-necrogenic satellite RNA (satRNA) variant. Transgenic plants showed reduced susceptibility to both CMV/satRNA combinations. While symptoms of the non-necrogenic inoculum were completely suppressed, a delayed onset of lethal disease occurred in about half of plants challenged with the necrogenic inoculum. RT-qPCR analysis showed a correlation between the systemin-mediated reduced susceptibility and the JA biosynthetic and signaling pathways (e.g. transcriptional alteration of lipoxygenase D and proteinase inhibitor II). Moreover, transgenically overexpressed systemin modulated the expression of a selected set of receptor-like protein kinase (RLK) genes, including some playing a known role in plant innate immunity. A significant correlation was found between the expression profiles of some RLKs and the systemin-mediated reduced susceptibility to CMV/satRNA. These results show that systemin can increase plant defenses against CMV/satRNA through transcriptional reprogramming of diverse signaling pathways.	[Bubici, Giovanni; Carluccio, Anna Vittoria; Stavolone, Livia; Cillo, Fabrizio] CNR, Ist Protez Sostenibile Piante, Bari, Italy; [Stavolone, Livia] Int Inst Trop Agr, Ibadan, Oyo State, Nigeria	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); CGIAR; International Institute of Tropical Agriculture (IITA)	Cillo, F (corresponding author), CNR, Ist Protez Sostenibile Piante, Bari, Italy.	fabrizio.cillo@cnr.it	Cillo, Fabrizio/G-1178-2010; Carluccio, Anna Vittoria/AAI-3463-2021; Stavolone, Livia/AAY-2967-2020; Bubici, Giovanni/O-4793-2015	Cillo, Fabrizio/0000-0001-9898-7533; Stavolone, Livia/0000-0002-0691-1302; Bubici, Giovanni/0000-0001-9143-2711	Ministry of Economy and Finance [I. 191/2009, PON02_00395_3082360]	Ministry of Economy and Finance	This work was supported with a grant from the Ministry of Economy and Finance to the CNR, "Integrate knowledge for Sustainability and Innovation of Made in Italy Agro-Food" (CISIA, I. 191/2009), and a grant to the Public-Private Laboratory GenoPom Integrating post-genomic platforms to enhance the tomato production chain (GenoPOMpro, Cod. PON02_00395_3082360).	Babu M, 2008, J GEN VIROL, V89, P1069, DOI 10.1099/vir.0.83531-0; Caarls L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00170; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Cillo F, 2007, J GEN VIROL, V88, P3166, DOI 10.1099/vir.0.83110-0; COLLMER CW, 1992, ANNU REV PHYTOPATHOL, V30, P419, DOI 10.1146/annurev.py.30.090192.002223; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Coppola M, 2015, PLANT MOL BIOL REP, V33, P1270, DOI 10.1007/s11105-014-0834-x; Corrado G, 2007, J CHEM ECOL, V33, P669, DOI 10.1007/s10886-007-9254-9; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Danna CH, 2011, P NATL ACAD SCI USA, V108, P9286, DOI 10.1073/pnas.1106366108; Diaz J, 2002, PLANT PHYSIOL, V129, P1341, DOI 10.1104/pp.001453; El Oirdi M, 2011, PLANT CELL, V23, P2405, DOI 10.1105/tpc.111.083394; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Garcia-Arenal F, 1999, CURR TOP MICROBIOL, V239, P37; Garcia-Marcos A, 2009, MOL PLANT MICROBE IN, V22, P1431, DOI 10.1094/MPMI-22-11-1431; Huang ZL, 2005, PLANT PHYSIOL, V137, P1147, DOI 10.1104/pp.104.056028; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Korner CJ, 2013, MOL PLANT MICROBE IN, V26, P1271, DOI 10.1094/MPMI-06-13-0179-R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo Y, 2011, PLANT PATHOLOGY J, V27, P53, DOI 10.5423/PPJ.2011.27.1.053; Malinowski R, 2009, PLANT MOL BIOL, V70, P603, DOI 10.1007/s11103-009-9494-x; Mascia T, 2010, MOL PLANT PATHOL, V11, P805, DOI [10.1111/j.1364-3703.2010.00646.x, 10.1111/j.1365-3059.2009.02239.x]; Maule AJ, 2000, MOL PLANT PATHOL, V1, P9, DOI 10.1046/j.1364-3703.2000.00002.x; MCGURL B, 1992, SCIENCE, V255, P1570, DOI 10.1126/science.1549783; MCGURL B, 1994, P NATL ACAD SCI USA, V91, P9799, DOI 10.1073/pnas.91.21.9799; Nicaise V, 2016, MOL PLANT PATHOL; Nicaise V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00660; OROZCOCARDENAS M, 1993, P NATL ACAD SCI USA, V90, P8273, DOI 10.1073/pnas.90.17.8273; Orsini F, 2010, PHYSIOL PLANTARUM, V138, P10, DOI 10.1111/j.1399-3054.2009.01292.x; OWEN J, 1988, VIROLOGY, V166, P495, DOI 10.1016/0042-6822(88)90520-X; Pacheco R, 2012, MOL PLANT MICROBE IN, V25, P709, DOI 10.1094/MPMI-11-11-0305; Pallas V, 2011, J GEN VIROL, V92, P2691, DOI 10.1099/vir.0.034603-0; Palukaitis P, 2003, ADV VIRUS RES, V62, P241, DOI 10.1016/S0065-3527(03)62005-1; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; ROOSSINCK MJ, 1992, MICROBIOL REV, V56, P265, DOI 10.1128/MMBR.56.2.265-279.1992; Ryan CA, 2000, BBA-PROTEIN STRUCT M, V1477, P112, DOI 10.1016/S0167-4838(99)00269-1; Ryu CM, 2004, PLANT J, V39, P381, DOI 10.1111/j.1365-313X.2004.02142.x; Scheer JM, 2002, P NATL ACAD SCI USA, V99, P9585, DOI 10.1073/pnas.132266499; Schilmiller AL, 2005, CURR OPIN PLANT BIOL, V8, P369, DOI 10.1016/j.pbi.2005.05.008; Schwessinger B, 2012, ANNU REV PLANT BIOL, V63, P451, DOI 10.1146/annurev-arplant-042811-105518; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; SLEAT DE, 1994, MOL PLANT MICROBE IN, V7, P189, DOI 10.1094/MPMI-7-0189; Sun JQ, 2011, MOL PLANT, V4, P607, DOI 10.1093/mp/ssr008; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Yi SY, 2010, NEW PHYTOL, V185, P701, DOI 10.1111/j.1469-8137.2009.03095.x; Yin YH, 2002, P NATL ACAD SCI USA, V99, P9090, DOI 10.1073/pnas.152330799; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	51	7	7	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171902	10.1371/journal.pone.0171902	http://dx.doi.org/10.1371/journal.pone.0171902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182745	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800131
J	Emrich, TE; Qi, Y; Lou, WDY; L'Abbe, MR				Emrich, Teri E.; Qi, Ying; Lou, Wendy Y.; L'Abbe, Mary R.			Traffic-light labels could reduce population intakes of calories, total fat, saturated fat, and sodium	PLOS ONE			English	Article							FOOD INFORMATION PROGRAM; HEALTHY FOOD; IMPACT; REFORMULATION; CHOICES; CANADA; DIET	Traffic-light labelling has been proposed as a public health intervention to improve the dietary intakes of consumers. OBJECTIVES: to model the potential impact of avoiding foods with red traffic lights on the label on the energy, total fat, saturated fat, sodium, and sugars intakes of Canadian adults. METHODS: Canadian adults aged 19 and older (n = 19,915) who responded to the Canadian Community Health Survey (CCHS), Cycle 2.2. The nutrient levels in foods consumed by Canadians in CCHS were profiled using the United Kingdom's criteria for traffic light labelling. Whenever possible, foods assigned a red traffic light for one or more of the profiled nutrients were replaced with a similar food currently sold in Canada, with nutrient levels not assigned any red traffic lights. Average intakes of calories, total fat, saturated fat, sodium, and sugars under the traffic light scenario were compared with actual intakes of calories and these nutrients (baseline) reported in CCHS. RESULTS: Under the traffic light scenario, Canadian's intake of energy, total fat, saturated fat, and sodium were significantly reduced compared to baseline; sugars intakes were not significantly reduced. Calorie intake was reduced by 5%, total fat 13%, saturated fat 14%, and sodium 6%. CONCLUSION: Governments and policy makers should consider the adoption of traffic light labelling as a population level intervention to improve dietary intakes and chronic disease risk.	[Emrich, Teri E.; L'Abbe, Mary R.] Univ Toronto, Dept Human Nutr, Toronto, ON, Canada; [Qi, Ying; Lou, Wendy Y.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University of Toronto	L'Abbe, MR (corresponding author), Univ Toronto, Dept Human Nutr, Toronto, ON, Canada.	mary.labbe@utoronto.ca	labbe, mary/AAC-3392-2020					[Anonymous], 2015, CANADA GAZETTE 1; Balcombe K, 2010, FOOD POLICY, V35, P211, DOI 10.1016/j.foodpol.2009.12.005; Beland Y, 2005, P AM STAT ASS JT STA, V6, P2738; Brownell KD, 2011, NEW ENGL J MED, V364, P2373, DOI 10.1056/NEJMp1101033; Buttriss JL, 2013, P NUTR SOC, V72, P61, DOI 10.1017/S0029665112002868; Canadian Council of Food and Nutrition, 2008, TRACK NUTR TRENDS 6; Department of Health, 2013, GUID CREAT FRONT PAC, P27; Dos Santos BA, 2015, J FOOD SCI, V80, pS1093, DOI 10.1111/1750-3841.12847; Dummer Jane, 2012, Can J Diet Pract Res, V73, pe227, DOI 10.3148/73.1.2012.e227; Emrich TE, 2014, APPL PHYSIOL NUTR ME, V39, P417, DOI 10.1139/apnm-2013-0304; Felicio TL, 2016, FOOD CHEM; Food Standards Agency Welsh Government, 2013, SCOTT GOV D H FRONT; Goodman S, 2011, J NUTR EDUC BEHAV, V43, P356, DOI 10.1016/j.jneb.2011.02.008; Government of Canada Health Canada Communications Marketing and Consultation DirectorateM and CCD, 2014, CONS CAN MOD IMPR LA; Hawley K.L., 2012, PUBLIC HEALTH NUTR, V1, P1; Health Canada, 2006, GUID ACC INT INT DAT; Health Canada, 2008, CAN NUTR FIL 2007; Health Canada, 1985, LAB PROC FOOD CHEM L; McCullum C, 1997, ADOLESCENCE, V32, P181; Raine KD, 2005, CAN J PUBLIC HEALTH, V96, pS8, DOI 10.1007/BF03405195; Roodenburg AJC, 2009, NUTR BULL, V34, P318, DOI 10.1111/j.1467-3010.2009.01767.x; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Sacks G, 2009, HEALTH PROMOT INT, V24, P344, DOI 10.1093/heapro/dap032; Schermel A, 2013, APPL PHYSIOL NUTR ME, V38, P666, DOI 10.1139/apnm-2012-0386; Statistics Canada, 2008, CAN COMM HLTH SURV 2; Temme EHM, 2011, PUBLIC HEALTH NUTR, V14, P635, DOI 10.1017/S1368980010002089; The Strategic Counsel, 2012, CAN UND US NUTR FACT; Thorndike AN, 2014, AM J PREV MED, V46, P143, DOI 10.1016/j.amepre.2013.10.002; Thorndike AN, 2012, AM J PUBLIC HEALTH, V102, P527, DOI 10.2105/AJPH.2011.300391; United States Department of Agriculture Agricultural Research Service, 2014, FOOD SURV AMPM USDA; van Raaij J, 2009, PUBLIC HEALTH NUTR, V12, P325, DOI 10.1017/S1368980008003376; Vyth EL, 2012, EUR J CLIN NUTR, V66, P510, DOI 10.1038/ejcn.2011.193; Vyth EL, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-65; Wartella EA, 2010, EXAMINATION FRONT PA; Williams P, 2003, HEALTH PROMOT INT, V18, P51, DOI 10.1093/heapro/18.1.51; Young L, 2002, HEALTH PROMOT INT, V17, P13, DOI 10.1093/heapro/17.1.13	36	43	44	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171188	10.1371/journal.pone.0171188	http://dx.doi.org/10.1371/journal.pone.0171188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182630	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800041
J	Gienger, CM; Brien, ML; Tracy, CR; Manolis, SC; Webb, GJW; Seymour, RS; Christian, KA				Gienger, C. M.; Brien, Matthew L.; Tracy, Christopher R.; Manolis, S. Charlie; Webb, Grahame J. W.; Seymour, Roger S.; Christian, Keith A.			Ontogenetic comparisons of standard metabolism in three species of crocodilians	PLOS ONE			English	Article							CROCODYLUS-POROSUS; ESTUARINE CROCODILE; GROWTH; ENERGETICS; EVOLUTION; BEHAVIOR; RATES; SIZE; FISH; MASS	Due in part to their large size, aggressive temperament, and difficulty in handling, there are few physiological studies of adult crocodilians in the literature. As a result, studies comparing individuals across an ontogenetic series and comparisons among species are also lacking. We addressed this gap in knowledge by measuring standard metabolic rates (SMR) of three species of crocodilians (Crocodylus porosus, C. johnsoni, and Alligator mississippiensis), and included individuals that ranged from 0.22 to 114 kg. Allometric scaling of SMR with body mass was similar among the species, but C. porosus had significantly higher SMR than did C. johnsoni or A. mississippiensis. Differences in SMR among species are potentially related to behavioural differences in levels of aggression; C. porosus are the most aggressive of the crocodilians measured, and have rates of standard metabolism that are approximately 36% higher at the grand mean body size than those measured for C. johnsoni or A. mississippiensis, which are among the least aggressive crocodilians.	[Gienger, C. M.; Brien, Matthew L.; Tracy, Christopher R.; Webb, Grahame J. W.; Christian, Keith A.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT, Australia; [Brien, Matthew L.; Manolis, S. Charlie; Webb, Grahame J. W.] Wildlife Management Int & Crocodylus Pk, Berrimah, NT, Australia; [Seymour, Roger S.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; Austin Peay State Univ, Dept Biol, Clarksville, TN 37044 USA; [Gienger, C. M.] Austin Peay State Univ, Ctr Excellence Field Biol, Clarksville, TN 37044 USA; [Brien, Matthew L.] Queensland Govt, Dept Environm & Heritage Protect, Cairns, Qld, Australia; [Tracy, Christopher R.] Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92634 USA	Charles Darwin University; University of Adelaide; Austin Peay State University; Austin Peay State University; California State University System; California State University Fullerton	Gienger, CM (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT, Australia.	giengerc@apsu.edu	; Gienger, Chris/D-1759-2010	Christian, Keith/0000-0001-6135-1670; Gienger, Chris/0000-0001-5045-3321				ANDREWS RM, 1985, PHYSIOL ZOOL, V58, P214, DOI 10.1086/physzool.58.2.30158569; Beaupre SJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P757, DOI 10.1086/322965; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Brien ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080872; Britton Adam R. C., 2012, Herpetological Review, V43, P541; Brown JH, 2003, MAR FRESHW BEHAV PHY, V36, P31, DOI 10.1080/1023624021000054307; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Careau V, 2010, INTEGR COMP BIOL, V50, pE24; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; COULSON R A, 1983, Comparative Biochemistry and Physiology B, V74, P1; COULSON RA, 1989, AM ZOOL, V29, P921; COULSON TD, 1973, ZOOLOGICA STUTTGART, V58, P47; Cutts CJ, 1998, J FISH BIOL, V52, P1026, DOI 10.1111/j.1095-8649.1998.tb00601.x; Cutts CJ, 2002, J FISH BIOL, V61, P1540, DOI [10.1006/jfbi.2002.2173, 10.1111/j.1095-8649.2002.tb02496.x]; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Franklin CE, 2003, J EXP ZOOL PART A, V298A, P86, DOI 10.1002/jez.a.10233; GARNETT ST, 1986, AUST J ZOOL, V34, P211, DOI 10.1071/ZO9860211; Gienger CM, 2011, AUST J ZOOL, V59, P416, DOI 10.1071/ZO12018; GRIGG GC, 1978, PHYSIOL ZOOL, V51, P354, DOI 10.1086/physzool.51.4.30160960; HEUSNER AA, 1985, ANNU REV NUTR, V5, P267, DOI 10.1146/annurev.nu.05.070185.001411; Hoogenboom MO, 2013, BEHAV ECOL, V24, P253, DOI 10.1093/beheco/ars161; Killen SS, 2016, AM NAT, V187, P592, DOI 10.1086/685893; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; Lang J.W., 1987, P273; LEWIS LY, 1985, COMP BIOCHEM PHYS A, V80, P441, DOI 10.1016/0300-9629(85)90065-9; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; MARLER CA, 1995, BEHAV ECOL SOCIOBIOL, V37, P225, DOI 10.1007/s002650050185; Nagy KA, 2000, HERPETOL MONOGR, V14, P378, DOI 10.2307/1467052; Peucker SKJ, 2005, CROCODILE FARMING RE; Reinhold K, 1999, FUNCT ECOL, V13, P217, DOI 10.1046/j.1365-2435.1999.00300.x; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Seymour RS, 2013, J COMP PHYSIOL B, V183, P491, DOI 10.1007/s00360-012-0732-1; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P385; WEBB GJW, 1989, AM ZOOL, V29, P953; WIESER W, 1984, RESP PHYSIOL, V55, P1, DOI 10.1016/0034-5687(84)90112-9; Withers PC, 2001, AUST J ZOOL, V49, P445, DOI 10.1071/ZO00057; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; Zar JH, 1999, BIOSTATISTICAL ANAL	38	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171082	10.1371/journal.pone.0171082	http://dx.doi.org/10.1371/journal.pone.0171082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182696	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800032
J	Taucher, J; Haunost, M; Boxhammer, T; Bach, LT; Alguero-Muniz, M; Riebesell, U				Taucher, Jan; Haunost, Mathias; Boxhammer, Tim; Bach, Lennart T.; Alguero-Muniz, Maria; Riebesell, Ulf			Influence of ocean acidification on plankton community structure during a winter-to-summer succession: An imaging approach indicates that copepods can benefit from elevated CO2 via indirect food web effects	PLOS ONE			English	Article							CENTRAL BALTIC SEA; PSEUDOCALANUS-ACUSPES; PHYTOPLANKTON BLOOM; SIZE DISTRIBUTIONS; SINKING VELOCITY; MU-M; ZOOPLANKTON; PATTERNS; TEMPERATURE; PARTICLES	Plankton communities play a key role in the marine food web and are expected to be highly sensitive to ongoing environmental change. Oceanic uptake of anthropogenic carbon dioxide (CO2) causes pronounced shifts in marine carbonate chemistry and a decrease in seawater pH. These changes-summarized by the term ocean acidification (OA)-can significantly affect the physiology of planktonic organisms. However, studies on the response of entire plankton communities to OA, which also include indirect effects via food-web interactions, are still relatively rare. Thus, it is presently unclear how OA could affect the functioning of entire ecosystems and biogeochemical element cycles. In this study, we report from a long-term in situ mesocosm experiment, where we investigated the response of natural plankton communities in temperate waters (Gullmarfjord, Sweden) to elevated CO2 concentrations and OA as expected for the end of the century (similar to 760 mu atm pCO(2)). Based on a plankton- imaging approach, we examined size structure, community composition and food web characteristics of the whole plankton assemblage, ranging from picoplankton to mesozooplankton, during an entire winter-to-summer succession. The plankton imaging system revealed pronounced temporal changes in the size structure of the copepod community over the course of the plankton bloom. The observed shift towards smaller individuals resulted in an overall decrease of copepod biomass by 25%, despite increasing numerical abundances. Furthermore, we observed distinct effects of elevated CO2 on biomass and size structure of the entire plankton community. Notably, the biomass of copepods, dominated by Pseudocalanus acuspes, displayed a tendency towards elevated biomass by up to 30-40% under simulated ocean acidification. This effect was significant for certain copepod size classes and was most likely driven by CO2-stimulated responses of primary producers and a complex interplay of trophic interactions that allowed this CO2 effect to propagate up the food web. Such OA-induced shifts in plankton community structure could have far-reaching consequences for food-web interactions, biomass transfer to higher trophic levels and biogeochemical cycling of marine ecosystems.	[Taucher, Jan; Haunost, Mathias; Boxhammer, Tim; Bach, Lennart T.; Riebesell, Ulf] GEOMAR Helmholtz Ctr Ocean Res, Kiel, Germany; [Alguero-Muniz, Maria] Alfred Wegener Inst Helmholtz Zentrum Polar & Mar, Inst Biol, Helgoland, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Taucher, J (corresponding author), GEOMAR Helmholtz Ctr Ocean Res, Kiel, Germany.	jtaucher@geomar.de	Algueró-Muñiz, María/AAA-9748-2020; Boxhammer, Tim/GLN-6190-2022; Riebesell, Ulf/AAC-9717-2020; Boxhammer, Tim/AAE-6416-2020; Taucher, Jan/AAA-9195-2019	Algueró-Muñiz, María/0000-0001-8064-6212; Boxhammer, Tim/0000-0002-9632-5947; Boxhammer, Tim/0000-0002-9632-5947; Riebesell, Ulf/0000-0002-9442-452X; Bach, Lennart/0000-0003-0202-3671; Taucher, Jan/0000-0001-9944-0775	German Federal Ministry of Science and Education (BMBF): BIOACID II project [FKZ 03F06550]; Leibniz Award by the German Science Foundation (DFG); Swedish Academy of Sciences	German Federal Ministry of Science and Education (BMBF): BIOACID II project(Federal Ministry of Education & Research (BMBF)); Leibniz Award by the German Science Foundation (DFG)(German Research Foundation (DFG)); Swedish Academy of Sciences	This work was supported by the German Federal Ministry of Science and Education (BMBF): BIOACID II project (FKZ 03F06550) https://www.bmbf.de (all authors); Leibniz Award 2012 by the German Science Foundation (DFG) (UR); Swedish Academy of Sciences (MAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KH, 2009, P ROY SOC B-BIOL SCI, V276, P109, DOI 10.1098/rspb.2008.0951; Andersen KH, ANN REV MARINE SCI, V8, P217; [Anonymous], 2011, BIOL REV, V86, P311, DOI [10.1111/j.1469-185X.2010.00148.x, DOI 10.1111/J.1469-185X.2010.00148.X]; Bach LT, 2016, GLOBAL BIOGEOCHEM CY, V30, P1145, DOI 10.1002/2016GB005372; Bach LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159068; Bach LT, 2015, PROG OCEANOGR, V135, P125, DOI 10.1016/j.pocean.2015.04.012; Bach LT, 2012, MAR BIOL, V159, P1853, DOI 10.1007/s00227-012-1945-2; Barnes C, 2010, ECOLOGY, V91, P222, DOI 10.1890/08-2061.1; Basedow SL, 2010, J PLANKTON RES, V32, P1105, DOI 10.1093/plankt/fbp110; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Behrenfeld MJ, 2014, ANNU REV MAR SCI, V6, P167, DOI 10.1146/annurev-marine-052913-021325; Benfield MC, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.63; Boissonnot L, 2016, J PLANKTON RES; BOUDREAU PR, 1992, CAN J FISH AQUAT SCI, V49, P1528, DOI 10.1139/f92-169; Boyd PW, 2007, PROG OCEANOGR, V72, P276, DOI 10.1016/j.pocean.2006.10.007; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Corkett CJ, ADV MARINE BIOL, P1; Cotonnec G, 2001, J PLANKTON RES, V23, P693, DOI 10.1093/plankt/23.7.693; Cripps G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151739; Cripps G, 2014, GLOBAL CHANGE BIOL, V20, P3377, DOI 10.1111/gcb.12582; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Edenhofer O., 2014, CONTRIBUTION WORKING; FALKOWSKI PG, 1988, CONT SHELF RES, V8, P457, DOI 10.1016/0278-4343(88)90064-7; Fitzer SC, 2012, J EXP MAR BIOL ECOL, V418, P30, DOI 10.1016/j.jembe.2012.03.009; Forest A, 2012, BIOGEOSCIENCES, V9, P1301, DOI 10.5194/bg-9-1301-2012; GAEDKE U, 1993, LIMNOL OCEANOGR, V38, P112, DOI 10.4319/lo.1993.38.1.0112; Gamble J.C., 1982, P25; Gao KS, 2014, FUNCT PLANT BIOL, V41, P449, DOI 10.1071/FP13247; Geurts P, 2009, MOL BIOSYST, V5, P1593, DOI 10.1039/b907946g; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; HEATH MR, 1995, ICES J MAR SCI, V52, P627, DOI 10.1016/1054-3139(95)80077-8; Hildebrandt N, 2015, J CONSEIL; Hildebrandt N, 2014, MAR POLLUT BULL, V80, P59, DOI 10.1016/j.marpolbul.2014.01.050; Hirst AG, 2003, LIMNOL OCEANOGR, V48, P1988, DOI 10.4319/lo.2003.48.5.1988; Huete-Ortega M, 2010, J PLANKTON RES, V32, P1, DOI 10.1093/plankt/fbp104; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jackson GA, 1997, DEEP-SEA RES PT I, V44, P1739, DOI 10.1016/S0967-0637(97)00029-0; Jennings S, 2003, ECOL LETT, V6, P971, DOI 10.1046/j.1461-0248.2003.00529.x; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; Litchman E, 2013, J PLANKTON RES, V35, P473, DOI 10.1093/plankt/fbt019; LOCHTE K, 1993, DEEP-SEA RES PT II, V40, P91, DOI 10.1016/0967-0645(93)90008-B; LOGAN BE, 1987, LIMNOL OCEANOGR, V32, P1034, DOI 10.4319/lo.1987.32.5.1034; McConville K, 2013, MAR POLLUT BULL, V73, P428, DOI 10.1016/j.marpolbul.2013.02.010; Peters J, 2006, MAR BIOL, V149, P1417, DOI 10.1007/s00227-006-0290-8; Platt T., 1978, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V173, P60; Rakotomalala R., 2005, MODULAD, P71; Renz J, 2007, MAR BIOL, V151, P515, DOI 10.1007/s00227-006-0510-2; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2013, BIOGEOSCIENCES, V10, P1835, DOI 10.5194/bg-10-1835-2013; Romagnan JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119219; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sala MM, 2016, ICES J MAR SCI, V73, P670, DOI 10.1093/icesjms/fsv130; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoo KL, 2013, MAR BIOL, V160, P2145, DOI 10.1007/s00227-012-2121-4; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; Sigaud O, 2007, SOFT COMPUT, V11, P1065, DOI 10.1007/s00500-007-0164-0; SILVERT W, 1978, LIMNOL OCEANOGR, V23, P813, DOI 10.4319/lo.1978.23.4.0813; Sommer U, ANN REV ECOLOGY EVOL, V43, P429; Sprules WG, 2016, CAN J FISH AQUAT SCI, V73, P477, DOI 10.1139/cjfas-2015-0115; Stemmann L, 2004, DEEP-SEA RES PT I, V51, P865, DOI 10.1016/j.dsr.2004.03.001; Stemmann L, BIOGEOSCIENCES; Thor P, 2015, GLOBAL CHANGE BIOL, V21, P2261, DOI 10.1111/gcb.12815; Thor P, 2015, MAR BIOL, V162, P799, DOI 10.1007/s00227-015-2625-9; Turner JT, 2015, PROG OCEANOGR, V130, P205, DOI 10.1016/j.pocean.2014.08.005; Vandromme P, 2014, OCEAN SCI, V10, P821, DOI 10.5194/os-10-821-2014; Vandromme P., 2012, METHODS OCEANOGRAPHY, V1, P3, DOI DOI 10.1016/J.MI0.2012.06.001; Veldhuis MJW, 2000, SCI MAR, V64, P121, DOI 10.3989/scimar.2000.64n2121; Weydmann A, 2012, J EXP MAR BIOL ECOL, V428, P39, DOI 10.1016/j.jembe.2012.06.002; Wiebe PH, 2003, PROG OCEANOGR, V56, P7, DOI 10.1016/S0079-6611(02)00140-4; Wolf-Gladrow D, 1997, MAR CHEM, V59, P17, DOI 10.1016/S0304-4203(97)00069-8; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; Zarauz L, 2009, J PLANKTON RES, V31, P193, DOI 10.1093/plankt/fbn107; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE; Zhou M, 1997, MAR ECOL PROG SER, V159, P61, DOI 10.3354/meps159061; Zhou M, 2006, J PLANKTON RES, V28, P437, DOI 10.1093/plankt/fbi119	86	27	27	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0169737	10.1371/journal.pone.0169737	http://dx.doi.org/10.1371/journal.pone.0169737			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178268	Green Published, Green Accepted, gold			2022-12-26	WOS:000393712500002
J	Anguiano, M; Castilla, C; Maska, M; Ederra, C; Pelaez, R; Morales, X; Munoz-Arrieta, G; Mujika, M; Kozubek, M; Munoz-Barrutia, A; Rouzaut, A; Arana, S; Garcia-Aznar, JM; Ortiz-de-Solorzano, C				Anguiano, Maria; Castilla, Carlos; Maska, Martin; Ederra, Cristina; Pelaez, Rafael; Morales, Xabier; Munoz-Arrieta, Gorka; Mujika, Maite; Kozubek, Michal; Munoz-Barrutia, Arrate; Rouzaut, Ana; Arana, Sergio; Manuel Garcia-Aznar, Jose; Ortiz-de-Solorzano, Carlos			Characterization of three-dimensional cancer cell migration in mixed collagen-Matrigel scaffolds using microfluidics and image analysis	PLOS ONE			English	Article							NETWORK GEOMETRY; BREAST-CANCER; TUMOR-CELLS; IN-VITRO; INVASION; TRANSITION; ADHESION; CONTRACTILITY; METASTASIS; ALGORITHM	Microfluidic devices are becoming mainstream tools to recapitulate in vitro the behavior of cells and tissues. In this study, we use microfluidic devices filled with hydrogels of mixed collagen-Matrigel composition to study the migration of lung cancer cells under different cancer invasion microenvironments. We present the design of the microfluidic device, characterize the hydrogels morphologically and mechanically and use quantitative image analysis to measure the migration of H1299 lung adenocarcinoma cancer cells in different experimental conditions. Our results show the plasticity of lung cancer cell migration, which turns from mesenchymal in collagen only matrices, to lobopodial in collagen-Matrigel matrices that approximate the interface between a disrupted basement membrane and the underlying connective tissue. Our quantification of migration speed confirms a biphasic role of Matrigel. At low concentration, Matrigel facilitates migration, most probably by providing a supportive and growth factor retaining environment. At high concentration, Matrigel slows down migration, possibly due excessive attachment. Finally, we show that antibody-based integrin blockade promotes a change in migration phenotype from mesenchymal or lobopodial to amoeboid and analyze the effect of this change in migration dynamics, in regards to the structure of the matrix. In summary, we describe and characterize a robust microfluidic platform and a set of software tools that can be used to study lung cancer cell migration under different microenvironments and experimental conditions. This platform could be used in future studies, thus benefitting from the advantages introduced by microfluidic devices: precise control of the environment, excellent optical properties, parallelization for high throughput studies and efficient use of therapeutic drugs.	[Anguiano, Maria; Castilla, Carlos; Ederra, Cristina; Pelaez, Rafael; Morales, Xabier; Ortiz-de-Solorzano, Carlos] Ctr Appl Med Res, Div Solid Tumors & Biomarkers, Lab Preclin Models & Analyt Tools, Navarra, Spain; [Anguiano, Maria; Castilla, Carlos; Ederra, Cristina; Pelaez, Rafael; Morales, Xabier; Ortiz-de-Solorzano, Carlos] CIBERONC, Navarra, Spain; [Maska, Martin; Kozubek, Michal] Masaryk Univ, Fac Informat, Ctr Biomed Image Anal, Brno, Czech Republic; [Munoz-Arrieta, Gorka; Mujika, Maite; Arana, Sergio] CEIT, Biodevices & MEMS Grp, Water & Hlth Div, Donostia San Sebastian, Gipuzkoa, Spain; [Munoz-Arrieta, Gorka; Mujika, Maite; Arana, Sergio] Univ Navarra, TECNUN, Donostia San Sebastian, Gipuzkoa, Spain; [Munoz-Barrutia, Arrate] Univ Carlos III Madrid, Bioengn & Aerosp Engn Dept, Madrid, Spain; [Munoz-Barrutia, Arrate] Inst Invest Sanitaria Gregorio Maranon, Biomed Engn Div, Madrid, Spain; [Rouzaut, Ana] Univ Navarra, Fac Sci, Dept Biochem & Genet, Navarra, Spain; [Rouzaut, Ana] CIMA, Dept Immunol & Inmunotherapy, Navarra, Spain; [Manuel Garcia-Aznar, Jose] Univ Zaragoza, Dept Mech Engn, Multiscale Mech & Biol Engn M2BE, Aragon Inst Engn Res I3A, Zaragoza, Spain; [Pelaez, Rafael] Ctr Biomed Res La Rioja CIBIR, Div Oncol, Dept Biomarkers & Mol Signaling, Logrono, La Rioja, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Masaryk University Brno; University of Navarra; University of Navarra; Universidad Carlos III de Madrid; University of Navarra; University of Navarra; University of Zaragoza	Ortiz-de-Solorzano, C (corresponding author), Ctr Appl Med Res, Div Solid Tumors & Biomarkers, Lab Preclin Models & Analyt Tools, Navarra, Spain.; Ortiz-de-Solorzano, C (corresponding author), CIBERONC, Navarra, Spain.	codesolorzano@unav.es	Munoz-Barrutia, Arrate/G-1776-2016; Maška, Martin/J-3302-2013; Arana, Sergio/C-7762-2017; Kozubek, Michal/G-8939-2013; Garcia-Aznar, Jose Manuel/F-8256-2010; Peláez, Rafael/R-9458-2019; Arana, Sergio/I-8913-2019; Rouzaut, Ana/I-2576-2017; Ortiz-de-Solorzano, Carlos/G-3278-2010	Munoz-Barrutia, Arrate/0000-0002-1573-1661; Maška, Martin/0000-0003-3544-6494; Arana, Sergio/0000-0003-0970-7638; Kozubek, Michal/0000-0001-7902-589X; Garcia-Aznar, Jose Manuel/0000-0002-9864-7683; Peláez, Rafael/0000-0002-4047-6017; Rouzaut, Ana/0000-0003-3226-9162; Ortiz-de-Solorzano, Carlos/0000-0001-8720-0205; Morales, Xabier/0000-0003-0303-9958	Spanish Ministry of Economy and Competitiveness [DPI2012-38090-C03-02, DPI2015-64221-C2-2-R, TEC2013-48552-C2-1-R, TEC2016-78052-R, TEC2015-73064-EXP]; Torres Quevedo program [PTQ-11-04778]; Spanish Ministry of Health [FIS PI13/02313]; Czech Science Foundation [302/12/G157]; European Research Council (ERC) [ERC-2012-StG 306751]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Torres Quevedo program; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Czech Science Foundation(Grant Agency of the Czech Republic); European Research Council (ERC)(European Research Council (ERC)European Commission)	We would like to acknowledge the support of the Spanish Ministry of Economy and Competitiveness, under grants number DPI2012-38090-C03-02 and DPI2015-64221-C2-2-R (COS), TEC2013-48552-C2-1-R, TEC2016-78052-R, TEC2015-73064-EXP (AMB) and the Torres Quevedo program PTQ-11-04778 (RP); the Spanish Ministry of Health (FIS PI13/02313) (AR); the Czech Science Foundation, under grant number 302/12/G157 (MK, MMaska); and the European Research Council (ERC) through project ERC-2012-StG 306751 (JMGA).; We would like to acknowledge the support of the Spanish Ministry of Economy and Competitiveness, under grants number DPI2012-38090-C03-02 and DPI2015-64221-C2-2-R (COS), TEC2013-48552-C2-1-R, TEC2016-78052-R, TEC2015-73064-EXP (AMB) and the Torres Quevedo program PTQ-11-04778 (RP); the Spanish Ministry of Health (FIS PI13/02313) (AR); the Czech Science Foundation, under grant number 302/12/G157 (MK, MMagka); and the European Research Council (ERC) through project ERC-2012-StG 306751 (JMGA).	Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Doyle AD, 2013, CURR OPIN CELL BIOL, V25, P642, DOI 10.1016/j.ceb.2013.06.004; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Hotaling NA, 2015, BIOMATERIALS, V61, P327, DOI 10.1016/j.biomaterials.2015.05.015; Jacob M, 2004, IEEE T PATTERN ANAL, V26, P1007, DOI 10.1109/TPAMI.2004.44; Jeon JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056910; Kiss A., 2014, PLOS ONE, V9, P1; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lang NR, 2015, ACTA BIOMATER, V13, P61, DOI 10.1016/j.actbio.2014.11.003; Lautscham LA, 2015, BIOPHYS J, V109, P900, DOI 10.1016/j.bpj.2015.07.025; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Mak M, 2013, LAB CHIP, V13, P340, DOI 10.1039/c2lc41117b; Maska M, 2015, IEEE IMAGE PROC, P1791, DOI 10.1109/ICIP.2015.7351109; Maska M, 2013, IEEE T MED IMAGING, V32, P995, DOI 10.1109/TMI.2013.2243463; Mickel W, 2008, BIOPHYS J, V95, P6072, DOI 10.1529/biophysj.108.135939; Okabe A., 2000, SPATIAL TESSELLATION, P43, DOI 10.1002/9780470317013.ch2; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Polacheck WJ, 2014, P NATL ACAD SCI USA, V111, P2447, DOI 10.1073/pnas.1316848111; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rasband W., 2006, IMAGEJ; Shaw Leslie M., 2004, V294, P97; Shin Y, 2012, NAT PROTOC, V7, P1247, DOI 10.1038/nprot.2012.051; Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756; Stein AM, 2008, J MICROSC-OXFORD, V232, P463, DOI 10.1111/j.1365-2818.2008.02141.x; Steinwachs J, 2016, NAT METHODS, V13, P171, DOI [10.1038/NMETH.3685, 10.1038/nmeth.3685]; Sung KE, 2011, INTEGR BIOL-UK, V3, P439, DOI 10.1039/c0ib00063a; Tsai KKC, 2005, CANCER RES, V65, P6734, DOI 10.1158/0008-5472.CAN-05-0703; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wu PH, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.030; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; ZHANG TY, 1984, COMMUN ACM, V27, P236, DOI 10.1145/357994.358023; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	45	79	81	8	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171417	10.1371/journal.pone.0171417	http://dx.doi.org/10.1371/journal.pone.0171417			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166248	Green Published, gold			2022-12-26	WOS:000393700100040
J	Van Goor, A; Ashwell, CM; Persia, ME; Rothschild, MF; Schmidt, CJ; Lamont, SJ				Van Goor, Angelica; Ashwell, Chris M.; Persia, Michael E.; Rothschild, Max F.; Schmidt, Carl J.; Lamont, Susan J.			Unique genetic responses revealed in RNA-seq of the spleen of chickens stimulated with lipopolysaccharide and short-term heat	PLOS ONE			English	Article							STRESS IMPAIRS PERFORMANCE; ACUTE-PHASE PROTEINS; ESCHERICHIA-COLI; BROILER-CHICKENS; INFLAMMATORY RESPONSE; IMMUNE-RESPONSES; VITAMIN-E; TEMPERATURE; EXPRESSION; PARAMETERS	Climate change and disease have large negative impacts on poultry production, but little is known about the interactions of responses to these stressors in chickens. Fayoumi (heat and disease resistant) and broiler (heat and disease susceptible) chicken lines were stimulated at 22 days of age, using a 2x2x2 factorial design including: breed (Fayoumi or broiler), inflammatory stimulus (lipopolysaccharide (LPS) or saline), and temperature (35 degrees C or 25 degrees C). Transcriptional changes in spleens were analyzed using RNA-sequencing on the Illumina HiSeq 2500. Thirty-two individual cDNA libraries were sequenced (four per treatment) and an average of 22 million reads were generated per library. Stimulation with LPS induced more differentially expressed genes (DEG, log2 fold change >= 2 and FDR <= 0.05) in the broiler (N = 283) than the Fayoumi (N = 85), whereas heat treatment resulted in fewer DEG in broiler (N = 22) compared to Fayoumi (N = 107). The double stimulus of LPS+ heat induced the largest numbers of changes in gene expression, for which broiler had 567 DEG and Fayoumi had 1471 DEG of which 399 were shared between breeds. Further analysis of DEG revealed pathways impacted by these stressors such as Remodelling of Epithelial Adherens Junctions due to heat stress, Granulocyte Adhesion and Diapedesis due to LPS, and Hepatic Fibrosis/Hepatic Stellate Cell Activation due to LPS+ heat. The genes and pathways identified provide deeper understanding of the response to the applied stressors and may serve as biomarkers for genetic selection for heat and disease tolerant chickens.	[Van Goor, Angelica; Rothschild, Max F.; Lamont, Susan J.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Ashwell, Chris M.] North Carolina State Univ, Dept Poultry Sci, Box 7608, Raleigh, NC 27695 USA; [Persia, Michael E.] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA; [Schmidt, Carl J.] Univ Delaware, Dept Anim & Food Sci, Newark, DE USA	Iowa State University; University of North Carolina; North Carolina State University; Virginia Polytechnic Institute & State University; University of Delaware	Lamont, SJ (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	sjlamont@iastate.edu	; Ashwell, Christopher/N-1332-2016	Schmidt, Carl/0000-0002-8386-4781; Ashwell, Christopher/0000-0002-8190-1147	U.S. Department of Agriculture [2011-38420-20050]; National Institute of Food and Agriculture [5358, 2011-67003-30228]	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by: U.S. Department of Agriculture (http.//www.usda.gov/), Award Number: 2011-38420-20050, Recipient: Susan J. Lamont; National Institute of Food and Agriculture (http://www.usda.gov/), Award Number: 5358, Recipient: Susan J. Lamont; National Institute of Food and Agriculture (http://www.usda.gov/), Award Number: 2011-67003-30228, Recipient: Carl J Schmidt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2009, POULTRY SCI, V88, P744, DOI 10.3382/ps.2008-00419; Alam MS, 2010, P NATL ACAD SCI USA, V107, P5943, DOI 10.1073/pnas.0911755107; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Bartlett JR, 2003, POULTRY SCI, V82, P1580, DOI 10.1093/ps/82.10.1580; BIGGS PM, 1982, AVIAN PATHOL, V11, P281, DOI 10.1080/03079458208436101; Casebere KR, 2015, 661 AS AN IND; Chartoumpekis DV, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/340731; Cheeseman JH, 2007, DEV COMP IMMUNOL, V31, P52, DOI 10.1016/j.dci.2006.04.001; Cheng HW, 2004, POULTRY SCI, V83, P707, DOI 10.1093/ps/83.5.707; Chin CD, 2012, LAB CHIP, V12, P2118, DOI 10.1039/c2lc21204h; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; De Boever S, 2008, AVIAN PATHOL, V37, P39, DOI 10.1080/03079450701784875; DEATON JW, 1978, POULTRY SCI, V57, P1070, DOI 10.3382/ps.0571070; Deeb N, 2002, J HERED, V93, P107, DOI 10.1093/jhered/93.2.107; Deng W, 2012, POULTRY SCI, V91, P575, DOI 10.3382/ps.2010-01293; DONKER RA, 1990, POULTRY SCI, V69, P599, DOI 10.3382/ps.0690599; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GRABER CD, 1971, J AMER MED ASSOC, V216, P1195, DOI 10.1001/jama.216.7.1195; Haley P, 2005, TOX PATHOL, V33; HELLER ED, 1979, AVIAN PATHOL, V8, P195, DOI 10.1080/03079457908418345; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; JONES CA, 1981, POULTRY SCI, V60, P2189, DOI 10.3382/ps.0602189; JONES CA, 1983, POULTRY SCI, V62, P1553, DOI 10.3382/ps.0621553; Kaiser MG, 2012, POULTRY SCI, V91, P1893, DOI 10.3382/ps.2011-02116; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; KOGUT MH, 1994, MICROB PATHOGENESIS, V16, P141, DOI 10.1006/mpat.1994.1015; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; Leshchinsky TV, 2001, DEV COMP IMMUNOL, V25, P629, DOI 10.1016/S0145-305X(01)00023-4; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P287; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P117; Mashaly MM, 2004, POULTRY SCI, V83, P889, DOI 10.1093/ps/83.6.889; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; MELTZER A, 1982, BRIT POULTRY SCI, V23, P383, DOI 10.1080/00071688208447972; Meltzer A., 1983, BRIT POULT SCI, V24; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; NAKAMURA K, 1985, VET PATHOL, V22, P592, DOI 10.1177/030098588502200614; Nakamura K, 1998, POULTRY SCI, V77, P908, DOI 10.1093/ps/77.6.908; NATHAN D B, 1976, British Poultry Science, V17, P481, DOI 10.1080/00071667608416303; Niu ZY, 2009, POULTRY SCI, V88, P2101, DOI 10.3382/ps.2009-00220; NRC, 2001, NUTR REQ POULTR, P1262; Ostberg JR, 2000, J LEUKOCYTE BIOL, V68, P815; Post J, 2003, POULTRY SCI, V82, P1313, DOI 10.1093/ps/82.8.1313; Quinteiro WM, 2012, AVIAN PATHOL, V41, P421, DOI 10.1080/03079457.2012.709315; Quinteiro WM, 2012, J ANIM SCI, V90, P1986, DOI 10.2527/jas.2011-3949; Quinteiro WM, 2010, POULTRY SCI, V89, P1905, DOI 10.3382/ps.2010-00812; Redmond SB, 2009, VET IMMUNOL IMMUNOP, V132, P129, DOI 10.1016/j.vetimm.2009.05.010; SIJTSMA SR, 1991, DEV COMP IMMUNOL, V15, P349, DOI 10.1016/0145-305X(91)90027-V; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Star L, 2009, POULTRY SCI, V88, P2253, DOI 10.3382/ps.2008-00373; USDA, 2012, CLIM CHANG SCI WHIT; Van Goor A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2601-x; Van Goor A, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0176-7; VANDERHEL W, 1991, POULTRY SCI, V70, P1882, DOI 10.3382/ps.0701882; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Yao M, 2008, ENDOCRINOLOGY, V149, P2352, DOI 10.1210/en.2007-1551; Zhou WT, 1997, BRIT POULTRY SCI, V38, P107, DOI 10.1080/00071669708417949	61	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171414	10.1371/journal.pone.0171414	http://dx.doi.org/10.1371/journal.pone.0171414			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166270	Green Published, Green Submitted, gold			2022-12-26	WOS:000393700100039
J	Sok, SPM; Arshad, NM; Azmi, MN; Awang, K; Ozpolat, B; Nagoor, NH				Sok, Sophia P. M.; Arshad, Norhafiza M.; Azmi, Mohamad Nurul; Awang, Khalijah; Ozpolat, Bulent; Nagoor, Noor Hasima			The apoptotic effect of 1 ' S-1 '-Acetoxychavicol Acetate (ACA) enhanced by inhibition of noncanonical autophagy in human non-small cell lung cancer cells	PLOS ONE			English	Article							1'-ACETOXYCHAVICOL ACETATE; DEATH; RESVERATROL; EXPRESSION; RESISTANCE; BCL-2; ROS	Autophagy plays a role in deciding the fate of cells by inducing either survival or death. 1'S-1- acetoxychavicol acetate (ACA) is a phenylpropanoid isolated from rhizomes of Alpinia conchigera and has been reported previously on its apoptotic effects on various cancers. However, the effect of ACA on autophagy remains ambiguous. The aims of this study were to investigate the autophagy-inducing ability of ACA in human non-small cell lung cancer (NSCLC), and to determine its role as pro-survival or pro-death mechanism. Cell viability assay was conducted using MTT. The effect of autophagy was assessed by acridine orange staining, GFP-LC3 punctate formation assay, and protein level were analysed using western blot. Annexin V-FITC/PI staining was performed to detect percentage of cells undergoing apoptosis by using flow cytometry. ACA inhibits the cell viability and induced formation of cytoplasmic vacuoles in NSCLC cells. Acidic vesicular organelles and GFP-LC3 punctate formation were increased in response to ACA exposure in A549 and SK-LU-1 cell lines; implying occurrence of autophagy. In western blot, accumulation of LC3-II accompanied by degradation of p62 was observed, which further confirmed the full flux of autophagy induction by ACA. The reduction of Beclin-1 upon ACA treatment indicated the Beclin-1-independent autophagy pathway. An early autophagy inhibitor, 3-methyaldenine (3-MA), failed to suppress the autophagy triggered by ACA; validating the existence of Beclin-1-independent autophagy. Silencing of LC3-II using short interfering RNA (siRNA) abolished the autophagy effects, enhancing the cytotoxicity of ACA through apoptosis. This proposed ACA triggered a pro-survival autophagy in NSCLC cells. Consistently, co-treatment with lysosomal inhibitor, chloroquine (CQ), exerted a synergistic effect resulting in apoptosis. Our findings suggested ACA induced pro-survival autophagy through Beclin-1-independent pathway in NSCLC. Hence, targeting autophagy pathway using autophagy inhibitor such as CQ represented a novel promising approach to potentiate the cytotoxicity of ACA through apoptosis in NSCLC.	[Sok, Sophia P. M.; Arshad, Norhafiza M.; Nagoor, Noor Hasima] Univ Malaya, Inst Biol Sci Genet & Mol Biol, Fac Sci, Kuala Lumpur, Malaysia; [Arshad, Norhafiza M.; Nagoor, Noor Hasima] Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Malaysia; [Azmi, Mohamad Nurul; Awang, Khalijah] Univ Malaya, Dept Chem, Ctr Nat Prod Res & Drug Discovery CENAR, Fac Sci, Kuala Lumpur, Malaysia; [Ozpolat, Bulent] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Universiti Malaya; Universiti Malaya; Universiti Malaya; University of Texas System; UTMD Anderson Cancer Center	Nagoor, NH (corresponding author), Univ Malaya, Inst Biol Sci Genet & Mol Biol, Fac Sci, Kuala Lumpur, Malaysia.; Nagoor, NH (corresponding author), Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Malaysia.	hasima@um.edu.my	PITCHAI, NOOR HASIMA A K NAGOOR/B-9270-2010; ARSHAD, NORHAFIZA MOHD/N-7615-2018; AWANG, KHALIJAH/B-8781-2010; Mohamad Taib, Mohamad Nurul Azmi/L-5644-2016; Sok, Sophia P. M./AAA-6067-2021	ARSHAD, NORHAFIZA MOHD/0000-0003-1522-3373; AWANG, KHALIJAH/0000-0001-5971-6570; Mohamad Taib, Mohamad Nurul Azmi/0000-0002-2447-0897; Sok, Sophia P. M./0000-0001-5084-068X; Nagoor, Noor Hasima/0000-0003-3905-3129	Ministry of Science Technology and Innovation and University of Malaya through Science Fund [SF014-2013]; Research University Operation Grant, NHN [RU005C-2014]	Ministry of Science Technology and Innovation and University of Malaya through Science Fund; Research University Operation Grant, NHN	This work was supported by Ministry of Science Technology and Innovation and University of Malaya through Science Fund (SF014-2013) and Research University Operation Grant (RU005C-2014) respectively, NHN. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshad NM, 2015, ONCOTARGET, V6, P16151, DOI 10.18632/oncotarget.3951; Awang K, 2010, MOLECULES, V15, P8048, DOI 10.3390/molecules15118048; Chen WL, 2016, BMC CANCER, V16, DOI 10.1186/s12885-015-1988-0; Copetti T, 2009, AUTOPHAGY, V5, P858, DOI 10.4161/auto.8822; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; Dupont N, 2013, CURR PATHOBIOL REP, V1, P263, DOI [10.1007/s40139-013-0030-y, DOI 10.1007/S40139-013-0030-Y]; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gao P, 2010, J BIOL CHEM, V285, P25570, DOI 10.1074/jbc.M110.118125; Goldberg SB, 2012, J THORAC ONCOL, V7, P1602, DOI 10.1097/JTO.0b013e318262de4a; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hasima N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.467; Hsieh MJ, 2014, TOXICOL SCI, V137, P65, DOI 10.1093/toxsci/kft238; In LLA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-179; Ito K, 2004, CLIN CANCER RES, V10, P2120, DOI 10.1158/1078-0432.CCR-1142-03; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Kaminskyy VO, 2012, AUTOPHAGY, V8, P1032, DOI 10.4161/auto.20123; Kato R, 2014, CHEM-BIOL INTERACT, V212, P1, DOI 10.1016/j.cbi.2014.01.010; Kim JY, 2012, ARCH ORAL BIOL, V57, P1018, DOI 10.1016/j.archoralbio.2012.04.005; Lee YJ, 2011, KOREAN J PHYSIOL PHA, V15, P1, DOI 10.4196/kjpp.2011.15.1.1; Liu BQ, 2013, AUTOPHAGY, V9, P905, DOI 10.4161/auto.24292; Liu C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-622; Miki H, 2012, INT J ONCOL, V40, P1020, DOI 10.3892/ijo.2012.1325; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Ozpolat B, 2015, CANCER MANAG RES, V7, P291, DOI 10.2147/CMAR.S34859; PAGLIN S, 2001, CANC RES, V61; Phuah NH, 2013, REPROD SCI, V20, P567, DOI 10.1177/1933719112459220; Ricci MS, 2006, ONCOLOGIST, V11, P342, DOI 10.1634/theoncologist.11-4-342; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Smith DM, 2010, CELL DEATH DIFFER, V17, P1867, DOI 10.1038/cdd.2010.53; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Tang MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119135; Wang G, 2016, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND ENGINEERING MANAGEMENT: INNOVATION AND PRACTICE IN INDUSTRIAL ENGINEERING AND MANAGEMENT (VOL 2), P3, DOI 10.2991/978-94-6239-177-2_1; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Wu M, 2015, PHYTOMEDICINE, V22, P902, DOI 10.1016/j.phymed.2015.06.008; Zou YY, 2013, J THORAC ONCOL, V8, P693, DOI 10.1097/JTO.0b013e31828c7210	35	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171329	10.1371/journal.pone.0171329	http://dx.doi.org/10.1371/journal.pone.0171329			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158287	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000396161700061
J	Zahavi, T; Maimon, A; Kushnir, T; Lange, R; Berger, E; Kornspan, D; Grossman, R; Anzi, S; Shaulian, E; Karni, R; Nechushtan, H; Paroush, Z				Zahavi, T.; Maimon, A.; Kushnir, T.; Lange, R.; Berger, E.; Kornspan, D.; Grossman, R.; Anzi, S.; Shaulian, E.; Karni, R.; Nechushtan, H.; Paroush, Z.			Ras-Erk signaling induces phosphorylation of human TLE1 and downregulates its repressor function	ONCOGENE			English	Article							GROUCHO-MEDIATED REPRESSION; RECEPTOR TYROSINE KINASES; GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; CO-REPRESSORS; TRANSCRIPTION FACTORS; BREAST-CANCER; IN-VIVO; DROSOPHILA; PATHWAYS	Signaling mediated by the Ras-extracellular signal-regulated kinase (Erk) pathway often leads to the phosphorylation of transcriptional regulators, thereby modulating their activity and causing concerted changes in gene expression. In Drosophila, the induction of multiple Ras-Erk pathway target genes depends on prior phosphorylation of the general co-repressor Groucho, a modification that downregulates its repressive function. Here, we show that TLE1, one of the four human Groucho orthologs, is similarly phosphorylated in response to Ras-Erk pathway activation, and that this modification attenuates its capacity to repress transcription. Specifically, unphosphorylated TLE1 dominantly suppresses the induction of Ras-Erk pathway target genes in cultured human cells, and the expression of an unphosphorylatable TLE1 derivative causes severe phenotypes in a transgenic Drosophila model system, whereas a phosphomimetic variant of TLE1 exerts only negligible effects. We present data indicating that TLE1 is rapidly excluded from the nucleus following epidermal growth factor receptor pathway activation, an effect that likely accounts for its inability to mediate effective repression under such conditions. Significantly, we find that unphosphorylated TLE1 blocks oncogenic phenotypes induced by mutated H-Ras in human mammary cells, both in vitro and following their implantation in mice. Collectively, our data strongly indicate that phosphorylation of TLE family members and the consequent downregulation of their repressor function is a key conserved step in the transcriptional responses to Ras-Erk signaling, and possibly a critical event in the tumorigenic effects caused by excessive Ras-Erk pathway activity.	[Zahavi, T.; Kushnir, T.; Lange, R.; Berger, E.; Kornspan, D.; Grossman, R.; Paroush, Z.] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Dev Biol & Canc Res, POB 12272, IL-91120 Jerusalem, Israel; [Maimon, A.; Anzi, S.; Shaulian, E.; Karni, R.] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Biochem & Mol Biol, Jerusalem, Israel; [Kornspan, D.; Nechushtan, H.] Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Dept Oncol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Paroush, Z (corresponding author), Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Dev Biol & Canc Res, POB 12272, IL-91120 Jerusalem, Israel.	zparoush@cc.huji.ac.il	nechushtan, hovav/Z-3564-2019	Shaulian, Eitan/0000-0001-6242-6849; Kornspan, David/0000-0001-6848-2323	Israel Cancer Research Fund; Israel Science Foundation [1772/13, 1552/16]; Jan M and Eugenia Krol Charitable Foundation; Israel Cancer Association; Tsipora and Moshe Levin Foundation; Carole Annette Stevens-Walvish Postdoctoral Fellowship in Cancer Research; Lady Davis Postdoctoral Fellowship; Israel Cancer Research Fund Booster Fellowship	Israel Cancer Research Fund; Israel Science Foundation(Israel Science Foundation); Jan M and Eugenia Krol Charitable Foundation; Israel Cancer Association; Tsipora and Moshe Levin Foundation; Carole Annette Stevens-Walvish Postdoctoral Fellowship in Cancer Research; Lady Davis Postdoctoral Fellowship; Israel Cancer Research Fund Booster Fellowship	We thank members of our laboratory for continued help and encouragement during this project; David Engelberg, Shulamit Katzav, Oded Meyuhas, Joel Yisraeli and, particularly, Gerardo Jimenez for their insightful comments on the manuscript; Yosef Yarden and Stefano Stifani for providing us with DNA constructs and reagents; Konstantin Kogan, Vered Levin-Salomon and David Engelberg for their assistance with the Erk2 in vitro kinase assays and for contributing recombinant activated Erk2; Ahmad Mreisat for technical help; and Amir Orian for hosting TZ in his laboratory for some of her experiments. Work was supported by grants from the Israel Cancer Research Fund (Project Grant), Israel Science Foundation (Center of Excellence 1772/13 and 1552/16), and the Jan M and Eugenia Krol Charitable Foundation to ZP; and by the Israel Cancer Association to HN. TK received a Doctoral Fellowship from the Tsipora and Moshe Levin Foundation. DK is a recipient of a Carole Annette Stevens-Walvish Postdoctoral Fellowship in Cancer Research, a Lady Davis Postdoctoral Fellowship and an Israel Cancer Research Fund Booster Fellowship. ZP is an incumbent of the Lady Davis Professorship in Experimental Medicine and Cancer Research.	Agarwal M, 2015, IUBMB LIFE, V67, P472, DOI 10.1002/iub.1395; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Barker N, 2000, ADV CANCER RES, V77, P1; Beagle B, 2010, DEV DYNAM, V239, P2795, DOI 10.1002/dvdy.22439; Ben-Hur V, 2013, CELL REP, V3, P103, DOI 10.1016/j.celrep.2012.11.020; Bezniakow Natalia, 2014, Dev Period Med, V18, P285; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Cinnamon E, 2008, DEVELOPMENT, V135, P829, DOI 10.1242/dev.015206; Cinnamon E, 2008, CURR OPIN GENET DEV, V18, P435, DOI 10.1016/j.gde.2008.07.010; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; DAVIDSON NE, 1987, MOL ENDOCRINOL, V1, P216, DOI 10.1210/mend-1-3-216; Dayyani F, 2008, BLOOD, V111, P4338, DOI 10.1182/blood-2007-07-103291; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DELIDAKIS C, 1991, GENETICS, V129, P803; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; Goldstein RE, 2005, MOL CELL BIOL, V25, P10711, DOI 10.1128/MCB.25.24.10711-10720.2005; Hasson P, 2006, BRIT J CANCER, V94, P771, DOI 10.1038/sj.bjc.6603019; Hasson P, 2005, NAT GENET, V37, P101, DOI 10.1038/ng1486; Hasson P, 2001, EMBO J, V20, P5725, DOI 10.1093/emboj/20.20.5725; Helman A, 2012, DEVELOPMENT, V139, P3032, DOI 10.1242/dev.075812; Helman A, 2011, CURR BIOL, V21, P1102, DOI 10.1016/j.cub.2011.05.043; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Johnston MJ, 2016, DEVELOPMENT, V143, P4631, DOI 10.1242/dev.143263; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kim Y, 2010, CURR BIOL, V20, P446, DOI 10.1016/j.cub.2010.01.019; Kwong PN, 2015, J BIOL CHEM, V290, P30119, DOI 10.1074/jbc.M115.681171; Lee S, 2010, MOL CELL BIOL, V30, P2621, DOI 10.1128/MCB.00782-09; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Li Z, 2016, CELL DEATH DIFFER, V23, P583, DOI 10.1038/cdd.2015.125; Lien WH, 2014, NAT CELL BIOL, V16, P179, DOI 10.1038/ncb2903; Maimon A, 2014, CELL REP, V7, P501, DOI 10.1016/j.celrep.2014.03.041; McCurrach ME, 2001, METHOD CELL BIOL, V66, P197; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Mrozek K, 2008, CURR OPIN ONCOL, V20, P711, DOI 10.1097/CCO.0b013e32831369df; Paroush Z, 1997, DEVELOPMENT, V124, P3827; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Turki-Judeh W, 2012, CURR TOP DEV BIOL, V98, P65, DOI 10.1016/B978-0-12-386499-4.00003-3; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Yogev O, 2008, CANCER RES, V68, P1398, DOI 10.1158/0008-5472.CAN-07-2865	47	6	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 29	2017	36	26					3729	3739		10.1038/onc.2016.517	http://dx.doi.org/10.1038/onc.2016.517			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY9WM	28192406				2022-12-26	WOS:000404349700008
J	Alonge, KM; Meares, GP; Hillgartner, FB				Alonge, Kimberly M.; Meares, Gordon P.; Hillgartner, F. Bradley			Glucagon and Insulin Cooperatively Stimulate Fibroblast Growth Factor 21 Gene Transcription by Increasing the Expression of Activating Transcription Factor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; LIPID-METABOLISM; RAT HEPATOCYTES; PPAR-ALPHA; X RECEPTOR; HEPATIC GLUCONEOGENESIS; AKT ACTIVATION; BILE-ACIDS; FGF21	Previous studies have shown that glucagon cooperatively interacts with insulin to stimulate hepatic FGF21 gene expression. Here we investigated the mechanism by which glucagon and insulin increased FGF21 gene transcription in primary hepatocyte cultures. Transfection analyses demonstrated that glucagon plus insulin induction of FGF21 transcription was conferred by two activating transcription factor 4 (ATF4) binding sites in the FGF21 gene. Glucagon plus insulin stimulated a 5-fold increase in ATF4 protein abundance, and knockdown of ATF4 expression suppressed the ability of glucagon plus insulin to increase FGF21 expression. In hepatocytes incubated in the presence of insulin, treatment with a PKA-selective agonist mimicked the ability of glucagon to stimulate ATF4 and FGF21 expression. Inhibition of PKA, PI3K, Akt, and mammalian target of rapamycin complex 1 (mTORC1) suppressed the ability of glucagon plus insulin to stimulate ATF4 and FGF21 expression. Additional analyses demonstrated that chenodeoxycholic acid (CDCA) induced a 6-fold increase in ATF4 expression and that knockdown of ATF4 expression suppressed the ability of CDCA to increase FGF21 gene expression. CDCA increased the phosphorylation of eIF2 alpha, and inhibition of eIF2 alpha signaling activity suppressed CDCA regulation of ATF4 and FGF21 expression. These results demonstrate that glucagon plus insulin increases FGF21 transcription by stimulating ATF4 expression and that activation of cAMP/PKA and PI3K/Akt/mTORC1 mediates the effect of glucagon plus insulin on ATF4 expression. These results also demonstrate that CDCA regulation of FGF21 transcription is mediated at least partially by an eIF2 alpha-dependent increase in ATF4 expression.	[Alonge, Kimberly M.; Hillgartner, F. Bradley] West Virginia Univ, Dept Biochem, POB 9142, Morgantown, WV 26506 USA; [Meares, Gordon P.] West Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA	West Virginia University; West Virginia University	Hillgartner, FB (corresponding author), West Virginia Univ, Dept Biochem, POB 9142, Morgantown, WV 26506 USA.	fbhillgartner@hsc.wvu.edu	Meares, Gordon/AAJ-6716-2020	Meares, Gordon/0000-0002-0805-0155; Alonge, Kimberly/0000-0002-2171-1640	American Heart Association [17GRNT33210002]; American Diabetes Association Basic Science Award [1-12-BS-75]; West Virginia University Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Diabetes Association Basic Science Award(American Diabetes Association); West Virginia University Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Grant-in-aid 17GRNT33210002 (to F.B.H.), American Diabetes Association Basic Science Award 1-12-BS-75 (to F.B.H.), and a West Virginia University Foundation distinguished doctoral scholarship (to K.M.A.). The authors declare that they have no conflicts of interest with the contents of this article.	Almahariq M, 2014, TRENDS ENDOCRIN MET, V25, P60, DOI 10.1016/j.tem.2013.10.004; Anand P, 2005, J BIOL CHEM, V280, P16427, DOI 10.1074/jbc.M410576200; Arisawa S, 2009, BIOCHEM PHARMACOL, V77, P858, DOI 10.1016/j.bcp.2008.11.012; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; BEEBE SJ, 1988, METHOD ENZYMOL, V159, P118; Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853; BUCHER NLR, 1975, P NATL ACAD SCI USA, V72, P1157, DOI 10.1073/pnas.72.3.1157; Cai K, 2013, BIOCHEM J, V454, P267, DOI 10.1042/BJ20130609; Carey M.F., 2009, COLD SPRING HARB PRO, V2009; Chan CP, 2013, BBA-MOL CELL RES, V1833, P2165, DOI 10.1016/j.bbamcr.2013.05.002; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cook JR, 2015, J BIOL CHEM, V290, P13972, DOI 10.1074/jbc.M115.638197; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Cyphert HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094996; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; De Sousa-Coelho AL, 2013, J LIPID RES, V54, P1786, DOI 10.1194/jlr.M033415; Dent P, 2005, HEPATOLOGY, V42, P1291, DOI 10.1002/hep.20942; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Furusawa Y, 2014, GENES CELLS, V19, P864, DOI 10.1111/gtc.12186; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Haeusler RA, 2010, J BIOL CHEM, V285, P26861, DOI 10.1074/jbc.M110.134023; Hansmannel F, 2006, BIOCHEM J, V399, P275, DOI 10.1042/BJ20060811; HIDAKA H, 1991, METHOD ENZYMOL, V201, P328; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Jiang S, 2014, J BIOL CHEM, V289, P29751, DOI 10.1074/jbc.M114.565960; Kelly P, 2010, J BIOL CHEM, V285, P15777, DOI 10.1074/jbc.M109.069112; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kharitonenkov A, 2015, TRENDS ENDOCRIN MET, V26, P608, DOI 10.1016/j.tem.2015.09.007; Kimura M, 1997, EUR J PHARMACOL, V327, P87, DOI 10.1016/S0014-2999(97)89682-3; Laeger T, 2016, CELL REP, V16, P707, DOI 10.1016/j.celrep.2016.06.044; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Sokolovic M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-528; Stabile LP, 1998, J LIPID RES, V39, P1951; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tsai BP, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140180; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yang HH, 2016, J MOL ENDOCRINOL, V57, pR93, DOI 10.1530/JME-15-0316; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348	62	22	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5239	5252		10.1074/jbc.M116.762922	http://dx.doi.org/10.1074/jbc.M116.762922			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28188284	Green Published, hybrid			2022-12-26	WOS:000397875500008
J	Remesh, SG; Andreatta, M; Ying, G; Kaever, T; Nielsen, M; McMurtrey, C; Hildebrand, W; Peters, B; Zajonc, DM				Remesh, Soumya G.; Andreatta, Massimo; Ying, Ge; Kaever, Thomas; Nielsen, Morten; McMurtrey, Curtis; Hildebrand, William; Peters, Bjoern; Zajonc, Dirk M.			Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01 BREAKING CONFINEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII; T-CELLS; INTERFERON-GAMMA; PARASITE BURDEN; TAP TRANSPORT; MOLECULES; RECEPTOR; EPITOPES; MICE; ENCEPHALITIS	Peptide antigen presentation by major histocompatibility complex (MHC) class I proteins initiates CD8(+) T cell-mediated immunity against pathogens and cancers. MHCI molecules typically bind peptides with 9 amino acids in length with both ends tucked inside the major A and F binding pockets. It has been known for a while that longer peptides can also bind by either bulging out of the groove in the middle of the peptide or by binding in a zigzag fashion inside the groove. In a recent study, we identified an alternative binding conformation of naturally occurring peptides from Toxoplasma gondii bound by HLA-A*02:01. These peptides were extended at the C terminus (P Omega) and contained charged amino acids not more than 3 residues after the anchor amino acid at P Omega, which enabled them to open the F pocket and expose their C-terminal extension into the solvent. Here, we show that the mechanism of F pocket opening is dictated by the charge of the first charged amino acid found within the extension. Although positively charged amino acids result in the Tyr-84 swing, amino acids that are negatively charged induce a not previously described Lys-146 lift. Furthermore, we demonstrate that the peptides with alternative binding modes have properties that fit very poorly to the conventional MHC class I pathway and suggest they are presented via alternative means, potentially including cross-presentation via the MHC class II pathway.	[Remesh, Soumya G.; Ying, Ge; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Circle, La Jolla, CA 92037 USA; [Andreatta, Massimo; Kaever, Thomas; Peters, Bjoern] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Andreatta, Massimo; Nielsen, Morten] Univ Nacl San Martin, Inst Invest Biotecnol, RA-1650 San Martin, Argentina; [Nielsen, Morten] Tech Univ Denmark, Dept Bio & Hlth Informat, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [McMurtrey, Curtis; Hildebrand, William] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [McMurtrey, Curtis; Hildebrand, William] Pure MHC LLC, San Antonio, TX 78229 USA; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; La Jolla Institute for Immunology; Technical University of Denmark; University of Oklahoma System; University of Oklahoma Health Sciences Center; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.	dzajonc@lji.org	Nielsen, Morten/AAL-8700-2020; Remesh, Soumya G/I-3558-2019; Andreatta, Massimo/AAA-4061-2020	Nielsen, Morten/0000-0001-7885-4311; Andreatta, Massimo/0000-0002-8036-2647	National Institutes of Health [AI128609, AI062629]; Immune Epitope Database National Institutes of Health [HHSN272201200010C]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062629, R21AI128609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immune Epitope Database National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AI128609 (to D.M.Z.) and AI062629 (subcontract to W.H.) and Immune Epitope Database National Institutes of Health Contract HHSN272201200010C (to B.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Blanchard N, 2010, TRENDS IMMUNOL, V31, P414, DOI 10.1016/j.it.2010.08.004; Burrows SR, 2006, TRENDS IMMUNOL, V27, P11, DOI 10.1016/j.it.2005.11.001; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cong H, 2012, HUM IMMUNOL, V73, P1, DOI 10.1016/j.humimm.2011.10.006; Cong H, 2011, VACCINE, V29, P754, DOI 10.1016/j.vaccine.2010.11.015; DECKERTSCHLUTER M, 1994, INFECT IMMUN, V62, P221; Denkers EY, 1999, MICROBES INFECT, V1, P699, DOI 10.1016/S1286-4579(99)80071-9; Dubey JP., 2010, PARASIT VECTORS, V3, P112, DOI [10.1186/1756-3305-3-112, DOI 10.1186/1756-3305-3-112]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grover HS, 2012, INFECT IMMUN, V80, P3279, DOI 10.1128/IAI.00425-12; HAKIM FT, 1991, J IMMUNOL, V147, P2310; Hassan C, 2015, J BIOL CHEM, V290, P2593, DOI 10.1074/jbc.M114.607028; ISRAELSKI DM, 1993, CLIN INFECT DIS, V17, pS423, DOI 10.1093/clinids/17.Supplement_2.S423; Leroux LP, 2015, INT J PARASITOL, V45, P319, DOI 10.1016/j.ijpara.2015.01.003; Luder CGK, 2001, INT J PARASITOL, V31, P1355, DOI 10.1016/S0020-7519(01)00260-0; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMurtrey C, 2016, ELIFE, V5, DOI 10.7554/eLife.12556; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Saunders PM, 2015, IMMUNOL REV, V267, P148, DOI 10.1111/imr.12319; Schaible UE, 2000, J IMMUNOL, V164, P4843, DOI 10.4049/jimmunol.164.9.4843; Schittenhelm RB, 2015, ARTHRITIS RHEUMATOL, V67, P702, DOI 10.1002/art.38963; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Vivier E, 2004, NAT REV IMMUNOL, V4, P190, DOI 10.1038/nri1306	36	36	37	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5262	5270		10.1074/jbc.M117.776542	http://dx.doi.org/10.1074/jbc.M117.776542			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28179428	Green Published, hybrid			2022-12-26	WOS:000397875500010
J	Omar, S; Clarke, R; Abdullah, H; Brady, C; Corry, J; Winter, H; Touzelet, O; Power, UF; Lundy, F; McGarvey, LPA; Cosby, SL				Omar, Shadia; Clarke, Rebecca; Abdullah, Haniah; Brady, Clare; Corry, John; Winter, Hanagh; Touzelet, Olivier; Power, Ultan F.; Lundy, Fionnuala; McGarvey, Lorcan P. A.; Cosby, S. Louise			Respiratory virus infection up-regulates TRPV1, TRPA1 and ASICS3 receptors on airway cells	PLOS ONE			English	Article							SENSING ION CHANNELS; POTENTIAL VANILLOID-1; EXPRESSION; ACTIVATION; NEURONS; PROTEIN; MECHANISMS; RELEASE; ASTHMA; IL-8	Receptors implicated in cough hypersensitivity are transient receptor potential vanilloid 1 (TRPV1), transient receptor potential cation channel, Subfamily A, Member 1 (TRPA1) and acid sensing ion channel receptor 3 (ASIC3). Respiratory viruses, such as respiratory syncytial virus (RSV) and measles virus (MV) may interact directly and/or indirectly with these receptors on sensory nerves and epithelial cells in the airways. We used in vitro models of sensory neurones (SHSY5Y or differentiated IMR-32 cells) and human bronchial epithelium (BEAS-2B cells) as well as primary human bronchial epithelial cells (PBEC) to study the effect of MV and RSV infection on receptor expression. Receptor mRNA and protein levels were examined by qPCR and flow cytometry, respectively, following infection or treatment with UV inactivated virus, virus-induced soluble factors or pelleted virus. Concentrations of a range of cytokines in resultant BEAS-2B and PBEC supernatants were determined by ELISA. Up-regulation of TRPV1, TRPA1 and ASICS3 expression occurred by 12 hours postinfection in each cell type. This was independent of replicating virus, within the same cell, as virus-induced soluble factors alone were sufficient to increase channel expression. IL-8 and IL-6 increased in infected cell supernatants. Antibodies against these factors inhibited TRP receptor up-regulation. Capsazepine treatment inhibited virus induced up-regulation of TRPV1 indicating that these receptors are targets for treating virus-induced cough.	[Omar, Shadia; Clarke, Rebecca; Abdullah, Haniah; Brady, Clare; Corry, John; Winter, Hanagh; Touzelet, Olivier; Power, Ultan F.; Lundy, Fionnuala; McGarvey, Lorcan P. A.; Cosby, S. Louise] Queens Univ Belfast, Ctr Med Expt, Ctr Med Biol, Sch Med Dent & Biomed Sci, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast	Cosby, SL (corresponding author), Queens Univ Belfast, Ctr Med Expt, Ctr Med Biol, Sch Med Dent & Biomed Sci, Belfast BT7 1NN, Antrim, North Ireland.	l.cosby@qub.ac.uk	Linden, Gerard/AFN-7508-2022; Cosby, Louise/W-9239-2019; Lundy, Fionnuala/AAE-7128-2020	Linden, Gerard/0000-0003-1523-3934; Cosby, Louise/0000-0002-2617-8603; Power, Ultan/0000-0003-3246-3774; Lundy, Fionnuala/0000-0003-3150-1150	Department of Education and Learning, Northern Ireland	Department of Education and Learning, Northern Ireland	This work was supported by a Ph.D. studentship from Department of Education and Learning, Northern Ireland.; Shadia Omar was the recipient of a Ph.D. studentship from the Department of Education and Learning, Northern Ireland.	Abdullah H, 2014, THORAX, V69, P46, DOI 10.1136/thoraxjnl-2013-203894; Akopian AN, 2011, CURR PHARM BIOTECHNO, V12, P89; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; BIEDLER JL, 1973, CANCER RES, V33, P2643; Cosby SL, 2002, J NEUROVIROL, V8, P85, DOI 10.1080/13550280290167975; Deval E, 2004, J BIOL CHEM, V279, P19531, DOI 10.1074/jbc.M313078200; Dicpinigaitis Peter V, 2009, Cough, V5, P11, DOI 10.1186/1745-9974-5-11; Du Rand IA, 2013, THORAX, V68, P1, DOI 10.1136/thoraxjnl-2013-203618; Espinoza JA, 2013, P NATL ACAD SCI USA, V110, P9112, DOI 10.1073/pnas.1217508110; Fan X, 2009, BRAIN RES REV, V62, P99, DOI 10.1016/j.brainresrev.2009.09.006; Footitt J, 2009, PULM PHARMACOL THER, V22, P108, DOI 10.1016/j.pupt.2008.12.022; Grace M, 2012, THORAX, V67, P891, DOI 10.1136/thoraxjnl-2011-201443; Groneberg DA, 2004, AM J RESP CRIT CARE, V170, P1276, DOI 10.1164/rccm.200402-174OC; Guo-Parke H, 2013, AM J RESP CRIT CARE, V188, P842, DOI 10.1164/rccm.201304-0750OC; Hatano N, 2012, J BIOL CHEM, V287, P31962, DOI 10.1074/jbc.M112.361139; Hutchins SS, 2004, J INFECT DIS, V189, pS153, DOI 10.1086/379652; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Klouwenberg PK, 2009, CRIT REV IMMUNOL, V29, P531, DOI 10.1615/CritRevImmunol.v29.i6.40; Kollarik M, 2007, PULM PHARMACOL THER, V20, P402, DOI 10.1016/j.pupt.2006.11.010; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Li XQ, 2006, J VIROL, V80, P537, DOI 10.1128/JVI.80.1.537-540.2006; Louhivuori LM, 2009, J CELL PHYSIOL, V221, P67, DOI 10.1002/jcp.21828; McGarvey LP, 2013, J ALLERGY CLIN IMMUN, P01442; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Nagaeva EI, 2015, ACTA NATURAE, V7, P95, DOI 10.32607/20758251-2015-7-2-95-101; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Preti D, 2012, EXPERT OPIN THER PAT, V22, P663, DOI 10.1517/13543776.2012.696099; Ramadori P, 2010, LAB INVEST, V90, P1306, DOI 10.1038/labinvest.2010.85; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rehman R, 2013, INT IMMUNOPHARMACOL, V15, P597, DOI 10.1016/j.intimp.2013.02.010; Ristoiu V, 2011, PAIN, V152, P936, DOI 10.1016/j.pain.2011.02.024; Son GY, 2015, ARCH ORAL BIOL, V60, P526, DOI 10.1016/j.archoralbio.2014.12.014; Sui F, 2010, AM J CHINESE MED, V38, P789, DOI 10.1142/S0192415X1000824X; Sui F, 2010, J ETHNOPHARMACOL, V129, P361, DOI 10.1016/j.jep.2010.03.039; Takemura M, 2008, PULM PHARMACOL THER, V21, P833, DOI 10.1016/j.pupt.2008.09.005; Villenave R, 2013, TRENDS MICROBIOL, V21, P238, DOI 10.1016/j.tim.2013.02.004; Wang Z, 2011, MOL VIS, V17, P3137; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Westerly BD, 2010, IMMUNOL ALLERGY CLIN, V30, P523, DOI 10.1016/j.iac.2010.08.006; Yiangou YG, 2001, EUR J GASTROEN HEPAT, V13, P891, DOI 10.1097/00042737-200108000-00003; Yingjun G, 2013, CHANNELS, P7231; Yousaf Nadia, 2011, Cough, V7, P4, DOI 10.1186/1745-9974-7-4; Zhang F, 2007, J CELL PHYSIOL, V213, P730, DOI 10.1002/jcp.21141	43	57	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171681	10.1371/journal.pone.0171681	http://dx.doi.org/10.1371/journal.pone.0171681			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187208	Green Published, Green Submitted, gold			2022-12-26	WOS:000394244300037
J	Schechner, V; Carmeli, Y; Leshno, M				Schechner, Vered; Carmeli, Yehuda; Leshno, Moshe			A mathematical model of Clostridium difficile transmission in medical wards and a cost-effectiveness analysis comparing different strategies for laboratory diagnosis and patient isolation	PLOS ONE			English	Article							ASYMPTOMATIC CARRIAGE; INFECTION; CARRIERS; EPIDEMIOLOGY; ACQUISITION; STRAIN	Background Clostridium difficile infection (CDI) is a common and potentially fatal healthcare-associated infection. Improving diagnostic tests and infection control measures may prevent transmission. We aimed to determine, in resource-limited settings, whether it is more effective and cost-effective to allocate resources to isolation or to diagnostics. Methods We constructed a mathematical model of CDI transmission based on hospital data (9 medical wards, 350 beds) between March 2010 and February 2013. The model consisted of three compartments: susceptible patients, asymptomatic carriers and CDI patients. We used our model results to perform a cost-effectiveness analysis, comparing four strategies that were different combinations of 2 test methods (the two-step test and uniform PCR) and 2 infection control measures (contact isolation in multiple-bed rooms or single-bed rooms/ cohorting). For each strategy, we calculated the annual cost (of CDI diagnosis and isolation) for a decrease of 1 in the average daily number of CDI patients; the strategy of the two-step test and contact isolation in multiple-bed rooms was the reference strategy. Results Our model showed that the average number of CDI patients increased exponentially as the transmission rate increased. Improving diagnosis by adopting uniform PCR assay reduced the average number of CDI cases per day per 350 beds from 9.4 to 8.5, while improving isolation by using single-bed rooms reduced the number to about 1; the latter was cost saving. Conclusions CDI can be decreased by better isolation and more sensitive laboratory methods. From the hospital perspective, improving isolation is more cost-effective than improving diagnostics.	[Schechner, Vered; Carmeli, Yehuda] Tel Aviv Sourasky Med Ctr, Div Epidemiol, Tel Aviv, Israel; [Leshno, Moshe] Tel Aviv Univ, Fac Management, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University	Schechner, V (corresponding author), Tel Aviv Sourasky Med Ctr, Div Epidemiol, Tel Aviv, Israel.	vereds@tlvmc.gov.il						Adler A, 2014, CLIN MICROBIOL INFEC, V20, P904; Adler A, 2015, DIAGN MICR INFEC DIS, V83, P21, DOI 10.1016/j.diagmicrobio.2015.05.015; BARTLETT JG, 1994, CLIN INFECT DIS, V18, pS265, DOI 10.1093/clinids/18.Supplement_4.S265; Bracco D, 2007, INTENS CARE MED, V33, P836, DOI 10.1007/s00134-007-0559-5; Brecher SM, 2013, CLIN INFECT DIS, V57, P1175, DOI 10.1093/cid/cit424; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Curry SR, 2013, CLIN INFECT DIS, V57, P1094, DOI 10.1093/cid/cit475; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Gingras G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163880; Grein JD, 2014, CLIN MICROBIOL INFEC, V20, P65, DOI 10.1111/1469-0691.12198; Guerrero DM, 2013, J HOSP INFECT, V85, P155, DOI 10.1016/j.jhin.2013.07.002; JOHNSON S, 1990, AM J MED, V88, P137, DOI 10.1016/0002-9343(90)90462-M; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Longtin Y, 2016, JAMA INTERN MED, V176, P796, DOI [10.1001/jamainternmed.2016.0177, 10.1001/jama]; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Mermel LA, 2013, JT COMM J QUAL PATIE, V39, P298, DOI 10.1016/S1553-7250(13)39042-4; Muto CA, 2007, CLIN INFECT DIS, V45, P1266, DOI 10.1086/522654; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Teltsch DY, 2011, ARCH INTERN MED, V171, P32, DOI 10.1001/archinternmed.2010.469; Vedantam G, 2012, GUT MICROBES, V3, P121, DOI 10.4161/gmic.19399; Vonberg RP, 2008, CLIN MICROBIOL INFEC, V14, P2, DOI 10.1111/j.1469-0691.2008.01992.x	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171327	10.1371/journal.pone.0171327	http://dx.doi.org/10.1371/journal.pone.0171327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187144	Green Published, Green Submitted, gold			2022-12-26	WOS:000394244300018
J	Smith, AN; Kabelik, D				Smith, Alexandra N.; Kabelik, David			The effects of dopamine receptor 1 and 2 agonists and antagonists on sexual and aggressive behaviors in male green anoles	PLOS ONE			English	Article							MEDIAL PREOPTIC AREA; MALE-RAT; JAPANESE-QUAIL; CONSUMMATORY ASPECTS; COURTSHIP BEHAVIOR; ACCUMBAL DOPAMINE; NEURAL ACTIVITY; SOCIAL SIGNAL; BROWN ANOLE; CAROLINENSIS	The propensity to exhibit social behaviors during interactions with same-sex and opposite-sex conspecifics is modulated by various neurotransmitters, including dopamine. Dopamine is a conserved neurotransmitter among vertebrates and dopaminergic receptors are also highly conserved among taxa. Activation of D-1 and D-2 dopamine receptor subtypes has been shown to modulate social behaviors, especially in mammalian and avian studies. However, the specific behavioral functions of these receptors vary across taxa. In reptiles there have been few studies examining the relationship between dopaminergic receptors and social behaviors. We therefore examined the effects of D-1 and D-2 agonists and antagonists on sexual and aggressive behaviors in the male green anole lizard (Anolis carolinensis). Treatment with high doses of both D-1 and D-2 agonists was found to impair both sexual and aggressive behaviors. However, the D-1 agonist treatment was also found to impair motor function, suggesting that those effects were likely nonspecific. Lower doses of both agonists and antagonists failed to affect social behaviors. These findings provide some evidence for D-2 receptor regulation of social behaviors, but in contrast with previous research, these effects are all inhibitory and no effects were found for manipulations of D-1 receptors. A potential reason for the lack of more widespread effects on social behaviors using moderate or low drug doses is that systemic injection of drugs resulted in effects throughout the whole brain, thus affecting counteracting circuits which negated one another, making measurable changes in behavioral output difficult to detect. Future studies should administer drugs directly into brain regions known to regulate sexual and aggressive behaviors.	[Smith, Alexandra N.; Kabelik, David] Rhodes Coll, Dept Biol, Memphis, TN 38112 USA; [Smith, Alexandra N.; Kabelik, David] Rhodes Coll, Program Neurosci, Memphis, TN 38112 USA		Kabelik, D (corresponding author), Rhodes Coll, Dept Biol, Memphis, TN 38112 USA.; Kabelik, D (corresponding author), Rhodes Coll, Program Neurosci, Memphis, TN 38112 USA.	kabelikd@rhodes.edu	Kabelik, David/O-9932-2019	Kabelik, David/0000-0002-1196-8071	Rhodes College	Rhodes College	Funding for this study was provided by Rhodes College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AD, 2014, NEUROBIOL LEARN MEM, V108, P65, DOI 10.1016/j.nlm.2013.11.007; AHLENIUS S, 1990, EXPERIENTIA, V46, P1026, DOI 10.1007/BF01940663; ANDERSEN PH, 1990, EUR J PHARM-MOLEC PH, V188, P335, DOI 10.1016/0922-4106(90)90194-3; Balthazart J, 1997, PHYSIOL BEHAV, V62, P571, DOI 10.1016/S0031-9384(97)00163-7; Beck J, 2002, PHYSIOL BEHAV, V76, P91, DOI 10.1016/S0031-9384(02)00678-9; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; BITRAN D, 1989, PHARMACOL BIOCHEM BE, V34, P453, DOI 10.1016/0091-3057(89)90540-6; Castagna C, 1997, PHARMACOL BIOCHEM BE, V58, P403, DOI 10.1016/S0091-3057(97)00243-8; Clemens S, 2012, J NEUROPHYSIOL, V107, P2250, DOI 10.1152/jn.00366.2011; D'Aquila PS, 2003, EUR J PHARMACOL, V460, P71, DOI 10.1016/S0014-2999(02)02881-9; Dennis RL, 2011, POULTRY SCI, V90, P2440, DOI 10.3382/ps.2011-01513; Dominguez JM, 2005, PHYSIOL BEHAV, V86, P356, DOI 10.1016/j.physbeh.2005.08.006; Ferrari PF, 2003, EUR J NEUROSCI, V17, P371, DOI 10.1046/j.1460-9568.2003.02447.x; FOREMAN MM, 1987, J NEURAL TRANSM, V68, P153, DOI 10.1007/BF02098495; Forster GL, 2005, ANIM BEHAV, V69, P733, DOI 10.1016/j.anbehav.2004.06.026; Giuliano F, 2001, EUR UROL, V40, P601, DOI 10.1159/000049844; Goodson JL, 2009, FRONT NEUROENDOCRIN, V30, P429, DOI 10.1016/j.yfrne.2009.05.007; Hoglund E, 2005, BEHAV BRAIN RES, V156, P53, DOI 10.1016/j.bbr.2004.05.009; HULL EM, 1986, BRAIN RES, V370, P73, DOI 10.1016/0006-8993(86)91106-6; HULL EM, 1995, J NEUROSCI, V15, P7465; Kabelik D, 2014, BRAIN RES, V1553, P41, DOI 10.1016/j.brainres.2014.01.026; Kabelik D, 2013, HORM BEHAV, V63, P437, DOI 10.1016/j.yhbeh.2012.11.016; Kabelik D, 2010, NEUROPHARMACOLOGY, V58, P117, DOI 10.1016/j.neuropharm.2009.06.009; Kleitz-Nelson HK, 2010, EUR J NEUROSCI, V32, P118, DOI 10.1111/j.1460-9568.2010.07257.x; Kleitz-Nelson HK, 2010, BEHAV NEUROSCI, V124, P300, DOI 10.1037/a0018767; Kleitz-Nelson HK, 2010, BEHAV NEUROSCI, V124, P773, DOI 10.1037/a0021490; Korzan WJ, 2006, BEHAV NEUROSCI, V120, P93, DOI 10.1037/0735-7044.120.1.93; Korzan WJ, 2000, HORM BEHAV, V38, P193, DOI 10.1006/hbeh.2000.1619; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; LICHT P, 1973, COPEIA, P465; McHenry JA, 2012, BEHAV NEUROSCI, V126, P523, DOI 10.1037/a0028707; Miczek KA, 2002, PSYCHOPHARMACOLOGY, V163, P434, DOI 10.1007/s00213-002-1139-6; NODA K, 1985, Society for Neuroscience Abstracts, V11, P549; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; PFAUS JG, 1991, BEHAV NEUROSCI, V105, P727, DOI 10.1037/0735-7044.105.5.727; PUGLISIALLEGRA S, 1990, AGGRESSIVE BEHAV, V16, P271, DOI 10.1002/1098-2337(1990)16:3/4<271::AID-AB2480160312>3.0.CO;2-H; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Smeets W.J.A.J., 1994, P103; Smeets W. J. A. J., 1994, PHYLOGENY DEV CATECH; SWEIDAN S, 1991, BRAIN RES, V549, P127, DOI 10.1016/0006-8993(91)90608-X; van Erp AMM, 2000, J NEUROSCI, V20, P9320; Watt MJ, 2007, PHYSIOL BEHAV, V90, P567, DOI 10.1016/j.physbeh.2006.11.006; Woolley SC, 2004, PHYSIOL BEHAV, V83, P347, DOI 10.1016/j.physbeh.2004.08.021; Woolley SC, 2001, HORM BEHAV, V40, P483, DOI 10.1006/hbeh.2001.1713	44	8	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172041	10.1371/journal.pone.0172041	http://dx.doi.org/10.1371/journal.pone.0172041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187160	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300072
J	Zhang, Y; Wang, TL; Wei, J; He, JG; Wang, T; Liu, Y; Xu, H; Dong, JS				Zhang, Yi; Wang, Tingliang; Wei, Jiao; He, Jinguang; Wang, Tao; Liu, Ying; Xu, Hua; Dong, Jiasheng			What's the remedy for the distal necrosis of DIEP flap, better venous drain or more arterial supply?	PLOS ONE			English	Article							EPIGASTRIC PERFORATOR FLAP; UNILATERAL BREAST RECONSTRUCTION; VASCULAR AUGMENTATION; MODEL; EXPERIENCE; TRAM; ANASTOMOSIS; ANGIOSOMES; SELECTION; EFFICACY	Background We developed a novel pedicled DIEP flap model in rat to explore the possible remedy for the distal necrosis of the flap. Methods A deep inferior epigastric perforator (DIEP) flap, based on the second right cranial perforator (P2) as the main pedicle, was elevated in 48 Sprague-Dawley rats. The rats were randomized into 4 groups: group I, the left P2 remaining intact as supercharging; group II, the left P2 artery alone kept as supercharging; group III, the left P2 vein alone kept as supercharging; group IV, no supercharging. Transcutaneous oxygen pressure (TcPO2) and transcutaneous carbon dioxide pressure (TcPCO2) were measured immediately after flap elevation, protein level of Hif- 1a was measured 48 hours later, and flap survival was assessed 7 days postoperatively. Results Blockade of artery led to significantly lower TcPO2, higher TcPCO2, and higher expression level of Hif- 1a in the distal side of the flap in group III and group IV, than those of group I and group II. At 7 days post surgery, significantly lower flap survival rates were observed in group III (81.9 +/- 5.7%) and group IV (78.4 +/- 6.5%), compared to observed in group I (97.2 +/- 3.0%) and group II (94.2 +/- 6.2%). Conclusions It might be arterial insufficiency, not venous congestion, which mainly caused the distal necrosis of the DIEP flap in rat. Arterial instead of venous supercharging might be a more effective procedure that improves circulation to zone IV of the flap.	[Zhang, Yi; Wang, Tingliang; Wei, Jiao; He, Jinguang; Wang, Tao; Liu, Ying; Xu, Hua; Dong, Jiasheng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xu, H (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Shanghai, Peoples R China.	doctorxuhua@hotmail.com; dongjiasheng_9y@163.com		Wang, Tingliang/0000-0001-7440-7119				Agarwal JP, 2007, ANN PLAS SURG, V58, P359, DOI 10.1097/01.sap.0000239818.28900.81; Barabas AG, 2008, J PLAST RECONSTR AES, V61, P1249, DOI 10.1016/j.bjps.2008.01.018; Beahm EK, 2007, PLAST RECONSTR SURG, V120, P41, DOI 10.1097/01.prs.0000263729.26936.31; Blondeel PN, 2000, PLAST RECONSTR SURG, V106, P1295, DOI 10.1097/00006534-200011000-00009; Blondeel PN, 1999, BRIT J PLAST SURG, V52, P104, DOI 10.1054/bjps.1998.3033; Chang H, 2004, PLAST RECONSTR SURG, V113, P277, DOI 10.1097/01.PRS.0000095953.57320.2F; DellaCroce FJ, 2011, PLAST RECONSTR SURG, V127, P1093, DOI 10.1097/PRS.0b013e318205f223; Gimbel ML, 2009, PLAST RECONSTR SURG, V124, P796, DOI 10.1097/PRS.0b013e3181b03768; Groth AK, 2007, ACTA CIR BRAS, V22, P474, DOI 10.1590/S0102-86502007000600011; Gumus N, 2012, MICROSURG, V32, P303, DOI 10.1002/micr.21952; Hallock GG, 2005, PLAST RECONSTR SURG, V116, P551, DOI 10.1097/01.prs.0000172889.62564.e1; Hamdi M, 1999, PLAST RECONSTR SURG, V103, P86, DOI 10.1097/00006534-199901000-00015; Hamdi M, 2007, J PLAST RECONSTR AES, V60, P904, DOI 10.1016/j.bjps.2007.02.016; Holm C, 2007, J PLAST RECONSTR AES, V60, P946, DOI 10.1016/j.bjps.2005.12.066; Holm C, 2008, PLAST RECONSTR SURG, V122, P1612, DOI 10.1097/PRS.0b013e31818a9a3f; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; KOSHIMA I, 1989, BRIT J PLAST SURG, V42, P645, DOI 10.1016/0007-1226(89)90075-1; Kroll SS, 2000, PLAST RECONSTR SURG, V106, P576, DOI 10.1097/00006534-200009030-00008; Laporta R, 2015, AESTHET PLAST SURG, V39, P339, DOI 10.1007/s00266-015-0475-y; Li SK, 2002, J RECONSTR MICROSURG, V18, P161, DOI 10.1055/s-2002-28498; Mohan AT, 2016, PLAST RECONSTR SURG, V138, p790E, DOI 10.1097/PRS.0000000000002716; Nahabedian MY, 2002, PLAST RECONSTR SURG, V110, P466, DOI 10.1097/00006534-200208000-00015; NAKAYAMA Y, 1982, PLAST RECONSTR SURG, V69, P61, DOI 10.1097/00006534-198269010-00009; Oksar HS, 2001, PLAST RECONSTR SURG, V108, P125, DOI 10.1097/00006534-200107000-00018; Roberts AP, 1996, PLAST RECONSTR SURG, V97, P610, DOI 10.1097/00006534-199603000-00019; Rozen WM, 2009, PLAST RECONSTR SURG, V124, P848, DOI 10.1097/PRS.0b013e3181b037a2; Rubino C, 2009, J PLAST RECONSTR AES, V62, P1666, DOI 10.1016/j.bjps.2008.05.045; Talbot SG, 2010, J RECONSTR MICROSURG, V26, P513, DOI 10.1055/s-0030-1261697; TAYLOR GI, 1987, BRIT J PLAST SURG, V40, P113, DOI 10.1016/0007-1226(87)90185-8; TAYLOR GI, 1992, PLAST RECONSTR SURG, V89, P181, DOI 10.1097/00006534-199202000-00001; Walters JA, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000527; Wang T, 2015, AESTHET PLAST SURG, V39, P63, DOI 10.1007/s00266-014-0413-4; Xu H, 2009, PLAST RECONSTR SURG, V124, P1797, DOI 10.1097/PRS.0b013e3181bf81cf; Yamamoto Y, 2009, J PLAST RECONSTR AES, V62, P244, DOI 10.1016/j.bjps.2007.11.078; Zhang YH, 2015, CHIN J INTEGR MED, V10, P10, DOI DOI 10.1371/J0URNAL.P0NE.0131597	35	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171651	10.1371/journal.pone.0171651	http://dx.doi.org/10.1371/journal.pone.0171651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187214	Green Submitted, Green Published, gold			2022-12-26	WOS:000394244300033
J	Zhao, H; Yin, ZY; Xiang, HY; Liao, ZK; Wang, ZG				Zhao, Hui; Yin, Zhiyong; Xiang, Hongyi; Liao, Zhikang; Wang, Zhengguo			Preliminary study on alterations of altitude road traffic in China from 2006 to 2013	PLOS ONE			English	Article							FATALITIES	Introduction Road traffic can play an important role in strengthening regional economic activities, especially at high altitude, and it is necessary to know important traffic-related information. Although previous studies reported on road traffic in China, there has been little research on high-altitude road traffic to date. Method The annual official census of road traffic safety from 2006 to 2013 was used to obtain data on the general population, registered drivers, registered vehicles, newly built roads, road traffic accidents (RTAs), mortality rate per 100 000 populations and per 10 000 vehicles in high-altitude provinces, including Tibet, Qinghai, Xinjiang, Gansu, Yunnan, Sichuan, and Chongqing. These provincial data were reviewed retrospectively, with the national data as the reference. Statistical analysis (i.e., t test) was used to compare the estimated average annual change rate of population, number of registered drivers, registered vehicles, and newly built roads in high-altitude provinces with the national rates. Results Compared with the national data, there are significantly higher annual rates of population growth in Tibet and Xinjiang, registered drivers in Gansu, registered vehicles in Gansu, Sichuan, and Chongqing, and newly built roads in Tibet and Qinghai. Among the investigated provinces, Tibet, Qinghai, and Yunnan had a higher proportion of the roads with the high class. RTAs and RTA-induced casualties in the high-altitude provinces indicated a decreasing trend. The mortality rate per 10 000 vehicles and per 100 000 populations showed a decreasing trend, while the RTA-related mortality rate in Tibet, Qinghai, Xinjiang and Gansu remained high. Conclusions Major changes for road traffic in high-altitude provinces have occurred over the past decade; however, the RTA-related mortality rate in high-altitude provinces has remained high. This study furthers understanding about road traffic safety in China; further studies on road traffic safety at high altitude should be performed.	[Zhao, Hui; Yin, Zhiyong; Xiang, Hongyi; Liao, Zhikang; Wang, Zhengguo] Third Mil Med Univ, Chongqing Key Lab Vehicle Crash Bioimpact & Traff, Dept 4, Inst Surg Res,Daping Hosp, Chongqing, Peoples R China	Army Medical University	Zhao, H (corresponding author), Third Mil Med Univ, Chongqing Key Lab Vehicle Crash Bioimpact & Traff, Dept 4, Inst Surg Res,Daping Hosp, Chongqing, Peoples R China.	box.zhaohui@163.com		Zhao, Hui/0000-0001-5074-0128	National Natural Science Foundation of China [31470913]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Foundation of China (No. 31470913).	Brude U, 2015, ACCIDENT ANAL PREV, V74, P60, DOI 10.1016/j.aap.2014.10.004; Gururaj G, 2016, INT J INJ CONTROL SA, V23, P64, DOI 10.1080/17457300.2014.945465; Huang HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153251; Li YY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-46; Mishra Badrinarayan, 2010, Indian J Community Med, V35, P115, DOI 10.4103/0970-0218.62568; Ning PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164560; Organisation for Economic Co-operation and Development -OECD, 2015, ROAD SAF ANN REP 201; Organization WH, 2009, GLOB STAT REP ROAD S, V15, P286; Qiu J, 2015, TRAFFIC INJ PREV, V16, P565, DOI 10.1080/15389588.2014.973946; Qu JF, 2012, J TRAUMATIC SURG, V14, P317; Saha S, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0189-x; Traffic Administration Bureau of Police Ministry (TABPM), 2014, ROAD TRAFF ACC ANN C; Traffic Administration Bureau of Police Ministry (TABPM), 2008, ROAD TRAFF ACC ANN C; Traffic Administration Bureau of Police Ministry (TABPM), 2012, ROAD TRAFF ACC ANN C; Traffic Administration Bureau of Police Ministry (TABPM), 2011, ROAD TRAFF ACC ANN C; Traffic Administration Bureau of Police Ministry (TABPM), 2009, ROAD TRAFF ACC CENS; Traffic Administration Bureau of Police Ministry (TABPM), 2013, ROAD TRAFF ACC ANN C; Traffic Administration Bureau of Police Ministry (TABPM), 2010, ROAD TRAFF ACC ANN C; Traffic Administration Bureau of Police Ministry (TABPM), 2007, ROAD TRAFF ACC ANN C; Wang Q. Q., 2004, CHIN AGR SCI B, V20, P20; Wang TB, 2015, LANCET, V385, P1622, DOI 10.1016/S0140-6736(15)60794-2; Wang ZG, 2002, TRAFFIC INJ PREV, V3, P251; World Health Organisation, 2018, NONC DIS COUNTR PROF; World Health Organization, 2013, GLOB STAT REP ROAD S; Xu QH, 2005, CHINESE J NEUROSURGI, V4, P137; [张礼均 Zhang Lijun], 2006, [中华神经外科杂志, Chinese Journal of Neurosurgery], V22, P670; Zhang XJ, 2010, J SAFETY RES, V41, P521, DOI 10.1016/j.jsr.2010.09.003; Zhao H, 2016, CHIN J TRAUMA, V32, P360; Zhao SC, 2009, IATSS RES, V33, P125, DOI 10.1016/S0386-1112(14)60251-X; Zhou Ji-hong, 2003, Chin J Traumatol, V6, P355; Zhu HT, 2013, ACTA NEUROCHIR, V155, P655, DOI 10.1007/s00701-013-1618-z; [朱海涛 Zhu Haitao], 2011, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V33, P869; Zhu Xinglin, 2013, HIGHWAYS AUTOMOTIVE, P78	33	6	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171090	10.1371/journal.pone.0171090	http://dx.doi.org/10.1371/journal.pone.0171090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187203	Green Published, Green Submitted, gold			2022-12-26	WOS:000394244300010
J	Al-Mansob, RA; Ismail, A; Yusoff, NIM; Rahmat, RAOK; Borhan, MN; Albrka, SI; Azhari, CH; Karim, MR				Al-Mansob, Ramez A.; Ismail, Amiruddin; Yusoff, Nur Izzi Md.; Rahmat, Riza Atiq O. K.; Borhan, Muhamad Nazri; Albrka, Shaban Ismael; Azhari, Che Husna; Karim, Mohamed Rehan			Engineering characterisation of epoxidized natural rubber-modified hot-mix asphalt	PLOS ONE			English	Article							RHEOLOGICAL CHARACTERISTICS; RESISTANCE; COPOLYMER	Road distress results in high maintenance costs. However, increased understandings of asphalt behaviour and properties coupled with technological developments have allowed paving technologists to examine the benefits of introducing additives and modifiers. As a result, polymers have become extremely popular as modifiers to improve the performance of the asphalt mix. This study investigates the performance characteristics of epoxidized natural rubber (ENR)-modified hot-mix asphalt. Tests were conducted using ENR-asphalt mixes prepared using the wet process. Mechanical testing on the ENR-asphalt mixes showed that the resilient modulus of the mixes was greatly affected by testing temperature and frequency. On the other hand, although rutting performance decreased at high temperatures because of the increased elasticity of the ENR-asphalt mixes, fatigue performance improved at intermediate temperatures as compared to the base mix. However, durability tests indicated that the ENR-asphalt mixes were slightly susceptible to the presence of moisture. In conclusion, the performance of asphalt pavement can be enhanced by incorporating ENR as a modifier to counter major road distress.	[Al-Mansob, Ramez A.; Ismail, Amiruddin; Yusoff, Nur Izzi Md.; Rahmat, Riza Atiq O. K.; Borhan, Muhamad Nazri; Albrka, Shaban Ismael] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Civil & Struct Engn, Sustainable Urban Transport Res Ctr SUTRA, Bangi, Selangor, Malaysia; [Azhari, Che Husna] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Mech & Mat Engn, Bangi, Selangor, Malaysia; [Karim, Mohamed Rehan] Univ Malaya, Dept Civil Engn, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Malaya	Ismail, A (corresponding author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Civil & Struct Engn, Sustainable Urban Transport Res Ctr SUTRA, Bangi, Selangor, Malaysia.	aismail@ukm.edu.my	KARIM, MOHAMED REHAN/B-9040-2010; ISMAIL, AMIRUDDIN BIN/C-3140-2017; Zangena, Shaban Ali/L-1619-2017; Borhan, Muhamad Nazri/E-1035-2017; Yusoff, Nur Izzi Md/I-2043-2019; Al-Mansob, Ramez A./G-3023-2015	ISMAIL, AMIRUDDIN BIN/0000-0001-6547-8169; Zangena, Shaban Ali/0000-0003-1938-9127; Borhan, Muhamad Nazri/0000-0003-4517-5659; Yusoff, Nur Izzi Md/0000-0003-4449-4981; Al-Mansob, Ramez A./0000-0003-1702-4191	Universiti Kebangsaan Malaysia (UKM) through the project name Dana Impak Perdana coded [DIP-2015-019]; National University of Malaysia (UKM), Malaysia through the project Dana Impak Perdana [DIP-2015-019]	Universiti Kebangsaan Malaysia (UKM) through the project name Dana Impak Perdana coded; National University of Malaysia (UKM), Malaysia through the project Dana Impak Perdana	The funder is Universiti Kebangsaan Malaysia (UKM) through the project name Dana Impak Perdana coded, DIP-2015-019.; The authors would like to thank The National University of Malaysia (UKM), Malaysia for providing research funding through the project Dana Impak Perdana DIP-2015-019 and the Sustainable Urban Transport Research Centre (SUTRA) for providing research facilities. We also thank the faculty at the University of Malaya (UM) for their experimental collaboration.	AASHTO, 2018, T283 AASHTO; Airey GD, 2003, FUEL, V82, P1709, DOI 10.1016/S0016-2361(03)00146-7; Al-Hadidy AI, 2009, CONSTR BUILD MATER, V23, P2941, DOI 10.1016/j.conbuildmat.2009.02.023; Al-Mansob RA, 2016, CONSTR BUILD MATER, V102, P190, DOI 10.1016/j.conbuildmat.2015.10.133; Al-Mansob RA, 2014, APPL MECH MATER, V505-506, P174, DOI 10.4028/www.scientific.net/AMM.505-506.174; Al-Mansob RA, 2014, CONSTR BUILD MATER, V63, P242, DOI 10.1016/j.conbuildmat.2014.04.026; [Anonymous], 1995, ASTMD4123; [Anonymous], 1980, P 1 ASPH RUBB US PRO; [Anonymous], 2007, AASHTOT321; [Anonymous], 1980, VISCOELASTIC PROPERT; Asphalt Institute, 2007, ASPH HDB, V7th; BALaWC Vonk, 1984, THERM RUBB BIT BLEND; Becker Y, 2001, VIS TECNOL, V9, P39; Bennert T, 2010, J ASSOC ASPHALT PAV, V79, P773; Brown E., 2009, HOT MIX ASPHALT MAT; Brown E, 1989, D4123 ASTM; Christensen D.W., 1992, J ASS ASPH PAVING TE, V61, P67; Cominsky R.J., 1994, SUPERPAVE MIX DESIGN; Eaton RA, 1991, DTIC DOCUMENT; Fernando M, 1984, AUSTR ROAD RES, V12; Hunter R.N., 2015, SHELL BITUMEN HDB; Institution B.S, 1998, METHODS TEST DETERMI; IR G., 1991, J NAT RUBBER, V6, P184; Ismail A, 2012, AUSTR J BASIC APPL S, V6; Ismail H, 2001, EUR POLYM J, V37, P39, DOI 10.1016/S0014-3057(00)00099-9; Khodaii A, 2009, CONSTR BUILD MATER, V23, P2586, DOI 10.1016/j.conbuildmat.2009.02.015; Kim M-G, 1999, COATINGS IMPROVE LOW; Kulash DJ, 1994, P ICE TRANSP; Li J, 2008, CONSTR BUILD MATER, V22, P1067, DOI 10.1016/j.conbuildmat.2007.03.007; Lu X, 1997, CONSTR BUILD MATER, V11, P23, DOI 10.1016/S0950-0618(96)00033-5; Lundy JR, 1993, GROUND RUBBER TIRES; Michael A., 1992, FHWASA92022; Mo LT, 2012, MATER DESIGN, V37, P137, DOI 10.1016/j.matdes.2012.01.003; Moreno F, 2013, MATER DESIGN, V47, P274, DOI 10.1016/j.matdes.2012.12.022; Raad L, 1998, TRANSPORT RES REC, P73, DOI 10.3141/1639-08; Sargand S, 2001, 2 INT S MAINT REH PA; Shih CT, 1996, AM CHEM SOC FUEL CHE, V41, P1227; Tayfur S, 2007, CONSTR BUILD MATER, V21, P328, DOI 10.1016/j.conbuildmat.2005.08.014; Tian P, 1998, J TEST EVAL, V26, P329; Witczak M.W., 1995, LAB CHARACTERIZATION; Witczak M. W., 2005, SIMPLE PERFORMANCE T; Yidirim Y, 2007, CONSTR BUILD MATER, V21, P66, DOI 10.1016/j.conbuildmat.2005.07.007; Yoksan R, 2008, KASETSART JNAT SCI, V42, P325; Yousefi AA, 2002, IRAN POLYM J, V11, P303	44	11	12	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171648	10.1371/journal.pone.0171648	http://dx.doi.org/10.1371/journal.pone.0171648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182724	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800084
J	Skaaby, T; Husemoen, LLN; Thuesen, BH; Fenger, RV; Linneberg, A				Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbaek; Fenger, Runa Vavia; Linneberg, Allan			IgE sensitization to inhalant allergens and the risk of airway infection and disease: A population-based study	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; ASTHMA; IMMUNOTHERAPY; ADULTS; HEALTH; TRENDS; ATOPY	Background Immunoglobulin E (IgE) sensitization, which is the propensity to develop IgE antibodies against common environmental allergens, is associated with a lymphocyte T-helper type 2 (Th2) skewed immune response and a high risk of allergic respiratory disease. Little is known about whether IgE sensitization confers an increased risk of respiratory infections in adults. We investigated the association between IgE sensitization and the incidence of acute airway infections, other infections and chronic lower airway disease events as recorded in nationwide registries. Methods We included 14,849 persons from five population-based studies with measurements of serum specific IgE positivity against inhalant allergens. Participants were followed by linkage to Danish national registries (median follow-up time 11.3 years). The study-specific relative risks were estimated by Cox regression analysis, meta-analysed, and expressed as hazard ratios, HRs (95% confidence intervals, CIs). Results The relative risks for IgE sensitized vs. non-sensitized were: for pneumonia (HR = 1.20, 95% CI: 1.01, 1.41), other acute airway infection (HR = 0.86, 95% CI: 0.60, 1.22), infection (HR = 1.06, 95% CI: 0.90, 1.24), asthma (HR = 2.26, 95% CI: 1.79, 2.86), and other chronic lower airway disease (HR = 1.31, 95% CI: 1.08, 1.58). In never smokers, the higher risk of pneumonia (HR = 1.73, 95% CI: 1.23, 2.44) and asthma (HR = 3.17, 95% CI: 2.10, 4.76) among IgE sensitized was more pronounced. Conclusions IgE sensitization was associated with a higher risk of asthma, other chronic lower airway diseases, and pneumonia. However, the association between IgE sensitization and pneumonia may be explained by undiagnosed asthma causing the pneumonia. Further studies are needed for confirmation.	[Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbaek; Fenger, Runa Vavia; Linneberg, Allan] Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Linneberg, Allan] Glostrup Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Skaaby, T (corresponding author), Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark.	tea.skaaby.01@regionh.dk		Thuesen, Betina/0000-0001-9772-4344; Skaaby, Tea/0000-0003-0031-5726; Linneberg, Allan/0000-0002-0994-0184	Lundbeck Foundation [R165-2013-15410, R108-A10225]; Lundbeck Foundation [R219-2016-471] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	Tea Skaaby was supported by a grant from the Lundbeck Foundation (Grant number R165-2013-15410). Betina Heinsbaek Thuesen was Supported by a grant from the Lundbeck Foundation (Grant number R108-A10225). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Ciprandi G, 2013, J BIOL REG HOMEOS AG, V27, P1053; Ciprandi G, 2006, PEDIAT ALLERG IMM-UK, V17, P389, DOI 10.1111/j.1399-3038.2006.00413.x; Ciprandi G, 2009, ANN ALLERG ASTHMA IM, V102, P262, DOI 10.1016/S1081-1206(10)60095-6; Cirillo I, 2007, ALLERGY, V62, P1087, DOI 10.1111/j.1398-9995.2007.01401.x; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Fattahi F, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-10; Green RM, 2002, BMJ-BRIT MED J, V324, P763, DOI 10.1136/bmj.324.7340.763; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; James KM, 2012, J ALLERGY CLIN IMMUN, V130, P343, DOI 10.1016/j.jaci.2012.05.056; Juel K, 1999, DAN MED BULL, V46, P354; Jung JA, 2010, J ALLERGY CLIN IMMUN, V125, P217, DOI 10.1016/j.jaci.2009.10.045; Linneberg A, 2007, CLIN EXP ALLERGY, V37, P1137, DOI 10.1111/j.1365-2222.2007.02760.x; Linneberg A, 2006, ALLERGY, V61, P344, DOI 10.1111/j.1398-9995.2006.00968.x; Linneberg A, 2001, RESP MED, V95, P258, DOI 10.1053/rmed.2001.1031; Linneberg A, 2001, ALLERGY, V56, P328, DOI 10.1034/j.1398-9995.2000.00509.x-i1; Olenec JP, 2010, J ALLERGY CLIN IMMUN, V125, P1001, DOI 10.1016/j.jaci.2010.01.059; Osler M, 2011, INT J EPIDEMIOL, V40, P602, DOI 10.1093/ije/dyq041; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Petersen AB, 2004, CLIN BIOCHEM, V37, P882, DOI 10.1016/j.clinbiochem.2004.06.010; Rantala A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068582; Rantala A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027912; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Skaaby T, 2014, CLIN EXP ALLERGY, V44, P1361, DOI 10.1111/cea.12408; Skaaby T, 2014, ENDOCRINE; Skaaby T, 2014, ATOPY DEV CANC POPUL; Skaaby T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137406; Skaaby T, 2015, AUTOIMMUNITY, V48, P282, DOI 10.3109/08916934.2014.1003640	28	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171525	10.1371/journal.pone.0171525	http://dx.doi.org/10.1371/journal.pone.0171525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182643	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800069
J	van Rensburg, G; Mackedenski, S; Lee, CH				van Rensburg, Gerrit; Mackedenski, Sebastian; Lee, Chow H.			Characterizing the Coding Region Determinant-Binding Protein (CRD-BP)-Microphthalmia-associated Transcription Factor (MITF) mRNA interaction	PLOS ONE			English	Article							C-MYC; CRD-BP; KH DOMAINS; CANCER; EXPRESSION; MELANOMA; GROWTH; STABILIZATION; INHIBITION; CELLS	Coding region determinant-binding protein (CRD-BP) binds to the 3'-UTR of microphthalmia-associated transcription factor (MITF) mRNA to prevent its targeted degradation by miR-340. Here, we aim to further understand the molecular interaction between CRD-BP and MITF RNA. Using point mutation in the GXXG motif of each KH domains, we showed that all four KH domains of CRD-BP are important for their physical association with MITF RNA. We mapped the CRD-BP-binding site in the 3'-UTR of MITF RNA from nts 1330-1740 and showed that the 49-nt fragment 1621-1669 is the minimal size MITF RNA for binding. Upon deletion of nts 1621-1669 within the nts1550-1740 of MITF RNA, there was a 3-fold increase in dissociation constant Kd, which further confirms the critical role sequences within nts 1621-1669 in binding to CRD-BP. Amongst the eight antisense oligonucleotides designed against MITF RNA 1550-1740, we found MHO-1 and MHO-7 as potent inhibitors of the CRD-BP-MITF RNA interaction. Using RNase protection and fluorescence polarization assays, we showed that both MHO-1 and MHO-7 have affinity for the MITF RNA, suggesting that both antisense oligonucleotides inhibited CRD-BP-MITF RNA interaction by directly binding to MITF RNA. The new molecular insights provided in this study have important implications for understanding the oncogenic function of CRD-BP and development of specific inhibitors against CRD-BP-MITF RNA interaction.	[van Rensburg, Gerrit; Mackedenski, Sebastian; Lee, Chow H.] Univ Northern British Columbia, Chem Program, Prince George, BC, Canada	University of Northern British Columbia	Lee, CH (corresponding author), Univ Northern British Columbia, Chem Program, Prince George, BC, Canada.	chow.lee@unbc.ca						Barnes M, 2015, J BIOL CHEM, V290, P625, DOI 10.1074/jbc.M114.614735; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Boyerinas B, 2012, INT J CANCER, V130, P1787, DOI 10.1002/ijc.26190; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; Coulis CM, 2000, MOL PHARMACOL, V57, P485, DOI 10.1124/mol.57.3.485; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Git A, 2002, RNA, V8, P1319, DOI 10.1017/S135583820202705X; Goswami S, 2015, J BIOL CHEM, V290, P384, DOI 10.1074/jbc.M114.590158; Hamilton KE, 2013, CARCINOGENESIS, V34, P2647, DOI 10.1093/carcin/bgt217; Hsiao JJ, 2014, ARCH BIOCHEM BIOPHYS, V563, P28, DOI 10.1016/j.abb.2014.07.019; Ioannidis P, 2005, J BIOL CHEM, V280, P20086, DOI 10.1074/jbc.M410036200; King DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091585; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mehmood K, 2016, MOL PHARMACOL, V89, P695, DOI 10.1124/mol.115.102434; Mongroo PS, 2011, CANCER RES, V71, P2172, DOI 10.1158/0008-5472.CAN-10-3295; Nielsen FC, 2002, J CELL SCI, V115, P2087; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Sparanese D, 2007, NUCLEIC ACIDS RES, V35, P1209, DOI 10.1093/nar/gkl1148; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	26	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171196	10.1371/journal.pone.0171196	http://dx.doi.org/10.1371/journal.pone.0171196			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182633	Green Submitted, gold, Green Published			2022-12-26	WOS:000394231800043
J	Nicholas, D; Proctor, EA; Raval, FM; Ip, BC; Habib, C; Ritou, E; Grammatopoulos, TN; Steenkamp, D; Dooms, H; Apovian, CM; Lauffenburger, DA; Nikolajczyk, BS				Nicholas, Dequina; Proctor, Elizabeth A.; Raval, Forum M.; Ip, Blanche C.; Habib, Chloe; Ritou, Eleni; Grammatopoulos, Tom N.; Steenkamp, Devin; Dooms, Hans; Apovian, Caroline M.; Lauffenburger, Douglas A.; Nikolajczyk, Barbara S.			Advances in the quantification of mitochondrial function in primary human immune cells through extracellular flux analysis	PLOS ONE			English	Article							REGULATORY T-CELLS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; B-CELLS; ACTIVATED MACROPHAGES; CYTOKINE PRODUCTION; OXYGEN-CONSUMPTION; INFLAMMATION; OBESITY; GLUCOSE	Numerous studies show that mitochondrial energy generation determines the effectiveness of immune responses. Furthermore, changes in mitochondrial function may regulate lymphocyte function in inflammatory diseases like type 2 diabetes. Analysis of lymphocyte mitochondria) function has been facilitated by introduction of 96-well format extracellular flux (XF96) analyzers, but the technology remains imperfect for analysis of human lymphocytes. Limitations in XF technology include the lack of practical protocols for analysis of archived human cells, and inadequate data analysis tools that require manual quality checks. Current analysis tools for XF outcomes are also unable to automatically assess data quality and delete untenable data from the relatively high number of biological replicates needed to power complex human cell studies. The objectives of work presented herein are to test the impact of common cellular manipulations on XF outcomes, and to develop and validate a new automated tool that objectively analyzes a virtually unlimited number of samples to quantitate mitochondrial function in immune cells. We present significant improvements on previous XF analyses of primary human cells that will be absolutely essential to test the prediction that changes in immune cell mitochondrial function and fuel sources support immune dysfunction in chronic inflammatory diseases like type 2 diabetes.	[Nicholas, Dequina; Raval, Forum M.; Ip, Blanche C.; Dooms, Hans; Nikolajczyk, Barbara S.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Proctor, Elizabeth A.; Lauffenburger, Douglas A.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Habib, Chloe; Steenkamp, Devin; Apovian, Caroline M.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Ritou, Eleni; Grammatopoulos, Tom N.] BioEnerget LLC, Boston, MA USA; [Dooms, Hans] Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA; [Nikolajczyk, Barbara S.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Nikolajczyk, Barbara S.] Boston Univ, Sch Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Ip, Blanche C.] Brown Univ, Ctr Biomed Engn, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Boston University; Massachusetts Institute of Technology (MIT); Boston University; Boston University; Boston University; Boston University; Brown University	Nikolajczyk, BS (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.; Nikolajczyk, BS (corresponding author), Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA.; Nikolajczyk, BS (corresponding author), Boston Univ, Sch Med, Dept Mol & Cell Biol, Boston, MA 02118 USA.	bnikol@bu.edu	Proctor, Elizabeth A./K-2350-2012; Nicholas, Dequina/AAF-1412-2019	Proctor, Elizabeth A./0000-0002-7627-2198; Dooms, Hans/0000-0001-7964-0876; Nicholas, Dequina/0000-0003-4996-2190	National Institutes of Health [R56DK096525, R01DK108056, R24DK090963, P30DK057521]; BU Genome Sciences Institute; NIDDK Diabetic Complications Consortium [DK076169]; Hematology Training Program [HL007501]; Inflammatory Disorders Training Grant [Al1089673]; Metabolism, Endocrinology and Obesity Training Grant [DK007201]; Institute for Collaborative Biotechnologies through grant from the U.S. Army Research Office [W911NF-09-0001]; BioEnergetics LLC; NATIONAL CANCER INSTITUTE [U01CA182898] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BU Genome Sciences Institute; NIDDK Diabetic Complications Consortium; Hematology Training Program; Inflammatory Disorders Training Grant; Metabolism, Endocrinology and Obesity Training Grant; Institute for Collaborative Biotechnologies through grant from the U.S. Army Research Office; BioEnergetics LLC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health R56DK096525 (BN), R01DK108056 (BN, CA, DL), R24DK090963 (DL) and P30DK057521 (HD); The BU Genome Sciences Institute (www.bumc.bu.edu/gsi/) (BN); The NIDDK Diabetic Complications Consortium (DiaComp, www.diacomp.org) DK076169 (DN); the following National Institutes of Health training grants: The Hematology Training Program HL007501 (FR), The Inflammatory Disorders Training Grant Al1089673 (DN), The Metabolism, Endocrinology and Obesity Training Grant DK007201 (DN), and the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office www.icb.uscb. edu (DL). TG and ER are paid employees of BioEnergetics LLC, a commercial entity that provided financial support in the form of salaries, research materials, specialized equipment and technical support for assistance in study design, data collection and analysis. The specific roles of these authors are articulated in the author contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAND K, 1988, EUR J BIOCHEM, V172, P695, DOI 10.1111/j.1432-1033.1988.tb13944.x; Caro-Maldonado A, 2014, J IMMUNOL; Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; De Rosa V, 2015, NAT IMMUNOL, V16, P1174, DOI 10.1038/ni.3269; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Fabbrini E, 2013, GASTROENTEROLOGY, V145, P366, DOI 10.1053/j.gastro.2013.04.010; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Garedew A, 2010, CELL DEATH DIFFER, V17, P1540, DOI 10.1038/cdd.2010.27; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hartman ML, 2014, VASC MED, V19, P67, DOI 10.1177/1358863X14521315; Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051; Ip B, 2016, OBESITY, V24, P102, DOI 10.1002/oby.21243; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jagannathan M, 2010, DIABETOLOGIA, V53, P1461, DOI 10.1007/s00125-010-1730-z; Jagannathan-Bogdan M, 2011, J IMMUNOL, V186, P1162, DOI 10.4049/jimmunol.1002615; Jelley-Gibbs DM, 2000, J IMMUNOL, V165, P5017, DOI 10.4049/jimmunol.165.9.5017; Keane KN, 2015, CLIN SCI, V128, P723, DOI 10.1042/CS20140725; Kramer PA, 2014, JOVE-J VIS EXP, DOI 10.3791/51301; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; McLaughlin T, 2014, ARTERIOSCL THROM VAS, V34, P2637, DOI 10.1161/ATVBAHA.114.304636; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Milasta S, 2016, IMMUNITY, V44, P88, DOI 10.1016/j.immuni.2015.12.002; Nikolajczyk BS, 2010, CYTOKINE, V50, P234, DOI 10.1016/j.cyto.2010.02.022; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Perry CGR, 2013, DIABETES, V62, P1041, DOI 10.2337/db12-1219; Procaccini C, 2016, IMMUNITY, V44, P406, DOI 10.1016/j.immuni.2016.01.028; Raval Forum M, 2013, Discoveries (Craiova), V1, pe6; Renner K, 2015, EUR J IMMUNOL, V45, P2504, DOI 10.1002/eji.201545473; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shin H, 2009, J LEUKOCYTE BIOL, V85, P648, DOI 10.1189/jlb.0708428; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Vacaflores A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157175; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yin YM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0835	44	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170975	10.1371/journal.pone.0170975	http://dx.doi.org/10.1371/journal.pone.0170975			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178278	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500018
J	Nuvolone, M; Schmid, N; Miele, G; Sorce, S; Moos, R; Schori, C; Beerli, RR; Bauer, M; Saudan, P; Dietmeier, K; Lachmann, I; Linnebank, M; Martin, R; Kallweit, U; Kana, V; Rushing, EJ; Budka, H; Aguzzi, A				Nuvolone, Mario; Schmid, Nicolas; Miele, Gino; Sorce, Silvia; Moos, Rita; Schori, Christian; Beerli, Roger R.; Bauer, Monika; Saudan, Philippe; Dietmeier, Klaus; Lachmann, Ingolf; Linnebank, Michael; Martin, Roland; Kallweit, Ulf; Kana, Veronika; Rushing, Elisabeth J.; Budka, Herbert; Aguzzi, Adriano			Cystatin F is a biomarker of prion pathogenesis in mice	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; ALZHEIMERS-DISEASE; MOUSE MODELS; CYSTEINE PROTEASES; NEURONAL CELLS; CATHEPSIN-B; C GENE; EXPRESSION; SCRAPIE; PROTEIN	Misfolding of the cellular prion protein (PrPc) into the scrapie prion protein (PrPsc) results in progressive, fatal, transmissible neurodegenerative conditions termed prion diseases. Experimental and epidemiological evidence point toward a protracted, clinically silent phase in prion diseases, yet there is no diagnostic test capable of identifying asymptomatic individuals incubating prions. In an effort to identify early biomarkers of prion diseases, we have compared global transcriptional profiles in brains from pre-symptomatic prion-infected mice and controls. We identified Cst7, which encodes cystatin F, as the most strongly upregulated transcript in this model. Early and robust upregulation of Cst7 m RNA levels and of its cognate protein was validated in additional mouse models of prion disease. Surprisingly, we found no significant increase in cystatin F levels in both cerebrospinal fluid or brain parenchyma of patients with Creutzfeldt-Jakob disease compared to Alzheimer's disease or non demented controls. Our results validate cystatin F as a useful biomarker of early pathogenesis in experimental models of prion disease, and point to unexpected species-specific differences in the transcriptional responses to prion infections.	[Nuvolone, Mario; Schmid, Nicolas; Miele, Gino; Sorce, Silvia; Moos, Rita; Kana, Veronika; Rushing, Elisabeth J.; Budka, Herbert; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, Zurich, Switzerland; [Schori, Christian; Beerli, Roger R.; Bauer, Monika; Saudan, Philippe; Dietmeier, Klaus] Cytos Biotechnol AG, Zurich, Switzerland; [Lachmann, Ingolf] AJ Roboscreen GmbH, Leipzig, Germany; [Linnebank, Michael; Martin, Roland; Kallweit, Ulf] Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland; [Kallweit, Ulf] Univ Hosp Bern, Dept Neurol, Bern, Switzerland; [Kallweit, Ulf] Univ Bern, Bern, Switzerland; [Beerli, Roger R.] NBE Therapeut AG, Basel, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern; University of Bern	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Zurich, Switzerland.	adriano.aguzzi@usz.ch	Budka, Herbert/I-3486-2019; Kallweit, Ulf/AAM-3989-2021; Nuvolone, Mario/K-4763-2018	Budka, Herbert/0000-0002-1933-1577; Nuvolone, Mario/0000-0001-8334-1684; Sorce, Silvia/0000-0002-3843-8644; Kana, Veronika/0000-0002-9362-3156	European Research Council (ERC) [250356]; European Union; Swiss National Foundation; Swiss Initiative in Systems Biology; SystemsX.ch; Novartis Institutes of Biomedical Research; Klinische Forschungsschwerpunkte (KFSPs); Cytos Biotechnology; AJ Roboscreen GmbH	European Research Council (ERC)(European Research Council (ERC)European Commission); European Union(European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss Initiative in Systems Biology; SystemsX.ch; Novartis Institutes of Biomedical Research; Klinische Forschungsschwerpunkte (KFSPs); Cytos Biotechnology; AJ Roboscreen GmbH	AA is the recipient of an Advanced Grant of the European Research Council (ERC, No. 250356) and is supported by grants from the European Union (DEMTEST, NEURINOX), the Swiss National Foundation, the Swiss Initiative in Systems Biology, SystemsX.ch (PrionX, SynucleiX), the Novartis Institutes of Biomedical Research, and the Klinische Forschungsschwerpunkte (KFSPs) "small RNAs" and "Human Hemato-Lymphatic Diseases". GM was supported by a grant from the Swiss National Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CS, RRB, MB, PS and KD were employed by Cytos Biotechnology AG and IL by AJ Roboscreen GmbH. Cytos Biotechnology and AJ Roboscreen GmbH provided support in the form of salaries for authors CS, RRB, MB, PS and KD (Cytos Biotechnology AG) and IL (AJ Roboscreen GmbH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Aguzzi A, 2013, NAT REV IMMUNOL, V13, P888, DOI 10.1038/nri3553; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Baker CA, 1999, J VIROL, V73, P5089, DOI 10.1128/JVI.73.6.5089-5097.1999; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Beasley TM, 2005, AM J PHARMACOGENOMIC, V5, P197, DOI 10.2165/00129785-200505030-00006; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Beerli RR, 2008, P NATL ACAD SCI USA, V105, P14336, DOI 10.1073/pnas.0805942105; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Chong MS, 2005, LANCET NEUROL, V4, P576, DOI 10.1016/S1474-4422(05)70168-X; DIEDRICH JF, 1991, J VIROL, V65, P4759, DOI 10.1128/JVI.65.9.4759-4768.1991; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Duan W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052566; Halfon S, 1998, J BIOL CHEM, V273, P16400, DOI 10.1074/jbc.273.26.16400; Hamilton G, 2008, EMBO J, V27, P499, DOI 10.1038/sj.emboj.7601979; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Koller D, 2001, NAT BIOTECHNOL, V19, P851, DOI 10.1038/nbt0901-851; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kovacs GG, 2007, J NEUROPATH EXP NEUR, V66, P628, DOI 10.1097/nen.0b013e318093ecc7; LEVY E, 1989, J EXP MED, V169, P1771, DOI 10.1084/jem.169.5.1771; Llorens F, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00198; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luhr KM, 2004, NEUROREPORT, V15, P1663, DOI 10.1097/01.wnr.0000134931.81690.34; Luhr KM, 2004, J VIROL, V78, P4776, DOI 10.1128/JVI.78.9.4776-4782.2004; Ma JM, 2011, J NEUROSCI RES, V89, P639, DOI 10.1002/jnr.22567; Matthews SP, 2016, IMMUNITY, V44, P795, DOI 10.1016/j.immuni.2016.03.003; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Miele G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003870; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Morita M, 2000, GENOMICS, V67, P87, DOI 10.1006/geno.2000.6237; Ni J, 1998, J BIOL CHEM, V273, P24797, DOI 10.1074/jbc.273.38.24797; Nuvolone M, 2016, J EXP MED, V213, P313, DOI 10.1084/jem.20151610; Nuvolone M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117208; Nuvolone M, 2013, J EXP MED, V210, P2539, DOI 10.1084/jem.20131274; PALSDOTTIR A, 1988, LANCET, V2, P603; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Parchi P, 2012, ACTA NEUROPATHOL, V124, P517, DOI 10.1007/s00401-012-1002-8; Parchi P, 2012, FOLIA NEUROPATHOL, V50, P20; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Schinke-Braun Martina, 2007, Methods Mol Biol, V366, P13; Schneemann M, 2002, NAT IMMUNOL, V3, P102, DOI 10.1038/ni0202-102a; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Smith AM, 2014, TRENDS NEUROSCI, V37, P125, DOI 10.1016/j.tins.2013.12.001; Sorce S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004531; Stilling RM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00373; Stoeck K, 2012, BRAIN, V135, P3051, DOI 10.1093/brain/aws238; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Teunissen CE, 2014, CLIN BIOCHEM, V47, P288, DOI 10.1016/j.clinbiochem.2013.12.024; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal E, 2013, J COMP PATHOL, V148, P22, DOI 10.1016/j.jcpa.2012.05.004; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Xiang W, 2007, J NEUROCHEM, V102, P834, DOI 10.1111/j.1471-4159.2007.04566.x; Zanusso G, 2016, NAT REV NEUROL, V12, P325, DOI 10.1038/nrneurol.2016.65; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang YH, 2003, J GEN VIROL, V84, P2279, DOI 10.1099/vir.0.19153-0; Zhu CH, 2016, J EXP MED, V213, P1047, DOI 10.1084/jem.20151000; Zhu CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144983	66	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171923	10.1371/journal.pone.0171923	http://dx.doi.org/10.1371/journal.pone.0171923			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178353	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500079
J	Sharma, A; Kirkpatrick, G; Chen, V; Skolnik, K; Hollander, Z; Wilcox, P; Quon, BS				Sharma, Ashutosh; Kirkpatrick, Gordon; Chen, Virginia; Skolnik, Kate; Hollander, Zsuzsanna; Wilcox, Pearce; Quon, Bradley S.			Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PSEUDOMONAS-AERUGINOSA; INFLAMMATORY RESPONSE; HUMAN MONOCYTES; LUNG-DISEASE; INFECTION; FAILURE; MARKERS; EPIDEMIOLOGY; OUTCOMES	Rationale C-reactive protein (CRP) is a systemic marker of inflammation that correlates with disease status in cystic fibrosis (CF). The clinical utility of CRP measurement to guide pulmonary exacerbation (PEx) treatment decisions remains uncertain. Objectives To determine whether monitoring CRP during PEx treatment can be used to predict treatment response. We hypothesized that early changes in CRP can be used to predict treatment response. Methods We reviewed all PEx events requiring hospitalization for intravenous (IV) antibiotics over 2 years at our institution. 83 PEx events met our eligibility criteria. CRP levels from admission to day 5 were evaluated to predict treatment non-response, using a modified version of a prior published composite definition. CRP was also evaluated to predict time until next exacerbation (TUNE). Measurements and main results 53% of 83 PEx events were classified as treatment non-response. Paradoxically, 24% of PEx events were characterized by a >= 50% increase in CRP levels within the first five days of treatment. Absolute change in CRP from admission to day 5 was not associated with treatment non-response (p = 0.58). Adjusted for FEV1% predicted, admission log(10) CRP was associated with treatment non-response (OR: 2.39; 95% CI: 1.14 to 5.91; p = 0.03) and shorter TUNE (HR: 1.60; 95% CI: 1.13 to 2.27; p = 0.008). The area under the receiver operating characteristics (ROC) curve of admission CRP to predict treatment non-response was 0.72 (95% CI 0.61-0.83; p<0.001). 23% of PEx events were characterized by an admission CRP of > 75 mg/L with a specificity of 90% for treatment non-response. Conclusions Admission CRP predicts treatment non -response and time until next exacerbation. Avery elevated admission CRP (>75mg/L) is highly specific for treatment non -response and might be used to target high-risk patients for future interventional studies aimed at improving exacerbation outcomes.	[Sharma, Ashutosh; Wilcox, Pearce; Quon, Bradley S.] Univ British Columbia, Ctr Heart Lung Innovat, Dept Med, Vancouver, BC, Canada; [Sharma, Ashutosh; Wilcox, Pearce; Quon, Bradley S.] St Pauls Hosp, Vancouver, BC, Canada; [Kirkpatrick, Gordon; Wilcox, Pearce; Quon, Bradley S.] Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada; [Chen, Virginia; Hollander, Zsuzsanna] Prevent Organ Failure PROOF Ctr Excellence, Vancouver, BC, Canada; [Skolnik, Kate] Univ Calgary, Div Resp Med, Dept Med, Calgary, AB, Canada	University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of Calgary	Quon, BS (corresponding author), Univ British Columbia, Ctr Heart Lung Innovat, Dept Med, Vancouver, BC, Canada.; Quon, BS (corresponding author), St Pauls Hosp, Vancouver, BC, Canada.; Quon, BS (corresponding author), Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada.	bradley.quon@hli.ubc.ca			Cystic Fibrosis Canada; British Columbia Lung Association; University of British Columbia Summer Student Research Program; Providence Health Care Research Institute	Cystic Fibrosis Canada; British Columbia Lung Association; University of British Columbia Summer Student Research Program; Providence Health Care Research Institute	This study was supported by Cystic Fibrosis Canada (http://www.cystictihrosis.ca/research/what-we-are-funding), the British Columbia Lung Association (https://bc.lung.ca/recent-grant-recipients-0), the University of British Columbia Summer Student Research Program (http://www.med.ubc.ca/current-learners./summer-student-research- program/), and the Providence Health Care Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Janice, 2003, Paediatr Drugs, V5, P41, DOI 10.2165/00148581-200305010-00004; Bell SC, 2000, EUR J CLIN INVEST, V30, P553; Bilton D, 2011, J CYST FIBROS, V10, pS79, DOI 10.1016/S1569-1993(11)60012-X; DEKIMPE SJ, 1995, P NATL ACAD SCI USA, V92, P10359, DOI 10.1073/pnas.92.22.10359; DOFFERHOFF ASM, 1993, J ANTIMICROB CHEMOTH, V31, P373, DOI 10.1093/jac/31.3.373; Dovey M, 2007, CHEST, V132, P1212, DOI 10.1378/chest.07-0843; Duggan C, 1996, AM J CLIN NUTR, V64, P635, DOI 10.1093/ajcn/64.4.635; ELBORN JS, 1993, RESP MED, V87, P603, DOI 10.1016/S0954-6111(05)80263-X; Falagas ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3995; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; Gray RD, 2010, J CYST FIBROS, V9, P193, DOI 10.1016/j.jcf.2010.01.005; Heltshe SL, 2015, THORAX; Hendry J, 1999, EUR RESPIR J, V14, P435, DOI 10.1034/j.1399-3003.1999.14b32.x; Horsley AR, 2013, THORAX, V68, P532, DOI 10.1136/thoraxjnl-2012-202538; LEESON MC, 1994, SHOCK, V2, P235, DOI 10.1097/00024382-199410000-00001; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Mayer-Hamblett N, 2002, AM J RESP CRIT CARE, V166, P1550, DOI 10.1164/rccm.200202-087OC; McCoy KS, 2007, NEW ENGL J MED, V357, P2310, DOI 10.1056/NEJMc071717; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nixon LS, 1998, AM J RESP CRIT CARE, V157, P1764, DOI 10.1164/ajrccm.157.6.9704086; NORMAN D, 1991, THORAX, V46, P91, DOI 10.1136/thx.46.2.91; Ordonez CL, 2003, AM J RESP CRIT CARE, V168, P1471, DOI 10.1164/rccm.200306-731OC; Parkins MD, 2012, CHEST, V141, P485, DOI 10.1378/chest.11-0917; PECKHAM D, 1994, THORAX, V49, P803, DOI 10.1136/thx.49.8.803; Roderfeld M, 2009, J CYST FIBROS, V8, P338, DOI 10.1016/j.jcf.2009.06.001; Sagel SD, 2015, ANN AM THORAC SOC, V12, P708, DOI 10.1513/AnnalsATS.201410-493OC; Sanders DB, 2015, J CYST FIBROS, V14, P679, DOI 10.1016/j.jcf.2015.10.002; Sanders DB, 2010, AM J RESP CRIT CARE, V182, P627, DOI 10.1164/rccm.200909-1421OC; Sanders DB, 2010, PEDIATR PULM, V45, P127, DOI 10.1002/ppul.21117; Sequeiros IM, 2012, CHRON RESP DIS, V9, P9, DOI 10.1177/1479972311433575; Shoki AH, 2013, CHEST, V144, P1659, DOI 10.1378/chest.13-0693; Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88; Waters V, 2015, J CYSTIC FIBROSIS OF; Waters V, 2012, J CYST FIBROS, V11, P8, DOI 10.1016/j.jcf.2011.07.008; Waters VJ, 2015, JOURNAL OF CYSTIC FI; WATKIN SL, 1994, PEDIATR PULM, V17, P6, DOI 10.1002/ppul.1950170103; Wojewodka G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088567	37	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171229	10.1371/journal.pone.0171229	http://dx.doi.org/10.1371/journal.pone.0171229			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178305	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500033
J	Drannik, A; Martin, J; Peterson, R; Ma, XX; Jiang, F; Turnbull, J				Drannik, Anna; Martin, Joan; Peterson, Randy; Ma, Xiaoxing; Jiang, Fan; Turnbull, John			Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FRONTOTEMPORAL LOBAR DEGENERATION; MOTONEURON-LIKE CELLS; G93A SOD1 MICE; SPINAL-CORD; NUCLEOCYTOPLASMIC TRANSPORT; MOTOR-NEURONS; GLI PROTEINS; SIGNALING PATHWAY; REPEAT EXPANSION	Sonic hedgehog (Shh) is a morphogen essential to the developing nervous system that continues to play an important role in adult life by contributing to cell proliferation and differentiation, maintaining blood-brain barrier integrity, and being cytoprotective against oxidative and excitotoxic stress, all features of importance in amyotrophic lateral sclerosis (ALS). ALS is a fatal disease characterized by selective loss of motor neurons due to poorly understood mechanisms. Evidence indicates that Shh might play an important role in ALS, and that Shh signaling might be also adversely affected in ALS. Since little is known about the functional status of Shh pathway in patients with ALS, we therefore sought to determine whether Shh protein levels or biological activity in cerebrospinal fluid (CSF) was less in ALS patients than controls, and whether these measures could be correlated with ALS disease severity and disease progression, and with other CSF analytes of biological interest in ALS. Comparing Shh levels in the CSF of normal controls (n = 13), neurological controls (n = 12), and ALS patients (n = 9) measured by ELISA, we found that CSF Shh levels were not different between controls and ALS patients. However, when assessing Shh biological activity in CSF using in vitro cell-based assays, which measure Shh activity as inducible Gli-driven luminescence, we found that in the presence of exogenous recombinant Shh or the Shh agonist, purmorphamine, the inducible activity of CSF was significantly augmented in the control groups as expected, but not in the ALS group, suggesting the presence of an inhibitor of Shh signaling in ALS CSF samples. Since purmorphamine acts on Smoothened, downstream of Shh and its receptor Patched, the inhibitory action is downstream of Smoothened. Our results also demonstrated that while the inhibitory effect of ALS CSF on Shh signaling did not correlate significantly with ALS disease characteristics, the levels of IL-1 beta and TNF-alpha did. In addition to being significantly elevated in ALS CSF, these cytokines negatively correlated with the disease duration, whereas GDF11 was a favorable predictor of ALS clinical score. We also found that TNF-a significantly inhibited Shh biological activity in vitro, potentially suggesting a novel role of TNF-a in ALS pathogenesis. Collectively, this is the first report demonstrating that Shh signaling in CSF of ALS patients is compromised.	[Drannik, Anna; Martin, Joan; Ma, Xiaoxing; Jiang, Fan; Turnbull, John] McMaster Univ, Div Neurol, Dept Med, Hamilton, ON, Canada; [Peterson, Randy] SGS Life Sci Serv Canada, Life Sci Serv, Mississauga, ON, Canada	McMaster University	Turnbull, J (corresponding author), McMaster Univ, Div Neurol, Dept Med, Hamilton, ON, Canada.	turnbull@mcmaster.ca			ALS research at McMaster University	ALS research at McMaster University	This work was undertaken with the support of Mr David Hunt, whose charity has supported ALS research at McMaster University. Mr Hunt has had no role in the study design, data collection, analysis, or preparation of the manuscript.	Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Appel S H, 2011, Acta Myol, V30, P4; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Aronica E, 2015, NEUROBIOL DIS, V74, P359, DOI 10.1016/j.nbd.2014.12.002; Babu GN, 2008, NEUROCHEM RES, V33, P1145, DOI 10.1007/s11064-007-9564-x; Beers DR, 2011, BRAIN BEHAV IMMUN, V25, P1025, DOI 10.1016/j.bbi.2010.12.008; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen YB, 2013, CELL RES, V23, P186, DOI 10.1038/cr.2013.10; Cohen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7709; Colombrita C, 2012, J BIOL CHEM, V287, P15635, DOI 10.1074/jbc.M111.333450; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Drannik AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035866; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Furukawa T, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000138; Garbuzova-Davis S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00021; Garbuzova-Davis S, 2012, BRAIN RES, V1469, P114, DOI 10.1016/j.brainres.2012.05.056; Ghorpade DS, 2013, MOL CELL BIOL, V33, P543, DOI 10.1128/MCB.01108-12; Gonzalez-Reyes LE, 2012, NEURON, V75, P306, DOI 10.1016/j.neuron.2012.05.018; Hovden H, 2013, ACTA NEUROL SCAND, V128, P287, DOI 10.1111/ane.12125; Huang X, 2010, P NATL ACAD SCI USA, V107, P8422, DOI 10.1073/pnas.0911838107; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lee HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097518; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Lu FL, 2013, INVEST NEW DRUG, V31, P823, DOI 10.1007/s10637-012-9908-5; Ma XX, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-119; Ma XX, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-71; Maier O, 2013, NEUROCHEM INT, V62, P1029, DOI 10.1016/j.neuint.2013.03.008; Mir M, 2009, NEUROSCIENCE, V162, P959, DOI 10.1016/j.neuroscience.2009.05.049; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; Moreau C, 2005, NEUROLOGY, V65, P1958, DOI 10.1212/01.wnl.0000188907.97339.76; Murdock BJ, 2015, NEUROBIOL DIS, V77, P1, DOI 10.1016/j.nbd.2015.02.017; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Peterson R, 2012, J MOL NEUROSCI, V47, P31, DOI 10.1007/s12031-011-9660-x; Pitter KL, 2014, GLIA, V62, P1595, DOI 10.1002/glia.22702; Poloni M, 2000, NEUROSCI LETT, V287, P211, DOI 10.1016/S0304-3940(00)01177-0; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Raducu M, 2016, EMBO J, V35, P1400, DOI 10.15252/embj.201593374; Rentzos M, 2010, ACTA NEUROL SCAND, V122, P425, DOI 10.1111/j.1600-0404.2010.01333.x; Sasaki H NY, DEVELOPMENT, DOI [10.1242/JCS.142828, DOI 10.1242/JCS.142828]; Shi Q, 2014, J CELL SCI, V127, P1092, DOI 10.1242/jcs.142828; Shi YT, 2011, J NEUROSCI, V31, P883, DOI 10.1523/JNEUROSCI.2394-10.2011; Siklos L, 1996, ANN NEUROL, V39, P203, DOI 10.1002/ana.410390210; Tateishi T, 2010, J NEUROIMMUNOL, V222, P76, DOI 10.1016/j.jneuroim.2010.03.004; Traiffort E, 2010, J NEUROCHEM, V113, P576, DOI 10.1111/j.1471-4159.2010.06642.x; Vanbekbergen Nele, 2014, BMC Res Notes, V7, P766, DOI 10.1186/1756-0500-7-766; Wang Y, 2008, ANN NEUROL, V64, P417, DOI 10.1002/ana.21457; Winkler EA, 2013, ACTA NEUROPATHOL, V125, P111, DOI 10.1007/s00401-012-1039-8; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhu SL, 2015, RHEUMATOLOGY, V54, P1093, DOI 10.1093/rheumatology/keu421; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	70	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171668	10.1371/journal.pone.0171668	http://dx.doi.org/10.1371/journal.pone.0171668			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170441	gold, Green Published, Green Submitted			2022-12-26	WOS:000393705500051
J	Cantor, M; Pires, MM; Marquitti, FMD; Raimundo, RLG; Sebastian-Gonzalez, E; Coltri, PP; Perez, SI; Barneche, DR; Brandt, DYC; Nunes, K; Daura-Jorge, FG; Floeter, SR; Guimaraes, PR				Cantor, Mauricio; Pires, Mathias M.; Marquitti, Flavia M. D.; Raimundo, Rafael L. G.; Sebastian-Gonzalez, Esther; Coltri, Patricia P.; Perez, S. Ivan; Barneche, Diego R.; Brandt, Debora Y. C.; Nunes, Kelly; Daura-Jorge, Fabio G.; Floeter, Sergio R.; Guimaraes, Paulo R., Jr.			Nestedness across biological scales	PLOS ONE			English	Article							MUTUALISTIC NETWORKS; GENETIC-STRUCTURE; POPULATION-SIZE; ARCHITECTURE; COMMUNITIES; SPECIALIZATION; ORGANIZATION; SPLICEOSOME; INTEGRATION; MODULARITY	Biological networks pervade nature. They describe systems throughout all levels of biological organization, from molecules regulating metabolism to species interactions that shape ecosystem dynamics. The network thinking revealed recurrent organizational patterns in complex biological systems, such as the formation of semi-independent groups of connected elements (modularity) and non-random distributions of interactions among elements. Other structural patterns, such as nestedness, have been primarily assessed in ecological networks formed by two non-overlapping sets of elements; information on its occurrence on other levels of organization is lacking. Nestedness occurs when interactions of less connected elements form proper subsets of the interactions of more connected elements. Only recently these properties began to be appreciated in one-mode networks (where all elements can interact) which describe a much wider variety of biological phenomena. Here, we compute nestedness in a diverse collection of one-mode networked systems from six different levels of biological organization depicting gene and protein interactions, complex phenotypes, animal societies, metapopulations, food webs and vertebrate metacommunities. Our findings suggest that nestedness emerge independently of interaction type or biological scale and reveal that disparate systems can share nested organization features characterized by inclusive subsets of interacting elements with decreasing connectedness. We primarily explore the implications of a nested structure for each of these studied systems, then theorize on how nested networks are assembled. We hypothesize that nestedness emerges across scales due to processes that, although system-dependent, may share a general compromise between two features: specificity (the number of interactions the elements of the system can have) and affinity (how these elements can be connected to each other). Our findings suggesting occurrence of nestedness throughout biological scales can stimulate the debate on how pervasive nestedness may be in nature, while the theoretical emergent principles can aid further research on commonalities of biological networks.	[Cantor, Mauricio] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Pires, Mathias M.; Marquitti, Flavia M. D.; Raimundo, Rafael L. G.; Sebastian-Gonzalez, Esther; Guimaraes, Paulo R., Jr.] Univ Sao Paulo, Dept Ecol, Sao Paulo, Brazil; [Marquitti, Flavia M. D.] Univ Estadual Campinas, Dept Fis Materia Condensada, Campinas, SP, Brazil; [Sebastian-Gonzalez, Esther] Univ Hawaii, Dept Biol, Trop Conservat Biol & Environm Sci, Hilo, HI 96720 USA; [Coltri, Patricia P.] Univ Sao Paulo, Dept Biol Celular & Desenvolvimento, Sao Paulo, Brazil; [Coltri, Patricia P.] Univ Nacl La Plata, Div Antropol, Fac Ciencias Nat & Museo, La Plata, Buenos Aires, Argentina; [Perez, S. Ivan] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Barneche, Diego R.] Monash Univ, Sch Biol Sci, Ctr Geometr Biol, Clayton, Vic, Australia; [Brandt, Debora Y. C.; Nunes, Kelly] Univ Sao Paulo, Dept Genet & Biol Evolut, Sao Paulo, Brazil; [Cantor, Mauricio; Daura-Jorge, Fabio G.; Floeter, Sergio R.] Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil; [Raimundo, Rafael L. G.] Univ Fed Paraiba, Ctr Ciencias Aplicadas & Educ, Dept Engn & Meio Ambiente, Rio Tinto, Paraiba, Brazil	Dalhousie University; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Hawaii System; University Hawaii Hilo; Universidade de Sao Paulo; National University of La Plata; Museo La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Monash University; Universidade de Sao Paulo; Universidade Federal de Santa Catarina (UFSC); Universidade Federal da Paraiba	Cantor, M (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.; Cantor, M (corresponding author), Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil.	m.cantor@ymail.com	, Mauricio/E-6171-2012; Coltri, Patricia P./E-6294-2014; Marquitti, Flavia Maria/B-2697-2013; Guimarães-Junior, Paulo R/M-1298-2016; Raimundo, Rafael L. G./AAU-2695-2021; Raimundo, R./F-5083-2012; Guimaraes, Paulo R./E-1915-2016; Sebastián-González, Esther/J-7883-2012; Floeter, S. R./B-1438-2012; Nunes, Kelly/AAU-6879-2021; Pires, Mathias/I-4489-2012	, Mauricio/0000-0002-0019-5106; Coltri, Patricia P./0000-0001-8447-7516; Marquitti, Flavia Maria/0000-0003-0510-3992; Raimundo, Rafael L. G./0000-0001-8166-3241; Raimundo, R./0000-0001-8166-3241; Guimaraes, Paulo R./0000-0001-9161-8305; Sebastián-González, Esther/0000-0001-7229-1845; Floeter, S. R./0000-0002-3201-6504; Nunes, Kelly/0000-0003-0864-2414; Pires, Mathias/0000-0003-2500-4748; Daura-Jorge, Fabio/0000-0003-2923-1446; Barneche, Diego/0000-0002-4568-2362; Yoshihara Caldeira Brandt, Debora/0000-0002-9565-7835	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [202581/2011-0, 474672/2013-1, 407190/2012-0, 563276/2010-0]; Sao Paulo Research Foundation [2013/22016-6, 2011/11346-0, 2015/11985-3, 2011/13054-6, 2014/21106-4, 2011/17968, 2012/09950-9, 2012/ 22796-9, 2013/02738-7, 2009/54422-8]; Killam Trusts; Evaluation of Graduate Education within the Ministry of Education of Brazil; Fundacao de Amparo a Pesquisa e Inovagao do Estado de Santa Catarina through SISBIOTA-Mar [6308/2011-8, TR2012000295]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Killam Trusts; Evaluation of Graduate Education within the Ministry of Education of Brazil; Fundacao de Amparo a Pesquisa e Inovagao do Estado de Santa Catarina through SISBIOTA-Mar(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	Grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http:// cnpq.bri) supported MC (#202581/2011-0), PC (#474672/2013-1), FGDJ (#407190/2012-0), SRF (#563276/2010-0), and PRGJr; Grants from the Sao Paulo Research Foundation (http://www. fapesp.brien/) supported MMP (#2013/22016-6), FMDM (#2011/11346-0, #2015/11985-3), RLGR (#2011/13054-6, #2014/21106-4), ESG (#2011/17968), KN (#2012/09950-9), DYCB (#2012/ 22796-9), PC (#2013/02738-7) and PRGJr (#2009/54422-8); Grant from Killam Trusts (ht :/hen killamlaureates.ca) supported MC. The Brazilian Federal Agency for Support and Evaluation of Graduate Education within the Ministry of Education of Brazil (http://www.capes.gov.br) supported RLGR; Grants from Fundacao de Amparo a Pesquisa e Inovagao do Estado de Santa Catarina (http://www.fapesc.sc.gov.br) through SISBIOTA-Mar supported SRF (#6308/2011-8) and FGDJ (#TR2012000295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Baalsrud HT, 2014, MOL ECOL, V23, P2653, DOI 10.1111/mec.12770; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barneche DR, 2014, ECOL LETT, V17, P1067, DOI 10.1111/ele.12309; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI [10.1038/NMETH.2728, 10.1038/nmeth.2728]; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Bender MG, 2013, GLOBAL ECOL BIOGEOGR, V22, P1173, DOI 10.1111/geb.12099; Bender MG, 2016, ECOGRAPHY; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Cantor M, 2012, ANIM BEHAV, V84, P641, DOI 10.1016/j.anbehav.2012.06.019; Chernoff B., 1999, MORPHOLOGICAL INTEGR, P319; CHEVERUD JM, 1995, AM NAT, V145, P63, DOI 10.1086/285728; Coltri PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045678; Daura-Jorge FG, 2012, BIOL LETTERS, V8, P702, DOI 10.1098/rsbl.2012.0174; Dunne JA, 2006, SFI S SCI C, P27; Floeter SR, 2007, ENVIRON BIOL FISH, V78, P147, DOI 10.1007/s10641-006-9084-6; Gomez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016143; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Holekamp KE, 2012, MOL ECOL, V21, P613, DOI 10.1111/j.1365-294X.2011.05240.x; Holekamp KE, 2011, SOC DEMOGRAPHY GENET; Howells W. W., 1973, PAPERS PEABODY MUSEU, V67; Perez SI, 2009, EVOL BIOL, V36, P416, DOI 10.1007/s11692-009-9074-7; Jonhson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074025; Joppa LN, 2010, EVOL ECOL RES, V12, P35; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Kondoh M, 2010, ECOLOGY, V91, P3123, DOI 10.1890/09-2219.1; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kulbicki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081847; Lee DS, 2012, J KOREAN PHYS SOC, V60, P648, DOI 10.3938/jkps.60.648; Lewinsohn TM, 2006, OIKOS, V113, P174, DOI 10.1111/j.0030-1299.2006.14583.x; Lobato FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102094; Lorenz DM, 2011, PHYS LIFE REV, V8, P129, DOI 10.1016/j.plrev.2011.02.003; Luz JS, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-22; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Mouillot D, 2014, P NATL ACAD SCI USA, V111, P13757, DOI 10.1073/pnas.1317625111; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Neutel AM, 2007, NATURE, V449, P599, DOI 10.1038/nature06154; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Orchard S, 2012, NAT METHODS, V9, P345, DOI [10.1038/NMETH.1931, 10.1038/nmeth.1931]; Pascual M., 2005, ECOLOGICAL NETWORKS; Pires MM, 2011, J ANIM ECOL, V80, P896, DOI 10.1111/j.1365-2656.2011.01818.x; Pires MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14865; Pocock MJO, 2012, SCIENCE, V335, P973, DOI 10.1126/science.1214915; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rooney N, 2012, TRENDS ECOL EVOL, V27, P40, DOI 10.1016/j.tree.2011.09.001; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; SLATKIN M, 1995, GENETICS, V139, P457; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; Staniczenko PPA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2422; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Strona G, 2015, METHODS ECOL EVOL, V6, P907, DOI 10.1111/2041-210X.12395; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tinker MT, 2012, ECOL LETT, V15, P475, DOI 10.1111/j.1461-0248.2012.01760.x; Tufto J, 2005, AM NAT, V165, pE13, DOI 10.1086/426698; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Valtonen ET, 2001, PARASITOLOGY, V122, P471, DOI 10.1017/S0031182001007491; Voelkl B, 2008, J THEOR BIOL, V252, P77, DOI 10.1016/j.jtbi.2008.02.002; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wang S, 2013, POPULATION SIZE TIME; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wang SP, 2014, MOL ECOL, V23, P637, DOI 10.1111/mec.12634; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Woodward G, 2002, J ANIM ECOL, V71, P1063, DOI 10.1046/j.1365-2656.2002.00669.x	79	32	33	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171691	10.1371/journal.pone.0171691	http://dx.doi.org/10.1371/journal.pone.0171691			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166284	gold, Green Published			2022-12-26	WOS:000393700100062
J	Naruse, C; Shibata, S; Tamura, M; Kawaguchi, T; Abe, K; Sugihara, K; Kato, T; Nishiuchi, T; Wakana, S; Ikawa, M; Asano, M				Naruse, Chie; Shibata, Shinwa; Tamura, Masaru; Kawaguchi, Takayuki; Abe, Kanae; Sugihara, Kazushi; Kato, Tomoaki; Nishiuchi, Takumi; Wakana, Shigeharu; Ikawa, Masahito; Asano, Masahide			New insights into the role of Jmjd3 and Utx in axial skeletal formation in mice	FASEB JOURNAL			English	Article						homeotic transformation; histone demethylation; Hox; kyphosis; H3K27 methylation	EMBRYONIC STEM-CELLS; HOX GENE CLUSTERS; HISTONE H3; DEMETHYLASE JMJD3; DEVELOPMENTAL REGULATORS; NUCLEAR REORGANIZATION; POLYCOMB COMPLEXES; TARGET GENES; CHROMATIN; MOUSE	Jmjd3 and Utx are demethylases specific for lysine 27 of histone H3. Previous reports indicate that Jmjd3 is essential for differentiation of various cell types, such as macrophages and epidermal cells in mice, whereas Utx is involved in cancer and developmental diseases in humans and mice, as well as Hox regulation in zebrafish and nematodes. Here, we report that Jmjd3, but not Utx, is involved in axial skeletal formation in mice. A Jmjd3 mutant embryo (Jmjd3(Delta 18/Delta 18)), but not a catalytically inactive Utx truncation mutant (Utx(-/y)), showed anterior homeotic transformation. Quantitative RT-PCR and microarray analyses showed reduced Hox expression in both Jmjd3(Delta 18/Delta 18) embryos and tailbuds, whereas levels of Hox activators, such as Wnt signaling factors and retinoic acid synthases, did not decrease, which suggests that Jmjd3 plays a regulatory role in Hox expression during axial patterning. Chromatin immunoprecipitation analyses of embryo tailbud tissue showed trimethylated lysine 27 on histone H3 to be at higher levels at the Hox loci in Jmjd3(Delta 18/Delta 18) mutants compared with wild-type tailbuds. In contrast, trimethylated lysine 4 on histone H3 levels were found to be equivalent in wild-type and Jmjd3(Delta 18/Delta 18) tailbuds. Demethylase-inactive Jmjd3 mutant embryos showed the same phenotype as Jmjd3(Delta 18/Delta 18) mice. These results suggest that the demethylase activity of Jmjd3, but not that of Utx, affects mouse axial patterning in concert with alterations in Hox gene expression.	[Naruse, Chie; Sugihara, Kazushi; Asano, Masahide] Kyoto Univ, Inst Lab Anim, Grad Sch Med, Kyoto, Japan; [Naruse, Chie; Shibata, Shinwa; Kawaguchi, Takayuki; Abe, Kanae; Sugihara, Kazushi; Asano, Masahide] Kanazawa Univ, Div Transgen Anim Sci, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Kato, Tomoaki; Nishiuchi, Takumi] Kanazawa Univ, Div Funct Genom, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Tamura, Masaru; Wakana, Shigeharu] RIKEN, Technol & Dev Team Mouse Phenotype Anal, BioResource Ctr, Tsukuba, Ibaraki, Japan; [Ikawa, Masahito] Osaka Univ, Res Inst Microbial Dis, Anim Resource Ctr Infect Dis, Suita, Osaka, Japan	Kyoto University; Kanazawa University; Kanazawa University; RIKEN; Osaka University	Asano, M (corresponding author), Kyoto Univ, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	asano@anim.med.kyoto-u.ac.jp	ikawa, masahito/A-5315-2009	ikawa, masahito/0000-0001-9859-6217; Kawaguchi, Takayuki/0000-0001-6688-3879; Nishiuchi, Takumi/0000-0001-9429-5396	Grants-in-Aid for Scientific Research [15K14360, 16H06276] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abe K, 2011, BIOL REPROD, V85, P1013, DOI 10.1095/biolreprod.111.091512; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; Burgold T, 2012, CELL REP, V2, P1244, DOI 10.1016/j.celrep.2012.09.013; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chen F, 1998, MECH DEVELOP, V77, P49, DOI 10.1016/S0925-4773(98)00126-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dahle O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000841; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; Fukusumi Y, 2008, DEV DYNAM, V237, P618, DOI 10.1002/dvdy.21444; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Henriquez B, 2013, MOL CELL NEUROSCI, V57, P130, DOI 10.1016/j.mcn.2013.07.012; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Hurley I, 2005, EVOL DEV, V7, P556, DOI 10.1111/j.1525-142X.2005.05059.x; Ito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029873; IZPISUABELMONTE JC, 1991, EMBO J, V10, P2279, DOI 10.1002/j.1460-2075.1991.tb07764.x; Kang SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135276; Kappen C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146019; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Mallo M, 2013, DEVELOPMENT, V140, P3951, DOI 10.1242/dev.068346; Mashiko D, 2014, DEV GROWTH DIFFER, V56, P122, DOI 10.1111/dgd.12113; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nagy A., 2003, MANIPULATING MOUSE E; Niederreither K., 2008, NAT REV GENET; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; RANCOURT DE, 1995, GENE DEV, V9, P108, DOI 10.1101/gad.9.1.108; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sengoku T, 2011, GENE DEV, V25, P2266, DOI 10.1101/gad.172296.111; Shpargel KB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004507; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van den Akker E, 2001, DEVELOPMENT, V128, P1911; Vinagre T, 2010, DEV CELL, V18, P655, DOI 10.1016/j.devcel.2010.02.011; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zakany J, 1997, EMBO J, V16, P4393, DOI 10.1093/emboj/16.14.4393; Zhang F, 2015, J MOL CELL BIOL, V7, P23, DOI 10.1093/jmcb/mjv003	66	19	19	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2252	2266		10.1096/fj.201600642R	http://dx.doi.org/10.1096/fj.201600642R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28188179				2022-12-26	WOS:000401553400004
J	Han, YB; Chen, LQ; Li, Z; Tan, YM; Feng, Y; Yang, GY				Han, Yun-Bin; Chen, Liu-Qing; Li, Zhuo; Tan, Yu-Meng; Feng, Yan; Yang, Guang-Yu			Structural Insights into the Broad Substrate Specificity of a Novel Endoglycoceramidase I Belonging to a New Subfamily of GH5 Glycosidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; CERAMIDE-GLYCANASE; CRYPTOCOCCUS-NEOFORMANS; CRYSTAL-STRUCTURE; PROTEIN; GLYCOSPHINGOLIPIDS; PURIFICATION; OLIGOSACCHARIDE; XYLOGLUCAN; VALIDATION	Endoglycoceramidases (EGCases) specifically hydrolyze the glycosidic linkage between the oligosaccharide and the ceramide moieties of various glycosphingolipids, and they have received substantial attention in the emerging field of glycosphingolipidology. However, the mechanism regulating the strict substrate specificity of these GH5 glycosidases has not been identified. In this study, we report a novel EGCase I from Rhodococcus equi 103S (103S_ EGCase I) with remarkably broad substrate specificity. Based on phylogenetic analyses, the enzyme may represent a new subfamily of GH5 glycosidases. The X-ray crystal structures of 103S_ EGCase I alone and in complex with its substrates monosialodihexosylganglioside (GM3) and monosialotetrahexosylganglioside (GM1) enabled us to identify several structural features that may account for its broad specificity. Compared with EGCase II from Rhodococcus sp. M-777 (M777_ EGCase II), which possesses strict substrate specificity, 103S_ EGCase I possesses a longer alpha 7-helix and a shorter loop 4, which forms a larger substrate-binding pocket that could accommodate more extended oligosaccharides. In addition, loop 2 and loop 8 of the enzyme adopt a more open conformation, which also enlarges the oligosaccharide-binding cavity. Based on this knowledge, a rationally designed experiment was performed to examine the substrate specificity of EGCase II. The truncation of loop 4 in M777_ EGCase II increased its activity toward GM1 (163%). Remarkably, the S63G mutant of M777_ EGCase II showed a broader substrate spectra and significantly increased activity toward bulky substrates (up to > 1370-fold for fucosyl-GM1). Collectively, the results presented here reveal the exquisite substrate recognitionmechanismofEGCasesandprovideanopportunityfor further engineering of these enzymes.	[Han, Yun-Bin; Chen, Liu-Qing; Li, Zhuo; Tan, Yu-Meng; Feng, Yan; Yang, Guang-Yu] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, 800 Dongchuan Rd, Shanghai 200240, Peoples R China; [Han, Yun-Bin] ShanghaiTech Univ, Shanghai Inst Adv Immunol Studies, Shanghai 200031, Peoples R China; [Yang, Guang-Yu] East China Univ Sci & Technol, Shanghai Collaborat Innovat Ctr Biomfg, Shanghai 200237, Peoples R China	Shanghai Jiao Tong University; ShanghaiTech University; East China University of Science & Technology	Yang, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	yanggy@sjtu.edu.cn		Chen, Liuqing/0000-0002-2104-3697	National Basic Research Program of China [2012CB721003]; Natural Science Foundation of China [31470788, 11371142]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, 2012CB721003) and Natural Science Foundation of China Grants 31470788 and 11371142. The authors declare that they have no conflicts of interest with the contents of this article.	ASHIDA H, 1992, EUR J BIOCHEM, V205, P729, DOI 10.1111/j.1432-1033.1992.tb16836.x; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; BASU SS, 1994, ANAL BIOCHEM, V222, P270, DOI 10.1006/abio.1994.1484; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Caines MEC, 2007, J BIOL CHEM, V282, P14300, DOI 10.1074/jbc.M611455200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Correia MAS, 2011, J BIOL CHEM, V286, P22510, DOI 10.1074/jbc.M110.217315; D'Arcy A, 2014, ACTA CRYSTALLOGR F, V70, P1117, DOI 10.1107/S2053230X14015507; Dias FMV, 2004, J BIOL CHEM, V279, P25517, DOI 10.1074/jbc.M401647200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujitani N, 2011, J BIOL CHEM, V286, P41669, DOI 10.1074/jbc.M111.301796; Furukawa J, 2015, J LIPID RES, V56, P2399, DOI 10.1194/jlr.D062083; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horibata Y, 2004, J BIOL CHEM, V279, P33379, DOI 10.1074/jbc.M401460200; Horibata Y, 2000, J BIOL CHEM, V275, P31297, DOI 10.1074/jbc.M003575200; Ishibashi Y, 2007, J BIOL CHEM, V282, P11386, DOI 10.1074/jbc.M608445200; Ishibashi Y, 2012, J LIPID RES, V53, P2242, DOI 10.1194/jlr.D028951; Ishibashi Y, 2012, J BIOL CHEM, V287, P368, DOI 10.1074/jbc.M111.311340; ITO M, 1986, J BIOL CHEM, V261, P14278; ITO M, 1989, J BIOL CHEM, V264, P9510; Izu H, 1997, J BIOL CHEM, V272, P19846, DOI 10.1074/jbc.272.32.19846; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; LI SC, 1986, BIOCHEM BIOPH RES CO, V141, P346, DOI 10.1016/S0006-291X(86)80375-8; LI YT, 1987, BIOCHEM BIOPH RES CO, V149, P167, DOI 10.1016/0006-291X(87)91619-6; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Venditto I, 2015, J BIOL CHEM, V290, P10572, DOI 10.1074/jbc.M115.637827; Watanabe T, 2015, J BIOL CHEM, V290, P1005, DOI 10.1074/jbc.M114.616300; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhou P, 2014, ACTA CRYSTALLOGR D, V70, P2970, DOI 10.1107/S1399004714019762; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	43	36	38	2	41	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4789	4800		10.1074/jbc.M116.763821	http://dx.doi.org/10.1074/jbc.M116.763821			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28179425	hybrid, Green Published			2022-12-26	WOS:000397590400004
J	Serra-Varela, MJ; Alia, R; Portoles, J; Gonzalo, J; Solino, M; Grivet, D; Raposo, R				Jesus Serra-Varela, Maria; Alia, Ricardo; Portoles, Javier; Gonzalo, Julian; Solino, Mario; Grivet, Delphine; Raposo, Rosa			Incorporating exposure to pitch canker disease to support management decisions of Pinus pinaster Ait. in the face of climate change	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; FUSARIUM-CIRCINATUM; POTENTIAL DISTRIBUTION; BIOTIC INTERACTIONS; FOREST MANAGEMENT; RANGE SHIFTS; PART I; DISTRIBUTIONS; NICHE; CONSERVATION	Climate change is gravely affecting forest ecosystems, resulting in large distribution shifts as well as in increasing infection diseases and biological invasions. Accordingly, forest management requires an evaluation of exposure to climate change that should integrate both its abiotic and biotic components. Here we address the implications of climate change in an emerging disease by analysing both the host species (Pinus pinaster, Maritime pine) and the pathogen's (Fusarium circinatum, pitch canker) environmental suitability i.e. estimating the host's risk of habitat loss and the disease's future environmental range. We constrained our study area to the Spanish Iberian Peninsula, where accurate climate and pitch canker occurrence databases were available. While P. pinaster is widely distributed across the study area, the disease has only been detected in its north-central and north-western edges. We fitted species distribution models for the current distribution of the conifer and the disease. Then, these models were projected into nine Global Climate Models and two different climatic scenarios which totalled to 18 different future climate predictions representative of 2050. Based on the level of agreement among them, we created future suitability maps for the pine and for the disease independently, which were then used to assess exposure of current populations of P. pinaster to abiotic and biotic effects of climate change. Almost the entire distribution of P. pinaster in the Spanish Iberian Peninsula will be subjected to abiotic exposure likely to be driven by the predicted increase in drought events in the future. Furthermore, we detected a reduction in exposure to pitch canker that will be concentrated along the north-western edge of the study area. Setting up breeding programs is recommended in highly exposed and productive populations, while silvicultural methods and monitoring should be applied in those less productive, but still exposed, populations.	[Jesus Serra-Varela, Maria] Univ Valladolid, Dept Plant Prod & Forest Resources, Palencia, Spain; [Jesus Serra-Varela, Maria; Alia, Ricardo; Gonzalo, Julian; Solino, Mario; Grivet, Delphine; Raposo, Rosa] Univ Valladolid, Sustainable Forest Management Res Inst, INIA, Palencia, Spain; [Jesus Serra-Varela, Maria; Alia, Ricardo; Solino, Mario; Grivet, Delphine; Raposo, Rosa] Forest Res Ctr, INIA, Madrid, Spain; [Portoles, Javier] Fdn Invest Clima, Madrid, Spain	Universidad de Valladolid; Universidad de Valladolid; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Serra-Varela, MJ (corresponding author), Univ Valladolid, Dept Plant Prod & Forest Resources, Palencia, Spain.; Serra-Varela, MJ (corresponding author), Univ Valladolid, Sustainable Forest Management Res Inst, INIA, Palencia, Spain.; Serra-Varela, MJ (corresponding author), Forest Res Ctr, INIA, Madrid, Spain.	maje.serra@gmail.com	Grivet, Delphine/G-9708-2012; Soliño, Mario/A-5648-2012; Alia, Ricardo/B-5160-2011; Pórtoles, Javier/L-4612-2014; Raposo, Rosa/A-3185-2012	Grivet, Delphine/0000-0001-8168-4456; Alia, Ricardo/0000-0002-9426-0967; Pórtoles, Javier/0000-0002-5207-8825; Raposo, Rosa/0000-0002-4893-6874	Spanish Ministry of Agriculture, Food and Environment; Spanish National Research Plan AdapCon [CGL2011-30182-C02-01]; TipTree (BiodivERsA-ERANET); INIA Spanish Ministry of Economy and Competitiveness [RTA2013-00048-C03-01]; FPU from the Spanish Ministry of Education, Culture and Sport; Ramon y Cajal fellowship from the Spanish Ministry of Science and Innovation	Spanish Ministry of Agriculture, Food and Environment(Spanish Government); Spanish National Research Plan AdapCon; TipTree (BiodivERsA-ERANET); INIA Spanish Ministry of Economy and Competitiveness; FPU from the Spanish Ministry of Education, Culture and Sport; Ramon y Cajal fellowship from the Spanish Ministry of Science and Innovation(Spanish Government)	We thank the "Scientific research for the adaptation of Pinus pinaster Ait. and Pinus halapensis Mill. to climate change project, funded by the Spanish Ministry of Agriculture, Food and Environment, for enabling the collaboration between the different groups involved, as well as the Spanish National Research Plan AdapCon (CGL2011-30182-C02-01), and the TipTree (BiodivERsA-ERANET) which have supported the development of this paper. This study is framed within the project "Integrated Production in Spanish Pine Forests: From the Diversity of Species to Genetic Improvement Programs", funded by the the INIA Spanish Ministry of Economy and Competitiveness (RTA2013-00048-C03-01). MJSV was supported by a FPU from the Spanish Ministry of Education, Culture and Sport. D.G. was supported by a Ramon y Cajal fellowship from the Spanish Ministry of Science and Innovation.; We are grateful to Jesus Martinez Fernandez for his collaboration during the analysis stage and to Felipe Bravo-Oviedo for insightful discussion. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for the 5th Coupled Model Intercomparison Project CMIP, and we thank the climate modelling groups (listed in able 2 of this article) for producing and making available their model output. Thanks are extended to the Spanish Meteorological Agency (AEMET) for providing the climatic observational data, and to Gerardo Sanchez Pena at Spanish Ministry of Agriculture, Food and Environment for providing records of Fusarium circinatum. We also thank Grant&Co. Language Services, for kindly revising the language through the text. We thank the "Scientific research for the adaptation of Pinus pinaster Ait. and Pinus halapensis Mill. to climate change" project, funded by the Spanish Ministry of Agriculture, Food and Environment, for enabling the collaboration between the different groups involved, as well as the Spanish National Research Plan AdapCon (CGL2011-30182-C02-01), and the TipTree (BiodivERsA-ERANET) which have supported the development of this paper. This study is framed within the project "Integrated Production in Spanish Pine Forests: From the Diversity of Species to Genetic Improvement Programs", funded by the INIA Spanish Ministry of Economy and Competitiveness (RTA2013-00048-C03-01). MJSV was supported by a FPU from the Spanish Ministry of Education, Culture and Sport. D.G. was supported by a Ramon y Cajal fellowship from the Spanish Ministry of Science and Innovation.	Alia R, 2009, REGIONES PROCEDENCIA; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Arnaldo PS, 2005, FOREST ECOL MANAG, V210, P1, DOI 10.1016/j.foreco.2005.02.041; Austin MP, 2006, ECOL MODEL, V199, P197, DOI 10.1016/j.ecolmodel.2006.05.023; Baker R., 2010, EFSA J, V8, P1, DOI DOI 10.2903/J.EFSA.2010.AVAILABLE; Bakys R, 2009, PLANT PATHOL, V58, P284, DOI 10.1111/j.1365-3059.2008.01977.x; Barbero Marcel, 1998, P153; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bedia J, 2013, GLOBAL PLANET CHANGE, V107, P1, DOI 10.1016/j.gloplacha.2013.04.005; Belsley D. A., 1991, CONDITIONING DIAGNOS; Berbegal M, 2013, PHYTOPATHOLOGY, V103, P851, DOI 10.1094/PHYTO-11-12-0281-R; Bolte A, 2009, SCAND J FOREST RES, V24, P473, DOI 10.1080/02827580903418224; Bravo-Oviedo A, 2004, FOREST ECOL MANAG, V201, P187, DOI 10.1016/j.foreco.2004.06.031; Chakraborty S, 2013, GLOBAL CHANGE BIOL, V19, P1985, DOI 10.1111/gcb.12205; Coops NC, 2011, ECOL MODEL, V222, P2119, DOI 10.1016/j.ecolmodel.2011.03.033; da Silva RS, 2016, PEST MANAG SCI; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Edenhofer O., 2014, CONTRIBUTION WORKING; ELITH J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI [DOI 10.1146/ANNUREV.EC0LSYS.110308.120159, 10.1146/annurev.ecolsys.110308.120159, DOI 10.1146/ANNUREV.ECOLSYS.110308.120159]; Elvira-Recuenco M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114971; Fernandes PM, 2007, FOREST ECOL MANAG, V241, P1, DOI 10.1016/j.foreco.2007.01.010; Food and Agriculture Organization of the United Nations (FAO), 2006, BETT FOR LESS POV PR; Ganley RJ, 2009, CAN J FOREST RES, V39, P2246, DOI 10.1139/X09-131; Garcia J, 2001, MINISTERIO MEDIO AMB; Gaspar M. J., 2013, PLOS ONE, V8, P1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hair J.F., 1995, MULTIVARIATE DATA AN, V4th; Hamann A, 2013, DIVERS DISTRIB, V19, P268, DOI 10.1111/j.1472-4642.2012.00945.x; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hartkamp AD, 1999, NRG GEOGRAPHIC IN 99; Hastie T., 1986, STAT SCI, V1, P297; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Higgins SI, 2012, J BIOGEOGR, V39, P2132, DOI 10.1111/j.1365-2699.2012.02752.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchinson M.F., 1991, BMRC RES REP, V27, P104; Iturritxa E, 2015, PLANT PATHOL, V64, P880, DOI 10.1111/ppa.12328; Iturritxa E, 2012, AUSTRALAS PLANT PATH, V41, P601, DOI 10.1007/s13313-012-0160-4; Iturritxa E, 2011, FUNGAL BIOL-UK, V115, P288, DOI 10.1016/j.funbio.2010.12.014; Jarvis CH, 2001, J APPL METEOROL, V40, P1060, DOI 10.1175/1520-0450(2001)040<1060:ACASFI>2.0.CO;2; Johnston M. H., 2009, VULNERABILITY CANADA; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Madrigal-Gonzalez J, 2014, AGR FOREST METEOROL, V192, P18, DOI 10.1016/j.agrformet.2014.02.011; Maguire KC, 2015, ANNU REV ECOL EVOL S, V46, P343, DOI 10.1146/annurev-ecolsys-112414-054441; Martinez-Alvarez P, 2014, PLANT PATHOL, V63, P1086, DOI 10.1111/ppa.12187; Monjo R, 2014, THEOR APPL CLIMATOL, V117, P317, DOI 10.1007/s00704-013-1008-8; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Moykkynen T, 2014, ANN FOREST SCI, V72, P169; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Normand S, 2011, P ROY SOC B-BIOL SCI, V278, P3644, DOI 10.1098/rspb.2010.2769; Pautasso M, 2015, MICROB ECOL, V69, P826, DOI 10.1007/s00248-014-0545-8; Pautasso M, 2010, BIOL REV, V85, P729, DOI 10.1111/j.1469-185X.2010.00123.x; Pearson, 2010, LESSONS CONSERVATION, V3, P54, DOI [DOI 10.1016/S0140-6736(10)61462-6, 10.1016/S0140-6736(10)61462-6]; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Perez-Sierra A, 2007, MYCOL RES, V111, P832, DOI 10.1016/j.mycres.2007.05.009; Preston K, 2008, GLOBAL CHANGE BIOL, V14, P2501, DOI 10.1111/j.1365-2486.2008.01671.x; Prieto-Recio C, 2015, FOREST ECOL MANAG, V356, P74, DOI 10.1016/j.foreco.2015.07.033; R Core Team, 2021, R LANGUAGE ENV STAT; Ribalaygua J, 2013, THEOR APPL CLIMATOL, V111; Rosso PH, 2003, PHYTOPATHOLOGY, V93, P790, DOI 10.1094/PHYTO.2003.93.7.790; Sakamoto JM, 2006, PLANT PATHOL, V55, P130, DOI 10.1111/j.1365-3059.2005.01310.x; Sakamoto JM, 2007, CAN ENTOMOL, V139, P864, DOI 10.4039/N07-022; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; Schueler S, 2014, GLOBAL CHANGE BIOL, V20, P1498, DOI 10.1111/gcb.12476; Serra-Varela MJ, 2015, GLOBAL ECOL BIOGEOGR, V24, P1302, DOI 10.1111/geb.12369; Serra-Varela MJ, DIVERS DIST IN PRESS; Shabani F, 2016, ECOL EVOL, V6, P5973, DOI 10.1002/ece3.2332; Shabani F, 2014, AGR ECOSYST ENVIRON, V197, P96, DOI 10.1016/j.agee.2014.08.005; Sturrock RN, 2011, PLANT PATHOL, V60, P133, DOI 10.1111/j.1365-3059.2010.02406.x; Taylor K.E., 2009, SUMMARY CMIP5 EXPT D; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; THUILLER W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI DOI 10.1111/J.1365-2486.2005.01018.X; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Valladares F, 2014, ECOL LETT, V17, P1351, DOI 10.1111/ele.12348; Vivas M, 2012, FORESTRY, V85, P185, DOI 10.1093/forestry/cpr055; Walther G, 2012, NATURE, V416, P389; Watt MS, 2011, CAN J FOREST RES, V41, P412, DOI 10.1139/X10-204; Wingfield MJ, 2008, AUSTRALAS PLANT PATH, V37, P319, DOI 10.1071/AP08036; Zas R, 2005, ANN FOREST SCI, V62, P681, DOI 10.1051/forest:2005064; Zorita E, 1999, J CLIMATE, V12, P2474, DOI 10.1175/1520-0442(1999)012<2474:TAMAAS>2.0.CO;2	85	10	10	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171549	10.1371/journal.pone.0171549	http://dx.doi.org/10.1371/journal.pone.0171549			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192454	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423800029
J	Alzaharna, M; Alqouqa, I; Cheung, HY				Alzaharna, Mazen; Alqouqa, Iyad; Cheung, Hon-Yeung			Taxifolin synergizes Andrographolide-induced cell death by attenuation of autophagy and augmentation of caspase dependent and independent cell death in HeLa cells	PLOS ONE			English	Article							MITOCHONDRIAL-MEDIATED APOPTOSIS; BREAST-CANCER CELLS; N-TERMINAL KINASE; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAYS; JNK ACTIVATION; CYCLE ARREST; IN-VITRO; FLAVONOIDS; P53	Andrographolide (Andro) has emerged recently as a potential and effective anticancer agent with induction of apoptosis in some cancer cell lines while induction of G2/M arrest with weak apoptosis in others. Few studies have proved that Andro is also effective in combination therapy. The flavonoid Taxifolin (Taxi) has showed anti-oxidant and antiproliferative effects against different cancer cells. Therefore, the present study investigated the cytotoxic effects of Andro alone or in combination with Taxi on HeLa cells. The combination of Andro with Taxi was synergistic at all tested concentrations and combination ratios. Andro alone induced caspase-dependent apoptosis which was enhanced by the combination with Taxi and attenuated partly by using Z-Vad-Fmk. Andro induced a protective reactive oxygen species (ROS)-dependent autophagy which was attenuated by Taxi. The activation of p53 was involved in Andro-induced autophagy where the use of Taxi or pifithrin-alpha (PFT-alpha) decreased it while the activation of JNK was involved in the cell death of HeLa cells but not in the induction of autophagy. The mitochondrial outer-membrane permeabilization (MOMP) plays an important role in Andro-induced cell death in HeLa cells. Andro alone increased the MOMP which was further increased in the case of combination. This led to the increase in AIF and cytochrome c release from mitochondria which consequently increased caspase-dependent and independent cell death. In conclusion, Andro induced a protective autophagy in HeLa cells which was reduced by Taxi and the cell death was increased by increasing the MOMP and subsequently the caspase-dependent and independent cell death.	[Alzaharna, Mazen; Alqouqa, Iyad; Cheung, Hon-Yeung] City Univ Hong Kong, Dept Biomed Sci, Res Grp Bioact Prod, Hong Kong, Hong Kong, Peoples R China; [Alzaharna, Mazen] Islamic Univ Gaza, Fac Hlth Sci, Dept Med Lab Sci, Alremal, Gaza, Palestine	City University of Hong Kong	Alzaharna, M (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Res Grp Bioact Prod, Hong Kong, Hong Kong, Peoples R China.	mzaharna@iugaza.edu.ps	Alzaharna, Mazen/ABG-8279-2021	Alzaharna, Mazen/0000-0002-1111-958X				Akbar S, 2011, ALTERN MED REV, V16, P66; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Brusselmans K, 2005, J BIOL CHEM, V280, P5636, DOI 10.1074/jbc.M408177200; Campbell JK, 2006, J FOOD SCI, V71, pS358, DOI 10.1111/j.1750-3841.2006.00013.x; Chen W, 2012, CARCINOGENESIS, V33, P2190, DOI 10.1093/carcin/bgs264; Chen YQ, 2010, CAN J PHYSIOL PHARM, V88, P285, DOI 10.1139/Y10-010; Chen Z, 2016, CLIN CANCER RES, V22, P187, DOI 10.1158/1078-0432.CCR-15-0987; Cheng Y, 2008, BIOCHEM BIOPH RES CO, V376, P483, DOI 10.1016/j.bbrc.2008.09.018; Cheung HY, 2005, PLANTA MED, V71, P1106, DOI 10.1055/s-2005-873128; Cheung MTW, 2012, LIFE SCI, V91, P751, DOI 10.1016/j.lfs.2012.04.009; Duan WJ, 2011, BIOL PHARM BULL, V34, P47, DOI 10.1248/bpb.34.47; Faivre S, 2006, SEMIN ONCOL, V33, P407, DOI 10.1053/j.seminoncol.2006.04.005; Galati G, 2004, FREE RADICAL BIO MED, V37, P287, DOI 10.1016/j.freeradbiomed.2004.04.034; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Guo XL, 2012, CANCER LETT, V320, P171, DOI 10.1016/j.canlet.2012.03.002; He W, 2013, ONCOGENE; Hemalswarya S, 2007, ANN TRADITIONAL CHIN, P363; Jada SR, 2008, BRIT J PHARMACOL, V155, P641, DOI 10.1038/bjp.2008.368; Ji L, 2007, PLANTA MED, V73, P1397, DOI 10.1055/s-2007-990230; Jones Russell G, 2009, F1000 Biol Rep, V1, P68, DOI 10.3410/B1-68; Karna P, 2010, J BIOL CHEM, V285, P18737, DOI 10.1074/jbc.M109.091694; Kawaii S, 1999, BIOSCI BIOTECH BIOCH, V63, P896, DOI 10.1271/bbb.63.896; Kerr DJ, 2004, ANN ONCOL, V15, P1727, DOI 10.1093/annonc/mdh480; Kim RH, 2009, CANCER RES, V69, P700, DOI 10.1158/0008-5472.CAN-08-3157; Lee TJ, 2006, MOL CANCER THER, V5, P2398, DOI 10.1158/1535-7163.MCT-06-0167; Leung EL, 2013, BRIEF BIOINFORM, V14, P491, DOI 10.1093/bib/bbs043; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Li JL, 2007, EUR J PHARMACOL, V568, P31, DOI 10.1016/j.ejphar.2007.04.027; Li L, 2012, FREE RADICAL BIO MED, V53, P1399, DOI 10.1016/j.freeradbiomed.2012.07.011; Middleton E, 2000, PHARMACOL REV, V52, P673; Morse DL, 2005, MOL CANCER THER, V4, P1495, DOI 10.1158/1535-7163.MCT-05-0130; Notte A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.167; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Oi N, 2012, CANCER PREV RES, V5, P1103, DOI 10.1158/1940-6207.CAPR-11-0397; Raina K, 2007, ACTA PHARMACOL SIN, V28, P1466, DOI 10.1111/j.1745-7254.2007.00691.x; Rajagopal Sriram, 2003, J Exp Ther Oncol, V3, P147, DOI 10.1046/j.1359-4117.2003.01090.x; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Sharma DK, 2006, J SCI IND RES INDIA, V65, P477; Shen Kai-kai, 2009, Yaoxue Xuebao, V44, P973; Shi MD, 2008, CHEM-BIOL INTERACT, V174, P201, DOI 10.1016/j.cbi.2008.06.006; Shimizu S, 2010, ONCOGENE, V29, P2070, DOI 10.1038/onc.2009.487; Siegelin MD, 2008, MOL CANCER THER, V7, P3566, DOI 10.1158/1535-7163.MCT-08-0236; Sridharan Savitha, 2011, Cancers (Basel), V3, P2630, DOI 10.3390/cancers3022630; Tafolla E, 2005, J BIOL CHEM, V280, P19992, DOI 10.1074/jbc.M500331200; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Theriault A, 2000, J LIPID RES, V41, P1969; Tsao R, 2010, FRUIT VEGETABLE PHYT, P131; Tyagi AK, 2002, CLIN CANCER RES, V8, P3512; Vasantha S, 2010, DRUG INVENT TODAY, V2, P440; Verschooten L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048264; Vladimirov YA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P301, DOI 10.1134/S0006297909030092; Wang JP, 2000, MOL CARCINOGEN, V29, P179, DOI 10.1002/1098-2744(200011)29:3<179::AID-MC7>3.0.CO;2-K; Wang TG, 2004, J PHARMACOL EXP THER, V308, P975, DOI 10.1124/jpet.103.059683; Watjen W, 2005, J NUTR, V135, P525, DOI 10.1093/jn/135.3.525; Woo AYH, 2008, J PHARMACOL EXP THER, V325, P226, DOI 10.1124/jpet.107.133918; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Yang L, 2009, CANCER LETT, V276, P180, DOI 10.1016/j.canlet.2008.11.015; Yang S, 2010, CLIN CANCER RES, V16, P4755, DOI 10.1158/1078-0432.CCR-10-0883; Zhang H, 2016, ONCOTARGET, V7, P14350, DOI 10.18632/oncotarget.7320; Zhang XD, 2014, MOL CELL BIOCHEM, V385, P265, DOI 10.1007/s11010-013-1835-z; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]; Zhao F, 2008, J ASIAN NAT PROD RES, V10, P473, DOI [10.1080/10286020801948334, 10.1080/10286020801948599]; Zhou J, 2008, MOL CANCER THER, V7, P2170, DOI 10.1158/1535-7163.MCT-08-0071; Zhou J, 2012, AUTOPHAGY, V8, P338, DOI 10.4161/auto.18721	64	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171325	10.1371/journal.pone.0171325	http://dx.doi.org/10.1371/journal.pone.0171325			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182713	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800054
J	Chen, YW; Wang, JS; Sheu, WHH; Lin, SY; Lee, IT; Song, YM; Fu, CP; Lee, CL				Chen, Yu-Wei; Wang, Jun-Sing; Sheu, Wayne H-H; Lin, Shih-Yi; Lee, I-Te; Song, Yuh-Min; Fu, Chia-Po; Lee, Chia-Lin			Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes	PLOS ONE			English	Article							BIOLOGICAL VARIATION; IDENTIFIES SUBPOPULATIONS; TREATMENT INTENSIFICATION; INTENSIVE TREATMENT; OXIDATIVE STRESS; RANDOMIZED-TRIAL; GLYCEMIC CONTROL; DOUBLE-BLIND; INFLAMMATION; MONOTHERAPY	Introduction A high hemoglobin glycation index (HGI) and glycated hemoglobin (HbA1c) level are associated with greater inflammatory status, and dipeptidyl peptidase-4 (DPP-4) inhibitors can suppress inflammation. We aimed to evaluate the relationship between HGI and the therapeutic effect of DPP-4 inhibitors. Methods This retrospective cohort study followed 468 patients with type 2 diabetes receiving DPP-4 inhibitor treatment for 1 year. Estimated HbA1c was calculated using a linear regression equation derived from another 2969 randomly extracted patients with type 2 diabetes based on fasting plasma glucose (FPG) level. The subjects were divided into two groups based on HGI (HGI = observed HbA1c -estimated HbA1c). Mixed model repeated measures were used to compare the treatment efficacy after 1 year in patients with a low (HGI<0, n = 199) and high HGI (HGI >= 0, n = 269). Results There were no significant group differences in mean changes of FPG after 1 year (-12.8 and -13.4 mg/dL in the low and high HGI groups, respectively). However, the patients with a high HGI had a significantly greater reduction in HbA1c from baseline compared to those with a low HGI (-1.9 versus -0.3% [-20.8 versus -3.3 mmol/mol]). Improvements in glycemic control were statistically significantly associated with the tested DPP-4 inhibitors in the high HGI group (- 2.4, - 1.4, - 1.2 and - 2.2% [-26.2, - 15.3, - 13.1 and - 24.0 mmol/mol] for vildagliptin, linagliptin, saxagliptin and sitagliptin, respectively) but not in the low HGI group. Conclusions The HGI index derived from FPG and HbA1c may be able to identify who will have a better response to DPP-4 inhibitors.	[Chen, Yu-Wei; Wang, Jun-Sing; Sheu, Wayne H-H; Lin, Shih-Yi; Lee, I-Te; Song, Yuh-Min; Fu, Chia-Po; Lee, Chia-Lin] Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung, Taiwan; [Wang, Jun-Sing; Sheu, Wayne H-H; Lin, Shih-Yi; Lee, I-Te] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Sheu, Wayne H-H] Natl Def Med Ctr, Coll Med, Taipei, Taiwan; [Lin, Shih-Yi] Taichung Vet Gen Hosp, Ctr Geriatr & Gerontol, Taichung, Taiwan; [Fu, Chia-Po] Natl Taiwan Univ, Coll Elect Engn & Comp Sci, Grad Inst Biomed Elect & Bioinformat, Taipei, Taiwan; [Lee, Chia-Lin] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan; [Lee, Chia-Lin] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Taichung Veterans General Hospital; National Taiwan University; China Medical University Taiwan; Taichung Veterans General Hospital	Lee, CL (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung, Taiwan.; Lee, CL (corresponding author), China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan.; Lee, CL (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.	u502107@yahoo.com.tw		Lee, I-Te/0000-0003-2665-3635; Wang, Jun-Sing/0000-0002-0887-6432				Braga F, 2011, CLIN CHIM ACTA, V412, P1412, DOI 10.1016/j.cca.2011.04.014; Derosa G, 2010, METABOLISM, V59, P887, DOI 10.1016/j.metabol.2009.10.007; Domingueti CP, 2016, J DIABETES COMPLICAT, V30, P738, DOI 10.1016/j.jdiacomp.2015.12.018; Donath MY, 2013, DIABETES OBES METAB, V15, P193, DOI 10.1111/dom.12172; Esposito K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005892; Esposito K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005442; Fang FS, 2012, INTERNAL MED, V51, P3109, DOI 10.2169/internalmedicine.51.8077; Frandsen CSS, 2014, DIABETIC MED, V31, P1293, DOI 10.1111/dme.12561; Hempe JM, 2015, DIABETES CARE, V38, P1067, DOI 10.2337/dc14-1844; Hempe JM, 2002, J DIABETES COMPLICAT, V16, P313, DOI 10.1016/S1056-8727(01)00227-6; Kawamori R, 2012, DIABETES OBES METAB, V14, P348, DOI 10.1111/j.1463-1326.2011.01545.x; Ketema EB, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0088-6; Liu SQ, 2015, J CLIN ENDOCR METAB, V100, P2364, DOI 10.1210/jc.2014-4454; Matsubara J, 2013, CIRC J, V77, P1337, DOI 10.1253/circj.CJ-12-1168; McCarter RJ, 2004, DIABETES CARE, V27, P1259, DOI 10.2337/diacare.27.6.1259; McCoy RG, 2015, AM J MANAG CARE, V21, pE288; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; Nguyen Dung V, 2012, Front Endocrinol (Lausanne), V3, P170, DOI 10.3389/fendo.2012.00170; Pan C, 2008, DIABETIC MED, V25, P435, DOI 10.1111/j.1464-5491.2008.02391.x; Pfutzner A, 2011, DIABETES OBES METAB, V13, P567, DOI 10.1111/j.1463-1326.2011.01385.x; Pupillo Mario, 2008, Diabetes Res Clin Pract, V80, pe1, DOI 10.1016/j.diabres.2008.01.001; Riddle MC, 2015, DIABETES CARE, V38, pE170, DOI 10.2337/dc15-1073; Rizzo MR, 2012, DIABETES CARE, V35, P2076, DOI 10.2337/dc12-0199; Rohlfing C, 2002, CLIN CHEM, V48, P1116; Shinjo T, 2015, AM J PHYSIOL-ENDOC M, V309, pE214, DOI 10.1152/ajpendo.00553.2014; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Soros AA, 2010, PEDIATR DIABETES, V11, P455, DOI 10.1111/j.1399-5448.2009.00630.x; Tremblay AJ, 2014, METABOLISM, V63, P1141, DOI 10.1016/j.metabol.2014.06.004; Turner LW, 2014, DIABETES CARE, V37, P985, DOI 10.2337/dc13-2097; Wang JS, 2011, DIABETES-METAB RES, V27, P79, DOI 10.1002/dmrr.1149; Wang JS, 2016, DIABETES RES CLIN PR, V113, P108, DOI 10.1016/j.diabres.2015.12.010; Wilson DM, 2011, DIABETES CARE, V34, P1315, DOI 10.2337/dc10-1661; Wu D, 2014, DIABETES OBES METAB, V16, P30, DOI 10.1111/dom.12174; Xiaoyan C, 2016, CURR MED RES OPIN, P1; YUDKIN JS, 1990, DIABETOLOGIA, V33, P208, DOI 10.1007/BF00404798	35	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171753	10.1371/journal.pone.0171753	http://dx.doi.org/10.1371/journal.pone.0171753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182722	gold, Green Submitted, Green Published			2022-12-26	WOS:000394231800099
J	Flamier, A; Singh, S; Rasmussen, TP				Flamier, Anthony; Singh, Supriya; Rasmussen, Theodore P.			A standardized human embryoid body platform for the detection and analysis of teratogens	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; VALPROIC ACID; STEM-CELLS; DEVELOPMENTAL TOXICITY; THALIDOMIDE; CHEMICALS; EXPOSURE; CULTURE	Teratogens are compounds that can induce birth defects upon exposure of the developing fetus. To date, most teratogen studies utilize pregnant rodents to determine compound teratogenicity in vivo. However, this is a low throughput approach that cannot easily meet the need for comprehensive high-volume teratogen assessment, a goal of the US Environmental Protection Agency. In addition, rodent and human development differ substantially, and therefore the use of assays using relevant human cells has utility. For these reasons, interest has recently focused on the use of human embryonic stem cells for teratogen assessment. Here we present a highly standardized and quantitative system for the detection and analysis of teratogens that utilizes well-characterized and purified highly pluripotent stem cells. We have devised strategies to mass-produce thousands of uniformly sized spheroids of human ESCs (hESCs) that can be caused to undergo synchronous differentiation to yield embryoid bodies (EBs) in the presence and absence of suspected teratogens. The system uses all human cells and rigorously controlled and standardized EB culture conditions. Furthermore, the approach has been made quantitative by using high-content imaging approaches. Our system offers distinct advantages over earlier EB systems that rely heavily on the use on mouse ESCs and EB aggregates of stochastic sizes. Together, our results show that thousands of suspected teratogens could be assessed using human EB-based approaches.	[Flamier, Anthony; Rasmussen, Theodore P.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Singh, Supriya; Rasmussen, Theodore P.] Univ Connecticut, Biobehav Sci Grad Degree Program, Storrs, CT 06269 USA; [Rasmussen, Theodore P.] Univ Connecticut, Stem Cell Inst, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut; University of Connecticut	Rasmussen, TP (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA.; Rasmussen, TP (corresponding author), Univ Connecticut, Biobehav Sci Grad Degree Program, Storrs, CT 06269 USA.; Rasmussen, TP (corresponding author), Univ Connecticut, Stem Cell Inst, Storrs, CT 06269 USA.	theodore.rasmussen@uconn.edu		Rasmussen, Theodore/0000-0001-9450-3394				Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Colleoni S, 2014, TOXICOL LETT, V231, P38, DOI 10.1016/j.toxlet.2014.08.023; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Franks ME, 2004, LANCET, V363, P1802, DOI 10.1016/S0140-6736(04)16308-3; Gaffield W, 1999, CELL MOL BIOL, V45, P579; Holmes LB, 2002, AM J MED GENET, V112, P297, DOI 10.1002/ajmg.10781; Kleinstreuer NC, 2011, TOXICOL APPL PHARM, V257, P111, DOI 10.1016/j.taap.2011.08.025; Krueger WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067296; Krueger WH, 2013, CELL REPROGRAM, V15, P151, DOI 10.1089/cell.2012.0059; Kuegler PB, 2010, ALTEX-ALTERN ANIM EX, V27, P17; LAMMER EJ, 1987, TERATOLOGY, V35, P465, DOI 10.1002/tera.1420350319; Ma ZL, 2014, J CELL MOL MED, V18, P1134, DOI 10.1111/jcmm.12260; Ma ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034278; Mai CT, 2015, BIRTH DEFECTS RES A, V103, P972, DOI 10.1002/bdra.23461; Matthews SJ, 2003, CLIN THER, V25, P342, DOI 10.1016/S0149-2918(03)80085-1; Mayshar Y, 2011, J CELL MOL MED, V15, P1393, DOI 10.1111/j.1582-4934.2010.01105.x; Nathanson S, 2000, J AM SOC NEPHROL, V11, P874, DOI 10.1681/ASN.V115874; NAU H, 1994, CIBA F SYMP, V181, P144; NAU H, 1991, PHARMACOL TOXICOL, V69, P310, DOI 10.1111/j.1600-0773.1991.tb01303.x; Ornoy A, 2009, REPROD TOXICOL, V28, P1, DOI 10.1016/j.reprotox.2009.02.014; Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018; Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220; Smith J, 2009, NEONATAL NETW, V28, P363, DOI 10.1891/0730-0832.28.6.363; STEELE CE, 1991, HUM REPROD, V6, P144, DOI 10.1093/oxfordjournals.humrep.a137249; Tanasijevic B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021512; Tanasijevic B, 2009, EPIGENETICS-US, V4, P330, DOI 10.4161/epi.4.5.9275; Van Houtte E, 2014, INT J PEDIATR OTORHI, V78, P2007, DOI 10.1016/j.ijporl.2014.08.030; 2008, MORBIDITY MORTALITY, V57, P1	28	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171101	10.1371/journal.pone.0171101	http://dx.doi.org/10.1371/journal.pone.0171101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182681	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800033
J	Ogden, NH; Arsenault, J; Hatchette, TF; Mechai, S; Lindsay, LR				Ogden, Nicholas H.; Arsenault, Julie; hatchette, Todd F.; Mechai, Samir; Lindsay, L. Robbin			Antibody responses to Borrelia burgdorferi detected by western blot vary geographically in Canada	PLOS ONE			English	Article							LYME-DISEASE; SENSU-STRICTO; SURVEILLANCE; DIAGNOSIS; EMERGENCE; GENOTYPE; TICKS; C6	Lyme disease is emerging in eastern and central Canada, and most cases are diagnosed using the two-tier serological test (Enzyme Immuno Assay [EIA] followed by Western blot [WB]). Simplification of this algorithm would be advantageous unless it impacts test performance. In this study, accuracy of individual proteins of the IgG WB algorithm in predicting the overall test result in samples from Canadians was assessed. Because Borrelia burgdorferi strains vary geographically in Canada, geographic variations in serological responses were also explored. Metrics of relative sensitivity, specificity and the kappa statistic measure of concordance were used to assess the capacity of responses to individual proteins to predict the overall IgG WB result of 2524 EIA (C6)-positive samples from across Canada. Geographic and interannual variations in proportions of samples testing positive were explored by logistic regression. No one protein was highly concordant with the IgG WB result. Significant variations were found amongst years and geographic regions in the prevalence of samples testing positive using the overall IgG WB algorithm, and for individual proteins of the algorithm. In most cases the prevalence of samples testing positive were highest in Nova Scotia, and lower in samples from Manitoba westwards. These findings suggest that the current two tier test may not be simplified and continued use of the current two-tier test method and interpretation is recommended. Geographic and interannual variations in the prevalence of samples testing positive may be consistent with B. burgdorferi strain variation in Canada, and further studies are needed to explore this.	[Ogden, Nicholas H.] Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada; [Ogden, Nicholas H.; Arsenault, Julie; Mechai, Samir] GREZOSP, St Hyacinthe, PQ, Canada; [Arsenault, Julie; Mechai, Samir] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada; [hatchette, Todd F.] Nova Scotia Hlth Author, Dept Pathol & Lab Med, Halifax, NS, Canada; [hatchette, Todd F.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Lindsay, L. Robbin] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	Public Health Agency of Canada; Universite de Montreal; Dalhousie University; Public Health Agency of Canada	Ogden, NH (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada.; Ogden, NH (corresponding author), GREZOSP, St Hyacinthe, PQ, Canada.	nicholas.ogden@phac-aspc.gc.ca	DeHaas, Keith/I-4957-2017; Arsenault, Julie/D-5077-2015	Arsenault, Julie/0000-0001-8382-7326; Mechai, Sam/0000-0001-9979-5525; Hatchette, Todd/0000-0002-5377-2528; Lindsay, Robbin/0000-0001-7236-2930				Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Cameron Daniel, 2004, Expert Rev Anti Infect Ther, V2, pS1; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Dessau RB, 2015, J MED MICROBIOL, V64, P224, DOI 10.1099/jmm.0.000009; Fallon BA, 2014, CLIN INFECT DIS, V59, P1705, DOI 10.1093/cid/ciu703; Ferrouillet C, 2015, CAN J INFECT DIS MED, V26, P151, DOI 10.1155/2015/846963; Gabriele-Rivet V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131282; George D, 2003, SPSS WINDOWS STEP ST; Hanincova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073066; Hatchette TF, 2015, EMERG INFECT DIS, V21, P1751, DOI 10.3201/eid2110.141640; Johnson BJB, 2006, MANUAL OF MOLECULAR AND CLINICAL LABORATORY IMMUNOLOGY, 7TH EDITION, P493; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Magnarelli LA, 2000, J CLIN MICROBIOL, V38, P1735, DOI 10.1128/JCM.38.5.1735-1739.2000; Mechai S, 2015, APPL ENVIRON MICROB, V81, P1309, DOI 10.1128/AEM.03730-14; Molins CR, 2015, CLIN INFECT DIS, V60, P1767, DOI 10.1093/cid/civ185; Molins CR, 2014, J CLIN MICROBIOL, V52, P3755, DOI 10.1128/JCM.01409-14; Ogden N H, 2014, Can Commun Dis Rep, V40, P74; Ogden N H, 2015, Can Commun Dis Rep, V41, P132; Ogden NH, 2011, APPL ENVIRON MICROB, V77, P3244, DOI 10.1128/AEM.02636-10; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Ogden NH, 2009, CAN MED ASSOC J, V180, P1221, DOI 10.1503/cmaj.080148; Ogden NH, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00046; Panelius J, 2001, J CLIN MICROBIOL, V39, P4013, DOI 10.1128/JCM.39.11.4013-4019.2001; Patrick DM, 2015, CLIN INFECT DIS, V61, P1084, DOI 10.1093/cid/civ470; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; Tugwell P, 1997, ANN INTERN MED, V127, P1109, DOI 10.7326/0003-4819-127-12-199712150-00011; Wang GQ, 2002, J INFECT DIS, V186, P782, DOI 10.1086/343043; Wormser GP, 2008, CLIN INFECT DIS, V47, P910, DOI 10.1086/591529; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2013, DIAGN MICR INFEC DIS, V75, P9, DOI 10.1016/j.diagmicrobio.2012.09.003	30	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171731	10.1371/journal.pone.0171731	http://dx.doi.org/10.1371/journal.pone.0171731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182723	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800097
J	Vellinga, D; Bruijn, S; Briaire, JJ; Kalkman, RK; Frijns, JHM				Vellinga, Dirk; Bruijn, Saskia; Briaire, Jeroen J.; Kalkman, Randy K.; Frijns, Johan H. M.			Reducing interaction in simultaneous paired stimulation with CI	PLOS ONE			English	Article							COCHLEAR IMPLANT RECIPIENTS; COMPUTATIONAL MODEL; SPEECH RECOGNITION; PULSE-RATE; PSYCHOPHYSICS; EXCITATION; INTERFACE; STRATEGY; CHANNELS; MASKING	In this study simultaneous paired stimulation of electrodes in cochlear implants is investigated by psychophysical experiments in 8 post-lingually deaf subjects (and one extra subject who only participated in part of the experiments). Simultaneous and sequential monopolar stimulation modes are used as references and are compared to channel interaction compensation, partial tripolar stimulation and a novel sequential stimulation strategy named phased array compensation. Psychophysical experiments are performed to investigate both the loudness integration during paired stimulation at the main electrodes as well as the interaction with the electrode contact located halfway between the stimulating pair. The study shows that simultaneous monopolar stimulation has more loudness integration on the main electrodes and more interaction in between the electrodes than sequential stimulation. Channel interaction compensation works to reduce the loudness integration at the main electrodes, but does not reduce the interaction in between the electrodes caused by paired stimulation. Partial tripolar stimulation uses much more current to reach the needed loudness, but shows the same interaction in between the electrodes as sequential monopolar stimulation. In phased array compensation we have used the individual impedance matrix of each subject to calculate the current needed on each electrode to exactly match the stimulation voltage along the array to that of sequential stimulation. The results show that the interaction in between the electrodes is the same as monopolar stimulation. The strategy uses less current than partial tripolar stimulation, but more than monopolar stimulation. In conclusion, the paper shows that paired stimulation is possible if the interaction is compensated.	[Vellinga, Dirk; Bruijn, Saskia; Briaire, Jeroen J.; Kalkman, Randy K.; Frijns, Johan H. M.] Leiden Univ, Med Ctr, ENT Dept, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Briaire, JJ (corresponding author), Leiden Univ, Med Ctr, ENT Dept, Leiden, Netherlands.	j.j.briaire@lumc.nl	Kalkman, Randy/AAR-6911-2021; Briaire, Jeroen/A-7972-2008; Frijns, Johan H.M./H-6249-2011	Kalkman, Randy/0000-0002-4060-4138; Briaire, Jeroen/0000-0003-4302-817X; Frijns, Johan H.M./0000-0002-1180-3314				Battmer RD, 2010, INT J AUDIOL, V49, P657, DOI 10.3109/14992021003801471; Bierer JA, 2010, HEARING RES, V270, P134, DOI 10.1016/j.heares.2010.08.006; Bonham BH, 2008, HEARING RES, V242, P141, DOI 10.1016/j.heares.2008.03.006; Bonnet RM, 2012, EAR HEARING, V33, P489, DOI 10.1097/AUD.0b013e31824c761a; Buechner A, 2005, OTOL NEUROTOL, V26, P941, DOI 10.1097/01.mao.0000185069.27705.f0; Cohen LT, 2003, HEARING RES, V179, P72, DOI 10.1016/S0378-5955(03)00096-0; Compernolle Dv, 1985, SPEECH PROCESSING ST; Frijns JHM, 2011, ACTA OTO-LARYNGOL, V131, P362, DOI 10.3109/00016489.2010.541939; Goldwyn JH, 2010, HEARING RES, V268, P93, DOI 10.1016/j.heares.2010.05.005; Kalkman RK, 2015, HEARING RES, V322, P89, DOI 10.1016/j.heares.2014.12.004; Kalkman RK, 2014, HEARING RES, V315, P10, DOI 10.1016/j.heares.2014.06.003; Kiefer J, 2000, ANN OTO RHINOL LARYN, V109, P1009, DOI 10.1177/000348940010901105; Litvak LM, 2007, J ACOUST SOC AM, V122, P967, DOI 10.1121/1.2749414; Long CJ, 2014, JARO-J ASSOC RES OTO, V15, P293, DOI 10.1007/s10162-013-0437-5; Potts LG, 2007, EAR HEARING, V28, P495, DOI 10.1097/AUD.0b013e31806dc16e; Shefin SG, 2015, J NEURAL ENG, V12, DOI [10.1088/1741-2560/12/6/066005, DOI 10.1088/1741-2560/12/6/066005]; van den Honert C, 2007, J ACOUST SOC AM, V121, P3703, DOI 10.1121/1.2722047; Vanpoucke FJ, 2004, IEEE T BIO-MED ENG, V51, P2174, DOI 10.1109/TBME.2004.836518; Vellinga D, EAR HEARING IN PRESS; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; Zeng Fan-Gang, 2004, Trends Amplif, V8, P1, DOI 10.1177/108471380400800102; Zeng FG, 2008, IEEE REV BIOMEDICAL, V1; Zierhofer CM, 2008, IEEE T BIO-MED ENG, V55, P1907, DOI 10.1109/TBME.2008.919839	23	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171071	10.1371/journal.pone.0171071	http://dx.doi.org/10.1371/journal.pone.0171071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182685	Green Submitted, gold, Green Published			2022-12-26	WOS:000394231800031
J	Yan, LL; Su, JQ; Wang, ZP; Yan, XW; Yu, RH; Ma, PZ; Li, YC; Du, JP				Yan, Lulu; Su, Jiaqi; Wang, Zhaoping; Yan, Xiwu; Yu, Ruihai; Ma, Peizhen; Li, Yangchun; Du, Junpeng			Transcriptomic analysis of Crassostrea sikamea x Crassostrea angulata hybrids in response to low salinity stress	PLOS ONE			English	Article							NOD-LIKE RECEPTORS; SHRIMP LITOPENAEUS-VANNAMEI; GLYCOGEN-BINDING SUBUNIT; PACIFIC OYSTER; INNATE IMMUNITY; EXPRESSION ANALYSIS; PROTEIN PHOSPHATASE-1G; OXYGEN-CONSUMPTION; RECIPROCAL CROSSES; SUSPENDED CULTURE	Hybrid oysters often show heterosis in growth rate, weight, survival and adaptability to extremes of salinity. Oysters have also been used as model organisms to study the evolution of host-defense system. To gain comprehensive knowledge about various physiological processes in hybrid oysters under low salinity stress, we performed transcriptomic analysis of gill tissue of Crassostrea sikamea female x Crassostrea angulata male hybrid using the deep-sequencing platform Illumina HiSeq. We exploited the high-throughput technique to delineate differentially expressed genes (DEGs) in oysters maintained in hypotonic conditions. A total of 199,391 high quality unigenes, with average length of 644 bp, were generated. Of these 35 and 31 genes showed up- and down-regulation, respectively. Functional categorization and pathway analysis of these DEGs revealed enrichment for immune mechanism, apoptosis, energy metabolism and osmoregulation under low salinity stress. The expression patterns of 41 DEGs in hybrids and their parental species were further analyzed by quantitative real-time PCR (qRT-PCR). This study will serve as a platform for subsequent gene expression analysis regarding environmental stress. Our findings will also provide valuable information about gene expression to better understand the immune mechanism, apoptosis, energy metabolism and osmoregulation in hybrid oysters under low salinity stress.	[Yan, Lulu; Wang, Zhaoping; Yu, Ruihai; Ma, Peizhen; Li, Yangchun; Du, Junpeng] Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China; [Su, Jiaqi] Chinese Acad Fishery Sci, South China Sea Fisheries Res Inst, Key Lab South China Sea Fishery Resources Exploit, Minist Agr, Guangzhou, Guangdong, Peoples R China; [Yan, Xiwu] Dalian Ocean Univ, Coll Fisheries & Life Sci, Engn Res Ctr Shellfish Culture & Breeding Liaonin, Dalian, Liaoning, Peoples R China	Ocean University of China; Chinese Academy of Fishery Sciences; South China Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Dalian Ocean University	Wang, ZP (corresponding author), Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China.	zpwang@ouc.edu.cn			National Natural Science Foundation of China [31172403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (grant no.31172403). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basset C, 2003, VACCINE, V21, pS12, DOI 10.1016/S0264-410X(03)00195-6; Berger VJ, 1997, HYDROBIOLOGIA, V355, P115, DOI 10.1023/A:1003023322263; Berteau O, 2004, BIOCHEMISTRY-US, V43, P7881, DOI 10.1021/bi036066z; Box A, 2009, COMP BIOCHEM PHYS C, V149, P456, DOI 10.1016/j.cbpc.2008.10.107; BROWN JR, 1988, AQUACULTURE, V70, P231, DOI 10.1016/0044-8486(88)90099-3; BROWN JR, 1988, AQUACULTURE, V70, P253, DOI 10.1016/0044-8486(88)90100-7; Butt D, 2006, AQUACULTURE, V251, P159, DOI 10.1016/j.aquaculture.2005.05.045; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; Cheng W, 2004, FISH SHELLFISH IMMUN, V17, P235, DOI 10.1016/j.fsi.2004.03.007; Chong-Robles J, 2014, AQUACULTURE, V422, P261, DOI 10.1016/j.aquaculture.2013.11.034; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; Croke SJ, 2002, ENVIRON TOXICOL CHEM, V21, P1683, DOI [10.1897/1551-5028(2002)021<1683:TFDOIM>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;1683:TFDOIM&gt;2.0.CO;2]; Dautremepuits C, 2009, SCI TOTAL ENVIRON, V407, P1055, DOI 10.1016/j.scitotenv.2008.10.004; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; De Zoysa M, 2009, COMP BIOCHEM PHYS B, V154, P387, DOI 10.1016/j.cbpb.2009.08.002; Desjardins M, 2003, NAT REV IMMUNOL, V3, P280, DOI 10.1038/nri1053; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dunn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003366; Eierman LE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-503; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; EV K, 2004, GENOME BIOL, V5, P60; Fiol DF, 2011, BBA-GEN SUBJECTS, V1810, P439, DOI 10.1016/j.bbagen.2010.11.005; Fleury E, 2012, MAR BIOTECHNOL, V14, P203, DOI 10.1007/s10126-011-9403-6; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Gagnaire B, 2006, FISH SHELLFISH IMMUN, V20, P536, DOI 10.1016/j.fsi.2005.07.003; Gbulubo Awotongha J., 2011, Journal of Fisheries International, V6, P71; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; Gjedrem T., 2010, SELECTIVE BREEDING A; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Guo XM, 2015, FISH SHELLFISH IMMUN, V46, P107, DOI 10.1016/j.fsi.2015.05.018; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hosoi M, 2003, FISHERIES SCI, V69, P395, DOI 10.1046/j.1444-2906.2003.00634.x; Huang GH, 2009, CYTOKINE, V48, P161, DOI 10.1016/j.cyto.2009.08.002; HUBBARD MJ, 1989, EUR J BIOCHEM, V180, P457, DOI 10.1111/j.1432-1033.1989.tb14668.x; Huo ZM, 2014, J WORLD AQUACULT SOC, V45, P226, DOI 10.1111/jwas.12098; HUTCHINSON S, 1992, J MOLLUS STUD, V58, P215, DOI 10.1093/mollus/58.2.215; Inagaki M, 2008, J BIOL CHEM, V283, P33080, DOI 10.1074/jbc.M807574200; Intra J, 2007, GENE, V392, P34, DOI 10.1016/j.gene.2006.11.002; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; KAPLANHARRIS L, 1980, J LIPID RES, V21, P617; Knowles G, 2014, J INVERTEBR PATHOL, V121, P78, DOI 10.1016/j.jip.2014.06.013; Kumar V., 2011, INT J PHARM BIOL SCI, V1, P129; Labreuche Y, 2006, DEV COMP IMMUNOL, V30, P367, DOI 10.1016/j.dci.2005.05.003; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lockwood BL, 2011, MOL ECOL, V20, P517, DOI 10.1111/j.1365-294X.2010.04973.x; Luna-Acosta A, 2011, COMP BIOCHEM PHYS B, V159, P220, DOI 10.1016/j.cbpb.2011.04.009; Lutz CG, 2010, AQUAC RES, V41, pe770, DOI 10.1111/j.1365-2109.2010.02583.x; MACINNES JR, 1979, ARCH ENVIRON CON TOX, V8, P553, DOI 10.1007/BF01055036; MACKINTOSH C, 1988, FEBS LETT, V234, P189, DOI 10.1016/0014-5793(88)81331-0; Madsen LM, 1996, INFECT IMMUN, V64, P2425, DOI 10.1128/IAI.64.7.2425-2430.1996; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Matozzo V, 2007, MAR BIOL, V151, P1051, DOI 10.1007/s00227-006-0543-6; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058563; Meng XF, 2014, MOL NEUROBIOL, V49, P673, DOI 10.1007/s12035-013-8551-2; Moreira A, 2016, ENVIRON POLLUT, V214, P756, DOI 10.1016/j.envpol.2016.04.036; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Park EM, 2008, FISH SHELLFISH IMMUN, V24, P11, DOI 10.1016/j.fsi.2007.07.003; PIERCE SK, 1992, MAR BIOL, V113, P107, DOI 10.1007/BF00367644; PIERCE SK, 1982, BIOL BULL-US, V163, P405, DOI 10.2307/1541452; Qin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043653; Richter B W, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.44.pe1; Rosales C, 2011, ISJ-INVERT SURVIV J, V8, P109; Sekino M, 2009, FISHERIES SCI, V75, P819, DOI 10.1007/s12562-009-0100-6; Setiarto A, 2004, AQUAC RES, V35, P669, DOI 10.1111/j.1365-2109.2004.01064.x; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Shekhar MS, 2013, FISH SHELLFISH IMMUN, V35, P1957, DOI 10.1016/j.fsi.2013.09.038; SHUMWAY SE, 1982, MAR ECOL PROG SER, V9, P59, DOI 10.3354/meps009059; Silke J, 2001, J CELL SCI, V114, P1821; Sonoda Y, 2014, P CIVIL ENG OCEAN, V70, pI1164; Su J., 2015, THESIS; Tong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134280; Wang CD, 2011, AQUACULTURE, V310, P380, DOI 10.1016/j.aquaculture.2010.11.014; Wang H, 2013, PROCESS IDENTIFICATI; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Xu F, 2014, J MOLLUS STUD, V80, P435, DOI 10.1093/mollus/eyu040; Xu F, 2011, MAR BIOL RES, V7, P796, DOI 10.1080/17451000.2011.569555; Xu F, 2009, J SHELLFISH RES, V28, P453, DOI 10.2983/035.028.0305; Xu Z, 2015, PLOS ONE, V10; Yajima M, 2003, BIOCHEM J, V371, P205, DOI 10.1042/BJ20021603; Yao T, 2015, J OCEAN U CHINA, V14, P710, DOI 10.1007/s11802-015-2546-8; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang D, 2015, GENE; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang H, 2007, AQUACULTURE, V272, pS88, DOI 10.1016/j.aquaculture.2007.08.008; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z; Zhang Y, 2015, J PROTEOME RES, V14, P304, DOI 10.1021/pr500940s; Zhao Q, 2015, FISH SHELLFISH IMMUN, V42, P400, DOI 10.1016/j.fsi.2014.11.020; Zhao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046244	95	22	24	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171483	10.1371/journal.pone.0171483	http://dx.doi.org/10.1371/journal.pone.0171483			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182701	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800065
J	Dupret, V; Sanchez, S; Goujet, D; Ahlberg, PE				Dupret, Vincent; Sanchez, Sophie; Goujet, Daniel; Ahlberg, Per Erik			The internal cranial anatomy of Romundina stellina Orvig, 1975 (Vertebrata, Placodermi, Acanthothoraci) and the origin of jawed vertebrates-Anatomical atlas of a primitive gnathostome	PLOS ONE			English	Article							ARTHRODIRA; MORPHOLOGY; BRAINCASE; CHINA; GENUS; FISH; ACTINOLEPIDA; EVOLUTION; LAMPREY; EAR	Placoderms are considered as the first jawed vertebrates and constitute a paraphyletic group in the stem-gnathostome grade. The acanthothoracid placoderms are among the phylogenetically most basal and morphologically primitive gnathostomes, but their neurocranial anatomy is poorly understood. Here we present a near-complete three-dimensional skull of Romundina stellina, a small Early Devonian acanthothoracid from the Canadian Arctic Archipelago, scanned with propagation phase contrast microtomography at a 7.46 mu m isotropic voxel size at the European Synchrotron Radiation Facility, Grenoble, France. This is the first model of an early gnathostome skull produced using this technique, and as such represents a major advance in objectivity compared to past descriptions of placoderm neurocrania on the basis of grinding series. Despite some loss of material along an oblique crack, most of the internal structures are remarkably preserved, and most of the missing structures can be reconstructed by symmetry. This virtual approach offers the possibility to connect with certainty all the external foramina to the blood and nerve canals and the central structures, and thus identify accurate homologies without destroying the specimen. The high level of detail enables description of the main arterial, venous and nerve canals of the skull, and other perichondrally ossified endocranial structures such as the palatoquadrate articulations, the endocranial cavity and the inner ear cavities. The braincase morphology appears less extreme than that of Brindabellaspis, and is in some respects more reminiscent of a basal arthrodire such as Kujdanowiaspis.	[Dupret, Vincent; Sanchez, Sophie; Ahlberg, Per Erik] Sci Life Lab, Se Uppsala, Sweden; [Dupret, Vincent; Sanchez, Sophie; Ahlberg, Per Erik] Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, Se Uppsala, Sweden; [Sanchez, Sophie] European Synchrotron Radiat Facil, Grenoble, France; [Goujet, Daniel] UPMC Paris 6, CNRS, MNHN, CR2P UMR 7207,Sorbonne Univ,Museum Natl Hist Nat, Paris, France; [Dupret, Vincent] Australian Natl Univ, Dept Appl Math, Res Sch Phys & Engn, Canberra, ACT, Australia	Uppsala University; European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Australian National University	Dupret, V; Ahlberg, PE (corresponding author), Sci Life Lab, Se Uppsala, Sweden.; Dupret, V; Ahlberg, PE (corresponding author), Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, Se Uppsala, Sweden.; Dupret, V (corresponding author), Australian Natl Univ, Dept Appl Math, Res Sch Phys & Engn, Canberra, ACT, Australia.	vincent.dupret@anu.edu.au; Per.Ahlberg@ebc.uu.se	Sanchez, Sophie/AAE-1168-2022; Dupret, Vincent/L-2306-2015	Dupret, Vincent/0000-0002-6859-1041; Ahlberg, Per/0000-0001-9054-2900; Sanchez, Sophie/0000-0002-3611-6836	European Research Council Advanced Investigator Grant [233111]; Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation; ESRF; Museum National d'Histoire Naturelle	European Research Council Advanced Investigator Grant(European Research Council (ERC)); Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation; ESRF; Museum National d'Histoire Naturelle	This work was funded by European Research Council Advanced Investigator Grant 233111 (https://erc.europa.eu/)-funding only; Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation (https://www.wallenberg.com/)-funding only; and ESRF (https://www.esrf.en)-data collection (microtromography). The Museum National d'Histoire Naturelle provided support in the form of salaries for author DG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; BROILI FERDINAND, 1929, SITZUNGSBER MATH NATURWISS ABT BAYERISCHEN AKAD WISS MUNCHEN, V1929, P143; CARR RK, 1991, ZOOL J LINN SOC-LOND, V103, P349, DOI 10.1111/j.1096-3642.1991.tb00909.x; Clement AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141277; Collin SP, 2007, FISH PHYSIOL, V26, P121, DOI 10.1016/S1546-5098(07)26003-0; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; De Iuliis G., 2007, DISSECTION VERTEBRAT; Denison R. H, 1978, PLACODERMI; Dennis-Bryan Kim, 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P127; Dupret V, 2008, GEOL MAG, V145, P257, DOI 10.1017/S0016756807004207; Dupret V, 2010, 1975 COMPTE RENDUS P, V9, P369; Dupret V., 2004, FOSSILS STRATA, V50, P40; Dupret V, 2007, J VERTEBR PALEONTOL, V27, P266, DOI 10.1671/0272-4634(2007)27[266:ANGOPA]2.0.CO;2; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Dupret V, 2010, GEODIVERSITAS, V32, P5, DOI 10.5252/g2010n1a1; Dupret V, 2009, ZOOL J LINN SOC-LOND, V157, P70, DOI 10.1111/j.1096-3642.2009.00519.x; Francillon-Vieillot H., 1990, P471; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Giles S, 2015, NATURE; Goujet D, 2001, SYST ASSOC SPEC VOL, V61, P209; Goujet D., 1975, C INT CTR NAT RECH S, V218, P81; Goujet D, 1984, POISSONS PLACODERMES; Goujet D, 2004, RECENT ADV ORIGIN EA, P109; Goujet Daniel, 1995, Geobios Memoire Special (Villeurbanne), V19, P89; Gross W., 1959, Palaeontographica, V113A, P1; Gross W., 1958, Jahrbuch der Geologischen Bundesanstalt Wien, V101, P139; Hall B.K., 2015, BONES CARTILAGE DEV; Heintz, 1932, BASHFORD DEAN MEMORI, V4, P115; Hirasawa T, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-014-0007-7; Hueter RE, 2004, CRC MAR BIOL SER, P325; Jaekel O., 1919, SITZUNGSERICHTEN GES, V1919, P6; Janvier P., 1981, Palaeovertebrata (Montpellier), V11, P19; Janvier P, 2001, SYST ASSOC SPEC VOL, V61, P172; Janvier P., 1985, CEPHALASPIDES SPITZB; Janvier P., 1996, EARLY VERTEBRATES; Jarvik E., 1980, BASIC STRUCTURE EVOL; Johnson HG, 2000, ZOOL J LINN SOC-LOND, V129, P241, DOI 10.1006/zjls.1999.0206; King B, 2016, SYSTEMATIC BIOL; Kuratani S, 1999, DEV BIOL, V210, P381, DOI 10.1006/dbio.1999.9266; Kuratani S, 2005, J ANAT, V207, P489, DOI 10.1111/j.1469-7580.2005.00483.x; Kuratani S, 2001, PHILOS T ROY SOC B, V356, P1615, DOI 10.1098/rstb.2001.0976; Kuratani S, 2012, EVOL DEV, V14, P76, DOI 10.1111/j.1525-142X.2011.00523.x; Lelievre H, 2009, J VERTEBR PALEONTOL, V29, P584, DOI 10.1671/039.029.0233; Liu Yu-hai, 1991, P139; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Luksevics E, 2001, J VERTEBR PALEONTOL, V21, P687, DOI 10.1671/0272-4634(2001)021[0687:TONAOA]2.0.CO;2; Luksevics E., 1999, LATVIJAS GEOLOGIJAS, V7, P12; Lychakov DV, 2000, FISH RES, V46, P27, DOI 10.1016/S0165-7836(00)00130-2; Maisey JG, 2005, B AM MUS NAT HIST, P1; Maisey JG, 2001, J VERTEBR PALEONTOL, V21, P807, DOI 10.1671/0272-4634(2001)021[0807:CSRNCF]2.0.CO;2; Maisey JG, 2001, SYST ASSOC SPEC VOL, V61, P263; Maisey JG, 2001, J MORPHOL, V250, P236, DOI 10.1002/jmor.1068; Maisey JG, 2002, MAJOR EVENTS EARLY V, P263; Marss T., 2007, AGNATHA; McCoy F., 1848, ANN MAGAZINE NATURAL, V2, P1, DOI DOI 10.1080/03745485809496133; MILES RS, 1971, PHILOS T R SOC B, V263, P101, DOI 10.1098/rstb.1971.0111; Miller H., 1841, OLD RED SANDSTONES N; Millot J., 1958, ANATOMIE LATIMERIA C; Novitskaya LI., 1983, MORPHOLOGIJA DREVNIC; Oisi Y, 2013, NATURE, V493, P175, DOI 10.1038/nature11794; Olive S, 2011, GEODIVERSITAS, V33, P393, DOI 10.5252/g2011n3a1; Orvig T., 1975, PROBLEMES ACTUELS PA, V218, P41; Orvig T., 1962, EXTRAIT C INT CTR NA, V104, P49; Ota KG, 2007, INTEGR COMP BIOL, P1; Pan Z-H, 2015, COMPTES RENDUS PALEV; Pradel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024938; Retzius MG., 1881, GEHORORGAN WIERBELTH; Schultze HP, 2009, ACTA ZOOL-STOCKHOLM, V90, P22, DOI 10.1111/j.1463-6395.2008.00354.x; Smith R. E., 1980, GEOLOGICAL SURVEY CA, V308, P1, DOI DOI 10.4095/106238; Sollas WJ, 1904, PHILOS T R SOC LON B, V196, P257; Stensi/ E.A., 1969, TRAITE PALEONTOL, V4, P71; Stensio E., 1963, Skr Norske Vidensk-Akad Oslo Mat Nat Kl (NS), V13, P1; STENSIO E, 1971, Annales de Paleontologie Vertebres, V57, P1; Stensio E, 1934, KUNGLICA SVENSKA VET, V3, P1; Stensio E., 1948, PALAEOZOOL GROENL, V2, P5; STENSIO E., 1939, MEDDELELSER GRONLAND, V97, P1; Stensio E., 1963, TAXONOMIC APPENDIX K, V9, P1; Stensio E., 1931, MEDDELELSER GRONLAND, V86, P1; Stensio E., 1942, KUNGLIGA SVENSKA VET, V20, P1; Stensio E., 1950, CAVITE LABYRINTHIQUE, P9; Stensio E., TRAITE ZOOLOGIE; Stensio E. A., 1936, Mudd Gronland, V97, P1; Stensio E. A., 1945, K SVENSKA VETENSKAPSAKAD HANDL, V22, P1; Stensio E. A., 1947, Kungliga Svenska Vetenskapsakademiens Handlingar Stockholm (3), V24, P1; Stensio E. A., 1925, Field Museum Publications Chicago Geological Series, V4, P87; Stensio E. A., 1927, SKR SVALBARD ISHAVET, V12, P1; STENSIO ERIK, 1959, K SVENSKA VETENSKAPSAKAD HANDL, V8, P1; STENSIO ERIK A, 1934, MEDDELELSER OM GRONLAND, V97, P1; Stensio Erik A., 1944, ARKIV ZOOL [STOCKHOLM], V35A, P1; TESTER AL, 1972, PAC SCI, V26, P264; Trinajstic K, 2013, SCIENCE, V341, P160, DOI 10.1126/science.1237275; Trinajstic K, 2012, J VERTEBR PALEONTOL, V32, P757, DOI 10.1080/02724634.2012.661379; VANDERBRUGGHEN W, 1993, NATURE, V364, P107; WHITE E I, 1972, Bulletin of the British Museum (Natural History) Geology, V22, P379; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Woodward A. S., 1891, CATALOGUE FOSSIL FIS; Yopak KE, 2008, BRAIN BEHAV EVOLUT, V71, P287, DOI 10.1159/000127048; YOUNG G C, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V167, P10; Young GC, 2008, BIOL LETTERS, V4, P110, DOI 10.1098/rsbl.2007.0545; Young Gavin C., 1991, P67; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x; YOUNG GC, 1984, PALAEONTOLOGY, V27, P635; Young GC, 1980, ZOOLOGICAL J LINNEAN, V66, P309; Zhu M, 1996, J VERTEBR PALEONTOL, V16, P1, DOI 10.1080/02724634.1996.10011278; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; [No title captured]	106	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171241	10.1371/journal.pone.0171241	http://dx.doi.org/10.1371/journal.pone.0171241			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170434	Green Submitted, Green Published, gold			2022-12-26	WOS:000393705500025
J	Ciesielska, A; Samaranch, L; San Sebastian, W; Dickson, DW; Goldman, S; Forsayeth, J; Bankiewicz, KS				Ciesielska, Agnieszka; Samaranch, Lluis; San Sebastian, Waldy; Dickson, Dennis W.; Goldman, Samuel; Forsayeth, John; Bankiewicz, Krystof S.			Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial	PLOS ONE			English	Article							AMINO-ACID DECARBOXYLASE; CONVECTION-ENHANCED DELIVERY; L-DOPA THERAPY; BASAL GANGLIA; AAV-HAADC; MONKEYS; SEROTONIN; STRIATUM; LEVODOPA; NEURONS	In Parkinson's disease (PD), aromatic L-amino acid decarboxylase (AADC) is the rate-limiting enzyme in the conversion of L-DOPA (Sinemet) to dopamine (DA). Previous studies in PD animal models demonstrated that lesion of dopaminergic neurons is associated with profound loss of AADC activity in the striatum, blocking efficient conversion of L-DOPA to DA. Relatively few studies have directly analyzed AADC in PD brains. Thus, the aim of this study was to gain a better understanding of regional changes in AADC activity, DA, serotonin and their monoamine metabolites in the striatum of PD patients and experimentally lesioned animals (rat and MPTP-treated nonhuman primate, NHP). Striatal AADC activity was determined postmortem in neuropathologically confirmed PD subjects, animal models and controls. A regional analysis was performed for striatal AADC activity and monoamine levels in NHP tissue. Interestingly, analysis of putaminal AADC activity revealed that control human striatum contained much less AADC activity than rat and NHP striata. Moreover, a dramatic loss of AADC activity in PD striatum compared to controls was detected. In MPTP-treated NHP, caudate nucleus was almost as greatly affected as putamen, although mean DA turnover was higher in caudate nucleus. Similarly, DA and DA metabolites were dramatically reduced in different regions of PD brains, including caudate nucleus, whereas serotonin was relatively spared. After L-DOPA administration in MPTP-treated NHP, very poor conversion to DA was detected, suggesting that AADC in NHP nigrostriatal fibers is mainly responsible for L-DOPA to DA conversion. These data support further the rationale behind viral gene therapy with AAV2-hAADC to restore AADC levels in putamen and suggest further the advisability of expanding vector delivery to include coverage of anterior putamen and the caudate nucleus.	[Ciesielska, Agnieszka; Samaranch, Lluis; San Sebastian, Waldy; Forsayeth, John; Bankiewicz, Krystof S.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Dickson, Dennis W.] Mayo Clin, Jacksonville, FL 32224 USA; [Goldman, Samuel] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of California System; University of California San Francisco; Mayo Clinic; University of California System; University of California San Francisco	Bankiewicz, KS (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	Krystof.Bankiewicz@ucsf.edu	Samaranch, Lluis/AAU-8464-2021; Goldman, Samuel/A-2225-2014	Samaranch, Lluis/0000-0001-8151-473X; Goldman, Samuel/0000-0002-3039-9927	Kinetics Foundation	Kinetics Foundation	This study was funded by an unrestricted gift from the Kinetics Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Aminoff MJ, 2001, NEUROL CLIN, V19, P119, DOI 10.1016/S0733-8619(05)70008-6; Bankiewicz KS, 2006, MOL THER, V14, P564, DOI 10.1016/j.ymthe.2006.05.005; BANKIEWICZ KS, 1986, LIFE SCI, V39, P7, DOI 10.1016/0024-3205(86)90431-5; Bankiewicz KS, 2000, EXP NEUROL, V164, P2, DOI 10.1006/exnr.2000.7408; Brooks DJ, 2011, PROG NEUROBIOL, V95, P614, DOI 10.1016/j.pneurobio.2011.08.009; Carta M, 2010, MOVEMENT DISORD, V25, pS174, DOI 10.1002/mds.22792; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Ciesielska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122708; Doroudchi MM, 2005, J NEUROCHEM, V93, P634, DOI 10.1111/j.1471-4159.2005.03048.x; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Forsayeth JR, 2006, MOL THER, V14, P571, DOI 10.1016/j.ymthe.2006.04.008; GERMAN DC, 1993, J COMP NEUROL, V331, P297, DOI 10.1002/cne.903310302; GIBB JW, 1990, NEUROTOXICOLOGY, V11, P317; GOLDSTEIN DJ, 1988, ARCH NEUROL-CHICAGO, V45, P715, DOI 10.1001/archneur.1988.00520310017009; Huot P, 2013, PHARMACOL REV, V65, P171, DOI 10.1124/pr.111.005678; Ikemoto K, 1997, NEUROSCI LETT, V232, P111, DOI 10.1016/S0304-3940(97)00587-9; Johnston LC, 2008, MOL THER, V16, P1392, DOI 10.1038/mt.2008.113; Kells AP, 2010, J NEUROSCI, V30, P9567, DOI 10.1523/JNEUROSCI.0942-10.2010; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Kish SJ, 2008, BRAIN, V131, P120, DOI 10.1093/brain/awm239; Lima MMS, 2012, CNS NEUROL DISORD-DR, V11, P439; LLOYD KG, 1975, J PHARMACOL EXP THER, V195, P453; MARICLE RA, 1995, MOVEMENT DISORD, V10, P329, DOI 10.1002/mds.870100316; MARICLE RA, 1995, NEUROLOGY, V45, P1757, DOI 10.1212/WNL.45.9.1757; Melamed E, 1996, ADV NEUROL, V69, P545; Mittermeyer G, 2012, HUM GENE THER, V23, P377, DOI 10.1089/hum.2011.220; Nagatsu T, 2007, J NEURAL TRANSM-SUPP, P113; NAGATSU T, 1979, ANAL BIOCHEM, V100, P160, DOI 10.1016/0003-2697(79)90126-X; NYBERG P, 1985, BRAIN RES, V333, P139, DOI 10.1016/0006-8993(85)90133-7; Oiwa Y, 2003, FRONT BIOSCI, V8, pA155, DOI 10.2741/1104; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Poewe Werner, 2009, Parkinsonism Relat Disord, V15 Suppl 4, pS28, DOI 10.1016/S1353-8020(09)70831-4; Ravina B, 2012, MOVEMENT DISORD, V27, P1392, DOI 10.1002/mds.25157; Rickards H, 2005, J NEUROL NEUROSUR PS, V76, pI48, DOI 10.1136/jnnp.2004.060426; Sanchez-Pernaute R, 2001, MOL THER, V4, P324, DOI 10.1006/mthe.2001.0466; SKIRBOLL S, 1990, EXP NEUROL, V110, P187, DOI 10.1016/0014-4886(90)90029-R; Stoessl A Jon, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS55, DOI 10.1016/S1353-8020(11)70019-0; Stoessl AJ, 2011, LANCET NEUROL, V10, P987, DOI 10.1016/S1474-4422(11)70214-9; Vriend C, 2014, J NEUROL NEUROSUR PS, V85, P159, DOI 10.1136/jnnp-2012-304811; Whone AL, 2003, ANN NEUROL, V53, P206, DOI 10.1002/ana.10427	41	20	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0169965	10.1371/journal.pone.0169965	http://dx.doi.org/10.1371/journal.pone.0169965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166239	Green Published, Green Submitted, gold			2022-12-26	WOS:000393700100003
J	Fan, M; Li, H; Wang, SJ; Zheng, B; Zhang, J; Li, LH				Fan, Ming; Li, Hui; Wang, Shijian; Zheng, Bin; Zhang, Juan; Li, Lihua			Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer	PLOS ONE			English	Article							IMAGING FEATURES; NEOADJUVANT CHEMOTHERAPY; RADIOGENOMIC ANALYSIS; HETEROGENEITY; RECURRENCE; BIOMARKERS; DIAGNOSIS; THERAPY; IMAGES; IMMUNOHISTOCHEMISTRY	The purpose of this study was to investigate the role of features derived from breast dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and to incorporated clinical information to predict the molecular subtypes of breast cancer. In particular, 60 breast cancers with the following four molecular subtypes were analyzed: luminal A, luminal B, human epidermal growth factor receptor-2 (HER2)-over-expressing and basal-like. The breast region was segmented and the suspicious tumor was depicted on sequentially scanned MR images from each case. In total, 90 features were obtained, including 88 imaging features related to morphology and texture as well as dynamic features from tumor and background parenchymal enhancement (BPE) and 2 clinical information-based parameters, namely, age and menopausal status. An evolutionary algorithm was used to select an optimal subset of features for classification. Using these features, we trained a multi-class logistic regression classifier that calculated the area under the receiver operating characteristic curve (AUC). The results of a prediction model using 24 selected features showed high overall classification performance, with an AUC value of 0.869. The predictive model discriminated among the luminal A, luminal B, HER2 and basal-like subtypes, with AUC values of 0.867, 0.786, 0.888 and 0.923, respectively. An additional independent dataset with 36 patients was utilized to validate the results. A similar classification analysis of the validation dataset showed an AUC of 0.872 using 15 image features, 10 of which were identical to those from the first cohort. We identified clinical information and 3D imaging features from DCE-MRI as candidate biomarkers for discriminating among four molecular subtypes of breast cancer.	[Fan, Ming; Li, Hui; Wang, Shijian; Zheng, Bin; Li, Lihua] Hangzhou Dianzi Univ, Inst Biomed Engn & Instrumentat, Hangzhou, Zhejiang, Peoples R China; [Zheng, Bin] Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA; [Zhang, Juan] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China	Hangzhou Dianzi University; University of Oklahoma System; University of Oklahoma - Norman; Zhejiang Cancer Hospital	Li, LH (corresponding author), Hangzhou Dianzi Univ, Inst Biomed Engn & Instrumentat, Hangzhou, Zhejiang, Peoples R China.; Zhang, J (corresponding author), Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China.	zhangjuan_496@163.com; lilh@hdu.edu.cn			National Natural Science Foundation of China [61401131, 61271063]; National Basic Research Program of China (973 Program) [2013CB329502]; Natural Science Foundation of Zhejiang Province of China [LZ15F010001, LQ14F010011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province)	This work was supported in part by the financial support of the National Natural Science Foundation of China (61401131 and 61271063), the National Basic Research Program of China (973 Program) (2013CB329502), and the Natural Science Foundation of Zhejiang Province of China (LZ15F010001 and LQ14F010011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by financial support from the National Natural Science Foundation of China (61271063 and 61401131), the National Basic Research Program of China (973 Program) (2013CB329502), and the Natural Science Foundation of Zhejiang Province of China (LZ15F010001 and LQ14F010011).	Arvold ND, 2011, J CLIN ONCOL, V29, P3885, DOI 10.1200/JCO.2011.36.1105; Bae MS, 2015, ACTA RADIOL, V56, P269, DOI 10.1177/0284185114524197; Blaschke E, 2015, J MAGN RESON IMAGING, V42, P920, DOI 10.1002/jmri.24884; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chen W, 2007, MAGN RESON MED, V58, P562, DOI 10.1002/mrm.21347; Costantini M, 2012, CLIN BREAST CANCER, V12, P331, DOI 10.1016/j.clbc.2012.07.002; Crabb SJ, 2008, CLIN BREAST CANCER, V8, P249, DOI 10.3816/CBC.2008.n.028; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Engstrom MJ, 2013, BREAST CANCER RES TR, V140, P463, DOI 10.1007/s10549-013-2647-2; Foroutan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082875; Fusco R, 2016, J MED BIOL ENG, V36, P449, DOI 10.1007/s40846-016-0163-7; Fusco R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/237863; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Grimm LJ, 2016, J MAGN RESON IMAGING, V43, P1269, DOI 10.1002/jmri.25116; Grimm LJ, 2015, J MAGN RESON IMAGING, V42, P902, DOI 10.1002/jmri.24879; Hammond MEH, 2010, J ONCOL PRACT, V6, P195, DOI 10.1200/JOP.777003; Hylton N, 2006, J CLIN ONCOL, V24, P3293, DOI 10.1200/JCO.2006.06.8080; Just N, 2014, BRIT J CANCER, V111, P2205, DOI 10.1038/bjc.2014.512; King AD, 2013, RADIOLOGY, V266, P531, DOI 10.1148/radiol.12120167; Koo HR, 2012, J MAGN RESON IMAGING, V36, P145, DOI 10.1002/jmri.23635; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Mazurowski MA, 2015, J AM COLL RADIOL, V12, P862, DOI 10.1016/j.jacr.2015.04.019; Mazurowski MA, 2014, RADIOLOGY, V273, P365, DOI 10.1148/radiol.14132641; Metzger O, 2013, J CLIN ONCOL, V31, P3083, DOI 10.1200/JCO.2012.46.1574; Parikh J, 2014, RADIOLOGY, V272, P100, DOI 10.1148/radiol.14130569; Park S, 2012, BREAST, V21, P50, DOI 10.1016/j.breast.2011.07.008; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Scutt D, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1388; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Sung JS, 2013, BREAST J, V19, P643, DOI 10.1111/tbj.12182; Sutton EJ, 2016, J MAGN RESON IMAGING; Sutton EJ, 2015, J MAGN RESON IMAGING, V42, P1398, DOI 10.1002/jmri.24890; Uematsu T, 2009, RADIOLOGY, V250, P638, DOI 10.1148/radiol.2503081054; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Witten I. H., DATA MINING PRACTICA; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yamaguchi K, 2015, BREAST CANCER-TOKYO, V22, P496, DOI 10.1007/s12282-013-0512-0; Yamamoto S, 2012, AM J ROENTGENOL, V199, P654, DOI 10.2214/AJR.11.7824; Yang Q, 2015, MED PHYS, V42, P103, DOI 10.1118/1.4903280; Yang Q, 2014, EUR J RADIOL, V83, P1086, DOI 10.1016/j.ejrad.2014.03.014; Yang Q, 2014, J DIGIT IMAGING, V27, P152, DOI 10.1007/s10278-013-9617-4; Yoo C, 2012, J BREAST CANCER, V15, P203, DOI 10.4048/jbc.2012.15.2.203; Zhang C, 2014, MED IMAGING 2014 IMA; Zhao BS, 2009, J NUCL MED, V50, P239, DOI 10.2967/jnumed.108.056655	48	92	103	6	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171683	10.1371/journal.pone.0171683	http://dx.doi.org/10.1371/journal.pone.0171683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166261	Green Published, Green Submitted, gold			2022-12-26	WOS:000393700100061
J	Kwiatkowska, A; Granicka, LH; Grzeczkowicz, A; Stachowiak, R; Kaminski, M; Grubek, Z; Bielecki, J; Strawski, M; Szklarczyk, M				Kwiatkowska, Angelika; Granicka, Ludomira H.; Grzeczkowicz, Anna; Stachowiak, Radoslaw; Kaminski, Michal; Grubek, Zuzanna; Bielecki, Jacek; Strawski, Marcin; Szklarczyk, Marek			Stabilized nanosystem of nanocarriers with an immobilized biological factor for anti-tumor therapy	PLOS ONE			English	Article								Objective The inadequate efficiency of existing therapeutic anti-cancer regiments and the increase in the multidrug resistance of cancer cells underscore the need to investigate novel anticancer strategies. The induction of apoptosis in tumors by cytotoxic agents produced by pathogenic microorganisms is an example of such an approach. Nevertheless, even the most effective drug should be delivered directly to targeted sites to reduce any negative impact on other cells. Accordingly, the stabilized nanosystem (SNS) for active agent delivery to cancer cells was designed for further application in local anti-tumor therapy. A product of genetically modified Escherichia coli, listeriolysin O (LLO), was immobilized within the polyelectrolyte membrane (poly(ethylenimine)lhyaluronic acid) shells of 'LLO nanocarriers' coupled with the stabilizing element of natural origin. Methods and results The impact of LLO was evaluated in human leukemia cell lines in vitro. Correspondingly, the influence of the SNS and its elements was assessed in vitro. The viability of targeted cells was evaluated by flow cytometry. Visualization of the system structure was performed using confocal microscopy. The membrane shell applied to the nanocarriers was analyzed using atomic force microscopy and Fourier transform infrared spectroscopy techniques. Furthermore, the presence of a polyelectrolyte layer on the nanocarrier surface and/or in the cell was confirmed by flow cytometry. Finally, the structural integrity of the SNS and the corresponding release of the fluorescent solute listeriolysin were investigated. Conclusion The construction of a stabilized system offers LLO release with a lethal impact on model eukaryotic cells. The applied platform design may be recommended for local anti-tumor treatment purposes.	[Kwiatkowska, Angelika; Granicka, Ludomira H.; Grzeczkowicz, Anna] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Stachowiak, Radoslaw; Kaminski, Michal; Grubek, Zuzanna; Bielecki, Jacek] Univ Warsaw, Dept Appl Microbiol, Fac Biol, Warsaw, Poland; [Strawski, Marcin; Szklarczyk, Marek] Univ Warsaw, Fac Chem, Lab Electrochem, Warsaw, Poland	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; University of Warsaw; University of Warsaw	Granicka, LH (corresponding author), Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland.	l.granicka@ibib.waw.pl	Strawski, Marcin/ABD-2231-2020; Grzeczkowicz, Anna/G-3911-2016	Strawski, Marcin/0000-0002-8253-0878; Grzeczkowicz, Anna/0000-0002-8970-4578; Bielecki, Jacek/0000-0001-6533-2282; Stachowiak, Radoslaw/0000-0002-7207-9753	National Science Centre [DEC-2012/07/D/ST5/02257]	National Science Centre(National Science Centre, Poland)	This part of work was financed by The National Science Centre (the number of decisions: DEC-2012/07/D/ST5/02257).	Bienkowski K, 2011, J ELECTROANAL CHEM, V662, P196, DOI 10.1016/j.jelechem.2011.06.014; Carlini L, 2013, REV NANOSCI NANOTECH, V2; Center M., 2011, GLOBAL CANC FACTS FI; Chari RV, ACC CHEM RES, V41, P1; Craft N, J IMMUNOL, V175; Dejugnat C, 2004, LANGMUIR, V20, P7265, DOI 10.1021/la049706n; EKBLOM P, 1983, INT J CANC, V31; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Granicka L, 2014, MEMBRANES MEMBRANES, P355; Granicka L H, ARTIF CELL BLOOD SUB, V39, P5; Granicka L H, J BIOMED MAT RES A, V102; Granicka LH, 1996, ASAIO J, V42, pM863, DOI 10.1097/00002480-199609000-00114; Han F, 2013, J NANOSCI NANOTECHNO, V13, P6996, DOI 10.1166/jnn.2013.7759; Huang SK, 2013, BIOCHEM ENG J, V74, P20, DOI 10.1016/j.bej.2013.02.015; Itoh Y, 2004, CHEM LETT, V33; Jemal A, CA CANC J CLIN, V61; Jensen E R, J VIROL, V71; Kanavos P, 2006, ANN ONCOLOGY S8; Kurapati R, 2013, J MATER CHEM B, V1, P3175, DOI 10.1039/c3tb20192a; Lokeshwar VB, 2014, ADV CANCER RES, V123, P35, DOI 10.1016/B978-0-12-800092-2.00002-2; Lue SJ, 2013, J NANOSCI NANOTECHNO, V13, P5305, DOI 10.1166/jnn.2013.7532; Mainardes RM, 2012, J NANOSCI NANOTECHNO, V12, P8513, DOI 10.1166/jnn.2012.6638; Minotti G, 2004, PHARM REV, V2; Neu B, 2001, J MICROENCAPSUL, V18, P385; Pandey S, 2013, NANOSCI NANOTECHNOL, V5; Pollakis G, 1983, FEBS LETT, V2; SadAbadi H, 2013, J NANOSCI NANOTECHNO, V13; Safra T, 2000, ANN ONCOL, V11, P1029, DOI 10.1023/A:1008365716693; Schuerch D W, 2005, P NAT ACAD SCI US, V102; Shen X, PROT ENG DES SEL, V22, P12; Song J, 2013, J NANOSCI NANOTECHNO, V13; Soto ER, 2008, BIOCONJUGATE CHEM, V19, P840, DOI 10.1021/bc700329p; Stachowiak R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/954375; Stachowiak R, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-77; Stewart W., 2014, WORLD CANC REPORT 20; Sun R, HUM VACC IMMUNOTHER, V9, P5; Theerasilp M, 2013, J MICROENCAPSUL, V30, P390, DOI 10.3109/02652048.2012.746746; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; Wadajkar A S, 2012, REV NANOSCI NANOTECH, V1; Wang N, BR J PHARM, V164, p2b; Wang X., 2013, MATH PROBL ENG, V2013, P13, DOI DOI 10.1109/ICCIS.2013.384; Yoshimura K, CANC RES, V66; Zaboronok A, 2013, NANOSCI NANOTECHNOL, V5; Zhao F, 2013, J NANOSCI NANOTECHNO, V13; Zhao L, 2013, J NANOSCI NANOTECHNO, V13	45	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170925	10.1371/journal.pone.0170925	http://dx.doi.org/10.1371/journal.pone.0170925			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166290	Green Submitted, Green Published, gold			2022-12-26	WOS:000393700100016
J	Li, Q; Zhong, SF; Sun, SF; Fatima, SA; Zhang, M; Chen, WQ; Huang, QL; Tang, SW; Luo, PG				Li, Qing; Zhong, Shengfu; Sun, Sifan; Fatima, Syeda Akash; Zhang, Min; Chen, Wanquan; Huang, Qianglan; Tang, Shengwen; Luo, Peigao			Differential effect of whole-ear shading after heading on the physiology, biochemistry and yield index of stay-green and non-stay-green wheat genotypes	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; PHOTOSYNTHETIC PRODUCTIVITY; SUPEROXIDE-DISMUTASE; GRAIN-YIELD; RESISTANCE; CHROMOSOME; PEROXIDASE; CULTIVARS; RADIATION; GROWTH	Two winter wheat cultivars (the functional stay-green CN12 and non-stay-green CN19) were used to investigate the effects of ear-shading on grain yield and to elucidate the differential mechanisms of different cultivars. The photosynthetic parameters, chlorophyll fluorescence, antioxidant enzyme activities, and chlorophyll contents were measured 0, 15 and 30 days after heading (DAH) under both shaded and non-shaded conditions. The final grain-yield index was also measured. Shading had a smaller effect on the net photosynthetic rate (Pn), intercellular CO2 concentration (Ci), stomatal conductance (Gs), maximal photochemical efficiency of PSII (Fv/Fm) and coefficient of non-photochemical fluorescence quenching (qN) but a greater effect on both superoxide dismutase (SOD) and catalase (CAT) activities in CN12 than it did in CN19. Shading slightly altered the timeframe of leaf senescence in CN12 and may have accelerated leaf senescence in CN19. Moreover, shading had only a small effect on the weight of grains per spike (WGS) in CN12 compared with CN19, mainly resulting from the number of grains per spike (NGS) rather than the 1000-grain weight (SGW). In conclusion, the flag leaves of functional stay-green wheat could serve as potential "buffers" and/or "compensators" for ear photosynthesis, which is actively regulated by the antioxidant enzyme system and prevents yield loss. Thus, a functional stay-green genotype could be more tolerant to environmental stress than a non-stay-green genotype.	[Li, Qing; Zhong, Shengfu; Sun, Sifan; Fatima, Syeda Akash; Zhang, Min; Huang, Qianglan; Tang, Shengwen; Luo, Peigao] Sichuan Agr Univ, Prov Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China; [Li, Qing] Chongqing Ind & Trade Polytech, Dept Biol & Chem, Chongqing, Peoples R China; [Chen, Wanquan; Luo, Peigao] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China	Sichuan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Luo, PG (corresponding author), Sichuan Agr Univ, Prov Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China.; Luo, PG (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China.	lpglab@sicau.edu.cn	Fatima, Akash/ABH-9427-2020	Fatima, Akash/0000-0003-3660-7165	National Natural Science Foundation of China [31271721, 31571661]; Committee of Science and Technology of Fuling of Chongqing [FLKJ-2015ABB1048]; Chongqing Industry and Trade Polytechnic [ZR201507]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology of Fuling of Chongqing; Chongqing Industry and Trade Polytechnic	This work was supported by the National Natural Science Foundation of China (31271721 and 31571661), the Committee of Science and Technology of Fuling of Chongqing (FLKJ-2015ABB1048) and Chongqing Industry and Trade Polytechnic (ZR201507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bestwick CS, 1998, PLANT PHYSIOL, V118, P1067, DOI 10.1104/pp.118.3.1067; Chen JB, 2010, ACTA PHYSIOL PLANT, V32, P875, DOI 10.1007/s11738-010-0475-0; Chuartzman SG, 2008, PLANT CELL, V20, P1029, DOI 10.1105/tpc.107.055830; FISCHER RA, 1985, J AGR SCI, V105, P447, DOI 10.1017/S0021859600056495; Guo JW, 2015, CEREAL RES COMMUN, V43, P364, DOI 10.1556/0806.43.2015.014; Guo ZJ, 2014, FIELD CROP RES, V166, P102, DOI 10.1016/j.fcr.2014.06.004; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Herrmann B, 1998, PHYSIOL PLANTARUM, V103, P320, DOI 10.1034/j.1399-3054.1998.1030304.x; KEMP DR, 1980, AUST J PLANT PHYSIOL, V7, P501, DOI 10.1071/PP9800501; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Li HW, 2010, J GENET GENOMICS, V37, P399, DOI 10.1016/S1673-8527(09)60058-8; Li HW, 2010, EUR J AGRON, V33, P267, DOI 10.1016/j.eja.2010.07.002; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Luo PG, 2008, CAN J PLANT PATHOL, V30, P254, DOI 10.1080/07060661.2008.10540540; Luo PG, 2013, PLANT CELL ENVIRON, V36, P683, DOI 10.1111/pce.12006; Luo PG, 2008, GENOME, V51, P922, DOI 10.1139/G08-079; Luo PG, 2009, CAN J PLANT SCI, V89, P1, DOI 10.4141/CJPS07072; Luo Pei-Gao, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P330; Luo PG, 2006, CHINESE SCI BULL, V51, P2595, DOI 10.1007/s11434-006-2175-0; Luo PG, 2005, PHYTOPATHOLOGY, V95, P1266, DOI 10.1094/PHYTO-95-1266; Ma LX, 2015, PHYSIOL MOL PLANT P, V90, P39, DOI 10.1016/j.pmpp.2015.02.005; Mahalakshmi V, 2002, CROP SCI, V42, P965, DOI 10.2135/cropsci2002.0965; Matile P, 1999, ANNU REV PLANT PHYS, V50, P67, DOI 10.1146/annurev.arplant.50.1.67; Maydup ML, 2012, FIELD CROP RES, V134, P208, DOI 10.1016/j.fcr.2012.06.008; Maydup ML, 2010, FIELD CROP RES, V119, P48, DOI 10.1016/j.fcr.2010.06.014; Mu H, 2010, J AGRON CROP SCI, V196, P38, DOI 10.1111/j.1439-037X.2009.00394.x; Nigro D, 2014, J CHEM-NY, V2014, DOI 10.1155/2014/629379; Niinemets U, 2009, J EXP BOT, V60, P2249, DOI 10.1093/jxb/erp036; PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T; Qin XL, 2015, FIELD CROP RES, V177, P117, DOI 10.1016/j.fcr.2015.03.013; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Saxena I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00570; Shao HB, 2005, COLLOID SURFACE B, V45, P7, DOI 10.1016/j.colsurfb.2005.06.016; Spano G, 2003, J EXP BOT, V54, P1415, DOI 10.1093/jxb/erg150; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; Tang ZX, 2008, GENOME, V51, P399, DOI 10.1139/G08-027; Tang ZongXiang, 2006, Agricultural Sciences in China, V5, P417, DOI 10.1016/S1671-2927(06)60070-9; Thomas H, 2000, J EXP BOT, V51, P329, DOI 10.1093/jexbot/51.suppl_1.329; Wang FBA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161203; Wang Z, 2003, J AGRON CROP SCI, V189, P280, DOI 10.1046/j.1439-037X.2003.00041.x; Xu CL, 2016, J INTEGR AGR, V15, P63, DOI 10.1016/S2095-3119(15)61047-4; Xu D.Q., 1997, PLANT PHYSL COMMUN, V33, P241, DOI [10.13592/j.cnki.ppj.1997.04.001, DOI 10.13592/J.CNKI.PPJ.1997.04.001]; Yang SM, 2016, PLANT DIS, V100, P847, DOI 10.1094/PDIS-04-14-0398-RE; Zhang LF, 2014, SHANGHAI TEXTILE SCI, V42, P42; 任正隆, 2003, [麦类作物学报, Journal of triticeae crops], V23, P97; 任正隆, 2004, [麦类作物学报, Journal of triticeae crops], V24, P159	47	7	7	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171589	10.1371/journal.pone.0171589	http://dx.doi.org/10.1371/journal.pone.0171589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158297	Green Published, Green Submitted, gold			2022-12-26	WOS:000396161700104
J	Steineck, G; Skokic, V; Sjoberg, F; Bull, C; Alevronta, E; Dunberger, G; Bergmark, K; Wilderang, U; Oh, JH; Deasy, JO; Jornsten, R				Steineck, Gunnar; Skokic, Viktor; Sjoberg, Fei; Bull, Cecilia; Alevronta, Eleftheria; Dunberger, Gail; Bergmark, Karin; Wilderang, Ulrica; Oh, Jung Hun; Deasy, Joseph O.; Jornsten, Rebecka			Identifying radiation-induced survivorship syndromes affecting bowel health in a cohort of gynecological cancer survivors	PLOS ONE			English	Article							QUALITY-OF-LIFE; FECAL INCONTINENCE; BOOTSTRAP; DISEASE	Background During radiotherapy unwanted radiation to normal tissue surrounding the tumor triggers survivorship diseases; we lack a nosology for radiation-induced survivorship diseases that decrease bowel health and we do not know which symptoms are related to which diseases. Methods Gynecological-cancer survivors were followed-up two to 15 years after having undergone radiotherapy; they reported in a postal questionnaire the frequency of 28 different symptoms related to bowel health. Population-based controls gave the same information. With a modified factor analysis, we determined the optimal number of factors, factor loadings for each symptom, factor-specific factor-loading cutoffs and factor scores. Results Altogether data from 623 survivors and 344 population-based controls were analyzed. Six factors best explain the correlation structure of the symptoms; for five of these a statistically significant difference (P< 0.001, Mann-Whitney U test) was found between survivors and controls concerning factor score quantiles. Taken together these five factors explain 42 percent of the variance of the symptoms. We interpreted these five factors as radiation-induced syndromes that may reflect distinct survivorship diseases. We obtained the following frequencies, defined as survivors having a factor loading above the 95 percent percentile of the controls, urgency syndrome (190 of 623, 30 percent), leakage syndrome (164 of 623, 26 percent), excessive gas discharge (93 of 623, 15 percent), excessive mucus discharge (102 of 623, 16 percent) and blood discharge (63 of 623, 10 percent). Conclusion Late effects of radiotherapy include five syndromes affecting bowel health; studying them and identifying the underlying survivorship diseases, instead of the approximately 30 long- term symptoms they produce, will simplify the search for prevention, alleviation and elimination.	[Steineck, Gunnar; Skokic, Viktor; Sjoberg, Fei; Bull, Cecilia; Alevronta, Eleftheria; Bergmark, Karin; Wilderang, Ulrica] Univ Gothenburg, Inst Clin Sci, Div Clin Canc Epidemiol, Dept Oncol,Sahlgrenska Acad, Gothenburg, Sweden; [Steineck, Gunnar] Karolinska Inst, Div Clin Canc Epidemiol, Dept Pathol & Oncol, Stockholm, Sweden; [Dunberger, Gail] Ersta Skondal Univ Coll, Inst Caring Sci, Stockholm, Sweden; [Oh, Jung Hun; Deasy, Joseph O.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Jornsten, Rebecka] Chalmers, Gothenburg, Sweden	University of Gothenburg; Karolinska Institutet; Memorial Sloan Kettering Cancer Center; Chalmers University of Technology	Steineck, G (corresponding author), Univ Gothenburg, Inst Clin Sci, Div Clin Canc Epidemiol, Dept Oncol,Sahlgrenska Acad, Gothenburg, Sweden.; Steineck, G (corresponding author), Karolinska Inst, Div Clin Canc Epidemiol, Dept Pathol & Oncol, Stockholm, Sweden.	Gunnar.Steineck@gu.se	Steineck, Gunnar/W-1515-2019	Steineck, Gunnar/0000-0002-0787-3969; Oh, Jung Hun/0000-0001-8791-2755; Deasy, Joseph/0000-0002-9437-266X; Sjoberg, Fei/0000-0002-8305-7648	Swedish Cancer Society; King Gustav V Jubilee Clinic Cancer Foundation in Goteborg, Sweden; Swedish state under the ALF agreement in Gbteborg and Stockholm; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); King Gustav V Jubilee Clinic Cancer Foundation in Goteborg, Sweden; Swedish state under the ALF agreement in Gbteborg and Stockholm; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Swedish Cancer Society, the King Gustav V Jubilee Clinic Cancer Foundation in Goteborg, Sweden, the Swedish state under the ALF agreement in Gbteborg and Stockholm.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyev HJN, 2015, COLORECTAL DIS, V17, P2, DOI 10.1111/codi.12812; Andreyev HJN, 2015, FRONTLINE GASTROENTE, V6, P53, DOI 10.1136/flgastro-2014-100468; Bergmark K, 1999, NEW ENGL J MED, V340, P1383, DOI 10.1056/NEJM199905063401802; BUJA A, 1992, MULTIVAR BEHAV RES, V27, P509, DOI 10.1207/s15327906mbr2704_2; Choi J, 2010, STAT INTERFACE, V3, P429; Dunberger G, 2011, ACTA ONCOL, V50, P233, DOI 10.3109/0284186X.2010.535013; Dunberger G, 2010, INT J GYNECOL CANCER, V20, P449, DOI 10.1111/IGC.0b013e3181d373bf; Dunberger G, 2010, EUR J CANCER, V46, P606, DOI 10.1016/j.ejca.2009.10.023; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; GILMAN A, 1963, AM J SURG, V105, P574, DOI 10.1016/0002-9610(63)90232-0; GOODMAN LS, 1946, JAMA-J AM MED ASSOC, V132, P126, DOI 10.1001/jama.1946.02870380008004; Jackson A, 2010, INT J RADIAT ONCOL, V76, pS155, DOI 10.1016/j.ijrobp.2009.08.074; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kreicbergs U, 2004, NEW ENGL J MED, V351, P1175, DOI 10.1056/NEJMoa040366; Mansson A, 2004, EUR UROL, V46, P195, DOI 10.1016/j.eururo.2004.04.010; Michalski JM, 2010, INT J RADIAT ONCOL, V76, pS123, DOI 10.1016/j.ijrobp.2009.03.078; Oh JH, 2016, METHODS INF MED, V55; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Steineck G, 2002, ACTA ONCOL, V41, P244, DOI 10.1080/02841860260088782; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; Steineck G, 2016, SEMIN RADIAT ONCOL, V26, P236, DOI 10.1016/j.semradonc.2016.03.002; Teo MTW, 2015, CLIN ONCOL-UK, V27, P656, DOI 10.1016/j.clon.2015.06.010; Yamauchi FI, 2015, MAGN RESON IMAGING, V33, P525, DOI 10.1016/j.mri.2015.02.006; Zientek LR, 2007, BEHAV RES METHODS, V39, P318, DOI 10.3758/BF03193163	24	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171461	10.1371/journal.pone.0171461	http://dx.doi.org/10.1371/journal.pone.0171461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158314	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700081
J	Fabre, L; Bao, H; Innes, J; Duong, F; Rouiller, I				Fabre, Lucien; Bao, Huan; Innes, James; Duong, Franck; Rouiller, Isabelle			Negative Stain Single-particle EM of the Maltose Transporter in Nanodiscs Reveals Asymmetric Closure of MalK(2) and Catalytic Roles of ATP, MalE, and Maltose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; ABC TRANSPORTER; ELECTRON-MICROSCOPY; SUBUNIT INTERACTIONS; FACING CONFORMATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; HYDROLYSIS; DIMER	The Escherichia coli MalE-MalFGK(2) complex is one of the best characterized members of the large and ubiquitous family of ATP-binding cassette (ABC) transporters. It is composed of a membrane-spanning heterodimer, MalF-MalG; a homodimeric ATPase, MalK(2); and a periplasmic maltose receptor, MalE. Opening and closure of MalK(2) is coupled to conformational changes in MalF-MalG and the alternate exposition of the substrate-binding site to either side of the membrane. To further define this alternate access mechanism and the impact of ATP, MalE, and maltose on the conformation of the transporter during the transport cycle, we have reconstituted MalFGK(2) in nanodiscs and analyzed its conformations under 10 different biochemical conditions using negative stain single-particle EM. EM map results (at 15-25 angstrom resolution) indicate that binding of ATP to MalK(2) promotes an asymmetric, semi-closed conformation in accordance with the low ATPase activity of MalFGK(2). In the presence of MalE, the MalK dimer becomes fully closed, gaining the ability to hydrolyze ATP. In the presence of ADP or maltose, MalE.MalFGK(2) remains essentially in a semi-closed symmetric conformation, indicating that release of these ligands is required for the return to the initial state. Taken together, this structural information provides a rationale for the stimulation of MalK ATPase activity by MalE as well as by maltose.	[Fabre, Lucien; Innes, James; Rouiller, Isabelle] McGill Univ, Dept Anat & Cell Biol, Grp Rech Axe Struct Prot, Grp Etud Prot Membranaires, 3640 Univ St, Montreal, PQ H3A 2B2, Canada; [Bao, Huan; Duong, Franck] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	McGill University; University of British Columbia	Duong, F (corresponding author), Life Sci Ctr, Off 5407,2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.; Rouiller, I (corresponding author), Rm 115,Strathcona Anat & Dent Bldg,3640 Univ St, Montreal, PQ H3A 2B2, Canada.	fduong@mail.ubc.ca; isabelle.rouiller@mcgill.ca	Rouiller, Isabelle/AAE-9637-2019; rouiller, isabelle/K-7679-2012	rouiller, isabelle/0000-0002-1288-8575; Bao, Huan/0000-0002-4301-4627; Duong Van Hoa, Franck/0000-0001-7328-6124	Canadian Institutes of Health Research [86693MOP, 74525MOP]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04798]; Bourse de Prestige from the Groupe d'Etude des Proteines Membranaires (Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council of Canada Create Training Program in Bionanomachines	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Bourse de Prestige from the Groupe d'Etude des Proteines Membranaires (Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council of Canada Create Training Program in Bionanomachines	This work was supported by Canadian Institutes of Health Research Grants 86693MOP (to I. R.) and 74525MOP (to F. D.), the Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2014-04798 (to I. R.), a Bourse de Prestige from the Groupe d'Etude des Proteines Membranaires (which is supported by the Fonds de la Recherche en Sante du Quebec) (to L. F.), and a summer fellowship from the Natural Sciences and Engineering Research Council of Canada Create Training Program in Bionanomachines (to J. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez FJD, 2015, MOL MICROBIOL, V98, P878, DOI 10.1111/mmi.13165; Bao H, 2015, J BIOL CHEM, V290, P25452, DOI 10.1074/jbc.M115.671826; Bao H, 2014, J BIOL CHEM, V289, P9844, DOI 10.1074/jbc.M113.545525; Bao H, 2013, J BIOL CHEM, V288, P23666, DOI 10.1074/jbc.M113.489567; Bao H, 2013, BBA-BIOMEMBRANES, V1828, P1723, DOI 10.1016/j.bbamem.2013.03.024; Bao H, 2013, J BIOL CHEM, V288, P3439, DOI 10.1074/jbc.M112.431932; Bao H, 2012, JOVE-J VIS EXP, DOI 10.3791/3910; Bao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034836; Beis K, 2015, BIOCHEM SOC T, V43, P889, DOI 10.1042/BST20150047; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Daus ML, 2007, J BIOL CHEM, V282, P22387, DOI 10.1074/jbc.M701979200; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Hsu WL, 2016, J PHYS CHEM B, V120, P11102, DOI 10.1021/acs.jpcb.6b07332; Hunke S, 2000, J BIOL CHEM, V275, P15526, DOI 10.1074/jbc.275.20.15526; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2013, P NATL ACAD SCI USA, V110, P18132, DOI 10.1073/pnas.1311407110; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schuler Mary A, 2013, Methods Mol Biol, V974, P415, DOI 10.1007/978-1-62703-275-9_18; Seyffer F, 2015, BBA-GEN SUBJECTS, V1850, P449, DOI 10.1016/j.bbagen.2014.05.022; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Theodoulou FL, 2015, BIOCHEM SOC T, V43, P1033, DOI 10.1042/BST20150139	35	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5457	5464		10.1074/jbc.M116.757898	http://dx.doi.org/10.1074/jbc.M116.757898			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28188291	hybrid, Green Published			2022-12-26	WOS:000397875500025
J	Miyata, N; Tang, ZY; Conti, MA; Johnson, ME; Douglas, CJ; Hasson, SA; Damoiseaux, R; Chang, CEA; Koehler, CM				Miyata, Non; Tang, Zhiye; Conti, Michael A.; Johnson, Meghan E.; Douglas, Colin J.; Hasson, Samuel A.; Damoiseaux, Robert; Chang, Chia-en A.; Koehler, Carla M.			Adaptation of a Genetic Screen Reveals an Inhibitor for Mitochondrial Protein Import Component Tim44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; C-TERMINAL DOMAIN; INNER MEMBRANE; PRESEQUENCE TRANSLOCASE; INTERMEMBRANE SPACE; MULTIENZYME NANOSTRUCTURES; SUPEROXIDE-PRODUCTION; YEAST MITOCHONDRIA; TIM23 COMPLEX; MATRIX HSP70	Diverse protein import pathways into mitochondria use translocons on the outer membrane (TOM) and inner membrane (TIM). We adapted a genetic screen, based on Ura3 mis-targeting from mitochondria to the cytosol, to identify small molecules that attenuated protein import. Small molecule mitochondrial import blockers of the Carla Koehler laboratory (MB)-10 inhibited import of substrates that require the TIM23 translocon. Mutational analysis coupled with molecular docking and molecular dynamics modeling revealed that MB-10 binds to a specific pocket in the C-terminal domain of Tim44 of the protein-associated motor (PAM) complex. This region was proposed to anchor Tim44 to the membrane, but biochemical studies with MB-10 show that this region is required for binding to the translocating precursor and binding to mtHsp70 in low ATP conditions. This study also supports a direct role for the PAM complex in the import of substrates that are laterally sorted to the inner membrane, as well as the mitochondrial matrix. Thus, MB-10 is the first small molecule modulator to attenuate PAM complex activity, likely through binding to the C-terminal region of Tim44.	[Miyata, Non; Conti, Michael A.; Johnson, Meghan E.; Douglas, Colin J.; Hasson, Samuel A.; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, Box 95156, Los Angeles, CA 90095 USA; [Damoiseaux, Robert] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Koehler, Carla M.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Koehler, Carla M.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Tang, Zhiye] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Riverside	Koehler, CM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Box 95156, Los Angeles, CA 90095 USA.	koehler@chem.ucla.edu	Damoiseaux, Robert/F-1086-2011; Damoiseaux, Robert/S-6712-2019	Damoiseaux, Robert/0000-0002-7611-7534; Damoiseaux, Robert/0000-0002-7611-7534; Koehler, Carla/0000-0001-8685-2412; Tang, Zhiye/0000-0002-5092-1575; Hasson, Samuel/0000-0003-2258-0678	National Institutes of Health [GM073981, GM61721]; California Institute of Regenerative Medicine [RS1-00313, RB1-01397]; National Science Foundation [MCB-0919586]; U.S. Public Health Service NRSA [GM07185, GM08496]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061721, R01GM109045, T32GM007185, T32GM008496, R01GM073981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Science Foundation(National Science Foundation (NSF)); U.S. Public Health Service NRSA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM073981 and GM61721 (to C. M. K.), California Institute of Regenerative Medicine Grants RS1-00313 and RB1-01397 (to C. M. K.), National Science Foundation Grant MCB-0919586 (to C. A. C.), and U.S. Public Health Service NRSA Grants GM07185 (to M. E. J., M. A. C., and C. J. D.) and GM08496 (to S. A. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ai R, 2010, J COMPUT AID MOL DES, V24, P819, DOI 10.1007/s10822-010-9376-y; Alder NN, 2008, CELL, V134, P439, DOI 10.1016/j.cell.2008.06.007; Banerjee R, 2015, ELIFE, V4, DOI 10.7554/eLife.11897; BEASLEY EM, 1993, EMBO J, V12, P2303, DOI 10.1002/j.1460-2075.1993.tb05884.x; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bonora E, 2006, BRIT J CANCER, V95, P1529, DOI 10.1038/sj.bjc.6603455; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2010, MOL CELL BIOL, V30, P307, DOI 10.1128/MCB.00749-09; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chang CE, 2003, J COMPUT CHEM, V24, P1987, DOI 10.1002/jcc.10325; D'Silva P, 2004, NAT STRUCT MOL BIOL, V11, P1084, DOI 10.1038/nsmb846; D'Silva PR, 2008, MOL BIOL CELL, V19, P424, DOI 10.1091/mbc.E07-08-0748; Dabir DV, 2013, DEV CELL, V25, P81, DOI 10.1016/j.devcel.2013.03.006; Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; DePaul AJ, 2010, NUCLEIC ACIDS RES, V38, P4856, DOI 10.1093/nar/gkq134; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Handa N, 2007, ACTA CRYSTALLOGR D, V63, P1225, DOI 10.1107/S0907444907051463; Hasson SA, 2010, P NATL ACAD SCI USA, V107, P9578, DOI 10.1073/pnas.0914387107; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutu DP, 2008, MOL BIOL CELL, V19, P2642, DOI 10.1091/mbc.E07-12-1226; HWANG ST, 1991, J BIOL CHEM, V266, P21083; Josyula R, 2006, J MOL BIOL, V359, P798, DOI 10.1016/j.jmb.2006.04.020; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; LALORAYA S, 1995, MOL CELL BIOL, V15, P7098; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; LONCHARICH RJ, 1992, BIOPOLYMERS, V32, P523, DOI 10.1002/bip.360320508; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MAARSE AC, 1992, EMBO J, V11, P3619, DOI 10.1002/j.1460-2075.1992.tb05446.x; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Matsuoka T, 2005, DIABETES, V54, P2882, DOI 10.2337/diabetes.54.10.2882; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Milisav I, 2001, J BIOL CHEM, V276, P25856, DOI 10.1074/jbc.M102132200; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ojala T, 2012, PEDIATR RES, V72, P432, DOI 10.1038/pr.2012.92; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; Popov-Celeketic D, 2011, EMBO REP, V12, P542, DOI 10.1038/embor.2011.72; RASSOW J, 1994, J CELL BIOL, V127, P1547, DOI 10.1083/jcb.127.6.1547; Roberts CC, 2016, J PHYS CHEM B, V120, P8518, DOI 10.1021/acs.jpcb.6b02236; Roberts CC, 2015, J CHEM THEORY COMPUT, V11, P286, DOI 10.1021/ct5007482; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Tagliati F, 2010, ENDOCRINOLOGY, V151, P4635, DOI 10.1210/en.2010-0441; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; UNGERMANN C, 1994, SCIENCE, V266, P1250, DOI 10.1126/science.7973708; Ungermann C, 1996, EMBO J, V15, P735, DOI 10.1002/j.1460-2075.1996.tb00409.x; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; Vogel B, 2009, BIOCHEM BIOPH RES CO, V390, P516, DOI 10.1016/j.bbrc.2009.09.129; VOOS W, 1994, MOL CELL BIOL, V14, P6627, DOI 10.1128/MCB.14.10.6627; VOOS W, 1993, J CELL BIOL, V123, P119, DOI 10.1083/jcb.123.1.119; Wada J, 1998, P NATL ACAD SCI USA, V95, P144, DOI 10.1073/pnas.95.1.144; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang YL, 2006, J AM SOC NEPHROL, V17, P1090, DOI 10.1681/ASN.2005111148	56	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5429	5442		10.1074/jbc.M116.770131	http://dx.doi.org/10.1074/jbc.M116.770131			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28167535	Green Published, hybrid			2022-12-26	WOS:000397875500023
J	Nakano, M; Fukami, T; Gotoh, S; Nakajima, M				Nakano, Masataka; Fukami, Tatsuki; Gotoh, Saki; Nakajima, Miki			A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCED FOLATE CARRIER; INOSINE RNA; MAMMALIAN-CELLS; ADENOSINE DEAMINASES; THYMIDYLATE SYNTHASE; ADAR DEAMINASES; L5178Y CELLS; 2 FORMS; EXPRESSION; METHOTREXATE	Dihydrofolate reductase (DHFR) plays a key role in folate metabolism and is a target molecule of methotrexate. An increase in the cellular expression level of DHFR is one of the mechanisms of tumor resistance to methotrexate. The pres-ent study investigated the possibility that adenosine-to-inosine RNA editing, which causes nucleotide conversion by adenosine deaminase acting on RNA (ADAR) enzymes, might modulate DHFR expression. In human breast adenocarcinoma-derived MCF-7 cells, 26 RNA editing sites were identified in the 3 ' -UTR of DHFR. Knockdown of ADAR1 decreased the RNA editing levels of DHFR and resulted in a decrease in the DHFR mRNA and protein levels, indicating that ADAR1 up-regulates DHFR expression. Using a computational analysis, miR-25-3p and miR-125a-3p were predicted to bind to the non-edited 3 ' -UTR of DHFR but not to the edited sequence. The decrease in DHFR expression by the knockdown of ADAR1 was restored by transfection of antisense oligonucleotides for these miRNAs, suggesting that RNA editing mediated up-regulation of DHFR requires the function of these miRNAs. Interestingly, we observed that the knockdown of ADAR1 decreased cell viability and increased the sensitivity of MCF-7 cells to methotrexate. ADAR1 expression levels and the RNA editing levels in the 3 ' -UTR of DHFR in breast cancer tissues were higher than those in adjacent normal tissues. Collectively, the present study dem-onstrated that ADAR1 positively regulates the expression of DHFR by editing the miR-25-3p and miR-125a-3p binding sites in the 3 ' -UTR of DHFR, enhancing cellular proliferation and resistance to methotrexate.	[Nakano, Masataka; Fukami, Tatsuki; Gotoh, Saki; Nakajima, Miki] Kanazawa Univ, Fac Pharmaceut Sci, Drug Metab & Toxicol, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Nakajima, M (corresponding author), Kanazawa Univ, Fac Pharmaceut Sci, Drug Metab & Toxicol, Kanazawa, Ishikawa 9201192, Japan.	nmiki@p.kanazawa-u.ac.jp		Fukami, Tatsuki/0000-0003-2416-5988	Japan Society for the Promotion of Science [15H04663]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant- in-Aid for Scientific Research ( B) from Japan Society for the Promotion of Science number 15H04663. The authors declare that they have no conflicts of interest with contents of this article.	Abali EE, 2008, VITAM HORM, V79, P267, DOI 10.1016/S0083-6729(08)00409-3; ALBRECHT AM, 1972, CANCER RES, V32, P1539; ALT FW, 1978, J BIOL CHEM, V253, P1357; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Banerjee D, 2002, BBA-MOL BASIS DIS, V1587, P164, DOI 10.1016/S0925-4439(02)00079-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass BL, 1997, RNA, V3, P947; Borchert GM, 2009, HUM MOL GENET, V18, P4801, DOI 10.1093/hmg/ddp443; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Chan THM, 2014, GUT, V63, P832, DOI 10.1136/gutjnl-2012-304037; CHEN LC, 1989, P NATL ACAD SCI USA, V86, P7204, DOI 10.1073/pnas.86.18.7204; Deffit SN, 2016, WIRES RNA, V7, P113, DOI 10.1002/wrna.1319; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371; DOLNICK BJ, 1979, J CELL BIOL, V83, P394, DOI 10.1083/jcb.83.2.394; DYNAN WS, 1986, NATURE, V319, P246, DOI 10.1038/319246a0; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Fix Lindsey N., 2010, Cancer Genomics & Proteomics, V7, P261; Fowler B, 2001, KIDNEY INT, V59, pS221, DOI 10.1046/j.1523-1755.2001.07851.x; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Gallo A, 2008, RNA BIOL, V5, P135, DOI 10.4161/rna.5.3.6739; Gerber A, 1997, RNA, V3, P453; GOLDIE JH, 1980, EUR J CANCER, V16, P1539, DOI 10.1016/0014-2964(80)90026-2; He H, 2015, GENET MOL RES, V14, P17927, DOI 10.4238/2015.December.22.17; HILL BT, 1979, CANCER RES, V39, P2440; JACKSON RC, 1976, CANCER RES, V36, P1991; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kobayashi H, 1998, CANCER LETT, V124, P135, DOI 10.1016/S0304-3835(97)00464-3; Komagata S, 2009, MOL PHARMACOL, V76, P702, DOI 10.1124/mol.109.056986; Liang H, 2007, RNA, V13, P463, DOI 10.1261/rna.296407; Liu H, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-44; Llado V, 2009, P NATL ACAD SCI USA, V106, P13754, DOI 10.1073/pnas.0907300106; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; McEntee G, 2011, P NATL ACAD SCI USA, V108, P15157, DOI 10.1073/pnas.1103605108; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Morabito MV, 2010, NEUROBIOL DIS, V39, P169, DOI 10.1016/j.nbd.2010.04.004; MOSCOW JA, 1995, CANCER RES, V55, P3790; Nakano M, 2016, J BIOL CHEM, V291, P894, DOI 10.1074/jbc.M115.699363; Nazki FH, 2014, GENE, V533, P11, DOI 10.1016/j.gene.2013.09.063; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Qin YR, 2014, CANCER RES, V74, P840, DOI 10.1158/0008-5472.CAN-13-2545; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Salonga D, 2000, CLIN CANCER RES, V6, P1322; SCHWEITZER BI, 1990, FASEB J, V4, P2441, DOI 10.1096/fasebj.4.8.2185970; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Song B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-96; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Stellos K, 2016, NAT MED, V22, P1140, DOI 10.1038/nm.4172; Tariq A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00099; Tsuchiya Y, 2004, CANCER RES, V64, P3119, DOI 10.1158/0008-5472.CAN-04-0166; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang Qiong, 2013, RNA, V19, P1525, DOI 10.1261/rna.041533.113; Wu XJ, 2015, GENE, V557, P195, DOI 10.1016/j.gene.2014.12.030; Xu X, 2016, BIOCHEM BIOPH RES CO, V479, P893, DOI 10.1016/j.bbrc.2016.09.087; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yoon SA, 2010, CANCER RES TREAT, V42, P163, DOI 10.4143/crt.2010.42.3.163	66	55	58	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4873	4884		10.1074/jbc.M117.775684	http://dx.doi.org/10.1074/jbc.M117.775684			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28188287	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000397590400011
J	Tsai, HH; Yen, RF; Lin, CL; Kao, CH				Tsai, Hsin-Hsi; Yen, Ruoh-Fang; Lin, Cheng-Li; Kao, Chia-Hung			Increased risk of dementia in patients hospitalized with acute kidney injury: A nationwide population-based cohort study	PLOS ONE			English	Article							DISEASE; PREVALENCE; EPIDEMIOLOGY; MORTALITY; OUTCOMES	Purpose To determine whether acute kidney injury (AKI) is a risk factor for dementia. Methods This nationwide population-based cohort study was based on data from the Taiwan National Health Insurance Research Database for 2000-2011. The incidence and relative risk of dementia were assessed in 207788 patients hospitalized for AKI. The comparison control was selected using the propensity score based on age, sex, index year and comorbidities. Results During the 12-year follow-up, patients with AKI had a significantly higher incidence for developing dementia than did the controls (8.84 vs 5.75 per 1000 person -y). A 1.88-fold increased risk of dementia (95% confidence interval, 1.76-2.01) was observed after adjustment for age, sex, and several comorbidities (diabetes, hypertension, hyperlipidemia, head injury, depression, stroke, chronic obstructive pulmonary disease, coronary artery disease, congestive heart failure, atrial fibrillation, cancer, liver disease, chronic infection/inflammation, autoimmune disease, malnutrition). Conclusions We found that patients with AKI exhibited a significantly increased risk of developing dementia. This study provides evidence on the association between AKI and long-term adverse outcomes. Additional clinical studies investigating the related pathways are warranted.	[Tsai, Hsin-Hsi] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Yen, Ruoh-Fang] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Yen, Ruoh-Fang] Natl Taiwan Univ, Coll Med, Dept Radiol, Taipei, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Kao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.; Kao, CH (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	d10040@mail.cmuh.org.tw	Tsai, Cynthia/AAT-2420-2021	YEN, RUOH-FANG/0000-0003-1648-6482	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Chawla LS, 2011, CONTRIB NEPHROL, V174, P182, DOI 10.1159/000329396; Cheng KC, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-129; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2010, AM J KIDNEY DIS, V56, P122, DOI 10.1053/j.ajkd.2009.12.034; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Doyle JF, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1353-y; Etgen T, 2012, AM J NEPHROL, V35, P474, DOI 10.1159/000338135; Gaudry S, 2014, J CRIT CARE, V29, P1022, DOI 10.1016/j.jcrc.2014.07.014; Hassoun HT, 2007, AM J PHYSIOL-RENAL, V293, pF30, DOI 10.1152/ajprenal.00023.2007; Helmer C, 2011, NEUROLOGY, V77, P2043, DOI 10.1212/WNL.0b013e31823b4765; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Jacqmin-Gadda H, 2013, EUR J EPIDEMIOL, V28, P493, DOI 10.1007/s10654-013-9818-7; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; Klein CL, 2008, KIDNEY INT, V74, P901, DOI 10.1038/ki.2008.314; Liu MC, 2008, J AM SOC NEPHROL, V19, P1360, DOI 10.1681/ASN.2007080901; Mogi M, 2011, CARDIOL RES PRACT, V2011, DOI DOI 10.4061/2011/306189; Ologunde R, 2014, INT UROL NEPHROL, V46, P2337, DOI 10.1007/s11255-014-0766-2; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Raz L, 2015, J CEREB BLOOD FLOW M; Sasaki Y, 2011, J AM GERIATR SOC, V59, P1175, DOI 10.1111/j.1532-5415.2011.03477.x; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Serteser M, 2002, J SURG RES, V107, P234, DOI 10.1006/jsre.2002.6513; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Talabani B, 2014, NEPHROLOGY, V19, P282, DOI 10.1111/nep.12221; Tamura MK, 2011, KIDNEY INT, V79, P14, DOI 10.1038/ki.2010.336; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487; Wonnacott A, 2014, CLIN J AM SOC NEPHRO, V9, P1007, DOI 10.2215/CJN.07920713; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610; Wu Y-T, 2015, LANCET NEUROL	33	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171671	10.1371/journal.pone.0171671	http://dx.doi.org/10.1371/journal.pone.0171671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192452	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423800037
J	Moreno, LF; Feng, PY; Weiss, VA; Vicente, VA; Stielow, JB; de Hoog, S				Moreno, Leandro Ferreira; Feng, Peiying; Weiss, Vinicius Almir; Vicente, Vania Aparecida; Stielow, J. Benjamin; de Hoog, Sybren			Phylogenomic analyses reveal the diversity of laccase-coding genes in Fonsecaea genomes	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; FUNGAL LACCASE; MELANOCARPUS-ALBOMYCES; WANGIELLA-DERMATITIDIS; FUSARIUM-OXYSPORUM; DIRECTED EVOLUTION; CRYSTAL-STRUCTURE; PHEOHYPHOMYCOSIS; MELANIN; FAMILY	The genus Fonsecaea comprises black yeast-like fungi of clinical relevance, including etiologic agents of chromoblastomycosis and cerebral phaeohyphomycosis. Presence of melanin and assimilation of monoaromatic hydrocarbons and alkylbenzenes have been proposed as virulence factors. Multicopper oxidase (MCO) is a family of enzymes including lac cases, ferroxidases and ascorbate oxidases which are able to catalyze the oxidation of various aromatic organic compounds with the reduction of molecular oxygen to water. Additionally, laccases are required for the production of fungal melanins, a cell-wall black pigment recognized as a key polymer for pathogenicity and extremotolerance in black yeast like fungi. Although the activity of laccase enzymes has previously been reported in many wood-rotting fungi, the diversity of laccase genes in Fonsecaea has not yet been assessed. In this study, we identified and characterized laccase-coding genes and determined their genomic location in five clinical and environmental Fonsecaea species. The identification of laccases sensu stricto will provide insights into carbon acquisition strategies as well as melanin production in Fonsecaea.	[Moreno, Leandro Ferreira; Feng, Peiying; Stielow, J. Benjamin; de Hoog, Sybren] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [Moreno, Leandro Ferreira; de Hoog, Sybren] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Moreno, Leandro Ferreira; Weiss, Vinicius Almir; Vicente, Vania Aparecida; de Hoog, Sybren] Univ Fed Parana, Dept Basic Pathol, Curitiba, Parana, Brazil; [Feng, Peiying; de Hoog, Sybren] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Dermatol, Guangzhou, Guangdong, Peoples R China	Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); University of Amsterdam; Universidade Federal do Parana; Sun Yat Sen University	de Hoog, S (corresponding author), CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands.; de Hoog, S (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.; de Hoog, S (corresponding author), Univ Fed Parana, Dept Basic Pathol, Curitiba, Parana, Brazil.; de Hoog, S (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Dermatol, Guangzhou, Guangdong, Peoples R China.	s.hoog@cbs.knaw.nl	vicente, vania/AAF-3464-2020	vicente, vania/0000-0002-2953-4861	Science without Borders fellowship [1331-13-2]; CAPES-Brazil; National Science Foundation of China [81401650]; Young Teacher Foundation of Sun Yat-sen University [13ykpy32]	Science without Borders fellowship; CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Teacher Foundation of Sun Yat-sen University	LFM was funded by the Science without Borders fellowship (Process-number: 1331-13-2), CAPES-Brazil [capes.gov.br]. PF was partly funded by the National Science Foundation of China No. 81401650 and the Young Teacher Foundation of Sun Yat-sen University No. 13ykpy32. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bleve G, 2014, APPL BIOCHEM BIOTECH, V172, P2916, DOI 10.1007/s12010-014-0734-4; Bleve G, 2013, PROTEIN ENG DES SEL, V26, P1, DOI 10.1093/protein/gzs056; Bulter T, 2003, APPL ENVIRON MICROB, V69, P987, DOI 10.1128/AEM.69.2.987-995.2003; Canero DC, 2008, PHYTOPATHOLOGY, V98, P509, DOI 10.1094/PHYTO-98-5-0509; Chen ZH, 2014, G3-GENES GENOM GENET, V4, P561, DOI 10.1534/g3.113.009241; Courty PE, 2009, NEW PHYTOL, V182, P736, DOI 10.1111/j.1469-8137.2009.02774.x; da Silva MB, 2006, MICROBES INFECT, V8, P197, DOI 10.1016/j.micinf.2005.06.018; de Azevedo CMPS, 2015, J CLIN MICROBIOL, V53, P2674, DOI 10.1128/JCM.00637-15; de Hoog GS, 2004, MED MYCOL, V42, P405, DOI 10.1080/13693780410001661464; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; Gianfreda L., 1999, BIOREMEDIAT J, V3, P1, DOI DOI 10.1080/10889869991219163; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Hakulinen N, 2008, J STRUCT BIOL, V162, P29, DOI 10.1016/j.jsb.2007.12.003; Hakulinen N, 2002, NAT STRUCT BIOL, V9, P601, DOI 10.1038/nsb823; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kallio JP, 2011, FEBS J, V278, P2283, DOI 10.1111/j.1742-4658.2011.08146.x; Kilaru S, 2006, CURR GENET, V50, P45, DOI 10.1007/s00294-006-0074-1; Koo S, 2010, MED MYCOL, V48, P769, DOI 10.3109/13693780903471081; Kumar SVS, 2003, BIOTECHNOL BIOENG, V83, P386, DOI 10.1002/bit.10681; Kwiatos N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00933; Kwon-Chung KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019760; Lettera V, 2010, FUNGAL BIOL-UK, V114, P724, DOI 10.1016/j.funbio.2010.06.004; Li XQ, 2016, STUD MYCOL, P1, DOI 10.1016/j.simyco.2016.02.001; Li XQ, 2016, STUDIES MYCOLOGY; Mate DM, 2015, BIOTECHNOL ADV, V33, P25, DOI 10.1016/j.biotechadv.2014.12.007; Najafzadeh MJ, 2010, MED MYCOL, V48, P800, DOI 10.3109/13693780903503081; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; POLACHECK I, 1990, INFECT IMMUN, V58, P2919, DOI 10.1128/IAI.58.9.2919-2922.1990; POLACHECK I, 1982, J BACTERIOL, V150, P1212, DOI 10.1128/JB.150.3.1212-1220.1982; Prenafeta-Boldu FX, 2006, FEMS MICROBIOL REV, V30, P109, DOI 10.1111/j.1574-6976.2005.00007.x; Ramos JAT, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-78; Riley R, 2016, P NATL ACAD SCI USA, V113, P9882, DOI 10.1073/pnas.1603941113; Schnitzler N, 1999, INFECT IMMUN, V67, P94, DOI 10.1128/IAI.67.1.94-101.1999; Sirim Demet, 2011, Database (Oxford), V2011, pbar006, DOI 10.1093/database/bar006; Surash S, 2005, MED MYCOL, V43, P465, DOI 10.1080/13693780500220373; Takei H, 2007, CLIN NEUROPATHOL, V26, P21; Teixeira MdM, 2016, STUDIES MYC IN PRESS; Tetsch L, 2005, FEMS MICROBIOL LETT, V245, P161, DOI 10.1016/j.femsle.2005.03.007; Vicente VA, 2014, FUNGAL DIVERS, V65, P47, DOI 10.1007/s13225-013-0246-5; Vicente VA, 2012, VET MICROBIOL, V158, P109, DOI 10.1016/j.vetmic.2012.01.031; Cazares-Garcia SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055295; Vite-Vallejo O, 2009, ENZYME MICROB TECH, V45, P233, DOI 10.1016/j.enzmictec.2009.05.007; Wahleithner JA, 1996, CURR GENET, V29, P395, DOI 10.1007/BF02208621; Wheeler M H, 1988, Curr Top Med Mycol, V2, P338; Yanagihara S, 2015, J DERMATOL, V42, P833, DOI 10.1111/1346-8138.12898; Yang S, 2013, BIORESOURCE TECHNOL, V141, P97, DOI 10.1016/j.biortech.2013.01.173; Zhu XD, 2004, FEMS YEAST RES, V5, P1, DOI 10.1016/j.femsyr.2004.04.004	48	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171291	10.1371/journal.pone.0171291	http://dx.doi.org/10.1371/journal.pone.0171291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187150	Green Published, Green Submitted, gold			2022-12-26	WOS:000394244300015
J	Wood, G; Miles, CAL; Coyles, G; Alizadehkhaiyat, O; Vine, SJ; Vickers, JN; Wilson, MR				Wood, Greg; Miles, Charlotte A. L.; Coyles, Ginny; Alizadehkhaiyat, Omid; Vine, Samuel J.; Vickers, Joan N.; Wilson, Mark R.			A randomized controlled trial of a group-based gaze training intervention for children with Developmental Coordination Disorder	PLOS ONE			English	Article							PERFORMANCE	The aim of this study was to integrate a gaze training intervention (i.e., quiet eye training; QET) that has been shown to improve the throwing and catching skill of children with Developmental Coordination Disorder (DCD), within an approach (i.e., group therapy) that might alleviate the negative psychosocial impact of these motor skill deficits. Twenty-one children with DCD were split into either QET (8 male 3 female, mean age of 8.6 years (SD = 1.04) or technical training (TT) groups (7 male 3 female, mean age of 8.6 years (SD = 1.84). The TT group were given movement-related instructions via video, relating to the throw and catch phases, while the QET group were also taught to fixate a target location on the wall prior to the throw (QE1) and to track the ball prior to the catch (QE2). Each group partook in a 4 week, group therapy intervention and measurements of QE duration and catching performance were taken before and after training, and at a 6-week delayed retention test. Parental feedback on psychosocial and motor skill outcomes was provided at delayed retention. Children improved their gaze control and catching coordination following QET, compared to TT. Mediation analysis showed that a longer QE aiming duration (QE1) predicted an earlier onset of tracking the ball prior to catching (QE2) which predicted catching success. Parents reported enhanced perceptions of their child's catching ability and general coordination in the QET group compared to the TT group. All parents reported improvements in their child's confidence, social skills and predilection for physical activity following the trial. The findings offer initial support for an intervention that practitioners could apply to address deficits in the motor and psychosocial skills of children with DCD.	[Wood, Greg] Manchester Metropolitan Univ, Ctr Hlth Exercise & Act Living, Crewe, England; [Wood, Greg; Miles, Charlotte A. L.; Coyles, Ginny; Alizadehkhaiyat, Omid] Liverpool Hope Univ, Dept Hlth Sci, Liverpool, Merseyside, England; [Vine, Samuel J.; Wilson, Mark R.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Vickers, Joan N.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada	Manchester Metropolitan University; Liverpool Hope University; University of Exeter; University of Calgary	Wood, G (corresponding author), Manchester Metropolitan Univ, Ctr Hlth Exercise & Act Living, Crewe, England.; Wood, G (corresponding author), Liverpool Hope Univ, Dept Hlth Sci, Liverpool, Merseyside, England.	greg.wood@mmu.ac.uk	Vickers, Joan/AAW-2815-2020; Vine, Samuel J/AAD-5226-2019	Vine, Samuel J/0000-0001-9329-1262; Wood, Greg/0000-0003-0851-7090	Liverpool Hope University (HEIF5 Programme); Waterloo Foundation [1119/1603]	Liverpool Hope University (HEIF5 Programme); Waterloo Foundation	This research was funded by grants from Liverpool Hope University (HEIF5 Programme 2011-2015) and The Waterloo Foundation (1119/1603). The funders were not involved in the study design, data collection, data analysis, manuscript preparation, nor publication decisions. The authors have stated that they had no interests that might be perceived as posing a conflict or bias.	Alloway TP, 2011, CHILD NEUROPSYCHOL, V17, P483, DOI 10.1080/09297049.2011.553590; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2005, BRIT J OCCUP THER, DOI [10.1177/030802260506800903, DOI 10.1177/030802260506800903]; Bart O, 2010, RES DEV DISABIL, V31, P46, DOI 10.1016/j.ridd.2009.07.021; Biotteau M., 2016, CURR DEV DISORD REP, V3, P152, DOI DOI 10.1007/S40474-016-0084-8; Bunker D, 1994, PRIMARY PHYS ED IMPL; Candler C, 2002, AM J OCCUP THER, V56, P429, DOI 10.5014/ajot.56.4.429; Chen Hsiu-Fen, 2003, Physical & Occupational Therapy in Pediatrics, V23, P61, DOI 10.1300/J006v23n04_05; Cole F L, 1988, Clin Nurse Spec, V2, P53, DOI 10.1097/00002800-198800210-00025; Cummins A, 2005, DEV MED CHILD NEUROL, V47, P437, DOI 10.1017/S001216220500085X; Debrabant J, 2013, RES DEV DISABIL, V34, P1478, DOI 10.1016/j.ridd.2013.02.008; DuPaul GJ, 1998, J PSYCHOPATHOL BEHAV, V20, P83, DOI 10.1023/A:1023087410712; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Henderson S., 2007, MOVEMENT ASSESSMENT, DOI 10.1037/t55281-000; Miles CAL, 2015, RES DEV DISABIL, V40, P31, DOI 10.1016/j.ridd.2015.01.005; Miles CA, 2015, EUROPEAN J SPORT SCI, V19, P1; Miles CAL, 2014, PSYCHOL SPORT EXERC, V15, P511, DOI 10.1016/j.psychsport.2014.04.009; Morgan R, 2012, BRIT J OCCUP THER, V75, P10, DOI 10.4276/030802212X13261082051337; Pless M, 2000, ADAPT PHYS ACT Q, V17, P381, DOI 10.1123/apaq.17.4.381; Poulsen AA, 2007, AM J OCCUP THER, V61, P451, DOI 10.5014/ajot.61.4.451; Robert MP, 2014, DEV MED CHILD NEUROL, V56, P595, DOI 10.1111/dmcn.12384; Sugden D., 2006, LEEDS CONSENSUS STAT; Sumner E, 2016, OCULOMOTOR ATYPICALI; Vickers JN, 1996, J EXP PSYCHOL HUMAN, V22, P342, DOI 10.1037/0096-1523.22.2.342; Vine SJ, 2013, INT J SPORT PSYCHOL, V44, P367, DOI 10.7352/IJSP2013.44.367; Wilson MR, 2013, MED SCI SPORT EXER, V45, P1144, DOI 10.1249/MSS.0b013e31828288f1; Wilson MR, 2011, SURG ENDOSC, V25, P2268, DOI 10.1007/s00464-010-1546-4; Wilson MR, 2016, CURRENT ISSUES SPORT, V1, P117, DOI DOI 10.15203/CISS_2016.117; Wilson PH, 2013, DEV MED CHILD NEUROL, V55, P217, DOI 10.1111/j.1469-8749.2012.04436.x	29	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171782	10.1371/journal.pone.0171782	http://dx.doi.org/10.1371/journal.pone.0171782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187138	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000394244300043
J	Zavorsky, GS; Tomko, KA; Smoliga, JM				Zavorsky, Gerald S.; Tomko, Kelly A.; Smoliga, James M.			Declines in marathon performance: Sex differences in elite and recreational athletes	PLOS ONE			English	Article							AGE; PARTICIPATION; SEDENTARY; RUNNERS; TRENDS; TIME; HALF	The first aim of this study was to determine the age group at which marathon performance declines in top male and female runners and to compare that to the runners of average ability. Another aim of this of this study was to examine the age-related yearly decline in marathon performance between age group winners and the average marathon finisher. Data from the New York (NYC), Boston, and Chicago marathons from 2001-2016 were analyzed. Age, sex, and location were used in multiple linear regression models to determine the rate of decline in marathon times. Winners of each age group were assessed in 5-year increments from 16 through 74 years old (n = 47 per age group). The fastest times were between 25 - 34 years old, with overall champion males at 28.3 years old, and overall champion females at 30.8 years old (p = 0.004). At 35 years of age up to 74 years of age, female age group winners had a faster yearly decline in marathon finishing times compared to male age group winners, irrespective of marathon location [women = (min: sec) 2: 33 per year, n = 336; men = 2: 06 per year, n = 373, p < 0.01]. The median times between each age group only slowed beginning at 50 years old, thereafter the decline was similar between both men and women (women = 2: 36, n = 140; men = 2: 57, n = 150, p = 0.11). The median times were fastest at Boston and similar between Chicago and NYC. In conclusion, the rate of decline at 35 years old up to 74 years old is roughly linear (adjusted r(2) = 0.88, p < 0.001) with female age group winners demonstrating 27 s per year greater decline per year compared to male age group winners.	[Zavorsky, Gerald S.] Georgia State Univ, Dept Resp Therapy, Atlanta, GA 30303 USA; [Tomko, Kelly A.] Univ Bridgeport, Bridgeport, CT USA; [Smoliga, James M.] High Point Univ, Dept Phys Therapy, High Point, NC USA	University System of Georgia; Georgia State University; University of Bridgeport	Zavorsky, GS (corresponding author), Georgia State Univ, Dept Resp Therapy, Atlanta, GA 30303 USA.	zavorsky@gsu.edu	Zavorsky, Gerald S./I-7753-2013; Zavorsky, Gerald S./AAI-1422-2021	Zavorsky, Gerald S./0000-0002-4473-1601; Zavorsky, Gerald S./0000-0002-4473-1601; Smoliga, James/0000-0002-1895-5687				Addison Odessa, 2015, Br J Med Med Res, V8, P1074; Ahmadyar B, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1254-6; Anthony D, 2014, CHINESE J PHYSIOL, V57, P209, DOI 10.4077/CJP.2014.BAC219; Berthelot G, 2012, AGE, V34, P1001, DOI 10.1007/s11357-011-9274-9; Billat VL, 2001, MED SCI SPORT EXER, V33, P2089, DOI 10.1097/00005768-200112000-00018; Brendle DC, 2003, AM J CARDIOL, V91, P1154, DOI 10.1016/S0002-9149(03)00174-7; Bruinvels G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149881; Connick MJ, 2015, J SPORT SCI MED, V14, P669; Deaner RO, 2015, MED SCI SPORT EXER, V47, P607, DOI 10.1249/MSS.0000000000000432; El Helou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037407; Ely MR, 2007, MED SCI SPORT EXER, V39, P487, DOI 10.1249/mss.0b013e31802d3aba; Fields A., 2014, DISCOVERING STAT USI; Florence SL, 1997, EUR J APPL PHYSIOL O, V75, P274, DOI 10.1007/s004210050160; Hagan R D, 1987, Br J Sports Med, V21, P3; Hagmar M, 2006, CLIN J SPORT MED, V16, P247, DOI 10.1097/00042752-200605000-00011; Hunter SK, 2013, MED SCI SPORT EXER, V45, P148, DOI 10.1249/MSS.0b013e31826900f6; Hunter SK, 2011, MED SCI SPORT EXER, V43, P656, DOI 10.1249/MSS.0b013e3181fb4e00; Jokl P, 2004, BRIT J SPORT MED, V38, P408, DOI 10.1136/bjsm.2002.003566; Katzel LI, 2001, J AM GERIATR SOC, V49, P1657, DOI 10.1046/j.1532-5415.2001.t01-1-49276.x; Knechtle B, 2017, J SPORT SCI, V35, P1012, DOI 10.1080/02640414.2016.1209302; Knechtle B, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-31; Lara B, 2014, AGE, V36, P1003, DOI 10.1007/s11357-013-9614-z; Lavin KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044513; Lehto N, 2016, J SPORT HEALTH SCI, V5, P349, DOI 10.1016/j.jshs.2015.01.008; Lepers R, 2012, AGE, V34, P773, DOI 10.1007/s11357-011-9271-z; Leyk D, 2007, INT J SPORTS MED, V28, P513, DOI 10.1055/s-2006-924658; Leyk D, 2010, DTSCH ARZTEBL INT, V107, P809, DOI 10.3238/arztebl.2010.0809; Loftin M, 2007, J STRENGTH COND RES, V21, P1188; Maharam LG, 1999, SPORTS MED, V28, P273, DOI 10.2165/00007256-199928040-00005; March DS, 2011, J STRENGTH COND RES, V25, P386, DOI 10.1519/JSC.0b013e3181bffd0f; MAUGHAN RJ, 1983, EUR J APPL PHYSIOL O, V52, P80, DOI 10.1007/BF00429030; Medic N, 2013, J SPORT SCI MED, V12, P724; Nikolaidis PT, 2016, J STRENGTH COND RES; Santos-Lozano A, 2015, INT J SPORT PHYSIOL, V10, P840, DOI 10.1123/ijspp.2014-0366; Tanaka H, 2008, J PHYSIOL-LONDON, V586, P55, DOI 10.1113/jphysiol.2007.141879; Tomten SE, 1996, SCAND J MED SCI SPOR, V6, P164; Trappe S, 2007, SPORTS MED, V37, P302, DOI 10.2165/00007256-200737040-00008	37	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172121	10.1371/journal.pone.0172121	http://dx.doi.org/10.1371/journal.pone.0172121			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187185	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300081
J	Malinova, V; Psychogios, MN; Tsogkas, I; Koennecke, B; Bleuel, K; Iliev, B; Rohde, V; Mielke, D				Malinova, Vesna; Psychogios, Marios N.; Tsogkas, Ioannis; Koennecke, Birte; Bleuel, Kim; Iliev, Bogdan; Rohde, Veit; Mielke, Dorothee			MR-angiography allows defining severity grades of cerebral vasospasm in an experimental double blood injection subarachnoid hemorrhage model in rats	PLOS ONE			English	Article							ARTERY OCCLUSION; ISCHEMIA; METAANALYSIS	Objective Magnetic resonance (MR) imaging has been used for the detection of cerebral vasospasm (VSP) related infarction in experimental subarachnoid hemorrhage (eSAH) in rats. Conventional angiography is generally used to visualize VSP, which is an invasive technique with a possible increase in morbidity and mortality. In this study we evaluated the validity of MR-angiography (MRA) in detecting VSP and its feasibility to define VSP severity grades after eSAH in rats. Methods SAH was induced using the double-hemorrhage model in 12 rats. In two rats, saline solution was injected instead of blood (sham group). MR was performed on day 1, 2 and on day 5. T1-, T2-, T2*- weighted and time-of-flight MR sequences were applied, which were analyzed by two blinded neuroradiologists. Vessel narrowing of 25-50% was defined as mild, 50-75% as moderate and >75% as severe VSP. Results We performed a total of 34 MRAs in 14 rats. In 14 rats, MRA was performed on day 2 and day 5. In six rats MRA was additionally performed on day1 before the blood injection. A good visualization of cerebral vessels was possible in all cases. No VSP was seen in the sham group neither on day 2 nor on day 5. We found vasospasm on day 2 in 7 of the 14 rats (50%) whereas all 7 rats had mild and one rat had additionally moderate and severe vasospasm in one vessel, respectively. On day 5 we found vasospasm in 8 of the 14 rats (60%) whereas 4 rats had severe vasospasm, 1 rat had moderate vasospasm and 3 rats demonstrated mild vasospasm. In 4 of the 14 rats (30%) an ischemic lesion was detected on day 5. Three of these rats had severe vasospasm and one rat had mild vasospasm. Severe vasospasm on day 5 was statistically significant correlated with the occurrence of ischemic lesions (Fisher's Exact test, OR 19.5, p = 0.03). Conclusions MRA is a noninvasive diagnostic tool, which allows a good visualization of the cerebral vasculature and provides reproducible results concerning the detection of VSP and the differentiation into three severity grades in rats. Future studies are needed to directly compare MRA with conventional angiography.	[Malinova, Vesna; Bleuel, Kim; Iliev, Bogdan; Rohde, Veit; Mielke, Dorothee] Georg August Univ Gottingen, Dept Neurosurg, Gottingen, Germany; [Psychogios, Marios N.; Tsogkas, Ioannis] Georg August Univ Gottingen, Dept Neuroradiol, Gottingen, Germany; [Koennecke, Birte] Georg August Univ Gottingen, Dept Neurol, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Malinova, V (corresponding author), Georg August Univ Gottingen, Dept Neurosurg, Gottingen, Germany.	vesna.malinova@gmail.com	Mielke, Dorothee/AAU-6776-2021					Cloft HJ, 1999, STROKE, V30, P317, DOI 10.1161/01.STR.30.2.317; Etminan N, 2011, J CEREBR BLOOD F MET, V31, P1443, DOI 10.1038/jcbfm.2011.7; Gerriets T, 2004, STROKE, V35, P2372, DOI 10.1161/01.STR.0000142134.37512.a7; Grandin CB, 2000, AM J NEURORADIOL, V21, P1611; Guresir E, 2012, ACTA NEUROCHIR, V154, P11, DOI 10.1007/s00701-011-1191-2; Gules I, 2002, AM J PHYSIOL-HEART C, V283, pH2551, DOI 10.1152/ajpheart.00616.2002; Koktekir E, 2010, ACTA NEUROCHIR, V152, P463, DOI 10.1007/s00701-009-0540-x; Lee JY, 2009, NEUROSURGERY, V65, P331, DOI 10.1227/01.NEU.0000345649.78556.26; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Prunell GF, 2004, NEUROSURGERY, V54, P426, DOI 10.1227/01.NEU.0000103670.09687.7A; Rowland MJ, 2012, BRIT J ANAESTH, V109, P315, DOI 10.1093/bja/aes264; Sehba FA, 2014, TRANSL STROKE RES, V5, P660, DOI 10.1007/s12975-014-0368-4; van den Bergh WM, 2005, ACTA NEUROCHIR, V147, P977, DOI 10.1007/s00701-005-0539-x; Vatter H, 2006, NEUROSURGERY, V58, P1190, DOI 10.1227/01.NEU.0000199346.74649.66	14	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171121	10.1371/journal.pone.0171121	http://dx.doi.org/10.1371/journal.pone.0171121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182715	Green Submitted, gold, Green Published			2022-12-26	WOS:000394231800034
J	Jo, K; Bajgur, SS; Kim, H; Choi, HA; Huh, PW; Lee, K				Jo, KwangWook; Bajgur, Suhas S.; Kim, Hoon; Choi, Huimahn A.; Huh, Pil-Woo; Lee, Kiwon			A simple prediction score system for malignant brain edema progression in large hemispheric infarction	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; ACUTE ISCHEMIC-STROKE; CT ANGIOGRAPHY; DECOMPRESSIVE HEMICRANIECTOMY; RANDOMIZED-TRIAL; ALBERTA STROKE; OCCLUSION; THROMBECTOMY; MULTICENTER; CRANIECTOMY	Malignant brain edema (MBE) due to hemispheric infarction can result in brain herniation, poor outcomes, and death; outcome may be improved if certain interventions, such as decompressive craniectomy, are performed early. We sought to generate a prediction score to easily identify those patients at high risk for MBE. 121 patients with large hemispheric infarction (LHI) (2011 to 2014) were included. Patients were divided into two groups: those who developed MBE and those who did not. Independent predictors of MBE were identified by logistic regression and a score was developed. Four factors were independently associated with MBE: baseline National Institutes of Health Stroke Scale (NIHSS) score (p = 0.048), Alberta Stroke Program Early Computed Tomography Score (ASPECTS) (p = 0.007), collateral score (CS) (p<0.001) and revascularization failure (p = 0.013). Points were assigned for each factor as follows: NIHSS <= 8 (= 0), 9-17 (= 1), >= 18 (= 2); ASPECTS <= 7 (= 1), >8 (= 0); CS<2 (= 1), >= 2 (= 0); revascularization failure (= 1), success (= 0). The MBE Score (MBES) represents the sum of these individual points. Of 26 patients with a MBES of 0 to 1, none developed MBE. All patients with a MBES of 6 developed MBE. Both MBE development and functional outcomes were strongly associated with the MBES (p = 0.007 and 0.002, respectively). The MBE score is a simple reliable tool for the prediction of MBE.	[Jo, KwangWook; Kim, Hoon] Catholic Univ Korea, Bucheon St Marys Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea; [Bajgur, Suhas S.; Choi, Huimahn A.; Lee, Kiwon] Univ Texas Houston, Sch Med, Dept Neurosurg, Houston, TX USA; [Huh, Pil-Woo] Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea	Catholic University of Korea; University of Texas System; University of Texas Health Science Center Houston; Catholic University of Korea	Huh, PW (corresponding author), Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea.	jkw945453@gmail.com		Whang, Kum/0000-0002-3701-847X				Arnaout OM, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1160; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Burghaus L, 2008, NEUROCRIT CARE, V9, P13, DOI 10.1007/s12028-007-9025-z; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BCV, 2013, J CEREBR BLOOD F MET, V33, P1168, DOI 10.1038/jcbfm.2013.77; Chen R, 2015, J STROKE CEREBROVASC, V24, P958, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.016; Daou B, 2015, NEUROSURGERY, V77, P355, DOI 10.1227/NEU.0000000000000830; Efron B, 1994, INTRO BOOTSTRAPED; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2015, STROKE, V46, P2695, DOI 10.1161/STROKEAHA.115.010078; Jeon SB, 2014, J STROKE, V16, P146, DOI 10.5853/jos.2014.16.3.146; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kim H, 2015, J CLIN NEUROSCI, V22, P554, DOI 10.1016/j.jocn.2014.08.021; Kurland DB, 2015, NEUROCRIT CARE; Lemeshow S., 2004, APPLIED LOGISTIC REG; Lima FO, 2010, STROKE, V41, P2316, DOI 10.1161/STROKEAHA.110.592303; Lu XC, 2014, SCI REP-UK, V4, DOI 10.1038/srep07070; Maas MB, 2009, STROKE, V40, P2988, DOI 10.1161/STROKEAHA.109.555664; MacCallum C, 2014, CEREBROVASC DIS, V38, P39, DOI 10.1159/000363619; Miteff F, 2009, BRAIN, V132, P2231, DOI 10.1093/brain/awp155; MOULIN DE, 1985, STROKE, V16, P282, DOI 10.1161/01.STR.16.2.282; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Sillanpaa N, 2012, NEURORADIOLOGY, V54, P663, DOI 10.1007/s00234-011-0954-z; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tan IYL, 2009, AM J NEURORADIOL, V30, P525, DOI 10.3174/ajnr.A1408; Thomalla GJ, 2003, STROKE, V34, P1892, DOI 10.1161/01.STR.0000081985.44625.B6; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; ZWECKBERGER K, 2014, REV CEREBROVASC DIS, V38, P313, DOI DOI 10.1159/000365864	39	27	34	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171425	10.1371/journal.pone.0171425	http://dx.doi.org/10.1371/journal.pone.0171425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178299	Green Published, Green Submitted, gold			2022-12-26	WOS:000393712500041
J	Paul, M; Bhadra, A				Paul, Manabi; Bhadra, Anindita			Selfish Pups: Weaning Conflict and Milk Theft in Free-Ranging Dogs	PLOS ONE			English	Article							PARENT-OFFSPRING CONFLICT; EVOLUTION; BEHAVIOR; GROWTH; CARE	Parent-offspring conflict theory predicts the emergence of weaning conflict between a mother and her offspring arising from skewed relatedness benefits. Empirical observations of weaning conflict have not been carried out in canids. In a field-based study on free-ranging dogs we observed that nursing/suckling bout durations decrease, proportion of mother-initiated nursing bouts decrease and mother-initiated nursing/suckling terminations increase with pup age. We identified the 7th -13th week period of pup age as the zone of conflict between the mother and her pups, beyond which suckling solicitations cease, and before which suckling refusals are few. We also report for the first time milk theft by pups who take advantage of the presence of multiple lactating females, due to the promiscuous mating system of the dogs. This behaviour, though apparently disadvantageous for the mothers, is perhaps adaptive for the dogs in the face of high mortality and competition for resources.	[Paul, Manabi; Bhadra, Anindita] Indian Inst Sci Educ & Res Kolkata, Behav & Ecol Lab, Dept Biol Sci, Mohanpur, W Bengal, India	Indian Institute of Science Education & Research (IISER) - Kolkata	Bhadra, A (corresponding author), Indian Inst Sci Educ & Res Kolkata, Behav & Ecol Lab, Dept Biol Sci, Mohanpur, W Bengal, India.	abhadra@iiserkol.ac.in	Bhadra, Anindita/H-6899-2019	Bhadra, Anindita/0000-0002-3717-9732	CSIR, India [37(1399)/10/EMR-II]; SERB, India [SB/WEA-005/2013, SBNS/LS-38/2013]; IISER Kolkata	CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); SERB, India(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); IISER Kolkata	This project was funded by grants from CSIR, India (http://csirhrdg.res.in/), grant no. 37(1399)/10/EMR-II, and SERB, India (http://serbonline.in/SERB), grant nos. SB/WEA-005/2013 and SBNS/LS-38/2013. The work was supported by IISER Kolkata.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beaver B.V., 2009, CANINE BEHAV INSIGHT, Vsecond; Bhadra A, 2016, ETHOL ECOL EVOL, V28, P427, DOI 10.1080/03949370.2015.1076526; BOWEN WD, 1985, CAN J ZOOL, V63, P2841, DOI 10.1139/z85-424; Foster KR, 2006, TRENDS ECOL EVOL, V21, P57, DOI 10.1016/j.tree.2005.11.020; GADAGKAR R, 1990, PHILOS T ROY SOC B, V329, P17, DOI 10.1098/rstb.1990.0146; GODFRAY HCJ, 1992, ANIM BEHAV, V43, P473, DOI 10.1016/S0003-3472(05)80106-X; Kleiman D., 1968, International Zoo Yearbook, V8, P3, DOI 10.1111/j.1748-1090.1968.tb00419.x; Konig B, 1997, NATURWISSENSCHAFTEN, V84, P95, DOI 10.1007/s001140050356; LEE PC, 1991, J ZOOL, V225, P99, DOI 10.1111/j.1469-7998.1991.tb03804.x; MacLeod KJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0378; Majumder SS, 2014, ACTA ETHOL, V17, P1, DOI 10.1007/s10211-013-0158-0; Malm K, 1996, APPL ANIM BEHAV SCI, V49, P223, DOI 10.1016/0168-1591(96)01044-1; MARTIN P, 1984, ANIM BEHAV, V32, P1257, DOI 10.1016/S0003-3472(84)80245-6; Mech LD, 1999, CAN J ZOOL, V77, P1192, DOI 10.1139/cjz-77-8-1192; Oftedal O.T., 1985, BIOENERGETICS WILD H, V10, P215; Paul M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150580; Paul M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19641; Paul M, 2014, J ETHOL, V32, P75, DOI 10.1007/s10164-014-0396-2; Paul M, 2014, BEHAV PROCESS, V103, P17, DOI 10.1016/j.beproc.2013.10.006; PICKFORD M, 1960, J PHYSIOL-LONDON, V152, P515, DOI 10.1113/jphysiol.1960.sp006506; Pluhacek J, 2010, APPL ANIM BEHAV SCI, V122, P127, DOI 10.1016/j.applanim.2009.11.009; R Core Team, 2015, R LANG ENV STAT COMP; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; ROBINSON WB, 1952, J MAMMAL, V33, P470, DOI 10.2307/1376020; Sen Majumder S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143501; Spotte S, 2012, SOCIETIES OF WOLVES AND FREE-RANGING DOGS, P1, DOI 10.1017/CBO9781139057769; TRIVERS RL, 1974, AM ZOOL, V14, P249; UVNASMOBERG K, 1985, ACTA PHYSIOL SCAND, V124, P391, DOI 10.1111/j.1748-1716.1985.tb07674.x; van den Berg P, 2013, EVOL HUM BEHAV, V34, P405, DOI 10.1016/j.evolhumbehav.2013.07.004; Vanak AT, 2009, MAMMAL REV, V39, P265, DOI 10.1111/j.1365-2907.2009.00148.x; Vasquez CG, 2004, NEW ZEAL J AGR RES, V47, P1, DOI 10.1080/00288233.2004.9513565	33	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170590	10.1371/journal.pone.0170590	http://dx.doi.org/10.1371/journal.pone.0170590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178276	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500010
J	Quero, C; Monteys, VSI; Rosell, G; Puigmarti, M; Guerrero, A				Quero, Carmen; Sarto i Monteys, Victor; Rosell, Gloria; Puigmarti, Marc; Guerrero, Angel			Sexual communication in castniid moths: Males mark their territories and appear to bear all chemical burden	PLOS ONE			English	Article							PYRROLIZIDINE ALKALOIDS; BUTTERFLIES LEPIDOPTERA; NYMPHALIDAE; BIOLOGY	Castniid moths (Lepidoptera: Castniidae) display a butterfly-like reproductive behavior, i.e., they use visual stimuli for mate location and females have apparently lost their pheromone glands in an evolutionary context. In this paper we report for the first time the identification of three new compounds, namely n-octadecyl acetate, (Z)-9-octadecenyl acetate and (E,Z)-2,13-octadecadienyl acetate, in males of the Castniid Palm Borer, Paysandisia archon, which could be involved in its short-range courtship behavior, and also shed light on recent controversies on the sexual behavior of the species. The compounds are produced in a ring shaped gland of the male terminalia and have occasionally been detected in very minor amounts (ng) in ovipositor extracts of females, but only while mating or just after copulation. We also report that males use the already known (E,Z)-2,13-octadecadienol to mark their territory by rubbing their midlegs against the upper side of nearby leaves, especially palm leaves. This compound, produced in large amounts, is mostly concentrated in the midleg basitarsi and its maximum production is detected on the sexually mature 1-day-old specimens. In addition, analysis of male wings extracts confirms the presence of Z,E and E,E-farnesals, which are mostly produced in the median band of hindwings of 48-53 h-old insects. The biological significance of farnesals in this species is unknown. Our results point out that the chemical communication of P. archon relies mostly on males, which appear to bear all chemical burden in this respect.	[Quero, Carmen; Puigmarti, Marc; Guerrero, Angel] CSIC, IQAC, Dept Biol Chem & Mol Modelling, Barcelona, Spain; [Sarto i Monteys, Victor] Autonomous Univ Barcelona, Inst Environm Sci & Technol ICTA, Entomol Plants & Hlth, ICTA ICP Bldg, Bellaterra, Barcelona, Spain; [Sarto i Monteys, Victor] Catalonian Govt, Serv Plant Hlth, Dept Agr Livestock Fisheries & Food DARP, Barcelona, Spain; [Rosell, Gloria] Univ Barcelona, Dept Pharmacol & Therapeut Chem, CSIC, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona	Quero, C; Guerrero, A (corresponding author), CSIC, IQAC, Dept Biol Chem & Mol Modelling, Barcelona, Spain.	cqlqob@cid.csic.es; agpqob@cid.csic.es	Guerrero, Angel/AAW-3731-2020; MONTEYS, VICTOR SARTO I/ABE-7326-2020; Guerrero, Angel/G-8495-2015	Quero, Carmen/0000-0003-3599-2778; Guerrero, Angel/0000-0003-2323-2691	MINECO [AGL2012-39869-C02-01, AGL2015-66469-R]; European Regional Development Fund; CSIC	MINECO(Spanish Government); European Regional Development Fund(European Commission); CSIC	The research was partially supported by MINECO (grants AGL2012-39869-C02-01, AGL2015-66469-R, and a FPI contract to MP) with assistance from the European Regional Development Fund, and CSIC for a postdoctoral contract to CQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin P, 2009, INSECT BIOCHEM MOLEC, V39, P11, DOI 10.1016/j.ibmb.2008.09.007; BERNARDI R, 1967, TETRAHEDRON LETT, P3893; BOPPRE M, 1983, OECOLOGIA, V59, P414, DOI 10.1007/BF00378873; BROWER LINCOLN PIERSON, 1965, ZOOLOGICA [NEW YORK], V50, P1; BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; Costanzo K, 2007, P ROY SOC B-BIOL SCI, V274, P845, DOI 10.1098/rspb.2006.3729; Delle-Vedove R, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.52; Delle-Vedove R, 2012, EUR J ENTOMOL, V109, P289, DOI 10.14411/eje.2012.037; Edwards E.D., 1998, LEPIDOPTERA MOTHS BU, VIV, P181; EI-Sayed AM, PHEROBASE DATABASE I; Eisner T., 1987, P251; Frerot B, 2013, CHEMOECOLOGY, V23, P137, DOI 10.1007/s00049-013-0128-z; Hallberg E., 2003, LEPIDOPTERA MOTHS BU, V2, P361; Heikkila M, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0520-0; Jordan K., 1923, Novitates Zoologicae, V30, P159; Knudsen JT, 2002, AM J BOT, V89, P1772, DOI 10.3732/ajb.89.11.1772; Larsdotter-Mellstrom H, 2016, FRONT PHYSIOL, V7, P1; Le Cerf F., 1936, Bulletin de la Societe Entomologique de France Paris, V41, P191; Miller J. Y., 1986, Dissertation Abstracts International, B (Sciences and Engineering), V47, P2289; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; NATION JL, 1990, J CHEM ECOL, V16, P553, DOI 10.1007/BF01021786; Percy-Cunningham J.E., 1987, P27; Pliske TE, 1947, ANN ENTOMOL SOC AM, V68, P143; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Riolo P, 2014, J ECON ENTOMOL, V107, P1009, DOI 10.1603/EC13298; Ruschioni S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124607; Monteys VSI, 2016, B ENTOMOL RES, V106, P421, DOI 10.1017/S0007485316000158; Monteys VSI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029282; Sarto i Monteys Victor, 2005, Nachrichten des Entomologischen Vereins Apollo, V26, P61; Schultz S., 1993, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, V342, P161, DOI 10.1098/rstb.1993.0144; Schulz S, 2004, BIOCHEM SYST ECOL, V32, P699, DOI 10.1016/j.bse.2003.12.004; Tanahashi I., 2007, Aroma Research, V8, P390; TRIGO JR, 1994, J CHEM ECOL, V20, P2883, DOI 10.1007/BF02098396; Vassiliou V, 2014, 10 EUR C ENT 2014 3; Widemo F, 2006, P ROY SOC B-BIOL SCI, V273, P713, DOI 10.1098/rspb.2005.3379; Wiklund Christer, 2003, P67; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1; Yang CY, 2009, J CHEM ECOL, V35, P1197, DOI 10.1007/s10886-009-9694-5; ZAGATTI P, 1987, J CHEM ECOL, V13, P1561, DOI 10.1007/BF00980200; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	40	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171166	10.1371/journal.pone.0171166	http://dx.doi.org/10.1371/journal.pone.0171166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178286	Green Published, Green Submitted, gold			2022-12-26	WOS:000393712500029
J	Xu, X; Hu, JZ; Lu, HB				Xu, Xiang; Hu, Jianzhong; Lu, Hongbin			Histological observation of a gelatin sponge transplant loaded with bone marrow-derived mesenchymal stem cells combined with platelet-rich plasma in repairing an annulus defect	PLOS ONE			English	Article							INTERVERTEBRAL DISC; IN-VITRO; DIFFERENTIATION	Objective To research the histological characteristics of a gelatin sponge transplant loaded with goat BMSCs (bone marrow-derived mesenchymal stem cells) combined with PRP (platelet-rich plasma) in repairing an annulus defect. Method BMSCs were separated from the iliac crest of goats, sub-cultured and identified after the third generation. Then, PRP was obtained using blood from the jugular vein of goats via two degrees of centrifugation. In the animal experiments, the goats were divided into the following three groups: a sham group, an injury group and a therapeutic group. In the sham group, we decompressed the lamina and exposed the annulus fibrosus. In the injury group, we exposed the annulus fibrosus after decompression of the lamina and created a 1 x 1 cm defect in the annulus using surgical instruments. In the therapeutic group, after decompression of the lamina, we exposed the annulus, created a 1 x 1 cm defect using surgical instruments, and placed a gelatin sponge combined with BMSCs and PRP into the defect for a combined method of repair. Three, six and twelve weeks after the surgery, the previously damaged or undamaged annulus tissue was removed from the three groups. Then, the above tissue was assayed using HE (hematoxylin-eosin) staining, Masson trichrome staining, AB-PAS (Alcian blue-periodic acid Schiff) staining, and type II collagen staining and observed by microscopy. Results From the HE staining, we observed that the number of repair cells gradually increased. Compared to the injury group, the cell density and gross morphology of cells in the therapeutic group were closer to those of the sham group. As observed by Masson trichrome gelatin staining, many of the fibroblast cells or tissues were under repair, and as time progressed, the number of fibroblast cells and amount of tissue gradually increased. The results of the AB-PAS staining suggest that chondrocytes participated in the repair of the annulus. The level of type II collagen gradually increased, as determined by immunohistochemical staining. Conclusion Our results demonstrate that a gelatin sponge transplant loaded with BMSCs and PRP can effectively repair annulus defects.	[Xu, Xiang; Hu, Jianzhong] Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha, Hunan, Peoples R China; [Hu, Jianzhong; Lu, Hongbin] Key Lab Organ Injury Aging & Regenerat Med Hunan, Changsha, Hunan, Peoples R China; [Lu, Hongbin] Cent S Univ, Xiangya Hosp 10, Dept Sports Med, Res Ctr Sports Med, Changsha, Hunan, Peoples R China	Central South University; Central South University	Hu, JZ (corresponding author), Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha, Hunan, Peoples R China.; Hu, JZ; Lu, HB (corresponding author), Key Lab Organ Injury Aging & Regenerat Med Hunan, Changsha, Hunan, Peoples R China.; Lu, HB (corresponding author), Cent S Univ, Xiangya Hosp 10, Dept Sports Med, Res Ctr Sports Med, Changsha, Hunan, Peoples R China.	jianzhonghu@hotmail.com; hongbinlu@hotmail.com						Ahlgren BD, 2000, SPINE, V25, P2165, DOI 10.1097/00007632-200009010-00004; Cavallo C, 2014, J BONE JOINT SURG AM, V96A, P423, DOI 10.2106/JBJS.M.00726; Chen GX, 2011, CHIN J CLIN ELECTRON, V5, P1547; Forte A, 2012, CARDIOVASC DRUG THER, V26, P9, DOI 10.1007/s10557-011-6359-8; Kim TH, 2014, ARCH ORAL BIOL, V59, P550, DOI 10.1016/j.archoralbio.2014.02.004; Kozanoglu I, 2009, CYTOTHERAPY, V11, P527, DOI 10.1080/14653240902923153; Kushida S, 2014, J ARTIF ORGANS, V17, P186, DOI 10.1007/s10047-014-0761-5; Li ZH, 2015, J CLIN NEUROSCI, V22, P331, DOI 10.1016/j.jocn.2014.06.098; Liu Chen, 2014, Zhonghua Shao Shang Za Zhi, V30, P433; Man ZT, 2014, BIOMATERIALS, V35, P5250, DOI 10.1016/j.biomaterials.2014.03.031; Pan Bing, 2014, Zhongguo Gu Shang, V27, P712; Quah C, 2014, ANN ROY COLL SURG, V96, P140, DOI 10.1308/003588414X13814021676873; Saeed H, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0116-4; Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038; Tian Rong, 2014, Zhonghua Wai Ke Za Zhi, V52, P258; [王海燕 Wang Haiyan], 2009, [眼科研究, Ophthalmic Research], V27, P743; Wang ZC, 2014, EXP THER MED, V8, P1528, DOI 10.3892/etm.2014.1950; Wen J LD, 2014, MED RECAPITULATE, V20, P3473; Wu G, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-97; Xiao C, 2014, J CLIN MED LIT ELECT, V2, P132; Xu QC, 2014, INT J CLIN EXP PATHO, V7, P1580; Yao Gong-he, 2009, Zhongguo Gu Shang, V22, P247; [张巍 Zhang Wei], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P7047; Zhao Lin, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P145; Zhao QG, 2015, P NATL ACAD SCI USA, V112, P530, DOI 10.1073/pnas.1423008112	25	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171500	10.1371/journal.pone.0171500	http://dx.doi.org/10.1371/journal.pone.0171500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178294	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500048
J	Zhao, X; Yang, G				Zhao, Xia; Yang, Guang			Winter to winter recurrence of atmospheric circulation anomalies over East Asia and its impact on winter surface air temperature anomalies	PLOS ONE			English	Article							ARCTIC-OSCILLATION; SST ANOMALIES; TEMPORAL COHERENCE; MONSOON; REANALYSIS; VARIABILITY; NORTHERN; MODES	The persistence of atmospheric circulation anomalies over East Asia shows a winter to winter recurrence (WTWR) phenomenon. Seasonal variations in sea level pressure anomalies and surface wind anomalies display significantly different characteristics between WTWR and non-WTWR years. The WTWR years are characterized by the recurrence of both a strong (weak) anomalous Siberian High and an East Asian winter monsoon over two successive winters without persistence through the intervening summer. However, anomalies during the non-WTWR years have the opposite sign between the current and ensuing winters. The WTWR of circulation anomalies contributes to that of surface air temperature anomalies (SATAs), which is useful information for improving seasonal and interannual climate predictions over East Asia and China. In the positive (negative) WTWR years, SATAs are cooler (warmer) over East Asia in two successive winters, but the signs of the SATAs are opposite in the preceding and subsequent winters during the non-WTWR years.	[Zhao, Xia] Chinese Acad Sci, Key Lab Ocean Circulat & Waves, Qingdao, Peoples R China; [Zhao, Xia] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Zhao, Xia] Qingdao Natl Lab Marine Sci & Technol, Lab Ocean & Climate Dynam, Qingdao, Peoples R China; [Yang, Guang] State Ocean Adm, Inst Oceanog 1, Ctr Ocean & Climate Res, Qingdao, Peoples R China; [Yang, Guang] Qingdao Natl Lab Marine Sci & Technol, Lab Reg Oceanog & Numer Modeling, Qingdao, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; State Oceanic Administration; Qingdao National Laboratory for Marine Science & Technology	Zhao, X (corresponding author), Chinese Acad Sci, Key Lab Ocean Circulat & Waves, Qingdao, Peoples R China.; Zhao, X (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.; Zhao, X (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Ocean & Climate Dynam, Qingdao, Peoples R China.	zhaoxia@qdio.ac.cn			NSFC [41375094, 41406028]; Basic Scientific Research Fund for National Public Institutes of China [GY2015PO4]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA11010102]; NSFC-Shandong Joint Fund for Marine Science Research Centers [U1406401]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [41421005]; Open Fund of the Key Laboratory of Ocean Circulation and Waves, Chinese Academy of Sciences [KLOCAW1501]	NSFC(National Natural Science Foundation of China (NSFC)); Basic Scientific Research Fund for National Public Institutes of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC-Shandong Joint Fund for Marine Science Research Centers; Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of the Key Laboratory of Ocean Circulation and Waves, Chinese Academy of Sciences(Ministry of Education, ChinaChinese Academy of Sciences)	This work was supported by NSFC grant (Grant No. 41375094, 41406028), the Basic Scientific Research Fund for National Public Institutes of China (GY2015PO4), the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDA11010102), NSFC-Shandong Joint Fund for Marine Science Research Centers (Grant No. U1406401), the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (Grant No. 41421005), Open Fund of the Key Laboratory of Ocean Circulation and Waves, Chinese Academy of Sciences (KLOCAW1501).	ALEXANDER MA, 1995, J PHYS OCEANOGR, V25, P122, DOI 10.1175/1520-0485(1995)025<0122:AMFTRO>2.0.CO;2; Alexander MA, 1999, J CLIMATE, V12, P2419, DOI 10.1175/1520-0442(1999)012<2419:TROSAI>2.0.CO;2; Cassou C, 2007, J CLIMATE, V20, P3510, DOI 10.1175/JCLI4202.1; Chen W, 2000, ADV ATMOS SCI, V17, P48; Chen Z, 2014, J CLIMATE, V27, P5433, DOI 10.1175/JCLI-D-13-00731.1; Chen Z, 2014, J CLIMATE, V27, P835, DOI 10.1175/JCLI-D-13-00314.1; Deser C, 2003, J CLIMATE, V16, P57, DOI 10.1175/1520-0442(2003)016<0057:UTPOSS>2.0.CO;2; Gong DY, 2001, GEOPHYS RES LETT, V28, P2073, DOI 10.1029/2000GL012311; Huang R.-H., 1999, CHIN J ATMOS SCI, V23, P226; Huang R H, 2006, WINTER MONEX QUARTER, P126; Jhun JG, 2004, J CLIMATE, V17, P711, DOI 10.1175/1520-0442(2004)017&lt;0711:ANEAWM&gt;2.0.CO;2; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; [康丽华 KANG LiHua], 2006, [气候与环境研究, Climatic and environmental research], V11, P330; [康丽华 KANG Lihua], 2009, [气候与环境研究, Climatic and Environmental Research], V14, P45; 纪立人, 1997, Advances in Atmospheric Sciences, V14, P1; Kushnir Y, 2002, J CLIMATE, V15, P2233, DOI 10.1175/1520-0442(2002)015<2233:AGRTES>2.0.CO;2; Liu G, 2012, ATMOS OCEAN SCI LETT, V5, P195, DOI 10.1080/16742834.2012.11446985; NAMIAS J, 1970, J GEOPHYS RES, V75, P5952, DOI 10.1029/JC075i030p05952; NAMIAS J, 1974, J GEOPHYS RES, V79, P797, DOI 10.1029/JC079i006p00797; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Wang L, 2010, ADV ATMOS SCI, V27, P855, DOI 10.1007/s00376-009-9094-3; Wang L, 2009, J CLIMATE, V22, P4860, DOI 10.1175/2009JCLI2973.1; [王遵娅 Wang Zunya], 2006, [大气科学, Chinese Journal of Atmospheric Sciences], V30, P1068; Wu BY, 2006, MON WEATHER REV, V134, P2165, DOI 10.1175/MWR3150.1; Wu BY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015373; Wu BY, 2002, ADV ATMOS SCI, V19, P297; Wu RG, 2005, J CLIMATE, V18, P3048, DOI 10.1175/JCLI3465.1; Wu ZW, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011501; Xue X, 2015, THEOR APPL CLIMATOL, V120, P673, DOI 10.1007/s00704-014-1200-5; Zhao X, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008248; Zhao X, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007845; Zhao X, 2010, J CLIMATE, V23, P3835, DOI 10.1175/2009JCLI2583.1	32	0	0	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171641	10.1371/journal.pone.0171641	http://dx.doi.org/10.1371/journal.pone.0171641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178351	Green Published, Green Submitted, gold			2022-12-26	WOS:000393712500056
J	Paul, R; Choudhury, A; Kumar, S; Giri, A; Sandhir, R; Borah, A				Paul, Rajib; Choudhury, Amarendranath; Kumar, Sanjeev; Giri, Anirudha; Sandhir, Rajat; Borah, Anupom			Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress	PLOS ONE			English	Article							COMPLEX-I DEFICIENCY; BODY-MASS INDEX; ALPHA-SYNUCLEIN; ROTENONE MODEL; BRAIN; PATHOLOGY; IMPAIRMENT; PROTECTS; MICE; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE	Hypercholesterolemia is a known contributor to the pathogenesis of Alzheimer's disease while its role in the occurrence of Parkinson's disease (PD) is only conjecture and far from conclusive. Altered antioxidant homeostasis and mitochondrial functions are the key mechanisms in loss of dopaminergic neurons in the substantia nigra (SN) region of the midbrain in PD. Hypercholesterolemia is reported to cause oxidative stress and mitochondrial dysfunctions in the cortex and hippocampus regions of the brain in rodents. However, the impact of hypercholesterolemia on the midbrain dopaminergic neurons in animal models of PD remains elusive. We tested the hypothesis that hypercholesterolemia in MPTP model of PD would potentiate dopaminergic neuron loss in SN by disrupting mitochondrial functions and antioxidant homeostasis. It is evident from the present study that hypercholesterolemia in naive animals caused dopamine neuronal loss in SN with subsequent reduction in striatal dopamine levels producing motor impairment. Moreover, in the MPTP model of PD, hypercholesterolemia exacerbated MPTP-induced reduction of striatal dopamine as well as dopaminergic neurons in SN with motor behavioral depreciation. Activity of mitochondrial complexes, mainly complex-I and III, was impaired severely in the nigrostriatal pathway of hypercholesterolemic animals treated with MPTP. Hypercholesterolemia caused oxidative stress in the nigrostriatal pathway with increased generation of hydroxyl radicals and enhanced activity of antioxidant enzymes, which were further aggravated in the hypercholesterolemic mice with Parkinsonism. In conclusion, our findings provide evidence of increased vulnerability of the midbrain dopaminergic neurons in PD with hypercholesterolemia.	[Paul, Rajib; Choudhury, Amarendranath; Borah, Anupom] Assam Univ, Dept Life Sci & Bioinformat, Cellular & Mol Neurobiol Lab, Silchar, Assam, India; [Kumar, Sanjeev] Assam Univ, Dept Life Sci & Bioinformat, Microbial & Mol Immunol Lab, Silchar, Assam, India; [Giri, Anirudha] Assam Univ, Dept Life Sci & Bioinformat, Environm Toxicol Lab, Silchar, India; [Sandhir, Rajat] Panjab Univ, Dept Biochem, Chandigarh, India	Assam University; Assam University; Assam University; Panjab University	Borah, A (corresponding author), Assam Univ, Dept Life Sci & Bioinformat, Cellular & Mol Neurobiol Lab, Silchar, Assam, India.	anupomborahh@gmail.com	Choudhury, Amarendranath/A-1581-2018; Borah, Anupom/I-2967-2019	Choudhury, Amarendranath/0000-0002-7042-8139; Paul, Rajib/0000-0002-2433-9266; Borah, Anupom/0000-0002-6283-5367; Kumar, Sanjeev/0000-0002-4454-9914	Department of Biotechnology, Government of India [BT/230/NE/TBP/2011]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	We sincerely acknowledge the funding and support provided by Department of Biotechnology, Government of India (Sanction Order No. BT/230/NE/TBP/2011, dated April 23, 2012). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely acknowledge the support provided by the Department of Biotechnology, Government of India (Sanction Order No. BT/230/NE/TBP/2011, dated April 23, 2012).	Aebi H, 1984, Methods Enzymol, V105, P121; ALLAIN CC, 1974, CLIN CHEM, V20, P470; AMBANI LM, 1975, ARCH NEUROL-CHICAGO, V32, P114, DOI 10.1001/archneur.1975.00490440064010; Aytan N, 2008, BIOFACTORS, V33, P225, DOI 10.1002/biof.5520330308; Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Bhattacharjee Nivedita, 2016, Biochem Biophys Rep, V6, P47, DOI 10.1016/j.bbrep.2016.02.013; Bhattacharjee N, 2016, NEUROSCI LETT, V628, P225, DOI 10.1016/j.neulet.2016.06.011; Borah A, 2007, CELL MOL NEUROBIOL, V27, P985, DOI 10.1007/s10571-007-9213-6; Borah A, 2010, NEUROCHEM INT, V56, P357, DOI 10.1016/j.neuint.2009.11.008; Bousquet M, 2012, NEUROBIOL DIS, V45, P529, DOI 10.1016/j.nbd.2011.09.009; Choi JY, 2005, FREE RADICAL BIO MED, V38, P806, DOI 10.1016/j.freeradbiomed.2004.12.008; de Oliveira J, 2011, NEUROSCIENCE, V197, P99, DOI 10.1016/j.neuroscience.2011.09.009; de Oliveira J, 2013, NEUROCHEM RES, V38, P2028, DOI 10.1007/s11064-013-1110-4; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; Di Maio R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3634; Doria M, 2016, FREE RADICAL BIO MED, V101, P393, DOI 10.1016/j.freeradbiomed.2016.10.008; Govindaiah, 2000, DEV BRAIN RES, V124, P117; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Haobam R, 2005, BEHAV BRAIN RES, V163, P159, DOI 10.1016/j.bbr.2005.04.011; Hu G, 2008, NEUROLOGY, V70, P1972, DOI 10.1212/01.wnl.0000312511.62699.a8; Hu G, 2006, NEUROLOGY, V67, P1955, DOI 10.1212/01.wnl.0000247052.18422.e5; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Karuppagounder SS, 2013, NEUROSCIENCE, V236, P136, DOI 10.1016/j.neuroscience.2013.01.032; Knight EM, 2014, NEUROBIOL AGING, V35, P1821, DOI 10.1016/j.neurobiolaging.2014.02.010; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Marwarha G, 2011, J NEUROCHEM, V119, P1119, DOI 10.1111/j.1471-4159.2011.07497.x; Mazumder MK, 2013, CNS NEUROSCI THER, V19, P596, DOI 10.1111/cns.12113; Mazumder MK, 2016, LIFE SCI, V161, P27, DOI 10.1016/j.lfs.2016.07.020; Mazzoni P, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009282; Medeiros MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146129; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Meredith GE, 2011, J PARKINSON DIS, V1, P19, DOI 10.3233/JPD-2011-11023; Naskar A, 2015, J PINEAL RES, V58, P262, DOI 10.1111/jpi.12212; Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762; Pandey M, 2008, J NEUROCHEM, V104, P420, DOI 10.1111/j.1471-4159.2007.04996.x; Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; Paul R, 2016, BBA-GEN SUBJECTS, V1860, P1989, DOI 10.1016/j.bbagen.2016.06.018; Paul R, 2015, NEUROCHEM INT, V90, P125, DOI 10.1016/j.neuint.2015.07.025; Pearce RKB, 1997, J NEURAL TRANSM, V104, P661, DOI 10.1007/BF01291884; Prabhakara JPR, 2008, J NEUROCHEM, V107, P1722, DOI 10.1111/j.1471-4159.2008.05736.x; Prasanthi JRP, 2010, FREE RADICAL BIO MED, V49, P1212, DOI 10.1016/j.freeradbiomed.2010.07.007; Przedborski S, 1998, MOVEMENT DISORD, V13, P35; Rabot S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32484; Rao WW, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050516; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sindhu KM, 2006, PHARMACOL BIOCHEM BE, V84, P321, DOI 10.1016/j.pbb.2006.05.017; Tapias V, 2010, J NEUROSCI RES, V88, P420, DOI 10.1002/jnr.22201; Taylor TN, 2010, BEHAV BRAIN RES, V211, P1, DOI 10.1016/j.bbr.2010.03.004; Thomas B, 2004, J PINEAL RES, V36, P25, DOI 10.1046/j.1600-079X.2003.00096.x; Toyama K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10844; Tripathy D, 2014, CNS NEUROSCI THER, V20, P717, DOI 10.1111/cns.12295; Ullrich C, 2010, MOL CELL NEUROSCI, V45, P408, DOI 10.1016/j.mcn.2010.08.001; WEBER AF, 1956, J HISTOCHEM CYTOCHEM, V4, P308, DOI 10.1177/4.4.308; Wey MCY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031522; Zhu CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144983	59	54	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171285	10.1371/journal.pone.0171285	http://dx.doi.org/10.1371/journal.pone.0171285			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170429	Green Published, gold, Green Submitted			2022-12-26	WOS:000393705500029
J	Huang, WC; Tsai, HC; Tao, CW; Chen, JS; Shih, YJ; Kao, PM; Huang, TY; Hsu, BM				Huang, Wen-Chien; Tsai, Hsin-Chi; Tao, Chi-Wei; Chen, Jung-Sheng; Shih, Yi-Jia; Kao, Po-Min; Huang, Tung-Yi; Hsu, Bing-Mu			Approach to determine the diversity of Legionella species by nested PCR-DGGE in aquatic environments	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; POLYMERASE-CHAIN-REACTION; 16S RIBOSOMAL-RNA; DNA-EXTRACTION; COMMUNITIES; GENES; SOIL; PNEUMOPHILA; BACTERIA; PRIMERS	In this study, we describe a nested PCR-DGGE strategy to detect Legionella communities from river water samples. The nearly full-length 16S rRNA gene was amplified using bacterial primer in the first step. After, the amplicons were employed as DNA templates in the second PCR using Legionella specific primer. The third round of gene amplification was conducted to gain PCR fragments apposite for DGGE analysis. Then the total numbers of amplified genes were observed in DGGE bands of products gained with primers specific for the diversity of Legionella species. The DGGE patterns are thus potential for a high-throughput preliminary determination of aquatic environmental Legionella species before sequencing. Comparative DNA sequence analysis of excised DGGE unique band patterns showed the identity of the Legionella community members, including a reference profile with two pathogenic species of Legionella strains. In addition, only members of Legionella pneumophila and uncultured Legionella sp. were detected. Development of three step nested PCR-DGGE tactic is seen as a useful method for studying the diversity of Legionella community. The method is rapid and provided sequence information for phylogenetic analysis.	[Huang, Wen-Chien] Mackay Med Coll, Dept Med, Taipei, Taiwan; [Huang, Wen-Chien] Mackay Mem Hosp, Dept Thorac Surg, Taipei, Taiwan; [Huang, Wen-Chien] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Tsai, Hsin-Chi] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Tsai, Hsin-Chi] Tzu Chi Gen Hosp, Dept Psychiat, Hualien, Taiwan; [Tao, Chi-Wei] Cheng Hsin Gen Hosp, Sect Resp Therapy, Taipei, Taiwan; [Chen, Jung-Sheng] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Shih, Yi-Jia; Kao, Po-Min; Huang, Tung-Yi; Hsu, Bing-Mu] Natl Chung Cheng Univ, Dept Earth & Environm Sci, Chiayi, Taiwan	Mackay Medical College; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Cheng Hsin General Hospital; National Defense Medical Center; National Chung Cheng University	Hsu, BM (corresponding author), Natl Chung Cheng Univ, Dept Earth & Environm Sci, Chiayi, Taiwan.	bmhsu@ccu.edu.tw	Hsu, Bing-Mu/AAN-5768-2021; Chen, Jung-Sheng/GWR-2603-2022	Hsu, Bing-Mu/0000-0002-2988-8408; Shih, YiJia/0000-0001-9571-2171; Chen, Jung-Sheng/0000-0003-3187-9479	Mackay Medicine College and Hospital [105DMH0100139]; Ministry of Science and Technology of Republic of China (Taiwan) [MOST 104-2116-M-194-011]	Mackay Medicine College and Hospital; Ministry of Science and Technology of Republic of China (Taiwan)	This research was supported by grants from the Mackay Medicine College and Hospital (105DMH0100139), entitle by WCH and Ministry of Science and Technology of Republic of China (Taiwan) (MOST 104-2116-M-194-011), entitle by BMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeleke AA, 2001, INT J SYST EVOL MICR, V51, P1151, DOI 10.1099/00207713-51-3-1151; Boon N, 2002, FEMS MICROBIOL ECOL, V39, P101, DOI 10.1111/j.1574-6941.2002.tb00911.x; Cirillo JD, 1999, INFECT IMMUN, V67, P4427, DOI 10.1128/IAI.67.9.4427-4434.1999; Dar SA, 2005, APPL ENVIRON MICROB, V71, P2325, DOI 10.1128/AEM.71.5.2325-2330.2005; DROZANSKI W., 1956, ACTA MICROBIOL POLONICA, V5, P315; DROZANSKI WJ, 1991, INT J SYST BACTERIOL, V41, P82, DOI 10.1099/00207713-41-1-82; ElFantroussi S, 1997, APPL ENVIRON MICROB, V63, P806, DOI 10.1128/AEM.63.2.806-811.1997; ERB RW, 1993, APPL ENVIRON MICROB, V59, P4065, DOI 10.1128/AEM.59.12.4065-4073.1993; Fritsche TR, 1998, FEMS MICROBIOL LETT, V166, P231, DOI 10.1111/j.1574-6968.1998.tb13895.x; Heuer H., 1997, Modern soil microbiology., P353; La Scola B, 2001, J CLIN MICROBIOL, V39, P365, DOI 10.1128/JCM.39.1.365-366.2001; Levesque MJ, 1997, APPL MICROBIOL BIOT, V47, P719, DOI 10.1007/s002530051001; Liu YC, 1985, J FORMOS MED ASSOC, P1180; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Phillips CJ, 2000, APPL ENVIRON MICROB, V66, P5410, DOI 10.1128/AEM.66.12.5410-5418.2000; Pulawska J, 2005, J APPL MICROBIOL, V98, P710, DOI 10.1111/j.1365-2672.2004.02503.x; Regeard C, 2004, J MICROBIOL METH, V56, P107, DOI 10.1016/j.mimet.2003.09.019; ROSSEN L, 1992, INT J FOOD MICROBIOL, V17, P37, DOI 10.1016/0168-1605(92)90017-W; ROWBOTHAM TJ, 1986, ISRAEL J MED SCI, V22, P678; Shen SM, 2015, PATHOG GLOB HEALTH, V109, P236, DOI 10.1179/2047773215Y.0000000023; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Temmerman R, 2003, APPL ENVIRON MICROB, V69, P6380, DOI 10.1128/AEM.69.11.6380-6385.2003; World Health Organization, 2007, LEGIONELLA PREVENTIO	23	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170992	10.1371/journal.pone.0170992	http://dx.doi.org/10.1371/journal.pone.0170992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166249	Green Published, gold, Green Submitted			2022-12-26	WOS:000393700100017
J	Reynaud, Y; Zheng, C; Wu, GH; Sun, Q; Rastogi, N				Reynaud, Yann; Zheng, Chao; Wu, Guihui; Sun, Qun; Rastogi, Nalin			Bayesian population structure analysis reveals presence of phylogeographically specific sublineages within previously ill-defined T group of Mycobacterium tuberculosis	PLOS ONE			English	Article							GENETIC DIVERSITY; DRUG SUSCEPTIBILITY; COMPUTER-PROGRAM; DATABASE; IDENTIFICATION; ETHIOPIA; NUMBER	Mycobacterium tuberculosis genetic structure, and evolutionary history have been studied for years by several genotyping approaches, but delineation of a few sublineages remains controversial and needs better characterization. This is particularly the case of T group within lineage 4 (L4) which was first described using spoligotyping to pool together a number of strains with ill-defined signatures. Although T strains were not traditionally considered as a real phylogenetic group, they did contain a few phylogenetically meaningful sublineages as shown using SNPs. We therefore decided to investigate if this observation could be corroborated using other robust genetic markers. We consequently made a first assessment of genetic structure using 24-loci MIRU-VNTRs data extracted from the SITVIT2 database (n = 607 clinical isolates collected in Russia, Albania, Turkey, Iraq, Brazil and China). Combining Minimum Spanning Trees and Bayesian population structure analyses (using STRUCTURE and TESS softwares), we distinctly identified eight tentative phylogenetic groups (T1-T8) with a remarkable correlation with geographical origin. We further compared the present structure observed with other L4 sublineages (n = 416 clinical isolates belonging to LAM, Haarlem, X, S sublineages), and showed that 5 out of 8 T groups seemed phylogeographically well-defined as opposed to the remaining 3 groups that partially mixed with other L4 isolates. These results provide with novel evidence about phylogeographically specificity of a proportion of ill-defined T group of M. tuberculosis. The genetic structure observed will now be further validated on an enlarged worldwide dataset using Whole Genome Sequencing (WGS).	[Reynaud, Yann; Zheng, Chao; Rastogi, Nalin] Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranat TB Reference Lab, Morne Joliviere Abymes, Guadeloupe, France; [Zheng, Chao; Sun, Qun] Sichuan Univ, Coll Life Sci, Chengdu, Sichuan, Peoples R China; [Wu, Guihui] Chengdu Publ Hlth Clin Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University	Reynaud, Y; Rastogi, N (corresponding author), Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranat TB Reference Lab, Morne Joliviere Abymes, Guadeloupe, France.	yreynaud@pasteur-guadeloupe.fr; nrastogi@pasteur-guadeloupe.fr	RASTOGI, NALIN/AAP-1958-2020; Reynaud, Yann/ABD-7936-2021	RASTOGI, NALIN/0000-0002-7199-7747; Reynaud, Yann/0000-0002-1966-7249	European Regional Development Fund and European Social Fund (ERDF-ESF); Institut Pasteur International Network; China Scholarship Council (CSC) [201506240129]	European Regional Development Fund and European Social Fund (ERDF-ESF); Institut Pasteur International Network; China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by the European Regional Development Fund and European Social Fund (ERDF-ESF) under the scheme "Programme Operationnel FEDER-FSE Guadeloupe Conseil Regional 2014-2020" (Grant number pending). Yann Reynaud was awarded a Calmette and Yersin postdoctoral fellowship by the Institut Pasteur International Network. Chao Zheng was financially supported by China Scholarship Council (CSC, File NO.201506240129) under a co-training program for the fulfillment of his PhD research program between College of Life Sciences, Sichuan University, Chengdu, China, and Tuberculosis and Mycobacteria Unit, Institut Pasteur de la Guadeloupe.	Afanas'ev MV, 2011, EUR J CLIN MICROBIOL, V30, P181, DOI 10.1007/s10096-010-1067-z; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Amante C, NGDC24 NOAA NESDIS; Bouza E, 2005, ANAL MYCOBACTERIUM T, V43, P1797, DOI [10.1128/JCM.43.4.1797-1806.2005, DOI 10.1128/JCM.43.4.1797-1806.2005]; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Chen L, 2012, J CLIN MICROBIOL, V50, P1043, DOI 10.1128/JCM.06095-11; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dong H, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1155/2012/901842; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; HERMANS PWM, 1995, J INFECT DIS, V171, P1504, DOI 10.1093/infdis/171.6.1504; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lari N, 2005, J CLIN MICROBIOL, V43, P1617, DOI 10.1128/JCM.43.4.1617-1624.2005; Liu Q, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-288; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Mustafa Ali R, 2014, BIOMED RES INT, V2014, P1806, DOI [10.1093/bioinformatics/btm233, DOI 10.1093/BIOINFORMATICS/BTM233]; Ohata Ritsuko, 2004, Kekkaku, V79, P47; Olsen LR, 2013, J IMMUNOL METHODS, V400, P37, DOI 10.1016/j.jim.2013.08.014; Ozkara S, 2015, MIKROBIYOL BUL, V49, P143; Perdigao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-991; Pritchard JK, 2000, GENETICS, V155, P945; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tessema B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-131; Valcheva V, 2015, INT J MYCOBACT, V4, P191, DOI 10.1016/j.ijmyco.2015.04.003; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Zhang D, 2013, INFECT GENET EVOL, V13, P310, DOI 10.1016/j.meegid.2012.10.008; Zheng C, 2015, J CLIN MICROBIOL, V53, P2138, DOI 10.1128/JCM.03507-14	41	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171584	10.1371/journal.pone.0171584	http://dx.doi.org/10.1371/journal.pone.0171584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166309	Green Submitted, Green Published, gold			2022-12-26	WOS:000393700100055
J	Kelcher, AMH; Atanga, PA; Gamez, JD; Garcia, LMC; Teclaw, SJ; Pavelko, KD; Macura, SI; Johnson, AJ				Kelcher, April M. Huseby; Atanga, Pascal A.; Gamez, Jeffrey D.; Garcia, Luz M. Cumba; Teclaw, Stephanie J.; Pavelko, Kevin D.; Macura, Slobodan I.; Johnson, Aaron J.			Brain atrophy in picornavirus-infected FVB mice is dependent on the H-2D(b) class I molecule	FASEB JOURNAL			English	Article						neurodegeneration; MHC class I; viral clearance; TMEV; CD8 T cells	THEILERS VIRUS-INFECTION; T-CELL RESPONSE; RELAPSING MULTIPLE-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; MHC CLASS-I; INDUCED DEMYELINATION; PERSISTENT INFECTION; MURINE MODEL; AXONAL LOSS; PLASTICITY	Brain atrophy is a common feature of numerous neurologic diseases in which the role of neuro-inflammation remains ill-defined. In this study, we evaluated the contribution of major histocompatibility complex class I molecules to brain atrophy in Theiler's murine encephalomyelitis virus (TMEV)-infected transgenic FVB mice that express the D-b class I molecule. FVB/D-b and wild-type FVB mice were evaluated for changes in neuro-inflammation, virus clearance, neuropathology, and development of brain atrophy via T2-weighted MRI and subsequent 3-dimensional volumetric analysis. Significant brain atrophy and hippocampal neuronal loss were observed in TMEV-infected FVB/Db mice, but not in wild-type FVB mice. Brain atrophy was observed at 1 mo postinfection and persisted through the 4-mo observation period. Of importance, virus-infected FVB/D-b mice elicited a strong CD8 T-cell response toward the immunodominant D-b-restricted TMEV-derived peptide, VP2(121-130), and cleared TMEV from the CNS. In addition, immunofluorescence revealed CD8 T cells near virus-infected neurons; therefore, we hypothesize that class I restricted CD8 T-cell responses promote development of brain atrophy. This model provides an opportunity to analyze the contribution of immune cells to brain atrophy in a system where persistent virus infection and demyelination are not factors in long-term neuropathology.	[Kelcher, April M. Huseby; Garcia, Luz M. Cumba] Mayo Clin, Grad Sch Biomed Sci, Rochester, MN USA; [Kelcher, April M. Huseby; Garcia, Luz M. Cumba; Teclaw, Stephanie J.; Pavelko, Kevin D.; Johnson, Aaron J.] Mayo Clin, Dept Immunol, Guggenheim 4-11C,200 First St SW, Rochester, MN 55905 USA; [Atanga, Pascal A.; Gamez, Jeffrey D.; Johnson, Aaron J.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Macura, Slobodan I.] Mayo Clin, Nucl Magnet Resonance Core Facil, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Johnson, AJ (corresponding author), Mayo Clin, Dept Immunol, Guggenheim 4-11C,200 First St SW, Rochester, MN 55905 USA.	johnson.aaron2@mayo.edu	Pavelko, Kevin D/K-7072-2019	Pavelko, Kevin D/0000-0001-7555-1315; Huseby Kelcher, April/0000-0002-9665-2921	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke [R21 NS094765]; NIH [T32 AI07425-20]; Mayo Graduate School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS094765] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank and acknowledge the contributions of their former collaborator, Dr. Istvan Pirko (Department of Neurology, Mayo Clinic), who they will miss. The authors also thank Dr. Yong Guo (Department of Neurology, Mayo Clinic), for help with the histology aspects of this study. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant R21 NS094765 and intramural funds, as well as funding from NIH Ph.D. Training Grant in Basic Immunology (T32 AI07425-20) and the Mayo Graduate School. The authors declare no conflicts of interest.	ALTINTAS A, 1993, J IMMUNOL, V151, P2803; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; AZOULAY A, 1994, J VIROL, V68, P4049, DOI 10.1128/JVI.68.6.4049-4052.1994; Azoulay-Cayla A, 2001, J GEN VIROL, V82, P1043, DOI 10.1099/0022-1317-82-5-1043; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Brahic M, 2005, ANNU REV MICROBIOL, V59, P279, DOI 10.1146/annurev.micro.59.030804.121242; Chataway J, 2014, LANCET, V383, P2213, DOI 10.1016/S0140-6736(13)62242-4; Constantinescu SE, 2016, EXPERT REV CLIN PHAR, V9, P49, DOI 10.1586/17512433.2016.1108189; Dell'Orco JM, 2015, J NEUROSCI, V35, P11292, DOI 10.1523/JNEUROSCI.1357-15.2015; Denic Aleksandar, 2011, Pathophysiology, V18, P21, DOI 10.1016/j.pathophys.2010.04.004; Elmer BM, 2012, TRENDS NEUROSCI, V35, P660, DOI 10.1016/j.tins.2012.08.001; Farid N, 2012, RADIOLOGY, V264, P542, DOI 10.1148/radiol.12112638; Garcia LMC, 2016, J IMMUNOL METHODS, V439, P23, DOI 10.1016/j.jim.2016.09.002; Hainke U, 2016, EXPERT OPIN DRUG MET, V12, P701, DOI 10.1080/17425255.2016.1179279; Johnson AJ, 2007, INT REV NEUROBIOL, V79, P73, DOI 10.1016/S0074-7742(07)79004-9; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Johnson AJ, 2001, FASEB J, V15, P2760, DOI 10.1096/fj.01-0373fje; Johnson HL, 2012, J IMMUNOL, V189, P1937, DOI 10.4049/jimmunol.1200658; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Lee HM, 2014, NATURE, V509, P195, DOI 10.1038/nature13154; Likeman M, 2005, ARCH NEUROL-CHICAGO, V62, P1410, DOI 10.1001/archneur.62.9.1410; Lin XQ, 2002, J VIROL, V76, P7799, DOI 10.1128/JVI.76.15.7799-7811.2002; Mandolesi G, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.222; McDole J, 2006, NEUROL RES, V28, P256, DOI 10.1179/016164106X98125; McDole JR, 2010, AM J PATHOL, V177, P1823, DOI 10.2353/ajpath.2010.100231; McGavern DB, 1999, J NEUROSCI RES, V58, P492, DOI 10.1002/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P; McGavern DB, 2000, BRAIN, V123, P519, DOI 10.1093/brain/123.3.519; Mendez-Fernandez YV, 2005, J VIROL, V79, P3063, DOI 10.1128/JVI.79.5.3063-3070.2005; Mendez-Fernandez YV, 2003, EUR J IMMUNOL, V33, P2501, DOI 10.1002/eji.200324007; Miller SD, 2001, ADV EXP MED BIOL, V490, P99; Pavelko KD, 2007, BRAIN PATHOL, V17, P184, DOI 10.1111/j.1750-3639.2007.00062.x; Pavelko KD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002541; Pavelko KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020217; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Petito CK, 2006, J NEUROVIROL, V12, P272, DOI 10.1080/13550280600879204; Pirko I, 2011, NEUROIMAGE, V54, P802, DOI 10.1016/j.neuroimage.2010.08.055; Pirko I, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-31; Reed BK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137984; ROBB RA, 1989, IEEE T MED IMAGING, V8, P217, DOI 10.1109/42.34710; RODRIGUEZ M, 1985, J IMMUNOL, V135, P2145; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Siffrin V, 2010, TRENDS NEUROSCI, V33, P202, DOI 10.1016/j.tins.2010.01.002; Stadelmann C, 2011, CURR OPIN NEUROL, V24, P224, DOI 10.1097/WCO.0b013e328346056f; Tsunoda I, 2010, J NEUROIMMUNE PHARM, V5, P355, DOI 10.1007/s11481-009-9179-x; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; Zamolodchikov D, 2016, THROMB RES, V141, pS59, DOI 10.1016/S0049-3848(16)30367-X	47	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2267	2275		10.1096/fj.201601055R	http://dx.doi.org/10.1096/fj.201601055R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28188174	Green Published			2022-12-26	WOS:000401553400005
J	Safar, F; Hurdiss, E; Erotocritou, M; Greiner, T; Lape, R; Irvine, MW; Fang, GY; Jane, D; Yu, RL; Damgen, MA; Biggin, PC; Sivilotti, LG				Safar, Fatemah; Hurdiss, Elliot; Erotocritou, Marios; Greiner, Timo; Lape, Remigijus; Irvine, Mark W.; Fang, Guangyu; Jane, David; Yu, Rilei; Damgen, Marc A.; Biggin, Philip C.; Sivilotti, Lucia G.			The Startle Disease Mutation E103K Impairs Activation of Human Homomeric alpha 1 Glycine Receptors by Disrupting an Intersubunit Salt Bridge across the Agonist Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; SINGLE-CHANNEL; INTERMEDIATE STATES; FORCE-FIELD; MECHANISM; VALIDATION; DOMAIN; RECOGNITION; PRINCIPLES; MODEL	Glycine receptors (GlyR) belong to the pentameric ligandgated ion channel (pLGIC) superfamily and mediate fast inhibitory transmission in the vertebrate CNS. Disruption of glycinergic transmission by inherited mutations produces startle disease in man. Many startle mutations are in GlyRs and provide useful clues to the function of the channel domains. E103K is one of few startle mutations found in the extracellular agonist binding site of the channel, in loop A of the principal side of the subunit interface. Homology modeling shows that the side chain of Glu-103 is close to that of Arg-131, in loop E of the complementary side of the binding site, and may form a salt bridge at the back of the binding site, constraining its size. We investigated this hypothesis in recombinant human alpha 1 GlyR by site directed mutagenesis and functional measurements of agonist efficacy and potency by whole cell patch clamp and single channel recording. Despite its position near the binding site, E103K causes hyperekplexia by impairing the efficacy of glycine, its ability to gate the channel once bound, which is very high in wild type GlyR. Mutating Glu-103 and Arg-131 caused various degrees of loss-of-function in the action of glycine, whereas mutations in Arg-131 enhanced the efficacy of the slightly bigger partial agonist sarcosine (N-methylglycine). The effects of the single charge-swapping mutations of these two residues were largely rescued in the double mutant, supporting the possibility that they interact via a salt bridge that normally constrains the efficacy of larger agonist molecules.	[Safar, Fatemah; Hurdiss, Elliot; Erotocritou, Marios; Greiner, Timo; Lape, Remigijus; Sivilotti, Lucia G.] UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England; [Yu, Rilei; Damgen, Marc A.; Biggin, Philip C.] Univ Oxford, Dept Biochem Struct Bioinformat & Computat Bioche, South Parks Rd, Oxford OX1 3QU, England; [Irvine, Mark W.; Fang, Guangyu; Jane, David] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Yu, Rilei] Ocean Univ China, Sch Med & Pharm, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao 266003, Peoples R China	University of London; University College London; University of Oxford; University of Bristol; Ocean University of China	Sivilotti, LG (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	l.sivilotti@ucl.ac.uk	Greiner, Timo/Y-1900-2019; Lape, Remigijus/C-6175-2008; Erotocritou, Marios/HHN-1342-2022; Yu, Rilei/G-2353-2014	Greiner, Timo/0000-0002-0909-570X; Lape, Remigijus/0000-0002-6604-0828; Yu, Rilei/0000-0001-6625-2014; Biggin, Philip/0000-0001-5100-8836; Irvine, Mark/0000-0001-9321-1867	Medical Research Council [MR/J007110/1]; Kuwaiti state scholarship; UCL Impact studentship; Oxford Wolfson Marriott Biochemistry Graduate Scholarship; Studienstiftung des deutschen Volkes; MRC [MR/J007110/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kuwaiti state scholarship; UCL Impact studentship; Oxford Wolfson Marriott Biochemistry Graduate Scholarship; Studienstiftung des deutschen Volkes; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Medical Research Council Project Grant MR/J007110/1 ( to L. G. S. and P. C. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Kuwaiti state scholarship.; Supported by a UCL Impact studentship (to L. G. S.).; Supported by an Oxford Wolfson Marriott Biochemistry Graduate Scholarship and the Studienstiftung des deutschen Volkes.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Beato M, 2004, J NEUROSCI, V24, P895, DOI 10.1523/JNEUROSCI.4420-03.2004; Beato M, 2008, J NEUROSCI, V28, P7412, DOI 10.1523/JNEUROSCI.0581-08.2008; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berendsen H.J.C., 2007, SIMULATING PHYS WORL; Bode A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-2; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Jong DH, 2016, COMPUT PHYS COMMUN, V199, P1, DOI 10.1016/j.cpc.2015.09.014; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; GALZI JL, 1995, NEUROPHARMACOLOGY, V34, P563, DOI 10.1016/0028-3908(95)00034-4; Groot-Kormelink PJ, 2002, J NEUROSCI METH, V113, P207, DOI 10.1016/S0165-0270(01)00500-3; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Jadey S, 2012, J GEN PHYSIOL, V140, P17, DOI 10.1085/jgp.201210801; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jambeck JPM, 2013, J CHEM THEORY COMPUT, V9, P774, DOI 10.1021/ct300777p; Jambeck JPM, 2012, J CHEM THEORY COMPUT, V8, P2938, DOI 10.1021/ct300342n; Jambeck JPM, 2012, J PHYS CHEM B, V116, P3164, DOI 10.1021/jp212503e; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lape R, 2012, J NEUROSCI, V32, P1336, DOI 10.1523/JNEUROSCI.4346-11.2012; Lewis TM, 1998, J PHYSIOL-LONDON, V507, P25, DOI 10.1111/j.1469-7793.1998.025bu.x; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lynagh T, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00160; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Moorhouse AJ, 1999, MOL PHARMACOL, V55, P386, DOI 10.1124/mol.55.2.386; Moroni M, 2011, J BIOL CHEM, V286, P13414, DOI 10.1074/jbc.M110.204610; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pless SA, 2008, J NEUROSCI, V28, P10937, DOI 10.1523/JNEUROSCI.2540-08.2008; Plested AJR, 2007, J PHYSIOL-LONDON, V581, P51, DOI 10.1113/jphysiol.2006.126920; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmieden V, 1999, MOL PHARMACOL, V56, P464, DOI 10.1124/mol.56.3.464; Schrodinger LLC, 2013, MAESTR VERS 9 5; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sivilotti L, 2016, J GEN PHYSIOL, V148, P79, DOI 10.1085/jgp.201611649; Sivilotti LG, 2010, J PHYSIOL-LONDON, V588, P45, DOI 10.1113/jphysiol.2009.178525; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wassenaar TA, 2015, J CHEM THEORY COMPUT, V11, P2144, DOI 10.1021/acs.jctc.5b00209; Wassenaar TA, 2014, J CHEM THEORY COMPUT, V10, P676, DOI 10.1021/ct400617g; Wilkins ME, 2016, J PHYSIOL-LONDON, V594, P3589, DOI 10.1113/JP272122; Yu RL, 2014, BIOCHEMISTRY-US, V53, P6041, DOI 10.1021/bi500815f; Zhang HX, 2009, NEUROPHARMACOLOGY, V57, P551, DOI 10.1016/j.neuropharm.2009.07.019; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	58	6	6	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5031	5042		10.1074/jbc.M116.767616	http://dx.doi.org/10.1074/jbc.M116.767616			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28174298	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000397590400024
J	Jespersen, D; Belanger, FC; Huang, BR				Jespersen, David; Belanger, Faith C.; Huang, Bingru			Candidate genes and molecular markers associated with heat tolerance in colonial Bentgrass	PLOS ONE			English	Article							THERMAL AGROSTIS-SCABRA; INDUCED LEAF SENESCENCE; CREEPING BENTGRASS; DOLLAR SPOT; DROUGHT TOLERANCE; SHOCK PROTEINS; LINKAGE MAP; STRESS; IDENTIFICATION; EXPRESSION	Elevated temperature is a major abiotic stress limiting the growth of cool-season grasses during the summer months. The objectives of this study were to determine the genetic variation in the expression patterns of selected genes involved in several major metabolic pathways regulating heat tolerance for two genotypes contrasting in heat tolerance to confirm their status as potential candidate genes, and to identify PCR-based markers associated with candidate genes related to heat tolerance in a colonial (Agrostis capillaris L.) x creeping bentgrass (Agrostis stolonifera L.) hybrid backcross population. Plants were subjected to heat stress in controlled-environmental growth chambers for phenotypic evaluation and determination of genetic variation in candidate gene expression. Molecular markers were developed for genes involved in protein degradation (cysteine protease), antioxidant defense (catalase and glutathione-S-transferase), energy metabolism (glyceraldehyde-3-phosphate dehydrogenase), cell expansion (expansin), and stress protection (heat shock proteins HSP26, HSP70, and HSP101). Kruskal-Wallis analysis, a commonly used non parametric test used to compare population individuals with or without the gene marker, found the physiological traits of chlorophyll content, electrolyte leakage, normalized difference vegetative index, and turf quality were associated with all candidate gene markers with the exception of HSP101. Differential gene expression was frequently found for the tested candidate genes. The development of candidate gene markers for important heat tolerance genes may allow for the development of new cultivars with increased abiotic stress tolerance using marker-assisted selection.	[Jespersen, David; Belanger, Faith C.; Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA; [Jespersen, David] Univ Georgia, Dept Crop & Soil Sci, Griffin, GA USA	Rutgers State University New Brunswick; University System of Georgia; University of Georgia	Huang, BR (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.	Huang@aesop.rutgers.edu			United States Golf Association; New Jersey Agricultural Experimental Station	United States Golf Association; New Jersey Agricultural Experimental Station	This work was supported by the United States Golf Association and the New Jersey Agricultural Experimental Station for funding support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Beard J. B., 1972, TURFGRASS SCI CULTUR; Belanger FC, 2004, CROP SCI, V44, P581, DOI 10.2135/cropsci2004.5810; Belanger FC, 2003, CROP SCI, V43, P2172, DOI 10.2135/cropsci2003.2172; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; CARROW RN, 1996, GOLF COURSE MANAG, V64, P51; Chakraborty N, 2014, HORTIC ENVIRON BIOTE, V55, P329, DOI 10.1007/s13580-014-0015-8; Chen GH, 2002, PLANT CELL PHYSIOL, V43, P984, DOI 10.1093/pcp/pcf125; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; DaCosta M, 2007, J AM SOC HORTIC SCI, V132, P60, DOI 10.21273/JASHS.132.1.60; Fenstermaker-Shaulis L. K., 1997, Journal of Turfgrass Management, V2, P65, DOI 10.1300/J099v02n01_06; Guo Y, 2013, THEOR APPL GENET, V126, P1445, DOI 10.1007/s00122-013-2063-3; He YL, 2005, J AM SOC HORTIC SCI, V130, P521, DOI 10.21273/JASHS.130.4.521; Hendrick JP, 1995, FASEB J, V9, P1559, DOI 10.1096/fasebj.9.15.8529835; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Honig JA, 2014, MOL BREEDING, V34, P185, DOI 10.1007/s11032-014-0029-z; Jespersen D, 2013, INT TURFS SOC RES J, V12, P459; Jespersen D, 2015, CROP SCI, V55, P837, DOI 10.2135/cropsci2014.04.0335; Jespersen D, 2015, PROTEOMICS, V15, P798, DOI 10.1002/pmic.201400393; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lee DG, 2007, PROTEOMICS, V7, P3369, DOI 10.1002/pmic.200700266; Marcum KB, 1998, CROP SCI, V38, P1214, DOI 10.2135/cropsci1998.0011183X003800050017x; McCauley DE, 2003, MOL ECOL, V12, P777, DOI 10.1046/j.1365-294X.2003.01764.x; Merewitz EB, 2012, CROP SCI, V52, P1891, DOI 10.2135/cropsci2012.01.0037; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Pelleschi S, 1999, PLANT MOL BIOL, V39, P373, DOI 10.1023/A:1006116310463; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Pootakham W, 2015, GENOMICS, V105, P288, DOI 10.1016/j.ygeno.2015.02.002; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Quint M, 2002, THEOR APPL GENET, V105, P355, DOI 10.1007/s00122-002-0953-x; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Rotter D, 2012, PLANT BREEDING, V131, P193, DOI 10.1111/j.1439-0523.2011.01891.x; Rotter D, 2009, CROP SCI, V49, P1609, DOI 10.2135/cropsci2008.12.0714; SAS Institute, 1992, SAS STAT 9 2 US GUID; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiel T, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh006; THOMAS H, 1980, ANNU REV PLANT PHYS, V31, P83, DOI 10.1146/annurev.pp.31.060180.000503; Thudi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096758; Tian J, 2009, J PLANT PHYSIOL, V166, P588, DOI 10.1016/j.jplph.2008.09.003; Tondelli A, 2006, THEOR APPL GENET, V112, P445, DOI 10.1007/s00122-005-0144-7; TURGEON AJ, 1999, TURFGRASS MANAGEMENT; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Veerasamy M, 2007, J AM SOC HORTIC SCI, V132, P467, DOI 10.21273/JASHS.132.4.467; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Xu CP, 2010, PHYSIOL PLANTARUM, V139, P192, DOI 10.1111/j.1399-3054.2010.01357.x; Xu CP, 2008, J EXP BOT, V59, P4183, DOI 10.1093/jxb/ern258; Xu JC, 2007, J EXP BOT, V58, P3789, DOI 10.1093/jxb/erm229; Xu QZ, 2004, CROP SCI, V44, P553, DOI 10.2135/cropsci2004.0553; Xu Y, 2010, J EXP BOT, V61, P3273, DOI 10.1093/jxb/erq149; YANG YJ, 1993, PLANT PHYSIOL, V101, P209, DOI 10.1104/pp.101.1.209; Yu XQ, 2013, J EXP BOT, V64, P1537, DOI 10.1093/jxb/ert018; Zhou P, 2011, CROP SCI, V51, P333, DOI 10.2135/cropsci2010.07.0391	56	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171183	10.1371/journal.pone.0171183	http://dx.doi.org/10.1371/journal.pone.0171183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187136	gold, Green Published			2022-12-26	WOS:000394244300013
J	Turner, AH; Pritchard, AC; Matzke, NJ				Turner, Alan H.; Pritchard, Adam C.; Matzke, Nicholas J.			Empirical and Bayesian approaches to fossil only divergence times: A study across three reptile clades	PLOS ONE			English	Article							MOLECULAR TIMESCALES; EARLY EVOLUTION; TERMINAL TAXA; BODY-SIZE; PHYLOGENY; RADIATION; DIVERSIFICATION; CROCODYLIFORMES; CALIBRATIONS; PATTERNS	Estimating divergence times on phylogenies is critical in paleontological and neontological studies. Chronostratigraphically-constrained fossils are the only direct evidence of absolute timing of species divergence. Strict temporal calibration of fossil -only phylogenies provides minimum divergence estimates, and various methods have been proposed to estimate divergences beyond these minimum values. We explore the utility of simultaneous estimation of tree topology and divergence times using BEAST tip-dating on datasets consisting only of fossils by using relaxed morphological clocks and birth -death tree priors that include serial sampling (BDSS) at a constant rate through time. We compare BEAST results to those from the traditional maximum parsimony (MP) and undated Bayesian inference (BI) methods. Three overlapping datasets were used that span 250 million years of archosauromorph evolution leading to crocodylians. The first dataset focuses on early Sauria (31 taxa, 240 chars.), the second on early Archosauria (76 taxa, 400 chars.) and the third on Crocodyliformes (101 taxa, 340 chars.). For each dataset three time -calibrated trees (timetrees) were calculated: a minimum -age timetree with node ages based on earliest occurrences in the fossil record; a 'smoothed' timetree using a range of time added to the root that is then averaged over zero -length internodes; and a tip -dated timetree. Comparisons within data sets show that the smoothed and tip -dated timetrees provide similar estimates. Only near the root node do BEAST estimates fall outside the smoothed timetree range. The BEAST model is not able to overcome limited sampling to correctly estimate divergences considerably older than sampled fossil occurrence dates. Conversely, the smoothed timetrees consistently provide node -ages far older than the strict dates or BEAST estimates for morphologically conservative sister-taxa when they sit on long ghost lineages. In this latter case, the relaxed -clock model appears to be correctly moderating the node -age estimate based on the limited morphological divergence. Topologies are generally similar across analyses, but BEAST trees for crocodyliforms differ when clades are deeply nested but contain very old taxa. It appears that the constant -rate sampling assumption of the BDSS tree prior influences topology inference by disfavoring long, unsampled branches.	[Turner, Alan H.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Pritchard, Adam C.] Yale Univ, Dept Geol, New Haven, CT USA; [Matzke, Nicholas J.] Australian Natl Univ, Div Ecol Evolut & Genet, Res Sch Biol, Canberra, ACT, Australia	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yale University; Australian National University	Turner, AH (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.	alan.turner@stonybrook.edu	Matzke, Nicholas/L-4109-2015	Matzke, Nicholas/0000-0002-8698-7656	National Science Foundation Doctoral Dissertation Improvement Grant Award [DEB 1501851]; NI MBioS fellowship under National Science Foundation Award [EFJ0832858]; Australian Research Council DECRA fellowship [DE150101773]; National Science Foundation [0919124, EAR 1349654, DEB 1257485]; Direct For Biological Sciences [1300426, 1501851] Funding Source: National Science Foundation	National Science Foundation Doctoral Dissertation Improvement Grant Award; NI MBioS fellowship under National Science Foundation Award; Australian Research Council DECRA fellowship(Australian Research Council); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	AHT was supported under National Science Foundation Awards EAR 1349654 and DEB 1257485. ACP was supported under an National Science Foundation Doctoral Dissertation Improvement Grant Award (DEB 1501851) to AHT and ACP. NJM was supported by a NI MBioS fellowship under National Science Foundation Award #EFJ0832858, Australian Research Council DECRA fellowship DE150101773, and his work on BEASTmasteR began while supported by National Science Foundation 0919124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TL, 2014, J PALEONTOL, V88, P1031, DOI 10.1666/12-089; [Anonymous], 2014, TRACER V1 6; Arcila D, 2015, MOL PHYLOGENET EVOL, V82, P131, DOI 10.1016/j.ympev.2014.10.011; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bapst DW, 2014, PALEOBIOLOGY, V40, P331, DOI 10.1666/13033; Bapst DW, 2012, METHODS ECOL EVOL, V3, P803, DOI 10.1111/j.2041-210X.2012.00223.x; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Benton MJ, 2003, SCIENCE, V300, P1698, DOI 10.1126/science.1077795; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Clarke JA, 2008, SYST BIOL, V57, P185, DOI 10.1080/10635150802022231; Close RA, 2015, CURR BIOL, V25, P2137, DOI 10.1016/j.cub.2015.06.047; CODDINGTON J, 1994, CLADISTICS, V10, P415; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Gavryushkina A, SYSTEMATIC IN PRESS; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff Pablo A., 2005, P148; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Heath TA, 2014, P NATL ACAD SCI USA, V111, pE2957, DOI 10.1073/pnas.1319091111; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irmis RB, 2010, EARTH ENV SCI T R SO, V101, P397, DOI 10.1017/S1755691011020068; Irmis RB, 2014, JOURNAL OF VERTEBRAT, V2014, P153; Jouve S, 2009, J VERTEBR PALEONTOL, V29, P88, DOI 10.1080/02724634.2009.10010364; Laurin M, 2004, SYST BIOL, V53, P594, DOI 10.1080/10635150490445706; Lee MSY, 2009, MOL PHYLOGENET EVOL, V50, P661, DOI 10.1016/j.ympev.2008.11.024; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; Lee MSY, 2012, BIOL LETTERS, V8, P299, DOI 10.1098/rsbl.2011.0884; Lee MS, 2009, J EVOLUTIONARY BIOL, V22; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Marshall CR, 2008, AM NAT, V171, P726, DOI 10.1086/587523; MARSHALL CR, 1990, PALEOBIOLOGY, V16, P1, DOI 10.1017/S0094837300009672; Matzke N. J., 2015, BEASTMASTER CODE ARC; Matzke N.J., 2015, BEASTMASTER R TOOLS; Montefeltro FC, 2013, NATURWISSENSCHAFTEN, V100, P835, DOI 10.1007/s00114-013-1083-9; Near TJ, 2005, AM NAT, V165, P137, DOI 10.1086/427734; Nesbitt SJ, 2015, B AM MUS NAT HIST, P1; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Norell MA, 1992, TAXIC ORIGIN TEMPORA, P89; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; OREILLY JE, 2016, BIOL LETT, V12; Parham JF, 2008, AM NAT, V171, P132, DOI 10.1086/524198; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Pol D, 2013, BIOL REV, V88, P862, DOI 10.1111/brv.12030; Pritchard AC, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.911186; Puttick MN, 2016, EVOLUTION, V70, P873, DOI 10.1111/evo.12907; Pyron RA, 2011, SYST BIOL, V60, P466, DOI 10.1093/sysbio/syr047; R Core Team, 2021, R LANGUAGE ENV STAT; RAUP DM, 1984, P NATL ACAD SCI-BIOL, V81, P801, DOI 10.1073/pnas.81.3.801; RAUP DM, 1980, PALEOBIOLOGY, V6, P9, DOI 10.1017/S0094837300012458; Reisz RR, 2004, TRENDS GENET, V20, P237, DOI 10.1016/j.tig.2004.03.007; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Ruta M, 2006, P ROY SOC B-BIOL SCI, V273, P2107, DOI 10.1098/rspb.2006.3577; Sanchez IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143034; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; Simpson G. G., 1944, P1; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Slater GJ, 2015, PROCEEDINGS OF THE N, V112; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Spencer MR, 2013, CLADISTICS, V29, P663, DOI 10.1111/cla.12018; Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110; Stadler T, 2010, J THEOR BIOL, V267, P396, DOI 10.1016/j.jtbi.2010.09.010; Turner AH, 2016, J VERTEBRATE PALE ON, V36; Turner AH, 2013, ANATOMY PHYLOGENY AN, P379; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Turner AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118116; Turner AH, 2015, PEERJ, V3, DOI 10.7717/peerj.759; Turner AH, 2010, J VERTEBR PALEONTOL, V30, P177, DOI 10.1080/02724634.2010.532348; VRBA ES, 1985, S AFR J SCI, V81, P229; Warnock RCM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1013; Wood HM, 2013, SYST BIOL, V62, P264, DOI 10.1093/sysbio/sys092; Wright AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109210; Zhang C, 2016, SYST BIOL, V65, P228, DOI 10.1093/sysbio/syv080	77	29	29	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0169885	10.1371/journal.pone.0169885	http://dx.doi.org/10.1371/journal.pone.0169885			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187191	Green Published, Green Submitted, gold			2022-12-26	WOS:000394244300004
J	Gao, K; Tankovic, A; Zhang, YJ; Kusumoto, H; Zhang, J; Chen, WJ; XiangWei, WS; Shaulsky, GH; Hu, C; Traynelis, SF; Yuan, HJ; Jiang, YW				Gao, Kai; Tankovic, Anel; Zhang, Yujia; Kusumoto, Hirofumi; Zhang, Jin; Chen, Wenjuan; XiangWei, Wenshu; Shaulsky, Gil H.; Hu, Chun; Traynelis, Stephen F.; Yuan, Hongjie; Jiang, Yuwu			A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; GLUTAMATE BINDING-SITE; NMDA RECEPTOR; ZINC INHIBITION; INTELLECTUAL DISABILITY; MOLECULAR DETERMINANTS; SUBUNIT ARRANGEMENT; CHANNEL BLOCK; NR1 SUBUNIT; ION CHANNEL	Objective N-methyl-D-aspartate receptors (NMDAR) subunit GRIN2A/GluN2A mutations have been identified in patients with various neurological diseases, such as epilepsy and intellectual disability / developmental delay (ID/DD). In this study, we investigated the phenotype and underlying molecular mechanism of a GRIN2A missense mutation identified by next generation sequencing on idiopathic focal epilepsy using in vitro electrophysiology. Methods Genomic DNA of patients with epilepsy and ID/DD were sequenced by targeted next-generation sequencing within 300 genes related to epilepsy and ID/DD. The effects of one missense GRIN2A mutation on NMDAR function were evaluated by two-electrode voltage clamp current recordings and whole cell voltage clamp current recordings. Results We identified one de novo missense GRIN2A mutation (Asp731Asn, GluN2A(D731N)) in a child with unexplained epilepsy and DD. The D731N mutation is located in a portion of the agonist-binding domain (ABD) in the GluN2A subunit, which is the binding pocket for agonist glutamate. This residue in the ABD is conserved among vertebrate species and all other NMDAR subunits, suggesting an important role in receptor function. The proband shows developmental delay as well as EEG-confirmed seizure activity. Functional analyses reveal that the GluN2A(D731N) mutation decreases glutamate potency by over 3,000-fold, reduces amplitude of current response, shortens synaptic-like response time course, and decreases channel open probability, while enhancing sensitivity to negative allosteric modulators, including extracellular proton and zinc inhibition. The combined effects reduce NMDAR function. Significance We identified a de novo missense mutation in the GRIN2A gene in a patient with childhood focal epilepsy and acquired epileptic aphasia. The mutant decreases NMDAR activation suggesting NMDAR hypofunction may contribute to the epilepsy pathogenesis.	[Gao, Kai; Zhang, Yujia; XiangWei, Wenshu; Jiang, Yuwu] Peking Univ, Hosp 1, Dept Pediat, Beijing, Peoples R China; [Gao, Kai; Zhang, Yujia; XiangWei, Wenshu; Jiang, Yuwu] Peking Univ, Hosp 1, Pediat Epilepsy Ctr, Beijing, Peoples R China; [Tankovic, Anel; Kusumoto, Hirofumi; Zhang, Jin; Chen, Wenjuan; Shaulsky, Gil H.; Hu, Chun; Traynelis, Stephen F.; Yuan, Hongjie] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Chen, Wenjuan] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Traynelis, Stephen F.; Yuan, Hongjie] Emory Univ, Sch Med, CFERV, Atlanta, GA USA; [Jiang, Yuwu] Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing, Peoples R China; [Zhang, Jin] Shanxi Med Univ, Hosp 1, Dept Neurol, Taiyuan, Peoples R China	Peking University; Peking University; Emory University; Central South University; Emory University; Shanxi Medical University	Jiang, YW (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing, Peoples R China.; Jiang, YW (corresponding author), Peking Univ, Hosp 1, Pediat Epilepsy Ctr, Beijing, Peoples R China.; Yuan, HJ (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.; Jiang, YW (corresponding author), Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing, Peoples R China.	hyuan@emory.edu; jiangyuwu@bjmu.edu.cn	jiang, yu/HGU-0029-2022; Hu, Chun/AAZ-7920-2021	Hu, Chun/0000-0002-0949-9878; Yuan, Hongjie/0000-0002-8127-7145; Shaulsky, Gil/0000-0001-9723-4812	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD082373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS092989] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD082373] Funding Source: Medline; NINDS NIH HHS [R24 NS092989] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAZAWA C, 1994, J COMP NEUROL, V347, P150, DOI 10.1002/cne.903470112; Arning L, 2005, NEUROGENETICS, V6, P25, DOI 10.1007/s10048-004-0198-8; Bagasrawala I, 2016, CEREB CORTEX; Blanpied TA, 1997, J NEUROPHYSIOL, V77, P309, DOI 10.1152/jn.1997.77.1.309; Burnashev N, 2015, CURR OPIN PHARMACOL, V20, P73, DOI 10.1016/j.coph.2014.11.008; Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727; Chen PE, 2005, MOL PHARMACOL, V67, P1470, DOI 10.1124/mol.104.008185; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DeVries SP, 2013, PEDIATR NEUROL, V49, P482, DOI 10.1016/j.pediatrneurol.2013.08.023; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dravid SM, 2007, J PHYSIOL-LONDON, V581, P107, DOI 10.1113/jphysiol.2006.124958; Dyment DA, 2015, CLIN GENET, V88, P34, DOI 10.1111/cge.12464; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Erreger K, 2008, J PHYSIOL-LONDON, V586, P763, DOI 10.1113/jphysiol.2007.143941; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Ghasemi M, 2011, EPILEPSY BEHAV, V22, P617, DOI 10.1016/j.yebeh.2011.07.024; Hallett PJ, 2004, PHARMACOL THERAPEUT, V102, P155, DOI 10.1016/j.pharmthera.2004.04.001; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Hansen KB, 2014, NEURON, V81, P1084, DOI 10.1016/j.neuron.2014.01.035; Hansen KB, 2013, MOL PHARMACOL, V84, P114, DOI 10.1124/mol.113.085803; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Laube B, 2004, NEUROPHARMACOLOGY, V47, P994, DOI 10.1016/j.neuropharm.2004.07.041; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Lesca G, 2013, NAT GENET, V45, P1061, DOI 10.1038/ng.2726; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; Nicita F, 2012, SEIZURE-EUR J EPILEP, V21, P3, DOI 10.1016/j.seizure.2011.08.007; Ogden KK, 2017, PLOS GENETICS IN PRE; Saft Carsten, 2011, PLoS Curr, V3, pRRN1247, DOI 10.1371/currents.RRN1247; John A, 2013, AUTISM RES, V6, P69, DOI 10.1002/aur.1264; Swanger SA, 2016, AM J HUM GENET, V99, P1261, DOI 10.1016/j.ajhg.2016.10.002; Tassinari CA, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2009.02209.x; Traynelis SF, 1998, J NEUROSCI, V18, P6163; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vance KM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1295; Venkateswaran S, 2014, EPILEPSIA, V55, pE75, DOI 10.1111/epi.12663; Williams K, 1996, MOL PHARMACOL, V50, P701; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Xi D, 2009, J NEUROSCI METH, V176, P172, DOI 10.1016/j.jneumeth.2008.09.013; Yuan HJ, 2005, J BIOL CHEM, V280, P29708, DOI 10.1074/jbc.M414215200; Yuan HJ, 2015, MOL PHARMACOL, V88, P203, DOI 10.1124/mol.115.097998; Yuan HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4251; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zhang YH, 2015, CHIN J INTEGR MED, V10, P10, DOI DOI 10.1371/J0URNAL.P0NE.0131597; Zhu SJ, 2016, CELL, V165, P704, DOI 10.1016/j.cell.2016.03.028	52	37	39	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170818	10.1371/journal.pone.0170818	http://dx.doi.org/10.1371/journal.pone.0170818			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182669	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800018
J	Marana, MH; Jorgensen, LV; Skov, J; Chettri, JK; Mattsson, AH; Dalsgaard, I; Kania, PW; Buchmann, K				Marana, Moonika Haahr; Jorgensen, Louise von Gersdorff; Skov, Jakob; Chettri, Jiwan Kumar; Mattsson, Andreas Holm; Dalsgaard, Inger; Kania, Per Walter; Buchmann, Kurt			Subunit vaccine candidates against Aeromonas salmonicida in rainbow trout Oncorhynchus mykiss	PLOS ONE			English	Article							SALMO-SALAR L; OUTER-MEMBRANE PROTEINS; III SECRETION SYSTEM; A-LAYER PROTEIN; ATLANTIC SALMON; SUBSP SALMONICIDA; ESCHERICHIA-COLI; IN-VIVO; SIDEROPHORE RECEPTOR; VIRULENCE	Aeromonas salmonicida subsp. salmonicida is the etiological agent of furunculosis and a major fish health problem in salmonid aquaculture worldwide. Injection vaccination with commercial mineral oil-adjuvanted bacterin vaccines has been partly successful in preventing the disease but in Danish rainbow trout (Oncorhynchus mykiss, Walbaum) aquaculture furunculosis outbreaks still occur. In this study we tested the efficacy of experimental subunit vaccines against A. salmonicida infection in rainbow trout. We utilized in silico screening of the proteome of A. salmonicida subsp. salmonicida strain A449 and identified potential protective protein antigens that were tested by in vivo challenge trial. A total of 14 proteins were recombinantly expressed in Escherichia coli and prepared in 3 different subunit vaccine combinations to immunize 3 groups of rainbow trout by intraperitoneal (i.p.) injection. The fish were exposed to virulent A. salmonicida 7 weeks after immunization. To assess the efficacy of the subunit vaccines we evaluated the immune response in fish after immunization and challenge infection by measuring the antibody levels and monitoring the survival of fish in different groups. The survival of fish at 3 weeks after challenge infection showed that all 3 groups of fish immunized with 3 different protein combinations exhibited significantly lower mortalities (17-30%) compared to the control groups (48% and 56%). The ELISA results revealed significantly elevated antibody levels in fish against several protein antigens, which in some cases were positively correlated to the survival.	[Marana, Moonika Haahr; Jorgensen, Louise von Gersdorff; Skov, Jakob; Kania, Per Walter; Buchmann, Kurt] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, DK-1168 Copenhagen, Denmark; [Chettri, Jiwan Kumar; Dalsgaard, Inger] Tech Univ Denmark, Natl Vet Inst, Lyngby, Denmark; [Mattsson, Andreas Holm] Evax Biotech, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark	Marana, MH (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, DK-1168 Copenhagen, Denmark.	mmarana@hotmail.com	; Chettri, Jiwan Kumar/A-5243-2015	Dalsgaard, Inger/0000-0003-2066-1060; Buchmann, Kurt/0000-0002-2747-237X; Jorgensen, Louise von Gersdorff/0000-0002-6005-3249; Marana, Moonika/0000-0003-3535-6341; Chettri, Jiwan Kumar/0000-0001-8127-8773	Danish Council for Strategic Research under the PROFISH project [DSF: 11-116252]; European Commission FP7 project Targetfish [311993]	Danish Council for Strategic Research under the PROFISH project; European Commission FP7 project Targetfish	This study was funded by from the Danish Council for Strategic Research under the PROFISH project (Grant No. DSF: 11-116252) and the European Commission FP7 project Targetfish (Grant No. 311993). The funder provided support in the form of salaries for authors [MHM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. The commercial affiliation (Evaxion Biotech) did not provide financial support in this study. The commercial affiliation (Evaxion Biotech) provided the protein sequences tested in this study but played no role in data collection, analysis or decision to publish.	Amend D.F., 1981, FISH BIOL SERODIAGNO, V49, P447; Andreoni F, 2016, METHODS MOL BIOL, V1404, P181, DOI 10.1007/978-1-4939-3389-1_12; Andreoni F, 2013, VACCINE, V31, P820, DOI 10.1016/j.vaccine.2012.11.064; [Anonymous], F1000 BIOL REP; ARNESEN JA, 1993, J FISH DIS, V16, P409, DOI 10.1111/j.1365-2761.1993.tb00875.x; Bagnoli F, 2015, P NATL ACAD SCI USA, V112, P3680, DOI 10.1073/pnas.1424924112; Beaz-Hidalgo R, 2013, J FISH DIS, V36, P371, DOI 10.1111/jfd.12025; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bernoth Eva-Maria, 1997, P1, DOI 10.1016/B978-012093040-1/50003-8; BJORNSDOTTIR R, 1992, J FISH DIS, V15, P105, DOI 10.1111/j.1365-2761.1992.tb00645.x; Boyd JM, 2008, INFECT IMMUN, V76, P1445, DOI 10.1128/IAI.01019-07; Bricknell IR, 1997, FISH SHELLFISH IMMUN, V7, P1, DOI 10.1006/fsim.1996.0059; Burr SE, 2005, MICROBIOL-SGM, V151, P2111, DOI 10.1099/mic.0.27926-0; Burr SE, 2003, DIS AQUAT ORGAN, V57, P167, DOI 10.3354/dao057167; Burr SE, 2002, J BACTERIOL, V184, P5966, DOI 10.1128/JB.184.21.5966-5970.2002; Chettri JK, 2015, FISH SHELLFISH IMMUN, V44, P485, DOI 10.1016/j.fsi.2015.03.003; Chettri JK, 2013, VET IMMUNOL IMMUNOP, V154, P42, DOI 10.1016/j.vetimm.2013.04.001; CIPRIANO RC, 1982, CAN J FISH AQUAT SCI, V39, P218, DOI 10.1139/f82-028; CIPRIANO RC, 1982, CAN J FISH AQUAT SCI, V39, P1512, DOI 10.1139/f82-203; Dacanay A, 2006, MICROBIOL-SGM, V152, P1847, DOI 10.1099/mic.0.28768-0; Dalsgaard I, 2000, J FISH DIS, V23, P199, DOI 10.1046/j.1365-2761.2000.00242.x; Ebanks RO, 2004, PROTEOMICS, V4, P1074, DOI 10.1002/pmic.200300664; ELLIS AE, 1981, J FISH DIS, V4, P41, DOI 10.1111/j.1365-2761.1981.tb01108.x; ELLIS AE, 1991, J FISH DIS, V14, P265, DOI 10.1111/j.1365-2761.1991.tb00824.x; Emmerich R., 1894, ARCH HYG BAKTERIOL, V21, P1; Garduno R, 2000, CAN J MICROBIOL, V46, P660, DOI 10.1139/cjm-46-7-660; Gourlay LJ, 2009, HUM VACCINES, V5, P872, DOI 10.4161/hv.9778; HIRST ID, 1994, FISH SHELLFISH IMMUN, V4, P29, DOI 10.1006/fsim.1994.1004; KAY WW, 1981, J BACTERIOL, V147, P1077, DOI 10.1128/JB.147.3.1077-1084.1981; Koppang EO, 2008, J IMMUNOL, V181, P4807, DOI 10.4049/jimmunol.181.7.4807; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LEE KK, 1990, J BACTERIOL, V172, P5382, DOI 10.1128/jb.172.9.5382-5393.1990; Li L, 2008, INFECT IMMUN, V76, P2620, DOI 10.1128/IAI.01308-07; LILLEHAUG A, 1992, J FISH DIS, V15, P485, DOI 10.1111/j.1365-2761.1992.tb00680.x; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Lund V, 2003, FISH SHELLFISH IMMUN, V15, P367, DOI 10.1016/S1050-4648(02)00180-8; Mahendran R, 2016, DRUG DES DEV THER, V10, P1703, DOI 10.2147/DDDT.S95691; Marana MH, 2016, J FISH DIS; Menanteau-Ledouble S, 2016, J FISH DIS, V39, P1015, DOI 10.1111/jfd.12430; Menanteau-Ledouble S, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-29; Midtlying PJ, 1996, FISH SHELLFISH IMMUN, V6, P335, DOI 10.1006/fsim.1996.0034; Midtlyng PJ, 1996, FISH SHELLFISH IMMUN, V6, P599, DOI 10.1006/fsim.1996.0055; Morgan JK, 2014, MICROB PATHOGENESIS, V77, P42, DOI 10.1016/j.micpath.2014.10.010; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Mulder N., 2007, COMP GENOMICS, P59; Najimi M, 2008, ARCH MICROBIOL, V190, P439, DOI 10.1007/s00203-008-0391-5; NEELAM B, 1993, MICROBIOS, V74, P59; Pedersen K, 2008, J FISH DIS, V31, P659, DOI 10.1111/j.1365-2761.2008.00941.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Romstad AB, 2013, VACCINE, V31, P791, DOI 10.1016/j.vaccine.2012.11.069; Russo TA, 2003, INFECT IMMUN, V71, P7164, DOI 10.1128/IAI.71.12.7164-7169.2003; SAKAI DK, 1985, INFECT IMMUN, V48, P146, DOI 10.1128/IAI.48.1.146-152.1985; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Semmler ABT, 2000, MICROBIOL-UK, V146, P1321, DOI 10.1099/00221287-146-6-1321; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; SHIEH HS, 1975, INT J BIOCHEM, V6, P653, DOI 10.1016/0020-711X(75)90016-6; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Suyama M, 2003, BIOINFORMATICS, V19, P673, DOI 10.1093/bioinformatics/btg031; TATNER MF, 1991, J FISH DIS, V14, P395, DOI 10.1111/j.1365-2761.1991.tb00838.x; Thomson DU, 2009, FOODBORNE PATHOG DIS, V6, P871, DOI 10.1089/fpd.2009.0290; Vanden Bergh P, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-44; Vanden Bergh P, 2013, VACCINE, V31, P5256, DOI 10.1016/j.vaccine.2013.08.057; Vanden Bergh P, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-42; Villumsen KR, 2015, FISH SHELLFISH IMMUN, V42, P193, DOI 10.1016/j.fsi.2014.09.024; Villumsen KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046733; Wehbi H, 2011, J BACTERIOL, V193, P540, DOI 10.1128/JB.01048-10; Xueqin J, 2012, J FISH DIS, V35, P127, DOI 10.1111/j.1365-2761.2011.01329.x; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	71	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171944	10.1371/journal.pone.0171944	http://dx.doi.org/10.1371/journal.pone.0171944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182704	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800136
J	Nucci, LA; Santos, SS; Brunialti, MKC; Sharma, NK; Machado, FR; Assuncao, M; de Azevedo, LCP; Salomao, R				Nucci, Laura A.; Santos, Sidneia S.; Brunialti, Milena K. C.; Sharma, Narendra Kumar; Machado, Flavia R.; Assuncao, Murillo; de Azevedo, Luciano C. P.; Salomao, Reinaldo			Expression of genes belonging to the interacting TLR cascades, NADPH-oxidase and mitochondrial oxidative phosphorylation in septic patients	PLOS ONE			English	Article							CECAL LIGATION; MONONUCLEAR-CELLS; SEVERE SEPSIS; DYSFUNCTION; MONOCYTES; DEFINITIONS; RECOGNITION; ASSOCIATION; NEUTROPHILS; SEVERITY	Background and objectives Sepsis is a complex disease that is characterized by activation and inhibition of different cell signaling pathways according to the disease stage. Here, we evaluated genes involved in the TLR signaling pathway, oxidative phosphorylation and oxidative metabolism, aiming to assess their interactions and resulting cell functions and pathways that are disturbed in septic patients. Materials and methods Blood samples were obtained from 16 patients with sepsis secondary to community acquired pneumonia at admission (D0), and after 7 days (D7, N = 10) of therapy. Samples were also collected from 8 healthy volunteers who were matched according to age and gender. Gene expression of 84 genes was performed by real-time polymerase chain reactions. Their expression was considered up-or down-regulated when the fold change was greater than 1.5 compared to the healthy volunteers. A p-value of <= 0.05 was considered significant. Results Twenty-two genes were differently expressed in D0 samples; most of them were down-regulated. When gene expression was analyzed according to the outcomes, higher number of altered genes and a higher intensity in the disturbance was observed in non-survivor than in survivor patients. The canonical pathways altered in D0 samples included interferon and iNOS signaling; the role of JAK1, JAK2 and TYK2 in interferon signaling; mitochondrial dysfunction; and superoxide radical degradation pathways. When analyzed according to outcomes, different pathways were disturbed in surviving and non-surviving patients. Mitochondrial dysfunction, oxidative phosphorylation and superoxide radical degradation pathway were among the most altered in non-surviving patients. Conclusion Our data show changes in the expression of genes belonging to the interacting TLR cascades, NADPH-oxidase and oxidative phosphorylation. Importantly, distinct patterns are clearly observed in surviving and non-surviving patients. Interferon signaling, marked by changes in JAK-STAT modulation, had prominent changes in both survivors and non-survivors, whereas the redox imbalance (iNOS signaling, oxidative phosphorylation and superoxide radical degradation) affecting mitochondrial functions was prominent in non-surviving patients.	[Nucci, Laura A.; Santos, Sidneia S.; Brunialti, Milena K. C.; Sharma, Narendra Kumar; Machado, Flavia R.; Salomao, Reinaldo] Univ Fed Sao Paulo, Hosp Sao Paulo, Escola Paulista Med, Sao Paulo, Brazil; [Assuncao, Murillo] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [de Azevedo, Luciano C. P.] Hosp Sirio Libanes, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein; Hospital Sirio Libanes	Salomao, R (corresponding author), Univ Fed Sao Paulo, Hosp Sao Paulo, Escola Paulista Med, Sao Paulo, Brazil.	rsalomao@unifesp.br	Santos, Sidneia Sousa/O-5203-2017; Assuncao, Murillo S C/K-1040-2012; Brunialti, Milena K C/C-4905-2012; Salomao, Reinaldo/C-6419-2013; Sharma, Narendra/D-2451-2017	Santos, Sidneia Sousa/0000-0002-6807-9881; Assuncao, Murillo S C/0000-0002-0741-4869; Brunialti, Milena K C/0000-0003-2874-520X; Salomao, Reinaldo/0000-0003-1149-4598; Sharma, Narendra/0000-0002-8681-3840	Fundacao de Amparoa Pesquisa do Estado de Sao Paulo (FAPESP) [2011/20401-4]; Conselho Nacional de Desenvolvimento Cientificoe Tecnologico (CNPq) [305685/2011-2]	Fundacao de Amparoa Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientificoe Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	RS was by Fundacao de Amparoa Pesquisa do Estado de Sao Paulo (FAPESP-www.fapesp.br) - Grant number 2011/20401-4 and Conselho Nacional de Desenvolvimento Cientificoe Tecnologico (CNPq-www.cnp.br) - Grant number 305685/2011-2.	Adrie C, 2001, AM J RESP CRIT CARE, V164, P389, DOI 10.1164/ajrccm.164.3.2009088; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brunialti MKC, 2006, SHOCK, V25, P351, DOI 10.1097/01.shk.0000217815.57727.29; Cai B, 2015, INFLAMMATION, V38, P1599, DOI 10.1007/s10753-015-0135-z; Brunialti MKC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037393; Comim CM, 2008, MITOCHONDRION, V8, P313, DOI 10.1016/j.mito.2008.07.002; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Garrabou G, 2012, J INFECT DIS, V205, P392, DOI 10.1093/infdis/jir764; Hernandes MS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-36; Herzig D, 2012, SHOCK, V38, P395, DOI 10.1097/SHK.0b013e318265a2ab; Huang LJ, 2007, BBA-BIOENERGETICS, V1767, P888, DOI 10.1016/j.bbabio.2007.03.009; Hui L, 2009, J TRAUMA, V66, P859, DOI 10.1097/TA.0b013e318164d05f; Japiassu AM, 2011, CRIT CARE MED, V39, P1056, DOI 10.1097/CCM.0b013e31820eda5c; Jeger V, 2013, EUR J CLIN INVEST, V43, P532, DOI 10.1111/eci.12069; Lam GY, 2010, SEMIN IMMUNOPATHOL, V32, P415, DOI 10.1007/s00281-010-0221-0; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Li XY, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-19; Machado FR, 2013, CLINICS, V68, P586, DOI 10.6061/clinics/2013(05)02; Mendes ME, 2011, IMMUNOBIOLOGY, V216, P285, DOI 10.1016/j.imbio.2010.07.008; Ojeda MO, 2011, INFLAMM RES, V60, P289, DOI 10.1007/s00011-010-0267-4; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Pena G, 2010, J MOL MED, V88, P851, DOI 10.1007/s00109-010-0628-z; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pontes Azevedo Luciano Cesar, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P214; Salomao R, 2009, CRIT CARE MED, V37, P132, DOI 10.1097/CCM.0b013e318192fbaf; Salomao R, 2012, SHOCK, V38, P227, DOI 10.1097/SHK.0b013e318262c4b0; Santos Sidneia S, 2016, Intensive Care Med Exp, V4, P5, DOI 10.1186/s40635-016-0078-1; Santos SS, 2012, SHOCK, V38, P18, DOI 10.1097/SHK.0b013e318257114e; Scicluna BP, 2015, AM J RESP CRIT CARE, V192, P826, DOI 10.1164/rccm.201502-0355OC; Severino P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091886; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Singer M, 2014, VIRULENCE, V5, P66, DOI 10.4161/viru.26907; Szabo C, 2010, SHOCK, V34, P4, DOI 10.1097/SHK.0b013e3181e7e9ba; Weiss SL, 2015, PEDIATR CRIT CARE ME, V16, pE4, DOI 10.1097/PCC.0000000000000277; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	39	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172024	10.1371/journal.pone.0172024	http://dx.doi.org/10.1371/journal.pone.0172024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182798	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800142
J	Roche, R; Bain, R; Cumming, O				Roche, Rachel; Bain, Robert; Cumming, Oliver			A long way to go - Estimates of combined water, sanitation and hygiene coverage for 25 sub-Saharan African countries	PLOS ONE			English	Article							MILLENNIUM DEVELOPMENT GOALS; MIDDLE-INCOME SETTINGS; DRINKING-WATER; DIARRHEA; DISEASE; INTERVENTIONS; RISK; INDICATORS; COMMUNITY; BURDEN	Background Water, sanitation and hygiene (WASH) are essential for a healthy and dignified life. International targets to reduce inadequate WASH coverage were set under the Millennium Development Goals (MDGs, 1990-2015) and now the Sustainable Development Goals (SDGs, 2016-2030). The MDGs called for halving the proportion of the population without access to adequate water and sanitation, whereas the SDGs call for universal access, require the progressive reduction of inequalities, and include hygiene in addition to water and sanitation. Estimating access to complete WASH coverage provides a baseline for monitoring during the SDG period. Sub-Saharan Africa (SSA) has among the lowest rates of WASH coverage globally. Methods The most recent available Demographic Household Survey (DHS) or Multiple Indicator Cluster Survey (MICS) data for 25 countries in SSA were analysed to estimate national and regional coverage for combined water and sanitation (a combined MDG indicator for 'improved' access) and combined water with collection time within 30 minutes plus sanitation and hygiene (a combined SDG indicator for 'basic' access). Coverage rates were estimated separately for urban and rural populations and for wealth quintiles. Frequency ratios and percentage point differences for urban and rural coverage were calculated to give both relative and absolute measures of urban-rural inequality. Wealth inequalities were assessed by visual examination of coverage across wealth quintiles in urban and rural populations and by calculating concentration indices as standard measures of relative wealth related inequality that give an indication of how unevenly a health indicator is distributed across the wealth distribution. Results Combined MDG coverage in SSA was 20%, and combined basic SDG coverage was 4%; an estimated 921 million people lacked basic SDG coverage. Relative measures of inequality were higher for combined basic SDG coverage than combined MDG coverage, but absolute inequality was lower. Rural combined basic SDG coverage was close to zero in many countries. Conclusions Our estimates help to quantify the scale of progress required to achieve universal WASH access in low-income countries, as envisaged under the water and sanitation SDG. Monitoring and reporting changes in the proportion of the national population with access to water, sanitation and hygiene may be useful in focusing WASH policy and investments towards the areas of greatest need.	[Roche, Rachel; Cumming, Oliver] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London, England; [Bain, Robert] UNICEF, Div Data Res & Policy, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine; UNICEF	Roche, R (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London, England.	rachel.roche@gmail.com		Cumming, Oliver/0000-0002-5074-8709				Abdelkrim A., 2007, DASP DISTRIBUTIVE AN; Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; Bain RES, 2012, B WORLD HEALTH ORGAN, V90, P228, DOI 10.2471/BLT.11.094284; Bain R, 2014, TROP MED INT HEALTH, V19, P917, DOI 10.1111/tmi.12334; Bartram J, 2014, INT J ENV RES PUB HE, V11, P8137, DOI 10.3390/ijerph110808137; Benova L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106738; Biran A, 2008, TROP MED INT HEALTH, V13, P278, DOI 10.1111/j.1365-3156.2007.02001.x; Bradley DJ, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0420; Burt Z, 2016, GENDER EQUITY SANITA; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Cumming O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114699; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Dar OA, 2011, TROP MED INT HEALTH, V16, P540, DOI 10.1111/j.1365-3156.2011.02736.x; Ejemot-Nwadiaro RI, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004265.pub3; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Fewtrell L, 2005, WATER SCI TECHNOL, V52, P133, DOI 10.2166/wst.2005.0244; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Graham JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155981; Grimes JET, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003296; Hunter PR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000361; Hutton G, 2013, J WATER HEALTH, V11, P1, DOI 10.2166/wh.2012.105; JMP, 2015, JMP GREEN PAP GLOB M; JMP, 2012, PROGR DRINK WAT SAN; JMP, 2015, PROGR SAN DRINK WAT; KAWATA K, 1978, AM J CLIN NUTR, V31, P2114, DOI 10.1093/ajcn/31.11.2114; Kayser GL, 2013, INT J ENV RES PUB HE, V10, P4812, DOI 10.3390/ijerph10104812; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Loughnan L. C., 2015, Waterlines, V34, P296, DOI 10.3362/1756-3488.2015.028; Measure DHS/ICF International, 2008, DHS MOD QUEST PHAS 6; Onda Kyle, 2013, World Health Popul, V14, P32; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Rabie T, 2006, TROP MED INT HEALTH, V11, P258, DOI 10.1111/j.1365-3156.2006.01568.x; Rheingans R, 2014, TROP MED INT HEALTH, V19, P2, DOI 10.1111/tmi.12220; Rutstein S.O., 2004, DHS COMP REPORTS; Shaheed A, 2014, B WORLD HEALTH ORGAN, V92, P283, DOI 10.2471/BLT.13.119594; STANTON BF, 1987, B WORLD HEALTH ORGAN, V65, P217; StataCorp, 2015, STAT STAT SOFTW REL; Stocks ME, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001605; Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620; UNICEF, 2008, MICS 4 HOUS QUEST; United Nations, 2010, RES HUM RIGHT WAT SA; United Nations, 2015, SUSTAINABLE DEV GOAL, DOI DOI 10.1163/157180910X12665776638740; United Nations Economic and Social Council, 2016, STAT COMM 47 SESS RE; United Nations Population Division, 2014, WORLD URB PROSP 2014; Victora CG, 2005, LANCET, V366, P1460, DOI 10.1016/S0140-6736(05)67599-X; WAGNER E G, 1958, Monogr Ser World Health Organ, V39, P1; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Wagstaff A, 2005, HEALTH ECON, V14, P429, DOI 10.1002/hec.953; Walker CLF, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-70; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331	53	42	42	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171783	10.1371/journal.pone.0171783	http://dx.doi.org/10.1371/journal.pone.0171783			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182796	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000394231800110
J	Pikovski, A				Pikovski, Alexander			Note on a differentiation formula, with application to the two-dimensional Schrodinger equation	PLOS ONE			English	Article								A method for obtaining discretization formulas for the derivatives of a function is presented, which relies on a generalization of divided differences. These modified divided differences essentially correspond to a change of the dependent variable. This method is applied to the numerical solution of the eigenvalue problem for the two-dimensional Schrodinger equation, where standard methods converge very slowly while the approach proposed here gives accurate results. The presented approach has the merit of being conceptually simple and might prove useful in other instances.	[Pikovski, Alexander] Univ Colorado, NIST, JILA, Boulder, CO 80309 USA; [Pikovski, Alexander] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Pikovski, A (corresponding author), Univ Colorado, NIST, JILA, Boulder, CO 80309 USA.; Pikovski, A (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	alexander.pikovski@colorado.edu	Pikovski, Alexander/AAU-7813-2021	Pikovski, Alexander/0000-0003-3452-194X	Army Research Office	Army Research Office	This work was supported by the Army Research Office.	Castro Neto AH, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/8/082501; Grossmann C., 2007, NUMERICAL TREATMENT; Hildebrand F. B, 1987, INTRO NUMERICAL ANAL; Kantorovich L. V., 1964, APPROXIMATE METHODS; Leggett AJ, 2006, NAT PHYS, V2, P134, DOI 10.1038/nphys254; MANTEUFFEL TA, 1986, MATH COMPUT, V47, P511, DOI 10.1090/S0025-5718-1986-0856700-3; Reimann SM, 2002, REV MOD PHYS, V74, P1283, DOI 10.1103/RevModPhys.74.1283; Roy AK, 2008, INT J QUANTUM CHEM, V108, P827, DOI 10.1002/qua.21571; Smith CG, 1996, REP PROG PHYS, V59, P235, DOI 10.1088/0034-4885/59/2/003; Zadorin AI, 2009, NUMERICAL ANAL ITS A	10	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171444	10.1371/journal.pone.0171444	http://dx.doi.org/10.1371/journal.pone.0171444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178300	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500043
J	Komatsu, T; Sasaki, S; Manabe, Y; Hirata, T; Sugawara, T				Komatsu, Toshiyuki; Sasaki, Suguru; Manabe, Yuki; Hirata, Takashi; Sugawara, Tatsuya			Preventive effect of dietary astaxanthin on UVA-induced skin photoaging in hairless mice	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ULTRAVIOLET-RADIATION; CHOLESTEROL SULFATE; HUMAN HEALTH; EXTRACTION; EXPRESSION; TARGET; MODELS; ALPHA	Astaxanthin, a carotenoid found mainly in seafood, has potential clinical applications due to its antioxidant activity. In this study, we evaluated the effect of dietary astaxanthin derived from Haematococcus pluvialis on skin photoaging in UVA-irradiated hairless mice by assessing various parameters of photoaging. After chronic ultraviolet A (UVA) exposure, a significant increase in transepidermal water loss (TEWL) and wrinkle formation in the dorsal skin caused by UVA was observed, and dietary astaxanthin significantly suppressed these photoaging features. We found that the mRNA expression of lympho-epithelial Kazal-type-related inhibitor, steroid sulfatase, and aquaporin 3 in the epidermis was significantly increased by UVA irradiation for 70 days, and dietary astaxanthin significantly suppressed these increases in mRNA expression to be comparable to control levels. In the dermis, the mRNA expression of matrix metalloprotease 13 was increased by UVA irradiation and significantly suppressed by dietary astaxanthin. In addition, HPLC-PDA analysis confirmed that dietary astaxanthin reached not only the dermis but also the epidermis. Our results indicate that dietary astaxanthin accumulates in the skin and appears to prevent the effects of UVA irradiation on filaggrin metabolism and desquamation in the epidermis and the extracellular matrix in the dermis.	[Komatsu, Toshiyuki; Sasaki, Suguru; Manabe, Yuki; Hirata, Takashi; Sugawara, Tatsuya] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Hirata, Takashi] Shijonawate Gakuen Univ, Osaka, Japan	Kyoto University	Sugawara, T (corresponding author), Kyoto Univ, Grad Sch Agr, Kyoto, Japan.	sugawara@kais.kyoto-u.ac.jp	Manabe, Yuki/AAJ-2599-2020	Manabe, Yuki/0000-0002-5663-0074; Sugawara, Tatsuya/0000-0002-1203-5521	FUJIFILM Corporation	FUJIFILM Corporation	FUJIFILM Corporation funded this study and provided support for the author TS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	Ambati RR, 2014, MAR DRUGS, V12, P128, DOI 10.3390/md12010128; Bennett K, 2010, J PROTEOME RES, V9, P4289, DOI 10.1021/pr1003467; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bohm M, 2006, J INVEST DERMATOL, V126, P1966, DOI 10.1038/sj.jid.5700421; Bohm M, 2004, J BIOL CHEM, V279, P6959, DOI 10.1074/jbc.M312549200; Breithaupt DE, 2003, BRIT J NUTR, V90, P795, DOI 10.1079/BJN2003962; Chew BP, 1999, ANTICANCER RES, V19, P1849; Coral-Hinostroza GN, 2004, COMP BIOCHEM PHYS C, V139, P99, DOI 10.1016/j.cca.2004.09.011; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; de Veer SJ, 2014, TRENDS MOL MED, V20, P166, DOI 10.1016/j.molmed.2013.11.005; Denecker G, 2008, J CELL BIOL, V180, P451, DOI 10.1083/jcb.200709098; Elias PM, 2014, BBA-MOL CELL BIOL L, V1841, P353, DOI 10.1016/j.bbalip.2013.11.009; EPSTEIN EH, 1984, J AM ACAD DERMATOL, V10, P866, DOI 10.1016/S0190-9622(84)80144-9; Gilchrest BA, 1996, BRIT J DERMATOL, V135, P867, DOI 10.1046/j.1365-2133.1996.d01-1088.x; GILCHREST BA, 1992, BRIT J DERMATOL, V127, P25, DOI 10.1111/j.1365-2133.1992.tb16984.x; Guerin M, 2003, TRENDS BIOTECHNOL, V21, P210, DOI 10.1016/S0167-7799(03)00078-7; Hussein G, 2006, J NAT PROD, V69, P443, DOI 10.1021/np050354+; JYONOUCHI H, 1995, J NUTR, V125, P2483; Kidd P, 2011, ALTERN MED REV, V16, P355; Kishimoto Y, 2016, MAR DRUGS, V14, DOI 10.3390/md14020035; Kobayashi M, 2000, APPL MICROBIOL BIOT, V54, P550, DOI 10.1007/s002530000416; Kuttner V, 2014, J INVEST DERMATOL, V134, P2381, DOI 10.1038/jid.2014.185; Lamore SD, 2012, PHOTOCH PHOTOBIO SCI, V11, P163, DOI 10.1039/c1pp05131h; Lee CM, 1999, J NUTR, V129, P2271, DOI 10.1093/jn/129.12.2271; Lennikov Anton, 2012, Mol Vis, V18, P455; Lyons NM, 2002, J DERMATOL SCI, V30, P73, DOI 10.1016/S0923-1811(02)00063-4; Ma TH, 2002, J BIOL CHEM, V277, P17147, DOI 10.1074/jbc.M200925200; Mariani TJ, 1998, MOL BIOL CELL, V9, P1411, DOI 10.1091/mbc.9.6.1411; Martin HD, 1999, PURE APPL CHEM, V71, P2253, DOI 10.1351/pac199971122253; Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019; Miyazawa T, 2011, BIOSCI BIOTECH BIOCH, V75, P1856, DOI 10.1271/bbb.110368; Nakahigashi K, 2011, J INVEST DERMATOL, V131, P865, DOI 10.1038/jid.2010.395; Natarajan VT, 2014, NAT CHEM BIOL, V10, P542, DOI [10.1038/NCHEMBIO.1548, 10.1038/nchembio.1548]; Olsson M, 2006, ALLERGY, V61, P1132, DOI 10.1111/j.1398-9995.2006.01151.x; Parisi AV, 2000, J PHOTOCH PHOTOBIO B, V54, P126, DOI 10.1016/S1011-1344(00)00006-3; Pashkow FJ, 2008, AM J CARDIOL, V101, p58D, DOI 10.1016/j.amjcard.2008.02.010; Petri D, 2007, COMP BIOCHEM PHYS C, V145, P202, DOI 10.1016/j.cbpc.2006.12.008; Quan TH, 2009, J INVEST DERM SYMP P, V14, P20, DOI 10.1038/jidsymp.2009.8; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Sakabe J, 2013, J BIOL CHEM, V288, P17179, DOI 10.1074/jbc.M113.476820; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Shimada E, 2011, J OLEO SCI, V60, P321, DOI 10.5650/jos.60.321; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C., 2016, PHOTOCHEM PHOTOBIOL; Skobowiat C, 2016, EXP DERMATOL, V25, P120, DOI 10.1111/exd.12890; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2015, STEROIDS, V103, P72, DOI 10.1016/j.steroids.2015.04.006; Slominski AT, 2015, PHOTODERMATOL PHOTO, V31, P121, DOI 10.1111/phpp.12165; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Sugawara T, 2001, J NUTR, V131, P2921, DOI 10.1093/jn/131.11.2921; Trost A, 2007, EXP DERMATOL, V16, P185, DOI 10.1111/j.1600-0625.2006.00534.x; Tyrrell RM, 1996, BIOESSAYS, V18, P139, DOI 10.1002/bies.950180210; Urbach F, 1997, J PHOTOCH PHOTOBIO B, V40, P3, DOI 10.1016/S1011-1344(97)00029-8; Urikura I, 2011, BIOSCI BIOTECH BIOCH, V75, P757, DOI 10.1271/bbb.110040; Yamamoto M, 2012, J BIOL CHEM, V287, P32825, DOI 10.1074/jbc.M112.357467; Yoshihisa Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152288	59	57	60	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171178	10.1371/journal.pone.0171178	http://dx.doi.org/10.1371/journal.pone.0171178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170435	Green Published, gold			2022-12-26	WOS:000393705500022
J	Konstantakou, EG; Velentzas, AD; Anagnostopoulos, AK; Litou, ZI; Konstandi, OA; Giannopoulou, AF; Anastasiadou, E; Voutsinas, GE; Tsangaris, GT; Stravopodis, DJ				Konstantakou, Eumorphia G.; Velentzas, Athanassios D.; Anagnostopoulos, Athanasios K.; Litou, Zoi I.; Konstandi, Ourania A.; Giannopoulou, Aikaterini F.; Anastasiadou, Ema; Voutsinas, Gerassimos E.; Tsangaris, George Th.; Stravopodis, Dimitrios J.			Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; L-TYROSINE; THERAPEUTIC TARGETS; TUMOR-SUPPRESSOR; 14-3-3 PROTEINS; RAF INHIBITOR; GENE-FUNCTION; RESISTANCE; GROWTH	Cutaneous melanoma is a malignant tumor of skin melanocytes that are pigment-producing cells located in the basal layer (stratum basale) of epidermis. Accumulation of genetic mutations within their oncogenes or tumor-suppressor genes compels melanocytes to aberrant proliferation and spread to distant organs of the body, thereby resulting in severe and/or lethal malignancy. Metastatic melanoma's heavy mutational load, molecular heterogeneity and resistance to therapy necessitate the development of novel biomarkers and drug-based protocols that target key proteins involved in perpetuation of the disease. To this direction, we have herein employed a nano liquid chromatography-tandem mass spectrometry (nLCMS/MS) proteomics technology to profile the deep-proteome landscape of WM-266-4 human metastatic melanoma cells. Our advanced melanoma-specific catalogue proved to contain 6,681 unique proteins, which likely constitute the hitherto largest single cell-linederived proteomic collection of the disease. Through engagement of UNIPROT, DAVID, KEGG, PANTHER, INTACT, CYTOSCAPE, dbEMT and GAD bioinformatics resources, WM-266-4 melanoma proteins were categorized according to their sub-cellular compartmentalization, function and tumorigenicity, and successfully reassembled in molecular networks and interactomes. The obtained data dictate the presence of plastically inter-converted sub-populations of non-cancer and cancer stem cells, and also indicate the oncoproteomic resemblance of melanoma to glioma and lung cancer. Intriguingly, WM-266-4 cells seem to be subjected to both epithelial-to-mesenchymal (EMT) and mesenchymal-to-epithelial (MET) programs, with 1433G and ADT3 proteins being identified in the EMT/MET molecular interface. Oncogenic addiction of WM-266-4 cells to autocrine/paracrine signaling of IL17-, DLL3-, FGF(2/13)-and OSTP-dependent sub-routines suggests their critical contribution to the metastatic melanoma chemotherapeutic refractoriness. Interestingly, the 1433G family member that is shared between the BRAF-and EMT/MET-specific interactomes likely emerges as a novel and promising druggable target for the malignancy. Derailed proliferation and metastatic capacity of WM-266-4 cells could also derive from their metabolic addiction to pathways associated with glutamate/ammonia, propanoate and sulfur homeostasis, whose successful targeting may prove beneficial for advanced melanomaaffected patients.	[Konstantakou, Eumorphia G.; Velentzas, Athanassios D.; Litou, Zoi I.; Konstandi, Ourania A.; Giannopoulou, Aikaterini F.; Stravopodis, Dimitrios J.] Natl & Kapodistrian Univ Athens, Sch Sci, Sect Cell Biol & Biophys, Dept Biol, Athens, Greece; [Anagnostopoulos, Athanasios K.; Tsangaris, George Th.] Acad Athens, Prote Core Facil, Syst Biol Ctr, Biomed Res Fdn, Athens, Greece; [Anastasiadou, Ema] Acad Athens, Basic Res Ctr, Biomed Res Fdn, Athens, Greece; [Voutsinas, Gerassimos E.] Natl Ctr Sci Res Demokritos, Lab Environm Mutagenesis & Carcinogenesis, Inst Biosci & Applicat, Athens, Greece; [Konstantakou, Eumorphia G.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA	National & Kapodistrian University of Athens; Academy of Athens; Academy of Athens; National Centre of Scientific Research "Demokritos"; Harvard University; Massachusetts General Hospital	Stravopodis, DJ (corresponding author), Acad Athens, Prote Core Facil, Syst Biol Ctr, Biomed Res Fdn, Athens, Greece.	gthtsangaris@bioacademy.gr; dstravop@biol.uoa.gr	Tsangaris, George/Q-6139-2019; Konstantakou, Eumorphia/AAZ-7294-2020; Velentzas, Athanassios D/C-1261-2011; Anagnostopoulos, Athanasios/AAF-5809-2021	Konstantakou, Eumorphia/0000-0002-5160-4045; Velentzas, Athanassios D/0000-0002-9755-395X; Anagnostopoulos, Athanasios/0000-0001-5161-7850; Stravopodis, Dimitrios/0000-0002-9535-2134	European Social Fund UoA ((European Union) [MIS 375784]; Bodossaki Foundation	European Social Fund UoA ((European Union); Bodossaki Foundation	Financial support of the present work was kindly and generously provided by the (a) "European Social Fund UoA - MIS 375784" (European Union and Greek National Funds 2012 - 2015 / "THALIS" Program) and (b) "Bodossaki Foundation Donation Program" 2013 - 2014, Athens, Greece, to DJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Al-Ghoul M, 2008, J PROTEOME RES, V7, P4107, DOI 10.1021/pr800174k; Amaral AU, 2016, J NEUROCHEM, V137, P62, DOI 10.1111/jnc.13544; Anagnostopoulos AK, 2016, J CHROMATOGR B ANALY; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; [Anonymous], [No title captured]; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Ashkenazi S, 2016, ONCOTARGET, V7, P30166, DOI 10.18632/oncotarget.7379; Asnaghi L, 2012, CLIN CANCER RES, V18, P654, DOI 10.1158/1078-0432.CCR-11-1406; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Balter V, 2015, P NATL ACAD SCI USA, V112, P982, DOI 10.1073/pnas.1415151112; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Blackwell C, 2016, ONCOTARGET, V7, P39861, DOI 10.18632/oncotarget.9515; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2016, ONCOTARGET, V7, P17844, DOI 10.18632/oncotarget.7528; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Chapman G, 2011, HUM MOL GENET, V20, P905, DOI 10.1093/hmg/ddq529; Chartrain M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036762; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Coloff JL, 2016, CELL METAB, V23, P867, DOI 10.1016/j.cmet.2016.03.016; D'Mello SAN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071144; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DeBerardinis RJ, 2016, CELL METAB, V23, P957, DOI 10.1016/j.cmet.2016.05.008; Donoghue PCJ, 2008, BIOESSAYS, V30, P530, DOI 10.1002/bies.20767; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Fu BB, 2007, MOL CANCER THER, V6, P220, DOI 10.1158/1535-7163.MCT-06-0526; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Ghosh Papia, 2009, Expert Rev Dermatol, V4, P131, DOI 10.1586/edm.09.2; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Guo JY, 2013, AUTOPHAGY, V9, P1636, DOI 10.4161/auto.26123; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hagel M, 2015, CANCER DISCOV, V5, P424, DOI 10.1158/2159-8290.CD-14-1029; Halaban R, 2001, J BIOL CHEM, V276, P11933, DOI 10.1074/jbc.M008703200; Harder LM, 2014, AUTOPHAGY, V10, P339, DOI 10.4161/auto.26863; Hata S, 2008, INT J ONCOL, V33, P1065, DOI 10.3892/ijo_00000095; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Horswill AR, 2001, J BIOL CHEM, V276, P19094, DOI 10.1074/jbc.M100244200; Hoyne GF, 2011, IMMUNOL CELL BIOL, V89, P696, DOI 10.1038/icb.2010.154; Hu ZY, 2015, BBA-MOL BASIS DIS, V1852, P1876, DOI 10.1016/j.bbadis.2015.06.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang Q, 2016, AM J CANCER RES, V6, P440; Martinez AI, 2010, MOL GENET METAB, V101, P311, DOI 10.1016/j.ymgme.2010.08.002; Kale S, 2014, ONCOGENE, V33, P2295, DOI 10.1038/onc.2013.184; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kawai T, 2015, CLIN CANCER RES, V21, P3081, DOI 10.1158/1078-0432.CCR-14-1936; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kircher DA, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1128516; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kothari AN, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040039; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee MH, 2011, J CLIN ENDOCR METAB, V96, pE19, DOI 10.1210/jc.2010-1071; Lee S, 2014, NAT CHEM BIOL, V10, P1055, DOI 10.1038/nchembio.1669; Lefevre G, 2009, INVEST OPHTH VIS SCI, V50, P1047, DOI 10.1167/iovs.08-2378; Li W, 2009, ANAL BIOCHEM, V386, P282, DOI 10.1016/j.ab.2008.12.017; Phan L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8530; Lin X, 2016, CANCER SCI, V107, P1079, DOI 10.1111/cas.12978; Liu R, 2013, CANCER RES, V73, P5926, DOI 10.1158/0008-5472.CAN-12-4718; Lo JA, 2014, SCIENCE, V346, P945, DOI 10.1126/science.1253735; Ma JL, 2016, J SURG ONCOL, V114, P520, DOI 10.1002/jso.24348; Mallick P, 2010, NAT BIOTECHNOL, V28, P695, DOI 10.1038/nbt.1658; Markou A, 2011, CLIN CHEM, V57, P421, DOI 10.1373/clinchem.2010.154328; Matta A, 2012, EXPERT OPIN THER TAR, V16, P515, DOI 10.1517/14728222.2012.668185; Merlino G, 2003, TRENDS MOL MED, V9, P102, DOI 10.1016/S1471-4914(03)00006-6; Messaritou G, 2010, J BIOL CHEM, V285, P1692, DOI 10.1074/jbc.M109.045989; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Mori Mattia, 2013, Drug Discov Today Technol, V10, pe541, DOI 10.1016/j.ddtec.2012.10.001; Mort RL, 2015, DEVELOPMENT, V142, P620, DOI 10.1242/dev.106567; Mukhopadhyay A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26580; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Okada T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02899; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Panda D, 1997, P NATL ACAD SCI USA, V94, P9308, DOI 10.1073/pnas.94.17.9308; Parajuli P, 2016, ONCOTARGET, V7, P6121, DOI 10.18632/oncotarget.6847; Park D, 2016, BIOMATERIALS, V98, P131, DOI 10.1016/j.biomaterials.2016.05.007; Park HY, 2009, CELL MOL LIFE SCI, V66, P1493, DOI 10.1007/s00018-009-8703-8; Peng C, 2015, ONCOTARGET, V6, P20177, DOI 10.18632/oncotarget.3896; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Rad EB, 2016, CANCER RES, V76, P1690, DOI 10.1158/0008-5472.CAN-15-1722; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Raychaudhuri K, 2016, J BIOL CHEM, V291, P16068, DOI 10.1074/jbc.M116.723767; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Saunders LR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac9459; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Sciacovelli M, 2016, NATURE, V537, P544, DOI 10.1038/nature19353; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Shain AH, 2016, NAT REV CANCER, V16, P345, DOI 10.1038/nrc.2016.37; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheridan C, 2013, NAT BIOTECHNOL, V31, P775, DOI 10.1038/nbt0913-775a; Shtivelman E, 2014, ONCOTARGET, V5, P1701, DOI 10.18632/oncotarget.1892; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; SLOMINSKI A, 1989, LIFE SCI, V45, P1799, DOI 10.1016/0024-3205(89)90520-1; SLOMINSKI A, 1983, BIOSCIENCE REP, V3, P189, DOI 10.1007/BF01121951; SLOMINSKI A, 1988, J CELL SCI, V89, P287; SLOMINSKI A, 1985, J CANCER RES CLIN, V109, P29, DOI 10.1007/BF01884251; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Spagnolo F, 2012, ARCH DERMATOL RES, V304, P177, DOI 10.1007/s00403-012-1223-7; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Tollenaere MAX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10075; VanderVen BC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004679; Verdoodt B, 2006, CELL CYCLE, V5, P2920, DOI 10.4161/cc.5.24.3571; Viros A, 2014, NATURE, V511, P478, DOI 10.1038/nature13298; Waisbren SE, 2016, J INHERIT METAB DIS, V39, P573, DOI 10.1007/s10545-016-9942-0; Wang C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25722; Weiner ID, 2011, AM J PHYSIOL-RENAL, V300, pF11, DOI 10.1152/ajprenal.00554.2010; Wierer M, 2016, HUM MOL GENET, V25, pR106, DOI 10.1093/hmg/ddw208; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wolnicka-Glubisz A, 2015, ARCH DERMATOL RES, V307, P89, DOI 10.1007/s00403-014-1523-1; Woodcock JM, 2015, ONCOTARGET, V6, P14522, DOI 10.18632/oncotarget.3995; Xu J, 2015, CANCER CELL, V27, P177, DOI 10.1016/j.ccell.2014.11.025; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; Zhang Q, 2016, ONCOGENE; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012; Zhao LQ, 2016, ONCOTARGET, V7, P31572, DOI 10.18632/oncotarget.7765; Zhao M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11459; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	148	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171512	10.1371/journal.pone.0171512	http://dx.doi.org/10.1371/journal.pone.0171512			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158294	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700089
J	Pimviriyakul, P; Thotsaporn, K; Sucharitakul, J; Chaiyen, P				Pimviriyakul, Panu; Thotsaporn, Kittisak; Sucharitakul, Jeerus; Chaiyen, Pimchai			Kinetic Mechanism of the Dechlorinating Flavin-dependent Monooxygenase HadA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; 2-METHYL-3-HYDROXYPYRIDINE-5-CARBOXYLIC ACID OXYGENASE; SEQUENCE SIMILARITY NETWORKS; BURKHOLDERIA-CEPACIA AC1100; COUPLED ELECTRON-TRANSFER; ACINETOBACTER-BAUMANNII; REDUCED FLAVIN; 2,4,6-TRICHLOROPHENOL DEGRADATION; PENTACHLOROPHENOL HYDROXYLASE; CHLOROPHENOL 4-MONOOXYGENASE	The accumulation of chlorophenols (CPs) in the environment, due to their wide use as agrochemicals, has become a serious environmental problem. These organic halides can be degraded by aerobic microorganisms, where the initial steps of various biodegradation pathways include an oxidative dechlorinating process in which chloride is replaced by a hydroxyl substituent. Harnessing these dechlorinating processes could provide an opportunity for environmental remediation, but detailed catalytic mechanisms for these enzymes are not yet known. To close this gap, we now report transient kinetics and product analysis of the dechlorinating flavin-dependent monooxygenase, HadA, from the aerobic organism Ralstonia pickettii DTP0602, identifying several mechanistic properties that differ from other enzymes in the same class. We first overexpressed and purified HadA to homogeneity. Analyses of the products from single and multiple turnover reactions demonstrated thatHadAprefers 4-CP and 2-CP over CPs with multiple substituents. Stopped-flow and rapid-quench flow experiments of HadA with 4-CP show the involvement of specific intermediates (C4a-hydroperoxy-FAD and C4a-hydroxy-FAD) in the reaction, define rate constants and the order of substrate binding, and demonstrate that the hydroxylation step occurs prior to chloride elimination. The data also identify the non-productive and productive paths of the HadA reactions and demonstrate that product formation is the rate-limiting step. This is the first elucidation of the kinetic mechanism of a two-component flavin-dependent monooxygenase that can catalyze oxidative dechlorination of various CPs, and as such it will serve as the basis for future investigation of enzyme variants that will be useful for applications in detoxifying chemicals hazardous to human health.	[Pimviriyakul, Panu; Chaiyen, Pimchai] Mahidol Univ, Dept Biochem, Fac Sci, Bangkok 10400, Thailand; [Pimviriyakul, Panu; Chaiyen, Pimchai] Mahidol Univ, Ctr Excellence Prot & Enzyme Technol, Fac Sci, Bangkok 10400, Thailand; [Thotsaporn, Kittisak; Sucharitakul, Jeerus] Chulalongkorn Univ, Dept Biochem, Fac Dent, Bangkok 10300, Thailand	Mahidol University; Mahidol University; Chulalongkorn University	Chaiyen, P (corresponding author), Mahidol Univ, Dept Biochem, Fac Sci, Bangkok 10400, Thailand.; Chaiyen, P (corresponding author), Mahidol Univ, Ctr Excellence Prot & Enzyme Technol, Fac Sci, Bangkok 10400, Thailand.	pimchai.cha@mahidol.ac.th	Chaiyen, Pimchai/R-5052-2019	Chaiyen, Pimchai/0000-0002-8533-1604; Pimviriyakul, Panu/0000-0002-0410-0610	The Thailand Research Fund [RTA5980001]; Mahidol University; Development and Promotion of Science and Technology Talents Project (DPST) Scholarship	The Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; Development and Promotion of Science and Technology Talents Project (DPST) Scholarship	This work was supported by The Thailand Research Fund through Grant RTA5980001, a grant from Mahidol University (to P. C.), and a Development and Promotion of Science and Technology Talents Project (DPST) Scholarship (to P. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Agency for Toxic Substances and Disease Registry, 2015, PRIOR LIST HAZ SUBST; Agency for Toxic Substances and Disease Registry, 1999, TOX PROF CHLOR; Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; Arora PK, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-31; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; Bobyk KD, 2015, BIOCHEMISTRY-US, V54, P4487, DOI 10.1021/acs.biochem.5b00410; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P8060, DOI 10.1021/bi970089u; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chakraborty S, 2010, BIOCHEMISTRY-US, V49, P372, DOI 10.1021/bi901454u; Dadson OA, 2013, TOXICOLOGY, V306, P35, DOI 10.1016/j.tox.2013.01.023; DANGANAN CE, 1994, APPL ENVIRON MICROB, V60, P4100, DOI 10.1128/AEM.60.11.4100-4106.1994; Dhammaraj T, 2016, ACS CHEM BIOL, V11, P2889, DOI 10.1021/acschembio.6b00402; Dhammaraj T, 2015, ACS CATAL, V5, P4492, DOI 10.1021/acscatal.5b00439; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Fagan RL, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P37; FRANCISCO WA, 1993, J BIOL CHEM, V268, P24734; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Hatta T, 2012, BIOSCI BIOTECH BIOCH, V76, P892, DOI 10.1271/bbb.110843; Hayes RP, 2012, INT J MOL SCI, V13, P9769, DOI 10.3390/ijms13089769; Hlouchova K, 2012, BIOCHEMISTRY-US, V51, P3848, DOI 10.1021/bi300261p; Hu JM, 2015, J BIOL CHEM, V290, P590, DOI 10.1074/jbc.M114.605964; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Igbinosa EO, 2013, SCI WORLD J, DOI [10.1155/2013/460215, 10.1155/2013/798096]; Kitagawa W, 2004, J BACTERIOL, V186, P4894, DOI 10.1128/JB.186.15.4894-4902.2004; KIYOHARA H, 1992, APPL ENVIRON MICROB, V58, P1276, DOI 10.1128/AEM.58.4.1276-1283.1992; Kovacic P, 2014, J APPL TOXICOL, V34, P810, DOI 10.1002/jat.2980; Li YW, 2015, RSC ADV, V5, P13871, DOI 10.1039/c4ra16165c; Louie TM, 2002, J BACTERIOL, V184, P3492, DOI 10.1128/JB.184.13.3492-3500.2002; Luanloet T, 2015, FEBS J, V282, P3107, DOI 10.1111/febs.13220; MAEDAYORITA K, 1993, J BIOL CHEM, V268, P4134; Matus V, 2003, APPL ENVIRON MICROB, V69, P7108, DOI 10.1128/AEM.69.12.7108-7115.2003; Mayfield JA, 2010, J BIOL CHEM, V285, P30375, DOI 10.1074/jbc.M110.157578; Olaniran AO, 2011, CHEMOSPHERE, V83, P1297, DOI 10.1016/j.chemosphere.2011.04.009; Orru R, 2011, J BIOL CHEM, V286, P29284, DOI 10.1074/jbc.M111.255075; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Phongsak T, 2012, J BIOL CHEM, V287, P26213, DOI 10.1074/jbc.M112.354472; Romero E, 2012, BBA-PROTEINS PROTEOM, V1824, P850, DOI 10.1016/j.bbapap.2012.03.004; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Rudolph J, 2014, BIOCHEMISTRY-US, V53, P6539, DOI 10.1021/bi5010427; Shannon PT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-217; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suadee C, 2007, J BIOCHEM, V142, P539, DOI 10.1093/jb/mvm155; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Sucharitakul J, 2014, ARCH BIOCHEM BIOPHYS, V555, P33, DOI 10.1016/j.abb.2014.05.009; Sucharitakul J, 2013, J BIOL CHEM, V288, P35210, DOI 10.1074/jbc.M113.515205; Takeo M, 2003, J BIOSCI BIOENG, V95, P139, DOI 10.1016/S1389-1723(03)80119-6; Takeo M, 2008, J BACTERIOL, V190, P7367, DOI 10.1128/JB.00742-08; TAKIZAWA N, 1995, J FERMENT BIOENG, V80, P318, DOI 10.1016/0922-338X(95)94198-Z; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; Tinikul R, 2016, ADV BIOCHEM ENG BIOT, V154, P47, DOI 10.1007/10_2014_281; Tinikul R, 2013, BIOCHEMISTRY-US, V52, P6834, DOI 10.1021/bi4006545; Tongsook C, 2011, J BIOL CHEM, V286, P44491, DOI 10.1074/jbc.M111.284463; USEPA, 2014, PRIOR POLL LIST; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; Visitsatthawong S, 2015, J AM CHEM SOC, V137, P9363, DOI 10.1021/jacs.5b04328; Warner JR, 2007, BIOCHEMISTRY-US, V46, P13211, DOI 10.1021/bi701069n; Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135; Wongnate T, 2014, J AM CHEM SOC, V136, P241, DOI 10.1021/ja4088055; Xun LY, 2004, J BIOL CHEM, V279, P6696, DOI 10.1074/jbc.M312072200; XUN LY, 1992, J BACTERIOL, V174, P5745, DOI 10.1128/JB.174.17.5745-5747.1992; Yeh E, 2006, BIOCHEMISTRY-US, V45, P7904, DOI 10.1021/bi060607d; Zhan X, 2008, BIOCHEMISTRY-US, V47, P2221, DOI 10.1021/bi701853w	64	33	33	6	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4818	4832		10.1074/jbc.M116.774448	http://dx.doi.org/10.1074/jbc.M116.774448			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28159841	hybrid, Green Published			2022-12-26	WOS:000397590400007
J	Terrenato, I; D'Alicandro, V; Casini, B; Perracchio, L; Rollo, F; De Salvo, L; Di Filippo, S; Di Filippo, F; Pescarmona, E; Maugeri-Sacca, M; Mottolese, M; Buglioni, S				Terrenato, Irene; D'Alicandro, Valerio; Casini, Beatrice; Perracchio, Letizia; Rollo, Francesca; De Salvo, Laura; Di Filippo, Simona; Di Filippo, Franco; Pescarmona, Edoardo; Maugeri-Sacca, Marcello; Mottolese, Marcella; Buglioni, Simonetta			A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients	PLOS ONE			English	Article							NUCLEIC-ACID AMPLIFICATION; MOLECULAR METHOD; METASTASES; DISSECTION; INVOLVEMENT; DIAGNOSIS; METAANALYSIS; NOMOGRAM; RECEPTOR; BIOPSY	Since 2007, one-step nucleic acid amplification (OSNA) has been used as a diagnostic system for sentinel lymph node (SLN) examination in patients with breast cancer. This study aimed to define a new clinical cut-off of CK19 mRNA copy number based on the calculation of the risk that an axillary lymph node dissection (ALND) will be positive. We analyzed 1529 SLNs from 1140 patients with the OSNA assay and 318 patients with positive SLNs for micrometastasis (250 copies) and macrometastasis (5000 copies) underwent ALND. Axillary non-SLNs were routinely examined. ROC curves and Youden's index were performed in order to identify a new cut-off value. Logistic regression models were performed in order to compare OSNA categorical variables created on the basis of our and traditional cut-off to better identify patients who really need an axillary dissection. 69% and 31% of OSNA positive patients had a negative and positive ALND, respectively. ROC analysis identified a cutoff of 2150 CK19 mRNA copies with 95% sensitivity and 51% specificity. Positive and negative predictive values of this new cut-off were 47% and 96%, respectively. Logistic regression models indicated that the cut-off of 2150 copies better discriminates patients with node negative or positive in comparison with the conventional OSNA cut-off (p<0.0001). This cutoff identifies false positive and false negative cases and true-positive and true negative cases very efficiently, and therefore better identifies which patients really need an ALND and which patients can avoid one. This is why we suggest that the negative cut-off should be raised from 250 to 2150. Furthermore, we propose that for patients with a copy number that ranges between 2150 and 5000, there should be a multidisciplinary discussion concerning the clinical and bio-morphological features of primary breast cancer before any decision is taken on whether to perform an ALND or not.	[Terrenato, Irene] Regina Elena Inst Canc Res, Biostat Unit, Rome, Italy; [D'Alicandro, Valerio; Casini, Beatrice; Perracchio, Letizia; Rollo, Francesca; De Salvo, Laura; Pescarmona, Edoardo; Mottolese, Marcella; Buglioni, Simonetta] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; [Di Filippo, Simona; Di Filippo, Franco] Regina Elena Inst Canc Res, Dept Surg, Rome, Italy; [Maugeri-Sacca, Marcello] Regina Elena Inst Canc Res, Div Med Oncol B, Rome, Italy; [Maugeri-Sacca, Marcello] Regina Elena Inst Canc Res, Sci Direct, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Buglioni, S (corresponding author), Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy.	simonetta.buglioni@ifo.gov.it	D'Alicandro, Valerio/AAA-7751-2020; Terrenato, Irene/B-1308-2017; Maugeri-Saccà, Marcello/K-2350-2014; Rollo, Francesca/I-5249-2018; Rollo, Francesca/AAC-2775-2021	Terrenato, Irene/0000-0002-0187-9323; Maugeri-Saccà, Marcello/0000-0003-2287-9581; Rollo, Francesca/0000-0003-2724-872X; Rollo, Francesca/0000-0003-2724-872X; CASINI, BEATRICE/0000-0002-9038-0179; buglioni, simonetta/0000-0002-5066-1523; Pescarmona, Edoardo/0000-0002-0443-9331				Belda MA, 2012, INT J CANCER, V130, P2377, DOI [10.1002/ijc.26291, DOI 10.1002/IJC.26291]; Bernet L, 2011, HISTOPATHOLOGY, V58, P863, DOI 10.1111/j.1365-2559.2011.03836.x; Buglioni S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058823; Castellano I, 2012, ANN SURG, V255, P334, DOI 10.1097/SLA.0b013e31823000ed; Deambrogio C, 2014, J CLIN PATHOL, V67, P702, DOI 10.1136/jclinpath-2014-202384; Di Filippo F, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0246-2; Fattaneh A, 2003, PATHOLOGY GENETICS T; Feldman S, 2011, CANCER-AM CANCER SOC, V117, P2599, DOI 10.1002/cncr.25822; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Heilmann T, 2013, J CANCER RES CLIN, V139, P1649, DOI 10.1007/s00432-013-1481-6; Kamath VJ, 2001, ARCH SURG-CHICAGO, V136, P688, DOI 10.1001/archsurg.136.6.688; Khaddage A, 2011, ANTICANCER RES, V31, P585; Kim T, 2006, CANCER-AM CANCER SOC, V106, P4, DOI 10.1002/cncr.21568; Li CZ, 2015, EJSO-EUR J SURG ONC, V41, P958, DOI 10.1016/j.ejso.2015.05.007; Meretoja TJ, 2013, BREAST CANCER RES TR, V138, P817, DOI 10.1007/s10549-013-2468-3; Nos C, 2003, BRIT J SURG, V90, P1354, DOI 10.1002/bjs.4325; Peg V, 2013, BREAST CANCER RES TR, V139, P87, DOI 10.1007/s10549-013-2524-z; Rubio IT, 2014, BREAST CANCER RES TR, V147, P371, DOI 10.1007/s10549-014-3108-2; Sagara Y, 2013, BREAST CANCER-TOKYO, V20, P181, DOI 10.1007/s12282-011-0324-z; Schem C, 2009, VIRCHOWS ARCH, V454, P203, DOI 10.1007/s00428-008-0703-9; Senkus E, 2015, ANN ONCOL, V26, pV8, DOI 10.1093/annonc/mdv298; Snook KL, 2011, BRIT J SURG, V98, P527, DOI 10.1002/bjs.7347; Tamaki Y, 2009, CLIN CANCER RES, V15, P2879, DOI 10.1158/1078-0432.CCR-08-1881; Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Ugras S, 2014, ANN SURG ONCOL, V21, P3780, DOI 10.1245/s10434-014-3851-y; Visser M, 2008, INT J CANCER, V122, P2562, DOI 10.1002/ijc.23451; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Zhu LL, 2013, BREAST CANCER RES TR, V137, P783, DOI 10.1007/s10549-012-2360-6	28	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171517	10.1371/journal.pone.0171517	http://dx.doi.org/10.1371/journal.pone.0171517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187209	Green Published, Green Submitted, gold			2022-12-26	WOS:000394244300026
J	Alene, KA; Viney, K; McBryde, ES; Clements, ACA				Alene, Kefyalew Addis; Viney, Kerri; McBryde, Emma S.; Clements, Archie C. A.			Spatial patterns of multidrug resistant tuberculosis and relationships to socioeconomic, demographic and household factors in northwest Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; TRANSMISSION; REGION; PERU; MDR; TB	Background Understanding the geographical distribution of multidrug-resistant tuberculosis (MDR-TB) in high TB burden countries such as Ethiopia is crucial for effective control of TB epidemics in these countries, and thus globally. We present the first spatial analysis of multidrug resistant tuberculosis, and its relationship to socio-economic, demographic and household factors in northwest Ethiopia. Methods An ecological study was conducted using data on patients diagnosed with MDR-TB at the University of Gondar Hospital MDR-TB treatment centre, for the period 2010 to 2015. District level population data were extracted from the Ethiopia National and Regional Census Report. Spatial autocorrelation was explored using Moran's I statistic, Local Indicators of Spatial Association (LISA), and the Getis-Ord statistics. A multivariate Poisson regression model was developed with a conditional autoregressive (CAR) prior structure, and with posterior parameters estimated using a Bayesian Markov chain Monte Carlo (MCMC) simulation approach with Gibbs sampling, in WinBUGS. Results A total of 264 MDR-TB patients were included in the analysis. The overall crude incidence rate of MDR-TB for the six-year period was 3.0 cases per 100,000 population. The highest incidence rate was observed in Metema (21 cases per 100,000 population) and Humera (18 cases per 100,000 population) districts; whereas nine districts had zero cases. Spatial clustering of MDR-TB was observed in districts located in the Ethiopia-Sudan and Ethiopia-Eritrea border regions, where large numbers of seasonal migrants live. Spatial clustering of MDR-TB was positively associated with urbanization (RR: 1.02; 95% CI: 1.01, 1.04) and the percentage of men (RR: 1.58; 95% CI: 1.26, 1.99) in the districts; after accounting for these factors there was no residual spatial clustering. Conclusion Spatial clustering of MDR-TB, fully explained by demographic factors (urbanization and percent male), was detected in the border regions of northwest Ethiopia, in locations where seasonal migrants live and work. Cross-border initiatives including options for mobile TB treatment and follow up are important for the effective control of MDR-TB in the region.	[Alene, Kefyalew Addis; Viney, Kerri; Clements, Archie C. A.] Australian Natl Univ, Coll Med Biol & Environm, Res Sch Populat Hlth, Canberra, ACT, Australia; [Alene, Kefyalew Addis] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia; [McBryde, Emma S.] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [McBryde, Emma S.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [McBryde, Emma S.] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld, Australia	Australian National University; University of Gondar; Burnet Institute; University of Melbourne; James Cook University	Alene, KA (corresponding author), Australian Natl Univ, Coll Med Biol & Environm, Res Sch Populat Hlth, Canberra, ACT, Australia.; Alene, KA (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia.	kefyalew.alene@anu.edu.au	Clements, Archie/ABD-1615-2020; Alene, Dr Kefyalew Addis/V-8240-2018; McBryde, Emma/D-2220-2018	Alene, Dr Kefyalew Addis/0000-0002-1904-4682; McBryde, Emma/0000-0002-9570-9172				Agency CS, 2007, 2007 POP HOUS CENS E; Alene KA, 2016, TROPICAL MED INT HLT; [Anonymous], 2015, IMPL END TB STRAT ES; Asfaw W, 2010, NORSK GEOGR TIDSSKR, V64, P58, DOI 10.1080/00291950903557696; Biruck Kebede BA, 2013, GUIDELINES PROGRAMMA; Cain KP, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001791; CSA, 2013, POPULATION PROJECTIO; Dara M, 2012, EUR RESPIR J, V40, P1081, DOI 10.1183/09031936.00053012; ESRI, 2015, ARCGIS DESKT REL 10; Glaziou P, 2015, CSH PERSPECT MED, V5, DOI [10.1101/cshperspect.a017798, 10.1055/s-0038-1651492]; Guinand Y., 1999, UNDERDEVELOPED DROUG, P18; Gurjav U, 2015, INT J TUBERC LUNG D, V19, P1376, DOI 10.5588/ijtld.15.0361; Hirpa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-782; Jagielski T, 2015, EUR J CLIN MICROBIOL, V34, P41, DOI 10.1007/s10096-014-2202-z; Jenkins H, 2014, B EUROPEEN MALADIES, V19; Jenkins HE, 2013, EUR RESPIR J, V42, P1291, DOI 10.1183/09031936.00111812; Law DCG, 2004, SEX TRANSM INFECT, V80, P294, DOI 10.1136/sti.2003.006700; Leung ECC, 2012, EUROPEAN RESP J; Liestol K, 2009, INT J EPIDEMIOL, V38, P427, DOI 10.1093/ije/dyn347; Lin H, 2011, EPIDEMIOL INFECT, V139, P1784, DOI 10.1017/S0950268810002797; Lin HH, 2012, EMERG INFECT DIS, V18, P811, DOI 10.3201/eid1805.111467; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Lopes ML, 2012, REV PAN AMAZONICA SA, V3, P27; Manjourides J, 2012, TUBERCULOSIS, V92, P273, DOI 10.1016/j.tube.2012.02.003; [MOH Health EFMo], 2013, EXTR 5 YEARS TB TB H, V5; Paulson T, 2013, NATURE, V502, pS2, DOI 10.1038/502S2a; Rosas S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-442; Shah L, 2014, INT J TUBERC LUNG D, V18, P1307, DOI 10.5588/ijtld.14.0011; Suarez-Garcia I, 2009, EUR J CLIN MICROBIOL, V28, P325, DOI 10.1007/s10096-008-0627-y; Tang Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1789-z; Tesfay K, 2016, INT J MYCOBACTERIOLO; Touray K, 2010, TROP MED INT HEALTH, V15, P664, DOI 10.1111/j.1365-3156.2010.02533.x; Ullah I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147529; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2015, US HIGH BURD COUNTR; World Health Organization, 2013, DEFINITIONS REPORTIN; Zelner JL, 2015, J INFECT DIS; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370	40	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171800	10.1371/journal.pone.0171800	http://dx.doi.org/10.1371/journal.pone.0171800			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182726	Green Published, Green Accepted, gold			2022-12-26	WOS:000394231800114
J	Alston, CI; Dix, RD				Alston, Christine I.; Dix, Richard D.			Murine cytomegalovirus infection of mouse macrophages stimulates early expression of suppressor of cytokine signaling (SOCS) 1 and SOCS3	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; IFN-GAMMA; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; NEGATIVE REGULATORS; INTERFERON; VIRUS; ACTIVATION; REPLICATION; PROTEINS	Human cytomegalovirus (HCMV) is a species-specific beta-herpesvirus that infects for life up to 80% of the world's population and causes severe morbidity in at-risk immunocompromised populations. Suppressors of cytokine signaling (SOCS) 1 and SOCS3 are host proteins that act as inducible negative feedback regulators of cytokine signaling and have been implicated in several ocular diseases and viral infections. We recently found in our mouse model of experimental cytomegalovirus retinitis that subretinally-injected murine cytomegalovirus (MCMV) stimulates ocular SOCS1 and SOCS3 during retrovirus-induced immune suppression of murine AIDS (MAIDS), and that infiltrating macrophages are prominent cellular sources of retinal SOCS1 and SOCS3 expression. Herein we investigate possible virologic mechanisms whereby MCMV infection may stimulate SOCS1 and/or SOCS3 expression in cell culture. We report that infection of IC-21 mouse macrophages with MCMV propagated through the salivary glands of BALB/c mice, but not from tissue culture in C57BL/6 fibroblasts, transiently stimulates SOCS1 and SOCS3 mRNA transcripts, but not SOCS5 mRNA. Viral tegument proteins are insufficient for this stimulation, as replication-deficient UV-inactivated MCMV fails to stimulate SOCS1 or SOCS3 in IC-21 macrophages. By contrast, infection of murine embryonic fibroblasts (MEFs) with either productive MCMV or UV-inactivated MCMV significantly stimulates SOCS1 and SOCS3 mRNA expression early after infection. Treatment of MCMV-infected IC-21 mouse macrophages with the antiviral drug ganciclovir significantly decreases MCMV-stimulated SOCS3 expression at 3 days post-infection. These data suggest cell type-specific, different roles for viral immediate early or early gene expression and/or viral tegument proteins in the early stimulation of SOCS1 and SOCS3 during MCMV infection. Furthermore, putative biphasic stimulation of SOCS3 during late MCMV infection of IC-21 mouse macrophages may occur by divergent virologic mechanisms.	[Alston, Christine I.; Dix, Richard D.] Georgia State Univ, Viral Immunol Ctr, Dept Biol, Atlanta, GA 30302 USA; [Alston, Christine I.; Dix, Richard D.] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; Emory University	Dix, RD (corresponding author), Georgia State Univ, Viral Immunol Ctr, Dept Biol, Atlanta, GA 30302 USA.; Dix, RD (corresponding author), Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA.	rdix@gsu.edu			NIH [EY010568, EY024630]; NIH/NEI [P30/EY006360]; Emory Eye Center Vision Training Grant [NIH/NEI T32-EY007092]; Research to Prevent Blindness; Fight for Sight; NATIONAL EYE INSTITUTE [P30EY006360, R01EY024630, T32EY007092] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Emory Eye Center Vision Training Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Fight for Sight; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH Grant EY010568 (RDD), NIH Grant EY024630 (RDD), NIH/NEI Core Grant P30/EY006360, Emory Eye Center Vision Training Grant NIH/NEI T32-EY007092, Research to Prevent Blindness, and Fight for Sight.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Ahmed Amina, 2011, Infect Disord Drug Targets, V11, P475; Akhtar LN, 2011, J VIROL, V85, P1912, DOI 10.1128/JVI.01857-10; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Alexander WS, 1999, J LEUKOCYTE BIOL, V66, P588, DOI 10.1002/jlb.66.4.588; Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Blalock EL, 2013, CYTOKINE, V61, P862, DOI 10.1016/j.cyto.2013.01.009; CARDIN RD, 1995, VIROLOGY, V209, P236, DOI 10.1006/viro.1995.1249; Cheng TP, 2010, J VIROL, V84, P2623, DOI 10.1128/JVI.02142-09; Chidrawar S, 2009, CLIN EXP IMMUNOL, V155, P423, DOI 10.1111/j.1365-2249.2008.03785.x; Cousins SW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002671; Daley-Bauer LP, 2014, CELL HOST MICROBE, V15, P351, DOI 10.1016/j.chom.2014.02.002; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Dix RD, 2004, CURR EYE RES, V29, P173, DOI 10.1080/02713680490504876; DIX RD, 1994, CURR EYE RES, V13, P587, DOI 10.3109/02713689408999892; DUDGEON JA, 1971, ARCH DIS CHILD, V46, P581, DOI 10.1136/adc.46.249.581; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Harter G, 2012, EXPERT OPIN PHARMACO, V13, P623, DOI 10.1517/14656566.2012.658775; Hahn G, 1998, P NATL ACAD SCI USA, V95, P3937, DOI 10.1073/pnas.95.7.3937; Hanson LK, 1999, J VIROL, V73, P5970, DOI 10.1128/JVI.73.7.5970-5980.1999; Hanson LK, 2001, J VIROL, V75, P6292, DOI 10.1128/JVI.75.14.6292-6302.2001; Heiden D, 2007, PLOS MED, V4, P1845, DOI 10.1371/journal.pmed.0040334; HEISE MT, 1995, J VIROL, V69, P904, DOI 10.1128/JVI.69.2.904-909.1995; Heise MT, 1998, VIROLOGY, V241, P331, DOI 10.1006/viro.1997.8969; HERMISTON TW, 1987, J VIROL, V61, P3214, DOI 10.1128/JVI.61.10.3214-3221.1987; HOLLAND GN, 1982, AM J OPHTHALMOL, V93, P393, DOI 10.1016/0002-9394(82)90127-1; Holland GN TA, 1996, CYTOMEGALOVIRUS DIS; INADA T, 1985, J GEN VIROL, V66, P871, DOI 10.1099/0022-1317-66-4-871; INADA T, 1985, J GEN VIROL, V66, P879, DOI 10.1099/0022-1317-66-4-879; Jabs DA, 1997, AM J OPHTHALMOL, V124, P227, DOI 10.1016/S0002-9394(14)70789-5; JABS DA, 1989, ARCH OPHTHALMOL-CHIC, V107, P75, DOI 10.1001/archopht.1989.01070010077031; Jabs DA, 2011, AM J OPHTHALMOL, V151, P198, DOI 10.1016/j.ajo.2010.10.018; JORDAN MC, 1982, J CLIN INVEST, V70, P762, DOI 10.1172/JCI110672; KEIL GM, 1984, J VIROL, V50, P784, DOI 10.1128/JVI.50.3.784-795.1984; KEIL GM, 1985, J VIROL, V54, P422, DOI 10.1128/JVI.54.2.422-428.1985; KEIL GM, 1987, J VIROL, V61, P526, DOI 10.1128/JVI.61.2.526-533.1987; KELSEY DK, 1976, ANTIMICROB AGENTS CH, V9, P458, DOI 10.1128/AAC.9.3.458; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Kropp KA, 2011, J VIROL, V85, P10286, DOI 10.1128/JVI.00373-11; Le VTK, 2008, J GEN VIROL, V89, P1131, DOI 10.1099/vir.0.83538-0; LOH L, 1980, INFECT IMMUN, V27, P54, DOI 10.1128/IAI.27.1.54-60.1980; Lurain NS, 2010, CLIN MICROBIOL REV, V23, P689, DOI 10.1128/CMR.00009-10; MANNING WC, 1988, VIROLOGY, V167, P477, DOI 10.1016/0042-6822(88)90110-9; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; MAR EC, 1985, J VIROL, V53, P776, DOI 10.1128/JVI.53.3.776-780.1985; MATTHEWS T, 1988, REV INFECT DIS, V10, pS490; MAUEL J, 1971, J EXP MED, V134, P335, DOI 10.1084/jem.134.2.335; MESSERLE M, 1992, J VIROL, V66, P27, DOI 10.1128/JVI.66.1.27-36.1992; MIMS CA, 1978, J GEN VIROL, V41, P143, DOI 10.1099/0022-1317-41-1-143; Mocarski E.S, 2007, FIELDS VIROLOGY, P2702; Mocarski E.S., 2001, FIELDS VIROLOGY, V2, P2629; Mocarski Jr E, 2013, FIELDS VIROLOGY, V2, P1960; Noda S, 2006, BLOOD, V107, P30, DOI 10.1182/blood-2005-05-1833; OSBORN JE, 1971, INFECT IMMUN, V3, P228, DOI 10.1128/IAI.3.2.228-236.1971; Pilgrim MJ, 2007, EXP MOL PATHOL, V82, P269, DOI 10.1016/j.yexmp.2006.12.010; Pinto AK, 2006, J IMMUNOL, V177, P3225, DOI 10.4049/jimmunol.177.5.3225; Pomeroy C, 1998, J LAB CLIN MED, V132, P124, DOI 10.1016/S0022-2143(98)90007-5; Popkin DL, 2003, P NATL ACAD SCI USA, V100, P14309, DOI 10.1073/pnas.1835673100; Prichard MN, 2011, VIRUS RES, V157, P212, DOI 10.1016/j.virusres.2010.11.004; Qin HW, 2008, J IMMUNOL, V181, P3167, DOI 10.4049/jimmunol.181.5.3167; Ruzek MC, 1997, J EXP MED, V185, P1185, DOI 10.1084/jem.185.7.1185; Saederup N, 2001, J VIROL, V75, P9966, DOI 10.1128/JVI.75.20.9966-9976.2001; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SELGRADE MK, 1981, INFECT IMMUN, V33, P840, DOI 10.1128/IAI.33.3.840-847.1981; Sharma N, 2016, SCI REP-UK, V6, DOI 10.1038/srep27685; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SINICKAS VG, 1985, J GEN VIROL, V66, P747, DOI 10.1099/0022-1317-66-4-747; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stewart MW, 2010, CLIN OPHTHALMOL, V4, P285; STODDART CA, 1994, J VIROL, V68, P6243, DOI 10.1128/JVI.68.10.6243-6253.1994; Strobl B, 2005, J IMMUNOL, V175, P4000, DOI 10.4049/jimmunol.175.6.4000; Terhune SS, 2004, J VIROL, V78, P10390, DOI 10.1128/JVI.78.19.10390-10398.2004; Trilling M, 2014, J IMMUNOL, V192, P447, DOI 10.4049/jimmunol.1203516; TYMS AS, 1987, J GEN VIROL, V68, P1563, DOI 10.1099/0022-1317-68-6-1563; Vadlapudi Aswani D, 2012, Recent Pat Antiinfect Drug Discov, V7, P8; van den Pol AN, 1999, J NEUROSCI, V19, P10948, DOI 10.1523/JNEUROSCI.19-24-10948.1999; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Watanabe S, 1996, CURR OPIN GENET DEV, V6, P587, DOI 10.1016/S0959-437X(96)80088-8; YAMAGUCHI T, 1988, J GEN VIROL, V69, P2961, DOI 10.1099/0022-1317-69-12-2961; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zimmermann A, 2005, J EXP MED, V201, P1543, DOI 10.1084/jem.20041401	86	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171812	10.1371/journal.pone.0171812	http://dx.doi.org/10.1371/journal.pone.0171812			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182772	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800117
J	Aras, D; Cakar, Z; Ozkavukcu, S; Can, A; Cinar, O				Aras, Duru; Cakar, Zeynep; Ozkavukcu, Sinan; Can, Alp; Cinar, Ozgur			In Vivo acrylamide exposure may cause severe toxicity to mouse oocytes through its metabolite glycidamide	PLOS ONE			English	Article							REPRODUCTIVE TOXICITY; GERM-CELLS; ENVIRONMENTAL DEGRADATION; MICE; POLYACRYLAMIDES; MUTAGENICITY; GENOTOXICITY; CENTROSOME; SMOKE	High acrylamide (ACR) content in heat-processed carbohydrate-rich foods, as well as roasted products such as coffee, almonds etc., has been found to be as a risk factor for carcinogenicity and genotoxicity by The World Health Organization. Glycidamide (GLY), the epoxide metabolite of ACR, is processed by the cytochrome P-450 enzyme system and has also been found to be a genotoxic agent. The aim of this study was to determine whether ACR and/or GLY have any detrimental effect on the meiotic cell division of oocytes. For this purpose, germinal vesicle-stage mouse oocytes were treated with 0, 100, 500, or 1000 mu M ACR or 0, 25, or 250 mu M GLY in vitro. In vivo experiments were performed after an intraperitoneal injection of 25 mg/kg/day ACR of female BALB/c mice for 7 days. The majority of in vitro ACR-treated oocytes reached the metaphase-II stage following 18 hours of incubation, which was not significantly different from the control group. Maturation of the oocytes derived from in vivo ACR-treated mice was impaired significantly. Oocytes, reaching the M-II stage in the in vivo ACR-treated group, were characterized by a decrease in meiotic spindle mass and an increase in chromosomal disruption. In vitro GLY treatment resulted in the degeneration of all oocytes, indicating that ACR toxicity on female germ cells may occur through its metabolite, GLY. Thus, ACR exposure must be considered, together with its metabolite GLY, when female fertility is concerned.	[Aras, Duru; Cakar, Zeynep; Can, Alp; Cinar, Ozgur] Ankara Univ, Sch Med, Dept Histol & Embryol, Labs Stem Cells & Reprod Biol, Ankara, Turkey; [Ozkavukcu, Sinan] Ankara Univ, Sch Med, Ctr Assisted Reprod, Dept Obstet & Gynecol, Ankara, Turkey	Ankara University; Ankara University	Cinar, O (corresponding author), Ankara Univ, Sch Med, Dept Histol & Embryol, Labs Stem Cells & Reprod Biol, Ankara, Turkey.	ocinar@ankara.edu.tr	cinar, ozgur/ABI-5190-2020; Can, Alp/AAO-5734-2020; Ozkavukcu, Sinan/A-8802-2019; TOSUN, Duru ARAS/L-5783-2018	cinar, ozgur/0000-0003-2901-1910; Ozkavukcu, Sinan/0000-0003-4525-9027; TOSUN, Duru ARAS/0000-0001-8236-4315	Ankara University Scientific Research Council [BAP13B3330012]	Ankara University Scientific Research Council	This study was supported by Ankara University Scientific Research Council BAP13B3330012 to SO, AC, and OC. The funders had no role in study design, data collection and analysis, decisiontopublish, orpreparation of the manuscript.	ALKarim S., 2015, ASIAN PAC J REPROD, V4, P179, DOI [10.1016/j.apjr.2015.05.001, DOI 10.1016/j.apjr.2015.05.001]; Aras D, 2016, MOL HUM REPROD, V22, P57, DOI 10.1093/molehr/gav065; Can A, 2003, MOL HUM REPROD, V9, P749, DOI 10.1093/molehr/gag093; Cinar O, 2015, TOXICOL SCI, V144, P298, DOI 10.1093/toxsci/kfu317; COSTA LG, 1992, NEUROTOXICOLOGY, V13, P219; Dobrovolsky VN, 2016, FOOD CHEM TOXICOL, V87, P120, DOI 10.1016/j.fct.2015.12.006; Doerge DR, 2005, TOXICOL APPL PHARM, V202, P258, DOI 10.1016/j.taap.2004.07.001; Duan XY, 2015, EURASIP J WIREL COMM, DOI 10.1186/s13638-015-0405-3; Dybing E, 2003, TOXICOL SCI, V75, P7, DOI 10.1093/toxsci/kfg165; Exon J H, 2006, J Toxicol Environ Health B Crit Rev, V9, P397, DOI 10.1080/10937400600681430; FAO/WHO, 2002, HLTH IMPL ACR FOOD, V90; Favor J, 2005, MUTAT RES-GEN TOX EN, V580, P21, DOI 10.1016/j.mrgentox.2004.09.010; Friedman M, 2003, J AGR FOOD CHEM, V51, P4504, DOI 10.1021/jf030204+; Ghanayem BI, 2005, BIOL REPROD, V72, P157, DOI 10.1095/biolreprod.104.033308; Hagmar L, 2001, SCAND J WORK ENV HEA, V27, P219, DOI 10.5271/sjweh.608; HASHIMOTO K, 1981, ARCH TOXICOL, V47, P179, DOI 10.1007/BF00368678; HASHIMOTO K, 1985, MUTAT RES, V158, P129, DOI 10.1016/0165-1218(85)90075-8; HE FS, 1989, SCAND J WORK ENV HEA, V15, P125, DOI 10.5271/sjweh.1878; Hsu HT, 2016, FOOD CHEM, V211, P669, DOI 10.1016/j.foodchem.2016.05.125; Hulas-Stasiak M, 2013, REPROD TOXICOL, V42, P125, DOI 10.1016/j.reprotox.2013.08.007; Liu SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135818; Manjanatha MG, 2006, ENVIRON MOL MUTAGEN, V47, P6, DOI 10.1002/em.20157; Mojska H, 2016, ANN AGR ENV MED, V23, P456, DOI 10.5604/12321966.1219187; NICNAS, 2002, ACR PRIOR EX CHEM AS; Nixon BJ, 2012, TOXICOL SCI, V129, P135, DOI 10.1093/toxsci/kfs178; SAKAMOTO J, 1986, ARCH TOXICOL, V59, P201, DOI 10.1007/BF00290538; SHIRAISHI Y, 1978, MUTAT RES, V57, P313, DOI 10.1016/0027-5107(78)90216-6; Sickles DW, 2007, TOXICOL APPL PHARM, V222, P111, DOI 10.1016/j.taap.2007.04.006; Sickles DW, 1996, J NEUROSCI RES, V46, P7, DOI 10.1002/(SICI)1097-4547(19961001)46:1<7::AID-JNR2>3.0.CO;2-P; Smith EA, 1996, ECOTOX ENVIRON SAFE, V35, P121, DOI 10.1006/eesa.1996.0091; Smith EA, 1997, ECOTOX ENVIRON SAFE, V37, P76, DOI 10.1006/eesa.1997.1527; Sobinoff AP, 2013, TOXICOL APPL PHARM, V271, P156, DOI 10.1016/j.taap.2013.05.009; SUMNER SCJ, 1992, CHEM RES TOXICOL, V5, P81, DOI 10.1021/tx00025a014; Tardiff RG, 2010, FOOD CHEM TOXICOL, V48, P658, DOI 10.1016/j.fct.2009.11.048; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; Wei QW, 2014, REPROD TOXICOL, V46, P121, DOI 10.1016/j.reprotox.2014.03.007; ZENICK H, 1986, J TOXICOL ENV HEALTH, V17, P457, DOI 10.1080/15287398609530840	37	20	22	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172026	10.1371/journal.pone.0172026	http://dx.doi.org/10.1371/journal.pone.0172026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182799	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800143
J	Barnett, LM; Hughes, TE; Drobizhev, M				Barnett, Lauren M.; Hughes, Thomas E.; Drobizhev, Mikhail			Deciphering the molecular mechanism responsible for GCaMP6m's Ca2+-dependent change in fluorescence	PLOS ONE			English	Article							2-PHOTON ABSORPTION PROPERTIES; IMAGING NEURAL ACTIVITY; CALCIUM INDICATOR; STRUCTURAL BASIS; PROTEIN; STATE; PROBE; PH; CHROMOPHORE; ACTIVATION	The goal of this work is to determine how GCaMP6m's fluorescence is altered in response to Ca2+-binding. Our detailed spectroscopic study reveals the simplest explanation for how GCaMP6m changes fluorescence in response to Ca2+ is with a four-state model, in which a Ca2+-dependent change of the chromophore protonation state, due to a shift in pK(a), is the predominant factor. The pKa shift is quantitatively explained by a change in electrostatic potential around the chromophore due to the conformational changes that occur in the protein when calmodulin binds Ca2+ and interacts with the M13 peptide. The absolute pKa values for the Ca2+-free and Ca2+-saturated states of GCaMP6m are critical to its high signal-to-noise ratio. This mechanism has important implications for further improvements to GCaMP6m and potentially for other similarly designed biosensors.	[Barnett, Lauren M.; Hughes, Thomas E.; Drobizhev, Mikhail] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Drobizhev, M (corresponding author), Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA.	mikhail.drobijev@montana.edu		Drobizhev, Mikhail/0000-0001-9072-1300; Hughes, Thomas/0000-0002-8430-070X	NINDS NIH HHS [U01 NS094246] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS094246] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; Ast C, 2015, ELIFE, V4, DOI 10.7554/eLife.07113; Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Barnett L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043454; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Bhargava Y, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00026; Boyd AM, 2015, CELL REP, V10, P1032, DOI 10.1016/j.celrep.2015.01.047; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen YX, 2013, PROTEIN CELL, V4, P299, DOI 10.1007/s13238-013-2103-4; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Dana H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108697; De Michele R, 2013, ELIFE, V2, DOI 10.7554/eLife.00800; Ding JJ, 2014, SCI CHINA LIFE SCI, V57, P269, DOI 10.1007/s11427-013-4599-5; Drobizhev M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13223; Drobizhev M, 2012, J PHYS CHEM B, V116, P1736, DOI 10.1021/jp211020k; Drobizhev M, 2011, NAT METHODS, V8, P393, DOI [10.1038/nmeth.1596, 10.1038/NMETH.1596]; Grover D, 2016, NAT METHODS, V13, P569, DOI [10.1038/NMETH.3866, 10.1038/nmeth.3866]; Han Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113873; Hanson GT, 2002, BIOCHEMISTRY-US, V41, P15477, DOI 10.1021/bi026609p; Heckscher ES, 2015, NEURON, V88, P314, DOI 10.1016/j.neuron.2015.09.009; Hinckley CA, 2015, NEURON, V87, P1008, DOI 10.1016/j.neuron.2015.08.005; Inoue M, 2015, NATURE; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Jung G, 2005, BIOPHYS J, V88, P1932, DOI 10.1529/biophysj.104.044412; Kang BE, 2016, SCI REP-UK, V6, DOI 10.1038/srep23865; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lossau H, 1996, CHEM PHYS, V213, P1, DOI 10.1016/S0301-0104(96)00340-0; Makarov NS, 2008, INTEGRATED OPTOELECT; Martin ME, 2004, J AM CHEM SOC, V126, P5452, DOI 10.1021/ja037278m; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Marvin JS, 2011, PROTEINS, V79, P3025, DOI 10.1002/prot.23118; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Odaka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100252; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sarkisyan KS, 2015, BIOPHYS J, V109, P380, DOI 10.1016/j.bpj.2015.06.018; Scott JN, 2013, J PHYS CHEM B, V117, P9598, DOI 10.1021/jp4041716; Shen Y, 2014, J CELL BIOL, V207, P419, DOI 10.1083/jcb.201404107; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Stoltzfus CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11968; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tewson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042791; Theis L, 2016, NEURON, V90, P471, DOI 10.1016/j.neuron.2016.04.014; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Treger JS, 2015, ELIFE, V4, DOI [10.7554/eLife.10482.001, 10.7554/eLife.10482]; Tsai PS, 2002, METH NE FRO NEUROSCI, P113; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Ward WW, 2006, METHOD BIOCHEM ANAL, V47, P39; Warp E, 2012, CURR BIOL, V22, P93, DOI 10.1016/j.cub.2011.12.002; WARSHEL A, 1981, BIOCHEMISTRY-US, V20, P3167, DOI 10.1021/bi00514a028; Wu JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6262; Xie DQ, 2005, J COMPUT CHEM, V26, P1487, DOI 10.1002/jcc.20273; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zhang MY, 2013, ORG BIOMOL CHEM, V11, P1414, DOI 10.1039/c2ob26914g; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	69	54	54	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170934	10.1371/journal.pone.0170934	http://dx.doi.org/10.1371/journal.pone.0170934			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182677	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800024
J	Deng, L; Li, W; Zhong, ZJ; Gong, C; Cao, XF; Song, Y; Wang, WY; Huang, XM; Liu, XH; Hu, YC; Fu, HL; He, M; Wang, Y; Zhang, Y; Wu, KJ; Peng, GN				Deng, Lei; Li, Wei; Zhong, Zhijun; Gong, Chao; Cao, Xuefeng; Song, Yuan; Wang, Wuyou; Huang, Xiangming; Liu, Xuehan; Hu, Yanchun; Fu, Hualin; He, Min; Wang, Ya; Zhang, Yue; Wu, Kongju; Peng, Guangneng			Multi-locus genotypes of Enterocytozoon bieneusi in captive Asiatic black bears in southwestern China: High genetic diversity, broad host range, and zoonotic potential	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; CRYPTOSPORIDIUM SPP.; MICROSPORIDIOSIS; SEQUENCE; IDENTIFICATION; SPECIFICITY; HOMINIS	Enterocytozoon bieneusi is an obligate eukaryotic intracellular parasite that infects a wide variety of vertebrate and invertebrate hosts. Although considerable research has been conducted on this organism, relatively little information is available on the occurrence of E. bieneusi in captive Asiatic black bears. The present study was performed to determine the prevalence, genetic diversity, and zoonotic potential of E. bieneusi in captive Asiatic black bears in zoos in southwestern China. Fecal specimens from Asiatic black bears in four zoos, located in four different cities, were collected and analyzed for the prevalence of E. bieneusi. The average prevalence of E. bieneusi was 27.4% (29/106), with the highest prevalence in Guiyang Zoo (36.4%, 16/44). Altogether, five genotypes of E. bieneusi were identified among the 29 E. bieneusi-positive samples, including three known genotypes (CHB1, SC02, and horse2) and two novel genotypes named ABB1 and ABB2. Multi-locus sequence typing using three microsatellites (MS1, MS3, and MS7) and one minisatellite (MS4) revealed V, III, V, and IV genotypes at these four loci, respectively. Phylogenetic analysis showed that the genotypes SC02 and ABB2 were clustered into group 1 of zoonotic potential, the genotypes CHB1 and ABB1 were clustered into a new group, and the genotype horse2 was clustered into group 6 of unclear zoonotic potential. In conclusion, this study identified two novel E. bieneusi genotypes in captive Asiatic black bears, and used microsatellite and minisatellite markers to reveal E. bieneusi genetic diversity. Moreover, our findings show that genotypes SC02 (identified in humans) and ABB2 belong to group 1 with zoonotic potential, suggesting the risk of transmission of E. bieneusi from Asiatic black bears to humans and other animals.	[Deng, Lei; Li, Wei; Zhong, Zhijun; Gong, Chao; Cao, Xuefeng; Song, Yuan; Wang, Wuyou; Liu, Xuehan; Hu, Yanchun; Fu, Hualin; He, Min; Peng, Guangneng] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan Provinc, Peoples R China; [Huang, Xiangming; Wang, Ya; Zhang, Yue; Wu, Kongju] Chengdu Giant Panda Breeding Res Base, Chengdu, Sichuan Provinc, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Peng, GN (corresponding author), Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan Provinc, Peoples R China.; Wu, KJ (corresponding author), Chengdu Giant Panda Breeding Res Base, Chengdu, Sichuan Provinc, Peoples R China.	646401864@qq.com; pgn.sicau@163.com	Deng, Lei/AAB-5622-2020	Deng, Lei/0000-0003-0391-6180	Chengdu giant panda breeding research foundation [CPF2014-14, CPF2015-4]	Chengdu giant panda breeding research foundation	The study was financially supported by the Chengdu giant panda breeding research foundation(CPF2014-14; CPF2015-4).	Akinbo FO, 2013, AM J TROP MED HYG, V89, P157, DOI 10.4269/ajtmh.12-0635; Deng L, 2016, PARASITES VECTORS, V9; Deng LT, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0159458, 10.137]; DESPORTES I, 1985, J PROTOZOOL, V32, P250; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier ES, 2011, CURR OPIN INFECT DIS, V24, P490, DOI 10.1097/QCO.0b013e32834aa152; Duncan RB, 1999, J WILDLIFE DIS, V35, P381, DOI 10.7589/0090-3558-35.2.381; Feng YY, 2011, APPL ENVIRON MICROB, V77, P4822, DOI 10.1128/AEM.02803-10; Fuchang Y, 2014, PARASITOL RES, V113, P1; Guo YQ, 2014, APPL ENVIRON MICROB, V80, P218, DOI 10.1128/AEM.02997-13; Karim MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117991; Li JQ, 2015, J EUKARYOT MICROBIOL, V62, P833, DOI 10.1111/jeu.12269; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Li W, 2014, PARASITOL RES, V113, P1147, DOI 10.1007/s00436-014-3752-9; Li W, 2013, INFECT GENET EVOL, V14, P111, DOI 10.1016/j.meegid.2012.11.021; Li W, 2012, INT J PARASITOL, V42, P287, DOI 10.1016/j.ijpara.2012.01.003; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; Ma JB, 2015, VET PARASITOL, V207, P220, DOI 10.1016/j.vetpar.2014.10.011; Majid P, 2013, INFECT GENET EVOL; Matos Olga, 2012, J Parasitol Res, V2012, P981424, DOI 10.1155/2012/981424; Qi M, 2016, J EUKARYOT MICROBIOL; Sak B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109751; Sak B, 2011, VET PARASITOL, V178, P246, DOI 10.1016/j.vetpar.2010.12.044; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Santin M, 2009, J EUKARYOT MICROBIOL, V56, P34, DOI 10.1111/j.1550-7408.2008.00380.x; Sulaiman IM, 2003, APPL ENVIRON MICROB, V69, P4495, DOI 10.1128/AEM.69.8.4495-4501.2003; Thellier M, 2008, PARASITE, V15, P349, DOI 10.1051/parasite/2008153349; Wagnerova P, 2015, PARASITOL RES, V114, P1619, DOI 10.1007/s00436-015-4353-y; Wang L, 2013, J CLIN MICROBIOL, V51, P557, DOI 10.1128/JCM.02758-12; Wang XT, 2016, PARASITOL RES, V115, P1355, DOI 10.1007/s00436-016-4908-6; Wei JF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1795-8; Xiao LH, 2000, J PARASITOL, V86, P1166, DOI 10.1645/0022-3395(2000)086[1166:MCOACI]2.0.CO;2; Zhao GH, 2015, INFECT GENET EVOL, V34, P394, DOI 10.1016/j.meegid.2015.07.016; Zhao W, 2016, INFECT GENET EVOL, V40, P151, DOI 10.1016/j.meegid.2016.02.037; Zhao W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142611; Zhao W, 2014, PARASITOL RES, V113, P4243, DOI 10.1007/s00436-014-4100-9	36	25	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171772	10.1371/journal.pone.0171772	http://dx.doi.org/10.1371/journal.pone.0171772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182656	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800105
J	Palombella, S; Pirrone, C; Cherubino, M; Valdatta, L; Bernardini, G; Gornati, R				Palombella, Silvia; Pirrone, Cristina; Cherubino, Mario; Valdatta, Luigi; Bernardini, Giovanni; Gornati, Rosalba			Identification of reference genes for qPCR analysis during hASC long culture maintenance	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; POLYMERASE-CHAIN-REACTION; STEM-CELLS DIFFERENTIATE; REAL-TIME; IN-VITRO; QUANTITATIVE PCR; STROMAL CELLS; RT-PCR; EXPRESSION; QUANTIFICATION	Up to now quantitative PCR based assay is the most common method for characterizing or confirming gene expression patterns and comparing mRNA levels in different sample populations. Since this technique is relative easy and low cost compared to other methods of characterization, e.g. flow cytometry, we used it to typify human adipose-derived stem cells (hASCs). hASCs possess several characteristics that make them attractive for scientific research and clinical applications. Accurate normalization of gene expression relies on good selection of reference genes and the best way to choose them appropriately is to follow the common rule of the "Best3", at least three reference genes, three different validation software and three sample replicates. Analysis was performed on hASCs cultivated until the eleventh cell confluence using twelve candidate reference genes, initially selected from literature, whose stability was evaluated by the algorithms NormFinder, BestKeeper, RefFinder and IdealRef, a home-made version of GeNorm. The best gene panel (RPL13A, RPS18, GAPDH, B2M, PPIA and ACTB), determined in one patient by IdealRef calculation, was then investigated in other four donors. Although patients demonstrated a certain gene expression variability, we can assert that ACTB is the most unreliable gene whereas ribosomal proteins (RPL13A and RPS18) show minor inconstancy in their mRNA expression. This work underlines the importance of validating reference genes before conducting each experiment and proposes a free software as alternative to those existing.	[Palombella, Silvia; Pirrone, Cristina; Cherubino, Mario; Valdatta, Luigi; Bernardini, Giovanni; Gornati, Rosalba] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Bernardini, Giovanni; Gornati, Rosalba] CNR Milano, Politecn Milan, ICRM, Prot Factory Res Ctr, Milan, Italy; [Bernardini, Giovanni; Gornati, Rosalba] Univ Insubria, Milan, Italy	University of Insubria; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Polytechnic University of Milan; University of Insubria	Gornati, R (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy.; Gornati, R (corresponding author), CNR Milano, Politecn Milan, ICRM, Prot Factory Res Ctr, Milan, Italy.; Gornati, R (corresponding author), Univ Insubria, Milan, Italy.	rosalba.gornati@uninsubria.it	Bernardini, Giovanni/GRJ-0070-2022; Cherubino, Mario/N-1780-2019; Palombella, Silvia/AAU-2251-2020; Palombella, Silvia/K-5448-2018	Cherubino, Mario/0000-0003-1196-3075; Gornati, Rosalba/0000-0002-1544-2122; Palombella, Silvia/0000-0002-7628-5677; Valdatta, Luigi/0000-0003-1568-2262				Amable PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073792; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bonora-Centelles A, 2009, CELL TRANSPLANT, V18, P1319, DOI 10.3727/096368909X12483162197321; Boraas LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145084; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chapman JR, 2015, PLOS ONE, V10; Cheng WC, 2011, PLOS ONE, V6; Cherubino M, 2016, REGEN MED, V11, P261, DOI 10.2217/rme-2015-0010; Dijkstra JR, 2014, MOL ONCOL, V8, P813, DOI 10.1016/j.molonc.2013.12.016; Du YQ, 2010, MOL VIS, V16, P2680; Fink T, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-98; Gronthos S, 2011, METHODS MOL BIOL, V702, P109, DOI 10.1007/978-1-61737-960-4_9; Holmgren G, 2015, PHYSIOL GENOMICS, V47, P232, DOI 10.1152/physiolgenomics.00130.2014; Jang S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-25; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Lee J, 2008, BIOCHEM BIOPH RES CO, V375, P547, DOI 10.1016/j.bbrc.2008.08.064; Lemma S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149481; Li X, 2015, TRANSPL P, V47, P2017, DOI 10.1016/j.transproceed.2015.06.017; Li XY, 2015, MOL MED REP, V11, P1304, DOI 10.3892/mmr.2014.2841; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rauh J, 2015, TISSUE ENG PART C-ME, V21, P192, DOI [10.1089/ten.TEC.2014.0230, 10.1089/ten.tec.2014.0230]; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schmitz HD, 2002, CELL BIOL INT, V26, P155, DOI 10.1006/cbir.2001.0819; Studer D, 2012, TISSUE ENG PART C-ME, V18, P761, DOI 10.1089/ten.tec.2012.0081; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Xie F., 2012, PLANT MOL BIOL; Yang LQ, 2011, NEUROREPORT, V22, P370, DOI 10.1097/WNR.0b013e3283469615; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	35	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170918	10.1371/journal.pone.0170918	http://dx.doi.org/10.1371/journal.pone.0170918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182697	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800023
J	Reich, HG; Robertson, DL; Goodbody-Gringley, G				Reich, Hannah G.; Robertson, Deborah L.; Goodbody-Gringley, Gretchen			Do the shuffle: Changes in Symbiodinium consortia throughout juvenile coral development	PLOS ONE			English	Article							MUSTARD HILL CORAL; GREAT-BARRIER-REEF; AMINO-ACIDS MAAS; PORITES-ASTREOIDES; MONTASTRAEA-CAVERNOSA; SCLERACTINIAN CORALS; DIVERSITY; GROWTH; SPECIFICITY; POPULATIONS	Previous studies of symbiotic associations between scleractinians corals and Symbiodinium have demonstrated that the consortium of symbionts can change in response to environmental conditions. However, less is known about symbiont shuffling during early coral development, particularly in brooding species. This study examined whether Symbiodinium consortia (1) varied in Porites astreoides on shallow (10m) and upper mesophotic (30m) reefs, (2) changed during coral development, and (3) influenced growth of juveniles in different environments. Symbiodinium ITS2 sequences were amplified using universal primers and analyzed using phylotype-specific primers designed for phylotypes A, B, and C. Adults from both depths were found to host only phylotype A, phylotypes A and B, or phylotypes A, B, and C and the frequency of the phylotype composition did not vary with depth. However, phylotype A was the dominant symbiont that was vertically transmitted to the planulae. The presence of phylotypes B and C was detected in the majority of juveniles when transplanted onto the shallow and upper mesophotic reefs whereas only phylotype A was detected in the majority of juveniles reared in outdoor aquaria. In addition, growth of juvenile P. astreoides harboring different combinations of Symbiodinium phylotypes did not vary when transplanted to different reef zones. However, juveniles reared in in situ reef environments grew faster than those reared in ex situ outdoor aquaria. These results show that Symbiodinium consortia change during development of P. astreoides and are influenced by environmental conditions.	[Reich, Hannah G.; Robertson, Deborah L.] Clark Univ, Dept Biol, Worcester, MA 01610 USA; [Goodbody-Gringley, Gretchen] Bermuda Inst Ocean Sci, 17 Biol Lane, St George, Bermuda	Clark University; Bermuda Institute of Ocean Sciences	Reich, HG (corresponding author), Clark Univ, Dept Biol, Worcester, MA 01610 USA.	hgreich16@gmail.com	Robertson, Deborah/AAF-2512-2020		PADI Foundation [14837]; Bermuda Institute of Ocean Sciences Education Department; Albert, Normaand Howard Geller '77 Endowed Research Award	PADI Foundation; Bermuda Institute of Ocean Sciences Education Department; Albert, Normaand Howard Geller '77 Endowed Research Award	This study was funded by PADI Foundation grant #14837 (www.padifoundation. org), a Bermuda Institute of Ocean Sciences Grant-I n-Aid (www.bios.edu), funding from the Bermuda Institute of Ocean Sciences Education Department (www.bios.edu), an Albert, Normaand Howard Geller '77 Endowed Research Award (ClarkUniversity George Perkins Marsh Institute; www2. clarku.edu/departments/marsh/index.cfm), and a Phycological Society of America Grant-In-Aid of Research award (www.psaalgae.org/grants-in-aido f-research-program). Allaward swere to HGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Abrego D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050311; Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2014, R LANG ENV STAT COMP; Arif C, 2014, MOL ECOL, V23, P4418, DOI 10.1111/mec.12869; ARONSON RB, 1995, J EXP MAR BIOL ECOL, V192, P1, DOI 10.1016/0022-0981(95)00052-S; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Banaszak AT, 2006, J EXP MAR BIOL ECOL, V337, P131, DOI 10.1016/j.jembe.2006.06.014; Banaszak AT, 2000, J EXP MAR BIOL ECOL, V249, P219; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bongaerts P, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140297; Bongaerts P, 2015, SCI REP-UK, V5, DOI 10.1038/srep07652; Boulotte NM, 2016, ISME J, V10, P2693, DOI 10.1038/ismej.2016.54; Byler KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059596; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; CHORNESKY EA, 1987, BIOL BULL-US, V172, P161, DOI 10.2307/1541790; Coffroth MA, 2001, MAR ECOL PROG SER, V222, P85, DOI 10.3354/meps222085; Cunning R, 2015, CORAL REEFS, V34, P155, DOI 10.1007/s00338-014-1216-4; Cunning R, 2013, NAT CLIM CHANGE, V3, P259, DOI [10.1038/NCLIMATE1711, 10.1038/nclimate1711]; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DODGE RE, 1982, B MAR SCI, V32, P745; Edmunds PJ, 2008, MAR BIOL, V154, P153, DOI 10.1007/s00227-008-0910-6; Edmunds PJ, 2004, MAR ECOL PROG SER, V278, P115, DOI 10.3354/meps278115; Edmunds PJ, 2004, BIOL BULL-US, V206, P61, DOI 10.2307/1543536; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Goodbody-Gringley G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142427; Goodbody-Gringley G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045574; Goodbody-Gringley G, 2012, MAR ECOL-EVOL PERSP, V33, P32, DOI 10.1111/j.1439-0485.2011.00452.x; Goodbody-Gringley G, 2010, MAR BIOL, V157, P2591, DOI 10.1007/s00227-010-1521-6; Goodbody-Gringley G, 2010, J EXP MAR BIOL ECOL, V389, P70, DOI 10.1016/j.jembe.2010.03.016; Green DH, 2008, MAR ECOL PROG SER, V359, P1, DOI 10.3354/meps07454; Holstein DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146068; Jackson J, 2014, STATUS TRENDS CARIBB, DOI DOI 10.1111/1365-2664.12388; JOHANNES RE, 1970, LIMNOL OCEANOGR, V15, P822, DOI 10.4319/lo.1970.15.5.0822; Jones A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010437; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kenkel CD, 2015, HEREDITY, V115, P509, DOI 10.1038/hdy.2015.52; Kenkel CD, 2013, MOL ECOL, V22, P4335, DOI 10.1111/mec.12391; Kenkel CD, 2013, MOL ECOL, V22, P4322, DOI 10.1111/mec.12390; Kopp C, 2016, SCI ADV, V29, P255; Lee MJ, 2016, MICROB ECOL, V71, P771, DOI 10.1007/s00248-015-0724-2; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Marlow HQ, 2007, EVOL DEV, V9, P355, DOI 10.1111/j.1525-142X.2007.00173.x; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Mieog JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006364; Mitchell A, 2016, FUNCT ECOL, V30, P733, DOI 10.1111/1365-2435.12535; Nitschke MR, 2016, CORAL REEFS, V35, P335, DOI 10.1007/s00338-015-1349-0; Nunes F, 2009, MOL ECOL, V18, P4283, DOI 10.1111/j.1365-294X.2009.04347.x; Padilla-Gamino JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038440; Pochon X, 2001, MAR BIOL, V139, P1069; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Reynolds JM, 2008, P NATL ACAD SCI USA, V105, P13674, DOI 10.1073/pnas.0805187105; Sambrook J., 2001, MOL CLONING LAB MANU; Savage AM, 2002, MAR ECOL PROG SER, V244, P17, DOI 10.3354/meps244017; Serrano X, 2014, MOL ECOL, V23, P4226, DOI 10.1111/mec.12861; Serrano XM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21619; SIEGEL DA, 1995, J GEOPHYS RES-OCEANS, V100, P8695, DOI 10.1029/95JC00447; Silverstein RN, 2015, GLOBAL CHANGE BIOL, V21, P236, DOI 10.1111/gcb.12706; Stambler N, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P87, DOI 10.1007/978-94-007-0114-4_7; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Stat Michael, 2011, Journal of Marine Biology, V2011, P1; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Venn AA, 2006, PLANT CELL ENVIRON, V29, P2133, DOI 10.1111/j.1365-3040.2006.001587.x; Vermeij Mark J.A., 2011, Diversity, V3, P296, DOI 10.3390/d3030296; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Yamashita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097003; Yamashita H, 2011, MAR BIOL, V158, P87, DOI 10.1007/s00227-010-1544-z; Zar JH, 1999, BIOSTATISTICAL ANAL	71	28	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171768	10.1371/journal.pone.0171768	http://dx.doi.org/10.1371/journal.pone.0171768			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182684	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800104
J	Ryu, Y; Ogata, T; Nagao, M; Kitamura, T; Morioka, K; Ichihara, Y; Doi, T; Sawada, Y; Akai, M; Nishimura, R; Fujita, N				Ryu, Youngjae; Ogata, Toru; Nagao, Motoshi; Kitamura, Taku; Morioka, Kazuhito; Ichihara, Yoshinori; Doi, Toru; Sawada, Yasuhiro; Akai, Masami; Nishimura, Ryohei; Fujita, Naoki			The swimming test is effective for evaluating spasticity after contusive spinal cord injury	PLOS ONE			English	Article							LONG-LASTING REFLEXES; PERSISTENT SODIUM; MUSCLE SPASMS; H-REFLEX; RAT; RECOVERY; MOTONEURON; RECEPTOR; EXCITABILITY; MODULATION	Spasticity is a frequent chronic complication in individuals with spinal cord injury (SCI). However, the severity of spasticity varies in patients with SCI. Therefore, an evaluation method is needed to determine the severity of spasticity. We used a contusive SCI model that is suitable for clinical translation. In this study, we examined the feasibility of the swimming test and an EMG for evaluating spasticity in a contusive SCI rat model. Sprague-Dawley rats received an injury at the 8th thoracic vertebra. Swimming tests were performed 3 to 6 weeks after SCI induction. We placed the SCI rats into spasticity-strong or spasticity-weak groups based on the frequency of spastic behavior during the swimming test. Subsequently, we recorded the Hoffman reflex (H-reflex) and examined the immunoreactivity of serotonin (5HT) and its receptor (5-HT2A) in the spinal tissues of the SCI rats. The spasticity-strong group had significantly decreased rate-dependent depression of the H-reflex compared to the spasticity-weak group. The area of 5-HT2A receptor immunoreactivity was significantly increased in the spasticity-strong group. Thus, both electrophysiological and histological evaluations indicate that the spasticity-strong group presented with a more severe upper motor neuron syndrome. We also observed the groups in their cages for 20 hours. Our results suggest that the swimming test provides an accurate evaluation of spasticity in this contusive SCI model. We believe that the swimming test is an effective method for evaluating spastic behaviors and developing treatments targeting spasticity after SCI.	[Ryu, Youngjae; Nishimura, Ryohei; Fujita, Naoki] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Surg, Tokyo, Japan; [Ryu, Youngjae; Ogata, Toru; Nagao, Motoshi; Kitamura, Taku; Morioka, Kazuhito; Ichihara, Yoshinori; Doi, Toru; Sawada, Yasuhiro; Akai, Masami] Natl Rehabil Ctr, Res Inst, Dept Rehabil Movement Funct, Saitama, Japan; [Morioka, Kazuhito] Univ Calif San Francisco, Brain & Spinal Injury Ctr, Dept Neurosurg, San Francisco, CA 94143 USA; [Akai, Masami] Int Univ Hlth & Welf, Grad Sch, Tokyo, Japan	University of Tokyo; University of California System; University of California San Francisco; International University of Health & Welfare	Ogata, T (corresponding author), Natl Rehabil Ctr, Res Inst, Dept Rehabil Movement Funct, Saitama, Japan.	toogata-tky@umin.ac.jp	Sawada, Yasuhiro/H-8044-2012; Ogata, Toru/ADC-3560-2022; Ryu, Youngjae/ABE-9618-2020; Morioka, Kazuhito/AAH-7835-2020; Doi, Toru/AAC-3441-2020	Sawada, Yasuhiro/0000-0003-0625-3335; Ogata, Toru/0000-0001-9011-8640; Ryu, Youngjae/0000-0002-7921-7856; Morioka, Kazuhito/0000-0001-5407-8178; Doi, Toru/0000-0001-8833-2437; Ichihara, Yoshinori/0000-0002-6746-5617	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [24300197, 15H03048]	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by KAKENHI (24300197, 15H03048) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Bennett DJ, 2004, J NEUROPHYSIOL, V91, P2247, DOI 10.1152/jn.00946.2003; Bennett DJ, 1999, J NEUROTRAUM, V16, P69, DOI 10.1089/neu.1999.16.69; Bose P, 2002, J NEUROTRAUM, V19, P1231, DOI 10.1089/08977150260338029; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Corleto JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144642; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; D'Amico JM, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00036; Doly S, 2004, J COMP NEUROL, V472, P496, DOI 10.1002/cne.20082; Elbasiouny SM, 2010, NEUROREHAB NEURAL RE, V24, P23, DOI 10.1177/1545968309343213; Gonzenbach RR, 2010, ANN NEUROL, V68, P48, DOI 10.1002/ana.22009; Grey MJ, 2008, EXP BRAIN RES, V185, P189, DOI 10.1007/s00221-007-1142-6; Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1158, DOI 10.1152/jn.01088.2005; Kapitza S, 2012, EXP NEUROL, V236, P179, DOI 10.1016/j.expneurol.2012.04.023; Kitzman P, 2005, EXP NEUROL, V192, P100, DOI 10.1016/j.expneurol.2004.10.021; Kong XY, 2011, NEUROSCIENCE, V177, P114, DOI 10.1016/j.neuroscience.2010.12.062; LANCE JW, 1980, NEUROLOGY, V30, P1303, DOI 10.1212/WNL.30.12.1303; Lee JK, 2007, EXP NEUROL, V203, P502, DOI 10.1016/j.expneurol.2006.09.003; Lee JK, 2005, EXP NEUROL, V196, P430, DOI 10.1016/j.expneurol.2005.08.018; Li Y, 2004, J NEUROPHYSIOL, V91, P2236, DOI 10.1152/jn.01010.2003; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; LITTLE JW, 1989, AM J PHYS MED REHAB, V68, P32, DOI 10.1097/00002060-198902000-00009; Magnuson DSK, 2009, NEUROREHAB NEURAL RE, V23, P535, DOI 10.1177/1545968308331147; Murray KC, 2011, J NEUROPHYSIOL, V105, P731, DOI 10.1152/jn.00774.2010; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Navarrett S, 2012, NEUROSCI LETT, V506, P74, DOI 10.1016/j.neulet.2011.10.052; Pandyan AD, 2005, DISABIL REHABIL, V27, P2, DOI 10.1080/09638280400014576; Reese NB, 2006, SPINAL CORD, V44, P28, DOI 10.1038/sj.sc.3101810; Roy RR, 2012, EXP NEUROL, V235, P116, DOI 10.1016/j.expneurol.2012.01.017; Schmidt BJ, 2000, BRAIN RES BULL, V53, P689, DOI 10.1016/S0361-9230(00)00402-0; Singh A, 2011, J NEUROTRAUM, V28, P2405, DOI 10.1089/neu.2010.1660; Skold C, 1999, ARCH PHYS MED REHAB, V80, P1548, DOI 10.1016/S0003-9993(99)90329-5; Skold C, 2000, ARCH PHYS MED REHAB, V81, P144, DOI 10.1016/S0003-9993(00)90132-1; Smith RR, 2006, J NEUROTRAUM, V23, P1654, DOI 10.1089/neu.2006.23.1654; Snoek GJ, 2015, FUNCTIONAL HINDRANCE; Thompson FJ, 1998, J NEUROTRAUM, V15, P495, DOI 10.1089/neu.1998.15.495; Thompson FJ, 2001, J CHILD NEUROL, V16, P2, DOI 10.1177/088307380101600102; Trompetto C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/354906	37	19	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171937	10.1371/journal.pone.0171937	http://dx.doi.org/10.1371/journal.pone.0171937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182676	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800134
J	Sheu, JJ; Chu, KT; Li, NF; Lee, CC				Sheu, Jyh-Jian; Chu, Ko-Tsung; Li, Nien-Feng; Lee, Cheng-Chi			An efficient incremental learning mechanism for tracking concept drift in spam filtering	PLOS ONE			English	Article								This research manages in-depth analysis on the knowledge about spams and expects to propose an efficient spam filtering method with the ability of adapting to the dynamic environment. We focus on the analysis of email's header and apply decision tree data mining technique to look for the association rules about spams. Then, we propose an efficient systematic filtering method based on these association rules. Our systematic method has the following major advantages: (1) Checking only the header sections of emails, which is different from those spam filtering methods at present that have to analyze fully the email's content. Meanwhile, the email filtering accuracy is expected to be enhanced. (2) Regarding the solution to the problem of concept drift, we propose a window-based technique to estimate for the condition of concept drift for each unknown email, which will help our filtering method in recognizing the occurrence of spam. (3) We propose an incremental learning mechanism for our filtering method to strengthen the ability of adapting to the dynamic environment.	[Sheu, Jyh-Jian] Natl Chengchi Univ, Coll Commun, Taipei, Taiwan; [Chu, Ko-Tsung] Minghsin Univ Sci & Technol, Dept Finance, Hsinchu, Taiwan; [Li, Nien-Feng] Yilan Cty Govt Police Bur, Yilan, Taiwan; [Lee, Cheng-Chi] Fu Jen Catholic Univ, Dept Lib & Informat Sci, Taipei, Taiwan; [Lee, Cheng-Chi] Asia Univ, Dept Photon & Commun Engn, Taichung, Taiwan	National Chengchi University; Fu Jen Catholic University; Asia University Taiwan	Chu, KT (corresponding author), Minghsin Univ Sci & Technol, Dept Finance, Hsinchu, Taiwan.; Lee, CC (corresponding author), Fu Jen Catholic Univ, Dept Lib & Informat Sci, Taipei, Taiwan.; Lee, CC (corresponding author), Asia Univ, Dept Photon & Commun Engn, Taichung, Taiwan.	ktc1009@must.edu.tw; cclee@mail.fju.edu.tw	Lee, Cheng-Chi/AGH-0724-2022; Lee, Cheng-Chi/J-4185-2016	Lee, Cheng-Chi/0000-0002-8918-1703; Lee, Cheng-Chi/0000-0002-8918-1703	Ministry of Science and Technology, Taiwan, R.O.C. [MOST 105-2410-H-004-097-MY2]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This research was partially supported by the Ministry of Science and Technology, Taiwan, R.O.C., under contract no.: MOST 105-2410-H-004-097-MY2. All funders and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bansal RP, 2014, U. S. Patent, Patent No. [8,676,903, 8676903]; Carpinter J, 2006, COMPUT SECUR, V25, P566, DOI 10.1016/j.cose.2006.06.001; Carreras X., 2001, P RANLP, P58; Chiou PR, 2013, INT CONF ADV COMMUN, P184; Cohen W. W., 1996, AAAI SPRING S MACH L, V18, P25; DeBarr D, 2012, PATTERN RECOGN LETT, V33, P1237, DOI 10.1016/j.patrec.2012.03.012; Delany SJ, 2005, KNOWL-BASED SYST, V18, P187, DOI 10.1016/j.knosys.2004.10.002; Delany SJ, 2005, TCDCS200519 COMP SCI; Derhab A., 2014, P 21 IEEE INT C TEL; Drucker H, 1999, IEEE T NEURAL NETWOR, V10, P1048, DOI 10.1109/72.788645; Du L, 2014, INTELL DATA ANAL, V18, P337, DOI 10.3233/IDA-140645; Fdez-Riverola F, 2007, EXPERT SYST APPL, V33, P36, DOI 10.1016/j.eswa.2006.04.011; Fdez-Riverola F, 2007, DECIS SUPPORT SYST, V43, P722, DOI 10.1016/j.dss.2006.11.012; Hayat M. Zi, 2010, 2010 5th International Symposium on Telecommunications (IST), P531, DOI 10.1109/ISTEL.2010.5734082; He J., 2007, P 4 C EM ANT CEAS; Hsiao WF, 2008, EXPERT SYST APPL, V34, P1599, DOI 10.1016/j.eswa.2007.01.018; Jayanthi S.K., 2014, COMPUT SCI TELECOMMU, V41, P3; Khan WZ, 2015, IEEE COMMUN SURV TUT, V17, P2271, DOI 10.1109/COMST.2015.2459015; Klinkenberg R., 2004, Intelligent Data Analysis, V8, P281; Koychev I., 2005, P 25 SGAI INT C INN, P46; Lai CC, 2007, KNOWL-BASED SYST, V20, P249, DOI 10.1016/j.knosys.2006.05.016; Lazarescu M. M., 2004, Intelligent Data Analysis, V8, P29; Liu YN, 2014, ADV MATER RES-SWITZ, V846-847, P1672, DOI 10.4028/www.scientific.net/AMR.846-847.1672; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Prasse P, 2015, J MACH LEARN RES, V16, P3687; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Quinlan JR, 1996, J ARTIF INTELL RES, V4, P77, DOI 10.1613/jair.279; Rafique M.Z., 2011, P 16 GEN EV COMP C D; Sanpakdee U, 2006, ADV COMM TECHN ICACT, V1, P441; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Sheu JJ, 2009, INT J INNOV COMPUT I, V5, P3717; Stanley K.O, 2003, UTAITR03302 U TEX AU; Tretyakov K., 2004, TECHNICAL REPORT; Wang CC, 2007, COMPUT SECUR, V26, P381, DOI 10.1016/j.cose.2006.12.012; Widmer G, 1996, MACH LEARN, V23, P69, DOI 10.1007/BF00116900; Zhou B, 2014, J INTELL INF SYST, V42, P19, DOI 10.1007/s10844-013-0254-7	37	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171518	10.1371/journal.pone.0171518	http://dx.doi.org/10.1371/journal.pone.0171518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182691	Green Submitted, gold, Green Published			2022-12-26	WOS:000394231800068
J	Sung, JY; Tani, J; Chang, TS; Lin, CSY				Sung, Jia-Ying; Tani, Jowy; Chang, Tsui-San; Lin, Cindy Shin-Yi			Uncovering sensory axonal dysfunction in asymptomatic type 2 diabetic neuropathy	PLOS ONE			English	Article							STRENGTH-DURATION PROPERTIES; GLYCEMIC CONTROL; MOTOR AXONS; EXCITABILITY PROPERTIES; NERVE EXCITABILITY; NA+ CURRENTS; CONDUCTION; ISCHEMIA	This study investigated sensory and motor nerve excitability properties to elucidate the development of diabetic neuropathy. A total of 109 type 2 diabetes patients were recruited, and 106 were analyzed. According to neuropathy severity, patients were categorized into G0, G1, and G2+3 groups using the total neuropathy score-reduced (TNSr). Patients in the G0 group were asymptomatic and had a TNSr score of 0. Sensory and motor nerve excitability data from diabetic patients were compared with data from 33 healthy controls. Clinical assessment, nerve conduction studies, and sensory and motor nerve excitability testing data were analyzed to determine axonal dysfunction in diabetic neuropathy. In the G0 group, sensory excitability testing revealed increased stimulus for the 50% sensory nerve action potential (P<0.05), shortened strength-duration time constant (P<0.01), increased superexcitability (P<0.01), decreased subexcitability (P<0.05), decreased accommodation to depolarizing current (P<0.01), and a trend of decreased accommodation to hyperpolarizing current in threshold electrotonus. All the changes progressed into G1 (TNSr 1-8) and G2+3 (TNSr 9-24) groups. In contrast, motor excitability only had significantly increased stimulus for the 50% compound motor nerve action potential (P<0.01) in the G0 group. This study revealed that the development of axonal dysfunction in sensory axons occurred prior to and in a different fashion from motor axons. Additionally, sensory nerve excitability tests can detect axonal dysfunction even in asymptomatic patients. These insights further our understanding of diabetic neuropathy and enable the early detection of sensory axonal abnormalities, which may provide a basis for neuroprotective therapeutic approaches.	[Sung, Jia-Ying; Tani, Jowy] Taipei Med Univ, Wan Fang Hosp, Dept Neurol, Taipei, Taiwan; [Sung, Jia-Ying; Chang, Tsui-San] Taipei Med Univ, Sch Med, Dept Neurol, Coll Med, Taipei, Taiwan; [Tani, Jowy] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Tani, Jowy; Lin, Cindy Shin-Yi] Natl Hlth Res Inst, Taipei, Taiwan; [Lin, Cindy Shin-Yi] Taipei Med Univ, Coll Med Sci & Technol, Neural Regenerat Med, Taipei, Taiwan; [Lin, Cindy Shin-Yi] Univ New South Wales, Fac Med, Sch Med Sci, Translat Neurosci,Dept Physiol, Sydney, NSW, Australia	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; National Health Research Institutes - Taiwan; Taipei Medical University; University of New South Wales Sydney	Lin, CSY (corresponding author), Natl Hlth Res Inst, Taipei, Taiwan.	c.lin@unsw.edu.au		Lin, Cindy Shin-Yi/0000-0003-2379-7369				[Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; BRISMAR T, 1987, ANN NEUROL, V21, P504, DOI 10.1002/ana.410210515; BRISMAR T, 1993, DIABETIC MED, V10, pS110, DOI 10.1111/j.1464-5491.1993.tb00216.x; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Cavaletti G, 2003, NEUROLOGY, V61, P1297, DOI 10.1212/01.WNL.0000092015.03923.19; Cherian PV, 1996, J DIABETES COMPLICAT, V10, P192, DOI 10.1016/1056-8727(95)00084-4; Chowdhury SKR, 2013, NEUROBIOL DIS, V51, P56, DOI 10.1016/j.nbd.2012.03.016; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dyck PJ, 2011, MUSCLE NERVE, V44, P340, DOI 10.1002/mus.22074; Han SE, 2010, J PHYSIOL-LONDON, V588, P1737, DOI 10.1113/jphysiol.2010.188169; Hoeijmakers JGJ, 2014, TRENDS MOL MED, V20, P544, DOI 10.1016/j.molmed.2014.06.003; Hofmeijer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067113; Kiernan MC, 2004, J PHYSIOL-LONDON, V558, P341, DOI 10.1113/jphysiol.2004.063966; Kiernan MC, 2001, MUSCLE NERVE, V24, P883; Kiernan MC, 2000, BRAIN, V123, P2542, DOI 10.1093/brain/123.12.2542; Kitano Y, 2004, ANN NEUROL, V56, P462, DOI 10.1002/ana.20232; Krishnan AV, 2008, BRAIN, V131, P1209, DOI 10.1093/brain/awn052; Krishnan AV, 2008, J PERIPHER NERV SYST, V13, P7, DOI 10.1111/j.1529-8027.2008.00155.x; Krishnan AV, 2005, BRAIN, V128, P1178, DOI 10.1093/brain/awh476; Kuwabara S, 2002, INTERNAL MED, V41, P360, DOI 10.2169/internalmedicine.41.360; Kwai NCG, 2013, DIABETES CARE, V36, P1272, DOI 10.2337/dc12-1310; Lauria G, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0538-5; Lin CSY, 2002, J PHYSIOL-LONDON, V541, P1025, DOI 10.1113/jphysiol.2002.017848; Misawa S, 2006, NEUROLOGY, V66, P1545, DOI 10.1212/01.wnl.0000216260.39452.bf; Misawa S, 2005, CLIN NEUROPHYSIOL, V116, P254, DOI 10.1016/j.clinph.2004.08.003; Misawa S, 2009, J PERIPHER NERV SYST, V14, P279, DOI 10.1111/j.1529-8027.2009.00239.x; Mogyoros I, 1998, BRAIN, V121, P851, DOI 10.1093/brain/121.5.851; Mogyoros I, 1997, BRAIN, V120, P317, DOI 10.1093/brain/120.2.317; Moon HI, 2014, CLIN NEUROPHYSIOL, V125, P844, DOI 10.1016/j.clinph.2013.10.041; Sung JY, 2012, DIABETES, V61, P1592, DOI 10.2337/db11-1509; Van Acker K, 2009, DIABETES METAB, V35, P206, DOI 10.1016/j.diabet.2008.11.004; Vucic S, 2014, CLIN NEUROPHYSIOL, V125, P657, DOI 10.1016/j.clinph.2013.10.042; Waxman SG, 2014, NAT NEUROSCI, V17, P153, DOI 10.1038/nn.3602; Zenker J, 2013, TRENDS NEUROSCI, V36, P439, DOI 10.1016/j.tins.2013.04.008; Zenker J, 2012, J NEUROSCI, V32, P7493, DOI 10.1523/JNEUROSCI.0719-12.2012	37	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171223	10.1371/journal.pone.0171223	http://dx.doi.org/10.1371/journal.pone.0171223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182728	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800048
J	Backman, TWH; Evans, DS; Girke, T				Backman, Tyler William H.; Evans, Daniel S.; Girke, Thomas			Large-scale bioactivity analysis of the small molecule assayed proteome	PLOS ONE			English	Article							DRUG; DATABASE; RESOURCE	This study presents an analysis of the small molecule bioactivity profiles across large quantities of diverse protein families represented in PubChem BioAssay. We compared the bioactivity profiles of FDA approved drugs to non-FDA approved compounds, and report several distinct patterns characteristic of the approved drugs. We found that a large fraction of the previously reported higher target promiscuity among FDA approved compounds, compared to non-FDA approved bioactives, was frequently due to cross-reactivity within rather than across protein families. We identified 804 potentially novel protein target candidates for FDA approved drugs, as well as 901 potentially novel target candidates with active non-FDA approved compounds, but no FDA approved drugs with activity against these targets. We also identified 486348 potentially novel compounds active against the same targets as FDA approved drugs, as well as 153402 potentially novel compounds active against targets without active FDA approved drugs. By quantifying the agreement among replicated screens, we estimated that more than half of these novel outcomes are reproducible. Using biclustering, we identified many dense clusters of FDA approved drugs with enriched activity against a common set of protein targets. We also report the distribution of compound promiscuity using a Bayesian statistical model, and report the sensitivity and specificity of two common methods for identifying promiscuous compounds. Aggregator assays exhibited greater accuracy in identifying highly promiscuous compounds, while PAINS substructures were able to identify a much larger set of "middle range" promiscuous compounds. Additionally, we report a large number of promiscuous compounds not identified as aggregators or PAINS. In summary, the results of this study represent a rich reference for selecting novel drug and target protein candidates, as well as for eliminating candidate compounds with unselective activities.	[Backman, Tyler William H.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Backman, Tyler William H.; Girke, Thomas] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Evans, Daniel S.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA	University of California System; University of California Riverside; University of California System; University of California Riverside; California Pacific Medical Center; California Pacific Medical Center Research Institute	Girke, T (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	thomas.girke@ucr.edu		Backman, Tyler/0000-0002-6056-353X	National Science Foundation [ABI-0957099, MRI-1429826]; National Institutes of Health [U24AG051129, 1S10OD016290-01A1]; NATIONAL INSTITUTE ON AGING [U24AG051129] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Science Foundation: ABI-0957099 and MRI-1429826 to TG; and the National Institutes of Health: U24AG051129 to DE, and 1S10OD016290-01A1 to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman TWH, 2016, J CHEM INF MODEL; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bastian M., 2009, 3 INT AAAI C WEBL SO; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Cao Y, 2008, BIOINFORMATICS, V24, P1733, DOI 10.1093/bioinformatics/btn307; Cheng TJ, 2010, BIOINFORMATICS, V26, P2881, DOI 10.1093/bioinformatics/btq550; Consortium TU, 2011, NUCLEIC ACIDS RES, V40; Csardi G, 2006, INTERJOURNAL; Dancik V, 2014, J BIOMOL SCREEN, V19, P771, DOI 10.1177/1087057113520226; Dandapani S, 2010, NAT CHEM BIOL, V6, P861, DOI 10.1038/nchembio.479; Eddy Sean R, 2009, Genome Inform, V23, P205; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Han LY, 2009, BIOINFORMATICS, V25, P2251, DOI 10.1093/bioinformatics/btp380; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hauser M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-248; Hewett M, 2002, NUCLEIC ACIDS RES, V30, P163, DOI 10.1093/nar/30.1.163; Howe EA, 2015, NUCLEIC ACIDS RES, V43, pD1163, DOI 10.1093/nar/gku1244; Hu Y, 2013, F1000RES; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Jalencas X, 2013, MEDCHEMCOMM, V4, P80, DOI 10.1039/c2md20242e; Jasial S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153873; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Kumar R., 2013, ISRN CHEM ENG, V2013, P10, DOI DOI 10.1371/JOURNAL.PONE.0078174; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; Lee Shun J., 2009, Journal of Biology (London), V8, P30, DOI 10.1186/jbiol134; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Moya-Garcia AA, 2013, BIOINFORMATICS, V29, P1934, DOI 10.1093/bioinformatics/btt321; Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065; Saubern S, 2011, MOL INFORM, V30, P847, DOI 10.1002/minf.201100076; Schmidt U, 2009, NUCLEIC ACIDS RES, V37, pD295, DOI 10.1093/nar/gkn850; Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; van Uitert M, 2008, J COMPUT BIOL, V15, P1329, DOI 10.1089/cmb.2008.0066; Visser U, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-257; Wang YL, 2014, NUCLEIC ACIDS RES, V42, pD1075, DOI 10.1093/nar/gkt978; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wassermann AM, 2010, CHEMMEDCHEM, V5, P847, DOI 10.1002/cmdc.201000064; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yan SF, 2006, J CHEM INF MODEL, V46, P2381, DOI 10.1021/ci060102u; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867; Zhang JI, 2011, ANAL CHEM, V83, P4738, DOI 10.1021/ac1030946	57	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171413	10.1371/journal.pone.0171413	http://dx.doi.org/10.1371/journal.pone.0171413			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178331	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500040
J	Tripathi, VS; Brandt, AR				Tripathi, Vinay S.; Brandt, Adam R.			Estimating decades-long trends in petroleum field energy return on investment (EROI) with an engineering-based model	PLOS ONE			English	Article							OIL PRODUCTION; GHG EMISSIONS; GAS; EFFICIENCY	This paper estimates changes in the energy return on investment (EROI) for five large petroleum fields over time using the Oil Production Greenhouse Gas Emissions Estimator (OPGEE). The modeled fields include Cantarell (Mexico), Forties (U.K.), Midway-Sunset (U.S.), Prudhoe Bay (U.S.), and Wilmington (U.S.). Data on field properties and production/ processing parameters were obtained from a combination of government and technical literature sources. Key areas of uncertainty include details of the oil and gas surface processing schemes. We aim to explore how long-term trends in depletion at major petroleum fields change the effective energetic productivity of petroleum extraction. Four EROI ratios are estimated for each field as follows: The net energy ratio (NER) and external energy ratio (EER) are calculated, each using two measures of energy outputs, (1) oil-only and (2) all energy outputs. In all cases, engineering estimates of inputs are used rather than expenditure -based estimates (including off-site indirect energy use and embodied energy). All fields display significant declines in NER over the modeling period driven by a combination of (1) reduced petroleum production and (2) increased energy expenditures on recovery methods such as the injection of water, steam, or gas. The fields studied had NER reductions ranging from 46% to 88% over the modeling periods (accounting for all energy outputs). The reasons for declines in EROI differ by field. Midway-Sunset experienced a 5-fold increase in steam injected per barrel of oil produced. In contrast, Prudhoe Bay has experienced nearly a 30-fold increase in amount of gas processed and reinjected per unit of oil produced. In contrast, EER estimates are subject to greater variability and uncertainty due to the relatively small magnitude of external energy investments in most cases.	[Tripathi, Vinay S.; Brandt, Adam R.] Stanford Univ, Dept Energy Resources Engn, Stanford, CA 94305 USA	Stanford University	Brandt, AR (corresponding author), Stanford Univ, Dept Energy Resources Engn, Stanford, CA 94305 USA.	abrandt@stanford.edu			Stanford University	Stanford University(Stanford University)	VST was supported by Stanford University faculty support funds to ARB during the writing of this paper.	Alford WO, 1983, DOEET120595; [Anonymous], ANN REP STAT OIL GAS; [Anonymous], ALASKA OIL GAS CONSE; [Anonymous], INJ HIST PRUDH BAY P; AOGCC Pool Statistics Prudhoe Bay Unit, PRUDH OIL POOL; Bartosh EJ, 1938, AAPG BULL, V22, P1048; Beal C, 1945, DRILLING PRODUCTION; Berman B, 1987, GEOLOGIC FIELD GUIDE, P99; Brand PJ, 1996, J PETROL TECHNOL, V48, P280, DOI 10.2118/30440-JPT; Brandt AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144141; Brandt AR, 2015, ENVIRON SCI TECHNOL, V49, P13059, DOI 10.1021/acs.est.5b03540; Brandt AR, 2013, ENERGY, V55, P693, DOI 10.1016/j.energy.2013.03.080; Brandt AR, 2011, SUSTAINABILITY-BASEL, V3, P1833, DOI 10.3390/su3101833; Bujanos J.L. Sanchez, 2005, SPE LAT AM CAR PETR; Carpenter DE, 1992, SPE DOE ENH OIL REC; Chesterman A, 2009, 124605 SPE, V124605; Department for Business, ENT REG REF WELL INJ; Department for Business, ENT REG REF WELL PRO; El-Houjeiri HM, 2013, ENVIRON SCI TECHNOL, V47, P5998, DOI 10.1021/es304570m; El-Houjeiri HM, 2016, USER GUIDE TECHNICAL; El-Houjeiri HM, 2016, MODEL OIL PRODUCTION; Frame RG, 1957, ANN REPORT CALFORNIA, V43, P59; Hall CAS, 1981, ENERGY ECOLOGICAL MO, V1, P715; Hanson ES, 1985, SPE CAL REG M; Hook M, 2009, ENERG POLICY, V37, P2262, DOI 10.1016/j.enpol.2009.02.020; Hu Y, 2011, SUSTAINABILITY-BASEL, V3, P2323, DOI 10.3390/su3122323; Huey WF, 1964, ANN REPORT CALFORNIA, V50, P5; Kettles R, 2001, OFFSH TECHN C; Littlewood R, 2013, AP CORP 36 GAS LIFT; Lozada M, 2014, SPE INT S EXH FORM D; Murphy DJ, 2011, SUSTAINABILITY-BASEL, V3, P1888, DOI 10.3390/su3101888; Nogovitsyn R, 2014, SUSTAINABILITY-BASEL, V6, P6751, DOI 10.3390/su6106751; Odum HT, 2013, ENV POWER SOC 21 CEN; Parshall J, 2015, J PETROLEUM TECHNOLO; Poisson A, 2013, ENERGIES, V6, P5940, DOI 10.3390/en6115940; Rohatgi A., 2015, WEBPLOTDIGITIZER VER; Smith MI, 1997, OFFSH EUR C; Sun Y, 2015, OPERATING DATA CEIP; Thomas M, 2015, FORTIES AT 40 E P; Tripathi V. S., 2016, THESIS; UK Monthly Oil Production, UK MONTHL OIL PROD; Vafi K, 2014, ENVIRON SCI TECHNOL, V48, P10511, DOI 10.1021/es502107s; Webb MG, 1978, J CANADIAN PETROLEUM, V17; White B, 2015, PRUDHOE GAS SALES 20	44	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171083	10.1371/journal.pone.0171083	http://dx.doi.org/10.1371/journal.pone.0171083			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178318	Green Published, Green Submitted, gold			2022-12-26	WOS:000393712500021
J	Shadab, M; Jha, B; Asad, M; Deepthi, M; Kamran, M; Ali, N				Shadab, Md.; Jha, Baijayanti; Asad, Mohammad; Deepthi, Makaraju; Kamran, Mohd.; Ali, Nahid			Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; MITOCHONDRIAL DYSFUNCTION; MEDIATED APOPTOSIS; LIPID FORMULATIONS; OXIDATIVE STRESS; IMMUNE-RESPONSE; PLASMA-MEMBRANE; PHOSPHATIDYLSERINE; MECHANISMS; INHIBITION	Objective The present study aimed to elucidate the cell death mechanism in Leishmania donovani upon treatment with KalsomeTM10, a new liposomal amphotericin B. Methodology/Principal findings We studied morphological alterations in promastigotes through phase contrast and scanning electron microscopy. Phosphatidylserine (PS) exposure, loss of mitochondrial membrane potential and disruption of mitochondrial integrity was determined by flow cytometry using annexinV-FITC, JC-1 and mitotraker, respectively. For analysing oxidative stress, generation of H2O2 (bioluminescence kit) and mitochondrial superoxide O-2(-) (mitosox) were measured. DNA fragmentation was evaluated using terminal deoxyribonucleotidyl transferase mediated dUTP nick-end labelling (TUNEL) and DNA laddering assay. We found that KalsomeTM10 is more effective then Ambisome against the promastigote as well as intracellular amastigote forms. The mechanistic study showed that KalsomeTM10 induced several morphological alterations in promastigotes typical of apoptosis. KalsomeTM10 treatment showed a dose-and time-dependent exposure of PS in promastigotes. Further, study on mitochondrial pathway revealed loss of mitochondrial membrane potential as well as disruption in mitochondrial integrity with depletion of intracellular pool of ATP. KalsomeTM10 treated promastigotes showed increased ROS production, diminished GSH levels and increased caspase-like activity. DNA fragmentation and cell cycle arrest was observed in KalsomeTM10 treated promastigotes. Apoptotic DNA fragmentation was also observed in KalsomeTM10 treated intracellular amastigotes. KalsomeTM10 induced generation of ROS and nitric oxide leads to the killing of the intracellular parasites. Moreover, endocytosis is indispensable for KalsomeTM10 mediated anti-leishmanial effect in host macrophage. Conclusions KalsomeTM10 induces apoptotic-like cell death in L. donovani parasites to exhibit its antileishmanial function.	[Shadab, Md.; Jha, Baijayanti; Asad, Mohammad; Deepthi, Makaraju; Kamran, Mohd.; Ali, Nahid] Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Ali, N (corresponding author), Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata, W Bengal, India.	nali@iicb.res.in	KAMRAN, MOHD/ABF-8235-2021; Asad, Mohammad/AAE-4367-2020	KAMRAN, MOHD/0000-0001-9007-6735; Asad, Mohammad/0000-0003-3078-200X; Shadab, Mohammad/0000-0003-4148-0365	Council of Scientific and Industrial Research (CSIR), Government of India; CSIR-Senior Research Fellow [31/002(0831)/2010/EMR-I]; Indian Council of Medical Research (ICMR)	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR-Senior Research Fellow; Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	This work was supported through grants from Council of Scientific and Industrial Research (CSIR), Government of India to MS, a CSIR-Senior Research Fellow (No. 31/002(0831)/2010/EMR-I) and Indian Council of Medical Research (ICMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Asad M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0928-6; Awasthi BP, 2016, APOPTOSIS, V21, P941, DOI 10.1007/s10495-016-1259-9; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Banerjee A, 2008, J ANTIMICROB CHEMOTH, V61, P103, DOI 10.1093/jac/dkm396; Berman J, 2003, CURR OPIN INFECT DIS, V16, P397, DOI 10.1097/00001432-200310000-00005; Bogdan C, 1998, INT J PARASITOL, V28, P121, DOI 10.1016/S0020-7519(97)00169-0; Borutaite V, 2010, ENVIRON MOL MUTAGEN, V51, P406, DOI 10.1002/em.20564; Boswell GW, 1998, J CLIN PHARMACOL, V38, P583, DOI 10.1002/j.1552-4604.1998.tb04464.x; Brajtburg J, 1996, CLIN MICROBIOL REV, V9, P512, DOI 10.1128/CMR.9.4.512; Chowdhury S, 2012, EMBO MOL MED, V4, P1126, DOI 10.1002/emmm.201201316; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cohen-Sfady M, 2009, J IMMUNOL, V183, P890, DOI 10.4049/jimmunol.0804238; de Souza W, 2009, INT J BIOCHEM CELL B, V41, P2069, DOI 10.1016/j.biocel.2009.04.007; Debrabant A, 2003, INT J PARASITOL, V33, P257, DOI 10.1016/S0020-7519(03)00008-0; Di Giorgio C, 1999, J ANTIMICROB CHEMOTH, V44, P71, DOI 10.1093/jac/44.1.71; Dupont B, 2002, J ANTIMICROB CHEMOTH, V49, P31, DOI 10.1093/jac/49.suppl_1.31; Dutta A, 2007, J MED MICROBIOL, V56, P1196, DOI 10.1099/jmm.0.47114-0; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Gannavaram S, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00095; Gonzalez IJ, 2007, INT J PARASITOL, V37, P161, DOI 10.1016/j.ijpara.2006.10.004; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hiemenz JW, 1996, CLIN INFECT DIS, V22, pS133, DOI 10.1093/clinids/22.Supplement_2.S133; Holzmuller P, 2002, INFECT IMMUN, V70, P3727, DOI 10.1128/IAI.70.7.3727-3735.2002; Imbert L, 2012, ANAL BIOANAL CHEM, V402, P1169, DOI 10.1007/s00216-011-5520-3; Islamuddin M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00626; Kathuria M, 2014, ANTIMICROB AGENTS CH, V58, P5916, DOI 10.1128/AAC.02459-14; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; LANG T, 1994, J CELL SCI, V107, P2137; Lee N, 2002, CELL DEATH DIFFER, V9, P53, DOI 10.1038/sj.cdd.4400952; Lee N, 2007, EUKARYOT CELL, V6, P1745, DOI 10.1128/EC.00123-07; Lee SH, 2013, CELL DEATH DIFFER, V20, P64, DOI 10.1038/cdd.2012.93; Legrand P, 1996, J ANTIMICROB CHEMOTH, V37, P519, DOI 10.1093/jac/37.3.519; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200; Mishra J, 2013, INDIAN J MED RES, V137, P767; Mojic M, 2012, MOL PHARMACOL, V82, P700, DOI 10.1124/mol.112.077842; Mondal S, 2010, EXPERT REV ANTI-INFE, V8, P919, DOI 10.1586/ERI.10.78; Mourdjeva M, 2005, APOPTOSIS, V10, P209, DOI 10.1007/s10495-005-6076-5; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Nagao G, 2010, ANTICANCER RES, V30, P3167; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Persaud-Sawin DA, 2009, GLIA, V57, P320, DOI 10.1002/glia.20759; Ribeiro GA, 2013, J ANTIMICROB CHEMOTH, V68, P789, DOI 10.1093/jac/dks498; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Roy A, 2008, MOL PHARMACOL, V74, P1292, DOI 10.1124/mol.108.050161; Russo R, 1996, J INFECTION, V32, P133, DOI 10.1016/S0163-4453(96)91343-2; Saar Y, 1998, MOL BIOCHEM PARASIT, V95, P9, DOI 10.1016/S0166-6851(98)00062-0; Salih NA, 2014, TROP MED INT HEALTH, V19, P146, DOI 10.1111/tmi.12238; Sardar AH, 2013, EXP PARASITOL, V135, P715, DOI 10.1016/j.exppara.2013.10.011; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Shibuya-Fujiwara N, 2001, LIFE SCI, V70, P291, DOI 10.1016/S0024-3205(01)01392-3; SHIMASAKI H, 1994, METHOD ENZYMOL, V233, P338; Sinha R, 2015, ANTIMICROB AGENTS CH, V59, P344, DOI 10.1128/AAC.03305-14; Sundar S, 2010, J GLOB INFECT DIS, V2, P159, DOI 10.4103/0974-777X.62886; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vishwakarma P, 2016, J MOL MED, V94, P695, DOI 10.1007/s00109-016-1384-5; Waterhouse NJ, 1998, CELL DEATH DIFFER, V5, P1051, DOI 10.1038/sj.cdd.4400425; Weingartner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042070; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zangger H, 2002, CELL DEATH DIFFER, V9, P1126, DOI 10.1038/sj.cdd.4401071	73	40	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171306	10.1371/journal.pone.0171306	http://dx.doi.org/10.1371/journal.pone.0171306			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170432	gold, Green Submitted, Green Published			2022-12-26	WOS:000393705500031
J	Qu, F; Weschler, LB; Sun, YX; Sundell, J				Qu, Fang; Weschler, Louise B.; Sun, Yuexia; Sundell, Jan			High pneumonia lifetime-ever incidence in Beijing children compared with locations in other countries, and implications for national PCV and Hib vaccination	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; COMMUNITY-ACQUIRED PNEUMONIA; POPULATION-BASED SURVEILLANCE; INDOOR AIR-POLLUTION; CHILDHOOD PNEUMONIA; YOUNG-CHILDREN; RESPIRATORY-INFECTIONS; PRESCHOOL-CHILDREN; GLOBAL BURDEN; DISEASE	Objectives To compare the proportion of Beijing children who have ever had pneumonia (%Pneumonia) to those in other locations, and to estimate by how much national vaccine coverage with Pneumococcal Conjugate Vaccine (PCV) and Haemophilus lnfluenzae Type b (Hib) could reduce Beijing %Pneumonia. Methods %Pneumonia was obtained for each age group from 1 to 8 years inclusive from 5,876 responses to a cross-sectional questionnaire. Literature searches were conducted for world-wide reports of %Pneumonia. Previous vaccine trials conducted worldwide were used to estimate the pneumococcal (S. pneumoniae) and Hib (H. influenzae) burdens and % Pneumonia as well as the potential for PCV and Hib vaccines to reduce Beijing children's % Pneumonia. Findings The majority of pneumonia cases occurred by the age of three. The cumulative %Pneumonia for 3-8 year-old Beijing children, 26.9%, was only slightly higher than the 25.4% for the discrete 3 year-old age group, similar to trends for Tianjin (China) and Texas (USA). Beijing's %Pneumonia is disproportionally high relative to its Gross National Income (GNI) per capita, and markedly higher than %Pneumonia in the US and other high GNI per capita countries. Chinese diagnostic guidelines recommend chest X-ray confirmation while most other countries discourage it in favor of clinical diagnosis. Literature review shows that chest X-ray confirmation returns far fewer pneumonia diagnoses than clinical diagnosis. Accordingly, Beijing's %Pneumonia is likely higher than indicated by raw numbers. Vaccine trials suggest that national PCV and Hib vaccination could reduce Beijing's %Pneumonia from 26.9% to 19.7% and 24.9% respectively. Conclusion National PCV and Hib vaccination programs would substantially reduce Beijing children's pneumonia incidence.	[Qu, Fang] China Meteorol Adm, China Meteorol Adm Training Ctr, Beijing, Peoples R China; [Qu, Fang; Sundell, Jan] Tsinghua Univ, Dept Bldg Sci, Beijing, Peoples R China; [Sun, Yuexia] Tianjin Univ, Sch Environm Sci & Engn, Tianjin, Peoples R China	China Meteorological Administration; Tsinghua University; Tianjin University		lulu.weschler1@gmail.com		Weschler, Louise/0000-0002-5778-6134				Benavides JA, 2012, VACCINE, V30, P5886, DOI 10.1016/j.vaccine.2012.03.054; Andrade AL, 2012, VACCINE, V30, P1901, DOI 10.1016/j.vaccine.2011.12.012; Arguedas A, 2012, VACCINE, V30, P2342, DOI 10.1016/j.vaccine.2012.01.047; Ayalon I, 2013, PEDIATR EMERG CARE, V29, P893, DOI 10.1097/PEC.0b013e31829e7d6a; Ben Shimol S, 2012, EUR J PEDIATR, V171, P369, DOI 10.1007/s00431-011-1543-1; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Bruce N, 2007, B WORLD HEALTH ORGAN, V85, P535, DOI 10.2471/BLT.06.035832; Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; Castro-Rodriguez JA, 1999, AM J RESP CRIT CARE, V159, P1891, DOI 10.1164/ajrccm.159.6.9811035; Centers for Disease Control and Prevention, MMWR MORB MORTAL WKL; Che DT, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-56; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chiu SS, 2016, J MICROBIOL IMMUNOL, V49, P225, DOI 10.1016/j.jmii.2014.05.007; Clark JE, 2007, ARCH DIS CHILD, V92, P394, DOI 10.1136/adc.2006.097402; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Feikin DR, 2014, LANCET, V383, P1762, DOI 10.1016/S0140-6736(13)61682-7; Feng Xing Lin, 2012, J Glob Health, V2, P010405, DOI 10.7189/jogh.02.010405; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; Garces-Sanchez M D, 2005, An Pediatr (Barc), V63, P125; Gessner BD, 2014, VACCINE, V32, P3133, DOI 10.1016/j.vaccine.2014.04.019; GROSSMAN LK, 1988, ANN EMERG MED, V17, P43, DOI 10.1016/S0196-0644(88)80502-X; Guan XH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011721; Gupta D, 1996, J TROP PEDIATRICS, V42, P196, DOI 10.1093/tropej/42.4.196; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hazir T, 2006, BMJ-BRIT MED J, V333, P629, DOI 10.1136/bmj.38915.673322.80; Ho PL, 2007, VACCINE, V25, P6837, DOI 10.1016/j.vaccine.2007.07.039; Hvistendahl M, 2012, SCIENCE, V336, P795, DOI 10.1126/science.336.6083.795; International Vaccine Access Center (IVAC), 2016, VACC INF MAN SYST VI; Kuti BP, 2014, WORLD J MED MED SCI, V2, P1; Leonardi GS, 2002, EUR RESPIR J, V20, P890, DOI 10.1183/09031936.02.00260802; Li AG, 2014, CHINESE SCI BULL, V59, P2024, DOI 10.1007/s11434-014-0241-6; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Liu W, 2014, INDOOR BUILT ENVIRON, V23, P270, DOI 10.1177/1420326X13516970; Lu C, 2014, INDOOR BUILT ENVIRON, V23, P259, DOI 10.1177/1420326X13504423; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; Lucero MG, 2005, LANCET, V365, P1113, DOI 10.1016/S0140-6736(05)71853-5; Lynch T, 2004, PEDIATRICS, V113, pE186, DOI 10.1542/peds.113.3.e186; Lynch Tim, 2010, PLoS One, V5, pe11989, DOI 10.1371/journal.pone.0011989; MacIntyre CR, 2003, EPIDEMIOL INFECT, V131, P1091, DOI 10.1017/S0950268803001365; Madhi SA, 2013, PEDIATR INFECT DIS J, V32, pE119, DOI 10.1097/INF.0b013e3182784b26; Medicine CSoR, 2006, CHIN J TUBERCUL RESP, V29, P651; Mulholland EK, 2004, J HEALTH POPUL NUTR, V22, P257; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nelson JC, 2008, VACCINE, V26, P4947, DOI 10.1016/j.vaccine.2008.07.016; Neuman MI, 2010, PEDIATR EMERG CARE, V26, P817, DOI 10.1097/PEC.0b013e3181fb0d95; Njeze N. R., 2011, Advances in Bio Research, V2, P18; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Grady KAF, 2014, PNEUMONIA, V5, P38, DOI 10.15172/pneu.2014.5/482; Pilishvili T, 2013, J PEDIATR-US, V163, pS12, DOI 10.1016/j.jpeds.2013.03.025; POPE CA, 1989, AM J PUBLIC HEALTH, V79, P623, DOI 10.2105/AJPH.79.5.623; Qu F, 2013, CHINESE SCI BULL, V58, P4190, DOI 10.1007/s11434-013-5790-6; Richter SS, 2014, ANTIMICROB AGENTS CH, V58, P6484, DOI 10.1128/AAC.03344-14; Roca A, 2010, VACCINE, V28, P4851, DOI 10.1016/j.vaccine.2010.03.060; Rothrock SG, 2001, PEDIATR EMERG CARE, V17, P240, DOI 10.1097/00006565-200108000-00003; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Saadatian-Elahi M, 2016, VACCINE, V34, P1139, DOI 10.1016/j.vaccine.2016.01.021; Schnabel E, 2009, EUR J PEDIATR, V168, P1251, DOI 10.1007/s00431-008-0921-9; Shah S, 2010, PEDIATR INFECT DIS J, V29, P406, DOI 10.1097/INF.0b013e3181cb45a7; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Sun YX, 2011, J ASTHMA, V48, P790, DOI 10.3109/02770903.2011.604884; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P172, DOI 10.1093/ije/dyq033; Turner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054026; Wagner AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097800; Weigl JAI, 2003, EUR J PEDIATR, V162, P309, DOI 10.1007/s00431-002-1140-4; Wikipedia, 2016, LIST CHIN ADM DIV GD; World Bank, 2016, SCROLL EC GROWTH GDP; World Bank, 2016, SCROLL EC GROWTH GNI; Yan Shujuan, 2014, Zhonghua Yu Fang Yi Xue Za Zhi, V48, P484; Zhang YP, 2013, CHINESE SCI BULL, V58, P4182, DOI 10.1007/s11434-013-5914-z; Zhang YP, 2013, ENVIRON HEALTH PERSP, V121, P751, DOI 10.1289/ehp.1205983	71	14	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171438	10.1371/journal.pone.0171438	http://dx.doi.org/10.1371/journal.pone.0171438			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166256	Green Submitted, gold, Green Published			2022-12-26	WOS:000393700100043
J	Steenholt, JV; Nielsen, C; Baudewijn, L; Staal, A; Rasmussen, KS; Sabir, HJ; Barington, T; Husby, S; Toft-Hansen, H				Steenholt, Janni V.; Nielsen, Christian; Baudewijn, Leen; Staal, Anne; Rasmussen, Karina S.; Sabir, Hardee J.; Barington, Torben; Husby, Steffen; Toft-Hansen, Henrik			The composition of T cell subtypes in duodenal biopsies are altered in coeliac disease patients	PLOS ONE			English	Article							INTRAEPITHELIAL LYMPHOCYTES; SMALL-INTESTINE; PREVALENCE; CHILDREN; GLUTEN; EXPRESSION; PEPTIDES; TRIGGERS; COMPLEX; CD4(+)	One of the hallmarks of Celiac disease (CD) is intraepithelial lymphocytosis in the small intestine. Until now, investigations to characterize the T cell subpopulations within the epithelial layer have not discriminated between the heterodimeric co -receptor molecule, CD8 alpha beta, and the possibly immunoregulatory CD8 alpha alpha homodimer molecule. Besides TCR alpha beta+ CD4+ cells, no other phenotypes have been shown to be gluten -reactive. Using flow cytometry on lymphocytes from duodenal biopsies, we determined that the number of B cells (CD3-CD19 +) and the number of CD3+ CD4-CD8-double -negative (DN) T cells were elevated 6-7 fold in children with CD. We next isolated and quantified intraepithelial lymphocytes (IELs) from biopsies obtained from patients (both children and adults) with CD, potential CD and non -CD controls. Flow cytometric analysis of the duodenal T cell subpopulations was performed including the markers TCR alpha beta, TCR gamma delta, CD4, CD8a and CD8 beta. Proportions of gamma delta T cells and CD8 alpha beta+ cells among IELs were increased in CD patients, whereas proportions of CD4+ CD8 alpha alpha+ and CD4+ single -positive T cells were decreased. Additionally, two gluten -reactive T cell lines (TCLs) derived from CD biopsies were analyzed for changes in proportions of T cell subsets before and after gluten stimulation. In a proliferation assay, dividing cells were tracked with carboxyfluorescein succinimidyl ester (CFSE), and both alpha beta and gamma delta T cells proliferated in response to gluten. Changes in duodenal T cell subpopulations in potential CD patients followed the same pattern as for CD patients, but with less pronounced effect.	[Steenholt, Janni V.; Staal, Anne; Rasmussen, Karina S.; Husby, Steffen; Toft-Hansen, Henrik] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Odense, Denmark; [Steenholt, Janni V.; Nielsen, Christian; Baudewijn, Leen; Staal, Anne; Rasmussen, Karina S.; Sabir, Hardee J.; Barington, Torben; Toft-Hansen, Henrik] Odense Univ Hosp, Dept Clin Immunol, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Husby, S (corresponding author), Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Odense, Denmark.	steffen.husby@rsyd.dk	Barington, Torben/R-6841-2019; Barington, Torben/C-3922-2009	Barington, Torben/0000-0001-6968-148X; Husby, Steffen/0000-0002-6286-2496; Nielsen, Christian/0000-0002-5711-6595	Danish Council for Strategic Research, Programme Commission on Health, Food and Welfare [0603-00199B]; Odense University Hospital Research Council; Novo Nordisk Fonden [NNF14OC0012869] Funding Source: researchfish; The Danish Cancer Society [R71-A4807] Funding Source: researchfish	Danish Council for Strategic Research, Programme Commission on Health, Food and Welfare; Odense University Hospital Research Council; Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	This project was funded by The Danish Council for Strategic Research, Programme Commission on Health, Food and Welfare (contract no. 0603-00199B), and by a grant from Odense University Hospital Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2012, SEMIN IMMUNOPATHOL, V34, P551, DOI 10.1007/s00281-012-0316-x; Calleja S, 2011, DIGEST DIS SCI, V56, P2042, DOI 10.1007/s10620-010-1534-5; Carton J, 2004, EUR J GASTROEN HEPAT, V16, P961, DOI 10.1097/00042737-200410000-00003; Cheroutre H, 2008, IMMUNITY, V28, P149, DOI 10.1016/j.immuni.2008.01.005; Di Sabatino A, 2006, GUT, V55, P469, DOI 10.1136/gut.2005.068684; du Pre MF, 2015, BEST PRACT RES CL GA, V29, P413, DOI 10.1016/j.bpg.2015.04.001; Dydensborg S, 2012, ACTA PAEDIATR, V101, P179, DOI 10.1111/j.1651-2227.2011.02392.x; FERGUSON A, 1971, GUT, V12, P988, DOI 10.1136/gut.12.12.988; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Jarvinen TT, 2003, AM J GASTROENTEROL, V98, P1332, DOI 10.1016/S0002-9270(03)00230-2; JENKINS D, 1986, GUT, V27, P1330, DOI 10.1136/gut.27.11.1330; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kupfer Sonia S, 2012, Gastrointest Endosc Clin N Am, V22, P639, DOI 10.1016/j.giec.2012.07.003; Lonardi S, 2013, VIRCHOWS ARCH, V463, P409, DOI 10.1007/s00428-013-1448-7; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Mayans S, 2014, IMMUNITY, V41, P207, DOI 10.1016/j.immuni.2014.07.010; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Meresse B, 2012, IMMUNITY, V36, P907, DOI 10.1016/j.immuni.2012.06.006; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; SELBY WS, 1983, CLIN EXP IMMUNOL, V52, P219; Shaw S K, 1995, Semin Immunol, V7, P335, DOI 10.1016/1044-5323(95)90014-4; Silvester JA, 2016, CLIN PRACTICE J AM G; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Sperandeo MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021281; TERRY LA, 1990, TISSUE ANTIGENS, V35, P82, DOI 10.1111/j.1399-0039.1990.tb01761.x; Toft-Hansen H, 2014, CLIN IMMUNOL, V153, P323, DOI 10.1016/j.clim.2014.05.009; Tosco A, 2011, CLIN GASTROENTEROL H, V9, P320, DOI 10.1016/j.cgh.2010.09.006; VERKASALO MA, 1990, GUT, V31, P422, DOI 10.1136/gut.31.4.422; Volta U, 2015, CLIN PRACTICE J AM G; Witherden DA, 2013, J LEUKOCYTE BIOL, V94, P69, DOI 10.1189/jlb.0213101	41	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170270	10.1371/journal.pone.0170270	http://dx.doi.org/10.1371/journal.pone.0170270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166225	Green Submitted, Green Published, gold			2022-12-26	WOS:000393700100008
J	Liu, Z; Yanagisawa, K; Griesing, S; Iwai, M; Kano, K; Hotta, N; Kajino, T; Suzuki, M; Takahashi, T				Liu, Z.; Yanagisawa, K.; Griesing, S.; Iwai, M.; Kano, K.; Hotta, N.; Kajino, T.; Suzuki, M.; Takahashi, T.			TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas	ONCOGENE			English	Article							DNA-DAMAGE; THYROID TRANSCRIPTION; CHK1; ONCOGENE; EXPRESSION; CANCER; GENE; ACTIVATION; SURVIVAL; TARGETS	TTF-1, also known as NKX2-1, is a transcription factor that has indispensable roles in both lung development and physiology. We and others have reported that TTF-1 frequently exhibits high expression with increased copy number in lung adenocarcinomas, and also has a role as a lineage-survival oncogene through transcriptional activation of crucial target genes including ROR1 and LMO3. In the present study, we employed a global proteomic search for proteins that interact with TTF-1 in order to provide a more comprehensive picture of this still enigmatic lineage-survival oncogene. Our results unexpectedly revealed a function independent of its transcriptional activity, as TTF-1 was found to interact with DDB1 and block its binding to CHK1, which in turn attenuated ubiquitylation and subsequent degradation of CHK1. Furthermore, TTF-1 overexpression conferred resistance to cellular conditions under DNA replication stress (RS) and prevented an increase in consequential DNA double-strand breaks, as reflected by attenuated induction of pCHK2 and gamma H2AX. Our findings suggest that the novel non-transcriptional function of TTF-1 identified in this study may contribute to lung adenocarcinoma development by conferring tolerance to DNA RS, which is known to be inherently elicited by activation of various oncogenes.	[Liu, Z.; Yanagisawa, K.; Griesing, S.; Iwai, M.; Kano, K.; Hotta, N.; Kajino, T.; Suzuki, M.; Takahashi, T.] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Mol Carcinogenesis, Nagoya, Aichi, Japan	Nagoya University	Takahashi, T (corresponding author), Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Mol Carcinogenesis,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	tak@med.nagoya-u.ac.jp	Takahashi, Takashi/I-7262-2014	Takahashi, Takashi/0000-0003-0615-7001; Liu, Zhuoran/0000-0002-6679-4136	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; China Scholarship Council; Grants-in-Aid for Scientific Research [16H06277, 25293191, 15H05910, 25640076] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); China Scholarship Council(China Scholarship Council); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Science (JSPS) and by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. Zhuoran Liu was supported by a fellowship from the China Scholarship Council.	Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartkova J, 2007, ONCOGENE, V26, P7414, DOI 10.1038/sj.onc.1210553; Cardnell RJG, 2015, CLIN CANCER RES, V21, P3480, DOI 10.1158/1078-0432.CCR-14-3286; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guo TN, 2015, NAT MED, V21, P407, DOI 10.1038/nm.3807; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hills SA, 2014, CURR BIOL, V24, pR435, DOI 10.1016/j.cub.2014.04.012; Hosono Y, 2012, EMBO J, V31, P481, DOI 10.1038/emboj.2011.416; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Isogaya K, 2014, CELL RES, V24, P994, DOI 10.1038/cr.2014.97; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Lee MN, 2007, CLIN CANCER RES, V13, P832, DOI 10.1158/1078-0432.CCR-05-2694; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Lopez-Contreras AJ, 2012, J EXP MED, V209, P455, DOI 10.1084/jem.20112147; Maeda Y, 2006, J BIOL CHEM, V281, P9600, DOI 10.1074/jbc.M510435200; Maeda Y, 2012, J CLIN INVEST, V122, P4388, DOI 10.1172/JCI64048; Meuth M, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-21; Missero C, 2001, J BIOL CHEM, V276, P33569, DOI 10.1074/jbc.M104963200; Mizuno K, 2002, ONCOGENE, V21, P2328, DOI 10.1038/sj.onc.1205402; Osada H, 2002, ONCOGENE, V21, P2418, DOI 10.1038/sj.onc.1205303; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Tell G, 2002, J BIOL CHEM, V277, P14564, DOI 10.1074/jbc.M200582200; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Watanabe H, 2013, GENE DEV, V27, P197, DOI 10.1101/gad.203208.112; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yamaguchi T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10060; Yamaguchi T, 2013, CANCER CELL, V23, P718, DOI 10.1016/j.ccr.2013.04.002; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yatabe Y, 2002, AM J SURG PATHOL, V26, P767, DOI 10.1097/00000478-200206000-00010; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	41	16	17	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 29	2017	36	26					3740	3748		10.1038/onc.2016.524	http://dx.doi.org/10.1038/onc.2016.524			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY9WM	28192407				2022-12-26	WOS:000404349700009
J	Liu, BC; Hu, JZ; Wang, JN; Kong, DC				Liu, Bochao; Hu, Jiazhi; Wang, Jingna; Kong, Daochun			Direct Visualization of RNA-DNA Primer Removal from Okazaki Fragments Provides Support for Flap Cleavage and Exonucleolytic Pathways in Eukaryotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; SACCHAROMYCES-CEREVISIAE; POLYMERASE-DELTA; YEAST; EXCISION; PROTEIN; FEN-1; EXONUCLEASE; MATURATION; INTERACTS	During DNA replication in eukaryotic cells, short single stranded DNA segments known as Okazaki fragments are first synthesized on the lagging strand. The Okazaki fragments originate from similar to 35-nucleotide-long RNA-DNA primers. After Okazaki fragment synthesis, these primers must be removed to allow fragment joining into a continuous lagging strand. To date, the models of enzymatic machinery that removes the RNADNA primers have come almost exclusively from biochemical reconstitution studies and some genetic interaction assays, and there is little direct evidence to confirm these models. One obstacle to elucidating Okazaki fragment processing has been the lack of methods that can directly examine primer removal in vivo. In this study, we developed an electron microscopy assay that can visualize nucleotide flap structures on DNA replication forks in fission yeast (Schizosaccharomyces pombe). With this assay, we first demonstrated the generation of flap structures during Okazaki fragment processing in vivo. The mean and median lengths of the flaps in wild-type cells were similar to 51 and similar to 41 nucleotides, respectively. We also used yeast mutants to investigate the impact of deleting key DNA replication nucleases on these flap structures. Our results provided direct in vivo evidence for a previously proposed flap cleavage pathway and the critical function of Dna2 and Fen1 in cleaving these flaps. In addition, we found evidence for another previously proposed exonucleolytic pathway involving RNA-DNA primer digestion by exonucleases RNase H2and Exo1. Taken together, our observations suggest a dual mechanism for Okazaki fragment maturation in lagging strand synthesis and establish	[Liu, Bochao; Hu, Jiazhi; Wang, Jingna; Kong, Daochun] Peking Univ, Coll Life Sci, Peking Tsinghua Ctr Life Sci, Natl Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Peking University	Kong, DC (corresponding author), Peking Univ, Coll Life Sci, Peking Tsinghua Ctr Life Sci, Natl Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	kongdc@pku.edu.cn		Hu, Jiazhi/0000-0002-6345-0039	National Natural Science Foundation of China [31230021, 31400674]; Ministry of Science and Technology of China [2013CB911000]; Peking-Tsinghua Center for Life Sciences; School of Life Sciences; National Key Laboratory of Protein and Plant Gene Research	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Peking-Tsinghua Center for Life Sciences; School of Life Sciences; National Key Laboratory of Protein and Plant Gene Research	This work was supported by National Natural Science Foundation of China Grants 31230021 (to D.K.) and 31400674 (to J.W.), Ministry of Science and Technology of China Grant 2013CB911000 (to D.K.), and Peking-Tsinghua Center for Life Sciences, School of Life Sciences, and the National Key Laboratory of Protein and Plant Gene Research (to D.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; BULLOCK PA, 1991, MOL CELL BIOL, V11, P2350, DOI 10.1128/MCB.11.5.2350; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; BUSEN W, 1977, EUR J BIOCHEM, V74, P203, DOI 10.1111/j.1432-1033.1977.tb11382.x; BUSEN W, 1975, EUR J BIOCHEM, V52, P179, DOI 10.1111/j.1432-1033.1975.tb03985.x; ENGLER MJ, 1983, J BIOL CHEM, V258, P1197; Finger L David, 2012, Subcell Biochem, V62, P301, DOI 10.1007/978-94-007-4572-8_16; GOULIAN M, 1990, J BIOL CHEM, V265, P18461; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030; ISHIMI Y, 1988, J BIOL CHEM, V263, P19723; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; Kang HY, 2000, GENETICS, V155, P1055; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Levikova M, 2015, NUCLEIC ACIDS RES, V43, P7888, DOI 10.1093/nar/gkv710; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Liu SF, 2015, TECTONICS, V34, P413, DOI 10.1002/2014TC003784; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Miyabe I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002407; Mueser TC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-359; MURAKAMI Y, 1992, P NATL ACAD SCI USA, V89, P952, DOI 10.1073/pnas.89.3.952; OGAWA T, 1984, MOL GEN GENET, V193, P231, DOI 10.1007/BF00330673; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Qiu JZ, 1999, J BIOL CHEM, V274, P17893, DOI 10.1074/jbc.274.25.17893; Qiu JZ, 2004, J BIOL CHEM, V279, P24394, DOI 10.1074/jbc.M401464200; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; SAKABE K, 1966, BIOCHIM BIOPHYS ACTA, V129, P651, DOI 10.1016/0005-2787(66)90088-8; SIEGAL G, 1992, P NATL ACAD SCI USA, V89, P9377, DOI 10.1073/pnas.89.20.9377; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Stodola JL, 2016, NAT STRUCT MOL BIOL, V23, P402, DOI 10.1038/nsmb.3207; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; WAGA S, 1994, J BIOL CHEM, V269, P10923; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048	53	32	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4777	4788		10.1074/jbc.M116.758599	http://dx.doi.org/10.1074/jbc.M116.758599			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28159842	hybrid, Green Published			2022-12-26	WOS:000397590400003
J	Arita, M; Fertala, J; Hou, C; Kostas, J; Steplewski, A; Fertala, A				Arita, Machiko; Fertala, Jolanta; Hou, Cheryl; Kostas, James; Steplewski, Andrzej; Fertala, Andrzej			Prospects and limitations of improving skeletal growth in a mouse model of spondyloepiphyseal dysplasia caused by R992C (p.R1192C) substitution in collagen II	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOGENESIS IMPERFECTA; MECHANICAL-PROPERTIES; C57B1/6 MICE; BONE-GROWTH; TRANSPLANTATION; EXPRESSION; CARTILAGE; CHILDREN; THERAPEUTICS	Skeletal dysplasias form a group of skeletal disorders caused by mutations in macromolecules of cartilage and bone. The severity of skeletal dysplasias ranges from precocious arthropathy to perinatal lethality. Although the pathomechanisms of these disorders are generally well defined, the feasibility of repairing established aberrant skeletal tissues that developed in the presence of mutant molecules is currently unknown. Here, we employed a validated mouse model of spondyloepiphyseal dysplasia (SED) that enables temporal control of the production of the R992C (p.R1192C) collagen II mutant that causes this disease. Although in our earlier studies we determined that blocking the expression of this mutant at the early prenatal stages prevents a SED phenotype, the utility of blocking the R992C collagen II at the postnatal stages is not known. Here, by switching off the expression of R992C collagen II at various postnatal stages of skeletal development, we determined that significant improvements of cartilage and bone morphology were achieved only when blocking the production of the mutant molecules was initiated in newborn mice. Our study indicates that future therapies of skeletal dysplasias may require defining a specific time window when interventions should be applied to be successful.	[Arita, Machiko; Fertala, Jolanta; Hou, Cheryl; Kostas, James; Steplewski, Andrzej; Fertala, Andrzej] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Orthopaed Surg, Philadelphia, PA 19107 USA	Jefferson University	Fertala, A (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Orthopaed Surg, Philadelphia, PA 19107 USA.	andrzej.fertala@jefferson.edu						Arita M, 2015, AM J PATHOL, V185, P214, DOI 10.1016/j.ajpath.2014.09.003; Arnold WV, 2013, INT J BIOCHEM CELL B, V45, P1556, DOI 10.1016/j.biocel.2013.05.017; Briggs MD, 2015, EXPERT OPIN ORPHAN D, V3, P1137, DOI 10.1517/21678707.2015.1083853; Brodt MD, 1999, J BONE MINER RES, V14, P2159, DOI 10.1359/jbmr.1999.14.12.2159; Cabral WA, 2002, J BIOL CHEM, V277, P4215, DOI 10.1074/jbc.M109048200; Chambers MG, 2002, OSTEOARTHR CARTILAGE, V10, P51, DOI 10.1053/joca.2001.0481; CHAN D, 1993, J BIOL CHEM, V268, P15238; Chan JKY, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00223; Chung HJ, 2009, J MOL BIOL, V390, P306, DOI 10.1016/j.jmb.2009.05.004; Dawson PA, 2000, NUCLEIC ACIDS RES, V28, P4013, DOI 10.1093/nar/28.20.4013; Farquharson C, 2000, POULTRY SCI, V79, P994, DOI 10.1093/ps/79.7.994; Fertala A, 2001, BIOCHEMISTRY-US, V40, P14422, DOI 10.1021/bi0109109; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Gawron K, 2010, BIOCHEM BIOPH RES CO, V396, P213, DOI 10.1016/j.bbrc.2010.04.056; Gotherstrom C, 2014, STEM CELL TRANSL MED, V3, P255, DOI 10.5966/sctm.2013-0090; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Horwitz EM, 2001, BLOOD, V97, P1227, DOI 10.1182/blood.V97.5.1227; Ito H, 2005, J MOL BIOL, V352, P382, DOI 10.1016/j.jmb.2005.07.019; Jensen DA, 2011, HUM MUTAT, V32, P794, DOI 10.1002/humu.21506; Kanazawa H, 2003, J BONE MINER METAB, V21, P307, DOI 10.1007/s00774-003-0425-7; Kveiborg M, 2006, J BONE MINER RES, V21, P1288, DOI 10.1359/JBMR.060502; Le Blanc K, 2005, TRANSPLANTATION, V79, P1607, DOI 10.1097/01.TP.0000159029.48678.93; Lefebvre V, 2010, CURR TOP DEV BIOL, V90, P291, DOI 10.1016/S0070-2153(10)90008-2; Lin XB, 2014, J AM SOC NEPHROL, V25, P687, DOI 10.1681/ASN.2013070798; McBratney-Owen B, 2008, DEV BIOL, V322, P121, DOI 10.1016/j.ydbio.2008.07.016; Merritt TM, 2007, AM J PATHOL, V170, P293, DOI 10.2353/ajpath.2007.060530; Millington-Ward S, 2005, TRENDS MOL MED, V11, P299, DOI 10.1016/j.molmed.2005.04.006; Okada M, 2015, HUM MOL GENET, V24, P299, DOI 10.1093/hmg/ddu444; Peace BE, 2005, MOL THER, V12, P128, DOI 10.1016/j.ymthe.2005.02.015; POOLE CA, 1992, J CELL SCI, V103, P1101; POOLE CA, 1987, J ORTHOP RES, V5, P509, DOI 10.1002/jor.1100050406; Posey KL, 2014, J BONE MINER RES, V29, P1258, DOI 10.1002/jbmr.2139; Prein C, 2016, MATRIX BIOL, V50, P1, DOI 10.1016/j.matbio.2015.10.001; Richman C, 2001, J BONE MINER RES, V16, P386, DOI 10.1359/jbmr.2001.16.2.386; Rochet Jean-Christophe, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000385; Sloan LA, 2009, CURR OPIN DRUG DISC, V12, P666; Somerville JN, 2004, CALCIFIED TISSUE INT, V74, P469, DOI 10.1007/s00223-003-0101-x; Wang Q, 1996, J CLIN INVEST, V97, P448, DOI 10.1172/JCI118434; Yamashita A, 2014, NATURE, V513, P507, DOI 10.1038/nature13775	40	3	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172068	10.1371/journal.pone.0172068	http://dx.doi.org/10.1371/journal.pone.0172068			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182776	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800148
J	Buzanskas, ME; Ventura, RV; Chud, TCS; Bernardes, PA; Santos, DJD; Regitano, LCD; de Alencar, MM; Mudadu, MD; Zanella, R; da Silva, MVGB; Li, CX; Schenkel, FS; Munari, DP				Buzanskas, Marcos Eli; Ventura, Ricardo Vieira; Seleguim Chud, Tatiane Cristina; Bernardes, Priscila Arrigucci; de Abreu Santos, Daniel Jordan; de Almeida Regitano, Luciana Correia; de Alencar, Mauricio Mello; Mudadu, Mauricio de Alvarenga; Zanella, Ricardo; Gualberto Barbosa da Silva, Marcos Vinicius; Li, Changxi; Schenkel, Flavio Schramm; Munari, Danisio Prado			Study on the introgression of beef breeds in Canchim cattle using single nucleotide polymorphism markers	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; GROWTH TRAITS; ASSOCIATION; PREDICTION	The aim of this study was to evaluate the level of introgression of breeds in the Canchim (CA: 62.5% Charolais-37.5% Zebu) and MA genetic group (MA: 65.6% Charolais-34.4% Zebu) cattle using genomic information on Charolais (CH), Nelore (NE), and Indubrasil (IB) breeds. The number of animals used was 395 (CA and MA), 763 (NE), 338 (CH), and 37 (IB). The Bovine50SNP BeadChip from Illumina panel was used to estimate the levels of introgression of breeds considering the Maximum likelihood, Bayesian, and Single Regression method. After genotype quality control, 32,308 SNPs were considered in the analysis. Furthermore, three thresholds to prune out SNPs in linkage disequilibrium higher than 0.10, 0.05, and 0.01 were considered, resulting in 15,286, 7,652, and 1,582 SNPs, respectively. For k = 2, the proportion of taurine and indicine varied from the expected proportion based on pedigree for all methods studied. For k = 3, the Regression method was able to differentiate the animals in three main clusters assigned to each purebred breed, showing more reasonable according to its biological viewpoint. Analyzing the data considering k = 2 seems to be more appropriate for Canchim-MA animals due to its biological interpretation. The usage of 32,308 SNPs in the analyses resulted in similar findings between the estimated and expected breed proportions. Using the Regression approach, a contribution of Indubrasil was observed in Canchim-MA when k = 3 was considered. Genetic parameter estimation could account for this breed composition information as a source of variation in order to improve the accuracy of genetic models. Our findings may help assemble appropriate reference populations for genomic prediction for Canchim-MA in order to improve prediction accuracy. Using the information on the level of introgression in each individual could also be useful in breeding or crossing design to improve individual heterosis in crossbred cattle.	[Buzanskas, Marcos Eli; Seleguim Chud, Tatiane Cristina; Bernardes, Priscila Arrigucci; Munari, Danisio Prado] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Ciencias Exatas, Sao Paulo, Brazil; [Ventura, Ricardo Vieira] BIO, Guelph, ON, Canada; [Ventura, Ricardo Vieira] Univ Sao Paulo, FZEA, Dept Ciencias Basicas, Sao Paulo, Brazil; [de Abreu Santos, Daniel Jordan] Univ Estadual Paulista, Fac Ciencias Agrarias Vet, Sao Paulo, Brazil; [de Almeida Regitano, Luciana Correia; de Alencar, Mauricio Mello] Embrapa Southeast Livestock, Sao Carlos, SP, Brazil; [Mudadu, Mauricio de Alvarenga] Embrapa Agr Informat, Campinas, SP, Brazil; [Zanella, Ricardo] Univ Passo Fundo, Fac Agron Med Vet, Rio De Janeiro, Brazil; [Gualberto Barbosa da Silva, Marcos Vinicius] Embrapa Dairy Cattle, Juiz De Fora, MG, Brazil; [Li, Changxi] Univ Alberta, Dept Agr Food & Nutrit Sci, Edmonton, AB, Canada; [Li, Changxi] Lacombe Res & Dev Ctr, Agr & Agri Food Canada, 6000 C&E Trail, Lacombe, AB, Canada; [Schenkel, Flavio Schramm] Univ Guelph, CGIL, Dept Anim & Poultry Sci, Guelph, ON, Canada	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Passo Fundo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Alberta; Agriculture & Agri Food Canada; University of Guelph	Munari, DP (corresponding author), Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Ciencias Exatas, Sao Paulo, Brazil.	danisio@fcav.unesp.br	Schenkel, Flavio/ABG-1842-2021; Zanella, Ricardo/AAM-8508-2020; de Alvarenga Mudadu, Maurício/B-6524-2014; Buzanskas, Marcos Eli/C-8147-2012; Munari, Danisio P/C-6384-2012; Silva, Marcos Vinicius Gualberto Barbosa/AAS-1837-2020; de Almeida Regitano, Luciana Correia/C-7002-2012; Bernardes, Priscila Arrigucci/L-3170-2018; Zanella, Ricardo/A-4644-2011	Zanella, Ricardo/0000-0003-1449-6708; de Alvarenga Mudadu, Maurício/0000-0002-2767-2507; Buzanskas, Marcos Eli/0000-0002-2728-079X; Munari, Danisio P/0000-0001-6915-038X; Silva, Marcos Vinicius Gualberto Barbosa/0000-0001-5449-1413; de Almeida Regitano, Luciana Correia/0000-0001-9242-8351; Bernardes, Priscila Arrigucci/0000-0003-0864-8621; Zanella, Ricardo/0000-0003-1449-6708; Alencar, Mauricio/0000-0002-6102-663X; Schenkel, Flavio/0000-0001-8700-0633; Jordan de Abreu Santos, Daniel/0000-0002-7062-3372	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [449564/2014-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [02663/09-0]; Sao Paulo Research Foundation [FAPESP - 2012/23638-8]; FAPESP [2013/19335-2, 2015/08939-0, 2015/25096-6, 2015/12396-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - 449564/2014-2 (http//www.cnpq.br/),Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - 02663/09-0 (http.//www.capes.gov.br/), and Sao Paulo Research Foundation - FAPESP - 2012/23638-8 (http://www.fapesp.br/en/). MEB, TCSC, PAB, and DJAS are FAPESP fellows (grants n. 2013/19335-2, 2015/08939-0, 2015/25096-6, and 2015/12396-1). MVGBS, MMA, LCAR, and DPM are CNPq fellows. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Alencar MM., 1988, BOVINORAA CANCHIM OR; Alencar MM., 2000, CANCHIM BEEF CATTLE; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alexander DH, 2015, ADMIXTURE 1 3 SOFTWA, P1; Andrade PC, 2008, ANIM GENET, V39, P480, DOI 10.1111/j.1365-2052.2008.01755.x; [Anonymous], 2010, INTERBULL B; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Auguie B, 2017, GRIDEXTRA MISCELLANE; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Buzanskas ME, 2010, LIVEST SCI, V132, P107, DOI 10.1016/j.livsci.2010.05.008; Canaza-Cayo AW, 2016, LIVEST SCI; Chiang CWK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000866; Chud TCS, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0251-7; Espigolan R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-305; Frkonja A, 2012, ANIM GENET, V43, P696, DOI 10.1111/j.1365-2052.2012.02345.x; Grossi DD, 2015, MOL BIOL REP, V42, P245, DOI 10.1007/s11033-014-3767-4; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Lu Duc, 2012, Frontiers in Genetics, V3, P152, DOI 10.3389/fgene.2012.00152; Mao F, 2013, J ANIM SCI, V91, P2067, DOI 10.2527/jas.2012-5470; Mokry FB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S7-S6; Mokry FB, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-47; Montaldo H. H., 2012, Animal Frontiers, V2, P23, DOI 10.2527/af.2011-0029; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nielsen Rasmus, 2004, Human Genomics, V1, P218; O'Brien AMP, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0109-5; Porto-Neto LR, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-22; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Santiago AA., 1957, ZEBU SUA HIST EVOLUC; SVED J A, 1971, Theoretical Population Biology, V2, P125; Toosi A, 2010, J ANIM SCI, V88, P32, DOI 10.2527/jas.2009-1975; Ventura R, 2016, J ANIM SCI, V94, P1844, DOI 10.2527/jas.2016-0322; Wang Dai, 2009, BMC Proc, V3 Suppl 7, pS109	36	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171660	10.1371/journal.pone.0171660	http://dx.doi.org/10.1371/journal.pone.0171660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182737	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800086
J	Gebremariam, MK; Chinapaw, MJ; Bringolf-Isler, B; Bere, E; Kovacs, E; Verloigne, M; Stok, FM; Manios, Y; Brug, J; Lien, N				Gebremariam, Mekdes K.; Chinapaw, Mai J.; Bringolf-Isler, Bettina; Bere, Elling; Kovacs, Eva; Verloigne, Maite; Stok, F. Marijn; Manios, Yannis; Brug, Johannes; Lien, Nanna			Screen-based sedentary time: Association with soft drink consumption and the moderating effect of parental education in European children: The ENERGY study	PLOS ONE			English	Article							SOCIOECONOMIC POSITION; HEALTH INDICATORS; DIETARY-INTAKE; BEHAVIOR; TELEVISION; FOOD; OBESITY; YOUTH; PROJECT; SUGAR	Aim The aim of the present study was to explore if children who spend more time on screen-based sedentary behaviors (i.e. TV viewing and computer use) drink more sugar-sweetened soft drinks. The study also assessed whether these associations were independent of individual and home environmental correlates of soft drink consumption and whether they were moderated by parental education. Methods Data were collected from 7886 children participating in the EuropeaN Energy balance Research to prevent excessive weight Gain among Youth (ENERGY) survey conducted in eight European countries. Self-report questionnaires were used. Multilevel linear regression analyses with soft drink consumption as dependent variable, TV viewing and computer use as independent variables and age, gender, parental education, attitude towards soft drinks, self-efficacy, parental modelling, parental rules and home availability of soft drinks as covariates were conducted. Further interactions were tested to explore if these associations were moderated by parental education. Country-specific analyses were conducted. Results In six of the eight included countries, a significant positive association was observed between TV viewing (min/day) and soft drink consumption (ml/day), independent of individual and home environmental correlates of soft drink consumption (B = 0.46 (0.26-0.66) in Greece, B = 0.77 (0.36-1.17) in Norway, B = 0.82 (0.12-1.51) in Hungary, B = 1.06 (0.67-1.46) in Spain, B = 1.21 (0.67-1.74) in Belgium and B = 1.49 (0.72-2.27) in Switzerland). There was no significant association between computer use and soft drink consumption in six of the eight included countries in the final models. Moderation effects of parental education in the association between TV viewing and soft drink consumption were found in Norway and Hungary, the association being stronger among those with low parental education. Conclusions TV viewing appears to be independently associated with soft drink consumption and this association was moderated by parental education in two countries only. Reducing TV time might therefore favorably impact soft drink consumption.	[Gebremariam, Mekdes K.; Brug, Johannes; Lien, Nanna] Univ Oslo, Fac Med, Dept Nutr, Oslo, Norway; [Chinapaw, Mai J.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Bringolf-Isler, Bettina] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Bringolf-Isler, Bettina] Univ Basel, Basel, Switzerland; [Bere, Elling] Univ Agder, Dept Publ Hlth Sport & Nutr, Kristiansand, Norway; [Kovacs, Eva] Univ Pecs, Fac Med, Dept Paediat, Pecs, Hungary; [Kovacs, Eva] Ludwig Maximilians Univ Munchen, German Ctr Vertigo & Balance Disorders, Inst Med Informat Proc Biometr & Epidemiol, Munich, Germany; [Verloigne, Maite] Univ Ghent, Dept Movement & Sport Sci, Ghent, Belgium; [Stok, F. Marijn] Univ Konstanz, Dept Psychol Assessment & Hlth Psychol, Constance, Germany; [Manios, Yannis] Harokopio Univ, Sch Hlth Sci & Educ, Dept Nutr & Dietet, Athens, Greece; [Brug, Johannes] Univ Amsterdam, Fac Social & Behav Sci, Amsterdam, Netherlands	University of Oslo; Vrije Universiteit Amsterdam; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Agder; University of Pecs; University of Munich; Ghent University; University of Konstanz; Harokopio University Athens; University of Amsterdam	Gebremariam, MK (corresponding author), Univ Oslo, Fac Med, Dept Nutr, Oslo, Norway.	mekdes.gebremariam@medisin.uio.no	Paw, Mai Chin A/N-1665-2019; Manios, Yannis/AAM-8953-2021; Brug, Johannes/A-8242-2018	Paw, Mai Chin A/0000-0001-6259-2441; Manios, Yannis/0000-0001-6486-114X; Brug, Johannes/0000-0002-1904-7349	DEterminants of DIet and Physical ACtivity (DEDIPAC) Knowledge Hub; Joint Programming Initiative 'Healthy Diet for a Healthy Life'; The Research Council of Norway, Division for Society and Health; Seventh Framework Programme (CORDIS FP7) of the European Commision, HEALTH (FP7-HEALTH-B) [223254]	DEterminants of DIet and Physical ACtivity (DEDIPAC) Knowledge Hub; Joint Programming Initiative 'Healthy Diet for a Healthy Life'; The Research Council of Norway, Division for Society and Health(Research Council of Norway); Seventh Framework Programme (CORDIS FP7) of the European Commision, HEALTH (FP7-HEALTH-B)	The preparation of this paper was supported by the DEterminants of DIet and Physical ACtivity (DEDIPAC) Knowledge Hub. This work is supported by the Joint Programming Initiative 'Healthy Diet for a Healthy Life'. The funding agency supporting this work in Norway is The Research Council of Norway, Division for Society and Health. The ENERGY project was funded by the Seventh Framework Programme (CORDIS FP7) of the European Commision, HEALTH (FP7-HEALTH-2007-B), Grant agreement no. 223254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The preparation of this paper was supported by the DEterminants of DIet and Physical ACtivity (DEDIPAC) knowledge hub. This work is supported by the Joint Programming Initiative 'Healthy Diet for a Healthy Life'. The funding agency supporting this work in Norway is the Research Council of Norway, Division for Society and Health. The ENERGY-project is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-2007-B).	Aarts H, 1997, HEALTH EDUC RES, V12, P363, DOI 10.1093/her/12.3.363; Barnekow V., 2008, INEQUALITIES YOUNG P; Boulos R, 2012, PHYSIOL BEHAV, V107, P146, DOI 10.1016/j.physbeh.2012.05.022; Boyland EJ, 2011, PEDIATRICS, V128, pE93, DOI 10.1542/peds.2010-1859; Bray GA, 2014, DIABETES CARE, V37, P950, DOI 10.2337/dc13-2085; Brug J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034742; Buijzen M, 2008, APPETITE, V50, P231, DOI 10.1016/j.appet.2007.07.006; Caraher M, 2006, PUBLIC HEALTH NUTR, V9, P596, DOI 10.1079/PHN2005879; de Bruijn GJ, 2009, APPETITE, V53, P66, DOI 10.1016/j.appet.2009.05.008; DeMattia L, 2007, OBES REV, V8, P69, DOI 10.1111/j.1467-789X.2006.00259.x; Epstein LH, 2009, PSYCHOL REV, V116, P384, DOI 10.1037/a0015074; Gebremariam MK, 2015, OBES REV, V16, P988, DOI 10.1111/obr.12314; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Hastings G, 2003, REV RES EFFECTS FOOD, P1; Hobbs M, 2015, BRIT J SPORT MED, V49, P1179, DOI 10.1136/bjsports-2014-093754; Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Kremers SPJ, 2007, APPETITE, V48, P345, DOI 10.1016/j.appet.2006.10.002; Leung MM, 2012, J OBES, V2012, DOI 10.1155/2012/685430; Lissner L, 2012, EUR J EPIDEMIOL, V27, P705, DOI 10.1007/s10654-012-9718-2; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Matthews AE, 2008, EUR J PUBLIC HEALTH, V18, P7, DOI 10.1093/eurpub/ckm015; Olafsdottir S, 2014, INT J PUBLIC HEALTH, V59, P67, DOI 10.1007/s00038-013-0473-2; Pearson N, 2011, AM J PREV MED, V41, P178, DOI 10.1016/j.amepre.2011.05.002; Singh AS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-136; Sleddens EFC, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0164-x; Temple JL, 2007, AM J CLIN NUTR, V85, P355, DOI 10.1093/ajcn/85.2.355; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; van Ekris E, 2016, OBES REV, V17, P833, DOI 10.1111/obr.12426; van Stralen MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-65; Zarnowiecki DM, 2014, OBES REV, V15, P375, DOI 10.1111/obr.12139	31	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171537	10.1371/journal.pone.0171537	http://dx.doi.org/10.1371/journal.pone.0171537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182671	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800072
J	Rexford, A; Zorio, DAR; Miller, BG				Rexford, Alix; Zorio, Diego A. R.; Miller, Brian G.			Biochemical and biophysical investigations of the interaction between human glucokinase and pro-apoptotic BAD	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CELL; PHOSPHORYLATION; INHIBITOR; MUTATIONS; BCL-X(L); COMPLEX; IMAGE; SITE	The glycolytic enzyme glucokinase (GCK) and the pro-apoptotic protein BAD reportedly reside within a five-membered complex that localizes to the mitochondria of mammalian hepatocytes and pancreatic beta-cells. Photochemical crosslinking studies using a synthetic analog of BAD's BH3 domain and in vitro transcription/translation experiments support a direct interaction between BAD and GCK. To investigate the biochemical and biophysical consequences of the BAD: GCK interaction, we developed a method for the production of recombinant human BAD. Consistent with published reports, recombinant BAD displays high affinity for Bcl-xL (K-D = 7 nM), and phosphorylation of BAD at S118, within the BH3 domain, abolishes this interaction. Unexpectedly, we do not detect association of recombinant, full-length BAD with recombinant human pancreatic GCK over a range of protein concentrations using various biochemical methods including size-exclusion chromatography, chemical cross-linking, analytical ultracentrifugation, and isothermal titration calorimetry. Furthermore, fluorescence polarization assays and isothermal titration calorimetry detect no direct interaction between GCK and BAD BH3 peptides. Kinetic characterization of GCK in the presence of high concentrations of recombinant BAD show modest (< 15%) increases in GCK activity, observable only at glucose concentrations well below the K-0.5 value. GCK activity is unaffected by BAD BH3 peptides. These results raise questions as to the mechanism of action of stapled peptide analogs modeled after the BAD BH3 domain, which reportedly enhance the V-max value of GCK and stimulate insulin release in BAD-deficient islets. Based on our results, we postulate that the BAD: GCK interaction, and any resultant regulatory effect(s) upon GCK activity, requires the participation of additional members of the mitochondrial complex.	[Rexford, Alix; Zorio, Diego A. R.; Miller, Brian G.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Zorio, Diego A. R.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Miller, BG (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.	miller@chem.fsu.edu			National Institute of Diabetes and Digestive and Kidney Diseases [5R01DK081358]; National Institute of General Medical Sciences [1R01GM115388]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115388] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the National Institute of Diabetes and Digestive and Kidney Diseases [https://www.niddk.nih.gov/] 5R01DK081358 to BGM; and the National Institute of General Medical Sciences [https://www.nigms. nih.gov/] 1R01GM115388 to BGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; Bowler JM, 2013, ACS MED CHEM LETT, V4, P15, DOI 10.1021/ml400061x; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Cornish-Bowden A, 2004, FRONT DIABETES, V16, P125; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; Gimenez-Cassina A, 2014, CELL METAB, V19, P272, DOI 10.1016/j.cmet.2013.12.001; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Gloyn AL, 2003, HUM MUTAT, V22, P353, DOI 10.1002/humu.10277; Hemmer W, 1997, ANAL BIOCHEM, V245, P115, DOI 10.1006/abio.1996.9952; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Kamata K, 2004, STRUCTURE; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Larion M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001452; Larion M, 2010, BIOCHEMISTRY-US, V49, P7969, DOI 10.1021/bi101098f; Larion M, 2009, BIOCHEMISTRY-US, V48, P6157, DOI 10.1021/bi9007534; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; LIANG Y, 1990, J BIOL CHEM, V265, P16863; Livernois AM, 2009, ANAL BIOCHEM, V392, P70, DOI 10.1016/j.ab.2009.05.023; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Narayana N, 1997, BIOCHEMISTRY-US, V36, P4438, DOI 10.1021/bi961947+; NEET KE, 1990, BIOCHEMISTRY-US, V29, P770, DOI 10.1021/bi00455a026; Pal P, 2009, BIOCHEMISTRY-US, V48, P814, DOI 10.1021/bi802142q; Paz A, 2010, INSTRUMENTAL ANAL IN; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Sambrook J., 2001, MOL CLONING LAB MANU; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Szlyk B, 2014, NAT STRUCT MOL BIOL, V21, P36, DOI 10.1038/nsmb.2717; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776; Zhang HC, 2002, ANAL BIOCHEM, V307, P70, DOI 10.1016/S0003-2697(02)00028-3	42	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171587	10.1371/journal.pone.0171587	http://dx.doi.org/10.1371/journal.pone.0171587			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182770	gold, Green Submitted, Green Published			2022-12-26	WOS:000394231800077
J	Cassim, N; Schnippel, K; Coetzee, LM; Glencross, DK				Cassim, Naseem; Schnippel, Kathryn; Coetzee, Lindi Marie; Glencross, Deborah Kim			Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV plus patients with CD4 counts less than 100 cells/mu l using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa	PLOS ONE			English	Article							PROGRAM; CARE	Introduction Cryptococcal meningitis is a major cause of mortality and morbidity in countries with high HIV prevalence, primarily affecting patients whose CD4 are < = 100 cells/mu l. Routine Cryptococcal Antigen (CrAg) screening is thus recommended in the South African HIV treatment guidelines for all patients with CD4 counts < = 100 cells/mu l, followed by pre-emptive anti-fungal therapy where CrAg results are positive. A laboratory-based reflexed CrAg screening approach, using a Lateral Flow Assay (LFA) on remnant EDTA CD4 blood samples, was piloted at three CD4 laboratories. Objectives This study aimed to assess the cost-per-result of laboratory-based reflexed CrAg screening at one pilot CD4 referral laboratory. Methods CD4 test volumes from 2014 were extracted to estimate percentage of CD4 < = 100 cells/mu l. Daily average volumes were derived, assuming 12 months per/year and 21.73 working days per/month. Costing analyses were undertaken using Microsoft Excel and Stata with a provider prospective. The cost-per-result was estimated using a bottom-up method, inclusive of test kits and consumables (reagents), laboratory equipment and technical effort costs. The ZAR/$ exchange of 14.696/$1 was used, where applicable. One-way sensitivity analyses on the cost-per-result were conducted for possible error rates (3%-8%, reductions or increases in reagent costs as well as test volumes (ranging from -60% to +60%). Results The pilot CD4 laboratory performed 267000 CD4 tests in 2014; similar to 9.3% (27500) reported CD4< = 100 cells/mu l, equivalent to 106 CrAg tests performed daily. A batch of 30-tests could be performed in 1.6 hours, including preparation and analysis time. A cost-per-result of $4.28 was reported, with reagents contributing $3.11 (72.8%), while technical effort and laboratory equipment overheads contributed $1.17 (27.2%) and $0.03 (<1%) respectively. One-way sensitivity analyses including increasing or decreasing test volumes by 60% revealed a cost-per-result range of $3.84 to $6.03. Conclusion A cost-per-result of $4.28 was established in a typical CD4 service laboratory to enable local budgetary cost projections and programmatic cost-effectiveness modelling. Varying reagent costs linked to currency exchange and varying test volumes in different levels of service can lead to varying cost-per-test and technical effort to manage workload, with an inverse relationship of higher costs expected at lower volumes of tests.	[Cassim, Naseem; Coetzee, Lindi Marie; Glencross, Deborah Kim] NHLS, Natl Prior Programmes, Johannesburg, South Africa; [Cassim, Naseem; Coetzee, Lindi Marie; Glencross, Deborah Kim] Univ Witwatersrand, Fac Hlth Sci, Dept Mol Med & Haematol, Johannesburg, South Africa; [Schnippel, Kathryn] Right Care, Johannesburg, South Africa	National Health Laboratory Service; University of Witwatersrand	Glencross, DK (corresponding author), NHLS, Natl Prior Programmes, Johannesburg, South Africa.; Glencross, DK (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Mol Med & Haematol, Johannesburg, South Africa.	debbie.glencross@nhls.ac.za	Cassim, Naseem/GLR-4911-2022; Cassim, Naseem/AFU-5522-2022	Cassim, Naseem/0000-0003-4389-2849; Cassim, Naseem/0000-0003-4389-2849; Glencross, Deborah/0000-0001-7106-769X; Schnippel, Kathryn/0000-0003-0757-4325				Binnicker MJ, 2012, CLIN VACCINE IMMUNOL, V19, P1988, DOI 10.1128/CVI.00446-12; Cassim N, 2016, ESTIMATING COST RESU; Cassim N, 2015, 8 INT WORKSH HIV TRE; Coetzee LM, 2014, 7 SA AIDS C DURB S A; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS40, DOI 10.1002/cyto.b.20384; Glencross DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114727; Govender NP, 2012, SAMJ S AFR MED J, V102, P914, DOI [10.7196/samj.6228, 10.7196/SAMJ.6228]; Govender N. P. M G, 2013, GUIDELINE PREVENTION; Husereau Don, 2013, J Med Econ, V16, P713, DOI 10.3111/13696998.2013.784591; Jarvis JN, 2011, SAMJ S AFR MED J, V101, P232, DOI 10.7196/SAMJ.4752; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kozel Thomas R, 2012, Expert Opin Med Diagn, V6, P245, DOI 10.1517/17530059.2012.681300; Larson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158986; Mirza SA, 2003, CLIN INFECT DIS, V36, P789, DOI 10.1086/368091; National Department of Health (NDOH), 2013, 2012 NAT ANT SENT HI; [National Health Laboratory Service (NHLS) (CDW) CDW], 2015, CORP DAT WAR CCMT RE; NDoH, 2015, NAT CONS GUID PREV M; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Standard Bank of South Africa (SBSA), 2015, FOR CLOS IND RAT 23; Standard Bank of South Africa (SBSA), 2016, FOR CLOS IND RAT 04; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M	22	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171675	10.1371/journal.pone.0171675	http://dx.doi.org/10.1371/journal.pone.0171675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166254	Green Published, gold, Green Submitted			2022-12-26	WOS:000393700100060
J	Nyffenegger, C; Nordvang, RT; Jers, C; Meyer, AS; Mikkelsen, JD				Nyffenegger, Christian; Nordvang, Rune Thorbjorn; Jers, Carsten; Meyer, Anne S.; Mikkelsen, Jorn Dalgaard			Design of Trypanosoma rangeli sialidase mutants with improved trans-sialidase activity	PLOS ONE			English	Article							HUMAN-MILK OLIGOSACCHARIDES; BIOCATALYTIC PRODUCTION; 3'-SIALYLLACTOSE; MECHANISM	A sialidase (EC 3.2.1.18) from the non-pathogenic Trypanosoma rangeli, TrSA, has been shown to exert trans-sialidase activity after mutation of five specific amino acids in the active site (M96V, A98P, S120Y, G249Y, Q284P) to form the so-called TrSA(5mut) enzyme. By computational and hypothesis driven approaches additional mutations enhancing the transsialidase activity have been suggested. In the present work, we made a systematic combination of these mutations leading to seven new variants of the T. rangeli sialidase, having 6-16 targeted amino acid mutations. The resulting enzyme variants were analyzed via kinetics for their ability to carry out trans-sialidase reaction using CGMP and D-lactose as substrates. The sialidase variants with 15 and 16 mutations, respectively, exhibited significantly improved trans-sialidase activity for D-lactose sialylation. Our results corroborate, that computational studies of trans-glycosylation can be a valuable input in the design of novel trans-glycosidases, but also highlight the importance of experimental validation in order to assess the performance. In conclusion, two of the seven mutants displayed a dramatic switch in specificity from hydrolysis towards trans-sialylation and constitute the most potent trans-sialidase mutants of TrSA described in literature to date.	[Nyffenegger, Christian; Nordvang, Rune Thorbjorn; Jers, Carsten; Meyer, Anne S.; Mikkelsen, Jorn Dalgaard] Tech Univ Denmark, Dept Chem & Biochem Engn, Ctr BioProc Engn, Lyngby, Denmark	Technical University of Denmark	Jers, C (corresponding author), Tech Univ Denmark, Dept Chem & Biochem Engn, Ctr BioProc Engn, Lyngby, Denmark.	cjer@dtu.dk	Meyer, Anne S/AAN-2157-2020	Meyer, Anne S/0000-0001-8910-9931	Danish Dairy Research Foundation (Mejeribrugets Forskningsfond)	Danish Dairy Research Foundation (Mejeribrugets Forskningsfond)	This work was supported by the funding from Danish Dairy Research Foundation (Mejeribrugets Forskningsfond; www.ddrf.dk) (grant to JDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya MF, 2003, J MOL BIOL, V325, P773, DOI 10.1016/S0022-2836(02)01306-2; Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; Angeloni S, 2005, GLYCOBIOLOGY, V15, P31, DOI 10.1093/glycob/cwh143; Bissaro B, 2015, BIOCHEM J, V467, P17, DOI 10.1042/BJ20141412; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Castillo-Courtade L, 2015, ALLERGY, V70, P1091, DOI 10.1111/all.12650; Damager I, 2008, BIOCHEMISTRY-US, V47, P3507, DOI 10.1021/bi7024832; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Holck J, 2014, NEW BIOTECHNOL, V31, P156, DOI 10.1016/j.nbt.2013.11.006; Jers C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083902; Lin AE, 2014, J INFECT DIS, V209, P389, DOI 10.1093/infdis/jit464; Luo JQ, 2014, BIORESOURCE TECHNOL, V166, P9, DOI 10.1016/j.biortech.2014.05.003; Michalak M, 2014, PROCESS BIOCHEM, V49, P265, DOI 10.1016/j.procbio.2013.10.023; Nordvang RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158434; Paris G, 2005, J MOL BIOL, V345, P923, DOI 10.1016/j.jmb.2004.09.031; Pereira MEA, 1996, INFECT IMMUN, V64, P3884, DOI 10.1128/IAI.64.9.3884-3892.1996; Pierdominici-Sottile G, 2014, PROTEINS, V82, P424, DOI 10.1002/prot.24408; SAITO T, 1992, J DAIRY SCI, V75, P1768, DOI 10.3168/jds.S0022-0302(92)77936-3; Vera C, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2159-4; Zeuner B, 2014, ENZYME MICROB TECH, V55, P85, DOI 10.1016/j.enzmictec.2013.12.009	21	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171585	10.1371/journal.pone.0171585	http://dx.doi.org/10.1371/journal.pone.0171585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158299	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700103
J	Xiong, H; Ni, Z; He, J; Jiang, S; Li, X; He, J; Gong, W; Zheng, L; Chen, S; Li, B; Zhang, N; Lyu, X; Huang, G; Chen, B; Zhang, Y; He, F				Xiong, H.; Ni, Z.; He, J.; Jiang, S.; Li, X.; He, J.; Gong, W.; Zheng, L.; Chen, S.; Li, B.; Zhang, N.; Lyu, X.; Huang, G.; Chen, B.; Zhang, Y.; He, F.			LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells	ONCOGENE			English	Article							LONG NONCODING RNA; DOWN-REGULATION; USP22; CANCER; ACTIVATION; CHEMORESISTANCE; PROLIFERATION; CONTRIBUTES; MAINTENANCE; SUPPRESSES	Considerable evidences have shown that autophagy has an important role in tumor chemoresistance. However, it is still unknown whether the lncRNA HULC (highly upregulated in liver cancer) is involved in autophagy and chemoresistance of hepatocellular carcinoma (HCC). In this study, we for the first time demonstrated that treatment with antitumor reagents such as oxaliplatin, 5-fluorouracil and pirarubicin (THP) dramatically induced HULC expression and protective autophagy. Silencing of HULC sensitized HCC cells to the three antitumor reagents via inhibiting protective autophagy. Ectopic expression of HULC elicited the autophagy of HCC cells through stabilizing silent information regulator 1 (Sirt1) protein. The investigation for the corresponding mechanism by which HULC stabilized Sirt1 revealed that HULC upregulated ubiquitin-specific peptidase 22 (USP22), leading to the decrease of ubiquitin-mediated degradation of Sirt1 protein by removing the conjugated polyubiquitin chains from Sirt1. Moreover, we found that miR-6825-5p, miR-6845-5p and miR-6886-3p could decrease the level of USP22 protein by binding to the 3'-untranlated region of USP22 mRNA. All the three microRNAs (miRNAs) were downregulated by HULC, which resulted in the elevation of USP22. In addition, we showed that the level of HULC was positively correlated with that of Sirt1 protein in human HCC tissues. Collectively, our data reveals that the pathway 'HULC/USP22/Sirt1/protective autophagy' attenuates the sensitivity of HCC cells to chemotherapeutic agents, suggesting that this pathway may be a novel target for developing sensitizing strategy to HCC chemotherapy.	[Xiong, H.; Ni, Z.; Jiang, S.; Li, X.; He, J.; Gong, W.; Chen, S.; Li, B.; Zhang, N.; Lyu, X.; Huang, G.; Zhang, Y.; He, F.] Third Mil Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, 30 Gaotanyan, Chongqing 400038, Peoples R China; [He, J.] Third Mil Med Univ, Coll Prevent Med, Battal Students 17, Chongqing, Peoples R China; [Zheng, L.] Third Mil Med Univ, Xinqiao Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China; [Chen, B.] Third Mil Med Univ, Lab Anim Ctr, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Chen, B; Zhang, Y; He, F (corresponding author), Third Mil Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, 30 Gaotanyan, Chongqing 400038, Peoples R China.	chenbb81@126.com; tmmubiozy@163.com; hefengtian06@aliyun.com	He, Feng/HHS-6457-2022; HUANG, GANG/AAO-5503-2020	He, Feng/0000-0002-1996-0744; zhenhong, ni/0000-0002-7464-4074	National Natural Science Foundation of China [81672377, 31470066, 81472291, 81272690]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81672377, 31470066, 81472291 and 81272690).	Armour SM, 2013, MOL CELL BIOL, V33, P1487, DOI 10.1128/MCB.00971-12; Bae HJ, 2014, ONCOGENE, V33, P2557, DOI 10.1038/onc.2013.216; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Carew JS, 2007, AUTOPHAGY, V3, P464, DOI 10.4161/auto.4311; Chen HC, 2012, ANN SURG ONCOL, V19, P2011, DOI 10.1245/s10434-011-2159-4; Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274; Cui M, 2015, CANCER RES, V75, P846, DOI 10.1158/0008-5472.CAN-14-1192; Du YM, 2012, J BIOL CHEM, V287, P26302, DOI 10.1074/jbc.M112.342113; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Guo XL, 2014, CANCER LETT, V346, P278, DOI 10.1016/j.canlet.2014.01.011; Hammerle M, 2013, HEPATOLOGY, V58, P1703, DOI 10.1002/hep.26537; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; He JB, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/605946; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hu C, 2014, ONCOGENE, V33, P2888, DOI 10.1038/onc.2013.250; Hu C, 2015, GUT, V66, P31, DOI [10.1136/gutjn1-2015-309322, DOI 10.1136/GUTJN1-2015-309322]; Khorshid M, 2013, NAT METHODS, V10, P253, DOI [10.1038/NMETH.2341, 10.1038/nmeth.2341]; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Li L, 2014, CELL STEM CELL, V15, P431, DOI 10.1016/j.stem.2014.08.001; Li Q, 2015, AUTOPHAGY, V11, P1293, DOI 10.1080/15548627.2015.1058474; Li SP, 2016, ONCOTARGET, V7, P42431, DOI 10.18632/oncotarget.9883; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Lu ZP, 2016, ONCOTARGET, V7, P241, DOI 10.18632/oncotarget.6280; Luo T, 2016, AUTOPHAGY, V12, P1355, DOI 10.1080/15548627.2015.1034405; Peng LR, 2015, J BIOL CHEM, V290, P8904, DOI 10.1074/jbc.M114.612796; Qiu GL, 2015, FEBS LETT, V589, P2034, DOI 10.1016/j.febslet.2015.05.042; Schrecengost RS, 2014, CANCER RES, V74, P272, DOI 10.1158/0008-5472.CAN-13-1954; Shteingauz A, 2015, CANCER RES, V75, P3946, DOI 10.1158/0008-5472.CAN-15-0037; Song JR, 2009, AUTOPHAGY, V5, P1131, DOI 10.4161/auto.5.8.9996; Song YM, 2015, AUTOPHAGY, V11, P46, DOI 10.4161/15548627.2014.984271; Tang B, 2015, ONCOTARGET, V6, P12654, DOI 10.18632/oncotarget.3705; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4596; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhou P, 2014, CELL SIGNAL, V26, P1347, DOI 10.1016/j.cellsig.2014.02.020	40	260	282	7	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 22	2017	36	25					3528	3540		10.1038/onc.2016.521	http://dx.doi.org/10.1038/onc.2016.521			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY3NL	28166203				2022-12-26	WOS:000403878600003
J	Isoe, J; Petchampai, N; Isoe, YE; Co, K; Mazzalupo, S; Scaraffia, PY				Isoe, Jun; Petchampai, Natthida; Isoe, Yurika E.; Co, Katrina; Mazzalupo, Stacy; Scaraffia, Patricia Y.			Xanthine dehydrogenase-1 silencing in Aedes aegypti mosquitoes promotes a blood feeding-induced adulticidal activity	FASEB JOURNAL			English	Article						ammonia; antioxidant genes; gene silencing; metabolic target	DROSOPHILA-MELANOGASTER; PROTEIN CATABOLISM; AMMONIA METABOLISM; MEAL PROTEIN; STRESS; DENGUE; URATE; ACTIVATION; RECEPTORS; TOXICITY	Aedes aegypti has 2 genes encoding xanthine dehydrogenase (XDH). We analyzed XDH1 and XDH2 gene expression by real-time quantitative PCR in tissues from sugar-and blood-fed females. Differential XDH1 and XDH2 gene expression was observed in tissues dissected throughout a time course. We next exposed females to blood meals supplemented with allopurinol, a well-characterized XDH inhibitor. We also tested the effects of injecting double-stranded RNA(dsRNA) against XDH1, XDH2, or both. Disruption of XDH by allopurinol or XDH1 by RNA interference significantly affected mosquito survival, causing a disruption in blood digestion, excretion, oviposition, and reproduction. XDH1-deficient mosquitoes showed a persistence of serine proteases in the midgut at 48 h after blood feeding and a reduction in the uptake of vitellogenin by the ovaries. Surprisingly, analysis of the fat body from dsRNA-XDH1-injected mosquitoes fell into 2 groups: one group was characterized by a reduction of the XDH1 transcript, whereas the other group was characterized by an up-regulation of several transcripts, including XDH1, glutamine synthetase, alanine aminotransferase, catalase, superoxide dismutase, ornithine decarboxylase, glutamate receptor, and ammonia transporter. Our data demonstrate that XDH1 plays an essential role and that XDH1 has the potential to be used as a metabolic target for Ae. aegypti vector control.	[Isoe, Jun; Isoe, Yurika E.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Petchampai, Natthida; Co, Katrina; Scaraffia, Patricia Y.] Tulane Univ, Sch Publ Hlth & Trop Med, Vector Borne Infect Dis Res Ctr, Dept Trop Med, New Orleans, LA USA; [Mazzalupo, Stacy] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [Co, Katrina] Indiana Univ, Ryan White Ctr Infect Dis & Global Hlth, Indianapolis, IN 46204 USA; [Mazzalupo, Stacy] Roche Tissue Diagnost, Tucson, AZ USA	University of Arizona; Tulane University; University of Arizona; Indiana University System; Indiana University-Purdue University Indianapolis	Scaraffia, PY (corresponding author), Vector Borne Infect Dis Res Ctr, Dept Trop Med, 1430 Tulane Ave,SL-17,J Bennett Johnston Bldg, New Orleans, LA 70112 USA.	pscaraff@tulane.edu			Corine Adams Baines Professorship Award; U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases [R01AI088092]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088092] Funding Source: NIH RePORTER	Corine Adams Baines Professorship Award; U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the Louisiana Clinical and Translational Science Center (Baton Rouge, LA, USA) for statistical advice. This work was financially supported by Corine Adams Baines Professorship Award, and by the U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases (Grant R01AI088092 to P.Y.S.).	Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28; Barros MP, 2000, PHOTOCHEM PHOTOBIOL, V71, P648, DOI 10.1562/0031-8655(2000)071&lt;0648:LAUMAA&gt;2.0.CO;2; Belloni V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-373; Benedict MQ, 1996, ANN ENTOMOL SOC AM, V89, P261, DOI 10.1093/aesa/89.2.261; BRIEGEL H, 1985, J INSECT PHYSIOL, V31, P15, DOI 10.1016/0022-1910(85)90036-8; Buttner S, 2014, CELL CYCLE, V13, P3903, DOI 10.4161/15384101.2014.973309; Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135; Choumet V, 2015, REV SCI TECH OIE, V34, P473; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hermenegildo C, 2000, HEPATOLOGY, V31, P709, DOI 10.1002/hep.510310322; HILLIKER AJ, 1992, P NATL ACAD SCI USA, V89, P4343, DOI 10.1073/pnas.89.10.4343; Hrnjakovic Cvjetkovic Ivana B, 2015, Med Pregl, V68, P122; Ip YK, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00134; Isoe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065393; Kogan PH, 2000, J INSECT PHYSIOL, V46, P1079, DOI 10.1016/S0022-1910(99)00084-0; Krebs HA, 1932, H-S Z PHYSIOL CHEM, V210, P33, DOI 10.1515/bchm2.1932.210.1-2.33; Kularatne SAM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4661; Liyou N, 2000, EXP APPL ACAROL, V24, P235, DOI 10.1023/A:1006452325210; Mazzalupo S, 2016, FASEB J, V30, P111, DOI 10.1096/fj.15-277087; Minois N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.139; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Monfort P, 2000, NEUROCHEM INT, V37, P249, DOI 10.1016/S0197-0186(00)00027-9; Murthy CRK, 2001, J NEUROSCI RES, V66, P282, DOI 10.1002/jnr.1222; Nogueira NP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116712; Norwood PF, 2015, REV SCI TECH OIE, V34, P479, DOI 10.20506/rst.34.2.2373; Peng DD, 2016, PROTOPLASMA, V253, P1243, DOI 10.1007/s00709-015-0880-8; Petchampai N, 2016, ADV INSECT PHYSIOL, V51, P363, DOI 10.1016/bs.aiip.2016.04.002; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878; Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3; Sant'Anna MRV, 2008, INSECT BIOCHEM MOLEC, V38, P652, DOI 10.1016/j.ibmb.2008.03.012; Scaraffia PY, 2008, P NATL ACAD SCI USA, V105, P518, DOI 10.1073/pnas.0708098105; Scaraffia PY, 2006, INSECT BIOCHEM MOLEC, V36, P614, DOI 10.1016/j.ibmb.2006.05.003; Scaraffia PY, 2016, GENETIC CONTROL OF MALARIA AND DENGUE, P253; Scaraffia PY, 2010, J INSECT PHYSIOL, V56, P1040, DOI 10.1016/j.jinsphys.2010.02.016; Scaraffia PY, 2005, INSECT BIOCHEM MOLEC, V35, P491, DOI 10.1016/j.ibmb.2005.01.012; Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3; Souza AVG, 1997, FREE RADICAL BIO MED, V22, P209, DOI 10.1016/S0891-5849(96)00293-6; von Dungern P, 2001, J INSECT PHYSIOL, V47, P73, DOI 10.1016/S0022-1910(00)00095-0; von Dungern P, 2001, J INSECT PHYSIOL, V47, P131, DOI 10.1016/S0022-1910(00)00096-2; Zhou GL, 2004, J INSECT PHYSIOL, V50, P337, DOI 10.1016/j.jinsphys.2004.02.003	44	10	10	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2276	2286		10.1096/fj.201601185R	http://dx.doi.org/10.1096/fj.201601185R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28179423	Green Published			2022-12-26	WOS:000401553400006
J	Choo, M; Tan, HL; Ding, V; Castangia, R; Belgacem, O; Liau, B; Hartley-Tassell, L; Haslam, SM; Dell, A; Choo, A				Choo, Matthew; Tan, Heng Liang; Ding, Vanessa; Castangia, Roberto; Belgacem, Omar; Liau, Brian; Hartley-Tassell, Lauren; Haslam, Stuart M.; Dell, Anne; Choo, Andre			Characterization of H type 1 and type 1 N-acetyllactosamine glycan epitopes on ovarian cancer specifically recognized by the anti-glycan monoclonal antibody mAb-A4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; LEWIS Y ANTIGEN; EPITHELIAL OVARIAN; ESCHERICHIA-FREUNDII; BIOSYNTHETIC-PATHWAY; CYTOTOXIC ANTIBODY; MASS-SPECTROMETRY; GLYCOMIC ANALYSIS; DNA METHYLATION; GENE-EXPRESSION	Cancer-specific glycans of ovarian cancer are promising epitopes for targeting with monoclonal antibodies (mAb). Despite their potential, structural characterization of these glycan epitopes remains a significant challenge in mAb preclinical development. Our group generated the monoclonal antibody mAb-A4 against human embryonic stem cells (hESC), which also bound specifically to N-glycans present on 11 of 19 ovarian cancer (OC) and 8 of 14 breast cancer cell lines tested. Normal cell lines and tissue were unstained by mAb-A4. To characterize the N-linked glycan epitopes on OC cell lines targeted by mAb-A4, we used glycosidases, glycan microarray, siRNA, and advanced high sensitivity matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). The mAb-A4 epitopes were found to be Fuc alpha 1-2Gal beta 1-3GlcNAc beta (H type 1) and Gal beta 1-3GlcNAc beta (type 1 LacNAc). These structures were found to be present on multiple proteins from hESC and OC. Importantly, endo-beta-galactosidase coupled with MALDI-MS allowed these two epitopes, for the first time, to be directly identified on the polylactosamines of N-glycans of SKOV3, IGROV1, OV90, and OVCA433. Furthermore, siRNA knockdown of B3GALT5 expression in SKOV3 demonstrated that mAb-A4 binding was dependent on B3GALT5, providing orthogonal evidence of the epitopes' structures. The recognition of oncofetal H type 1 and type 1 LacNAc on OC by mAb-A4 is a novel and promising way to target OC and supports the theory that cancer can acquire stem-like phenotypes. We propose that the orthogonal framework used in this work could be the basis for advancing anti-glycan mAb characterization.	[Choo, Matthew; Haslam, Stuart M.; Dell, Anne] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Choo, Matthew; Tan, Heng Liang; Ding, Vanessa; Liau, Brian; Choo, Andre] Bioproc Technol Inst, Singapore 138668, Singapore; [Hartley-Tassell, Lauren] Griffith Univ, Inst Glyc, Southport, Qld 4215, Australia; [Castangia, Roberto; Belgacem, Omar] Shimadzu, Manchester M17 1GP, Lancs, England	Imperial College London; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); Griffith University	Dell, A (corresponding author), Imperial Coll London, Dept Life Sci, Fac Nat Sci, South Kensington Campus, London SW7 2AZ, England.; Choo, A (corresponding author), Bioproc Technol Inst, Stem Cell Grp 1, 20 Biopolis Way 06-01, Singapore 138668, Singapore.	a.dell@imperial.ac.uk; andre_choo@bti.a-star.edu.sg		Dell, Anne/0000-0003-1380-2347; Choo, Andre/0000-0001-9648-0755; Choo, Matthew Sern Farh/0000-0002-1376-3352; Liau, Brian/0000-0002-8233-771X	Strategic Positioning Fund ("GlycoSing") from the Biomedical Research Council of Agency for Science, Technology and Research (A*STAR), Singapore [SPF2013/001]; A*STAR's Joint Council Visiting Investigator Programme ("HighGlycoART"); A*STAR-Imperial College London Partnership; Biotechnology and Biological Sciences Research Council [BB/K016164/1] Funding Source: researchfish; BBSRC [BB/K016164/1] Funding Source: UKRI	Strategic Positioning Fund ("GlycoSing") from the Biomedical Research Council of Agency for Science, Technology and Research (A*STAR), Singapore; A*STAR's Joint Council Visiting Investigator Programme ("HighGlycoART"); A*STAR-Imperial College London Partnership; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Strategic Positioning Fund SPF2013/001 ("GlycoSing") from the Biomedical Research Council of Agency for Science, Technology and Research (A*STAR), Singapore, the A*STAR's Joint Council Visiting Investigator Programme ("HighGlycoART"), and the A*STAR-Imperial College London Partnership. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott KL, 2008, PROTEOMICS, V8, P3210, DOI 10.1002/pmic.200800157; Abbott KL, 2010, PROTEOMICS, V10, P470, DOI 10.1002/pmic.200900537; Anugraham M, 2014, MOL CELL PROTEOMICS, V13, P2213, DOI 10.1074/mcp.M113.037085; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; Chua JX, 2015, CLIN CANCER RES, V21, P2963, DOI 10.1158/1078-0432.CCR-14-3030; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Coberly SK, 2009, ARCH PATHOL LAB MED, V133, P1403, DOI 10.1043/1543-2165-133.9.1403; Coward JIG, 2015, INT J WOMENS HEALTH, V7, P189, DOI 10.2147/IJWH.S52379; Day CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004927; DELL A, 1994, METHOD ENZYMOL, V230, P108; DELL A, 1988, BIOMED ENVIRON MASS, V16, P19, DOI 10.1002/bms.1200160104; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Duk M, 1997, ANAL BIOCHEM, V253, P98, DOI 10.1006/abio.1997.9994; Escrevente C, 2006, INT J ONCOL, V29, P557; FUKUDA MN, 1976, J BIOL CHEM, V251, P6218; Gao C, 2014, J BIOL CHEM, V289, P16462, DOI 10.1074/jbc.M114.558932; Gao LL, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-15; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; Haslam SM, 2006, CURR OPIN STRUC BIOL, V16, P584, DOI 10.1016/j.sbi.2006.08.006; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Ismail MN, 2011, GLYCOBIOLOGY, V21, P82, DOI 10.1093/glycob/cwq134; Isshiki S, 1999, J BIOL CHEM, V274, P12499, DOI 10.1074/jbc.274.18.12499; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Katsumata N, 2013, LANCET ONCOL, V14, P1020, DOI 10.1016/S1470-2045(13)70363-2; Kemp Z, 2013, INT J WOMENS HEALTH, V5, P45, DOI 10.2147/IJWH.S30231; Kostlanova N, 2005, J BIOL CHEM, V280, P27839, DOI 10.1074/jbc.M505184200; Lee J, 2012, J CHROMATOGR A, V1270, P162, DOI 10.1016/j.chroma.2012.10.062; Liang YJ, 2011, STEM CELLS, V29, P1995, DOI 10.1002/stem.750; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Loo D, 2007, MOL CANCER THER, V6, P856, DOI 10.1158/1535-7163.MCT-06-0581; Lucena MC, 2016, J BIOL CHEM, V291, P12917, DOI 10.1074/jbc.M116.729236; Machado E, 2011, GLYCOBIOLOGY, V21, P376, DOI 10.1093/glycob/cwq170; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Miles D, 2011, ONCOLOGIST, V16, P1092, DOI 10.1634/theoncologist.2010-0307; National Cancer Institute, 2015, OV EP FALL TUB PRIM; Natunen S, 2011, GLYCOBIOLOGY, V21, P1125, DOI 10.1093/glycob/cwq209; Nonaka M, 2014, J BIOL CHEM, V289, P16478, DOI 10.1074/jbc.M114.559047; O'Cearbhaill R. E., 2014, ANN ONCOL, V25, piv311; Ojima T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14988; Pochechueva T, 2012, METABOLITES, V2, P913, DOI 10.3390/metabo2040913; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricardo S, 2015, MOL ONCOL, V9, P503, DOI 10.1016/j.molonc.2014.10.005; Ruhaak LR, 2013, MOL CELL PROTEOMICS, V12, P846, DOI 10.1074/mcp.R112.026799; Ruijter JM, 2014, MICROCHIM ACTA, V181, P1689, DOI 10.1007/s00604-013-1155-8; Ruijter JM, 2013, METHODS, V59, P32, DOI 10.1016/j.ymeth.2012.08.011; Satomaa T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-42; SCUDDER P, 1984, J BIOL CHEM, V259, P6586; Shibata TK, 2012, J BIOL CHEM, V287, P6592, DOI 10.1074/jbc.M111.305334; Shoreibah MG, 2011, STEM CELLS DEV, V20, P515, DOI 10.1089/scd.2010.0172; Spina E, 2004, RAPID COMMUN MASS SP, V18, P392, DOI 10.1002/rcm.1350; Sutton-Smith M, 2006, CELL BIOL LAB HDB, P425; Suzuki N, 2004, GYNECOL ONCOL, V95, P290, DOI 10.1016/j.ygyno.2004.06.024; Tan HL, 2009, STEM CELLS, V27, P1792, DOI 10.1002/stem.109; Tan TZ, 2013, EMBO MOL MED, V5, P1051, DOI 10.1002/emmm.201201823; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Trinchera Marco, 2014, Biology (Basel), V3, P484, DOI 10.3390/biology3030484; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Waespy M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004120; Wang YF, 2011, INT J MOL SCI, V12, P3409, DOI 10.3390/ijms12063409; Wong NK, 2003, J BIOL CHEM, V278, P28619, DOI 10.1074/jbc.M302741200; Zulueta A., 2014, THESIS	68	12	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6163	6176		10.1074/jbc.M116.768887	http://dx.doi.org/10.1074/jbc.M116.768887			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28167527	Green Published, hybrid			2022-12-26	WOS:000399538700013
J	Wu, YX; Chen, D; Zhu, SJ; Zhang, LF; Li, LJ				Wu, Yuxiang; Chen, Di; Zhu, Shuijin; Zhang, Lufei; Li, Lingjiao			A New Sythetic Hybrid (A(1)D(5)) between Gossypium herbaceum and G. raimondii and Its Morphological, Cytogenetic, Molecular Characterization	PLOS ONE			English	Article							GENE-EXPRESSION; INTERSPECIFIC HYBRIDIZATION; ALLOTETRAPLOID COTTON; SOMATIC HYBRIDS; GENOME; POLYPLOIDY; EVOLUTION; DIVERSITY; DOMINANCE; HIRSUTUM	The diploid species G. herbaceum (A1) and G. raimondii (D5) are the progenitors of allotetraploid cotton, respectively. However, hybrids between G. herbaceum and G. raimondii haven't been reported. In the present study, hybridization between G. herbaceum and G. raimondii was explored. Morphological, cytogenetic and molecular analyses were used to assess the hybridity. The interspecific hybrid plants were successfully obtained. Most of the morphological characteristics of the hybrids were intermediate between G. herbaceum and G. raimondii. However, the color of glands, anther cases, pollen and corolla, and the state of bracteoles in hybrids were associated with the G. herbaceum. The color of staminal columns and filaments in hybrids were associated with G. raimondii. Cytogenetic analysis confirmed abnormal meiotic behavior existed in hybrids. The hybrids couldn't produce boll -set. Simple sequence repeat results found that besides the fragments inherited from the two parents, some novel bands were amplified in hybrids, indicating that potential mutations and chromosomal recombination occurred between parental genomes during hybridization. These results may provide some novel insights in speciation, genome interaction, and evolution of the tetraploid cotton species.	[Wu, Yuxiang; Zhang, Lufei; Li, Lingjiao] Shanxi Agr Univ, Coll Agr, Taigu, Shanxi, Peoples R China; [Wu, Yuxiang; Zhu, Shuijin] Zhejiang Univ, Dept Agron, Coll Agr & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Chen, Di] Chinese Acad Agr Sci, Cotton Res Inst, Anyang, Henan, Peoples R China	Shanxi Agricultural University; Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Zhu, SJ (corresponding author), Zhejiang Univ, Dept Agron, Coll Agr & Biotechnol, Hangzhou, Zhejiang, Peoples R China.	shjzhu@zju.edu.cn			China Agriculture Research System [CARS-18-25]; National Natural Science Foundation of China [31171599, 31301364]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research work was financially supported by China Agriculture Research System (No. CARS-18-25) and National Natural Science Foundation of China (No. 31171599; No. 31301364).	Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Beaulieu J, 2009, MOL GENET GENOMICS, V281, P421, DOI 10.1007/s00438-008-0421-7; Benbouza H, MOL BREEDING; Brubaker CL, 1999, GENOME, V42, P184, DOI 10.1139/gen-42-2-184; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; ENDRIZZI JOHN E., 1960, CANADIAN JOUR GENET AND CYTOL, V2, P311; Flagel LE, 2010, NEW PHYTOL, V186, P184, DOI 10.1111/j.1469-8137.2009.03107.x; Fryxell P.A., 1992, RHEEDEA, V2, P108; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Grover CE, 2012, NEW PHYTOL, V196, P966, DOI 10.1111/j.1469-8137.2012.04365.x; Grover CE, 2004, GENOME RES, V14, P1474, DOI 10.1101/gr.2673204; HILU KW, 1993, AM J BOT, V80, P1494, DOI 10.2307/2445679; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kashkush K, 2002, GENETICS, V160, P1651; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Li B. L., 1987, Acta Genetica Sinica, V14, P121; Liu Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123209; Liu S, 2000, J HERED, V91, P326, DOI 10.1093/jhered/91.4.326; Madlung A, 2013, Cytogenet Genome Res, V140, P270, DOI 10.1159/000351430; MURAMOTO H, 1969, CROP SCI, V9, P27, DOI 10.2135/cropsci1969.0011183X000900010009x; Newaskar GS, 2013, PLANT BREEDING, V132, P211, DOI 10.1111/pbr.12031; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Noormohammadi Z., 2013, International Journal of Plant, Animal and Environmental Sciences, V3, P79; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Pires JC, 2004, AM J BOT, V91, P1022, DOI 10.3732/ajb.91.7.1022; Rieseberg LH, 2009, CURR BIOL, V19, pR119, DOI 10.1016/j.cub.2008.12.016; Rowe HC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-342; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Shan XH, 2005, MOL BIOL EVOL, V22, P976, DOI 10.1093/molbev/msi082; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; STEBBINS GL, 1958, ADV GENET, V9, P147, DOI 10.1016/S0065-2660(08)60162-5; Stewart J. M., 1994, CHALLENGING FUTURE, P313; Sun YQ, 2004, THEOR APPL GENET, V109, P472, DOI 10.1007/s00122-004-1663-3; Swanson-Wagner RA, 2009, SCIENCE, V326, P1118, DOI 10.1126/science.1178294; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wu YX, 2007, PLANT SYST EVOL, V268, P199, DOI 10.1007/s00606-007-0565-7; Wu YX, 2013, CARYOLOGIA, V66, P368, DOI 10.1080/00087114.2013.857830; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Yu XS, 2012, THEOR APPL GENET, V125, P1503, DOI 10.1007/s00122-012-1929-0; Zhang X, 2014, CROP J, V2, P272, DOI 10.1016/j.cj.2014.06.009; Zhang XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep18618; Zhu HY, 2009, PLANT SCI, V176, P397, DOI 10.1016/j.plantsci.2008.12.007	47	49	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0169833	10.1371/journal.pone.0169833	http://dx.doi.org/10.1371/journal.pone.0169833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187145	gold, Green Published, Green Submitted			2022-12-26	WOS:000394244300003
J	Bravo, SP; Cueto, VR; Gorosito, CA				Patricia Bravo, Susana; Rodolfo Cueto, Victor; Andres Gorosito, Cristian			Migratory timing, rate, routes and wintering areas of White-crested Elaenia (Elaenia albiceps chilensis), a key seed disperser for Patagonian forest regeneration	PLOS ONE			English	Article							BIRD MIGRATION; NORTHERN PATAGONIA; ANNUAL CYCLE; RAIN-FOREST; TRACKING; ABUNDANCE; SONGBIRD; HEMISPHERE; DIVERSITY; DYNAMICS	Migratory animals often play key ecological roles within the communities they visit throughout their annual journeys. As a consequence of the links between biomes mediated by migrants, changes in one biome could affect remote areas in unpredictable ways. Migratory routes and timing of most Neotropical austral migrants, which breed at south temperate latitudes of South America and overwinter closer to or within tropical latitudes of South America, have yet to be described in detail. As a result, our understanding about how these birds provide links between South American biomes is almost non-existent. White-crested Elaenia (Elaenia albiceps chilensis) is a long-distance austral migrant that breeds in the Patagonian Forest biome and overwinters in tropical South America. Because this small flycatcher plays a key role in the regeneration of this ecosystem, our objective was to describe the annual cycle of White-crested elaenias to evaluate the degree of migratory connectivity between breeding and wintering areas and therefore to determine if there are specific biomes of northern South America linked by elaenias to Patagonian forests. Fifteen individuals were successfully tracked throughout a complete migration cycle using miniature light-level geolocators. All individuals resided and moved through the same general regions. During fall (March-April-May), elaenias were located in the Caatinga and the Atlantic Forest biomes, from Rio de Janeiro to the region near Salvador da Bahia, Brazil. During winter (June-July-Aug.), birds were located further inland, within the Cerrado biome. Birds used three different routes during fall migration. Our results indicate that some individuals use a direct route, flying between 500-600 km/day, crossing desert and grasslands, while others took a detour, flying 100-200 km/day through forested areas with refueling opportunities. All birds used the Yunga forest during spring migration, with ten out of 15 individuals showing a clear counterclockwise loop trajectories throughout their annual cycle. None of the elaenias passed through Amazonia, traveled to western South America or crossed the Equator. Eleanias exhibited a high migratory connectivity between breeding area in Patagonian Forests and winter areas, Atlantic Forest and Cerrado. Our results suggest that Patagonian Forests could be strongly impacted by changes in those biomes or in the Yungas.	[Patricia Bravo, Susana; Rodolfo Cueto, Victor; Andres Gorosito, Cristian] UNPSJB, CONICET, CIEMEP, Esquel, Chubut, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bravo, SP (corresponding author), UNPSJB, CONICET, CIEMEP, Esquel, Chubut, Argentina.	sbravo@conicet.gov.ar	Gorosito, Cristian/GXZ-4845-2022	Cueto, Victor/0000-0001-9594-0086; Bravo, Susana/0000-0002-9745-6279; Gorosito, Cristian/0000-0002-9277-7903				Aizen MA, 2002, REV CHIL HIST NAT, V75, P79, DOI 10.4067/S0716-078X2002000100008; Aizen Marcelo A., 1998, Ecologia Austral, V8, P217; Akesson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041195; Amico Guillermo C, 2005, Ecol. austral, V15, P89; [Anonymous], TERR EC; ARMESTO JJ, 1987, REV CHIL HIST NAT, V60, P321; Bachler E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009566; Bairlein F, 2012, BIOL LETTERS, V8, P505, DOI 10.1098/rsbl.2011.1223; Batalha MA, 2004, AUST J BOT, V52, P149, DOI 10.1071/BT03098; Batalha MA, FLORIDA ENTOMOLOGIST, V98, P170; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; Beason JP, 2012, WILSON J ORNITHOL, V124, P1; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; Bravo SP, 2015, PLANT ECOL, V216, P383, DOI 10.1007/s11258-014-0443-7; Camilotti D. C., 2011, Iheringia, Serie Botanica, V66, P31; Campo de Ferreras A, 2004, CLIMA SO BONAERENSE; Cavallero L, 2013, BIOL CONSERV, V158, P342, DOI 10.1016/j.biocon.2012.10.004; Chesser R. Terry, 1994, Bird Conservation International, V4, P91; Cueto VR, 2016, EMU, V116, P301, DOI 10.1071/MU15078; Cueto VR, 2015, REV BRAS ORNITOL, V23, P18; Cueto Víctor R., 2008, Hornero, V23, P1; de Faria R.A.P.G., 2012, PHENOLOGY SPECIES CE; Delmore KE, 2012, P R SOC B, V279; Develey PF, 2000, J TROP ECOL, V16, P33, DOI 10.1017/S0266467400001255; Dingle H, 2008, EMU, V108, P341, DOI 10.1071/MU08010; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Fair J., 2010, ORNITHOLOGICAL COUNC; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; Fox JW., 2012, INTIGEO SERIES GEOLO; Fox JW., 2013, USER REFERENCE MANUA; Gill RE, 2014, ANIM BEHAV, V90, P117, DOI 10.1016/j.anbehav.2014.01.020; GRIGERA D, 1994, REV CHIL HIST NAT, V67, P273; Heckscher CM, 2011, AUK, V128, P531, DOI 10.1525/auk.2011.10280; Hobson KA, 2015, AUK, V132, P540, DOI 10.1642/AUK-14-260.1; Ippi S, 2009, ORNITOL NEOTROP, V20, P231; Jahn AE, 2004, AUK, V121, P1005, DOI 10.1642/0004-8038(2004)121[1005:RAHASA]2.0.CO;2; Jahn AE, 2009, P 4 INT PARTN FLIGHT, P557; Jahn AE, 2013, AUK, V130, P223, DOI 10.1525/auk.2013.12077; Jahn AE, 2013, AUK, V130, P247, DOI 10.1525/auk.2013.13010; Jimenez JE, 2016, WILSON J ORNITHOL, V128, P419, DOI 10.1676/1559-4491-128.2.419; Jimenez JE, 2000, J FIELD ORNITHOL, V71, P66, DOI 10.1648/0273-8570-71.1.66; Kitzberger T, 1997, J BIOGEOGR, V24, P35, DOI 10.1111/j.1365-2699.1997.tb00048.x; KITZBERGER T, 1995, CAN J FOREST RES, V25, P1684, DOI 10.1139/x95-182; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; La Sorte FA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2588; La Sorte FA, 2014, J BIOGEOGR, V41, P1685, DOI 10.1111/jbi.12328; La Sorte FA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0984; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; Lisovski S, 2012, METHODS ECOL EVOL, V3, P1055, DOI 10.1111/j.2041-210X.2012.00248.x; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; MARINI M A, 1990, Boletim do Museu Paraense Emilio Goeldi Serie Zoologia, V6, P59; Nazareno AG, 2016, NATURE, V531, P580, DOI 10.1038/531580e; Nilsson C, 2013, AM NAT, V181, P837, DOI 10.1086/670335; Olrog C. C., 1963, Opera Lilloana, VNo. 9, P1; Parker TA III, 1996, NEOTROPICAL BIRDS EC; Prohaska F., 1976, CLIMATE CENTRAL S AM, P57; Purificacao KN, 2014, BIOTA NEOTROP, V14, DOI 10.1590/1676-06032014006814; Pyle P., 2015, MANUAL AGEING SEXING; QGIS Development Team, 1991, QGIS GEOGR INF SYST; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Rodriguez-Ruiz J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115615; Schiavini I, 2014, BRAZ J BOT; Schmaljohann H, 2012, BEHAV ECOL SOCIOBIOL, V66, P915, DOI 10.1007/s00265-012-1340-5; Schmidt M.H., 2015, REV GEOPANTANAL, V18, P121; Sergio F, 2014, NATURE, V515, P410, DOI 10.1038/nature13696; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Silva FWS, 2015, FLA ENTOMOL, V98, P170, DOI 10.1653/024.098.0129; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Traylor MA, 1958, FIELDIANA ZOOL, V35, P87; VEBLEN TT, 1992, J VEG SCI, V3, P507, DOI 10.2307/3235807; Wolfe JD, 2015, J FIELD ORNITHOL, V86, P238, DOI 10.1111/jofo.12107	73	20	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170188	10.1371/journal.pone.0170188	http://dx.doi.org/10.1371/journal.pone.0170188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182628	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800007
J	Zhao, HL; Li, X; Zhao, TT; Zhang, HJ; Yan, MH; Dong, X; Chen, PM; Ma, L; Li, P				Zhao, Hailing; Li, Xin; Zhao, Tingting; Zhang, Haojun; Yan, Meihua; Dong, Xi; Chen, Pengmin; Ma, Liang; Li, Ping			Tangshen formula attenuates diabetic renal injuries by upregulating autophagy via inhibition of PLZF expression	PLOS ONE			English	Article							GROWTH; MECHANISMS	The Chinese herbal granule Tangshen Formula (TSF) has been proven to decrease proteinuria and improve estimated glomerular filtration rate (eGFR) in diabetic kidney disease (DKD) patients. However, the underlying mechanism of TSF on treatment of diabetic nephropathy (DN) remains unclear. The present study aimed to identify the therapeutic target of TSF in diabetic renal injuries through microarray-based gene expression profiling and establish its underlying mechanism. TSF treatment significantly attenuated diabetic renal injuries by inhibiting urinary excretion of albumin and renal histological injuries in diabetic (db/db) mice. We found that PLZF might be the molecular target of TSF in DN. In vivo, the db/db mice showed a significant increase in renal protein expression of PLZF and collagen III, and decrease in renal autophagy levels (downregulated LC3 II and upregulated p62/SQSTM1) compared to db/m mice. The application of TSF resulted in the downregulation of PLZF and collagen III and upregulation of autophagy level in the kidneys of db/db mice. In vitro, TSF reduced high glucose (HG)-induced cell proliferation for NRK52E cells. Further studies indicated that the exposure of NRK52E cells to high levels of glucose resulted in the downregulation of cellular autophagy and upregulation of collagen III protein, which was reversed by TSF treatment by decreasing PLZF expression. In conclusion, TSF might have induced cellular autophagy by inhibiting PLZF expression, which in turn resulted in an increase in autophagic degradation of collagen III that attenuated diabetic renal injuries.	[Zhao, Hailing; Li, Xin; Zhao, Tingting; Zhang, Haojun; Yan, Meihua; Dong, Xi; Chen, Pengmin; Ma, Liang; Li, Ping] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing, Peoples R China; [Ma, Liang] China Japan Friendship Hosp, Clin Lab, Beijing, Peoples R China	China-Japan Friendship Hospital; China-Japan Friendship Hospital	Li, P (corresponding author), China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing, Peoples R China.	lp8675@163.com; lp8675@163.com			International Cooperation and Exchange of the National Natural Science Foundation of China [81620108031]; International Collaboration in Science and Technology Grant, China [2011DFA31860]; National Natural Science Foundation of China [81503418, 81473526]	International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Collaboration in Science and Technology Grant, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from a Project of International Cooperation and Exchange of the National Natural Science Foundation of China (Grant No. 81620108031 to PL), http://www.nsfc.gov.cn/; a Project of International Collaboration in Science and Technology Grant, China (Grant No. 2011DFA31860 to PL), http://www.istcp.org.cn/; and the National Natural Science Foundation of China (Grant No. 81503418 to HLZ, No. 81473526 to TTZ), http://www.nsfc.gov.cn/.	Currie G, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0798-3; Gao JR, 2016, J ETHNOPHARMACOL; Hu C, 2015, CURR MED CHEM, V22, P2858, DOI 10.2174/0929867322666150625095407; Jia X, 2016, J DIABETES; Jones C, 2013, INT J CANCER, V133, P58, DOI 10.1002/ijc.28008; Kong Q, 2016, INT J MOL MED, V38, P1715, DOI 10.3892/ijmm.2016.2799; Li P, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1802036; Li P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126027; Liu N, 2016, KIDNEY DIS-BASEL, V2, P37, DOI 10.1159/000444841; Liu SL, 2016, ARCH BIOCHEM BIOPHYS, V590, P37, DOI 10.1016/j.abb.2015.11.001; Lu XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117400; Mao AP, 2016, P NATL ACAD SCI USA, V113, P7602, DOI 10.1073/pnas.1601504113; Peng KY, 2011, METABOLISM, V60, P888, DOI 10.1016/j.metabol.2010.08.009; Periyasamy-Thandavan S, 2008, KIDNEY INT, V74, P631, DOI 10.1038/ki.2008.214; Pushpakumar SB, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.63; Sun GD, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5749857; Suzuki H, 2017, CURR OPIN STRUC BIOL, V43, P10, DOI 10.1016/j.sbi.2016.09.010; Vallon V, 2013, AM J PHYSIOL-RENAL, V304, pF156, DOI 10.1152/ajprenal.00409.2012; Wang LL, 2015, MOL BIOSYST, V11, P3033, DOI 10.1039/c5mb00379b; Wang XT, 2013, FASEB J, V27, P4194, DOI 10.1096/fj.13-229070; Xiang L, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/1064924; Xu Y, 2016, PEERJ, V4, DOI 10.7717/peerj.1888; Zhang T, 2015, ELIFE, V4, DOI 10.7554/eLife.06734; Zhao TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147693	24	13	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171475	10.1371/journal.pone.0171475	http://dx.doi.org/10.1371/journal.pone.0171475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182710	Green Submitted, gold, Green Published			2022-12-26	WOS:000394231800063
J	Chan, HL; Sinjab, K; Chung, MP; Chiang, YC; Wang, HL; Giannobile, WV; Kripfgans, OD				Chan, Hsun-Liang; Sinjab, Khaled; Chung, Ming-Pang; Chiang, Yi-Chen; Wang, Hom-Lay; Giannobile, William V.; Kripfgans, Oliver D.			Non-invasive evaluation of facial crestal bone with ultrasonography	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; GINGIVAL THICKNESS; PERIODONTAL BIOTYPE; TISSUE BIOTYPE; AESTHETIC ZONE; DIMENSIONS; SWELLINGS; DIAGNOSIS; IMPLANTS; EFFICACY	Purpose Facial crestal bone level and dimension determine function and esthetics of dentition and dental implants. We have previously demonstrated that ultrasound can identify bony and soft tissue structures in the oral cavity. The aim of this study is to evaluate the accuracy of using ultrasound to measure facial crestal bone level and thickness. Materials and methods A commercially available medical ultrasound scanner, paired with a 14 MHz imaging probe was used to scan dental and periodontal tissues at the mid-facial site of each tooth on 6 fresh cadavers. The alveolar crest level in relation to the cemento-enamel junction and its thickness on ultrasound images were measured and compared to those on cone-beam computed tomography (CBCT) scans and/or direct measurements on a total of 144 teeth. Results The mean crestal bone level measured by means of ultrasound, CBCT and direct measures was 2.66 +/- 0.86 mm, 2.51 +/- 0.82 mm, and 2.71 +/- 1.04 mm, respectively. The mean crestal bone thickness was 0.71 +/- 0.44 mm and 0.74 +/- 0.34 mm, measured by means of ultrasound and CBCT, respectively. The correlations of the ultrasound readings to the other two methods were between 0.78 and 0.88. The mean absolute differences in crestal bone height and thickness between ultrasound and CBCT were 0.09 mm (-1.20 to 1.00 mm, p = 0.06) and 0.03 mm (-0.48 to 0.54 mm, p = 0.03), respectively. Conclusion Ultrasound was as accurate in determining alveolar bone level and its thickness as CBCT and direct measurements. Clinical trials will be required to further validate this non -ionizing and non-invasive method for determining facial crestal bone position and dimension.	[Chan, Hsun-Liang; Sinjab, Khaled; Chung, Ming-Pang; Chiang, Yi-Chen; Wang, Hom-Lay; Giannobile, William V.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Giannobile, William V.; Kripfgans, Oliver D.] Coll Engn, Dept Biomed Engn, Ann Arbor, MI USA; [Kripfgans, Oliver D.] Univ Michigan, Dept Radiol, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chan, HL (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.	hlchan@umich.edu	Kripfgans, Oliver/AAN-4919-2020	Kripfgans, Oliver/0000-0003-2905-1496; Giannobile, William/0000-0002-7102-9746	Michigan Institute for Clinical and Health Research (MICHR) [UL1TR000433]; University of Michigan Periodontal Graduate Student Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER	Michigan Institute for Clinical and Health Research (MICHR); University of Michigan Periodontal Graduate Student Research Fund(University of Michigan System); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was supported by a pilot grant (UL1TR000433) from the Michigan Institute for Clinical and Health Research (MICHR) and the University of Michigan Periodontal Graduate Student Research Fund.	Braut V, 2011, INT J PERIODONT REST, V31, P125; Chan HL, 2016, CLIN ORAL IMPLANTS R; Chan Hsun-Liang, 2015, Dent Clin North Am, V59, P981, DOI 10.1016/j.cden.2015.06.010; Chandak R, 2011, DENTOMAXILLOFAC RAD, V40, P213, DOI 10.1259/dmfr/68658286; Chao Yi-Chi, 2015, Int J Periodontics Restorative Dent, V35, pe75, DOI 10.11607/prd.2097; CLAFFEY N, 1986, J CLIN PERIODONTOL, V13, P654, DOI 10.1111/j.1600-051X.1986.tb00861.x; De Bruyckere T, 2015, J CLIN PERIODONTOL, V42, P876, DOI 10.1111/jcpe.12448; De Rouck T, 2009, J CLIN PERIODONTOL, V36, P428, DOI 10.1111/j.1600-051X.2009.01398.x; Eghbali A, 2014, CLIN IMPLANT DENT RE; Ferrus J, 2010, CLIN ORAL IMPLAN RES, V21, P22, DOI 10.1111/j.1600-0501.2009.01825.x; Friedrich RE, 2010, ANTICANCER RES, V30, P1787; Frost NA, 2015, J PERIODONTOL, V86, P1141, DOI 10.1902/jop.2015.140394; Fu JH, 2011, INT J ORAL MAX IMPL, V26, P499; Fu JH, 2010, J PERIODONTOL, V81, P569, DOI 10.1902/jop.2009.090591; HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021; Kan JYK, 2010, INT J PERIODONT REST, V30, P237; Lin GH, 2014, J PERIODONTOL, V85, P92, DOI 10.1902/jop.2013.130064; Muller HP, 2007, CLIN ORAL INVEST, V11, P439, DOI 10.1007/s00784-007-0125-0; Muller HP, 2005, J PERIODONTAL RES, V40, P239, DOI 10.1111/j.1600-0765.2005.00798.x; OLSSON M, 1991, J CLIN PERIODONTOL, V18, P78, DOI 10.1111/j.1600-051X.1991.tb01124.x; Pallagatti S, 2012, EUR J RADIOL, V81, P1821, DOI 10.1016/j.ejrad.2011.04.065; Timock AM, 2011, AM J ORTHOD DENTOFAC, V140, P734, DOI 10.1016/j.ajodo.2011.06.021; Vera C, 2012, INT J ORAL MAX IMPL, V27, P1514; Wakasugi-Sato N, 2010, INT J DENT, V2010, DOI 10.1155/2010/639382; Wang HM, 2014, INT J ORAL MAX IMPL, V29, P1123, DOI 10.11607/jomi.3348; Noriaki Y, 2011, ORAL ONCOL, V47, P163, DOI 10.1016/j.oraloncology.2010.10.015; Zweers J, 2014, J CLIN PERIODONTOL, V41, P958, DOI 10.1111/jcpe.12275	27	29	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171237	10.1371/journal.pone.0171237	http://dx.doi.org/10.1371/journal.pone.0171237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178323	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500034
J	Liu, WX; Golovatch, S; Wesener, T; Tian, MY				Liu, Weixin; Golovatch, Sergei; Wesener, Thomas; Tian, Mingyi			Convergent Evolution of Unique Morphological Adaptations to a Subterranean Environment in Cave Millipedes (Diplopoda)	PLOS ONE			English	Article							GENUS GLYPHIULUS GERVAIS; NEW-SPECIES DIPLOPODA; EUTRICHODESMUS SILVESTRI; DESMOXYTES CHAMBERLIN; DWELLING MILLIPEDE; SOUTHEAST-ASIA; CHINA; SPIROSTREPTIDA; POLYDESMIDA; CHORDEUMATIDA	Animal life in caves has fascinated researchers and the public alike because of the unusual and sometimes bizarre morphological adaptations observed in numerous troglobitic species. Despite their worldwide diversity, the adaptations of cave millipedes (Diplopoda) to a troglobitic lifestyle have rarely been examined. In this study, morphological characters were analyzed in species belonging to four different orders (Glomerida, Polydesmida, Chordeumatida, and Spirostreptida) and six different families (Glomeridae, Paradoxosomatidae, Polydesmidae, Haplodesmidae, Megalotylidae, and Cambalopsidae) that represent the taxonomic diversity of class Diplopoda. We focused on the recently discovered millipede fauna of caves in southern China. Thirty different characters were used to compare cave troglobites and epigean species within the same genera. A character matrix was created to analyze convergent evolution of cave adaptations. Males and females were analyzed independently to examine sex differences in cave adaptations. While 10 characters only occurred in a few phylogenetic groups, 20 characters were scored for in all families. Of these, four characters were discovered to have evolved convergently in all troglobitic millipedes. The characters that represented potential morphological cave adaptations in troglobitic species were: (1) a longer body; (2) a lighter body color; (3) elongation of the femora; and (4) elongation of the tarsi of walking legs. Surprisingly, female, but not male, antennae were more elongated in troglobites than in epigean species. Our study clearly shows that morphological adaptations have evolved convergently in different, unrelated millipede orders and families, most likely as a direct adaptation to cave life.	[Liu, Weixin; Tian, Mingyi] South China Agr Univ, Coll Agr, Dept Entomol, Guangzhou, Guangdong, Peoples R China; [Liu, Weixin; Wesener, Thomas] Leibniz Inst Terr Biodivers, Zool Res Museum A Koenig, Bonn, Germany; [Golovatch, Sergei] Russian Acad Sci, Inst Problems Ecol & Evolut, Moscow, Russia	South China Agricultural University; Russian Academy of Sciences	Tian, MY (corresponding author), South China Agr Univ, Coll Agr, Dept Entomol, Guangzhou, Guangdong, Peoples R China.; Wesener, T (corresponding author), Leibniz Inst Terr Biodivers, Zool Res Museum A Koenig, Bonn, Germany.	t.wesener@zfmk.de; mytian@scau.edu.cn	Liu, Weixin/AAL-6371-2020		China Scholarship Council [201508440257]	China Scholarship Council(China Scholarship Council)	Weixin Liu was financially supported by the China Scholarship Council (No.201508440257, www.csc.ed men) for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkari N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135243; [Anonymous], 1995, ADAPTATION NATURAL S, DOI DOI 10.4159/HARVARD.9780674419070; [Anonymous], 2015, MATH PROBL ENG, DOI DOI 10.1007/S00382-015-2782-Z; Ashe JS, 2000, ZOOL J LINN SOC-LOND, V130, P471, DOI 10.1111/j.1096-3642.2000.tb02197.x; BARR TC, 1967, AM NAT, V101, P475, DOI 10.1086/282512; BARR TC, 1985, ANNU REV ECOL SYST, V16, P313, DOI 10.1146/annurev.es.16.110185.001525; Barr TC, 1968, EVOLUTIONARY BIOL, P33; Barr TC, 1960, AM MIDL NAT, P45; Beron Petar, 2015, Historia Naturalis Bulgarica, V21, P169; Beron Petar, 2011, P583; Blanke A, 2014, ARTHROPOD STRUCT DEV, V43, P63, DOI 10.1016/j.asd.2013.10.003; Buzila R, 2000, EVOLUTION ADAPTATION, V6, P117; Causey N.B., 1971, Bulletin Ass mex Cave Stud, VNo. 4,1971, P23; CHRISTIANSEN K, 1961, EVOLUTION, V15, P288, DOI 10.2307/2406229; Christiansen K., 2012, ENCY CAVES, P517, DOI 10.1016/B978-0-12-383832-2.00075-X; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Culver DC, 2015, ACTA CARSOLOGICA, V44, P415; Culver DC, 2010, J CRUSTACEAN BIOL, V30, P68, DOI 10.1651/09-3156.1; Culver DC, 2006, ECOGRAPHY, V29, P120; Culver DC, 2014, Shallow Subterranean Habitats: Ecology, Evolution, and Conservation, P1, DOI 10.1093/acprof:oso/9780199646173.001.0001; CULVER DC, 1986, STYGOLOGIA, V2, P208; Culver DC, 2012, ENCY CAVES, P538; Darda DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127248; David J.-F., 2015, TREATISE ZOOLOGY ANA, V2, P303, DOI DOI 10.1163/9789004188273_013; De Azara LN, 2013, ZOOTAXA, V3709, P432; Deharveng L, 2000, ECOSY WORLD, V30, P603; Deharveng L., 2012, ENCY CAVES, P238, DOI [10.1016/B978-0-12-383832-2.00032-3, DOI 10.1016/B978-0-12-383832-2.00032-3]; Deharvening Louis, 2005, P166; Derkarabetian S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010388; Enghoff H., 1985, BIJDRAGEN DIERKUNDE, V55, P66; Enghoff H, 1985, LAVORI SOC VENEZIANA, V10, P69; Enghoff H., 2015, TREATISE ZOOLOGY ANA, V2, P363, DOI 10.1163/9789004188273_017; Enghoff H, 2013, ZOOTAXA, V 3736, P175, DOI 10.11646/zootaxa.3736.2.5; Enghoff H, 2013, J NAT HIST, V47, P1613, DOI 10.1080/00222933.2012.759289; Enghoff H, 2013, ZOOTAXA, V3652, P485, DOI 10.11646/zootaxa.3652.4.6; Enghoff Henrik, 2012, European Journal of Taxonomy, V15, P1; Fudge Douglas S., 2009, Aquatic Mammals, V35, P226, DOI 10.1578/AM.35.2.2009.226; Geoffroy J.-J., 2004, Arthropoda Selecta, V13, P19; Giachino P. M., 2010, WBA HDB, V3; Golovatch SI, 2014, ZOOTAXA, V3760, P275, DOI 10.11646/zootaxa.3760.2.7; Golovatch S. I., 2012, Russian Entomological Journal, V21, P133; Golovatch S. I., 2011, Arthropoda Selecta, V20, P167; Golovatch S. I., 2011, Arthropoda Selecta, V20, P149; Golovatch S. I., 2011, Arthropoda Selecta, V20, P65; Golovatch S. I., 2010, Arthropoda Selecta, V19, P63; Golovatch S. I., 2010, Arthropoda Selecta, V19, P57; Golovatch SI, 2007, ZOOSYSTEMA, V29, P417; Golovatch SI, 2007, ZOOSYSTEMA, V29, P7; Golovatch Sergei I., 2003, Vieraea, V31, P9; Golovatch SI, 2006, ZOOTAXA, P363; Golovatch SI, 2015, ZOOKEYS, P79, DOI 10.3897/zookeys.510.8640; Golovatch SI, 2015, ZOOKEYS, P1, DOI 10.3897/zookeys.505.9862; Golovatch SI, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.185.3082; Golovatch SI, 2012, ZOOTAXA, P1; Golovatch Sergei I., 2014, Russian Entomological Journal, V23, P91; Golovatch Sergei I., 2013, Fragmenta Faunistica (Warsaw), V56, P157, DOI 10.3161/00159301FF2013.56.2.157; Golovatch SI, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.12.167; Golovatch Sergei I., 2006, Arthropoda Selecta, V15, P81; Golovatch SI, 2006, ZOOSYSTEMA, V28, P75; Harvey MS, 2000, ECOSY WORLD, V30, P79; Hedin M, 2010, MOL PHYLOGENET EVOL, V54, P107, DOI 10.1016/j.ympev.2009.08.020; Hild S, 2009, J STRUCT BIOL, V168, P426, DOI 10.1016/j.jsb.2009.07.017; Hoffman Richard L., 1994, Myriapodologica, V3, P19; Hoffman RL, 1956, ALABAMA GEOLOGICAL S, V35, P5; Hopkin P.S., 1992, BIOL MILLIPEDES; HOWARTH FG, 1983, ANNU REV ENTOMOL, V28, P365, DOI 10.1146/annurev.en.28.010183.002053; Howes C., 1994, P U BRISTOL SPELAEOL, V20, P15; Huppop K., 2012, ENCY CAVES, V2nd ed., P1, DOI 10.1016/B978-0-12-383832-2.00001-3; Ishii K, 1996, MEMOIR MUS NATL HIST, V169, P101; Jeannel R., 1949, FOSSILES VIVANTS CAV; Juan C, 2010, MOL ECOL, V19, P3865, DOI 10.1111/j.1365-294X.2010.04759.x; Juberthie C, 1980, MEMOIRES BIOSPEOLO, V7, P719; JUBERTHIE C, 1995, UNDERGROUND HABITATS; KOHLER HR, 1990, ZOOL SCR, V19, P195, DOI 10.1111/j.1463-6409.1990.tb00255.x; Lamprecht G, 1979, REGRESSIVE EVOLUTION, V18, P69; Lewis JJ, 2005, ZOOTAXA, P17, DOI 10.11646/zootaxa.1080.1.2; Liu WX, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.577.7825; Liu WX, 2015, ZOOKEYS, P123, DOI 10.3897/zookeys.517.9949; Liu WX, 2014, ZOOKEYS, P9, DOI 10.3897/zookeys.448.8081; Liu WX, 2013, ZOOTAXA, V3734, P281, DOI 10.11646/zootaxa.3734.2.11; Loria Stephanie F., 2011, International Journal of Myriapodology, V5, P35, DOI 10.3897/ijm.5.1891; Manton SM, 1954, J LINN SOC LOND, P299, DOI DOI 10.1111/J.1096-3642.1954.TB02211.X; Mauries J.-P., 2004, ENCYCLOPAEDIA CAVE K, P534; Mauries Jean-Paul, 2005, Arthropoda Selecta, V14, P241; Miller JA, 2005, ZOOL SCR, V34, P565, DOI 10.1111/j.1463-6409.2005.00206.x; Moldovan O. T, 2012, ENCY CAVES, P54, DOI DOI 10.1016/B978-0-12-383832-2.00008-6; Moldovan Oana Teodora, 2004, Natura Croatica, V13, P1; Iniesta LFM, 2012, ZOOTAXA, P26; Muller C.H.G., 2015, TREATISE ZOOLOGY ANA, V2, P181; Pipan T, 2012, BIOL J LINN SOC, V107, P1, DOI 10.1111/j.1095-8312.2012.01964.x; POULSON THOMAS L., 1963, AMER MIDLAND NAT, V70, P257, DOI 10.2307/2423056; POULSON TL, 1969, SCIENCE, V165, P971; Pricop Emilian, 2009, ELBA Bioflux, V1, P41; Racovita E.G., 2006, EG RACOVITZA ESSAY B, P127; Reboleira ASPS, 2015, EUR J TAXON, V161, P1, DOI 10.5852/ejt.2015.161; Reboleira ASPS, 2014, J CAVE KARST STUD, V76, P20, DOI 10.4311/2013LSC0113; ROUCH R, 1987, STYGOLOGIA, V3, P345; Schonhofer AL, 2012, ORG DIVERS EVOL, V12, P409, DOI 10.1007/s13127-012-0073-7; Shear WA, 1977, QUADERNO ACCAD NAZ L, V171, P235; Shear WA, 2015, BIOCHEM SYST ECOL, V61, P78, DOI 10.1016/j.bse.2015.04.033; Shear William A., 2002, Proceedings of the California Academy of Sciences, V53, P63; Shear WA, 2009, ZOOTAXA, P47; Sket B., 1985, Bulletin of the National Speleological Society, V47, P78; Stahl BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140484; Stoev P, 2005, J NAT HIST, V39, P1875, DOI 10.1080/00222930400025896; Stoev P, 2004, ZOOTAXA, P1; Stoev Pavel, 2004, Acta Arachnologica, V53, P93, DOI 10.2476/asjaa.53.93; Tabacaru I., 1963, LUCRARILE I SPEOLOGI, V1-2, P341; Tabacura I, 2003, TRAVAUX I SPEOLOGIE, P121; Taylor SJ, 2008, ENCY ENTOMOLOGY, P803; Tian MY, 2016, ZOOKEYS, P121, DOI 10.3897/zookeys.564.6819; Trontelj P, 2012, EVOLUTION, V66, P3852, DOI 10.1111/j.1558-5646.2012.01734.x; TUTTLE MD, 1977, AM MIDL NAT, V97, P235, DOI 10.2307/2424704; Vandel A., 1965, BIOSPELEOLGY BIOL CA; Veni, 1994, CAVES KARST TEXAS, P31; Wesener T, 2009, CLADISTICS, V25, P545, DOI 10.1111/j.1096-0031.2009.00267.x; Wesener T, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.19.221; Whitten T, 2009, J APPL ECOL, V46, P520, DOI 10.1111/j.1365-2664.2009.01630.x; Zapparoli M, 1997, INT J SPELEOL, V25, P59	119	35	37	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170717	10.1371/journal.pone.0170717	http://dx.doi.org/10.1371/journal.pone.0170717			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178274	Green Submitted, Green Published, gold			2022-12-26	WOS:000393712500014
J	Cox, MJ; Turek, EM; Hennessy, C; Mirza, GK; James, PL; Coleman, M; Jones, A; Wilson, R; Bilton, D; Cookson, WOC; Moffatt, MF; Loebinger, MR				Cox, Michael J.; Turek, Elena M.; Hennessy, Catherine; Mirza, Ghazala K.; James, Phillip L.; Coleman, Meg; Jones, Andrew; Wilson, Robert; Bilton, Diana; Cookson, William O. C.; Moffatt, Miriam F.; Loebinger, Michael R.			Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients	PLOS ONE			English	Article							AIRWAY MICROBIOTA; PULMONARY	Background Bronchiectasis is accompanied by chronic bronchial infection that may drive disease progression. However, the evidence base for antibiotic therapy is limited. DNA based methods offer better identification and quantification of microbial constituents of sputum than standard clinical culture and may help inform patient management strategies. Our study objective was to determine the longitudinal variability of the non-cystic fibrosis (CF) bronchiectasis microbiome in sputum with respect to clinical variables. Eighty-five patients with non-CF bronchiectasis and daily sputum production were recruited from outpatient clinics and followed for six months. Monthly sputum samples and clinical measurements were taken, together with additional samples during exacerbations. 16S rRNA gene sequencing of the sputum microbiota was successful for 381 samples from 76 patients and analysed in conjunction with clinical data. Results Microbial communities were highly individual in composition and stability, usually with limited diversity and often containing multiple pathogens. When compared to DNA sequencing, microbial culture had restricted sensitivity in identifying common pathogens such as Pseudomonas aeruginosa, Haemophilus influenzae, Moraxella catarrhalis. With some exceptions, community characteristics showed poor correlations with clinical features including underlying disease, antibiotic use and exacerbations, with the subject showing the strongest association with community structure. When present, the pathogens mucoid Pseudomonas aeruginosa and Haemophilus influenzae may also shape the structure of the rest of the microbial community. Conclusions The use of microbial community analysis of sputum added to information from microbial culture. A simple model of exacerbations driven by bacterial overgrowth was not supported, suggesting a need for revision of principles for antibiotic therapy. In individual patients, the management of chronic bronchial infection may be improved by therapy specific to their microbiome, taking into account pathogen load, community stability, and acute and chronic community responses to antibiotics.	[Cox, Michael J.; Turek, Elena M.; Mirza, Ghazala K.; James, Phillip L.; Bilton, Diana; Cookson, William O. C.; Moffatt, Miriam F.; Loebinger, Michael R.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Hennessy, Catherine; James, Phillip L.; Coleman, Meg; Jones, Andrew; Wilson, Robert; Bilton, Diana; Cookson, William O. C.; Loebinger, Michael R.] Royal Brompton & Harefield NHS Fdn Trust, London, England	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust	Moffatt, MF; Loebinger, MR (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.; Loebinger, MR (corresponding author), Royal Brompton & Harefield NHS Fdn Trust, London, England.	m.moffatt@imperial.ac.uk; m.loebinger@imperial.ac.uk	Bilton, Diana/D-2972-2012; Cookson, William/HHC-1790-2022	Cox, Michael/0000-0002-4002-1506; Bilton, Diana/0000-0002-1913-9171	Wellcome Trust [WT077959, WT096964]; NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust; Imperial College London; Novartis UK; Wellcome Trust Joint Senior Investigator's Award; Medical Research Council [G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10126] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre, MRC-AsthmaUKCentre] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust; Imperial College London(General Electric); Novartis UK(Novartis); Wellcome Trust Joint Senior Investigator's Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	The study was funded by the Wellcome Trust under WT077959 and WT096964. This project was funded and supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London. The views expressed in this publication are those of the authors and not necessarily those of the NHS, The National Institute for Health Research or the Department of Health. Funding for sequencing was provided by a grant to DB from Novartis UK. WOCC and MFM are supported by a Wellcome Trust Joint Senior Investigator's Award, which also supports MJC and EMT and WOCC is an NIHR Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Carmody LA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0074-9; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Cox MJ, 2016, BIORXIV; Cox MJ, 2015, ATS J; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fierer N, 2008, P NATL ACAD SCI USA, P105; Flynn JM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005846; Haworth CS, 2014, AM J RESP CRIT CARE, V189, P975, DOI 10.1164/rccm.201312-2208OC; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Jorth P, 2015, CELL HOST MICROBE, V18, P307, DOI 10.1016/j.chom.2015.07.006; Levy H, 2008, PEDIATR PULM, V43, P463, DOI 10.1002/ppul.20794; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Molyneaux PL, 2013, AM J RESP CRITICAL C; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Rogers GB, 2014, LANCET RESP MED, V2, P988, DOI 10.1016/S2213-2600(14)70213-9; Rogers Geraint B, 2009, BMC Pulm Med, V9, P14, DOI 10.1186/1471-2466-9-14; Seitz AE, 2010, CHEST, V138, P944, DOI 10.1378/chest.10-0099; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Stressmann FA, 2011, J CYST FIBROS, V10, P357, DOI 10.1016/j.jcf.2011.05.002; Team RC, 2014, R A LANGUAGE AND ENV; Tunney MM, 2011, THORAX, V66, P579, DOI 10.1136/thx.2010.137281; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; Zhao J, 2012, P NATL ACAD SCI	28	71	72	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170622	10.1371/journal.pone.0170622	http://dx.doi.org/10.1371/journal.pone.0170622			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170403	Green Published, Green Submitted, gold			2022-12-26	WOS:000393705500007
J	Nesterenko, AM; Kuznetsov, MB; Korotkova, DD; Zaraisky, AG				Nesterenko, Alexey M.; Kuznetsov, Maxim B.; Korotkova, Daria D.; Zaraisky, Andrey G.			Morphogene adsorption as a Turing instability regulator: Theoretical analysis and possible applications in multicellular embryonic systems	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; BIOLOGICAL PATTERN-FORMATION; REACTION-DIFFUSION SYSTEM; TRANSCRIPTIONAL RESPONSE; SPEMANNS ORGANIZER; XENOPUS-EMBRYOS; PROTEIN; SIZE; WNT; MECHANISM	The Turing instability in the reaction-diffusion system is a widely recognized mechanism of the morphogen gradient self-organization during the embryonic development. One of the essential conditions for such self-organization is sharp difference in the diffusion rates of the reacting substances (morphogens). In classical models this condition is satisfied only for significantly different values of diffusion coefficients which cannot hold for morphogens of similar molecular size. One of the most realistic explanations of the difference in diffusion rate is the difference between adsorption of morphogens to the extracellular matrix (ECM). Basing on this assumption we develop a novel mathematical model and demonstrate its effectiveness in describing several well-known examples of biological patterning. Our model consisting of three reaction-diffusion equations has the Turing-type instability and includes two elements with equal diffusivity and immobile binding sites as the third reaction substance. The model is an extension of the classical Gierer-Meinhardt two-components model and can be reduced to it under certain conditions. Incorporation of ECM in the model system allows us to validate the model for available experimental parameters. According to our model introduction of binding sites gradient, which is frequently observed in embryonic tissues, allows one to generate more types of different spatial patterns than can be obtained with two-components models. Thus, besides providing an essential condition for the Turing instability for the system of morphogen with close values of the diffusion coefficients, the morphogen adsorption on ECM may be important as a factor that increases the variability of self-organizing structures.	[Nesterenko, Alexey M.; Korotkova, Daria D.; Zaraisky, Andrey G.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Nesterenko, Alexey M.] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Kuznetsov, Maxim B.] Russian Acad Sci, Lebedev Physcal Inst, Moscow, Russia; [Korotkova, Daria D.] Lomonosov Moscow State Univ, Dept Embryol, Fac Biol, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University; Russian Academy of Sciences; Lomonosov Moscow State University	Nesterenko, AM; Zaraisky, AG (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.; Nesterenko, AM (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia.	comconadin@gmail.com; azaraisky@gmail.com	Zaraisky, Andrey G/Q-2323-2016; , Alexey Nesterenko/C-8646-2012; Kuznetsov, Maxim B/M-3539-2015	Zaraisky, Andrey G/0000-0003-4681-8169; , Alexey Nesterenko/0000-0003-1592-257X; Kuznetsov, Maxim B/0000-0002-0004-9002; Korotkova, Daria/0000-0001-7098-0962	Russian Science Foundation [14-14-00557]; Russian Foundation for Basic Research [14-01-00196]; RSCF [14-14-00557]; RFBR [14-01-00196]; Russian Science Foundation [17-14-00022] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RSCF(Russian Science Foundation (RSF)); RFBR(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation (Grant: 14-14-00557, www.rscf.ru) to AGZ. Particularly, the work on computational scheme was supported the Russian Foundation for Basic Research (Grant: 14-01-00196, www.rfbr.ru) to MBK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by RSCF grant 14-14-00557 (AGZ). Computational experiments were performed at computers of Sector of Mathematical Biophysics of Complex Systems (Faculty of Biology, Lomonosov Moscow State University). Computational scheme development and coding was supported by RFBR 14-01-00196 (MBK). Authors thank Tatyana Galochkina for fruitful discussion.	Asai R, 1999, MECH DEVELOP, V89, P87, DOI 10.1016/S0925-4773(99)00211-7; BAKER BI, 1994, TRENDS ENDOCRIN MET, V5, P120, DOI 10.1016/1043-2760(94)90093-0; Belintsev B. N., 1983, Soviet Physics - Uspekhi, V26, P775, DOI 10.1070/PU1983v026n09ABEH004492; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Crank J., 1975, MATH DIFFUSION; Dawes JHP, 2010, PHILOS T R SOC A, V368, P3519, DOI 10.1098/rsta.2010.0057; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Eames BF, 2005, DEVELOPMENT, V132, P1499, DOI 10.1242/dev.01719; Eom DS, 2015, ELIFE, V4, DOI 10.7554/eLife.12401; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Eroshkin FM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23049; Fedorenko R. P., 1994, INTRO COMPUTATIONAL; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Gonpot P., 2008, TRENDS APPL SCI RES, V3, P115, DOI [10.3923/tasr.2008.115.128, DOI 10.3923/TASR.2008.115.128]; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Inomata H, 2013, CELL, V153, P1296, DOI 10.1016/j.cell.2013.05.004; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kiryanov D, 2007, COMPUTATIONAL SCI IN; Kringstein AM, 1998, P NATL ACAD SCI USA, V95, P13670, DOI 10.1073/pnas.95.23.13670; Levin M, 2012, BIOSYSTEMS, V109, P243, DOI 10.1016/j.biosystems.2012.04.005; Maini PK, 2012, INTERFACE FOCUS, V2, P487, DOI 10.1098/rsfs.2011.0113; McClure M, 2003, EVOLUTION, V57, P1863, DOI 10.1111/j.0014-3820.2003.tb00594.x; McNally JG, 2008, METHOD CELL BIOL, V85, P329, DOI 10.1016/S0091-679X(08)85014-5; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Meinhardt H, 2006, DEV DYNAM, V235, P2907, DOI 10.1002/dvdy.20952; Meinhardt H, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001362; Mii Y, 2011, DEV GROWTH DIFFER, V53, P911, DOI 10.1111/j.1440-169X.2011.01299.x; Moos M, 1995, DEVELOPMENT, V121, P4293; Muller P, 2012, SCIENCE, V336, P721, DOI 10.1126/science.1221920; MURRAY JD, 1991, J THEOR BIOL, V149, P339, DOI 10.1016/S0022-5193(05)80310-8; Nesterenko AM, 2015, BIOCHEM BIOPH RES CO, V468, P331, DOI 10.1016/j.bbrc.2015.10.100; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Petrov I.B., 2006, LECT COMPUTATIONAL M; Plouhinec JL, 2013, P NATL ACAD SCI USA, V110, P20372, DOI 10.1073/pnas.1319745110; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Satnoianu RA, 2000, J MATH BIOL, V41, P493, DOI 10.1007/s002850000056; Sen S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046212; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; SMITH WC, 1993, NATURE, V361, P547, DOI 10.1038/361547a0; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Veitia RA, 2003, BIOL REV, V78, P149, DOI 10.1017/S1464793102006036; Wartlick O, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001255; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001; Yang LF, 2002, J CHEM PHYS, V117, P7259, DOI 10.1063/1.1507110; Zaraiskii A, 1990, ONTOGENEZ, V22, P365; ZHABOTINSKY AM, 1995, J CHEM PHYS, V103, P10306, DOI 10.1063/1.469932	52	10	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171212	10.1371/journal.pone.0171212	http://dx.doi.org/10.1371/journal.pone.0171212			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170437	Green Published, Green Submitted, gold			2022-12-26	WOS:000393705500023
J	Florence, JM; Krupa, A; Booshehri, LM; Allen, TC; Kurdowska, AK				Florence, Jon M.; Krupa, Agnieszka; Booshehri, Laela M.; Allen, Timothy C.; Kurdowska, Anna K.			Metalloproteinase-9 contributes to endothelial dysfunction in atherosclerosis via protease activated receptor-1	PLOS ONE			English	Article							BRUTONS TYROSINE KINASE; CARDIOVASCULAR-DISEASE; VASCULAR-DISEASE; MOUSE MODELS; MATRIX-METALLOPROTEINASE-9; INFLAMMATION; MICE; ASSOCIATION; NEUTROPHILS; MARKERS	The atherosclerotic process begins when vascular endothelial cells undergo pro-inflammatory changes such as aberrant activation to dysfunctional phenotypes and apoptosis, leading to loss of vascular integrity. Our laboratory has demonstrated that exposure of mice to second hand smoke triggers an increase in expression of metalloproteinase-9. Further, metalloproteinase-9 released by second hand smoke activated leukocytes may propagate pro-atherogenic alterations in endothelial cells. We have shown that levels of metalloproteinase-9 were increased in the plasma from apolipoprotein E deficient (ApoE(-/-)) mice exposed to second hand smoke relative to non-exposed controls. Moreover, we have collected data from two different, but complementary, treatments of second hand smoke exposed atherosclerotic mice. Animals received either cell specific metalloproteinase-9 directed siRNA to minimize metalloproteinase-9 expression in neutrophils and endothelial cells, or a pharmacological inhibitor of Bruton's tyrosine kinase which indirectly limits metalloproteinase-9 production in neutrophils. These treatments reduced atherosclerotic changes in mice and improved overall vascular health. We also demonstrated that metalloproteinase-9 could activate endothelial cells and induce their apoptosis via cleavage of protease activated receptor-1. In summary, better understanding of metalloproteinase-9's pathogenic capabilities as well as novel signaling pathways involved may lead to development of treatments which may provide additional benefits to atherosclerosis patients with a history of second hand smoke exposure.	[Florence, Jon M.; Krupa, Agnieszka; Booshehri, Laela M.; Kurdowska, Anna K.] Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75799 USA; [Krupa, Agnieszka] Polish Acad Sci, Inst Med Biol, Lodz, Poland; [Allen, Timothy C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; University of Texas System; University of Texas Medical Branch Galveston	Kurdowska, AK (corresponding author), Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75799 USA.	Anna.Kurdowska@uthct.edu		Krupa, Agnieszka/0000-0003-1303-4608	Flight Attendant Medical Research Institute (FAMRI) [113016_CIA]	Flight Attendant Medical Research Institute (FAMRI)	This work was supported by Flight Attendant Medical Research Institute (FAMRI ID# 113016_CIA) to AKK (http://famri.org/researchers/awards_history.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes JA, 2004, MOL CELL BIOCHEM, V263, P227, DOI 10.1023/B:MCBI.0000041864.14092.5b; Boekhorst BCT, 2011, CARDIOVASC RES, V89, P680, DOI 10.1093/cvr/cvq340; Chambers RC, 2008, BRIT J PHARMACOL, V153, pS367, DOI 10.1038/sj.bjp.0707603; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Constans J, 2006, CLIN CHIM ACTA, V368, P33, DOI 10.1016/j.cca.2005.12.030; Corrado E, 2005, ACTA CHIR BELG, V105, P567, DOI 10.1080/00015458.2005.11679782; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Eriksson EE, 2001, FASEB J, V15, P1149, DOI 10.1096/fj.00-0537com; Gottipati KR, 2008, EXP DERMATOL, V17, P780, DOI 10.1111/j.1600-0625.2007.00685.x; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; Krupa A, 2014, AM J PHYSIOL-LUNG C, V307, pL435, DOI 10.1152/ajplung.00234.2013; Krupa A, 2013, AM J RESP CELL MOL, V48, P240, DOI 10.1165/rcmb.2012-0039OC; Krupa A, 2009, AM J RESP CELL MOL, V41, P155, DOI 10.1165/rcmb.2008-0183OC; Kuldo Joanna M., 2005, Current Vascular Pharmacology, V3, P11, DOI 10.2174/1570161052773898; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; Maganto-Garcia E, 2012, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1524s96; Meuwese MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014262; Monier F, 2000, CLIN CHIM ACTA, V299, P11, DOI 10.1016/S0009-8981(00)00271-0; Olson FJ, 2008, J INTERN MED, V263, P626, DOI 10.1111/j.1365-2796.2008.01927.x; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Rauch I, 2008, EUR J CLIN INVEST, V38, P24, DOI 10.1111/j.1365-2362.2007.01902.x; Raupach T, 2006, EUR HEART J, V27, P386, DOI 10.1093/eurheartj/ehi601; Steinberg SF, 2005, MOL PHARMACOL, V67, P2, DOI 10.1124/mol.104.003103; Szmitko PE, 2003, CIRCULATION, V108, P2041, DOI 10.1161/01.CIR.0000089093.75585.98; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Yabluchanskiy A, 2013, PHYSIOLOGY, V28, P391, DOI 10.1152/physiol.00029.2013; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570; Zhao HJ, 2006, CIRC J, V70, P615, DOI 10.1253/circj.70.615	33	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171427	10.1371/journal.pone.0171427	http://dx.doi.org/10.1371/journal.pone.0171427			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166283	Green Submitted, gold, Green Published			2022-12-26	WOS:000393700100041
J	Forstner, AJ; Hecker, J; Hofmann, A; Maaser, A; Reinbold, CS; Muhleisen, TW; Leber, M; Strohmaier, J; Degenhardt, F; Treutlein, J; Mattheisen, M; Schumacher, J; Streit, F; Meier, S; Herms, S; Hoffmann, P; Lacour, A; Witt, SH; Reif, A; Muller-Myhsok, B; Lucae, S; Maier, W; Schwarz, M; Vedder, H; Kammerer-Ciernioch, J; Pfennig, A; Bauer, M; Hautzinger, M; Moebus, S; Schenk, LM; Fischer, SB; Sivalingam, S; Czerski, PM; Hauser, J; Lissowska, J; Szeszenia-Dabrowska, N; Brennan, P; McKay, JD; Wright, A; Mitchell, PB; Fullerton, JM; Schofield, PR; Montgomery, GW; Medland, SE; Gordon, SD; Martin, NG; Krasnov, V; Chuchalin, A; Babadjanova, G; Pantelejeva, G; Abramova, LI; Tiganov, AS; Polonikov, A; Khusnutdinova, E; Alda, M; Cruceanu, C; Rouleau, GA; Turecki, G; Laprise, C; Rivas, F; Mayoral, F; Kogevinas, M; Grigoroiu-Serbanescu, M; Becker, T; Schulze, TG; Rietschel, M; Cichon, S; Fier, H; Nothen, MM				Forstner, Andreas J.; Hecker, Julian; Hofmann, Andrea; Maaser, Anna; Reinbold, Celine S.; Muehleisen, Thomas W.; Leber, Markus; Strohmaier, Jana; Degenhardt, Franziska; Treutlein, Jens; Mattheisen, Manuel; Schumacher, Johannes; Streit, Fabian; Meier, Sandra; Herms, Stefan; Hoffmann, Per; Lacour, Andre; Witt, Stephanie H.; Reif, Andreas; Mueller-Myhsok, Bertram; Lucae, Susanne; Maier, Wolfgang; Schwarz, Markus; Vedder, Helmut; Kammerer-Ciernioch, Jutta; Pfennig, Andrea; Bauer, Michael; Hautzinger, Martin; Moebus, Susanne; Schenk, Lorena M.; Fischer, Sascha B.; Sivalingam, Sugirthan; Czerski, Piotr M.; Hauser, Joanna; Lissowska, Jolanta; Szeszenia-Dabrowska, Neonila; Brennan, Paul; McKay, James D.; Wright, Adam; Mitchell, Philip B.; Fullerton, Janice M.; Schofield, Peter R.; Montgomery, Grant W.; Medland, Sarah E.; Gordon, Scott D.; Martin, Nicholas G.; Krasnov, Valery; Chuchalin, Alexander; Babadjanova, Gulja; Pantelejeva, Galina; Abramova, Lilia I.; Tiganov, Alexander S.; Polonikov, Alexey; Khusnutdinova, Elza; Alda, Martin; Cruceanu, Cristiana; Rouleau, Guy A.; Turecki, Gustavo; Laprise, Catherine; Rivas, Fabio; Mayoral, Fermin; Kogevinas, Manolis; Grigoroiu-Serbanescu, Maria; Becker, Tim; Schulze, Thomas G.; Rietschel, Marcella; Cichon, Sven; Fier, Heide; Noethen, Markus M.			Identification of shared risk loci and pathways for bipolar disorder and schizophrenia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DORSOLATERAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; PSYCHIATRIC-DISORDERS; GENE-EXPRESSION; ENRICHMENT; COMMON; METAANALYSIS; POPULATIONS; GLUTAMATE	Bipolar disorder (BD) is a highly heritable neuropsychiatric disease characterized by recurrent episodes of mania and depression. BD shows substantial clinical and genetic overlap with other psychiatric disorders, in particular schizophrenia (SCZ). The genes underlying this etiological overlap remain largely unknown. A recent SCZ genome wide association study (GWAS) by the Psychiatric Genomics Consortium identified 128 independent genome-wide significant single nucleotide polymorphisms (SNPs). The present study investigated whether these SCZ-associated SNPs also contribute to BD development through the performance of association testing in a large BD GWAS dataset (9747 patients, 14278 controls). After re-imputation and correction for sample overlap, 22 of 107 investigated SCZ SNPs showed nominal association with BD. The number of shared SCZ-BD SNPs was significantly higher than expected (p = 1.46x10(-8)). This provides further evidence that SCZ-associated loci contribute to the development of BD. Two SNPs remained significant after Bonferroni correction. The most strongly associated SNP was located near TRANK1, which is a reported genome-wide significant risk gene for BD. Pathway analyses for all shared SCZ-BD SNPs revealed 25 nominally enriched gene-sets, which showed partial overlap in terms of the underlying genes. The enriched gene-sets included calcium-and glutamate signaling, neuropathic pain signaling in dorsal horn neurons, and calmodulin binding. The present data provide further insights into shared risk loci and disease-associated pathways for BD and SCZ. This may suggest new research directions for the treatment and prevention of these two major psychiatric disorders.	[Forstner, Andreas J.; Hofmann, Andrea; Maaser, Anna; Muehleisen, Thomas W.; Degenhardt, Franziska; Mattheisen, Manuel; Schumacher, Johannes; Herms, Stefan; Hoffmann, Per; Schenk, Lorena M.; Sivalingam, Sugirthan; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Forstner, Andreas J.; Hofmann, Andrea; Maaser, Anna; Muehleisen, Thomas W.; Degenhardt, Franziska; Schumacher, Johannes; Herms, Stefan; Hoffmann, Per; Schenk, Lorena M.; Sivalingam, Sugirthan; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Dept Gen Life & Brain Ctr, Bonn, Germany; [Forstner, Andreas J.] Univ Basel, Dept Psychiat, Basel, Switzerland; [Forstner, Andreas J.; Reinbold, Celine S.; Muehleisen, Thomas W.; Herms, Stefan; Hoffmann, Per; Fischer, Sascha B.; Cichon, Sven] Univ Basel, Dept Biomed, Human Genom Res Grp, Basel, Switzerland; [Forstner, Andreas J.; Reinbold, Celine S.; Muehleisen, Thomas W.; Herms, Stefan; Hoffmann, Per; Fischer, Sascha B.; Cichon, Sven] Univ Basel Hosp, Inst Med Genet & Pathol, Basel, Switzerland; [Hecker, Julian; Fier, Heide] Univ Bonn, Inst Genom Math, Bonn, Germany; [Hofmann, Andrea] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Muehleisen, Thomas W.; Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, Julich, Germany; [Leber, Markus] Univ Cologne, Dept Psychiat & Psychotherapy, Cologne, Germany; [Strohmaier, Jana; Treutlein, Jens; Streit, Fabian; Meier, Sandra; Witt, Stephanie H.; Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Mattheisen, Manuel] Aarhus Univ, iSEQ, Dept Biomed, Aarhus, Denmark; [Mattheisen, Manuel] Aarhus Univ, iSEQ, Ctr Integrat Sequencing, Aarhus, Denmark; [Mattheisen, Manuel; Meier, Sandra] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Aarhus, Denmark; [Mattheisen, Manuel; Meier, Sandra] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Copenhagen, Denmark; [Meier, Sandra] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Lacour, Andre; Becker, Tim] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Reif, Andreas] Univ Hosp Frankfurt Am Main, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Mueller-Myhsok, Bertram; Lucae, Susanne] Max Planck Inst Psychiat, Munich, Germany; [Mueller-Myhsok, Bertram] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Mueller-Myhsok, Bertram] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [Maier, Wolfgang] Univ Bonn, Dept Psychiat, Bonn, Germany; [Schwarz, Markus; Vedder, Helmut] Psychiat Ctr Nordbaden, Wiesloch, Germany; [Kammerer-Ciernioch, Jutta] Ctr Psychiat Weinsberg, Weinsberg, Germany; [Pfennig, Andrea; Bauer, Michael] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Psychiat & Psychotherapy, Dresden, Germany; [Hautzinger, Martin] Univ Tubingen, Dept Psychol Clin Psychol & Psychotherapy, Tubingen, Germany; [Moebus, Susanne] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Czerski, Piotr M.; Hauser, Joanna] Poznan Univ Med Sci, Dept Psychiat, Lab Psychiat Genet, Poznan, Poland; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol Warsaw, Warsaw, Poland; [Szeszenia-Dabrowska, Neonila] Nofer Inst Occupat Med, Dept Epidemiol, Lodz, Poland; [Brennan, Paul] Int Agcy Res Canc, Genet Epidemiol Grp, Lyon, France; [McKay, James D.] Int Agcy Res Canc, Genet Canc Susceptibil Grp, Lyon, France; [Wright, Adam; Mitchell, Philip B.] Univ New S Wales, Sch Psychiat, Randwick, NSW, Australia; [Wright, Adam; Mitchell, Philip B.] Prince Wales Hosp, Black Dog Inst, Randwick, NSW, Australia; [Fullerton, Janice M.; Schofield, Peter R.] Neurosci Res Australia, Sydney, NSW, Australia; [Fullerton, Janice M.; Schofield, Peter R.] Univ New S Wales, Fac Med, Sch Med Sci, Sydney, NSW, Australia; [Montgomery, Grant W.; Medland, Sarah E.; Gordon, Scott D.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld, Australia; [Krasnov, Valery] Moscow Res Inst Psychiat, Moscow, Russia; [Chuchalin, Alexander; Babadjanova, Gulja] Russian State Med Univ, Inst Pulmonol, Moscow, Russia; [Pantelejeva, Galina; Abramova, Lilia I.; Tiganov, Alexander S.] Russian Acad Med Sci, Mental Hlth Res Ctr, Moscow, Russia; [Polonikov, Alexey] Kursk State Med Univ, Dept Biol Med Genet & Ecol, Kursk, Russia; [Polonikov, Alexey] Kursk State Med Univ, Res Inst Genet & Mol Epidemiol, Kursk, Russia; [Khusnutdinova, Elza] Russian Acad Sci, Ufa Sci Ctr, Inst Biochem & Genet, Ufa, Russia; [Khusnutdinova, Elza] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa, Russia; [Alda, Martin] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Alda, Martin] NIMH, Klecany, Czech Republic; [Cruceanu, Cristiana; Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Cruceanu, Cristiana; Turecki, Gustavo] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Cruceanu, Cristiana; Turecki, Gustavo] McGill Grp Suicide Studies, Montreal, PQ, Canada; [Cruceanu, Cristiana; Turecki, Gustavo] Douglas Res Inst, Montreal, PQ, Canada; [Turecki, Gustavo] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Laprise, Catherine] Univ Quebec Chicoutimi UQAC, Dept Sci Fondamentales, Saguenay, PQ, Canada; [Rivas, Fabio; Mayoral, Fermin] Hosp Reg Univ, Biomed Inst Malaga, Dept Psychiat, Malaga, Spain; [Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Grigoroiu-Serbanescu, Maria] Alexandru Obregia Clin Psychiat Hosp, Biometr Psychiat Genet Res Unit, Bucharest, Romania; [Becker, Tim] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Schulze, Thomas G.] Univ Munich, Inst Psychiat Phen & Genom, Munich, Germany	University of Bonn; University of Bonn; University of Basel; University of Basel; University of Basel; University of Bonn; University of Bonn; Helmholtz Association; Research Center Julich; University of Cologne; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Goethe University Frankfurt; Goethe University Frankfurt Hospital; Max Planck Society; University of Munich; University of Liverpool; University of Bonn; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Eberhard Karls University of Tubingen; University of Duisburg Essen; Poznan University of Medical Sciences; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Nofer Institute of Occupational Medicine; World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); University of New South Wales Sydney; Black Dog Institute; Neuroscience Research Australia; University of New South Wales Sydney; QIMR Berghofer Medical Research Institute; Pirogov Russian National Research Medical University; Russian Academy of Medical Sciences; Kursk State Medical University; Kursk State Medical University; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University; Dalhousie University; National Institute of Mental Health - Czech Republic; McGill University; McGill University; McGill University; McGill University; University of Quebec; University of Quebec Chicoutimi; Pompeu Fabra University; University of Bonn; University of Munich	Nothen, MM (corresponding author), Univ Bonn, Inst Human Genet, Bonn, Germany.; Nothen, MM (corresponding author), Univ Bonn, Dept Gen Life & Brain Ctr, Bonn, Germany.	markus.noethen@uni-bonn.de	Krasnov, Valery N/A-5117-2013; Hoffmann, Per/A-5149-2010; Mattheisen, Manuel/B-4949-2012; Mattheisen, Manuel/S-3725-2019; Khusnutdinova, Elza Kamilevna/A-4810-2013; Lissowska, Jolanta/AAH-3252-2020; Fullerton, Janice/F-8485-2013; Meier, Sandra/AAB-1242-2021; Degenhardt, Franziska/H-4169-2017; Serbanescu, Maria/D-4306-2011; Panteleeva, G/K-4636-2013; Polonikov, Alexey/R-7537-2016; Herms, Stefan/J-1949-2014; Montgomery, Grant W/B-7148-2008; Abramova, Liliya/K-4665-2013; Alda, Martin/F-5812-2010; Tiganov, Alexander S/B-6768-2016; Medland, Sarah E/C-7630-2013; Kogevinas, Manolis/C-3918-2017; Medland, Sarah/AAT-7595-2020; Cruceanu, Cristiana/AAK-2885-2021; Grigoroiu-Serbanescu, Maria/R-3689-2019; Schofield, Peter/C-9669-2011; Cucalin, Aleksandr/P-5678-2018; Cichon, Sven/B-9618-2014	Hoffmann, Per/0000-0002-6573-983X; Mattheisen, Manuel/0000-0002-8442-493X; Mattheisen, Manuel/0000-0002-8442-493X; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Lissowska, Jolanta/0000-0003-2695-5799; Fullerton, Janice/0000-0003-4014-4490; Serbanescu, Maria/0000-0002-1304-6687; Panteleeva, G/0000-0002-5001-3198; Polonikov, Alexey/0000-0001-6280-247X; Herms, Stefan/0000-0002-2786-8200; Montgomery, Grant W/0000-0002-4140-8139; Abramova, Liliya/0000-0003-4397-924X; Alda, Martin/0000-0001-9544-3944; Tiganov, Alexander S/0000-0003-0148-7538; Medland, Sarah E/0000-0003-1382-380X; Kogevinas, Manolis/0000-0002-9605-0461; Medland, Sarah/0000-0003-1382-380X; Cruceanu, Cristiana/0000-0002-7799-5531; Grigoroiu-Serbanescu, Maria/0000-0002-1304-6687; Reinbold, Celine S/0000-0002-3394-3158; Laprise, Catherine/0000-0001-5526-9945; Maaser-Hecker, Anna/0000-0002-9440-0712; Schofield, Peter/0000-0003-2967-9662; Czerski, Piotr M./0000-0003-0745-5916; Cucalin, Aleksandr/0000-0002-6808-5528; Streit, Fabian/0000-0003-1080-4339; Cichon, Sven/0000-0002-9475-086X; Turecki, Gustavo/0000-0003-4075-2736; Krasnov, Valery/0000-0002-5249-3316; Moebus, Susanne/0000-0002-0072-5410; Mayoral-Cleries, Fermin/0000-0002-9710-9672; Lacour, Andre/0000-0003-2692-2583	German Federal Ministry of Education and Research (BMBF) [01ZX1314A, 01ZX1314G]; DFG [RI 908/7-1]; German Research Foundation (DFG) [FOR2107, RI908/11-1, N0246/10-1]; Swiss National Science Foundation (SNSF) [156791]; UEFISCDI, Romania [89/2012]; Heinz Nixdorf Foundation; Australian NHMRC program [1037196]; Canadian Institutes of Health Research [64410, MOP-13506]; European Commission, GABRIEL [018996, LSH-2004-1.2.5-1]; Wellcome Trust [084703]; Canada Research Chair Environment; Quebec Respiratory Network of the Fonds de rechercheen Sante du Quebec (FRQS); Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); UEFISCDI, Romania(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Heinz Nixdorf Foundation; Australian NHMRC program(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European Commission, GABRIEL(European Commission); Wellcome Trust(Wellcome Trust); Canada Research Chair Environment; Quebec Respiratory Network of the Fonds de rechercheen Sante du Quebec (FRQS); Lundbeck Foundation(Lundbeckfonden)	The study was supported by the German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders), under the auspices of the e:Med Programme (grant 01ZX1314A to M.M.N. and S.C., grant 01ZX1314G to M.R.). M.M.N. is a member of the DFG-funded Excellence-Cluster ImmunoSensation. M.M.N. also received support from the Alfried Krupp von Bohlen and Halbach-Stiftung. The study was supported by the German Research Foundation (DFG; grant FOR2107; RI908/11-1 to M.R.; N0246/10-1 to M.M.N.). The study was also supported by the Swiss National Science Foundation (SNSF, grant 156791 to S.C.). M.G.S. received grant no. 89/2012 from UEFISCDI, Romania. Canadian patients were genotyped within the ConLiGen project (www.ConLiGen.org), with the support of a grant from the DFG to M.R., M.B., and T.G.S. (RI 908/7-1). Controls for Germany II were drawn from the Heinz Nixdorf Recall Study (HNR) cohort, which was established with the support of the Heinz Nixdorf Foundation. Recruitment of the Australian sample was supported by an Australian NHMRC program grant (number 1037196). The recruitment of the Canadian patients was supported by a grant from the Canadian Institutes of Health Research #64410 to M.A. The study also used data generated by the GABRIEL consortium (controls for the sample Russia). Funding for the generation of these data was provided by the European Commission as part of GABRIEL contract number 018996 under the Integrated Program LSH-2004-1.2.5-1. Post genomic approaches to understand the molecular basis of asthma aiming at a preventive or therapeutic control and the Wellcome Trust under award 084703. Canadian controls were drawn from the French Canadian study (SLSJ), which was supported in part by the Canada Research Chair Environment and genetics of respiratory diseases and allergy, the Canadian Institutes of Health Research (Operating grant No. MOP-13506), and the Quebec Respiratory Network of the Fonds de rechercheen Sante du Quebec (FRQS). Polish controls were recruited by the International Agency for Research on Cancer (IARC)/Centre National de Genotypage (CNG) GWAS Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Chen DT, 2013, MOL PSYCHIATR, V18, P195, DOI 10.1038/mp.2011.157; Cherlyn SYT, 2010, NEUROSCI BIOBEHAV R, V34, P958, DOI 10.1016/j.neubiorev.2010.01.002; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Craddock N, 2013, LANCET, V381, P1654, DOI 10.1016/S0140-6736(13)60855-7; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fillman SG, 2013, MOL PSYCHIATR, V18, P206, DOI 10.1038/mp.2012.110; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Green EK, 2013, MOL PSYCHIATR, V18, P1302, DOI 10.1038/mp.2012.142; Green EK, 2013, MOL PSYCHIATR, V18, P614, DOI 10.1038/mp.2012.48; Gyorgy AB, 2008, EUR J NEUROSCI, V27, P865, DOI 10.1111/j.1460-9568.2008.06061.x; Hannon E, 2016, NAT NEUROSCI, V19, P48, DOI 10.1038/nn.4182; Harrison PJ, 2016, CURR OPIN NEUROBIOL, V36, P1, DOI 10.1016/j.conb.2015.07.002; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Miro X, 2012, AM J PSYCHIAT, V169, P982, DOI 10.1176/appi.ajp.2012.11101585; Muhleisen TW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4339; Muhleisen TW, 2012, SCHIZOPHR RES, V138, P69, DOI 10.1016/j.schres.2012.03.007; Nothen Markus M, 2010, Dialogues Clin Neurosci, V12, P85; Nurnberger JI, 2014, JAMA PSYCHIAT, V71, P657, DOI 10.1001/jamapsychiatry.2014.176; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; Ohi K, 2016, PSYCHIAT GENET, V26, P142, DOI 10.1097/YPG.0000000000000127; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rosenfeld JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006568; Ruderfer DM, 2014, MOL PSYCHIATR, V19, P1017, DOI 10.1038/mp.2013.138; Salavati B, 2015, SCHIZOPHRENIA BULL, V41, P44, DOI 10.1093/schbul/sbu132; Shim SS, 2012, NEUROSCI LETT, V524, P5, DOI 10.1016/j.neulet.2012.06.047; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Tarabeux J, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.52; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Winham SJ, 2014, J AFFECT DISORDERS, V165, P151, DOI 10.1016/j.jad.2014.04.026; Xu W, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-2	46	55	58	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171595	10.1371/journal.pone.0171595	http://dx.doi.org/10.1371/journal.pone.0171595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166306	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000393700100056
J	Hershaw, JN; Barry, DM; Ettenhofer, ML				Hershaw, Jamie N.; Barry, David M.; Ettenhofer, Mark L.			Increased risk for age-related impairment in visual attention associated with mild traumatic brain injury: Evidence from saccadic response times	PLOS ONE			English	Article							COGNITIVE DECLINE; TASK; COMPENSATION; MAINTENANCE; DYSFUNCTION; CONCUSSION; EFFICIENCY; COMPLAINTS; DEFICITS; HISTORY	It was hypothesized that risk for age-related impairment in attention would be greater among those with remote history of mild TBI than individuals without history of head injury. Twenty-seven adults with remote history of mild TBI and a well-matched comparison group of 54 uninjured controls completed a computerized test of visual attention while saccadic and manual response times were recorded. Within the mild TBI group only, older age was associated with slower saccadic responses and poorer saccadic inhibition. Saccadic slowing was mitigated in situations where the timing and location of attention targets was fully predictable. Mild TBI was not associated with age-related increases in risk for neuropsychological impairment or neurobehavioral symptoms. These results provide preliminary evidence that risk for age-related impairment in visual attention may be higher among those with a history of mild TBI. Saccadic measures may provide enhanced sensitivity to this subtle form of cognitive impairment.	[Hershaw, Jamie N.; Ettenhofer, Mark L.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA; [Barry, David M.] Madigan Army Med Ctr, Dept Behav Hlth, Tacoma, WA 98431 USA	Uniformed Services University of the Health Sciences - USA; Madigan Army Medical Center	Hershaw, JN (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA.	jamie.hershaw.ctr@usuhs.edu	Ettenhofer, Mark L./J-7171-2019	Ettenhofer, Mark L./0000-0001-9381-7578	Uniformed Services University of Health Sciences (USUHS) Research [R072LP]; USUHS	Uniformed Services University of Health Sciences (USUHS) Research; USUHS	This study was supported by Uniformed Services University of Health Sciences (USUHS) Research Award #R072LP to MLE and institutional support from USUHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MP, 1995, NEUROLOGY; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Bellgrove MA, 2004, NEUROPSYCHOLOGIA, V42, P1910, DOI 10.1016/j.neuropsychologia.2004.05.007; Bigler ED, 2007, TRAUMATIC BRAIN INJU; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Chen NK, 2009, BRAIN STRUCT FUNCT, V213, P571, DOI 10.1007/s00429-009-0218-4; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Conners C.K., 2000, CONNERSCONTINUOUS PE; CREMONAMETEYARD SL, 1994, BRAIN INJURY, V8, P541, DOI 10.3109/02699059409151006; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis DC, 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Ettenhofer ML, 2016, J NEUROPSYCH CLIN N, V28, P223, DOI 10.1176/appi.neuropsych.15100243; Ettenhofer ML, 2016, J CLIN EXP NEUROPSYC, V38, P96, DOI 10.1080/13803395.2015.1089978; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fernandez-Duque D, 2006, NEUROPSYCHOLOGY, V20, P133, DOI 10.1037/0894-4105.20.2.133; FOLK CL, 1992, PSYCHOL AGING, V7, P453, DOI 10.1037/0882-7974.7.3.453; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Holdnack J, 2001, WECHSLER TEST ADULT; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Jennings JM, 2007, AGING NEUROPSYCHOL C, V14, P353, DOI 10.1080/13825580600788837; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [DOI 10.1097/00001199-199309000-00010, 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00009]; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Li L, 2013, NEUROBIOL AGING, V34, P477, DOI 10.1016/j.neurobiolaging.2012.02.025; Madden DJ, 2007, NEUROBIOL AGING, V28, P459, DOI 10.1016/j.neurobiolaging.2006.01.005; Mahoney JR, 2010, J INT NEUROPSYCH SOC, V16, P877, DOI 10.1017/S1355617710000767; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Ozen LJ, 2015, AGING NEUROPSYCHOL C, V22, P517, DOI 10.1080/13825585.2014.993584; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stuss D., 1994, NEUROPSYCHOLOGY, V8, P316, DOI [DOI 10.1037/0894-4105.8.3.316, DOI 10.1037//0894-4105.8.3.316]; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wechsler D., 2008, ADV CLIN SOLUTIONS W; Wechsler D., 2012, WAIS 4 KASIKIRJA; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	58	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171752	10.1371/journal.pone.0171752	http://dx.doi.org/10.1371/journal.pone.0171752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166259	gold, Green Published, Green Submitted			2022-12-26	WOS:000393700100070
J	Lee, W; Lim, S; Kim, Y				Lee, Wanho; Lim, Sookkyung; Kim, Yangjin			The role of myosin II in glioma invasion: A mathematical model	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CELL-MIGRATION; MATRIX METALLOPROTEINASES; GLIOBLASTOMA CELLS; MALIGNANT GLIOMA; HYBRID MODEL; TUMOR; PROLIFERATION; MOTILITY; BLEBBISTATIN	Gliomas are malignant tumors that are commonly observed in primary brain cancer. Glioma cells migrate through a dense network of normal cells in microenvironment and spread long distances within brain. In this paper we present a two-dimensional multiscale model in which a glioma cell is surrounded by normal cells and its migration is controlled by cell-mechanical components in the microenvironment via the regulation of myosin II in response to chemoattractants. Our simulation results show that the myosin II plays a key role in the deformation of the cell nucleus as the glioma cell passes through the narrow intercellular space smaller than its nuclear diameter. We also demonstrate that the coordination of biochemical and mechanical components within the cell enables a glioma cell to take the mode of amoeboid migration. This study sheds lights on the understanding of glioma infiltration through the narrow intercellular spaces and may provide a potential approach for the development of antiinvasion strategies via the injection of chemoattractants for localization.	[Lee, Wanho] Natl Inst Math Sci, Daejeon 34047, South Korea; [Lim, Sookkyung] Univ Cincinnati, Dept Math Sci, Cincinnati, OH 45221 USA; [Kim, Yangjin] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Kim, Yangjin] Konkuk Univ, Dept Math, Seoul 05029, South Korea	National Institute for Mathematical Sciences (NIMS), Republic of Korea; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University; Konkuk University	Kim, Y (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.; Kim, Y (corresponding author), Konkuk Univ, Dept Math, Seoul 05029, South Korea.	ahyouhappy@konkuk.ac.kr	Kim, Yangjin/C-9681-2014	Kim, Yangjin/0000-0002-8905-8481	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A01058702]; faculty research fund of Konkuk University; National Institute for Mathematical Sciences (NIMS) - Korea government [A21300000]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; faculty research fund of Konkuk University; National Institute for Mathematical Sciences (NIMS) - Korea government	This research (Y. Kim) was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A01058702) and the faculty research fund of Konkuk University in 2014. Lee's work was supported by the National Institute for Mathematical Sciences (NIMS) grant funded by Korea government (A21300000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves TR, 2011, LIFE SCI, V89, P532, DOI 10.1016/j.lfs.2011.04.022; Amberger VR, 1998, CANCER RES, V58, P149; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Cancer Genome Atlas Research Network, 2010, NATURE, V455, P1061; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Chintala SK, 1999, INT J DEV NEUROSCI, V17, P495, DOI 10.1016/S0736-5748(99)00010-6; Choe GY, 2002, CLIN CANCER RES, V8, P2894; Coghill PA, 2013, BIOMED MICRODEVICES, V15, P183, DOI 10.1007/s10544-012-9715-y; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; de Groot JF, 2007, CURR OPIN NEUROL, V20, P712, DOI 10.1097/WCO.0b013e3282f15650; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; de los Reyes AA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1392; DEMBO M, 1986, BIOPHYS J, V50, P109, DOI 10.1016/S0006-3495(86)83444-0; El-Obeid A, 1997, CANCER RES, V57, P5598; Ernest NJ, 2005, AM J PHYSIOL-CELL PH, V288, pC1451, DOI 10.1152/ajpcell.00503.2004; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Fillmore HL, 2001, J NEURO-ONCOL, V53, P187, DOI 10.1023/A:1012213604731; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Giese A, 1996, NEUROSURGERY, V38, P755, DOI 10.1227/00006123-199604000-00026; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gillespie GY, 1999, CANCER RES, V59, P2076; Godlewski J, 2010, CELL CYCLE, V9, P2742, DOI 10.4161/cc.9.14.12248; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Goldbrunner RH, 1999, ACTA NEUROCHIR, V141, P295, DOI 10.1007/s007010050301; Gordon K, 2006, THESIS; Gracheva ME, 2004, B MATH BIOL, V66, P167, DOI 10.1016/j.bulm.2003.08.007; HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907; Ivkovic S, 2012, MOL BIOL CELL, V23, P533, DOI 10.1091/mbc.E11-01-0039; Jaalinoja J, 2000, J NEURO-ONCOL, V46, P81, DOI 10.1023/A:1006421112839; Jadhav S, 2005, BIOPHYS J, V88, P96, DOI 10.1529/biophysj.104.051029; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Kim HD, 2008, MOL BIOL CELL, V19, P4249, DOI 10.1091/mbc.E08-05-0501; Kim Y, 2017, IEEE T BIO-MED ENG, V64, P519, DOI 10.1109/TBME.2016.2637828; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114370; Kim Y, 2013, B MATH BIOL, V75, P1304, DOI 10.1007/s11538-012-9787-0; Kim Y, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00053; Kim Y, 2013, DISCRETE CONT DYN-B, V18, P969, DOI 10.3934/dcdsb.2013.18.969; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Kim Y, 2010, B MATH BIOL, V72, P1029, DOI 10.1007/s11538-009-9481-z; Kim Y, 2010, J MATH BIOL, V61, P401, DOI 10.1007/s00285-009-0307-2; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; Koo S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-143; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; KUDLOW JE, 1986, J BIOL CHEM, V261, P4134; Lamszus K, 1998, INT J CANCER, V75, P19, DOI 10.1002/(SICI)1097-0215(19980105)75:1<19::AID-IJC4>3.0.CO;2-4; Laurent VM, 2005, BIOPHYS J, V89, P667, DOI 10.1529/biophysj.104.052316; Lee HG, 2015, JPN J IND APPL MATH, V32, P771, DOI 10.1007/s13160-015-0188-2; Lim FY, 2013, COMPUT METHOD BIOMEC, V16, P1085, DOI 10.1080/10255842.2012.757598; LUNDJOHANSEN M, 1990, CANCER RES, V50, P6039; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mammoto T, 2013, AM J PATHOL, V183, P1293, DOI 10.1016/j.ajpath.2013.06.026; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; Mertsch S, 2013, MOL NEUROBIOL, V48, P169, DOI 10.1007/s12035-013-8429-3; Mogilner A, 2009, J MATH BIOL, V58, P105, DOI 10.1007/s00285-008-0182-2; MOHANAM S, 1994, J NEURO-ONCOL, V22, P153, DOI 10.1007/BF01052890; Nabors LB, 2007, J CLIN ONCOL, V25, P1651, DOI 10.1200/JCO.2006.06.6514; Nagane M, 1996, CANCER RES, V27, P25639; Newell-Litwa KA, 2015, DIS MODEL MECH, V8, P1495, DOI 10.1242/dmm.022103; O'Brien ER, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00040; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Peskin CS, 2002, ACT NUMERIC, V11, P479, DOI 10.1017/S0962492902000077; Placone AL, 2016, TUMOR BIOL, V37, P61, DOI 10.1007/s13277-015-4242-0; Platten M, 2001, MICROSC RES TECHNIQ, V52, P401, DOI 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C; Powathil GG, 2012, J THEOR BIOL, V308, P1, DOI 10.1016/j.jtbi.2012.05.015; Pozrikidis C., 2003, MODELING SIMULATION, DOI [10.1201/9780203503959, DOI 10.1201/9780203503959]; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Rejniak K.A., 2007, COMPUT MATH METHOD M, V8, P51, DOI DOI 10.1080/17486700701303143; Rejniak KA, 2007, J THEOR BIOL, V247, P186, DOI 10.1016/j.jtbi.2007.02.019; Rejniak KA, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00111; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rowat AC, 2013, J BIOL CHEM, V288, P8610, DOI 10.1074/jbc.M112.441535; Ruprecht V, 2015, CELL, V160, P673, DOI 10.1016/j.cell.2015.01.008; Sakamoto Y, 2014, J MATH BIOL, V68, P267, DOI 10.1007/s00285-012-0634-6; Sakamoto Y, 2011, ANN BIOMED ENG, V39, P2735, DOI 10.1007/s10439-011-0360-z; Salhia B, 2008, CELL MOTIL CYTOSKEL, V65, P12, DOI 10.1002/cm.20240; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schattler H, 2013, IEEE DECIS CONTR P, P1810, DOI 10.1109/CDC.2013.6760145; Scherer HJ, 1940, J NEUROL PSYCHIATRY, V3, P147, DOI 10.1136/jnnp.3.2.147; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Shu S, 2005, P NATL ACAD SCI USA, V102, P1472, DOI 10.1073/pnas.0409528102; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Swift LM, 2012, PFLUG ARCH EUR J PHY, V464, P503, DOI 10.1007/s00424-012-1147-2; Taft JR, 2005, INT J NEUROSCI, V115, P1333, DOI 10.1080/00207450590934570; Thiam HR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10997; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Thorne RG, 2004, J NEUROPHYSIOL, V92, P3471, DOI 10.1152/jn.00352.2004; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Watters JJ, 2005, J NEUROSCI RES, V81, P447, DOI 10.1002/jnr.20485; Westphal M, 2003, LOCAL THERAPIES GLIO, DOI [10.1007/978-3-7091-6090-9, DOI 10.1007/978-3-7091-6090-9]; Wick W, 2001, J NEURO-ONCOL, V53, P177, DOI 10.1023/A:1012209518843; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; WULLICH B, 1994, ANTICANCER RES, V14, P577; Xie Q, 2014, NEURO-ONCOLOGY, V16, P1575, DOI 10.1093/neuonc/nou147; Young N, 2007, EXP CELL RES, V313, P1615, DOI 10.1016/j.yexcr.2007.02.009; Zhong J, 2010, J ONCOL, V2010, DOI 10.1155/2010/430142; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200	106	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e171312	10.1371/journal.pone.0171312	http://dx.doi.org/10.1371/journal.pone.0171312			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166231	Green Published, gold, Green Submitted			2022-12-26	WOS:000393700100033
J	Gauthier, L; Bonnin, RA; Dortet, L; Naas, T				Gauthier, Lauraine; Bonnin, Remy A.; Dortet, Laurent; Naas, Thierry			Retrospective and prospective evaluation of the Carbapenem inactivation method for the detection of carbapenemase-producing Enterobacteriaceae	PLOS ONE			English	Article							NP TEST; PSEUDOMONAS-AERUGINOSA; RAPID DETECTION; OXA-48; ASSAY; TIME; IDENTIFICATION; SPREAD; KPC	Background There is an urgent need for accurate and rapid diagnostic tests to identify carbapenemase producing enterobacteria (CPE). Here, we have evaluated the Carbapenem Inactivation Method (CIM) test to detect CPEs from cultured colonies. Methods A total of 256 enterobacterial isolates were used to evaluate the performance of the CIM in comparison to Carba NP test and molecular detection used a reference method. Ninety three well-characterized isolates (including 29 non-CPE and 63 CPEs of worldwide origin) with decreased susceptibility to at least one carbapenem were used to (i) evaluate the efficacy of CIM test and (ii) to compare it to the Carba NP test. We also tested different carbapenems to determine the best substrate for this test. Finally, the CIM test was then evaluated prospectively against 164 isolates referred to the French National Reference Center (NRC) for Antimicrobial Resistance from may 2016 to july 2016. Results Based on the results of this retrospective study, sensitivity and specificity of the CIM and the Carba NP test were 92.1% and 100%, respectively. We demonstrated that the meropenem was the best substrate to perform the CIM test since sensitivity and specificity were 81.1% and 100% using ertapenem disk, and 100% and 65.6% using imipenem disk, and respectively. Taking in account the results of retrospective and prospective studies, CIM and Carba NP tests have similar sensitivity, specificity, positive predictive value and negative predictive values being 96.3%, 98.9%, 99.0% and 98.4% for the CIM test versus 96.9%, 100%, 100% and 100% for the Carba NP test. Conclusions Our results confirm that the CIM test may be a useful tool for the reliable confirmation of carbapenemase- activity in enterobacterial isolates, especially in clinical microbiological laboratories with limited resources, no trained personnel, and no specialized equipment.	[Gauthier, Lauraine; Bonnin, Remy A.; Dortet, Laurent; Naas, Thierry] Univ Paris Sud, French Natl Reference Ctr Antibiot Resistance Car, Bicetre Hosp,LabEx Lermit,Fac Med, AP HP,Bacteriol Hyg Unit,Struct Dynam Funct & Exp, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Naas, T (corresponding author), Univ Paris Sud, French Natl Reference Ctr Antibiot Resistance Car, Bicetre Hosp,LabEx Lermit,Fac Med, AP HP,Bacteriol Hyg Unit,Struct Dynam Funct & Exp, Le Kremlin Bicetre, France.	thierry.naas@aphp.fr	Naas, Thierry/O-3999-2018; DORTET, Laurent/D-5159-2014	Naas, Thierry/0000-0001-9937-9572; DORTET, Laurent/0000-0001-6596-7384; Bonnin, Remy A./0000-0002-2307-3232	Ministere de l'Education Nationale et de la Recherche, Universite Paris Sud [EA7361]; ANR "Agence National pour la Recherche" [ANR-10-LABX-33]	Ministere de l'Education Nationale et de la Recherche, Universite Paris Sud; ANR "Agence National pour la Recherche"(French National Research Agency (ANR))	This work was funded by a grant from the Ministere de l'Education Nationale et de la Recherche (EA7361), Universite Paris Sud. LG, RAB, LD and TN are members of the Laboratory of Excellence LERMIT supported by a grant from ANR "Agence National pour la Recherche" (ANR-10-LABX-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayramoglu G, 2016, MIKROBIYOL BUL, V50, P505, DOI 10.5578/mb.26497; Bogaerts P, 2016, J CLIN MICROBIOL, V54, P349, DOI 10.1128/JCM.02404-15; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Cuzon G, 2013, DIAGN MICR INFEC DIS, V76, P502, DOI 10.1016/j.diagmicrobio.2013.05.004; Dortet L, 2016, J ANTIMICROB CHEMOTH, V71, P1834, DOI 10.1093/jac/dkw058; Dortet L, 2016, ANTIMICROB AGENTS CH, V60, P3832, DOI 10.1128/AAC.00517-16; Dortet L, 2016, J ANTIMICROB CHEMOTH, V71, P135, DOI 10.1093/jac/dkv308; Dortet L, 2015, J ANTIMICROB CHEMOTH, V70, P3014, DOI 10.1093/jac/dkv213; Dortet L, 2015, ANTIMICROB AGENTS CH, V59, P7100, DOI 10.1128/AAC.01512-15; Dortet L, 2012, ANTIMICROB AGENTS CH, V56, P6437, DOI 10.1128/AAC.01395-12; Glasner C., 2013, EURP SURVEILL, P18, DOI DOI 10.2807/1560-7917.ES2013.18.28.20525; Glupczynski Y, 2016, J ANTIMICROB CHEMOTH, V71, P1217, DOI 10.1093/jac/dkv472; Hemarajata P, 2015, ANTIMICROB AGENTS CH, V59, P5574, DOI 10.1128/AAC.00425-15; Hrabak J, 2014, CLIN MICROBIOL INFEC, V20, P839, DOI 10.1111/1469-0691.12678; Kabir MH, 2016, J ANTIMICROB CHEMOTH, V71, P1213, DOI 10.1093/jac/dkv468; Lasserre C, 2015, J CLIN MICROBIOL, V53, P2163, DOI 10.1128/JCM.03467-14; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Osterblad M, 2014, ANTIMICROB AGENTS CH, V58, P7553, DOI 10.1128/AAC.02761-13; Tijet N, 2016, J ANTIMICROB CHEMOTH, V71, P274, DOI 10.1093/jac/dkv283; Tijet Nathalie, 2013, Antimicrob Agents Chemother, V57, P4578, DOI 10.1128/AAC.00878-13; Tsakris A, 2015, J CLIN MICROBIOL, V53, P1245, DOI 10.1128/JCM.03318-14; van der Zwaluw K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123690; Yamada K, 2016, J MICROBIOL METH, V128, P48, DOI 10.1016/j.mimet.2016.06.019	23	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170769	10.1371/journal.pone.0170769	http://dx.doi.org/10.1371/journal.pone.0170769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158310	Green Published, gold			2022-12-26	WOS:000396161700017
J	Masilamani, AP; Ferrarese, R; Kling, E; Thudi, NK; Kim, H; Scholtens, DM; Dai, F; Hadler, M; Unterkircher, T; Platania, L; Weyerbrock, A; Prinz, M; Gillespie, GY; Harsh, GR IV; Bredel, M; Carro, MS				Masilamani, A. P.; Ferrarese, R.; Kling, E.; Thudi, N. K.; Kim, H.; Scholtens, D. M.; Dai, F.; Hadler, M.; Unterkircher, T.; Platania, L.; Weyerbrock, A.; Prinz, M.; Gillespie, G. Y.; Harsh, G. R., IV; Bredel, M.; Carro, M. S.			KLF6 depletion promotes NF-kappa B signaling in glioblastoma	ONCOGENE			English	Article							TUMOR-SUPPRESSOR GENE; KRUPPEL-LIKE FACTOR-6; ZINC-FINGER PROTEIN; EXPRESSION; MUTATIONS; CELL; ACTIVATION; TRANSCRIPTION; APOPTOSIS; TARGETS	Dysregulation of the NF-kappa B transcription factor occurs in many cancer types. Kruppel-like family of transcription factors (KLFs) regulate the expression of genes involved in cell proliferation, differentiation and survival. Here, we report a new mechanism of NF kappa B activation in glioblastoma through depletion of the KLF6 tumor suppressor. We show that KLF6 transactivates multiple genes negatively controlling the NF-kappa B pathway and consequently reduces NF-kappa B nuclear localization and downregulates NF-kappa B targets. Reconstitution of KLF6 attenuates their malignant phenotype and induces neural-like differentiation and senescence, consistent with NF-kappa B pathway inhibition. KLF6 is heterozygously deleted in 74.5% of the analyzed glioblastomas and predicts unfavorable patient prognosis suggesting that haploinsufficiency is a clinically relevant means of evading KLF6-dependent regulation of NF-kappa B. Together, our study identifies a new mechanism by which KLF6 regulates NF-kappa B signaling, and how this mechanism is circumvented in glioblastoma through KLF6 loss.	[Masilamani, A. P.; Ferrarese, R.; Kling, E.; Dai, F.; Hadler, M.; Unterkircher, T.; Platania, L.; Weyerbrock, A.; Carro, M. S.] Univ Freiburg, Med Ctr, Dept Neurosurg, Breisacherstr 64, D-79106 Freiburg, Germany; [Masilamani, A. P.; Ferrarese, R.; Kling, E.; Dai, F.; Hadler, M.; Unterkircher, T.; Platania, L.; Weyerbrock, A.; Carro, M. S.] Univ Freiburg, Fac Med, Freiburg, Germany; [Thudi, N. K.; Bredel, M.] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Sch Med, Dept Radiat Oncol, 1700 6th Ave South Birmingham, Birmingham, AL 35233 USA; [Kim, H.] Jackson Lab Genom Med, Farmington, CT USA; [Scholtens, D. M.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Prinz, M.] Univ Freiburg, Inst Neuropathol, Freiburg, Germany; [Prinz, M.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Gillespie, G. Y.] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Sch Med, Dept Neurosurg, Birmingham, AL USA; [Harsh, G. R., IV] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA	University of Freiburg; University of Freiburg; University of Alabama System; University of Alabama Birmingham; Jackson Laboratory; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; University of Freiburg; University of Freiburg; University of Alabama System; University of Alabama Birmingham; Stanford University	Carro, MS (corresponding author), Univ Freiburg, Med Ctr, Dept Neurosurg, Breisacherstr 64, D-79106 Freiburg, Germany.; Bredel, M (corresponding author), Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Sch Med, Dept Radiat Oncol, 1700 6th Ave South Birmingham, Birmingham, AL 35233 USA.	mbredel@uab.edu; maria.carro@uniklinik-freiburg.de	Stella, Maria Stella/GVS-1585-2022; Ferrarese, Roberto/GSJ-3449-2022	Ferrarese, Roberto/0000-0003-0625-3319; Carro, Maria Stella/0000-0002-8570-7691; Masilamani, Anie Priscilla/0000-0003-2503-1244; Gillespie, George/0000-0001-6436-9542; Weyerbrock, Astrid/0000-0001-9060-4462	National Cancer Institute [P20 CA151129-01A1/UAB]; German Cancer Aid Grant Award, State of Alabama Investment Pool for Action (IMPACT) funds [107714]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Cancer Aid Grant Award, State of Alabama Investment Pool for Action (IMPACT) funds	This study was supported by National Cancer Institute grant P20 CA151129-01A1/UAB Specialized Program of Research Excellence (SPORE) in Brain Cancer (M Bredel), German Cancer Aid Grant Award (107714, M Bredel), State of Alabama Investment Pool for Action (IMPACT) funds (M Bredel). We thank Jugen Beck (University of Freiburg) for helping in preparing reagents, Maria Oberle (University of Freiburg) for help with mice brain histology, Dr Veerle Baekelandt (University of Leuven) for providing the PCHMWS- eGFP- IRES lentiviral vector, Dr Thomas Brabletz (University of Erlangen) for providing NF-<INF>k</INF>B luciferase vectors and Darren O hAilin (University of Freiburg) and Susanne Nozell (UAB) for editing the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Angileri FF, 2008, CANCER-AM CANCER SOC, V112, P2258, DOI 10.1002/cncr.23407; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bredel M, 2011, NEW ENGL J MED, V364, P627, DOI 10.1056/NEJMoa1006312; Cabannes E, 1999, ONCOGENE, V18, P3063, DOI 10.1038/sj.onc.1202893; Camacho-Vanegas O, 2007, INT J CANCER, V121, P1390, DOI 10.1002/ijc.22809; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Date D, 2014, J BIOL CHEM, V289, P10318, DOI 10.1074/jbc.M113.526749; Difeo A, 2008, CANCER RES, V68, P965, DOI 10.1158/0008-5472.CAN-07-2604; Difeo A, 2009, CANCER RES, V69, P4733, DOI 10.1158/0008-5472.CAN-08-4282; Difeo A, 2009, DRUG RESIST UPDATE, V12, P1, DOI 10.1016/j.drup.2008.11.001; Dionyssiou MG, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-7; Eckhardt I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.457; Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627; Ferrarese R, 2014, J CLIN INVEST, V124, P2861, DOI 10.1172/JCI68836; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791; Gurevich I, 2012, BBA-GENE REGUL MECH, V1819, P1, DOI 10.1016/j.bbagrm.2011.09.006; Hatami R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004688; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Hoeferlin L Alexis, 2011, Genes Cancer, V2, P889, DOI 10.1177/1947601911432495; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jeng YM, 2003, INT J CANCER, V105, P625, DOI 10.1002/ijc.11123; Jennewein C, 2012, ONCOGENE, V31, P1468, DOI 10.1038/onc.2011.333; Jungnickel B, 2000, J EXP MED, V191, P395, DOI 10.1084/jem.191.2.395; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Keung EZ, 2015, J CLIN INVEST, V125, P2965, DOI 10.1172/JCI77976; Kimmelman AC, 2004, ONCOGENE, V23, P5077, DOI 10.1038/sj.onc.1207662; Kohler B, 2004, INT J CANCER, V111, P644, DOI 10.1002/ijc.20302; Koivisto PA, 2004, INT J CANCER, V111, P642, DOI 10.1002/ijc.20301; Kremer-Tal S, 2004, HEPATOLOGY, V40, P1047, DOI 10.1002/hep.20460; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lai TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073153; Lee DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057489; Lee YD, 2014, BMB REP, V47, P262, DOI 10.5483/BMBRep.2014.47.5.172; Masica DL, 2011, CANCER RES, V71, P4550, DOI 10.1158/0008-5472.CAN-11-0180; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Montanini L, 2004, INT J CANCER, V111, P640, DOI 10.1002/ijc.20303; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Narla G, 2008, J CLIN INVEST, V118, P2711, DOI 10.1172/JCI34780; Nogueira L, 2011, ONCOGENE, V30, P3537, DOI 10.1038/onc.2011.74; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Osborne J, 2005, INT J CANCER, V116, P646, DOI 10.1002/ijc.21036; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Raychaudhuri B, 2007, J NEURO-ONCOL, V85, P39, DOI 10.1007/s11060-007-9390-7; Reeves HL, 2004, GASTROENTEROLOGY, V126, P1090, DOI 10.1053/j.gastro.2004.01.005; Rodriguez E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012639; Sadelain Michel, 2011, Nat Rev Cancer, V12, P51, DOI 10.1038/nrc3179; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Takemura M, 2002, J NEUROSCI, V22, P6972; Tracey L, 2005, J PATHOL, V206, P123, DOI 10.1002/path.1768; Tsunoda Keishi, 2005, Brain Tumor Pathol, V22, P79, DOI 10.1007/s10014-005-0186-1; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Watanabe A, 2006, J NEURO-ONCOL, V77, P25, DOI 10.1007/s11060-005-9010-3; Westhoff MA, 2013, MOL CANCER RES, V11, P1611, DOI 10.1158/1541-7786.MCR-13-0435-T; Yao YL, 2015, CNS NEUROSCI THER, V21, P40, DOI 10.1111/cns.12321; Zhang Y, 2014, J BIOL CHEM, V289, P12876, DOI 10.1074/jbc.M113.535831	61	24	24	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 22	2017	36	25					3562	3575		10.1038/onc.2016.507	http://dx.doi.org/10.1038/onc.2016.507			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY3NL	28166199	Green Published, hybrid			2022-12-26	WOS:000403878600006
J	Xu, DQ; Zhou, JL; Lou, XD; He, JH; Ran, TT; Wang, WW				Xu, Dongqing; Zhou, Jiale; Lou, Xiangdi; He, Jianhua; Ran, Tingting; Wang, Weiwu			Myroilysin Is a New Bacterial Member of the M12A Family of Metzincin Metallopeptidases and Is Activated by a Cysteine Switch Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOCELLULAR PROTEASE; ALKALINE PROTEASE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; STRUCTURAL BASIS; ASTACIN; CRYSTALLIZATION; SUPERFAMILY; SERRALYSINS; VALIDATION	Proteases play important roles in all living organisms and also have important industrial applications. Family M12A metalloproteases, mainly found throughout the animal kingdom, belong to the metzincin protease family and are synthesized as inactive precursors. So far, only flavastacin and myroilysin, isolated from bacteria, were reported to be M12A proteases, whereas the classification of myroilysin is still unclear due to the lack of structural information. Here, we report the crystal structures of pro-myroilysin from bacterium Myroides sp. cslb8. The catalytic zinc ion of pro-myroilysin, at the bottom of a deep active site, is coordinated by three histidine residues in the conserved motif HEXXHXXGXXH; the cysteine residue in the propeptide coordinates the catalytic zinc ion and inhibits myroilysin activity. Structure comparisons revealed that myroilysin shares high similarity with the members of the M12A, M10A, and M10B families of metalloproteases. However, a unique "cap" structure tops the active site cleft in the structure of pro-myroilysin, and this "cap" structure does not exist in the above structure-reported subfamilies. Further structure-based sequence analysis revealed that myroilysin appears to belong to the M12A family, but pro-myroilysin uses a "cysteine switch" activation mechanism with a unique segment, including the conserved cysteine residue, whereas other reported M12A family proteases use an "aspartate switch" activation mechanism. Thus, our results suggest that myroilysin is a new bacterial member of the M12A family with an exceptional cysteine switch activation mechanism. Our results shed new light on the classification of the M12A family and may suggest a divergent evolution of the M12 family.	[Xu, Dongqing; Zhou, Jiale; Lou, Xiangdi; Ran, Tingting; Wang, Weiwu] Nanjing Agr Univ, Key Lab Agr & Environm Microbiol, Minist Agr, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China; [He, Jianhua] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201204, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Ran, TT; Wang, WW (corresponding author), Nanjing Agr Univ, Key Lab Agr & Environm Microbiol, Minist Agr, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China.	rantt@njau.edu.cn; wwwang@njau.edu.cn	wang, weiwu/AAD-1490-2022	Xu, Dongqing/0000-0002-8388-2330; , weiwu/0000-0001-6922-9207; , Tingting/0000-0002-5541-3553	National Natural Science Foundation of China [31400055, 31170686, 31100028]; Natural Science Foundation of Jiangsu Province [BK20140690]; Youth Science and Technology Innovation Fund from Nanjing Agricultural University [KJ2013027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Youth Science and Technology Innovation Fund from Nanjing Agricultural University	This work was supported by National Natural Science Foundation of China Grants 31400055, 31170686, and 31100028; Natural Science Foundation of Jiangsu Province Grant BK20140690; and Youth Science and Technology Innovation Fund from Nanjing Agricultural University Grant KJ2013027. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AEHLE W, 1993, J BIOTECHNOL, V28, P31, DOI 10.1016/0168-1656(93)90123-5; Arolas JL, 2012, P NATL ACAD SCI USA, V109, P16131, DOI 10.1073/pnas.1211076109; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Bramucci E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S2; Cerda-Costa N, 2011, MOL MICROBIOL, V79, P119, DOI 10.1111/j.1365-2958.2010.07434.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XL, 2009, APPL ENVIRON MICROB, V75, P1838, DOI 10.1128/AEM.02285-08; Cheng SW, 1995, BIOSCI BIOTECH BIOCH, V59, P2239, DOI 10.1271/bbb.59.2239; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLEMING AB, 1995, APPL ENVIRON MICROB, V61, P3775, DOI 10.1128/AEM.61.11.3775-3780.1995; FRANKENA J, 1986, APPL MICROBIOL BIOT, V24, P106, DOI 10.1007/BF00938779; GOMISRUTH FX, 1993, J MOL BIOL, V229, P945, DOI 10.1006/jmbi.1993.1098; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; Guevara T, 2013, ACTA CRYSTALLOGR F, V69, P472, DOI 10.1107/S1744309113007392; Guevara T, 2010, J BIOL CHEM, V285, P13958, DOI 10.1074/jbc.M109.097436; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Ichida JM, 2001, J MICROBIOL METH, V47, P199, DOI 10.1016/S0167-7012(01)00302-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu LH, 2009, VET PARASITOL, V164, P173, DOI 10.1016/j.vetpar.2009.05.016; Lopez-Pelegrin M, 2015, J BIOL CHEM, V290, P4728, DOI 10.1074/jbc.M114.605956; Mac Sweeney A, 2008, J MOL BIOL, V384, P228, DOI 10.1016/j.jmb.2008.09.029; Maeda H, 1996, MICROBIOL IMMUNOL, V40, P685, DOI 10.1111/j.1348-0421.1996.tb01129.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Morales R, 2004, J MOL BIOL, V341, P1063, DOI 10.1016/j.jmb.2004.06.039; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholas K.B., 1997, EMBNETNEWS, V4, P1; NISHINA Y, 1992, INFECT IMMUN, V60, P2128, DOI 10.1128/IAI.60.5.2128-2132.1992; Okada A, 2010, J MOL BIOL, V402, P865, DOI 10.1016/j.jmb.2010.08.023; Okujo N, 1996, MICROBIOL IMMUNOL, V40, P595, DOI 10.1111/j.1348-0421.1996.tb01114.x; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PLUMMER TH, 1995, J BIOL CHEM, V270, P13192, DOI 10.1074/jbc.270.22.13192; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Rawlings ND, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P325, DOI 10.1016/B978-0-12-382219-2.00077-6; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; REINHOLD BB, 1995, J BIOL CHEM, V270, P13197, DOI 10.1074/jbc.270.22.13197; REYSSET G, 1972, BIOCHEM BIOPH RES CO, V49, P328, DOI 10.1016/0006-291X(72)90414-7; Rosenthal C, 2006, ACTA CRYSTALLOGR F, V62, P1286, DOI 10.1107/S174430910605041X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SASTRY KJ, 1983, J BACTERIOL, V153, P511, DOI 10.1128/JB.153.1.511-519.1983; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; STOCKER W, 1995, PROTEIN SCI, V4, P823; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; TARENTINO AL, 1995, ARCH BIOCHEM BIOPHYS, V319, P281, DOI 10.1006/abbi.1995.1293; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Wu DX, 2016, ACTA CRYSTALLOGR F, V72, P10, DOI 10.1107/S2053230X15023092; Gomis-Ruth FX, 2012, BIOL CHEM, V393, P1027, DOI 10.1515/hsz-2012-0149; Yiallouros I, 2002, J MOL BIOL, V324, P237, DOI 10.1016/S0022-2836(02)01102-6; ZHU WS, 1990, DIAGN MICR INFEC DIS, V13, P491, DOI 10.1016/0732-8893(90)90081-6	61	6	7	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5195	5206		10.1074/jbc.M116.758110	http://dx.doi.org/10.1074/jbc.M116.758110			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28188295	Green Published, hybrid			2022-12-26	WOS:000397875500004
J	Pandey, KK; Bera, S; Shi, K; Aihara, H; Grandgenett, DP				Pandey, Krishan K.; Bera, Sibes; Shi, Ke; Aihara, Hideki; Grandgenett, Duane P.			A C-terminal "Tail" Region in the Rous Sarcoma Virus Integrase Provides High Plasticity of Functional Integrase Oligomerization during Intasome Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL-DNA ENDS; AVIAN RETROVIRUS INTEGRASE; HIV-1 INTEGRASE; SYNAPTIC COMPLEX; CRYSTAL-STRUCTURE; BINDING PROTEIN; DOMAIN; ENDONUCLEASE; PHOSPHORYLATION; ORGANIZATION	The retrovirus integrase (IN) inserts the viral cDNA into the host DNA genome. Atomic structures of five different retrovirus INs complexed with their respective viral DNA or branched viral/target DNA substrates have indicated these intasomes are composed of IN subunits ranging from tetramers, to octamers, or to hexadecamers. IN precursors are monomers, dimers, or tetramers in solution. But how intasome assembly is controlled remains unclear. Therefore, we sought to unravel the functional mechanisms in different intasomes. We produced kinetically stabilized Rous sarcoma virus (RSV) intasomes with human immunodeficiency virus type 1 strand transfer inhibitors that interact simultaneously with IN and viral DNA within intasomes. We examined the ability of RSV IN dimers to assemble two viral DNA molecules into intasomes containing IN tetramers in contrast to one possessing IN octamers. We observed that the last 18 residues of the C terminus ("tail" region) of IN (residues 1-286) determined whether an IN tetramer or octamer assembled with viral DNA. A series of truncations of the tail region indicated that these 18 residues are critical for the assembly of an intasome containing IN octamers but not for an intasome containing IN tetramers. The C-terminally truncated IN (residues 1-269) produced an intasome that contained tetramers but failed to produce an intasome with octamers. Both intasomes have similar catalytic activities. The results suggest a high degree of plasticity for functional multimerization and reveal a critical role of the C-terminal tail region of IN in higher order oligomerization of intasomes, potentially informing future strategies to prevent retroviral integration.	[Pandey, Krishan K.; Bera, Sibes; Grandgenett, Duane P.] St Louis Univ, Inst Mol Virol, Dept Microbiol & Immunol, 1100 S Grand Blvd, St Louis, MO 63104 USA; [Shi, Ke; Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Saint Louis University; University of Minnesota System; University of Minnesota Twin Cities	Grandgenett, DP (corresponding author), St Louis Univ, Inst Mol Virol, Dept Microbiol & Immunol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	grandgdp@slu.edu		, Ke/0000-0003-4175-3714; Pandey, Krishan/0000-0002-3973-9844	National Institutes of Health [AI127196, GM118047]; Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI127196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109770, R35GM118047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AI127196 (to D. P. G.) and GM118047 (to H. A.) and by Saint Louis University (to D. P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALEXANDER F, 1987, J VIROL, V61, P534, DOI 10.1128/JVI.61.2.534-542.1987; Andrake MD, 2015, ANNU REV VIROL, V2, P241, DOI 10.1146/annurev-virology-100114-055043; [Anonymous], 2013, MOL OP ENV MOE; Ballandras-Colas A, 2017, SCIENCE, V355, P93, DOI 10.1126/science.aah7002; Ballandras-Colas A, 2016, NATURE, V530, P358, DOI 10.1038/nature16955; Bera S, 2005, BIOCHEMISTRY-US, V44, P15106, DOI 10.1021/bi0508340; Bera S, 2009, J MOL BIOL, V389, P183, DOI 10.1016/j.jmb.2009.04.007; Bojja RS, 2011, J BIOL CHEM, V286, P17047, DOI 10.1074/jbc.M110.212571; Chen HM, 1999, J BIOL CHEM, V274, P17358, DOI 10.1074/jbc.274.24.17358; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chen ZG, 2000, J MOL BIOL, V296, P521, DOI 10.1006/jmbi.1999.3451; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chiu R, 2003, J VIROL, V77, P6482, DOI 10.1128/JVI.77.11.6482-6492.2003; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Dar MJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-94; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; GRANDGENETT D, 1985, J BIOL CHEM, V260, P8243; GRANDGENETT DP, 1978, VIROLOGY, V89, P119, DOI 10.1016/0042-6822(78)90046-6; Grandgenett Duane P, 2015, World J Biol Chem, V6, P83, DOI 10.4331/wjbc.v6.i3.83; Grobler JA, 2009, ANTIVIR THER, V14, pA27; Gupta K, 2012, STRUCTURE, V20, P1918, DOI 10.1016/j.str.2012.08.023; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Heuer TS, 1997, BIOCHEMISTRY-US, V36, P10655, DOI 10.1021/bi970782h; HIPPENMEYER PJ, 1984, VIROLOGY, V137, P358, DOI 10.1016/0042-6822(84)90228-9; HORTON R, 1988, J VIROL, V62, P2067, DOI 10.1128/JVI.62.6.2067-2075.1988; HORTON R, 1991, J VIROL, V65, P1141, DOI 10.1128/JVI.65.3.1141-1148.1991; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; KATZ RA, 1988, J VIROL, V62, P2686, DOI 10.1128/JVI.62.8.2686-2695.1988; KATZ RA, 1988, J VIROL, V62, P528, DOI 10.1128/JVI.62.2.528-533.1988; Kotova S, 2010, J MOL BIOL, V399, P491, DOI 10.1016/j.jmb.2010.04.026; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; Lesbats P, 2016, CHEM REV, V116, P12730, DOI 10.1021/acs.chemrev.6b00125; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Li M, 2009, METHODS, V47, P237, DOI 10.1016/j.ymeth.2009.02.001; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; McCord M, 1998, PROTEIN EXPRES PURIF, V14, P167, DOI 10.1006/prep.1998.0954; Mohammed KD, 2011, J VIROL, V85, P4654, DOI 10.1128/JVI.02374-10; Moreau K, 2003, EUR J BIOCHEM, V270, P4426, DOI 10.1046/j.1432-1033.2003.03833.x; MUMM SR, 1991, J VIROL, V65, P1160, DOI 10.1128/JVI.65.3.1160-1167.1991; MUMM SR, 1992, J VIROL, V66, P1995, DOI 10.1128/JVI.66.4.1995-1999.1992; Pandey KK, 2014, J BIOL CHEM, V289, P19648, DOI 10.1074/jbc.M114.573311; Pandey KK, 2011, BIOCHEMISTRY-US, V50, P9788, DOI 10.1021/bi201247f; Pandey KK, 2010, BIOCHEMISTRY-US, V49, P8376, DOI 10.1021/bi100514s; Passos DO, 2017, SCIENCE, V355, P89, DOI 10.1126/science.aah5163; Pommier Y, 2015, BIOORG MED CHEM LETT, V25, P3961, DOI 10.1016/j.bmcl.2015.07.032; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHWARTZ DE, 1983, CELL, V32, P853, DOI 10.1016/0092-8674(83)90071-5; Shi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056892; Skalka AM, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0005-2014; Vora A, 2004, J BIOL CHEM, V279, P18670, DOI 10.1074/jbc.M314270200; Vora A, 2001, J VIROL, V75, P3556, DOI 10.1128/JVI.75.8.3556-3567.2001; Wei SQ, 1998, P NATL ACAD SCI USA, V95, P10535, DOI 10.1073/pnas.95.18.10535; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yin ZQ, 2016, NATURE, V530, P362, DOI 10.1038/nature16950; Yin ZQ, 2012, PROTEIN SCI, V21, P1849, DOI 10.1002/pro.2166	57	4	4	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5018	5030		10.1074/jbc.M116.773382	http://dx.doi.org/10.1074/jbc.M116.773382			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28184005	Green Published, hybrid			2022-12-26	WOS:000397590400023
J	Pires, VMR; Pereira, PMM; Bras, JLA; Correia, M; Cardoso, V; Bule, P; Alves, VD; Najmudin, S; Venditto, I; Ferreira, LMA; Romao, MJ; Carvalho, AL; Fontes, CMGA; Prazeres, DM				Pires, Virgnia M. R.; Pereira, Pedro M. M.; Bras, Joana L. A.; Correia, Marcia; Cardoso, Vania; Bule, Pedro; Alves, Victor D.; Najmudin, Shabir; Venditto, Immacolata; Ferreira, Luis M. A.; Romao, Maria Joao; Carvalho, Ana Luisa; Fontes, Carlos M. G. A.; Prazeres, Duarte Miguel			Stability and Ligand Promiscuity of Type A Carbohydrate-binding Modules Are Illustrated by the Structure of Spirochaeta thermophila StCBM64C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULOSE-BINDING; CLOSTRIDIUM-THERMOCELLUM; DOMAIN; FAMILY; RECOGNITION; DISPLAY; HYDROLYSIS; ANTIBODIES; DISTINCT; SYSTEM	Deconstruction of cellulose, the most abundant plant cell wall polysaccharide, requires the cooperative activity of a large repertoire of microbial enzymes. Modular cellulases contain noncatalytic type A carbohydrate-binding modules (CBMs) that specifically bind to the crystalline regions of cellulose, thus promoting enzyme efficacy through proximity and targeting effects. Although type A CBMs play a critical role in cellulose recycling, their mechanism of action remains poorly understood. Here we produced a library of recombinant CBMs representative of the known diversity of typeAmodules. The binding properties of 40 CBMs, in fusion with an N-terminal GFP domain, revealed that type A CBMs possess the ability to recognize different crystalline forms of cellulose and chitin over a wide range of temperatures, pH levels, and ionic strengths. ASpirochaeta thermophila CBM64, in particular, displayed plasticity in its capacity to bind both crystalline and soluble carbohydrates under a wide range of extreme conditions. The structure of S. thermophila StCBM64C revealed an untwisted, flat, carbohydrate-binding interface comprising the side chains of four tryptophan residues in a coplanar linear arrangement. Significantly, two highly conserved asparagine side chains, each one located between two tryptophan residues, are critical to insoluble and soluble glucan recognition but not to bind xyloglucan. Thus, CBM64 compact structure and its extended and versatile ligand interacting platform illustrate how type A CBMs target their appended plant cell wall-degrading enzymes to a diversity of recalcitrant carbohydrates under a wide range of environmental conditions.	[Pires, Virgnia M. R.; Bras, Joana L. A.; Cardoso, Vania; Bule, Pedro; Alves, Victor D.; Najmudin, Shabir; Venditto, Immacolata; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.] Univ Lisbon, CIISA, Fac Med Vet, Polo Univ Ajuda, P-1300477 Lisbon, Portugal; [Pereira, Pedro M. M.; Prazeres, Duarte Miguel] Univ Lisbon, Inst Bioengn & Biosci, Inst Super Tecn, Dept Bioengn, P-1049001 Lisbon, Portugal; [Bras, Joana L. A.; Cardoso, Vania; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.] NZYTech Genes Enzymes, P-1649038 Lisbon, Portugal; [Correia, Marcia; Romao, Maria Joao; Carvalho, Ana Luisa] Univ Nova Lisboa, Dept Quim, UCIBIO REQUIMTE, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal	Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; Universidade Nova de Lisboa	Fontes, CMGA (corresponding author), Univ Lisbon, CIISA, Fac Med Vet, Polo Univ Ajuda, P-1300477 Lisbon, Portugal.; Prazeres, DM (corresponding author), Univ Lisbon, Inst Bioengn & Biosci, Inst Super Tecn, Dept Bioengn, P-1049001 Lisbon, Portugal.; Fontes, CMGA (corresponding author), NZYTech Genes Enzymes, P-1649038 Lisbon, Portugal.	cafontes@fmv.ulisboa.pt; miguelprazeres@tecnico.ulisboa.pt	Pires, Virginia/J-4799-2013; UCIBIO, U Cienc Biom Apl/F-7948-2017; Prazeres, Duarte Miguel F/E-2526-2011; Romao, Maria J/A-4115-2013; Bule, Pedro/W-6838-2019; Carvalho, Ana Luísa/G-5638-2011; Correia, Márcia/D-2077-2013	Pires, Virginia/0000-0003-1307-3797; UCIBIO, U Cienc Biom Apl/0000-0002-3004-0543; Prazeres, Duarte Miguel F/0000-0002-6928-692X; Romao, Maria J/0000-0002-3004-0543; Bule, Pedro/0000-0003-2531-9926; Carvalho, Ana Luísa/0000-0002-3824-0240; Correia, Márcia/0000-0003-0636-8095; Cardoso, Vania/0000-0001-8389-7543; Alves, Victor Diogo/0000-0002-8430-4380; Bras, Joana/0000-0002-1141-5530; VENDITTO, IMMACOLATA/0000-0003-0392-2871; Fontes, Carlos/0000-0002-1219-9753; Najmudin, Shabir/0000-0002-0429-5454	Qren [30270]; Fundacao para a Ciencia e Tecnologia [PTDC/BIA-MIC/5947/2014, IF/01621/2013, RECI/BBB-BEP/0124/2012, PEst-C/EQB/LA0006/2013, UID/Multi/04378/2013]; Institute for Bio engineering and Biosciences through FCT-Portuguese Foundation for Science and Technology [UID/BIO/04565/2013]; Programa Operacional Regional de Lisboa [007317];  [SFRH/BPD/64917/2009];  [SFRH/BD/86821/2012];  [SFRH/BDE/101026/2014]	Qren; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Institute for Bio engineering and Biosciences through FCT-Portuguese Foundation for Science and Technology; Programa Operacional Regional de Lisboa; ; ; 	This work was supported by Qren, Grant 30270, and by Fundacao para a Ciencia e Tecnologia through projects PTDC/BIA-MIC/5947/2014, IF/01621/2013, RECI/BBB-BEP/0124/2012, PEst-C/EQB/LA0006/2013, and UID/Multi/04378/2013. This work was also supported by Fellowships IF/01621/2013 (to V. M. R. P.), SFRH/BPD/64917/2009 (to M. C.), SFRH/BD/86821/2012 (to P. B.), and SFRH/BDE/101026/2014 (to V. C.) and by Institute for Bio engineering and Biosciences through FCT-Portuguese Foundation for Science and Technology Grant UID/BIO/04565/2013 and by Programa Operacional Regional de Lisboa 2020 Project 007317. C. M. G. A. F. is financial beneficiary of the company that sells the cloning kits used in this study.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angelov A, 2011, APPL ENVIRON MICROB, V77, P5483, DOI 10.1128/AEM.00523-11; Bolam DN, 2004, J BIOL CHEM, V279, P22953, DOI 10.1074/jbc.M313317200; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2005, BIOCHEM J, V385, P479, DOI 10.1042/BJ20041473; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cao Y, 2007, J CHROMATOGR A, V1149, P228, DOI 10.1016/j.chroma.2007.03.032; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; GILBERT HJ, 1990, MOL MICROBIOL, V4, P759, DOI 10.1111/j.1365-2958.1990.tb00646.x; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Hernandez-Gomez MC, 2015, FEBS LETT, V589, P2297, DOI 10.1016/j.febslet.2015.07.009; Hussack G, 2009, SENSORS-BASEL, V9, P5351, DOI 10.3390/s90705351; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LAMED R, 1980, J BACTERIOL, V144, P569, DOI 10.1128/JB.144.2.569-578.1980; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luis AS, 2013, J BIOL CHEM, V288, P4799, DOI 10.1074/jbc.M112.432781; Ofir K, 2005, PROTEOMICS, V5, P1806, DOI 10.1002/pmic.200401078; Oliveira C, 2015, BIOTECHNOL ADV, V33, P358, DOI 10.1016/j.biotechadv.2015.02.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raghothama S, 2000, BIOCHEMISTRY-US, V39, P978, DOI 10.1021/bi992163+; Rosa AMM, 2014, ANAL CHEM, V86, P4340, DOI 10.1021/ac5001288; Saez NJ, 2014, METHODS MOL BIOL, V1091, P33, DOI 10.1007/978-1-62703-691-7_3; Schiefner A, 2016, PROTEINS, V84, P855, DOI 10.1002/prot.25010; Sequeira AF, 2016, MOL BIOTECHNOL, V58, P573, DOI 10.1007/s12033-016-9957-7; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tolba M, 2010, APPL ENVIRON MICROB, V76, P528, DOI 10.1128/AEM.02294-09; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Wang AJA, 2002, APPL ENVIRON MICROB, V68, P1684, DOI 10.1128/AEM.68.4.1684-1689.2002; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011	42	15	15	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4847	4860		10.1074/jbc.M116.767541	http://dx.doi.org/10.1074/jbc.M116.767541			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28179427	Green Published, hybrid			2022-12-26	WOS:000397590400009
J	da Silva, RA; Souza, G; Lemos, LSL; Lopes, UV; Patrocinio, NGRB; Alves, RM; Marcellino, LH; Clement, D; Micheli, F; Gramacho, KP				da Silva, Rangeline Azevedo; Souza, Gustavo; Lima Lemos, Livia Santos; Lopes, Uilson Vanderlei; Ribeiro Braz Patrocinio, Nara Georgia; Alves, Rafael Moyses; Marcellino, Lucilia Helena; Clement, Didier; Micheli, Fabienne; Gramacho, Karina Peres			Genome size, cytogenetic data and transferability of EST-SSRs markers in wild and cultivated species of the genus Theobroma L. (Byttnerioideae, Malvaceae)	PLOS ONE			English	Article							FLOW-CYTOMETRIC ESTIMATION; NUCLEAR-DNA CONTENT; MICROSATELLITE MARKERS; STOICHIOMETRIC ERROR; GENETIC DIVERSITY; WITCHES-BROOM; LINKAGE MAP; CACAO; CHROMOSOMES; CONSEQUENCES	The genus Theobroma comprises several trees species native to the Amazon. Theobroma cacao L. plays a key economic role mainly in the chocolate industry. Both cultivated and wild forms are described within the genus. Variations in genome size and chromosome number have been used for prediction purposes including the frequency of interspecific hybridization or inference about evolutionary relationships. In this study, the nuclear DNA content, karyotype and genetic diversity using functional microsatellites (EST-SSR) of seven Theobroma species were characterized. The nuclear content of DNA for all analyzed Theobroma species was 1C = -0.46 pg. These species presented 2n = 20 with small chromosomes and only one pair of terminal heterochromatic bands positively stained (CMA+/DAPI- bands). The small size of Theobroma ssp. genomes was equivalent to other Byttnerioideae species, suggesting that the basal lineage of Malvaceae have smaller genomes and that there was an expansion of 2C values in the more specialized family clades. A set of 20 EST-SSR primers were characterized for related species of Theobroma, in which 12 loci were polymorphic. The polymorphism information content (PIC) ranged from 0.23 to 0.65, indicating a high level of information per locus. Combined results of flow cytometry, cytogenetic data and EST-SSRs markers will contribute to better describe the species and infer about the evolutionary relationships among Theobroma species. In addition, the importance of a core collection for conservation purposes is highlighted.	[da Silva, Rangeline Azevedo; Ribeiro Braz Patrocinio, Nara Georgia; Micheli, Fabienne] Univ Estadual Santa Cruz, Ilheus, BA, Brazil; [da Silva, Rangeline Azevedo; Lima Lemos, Livia Santos; Lopes, Uilson Vanderlei; Ribeiro Braz Patrocinio, Nara Georgia; Clement, Didier; Gramacho, Karina Peres] CEPLAC CEPEC, Cocoa Res Ctr, Itabuna, BA, Brazil; [Souza, Gustavo] Univ Fed Pernambuco, Recife, PE, Brazil; [Alves, Rafael Moyses] Embrapa Amazonia Oriental, Belem, Para, Brazil; [Marcellino, Lucilia Helena] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [Clement, Didier; Micheli, Fabienne] UMR AGAP, CIRAD, Montpellier, France; [da Silva, Rangeline Azevedo] Inst Oswaldo Cruz, Inst Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [Lima Lemos, Livia Santos] Univ Fed Sul Bahia, Teixeira De Freitas, BA, Brazil	Universidade Estadual de Santa Cruz; Universidade Federal de Pernambuco; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CIRAD; Universite de Montpellier; Fundacao Oswaldo Cruz; Universidade Federal do Sul da Bahia	Gramacho, KP (corresponding author), CEPLAC CEPEC, Cocoa Res Ctr, Itabuna, BA, Brazil.	gramachokp@hotmail.com	Azevedo da Silva, Rangeline/X-9939-2018; da Silva, Rangeline Azevedo/R-4604-2018; GRAMACHO, KARINA PERES/AAO-8862-2020; Souza, Luiz Gustavo/C-2307-2019; GRAMACHO, KARINA PERES/J-3868-2014; Micheli, Fabienne/AAL-9895-2021; Marcellino, Lucilia/N-1967-2016	Azevedo da Silva, Rangeline/0000-0001-6903-1137; GRAMACHO, KARINA PERES/0000-0003-4037-1554; Souza, Luiz Gustavo/0000-0002-5700-6097; GRAMACHO, KARINA PERES/0000-0003-4037-1554; CLEMENT, Didier/0000-0002-7602-6472; Marcellino, Lucilia/0000-0002-0430-2490; Micheli, Fabienne/0000-0002-9031-362X	Cocoa Reserarch Center (CEPEC/CEPLAC); Brazilian Agricultural Research Corporation (EMBRAPA); Santa Cruz State University, (UESC), Coordination for the Improvement of Higher Education Personnel (CAPES); FINEP/CNPq; CAPES	Cocoa Reserarch Center (CEPEC/CEPLAC); Brazilian Agricultural Research Corporation (EMBRAPA)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Santa Cruz State University, (UESC), Coordination for the Improvement of Higher Education Personnel (CAPES); FINEP/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Financiadora de Inovacao e Pesquisa (Finep)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Cocoa Reserarch Center (CEPEC/CEPLAC); Brazilian Agricultural Research Corporation (EMBRAPA); Santa Cruz State University, (UESC), Coordination for the Improvement of Higher Education Personnel (CAPES); FINEP/CNPq. The funder provided support in the form of either research material/ or salaries for authors KPG, UVL, RMA, and LHM, and CAPES provided scholarship to RAS, but they did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aime MC, 2005, MYCOLOGIA, V97, P1012, DOI 10.3852/mycologia.97.5.1012; Alverson WS, 1999, AM J BOT, V86, P1474, DOI 10.2307/2656928; Alves RM, 2006, MOL ECOL NOTES, V6, P1219, DOI 10.1111/j.1471-8286.2006.01496.x; Alves RM, 2013, REV BRAS FRUTIC, V35, P818, DOI 10.1590/S0100-29452013000300019; [Anonymous], 1996, 5000 CNRS UMR; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Avise JC, 2010, CONSERV GENET, V11, P665, DOI 10.1007/s10592-009-0006-y; Ayala-Navarrete L, 2007, THEOR APPL GENET, V116, P63, DOI 10.1007/s00122-007-0647-5; Silva AEBE, 2010, BIOTECH HISTOCHEM, V85, P115, DOI [10.3109/10520290903149596, 10.1080/10520290903149596]; Bayer C, 1999, BOT J LINN SOC, V129, P267, DOI 10.1006/bojl.1998.0226; Bennett MD, 2000, ANN BOT-LONDON, V86, P859, DOI 10.1006/anbo.2000.1253; Bennett Michael D., 2005, P89, DOI 10.1016/B978-012301463-4/50004-8; Benor S, 2011, GENOME, V54, P575, DOI [10.1139/G11-021, 10.1139/g11-021]; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Chistiakov DA, 2006, AQUACULTURE, V255, P1, DOI 10.1016/j.aquaculture.2005.11.031; Costa MP, 2016, J DAIRY RES, V83, P493, DOI 10.1017/S0022029916000674; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Cuatrecasas J., 1964, CONTRIB US NAT MUS, V35, P379, DOI DOI 10.1016/0165-5728(95)00055-7; Dantas LG, 2010, GENET MOL BIOL, V33, P94, DOI 10.1590/S1415-47572009005000103; Dolezel J, 1998, ANN BOT-LONDON, V82, P17, DOI 10.1006/anbo.1998.0730; DOLEZEL J, 1992, PHYSIOL PLANTARUM, V85, P625, DOI 10.1111/j.1399-3054.1992.tb04764.x; Efraim P., 2006, Brazilian Journal of Food Technology, V9, P229; Oliveira GAF, 2013, BRAZ ARCH BIOL TECHN, V56, P785, DOI 10.1590/S1516-89132013000500009; Faleiro FG, 2005, MARACUJA GERMOPLASMA; Felix LP, 2010, BOT J LINN SOC, V163, P234, DOI 10.1111/j.1095-8339.2010.01059.x; FIGUEIRA A, 1992, J AM SOC HORTIC SCI, V117, P673, DOI 10.21273/JASHS.117.4.673; FLAVELL RB, 1988, J MOL BIOL, V204, P523, DOI 10.1016/0022-2836(88)90352-X; Galbraith DW, 2002, CURRENT PROTOCOLS CY, V76, P1; Galvao KSC, 2015, GENET MOL RES, V14, P7344, DOI 10.4238/2015.July.3.10; Gesteira AS, 2007, ANN BOT-LONDON, V100, P129, DOI 10.1093/aob/mcm092; GLICENSTEIN LJ, 1989, J HERED, V80, P464, DOI 10.1093/oxfordjournals.jhered.a110899; Gramacho KP, 2009, OBTENC LITES GENOTIP, V196, P1106, DOI [10.1111/j.1365-294X.2007.03089, DOI 10.1111/J.1365-294X.2007.03089.X]; Gregory TR, 2005, ANN BOT-LONDON, V95, P133, DOI 10.1093/aob/mci009; GREILHUBER J, 1986, CAN J GENET CYTOL, V28, P409, DOI 10.1139/g86-060; Greilhuber J, 2006, PLANT BIOLOGY, V8, P770, DOI 10.1055/s-2006-924101; Greilhuber J, 1988, P 3 CHROM C KEW 1 4, P39; GRIME JP, 1982, NATURE, V299, P151, DOI 10.1038/299151a0; Guerra M, 2000, GENET MOL BIOL, V23, P1029, DOI 10.1590/S1415-47572000000400049; Gupta P. K., 2004, Functional & Integrative Genomics, V4, P139, DOI 10.1007/s10142-004-0107-0; Gupta S, 2009, GENOME, V52, P761, DOI [10.1139/g09-051, 10.1139/G09-051]; Hagras AAA, 2005, BREEDING SCI, V55, P335, DOI 10.1270/jsbbs.55.335; Hou MH, 2004, NUCLEIC ACIDS RES, V32, P2214, DOI 10.1093/nar/gkh549; JMO, 1948, EST CROM GEN THEOBR; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Kawara S, 1999, J DERMATOL SCI, V21, P23, DOI 10.1016/S0923-1811(99)00009-2; Kerr WE, 1980, ACTA AMAZONICA, V10; Lannes Suzana Caetano da Silva, 2002, Rev. Bras. Cienc. Farm., V38, P463, DOI 10.1590/S1516-93322002000400009; Lemos LSL, THESIS; Lemos LSL, 2007, THESIS; Lima LS, 2008, MOL BREEDING, V22, P315, DOI 10.1007/s11032-008-9174-6; Loureiro J, 2007, ANN BOT-LONDON, V100, P875, DOI 10.1093/aob/mcm152; Loureiro J, 2010, PRESLIA, V82, P3; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Machado RCR, 1998, P 10 INT COC RES C P, P151; Mantello Camila C, 2012, BMC Res Notes, V5, P329, DOI 10.1186/1756-0500-5-329; Marinho RC, 2014, PLANT BIOLOGY, V16, P508, DOI 10.1111/plb.12135; Marita JM, 2001, CROP SCI, V41, P1305, DOI 10.2135/cropsci2001.4141305x; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Noirot M, 2005, ANN BOT-LONDON, V95, P111, DOI 10.1093/aob/mci006; Noirot M, 2003, ANN BOT-LONDON, V92, P259, DOI 10.1093/aob/mcg139; Noirot M, 2000, ANN BOT-LONDON, V86, P309, DOI 10.1006/anbo.2000.1187; Ochatt SJ, 2008, CYTOM PART A, V73A, P581, DOI 10.1002/cyto.a.20562; Ogutu C, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1014-y; Pellicer J, 2010, PLANT BIOLOGY, V12, P820, DOI 10.1111/j.1438-8677.2009.00268.x; Teixeira PJPL, 2014, PLANT CELL, V26, P4245, DOI 10.1105/tpc.114.130807; Pinent M, 2016, J SCI FOOD AGR, V96, P178, DOI 10.1002/jsfa.7079; Poncet V, 2006, MOL GENET GENOMICS, V276, P436, DOI 10.1007/s00438-006-0153-5; Risterucci AM, 2000, THEOR APPL GENET, V101, P948, DOI 10.1007/s001220051566; Roiaini M, 2016, INT FOOD RES J, V23, P47; Rowland LJ, 2003, HORTSCIENCE, V38, P1428, DOI 10.21273/HORTSCI.38.7.1428; SAMAD M A, 1992, Cytologia (Tokyo), V57, P21, DOI 10.1508/cytologia.57.21; Santos L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154519; Santos R. M. F., 2014, African Journal of Biotechnology, V13, P814; Sargent DJ, 2007, THEOR APPL GENET, V114, P373, DOI 10.1007/s00122-006-0441-9; Sarkar D, 2011, CARYOLOGIA, V64, P147, DOI 10.1080/00087114.2002.10589776; SAS Institute, 2008, SAS STAT US GUID; Silva CRS, 2005, PLANT SYST EVOL, V250, P93, DOI 10.1007/s00606-004-0223-2; Silva FCO, 1998, GENET MOL BIOL, V21, P205; Sullivan AR, 2013, PLANT MOL BIOL REP, V31, P231, DOI 10.1007/s11105-012-0495-6; Tang JF, 2006, EUPHYTICA, V151, P87, DOI 10.1007/s10681-006-9131-6; Ul Haq S, 2016, GENET RES INT, V2016, DOI 10.1155/2016/7052323; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Venturieri Giorgini Augusto, 2004, Acta Amaz., V34, P507, DOI 10.1590/S0044-59672004000400004; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Silva SDVM, 2010, PESQUI AGROPECU BRAS, V45, P680, DOI 10.1590/S0100-204X2010000700007; WARREN AM, 1991, GENET RES, V58, P225, DOI 10.1017/S0016672300029979; Whitlock BA, 1999, SYST BOT, V24, P128, DOI 10.2307/2419544; Wollgast J, 2000, FOOD RES INT, V33, P423, DOI 10.1016/S0963-9969(00)00068-5; ZHANG MF, 2014, PLOS MED, V11, DOI DOI 10.1371/JOURNAL.PONE.0094881; Zhou R, 2015, GENET MOL RES, V14, P13184, DOI 10.4238/2015.October.26.14	92	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0170799	10.1371/journal.pone.0170799	http://dx.doi.org/10.1371/journal.pone.0170799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187131	Green Published, Green Submitted, gold			2022-12-26	WOS:000394244300008
J	Ng, ST; Tey, NP; Asadullah, MN				Ng, Sor Tho; Tey, Nai Peng; Asadullah, M. Niaz			What matters for life satisfaction among the oldest-old? Evidence from China	PLOS ONE			English	Article							QUALITY-OF-LIFE; LIVING ARRANGEMENTS; SINGLE-ITEM; SOCIAL SUPPORT; RECENT TRENDS; HEALTH; HAPPINESS; DISABILITY; PEOPLE; SCALES	Objective The world population is aging rapidly and the well-being of older people is of great interest. Therefore, this study investigates the determinants of life satisfaction among the oldest-old (i.e. individuals aged 80 or over) in China. Materials and methods We use the 2011/2012 Chinese Longitudinal Healthy Longevity Survey data (n= 6530) for this paper. Logistic regression is used to analyse the effects of socio-demographic, economic, health, instrumental activities of daily living, family and community factors on life satisfaction and depression among the oldest-old in China. Results Our analysis confirms the significance of many factors affecting life satisfaction among the oldest-old in China. Factors that are correlated with life satisfaction include respondent's sex, education, place of residence, self-rated health status, cognitive ability (using mini mental state examination), regular physical examination, perceived relative economic status, access to social security provisions, commercialized insurances, living arrangements, and number of social services available in the community (p<0.05 for all these variables). Although life satisfaction is negatively associated with instrumental activities of daily living (beta =-0.068, 95%CI =-.093-.043), and depression (beta =-0.463, 95%Cl =-.644-.282), the overall effect of self-rated health status is positive (p<0.001). This confirms the primacy of health as the determinant of well-being among the oldest-old. Conclusions Majority of the oldest-old in China rated their life satisfaction as good or very good. Our findings show that health and economic status are by far the most significant predictors of life satisfaction. Our finding on the primacy of health and relative income as determinants of well-being among the oldest-old, and the greater influence of self-rated health status over objective health measures is consistent with the findings of many past studies. Our results suggest that efforts should be directed at enhancing family support as well as health and social service provisions in the community to improve life satisfaction of older people.	[Ng, Sor Tho; Tey, Nai Peng; Asadullah, M. Niaz] Univ Malaya, Fac Econ & Adm, Kuala Lumpur, Malaysia; [Asadullah, M. Niaz] Univ Reading, Dept Econ, Reading, Berks, England; [Asadullah, M. Niaz] Univ Oxford, Ctr Skills Knowledge & Organisat Performance, Oxford, England; [Asadullah, M. Niaz] IZA Inst Labor Econ, Bonn, Germany; [Asadullah, M. Niaz] Univ Manchester, Sch Environm Educ & Dev, Manchester, Lancs, England	Universiti Malaya; University of Reading; University of Oxford; IZA Institute Labor Economics; University of Manchester	Ng, ST (corresponding author), Univ Malaya, Fac Econ & Adm, Kuala Lumpur, Malaysia.	ngst@um.edu.my	Asadullah, M Niaz/H-6768-2013; TEY, NAI PENG/B-5270-2010; Ng, Sor Tho/B-9233-2010	Asadullah, M Niaz/0000-0001-8047-5548; TEY, NAI PENG/0000-0003-3707-5033; Ng, Sor Tho/0000-0001-9251-2377	Population Studies Unit, Faculty of Economics & Administration, University of Malaya [IF002-2014]	Population Studies Unit, Faculty of Economics & Administration, University of Malaya	This research is supported by Population Studies Unit, Faculty of Economics & Administration, University of Malaya, IF002-2014 (University of Malaya). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini V, 2012, SOC INDIC RES, V105, P293, DOI 10.1007/s11205-011-9882-x; Angner E, 2011, J ECON PSYCHOL, V32, P357, DOI 10.1016/j.joep.2011.01.002; Asadullah MN, 2016, CHINA ECON REV; Asadullah MN, 2012, J ECON PSYCHOL, V33, P940, DOI 10.1016/j.joep.2012.05.003; Asian Development Bank, 2010, POP AG LONG TERM HLT; Beckett M, 2000, AM J EPIDEMIOL, V151, P315, DOI 10.1093/oxfordjournals.aje.a010208; Brown P. H., 2009, J SOCIO-ECON, V38, P310, DOI DOI 10.1016/J.SOCEC.2008.07.014; Camfield L, 2014, WORLD DEV, V59, P212, DOI 10.1016/j.worlddev.2014.01.018; Carlsson F, 2009, OXFORD ECON PAP, V61, P52, DOI 10.1093/oep/gpn015; Chen FN, 2008, J FAM ISSUES, V29, P1379, DOI 10.1177/0192513X07313602; Chen ZH, 2008, J HAPPINESS STUD, V9, P589, DOI 10.1007/s10902-008-9092-7; Chi I, 2001, INT J AGING HUM DEV, V52, P231, DOI 10.2190/V5K8-CNMG-G2UP-37QV; Chou KL, 2003, AGING MENT HEALTH, V7, P224, DOI 10.1080/136031000101210; Chou KL, 1999, AGING MENT HEALTH, V3, P328, DOI 10.1080/13607869956109; Cigolle C, 2016, J GERONTOL B-PSYCHOL; Clark AE, 2008, J ECON LIT, V46, P95, DOI 10.1257/jel.46.1.95; Corazzini L, 2012, J ECON BEHAV ORGAN, V81, P715, DOI 10.1016/j.jebo.2010.12.016; de Boer AGEM, 2004, QUAL LIFE RES, V13, P311, DOI 10.1023/B:QURE.0000018499.64574.1f; Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033; Deaton A, 2013, AM ECON REV, V103, P591, DOI 10.1257/aer.103.3.591; Diamantopoulos A, 2012, J ACAD MARKET SCI, V40, P434, DOI 10.1007/s11747-011-0300-3; DIENER E, 1995, J PERS SOC PSYCHOL, V68, P653, DOI 10.1037/0022-3514.68.4.653; Diener E, 2013, SOC INDIC RES, V112, P497, DOI 10.1007/s11205-012-0076-y; Diener E, 2010, J PERS SOC PSYCHOL, V99, P52, DOI 10.1037/a0018066; Dobson AJ, INTRO GEN LINEAR MOD; Easterlin RA, 2012, P NATL ACAD SCI USA, V109, P9775, DOI 10.1073/pnas.1205672109; Easterlin RA, 2010, P NATL ACAD SCI USA, V107, P22463, DOI 10.1073/pnas.1015962107; Flores G, 2015, J HEALTH ECON, V44, P150, DOI 10.1016/j.jhealeco.2015.09.003; Fong H, 2015, CHINESE J GERONTOL, V35, P208; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Gardner DG, 1998, EDUC PSYCHOL MEAS, V58, P898, DOI 10.1177/0013164498058006003; Graham C, 2015, WORLD DEV, V68, P163, DOI 10.1016/j.worlddev.2014.11.018; Gwozdz W, 2010, SOC INDIC RES, V97, P397, DOI 10.1007/s11205-009-9508-8; Hlavac M, 2011, SUBJECTIVE LIFE SATI; Hu H, 2012, CHINA SOFT SCI, V11, P41; Huang CQ, 2010, AGE AGEING, V39, P23, DOI 10.1093/ageing/afp187; Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47; Jagodzinski W, 2010, SOC INDIC RES, V97, P85, DOI 10.1007/s11205-009-9555-1; Knight J, 2014, CSAE WORKING PAPER S; KRAUSE N, 1993, J GERONTOL, V48, pP282, DOI 10.1093/geronj/48.6.P282; Layard R, 2013, IZA J LABOR POLICY, V2, DOI 10.1186/2193-9004-2-2; LEMON BW, 1972, J GERONTOL, V27, P511, DOI 10.1093/geronj/27.4.511; Li D., 2008, CHIN J GERONTOL, V19, P1943; Li D., 2008, HLTH LONGEVITY CHINA, P347, DOI [10.1007/978-1-4020-6752-5_21, DOI 10.1007/978-1-4020-6752-5_21]; [李德明 LI DeMing], 2007, [中国老年学杂志, Chinese Journal of Gerontology], V27, P1193; Li H, 2014, DOES MONEY BUY HAPPI; Li LW, 2007, PSYCHOL AGING, V22, P386, DOI 10.1037/0882-7974.22.2.386; Li Q, 2005, 2005011 MPIDR WP; Liu J, 2015, SCI RES AGING, V3, P69; Liu LJ, 2008, QUAL LIFE RES, V17, P823, DOI 10.1007/s11136-008-9370-1; Lou VWQ, 2010, SOC INDIC RES, V95, P377, DOI 10.1007/s11205-009-9526-6; Luo W., 2011, POPUL RES, V35, P51; Michael YL, 2001, AM J EPIDEMIOL, V153, P123, DOI 10.1093/aje/153.2.123; Mudege NN, 2009, J AGING STUD, V23, P245, DOI 10.1016/j.jaging.2007.12.021; Perez-Truglia R, 2015, J ECON PSYCHOL, V49, P74, DOI 10.1016/j.joep.2015.05.002; Piazza JR, 2007, J GERONTOL B-PSYCHOL, V62, pP313, DOI 10.1093/geronb/62.6.P313; Ravallion M, 2010, J ECON BEHAV ORGAN, V73, P171, DOI 10.1016/j.jebo.2009.08.008; Ren Q, 2015, CHINESE SOCIOL REV, V47, P255, DOI 10.1080/21620555.2015.1032162; Rocco, 2016, 10022 IZA; Rodriguez A, 2008, SOC INDIC RES, V86, P163, DOI 10.1007/s11205-007-9101-y; ROOK KS, 1984, J PERS SOC PSYCHOL, V46, P1097, DOI 10.1037/0022-3514.46.5.1097; Rowe JW, 1998, SUCCESSFUL AGING; Schwartz CE, 1999, SOC SCI MED, V48, P1531, DOI 10.1016/S0277-9536(99)00047-7; Sereny M, 2011, RES AGING, V33, P172, DOI 10.1177/0164027510392387; Silverstein M, 2002, RES AGING, V24, P528, DOI 10.1177/0164027502245003; State Council Information Office (SCIO) of the People's Republic of China, 2006, WHIT PAP SEN CIT CHI; Steptoe A, 2015, LANCET, V385, P640, DOI 10.1016/S0140-6736(13)61489-0; Steptoe A, 2012, ARCH INTERN MED, V172, P273, DOI 10.1001/archinternmed.2011.1028; Tey NP, 2016, MATURITAS, V94, P39, DOI 10.1016/j.maturitas.2016.08.016; Tian MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083822; Tomioka K, 2016, AGE AGEING; Wang DW, 2009, AGEING SOC, V29, P1141, DOI 10.1017/S0144686X09008629; Wang JF, 2014, AGING MENT HEALTH, V18, P232, DOI 10.1080/13607863.2013.837143; Wang Y, 2014, CHINA EC STUD, V5, P19; Wikman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018952; Zeng Y, 2002, POPUL DEV REV, V28, P251; Zeng Y, 2003, CHINA REV, V3, P95, DOI [DOI 10.1007/S42379-018-0010-3, 10.1007/978-90-481-8906-9_14]; Zeng Y, 2012, CHINA ECON J, V5, P131, DOI 10.1080/17538963.2013.764677; Zhang L., 2015, OPEN J SOCIAL SCI, V3, P150, DOI [DOI 10.4236/JSS.2015.33024, 10.4236/jss.2015.33024]; Zhang M, 2016, INVESTIGATION ELDERL; Zhang W, 2014, SCI RES AGING, V2, P59; Zhou M, 2008, HLTH LONGEVITY CHINA, P357, DOI DOI 10.1007/978-1-4020-6752-5_22; Zhou YC, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0136-4; 庞宝华, 2015, [中国老年学杂志, Chinese Journal of Gerontology], V35, P798; 李德明, 2009, [中国老年学杂志, Chinese Journal of Gerontology], V29, P2513	85	71	75	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171799	10.1371/journal.pone.0171799	http://dx.doi.org/10.1371/journal.pone.0171799			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187153	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000394244300044
J	Pittet, V; Vaucher, C; Froehlich, F; Burnand, B; Michetti, P; Maillard, MH				Pittet, Valerie; Vaucher, Carla; Froehlich, Florian; Burnand, Bernard; Michetti, Pierre; Maillard, Michel H.		Swiss IBD Cohort Study Grp	Patient self-reported concerns in inflammatory bowel diseases: A gender specific subjective quality-of-life indicator	PLOS ONE			English	Article							HEALTH-STATUS; PART II; WORRIES; WOMEN; INFORMATION; PHYSICIANS; SEXUALITY; FATIGUE; IBD	Background Patient-reported disease perceptions are important components to be considered within a holistic model of quality of care. Gender may have an influence on these perceptions. We aimed to explore gender-specific concerns of patients included in a national bilingual inflammatory bowel disease cohort. Methods Following a qualitative study, we built a questionnaire comprising 37 items of concern. Answers were collected on a visual analog scale ranging from 0 to 100. Principal axis factor analysis was used to explore concern domains. Linear multiple regressions were conducted to assess associations with patient characteristics. Results Of 1102 patients who replied to the survey, 54% were female and 54% had Crohn's disease. We identified six domains of concern: socialization and stigmatization, disease-related constraints and uncertainty, symptoms and their impact on body and mind, loss of body control (including sexuality), disease transmission, and long-term impact of the disease. Cancer concerns were among the highest scored by all patients (median 61.8). Severity of symptoms was the only factor associated with concerns, unrelated to dimension and gender (p<0.015). In women, being >40 years decreased disease-related constraints and uncertainty concerns, and being at home or unemployed increased them. Treatments were associated with increased socialization and stigmatization and with increased disease-related constraints and uncertainty concerns in men. Overall, psychosomatic characteristics were highly associated with concerns for both men and women. Depending on the concern dimensions, increased levels of concern were associated with the highest signs of anxiety in women or depression in men, as well as lower health-related quality of life in men. Conclusions Patients have numerous concerns related to their illness that need to be reassessed regularly. Concerns differ between men and women, suggesting that information and communication about the disease should take gender differences and subjective perceptions of quality of life into consideration.	[Pittet, Valerie; Vaucher, Carla; Burnand, Bernard] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Froehlich, Florian; Maillard, Michel H.] Univ Lausanne Hosp, Div Gastroenterol & Hepatol, Lausanne, Switzerland; [Froehlich, Florian] Univ Basel Hosp, Div Gastroenterol & Hepatol, Basel, Switzerland; [Michetti, Pierre] Clin Source Beaulieu, Crohn & Colitis Ctr, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel	Pittet, V (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	Valerie.pittet@chuv.ch		Braegger, Christian/0000-0001-8069-9875; Pittet, Valerie/0000-0003-2208-966X	Swiss National Science Foundation (SNSF) [33CS30-148422, 32473B-138498]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	The study was supported by the Swiss National Science Foundation (SNSF) grants No 33CS30-148422 (Swiss IBD cohort study) and 32473B-138498 (Appropriateness of care in IBD) to VP.	Aghamohammadi-Kalkhoran M, 2014, J HLTH PSYCHOL; Anderson KL, 1999, J ADV NURS, V29, P298, DOI 10.1046/j.1365-2648.1999.00889.x; Barbour R., 2007, DOING FOCUS GROUPS; Berroa E, 2015, INFLAMM BOWEL DIS, V21, pE22, DOI 10.1097/MIB.0000000000000539; Borum ML, 2010, INFLAMM BOWEL DIS, V16, P181, DOI 10.1002/ibd.20955; Borum ML, 2009, INFLAMM BOWEL DIS, V15, P1773, DOI 10.1002/ibd.20871; Camara RJA, 2011, INFLAMM BOWEL DIS, V17, P1277, DOI 10.1002/ibd.21481; Fernandez JC, 2010, PSICOTHEMA, V22, P208; Casati J, 2000, DIGEST DIS SCI, V45, P26, DOI 10.1023/A:1005492806777; de Rooy EC, 2001, AM J GASTROENTEROL, V96, P1816, DOI 10.1016/S0002-9270(01)02440-6; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DROSSMAN DA, 1991, PSYCHOSOM MED, V53, P701, DOI 10.1097/00006842-199111000-00010; DROSSMAN DA, 1991, DIGEST DIS SCI, V36, P1746, DOI 10.1007/BF01296620; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Fletcher PC, 2008, CLIN NURSE SPEC, V22, P278, DOI 10.1097/01.NUR.0000325382.99717.ac; Fletcher PC, 2008, CLIN NURSE SPEC, V22, P184, DOI 10.1097/01.NUR.0000311707.32566.c8; Hair JF, 1998, MULTIVAR DATA ANAL, VXX, P730; Hauser G, 2011, COLLEGIUM ANTROPOL, V35, P203; Hjortswang H, 1998, AM J GASTROENTEROL, V93, P2203, DOI 10.1111/j.1572-0241.1998.00537.x; Jamieson AE, 2007, CLIN NURSE SPEC, V21, P152, DOI 10.1097/01.NUR.0000270015.97457.9c; Jelsness-Jorgensen LP, 2012, J PSYCHOSOM RES, V73, P469, DOI 10.1016/j.jpsychores.2012.08.009; Jelsness-Jorgensen LP, 2012, WORLD J GASTROENTERO, V18, P445, DOI 10.3748/wjg.v18.i5.445; Jelsness-Jorgensen LP, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/492034; Lagro-Janssen Toine, 2008, Eur J Gen Pract, V14 Suppl 1, P33, DOI 10.1080/13814780802436127; Levenstein S, 2001, AM J GASTROENTEROL, V96, P1822, DOI 10.1016/S0002-9270(01)02441-8; Maunder R, 1999, CAN J GASTROENTEROL, V13, P728, DOI 10.1155/1999/701645; MOSER G, 1995, EUR J GASTROEN HEPAT, V7, P853; Muller KR, 2010, INFLAMM BOWEL DIS, V16, P657, DOI 10.1002/ibd.21090; Multone E, 2015, SCAND J GASTROENTERO, P1; Mussell M, 2004, EUR J GASTROEN HEPAT, V16, P1273, DOI 10.1097/00042737-200412000-00007; Okoro Ngozi Ivunanya, 2009, Expert Rev Gastroenterol Hepatol, V3, P145, DOI 10.1586/egh.09.1; Reddy S I, 2001, J Am Osteopath Assoc, V101, pS17; Stjernman H, 2010, SCAND J GASTROENTERO, V45, P696, DOI 10.3109/00365521003734141; Trachter AB, 2002, INFLAMM BOWEL DIS, V8, P413, DOI 10.1097/00054725-200211000-00006; Vaucher C, 2016, SCAND J GASTROENTERO, P1	36	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171864	10.1371/journal.pone.0171864	http://dx.doi.org/10.1371/journal.pone.0171864			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187201	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300054
J	Broring, T; Oostrom, KJ; Lafeber, HN; Jansma, EP; Oosterlaan, J				Broering, Tinka; Oostrom, Kim J.; Lafeber, Harrie N.; Jansma, Elise P.; Oosterlaan, Jaap			Sensory modulation in preterm children: Theoretical perspective and systematic review	PLOS ONE			English	Review							NEONATAL INTENSIVE-CARE; BIRTH-WEIGHT CHILDREN; BRAIN-DEVELOPMENT; PROCESSING DISORDER; BEHAVIORAL OUTCOMES; DEVELOPMENTAL CARE; EVERYDAY LIFE; INFANTS; BORN; AGE	Background Neurodevelopmental sequelae in preterm born children are generally considered to result from cerebral white matter damage and noxious effects of environmental factors in the neonatal intensive care unit (NICU). Cerebral white matter damage is associated with sensory processing problems in terms of registration, integration and modulation. However, research into sensory processing problems and, in particular, sensory modulation problems, is scarce in preterm children. Aim This review aims to integrate available evidence on sensory modulation problems in preterm infants and children (<37 weeks of gestation) and their association with neurocognitive and behavioral problems. Method Relevant studies were extracted from PubMed, EMBASE.com and PsycINFO following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Selection criteria included assessment of sensory modulation in preterm born children (<37 weeks of gestation) or with prematurity as a risk factor. Results Eighteen studies were included. Results of this review support the presence of sensory modulation problems in preterm children. Although prematurity may distort various aspects of sensory modulation, the nature and severity of sensory modulation problems differ widely between studies. Conclusions Sensory modulation problems may play a key role in understanding neurocognitive and behavioral sequelae in preterm children. Some support is found for a dose-response relationship between both white matter brain injury and length of NICU stay and sensory modulation problems.	[Broering, Tinka; Oostrom, Kim J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands; [Lafeber, Harrie N.] Vrije Univ Amsterdam, Med Ctr, Dept Neonatol, Amsterdam, Netherlands; [Jansma, Elise P.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Jansma, Elise P.] Vrije Univ Amsterdam, Med Ctr, Med Lib, Amsterdam, Netherlands; [Oosterlaan, Jaap] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Broring, T (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.	t.broring@vumc.nl	Jansma, Elise/AAG-7983-2020; Jansma, Elise P/E-8358-2016	Jansma, Elise P/0000-0002-1516-2171				Aarnoudse-Moens CSH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055994; Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Adams JN, 2015, EARLY HUM DEV, V91, P227, DOI 10.1016/j.earlhumdev.2015.01.013; Als H, 1997, SEMIN PERINATOL, V21, P178, DOI 10.1016/S0146-0005(97)80062-6; Als H, 2004, PEDIATRICS, V113, P846, DOI 10.1542/peds.113.4.846; ALS H, 1994, JAMA-J AM MED ASSOC, V272, P853, DOI 10.1001/jama.272.11.853; ALS H, 1986, PEDIATRICS, V78, P1123; Als H., 1986, PHYS OCCUP THER PEDI, V6, P3, DOI DOI 10.1080/J006V06N03_02; Anand KJS, 2000, BIOL NEONATE, V77, P69, DOI 10.1159/000014197; Anderson PJ, 2014, SEMIN FETAL NEONAT M, V19, P90, DOI 10.1016/j.siny.2013.11.012; Aucott S, 2002, MENT RETARD DEV D R, V8, P298, DOI 10.1002/mrdd.10040; Bart O, 2011, RES DEV DISABIL, V32, P2732, DOI 10.1016/j.ridd.2011.05.037; Bayley N, 1993, BAYLEY SCALES INFANT; Ben-Sasson A, 2009, J AUTISM DEV DISORD, V39, P1, DOI 10.1007/s10803-008-0593-3; Bhutta AT, 2002, CLIN PERINATOL, V29, P357, DOI 10.1016/S0095-5108(02)00011-8; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Bisiacchi PS, 2009, BIOL PSYCHOL; Cabral TI, 2016, EARLY HUM DEV; Cascio CJ, 2010, J NEURODEV DISORD, V2, P62, DOI 10.1007/s11689-010-9046-3; Case-Smith J, 1998, AM J OCCUP THER, V52, P547, DOI 10.5014/ajot.52.7.547; Chorna O, 2014, ARCH DIS CHILD-FETAL, V99, pF475, DOI 10.1136/archdischild-2014-306486; Christou Helen, 2005, J Intensive Care Med, V20, P76, DOI 10.1177/0885066604273494; Crepeau-Hobson MF, 2009, J DEV PHYS DISABIL, V21, P315, DOI 10.1007/s10882-009-9144-x; Crozier SC, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.018747; de Kieviet JF, 2012, DEV MED CHILD NEUROL, V54, P313, DOI 10.1111/j.1469-8749.2011.04216.x; de Kieviet JF, 2009, JAMA-J AM MED ASSOC, V302, P2235, DOI 10.1001/jama.2009.1708; DeGangi GA., 1989, TEST SENSORY FUNCTIO; Dubois J, 2008, BRAIN; Dubois J, 2008, CEREB CORTEX; Dudova I, 2014, NEUROPSYCH DIS TREAT, V10, P277, DOI 10.2147/NDT.S57057; Dunn W, 1997, INFANT YOUNG CHILD, V9, P23, DOI 10.1097/00001163-199704000-00005; Dunn W, 2002, J EARLY INTERVENTION, V25, P27, DOI 10.1177/105381510202500104; Dunn W, 2001, AM J OCCUP THER, V55, P608, DOI 10.5014/ajot.55.6.608; Dunn W, 1999, SENSORY PROFILE USER; Dunn W., 2002, INFANT TODDLER SENSO; Dunn W, 2007, INFANT YOUNG CHILD, V20, P84, DOI 10.1097/01.IYC.0000264477.05076.5d; Ecevit A, 2012, TURKISH J PEDIATR, V54, P509; Eeles AL, 2013, EARLY HUM DEV, V89, P1075, DOI 10.1016/j.earlhumdev.2013.07.027; Eeles AL, 2013, EARLY HUM DEV, V89, P727, DOI 10.1016/j.earlhumdev.2013.05.005; Eeles AL, 2013, DEV MED CHILD NEUROL, V55, P314, DOI 10.1111/j.1469-8749.2012.04434.x; Geldof CJA, 2012, RES DEV DISABIL, V33, P726, DOI 10.1016/j.ridd.2011.08.025; Geldof CJA, 2014, DEV MED CHILD NEUROL, V56, P862, DOI 10.1111/dmcn.12404; Gioia GA, 2003, BRIEF P BEHAV RATING; Goldsmith HH, 1996, CHILD DEV, V67, P218, DOI 10.1111/j.1467-8624.1996.tb01730.x; Gomot M, 2007, INT J PSYCHOPHYSIOL, V64, P123, DOI 10.1016/j.ijpsycho.2007.01.003; Hille ETM, 2007, PEDIATRICS, V120, pE587, DOI 10.1542/peds.2006-2407; Janssens A, 2009, ACTA PAEDIATR, V98, P1988, DOI 10.1111/j.1651-2227.2009.01488.x; Jiang ZD, 2013, EUR J PEDIATR, V172, P1033, DOI 10.1007/s00431-013-1989-4; Johnson S, 2007, SEMIN FETAL NEONAT M, V12, P363, DOI 10.1016/j.siny.2007.05.004; Kaindl AN, 2009, J CHILD NEUROL, V24, P1112, DOI 10.1177/0883073809337920; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Koziol LF, 2011, CEREBELLUM, V10, P770, DOI 10.1007/s12311-011-0288-8; Lane AE, 2010, J AUTISM DEV DISORD, V40, P112, DOI 10.1007/s10803-009-0840-2; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lickliter R, 2011, CLIN PERINATOL, V38, P591, DOI 10.1016/j.clp.2011.08.007; Limperopoulos C, 2008, PEDIATRICS, V121, P758, DOI 10.1542/peds.2007-2158; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Mangeot SD, 2001, DEV MED CHILD NEUROL, V43, P399, DOI 10.1017/S0012162201000743; Maroney Dianne I, 2003, J Perinatol, V23, P679, DOI 10.1038/sj.jp.7211010; May-Benson TA, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.031.2009; McIntosh D. N., 1999, OVERVIEW SHORT SENSO; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Mento G, 2012, NEUROSCIENCE BIOBEHA; Mento G, 2010, EUR J NEUROSCI; Milgrom J, 2010, PEDIAT RES; Miller LJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.022.2009; Miller LJ, 2007, AM J OCCUP THER, V61, P135, DOI 10.5014/ajot.61.2.135; Miller LJ, 2012, RES DEV DISABIL, V33, P804, DOI 10.1016/j.ridd.2011.12.005; Mitchell A, 2015, AM J OCCUP THER, V1-11; Mitha A, 2013, PEDIATRICS, V132, pE372, DOI 10.1542/peds.2012-3979; National Center for Infants Toddlers and Families, 1994, ZER TOT 3 DIAGN CLAS; Nevalainen P, 2008, INT J PSYCHOPHYSIOL, V68, P85, DOI 10.1016/j.ijpsycho.2007.10.014; Ortibus EL, 2011, PEDIATR NEUROL, V45, P1, DOI 10.1016/j.pediatrneurol.2011.02.008; Owen JP, 2013, NEUROIMAGE-CLIN, V2, P844, DOI 10.1016/j.nicl.2013.06.009; Pekcetin S, 2016, PERCEPT MOTOR SKILL, V123, P411, DOI 10.1177/0031512516662895; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Provost B, 1994, SENSORY RATING SCALE, V13, P15; Rahkonen P, 2015, ACTA PAEDIATR, V104, P522, DOI 10.1111/apa.12911; Roofthooft DWE, 2014, NEONATOLOGY, V105, P218, DOI 10.1159/000357207; Schendel D, 2008, PEDIATRICS, V121, P1155, DOI 10.1542/peds.2007-1049; Scher MS, 2009, CLIN NEUROPHYSIOL; Scherder EJA, 2008, EUR J PAEDIATR NEURO, V12, P461, DOI 10.1016/j.ejpn.2007.11.004; Shea B., 2011, NEW CASTLE OTTAWA SC; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Smith GC, 2011, ANN NEUROL, V70, P541, DOI 10.1002/ana.22545; Symington A, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001814.pub2; Treyvaud K, 2013, J CHILD PSYCHOL PSYC, V54, P772, DOI 10.1111/jcpp.12040; Van Hulle C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129968; van Noort-van der Spek IL, 2012, PEDIATRICS, V129, P745, DOI 10.1542/peds.2011-1728; Verkerk G, 2011, J PEDIATR-US, V159, P933, DOI 10.1016/j.jpeds.2011.05.035; Volpe J.J., 2008, NEUROLOGY NEWBORN; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Walker SM, 2009, PAIN, V141, P79, DOI 10.1016/j.pain.2008.10.012; Weisglas-Kuperus N, 2009, ARCH DIS CHILD-FETAL, V94, pF196, DOI 10.1136/adc.2007.135095; Wickremasinghe AC, 2013, J PERINATOL, V33, P631, DOI 10.1038/jp.2013.12; Wiener Andrea Santman, 1996, Physical and Occupational Therapy in Pediatrics, V16, P1, DOI 10.1300/J006v16n04_01; World Health Organization, 1992, INT CLASS DIS REL HL	99	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170828	10.1371/journal.pone.0170828	http://dx.doi.org/10.1371/journal.pone.0170828			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182680	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800020
J	Callebaut, C; Liu, Y; Babusis, D; Ray, A; Miller, M; Kitrinos, K				Callebaut, Christian; Liu, Yang; Babusis, Darius; Ray, Adrian; Miller, Michael; Kitrinos, Kathryn			Viability of primary osteoblasts after treatment with tenofovir alafenamide: Lack of cytotoxicity at clinically relevant drug concentrations	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; ACTIVATION; DISEASE; EMTRICITABINE; INHIBITORS; TURNOVER; PRODRUGS; ADULTS	Tenofovir alafenamide (TAF) is a phosphonoamidate prodrug of the nucleotide HIV reverse transcriptase inhibitor tenofovir (TFV). TAF is approved for the treatment of HIV-1 infection as part of the single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and TAF. When dosed once-daily, TAF results in approximately 90% lower levels of plasma TFV and a 4-fold increase in intracellular TFV-diphosphate (TFV-DP) in PBMCs compared with the TFV prodrug tenofovir disoproxil fumarate (TDF). Several antiretrovirals, including TDF, have been associated with bone mineral density decreases in patients; the effect of clinically relevant TAF concentrations on primary osteoblast viability was therefore assessed in vitro. Studies in PBMCs determined that a 2-hour TAF exposure at concentrations similar to human plasma C-max achieved intracellular TFV-DP levels comparable to those observed after the maximum recommended human dose of 25 mg TAF. Comparable intracellular TFV-DP levels were achieved in primary osteoblasts with 2-hour TAF exposure daily for 3 days at concentrations similar to those used for PBMCs (100-400 nM). No change in cell viability was observed in either primary osteoblasts or PBMCs. The mean TAF CC50 in primary osteoblasts after 3 days of daily 2-hour pulses was >500 mu M, which is >1033 times higher than the TAF maximum recommended human dose plasma Cmax. In summary, primary osteoblasts were not preferentially loaded by TAF compared with PBMCs, with comparable TFV-DP levels achieved in both cell types. Furthermore, there was no impact on osteoblast cell viability at clinically relevant TAF concentrations.	[Callebaut, Christian; Liu, Yang; Miller, Michael; Kitrinos, Kathryn] Gilead Sci, Dept Clin Virol, Foster City, CA 94404 USA; [Babusis, Darius; Ray, Adrian] Gilead Sci, Dept Drug Metab, Foster City, CA USA	Gilead Sciences; Gilead Sciences	Callebaut, C (corresponding author), Gilead Sci, Dept Clin Virol, Foster City, CA 94404 USA.	christian.callebaut@gilead.com		Ray, Adrian/0000-0002-3508-3008				Abbott, KALETRA LOPINAVIR RI; Agouron Pharmaceuticals Inc, 2013, VIRACEPT NELF TABL O; Amiel C, 2004, J BONE MINER RES, V19, P402, DOI 10.1359/JBMR.0301246; Arimilli MN, 1997, ANTIVIR CHEM CHEMOTH, V8, P557, DOI 10.1177/095632029700800610; Bedimo R, 2012, AIDS; Birkus G, 2008, MOL PHARMACOL, V74, P92, DOI 10.1124/mol.108.045526; Callebaut C, 2015, ANTIMICROB AGENTS CH; Callebaut C, 2011, ANTIMICROB AGENTS CH, V55, P1366, DOI 10.1128/AAC.01183-10; Durand-Gasselin L, 2009, MOL PHARMACEUT, V6, P1145, DOI 10.1021/mp900036s; Duvivier C, 2009, AIDS, V23, P817, DOI 10.1097/QAD.0b013e328328f789; Foisy MM, 2013, AM J HEALTH-SYST PH, V70, P1272, DOI 10.2146/ajhp120030; Gilead Sciences Inc, VIREAD TEN DIS FUM T; Grigsby IF, 2010, BIOCHEM BIOPH RES CO, V394, P48, DOI 10.1016/j.bbrc.2010.02.080; Hall AM, 2011, AM J KIDNEY DIS, V57, P773, DOI 10.1053/j.ajkd.2011.01.022; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Lee WA, 2005, ANTIMICROB AGENTS CH, V49, P1898, DOI 10.1128/AAC.49.5.1898-1906.2005; Lee WA, 2006, ANTIVIR RES, V71, P254, DOI 10.1016/j.antiviral.2006.05.020; Lenzi L, 2013, INT J CLIN PHARM TH, V51, P141, DOI 10.5414/CP201818; Malizia AP, 2007, ANTIVIR RES, V74, P72, DOI 10.1016/j.antiviral.2006.12.003; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; McComsey GA, 2010, CLIN INFECT DIS, V51, P937, DOI 10.1086/656412; Mooser V, 2003, AIDS, V17, pS65, DOI 10.1097/00002030-200304001-00009; Naesens L, 1998, ANTIMICROB AGENTS CH, V42, P1568, DOI 10.1128/AAC.42.7.1568; Pozniak A, 2015, J ACQUIR IMMUNE DEFI; Ray AS, 2016, ANTIVIR RES, V125, P63, DOI 10.1016/j.antiviral.2015.11.009; ROBBINS BL, 1995, ANTIMICROB AGENTS CH, V39, P2304, DOI 10.1128/AAC.39.10.2304; Rowe PS, 2015, CURR OPIN PHARMACOL, V22, P64, DOI 10.1016/j.coph.2015.03.006; Ruane P, 2012, 19 C RETR OPP INF CR; Ruane PJ, 2013, JAIDS-J ACQ IMM DEF, V63, P449, DOI 10.1097/QAI.0b013e3182965d45; Sax P, 2013, 53 ICAAC; Sax Paul E, 2014, J Acquir Immune Defic Syndr, V67, P52, DOI 10.1097/QAI.0000000000000225; Sax PE, 2015, LANCET, V385, P2606, DOI 10.1016/S0140-6736(15)60616-X; Schafer JJ, 2013, PHARMACOTHERAPY, V33, P665, DOI 10.1002/phar.1257; Seminari E, 2005, HIV MED, V6, P145, DOI 10.1111/j.1468-1293.2005.00278.x; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; Tebas P, 2000, AIDS, V14, pF63, DOI 10.1097/00002030-200003100-00005; Tozser J, 2001, ANN NY ACAD SCI, V946, P145, DOI 10.1111/j.1749-6632.2001.tb03909.x; Vigouroux C, 1999, DIABETES METAB, V25, P383; Yin MT, 2012, AIDS, V26, P2175, DOI 10.1097/QAD.0b013e328359a8ca; Zolopa A, 2013, 20 C RETR OPP INF 20	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0169948	10.1371/journal.pone.0169948	http://dx.doi.org/10.1371/journal.pone.0169948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182625	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800006
J	Hughes, J; Huo, X; Falk, L; Hurford, A; Lan, KQ; Coburn, B; Morris, A; Wu, JH				Hughes, Josie; Huo, Xi; Falk, Lindsey; Hurford, Amy; Lan, Kunquan; Coburn, Bryan; Morris, Andrew; Wu, Jianhong			Benefits and unintended consequences of antimicrobial de-escalation: Implications for stewardship programs	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; VENTILATOR-ASSOCIATED PNEUMONIA; PSEUDOMONAS-AERUGINOSA ACQUISITION; CLOSTRIDIUM-DIFFICILE INFECTION; ANTIBIOTIC-RESISTANCE; RISK-FACTORS; CLINICAL-OUTCOMES; DISEASES SOCIETY; SEVERE SEPSIS; ICU	Sequential antimicrobial de-escalation aims to minimize resistance to high-value broad-spectrum empiric antimicrobials by switching to alternative drugs when testing confirms susceptibility. Though widely practiced, the effects de-escalation are not well understood. Definitions of interventions and outcomes differ among studies. We use mathematical models of the transmission and evolution of Pseudomonas aeruginosa in an intensive care unit to assess the effect of de-escalation on a broad range of outcomes, and clarify expectations. In these models, de-escalation reduces the use of high-value drugs and preserves the effectiveness of empiric therapy, while also selecting for multidrug-resistant strains and leaving patients vulnerable to colonization and superinfection. The net effect of de-escalation in our models is to increase infection prevalence while also increasing the probability of effective treatment. Changes in mortality are small, and can be either positive or negative. The clinical significance of small changes in outcomes such as infection prevalence and death may exceed more easily detectable changes in drug use and resistance. Integrating harms and benefits into ranked outcomes for each patient may provide a way forward in the analysis of these tradeoffs. Our models provide a conceptual framework for the collection and interpretation of evidence needed to inform antimicrobial stewardship.	[Hughes, Josie; Huo, Xi; Wu, Jianhong] York Univ, Ctr Dis Modelling, Toronto, ON, Canada; [Huo, Xi; Lan, Kunquan] Ryerson Univ, Dept Math, Toronto, ON, Canada; [Falk, Lindsey] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Hurford, Amy] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Hurford, Amy] Mem Univ Newfoundland, Dept Math & Stat, St John, NF, Canada; [Coburn, Bryan] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Coburn, Bryan; Morris, Andrew] Sinai Hlth Syst, Dept Med, Toronto, ON, Canada; [Coburn, Bryan; Morris, Andrew] Univ Hlth Network, Toronto, ON, Canada; [Morris, Andrew] Univ Toronto, Dept Med, Toronto, ON, Canada; [Falk, Lindsey] Hlth Qual Ontario, Toronto, ON, Canada	York University - Canada; Toronto Metropolitan University; University of Toronto; Memorial University Newfoundland; Memorial University Newfoundland; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Wu, JH (corresponding author), York Univ, Ctr Dis Modelling, Toronto, ON, Canada.; Morris, A (corresponding author), Sinai Hlth Syst, Dept Med, Toronto, ON, Canada.; Morris, A (corresponding author), Univ Hlth Network, Toronto, ON, Canada.; Morris, A (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	Andrew.Morris@sinaihealthsystem.ca; wujh@yorku.ca	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; Coburn, Bryan/0000-0003-0150-4510; Hughes, Josie/0000-0001-7875-9015				Agodi A, 2007, INTENS CARE MED, V33, P1155, DOI 10.1007/s00134-007-0671-6; Alyaseen SA, 2005, ANTIMICROB AGENTS CH, V49, P2543, DOI 10.1128/AAC.49.6.2543-2545.2005; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; [Anonymous], 2001, PATHOL BIOL, V49, P620, DOI [10.1016/S0369-8114(01)00219-X, DOI 10.1016/S0369-8114(01)00219-X]; [Anonymous], 2016, CLIN INFECT DIS, DOI DOI 10.1093/cid/civ1199; Boyer A, 2011, CRIT CARE, V15, DOI 10.1186/cc10026; Braykov NP, 2014, LANCET INFECT DIS, V14, P1220, DOI 10.1016/S1473-3099(14)70952-1; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105454; Carnell R, 2016, LHS LATIN HYPERCUBE; Cobos-Trigueros N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0916-7; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Eagye KJ, 2009, SEMIN RESP CRIT CARE, V30, P116, DOI 10.1055/s-0028-1119815; Evans SR, 2015, CLIN INFECT DIS, V61, P800, DOI 10.1093/cid/civ495; Fournier D, 2013, J ANTIMICROB CHEMOTH, V68, P1772, DOI 10.1093/jac/dkt098; Garnacho-Montero J, 2015, CURR OPIN INFECT DIS, V28, P193, DOI 10.1097/QCO.0000000000000141; Gehring R, 2010, J THEOR BIOL, V262, P97, DOI 10.1016/j.jtbi.2009.09.002; Geli P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029838; Giantsou E, 2007, INTENS CARE MED, V33, P1533, DOI 10.1007/s00134-007-0619-x; Haber M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-254; Harper EB, 2011, ECOL APPL, V21, P1225, DOI 10.1890/10-0506.1; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249, DOI 10.1164/ajrccm.159.4.9807050; Hindler JF, 2007, CLIN INFECT DIS, V44, P867, DOI 10.1086/511864; Hughes JS, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012040; Hurford A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138216; Hurford A, 2012, EPIDEMICS-NETH, V4, P203, DOI 10.1016/j.epidem.2012.12.001; Jin-Hee Kim, 2012, International Journal of Photoenergy, DOI 10.1155/2012/957847; Kaye KS, 2012, J HOSP MED, V7, pS13, DOI 10.1002/jhm.983; Khasawneh FA, 2014, INFECTION, V42, P829, DOI 10.1007/s15010-014-0639-8; Kollef MH, 2006, CHEST, V129, P1210, DOI 10.1378/chest.129.5.1210; Kouyos RD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0566; Kouyos RD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001094; Lambert ML, 2011, LANCET INFECT DIS, V11, P30, DOI 10.1016/S1473-3099(10)70258-9; Leone M, 2014, INTENS CARE MED, V40, P1399, DOI 10.1007/s00134-014-3411-8; Llanes C, 2013, J ANTIMICROB CHEMOTH, V68, P1763, DOI 10.1093/jac/dkt115; MacLean RC, 2010, NAT REV GENET, V11, P405, DOI 10.1038/nrg2778; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Mokart D, 2014, INTENS CARE MED, V40, P41, DOI 10.1007/s00134-013-3148-9; Morita Y, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00422; Morris Andrew M, 2014, Curr Treat Options Infect Dis, V6, P101; Nichol D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004493; Obolski U, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004340; Opatowski L, 2011, CURR OPIN INFECT DIS, V24, P279, DOI 10.1097/QCO.0b013e3283462362; Owens RC, 2008, CLIN INFECT DIS, V46, pS19, DOI 10.1086/521859; Paskovaty A, 2015, INTENS CARE MED, V41, P2022, DOI 10.1007/s00134-015-4016-6; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Perron GG, 2012, APPL ENVIRON MICROB, V78, P6137, DOI 10.1128/AEM.01078-12; Poole K, 2014, CAN J MICROBIOL, V60, P783, DOI 10.1139/cjm-2014-0666; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Pujol G., 2015, SENSITIVITY SENSITIV; RADBERG G, 1990, ANTIMICROB AGENTS CH, V34, P2142, DOI 10.1128/AAC.34.11.2142; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Schumacher M, 2013, INT J EPIDEMIOL, V42, P1502, DOI 10.1093/ije/dyt111; Schwaber MJ, 2004, NAT REV MICROBIOL, V2, P979, DOI 10.1038/nrmicro1047; Shime N, 2013, INFECTION, V41, P203, DOI 10.1007/s15010-012-0388-5; Silva BNG, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007934.pub3; Slimings C, 2014, J ANTIMICROB CHEMOTH, V69, P881, DOI 10.1093/jac/dkt477; Smith DL, 2005, P NATL ACAD SCI USA, V102, P3153, DOI 10.1073/pnas.0409523102; Spicknall IH, 2013, AM J EPIDEMIOL, V178, P508, DOI 10.1093/aje/kwt017; Talaminos A, 2016, EPIDEMIOL INFECT, P1; Therneau T, 2015, RPART RECURSIVE PART; Thuong M, 2003, J HOSP INFECT, V53, P274, DOI 10.1053/jhin.2002.1370; Timsit JF, 2014, INTENS CARE MED, V40, P1580, DOI 10.1007/s00134-014-3485-3; Tumbarello M, 2013, INTENS CARE MED, V39, P682, DOI 10.1007/s00134-013-2828-9; U.S. Food and Drug Administration, 2016, FDA STRENGTH KIDN WA; van Kleef E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-294; Venier AG, 2014, J HOSP INFECT, V88, P103, DOI 10.1016/j.jhin.2014.06.018; WHO, 2011, WHO LIB CAT PUBL DAT; Wolkewitz M, 2008, STAT MED, V27, P6522, DOI 10.1002/sim.3419; Wolkewitz M, 2014, CRIT CARE, V18, DOI 10.1186/cc13821; Wolter DJ, 2007, ANTIMICROB AGENTS CH, V51, P2997, DOI 10.1128/AAC.00111-07; zur Wiesch PA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004225; [No title captured]	75	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171218	10.1371/journal.pone.0171218	http://dx.doi.org/10.1371/journal.pone.0171218			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182774	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800046
J	Kenmogne, LC; Roy, J; Maltais, R; Rouleau, M; Neveu, B; Pouliot, F; Poirier, D				Kenmogne, Lucie Carolle; Roy, Jenny; Maltais, Rene; Rouleau, Melanie; Neveu, Bertrand; Pouliot, Frederic; Poirier, Donald			Investigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17 beta-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor models	PLOS ONE			English	Article							ANDROGEN RECEPTOR; DIFFERENTIAL EXPRESSION; DIHYDROTESTOSTERONE; TESTOSTERONE; TARGET; GENE; ANDROSTANEDIOL; AMPLIFICATION; METABOLITES; MUTATIONS	In the fight against androgen-sensitive prostate cancer, the enzyme 17 beta-hydroxysteroid dehydrogenase type 3 (17 beta-HSD3) is an attractive therapeutic target considering its key role in the formation of androgenic steroids. In this study, we attempted to assess the in vivo efficacy of the compound RM-532-105, an androsterone derivative developed as an inhibitor of 17 beta-HSD3, in the prostate cancer model of androgen-sensitive LAPC-4 cells xenografted in nude mice. RM-532-105 did not inhibit the tumor growth induced by 4-androstene-3,17-dione (4-dione); rather, the levels of the androgens testosterone (T) and dihydrotestosterone (DHT) increased within the tumors. In plasma, however, DHT levels increased but T levels did not. In troubleshooting experiments, the non-androgenic potential of RM-532-105 was confirmed by two different assays (LAPC-4 proliferation and androgen receptor transcriptional activity assays). The enzyme 5 alpha-reductase was also revealed to be the predominant enzyme metabolizing 4-dione in LAPC-4 cells, yielding 5 alpha-androstane-3,17-dione and not T. Other 17 beta-HSDs than 17 beta-HSD3 seem responsible in the androgen synthesis. From experiments with LAPC-4 cells, we fortuitously came across the interesting finding that 17 beta-HSD3 inhibitor RM-532-105 is concentrated inside tumors.	[Kenmogne, Lucie Carolle; Roy, Jenny; Maltais, Rene; Poirier, Donald] CHU Quebec, Res Ctr, CHUL, Lab Med Chem,T4, Quebec City, PQ, Canada; [Rouleau, Melanie; Neveu, Bertrand; Pouliot, Frederic] CHU Quebec, Res Ctr, Axe Canc, Quebec City, PQ, Canada; [Pouliot, Frederic] Univ Laval, Fac Med, Dept Surg, Quebec City, PQ, Canada; [Poirier, Donald] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University	Poirier, D (corresponding author), CHU Quebec, Res Ctr, CHUL, Lab Med Chem,T4, Quebec City, PQ, Canada.; Poirier, D (corresponding author), Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ, Canada.	donald.poirier@crchul.ulaval.ca		Rouleau, Melanie/0000-0003-4154-3127; Pouliot, Frederic/0000-0002-6651-1079; Neveu, Bertrand/0000-0002-6505-6692	Canadian Institute of Health Research (POP-Phase I)	Canadian Institute of Health Research (POP-Phase I)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institute of Health Research (POP-Phase I). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman DR, 2006, MOL ENDOCRINOL, V20, P444, DOI 10.1210/me.2005-0287; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Chouinard S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703370200; Das K, 2010, ENDOCR-RELAT CANCER, V17, P757, DOI 10.1677/ERC-10-0022; Djigoue GB, 2015, BIOORGAN MED CHEM, V23, P5433, DOI 10.1016/j.bmc.2015.07.049; Endo S, 2016, BIOCHEM BIOPH RES CO, V472, P231, DOI 10.1016/j.bbrc.2016.01.190; Fenton MA, 1997, CLIN CANCER RES, V3, P1383; GADDIPATI JP, 1994, CANCER RES, V54, P2861; Hara T, 2003, CANCER RES, V63, P149; Ishizaki F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01528; Jain P, 2016, SCI REP-UK, V6, DOI 10.1038/srep33968; Kaisary AV, 1996, BRIT J HOSP MED, V55, P359; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Knuuttila M, 2014, AM J PATHOL, V184, P2163, DOI 10.1016/j.ajpath.2014.04.010; Koh E, 2002, PROSTATE, V53, P154, DOI 10.1002/pros.10139; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; LABRIE F, 1991, MOL CELL ENDOCRINOL, V78, pC113, DOI 10.1016/0303-7207(91)90116-A; Labrie F, 2006, J STEROID BIOCHEM, V99, P182, DOI 10.1016/j.jsbmb.2006.02.004; Labrie F, 2011, NAT REV UROL, V8, P73, DOI 10.1038/nrurol.2010.231; Laplante Y, 2008, STEROIDS, V73, P266, DOI 10.1016/j.steroids.2007.10.009; Luu-The V, 2008, BEST PRACT RES CL EN, V22, P207, DOI 10.1016/j.beem.2008.01.008; Maltais R, 2002, J MED CHEM, V45, P640, DOI 10.1021/jm010286y; Maltais R, 2011, BIOORGAN MED CHEM, V19, P4652, DOI 10.1016/j.bmc.2011.06.003; Mohler JL, 2011, CLIN CANCER RES, V17, P5844, DOI 10.1158/1078-0432.CCR-11-0644; Mohler JL, 2011, CANCER RES, V71, P1486, DOI 10.1158/0008-5472.CAN-10-1343; Mostaghel EA, 2013, TRANSL ANDROL UROL, V2, P212, DOI 10.3978/j.issn.2223-4683.2013.09.16; Neumann F, 1982, CLIN ONCOLOGY, V1, P41; Neveu B, 2016, ONCOTARGET, V7, P1300, DOI 10.18632/oncotarget.6360; Ngatcha BT, 2005, J MED CHEM, V48, P5257, DOI 10.1021/jm058179h; Penning TM, 2015, J STEROID BIOCHEM, V153, P105, DOI 10.1016/j.jsbmb.2015.05.010; Pouliot F, 2013, MOL THER, V21, P554, DOI 10.1038/mt.2012.259; RADWANSKI E, 1989, J CLIN PHARMACOL, V29, P554, DOI 10.1002/j.1552-4604.1989.tb03381.x; Roy J, 2014, J STEROID BIOCHEM, V141, P44, DOI 10.1016/j.jsbmb.2013.12.019; Sato M, 2005, CLIN CANCER RES, V11, P3743, DOI 10.1158/1078-0432.CCR-04-1990; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sobel RE, 2005, J UROLOGY, V173, P360, DOI 10.1097/01.ju.0000149989.01263.dc; Statistics CCSsACoC, 2015, CAN CANC STAT 2015; Taplin ME, 1999, CANCER RES, V59, P2511; Van LT, 2013, J STEROID BIOCHEM, V137, P176, DOI 10.1016/j.jsbmb.2013.05.017; Yin YRD, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00159	40	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171871	10.1371/journal.pone.0171871	http://dx.doi.org/10.1371/journal.pone.0171871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182747	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800129
J	Kinar, Y; Akiva, P; Choman, E; Kariv, R; Shalev, V; Levin, B; Narod, SA; Goshen, R				Kinar, Yaron; Akiva, Pinchas; Choman, Eran; Kariv, Revital; Shalev, Varda; Levin, Bernard; Narod, Steven A.; Goshen, Ran			Performance analysis of a machine learning flagging system used to identify a group of individuals at a high risk for colorectal cancer	PLOS ONE			English	Article								Individuals with colorectal cancer (CRC) have a tendency to intestinal bleeding which may result in mild to severe iron deficiency anemia, but for many colon cancer patients hematological abnormalities are subtle. The fecal occult blood test (FOBT) is used as a pre-screening test whereby those with a positive FOBT are referred to colonscopy. We sought to determine if information contained in the complete blood count (CBC) report coud be processed automatically and used to predict the presence of occult colorectal cancer (CRC) in the setting of a large health services plan. Using the health records of the Maccabi Health Services (MHS) we reviewed CBC reports for 112,584 study subjects of whom 133 were diagnosed with CRC in 2008 and analysed these with the MeScore tool. The odds ratio for being diagnosed with CRC in 2008 was calculated with regards to the MeScore, using cutoff levels of 97% and 99% percentiles. For individuals in the highest one percentile, the odds ratio for CRC was 21.8 (95% CI 13.8 to 34.2). For the majority of the individuals with cancer, CRC was not suspected at the time of the blood draw. Frequent use of anticoagulants, the presence of other gastrointestinal pathologies and non-GI malignancies were assocaitged with false positive MeScores. The MeScore can help identify individuals in the population who would benefit most from CRC screening, including those with no clinical signs or symptoms of CRC.	[Kinar, Yaron; Akiva, Pinchas] Medial Res, Kfar Malal, Israel; [Choman, Eran; Levin, Bernard; Goshen, Ran] Medial EarlySign, Kfar Malal, Israel; [Kariv, Revital] Souraski Med Ctr, Dept Gastroenterol, Tel Aviv, Israel; [Kariv, Revital] Tel Aviv Univ, Fac Med, Tel Aviv, Israel; [Shalev, Varda] Maccabi Healthcare Serv, Inst Hlth Res & Innovat, Tel Aviv, Israel; [Narod, Steven A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Narod, Steven A.] Womens Coll, Res Inst, Toronto, ON, Canada	Tel Aviv University; University of Toronto; University of Toronto; Women's College Research Institute	Goshen, R (corresponding author), Medial EarlySign, Kfar Malal, Israel.	ran@earlysign.com	Narod, Steven A/AAA-6112-2022		Medial Research	Medial Research	The study was funded by Medial Research. Thefunder (Medial) provided support in the form of salaries for authors RG, YK, BL, PA and EC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Guillem-Llobat P, 2014, SEMIN ONCOL, V41, P385, DOI 10.1053/j.seminoncol.2014.04.008; Kershenbaum A, 2013, EUR J CANCER, V49, P923, DOI 10.1016/j.ejca.2012.09.020; Kinar Y, 2016, J AM MED INFORM ASSN, V23, P879, DOI 10.1093/jamia/ocv195; ROCKEY DC, 1993, NEW ENGL J MED, V329, P1691, DOI 10.1056/NEJM199312023292303; Rossi PG, 2015, AM J GASTROENTEROL, V110, P1359, DOI 10.1038/ajg.2015.240; Seretis C, 2015, PLATELETS, V26, P114, DOI 10.3109/09537104.2014.894969	9	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171759	10.1371/journal.pone.0171759	http://dx.doi.org/10.1371/journal.pone.0171759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182647	Green Submitted, gold, Green Published			2022-12-26	WOS:000394231800103
J	Stott, SRW; Hayat, S; Carnwath, T; Garas, S; Sleeman, JP; Barker, RA				Stott, Simon R. W.; Hayat, Shaista; Carnwath, Tom; Garas, Shaady; Sleeman, Jonathan P.; Barker, Roger A.			CD24 expression does not affect dopamine neuronal survival in a mouse model of Parkinson's disease	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HEAT-STABLE ANTIGEN; VENTRAL TEGMENTAL AREA; CENTRAL-NERVOUS-SYSTEM; SUBSTANTIA-NIGRA; RAT MODEL; MULTIPLE-SCLEROSIS; NEURITE OUTGROWTH; GENE-EXPRESSION; ALPHA-SYNUCLEIN	Parkinson's disease (PD) is a progressive neurodegenerative condition that is characterised by the loss of specific populations of neurons in the brain. The mechanisms underlying this selective cell death are unknown but by using laser capture microdissection, the glycoprotein, CD24 has been identified as a potential marker of the populations of cells that are affected in PD. Using in situ hybridization and immunohistochemistry on sections of mouse brain, we confirmed that CD24 is robustly expressed by many of these subsets of cells. To determine if CD24 may have a functional role in PD, we modelled the dopamine cell loss of PD in Cd24 mutant mice using striatal delivery of the neurotoxin 6-OHDA. We found that Cd24 mutant mice have an anatomically normal dopamine system and that this glycoprotein does not modulate the lesion effects of 6-OHDA delivered into the striatum. We then undertook in situ hybridization studies on sections of human brain and found-as in the mouse brain-that CD24 is expressed by many of the subsets of the cells that are vulnerable in PD, but not those of the midbrain dopamine system. Finally, we sought to determine if CD24 is required for the neuroprotective effect of Glial cell-derived neurotrophic factor (GDNF) on the dopaminergic nigrostriatal pathway. Our results indicate that in the absence of CD24, there is a reduction in the protective effects of GDNF on the dopaminergic fibres in the striatum, but no difference in the survival of the cell bodies in the midbrain. While we found no obvious role for CD24 in the normal development and maintenance of the dopaminergic nigrostriatal system in mice, it may have a role in mediating the neuroprotective aspects of GDNF in this system.	[Stott, Simon R. W.; Hayat, Shaista; Carnwath, Tom; Garas, Shaady; Barker, Roger A.] John Van Geest Ctr Brain Repair, ED Adrian Bldg,Forvie Site,Robinson Way, Cambridge, England; [Sleeman, Jonathan P.] Heidelberg Univ, Med Fac Mannheim, Mannheim, Germany; [Sleeman, Jonathan P.] Karlsruhe Inst Technol, Inst Toxicol & Genet, Karlsruhe, Germany; [Barker, Roger A.] Wellcome Trust MRC Stem Cell Inst, Cambridge, England	University of Cambridge; Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology	Stott, SRW (corresponding author), John Van Geest Ctr Brain Repair, ED Adrian Bldg,Forvie Site,Robinson Way, Cambridge, England.	ss2060@cam.ac.uk	Sleeman, Jonathan P/H-2515-2013	Sleeman, Jonathan P/0000-0003-1718-7687; Barker, Roger Alistair/0000-0001-8843-7730; Stott, Simon/0000-0002-5741-4664	Parkinson's UK Innovation grant; Cure Parkinsons's trust grant; DDPDGENES (FP7-HEALTH) [278871]; DDPDGENES; Klinikum Mannheim gGmbH; NIHR Biomedical Research Centre; UKRMP PSP hub; Parkinson's UK; Cambridge Brain Bank - NIHR Cambridge Biomedical Research Centre; charity registered in England; charity registered in Wales [258197]; charity registered in Scotland [SC037554]; Medical Research Council [MC_PC_12009] Funding Source: researchfish; National Institute for Health Research [NF-SI-0616-10011] Funding Source: researchfish; Parkinson&quot;s UK [K-1011] Funding Source: researchfish	Parkinson's UK Innovation grant; Cure Parkinsons's trust grant; DDPDGENES (FP7-HEALTH); DDPDGENES; Klinikum Mannheim gGmbH; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); UKRMP PSP hub; Parkinson's UK(Parkinson's UK); Cambridge Brain Bank - NIHR Cambridge Biomedical Research Centre; charity registered in England; charity registered in Wales; charity registered in Scotland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK)	SRWS was funded by a Parkinson's UK Innovation grant (https://www.parkinsons.org.uk/); Cure Parkinsons's trust grant (https://www.cureparkinsons.org.uk/); and DDPDGENES (FP7-HEALTH #278871; http://cordis.europa.eu/project/rcn/101801_en.html). SH was also funded by DDPDGENES. TC & SG received no specific funding for this work (summer interns). JPS was funded by the Klinikum Mannheim gGmbH. RAB was funded by the NIHR Biomedical Research Centre and also receives funding from the UKRMP PSP hub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Leigh-Anne McDuffus, Dr Julia Jones and Dr Will Howat at the Histopathology/ISH facility, Cambridge Research Institute for the scanning of DAB stained slides and technical support with the in situ hybridization work. The authors would like to thank Dr Kieren Allinson of the Cambridge Brain Bank for help with the neuroanatomy of human brain sections. Tissue samples, associated clinical and neuropathological data were supplied by the Parkinson's UK Brain Bank, funded by Parkinson's UK, a charity registered in England and Wales (258197) and in Scotland (SC037554), and by the Cambridge Brain Bank which is supported by the NIHR Cambridge Biomedical Research Centre. The authors would also like to thank Prof Anders Bjorklund (Lund University) for supplying the AAV-GDNF virus used in this study. And finally, the authors would like to thank Dr Wei-Li Kuan for constructive feedback on the manuscript.	Alvarez-Fischer D, 2008, EXP NEUROL, V210, P182, DOI 10.1016/j.expneurol.2007.10.012; Bai XF, 2004, J EXP MED, V200, P447, DOI 10.1084/jem.20040131; Bai XF, 2000, J CLIN INVEST, V105, P1227, DOI 10.1172/JCI9012; BRAAK H, 1994, ACTA NEUROPATHOL, V88, P493, DOI 10.1007/BF00296485; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Breysse N, 2007, J NEUROSCI, V27, P5849, DOI 10.1523/JNEUROSCI.0626-07.2007; Brichta L, 2015, NAT NEUROSCI, V18, P1325, DOI 10.1038/nn.4070; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Carlsson T, 2007, J NEUROSCI, V27, P8011, DOI 10.1523/JNEUROSCI.2079-07.2007; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Christophersen NS, 2007, EXP NEUROL, V204, P791, DOI 10.1016/j.expneurol.2007.01.014; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; DANIEL SE, 1992, LANCET, V340, P186, DOI 10.1016/0140-6736(92)93275-R; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; Decressac M, 2012, NEUROBIOL DIS, V45, P939, DOI 10.1016/j.nbd.2011.12.013; Decressac M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004676; Del Tredici K, 2012, MOVEMENT DISORD, V27, P597, DOI 10.1002/mds.24921; Diaz-Gallo LM, 2011, HUM IMMUNOL, V72, P969, DOI 10.1016/j.humimm.2011.05.028; Engler H, 2009, BRAIN BEHAV IMMUN, V23, P518, DOI 10.1016/j.bbi.2009.01.018; Fang XF, 2010, CELL MOL IMMUNOL, V7, P100, DOI 10.1038/cmi.2009.119; Gao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062456; GOTO S, 1991, ANN NEUROL, V30, P192, DOI 10.1002/ana.410300211; Guillery RW, 1997, J COMP NEUROL, V386, P2, DOI 10.1002/(SICI)1096-9861(19970915)386:1<2::AID-CNE2>3.0.CO;2-6; Jacobs FMJ, 2007, DEVELOPMENT, V134, P2673, DOI 10.1242/dev.02865; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; JAVOYAGID F, 1980, NEUROLOGY, V30, P1326, DOI 10.1212/WNL.30.12.1326; JELLINGER K, 1988, J NEUROL NEUROSUR PS, V51, P540, DOI 10.1136/jnnp.51.4.540; JEON BS, 1995, NEURODEGENERATION, V4, P131, DOI 10.1006/neur.1995.0016; Jevsek M, 2006, P NATL ACAD SCI USA, V103, P6374, DOI 10.1073/pnas.0601468103; Kirik D, 2001, J NEUROSCI, V21, P2889, DOI 10.1523/JNEUROSCI.21-08-02889.2001; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Kollaee A, 2011, INT J NEUROSCI, V121, P684, DOI 10.3109/00207454.2011.610529; Lewandowski NM, 2010, P NATL ACAD SCI USA, V107, P16970, DOI 10.1073/pnas.1011751107; Liu JQ, 2007, J IMMUNOL, V178, P6227, DOI 10.4049/jimmunol.178.10.6227; Liu Y, 1997, J EXP MED, V185, P251, DOI 10.1084/jem.185.2.251; LIU Y, 1992, EUR J IMMUNOL, V22, P2855, DOI 10.1002/eji.1830221115; Lundblad M, 2004, NEUROBIOL DIS, V16, P110, DOI 10.1016/j.nbd.2004.01.007; Manfredsson FP, 2009, MOL THER, V17, P980, DOI 10.1038/mt.2009.45; McClung CA, 2005, J NEUROSCI, V25, P6005, DOI 10.1523/JNEUROSCI.0062-05.2005; McRitchie DA, 1997, EXP NEUROL, V144, P202, DOI 10.1006/exnr.1997.6418; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Nielsen PJ, 1997, BLOOD, V89, P1058, DOI 10.1182/blood.V89.3.1058; Pandey V, 2010, TRANSL ONCOL, V3, P218, DOI 10.1593/tlo.09325; Reyes S, 2013, NEUROBIOL AGING, V34, P873, DOI 10.1016/j.neurobiolaging.2012.07.019; Sanchez E, 2007, ARTHRITIS RHEUM, V56, P3080, DOI 10.1002/art.22871; Schack LM, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1319578; Shewan D, 1996, J NEUROSCI, V16, P2624; Stott SRW, 2014, EUR J NEUROSCI, V39, P1042, DOI 10.1111/ejn.12459; Stott SRW, 2013, J NEUROSCI, V33, P8022, DOI 10.1523/JNEUROSCI.4774-12.2013; Thompson L, 2005, J NEUROSCI, V25, P6467, DOI 10.1523/JNEUROSCI.1676-05.2005; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Wu Y, 1998, J EXP MED, V187, P1151, DOI 10.1084/jem.187.7.1151; Zhou QM, 2003, P NATL ACAD SCI USA, V100, P15041, DOI 10.1073/pnas.2533866100	56	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171748	10.1371/journal.pone.0171748	http://dx.doi.org/10.1371/journal.pone.0171748			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182766	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800098
J	Kim, SS; Shin, N; Bae, SS; Lee, MY; Rhee, H; Kim, IY; Seong, EY; Lee, DW; Lee, SB; Kwak, IS; Lovett, DH; Song, SH				Kim, Sang Soo; Shin, Nari; Bae, Sun Sik; Lee, Min Young; Rhee, Harin; Kim, Il Young; Seong, Eun Young; Lee, Dong Won; Lee, Soo Bong; Kwak, Ihm Soo; Lovett, David H.; Song, Sang Heon			Enhanced expression of two discrete isoforms of matrix metalloproteinase-2 in experimental and human diabetic nephropathy	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE KIDNEY INJURY; OXIDATIVE STRESS; INHIBITION	Background We recently reported on the enhanced expression of two isoforms of matrix metalloproteinase-2 (MMP-2) in human renal transplantation delayed graft function. These consist of the conventional secreted, full length MMP-2 isoform (FL-MMP-2) and a novel intracellular N Terminal Truncated isoform (NTT-MMP-2) generated by oxidative stress-mediated activation of an alternate promoter in the MMP-2 first intron. Here we evaluated the effect of hyperglycemia and diabetes mellitus on the in vitro and in vivo expression of the two MMP-2 isoforms. Methods We quantified the abundance of the FL-MMP-2 and NTT-MMP-2 transcripts by qPCR in HK2 cells cultured in high glucose or 4-hydroxy-2-hexenal (HHE) and tested the effects of the NF-kB inhibitor pyrrolidine dithiocarbamate (PDTC). The streptozotocin (STZ) murine model of Type I diabetes mellitus and renal biopsies of human diabetic nephropathy were used in this study. Results Both isoforms of MMP-2 in HK2 cells were upregulated by culture in high glucose or with HHE. PDTC treatment did not suppress high glucose -mediated FL-MMP-2 expression but potently inhibited NTT-MMP-2 expression. With STZ-treated mice, renal cortical expression of both isoforms was increased (FL-MMP-2, 1.8-fold; NTT-MMP-2, greater than 7-fold). Isoform-specific immunohistochemical staining revealed low, but detectable levels of the FL-MMP-2 isoform in controls, while NTT-MMP-2 was not detected. While there was a modest increase in tubular epithelial cell staining for FL-MMP-2 in STZ-treated mice, NTT-MMP-2 was intensely expressed in a basolateral pattern. FL-MMP-2 and NTT-MMP-2 isoform expression as quantified by qPCR were both significantly elevated in renal biopsies of human diabetic nephropathy (12 -fold and 3 -fold, respectively). Conclusions The expression of both isoforms of MMP-2 was enhanced in an experimental model of diabetic nephropathy and in human diabetic nephropathy. Selective MMP-2 isoform inhibition could offer a novel approach for the treatment of diabetic renal disease.	[Kim, Sang Soo; Lee, Min Young; Rhee, Harin; Seong, Eun Young; Kwak, Ihm Soo; Song, Sang Heon] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Kim, Sang Soo; Lee, Min Young; Rhee, Harin; Seong, Eun Young; Kwak, Ihm Soo; Song, Sang Heon] Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea; [Shin, Nari] Pusan Natl Univ, Dept Pathol, Yangsan Hosp, Yangsan, Gyeongnam, South Korea; [Bae, Sun Sik] Pusan Natl Univ, Sch Med, MRC Ischem Tissue Regenerat, Med Res Inst, Yangsan, South Korea; [Bae, Sun Sik] Pusan Natl Univ, Sch Med, Dept Phamacol, Yangsan, South Korea; [Kim, Il Young; Lee, Dong Won; Lee, Soo Bong] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, Gyeongnam, South Korea; [Kim, Il Young; Lee, Dong Won; Lee, Soo Bong] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Yangsan, Gyeongnam, South Korea; [Lovett, David H.] Univ Calif San Francisco, San Francisco Dept Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94143 USA	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; University of California System; University of California San Francisco	Song, SH (corresponding author), Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.; Song, SH (corresponding author), Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea.	shsong0209@gmail.com	Kim, Il Young/ABG-2156-2021; Kim, Il Young/ABG-2153-2021	Kim, Il Young/0000-0002-1731-6357; Kim, Sang Soo/0000-0002-9687-8357	Biomedical Research Institute Grant [2015-3]; Pusan National University Hospital; Department of Veterans Affairs Merit Review [I-1BX000593]; National Institutes of Diabetes, Digestive and Kidney Disease [R01DK39776]	Biomedical Research Institute Grant; Pusan National University Hospital(Pusan National University); Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); National Institutes of Diabetes, Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Biomedical Research Institute Grant (2015-3), Pusan National University Hospital (www.pnuh.co.kr). The bio-specimens and data used for this study were provided by the Biobank of Pusan National University Hospital, a member of the Korean Biobank Network. DHL was supported by Department of Veterans Affairs Merit Review Award I-1BX000593 and National Institutes of Diabetes, Digestive and Kidney Disease grant R01DK39776. DHL's contributions are the result of work supported with the resources and the use of facilities at the San Francisco VA Medical Center.	Alfonso-Jaume MA, 2006, AM J PHYSIOL-HEART C, V291, pH1838, DOI 10.1152/ajpheart.00026.2006; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chang CM, 2012, ACTA DIABETOL, V49, pS171, DOI 10.1007/s00592-012-0398-x; Cheng SF, 2003, AM J PATHOL, V162, P1937, DOI 10.1016/S0002-9440(10)64327-1; Cheng S, 2006, FASEB J, V20, P1898, DOI 10.1096/fj.06-5898fje; Dejonckheere E, 2011, DRUG DISCOV TODAY, V16, P762, DOI 10.1016/j.drudis.2011.06.009; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; Kunugi S, 2011, LAB INVEST, V91, P170, DOI 10.1038/labinvest.2010.174; Lovett DH, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00363; Lovett DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068154; Lovett DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034177; Mertens PR, 1998, J BIOL CHEM, V273, P32957, DOI 10.1074/jbc.273.49.32957; Mertens PR, 2002, J BIOL CHEM, V277, P24875, DOI 10.1074/jbc.M200445200; Novak KB, 2010, PEDIATR RES, V67, P257, DOI 10.1203/PDR.0b013e3181ca0aa2; Peng JP, 2015, KIDNEY INT, V87, P137, DOI 10.1038/ki.2014.226; Wanga S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136276; Xu X, 2014, CURR MED CHEM, V21, P3244, DOI 10.2174/0929867321666140716092052	19	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171625	10.1371/journal.pone.0171625	http://dx.doi.org/10.1371/journal.pone.0171625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178341	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500054
J	Luz, LL; Currie, SP; Daw, MI				Luz, Liliana L.; Currie, Stephen P.; Daw, Michael I.			Alterations in the properties of neonatal thalamocortical synapses with time in in vitro slices	PLOS ONE			English	Article							NASCENT DENDRITIC SPINES; BARREL CORTEX; DEPENDENT PLASTICITY; NEUROTROPHIC FACTOR; KAINATE RECEPTOR; VIVO; INHIBITION; MATURATION; NEOCORTEX; STABILIZATION	New synapses are constantly being generated and lost in the living brain with only a subset of these being stabilized to form an enduring component of neuronal circuitry. The properties of synaptic transmission have primarily been established in a variety of in vitro neuronal preparations. It is not clear, however, if newly-formed and persistent synapses contribute to the results of these studies consistently throughout the lifespan of these preparations. In neonatal somatosensory, barrel, cortex we have previously hypothesized that a population of thalamocortical synapses displaying unusually slow kinetics represent newly-formed, default-transient synapses. This clear phenotype would provide an ideal tool to investigate if such newly formed synapses consistently contribute to synaptic transmission throughout a normal experimental protocol. We show that the proportion of synapses recorded in vitro displaying slow kinetics decreases with time after brain slice preparation. However, slow synapses persist in vitro in the presence of either minocycline, an inhibitor of microglia-mediated synapse elimination, or the TrkB agonist 7,8-dihydroxyflavone a promoter of synapse formation. These findings show that the observed properties of synaptic transmission may systematically change with time in vitro in a standard brain slice preparation.	[Luz, Liliana L.; Currie, Stephen P.; Daw, Michael I.] Univ Edinburgh, Ctr Integrat Physiol, George Sq, Edinburgh, Midlothian, Scotland; [Luz, Liliana L.] Univ Porto, Inst Mol & Cell Biol IBMC, Inst Res & Innovat Hlth I3S, Oporto, Portugal	University of Edinburgh; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto	Daw, MI (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, George Sq, Edinburgh, Midlothian, Scotland.	michael.daw@ed.ac.uk	Luz, Liliana L/A-4208-2019	Luz, Liliana L/0000-0001-8109-3891; Daw, Michael/0000-0002-8374-5977; Currie, Stephen/0000-0002-6994-1568	UK Medical Research Council [G0900461/1]; MRC [G0900461] Funding Source: UKRI; Medical Research Council [G0900461] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded in full by the UK Medical Research Council (grant no G0900461/1 (http://www.mrc.ac.uk/?nav=main)). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Ashby MC, 2011, NEURON, V70, P510, DOI 10.1016/j.neuron.2011.02.057; Bannister NJ, 2005, J NEUROSCI, V25, P5259, DOI 10.1523/JNEUROSCI.0827-05.2005; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Bruno RM, 2002, J NEUROSCI, V22, P10966; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Crocker-Buque A, 2015, CEREB CORTEX, V25, P2255, DOI 10.1093/cercor/bhu031; Daw MI, 2006, J NEUROSCI, V26, P4178, DOI 10.1523/JNEUROSCI.0150-06.2006; Daw MI, 2007, NAT NEUROSCI, V10, P453, DOI 10.1038/nn1866; De Roo M, 2008, CEREB CORTEX, V18, P151, DOI 10.1093/cercor/bhm041; Dziembowska M, 2013, AM J MED GENET A, V161, P1897, DOI 10.1002/ajmg.a.36023; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Hill TC, 2013, J NEUROSCI, V33, P678, DOI 10.1523/JNEUROSCI.1404-12.2013; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Hoshiko M, 2012, J NEUROSCI, V32, P15106, DOI 10.1523/JNEUROSCI.1167-12.2012; Je HS, 2012, P NATL ACAD SCI USA, V109, P15924, DOI 10.1073/pnas.1207767109; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kidd FL, 2002, NEURON, V34, P635, DOI 10.1016/S0896-6273(02)00699-2; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Kirov SA, 1999, J NEUROSCI, V19, P2876; Koyama R, 2015, NEUROSCI RES, V100, P1, DOI 10.1016/j.neures.2015.06.005; Le Be JV, 2006, P NATL ACAD SCI USA, V103, P13214, DOI 10.1073/pnas.0604691103; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maximo JO, 2014, NEUROPSYCHOL REV, V24, P16, DOI 10.1007/s11065-014-9250-0; Nicolescu AC, 2009, BIOCHEM BIOPH RES CO, V387, P646, DOI 10.1016/j.bbrc.2009.07.080; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Sajikumar S, 2005, CURR OPIN NEUROBIOL, V15, P607, DOI 10.1016/j.conb.2005.08.009; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; SCHURR A, 1984, BRAIN RES, V297, P357, DOI 10.1016/0006-8993(84)90576-6; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171897	10.1371/journal.pone.0171897	http://dx.doi.org/10.1371/journal.pone.0171897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178342	Green Submitted, gold, Green Published			2022-12-26	WOS:000393712500077
J	Schrapers, P; Ilina, J; Gregg, CM; Mebs, S; Jeoung, JH; Dau, H; Dobbek, H; Haumann, M				Schrapers, Peer; Ilina, Julia; Gregg, Christina M.; Mebs, Stefan; Jeoung, Jae-Hun; Dau, Holger; Dobbek, Holger; Haumann, Michael			Ligand binding at the A-cluster in full-length or truncated acetyl-CoA synthase studied by X-ray absorption spectroscopy	PLOS ONE			English	Article							CARBON-MONOXIDE DEHYDROGENASES; COENZYME-A; METHANOSARCINA-THERMOPHILA; DECARBONYLASE/SYNTHASE COMPLEX; CRYSTAL-STRUCTURE; SITE STRUCTURE; METAL CENTERS; SUBUNIT-BETA; IRON-SULFUR; MECHANISM	Bacteria integrate CO2 reduction and acetyl coenzyme-A (CoA) synthesis in the WoodLjungdal pathway. The acetyl-CoA synthase (ACS) active site is a [4Fe4S]-[NiNi] complex (A-cluster). The dinickel site structure (with proximal, p, and distal, d, ions) was studied by X-ray absorption spectroscopy in ACS variants comprising all three protein domains or only the C-terminal domain with the A-cluster. Both variants showed two square-planar Ni(II) sites and an OH- bound at Ni(II)(p) in oxidized enzyme and a H2O at Ni(l)(p) in reduced enzyme; a Ni (l)p-CO species was induced by CO incubation and a Ni(II)-CH3- species with an additional water ligand by a methyl group donor. These findings render a direct effect of the N-terminal and middle domains on the A-cluster structure unlikely.	[Schrapers, Peer; Mebs, Stefan; Dau, Holger; Haumann, Michael] Free Univ Berlin, Dept Phys, Berlin, Germany; [Ilina, Julia; Gregg, Christina M.; Jeoung, Jae-Hun; Dobbek, Holger] Humboldt Univ, Inst Biol Struct Biol Biochem, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin	Haumann, M (corresponding author), Free Univ Berlin, Dept Phys, Berlin, Germany.	michael.haumann@fu-berlin.de	MIchael, Haumann/A-7087-2013	Gregg, Christina/0000-0003-4440-4624	Deutsche Forschungsgemeinschaft, Berlin Cluster of Excellence "Unifying Concepts in Catalysis"; Bundesministerium fur Bildung and Forschung, PT-DESY [05K14KE1]	Deutsche Forschungsgemeinschaft, Berlin Cluster of Excellence "Unifying Concepts in Catalysis"; Bundesministerium fur Bildung and Forschung, PT-DESY	This work was supported by Deutsche Forschungsgemeinschaft, Berlin Cluster of Excellence "Unifying Concepts in Catalysis", hftps:// www.unicat.tu-berlin.de; and Bundesministerium fur Bildung and Forschung, PT-DESY, 05K14KE1, https//pt.desy.de.	Amara P, 2005, J AM CHEM SOC, V127, P2776, DOI 10.1021/ja0439221; Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Bachmeier A, 2015, CURR OPIN CHEM BIOL, V25, P141, DOI 10.1016/j.cbpa.2015.01.001; Bender G, 2011, METALLOMICS, V3, P797, DOI 10.1039/c1mt00042j; Bender G, 2010, BIOCHEMISTRY-US, V49, P7516, DOI 10.1021/bi1010128; Burgdorf T, 2005, J AM CHEM SOC, V127, P576, DOI 10.1021/ja0461926; Can M, 2014, CHEM REV, V114, P4149, DOI 10.1021/cr400461p; Darnault C, 2003, NAT STRUCT BIOL, V10, P271, DOI 10.1038/nsb912; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Doukov TI, 2008, BIOCHEMISTRY-US, V47, P3474, DOI 10.1021/bi702386t; Evans DJ, 2005, COORDIN CHEM REV, V249, P1582, DOI 10.1016/j.ccr.2004.09.012; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Funk T, 2004, J AM CHEM SOC, V126, P88, DOI 10.1021/ja0366033; Gencic S, 2010, J BIOL CHEM, V285, P15450, DOI 10.1074/jbc.M109.080994; George SJ, 2005, J AM CHEM SOC, V127, P13500, DOI 10.1021/ja0528329; Goetzl S, 2014, THESIS; Greco C, 2015, CHEM COMMUN, V51, P8551, DOI 10.1039/c5cc01575h; Gu WW, 2015, J SYNCHROTRON RADIAT, V22, P124, DOI 10.1107/S1600577514025041; Gu WW, 2003, J AM CHEM SOC, V125, P15343, DOI 10.1021/ja036602a; Gu WW, 2003, J INORG BIOCHEM, V93, P41, DOI 10.1016/S0162-0134(02)00494-4; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hegg EL, 2004, ACCOUNTS CHEM RES, V37, P775, DOI 10.1021/ar040002e; Jeoung JH, 2007, SCIENCE, V318, P1461, DOI 10.1126/science.1148481; Jeoung JH, 2014, METAL IONS LIFE SCI, V14, P37, DOI 10.1007/978-94-017-9269-1_3; Jeoung JH, 2014, BIOL CHEM, V395, P545, DOI 10.1515/hsz-2013-0290; Klockenkamper R., 1996, TOTAL REFLECTION XRA; Koningsberger D.C., 1988, XRAY ABSORPTION PRIN; Kung Y, 2011, CURR OPIN CHEM BIOL, V15, P276, DOI 10.1016/j.cbpa.2010.11.005; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Lindahl PA, 2004, J BIOL INORG CHEM, V9, P516, DOI 10.1007/s00775-004-0564-x; Loscher S, 2007, INORG CHEM, V46, P11094, DOI 10.1021/ic701255p; Ottenwaelder X, 2005, DALTON T, P2516, DOI 10.1039/b502478a; Ragsdale SW, 2006, CHEM REV, V106, P3317, DOI 10.1021/cr0503153; Ragsdale SW, 2012, BIOCHEM SOC T, V40, P501, DOI 10.1042/BST20120083; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; RAGSDALE SW, 1987, J BIOL CHEM, V262, P14289; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Rehr JJ, 2010, PHYS CHEM CHEM PHYS, V12, P5503, DOI 10.1039/b926434e; Russell WK, 1998, J AM CHEM SOC, V120, P7502, DOI 10.1021/ja981165z; Schrapers P, 2016, J PHYS CONF SER, V712, DOI 10.1088/1742-6596/712/1/012029; Schrapers P, 2016, PLOSONE; Schuth N, 2016, J PHYS CONF SER, V712, DOI 10.1088/1742-6596/712/1/012134; Seravalli J, 2004, BIOCHEMISTRY-US, V43, P3944, DOI 10.1021/bi036194n; Sigfridsson KGV, 2015, BBA-BIOENERGETICS, V1847, P162, DOI 10.1016/j.bbabio.2014.06.011; Svetlitchnyi V, 2004, P NATL ACAD SCI USA, V101, P446, DOI 10.1073/pnas.0304262101; Tan X, 2008, J AM CHEM SOC, V130, P6712, DOI 10.1021/ja801981h; Tan XS, 2004, J AM CHEM SOC, V126, P5954, DOI 10.1021/ja039600z; Volbeda A, 2009, BIOCHEMISTRY-US, V48, P7916, DOI 10.1021/bi9003952; Wang VCC, 2014, METAL IONS LIFE SCI, V14, P71, DOI 10.1007/978-94-017-9269-1_4	49	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171039	10.1371/journal.pone.0171039	http://dx.doi.org/10.1371/journal.pone.0171039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178309	Green Published, Green Submitted, gold			2022-12-26	WOS:000393712500020
J	Sabe, VT; Basson, AR; Jordaan, E; Mazinu, M				Sabe, Victor Tinashe; Basson, Abigail Raffner; Jordaan, Esme; Mazinu, Mikateko			The association between environmental exposures during childhood and the subsequent development of Crohn's disease: A score analysis approach	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; RISK-FACTORS; HYGIENE HYPOTHESIS; ULCERATIVE-COLITIS; PATHOGENESIS; POPULATION; MICROBIOME; PREVALENCE; MECHANISMS; MUTATIONS	Background Environmental factors during childhood are thought to play a role in the aetiology of Crohn's Disease (CD). In South Africa, recently published work based on an investigation of 14 childhood environmental exposures during 3 age intervals (0-5, 6-10 and 11-18 years) has provided insight into the role of timing of exposure in the future development of CD. The `overlapping' contribution of the investigated variables however, remains unclear. The aim of this study was to perform a post hoc analysis using this data and investigate the extent to which each variable contributes to the subsequent development of CD relative to each aforementioned age interval, based on a score analysis approach. Methods Three methods were used for the score analysis. Two methods employed the subgrouping of one or more (similar) variables (methods A and B), with each subgroup assigned a score value weighting equal to one. For comparison, the third approach (method 0) involved no grouping of the 14 variables. Thus, each variable held a score value of one. Results Results of the score analysis (Method 0) for the environmental exposures during 3 age intervals (0-5, 6-10 and 11-18 years) revealed no significant difference between the case and control groups. By contrast, results from Method A and Method B revealed a significant difference during all 3 age intervals between the case and control groups, with cases having significantly lower exposure scores (approximately 30% and 40% lower, respectively). Conclusion Results from the score analysis provide insight into the `compound' effects from multiple environmental exposures in the aetiology of CD.	[Sabe, Victor Tinashe; Basson, Abigail Raffner] Univ Western Cape, Med BioSci Dept, Bellville, Western Cape, South Africa; [Basson, Abigail Raffner] Case Western Reserve Univ, Sch Med, Div Gastroenterol & Liver Dis, Cominelli Lab, Cleveland, OH USA; [Jordaan, Esme; Mazinu, Mikateko] Med Res Council South Africa, Biostat Unit, Parow, Western Cape, South Africa; [Mazinu, Mikateko] Univ Western Cape, Populat Studies Dept, Bellville, Western Cape, South Africa	University of the Western Cape; Case Western Reserve University; University of the Western Cape	Sabe, VT (corresponding author), Univ Western Cape, Med BioSci Dept, Bellville, Western Cape, South Africa.	vt.sabe@gmail.com		Basson, Abigail/0000-0002-8369-919X	Scholarship in Gastroenterology; AstraZeneca/South African Gastroenterology Society (SAGES); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097948, T32DK083251] Funding Source: NIH RePORTER	Scholarship in Gastroenterology; AstraZeneca/South African Gastroenterology Society (SAGES); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the 2011 Scholarship in Gastroenterology; a grant from the AstraZeneca/South African Gastroenterology Society (SAGES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2014, AM J GASTROENTEROL, V109, P395, DOI 10.1038/ajg.2013.464; Basson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115492; Basson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104859; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P993, DOI 10.1111/j.1572-0241.2006.00381.x; Biswas A, 2012, J MOL MED, V90, P15, DOI 10.1007/s00109-011-0802-y; Castiglione F, 2012, J CROHNS COLITIS, V6, P324, DOI 10.1016/j.crohns.2011.09.003; Chamberlin WM, 2006, MED SCI MONITOR, V12, pRA27; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Danese S, 2004, AUTOIMMUN REV, V3, P394, DOI 10.1016/j.autrev.2004.03.002; De Hertogh G, 2008, WORLD J GASTROENTERO, V14, P845, DOI 10.3748/wjg.14.845; Epstein D, 2007, ALIMENT PHARM THER, V25, P1373, DOI 10.1111/j.1365-2036.2007.03332.x; Foster A, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00034; Gearry RB, 2010, J GASTROEN HEPATOL, V25, P325, DOI 10.1111/j.1440-1746.2009.06140.x; Guarner F, 2006, NAT CLIN PRACT GASTR, V3, P275, DOI 10.1038/ncpgasthep0471; Guo AY, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0216-8; Hampe J, 2003, INT J COLORECTAL DIS, V18, P413, DOI 10.1007/s00384-003-0484-1; Han DY, 2010, MUTAT RES-FUND MOL M, V690, P116, DOI 10.1016/j.mrfmmm.2009.09.002; Hansen TS, 2011, J CROHNS COLITIS, V5, P577, DOI 10.1016/j.crohns.2011.05.010; Hildebrand H, 2008, SCAND J GASTROENTERO, V43, P961, DOI 10.1080/00365520801971736; Hlavaty T, 2013, UNITED EUR GASTROENT, V1, P109, DOI 10.1177/2050640613478011; Hugot JP, 2007, AM J GASTROENTEROL, V102, P1259, DOI 10.1111/j.1572-0241.2007.01149.x; Johnson CL, 2012, PEDIATRICS, V129, P950, DOI 10.1542/peds.2011-2736; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Karatzas PS, 2014, ANN GASTROENTEROL, V27, P125; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Koloski NA, 2008, WORLD J GASTROENTERO, V14, P165, DOI 10.3748/wjg.14.165; Korzenik JR, 2005, J CLIN GASTROENTEROL, V39, pS59, DOI 10.1097/01.mcg.0000155553.28348.fc; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Leone V, 2013, J GASTROENTEROL, V48, P315, DOI 10.1007/s00535-013-0777-2; Loftus Edward V Jr, 2004, Curr Gastroenterol Rep, V6, P506, DOI 10.1007/s11894-004-0073-7; Lopez-Serrano P, 2010, SCAND J GASTROENTERO, V45, P1464, DOI 10.3109/00365521.2010.510575; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Rogler G, 2015, INFLAMM BOWEL DIS, V21, P400, DOI 10.1097/MIB.0000000000000229; Rosenfeld G, 2010, CAN J GASTROENTEROL, V24, P619, DOI 10.1155/2010/698362; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Strisciuglio C, 2016, J PAEDIATR GASTROENT; Strisciuglio C, 2014, DIGEST LIVER DIS, V46, P512, DOI 10.1016/j.dld.2014.02.016; Strober W, 2008, MUCOSAL IMMUNOL, V1, pS5, DOI 10.1038/mi.2008.42	40	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171742	10.1371/journal.pone.0171742	http://dx.doi.org/10.1371/journal.pone.0171742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170439	gold, Green Published, Green Submitted			2022-12-26	WOS:000393705500053
J	Grondin, JM; Duan, D; Kirlin, AC; Abe, KT; Chitayat, S; Spencer, HL; Spencer, C; Campigotto, A; Houliston, S; Arrowsmith, CH; Allingham, JS; Boraston, AB; Smith, SP				Grondin, Julie M.; Duan, Da; Kirlin, Alyssa C.; Abe, Kento T.; Chitayat, Seth; Spencer, Holly L.; Spencer, Craig; Campigotto, Alisha; Houliston, Scott; Arrowsmith, Cheryl H.; Allingham, John S.; Boraston, Alisdair B.; Smith, Steven P.			Diverse modes of galacto-specific carbohydrate recognition by a family 31 glycoside hydrolase from Clostridium perfringens	PLOS ONE			English	Article							BINDING MODULE; STRUCTURAL-ANALYSIS; N-ACETYLGLUCOSAMINIDASE; MOLECULAR-BASIS; BACTERIA; SEQUENCE; INSIGHTS; DYNAMICS; QUALITY; SYSTEM	Clostridium perfringens is a commensal member of the human gut microbiome and an opportunistic pathogen whose genome encodes a suite of putative large, multi-modular carbohydrate-active enzymes that appears to play a role in the interaction of the bacterium with mucin-based carbohydrates. Among the most complex of these is an enzyme that contains a presumed catalytic module belonging to glycoside hydrolase family 31 (GH31). This large enzyme, which based on its possession of a GH31 module is a predicted a-glucosidase, contains a variety of non-catalytic ancillary modules, including three CBM32 modules that to date have not been characterized. NMR-based experiments demonstrated a preference of each module for galacto-configured sugars, including the ability of all three CBM32s to recognize the common mucin monosaccharide GalNAc. X-ray crystal structures of the CpGH31 CBM32s, both in apo form and bound to GalNAc, revealed the finely-tuned molecular strategies employed by these sequentially variable CBM32s in coordinating a common ligand. The data highlight that sequence similarities to previously characterized CBMs alone are insufficient for identifying the molecular mechanism of ligand binding by individual CBMs. Furthermore, the overlapping ligand binding profiles of the three CBMs provide a fail-safe mechanism for the recognition of GalNAc among the dense eukaryotic carbohydrate networks of the colonic mucosa. These findings expand our understanding of ligand targeting by large, multi-modular carbohydrate-active enzymes, and offer unique insights into of the expanding ligand-binding preferences and binding site topologies observed in CBM32s.	[Grondin, Julie M.; Duan, Da; Kirlin, Alyssa C.; Chitayat, Seth; Spencer, Holly L.; Spencer, Craig; Campigotto, Alisha; Allingham, John S.; Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Grondin, Julie M.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Abe, Kento T.; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Houliston, Scott; Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Houliston, Scott; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	Queens University - Canada; Agriculture & Agri Food Canada; University of Victoria; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Smith, SP (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	steven.smith@queensu.ca	Allingham, John/AAW-9262-2020	Arrowsmith, Cheryl/0000-0002-4971-3250; Smith, Steven/0000-0003-2710-4400; Boraston, Alisdair/0000-0001-6417-0592	Canadian Institutes of Health Research [MOP-68913]; Natural Science and Engineering Council of Canada (NSERC) [RGPIN-2015-06667]; NSERC PGS-D fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC PGS-D fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a Canadian Institutes of Health Research operating grant (MOP-68913) awarded to ABB and SPS and a Natural Science and Engineering Council of Canada (NSERC) Discovery grant (RGPIN-2015-06667) to SPS. JMG was a recipient of a NSERC PGS-D fellowship. JAA is a Tier 2 Canada Research Chair in Structural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Abbott DW, 2014, CURR OPIN STRUC BIOL, V28, P32, DOI 10.1016/j.sbi.2014.07.004; Adams JJ, 2008, P NATL ACAD SCI USA, V103, P305; Adams PD, 2013, ANNU REV BIOPHYS, V42, P265, DOI 10.1146/annurev-biophys-083012-130253; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Sainz-Polo MA, 2014, J BIOL CHEM, V289, P31088, DOI 10.1074/jbc.M114.597732; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Brynestad S, 2002, INT J FOOD MICROBIOL, V74, P195, DOI 10.1016/S0168-1605(01)00680-8; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Correia MAS, 2010, BIOCHEMISTRY-US, V49, P6193, DOI 10.1021/bi1006139; Crost EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076341; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deplancke B, 2002, AM J CLIN NUTR, V76, P1117, DOI 10.1093/ajcn/76.5.1117; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etzold S, 2014, CURR OPIN STRUC BIOL, V28, P23, DOI 10.1016/j.sbi.2014.07.002; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Ficko-Blean E, 2012, CURR OPIN STRUC BIOL, V22, P570, DOI 10.1016/j.sbi.2012.07.009; Ficko-Blean E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033524; Ficko-Blean E, 2012, GLYCOBIOLOGY, V22, P590, DOI 10.1093/glycob/cwr165; Ficko-Blean E, 2009, J MOL BIOL, V390, P208, DOI 10.1016/j.jmb.2009.04.066; Ficko-Blean E, 2009, J BIOL CHEM, V284, P9876, DOI 10.1074/jbc.M808954200; Ghosh A, 2014, BIOCHEMISTRY-MOSCOW+, V79, P672, DOI 10.1134/S0006297914070098; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gregg KJ, 2008, J BIOL CHEM, V283, P12604, DOI 10.1074/jbc.M709865200; Grondin JM, 2014, J MOL BIOL, V426, P869, DOI 10.1016/j.jmb.2013.11.029; Grondin JM, 2012, BIOMOL NMR ASSIGN, V6, P139, DOI 10.1007/s12104-011-9342-1; Higgins MA, 2011, J MOL BIOL, V411, P1017, DOI 10.1016/j.jmb.2011.06.035; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Marcobal A, 2013, GLYCOBIOLOGY, V23, P1038, DOI 10.1093/glycob/cwt040; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Scharpf M, 2002, BIOCHEMISTRY-US, V41, P4255, DOI 10.1021/bi015866b; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004364; Stevens DL, 2012, ANAEROBE, V18, P254, DOI 10.1016/j.anaerobe.2011.11.001; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Viegas A, 2013, BIOCHEM J, V451, P289, DOI 10.1042/BJ20120627; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	54	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171606	10.1371/journal.pone.0171606	http://dx.doi.org/10.1371/journal.pone.0171606			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158290	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161700108
J	Scheuerle, RL; Bruggraber, SFA; Gerrard, SE; Kendall, RA; Tuleu, C; Slater, NKH				Scheuerle, Rebekah L.; Bruggraber, Sylvaine F. A.; Gerrard, Stephen E.; Kendall, Richard A.; Tuleu, Catherine; Slater, Nigel K. H.			Characterisation of zinc delivery from a nipple shield delivery system using a breastfeeding simulation apparatus	PLOS ONE			English	Article							MILK; SUPPLEMENTATION; CHILDREN; HIV	Zinc delivery from a nipple shield delivery system (NSDS), a novel platform for administering medicines to infants during breastfeeding, was characterised using a breastfeeding simulation apparatus. In this study, human milk at flow rates and pressures physiologically representative of breastfeeding passed through the NSDS loaded with zinc-containing rapidly disintegrating tablets, resulting in release of zinc into the milk. Inductively coupled plasma optical emission spectrometry was used to detect the zinc released, using a method that does not require prior digestion of the samples and that could be applied in other zinc analysis studies in breast milk. Four different types of zinc-containing tablets with equal zinc load but varying excipient compositions were tested in the NSDS in vitro. Zinc release measured over 20 minutes ranged from 32-51% of the loaded dose. Total zinc release for sets tablets of the same composition but differing hardness were not significantly different from one another with P = 0.3598 and P = 0.1270 for two tested pairs using unpaired t tests with Welch's correction. By the same test total zinc release from two sets of tablets having similar hardness but differing composition were also not significantly significant with P = 0.2634. Future zinc tablet composition and formulation optimisation could lead to zinc supplements and therapeutics with faster drug release, which could be administered with the NSDS during breastfeeding. The use of the NSDS to deliver zinc could then lead to treatment and prevention of some of the leading causes of child mortality, including diarrheal disease and pneumonia.	[Scheuerle, Rebekah L.; Gerrard, Stephen E.; Slater, Nigel K. H.] Univ Cambridge, Dept Chem Engn & Biotechnol, BioSci Engn Res Grp, New Museums Site,Pembroke St, Cambridge, England; [Bruggraber, Sylvaine F. A.] Elsie Widdowson Lab, Biomineral Res Grp, Med Res Council Human Nutr Res, Cambridge, England; [Tuleu, Catherine] UCL, Sch Pharm, Dept Pharmaceut, London, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; University of London; University College London; University of London School of Pharmacy	Scheuerle, RL (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, BioSci Engn Res Grp, New Museums Site,Pembroke St, Cambridge, England.	rs765@cam.ac.uk	tuleu, catherine/AAL-5039-2020	Scheuerle, Rebekah/0000-0001-6396-5043	United States Agency for International Development (USAID); Government of Norway; Bill & Melinda Gates Foundation; Grand Challenges Canada; UK Department for International Development (DFID) [0454-03]; Medical Research Council [MC_US_A090_0008, U1059]; MRC [MC_U105960399] Funding Source: UKRI; Medical Research Council [MC_U105960399] Funding Source: researchfish	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Government of Norway; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Grand Challenges Canada(CGIAR); UK Department for International Development (DFID); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was made possible for all authors through the support of the Saving Lives at Birth partners: the United States Agency for International Development (USAID), the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada and the UK Department for International Development (DFID) through the Saving Lives at Birth Award Scheme, grant number 0454-03. The website for the award scheme is https://savinglivesatbirth.net/. We also thank the Medical Research Council (grant number MC_US_A090_0008/Unit Programme number U1059) for their support of Sylvaine Bruggraber (S. F.A.B.). The website for this grant is http://www.mrc-ewl.cam.ac.uk/. The Gates Cambridge Trust is also thanked for their funding of Rebekah Scheuerle (R.L.S) through an academic scholarship. Their website is https://www.gatescambridge.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 1998, AM J CLIN NUTR, V68, p495S, DOI 10.1093/ajcn/68.2.495S; [Anonymous], 2013, BRADFORD ASSAY SIGMA; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Black RE, 2003, J NUTR, P1485; Brown KH, 2013, FOOD NUTR BULL, V34, P199, DOI 10.1177/156482651303400209; Charoo NA, 2012, INT J PHARMACEUT, V423, P167, DOI 10.1016/j.ijpharm.2011.12.024; Costa P, 2001, INT J PHARM, V220, P77, DOI 10.1016/S0378-5173(01)00651-2; Geddes DT, 2008, EARLY HUM DEV, V84, P471, DOI 10.1016/j.earlhumdev.2007.12.008; Gerrard SE, 2013, J PHARM SCI-US, V102, P3773, DOI 10.1002/jps.23688; Gerrard SE, 2013, BIOTECHNOL BIOENG, V110, P2058, DOI 10.1002/bit.24867; Hart CW, 2015, J HUM LACT, V31, P68, DOI 10.1177/0890334414559980; Hassan A, 2012, ZINC SUPPLEMENTATION; Kasper SC, 1999, J CHROMATOGR B, V726, P203, DOI 10.1016/S0378-4347(99)00017-1; Kent JC, 2006, PEDIATRICS, V117, pE387, DOI 10.1542/peds.2005-1417; Larson CP, 2008, J HEALTH POPUL NUTR, V26, P356; LUCAS A, 1978, BRIT MED J, V1, P1018, DOI 10.1136/bmj.1.6119.1018; Ninonuevo MR, 2009, NUTR REV S2, V67; Ramsay DT, 2004, PEDIATRICS, V113, P361, DOI 10.1542/peds.113.2.361; Sazawal S, 2013, J HUM NUTR FOOD SCI, V1, P1; Scheuerle RL, 2015, INT J PHARMACEUT, V486, P136, DOI 10.1016/j.ijpharm.2015.03.023; Sokal DC, 2013, United States Patent, P0, Patent No. 2013212012; Wang C D, 1999, J Perinatol, V19, P343, DOI 10.1038/sj.jp.7200204; World Health Organization, 2015, WHO MOD LIST ESS MED; World Health Organization, 2014, REV WHO CLASS TREATM; World Health Organization, 2004, WORLD HEAL J, V1, P11, DOI DOI 10.1089/ACM.2009.0657; World Health Organization, 2015, ZINC SUPPL MAN DIARR; Zoppou C, 1997, B MATH BIOL, V59, P953, DOI 10.1007/BF02460001; Zoppou C, 1997, J Hum Lact, V13, P195, DOI 10.1177/089033449701300307	28	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171624	10.1371/journal.pone.0171624	http://dx.doi.org/10.1371/journal.pone.0171624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158283	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700115
J	Villalobos, C; Maldonado, PE; Valdes, JL				Villalobos, Claudio; Maldonado, Pedro E.; Valdes, Jose L.			Asynchronous ripple oscillations between left and right hippocampi during slow-wave sleep	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; SPATIAL MEMORY; EPISODIC MEMORY; TAXI DRIVERS; NETWORK; RAT; ACTIVATION; ALLOCATION; ASYMMETRY; PATTERNS	Spatial memory, among many other brain processes, shows hemispheric lateralization. Most of the published evidence suggests that the right hippocampus plays a leading role in the manipulation of spatial information. Concurrently in the hippocampus, memory consolidation during sleep periods is one of the key steps in the formation of newly acquired spatial memory traces. One of the most characteristic oscillatory patterns in the hippocampus are sharp-wave ripple (SWR) complexes. Within this complex, fast -field oscillations or ripples have been demonstrated to be instrumental in the memory consolidation process. Since these ripples are relevant for the consolidation of memory traces associated with spatial navigation, and this process appears to be lateralized, we hypothesize that ripple events between both hippocampi would exhibit different temporal dynamics. We tested this idea by using a modified "split-hyperdrive" that allows us to record simultaneous LFPs from both right and left hippocampi of Sprague-Dawley rats during sleep. We detected individual events and found that during sleep periods these ripples exhibited a different occurrence patterns between hemispheres. Most ripple events were synchronous between intra- rather than inter -hemispherical recordings, suggesting that ripples in the hippocampus are independently generated and locally propagated within a specific hemisphere. In this study, we propose the ripples' lack of synchrony between left and right hippocampi as the putative physiological mechanism underlying lateralization of spatial memory.	[Villalobos, Claudio; Maldonado, Pedro E.; Valdes, Jose L.] Univ Chile, Fac Med, ICBM, Programa Disciplinario Fisiol & Biofis, Santiago, Chile; [Villalobos, Claudio; Maldonado, Pedro E.; Valdes, Jose L.] Univ Chile, Biomed Neurosci Inst, Santiago, Chile; [Villalobos, Claudio] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat, Los Angeles, CA USA; [Villalobos, Claudio] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Biobehav Sci, Los Angeles, CA USA	Universidad de Chile; Universidad de Chile; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Maldonado, PE; Valdes, JL (corresponding author), Univ Chile, Fac Med, ICBM, Programa Disciplinario Fisiol & Biofis, Santiago, Chile.; Maldonado, PE; Valdes, JL (corresponding author), Univ Chile, Biomed Neurosci Inst, Santiago, Chile.	pedro@neuro.med.uchile.cl; jlvaldes@med.uchile.cl	Maldonado, Pedro/AAH-7670-2019	Valdes, Jose L/0000-0002-9178-2743; VILLALOBOS, CLAUDIO/0000-0002-7943-5888	Iniciativa Cientifica Milenio, Center for Neuroscience of Memory [P10-001-F]; Iniciativa Cientifica Milenio, Biomedical Neuroscience Institute [ICM P09-015-F]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [3140473]; Anillo Conicyt [ACT-66]; Puelma Foundation	Iniciativa Cientifica Milenio, Center for Neuroscience of Memory; Iniciativa Cientifica Milenio, Biomedical Neuroscience Institute; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Anillo Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); Puelma Foundation	This work was supported by Iniciativa Cientifica Milenio, Center for Neuroscience of Memory, #P10-001-F and Iniciativa Cientifica Milenio, Biomedical Neuroscience Institute, ICM P09-015-F (JLV, PEM) http:/www.iniciativamilenio.cl, Fondo Nacional de Desarrollo Cientifico y Tecnologico #3140473 (CV) Anillo Conicyt ACT-66 (PEM, JLV) http://www.conicyt.cl/ fondecyt, Puelma Foundation (PEM, JLV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 1997, NEUROPSYCHOLOGIA, V35, P11, DOI 10.1016/S0028-3932(96)00051-6; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Bohbot VD, 2002, PHYSIOL RES, V51, pS49; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Eichenbaum H, 2012, NEUROSCI BIOBEHAV R, V36, P1597, DOI 10.1016/j.neubiorev.2011.07.006; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Herve PY, 2013, TRENDS COGN SCI, V17, P69, DOI 10.1016/j.tics.2012.12.004; Igloi K, 2010, P NATL ACAD SCI USA, V107, P14466, DOI 10.1073/pnas.1004243107; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 1997, J NEUROSCI, V17, P7103; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Motley SE, 2012, J NEUROSCI, V32, P13076, DOI 10.1523/JNEUROSCI.5920-11.2012; Oliva A, 2016, NEURON, V91, P1342, DOI 10.1016/j.neuron.2016.08.008; Patel J, 2013, J NEUROSCI, V 33, P17029, DOI 10.1523/JNEUROSCI.2036-13.2013; Rogers LJ, 2014, GENESIS, V52, P555, DOI 10.1002/dvg.22741; Roumis DK, 2015, CURR OPIN NEUROBIOL, V35, P6, DOI 10.1016/j.conb.2015.05.001; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Shipton OA, 2014, P NATL ACAD SCI USA, V111, P15238, DOI 10.1073/pnas.1405648111; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; YLINEN A, 1995, J NEUROSCI, V15, P30; Yun SH, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-05-j0003.2002	31	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171304	10.1371/journal.pone.0171304	http://dx.doi.org/10.1371/journal.pone.0171304			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158285	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700057
J	Yang, CR; Shang, XY; Cheng, L; Yang, L; Liu, XF; Bai, CL; Wei, ZY; Hua, JL; Li, GP				Yang, Chunrong; Shang, Xueying; Cheng, Lei; Yang, Lei; Liu, Xuefei; Bai, Chunling; Wei, Zhuying; Hua, Jinlian; Li, Guangpeng			DNMT 1 maintains hypermethylation of CAG promoter specific region and prevents expression of exogenous gene in fat-1 transgenic sheep	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DNA METHYLATION; STEM-CELLS; MICE; GENOME; MUSCLE; CATTLE; MODEL; PIGS	Methylation is an important issue in gene expression regulation and also in the fields of genetics and reproduction. In this study, we created fat-1 transgenic sheep, investigated the fine-mapping and the modulatory mechanisms of promoter methylation. Sheep fetal fibroblasts were transfected by pCAG-fat1-IRES-EGFP. Monoclonal cell line was screened as nuclear donor and carried out nuclear transfer (441 transgenic cloned embryos, 52 synchronism recipient sheep). Six offsprings were obtained. Expressions of exogenous genes fat-1 and EGFP were detectable in 10 examined tissues and upregulated omega-3 fatty acid content. Interestingly, more or less EGFP negative cells were detectable in the positive transgenic fetal skin cells. EGFP negative and positive cells were sorted by flow cytometry, and their methylation status in the whole promoter region (1701 nt) were investigated by bisulphate sequencing. The fine-mapping of methylation in CAG promoter were proposed. The results suggested that exogenous gene expression was determined by the methylation status from 721-1346 nt and modulated by methylation levels at 101, 108 and 115 nt sites in CAG promoter. To clarify the regulatory mechanism of methylation, examination of four DNA methyltransferases (DNMTs) demonstrated that hypermethylation of CAG promoter is mainly maintained by DNMT 1 in EGFP negative cells. Furthermore, investigation of the cell surface antigen CD34, CD45 and CD166 indicated that EGFP positive and negative cells belong to different types. The present study systematically clarified methylation status of CAG promoter in transgenic sheep and regulatory mechanism, which will provide research strategies for gene expression regulation in transgenic animals.	[Yang, Chunrong; Cheng, Lei; Yang, Lei; Liu, Xuefei; Bai, Chunling; Wei, Zhuying; Li, Guangpeng] Inner Mongolia Univ, Res Ctr Lab Anim Sci, Hohhot, Peoples R China; [Yang, Chunrong] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan, Peoples R China; [Shang, Xueying] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China; [Hua, Jinlian] Northwest A&F Univ, Coll Vet Med, Yangling, Peoples R China	Inner Mongolia University; Huazhong Agricultural University; Northwest A&F University - China; Northwest A&F University - China	Li, GP (corresponding author), Inner Mongolia Univ, Res Ctr Lab Anim Sci, Hohhot, Peoples R China.	gpengli@imu.edu.cn		Yang, Lei/0000-0002-9767-9026	National Natural Science Foundation of China [31372289]; Key basic research project of Inner Mongolia Autonomous Region [20130902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key basic research project of Inner Mongolia Autonomous Region	This work was supported by National Natural Science Foundation of China (grant No. 31372289) and Key basic research project of Inner Mongolia Autonomous Region (grant No. 20130902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak DH, 2015, SCI REP-UK, V5, DOI 10.1038/srep15465; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; Duan B, 2012, THERIOGENOLOGY, V78, P793, DOI 10.1016/j.theriogenology.2012.03.027; Gao MM, 2014, CELL RES, V24, P380, DOI 10.1038/cr.2014.2; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Guo HS, 2013, GENOME RES, V23, P2126, DOI 10.1101/gr.161679.113; Guo T, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-244; Gurtu V, 1996, BIOCHEM BIOPH RES CO, V229, P295, DOI 10.1006/bbrc.1996.1795; Han YM, 2016, INT J CANCER, V138, P2247, DOI 10.1002/ijc.29956; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep08292; Li ZG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0685-2; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Liu X, 2015, NANOSCALE RES LETT, V10, P1, DOI 10.1186/s11671-015-0895-2; McKinney-Freeman S, 2002, EXP HEMATOL, V30, P47; Miao XY, 2013, CELL MOL LIFE SCI, V70, P815, DOI 10.1007/s00018-012-1081-7; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Poh WJ, 2016, THERANOSTICS, V6, P369, DOI 10.7150/thno.13438; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Richards MP, 2011, FOOD BIOTECHNOL, V25, P103, DOI 10.1080/08905436.2011.576552; Samiec M, 2005, MED WETER, V61, P24; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Venkatesh MN, 2008, RES J BIOTECHNOL, V3, P53; Wang W, 2012, J ANIM VET ADV, V11, P1041; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Yang C, 2012, J FISH BIOL, V80, P2605, DOI 10.1111/j.1095-8649.2012.03316.x; Zeyland J, 2013, J APPL GENET, V54, P293, DOI 10.1007/s13353-013-0156-y; Zhang P, 2012, CELL REPROGRAM, V14, P258, DOI 10.1089/cell.2011.0073; Zhou L, 2014, MOL HUM REPROD, V20, P271, DOI 10.1093/molehr/gat081; Zhou Y, 2014, MOL BIOL REP, V41, P5177, DOI 10.1007/s11033-014-3385-1	39	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171442	10.1371/journal.pone.0171442	http://dx.doi.org/10.1371/journal.pone.0171442			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158319	Green Published, gold, Green Submitted			2022-12-26	WOS:000396161700080
J	Boulton, S; Akimoto, M; Akbarizadeh, S; Melacini, G				Boulton, Stephen; Akimoto, Madoka; Akbarizadeh, Sam; Melacini, Giuseppe			Free energy landscape remodeling of the cardiac pacemaker channel explains the molecular basis of familial sinus bradycardia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR CHEMICAL-SHIFTS; DRIVEN PROTEIN ALLOSTERY; HCN ION CHANNELS; CONFORMATIONAL DYNAMICS; STRUCTURAL BASIS; LIGAND-BINDING; COVARIANCE ANALYSIS; CAMP SENSITIVITY; KINASE-A; DOMAIN	The hyperpolarization-activated and cyclic nucleotide-modulated ion channel (HCN) drives the pacemaker activity in the heart, and its malfunction can result in heart disorders. One such disorder, familial sinus bradycardia, is caused by the S672R mutation in HCN, whose electrophysiological phenotypes include a negative shift in the channel activation voltage and an accelerated HCN deactivation. The outcomes of these changes are abnormally low resting heart rates. However, the molecular mechanism underlying these electrophysiological changes is currently not fully understood. Crystallographic investigations indicate that the S672R mutation causes limited changes in the structure of the HCN intracellular gating tetramer, but its effects on protein dynamics are unknown. Here, we utilize comparative S672R versus WT NMR analyses to show that the S672R mutation results in extensive perturbations of the dynamics in both apo- and holo-forms of the HCN4 isoform, reflecting how S672R remodels the free energy landscape for the modulation of HCN4 by cAMP, i.e. the primary cyclic nucleotide modulator of HCN channels. We show that the S672R mutation results in a constitutive shift of the dynamic auto-inhibitory equilibrium toward inactive states of HCN4 and broadens the free-energy well of the apo-form, enhancing the millisecond to microsecond dynamics of the holo-form at sites critical for gating cAMP binding. These S672R-induced variations in dynamics provide a molecular basis for the electrophysiological phenotypes of this mutation and demonstrate that the pathogenic effects of the S672R mutation can be rationalized primarily in terms of modulations of protein dynamics.	[Boulton, Stephen; Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada; [Akimoto, Madoka; Akbarizadeh, Sam; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada	McMaster University; McMaster University	Melacini, G (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada.; Melacini, G (corresponding author), McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca	Boulton, Stephen/AAM-3440-2021	Boulton, Stephen/0000-0002-2521-2240	Canadian Institutes of Health Research [MOP-68897]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04514]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Canadian Institutes of Health Research Grant MOP-68897 (to G.M.) and Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2014-04514 (to G.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Akimoto M, 2014, J BIOL CHEM, V289, P22205, DOI 10.1074/jbc.M114.572164; Akimoto M, 2013, P NATL ACAD SCI USA, V110, P14231, DOI 10.1073/pnas.1312644110; Baruscotti M, 2017, EUR HEART J, V38, P280, DOI 10.1093/eurheartj/ehv582; Benarroch EE, 2013, NEUROLOGY, V80, P304, DOI 10.1212/WNL.0b013e31827dec42; Boulton S, 2016, CHEM REV, V116, P6267, DOI 10.1021/acs.chemrev.5b00718; Boulton S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07306; Boulton S, 2014, BIOCHEM SOC T, V42, P302, DOI 10.1042/BST20130282; Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429; Cembran A, 2014, PHYS CHEM CHEM PHYS, V16, P6508, DOI 10.1039/c4cp00110a; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiFrancesco D, 2013, J PHYSIOL-LONDON, V591, P4117, DOI 10.1113/jphysiol.2013.253765; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Goddard T. D., 2008, SPARKY3; Greenwood AI, 2011, J BIOMOL NMR, V51, P21, DOI 10.1007/s10858-011-9538-9; Guo C, 2016, P NATL ACAD SCI USA, V113, pE6776, DOI 10.1073/pnas.1610142113; Guo JJ, 2016, CHEM REV, V116, P6503, DOI 10.1021/acs.chemrev.5b00590; Guo JJ, 2015, BIOPHYS J, V108, P2771, DOI 10.1016/j.bpj.2015.04.035; Kim J, 2015, P NATL ACAD SCI USA, V112, P3716, DOI 10.1073/pnas.1502299112; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Loh AP, 1999, BIOCHEMISTRY-US, V38, P12547, DOI 10.1021/bi9913707; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Ma BY, 2016, NAT CHEM BIOL, V12, P890, DOI 10.1038/nchembio.2212; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Moleschi KJ, 2015, J AM CHEM SOC, V137, P10777, DOI 10.1021/jacs.5b06557; Ng LCT, 2016, STRUCTURE, V24, P1629, DOI 10.1016/j.str.2016.06.024; Nussinov R, 2016, CHEM REV, V116, P6263, DOI 10.1021/acs.chemrev.6b00283; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Omidvar R, 2016, BBA-PROTEINS PROTEOM, V1864, P1739, DOI 10.1016/j.bbapap.2016.08.017; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Schuetz AK, 2016, ELIFE, V5, DOI 10.7554/eLife.20143; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; Schweizer PA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P542, DOI 10.1161/CIRCEP.110.949768; Seifert R, 2016, STRUCTURE, V24, P1627, DOI 10.1016/j.str.2016.09.002; Sekhar A, 2016, P NATL ACAD SCI USA, V113, pE6939, DOI 10.1073/pnas.1611418113; Selvaratnam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048707; Selvaratnam R, 2012, BIOPHYS J, V102, P630, DOI 10.1016/j.bpj.2011.12.030; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; VanSchouwen B, 2016, J PHYS CHEM B, V120, P10936, DOI 10.1021/acs.jpcb.6b07735; VanSchouwen B, 2015, J BIOL CHEM, V290, P28631, DOI 10.1074/jbc.M115.685305; VanSchouwen B, 2015, J BIOL CHEM, V290, P17642, DOI 10.1074/jbc.M115.651877; Verkerk AO, 2014, EUROPACE, V16, P384, DOI 10.1093/europace/eut348; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang CY, 2001, J MOL BIOL, V313, P873, DOI 10.1006/jmbi.2001.5083; Wicks NL, 2011, P NATL ACAD SCI USA, V108, P609, DOI 10.1073/pnas.1012750108; Xu XP, 2012, STRUCTURE, V20, P2116, DOI 10.1016/j.str.2012.09.017; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012	56	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6414	6428		10.1074/jbc.M116.773697	http://dx.doi.org/10.1074/jbc.M116.773697			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28174302	Green Published, hybrid			2022-12-26	WOS:000399538700033
J	Lanfranco, MF; Garate, F; Engdahl, AJ; Maillard, RA				Lanfranco, Maria Fe; Garate, Fernanda; Engdahl, Ashton J.; Maillard, Rodrigo A.			Asymmetric configurations in a reengineered homodimer reveal multiple subunit communication pathways in protein allostery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP RECEPTOR PROTEIN; CYCLIC-NUCLEOTIDE BINDING; GENE ACTIVATOR PROTEIN; SINGLE-SITE MUTATIONS; ESCHERICHIA-COLI; DNA RECOGNITION; DESIGN; ENSEMBLES; SWITCHES; MUTANT	Many allosteric proteins form homo-oligomeric complexes to regulate a biological function. In homo-oligomers, subunits establish communication pathways that are modulated by external stimuli like ligand binding. A challenge for dissecting the communication mechanisms in homo-oligomers is identifying intermediate liganded states, which are typically transiently populated. However, their identities provide the most mechanistic information on how ligand-induced signals propagate from bound to empty subunits. Here, we dissected the directionality and magnitude of subunit communication in a reengineered single-chain version of the homodimeric transcription factor cAMP receptor protein. By combining wild-type and mutant subunits in various asymmetric configurations, we revealed a linear relationship between the magnitude of cooperative effects and the number of mutant subunits. We found that a single mutation is sufficient to change the global allosteric behavior of the dimer even when one subunit was wild type. Dimers harboring two mutations with opposite cooperative effects had different allosteric properties depending on the arrangement of the mutations. When the two mutations were placed in the same subunit, the resulting cooperativity was neutral. In contrast, when placed in different subunits, the observed cooperativity was dominated by the mutation with strongest effects over cAMP affinity relative to wild type. These results highlight the distinct roles of intrasubunit interactions and intersubunit communication in allostery. Finally, dimers bound to either one or two cAMP molecules had similar DNA affinities, indicating that both asymmetric and symmetric liganded states activate DNA interactions. These studies have revealed the multiple communication pathways that homo-oligomers employ to transduce signals.	[Lanfranco, Maria Fe; Garate, Fernanda; Engdahl, Ashton J.; Maillard, Rodrigo A.] Georgetown Univ, Dept Chem, 37th & O St NW, Washington, DC 20057 USA	Georgetown University	Maillard, RA (corresponding author), Georgetown Univ, Dept Chem, 37th & O St NW, Washington, DC 20057 USA.	rodrigo.maillard@georgetown.edu			startup funds from Georgetown University	startup funds from Georgetown University	This work was supported with startup funds from Georgetown University. The authors declare that they have no conflicts of interest with the contents of this article.	Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Choi JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7968; Dai JY, 2004, BIOCHEMISTRY-US, V43, P8901, DOI 10.1021/bi0499359; Dayhoff JE, 2010, J MOL BIOL, V395, P860, DOI 10.1016/j.jmb.2009.10.052; Gekko K, 2004, BIOCHEMISTRY-US, V43, P3844, DOI 10.1021/bi036271e; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; GORSHKOVA I, 1995, J BIOL CHEM, V270, P21679, DOI 10.1074/jbc.270.37.21679; Ha JH, 2012, CHEM-EUR J, V18, P7984, DOI 10.1002/chem.201200348; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Kar G, 2010, CURR OPIN PHARMACOL, V10, P715, DOI 10.1016/j.coph.2010.09.002; Kornev AP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000056; Li JQ, 2011, BIOPHYS CHEM, V159, P210, DOI 10.1016/j.bpc.2011.06.015; Li PTX, 2002, J BIOL CHEM, V277, P11838, DOI 10.1074/jbc.M110860200; Lin SH, 2002, BIOCHEMISTRY-US, V41, P14935, DOI 10.1021/bi026756n; Lin SH, 2002, BIOCHEMISTRY-US, V41, P11857, DOI 10.1021/bi026099z; Lin SH, 2002, BIOCHEMISTRY-US, V41, P2946, DOI 10.1021/bi0119215; Makhlynets OV, 2015, BIOCHEMISTRY-US, V54, P1444, DOI 10.1021/bi5015248; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Motlagh HN, 2012, P NATL ACAD SCI USA, V109, P4134, DOI 10.1073/pnas.1120519109; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; REZNIKOFF WS, 1992, J BACTERIOL, V174, P655, DOI 10.1128/jb.174.3.655-658.1992; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Wenthur CJ, 2014, ANNU REV PHARMACOL, V54, P165, DOI 10.1146/annurev-pharmtox-010611-134525; Yu SN, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404806	32	6	6	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6086	6093		10.1074/jbc.M117.776047	http://dx.doi.org/10.1074/jbc.M117.776047			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28188293	Green Published, hybrid			2022-12-26	WOS:000399538700006
J	Benoit, J; Norton, LA; Manger, PR; Rubidge, BS				Benoit, Julien; Norton, Luke A.; Manger, Paul R.; Rubidge, Bruce S.			Reappraisal of the envenoming capacity of Euchambersia mirabilis (Therapsida, Therocephalia) using mu CT-scanning techniques	PLOS ONE			English	Article							TOOTH REPLACEMENT; VENOM; PATTERNS; MORPHOLOGY; MAMMALS; ORGANS; GLAND	Euchambersia mirabilis is an iconic species of Permo-Triassic therapsid because of its unusually large external maxillary fossa linked through a sulcus to a ridged canine. This anatomy led to the commonly accepted conclusion that the large fossa accommodated a venom gland. However, this hypothesis remains untested so far. Here, we conducted a mu CT scan assisted reappraisal of the envenoming capacity of Euchambersia, with a special focus on the anatomy of the maxillary fossa and canines. This study shows that the fossa, presumably for the venom-producing gland, is directly linked to the maxillary canal, which carries the trigeminal nerve (responsible for the sensitivity of the face). The peculiar anatomy of the maxillary canal suggests important reorganisation in the somatosensory system and that a ganglion could possibly have been present in the maxillary fossa instead of a venom gland. Nevertheless, the venom gland hypothesis is still preferred since we describe, for the first time, the complete crown morphology of the incisiform teeth of Euchambersia, which strongly suggests that the complete dentition was ridged. Therefore Euchambersia manifests evidence of all characteristics of venomous animals: a venom gland (in the maxillary fossa), a mechanism to deliver the venom (the maxillary canal and/or the sulcus located ventrally to the fossa); and an apparatus with which to inflict a wound for venom delivery (the ridged dentition).	[Benoit, Julien; Norton, Luke A.; Rubidge, Bruce S.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, Gauteng, South Africa; [Benoit, Julien; Manger, Paul R.] Univ Witwatersrand, Sch Anat Sci, Johannesburg, Gauteng, South Africa; [Benoit, Julien; Norton, Luke A.; Rubidge, Bruce S.] Univ Witwatersrand, Sch Geosci, Johannesburg, Gauteng, South Africa	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Benoit, J (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, Gauteng, South Africa.; Benoit, J (corresponding author), Univ Witwatersrand, Sch Anat Sci, Johannesburg, Gauteng, South Africa.; Benoit, J (corresponding author), Univ Witwatersrand, Sch Geosci, Johannesburg, Gauteng, South Africa.	julien.benoit@wits.ac.za	Norton, Luke/R-2446-2017; Rubidge, Bruce/AAE-7021-2019	Norton, Luke/0000-0002-9434-9267; Rubidge, Bruce/0000-0003-2477-1873; Benoit, Julien/0000-0001-5378-3940	PAST; Scatterlings projects; NRF African Origins Platform; DST-NRF Centre of Excellence in Palaeosciences	PAST; Scatterlings projects; NRF African Origins Platform; DST-NRF Centre of Excellence in Palaeosciences	This research was conducted with financial support from PAST and its Scatterlings projects; the NRF African Origins Platform; and the DST-NRF Centre of Excellence in Palaeosciences (CoE in Palaeosciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Kader TG, 2011, LIFE SCI J, V8, P650; Barone R., 1999, ANATOMIE COMP MAMMIF, V1; BELLAIRS AD, 1949, J ANAT, V83, P116; Benoit J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25604; Benoit J, 2005, SCI NAT, V102, P69; Benoit J, 2016, B SOC GEOL FR, V187, P217, DOI 10.2113/gssgfbull.187.4-5.217; Benoit J, 2016, ACTA PALAEONTOL POL, V61, P777, DOI 10.4202/app.00219.2015; Boonstra L. D., 1962, Annals of the South African Museum, V46, P57; BOONSTRA LIEUWE D., 1934, ANN S AFRICAN MUS, V31, P215; BRINK A. S., 1986, HDB GEOLOGICAL SURVE, V10, P1; Broom, 1932, MAMMAL LIKE REPTILES; BROOM R., 1931, REC ALBANY MUS [GRAHAMSTOWN], V4, P161; Edmund A.G., 1962, Contributions of the Royal Ontario Museum (Life Sci), V56, P1; Edmund A.G., 1960, CONTR LIFE SCI DIV R, V52, P1, DOI DOI 10.5962/BHL.TITLE.52196; Faurie S., 1974, Annals S Afr Mus, V65, P337; Fernandez V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064978; Folinsbee KE, 2007, J VERTEBR PALEONTOL, V27, P547, DOI 10.1671/0272-4634(2007)27[547:CGMFAR]2.0.CO;2; Fry BG, 2009, P NATL ACAD SCI USA, V106, P8969, DOI 10.1073/pnas.0810883106; Gans C., 1978, P1; Godefroit Pascal, 1997, Palaeovertebrata (Montpellier), V26, P1; Gong EP, 2011, PALAEONTOL Z, V85, P109, DOI 10.1007/s12542-010-0076-7; Gong EP, 2010, P NATL ACAD SCI USA, V107, P766, DOI 10.1073/pnas.0912360107; Goris RC, 2011, J HERPETOL, V45, P2, DOI 10.1670/10-238.1; GRINE F E, 1979, Palaeontologia Africana, V22, P35; Hillenius WJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1019, DOI 10.1086/425185; Holloway RL, 2014, P NATL ACAD SCI USA, V111, P13022, DOI 10.1073/pnas.1402905111; HOPSON JAMES A., 1964, PROC ZOOL SOC LONDON, V142, P625; Hotton N. III, 1991, P598; Hurum JH, 2006, ACTA PALAEONTOL POL, V51, P1; Huttenlocker AK, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.969400; Ivakhnenko MF, 2008, PALEONTOL J+, V42, P409, DOI 10.1134/S0031030108040102; Kemp T.S, 1982, MAMMAL LIKE REPTILES; KEMP TS, 2005, ORIGIN EVOLUTION MAM; KERMACK KA, 1956, PHILOS T ROY SOC B, V240, P95, DOI 10.1098/rstb.1956.0013; KIESER JA, 1993, J MORPHOL, V218, P195, DOI 10.1002/jmor.1052180208; Kitching J.W., 1977, Memoirs Bernard Price Inst palaeont Res, VNo. 1, P1; Krochmal AR, 2004, J EXP BIOL, V207, P4231, DOI 10.1242/jeb.01278; Lebrun R., 2014, 12 ANN M EAVP TOR IT; Lehman JP, 1961, TRAITE PALEONTOL, V6, P224; Leitch DB, 2012, J EXP BIOL, V215, P4217, DOI 10.1242/jeb.076836; Ligabue-Braun R, 2012, TOXICON, V59, P680, DOI 10.1016/j.toxicon.2012.02.012; Macpherson C. B., 1968, ETHNIC GROUPS BOUND, V1968, P9; Mebs D., 2002, VENOMOUS POISONOUS A; Mendrez C., 1975, Colloques Internationaux du Centre National de la Recherche Scientifique, P379; Mitchell JS, 2010, NATURWISSENSCHAFTEN, V97, P1117, DOI 10.1007/s00114-010-0729-0; Muchlinski MN, 2010, J HUM EVOL, V58, P447, DOI 10.1016/j.jhevol.2010.01.012; NOPCSA FRANCIS, 1933, ANN AND MAG NAT HIST, V12, P125; Norton L, 2009, J VERTEBR PALEONTOL, V29, p156A; Orr CM, 2007, J VERTEBR PALEONTOL, V27, P541, DOI 10.1671/0272-4634(2007)27[541:TCMATI]2.0.CO;2; POOLE D. F. G., 1961, PROC ZOOL SOC LONDON, V136, P131; Quay W.B., 1979, P245; Rehorek SJ, 2005, CHEM SIGNAL, V10, P152, DOI 10.1007/0-387-25160-X_19; Rehorek SJ, 2010, ANAT REC, V293, P1433, DOI 10.1002/ar.21046; Rodriguez-de la Rosa Ruben A., 2000, Journal of Vertebrate Paleontology, V20, p64A; Romer A, 1956, OSTEOLOGY REPTILES; Romer A. S., 1940, GEOLOGICAL SOC AM SP, V28, P1, DOI DOI 10.1130/SPE28-P1; Romer A.S., 1945, VERTEBRATE PALEONTOL; Romer AS, 1961, INT C EV LOW NONSP 1, V1, P9; Rubidge BS, 2001, ANNU REV ECOL SYST, V32, P449, DOI 10.1146/annurev.ecolsys.32.081501.114113; Sawin H. J., 1941, BULL MUS COMP ZOOL HARVARD UNIV, V88, P407; Sigogneau D., 1970, CAHIERS PALEONTOLOGI; Sigogneau-Russell D., 1989, ENCY PALEOHERPET 17B, P1; Sues HD, 1996, J VERTEBR PALEONTOL, V16, P571, DOI 10.1080/02724634.1996.10011340; SUES HD, 1991, NATURE, V351, P141, DOI 10.1038/351141a0; Szaniawski H, 2009, ACTA PALAEONTOL POL, V54, P669, DOI 10.4202/app.2009.0045; Tatarinov LP., 1976, MORPHOLOGICAL EVOLUT; VAETH RH, 1985, J HERPETOL, V19, P20, DOI 10.2307/1564416; Van Den Heever J., 1987, THESIS; Van den Heever J.A., 1994, Universiteit van Stellenbosch Annale, V1, P1; VANVALEN L, 1960, EVOLUTION, V14, P304, DOI 10.1111/j.1558-5646.1960.tb03092.x; Vjuschkov BP, 1964, FUNDAMENTALS PALEONT, P275; von During M., 1979, P407; Weinstein S. A., 2009, HDB VENOMS TOXINS RE, P76; Young Bruce A., 1996, Amphibia-Reptilia, V17, P261, DOI 10.1163/156853896X00432	74	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172047	10.1371/journal.pone.0172047	http://dx.doi.org/10.1371/journal.pone.0172047			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187210	gold, Green Published, Green Submitted			2022-12-26	WOS:000394244300074
J	Conte, F; Fiscon, G; Chiara, M; Colombo, T; Farina, L; Paci, P				Conte, Federica; Fiscon, Giulia; Chiara, Matteo; Colombo, Teresa; Farina, Lorenzo; Paci, Paola			Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer	PLOS ONE			English	Article							COMPETING ENDOGENOUS RNA; MESSENGER-RNAS; MICRORNA SPONGES; TUMOR-SUPPRESSOR; REPRESSORS ZEB1; CIRCULAR RNAS; HUMAN GENOME; EXPRESSION; TRANSCRIPTS; LNCRNA	Recent findings have identified competing endogenous RNAs (ceRNAs) as the drivers in many disease conditions, including cancers. The ceRNAs indirectly regulate each other by reducing the amount of microRNAs (miRNAs) available to target messenger RNAs (mRNAs). The ceRNA interactions mediated by miRNAs are modulated by a titration mechanism, i. e. large changes in the ceRNA expression levels either overcome, or relieve, the miRNA repression on competing RNAs; similarly, a very large miRNA overexpression may abolish competition. The ceRNAs are also called miRNA "decoys" or miRNA "sponges" and encompass different RNAs competing with each other to attract miRNAs for interactions: mRNA, long non-coding RNAs (lncRNAs), pseudogenes, or circular RNAs. Recently, we developed a computational method for identifying ceRNA-ceRNA interactions in breast invasive carcinoma. We were interested in unveiling which lncRNAs could exert the ceRNA activity. We found a drastic rewiring in the cross-talks between ceRNAs from the physiological to the pathological condition. The main actor of this dysregulated lncRNA-associated ceRNA network was the lncRNA PVT1, which revealed a net biding preference towards the miR-200 family members in normal breast tissues. Despite its up-regulation in breast cancer tissues, mimicked by the miR-200 family members, PVT1 stops working as ceRNA in the cancerous state. The specific conditions required for a ceRNA landscape to occur are still far from being determined. Here, we emphasized the importance of the relative concentration of the ceRNAs, and their related miRNAs. In particular, we focused on the withdrawal in breast cancer tissues of the PVT1 ceRNA activity and performed a gene expression and sequence analysis of its multiple isoforms. We found that the PVT1 isoform harbouring the binding site for a representative miRNA of the miR-200 family shows a drastic decrease in its relative concentration with respect to the miRNA abundance in breast cancer tissues, providing a plausibility argument to the breakdown of the sponge program orchestrated by the oncogene PVT1.	[Conte, Federica; Fiscon, Giulia; Colombo, Teresa; Paci, Paola] CNR, Inst Syst Anal & Comp Sci Antonio Ruberti, Rome, Italy; [Chiara, Matteo] Univ Milan, Dept Biosci, Milan, Italy; [Farina, Lorenzo] Univ Sapienza, Dept Comp Control & Management Engn, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); University of Milan; Sapienza University Rome	Paci, P (corresponding author), CNR, Inst Syst Anal & Comp Sci Antonio Ruberti, Rome, Italy.	paola.paci@iasi.cnr.it	Colombo, Teresa/P-2959-2018; FISCON, GIULIA/J-3442-2019	Colombo, Teresa/0000-0003-2415-7507; FISCON, GIULIA/0000-0002-3354-8203; Paci, Paola/0000-0002-9393-2047; Conte, Federica/0000-0003-0427-1476; CHIARA, MATTEO/0000-0003-3983-4961; Farina, Lorenzo/0000-0001-8314-6029	Epigenomics Flagship Project (Progetto Bandiera Epigenomica) EPIGEN; National Research Council of Italy (CNR); Italian Ministry of Education, University and Research (MIUR)	Epigenomics Flagship Project (Progetto Bandiera Epigenomica) EPIGEN; National Research Council of Italy (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was financially support by The Epigenomics Flagship Project (Progetto Bandiera Epigenomica) EPIGEN funded by Italian Ministry of Education, University and Research (MIUR) and the National Research Council of Italy (CNR), URL: http://www.epigen.it/.	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Barsotti AM, 2012, J BIOL CHEM, V287, P2509, DOI 10.1074/jbc.M111.322875; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brooksbank C, 2014, NUCLEIC ACIDS RES, V42, pD18, DOI 10.1093/nar/gkt1206; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chang HY, 2013, BLOOD, V122; Chapman MH, 2012, J HEPATOL, V56, P877, DOI 10.1016/j.jhep.2011.10.022; Clark MB, 2011, SEMIN CELL DEV BIOL, V22, P366, DOI 10.1016/j.semcdb.2011.01.001; Colombo T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/304208; Cong NN, 2013, ONCOL REP, V29, P1579, DOI 10.3892/or.2013.2267; Cui D, 2016, TUMOR BIOL, V37, P4127, DOI 10.1007/s13277-015-4261-x; Dey BK, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/21541272.2014.944014; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ergun S, 2015, TUMOR BIOL, V36, P3129, DOI 10.1007/s13277-015-3346-x; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fan M, 2013, EXP THER MED, V5, P1143, DOI 10.3892/etm.2013.933; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fiscon G, 2016, JOURNAL OF GENETICS, V3; Fiscon G, 2015, CURR BIOINFORM, V10, P242, DOI 10.2174/1574893609666140820224651; Fiscon G, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S6-S1; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRAHAM M, 1986, EMBO J, V5, P2845, DOI 10.1002/j.1460-2075.1986.tb04578.x; GRAHAM M, 1985, NATURE, V314, P740, DOI 10.1038/314740a0; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Guo LL, 2015, WORLD J GASTROENTERO, V21, P11680, DOI 10.3748/wjg.v21.i41.11680; Hamilton MJ, 2015, AIMS BIOPHYS, V2, P794, DOI 10.3934/biophy.2015.4.794; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansji H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00379; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Humphries B, 2015, ONCOTARGET, V6, P6472, DOI 10.18632/oncotarget.3052; HUPPI K, 1994, INT J CANCER, V59, P848, DOI 10.1002/ijc.2910590623; HUPPI K, 1990, P NATL ACAD SCI USA, V87, P6964, DOI 10.1073/pnas.87.18.6964; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Iden M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156274; Jackson JE, 2005, A USERS GUIDE TO PRI, V587; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kagami H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14577; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Knowling S, 2011, BIOCHIMIE, V93, P1922, DOI 10.1016/j.biochi.2011.07.031; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; Larriba E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040452; LEMAY G, 1984, P NATL ACAD SCI-BIOL, V81, P38, DOI 10.1073/pnas.81.1.38; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li XL, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/870597; Li XL, 2013, MED RES REV, V33, P517, DOI 10.1002/med.21254; Liang JC, 2011, MOL CELL, V43, P915, DOI 10.1016/j.molcel.2011.08.023; Liu FT, 2016, MINERVA MED, V107, P77; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Marques AC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r102; Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001; Memczak S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141214; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; Morlando M, 2014, CHEMMEDCHEM, V9, P505, DOI 10.1002/cmdc.201300569; Mortimer SA, 2014, NAT REV GENET, V15, P469, DOI 10.1038/nrg3681; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Novikova IV, 2012, NUCLEIC ACIDS RES, V40, P5034, DOI 10.1093/nar/gks071; Paci P, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-83; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Parasramka MA, 2016, PHARMACOL THERAPEUT, V161, P67, DOI 10.1016/j.pharmthera.2016.03.004; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Posa I., 2016, ONCOTARGET; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Qi XL, 2015, J MED GENET, V52, P710, DOI 10.1136/jmedgenet-2015-103334; Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sarver AL, 2016, CELL CYCLE, V15, P881, DOI 10.1080/15384101.2016.1149660; Saxena A, 2011, BIOESSAYS, V33, P830, DOI 10.1002/bies.201100084; Shi Q, 2016, J CELL PHYSIOL, V231, P751, DOI 10.1002/jcp.25174; Somarowthu S, 2015, MOL CELL, V58, P353, DOI 10.1016/j.molcel.2015.03.006; Sosinska P, 2015, MUTAT RES-REV MUTAT, V766, P58, DOI 10.1016/j.mrrev.2015.08.002; Tan JY, 2016, BIOESSAYS, V38, P295, DOI 10.1002/bies.201500148; Tang JY, 2013, SCI WORLD J, V2013, DOI DOI 10.1155/2013/943539; Tano Keiko, 2012, Frontiers in Genetics, V3, P219, DOI 10.3389/fgene.2012.00219; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; VILLENEUVE L, 1986, MOL CELL BIOL, V6, P1834, DOI 10.1128/MCB.6.5.1834; Wang F, 2014, HEPATOLOGY, V60, P1278, DOI 10.1002/hep.27239; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang L, 2013, CARCINOGENESIS, V34, P1773, DOI 10.1093/carcin/bgt139; Wang P, 2015, NUCLEIC ACIDS RES, V43, P3478, DOI 10.1093/nar/gkv233; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xiao HB, 2015, ONCOTARGET, V6, P38005, DOI 10.18632/oncotarget.5357; Xie J, 2015, J BIOMATER TISS ENG, V5, P872, DOI 10.1166/jbt.2015.1389; Yang C, 2016, ONCOTARGET, V7, P13479, DOI 10.18632/oncotarget.7266; Yang GD, 2014, BBA-GENE REGUL MECH, V1839, P1097, DOI 10.1016/j.bbagrm.2014.08.012; Yu G, 2014, MOL CANCER THER, V13, P3086, DOI 10.1158/1535-7163.MCT-14-0245; Zhang X, 2010, ENDOCRINOLOGY, V151, P939, DOI 10.1210/en.2009-0657; Zheng LF, 2015, BREAST CANCER RES TR, V150, P105, DOI 10.1007/s10549-015-3298-2; Zhou M., 2016, ONCOTARGET; Zhou QY, 2016, TUMOR BIOL, V37, P3105, DOI 10.1007/s13277-015-4149-9; Zhou XY, 2015, CELL PHYSIOL BIOCHEM, V36, P1440, DOI 10.1159/000430309; Zhuang CL, 2015, ONCOTARGET, V6, P41194, DOI 10.18632/oncotarget.5880; Zlotorynski E, 2015, NAT REV MOL CELL BIO, V16, DOI 10.1038/nrm4079	125	85	87	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171661	10.1371/journal.pone.0171661	http://dx.doi.org/10.1371/journal.pone.0171661			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187158	Green Published, gold, Green Submitted			2022-12-26	WOS:000394244300035
J	Della Ventura, B; Iannaccone, M; Funari, R; Ciamarra, MP; Altucci, C; Capparelli, R; Roperto, S; Velotta, R				Della Ventura, Bartolomeo; Iannaccone, Marco; Funari, Riccardo; Ciamarra, Massimo Pica; Altucci, Carlo; Capparelli, Rosanna; Roperto, Sante; Velotta, Raffaele			Effective antibodies immobilization and functionalized nanoparticles in a quartz-crystal microbalance-based immunosensor for the detection of parathion	PLOS ONE			English	Article							GOLD NANOPARTICLES; SENSITIVE DETECTION; QCM IMMUNOSENSOR; PIEZOELECTRIC IMMUNOSENSOR; SMALL MOLECULES; BIOSENSORS; AMPLIFICATION; ORIENTATION	Background Biosensor-based detection provides a rapid and low-cost alternative to conventional analytical methods for revealing the presence of the contaminants in water as well as solid matrices. Although important to be detected, small analytes (few hundreds of Daltons) are an issue in biosensing since the signal they induce in the transducer, and specifically in a Quartz-Crystal Microbalance, is undetectable. A pesticide like parathion (M = 292 Da) is a typical example of contaminant for which a signal amplification procedure is desirable. Methods/Findings The ballasting of the analyte by gold nanoparticles has been already applied to heavy target as proteins or bacteria to improve the limit of detection. In this paper, we extend the application of such a method to small analytes by showing that once the working surface of a QuartzCrystal Microbalance (QCM) has been properly functionalized, a limit of detection lower than 1 ppb is reached for parathion. The effective surface functionalization is achieved by immobilizing antibodies upright oriented on the QCM gold surface by a simple photochemical technique (Photonic Immobilization Technique, PIT) based on the UV irradiation of the antibodies, whereas a simple protocol provided by the manufacturer is applied to functionalize the gold nanoparticles. Thus, in a non-competitive approach, the small analyte is made detectable by weighing it down through a "sandwich protocol" with a second antibody tethered to heavy gold nanoparticles. The immunosensor has been proved to be effective against the parathion while showing no cross reaction when a mixture of compounds very similar to parathion is analyzed. Conclusion/Significance The immunosensor described in this paper can be easily applied to any small molecule for which polyclonal antibodies are available since both the functionalization procedure of the QCM probe surface and gold nanoparticle can be applied to any IgG, thereby making our device of general application in terms of target analyte.	[Della Ventura, Bartolomeo; Funari, Riccardo; Altucci, Carlo; Velotta, Raffaele] Univ Naples Federico II, Dept Phys Ettore Pancini, Naples, Italy; [Iannaccone, Marco; Capparelli, Rosanna; Roperto, Sante] Univ Naples Federico II, Dept Agr, Portici, Italy; [Ciamarra, Massimo Pica] Nanyang Technol Univ, Sch Math Sci, Div Phys & Appl Phys, Singapore, Singapore; [Ciamarra, Massimo Pica] Univ Naples Federico II, CNR, SPIN, Naples, Italy	University of Naples Federico II; University of Naples Federico II; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II	Velotta, R (corresponding author), Univ Naples Federico II, Dept Phys Ettore Pancini, Naples, Italy.	rvelotta@unina.it	DELLA VENTURA, BARTOLOMEO/AAC-7761-2022; Ciamarra, Massimo Pica/F-2865-2011; Velotta, Raffaele/I-5298-2012; Iannaccone, Marco/K-7559-2016; Pica Ciamarra, Massimo/GRR-4883-2022; Capparelli, Rosanna/Q-3144-2017; Altucci, Carlo/AAK-1271-2020; Funari, Riccardo/N-3541-2017	DELLA VENTURA, BARTOLOMEO/0000-0003-2920-6187; Ciamarra, Massimo Pica/0000-0001-8931-9058; Velotta, Raffaele/0000-0003-1077-8353; Iannaccone, Marco/0000-0002-2283-6613; Capparelli, Rosanna/0000-0001-8614-6251; Altucci, Carlo/0000-0003-2270-9128; Funari, Riccardo/0000-0003-1786-3833; roperto, sante/0000-0001-6210-5519	Fondazione con ilSud [2011-PDR-18]; Italian Ministry for Reaserch (MIUR) [PON_0101517]	Fondazione con ilSud; Italian Ministry for Reaserch (MIUR)(Ministry of Education, Universities and Research (MIUR))	We acknowledge the financial support of the "Fondazione con ilSud" (project Nr. 2011-PDR-18, "Biosensoripiezoelettrici a risposta in tempo reale per applicazioniambientali e agro-alimentari" and the Italian Ministry for Reaserch (MIUR) under the Grant No. PON_0101517.	Aitken A., 2002, PROTEIN PROTOCOLS HD; Akter R, 2015, BIOSENS BIOELECTRON, V66, P539, DOI 10.1016/j.bios.2014.12.007; Chauhan R, 2016, SENSOR ACTUAT B-CHEM, V222, P804, DOI 10.1016/j.snb.2015.08.117; Cheng SY, 2012, ANAL CHEM, V84, P2129, DOI 10.1021/ac3001463; Chu X, 2006, SENSOR ACTUAT B-CHEM, V114, P696, DOI 10.1016/j.snb.2005.06.014; Della Ventura B, 2015, APPL PHYS B-LASERS O, V119, P497, DOI 10.1007/s00340-015-6091-3; Della Ventura B, 2011, BIOMED OPT EXPRESS, V2, P3223, DOI 10.1364/BOE.2.003223; Ding PF, 2013, SENSOR ACTUAT B-CHEM, V188, P1277, DOI 10.1016/j.snb.2013.07.099; Fonseca RAS, 2011, SENSORS-BASEL, V11, P10785, DOI 10.3390/s111110785; Funari R, 2016, LANGMUIR; Funari R, 2015, BIOSENS BIOELECTRON, V67, P224, DOI 10.1016/j.bios.2014.08.020; Funari R, 2013, ANAL CHEM, V85, P6392, DOI 10.1021/ac400852c; Geschwindner S, 2012, SENSORS-BASEL, V12, P4311, DOI 10.3390/s120404311; Hao RZ, 2011, BIOSENS BIOELECTRON, V26, P3398, DOI 10.1016/j.bios.2011.01.010; Ioerger TR, 1999, MOL IMMUNOL, V36, P373, DOI 10.1016/S0161-5890(99)00032-2; Jiang XS, 2011, BIOSENS BIOELECTRON, V29, P23, DOI 10.1016/j.bios.2011.07.059; Jin XF, 2009, ANAL CHIM ACTA, V645, P92, DOI 10.1016/j.aca.2009.04.041; Jones AM, 2013, CURR OPIN PLANT BIOL, V16, P389, DOI 10.1016/j.pbi.2013.02.010; Jung Y, 2008, ANALYST, V133, P697, DOI 10.1039/b800014j; Justino CIL, 2016, TRAC TRENDS ANAL CHE; Leng CA, 2010, ANAL CHIM ACTA, V666, P97, DOI 10.1016/j.aca.2010.03.060; Li DJ, 2011, BIOSENS BIOELECTRON, V26, P4146, DOI 10.1016/j.bios.2011.04.010; Li YY, 2010, GOLD BULL, V43, P29, DOI 10.1007/BF03214964; Masson J-F, 2015, NANOBIOSENSORS NANOB, P305; MILLES HL, 1950, BRIT MED J, V2, P444, DOI 10.1136/bmj.2.4676.444; Mitchell JS, 2010, BIOSENSORS, P151; Neves-Petersen M. T., 2012, MOL PHOTOCHEMISTRY V; Neves-Petersen MT, 2002, PROTEIN SCI, V11, P588, DOI 10.1110/ps.06002; Nicu L, 2008, J APPL PHYS, V104, DOI 10.1063/1.2973147; Salam F, 2013, TALANTA, V115, P761, DOI 10.1016/j.talanta.2013.06.034; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Schultz NM, 1997, HDB CAPILLARY ELECTR, P611; Sharma V, 2009, MAT SCI ENG R, V65, P1, DOI 10.1016/j.mser.2009.02.002; Springer T, 2014, ANAL CHEM, V86, P10350, DOI 10.1021/ac502637u; Trilling AK, 2013, ANALYST, V138, P1619, DOI 10.1039/c2an36787d; Trilling AK, 2013, BIOSENS BIOELECTRON, V40, P219, DOI 10.1016/j.bios.2012.07.027; Vashist SK, 2011, J SENSORS, V2011, DOI 10.1155/2011/571405; VIOT P, 1992, J CHEM PHYS, V97, P5212, DOI 10.1063/1.463820; Wang JL, 2008, ANAL CHEM, V80, P7174, DOI 10.1021/ac801281c; Wang XH, 2008, SENSORS-BASEL, V8, P6045, DOI 10.3390/s8096045; Xia F, 2010, P NATL ACAD SCI USA, V107, P10837, DOI 10.1073/pnas.1005632107; Zheng B, 2013, ANAL BIOCHEM, V438, P144, DOI 10.1016/j.ab.2013.03.030	42	25	25	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171754	10.1371/journal.pone.0171754	http://dx.doi.org/10.1371/journal.pone.0171754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182720	Green Published, gold			2022-12-26	WOS:000394231800100
J	Salih, RHM; Majesky, L; Schwarzacher, T; Gornall, R; Heslop-Harrison, P				Salih, Rubar Hussein M.; Majesky, Lubos; Schwarzacher, Trude; Gornall, Richard; Heslop-Harrison, Pat			Complete chloroplast genomes from apomictic Taraxacum (Asteraceae): Identity and variation between three microspecies	PLOS ONE			English	Article							GENETIC-STRUCTURE; PLASTID GENOMES; DNA; SEQUENCE; EVOLUTION; ORGANIZATION; INHERITANCE; IDENTIFICATION; ANGIOSPERMS; COMPOSITAE	Chloroplast DNA sequences show substantial variation between higher plant species, and less variation within species, so are typically excellent markers to investigate evolutionary, population and genetic relationships and phylogenies. We sequenced the plastomes of Taraxacum obtusifrons Markl. (O978); T. stridulum Travnicek ined. (S3); and T. amplum Markl. (A978), three apomictic triploid (2n = 3x = 24) dandelions from the T. officinale agg. We aimed to characterize the variation in plastomes, define relationships and correlations with the apomictic microspecies status, and refine placement of the microspecies in the evolutionary or phylogenetic context of the Asteraceae. The chloroplast genomes of accessions O978 and S3 were identical and 151,322 bp long (where the nuclear genes are known to show variation), while A978 was 151,349 bp long. All three genomes contained 135 unique genes, with an additional copy of the trnF-GGA gene in the LSC region and 20 duplicated genes in the IR region, along with short repeats, the typical major Inverted Repeats (IR1 and IR2, 24,431bp long), and Large and Small Single Copy regions (LSC 83,889bp and SSC 18,571bp in O978). Between the two Taraxacum plastomes types, we identified 28 SNPs. The distribution of polymorphisms suggests some parts of the Taraxacum plastome are evolving at a slower rate. There was a hemi-nested inversion in the LSC region that is common to Asteraceae, and an SSC inversion from ndhF to rps15 found only in some Asteraceae lineages. A comparative repeat analysis showed variation between Taraxacum and the phylogenetically close genus Lactuca, with many more direct repeats of 40bp or more in Lactuca (1% larger plastome than Taraxacum). When individual genes and non-coding regions were for Asteraceae phylogeny reconstruction, not all showed the same evolutionary scenario suggesting care is needed for interpretation of relationships if a limited number of markers are used. Studying genotypic diversity in plastomes is important to characterize the nature of evolutionary processes in nuclear and cytoplasmic genomes with the different selection pressures, population structures and breeding systems.	[Salih, Rubar Hussein M.; Schwarzacher, Trude; Gornall, Richard; Heslop-Harrison, Pat] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Salih, Rubar Hussein M.] Univ Sulaimani, Fac Agr Sci, Field Crops Dept, Sulaimani, Kurdistan Regio, Iraq; [Majesky, Lubos] Palacky Univ Olomouc, Fac Sci, Dept Bot, Olomouc, Olomouc Holice, Czech Republic	University of Leicester; University of Sulimanyah; Palacky University Olomouc	Salih, RHM; Heslop-Harrison, P (corresponding author), Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England.; Salih, RHM (corresponding author), Univ Sulaimani, Fac Agr Sci, Field Crops Dept, Sulaimani, Kurdistan Regio, Iraq.	river202002@yahoo.com; phh4@le.ac.uk	Heslop-Harrison, J.S./M-9826-2019	Heslop-Harrison, J.S./0000-0002-3105-2167; Schwarzacher, Trude/0000-0001-8310-5489; Majesky, Lubos/0000-0002-8860-5703				Ahmed I, 2012, GENOME BIOL EVOL, V4, P1316, DOI 10.1093/gbe/evs110; Asker S. E., 1992, APOMIXIS PLANTS; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Bruni I, 2015, FOOD CHEM, V170, P308, DOI 10.1016/j.foodchem.2014.08.060; Bruni I, 2010, INT J LEGAL MED, V124, P595, DOI 10.1007/s00414-010-0447-3; Choi KS, 2015, GENE, V572, P214, DOI 10.1016/j.gene.2015.07.020; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Curci PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120589; Dempewolf H, 2010, MOL ECOL RESOUR, V10, P1048, DOI 10.1111/j.1755-0998.2010.02859.x; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Doorduin L, 2011, DNA RES, V28; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ellis JR, 2008, HEREDITY, V100, P574, DOI 10.1038/hdy.2008.11; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FORD H, 1985, BIOL J LINN SOC, V25, P169, DOI 10.1111/j.1095-8312.1985.tb00390.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Heslop-Harrison JS, 1997, GENETICA, V100, P197, DOI 10.1023/A:1018337831039; Hollingsworth PM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0338; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kanamoto H, 2004, PLANT CELL PHYSIOL, V45, pS39; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kilian N., 2009, SYSTEMATICS, P343; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; KING LM, 1990, P NATL ACAD SCI USA, V87, P998, DOI 10.1073/pnas.87.3.998; Kirschner J, 2003, PLANT SYST EVOL, V239, P231, DOI 10.1007/s00606-003-0002-5; Kirschner J, 2016, PRESLIA, V88, P1; Kirschner J, 2015, PLANT SYST EVOL, V301, P1135, DOI 10.1007/s00606-014-1139-0; Kumar S, 2009, BMC PLANT BIOL, V17, P1; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Liu PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048970; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu C, 2015, MITOCHONDR DNA, P1; Luo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099016; Majesky L, 2015, PLANT SYST EVOL, V301, P2105, DOI 10.1007/s00606-015-1218-x; Majesky L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041868; McCauley DE, 2007, AM J BOT, V94, P1333, DOI 10.3732/ajb.94.8.1333; MENDEL G, 1951, J HERED, V42, P3; Mes THM, 2002, MOL ECOL, V11, P253, DOI 10.1046/j.1365-294X.2002.01427.x; Mes THM, 2000, GENOME, V43, P634, DOI 10.1139/gen-43-4-634; MOGIE M, 1988, BIOL J LINN SOC, V35, P155, DOI 10.1111/j.1095-8312.1988.tb00463.x; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Nogler G. A, 1984, GAMETOPHYTIC APOMIXI; PALMER JD, 1982, CELL, V29, P537, DOI 10.1016/0092-8674(82)90170-2; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; RAUBESON LA, 1992, BIOCHEM SYST ECOL, V20, P17, DOI 10.1016/0305-1978(92)90067-N; Richards A. J., 1986, PLANT BREEDING SYSTE; RICHARDS AJ, 1973, BOT J LINN SOC, V66, P189, DOI 10.1111/j.1095-8339.1973.tb02169.x; RICHARDS AJ, 1989, PLANT SYST EVOL, V163, P177, DOI 10.1007/BF00936513; Saeidi H, 2006, GENET RESOUR CROP EV, V53, P1477, DOI 10.1007/s10722-005-7110-8; Sarkinen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082266; Shaw J, 2014, AM J BOT, V101, P1987, DOI 10.3732/ajb.1400398; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Stegemann S, 2012, P NATL ACAD SCI USA, V109, P2434, DOI 10.1073/pnas.1114076109; Sterk AA, 1987, PAARDE BLOEMEN PLANT, P184; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Tremetsberger K, 2013, ORG DIVERS EVOL, V13, P1, DOI 10.1007/s13127-012-0094-2; Turner KG, 2014, CENTAUREA DIFFUSA, V1; van der Hulst RGM, 2000, MOL ECOL, V9, P1, DOI 10.1046/j.1365-294x.2000.00704.x; Van der Hulst RGM, 2003, HEREDITY, V90, P326, DOI 10.1038/sj.hdy.6800248; Walker JF, 2014, AM J BOT, V101, P722, DOI 10.3732/ajb.1400049; Wang MX, 2015, PLANT MOL BIOL REP, V33, P1526, DOI 10.1007/s11105-015-0853-2; Wang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082692; Wittzell H, 1999, MOL ECOL, V8, P2023, DOI 10.1046/j.1365-294x.1999.00807.x; Wojciechowski MF, 2006, IRLC; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zehdi-Azouzi S, 2015, ANN BOT-LONDON, V116, P101, DOI 10.1093/aob/mcv068; Zhang Y, 2014, GENE, V549, P58, DOI 10.1016/j.gene.2014.07.041	76	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0168008	10.1371/journal.pone.0168008	http://dx.doi.org/10.1371/journal.pone.0168008			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182646	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800003
J	Gluchowska, M; Trudnowska, E; Goszczko, I; Kubiszyn, AM; Blachowiak-Samolyk, K; Walczowski, W; Kwasniewski, S				Gluchowska, Marta; Trudnowska, Emilia; Goszczko, Ilona; Kubiszyn, Anna Maria; Blachowiak-Samolyk, Katarzyna; Walczowski, Waldemar; Kwasniewski, Slawomir			Variations in the structural and functional diversity of zooplankton over vertical and horizontal environmental gradients en route to the Arctic Ocean through the Fram Strait	PLOS ONE			English	Article							WEST SPITSBERGEN CURRENT; MARGINAL ICE-ZONE; CALANUS-FINMARCHICUS; COMMUNITY STRUCTURE; NORTH-ATLANTIC; GREENLAND SEA; BARENTS-SEA; NORDIC SEAS; CANADA BASIN; SPRING BLOOM	A multi-scale approach was used to evaluate which spatial gradient of environmental variability is the most important in structuring zooplankton diversity in the West Spitsbergen Current (WSC). The WSC is the main conveyor of warm and biologically rich Atlantic water to the Arctic Ocean through the Fram Strait. The data set included 85 stratified vertical zooplankton samples (obtained from depths up to 1000 metres) covering two latitudinal sections (76 degrees 30' N and 79 degrees N) located across the multi-path WSC system. The results indicate that the most important environmental variables shaping the zooplankton structural and functional diversity and standing stock variability are those associated with depth, whereas variables acting in the horizontal dimension are of lesser importance. Multivariate analysis of the zooplankton assemblages, together with different univariate descriptors of zooplankton diversity, clearly illustrated the segregation of zooplankton taxa in the vertical plane. The epipelagic zone (upper 200 m) hosted plentiful, Oithona similis-dominated assemblages with a high proportion of filter-feeding zooplankton. Although total zooplankton abundance declined in the mesopelagic zone (200 - 1000 m), zooplankton assemblages in that zone were more diverse and more evenly distributed, with high contributions from both herbivorous and carnivorous taxa. The vertical distribution of integrated biomass (mg DW m (-2)) indicated that the total zooplankton biomass in the epipelagic and mesopelagic zones was comparable. Environmental gradients acting in the horizontal plane, such as the ones associated with different ice cover and timing of the spring bloom, were reflected in the latitudinal variability in protist community structure and probably caused differences in succession in the zooplankton community. High abundances of Calanus finmarchicus in the WSC core branch suggest the existence of mechanisms advantageous for higher productivity or/and responsible for physical concentration of zooplankton. Our results indicate that regional hydrography plays a primary role in shaping zooplankton variability in the WSC on the way to the Arctic Ocean, with additional effects caused by biological factors related to seasonality in pelagic ecosystem development, resulting in regional differences in food availability or biological production between the continental slope and the deep ocean regions.	[Gluchowska, Marta; Trudnowska, Emilia; Goszczko, Ilona; Kubiszyn, Anna Maria; Blachowiak-Samolyk, Katarzyna; Walczowski, Waldemar; Kwasniewski, Slawomir] Inst Oceanol Polish Acad Sci, Powstancow Warszawy Sopo, Poland	Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences	Gluchowska, M (corresponding author), Inst Oceanol Polish Acad Sci, Powstancow Warszawy Sopo, Poland.	mgluchowska@iopan.gda.pl	; Trudnowska, Emilia/K-9293-2016	Blachowiak-Samolyk, Katarzyna/0000-0001-8076-2168; Gluchowska, Marta/0000-0002-3032-4925; Walczowski, Waldemar/0000-0002-0243-3307; Trudnowska, Emilia/0000-0003-3471-6632; Kwasniewski, Slawomir/0000-0003-3104-0761; Goszczko, Ilona/0000-0002-5719-5860	Polish Scientific Council project KongHau_ZOOM [2375/Svalbard/2012/2]; Polish-Norwegian grant PAVE (Atlantic Water Pathways to the Arctic: Variability and Effects on Climate and Ecosystems) [POL-NOR/202006/10/2013]; Research Council of Norway project CarbonBridge (Bridging productivity regimes in the Arctic Ocean) [226415/E10]; Leading National Research Centre (KNOW); Institute of Oceanology, Polish Academy of Sciences (10 PAN)	Polish Scientific Council project KongHau_ZOOM; Polish-Norwegian grant PAVE (Atlantic Water Pathways to the Arctic: Variability and Effects on Climate and Ecosystems); Research Council of Norway project CarbonBridge (Bridging productivity regimes in the Arctic Ocean); Leading National Research Centre (KNOW); Institute of Oceanology, Polish Academy of Sciences (10 PAN)	The research leading to the presented results has received main financing from the Polish Scientific Council project KongHau_ZOOM (2375/Svalbard/2012/2). Additionally, it was also a contribution of the Polish-Norwegian grant PAVE (Atlantic Water Pathways to the Arctic: Variability and Effects on Climate and Ecosystems, No. POL-NOR/202006/10/2013); the Research Council of Norway project CarbonBridge (Bridging productivity regimes in the Arctic Ocean, No. 226415/E10); the funds of the Leading National Research Centre (KNOW) received by the Centre for Polar Studies for the period 2014-2018, and, last but not least, from the budget of the statutory activity of the Institute of Oceanology, Polish Academy of Sciences (10 PAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAGAARD K, 1987, J GEOPHYS RES-OCEANS, V92, P3778, DOI 10.1029/JC092iC04p03778; Aarbakke ONS, 2017, POLAR BIOL, V40, P51, DOI 10.1007/s00300-016-1923-0; aeter T., 1994, PHYS BIOL FACTORS IN; Anderson M., 2005, PERMANOVA PERMUTATIO; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Auel H, 2003, J EXP MAR BIOL ECOL, V296, P183, DOI 10.1016/S0022-0981(03)00321-6; Auel H, 2002, MAR BIOL, V140, P1013, DOI 10.1007/s00227-001-0775-4; BAMSTEDT U, 1991, POLAR RES, V10, P339, DOI 10.1111/j.1751-8369.1991.tb00658.x; Bamstedt U, 1986, CHEM COMPOSITION ENE, P1; BANSE K., 1964, PROGR OCEANOGR, V2, P53, DOI 10.1016/0079-6611(64)90003-5; Beaugrand G, 2000, MAR ECOL PROG SER, V204, P299, DOI 10.3354/meps204299; Beaugrand G, 2002, MAR ECOL PROG SER, V232, P179, DOI 10.3354/meps232179; BERESTOVSKII EG, 1989, RELATIONSHIPS SIZE B; Beszczynska-Moller A, 2012, ICES J MAR SCI, V69, P852, DOI 10.1093/icesjms/fss056; Biswas SR, 2010, ECOLOGY, V91, P28, DOI 10.1890/08-0887.1; Blachowiak-Samolyk K, 2006, MAR ECOL PROG SER, V308, P101, DOI 10.3354/meps308101; Blachowiak-Samolyk K, 2008, DEEP-SEA RES PT II, V55, P2210, DOI 10.1016/j.dsr2.2008.05.018; Blachowiak-Samolyk K, 2007, DEEP-SEA RES PT II, V54, P2716, DOI 10.1016/j.dsr2.2007.08.004; BOURKE RH, 1988, J GEOPHYS RES-OCEANS, V93, P14065, DOI 10.1029/JC093iC11p14065; Carmack E, 2006, PROG OCEANOGR, V71, P446, DOI 10.1016/j.pocean.2006.10.004; Carstensen J, 2012, J PLANKTON RES, V34, P951, DOI 10.1093/plankt/fbs059; Cherkasheva A, 2014, J MARINE SYST, V132, P196, DOI 10.1016/j.jmarsys.2013.11.008; Clarke K., 2001, PRIMER V5 USER MANUA; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Daase M, 2008, MAR BIOL RES, V4, P193, DOI 10.1080/17451000801907948; DEIBEL D, 1986, MAR BIOL, V93, P429, DOI 10.1007/BF00401110; Edler L., RECOMMENDATIONS METH; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; EILERTSEN HC, 1989, POLAR BIOL, V9, P253, DOI 10.1007/BF00263773; Estrada R, 2012, PROG OCEANOGR, V101, P121, DOI 10.1016/j.pocean.2012.02.003; Evans C, 1983, MANUAL MEASUREMENT C; Falk-Petersen S, 2000, J MARINE SYST, V27, P131, DOI 10.1016/S0924-7963(00)00064-6; FENAUX R, 1976, MAR BIOL, V34, P229, DOI 10.1007/BF00388800; Folt CL, 1999, TRENDS ECOL EVOL, V14, P300, DOI 10.1016/S0169-5347(99)01616-X; FRANKS PJS, 1992, MAR ECOL PROG SER, V82, P1, DOI 10.3354/meps082001; Gallienne CP, 2001, J PLANKTON RES, V23, P1421, DOI 10.1093/plankt/23.12.1421; Garcon VC, 2001, DEEP-SEA RES PT II, V48, P2199, DOI 10.1016/S0967-0645(00)00183-1; Gislason A., 2003, LIFE CYCLE STRATEGIE; Godo OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030161; GRADINGER RR, 1991, MAR BIOL, V111, P311, DOI 10.1007/BF01319714; Hansen BW, 1999, AQUAT MICROB ECOL, V16, P233, DOI 10.3354/ame016233; Hansen PJ, 1997, LIMNOL OCEANOGR, V42, P687, DOI 10.4319/lo.1997.42.4.0687; Harris R., 2000, ICES ZOOPLANKTON MET; Hawkins BA, 2004, ECOGRAPHY, V27, P268, DOI 10.1111/j.0906-7590.2004.03883.x; HAY SJ, 1991, CONT SHELF RES, V11, P1453, DOI 10.1016/0278-4343(91)90021-W; Head EJH, 2003, PROG OCEANOGR, V59, P1, DOI 10.1016/S0079-6611(03)00111-3; Heip C, 1985, MARINE BIOL; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hirche H.-J., 1991, Journal of Marine Systems, V2, P477, DOI 10.1016/0924-7963(91)90048-Y; Hirche HJ, 2007, DEEP-SEA RES PT II, V54, P2729, DOI 10.1016/j.dsr2.2007.08.006; Hirche HJ, 1996, OPHELIA, V44, P129, DOI 10.1080/00785326.1995.10429843; Hop H, 2006, PROG OCEANOGR, V71, P182, DOI 10.1016/j.pocean.2006.09.007; Hopcroft RR, 1998, MAR BIOL, V132, P67, DOI 10.1007/s002270050372; Hopcroft RR, 2005, POLAR BIOL, V28, P198, DOI 10.1007/s00300-004-0680-7; Hopcroft RR, 2010, DEEP-SEA RES PT II, V57, P27, DOI 10.1016/j.dsr2.2009.08.003; Hygum BH, 2000, MAR BIOL, V136, P1075, DOI 10.1007/s002270000313; Hygum BH, 2000, ICES J MAR SCI, V57, P1740, DOI 10.1006/jmsc.2000.0956; Ikeda T, 1999, J PLANKTON RES, V21, P299, DOI 10.1093/plankt/21.2.299; Ingels J, 2013, BIOGEOSCIENCES, V10, P4547, DOI 10.5194/bg-10-4547-2013; Kosobokova K, 2000, DEEP-SEA RES PT I, V47, P2029, DOI 10.1016/S0967-0637(00)00015-7; Kosobokova K, 2009, PROG OCEANOGR, V82, P265, DOI 10.1016/j.pocean.2009.07.006; Kosobokova KN, 2010, DEEP-SEA RES PT II, V57, P96, DOI 10.1016/j.dsr2.2009.08.009; Kubiszyn A, 2014, J PLANKTON RES; Kwasniewski S, 2003, J PLANKTON RES, V25, P1, DOI 10.1093/plankt/25.1.1; Kwasniewski S, 2010, PROG OCEANOGR, V87, P72, DOI 10.1016/j.pocean.2010.06.004; Labat JP, 2009, DEEP-SEA RES PT I, V56, P1742, DOI 10.1016/j.dsr.2009.05.013; Lane PVZ, 2008, J MARINE SYST, V70, P97, DOI 10.1016/j.jmarsys.2007.04.001; Loeng H, 2007, DEEP-SEA RES PT II, V54, P2478, DOI 10.1016/j.dsr2.2007.08.013; MACKAS DL, 1982, J MAR RES, V40, P1173; MATTHEWS JBL, 1977, SARSIA, V63, P57, DOI 10.1080/00364827.1977.10411322; Mayzaud P, 2013, MAR BIOL, V160, P383, DOI 10.1007/s00227-012-2095-2; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Miles MW, 2014, GEOPHYS RES LETT, V41, P463, DOI 10.1002/2013GL058084; Morison J, 2000, ARCTIC, V53, P359; Mumm N., 1991, SUMMERLY DISTRIBUTIO, P92; Nilsen F, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002991; Nothig EM, 2015, POLAR RES, V34, DOI 10.3402/polar.v34.23349; Nost OA, 2003, J MAR RES, V61, P175, DOI 10.1357/002224003322005069; Oliver KIC, 2008, J PHYS OCEANOGR, V38, P2755, DOI 10.1175/2008JPO3844.1; Paganelli D, 2012, ESTUAR COAST SHELF S, V96, P245, DOI 10.1016/j.ecss.2011.11.014; PEDERSEN G, 1995, ICES J MAR SCI, V52, P523, DOI 10.1016/1054-3139(95)80066-2; PERKIN RG, 1984, J PHYS OCEANOGR, V14, P1315, DOI 10.1175/1520-0485(1984)014<1315:MITWSC>2.0.CO;2; Piwosz K, 2009, POLAR BIOL, V32, P549, DOI 10.1007/s00300-008-0549-2; Poltermann M., 1997, BIOL ECOLOGY CRYOPEL, P225; Polyakov IV, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023740; Pomerleau C, 2015, J PLANKTON RES, V37, P712, DOI 10.1093/plankt/fbv045; QUADFASEL D, 1987, J GEOPHYS RES-OCEANS, V92, P6719, DOI 10.1029/JC092iC07p06719; Reigstad M, 2011, PROG OCEANOGR, V90, P33, DOI 10.1016/j.pocean.2011.02.005; Richter C., 1994, BER POLARFORSCH, V154, P1, DOI 10.2312/BzP_0154_1994; Saiz E, 2013, DEEP-SEA RES PT I, V72, P17, DOI 10.1016/j.dsr.2012.10.003; SAMEOTO DD, 1984, POLAR BIOL, V2, P213, DOI 10.1007/BF00263627; Schauer U, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001823; Schittko C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099065; Schlitzer R., 2021, OCEAN DATA VIEW VS 5; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Seuthe L, 2011, POLAR BIOL, V34, P751, DOI 10.1007/s00300-010-0930-9; SMITH SL, 1988, J MAR RES, V46, P145, DOI 10.1357/002224088785113720; Soreide JE, 2008, DEEP-SEA RES PT II, V55, P2225, DOI 10.1016/j.dsr2.2008.05.024; Speirs DC, 2006, MARINE ECOLOGY PROGR, V313; SPIES A, 1987, POLAR BIOL, V7, P195, DOI 10.1007/BF00287416; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Svensen C, 2011, PROG OCEANOGR, V91, P534, DOI 10.1016/j.pocean.2011.08.001; Teigen SH, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005996; Thor P, 2005, J PLANKTON RES, V27, P341, DOI 10.1093/plankt/fbi010; Trudnowska E, 2016, MAR ECOL PROG SER, V560, P1, DOI 10.3354/meps11925; Turner JT, 2001, MAR ECOL PROG SER, V221, P209, DOI 10.3354/meps221209; Turner JT, 2004, ZOOL STUD, V43, P255; Utermohl H., 1958, VERVOLLKOMMNUNG QUAN; Walczowski W, 2005, DEEP-SEA RES PT I, V52, P1374, DOI 10.1016/j.dsr.2005.03.009; Walczowski W, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029974; Walczowski W, 2011, INT J CLIMATOL, V31, P1088, DOI 10.1002/joc.2338; Weydmann A, 2014, MAR ECOL PROG SER, V501, P41, DOI 10.3354/meps10694; Wiebe PH, 2003, PROG OCEANOGR, V56, P7, DOI 10.1016/S0079-6611(02)00140-4; Woodd-Walker RS, 2002, MAR ECOL PROG SER, V236, P189, DOI 10.3354/meps236189; Yamaguchi A, 2000, MAR BIOL, V137, P99; Yebra L, 2009, DEEP-SEA RES PT I, V56, P703, DOI 10.1016/j.dsr.2008.11.008	116	21	24	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171715	10.1371/journal.pone.0171715	http://dx.doi.org/10.1371/journal.pone.0171715			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178320	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000393712500062
J	Hendrikx, T; Sundqvist, M; Sandstrom, H; Sahlin, C; Rohani, M; Al-Khalili, F; Hornsten, R; Blomberg, A; Wester, P; Rosenqvist, M; Franklin, KA				Hendrikx, Tijn; Sundqvist, Martin; Sandstrom, Herbert; Sahlin, Carin; Rohani, Morteza; Al-Khalili, Faris; Hornsten, Rolf; Blomberg, Anders; Wester, Per; Rosenqvist, Marten; Franklin, Karl A.			Atrial fibrillation among patients under investigation for suspected obstructive sleep apnea	PLOS ONE			English	Article							DAYTIME SLEEPINESS; RISK-FACTOR; ASSOCIATION; STROKE; GUIDELINES; MANAGEMENT; RECURRENCE	Study objectives Obstructive sleep apnea is common among patients with atrial fibrillation, but the prevalence and risk factors for atrial fibrillation among patients who are being investigated on suspicion of sleep apnea are not well known. The aim of the study was to estimate the prevalence of atrial fibrillation among patients investigated for suspected obstructive sleep apnea and to identify risk factors for atrial fibrillation among them. Methods The prevalence of atrial fibrillation was investigated among 201 patients referred for suspected obstructive sleep apnea. Patients without known atrial fibrillation were investigated with a standard 12 -lead ECG at hospital and short intermittent handheld ECG recordings at home, during 14 days. Results Atrial fibrillation occurred in 13 of 201 subjects (6.5%), and in 12 of 61 men aged 60 years and older (20%). The prevalence of atrial fibrillation increased with sleep apnea severity (p = 0.038). All patients with atrial fibrillation were men and all had sleep apnea. Age 60 or older, the occurrence of central sleep apnea and diabetes mellitus were independent risk factors for atrial fibrillation after adjustments for body mass index, gender, sleep apnea and cardiovascular disease. Conclusions Atrial fibrillation is common among subjects referred for sleep apnea investigation and the prevalence of atrial fibrillation increases with sleep apnea severity. Independent risk factors for atrial fibrillation among patients investigated for suspected obstructive sleep apnea include the occurrence of coexisting central sleep apnea, age 60 years or older and diabetes mellitus.	[Hendrikx, Tijn; Sandstrom, Herbert] Umea Univ, Publ Hlth & Clin Med, Family Med, Umea, Sweden; [Sundqvist, Martin] Soder Sjukhuset, Karolinska Inst, Clin Sci & Educ, Stockholm, Sweden; [Sahlin, Carin; Blomberg, Anders; Wester, Per] Umea Univ, Publ Hlth & Clin Med, Med, Umea, Sweden; [Rohani, Morteza; Al-Khalili, Faris] Danderyd Hosp, Karolinska Inst, Clin Sci, Stockholm, Sweden; [Rohani, Morteza] Nord Heart Ctr, Stockholm, Sweden; [Al-Khalili, Faris] Stockholm Heart Ctr, Stockholm, Sweden; [Hornsten, Rolf] Umea Univ, Clin Physiol, Surg & Perioperat Sci, Umea, Sweden; [Rosenqvist, Marten] Danderyd Hosp, Karolinska Inst, Clin Sci, Stockholm, Sweden; [Franklin, Karl A.] Umea Univ, Surg & Perioperat Sci, Surg, Umea, Sweden	Umea University; Karolinska Institutet; Sodersjukhuset Hospital; Umea University; Danderyds Hospital; Karolinska Institutet; Umea University; Danderyds Hospital; Karolinska Institutet; Umea University	Hendrikx, T (corresponding author), Umea Univ, Publ Hlth & Clin Med, Family Med, Umea, Sweden.	tijn.hendrikx@fammed.umu.se		Blomberg, Anders/0000-0002-2452-7347; Franklin, Karl/0000-0002-5306-1697	Vinnvard Foundation; Swedish Heart and Lung Foundation; Umea University	Vinnvard Foundation; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Umea University	This study was supported by grants from the Vinnvard Foundation, the Swedish Heart and Lung Foundation and Umea University. Zenicor Medical Systems AB, Stockholm, provided handheld ECG devices (Zenicor-EKG (R)) at a reduced price. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albuquerque FN, 2012, CHEST, V141, P967, DOI 10.1378/chest.11-0975; Asirvatham SJ, 2009, J AM COLL CARDIOL, V54, P2084, DOI 10.1016/j.jacc.2009.09.017; BALFORS EM, 1994, AM J RESP CRIT CARE, V150, P1587, DOI 10.1164/ajrccm.150.6.7952619; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Braga B, 2009, SLEEP MED, V10, P212, DOI 10.1016/j.sleep.2007.12.007; Cadby G, 2015, CHEST, V148, P945, DOI 10.1378/chest.15-0229; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Doliwa PS, 2009, SCAND CARDIOVASC J, V43, P163, DOI 10.1080/14017430802593435; Falk RH, 2001, NEW ENGL J MED, V344, P1067, DOI 10.1056/NEJM200104053441407; Fein AS, 2013, J AM COLL CARDIOL, V62, P300, DOI 10.1016/j.jacc.2013.03.052; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Franklin KA AS, 2007, REPORT OF A JOINT NO; Friberg L, 2013, J Intern Med, V274, P461, DOI 10.1111/joim.12114; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Gami AS, 2004, CIRCULATION, V110, P364, DOI 10.1161/01.CIR.0000136587.68725.8E; Ghias M, 2009, J AM COLL CARDIOL, V54, P2075, DOI 10.1016/j.jacc.2009.09.014; HEDNER J, 1988, J HYPERTENS, V6, pS529, DOI 10.1097/00004872-198812040-00166; Javaheri S, 1999, NEW ENGL J MED, V341, P949, DOI 10.1056/NEJM199909233411304; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kanagala R, 2003, CIRCULATION, V107, P2589, DOI 10.1161/01.CIR.0000068337.25994.21; KANNEL WB, 1998, AM J CARDIOL, V0082; Leung RST, 2005, SLEEP, V28, P1543, DOI 10.1093/sleep/28.12.1543; Marin JM, 2014, J INTERN MED, V276, P648, DOI 10.1111/joim.12300; Mehra R, 2006, AM J RESP CRIT CARE, V173, P910, DOI 10.1164/rccm.200509-1442OC; Neilan TG, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000421; Parra O, 2000, AM J RESP CRIT CARE, V161, P375, DOI 10.1164/ajrccm.161.2.9903139; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Sahlin C, 2008, ARCH INTERN MED, V168, P297, DOI 10.1001/archinternmed.2007.70; Shukla Ashish, 2015, JACC Clin Electrophysiol, V1, P41, DOI 10.1016/j.jacep.2015.02.014; Sin DD, 1999, AM J RESP CRIT CARE, V160, P1101, DOI 10.1164/ajrccm.160.4.9903020; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Valham F, 2008, CIRCULATION, V118, P955, DOI 10.1161/CIRCULATIONAHA.108.783290; Wilson D, 2014, INT J CARDIOL, V172, P297, DOI 10.1016/j.ijcard.2014.01.007; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104	36	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171575	10.1371/journal.pone.0171575	http://dx.doi.org/10.1371/journal.pone.0171575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178304	Green Submitted, Green Published, gold			2022-12-26	WOS:000393712500051
J	Levy, TS; Mendez-Gomez-Humaran, I; Ruan, MDM; Tapia, BM; Hernandez, SV; Avila, MH				Shamah Levy, Teresa; Mendez-Gomez-Humaran, Ignacio; Morales Ruan, Maria del Carmen; Martinez Tapia, Brenda; Villalpando Hernandez, Salvador; Hernandez Avila, Mauricio			Validation of Masimo Pronto 7 and HemoCue 201 for hemoglobin determination in children from 1 to 5 years of age	PLOS ONE			English	Article							CAPILLARY; ACCURACY; DEVICE; ANEMIA; SYSTEM; BLOOD	Objective To evaluate the accuracy and precision of HemoCue 201 (HemoCue) and Masimo Pronto 7 (Masimo) devices for measuring hemoglobin (Hb) in epidemiological studies, having venous blood samples as a gold standard. Material and methods We measured Hb concentrations in a field sample of 148 children from one to five years of age. Masimo and HemoCue were used for capillary blood samples and an automatic analyzer for venous blood samples. Regression models with no intercept were constructed to measure precision and predictability, concordance correlations to measure accuracy and precision, and Bland-Altman limits of agreement as well as hierarchical linear models to estimate variance. Results Both HemoCue and Masimo underestimated Hb concentrations compared to the gold standard. They respectively yielded the following results: regression coefficients of 0.887 and 0.876 with 98.7% and 98.6% predictability; concordance correlation coefficients of 0.183 (p<0.001) and 0.166 (p<0.001); and Bland-Altman variances of -1.51 and -1.62. With regard to Masimo specifically, the three-level Hierarchical Linear Model showed that 57.9% of total variance stemmed from random errors in repeated measures from the same subject. Conclusions HemoCue and Masimo measure lower Hb concentrations than the gold standard. Their accuracy and precision levels are comparable. It is essential to ensure proper use of devices through enhanced training of field workers.	[Shamah Levy, Teresa; Morales Ruan, Maria del Carmen; Martinez Tapia, Brenda; Villalpando Hernandez, Salvador; Hernandez Avila, Mauricio] Natl Publ Hlth Inst INSP, Cuernavaca, Morelos, Mexico; [Mendez-Gomez-Humaran, Ignacio] Ctr Res Math, Aguascalientes, Aguascalientes, Mexico		Mendez-Gomez-Humaran, I (corresponding author), Ctr Res Math, Aguascalientes, Aguascalientes, Mexico.	imendez@cimat.mx	HUMARAN, IGNACIO MENDEZ GOMEZ/S-7593-2018	HUMARAN, IGNACIO MENDEZ GOMEZ/0000-0002-3908-0867; Morales Ruan, Carmen/0000-0002-6754-4630	Laboratorio Reactivos y Quimicos S.A. de C.V. from Mexico	Laboratorio Reactivos y Quimicos S.A. de C.V. from Mexico	The funds for this study were supported by the Laboratorio Reactivos y Quimicos S.A. de C.V. from Mexico. The grant was 10,000 USD. The funders had no role in study design, data collectionand analysis, decision to publish, or preparation of the manuscript.	Amano I, 2013, PEDIATR INT, V55, P803, DOI 10.1111/ped.12236; [Anonymous], 2010, OPERATORS MANUAL; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bridges N, 1987, AM CLIN PROD REV, V6, P22; Bruells CS, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-159; CHEN PP, 1992, ANAESTH INTENS CARE, V20, P497, DOI 10.1177/0310057X9202000419; COHEN AR, 1988, AM J CLIN PATHOL, V90, P302, DOI 10.1093/ajcp/90.3.302; Morales-Ruan MD, 2013, SALUD PUBLICA MEXICO, V55, pS199; Giraud B, 2013, BRIT J ANAESTH, V111, P946, DOI 10.1093/bja/aet252; Gutierrez JP, 2012, ENCUESTA NACL SALUDY; Hiscock R, 2015, ANAESTH INTENS CARE, V43, P341, DOI 10.1177/0310057X1504300310; International committee for standardization in haematology, 1967, BRIT J HAEMATOL, V13, P71; Lamhaut L, 2011, ANESTHESIOLOGY, V115, P548, DOI 10.1097/ALN.0b013e3182270c22; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Neufeld L, 2002, SALUD PUBLICA MEXICO, V44, P219, DOI 10.1590/S0036-36342002000300005; NEVILLE RG, 1987, BRIT MED J, V294, P1263, DOI 10.1136/bmj.294.6582.1263; Patel AJ, 2013, VOX SANG, V104, P317, DOI 10.1111/vox.12006; Vankampen E, 1961, CLIN CHIM ACTA, V6, P538, DOI 10.1016/0009-8981(61)90145-0; VONSCHENCK H, 1986, CLIN CHEM, V32, P526; WHO/UNICEF, 2014, GLOB NUTR TARG 2025, DOI [10.1057/9781137477699_6, DOI 10.1057/9781137477699_6]; World Health Organization, 2011, SER FERR CONC ASS IR	22	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170990	10.1371/journal.pone.0170990	http://dx.doi.org/10.1371/journal.pone.0170990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170445	Green Submitted, Green Published, gold			2022-12-26	WOS:000393705500016
J	Agusto, FB; ELmojtaba, IM				Agusto, Folashade B.; ELmojtaba, Ibrahim M.			Optimal control and cost-effective analysis of malaria/visceral leishmaniasis co-infection	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; SENSITIVITY ANALYSIS; SELF-MEDICATION; RISK-FACTORS; KALA-AZAR; MALARIA; IDENTIFICATION; TRANSMISSION; PREVALENCE; RESERVOIRS	In this paper, a deterministic model involving the transmission dynamics of malaria/visceral leishmaniasis co-infection is presented and studied. Optimal control theory is then applied to investigate the optimal strategies for curtailing the spread of the diseases using the use of personal protection, indoor residual spraying and culling of infected reservoirs as the system control variables. Various combination strategies were examined so as to investigate the impact of the controls on the spread of the disease. And we investigated the most cost-effective strategy of all the control strategies using three approaches, the infection averted ratio (IAR), the average cost-effectiveness ratio (ACER) and incremental cost-effectiveness ratio (ICER). Our results show that the implementation of the strategy combining all the time dependent control variables is the most cost-effective control strategy. This result is further emphasized by using the results obtained from the cost objective functional, the ACER, and the ICER.	[Agusto, Folashade B.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [ELmojtaba, Ibrahim M.] Sultan Qaboos Univ, Coll Sci, Dept Math & Stat, POB 36, Al Khoud, Oman	University of Kansas; Sultan Qaboos University	Agusto, FB (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	fbagusto@gmail.com	Elmojtaba, Ibrahim/AAH-4270-2020	ELmojtaba, Ibrahim/0000-0001-6018-4671; Agusto, Folashade/0000-0001-6137-6480	Sultan Qaboos University [IG\DOMS\16\16]	Sultan Qaboos University	ELmojtaba was supported by grant No: IG\DOMS\16\16, from Sultan Qaboos University.; The research of I. M. Elmojtaba is supported by grant No: IG\DOMS\16\16, from Sultan Qaboos University.	Agusto FB, 2013, BIOSYSTEMS, V113, P155, DOI 10.1016/j.biosystems.2013.06.004; Agusto F, 2013, J BIOL SYST, V21, DOI 10.1142/S0218339013400020; Agusto FB, 2012, ELECTRON J DIFFER EQ; [Anonymous], 2013, AFR J PHARM THER; Arriola LM, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.27; Awad A, 2005, J PHARM PHARM SCI, V8, P326; Bashaye S, 2009, AM J TROP MED HYG, V81, P34, DOI 10.4269/ajtmh.2009.81.34; Chipwaza B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-252; Chitnis N, 2006, SIAM J APPL MATH, V67, P24, DOI 10.1137/050638941; Chitnis N, 2013, J BIOL DYNAM, V7, P11, DOI 10.1080/17513758.2012.733427; Coutinho FAB, 2005, MATH COMPUT SIMULAT, V70, P149, DOI 10.1016/j.matcom.2005.06.003; Deressa W, 2003, B WORLD HEALTH ORGAN, V81, P261; Dereure J, 2000, T ROY SOC TROP MED H, V94, P154, DOI 10.1016/S0035-9203(00)90253-0; Dereure J, 2003, MICROBES INFECT, V5, P1103, DOI 10.1016/j.micinf.2003.07.003; Diniz SA, 2008, J INFECT DEV COUNTR, V2, P24; ELmojtaba IM, 2016, MATH METHOD APPL SCI, V39, P4334, DOI 10.1002/mma.3864; FIALHO RF, 1995, J ANIM ECOL, V64, P553, DOI 10.2307/5799; Fleming WH, 2012, DETERMINISTIC STOCHA, V1; Gasim S, 2000, CLIN EXP IMMUNOL, V119, P523, DOI 10.1046/j.1365-2249.2000.01163.x; Gemperli A, 2006, AM J EPIDEMIOL, V163, P289, DOI 10.1093/aje/kwj026; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Hassan MM, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-26; HELTON JC, 1985, ECOL MODEL, V28, P243, DOI 10.1016/0304-3800(85)90077-8; Joshi HR, 2002, OPTIM CONTR APPL MET, V23, P199, DOI 10.1002/oca.710; Jung E, 2002, DISCRETE CONT DYN-B, V2, P473; Kasap OE, 2006, J VECTOR ECOL, V31, P378, DOI 10.3376/1081-1710(2006)31[378:CDOTSF]2.0.CO;2; Kern Daniel L, 2007, J Biol Dyn, V1, P413, DOI 10.1080/17513750701605556; Kirschner D, 1997, J MATH BIOL, V35, P775, DOI 10.1007/s002850050076; LAINSON R, 1987, Memorias do Instituto Oswaldo Cruz, V82, P421, DOI 10.1590/S0074-02761987000300015; Laxminarayan R, 2004, AM J TROP MED HYG, V71, P187, DOI 10.4269/ajtmh.2004.71.187; Lenhart S., 2007, OPTIMAL CONTROL APPL; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Maroli M., 2004, Parassitologia (Rome), V46, P211; MUTINGA MJ, 1980, ANN TROP MED PARASIT, V74, P139, DOI 10.1080/00034983.1980.11687323; Osemene KP, 2012, TROP J PHARM RES, V11, P683, DOI 10.4314/tjpr.v11i4.21; Pang LY, 2016, CHAOS SOLITON FRACT, V87, P293, DOI 10.1016/j.chaos.2016.03.032; Pontryagin LS, 1987, MATH THEORY OPTIMAL; Stager S, 2010, IMMUNOL RES, V47, P14, DOI 10.1007/s12026-009-8135-4; Sundar S, 2001, BRIT MED J, V323, P419, DOI 10.1136/bmj.323.7310.419; van den Bogaart E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-332; van den Bogaart E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001617; WHO, 2012, POST KAL AZ DERM LEI; Yan X, 2008, MATH COMPUT MODEL, V47, P235, DOI 10.1016/j.mcm.2007.04.003; Zijistra EE, 2003, LANCET INFECT DIS, V3, P87, DOI 10.1016/S1473-3099(03)00517-6; Zijlstra EE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1721-0	45	38	38	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171102	10.1371/journal.pone.0171102	http://dx.doi.org/10.1371/journal.pone.0171102			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166308	Green Submitted, Green Published, gold			2022-12-26	WOS:000393700100022
J	Cho, S; Lee, TS; Song, IH; Kim, AR; Lee, YJ; Kim, H; Hwang, H; Jeong, MS; Kang, SG; Hong, HJ				Cho, Seulki; Lee, Tae Sup; Song, In Ho; Kim, A-Ram; Lee, Yoon-Jin; Kim, Haejung; Hwang, Haein; Jeong, Mun Sik; Kang, Seung Goo; Hong, Hyo Jeong			Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma	PLOS ONE			English	Article							BILIARY-TRACT CANCER; FACTOR RECEPTOR ACTIVATION; GALLBLADDER CARCINOMA; OPEN-LABEL; PHASE-II; N-CAM; L1; MULTICENTER; L1CAM; OXALIPLATIN	Cholangiocarcinoma has a poor prognosis and is refractory to conventional chemotherapy and radiation therapy. Improving survival of patients with advanced cholangiocarcinoma urgently requires the development of new effective targeted therapies in combination with chemotherapy. We previously developed a human monoclonal antibody (mAb) Ab417 that binds to both the human and mouse L1 cell adhesion molecule (L1CAM) with high affinities. In the present study, we observed that Ab417 exhibited tumor targeting ability in biodistribution studies and dose-dependent tumor growth inhibition in an intrahepatic cholangiocarcinoma (Choi-CK) xenograft mouse model. Regarding the mechanism of action, Ab417 was internalized into the tumor cells and thereby down-regulated membrane L1CAM, and inhibited tumor growth by reducing tumor cell proliferation in vivo. Gemcitabine inhibited the tumor growth in a dose-dependent manner in the Choi-CK xenograft model. However, cisplatin inhibited the tumor growth moderately and not in a dose-dependent way, suggesting that the tumors may have developed resistance to apoptosis induced by cisplatin. Combined treatment with Ab417 and gemcitabine or cisplatin exerted enhanced tumor growth inhibition compared to treatment with antibody or drug alone. The results suggest that Ab417 in combination with chemotherapy may have potential as a new therapeutic regimen for cholangiocarcinoma. Our study is the first to show an enhanced therapeutic effect of a therapeutic antibody targeting L1CAM in combination with chemotherapy in cholangiocarcinoma models.	[Cho, Seulki] Univ Sci & Technol, Dept Funct Genom, Daejeon, South Korea; [Cho, Seulki; Hong, Hyo Jeong] Kangwon Natl Univ, Inst Biosci & Biotechnol, Chunchon, South Korea; [Lee, Tae Sup; Song, In Ho] Korea Inst Radiol & Med Sci, Div RI Convergence Res, Seoul, South Korea; [Kim, A-Ram; Lee, Yoon-Jin] Korea Inst Radiol & Med Sci, Div Basic Radiat Biosci, Seoul, South Korea; [Kim, Haejung] Kangwon Natl Univ, Dept Biol, Chunchon, South Korea; [Hwang, Haein; Jeong, Mun Sik; Kang, Seung Goo; Hong, Hyo Jeong] Kangwon Natl Univ, Dept Syst Immunol, Chunchon, South Korea	University of Science & Technology (UST); Kangwon National University; Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; Kangwon National University; Kangwon National University	Hong, HJ (corresponding author), Kangwon Natl Univ, Inst Biosci & Biotechnol, Chunchon, South Korea.; Hong, HJ (corresponding author), Kangwon Natl Univ, Dept Syst Immunol, Chunchon, South Korea.	hjhong@kangwon.ac.kr	LEE, TAE SUP/K-9638-2019	Kang, Seung Goo/0000-0003-3981-1399; Lee, Tae Sup/0000-0002-8266-7380	Korea Drug Development Fund (KDDF) - Ministry of Science, ICT and Future Planning, Ministry of Trade, Industry & Energy and Ministry of Health Welfare [KDDF-201212-12]; Kangwon National University [520160427]; Leaders INdustry-university Cooperation Project - Ministry of Education, Science & Technology (MEST) [C1012957-01-01]	Korea Drug Development Fund (KDDF) - Ministry of Science, ICT and Future Planning, Ministry of Trade, Industry & Energy and Ministry of Health Welfare; Kangwon National University; Leaders INdustry-university Cooperation Project - Ministry of Education, Science & Technology (MEST)	This research was supported by a grant (KDDF-201212-12) from the Korea Drug Development Fund (KDDF) funded by Ministry of Science, ICT and Future Planning, Ministry of Trade, Industry & Energy and Ministry of Health & Welfare, 2016 Research Grant from Kangwon National University (No. 520160427), and the Leaders INdustry-university Cooperation Project supported by the Ministry of Education, Science & Technology (MEST) (No. C1012957-01-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altevogt P, 2016, INT J CANCER, V138, P1565, DOI 10.1002/ijc.29658; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Cho S, 2016, MABS-AUSTIN, V8, P414, DOI 10.1080/19420862.2015.1125067; Choi SY, 2011, HUM PATHOL, V42, P1476, DOI 10.1016/j.humpath.2011.01.003; Colombo F, 2015, TRENDS PHARMACOL SCI, V36, P769, DOI 10.1016/j.tips.2015.08.004; Debiec H, 1998, J CELL BIOL, V143, P2067, DOI 10.1083/jcb.143.7.2067; Ebeling O, 1996, EUR J IMMUNOL, V26, P2508, DOI 10.1002/eji.1830261035; Haspel J, 2003, FRONT BIOSCI-LANDMRK, V8, pS1210, DOI 10.2741/1108; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Jung J, 2011, ONCOL REP, V25, P945, DOI 10.3892/or.2011.1181; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Kim DG, 2001, GENE CHROMOSOME CANC, V30, P48, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1053>3.0.CO;2-P; Lee CS, 1995, PATHOL RES PRACT, V191, P1087, DOI 10.1016/S0344-0338(11)80652-7; Lee J, 2012, LANCET ONCOL, V13, P181, DOI 10.1016/S1470-2045(11)70301-1; Li S, 2009, CLIN CANCER RES, V15, P7345, DOI 10.1158/1078-0432.CCR-09-0959; Malka D, 2014, LANCET ONCOL, V15, P819, DOI 10.1016/S1470-2045(14)70212-8; Min JK, 2010, CLIN CANCER RES, V16, P3571, DOI 10.1158/1078-0432.CCR-09-3075; Okusaka T, 2006, CANCER CHEMOTH PHARM, V57, P647, DOI 10.1007/s00280-005-0095-3; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Pancook JD, 1997, J IMMUNOL, V158, P4413; Press OW, 1996, CANCER RES, V56, P2123; Ramirez-Merino N, 2013, WORLD J GASTRO ONCOL, V5, P171, DOI 10.4251/wjgo.v5.i7.171; RATHJEN FG, 1984, EMBO J, V3, P1; Rizvi S, 2014, SEMIN LIVER DIS, V34, P456, DOI 10.1055/s-0034-1394144; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Song IH, 2016, J NUCL MED, V57, P1105, DOI 10.2967/jnumed.115.167155; THOR G, 1987, EMBO J, V6, P2581, DOI 10.1002/j.1460-2075.1987.tb02548.x; Valle JW, 2009, BRIT J CANCER, V101, P621, DOI 10.1038/sj.bjc.6605211; Yoon H, 2012, CANCER LETT, V316, P70, DOI 10.1016/j.canlet.2011.10.024; Yoon JH, 2004, J HEPATOL, V41, P808, DOI 10.1016/j.jhep.2004.07.016	30	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170078	10.1371/journal.pone.0170078	http://dx.doi.org/10.1371/journal.pone.0170078			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166242	Green Published, gold, Green Submitted			2022-12-26	WOS:000393700100004
J	Huang, N; Wang, WW; Yao, YL; Zhu, FX; Wang, WP; Chang, XJ				Huang, Nan; Wang, Weiwei; Yao, Yanlai; Zhu, Fengxiang; Wang, Weiping; Chang, Xiaojuan			The influence of different concentrations of bio-organic fertilizer on cucumber Fusarium wilt and soil microflora alterations	PLOS ONE			English	Article							SUBTILIS SQR 9; MICROBIAL COMMUNITY; RHIZOSPHERE SOIL; IDENTIFICATION; BIOFERTILIZER; COLONIZATION; DISCRIMINATE; SUPPRESSION; BIOCONTROL; DISEASE	Fusarium wilt is one of the main diseases of cucumber, and bio-organic fertilizer has been used to control Fusarium wilt. In this study, a pot experiment was conducted to evaluate the effects of bio-organic fertilizer applied at four levels on the suppression of Fusarium wilt disease in cucumber, the soil physico-chemical properties and the microbial communities. In comparison with the control (CK), low concentrations of bio-organic fertilizer (BIO2.5 and BIO5) did not effectively reduce the disease incidence and had little effect on soil microorganisms. High concentrations of bio-organic fertilizer (BIO10 and BIO20) significantly reduced the disease incidence by 33.3%-66.7% and the production was significantly improved by 83.8%-100.3%. The soil population of F. oxysporum f. sp. cucumerinum was significantly lower in bio-organic fertilizer treatments, especially in BIO10 and BIO20. The microorganism activity increased with the bio-organic fertilizer concentration. High-throughput sequencing demonstrated that, at the order level, Sphingomonadales, Bacillales, Solibacterales and Xylariales were significantly abundant in BIO10 and BIO20 soils. At the genus level, the abundance and composition of bacterial and fungal communities in BIO10 and BIO20 were similar, illustrating that high concentrations of bio-organic fertilizer activated diverse groups of microorganisms. Redundancy analysis (RDA) showed that Xanthomonadales, Sphingomonadales, Bacillales, Orbiliales, Sordariales, and Mucorales occurred predominantly in the BIO10 and BIO20. These microorganisms were related to the organic matter, available potassium and available phosphorus contents. In conclusion, a high concentration of bio-organic fertilizer application suppressed the Fusarium wilt disease and increased cucumber production after continuous cropping might through improving soil chemical condition and manipulating the composition of soil microbial community.	[Huang, Nan; Wang, Weiwei; Chang, Xiaojuan] Northwest Univ Xian, Coll Life Sci, Xian, Shaanxi, Peoples R China; [Wang, Weiwei] Northwest Univ Xian, Coll Life Sci, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Xian, Shaanxi, Peoples R China; [Yao, Yanlai; Zhu, Fengxiang; Wang, Weiping] Zhejiang Acad Agr Sci, Inst Environm Resource Soil & Fertilizer, Hangzhou, Zhejiang, Peoples R China	Northwest University Xi'an; Northwest University Xi'an; Zhejiang Academy of Agricultural Sciences	Wang, WW (corresponding author), Northwest Univ Xian, Coll Life Sci, Xian, Shaanxi, Peoples R China.; Wang, WW (corresponding author), Northwest Univ Xian, Coll Life Sci, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Xian, Shaanxi, Peoples R China.; Yao, YL (corresponding author), Zhejiang Acad Agr Sci, Inst Environm Resource Soil & Fertilizer, Hangzhou, Zhejiang, Peoples R China.	wwwang@nwu.edu.cn; yaoyl0679@hotmail.com		Yao, Yanlai/0000-0003-4086-2556	National Natural Science Foundation [41571243]; Special Fund for Agro-scientific Research in the Public Interest [201503110, 201103004]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the National Natural Science Foundation, grant # No. 41571243 to WWW and the Special Fund for Agro-scientific Research in the Public Interest, grant # No. 201503110 and No. 201103004 to NH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atiyeh RM, 2001, BIORESOURCE TECHNOL, V78, P11, DOI 10.1016/S0960-8524(00)00172-3; Avis TJ, 2008, SOIL BIOL BIOCHEM, V40, P1733, DOI 10.1016/j.soilbio.2008.02.013; Bergkemper F, 2016, ENV MICROBIOL, V18; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P2519, DOI 10.1128/AEM.03870-12; Campbell CD, 1997, J MICROBIOL METH, V30, P33, DOI 10.1016/S0167-7012(97)00041-9; Cao Y, 2012, SCI HORTIC-AMSTERDAM, V135, P32, DOI 10.1016/j.scienta.2011.12.002; Cao Y, 2011, BIOL FERT SOILS, V47, P495, DOI 10.1007/s00374-011-0556-2; Chauvin C, 2015, APPL SOIL ECOL, V96, P131, DOI 10.1016/j.apsoil.2015.07.013; Chellemi DO, 2016, PHYTOPATHOLOGY, V106, P216, DOI 10.1094/PHYTO-09-15-0204-RVW; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Garland JL, 1996, SOIL BIOL BIOCHEM, V28, P213, DOI 10.1016/0038-0717(95)00112-3; Giuliano B, 2010, SOIL BIOL BIOCHEM, V42, P136; Huang XQ, 2012, MICROBIOL RES, V167, P135, DOI 10.1016/j.micres.2011.06.002; Klaubauf S, 2010, FUNGAL DIVERS, V44, P65, DOI 10.1007/s13225-010-0053-1; Lam MK, 2012, APPL ENERG, V94, P303, DOI 10.1016/j.apenergy.2012.01.075; Leps J., 2005, AUSTRAL ECOL, V86, P6, DOI [10.1890/0012-9623(2005)86[6a:MAOEDU]2.0.CO;2, DOI 10.1111/J.1442-9993.2005.01433.X]; Li CG, 2010, PLANT SOIL, V330, P423, DOI 10.1007/s11104-009-0216-6; Lievens B, 2007, ENVIRON MICROBIOL, V9, P2145, DOI 10.1111/j.1462-2920.2007.01329.x; Ling N, 2010, BIOCONTROL, V55, P673, DOI 10.1007/s10526-010-9290-1; Liu LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121304; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes AR, 2014, FEMS MICROBIOL ECOL, V87, P650, DOI 10.1111/1574-6941.12253; Luo J, 2010, SOIL SCI SOC AM J, V74, P2039, DOI 10.2136/sssaj2009.0437; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Pegg K. G., 2002, P299, DOI 10.1079/9780851993577.0299; Phitsuwan P, 2013, FOLIA MICROBIOL, V58, P163, DOI 10.1007/s12223-012-0184-8; Qiu MH, 2014, BIOL FERT SOILS, V50, P217, DOI 10.1007/s00374-013-0835-1; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Raza W, 2009, EUR J PLANT PATHOL, V125, P471, DOI 10.1007/s10658-009-9496-1; Schutter ME, 2001, SOIL BIOL BIOCHEM, V33, P1947, DOI 10.1016/S0038-0717(01)00123-7; Senechkin IV, 2014, APPL SOIL ECOL, V73, P148, DOI 10.1016/j.apsoil.2013.09.003; Shen ZZ, 2015, BIOL FERT SOILS, V51, P553, DOI 10.1007/s00374-015-1002-7; Shen ZZ, 2013, EUR J SOIL BIOL, V57, P1, DOI 10.1016/j.ejsobi.2013.03.006; Vasileiadis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042671; Wang X, 2015, BIOESSAYS, V37, P1045, DOI 10.1002/bies.201500071; Weng J, 2013, APPL MICROBIOL BIOT, V97, P8823, DOI 10.1007/s00253-012-4572-4; Wu SC, 2005, GEODERMA, V125, P155, DOI 10.1016/j.geoderma.2004.07.003; Xu JB, 2013, BIOL FERT SOILS, V49, P839, DOI 10.1007/s00374-013-0777-7; Yao H, 2000, MICROB ECOL, V40, P223; Zhang N, 2014, PLANT SOIL, V374, P689, DOI 10.1007/s11104-013-1915-6	41	35	39	12	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171490	10.1371/journal.pone.0171490	http://dx.doi.org/10.1371/journal.pone.0171490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166302	gold, Green Published, Green Submitted			2022-12-26	WOS:000393700100047
J	Mujtaba, G; Shuib, L; Raj, RG; Rajandram, R; Shaikh, K; Al-Garadi, MA				Mujtaba, Ghulam; Shuib, Liyana; Raj, Ram Gopal; Rajandram, Retnagowri; Shaikh, Khairunisa; Al-Garadi, Mohammed Ali			Automatic ICD-10 multi-class classification of cause of death from plaintext autopsy reports through expert-driven feature selection	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; TEXT; EXTRACTION	Objectives Widespread implementation of electronic databases has improved the accessibility of plain text clinical information for supplementary use. Numerous machine learning techniques, such as supervised machine learning approaches or ontology-based approaches, have been employed to obtain useful information from plaintext clinical data. This study proposes an automatic multi-class classification system to predict accident-related causes of death from plaintext autopsy reports through expert-driven feature selection with supervised automatic text classification decision models. Methods Accident-related autopsy reports were obtained from one of the largest hospital in Kuala Lumpur. These reports belong to nine different accident-related causes of death. Master feature vector was prepared by extracting features from the collected autopsy reports by using unigram with lexical categorization. This master feature vector was used to detect cause of death [according to internal classification of disease version 10 (ICD-10) classification system] through five automated feature selection schemes, proposed expert-driven approach, five subset sizes of features, and five machine learning classifiers. Model performance was evaluated using precision(M), recall(M), F-measure(M), accuracy, and area under ROC curve. Four baselines were used to compare the results with the proposed system. Results Random forest and J48 decision models parameterized using expert-driven feature selection yielded the highest evaluation measure approaching (85% to 90%) for most metrics by using a feature subset size of 30. The proposed system also showed approximately 14% to 16% improvement in the overall accuracy compared with the existing techniques and four baselines. Conclusion The proposed system is feasible and practical to use for automatic classification of ICD-10-related cause of death from autopsy reports. The proposed system assists pathologists to accurately and rapidly determine underlying cause of death based on autopsy findings. Furthermore, the proposed expert-driven feature selection approach and the findings are generally applicable to other kinds of plaintext clinical reports.	[Mujtaba, Ghulam; Shuib, Liyana; Al-Garadi, Mohammed Ali] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Informat Syst, Kuala Lumpur, Malaysia; [Mujtaba, Ghulam] Sukkur Inst Business Adm, Dept Comp Sci, Sukkur, Pakistan; [Raj, Ram Gopal] Univ Malaya, Dept Artificial Intelligence, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia; [Rajandram, Retnagowri] Univ Malaya, Dept Surg, Fac Med, Kuala Lumpur, Malaysia; [Shaikh, Khairunisa] Shaheed Mohtarma Benazir Bhutto Med Univ, Dept Community Med, Larkana, Pakistan	Universiti Malaya; Universiti Malaya; Universiti Malaya	Mujtaba, G (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Dept Informat Syst, Kuala Lumpur, Malaysia.; Mujtaba, G (corresponding author), Sukkur Inst Business Adm, Dept Comp Sci, Sukkur, Pakistan.; Raj, RG (corresponding author), Univ Malaya, Dept Artificial Intelligence, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia.	mujtaba@siswa.um.edu.my; ramdr@um.edu.my	Rajandram, Retnagowri/O-6135-2019; Rajandram, Retnagowri/E-4709-2010; Raj, Ram Gopal/B-3399-2010; Shuib, Liyana/ABH-6159-2020; Rajandram, Retnagowri/E-1245-2012; Ali Al-Garadi, Mohammed/GXM-3256-2022; Mujtaba, Ghulam/AAW-4254-2021; Shuib, Nor Liyana Mohd/M-8698-2013	Rajandram, Retnagowri/0000-0001-5247-2817; Rajandram, Retnagowri/0000-0001-5247-2817; Raj, Ram Gopal/0000-0002-8627-1113; Shuib, Liyana/0000-0002-7907-0671; Rajandram, Retnagowri/0000-0001-5247-2817; Shuib, Nor Liyana Mohd/0000-0002-7907-0671	University Malaya Research Grant [RP026-14AET]	University Malaya Research Grant	This research was fully funded by the University Malaya Research Grant (Grant No: RP026-14AET), Grant Number: RP026-14AET [https://umresearch.um.edu.my/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal C. C., 2012, MINING TEXT DATA SPR; Al-Garadi MA, 2016, J BIOMED INFORM, V62, P1, DOI 10.1016/j.jbi.2016.05.005; Al-garadr MA, 2016, COMPUT HUM BEHAV, V63, P433, DOI 10.1016/j.chb.2016.05.051; Bao YG, 2004, LECT NOTES COMPUT SC, V3177, P634; Ben Abacha A, 2015, J BIOMED INFORM, V58, P122, DOI 10.1016/j.jbi.2015.09.015; Bird S., 2009, NATURAL LANGUAGE PRO; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cheng QA, 2011, IEEE T PATTERN ANAL, V33, P1217, DOI 10.1109/TPAMI.2010.195; Chomutare T, 2014, L N INST COMP SCI SO, V100, P125, DOI 10.1007/978-3-319-11564-1_13; Costache Mariana, 2014, Maedica (Bucur), V9, P261; Cristianini N, 2000, INTRO SUPPORT VECTOR; Dahiya Shashi, 2016, International Journal of Advanced Research in Artificial Intelligence, V5, P1; Danso S, 2014, ARXIV14024380; Danso S, 2013, LECT NOTES ARTIF INT, V8105, P47, DOI 10.1007/978-3-642-40722-2_5; Davies DJ, 2004, MED J AUSTRALIA, V180, P281, DOI 10.5694/j.1326-5377.2004.tb05926.x; de la Iglesia D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110331; Domingos P, 2012, COMMUN ACM, V55, P78, DOI 10.1145/2347736.2347755; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Fukunaga K., 2013, INTRO STAT PATTERN R; Gerbis N, 2010, LIVE SCI; Gurm HS, 2014, PLOS ONE, V9, P9; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hall M.A., 1998, PRACTICAL FEATURE SU; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Hoelz BW, 2009, ARTIF INTELL, P883; Iqbal E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134208; Jouhet V, 2012, METHOD INFORM MED, V51, P242, DOI 10.3414/ME11-01-0005; Kang N, 2012, J BIOMED INFORM, V45, P423, DOI 10.1016/j.jbi.2011.12.009; Kasthurirathne SN, 2016, J BIOMED INFORM, V60, P145, DOI 10.1016/j.jbi.2016.01.008; Khalilia M, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-51; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Koopman B, 2015, INT J MED INFORM, V84, P956, DOI 10.1016/j.ijmedinf.2015.08.004; Koopman B, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0174-2; Krauthammer M, 2004, J BIOMED INFORM, V37, P512, DOI 10.1016/j.jbi.2004.08.004; Lewis D. D., 1998, Machine Learning: ECML-98. 10th European Conference on Machine Learning. Proceedings, P4, DOI 10.1007/BFb0026666; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Mahmood T, 2014, INF SYST E-BUS MANAG, V12, P213, DOI 10.1007/s10257-013-0222-3; Mahmood T, 2013, EXPERT SYST APPL, V40, P1152, DOI 10.1016/j.eswa.2012.08.022; Manavalan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106542; Marafino B, 2014, J AM MED INFORM ASSN, V21, P871, DOI 10.1136/amiajnl-2014-002694; Miasnikof P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0521-2; Mujtaba G, 2011, ADAPTIVE AUTOMATED 1, P1; Ong MS, 2010, QUAL SAF HEALTH CARE, V19, P7; Organization WH, 1979, MED CERTIFICATION CA; Osanaiye O, 2016, EURASIP J WIREL COMM, DOI 10.1186/s13638-016-0623-3; Prati RC, 2012, COMBINING FEATURE RA, P1; Provost F., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P445; Provost F., 1997, Proceedings of the Third International Conference on Knowledge Discovery and Data Mining, P43; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Refaeilzadeh P., 2009, ENCYCL DATABASE SYST, P532, DOI [10.1007/978-0-387-39940-9, DOI 10.1007/978-0-387-39940-9_565]; Romero R, 2014, BIOCLASS TOOL BIOMED, P243; Sarker A, 2015, J BIOMED INFORM, V53, P196, DOI 10.1016/j.jbi.2014.11.002; Schuemie MJ, 2012, PHARMACOEPIDEM DR S, V21, P651, DOI 10.1002/pds.3205; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Siddiqui MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135875; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Spasic I, 2014, INT J MED INFORM, V83, P605, DOI 10.1016/j.ijmedinf.2014.06.009; Steven B., 2006, P COLING ACL 2006 IN, DOI 10.3115/1225403.1225421; Uysal AK, 2016, EXPERT SYST APPL, V43, P82, DOI 10.1016/j.eswa.2015.08.050; van den Tweel JG, 2016, VIRCHOWS ARCH, V468, P75, DOI 10.1007/s00428-015-1833-5; Witten I. H., 2005, DATA MINING PRACTICA; Wolpert D.H., 1995, SFITR9502010; Yeow WL, 2014, EXPERT SYST APPL, V41, P3497, DOI 10.1016/j.eswa.2013.10.054; You ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125811; Zang H., 2004, AA, V1, P3; Zhang YD, 2015, J MED IMAG HEALTH IN, V5, P1395, DOI 10.1166/jmihi.2015.1542; Zhang YD, 2014, KNOWL-BASED SYST, V64, P22, DOI 10.1016/j.knosys.2014.03.015; Zhang YD, 2012, SENSORS-BASEL, V12, P12489, DOI 10.3390/s120912489; Zhao YH, 2008, ADV SPACE RES, V41, P1955, DOI 10.1016/j.asr.2007.07.020	73	33	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170242	10.1371/journal.pone.0170242	http://dx.doi.org/10.1371/journal.pone.0170242			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166263	Green Published, gold, Green Submitted			2022-12-26	WOS:000393700100006
J	Stone, DU; Fife, D; Brown, M; Earley, KE; Radfar, L; Kaufman, CE; Lewis, DM; Rhodus, NL; Segal, BM; Wallace, DJ; Weisman, MH; Venuturupalli, S; Brennan, MT; Lessard, CJ; Montgomery, CG; Scofield, RH; Sivils, KL; Rasmussen, A				Stone, Donald U.; Fife, Dustin; Brown, Michael; Earley, Keith E.; Radfar, Lida; Kaufman, C. Erick; Lewis, David M.; Rhodus, Nelson L.; Segal, Barbara M.; Wallace, Daniel J.; Weisman, Michael H.; Venuturupalli, Swamy; Brennan, Michael T.; Lessard, Christopher J.; Montgomery, Courtney G.; Scofield, R. Hal; Sivils, Kathy L.; Rasmussen, Astrid			Effect of Tobacco Smoking on The Clinical, Histopathological, and Serological Manifestations of Sjogren's Syndrome	PLOS ONE			English	Article							CIGARETTE-SMOKING; RISK-FACTORS; CLASSIFICATION CRITERIA; AUTOANTIBODY PRODUCTION; RHEUMATOID-ARTHRITIS; T-CELL; ASSOCIATION; DISEASE; SICCA; ANTIBODIES	Objectives To assess the association of smoking habits with the clinical, serological, and histopathological manifestations of Sjogren's syndrome (SS) and non-Sjogren's sicca (non-SS sicca). Methods Cross-sectional case-control study of 1288 patients with sicca symptoms (587 SS and 701 non-SS sicca) evaluated in a multi-disciplinary research clinic. Smoking patterns were obtained from questionnaire data and disease-related clinical and laboratory data were compared between current, past, ever, and never smokers. Results Current smoking rates were 4.6% for SS patients compared to 14.1% in non-SS sicca (p = 5.17x10E-09), 18% in a local lupus cohort (p = 1.13x10E-14) and 16.8% in the community (p = 4.12x10E-15). Current smoking was protective against SS classification (OR 0.35, 95%Cl 0.22-0.56, FDR q = 1.9E10-05), focal lymphocytic sialadenitis (OR 0.26, 95`)/X10.15-0.44, FDR q = 1.52x10E-06), focus score >= 1 (OR 0.22, 95%Cl 0.13-0.39, FDR q = 1.43x10E-07), and anti-Ro/SSA(+) (OR 0.36, 95%Cl 0.2-0.64, FDR q = 0.0009); ever smoking was protective against the same features and against anti-La/SSB(+) (OR 0.52, 95%Cl 0.39-0.70, FDR q = 5.82x10E-05). Duration of smoking was inversely correlated with SS even after controlling for socioeconomic status, BMI, alcohol and caffeine consumption. Conclusions Current tobacco smoking is negatively and independently associated with SS, protecting against disease-associated humoral and cellular autoimmunity. The overall smoking rate amongst SS patients is significantly lower than in matched populations and the effects of smoking are proportional to exposure duration. In spite of the protective effects of tobacco on SS manifestations, it is associated with other serious comorbidities such as lung disease, cardiovascular risk and malignancy, and should thus be strongly discouraged in patients with sicca.	[Stone, Donald U.] Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD USA; [Stone, Donald U.] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia; [Fife, Dustin; Brown, Michael; Lessard, Christopher J.; Montgomery, Courtney G.; Scofield, R. Hal; Sivils, Kathy L.; Rasmussen, Astrid] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Earley, Keith E.] Joint Base San Antonio Lackland Air Force Base, US Air Force 59th Med Wing, San Antonio, TX USA; [Radfar, Lida] Univ Oklahoma, Dept Oral Diag & Radiol, Coll Dent, Oklahoma City, OK USA; [Kaufman, C. Erick] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Lewis, David M.] Univ Oklahoma, Coll Dent, Dept Oral Pathol, Oklahoma City, OK USA; [Rhodus, Nelson L.] Univ Minnesota, Sch Dent, Dept Oral Surg, Minneapolis, MN 55455 USA; [Segal, Barbara M.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Wallace, Daniel J.; Weisman, Michael H.; Venuturupalli, Swamy] Cedars Sinai Med Ctr, Div Rheumatol, Los Angeles, CA 90048 USA; [Brennan, Michael T.] Carolinas Med Ctr, Dept Oral Med, Charlotte, NC 28203 USA; [Scofield, R. Hal] Dept Vet Affairs Med Ctr, Oklahoma City, OK USA	Johns Hopkins University; King Khaled Eye Specialist Hospital; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Minnesota System; University of Minnesota Twin Cities; Hennepin County Medical Center; Cedars Sinai Medical Center; Carolinas Medical Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rasmussen, A (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Astrid-Rasmussen@omrf.org	Brennan, Michael/AAZ-2891-2020; Scofield, Robert Hal/AEJ-8314-2022	Montgomery, Courtney/0000-0002-9606-3772; Scofield, Robert Hal/0000-0003-1015-5850; Lessard, Christopher J./0000-0003-2440-3843	National Institutes of Health [AR053483, AR050782, DE018209, DE015223, AI082714, GM104938, AR060804, AI118787-01A1, AI012717, GM103510, AR065953, RR020143]; Oklahoma Medical Research Foundation; Phileona Foundation; Sjogren's Syndrome Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Medical Research Foundation; Phileona Foundation; Sjogren's Syndrome Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health [grant numbers AR053483, AR050782, DE018209, DE015223, AI082714, GM104938, AR060804 to KLS; AI118787-01A1, AI012717, GM103510 to AR; and AR065953, RR020143 to CJL], the Oklahoma Medical Research Foundation, the Phileona Foundation, and the Sjogren's Syndrome Foundation to KLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altinors DD, 2006, AM J OPHTHALMOL, V141, P1016, DOI 10.1016/j.ajo.2005.12.047; Alunno A, 2014, J AUTOIMMUN, V51, P38, DOI 10.1016/j.jaut.2014.01.030; Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Bartoloni E, 2015, J INTERN MED, V278, P185, DOI 10.1111/joim.12346; BASCOM R, 1991, ENVIRON HEALTH PERSP, V95, P39, DOI 10.2307/3431104; Beklen A, 2008, ORAL MICROBIOL IMMUN, V23, P425, DOI 10.1111/j.1399-302X.2008.00448.x; Caramori G, 2015, ANN NY ACAD SCI, V1340, P55, DOI 10.1111/nyas.12619; Chang K, 2014, INT J MOL SCI, V15, P22279, DOI 10.3390/ijms151222279; Csordas A, 2013, NAT REV CARDIOL, V10, P219, DOI 10.1038/nrcardio.2013.8; Daniels TE, 2011, ARTHRITIS RHEUM-US, V63, P2021, DOI 10.1002/art.30381; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Freemer MM, 2006, ANN RHEUM DIS, V65, P581, DOI 10.1136/ard.2005.039438; Fujinami Y, 2009, ORAL DIS, V15, P466, DOI 10.1111/j.1601-0825.2009.01572.x; Galor A, 2011, CURR OPIN OPHTHALMOL, V22, P477, DOI 10.1097/ICU.0b013e32834bbe7a; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Goransson LG, 2011, SCAND J RHEUMATOL, V40, P221, DOI 10.3109/03009742.2010.536164; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jamal A, 2015, MMWR-MORBID MORTAL W, V64, P1233, DOI 10.15585/mmwr.mm6444a2; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Kallberg H, 2011, ANN RHEUM DIS, V70, P508, DOI 10.1136/ard.2009.120899; Karabulut G, 2011, MOD RHEUMATOL, V21, P602, DOI 10.1007/s10165-011-0446-3; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Lee YH, 2014, INT J RHEUM DIS, V17, P528, DOI 10.1111/1756-185X.12307; Lessard CJ, 2013, NAT GENET, V45, P1284, DOI 10.1038/ng.2792; Lin X, 2014, ANN RHEUM DIS, V73, DOI [10.1136/annrheumdis-2014-205521, 10.1136/annrheumdis-2013-204584]; Mahanonda R, 2009, J PERIODONTAL RES, V44, P557, DOI 10.1111/j.1600-0765.2008.01153.x; MAIER H, 1988, KLIN WOCHENSCHR, V66, P140; Manthorpe R, 2000, ANN RHEUM DIS, V59, P54, DOI 10.1136/ard.59.1.54; Masdottir B, 2000, RHEUMATOLOGY, V39, P1202, DOI 10.1093/rheumatology/39.11.1202; MATHEWS JD, 1973, LANCET, V2, P754; Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC; Nilsson AM, 2015, J RHEUMATOL, V42, P464, DOI 10.3899/jrheum.140370; Ozaki Y, 2001, ARTHRITIS RHEUM-US, V44, P419, DOI 10.1002/1529-0131(200102)44:2<419::AID-ANR61>3.0.CO;2-U; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Parascandola M, 2001, J EPIDEMIOL COMMUN H, V55, P905, DOI 10.1136/jech.55.12.905; Pavlov VA, 2015, IMMUNOL RES, V63, P38, DOI 10.1007/s12026-015-8718-1; Perez-De-Lis M, 2010, LUPUS, V19, P941, DOI 10.1177/0961203310367504; Rad Maryam, 2010, J Dent Res Dent Clin Dent Prospects, V4, P110, DOI 10.5681/joddd.2010.028; Rasmussen A, 2014, ANN RHEUM DIS, V73, P31, DOI 10.1136/annrheumdis-2013-203845; Rasmussen A, 2011, RHEUMATOLOGY, V50, P47, DOI 10.1093/rheumatology/keq302; Rodriguez JW, 1999, IMMUNOPHARM IMMUNOT, V21, P379, DOI 10.3109/08923979909052769; Saha SP, 2007, INT J ANGIOL, V16, P77; Shiels MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju294; Singh N, 2012, J AUTOIMMUN, V39, P229, DOI 10.1016/j.jaut.2012.05.019; Smith CJ, 2001, ATHEROSCLEROSIS, V158, P257, DOI 10.1016/S0021-9150(01)00570-6; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Sorensen LT, 2012, ANN SURG, V255, P1069, DOI 10.1097/SLA.0b013e31824f632d; Soy M, 2000, CLIN RHEUMATOL, V19, P508, DOI 10.1007/s100670070020; Sparks JA, 2016, ARTHRITIS RHEUMATOLO; Sparks JA, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0563-2; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; TOLLERUD DJ, 1991, AM REV RESPIR DIS, V144, P612, DOI 10.1164/ajrccm/144.3_Pt_1.612; Tzioufas AG, 2008, NEUROIMMUNOMODULAT, V15, P37, DOI 10.1159/000135622; van der Mei IAF, 2016, MULT SCLER J, V22, P461, DOI 10.1177/1352458515594040; VANBIJSTERVELD OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P189; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Whitcher JP, 2010, AM J OPHTHALMOL, V149, P405, DOI 10.1016/j.ajo.2009.09.013; Young KA, 2014, LUPUS, V23, P360, DOI 10.1177/0961203314520838; Zintzaras E, 2005, ARCH INTERN MED, V165, P2337, DOI 10.1001/archinte.165.20.2337; Zuo L, 2014, AM J PHYSIOL-LUNG C, V307, pL205, DOI 10.1152/ajplung.00330.2013	61	22	22	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170249	10.1371/journal.pone.0170249	http://dx.doi.org/10.1371/journal.pone.0170249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166540	gold, Green Published, Green Submitted			2022-12-26	WOS:000393700100007
J	Roeleveld, DM; Marijnissen, RJ; Walgreen, B; Helsen, MM; van den Bersselaar, L; de Loo, FAV; van Lent, PL; van der Kraan, PM; van den Berg, WB; Koenders, MI				Roeleveld, Debbie M.; Marijnissen, Renoud J.; Walgreen, Birgitte; Helsen, Monique M.; van den Bersselaar, Liduine; de Loo, Fons A. van; van Lent, Peter L.; van der Kraan, Peter M.; van den Berg, Wim B.; Koenders, Marije I.			Higher efficacy of anti-IL-6/IL-21 combination therapy compared to monotherapy in the induction phase of Th17-driven experimental arthritis	PLOS ONE			English	Article							ANTI-INTERLEUKIN-17 MONOCLONAL-ANTIBODY; COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; NECROSIS-FACTOR; DOUBLE-BLIND; INADEQUATE RESPONSE; PROMOTES OSTEOCLASTOGENESIS; CARTILAGE DESTRUCTION; TH17 DIFFERENTIATION; INCOMPLETE RESPONSE	Th17 cells and their cytokines are linked to the pathogenesis of rheumatoid arthritis, a chronic autoimmune disease characterized by joint inflammation. Th17 development is initiated by combined signaling of TGF-beta and IL-6 or IL-21, and can be reduced in the absence of either IL-6 or IL-21. The aim of this study was to assess whether combinatorial IL-6/IL-21 blockade would more potently inhibit Th17 development, and be more efficacious in treating arthritis than targeting either cytokine. We assessed in vitro Th17 differentiation efficacy in the absence of IL-6 and/or IL-21. To investigate in vivo effects of IL-6/IL-21 blockade on Th17 and arthritis development, antigen-induced arthritis (AIA) was induced in IL-6(-/-) x IL-21R(-/-) mice. The therapeutic potential of this combined blocking strategy was assessed by treating mice with collagen-induced arthritis (CIA) with anti-IL-6R antibodies and soluble (s) IL-21R.Fc. We demonstrated that combined IL-6/IL-21 blocking synergistically reduced in vitro Th17 differentiation. In mice with AIA, absence of IL-6 and IL-21 signaling more strongly reduced Th17 levels and resulted in stronger suppression of arthritis than the absence of either cytokine. Additionally, anti-IL-6/anti-IL-21 treatment of CIA mice during the arthritis induction phase reduced disease development more potent than IL-6 or IL-21 inhibition alone, as effective as anti-TNF treatment. Collectively, these results suggest dual IL-6/IL-21 inhibition may be a more efficacious therapeutic strategy compared to single cytokine blockade to suppress arthritis development.	[Roeleveld, Debbie M.; Marijnissen, Renoud J.; Walgreen, Birgitte; Helsen, Monique M.; van den Bersselaar, Liduine; de Loo, Fons A. van; van Lent, Peter L.; van der Kraan, Peter M.; van den Berg, Wim B.; Koenders, Marije I.] Radboud Univ Nijmegen, Med Ctr, Dept Expt Rheumatol, Nijmegen, Netherlands	Radboud University Nijmegen	Roeleveld, DM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Expt Rheumatol, Nijmegen, Netherlands.	Debbie.Roeleveld@radboudumc.nl	van der Kraan, Peter M/D-9115-2011; van de Loo, Fons AJ/A-3425-2014; van Lent, Peter/A-4047-2014; Koenders, Marije I/A-1341-2012; Marijnissen, Renoud/M-5541-2013; Roeleveld, Debbie/P-8730-2015	van de Loo, Fons AJ/0000-0002-5851-099X; Koenders, Marije I/0000-0001-5845-8362; Marijnissen, Renoud/0000-0002-6836-675X; Roeleveld, Debbie/0000-0002-5414-3299	Innovative Medicines Initiative Joint Undertaking [115142-2]	Innovative Medicines Initiative Joint Undertaking	DR received funding from the Innovative Medicines Initiative Joint Undertaking funded project BTCure [http://btcure.eu/ grant number: 115142-2]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts NE, 2010, RHEUMATOLOGY, V49, P2264, DOI 10.1093/rheumatology/keq224; Alzabin S, 2012, ANN RHEUM DIS, V71, P1741, DOI 10.1136/annrheumdis-2011-201024; Baeten D, 2015, NEW ENGL J MED, V373, P2534, DOI 10.1056/NEJMoa1505066; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Block KE, 2013, J IMMUNOL, V191, P2948, DOI 10.4049/jimmunol.1301173; Burmester GR, 2016, RHEUMATOLOGY, V55, P49, DOI 10.1093/rheumatology/kev258; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chen DY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3431; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; de Hooge ASK, 2000, AM J PATHOL, V157, P2081, DOI 10.1016/S0002-9440(10)64846-8; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Genovese MC, 2014, ARTHRITIS RHEUMATOL, V66, P1693, DOI 10.1002/art.38617; Genovese MC, 2014, J RHEUMATOL, V41, P414, DOI 10.3899/jrheum.130637; Genovese MC, 2013, ANN RHEUM DIS, V72, P863, DOI 10.1136/annrheumdis-2012-201601; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Kim KW, 2012, ARTHRITIS RHEUM-US, V64, P1015, DOI 10.1002/art.33446; Koenders MI, 2015, TRENDS PHARMACOL SCI, V36, P189, DOI 10.1016/j.tips.2015.02.001; Koenders MI, 2011, ARTHRITIS RHEUM-US, V63, P2329, DOI 10.1002/art.30418; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; Kwok SK, 2012, ARTHRITIS RHEUM-US, V64, P740, DOI 10.1002/art.33390; Leipe J, 2011, ANN RHEUM DIS, V70, P1453, DOI 10.1136/ard.2011.152074; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Marijnissen RJ, 2014, ARTHRITIS RHEUMATOL, V66, P886, DOI 10.1002/art.38312; Martin DA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4347; McInnes IB, 2015, LANCET, V386, P1137, DOI 10.1016/S0140-6736(15)61134-5; Mease PJ, 2015, NEW ENGL J MED, V373, P1329, DOI 10.1056/NEJMoa1412679; Moran EM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2772; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Nishimoto N, 2009, MOD RHEUMATOL, V19, P12, DOI 10.1007/s10165-008-0125-1; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Pavelka K, 2015, J RHEUMATOL, V42, P912, DOI 10.3899/jrheum.141271; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Roeleveld DM, 2015, CYTOKINE, V74, P101, DOI 10.1016/j.cyto.2014.10.006; Rosu A, 2012, ROM J MORPHOL EMBRYO, V53, P73; Sakuraba K, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1086-y; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P2499, DOI 10.1002/art.34477; Sonderegger I, 2008, EUR J IMMUNOL, V38, P1833, DOI 10.1002/eji.200838511; Song SNJ, 2015, EXPERT OPIN DRUG MET, V11, P307, DOI 10.1517/17425255.2015.992779; Takagi N, 1998, ARTHRITIS RHEUM, V41, P2117, DOI 10.1002/1529-0131(199812)41:12<2117::AID-ART6>3.3.CO;2-G; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yoshida H, 2011, RHEUMATOL INT, V31, P127, DOI 10.1007/s00296-010-1552-9; Zhao L, 2013, INT J RHEUM DIS, V16, P518, DOI 10.1111/1756-185X.12099; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	54	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171757	10.1371/journal.pone.0171757	http://dx.doi.org/10.1371/journal.pone.0171757			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158305	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700122
J	Houthuijzen, JM; Oosterom, I; Hudson, BD; Hirasawa, A; Daenen, LGM; McLean, CM; Hansen, SVF; van Jaarsveld, MTM; Peeper, DS; Sadatmand, SJ; Roodhart, JML; van de Lest, CHA; Ulven, T; Ishihara, K; Milligan, G; Voest, EE				Houthuijzen, Julia M.; Oosterom, Ilse; Hudson, Brian D.; Hirasawa, Akira; Daenen, Laura G. M.; McLean, Chelsea M.; Hansen, Steffen V. F.; van Jaarsveld, Marijn T. M.; Peeper, Daniel S.; Sadatmand, Sahar Jafari; Roodhart, Jeanine M. L.; van de Lest, Chris H. A.; Ulven, Trond; Ishihara, Kenji; Milligan, Graeme; Voest, Emile E.			Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance	FASEB JOURNAL			English	Article						FFAR4; GPR40; FFAR1; PIFA	RECEPTOR GPR40; GPR120; IDENTIFICATION; AGONISTS; CELLS; CANCER; POTENT; OMEGA-3-FATTY-ACIDS; PHARMACOLOGY; SECRETION	Although chemotherapy is designed to eradicate tumor cells, it also has significant effects on normal tissues. The platinum-induced fatty acid 16:4(n-3) (hexadeca-4,7,10,13-tetraenoic acid) induces systemic resistance to a broad range of DNA-damaging chemotherapeutics. We show that 16:4(n-3) exerts its effect by activating splenic F4/80(+)/CD11b(low) macrophages, which results in production of chemoprotective lysophosphatidylcholines (LPCs). Pharmacologic studies, together with analysis of expression patterns, identified GPR120 on F4/80(+)/CD11b(low) macrophages as the relevant receptor for 16:4(n-3). Studies that used splenocytes from GPR120-deficient mice have confirmed this conclusion. Activation of the 16:4(n-3)-GPR120 axis led to enhanced cPLA(2) activity in these splenic macrophages and secretion of the resistance-inducing lipid mediator, lysophosphatidylcholine(24:1). These studies identify a novel and unexpected function for GPR120 and suggest that antagonists of this receptor might be effective agents to limit development of chemotherapy resistance.-Houthuijzen, J. M., Oosterom, I., Hudson, B. D., Hirasawa, A., Daenen, L. G. M., McLean, C. M., Hansen, S. V. F., van Jaarsveld, M. T. M., Peeper, D. S., Jafari Sadatmand, S., Roodhart, J. M. L., van de Lest, C. H. A., Ulven, T., Ishihara, K., Milligan, G., Voest, E. E. Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance.	[Houthuijzen, Julia M.; McLean, Chelsea M.; van Jaarsveld, Marijn T. M.; Peeper, Daniel S.; Sadatmand, Sahar Jafari; Voest, Emile E.] Netherlands Canc Inst, Dept Mol Oncol, Amsterdam, Netherlands; [Houthuijzen, Julia M.] Netherlands Canc Inst, Dept Mol Pathol, Amsterdam, Netherlands; [Oosterom, Ilse; Daenen, Laura G. M.; Roodhart, Jeanine M. L.] Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands; [Hudson, Brian D.; Milligan, Graeme] Univ Glasgow, Ctr Translat Pharmacol, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Hirasawa, Akira] Kyoto Univ, Dept Genom Drug Discovery Sci, Kyoto, Japan; [Hansen, Steffen V. F.; Ulven, Trond] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense, Denmark; [van de Lest, Chris H. A.] Univ Utrecht, Dept Biochem & Cell Biol, Fac Vet Med, Utrecht, Netherlands; [Ishihara, Kenji] Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa, Japan	Netherlands Cancer Institute; Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center; University of Glasgow; Kyoto University; University of Southern Denmark; Utrecht University; Japan Fisheries Research & Education Agency (FRA)	Voest, EE (corresponding author), Netherlands Canc Inst Raad van Bestuur, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	e.voest@nki.nl	Peeper, Daniel/AAA-2430-2020; Ulven, Trond/H-5500-2015; Hudson, Brian/H-4845-2013	Ulven, Trond/0000-0002-8135-1755; Houthuijzen, Julia/0000-0003-0404-1961; Hudson, Brian/0000-0001-7059-0091; McLean, Chelsea/0000-0002-3548-3482	Dutch Cancer Society (KWF) [UU 2009-4534]; Biotechnology and Biologic Sciences Research Council [BB/K019864/1]; University of Glasgow Leadership Fellowship; Danish Council for Strategic Research [11-1161-96]; BBSRC [BB/K019864/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K019864/1] Funding Source: researchfish	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Biotechnology and Biologic Sciences Research Council; University of Glasgow Leadership Fellowship; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Dutch Cancer Society (KWF; Grant UU 2009-4534), Biotechnology and Biologic Sciences Research Council (Grant BB/K019864/1), a University of Glasgow Leadership Fellowship (to B.D.H.), and the Danish Council for Strategic Research (Grant 11-1161-96). The authors declare no conflicts of interest.	Azevedo CMG, 2016, J MED CHEM, V59, P8868, DOI 10.1021/acs.jmedchem.6b00685; Bolognini D, 2016, MOL PHARMACOL, V89, P388, DOI 10.1124/mol.115.102301; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Colussi G., 2016, NUTR METAB CARDIOVAS; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Fukushima K, 2015, BIOCHEM BIOPH RES CO, V465, P512, DOI 10.1016/j.bbrc.2015.08.050; Gao B, 2015, SCI REP-UK, V5, DOI 10.1038/srep14080; Gras D, 2009, AM J PHYSIOL-LUNG C, V296, pL970, DOI 10.1152/ajplung.90219.2008; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hopkins MM, 2017, HANDB EXP PHARMACOL, V236, P233, DOI 10.1007/164_2016_48; Houthuijzen JM, 2016, MOL PHARMACOL, V90, P738, DOI 10.1124/mol.116.105932; Houthuijzen JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6275; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Ishihara K, 2000, BIOSCI BIOTECH BIOCH, V64, P2454, DOI 10.1271/bbb.64.2454; Li Z, 2016, EXPERT OPIN INV DRUG, V25, P871, DOI 10.1080/13543784.2016.1189530; Liu YQ, 2014, IMMUNOLOGY, V143, P81, DOI 10.1111/imm.12296; Liu Z, 2015, J PHARMACOL EXP THER, V352, P380, DOI 10.1124/jpet.114.218974; Miyauchi S, 2009, N-S ARCH PHARMACOL, V379, P427, DOI 10.1007/s00210-008-0390-8; Mizuta K, 2015, AM J PHYSIOL-LUNG C, V309, pL970, DOI 10.1152/ajplung.00041.2015; Oh DY, 2014, NAT MED, V20, P942, DOI 10.1038/nm.3614; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Raynor A, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0070-x; Retra K, 2008, RAPID COMMUN MASS SP, V22, P1853, DOI 10.1002/rcm.3562; Roodhart JML, 2011, CANCER CELL, V20, P370, DOI 10.1016/j.ccr.2011.08.010; Schneider G, 2014, MOL CANCER RES, V12, P1560, DOI 10.1158/1541-7786.MCR-14-0188; Shimpukade B, 2012, J MED CHEM, V55, P4511, DOI 10.1021/jm300215x; Sparks SM, 2014, BIOORG MED CHEM LETT, V24, P3100, DOI [10.1016/j.bmcl.2014.05.012, 10.1016/j.bmcl.2014.07.008]; Sun Q, 2010, MOL PHARMACOL, V78, P804, DOI 10.1124/mol.110.066324; Ulven T, 2015, ANNU REV NUTR, V35, P239, DOI 10.1146/annurev-nutr-071714-034410; Wauquier F, 2013, J BIOL CHEM, V288, P6542, DOI 10.1074/jbc.M112.429084; Wu JHY, 2012, BRIT J NUTR, V107, pS214, DOI 10.1017/S0007114512001602; Wu Q, 2013, ONCOGENE, V32, P5541, DOI 10.1038/onc.2013.264; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035	37	20	22	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2195	2209		10.1096/fj.201601248R	http://dx.doi.org/10.1096/fj.201601248R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28183801	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000399195500037
J	Wijesinghe, KJ; Urata, S; Bhattarai, N; Kooijman, EE; Gerstman, BS; Chapagain, PP; Li, S; Stahelin, RV				Wijesinghe, Kaveesha J.; Urata, Sarah; Bhattarai, Nisha; Kooijman, Edgar E.; Gerstman, Bernard S.; Chapagain, Prem P.; Li, Sheng; Stahelin, Robert V.			Detection of lipid-induced structural changes of the Marburg virus matrix protein VP40 using hydrogen/deuterium exchange-mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EBOLA-VIRUS; PLASMA-MEMBRANE; PHOSPHOLIPASE A(2); VIRAL-EGRESS; MOLECULAR-DYNAMICS; BINDING; DOMAIN; OLIGOMERIZATION; ENVELOPE; THERAPEUTICS	Marburg virus (MARV) is a lipid-enveloped virus from the Filoviridae family containing a negative sense RNA genome. One of the seven MARV genes encodes the matrix protein VP40, which forms a matrix layer beneath the plasma membrane inner leaflet to facilitate budding from the host cell. MARV VP40 (mVP40) has been shown to be a dimeric peripheral protein with a broad and flat basic surface that can associate with anionic phospholipids such as phosphatidylserine. Although a number of mVP40 cationic residues have been shown to facilitate binding to membranes containing anionic lipids, much less is known on how mVP40 assembles to form the matrix layer following membrane binding. Here we have used hydrogen/deuterium exchange (HDX) mass spectrometry to determine the solvent accessibility of mVP40 residues in the absence and presence of phosphatidylserine and phosphatidylinositol 4,5-bisphosphate. HDX analysis demonstrates that two basic loops in the mVP40 C-terminal domain make important contributions to anionic membrane binding and also reveals a potential oligomerization interface in the C-terminal domain as well as a conserved oligomerization interface in the mVP40 N-terminal domain. Lipid binding assays confirm the role of the two basic patches elucidated with HD/X measurements, whereas molecular dynamics simulations and membrane insertion measurements complement these studies to demonstrate that mVP40 does not appreciably insert into the hydrocarbon region of anionic membranes in contrast to the matrix protein from Ebola virus. Taken together, we propose a model by which association of the mVP40 dimer with the anionic plasma membrane facilitates assembly of mVP40 oligomers.	[Wijesinghe, Kaveesha J.; Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Wijesinghe, Kaveesha J.; Stahelin, Robert V.] Univ Notre Dame, Boler Parseghian Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Urata, Sarah; Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Bhattarai, Nisha; Gerstman, Bernard S.; Chapagain, Prem P.] Florida Int Univ, Dept Phys, Miami, FL 33199 USA; [Gerstman, Bernard S.; Chapagain, Prem P.] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA; [Kooijman, Edgar E.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA	University of Notre Dame; University of Notre Dame; University of California System; University of California San Diego; State University System of Florida; Florida International University; State University System of Florida; Florida International University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Indiana University System; Indiana University South Bend	Li, S (corresponding author), Univ Calif San Diego, 9500 Gilman Dr,0652, La Jolla, CA 92093 USA.; Stahelin, RV (corresponding author), Indiana Univ Sch Med, 1234 Notre Dame Ave, South Bend, IN 46617 USA.	s4li@ucsd.edu; rstaheli@iu.edu	Stahelin, Robert/L-3567-2019; Wijesinghe, Kaveesha/AAF-5610-2020	Stahelin, Robert/0000-0001-5443-7863; Chapagain, Prem/0000-0002-0999-4975	National Institutes of Health Grants [AI081077, 1U19AI117905, R01GM020501, R01AI101436]; CBBI fellowship - National Institutes of Health Grant [T32GM075762]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117905, R01AI081077, R01AI101436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501, T32GM075762] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CBBI fellowship - National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AI081077 (to R. V. S.), 1U19AI117905, R01GM020501, and R01AI101436 (to S. L.), and a CBBI fellowship funded by National Institutes of Health Grant T32GM075762 (to K. J. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adu-Gyamfi E, 2015, J VIROL, V89, P9440, DOI 10.1128/JVI.01087-15; Adu-Gyamfi E, 2013, J BIOL CHEM, V288, P5779, DOI 10.1074/jbc.M112.443960; Adu-Gyamfi E, 2012, BIOPHYS J, V102, P2517, DOI 10.1016/j.bpj.2012.04.022; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bornholdt ZA, 2013, CELL, V154, P763, DOI 10.1016/j.cell.2013.07.015; Calvez P, 2009, BIOCHIMIE, V91, P718, DOI 10.1016/j.biochi.2009.03.018; Dolnik O, 2010, J VIROL, V84, P7847, DOI 10.1128/JVI.00476-10; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Garcia RA, 2004, ASSAY DRUG DEV TECHN, V2, P81, DOI 10.1089/154065804322966342; Gomis-Roth FX, 2003, STRUCTURE, V11, P423, DOI 10.1016/S0969-2126(03)00050-9; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hamuro Yoshitomo, 2003, J Biomol Tech, V14, P171; Hsu YH, 2008, J BIOL CHEM, V283, P9820, DOI 10.1074/jbc.M708143200; Hsu YH, 2009, J BIOL CHEM, V284, P23652, DOI 10.1074/jbc.M109.021857; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jasenosky LD, 2001, J VIROL, V75, P5205, DOI 10.1128/JVI.75.11.5205-5214.2001; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Johnson KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19125; Kolesnikova L, 2004, J VIROL, V78, P12277, DOI 10.1128/JVI.78.22.12277-12287.2004; Kolesnikova L, 2012, CELL MICROBIOL, V14, P182, DOI 10.1111/j.1462-5822.2011.01709.x; Kooijman EE, 2009, BIOCHEMISTRY-US, V48, P9360, DOI 10.1021/bi9008616; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Mendoza EJ, 2016, TRENDS MOL MED, V22, P164, DOI 10.1016/j.molmed.2015.12.005; Miles P, 2015, SOFT MATTER, V11, P7722, DOI 10.1039/c5sm01695a; Natesan M, 2016, CLIN VACCINE IMMUNOL, V23, P717, DOI 10.1128/CVI.00107-16; Oda S, 2016, J VIROL, V90, P1839, DOI 10.1128/JVI.01597-15; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rathnayake SS, 2014, BBA-BIOMEMBRANES, V1838, P482, DOI 10.1016/j.bbamem.2013.09.020; Rougeron V, 2015, J CLIN VIROL, V64, P111, DOI 10.1016/j.jcv.2015.01.014; Soni SP, 2013, BIOPHYS J, V104, P1940, DOI [10.1016/j.bpj.2013.03.021, 10.1016/j.bPj.2013.03.021]; Stahelin RV, 2007, J BIOL CHEM, V282, P25737, DOI 10.1074/jbc.M702861200; Stahelin RV, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00300; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Timmins J, 2001, VIROLOGY, V283, P1, DOI 10.1006/viro.2001.0860; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wei H, 2014, DRUG DISCOV TODAY, V19, P95, DOI 10.1016/j.drudis.2013.07.019; Wijesinghe KJ, 2016, J VIROL, V90, P3074, DOI 10.1128/JVI.02607-15; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1	42	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6108	6122		10.1074/jbc.M116.758300	http://dx.doi.org/10.1074/jbc.M116.758300			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28167534	hybrid, Green Published			2022-12-26	WOS:000399538700009
J	Budinich, M; Bourdon, J; Larhlimi, A; Eveillard, D				Budinich, Marko; Bourdon, Jeremie; Larhlimi, Abdelhalim; Eveillard, Damien			A multi-objective constraint-based approach for modeling genome-scale microbial ecosystems	PLOS ONE			English	Article							COMMUNITY ECOLOGY; SYSTEMS; THERMODYNAMICS; RECONSTRUCTION; OPTIMIZATION; FIXATION; ENTROPY; BALANCE; BIOLOGY; CYCLE	Interplay within microbial communities impacts ecosystems on several scales, and elucidation of the consequent effects is a difficult task in ecology. In particular, the integration of genome-scale data within quantitative models of microbial ecosystems remains elusive. This study advocates the use of constraint-based modeling to build predictive models from recent high-resolution-omics datasets. Following recent studies that have demonstrated the accuracy of constraint-based models (CBMs) for simulating single-strain metabolic networks, we sought to study microbial ecosystems as a combination of single-strain metabolic networks that exchange nutrients. This study presents two multi-objective extensions of CBMs for modeling communities: multi-objective flux balance analysis (MO-FBA) and multi objective flux variability analysis (MO-FVA). Both methods were applied to a hot spring mat model ecosystem. As a result, multiple trade-offs between nutrients and growth rates, as well as thermodynamically favorable relative abundances at community level, were emphasized. We expect this approach to be used for integrating genomic information in microbial ecosystems. Following models will provide insights about behaviors (including diversity) that take place at the ecosystem scale.	[Budinich, Marko; Bourdon, Jeremie; Larhlimi, Abdelhalim; Eveillard, Damien] Univ Nantes, Computat Biol Grp, LINA UMR CNRS 6241, EMN, Nantes, France	IMT - Institut Mines-Telecom; IMT Atlantique; Nantes Universite	Budinich, M (corresponding author), Univ Nantes, Computat Biol Grp, LINA UMR CNRS 6241, EMN, Nantes, France.	marko.budinich@univ-nantes.fr	eveillard, damien/AAQ-2363-2020	eveillard, damien/0000-0002-8162-7360; Bourdon, Jeremie/0000-0001-6674-8626; Larhlimi, Abdelhalim/0000-0002-1709-2648; Budinich, Marko/0000-0003-3541-0547	CNRS; Region Pays de la Loire funding (GRIOTE project); ANR (IMPEKAB) [ANR-15-CE02-001-03]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Pays de la Loire funding (GRIOTE project)(Region Pays de la Loire); ANR (IMPEKAB)(French National Research Agency (ANR))	MB is supported by CNRS and Region Pays de la Loire funding (GRIOTE project, http://griote.univ-nantes.fr/). This study is supported by ANR (IMPEKAB, ANR-15-CE02-001-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberty RA, 2006, APPLICATIONS OF MATH; ANDERSON KL, 1987, APPL ENVIRON MICROB, V53, P2343, DOI 10.1128/AEM.53.10.2343-2352.1987; Aoki I, 1998, J PHYS SOC JPN, V67, P2132, DOI 10.1143/JPSJ.67.2132; Beard DA, 2002, BIOPHYS J, V83, P79, DOI 10.1016/S0006-3495(02)75150-3; Benson HP, 1998, J GLOBAL OPTIM, V13, P1, DOI 10.1023/A:1008215702611; Biggs MB, 2015, WIRES SYST BIOL MED, V7, P317, DOI 10.1002/wsbm.1308; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Bordron P, 2016, MICROBIOLOGYOPEN, V5, P106, DOI 10.1002/mbo3.315; Borenstein E, 2008, P NATL ACAD SCI USA, V105, P14482, DOI 10.1073/pnas.0806162105; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Czyzyk J, 1998, IEEE COMPUT SCI ENG, V5, P68, DOI 10.1109/99.714603; Dantzig GB, 1983, MATH PROGRAMMING STA, P78, DOI [10.1007/978- 3- 642- 68874- 4, DOI 10.1007/978-3-642-68874-4]; Dillon JG, 2007, APPL ENVIRON MICROB, V73, P5218, DOI 10.1128/AEM.00357-07; Dolan E, 2001, TECHNICAL MEMORANDUM; Ehrgott M, 2005, MULTICRITERIA OPTIMI; Ehrgott M, 2005, INT SER OPER RES MAN, V78, P667, DOI 10.1007/0-387-23081-5_17; Ehrgott M, 2012, J GLOBAL OPTIM, V52, P757, DOI 10.1007/s10898-011-9709-y; Ehrgott M, 2011, J GLOBAL OPTIM, V50, P397, DOI 10.1007/s10898-010-9588-7; England JL, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818538; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; Fleming RMT, 2010, J THEOR BIOL, V264, P683, DOI 10.1016/j.jtbi.2010.02.044; Fuhrman JA, 2015, NAT REV MICROBIOL, V13, P133, DOI 10.1038/nrmicro3417; Gropp W., 1997, APPROXIMATION THEORY, P167; Gurobi Optimization I, 2015, GUROBI OPTIMIZER REF; Hamel AH, 2014, J GLOBAL OPTIM, V59, P811, DOI 10.1007/s10898-013-0098-2; Hanemaaijer M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00213; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Hoppe A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-23; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Khandelwal RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064567; Kim TY, 2012, CURR OPIN BIOTECH, V23, P617, DOI 10.1016/j.copbio.2011.10.007; Kim YM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00209; Klatt CG, 2013, ISME J, V7, P1775, DOI 10.1038/ismej.2013.52; Klitgord N, 2009, GENOME INFORM SER, V22, P41; Klitgord N, 2011, CURR OPIN BIOTECH, V22, P541, DOI 10.1016/j.copbio.2011.04.018; Koch S, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0429-x; Krause S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00251; Kschischo M, 2010, EUR PHYS J-SPEC TOP, V187, P255, DOI 10.1140/epjst/e2010-01290-3; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Lin BL, 2000, ECOL MODEL, V135, P89, DOI 10.1016/S0304-3800(00)00372-0; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Lohne A, 2015, BENSOLVE VLP SOLVER; Marler RT, 2004, STRUCT MULTIDISCIP O, V26, P369, DOI 10.1007/s00158-003-0368-6; Martyushev LM, 2006, PHYS REP, V426, P1, DOI 10.1016/j.physrep.2005.12.001; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Nash SG, 2000, J COMPUT APPL MATH, V124, P45, DOI 10.1016/S0377-0427(00)00426-X; Oberhardt Matthew A., 2009, V500, P61, DOI 10.1007/978-1-59745-525-1_3; Perez-Garcia O, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00673; Qian H, 2003, EUR J BIOCHEM, V270, P415, DOI 10.1046/j.1432-1033.2003.03357.x; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Rodriguez J, 2006, BIOTECHNOL BIOENG, V93, P592, DOI 10.1002/bit.20765; Rullkotter J., 2006, MARINE GEOCHEMISTRY, P125, DOI DOI 10.1007/3-540-32144-6_4; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Segata N, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.22; STADLER W, 1979, J OPTIMIZ THEORY APP, V29, P1, DOI 10.1007/BF00932634; Steunou AS, 2008, ISME J, V2, P364, DOI 10.1038/ismej.2007.117; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Stolyar S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100131; Taffs R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-114; Tawarmalani M, 2005, MATH PROGRAM, V103, P225, DOI 10.1007/s10107-005-0581-8; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Vo TD, 2004, J BIOL CHEM, V279, P39532, DOI 10.1074/jbc.M403782200; Waldor MK, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002050; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zengler K, 2012, NAT REV MICROBIOL, V10, P366, DOI 10.1038/nrmicro2763; Zomorrodi AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002363; Zomorrodi AR, 2014, ACS SYNTH BIOL, V3, P247, DOI 10.1021/sb4001307	69	36	38	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171744	10.1371/journal.pone.0171744	http://dx.doi.org/10.1371/journal.pone.0171744			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187207	Green Published, Green Submitted, gold			2022-12-26	WOS:000394244300042
J	Pfistermeister, B; Tumena, T; Gassmann, KG; Maas, R; Fromm, MF				Pfistermeister, Barbara; Tuemena, Thomas; Gassmann, Karl-Guenter; Maas, Renke; Fromm, Martin F.			Anticholinergic burden and cognitive function in a large German cohort of hospitalized geriatric patients	PLOS ONE			English	Article							MINI-MENTAL-STATE; POTENTIALLY INAPPROPRIATE MEDICATIONS; GIB-DAT; IMPLEMENTATION; DEMENTIA; IMPACT; DRUGS; RISK; IMPAIRMENT; BAVARIA	Purpose Previous studies suggest an association between use of anticholinergic drugs in elderly patients and cognitive impairment. However, there are still limited data on the association of anticholinergic drug use and cognitive impairment as well as contribution of individual drugs to anticholinergic load using large, well-documented patient cohorts treated in geriatric units from Europe. Methods We investigated 797,440 prescriptions to 89,579 hospitalized patients treated in geriatric units within the GiB-DAT database. Data of all patients discharged between 1 January 2013 and 30 June 2015 was included. The Anticholinergic Cognitive Burden (ACB) scale was used to classify anticholinergic drugs as definite (score 2 or 3) and possible anticholinergics (score 1). Cognitive function was determined using Mini-Mental State Examination (MMSE) and the standardized scale for dementia (4D+S). Results In two multivariable logistic regression models age, sex, number of drugs and ACB total scores were identified as variables independently associated with cognitive impairment as measured by MMSE (odds ratio per ACB unit 1.114, 95% CI 1.099-1.130) or the diagnosis dementia (odds ratio 1.159 per ACB unit, 95% CI 1.144-1.173, both p < 0.0001). High anticholinergic load was associated with patients with severe cognitive impairment (p < 0.05 for all pairwise comparisons). ACB score 3 anticholinergic drugs contributed 77.9% to the cumulative amount of ACB points in patients with an anticholinergic load of 3 and higher. Conclusions Using a cross-sectional study design, a significant positive association between anticholinergic drug load and cognitive impairment in European patients treated in specialised geriatric units was found. The most frequently used definitve anticholinergic drugs were quetiapine, amitriptyline and carbamazepine.	[Pfistermeister, Barbara; Maas, Renke; Fromm, Martin F.] Friedrich Alexander Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Fahrstr 17, Erlangen, Germany; [Tuemena, Thomas; Gassmann, Karl-Guenter] GiB DAT Database, Nurnberg, Germany; [Gassmann, Karl-Guenter] Waldkrankenhaus St Marien gGmbH, Internal Med 3, Geriatr Ctr Erlangen, Erlangen, Germany	University of Erlangen Nuremberg	Fromm, MF (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Fahrstr 17, Erlangen, Germany.	martin.fromm@fau.de						Aging Brain Care, ANT COGN BURD SCAL 2; Ancelin ML, 2006, BMJ-BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; Block CK, 2015, ARCH CLIN NEUROPSYCH, V30, P105, DOI 10.1093/arclin/acu073; Boudreau DM, 2011, J AM GERIATR SOC, V59, P2069, DOI 10.1111/j.1532-5415.2011.03654.x; Boustani M., 2008, AGING HLTH, V4, P311, DOI [10.2217/1745509x.4.3.311, DOI 10.2217/1745509X.4.3.311, 10.2217/1745509XA3.311, 10.2217/1745509X.4.3.311]; Cai XY, 2013, ALZHEIMERS DEMENT, V9, P377, DOI 10.1016/j.jalz.2012.02.005; Callegari E, 2011, BRIT J CLIN PHARMACO, V72, P235, DOI 10.1111/j.1365-2125.2011.03961.x; Campbell NL, 2010, NEUROLOGY, V75, P152, DOI 10.1212/WNL.0b013e3181e7f2ab; Campbell N, 2009, CLIN INTERV AGING, V4, P225; Chancellor M, 2012, CNS NEUROSCI THER, V18, P167, DOI 10.1111/j.1755-5949.2011.00248.x; Chancellor MB, 2012, DRUG AGING, V29, P259, DOI 10.2165/11597530-000000000-00000; Duran CE, 2013, EUR J CLIN PHARMACOL, V69, P1485, DOI 10.1007/s00228-013-1499-3; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox C, 2011, AGE AGEING, V40, P730, DOI 10.1093/ageing/afr102; Fox C, 2011, J AM GERIATR SOC, V59, P1477, DOI 10.1111/j.1532-5415.2011.03491.x; Fromm MF, 2013, EUR J CLIN PHARMACOL, V69, P975, DOI 10.1007/s00228-012-1425-0; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gassmann KG, 2012, Z GERONTOL GERIATR, V45, P455, DOI 10.1007/s00391-012-0382-7; Gnjidic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083224; Gray SL, 2015, JAMA INTERN MED, V175, P401, DOI 10.1001/jamainternmed.2014.7663; Holt S, 2010, DTSCH ARZTEBL INT, V107, P543, DOI 10.3238/arztebl.2010.0543; Jessen F, 2010, EUR ARCH PSY CLIN N, V260, pS111, DOI 10.1007/s00406-010-0156-4; Kersten H, 2013, J GERONTOL A-BIOL, V68, P271, DOI 10.1093/gerona/gls176; Lechevallier-Michel N, 2005, BRIT J CLIN PHARMACO, V59, P143, DOI 10.1111/j.1365-2125.2004.02232.x; Lopez M, 2005, ASSESSMENT, V12, P137, DOI 10.1177/1073191105275412; Mate KE, 2015, DRUG AGING, V32, P159, DOI 10.1007/s40266-014-0230-0; Mayer T, 2015, EUR J CLIN PHARMACOL, V71, P1299, DOI 10.1007/s00228-015-1932-x; Mintzer J, 2000, J ROY SOC MED, V93, P457, DOI 10.1177/014107680009300903; Schachtele S, 2015, E HLTH 2015, P116; Schachtele S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155649; Schachtele S, 2014, DTSCH ARZTEBL INT, V111, P255, DOI 10.3238/arztebl.2014.0255; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Trogner J, 2006, Z GERONTOL GERIATR, V39, P126, DOI 10.1007/s00391-006-0338-x; Trogner J, 2006, Z GERONTOL GERIATR, V39, P134, DOI 10.1007/s00391-006-0339-9; Tune LE, 2001, J CLIN PSYCHIAT, V62, P11; WHO Collaborating Centre for Drug Statistics Methodology, ATC STRUCT PRINC; Yeh YC, 2013, GERIATR GERONTOL INT, V13, P694, DOI 10.1111/ggi.12000	38	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171353	10.1371/journal.pone.0171353	http://dx.doi.org/10.1371/journal.pone.0171353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187171	Green Submitted, Green Published, gold			2022-12-26	WOS:000394244300021
J	Cha, S; Chae, HM; Lee, SH; Shim, JK				Cha, Sangsub; Chae, Hee-Myung; Lee, Sang-Hoon; Shim, Jae-Kuk			Effect of elevated atmospheric CO2 concentration on growth and leaf litter decomposition of Quercus acutissima and Fraxinus rhynchophylla	PLOS ONE			English	Article							GLOBAL CLIMATE-CHANGE; MICROBIAL BIOMASS; SOIL CARBON; TEMPERATURE SENSITIVITY; NITROGEN LIMITATION; LIGNIN CONTROL; PLANT-GROWTH; ROOT-GROWTH; ENRICHMENT; DYNAMICS	The atmospheric carbon dioxide (CO2) level is expected to increase substantially, which may change the global climate and carbon dynamics in ecosystems. We examined the effects of an elevated atmospheric CO2 level on the growth of Quercus acutissima and Fraxinus rhynchophylla seedlings. We investigated changes in the chemical composition of leaf litter, as well as litter decomposition. Q. acutissima and F. rhynchophylla did not show differences in dry weight between ambient CO2 and enriched CO2 treatments, but they exhibited different patterns of carbon allocation, namely, lower shoot/root ratio (S/R) and decreased specific leaf area (SLA) under CO2-enriched conditions. The elevated CO2 concentration significantly reduced the nitrogen concentration in leaf litter while increasing lignin concentrations and carbon/nitrogen (C/N) and lignin/N ratios. The microbial biomass associated with decomposing Q. acutissima leaf litter was suppressed in CO2 enrichment chambers, while that of F. rhynchophylla was not. The leaf litter of Q. acutissima from the CO2-enriched chambers, in contrast with F. rhynchophylla, contained much lower nutrient concentrations than that of the litter in the ambient air chambers. Consequently, poorer litter quality suppressed decomposition.	[Cha, Sangsub; Chae, Hee-Myung; Lee, Sang-Hoon; Shim, Jae-Kuk] Chung Ang Univ, Dept Life Sci, Seoul, South Korea	Chung Ang University	Shim, JK (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul, South Korea.	shimjk@cau.ac.kr						Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; Allen S.E., 1974, CHEM ANAL ECOLOGICAL; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Andresen LC, 2010, PLANT SOIL, V328, P381, DOI 10.1007/s11104-009-0118-7; [Anonymous], 2014, CLIMATE CHANGE 2013; [Anonymous], 2015, WMO GREENH GAS B; BAZZAZ FA, 1990, ANNU REV ECOL SYST, V21, P167, DOI 10.1146/annurev.es.21.110190.001123; BEARE MH, 1991, AGR ECOSYST ENVIRON, V34, P65, DOI 10.1016/0167-8809(91)90094-E; Berg B., 2008, PLANT LITTER; Bloom AJ, 2014, NAT CLIM CHANGE, V4, P477, DOI [10.1038/NCLIMATE2183, 10.1038/nclimate2183]; Brandstatter C, 2013, PLANT SOIL, V371, P139, DOI 10.1007/s11104-013-1671-7; Brandt LA, 2007, GLOBAL CHANGE BIOL, V13, P2193, DOI 10.1111/j.1365-2486.2007.01428.x; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Ceulemans R, 1999, ANN BOT-LONDON, V84, P577, DOI 10.1006/anbo.1999.0945; CEULEMANS R, 1994, NEW PHYTOL, V127, P425, DOI 10.1111/j.1469-8137.1994.tb03961.x; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Cotrufo M. Francesca, 1998, Environmental Reviews, V6, P1, DOI 10.1139/a97-013; Cotrufo MF, 1996, OECOLOGIA, V106, P525, DOI 10.1007/BF00329711; COTRUFO MF, 1994, PLANT SOIL, V163, P121, DOI 10.1007/BF00033948; Cotrufo MF, 1998, SOIL BIOL BIOCHEM, V30, P1565, DOI 10.1016/S0038-0717(98)00032-7; COUTEAUX MM, 1991, OIKOS, V61, P54, DOI 10.2307/3545406; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; De Angelis P, 2000, PLANT SOIL, V224, P31, DOI 10.1023/A:1004790328560; de Graaff MA, 2006, GLOBAL CHANGE BIOL, V12, P2077, DOI 10.1111/j.1365-2486.2006.01240.x; de la Mata L, 2012, J PLANT PHYSIOL, V169, P1392, DOI 10.1016/j.jplph.2012.05.024; de Oliveira ED, 2013, FUNCT PLANT BIOL, V40, P160, DOI 10.1071/FP12206; Eamus D, 2004, ADV ECOL RES, V34; Entry JA, 1998, ROOT DEMOGRAPHICS TH; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; Faria T, 1996, J EXP BOT, V47, P1755, DOI 10.1093/jxb/47.11.1755; Ferreira V, 2011, OECOLOGIA, V167, P279, DOI 10.1007/s00442-011-1976-2; Finzi AC, 2006, ECOLOGY, V87, P15, DOI 10.1890/04-1748; Gavazov KS, 2010, PLANT SOIL, V337, P19, DOI 10.1007/s11104-010-0477-0; Gebauer RLE, 1998, OECOLOGIA, V113, P29, DOI 10.1007/s004420050350; Heagle AS, 2002, ENVIRON ENTOMOL, V31, P594, DOI 10.1603/0046-225X-31.4.594; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Helrich K, 1990, OFF METH AN AOAC, V1; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; Hunt R., 1990, BASIC PLANT GROWTH A, DOI 10.1007/978-94-010-9117-6; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jarvis PG, 1998, EUROPEAN FORESTS GLO; Jastrow JD, 2005, GLOBAL CHANGE BIOL, V11, P2057, DOI 10.1111/j.1365-2486.2005.01077.x; Jiang S, 2016, ENTOMOL EXP ET APPL; JOERGENSEN RG, 1990, SOIL BIOL BIOCHEM, V22, P1023, DOI 10.1016/0038-0717(90)90027-W; Kardol P, 2011, APPL SOIL ECOL, V47, P37, DOI 10.1016/j.apsoil.2010.11.001; Kasurinen A, 2006, PLANT SOIL, V282, P261, DOI 10.1007/s11104-005-6026-6; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Keiser AD, 2013, PLANT SOIL, V372, P167, DOI 10.1007/s11104-013-1730-0; Khalsa SDS, 2016, SOIL SCI PLANT NUTR, V62, P271, DOI 10.1080/00380768.2016.1188413; Kohen AE, 1992, ANN SCI FORESTIERES; Korner C, 2005, SCIENCE, V309, P1360, DOI 10.1126/science.1113977; Korner C, 2003, J ECOL, V91, P4, DOI 10.1046/j.1365-2745.2003.00742.x; Larsen KS, 2011, GLOBAL CHANGE BIOL, V17, P1884, DOI 10.1111/j.1365-2486.2010.02351.x; Lee T. B., 2003, COLOURED FLORA KOREA, V1; Lee TB, 2003, COLOURED FLORA KOREA, V2; Lee TD, 2003, OECOLOGIA, V137, P22, DOI 10.1007/s00442-003-1309-1; Li TQ, 2012, PLANT SOIL, V354, P325, DOI 10.1007/s11104-011-1068-4; Lindroth RL, 2010, J CHEM ECOL, V36, P2, DOI 10.1007/s10886-009-9731-4; Lopes A, 2015, HYDROBIOLOGIA, P1; Loudermilk EL, 2013, GLOBAL CHANGE BIOL, V19, P3502, DOI 10.1111/gcb.12310; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; Lynch JP, 2004, FIELD CROP RES, V90, P101, DOI 10.1016/j.fcr.2004.07.008; Madhu M, 2013, AGRON J, V105, P657, DOI 10.2134/agronj2013.0018; Martin PH, 2001, ANNU REV ENERG ENV, V26, P435, DOI 10.1146/annurev.energy.26.1.435; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Melillo J., 1983, WILL INCREASES ATMOS, P10; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Murray TJ, 2013, GLOBAL CHANGE BIOL, V19, P1407, DOI 10.1111/gcb.12142; Nakamoto T, 2004, PLANT PROD SCI, V7, P70, DOI 10.1626/pps.7.70; Neha Sharma, 2014, Climate Change and Environmental Sustainability, V2, P69, DOI 10.5958/2320-642X.2014.00001.5; Norby RJ, 2011, ANNU REV ECOL EVOL S, V42, P181, DOI 10.1146/annurev-ecolsys-102209-144647; Norby RJ, 1999, PLANT CELL ENVIRON, V22, P683, DOI 10.1046/j.1365-3040.1999.00391.x; Norby RJ, 2001, OECOLOGIA, V127, P153, DOI 10.1007/s004420000615; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Pardos M, 2006, TREES-STRUCT FUNCT, V20, P713, DOI 10.1007/s00468-006-0086-y; PARMELEE RW, 1989, SOIL BIOL BIOCHEM, V21, P97, DOI 10.1016/0038-0717(89)90017-5; Pendall E, 2004, NEW PHYTOL, V162, P311, DOI 10.1111/j.1469-8137.2004.01053.x; Pritchard SG, 1999, GLOB CHANGE BIOL, V5, P807, DOI 10.1046/j.1365-2486.1999.00268.x; Reich PB, 2014, NAT GEOSCI, V7, P920, DOI [10.1038/NGEO2284, 10.1038/ngeo2284]; Reverchon F, 2012, J SOIL SEDIMENT, V12, P150, DOI 10.1007/s11368-011-0445-1; Richet N, 2012, J EXP BOT, V63, P4291, DOI 10.1093/jxb/ers118; ROWLAND AP, 1994, COMMUN SOIL SCI PLAN, V25, P269, DOI 10.1080/00103629409369035; Rutledge S, 2010, GLOBAL CHANGE BIOL, V16, P3065, DOI 10.1111/j.1365-2486.2009.02149.x; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Smith AR, 2013, GLOBAL CHANGE BIOL, V19, P217, DOI 10.1111/gcb.12039; Stevenson F.J., 1994, HUMUS CHEM GENESIS C; Sulman BN, 2014, NAT CLIM CHANGE, V4, P1099, DOI [10.1038/nclimate2436, 10.1038/NCLIMATE2436]; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Talbot JM, 2012, ECOLOGY, V93, P345, DOI 10.1890/11-0843.1; Taub DR, 2008, J INTEGR PLANT BIOL, V50, P1365, DOI 10.1111/j.1744-7909.2008.00754.x; TAYLOR BR, 1989, ECOLOGY, V70, P97, DOI 10.2307/1938416; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Tissue DT, 1997, PLANT CELL ENVIRON, V20, P1123, DOI 10.1046/j.1365-3040.1997.d01-140.x; Tyrrell ML, 2012, MANAGING EST CARB; van Groenigen KJ, 2014, SCIENCE, V344, P508, DOI 10.1126/science.1249534; van Groenigen KJ, 2006, P NATL ACAD SCI USA, V103, P6571, DOI 10.1073/pnas.0509038103; Varga B, 2016, J AGRONOMY CROP SCI; Wamelink GWW, 2009, FOREST ECOL MANAG, V258, P1794, DOI 10.1016/j.foreco.2009.05.018; Ward SE, 2015, ECOLOGY, V96, P113, DOI 10.1890/14-0292.1; Wymore AS, 2016, MICROB ECOL, V71, P825, DOI 10.1007/s00248-016-0735-7; Xu CY, 2012, J EXP BOT, V63, P5829, DOI 10.1093/jxb/ers231; Yuan ZY, 2015, NAT CLIM CHANGE, V5, P465, DOI [10.1038/nclimate2549, 10.1038/NCLIMATE2549]; Zhu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062073; Ziska LH, 2005, GLOBAL CHANGE BIOL, V11, P1325, DOI 10.1111/j.1365-2486.2005.00992.x	109	21	22	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171197	10.1371/journal.pone.0171197	http://dx.doi.org/10.1371/journal.pone.0171197			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182638	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800044
J	Huang, P; Li, WS; Yang, ZF; Zhang, N; Xu, YX; Bao, JY; Jiang, DK; Dong, XP				Huang, Peng; Li, Wenshu; Yang, Zhifang; Zhang, Ning; Xu, Yixin; Bao, Jianying; Jiang, Deke; Dong, Xianping			LYZL6, an acidic, bacteriolytic, human sperm-related protein, plays a role in fertilization	PLOS ONE			English	Article							LYSOZYME-LIKE PROTEIN; PICHIA-PASTORIS; EGG FUSION; BINDING; SLLP1; SPERMATOZOA; EXPRESSION; PLASMA	Lysozyme-like proteins (LYZLs) belong to the c-type lysozyme/alpha-lactalbumin family and are selectively expressed in the mammalian male reproductive tract. Two members, human sperm lysozyme-like protein (SLLP) -1 and mouse LYZL4, have been reported to contribute to fertilization but show no bacteriolytic activity. Here, we focused on the possible contribution of LYZL6 to immunity and fertilization. In humans, LYZL6 was selectively expressed by the testis and epididymis and became concentrated on spermatozoa. Native LYZL6 isolated from sperm extracts exhibited bacteriolytic activity against Micrococcus lysodeikticus. Recombinant LYZL6 (rLYZL6) reached its peak activity at pH 5.6 and 15 mM of Na+, and could inhibit the growth of Gram-positive, but not Gram-negative bacteria. Nevertheless, the bacteriolytic activity of rLYZL6 proved to be much lower than that of human lysozyme under physiological conditions. Immunodetection with a specific antiserum localized the LYZL6 protein on the postacrosomal membrane of mature spermatozoa. Immunoneutralization of LYZL6 significantly decreased the numbers of human spermatozoa fused with zona-free hamster eggs in a dose-dependent manner in vitro. Thus, we report here for the first time that LYZL6, an acidic, bacteriolytic and human sperm-related protein, is likely important for fertilization but not for the innate immunity of the male reproductive tract.	[Huang, Peng; Yang, Zhifang; Zhang, Ning; Bao, Jianying] Shanghai Univ Med & Hlth Sci, Coll Basic Med, Shanghai, Peoples R China; [Li, Wenshu] New York Univ, Coll Arts & Sci, Shanghai, Peoples R China; [Xu, Yixin] Shanghai Univ Med & Hlth Sci, Coll Pharm, Shanghai, Peoples R China; [Jiang, Deke] Southern Med Univ, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Dong, Xianping] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada	Shanghai University of Medicine & Health Sciences; Shanghai University of Medicine & Health Sciences; Southern Medical University - China; Dalhousie University	Huang, P (corresponding author), Shanghai Univ Med & Hlth Sci, Coll Basic Med, Shanghai, Peoples R China.; Dong, XP (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada.	huangp_15@sumhs.edu.cn; xpdong@dal.ca		Dong, Xianping/0000-0002-4496-7104	Science and Technology Commission of Shanghai Municipality [15ZR1421800]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the Science and Technology Commission of Shanghai Municipality (no. 15ZR1421800). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Doussau M, 2008, FERTIL STERIL, V90, P853, DOI 10.1016/j.fertnstert.2007.07.1329; Herrero MB, 2005, DEV BIOL, V284, P126, DOI 10.1016/j.ydbio.2005.05.008; Huang P, 2011, MOL IMMUNOL, V48, P524, DOI 10.1016/j.molimm.2010.10.008; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; KLOCKARS M, 1975, J HISTOCHEM CYTOCHEM, V23, P932, DOI 10.1177/23.12.1104708; Malm J, 2000, INFECT IMMUN, V68, P4297, DOI 10.1128/IAI.68.7.4297-4302.2000; Mandal A, 2003, BIOL REPROD, V68, P1525, DOI 10.1095/biolreprod.102.010108; MASON DY, 1975, J CLIN PATHOL, V28, P124, DOI 10.1136/jcp.28.2.124; Narmadha G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027659; Prager E.M., 1996, Experientia Supplementum (Basel), V75, P323; Prager E.M., 1996, Experientia Supplementum (Basel), V75, P9; Rubinstein E, 2006, SEMIN CELL DEV BIOL, V17, P254, DOI 10.1016/j.semcdb.2006.02.012; Sachdev M, 2012, DEV BIOL, V363, P40, DOI 10.1016/j.ydbio.2011.12.021; SAMUEL T, 1987, CLIN EXP IMMUNOL, V67, P454; Sava G, 1996, EXS, V75, P433; Sinclair G, 2002, PROTEIN EXPRES PURIF, V26, P96, DOI 10.1016/S1046-5928(02)00526-0; Stein KK, 2004, J CELL SCI, V117, P6269, DOI 10.1242/jcs.01598; Sun RL, 2011, ACTA BIOCH BIOPH SIN, V43, P346, DOI 10.1093/abbs/gmr017; Wei J, 2013, ASIAN J ANDROL, V15, P824, DOI 10.1038/aja.2013.93; Yanagimachi R., 1994, P189; Yenugu S, 2004, BIOL REPROD, V71, P1484, DOI 10.1095/biolreprod.104.031567; Yudin AI, 2005, BIOL REPROD, V73, P1243, DOI 10.1095/biolreprod.105.042432; Zhang KX, 2005, BIOL REPROD, V73, P1064, DOI 10.1095/biolreprod.105.041889; Zhou XY, 2014, J BIOSCI BIOENG, V118, P420, DOI 10.1016/j.jbiosc.2014.03.009	25	8	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171452	10.1371/journal.pone.0171452	http://dx.doi.org/10.1371/journal.pone.0171452			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182716	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800060
J	Wu, CH; Chang, CS; Yang, YK; Shen, LH; Yao, WJ				Wu, Chih-Hsing; Chang, Chin-Sung; Yang, Yen Kuang; Shen, Lie-Hang; Yao, Wei-Jen			Comparison of brain serotonin transporter using [I-123]-ADAM between obese and non-obese young adults without an eating disorder	PLOS ONE			English	Article							BODY-MASS INDEX; HEALTHY-VOLUNTEERS; I-123 ADAM; AVAILABILITY; SPECT; DOPAMINE; BINDING; ASSOCIATION; WEIGHT; DRUGS	Cerebral serotonin metabolism has an important but controversial role in obesity. However, it is not given enough attention in morbidly obese young adults. We used single photon emission computed tomography (SPECT) with [I-123]-labeled 2-((2-((dimethylamino) methyl) phenyl) thio)-5- iodophenylamine (ADAM) to investigate changes in serotonin transporter (SERT) availability in 10 morbidly obese young adults without an eating disorder (M/F =5/5, body mass index (BMI): 40.3 +/- 4.1 kg/m(2), percentage of body fat (BF%): 46.0 +/- 3.9%) and 10 age- and sex-matched non-obese controls (BMI: 20.3 +/- 1.2 kg/m(2), BF%: 20.6 +/- 8.9%). All participants underwent SPECT at 10 min and 6 h after an injection of 200 MBq of [I-123]-ADAM. The SERT binding site (midbrain) was drawn with cerebellum normalization. The BF% and fat distribution were measured using dual-energy X-ray absorptiometry. The midbrain/cerebellum SERT binding ratios (2.49 +/- 0.46 vs. 2.47 +/- 0.47; p = 0.912) at 6 h were not significantly different between groups, nor was the distribution of the summed images at 10 min (1.36 +/- 0.14 vs. 1.35 +/- 0.11; p = 0.853). There were no significant correlations between midbrain/cerebellum SERT binding ratio and age, BMI, BF%, or fat distribution. No significant difference in SERT availability in the midbrain between morbidly obese and non-obese young adults without an eating disorder indicates an unmet need for investigating the role of cerebral serotonin in obesity.	[Wu, Chih-Hsing; Chang, Chin-Sung] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Family Med, Tainan, Taiwan; [Wu, Chih-Hsing; Yang, Yen Kuang] Natl Cheng Kung Univ, Coll Med, Inst Behav Med, Tainan, Taiwan; [Wu, Chih-Hsing] Natl Cheng Kung Univ, Coll Med, Inst Gerontol, Tainan, Taiwan; [Chang, Chin-Sung] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan, Taiwan; [Yang, Yen Kuang] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Psychiat, Tainan, Taiwan; [Shen, Lie-Hang] Inst Nucl Energy Res, Taoyuan, Taiwan; [Yao, Wei-Jen] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Nucl Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Institute of Nuclear Energy Research - Taiwan; National Cheng Kung University	Yao, WJ (corresponding author), Natl Cheng Kung Univ, Coll Med & Hosp, Dept Nucl Med, Tainan, Taiwan.	wjyao@mail.ncku.edu.tw						Acton PD, 2001, J NUCL MED, V42, P1556; Adan RAH, 2013, TRENDS NEUROSCI, V36, P133, DOI 10.1016/j.tins.2012.12.001; Allison DB, 2008, OBESITY, V16, P1161, DOI 10.1038/oby.2008.231; Bays HE, 2004, OBES RES, V12, P1197, DOI 10.1038/oby.2004.151; Bello NT, 2011, DRUG DES DEV THER, V5, P95, DOI 10.2147/DDDT.S11859; Berlie HD, 2013, EXPERT OPIN DRUG MET, V9, P1053, DOI 10.1517/17425255.2013.798643; Borgers AJ, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00106; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Chang WH, 2015, PSYCHIAT RES-NEUROIM, V231, P320, DOI 10.1016/j.pscychresns.2015.01.015; Chen PS, 2008, NEUROIMAGE, V40, P275, DOI 10.1016/j.neuroimage.2007.11.007; Cheng YS, 2011, PSYCHIAT RES-NEUROIM, V194, P396, DOI 10.1016/j.pscychresns.2011.04.005; Chou MH, 2012, PSYCHOPHARMACOLOGY, V219, P1011, DOI 10.1007/s00213-011-2431-0; Chou YH, 2009, PSYCHIAT RES-NEUROIM, V172, P38, DOI 10.1016/j.pscychresns.2008.12.006; Colman E, 2012, NEW ENGL J MED, V367, P1577, DOI 10.1056/NEJMp1211277; Darby A, 2007, INT J OBESITY, V31, P876, DOI 10.1038/sj.ijo.0803501; Darby A, 2009, INT J EAT DISORDER, V42, P104, DOI 10.1002/eat.20601; Erlandsson K, 2005, EUR J NUCL MED MOL I, V32, P1329, DOI 10.1007/s00259-005-1912-y; Erritzoe D, 2010, NEUROIMAGE, V52, P284, DOI 10.1016/j.neuroimage.2010.03.086; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Giannaccini G, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-128; Gibson CD, 2010, J NEUROENDOCRINOL, V22, P833, DOI 10.1111/j.1365-2826.2010.02025.x; Heils A, 1997, J NEURAL TRANSM, V104, P1005, DOI 10.1007/BF01273314; Hesse S, 2014, EUR NEUROPSYCHOPHARM, V24, P1240, DOI 10.1016/j.euroneuro.2014.05.005; Hsu JW, 2011, PSYCHIAT RES-NEUROIM, V194, P224, DOI 10.1016/j.pscychresns.2011.04.011; Huang CI, 2010, NUCL MED COMMUN, V31, P734, DOI 10.1097/MNM.0b013e32833b7534; Huang HY, 2013, J PSYCHOSOM RES, V75, P577, DOI 10.1016/j.jpsychores.2013.09.006; Koebnick C, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-15; Koopman KE, 2013, MOL METAB, V2, P417, DOI 10.1016/j.molmet.2013.07.006; Koskela AK, 2008, PHYSIOL BEHAV, V93, P724, DOI 10.1016/j.physbeh.2007.11.043; Koskela AK, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-19; Kuikka JT, 2001, PSYCHOPHARMACOLOGY, V155, P310, DOI 10.1007/s002130100716; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Lin KJ, 2006, NUCL MED BIOL, V33, P193, DOI 10.1016/j.nucmedbio.2005.10.006; Marston OJ, 2011, EUR J PHARMACOL, V660, P70, DOI 10.1016/j.ejphar.2010.12.024; Meguid MM, 2000, NUTRITION, V16, P843, DOI 10.1016/S0899-9007(00)00449-4; Mond JM, 2007, OBESITY, V15, P2769, DOI 10.1038/oby.2007.329; Morgan JF, 1999, BRIT MED J, V319, P1467, DOI 10.1136/bmj.319.7223.1467; Nigro SC, 2013, CURR MED RES OPIN, V29, P839, DOI 10.1185/03007995.2013.794776; Organization WH, 1998, WELLB MEAS PRIM HLTH; Oya S, 2000, NUCL MED BIOL, V27, P249, DOI 10.1016/S0969-8051(00)00084-6; Pedersen Sue D, 2012, Endocrinol Nutr, V59, P521, DOI 10.1016/j.endonu.2012.07.001; Sargent BJ, 2011, CURR OPIN PHARMACOL, V11, P52, DOI 10.1016/j.coph.2011.01.005; SILVERSTONE T, 1986, APPETITE, V7, P85, DOI 10.1016/S0195-6663(86)80054-X; Thomsen G, 2013, OBESITY, V21, P1803, DOI 10.1002/oby.20225; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wolfe BE, 2000, NEUROPSYCHOPHARMACOL, V22, P257, DOI 10.1016/S0893-133X(99)00117-7; Wu CH, 1998, ATHEROSCLEROSIS, V137, P157, DOI 10.1016/S0021-9150(97)00270-0; Wu CH, 2009, ASIA PAC J CLIN NUTR, V18, P423; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	50	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170886	10.1371/journal.pone.0170886	http://dx.doi.org/10.1371/journal.pone.0170886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182708	Green Submitted, gold, Green Published			2022-12-26	WOS:000394231800021
J	Alta, RYP; Vitorino, HA; Goswami, D; Liria, CW; Wisnovsky, SP; Kelley, SO; Machini, MT; Esposito, BP				Alta, Roxana Y. P.; Vitorino, Hector A.; Goswami, Dibakar; Liria, Cleber W.; Wisnovsky, Simon P.; Kelley, Shana O.; Machini, M. Teresa; Esposito, Breno P.			Mitochondria-penetrating peptides conjugated to desferrioxamine as chelators for mitochondrial labile iron	PLOS ONE			English	Article							FRIEDREICHS-ATAXIA; OVERLOAD DISEASE; CELL-DEATH; DOXORUBICIN; DELIVERY; DNA	Desferrioxamine (DFO) is a bacterial siderophore with a high affinity for iron, but low cell penetration. As part of our ongoing project focused on DFO-conjugates, we synthesized, purified, characterized and studied new mtDFOs (DFO conjugated to the Mitochondria Penetrating Peptides TAT(49-57), 1A, SS02 and SS20) using a succinic linker. These new conjugates retained their strong iron binding ability and antioxidant capacity. They were relatively non toxic to A2780 cells (IC50 40-100 mu M) and had good mitochondrial localization (Rr +0.45-+0.68) as observed when labeled with carboxy-tetramethylrhodamine (TAMRA) In general, mtDFO caused only modest levels of mitochondrial DNA (mtDNA) damage. DFO-SS02 retained the antioxidant ability of the parent peptide, shown by the inhibition of mitochondrial superoxide formation. None of the compounds displayed cell cycle arrest or enhanced apoptosis. Taken together, these results indicate that mtDFO could be promising compounds for amelioration of the disease symptoms of iron overload in mitochondria.	[Alta, Roxana Y. P.; Vitorino, Hector A.; Esposito, Breno P.] Univ Sao Paulo, Inst Chem, Dept Fundamental Chem, Sao Paulo, Brazil; [Alta, Roxana Y. P.; Liria, Cleber W.; Machini, M. Teresa] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Goswami, Dibakar] Bhabha Atom Res Ctr, Bombay, Maharashtra, India; [Wisnovsky, Simon P.; Kelley, Shana O.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Kelley, Shana O.] Univ Toronto, Fac Pharm, Toronto, ON, Canada	Universidade de Sao Paulo; Universidade de Sao Paulo; Bhabha Atomic Research Center (BARC); University of Toronto; University of Toronto	Esposito, BP (corresponding author), Univ Sao Paulo, Inst Chem, Dept Fundamental Chem, Sao Paulo, Brazil.; Machini, MT (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.	breno@iq.usp.br; mtmachini@iq.usp.br	goswami, dibakar/AAE-2672-2019; Kelley, Shana/H-5856-2015; PASTRANA ALTA, ROXANA YESENIA/K-2351-2017; Esposito, Breno/B-7136-2008; Vitorino, Hector Aguilar/T-5780-2019; Machini, M. Teresa/D-2009-2012; Vitorino, Hector Aguilar/J-2749-2015; Kelley, Shana/ABA-7403-2021	Kelley, Shana/0000-0003-3360-5359; PASTRANA ALTA, ROXANA YESENIA/0000-0002-8671-4578; Esposito, Breno/0000-0002-1447-435X; Vitorino, Hector Aguilar/0000-0002-6891-0524; Machini, M. Teresa/0000-0001-5772-004X; Vitorino, Hector Aguilar/0000-0002-6891-0524; PASTRANA ALTA, ROXANA YESENIA/0000-0003-4316-6572	FAPESP (Brazilian agency) [2011/50318-1, 2016/03709-9, 2012/09068-4]; CNPq (Brazilian agency); CAPES (Brazilian agency)	FAPESP (Brazilian agency)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Brazilian agency)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Brazilian agency)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We declare financial support from FAPESP (grants 2011/50318-1 and 2016/03709-9 for BPE and 2012/09068-4 for MTM), CNPq and CAPES (Brazilian agencies).	Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433; Breuer W, 2001, ANAL BIOCHEM, V299, P194, DOI 10.1006/abio.2001.5378; Cabantchik ZI, 2013, THALASS REP, V3, P7, DOI 10.4081/thal.2013.s1.e3; Chamberlain GR, 2013, ACS CHEM BIOL, V8, P1389, DOI 10.1021/cb400095v; Cowan J.A., 1997, INORGANIC BIOCH INTR; Del Gaizo V, 2003, MOL GENET METAB, V80, P170, DOI 10.1016/j.ymgme.2003.08.017; Doulias PT, 2003, FREE RADICAL BIO MED, V35, P719, DOI 10.1016/S0891-5849(03)00396-4; Dusek P, 2016, J TRACE ELEM MED BIO, V38, P81, DOI 10.1016/j.jtemb.2016.03.010; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Esposito BP, 2002, ANAL BIOCHEM, V304, P1, DOI 10.1006/abio.2002.5611; Farkas E, 1997, J INORG BIOCHEM, V65, P281, DOI 10.1016/S0162-0134(96)00144-4; Fonseca SB, 2011, CHEM BIOL, V18, P445, DOI 10.1016/j.chembiol.2011.02.010; Goswami D, 2015, BIOMETALS, V28, P869, DOI 10.1007/s10534-015-9873-5; Goswami D, 2014, BIOCONJUGATE CHEM, V25, P2067, DOI 10.1021/bc5004197; Grubman A, 2014, BRIT J PHARMACOL, V171, P2159, DOI 10.1111/bph.12513; Halliwell B., 2007, FREE RADICALS BIOL M; Hider RC, 1999, BIOCHEM PHARMACOL, V57, P1031, DOI 10.1016/S0006-2952(99)00014-3; Horton KL, 2008, CHEM BIOL, V15, P375, DOI 10.1016/j.chembiol.2008.03.015; Jean SR, 2015, ACS CHEM BIOL, V10, P2007, DOI 10.1021/acschembio.5b00268; Kalinowski DS, 2008, J MED CHEM, V51, P331, DOI 10.1021/jm7012562; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kwiatkowski JL, 2011, HEMATOL-AM SOC HEMAT, P451, DOI 10.1182/asheducation-2011.1.451; Loffredo C, 2009, J PEPT SCI, V15, P808, DOI 10.1002/psc.1178; Marmolino D, 2011, BRAIN RES REV, V67, P311, DOI 10.1016/j.brainresrev.2011.04.001; Mourtada R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060253; Orrenius S, 2011, TOXICOL SCI, V119, P3, DOI 10.1093/toxsci/kfq268; Rapoport M, 2011, J MOL MED, V89, P161, DOI 10.1007/s00109-010-0693-3; Richardson DR, 2001, BBA-MOL BASIS DIS, V1536, P133, DOI 10.1016/S0925-4439(01)00041-2; Ross MF, 2004, BIOCHEM J, V383, P457, DOI 10.1042/BJ20041095; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Sohn YS, 2008, BLOOD, V111, P1690, DOI 10.1182/blood-2007-07-102335; Sooriyaarachchi M, 2010, DALTON T, V39, P7466, DOI 10.1039/c0dt00229a; Srinivasan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017732; Velasco-Sanchez D, 2011, CEREBELLUM, V10, P1, DOI 10.1007/s12311-010-0212-7; VOEST EE, 1993, CELL PROLIFERAT, V26, P77, DOI 10.1111/j.1365-2184.1993.tb00008.x; Vyas PM, 2012, HUM MOL GENET, V21, P1230, DOI 10.1093/hmg/ddr554; Wilson RB, 2012, J CHILD NEUROL, V27, P1212, DOI 10.1177/0883073812449691; Wisnovsky SP, 2013, CHEM BIOL, V20, P1323, DOI 10.1016/j.chembiol.2013.08.010; Yamada Y, 2008, ADV DRUG DELIVER REV, V60, P1439, DOI 10.1016/j.addr.2008.04.016; Yousif LF, 2009, CHEMBIOCHEM, V10, P2081, DOI 10.1002/cbic.200900017; Yousif LF, 2009, CHEMBIOCHEM, V10, P1939, DOI 10.1002/cbic.200900185; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	42	17	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171729	10.1371/journal.pone.0171729	http://dx.doi.org/10.1371/journal.pone.0171729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178347	Green Submitted, gold, Green Published			2022-12-26	WOS:000393712500064
J	Hellinger, J; Jagers, P; Donner, M; Sutt, F; Mark, MD; Senen, B; Tollrian, R; Herlitze, S				Hellinger, Jens; Jaegers, Peter; Donner, Marcel; Sutt, Franziska; Mark, Melanie D.; Senen, Budiono; Tollrian, Ralph; Herlitze, Stefan			The Flashlight Fish Anomalops katoptron Uses Bioluminescent Light to Detect Prey in the Dark	PLOS ONE			English	Article							CORAL-REEF FISH; SIPHAMIA-VERSICOLOR; LEIOGNATHID FISH; SOUTH-PACIFIC; ORGAN; BERYCIFORMES; LUMINESCENCE; SEA; PHOTOPHORES; COMPETITION	Bioluminescence is a fascinating phenomenon occurring in numerous animal taxa in the ocean. The reef dwelling splitfin flashlight fish (Anomalops katoptron) can be found in large schools during moonless nights in the shallow water of coral reefs and in the open surrounding water. Anomalops katoptron produce striking blink patterns with symbiotic bacteria in their sub-ocular light organs. We examined the blink frequency in A. katoptron under various laboratory conditions. During the night A. katoptron swims in schools roughly parallel to their conspecifics and display high blink frequencies of approximately 90 blinks/minute with equal on and off times. However, when planktonic prey was detected in the experimental tank, the open time increased compared to open times in the absence of prey and the frequency decreased to 20% compared to blink frequency at night in the absence of planktonic prey. During the day when the school is in a cave in the reef tank the blink frequency decreases to approximately 9 blinks/minute with increasing off-times of the light organ. Surprisingly the non-luminescent A. katoptron with non-functional light organs displayed the same blink frequencies and light organ open/closed times during the night and day as their luminescent conspecifics. In the presence of plankton non-luminescent specimens showed no change in the blink frequency and open/closed times compared to luminescent A. katoptron. Our experiments performed in a coral reef tank show that A. katoptron use bioluminescent illumination to detect planktonic prey and that the blink frequency of A. katoptron light organs follow an exogenous control by the ambient light.	[Hellinger, Jens; Jaegers, Peter; Donner, Marcel; Sutt, Franziska; Mark, Melanie D.; Herlitze, Stefan] Ruhr Univ, Fac Biol & Biotechnol, Dept Zool & Neurobiol, Bochum, Germany; [Senen, Budiono] Fisheries Coll Hatta Syahrir, Banda Naira, Malukuh Tengah, Indonesia; [Tollrian, Ralph] Ruhr Univ, Fac Biol & Biotechnol, Dept Anim Ecol Evolut & Biodivers, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Herlitze, S (corresponding author), Ruhr Univ, Fac Biol & Biotechnol, Dept Zool & Neurobiol, Bochum, Germany.	sxh106@gmail.com	Mark, Melanie/ABF-9102-2020; Senen, Budiono/AAF-6631-2021	Mark, Melanie/0000-0002-2788-6003; 	Ruhr-University Bochum, Germany	Ruhr-University Bochum, Germany	The work was supported by funds from the Ruhr-University Bochum, Germany.	Baldwin CC, 1997, P BIOL SOC WASH, V110, P373; Bassot J.-M., 1968, B SOC ZOOLOGIQUE FRA, V9, P569; Boddaert P., 1781, NEUE NORDISCHE BEITR, V2, P55, DOI DOI 10.5962/BHL.TITLE.48400; Bonin MC, 2015, ANNU REV ECOL EVOL S, V46, P169, DOI 10.1146/annurev-ecolsys-112414-054413; Calado R, 2004, J PLANKTON RES, V26, P737, DOI 10.1093/plankt/fbh072; Claes JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04328; Claes JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01308; Claes JM, 2012, J EXP BIOL, V215, P1691, DOI 10.1242/jeb.066704; Dahlgren U, 1928, SCIENCE, V68, P65, DOI 10.1126/science.68.1751.65; Davis MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155154; Dunlap PV, 2012, J FISH BIOL, V81, P1340, DOI 10.1111/j.1095-8649.2012.03415.x; Dunlap PV, 2011, J MORPHOL, V272, P897, DOI 10.1002/jmor.10956; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; HAGER MC, 1991, BEHAV ECOL SOCIOBIOL, V29, P271, DOI 10.1007/BF00163984; HANEDA Y, 1971, SCIENCE, V173, P143, DOI 10.1126/science.173.3992.143; Harvey EN, 1921, SCIENCE, V53, P314, DOI 10.1126/science.53.1370.314; HAYGOOD MG, 1993, CRIT REV MICROBIOL, V19, P191, DOI 10.3109/10408419309113529; HAYGOOD MG, 1993, NATURE, V363, P154, DOI 10.1038/363154a0; Hendry TA, 2014, ENVIRON MICROBIOL, V16, P2611, DOI 10.1111/1462-2920.12302; Herring P. J., 1987, BIOLUMINESCENCE ACTI, P273; Herring PJ, 2005, MAR BIOL, V148, P383, DOI 10.1007/s00227-005-0085-3; Ho HC, 2012, ZOOTAXA, P77; Ikejima K, 2008, MAR BIOL, V153, P1009, DOI 10.1007/s00227-007-0869-8; JOHNSON GD, 1988, ZOOL J LINN SOC-LOND, V94, P65, DOI 10.1111/j.1096-3642.1988.tb00882.x; Johnson GD, 2001, P BIOL SOC WASH, V114, P497; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; MCCOSKER JE, 1977, SCI AM, V236, P106, DOI 10.1038/scientificamerican0377-106; MCCOSKER JE, 1987, JPN J ICHTHYOL, V34, P157, DOI 10.1007/BF02912410; MCFALLNGAI MJ, 1983, MAR BIOL, V73, P227, DOI 10.1007/BF00392247; MENSINGER AF, 1990, J EXP MAR BIOL ECOL, V144, P1, DOI 10.1016/0022-0981(90)90015-5; MEYERROCHOW VB, 1976, EXPERIENTIA, V32, P1175, DOI 10.1007/BF01927610; MORIN JG, 1975, SCIENCE, V190, P74, DOI 10.1126/science.190.4209.74; Munday PL, 2001, ECOLOGY, V82, P2177, DOI 10.1890/0012-9658(2001)082[2177:ICACIA]2.0.CO;2; Munk O, 1999, ACTA ZOOL-STOCKHOLM, V80, P265, DOI 10.1046/j.1463-6395.1999.00023.x; PITCHER TJ, 1982, BEHAV ECOL SOCIOBIOL, V10, P149, DOI 10.1007/BF00300175; ROSENBLATT RH, 1991, P BIOL SOC WASH, V104, P328; ROSENBLATT RH, 1976, COPEIA, P510; SCHLICHTER D, 1986, MAR BIOL, V91, P403, DOI 10.1007/BF00428634; Siebeck UE, 2008, J EXP BIOL, V211, P354, DOI 10.1242/jeb.012880; SILVESTER CHARLES F., 1926, PROC ACAD NAT SCI PHILADELPHIA, V78, P245; Steche Otto, 1909, Zeitschrift fuer Wissenschaftliche Zoologie Leipzig, V93; THETMEYER H, 1995, MAR ECOL PROG SER, V126, P1, DOI 10.3354/meps126001; WATSON M, 1978, PROC R SOC SER B-BIO, V202, P339, DOI 10.1098/rspb.1978.0071; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269	44	16	16	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170489	10.1371/journal.pone.0170489	http://dx.doi.org/10.1371/journal.pone.0170489			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178297	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500007
J	Lozano-Garcia, M; Fiz, JA; Martinez-Rivera, C; Torrents, A; Ruiz-Manzano, J; Jane, R				Lozano-Garcia, Manuel; Antonio Fiz, Jose; Martinez-Rivera, Carlos; Torrents, Aurora; Ruiz-Manzano, Juan; Jane, Raimon			Novel approach to continuous adventitious respiratory sound analysis for the assessment of bronchodilator response	PLOS ONE			English	Article							FORCED EXHALATION; LUNG SOUNDS; WHEEZE; ASTHMA; CHILDREN	Background A thorough analysis of continuous adventitious sounds (CAS) can provide distinct and complementary information about bronchodilator response (BDR), beyond that provided by spirometry. Nevertheless, previous approaches to CAS analysis were limited by certain methodology issues. The aim of this study is to propose a new integrated approach to CAS analysis that contributes to improving the assessment of BDR in clinical practice for asthma patients. Methods Respiratory sounds and flow were recorded in 25 subjects, including 7 asthma patients with positive BDR (BDR+), assessed by spirometry, 13 asthma patients with negative BDR (BDR-), and 5 controls. A total of 5149 acoustic components were characterized using the Hilbert spectrum, and used to train and validate a support vector machine classifier, which distinguished acoustic components corresponding to CAS from those corresponding to other sounds. Once the method was validated, BDR was assessed in all participants by CAS analysis, and compared to BDR assessed by spirometry. Results BDR+ patients had a homogenous high change in the number of CAS after bronchodilation, which agreed with the positive BDR by spirometry, indicating high reversibility of airway obstruction. Nevertheless, we also found an appreciable change in the number of CAS in many BDR-patients, revealing alterations in airway obstruction that were not detected by spirometry. We propose a categorization for the change in the number of CAS, which allowed us to stratify BDR-patients into three consistent groups. From the 13 BDR-patients, 6 had a high response, similar to BDR+ patients, 4 had a noteworthy medium response, and 1 had a low response. Conclusions In this study, a new non-invasive and integrated approach to CAS analysis is proposed as a high-sensitive tool for assessing BDR in terms of acoustic parameters which, together with spirometry parameters, contribute to improving the stratification of BDR levels in patients with obstructive pulmonary diseases.	[Lozano-Garcia, Manuel; Antonio Fiz, Jose; Jane, Raimon] Inst Bioengn Catalonia IBEC, Biomed Signal Proc & Interpretat Grp, Barcelona, Spain; [Lozano-Garcia, Manuel; Antonio Fiz, Jose; Jane, Raimon] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona, Spain; [Antonio Fiz, Jose; Martinez-Rivera, Carlos; Torrents, Aurora; Ruiz-Manzano, Juan] Germans Trias & Pujol Univ Hosp, Pulmonol Serv, Badalona, Spain; [Jane, Raimon] Univ Politecn Cataluna, Barcelona Tech, Dept Automat Control ESAII, Barcelona, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universitat Politecnica de Catalunya	Lozano-Garcia, M (corresponding author), Inst Bioengn Catalonia IBEC, Biomed Signal Proc & Interpretat Grp, Barcelona, Spain.; Lozano-Garcia, M (corresponding author), Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona, Spain.	mlozanogar@gmail.com	García, Manuel Lozano/S-2482-2018	García, Manuel Lozano/0000-0002-4146-9839; Jane, Raimon/0000-0002-6541-8729	Secretary of Universities and Research of the Department of Economy and Knowledge of the Government of Catalonia [GRC 2014 SGR 1569]; CERCA Programme / Generalitat de Catalunya; Spanish Ministry of Economy and Competitiveness; European Regional Development Fund [DPI2015-68820-R]	Secretary of Universities and Research of the Department of Economy and Knowledge of the Government of Catalonia; CERCA Programme / Generalitat de Catalunya; Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund(European Commission)	This work was supported by Secretary of Universities and Research of the Department of Economy and Knowledge of the Government of Catalonia (http://universitatsirecerca.gencat. cat/ca/inici/) (Consolidated research group GRC 2014 SGR 1569), RJ; CERCA Programme / Generalitat de Catalunya (http://cerca.cat/en/), RJ; The Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/portal/site/mineco/menuitem. 19368ee62a6eae4c2adf03a0026041a0/? vgnextoid=f2e9154527515310VgnVCM 1000001d04140aRCRD&lang_choosen=en) and the European Regional Development Fund (http://ec.europa.eu/regional_policy/en/funding/erdf/) (DPI2015-68820-R), RJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUGHMAN RP, 1984, CHEST, V86, P718, DOI 10.1378/chest.86.5.718; Bentur L, 2003, EUR RESPIR J, V21, P621, DOI 10.1183/09031936.03.00036302; BOHADANA AB, 1995, THORAX, V50, P955, DOI 10.1136/thx.50.9.955; Bohadana A, 2014, NEW ENGL J MED, V370, P744, DOI 10.1056/NEJMra1302901; BRAND PLP, 1992, THORAX, V47, P429, DOI 10.1136/thx.47.6.429; Calverley PMA, 2003, THORAX, V58, P659, DOI 10.1136/thorax.58.8.659; Charbonneau G., 2000, EUR RESPIR REV, V10, P625; Fiz JA, 2006, RESPIRATION, V73, P55, DOI 10.1159/000087690; Fiz JA, 2002, CHEST, V122, P186, DOI 10.1378/chest.122.1.186; Fiz JA, 1999, CHEST, V116, P633, DOI 10.1378/chest.116.3.633; Fiz JA, 2014, PLOS ONE; GAVRIELY N, 1994, EUR RESPIR J, V7, P35, DOI 10.1183/09031936.94.07010035; Gjevre John A, 2006, Can Respir J, V13, P433; Global Initiative for Asthma, 2021, GLOB STRAT ASTHM MAN; Gong H, 1990, CLIN METHODS HIST PH; Guntupalli KK, 2008, J ASTHMA, V45, P923, DOI 10.1080/02770900802395496; Hegewald MJ, 2012, RESP CARE, V57, P1564, DOI 10.4187/respcare.01537; Homs-Corbera A, 2004, IEEE T BIO-MED ENG, V51, P182, DOI 10.1109/TBME.2003.820359; Hsu C, 2016, PRACTICAL GUIDE SUPP; Jin F, 2011, IEEE T BIO-MED ENG, V58, P3078, DOI 10.1109/TBME.2011.2160721; KERSTJENS HAM, 1994, THORAX, V49, P1109, DOI 10.1136/thx.49.11.1109; Lehmann S, 2007, RESP MED, V101, P1183, DOI 10.1016/j.rmed.2006.11.007; Lin BS, 2006, BIOMED ENG-APP BAS C, V18, P128, DOI 10.4015/S1016237206000221; Loudon RG, 1997, THE LUNG, P1383; Lozano M, 2016, IEEE J BIOMED HEALTH, V20, P486, DOI 10.1109/JBHI.2015.2396636; Lozano M, 2016, SIGNAL PROCESS, V120, P99, DOI 10.1016/j.sigpro.2015.09.005; MARINI JJ, 1979, AM REV RESPIR DIS, V120, P1069; Melbye H, 2016, BMJ OPEN RESPIR RES, V3, DOI 10.1136/bmjresp-2016-000136; MESLIER N, 1995, EUR RESPIR J, V8, P1942, DOI 10.1183/09031936.95.08111942; Nagasaka Y, 2012, ALLERGOL INT, V61, P353, DOI 10.2332/allergolint.12-RAI-0449; Olson D.L., 2008, TECHNIQUES, DOI [10.1007/978-3-540-76917-0, DOI 10.1007/978-3-540-76917-0]; Ouksel H, 2003, RESPIRATION, V70, P54, DOI 10.1159/000068419; Pasterkamp H, 2016, EUR RESPIR J, V47, P724, DOI 10.1183/13993003.01132-2015; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Richter Daphne C, 2008, Int J Chron Obstruct Pulmon Dis, V3, P693; RIETVELD S, 1995, THORAX, V50, P143, DOI 10.1136/thx.50.2.143; Rossi M, 2000, EUR RESPIR REV, V10, P611; Sanchez I, 2005, RESPIROLOGY, V10, P603, DOI 10.1111/j.1440-1843.2005.00756.x; Sarkar M, 2015, ANN THORAC MED, V10, P158, DOI 10.4103/1817-1737.160831; Schreur HJW, 1996, AM J RESP CRIT CARE, V153, P1474, DOI 10.1164/ajrccm.153.5.8630589; SCHREUR HJW, 1994, CHEST, V106, P91, DOI 10.1378/chest.106.1.91; SHIM CS, 1983, ARCH INTERN MED, V143, P890, DOI 10.1001/archinte.143.5.890; Sovijû±rvi ARA., 2000, EUR RESPIR REV, V10, P591; Tan WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058932; Taplidou SA, 2004, P ANN INT IEEE EMBS, V26, P3832; Taplidou SA, 2007, COMPUT BIOL MED, V37, P1073, DOI 10.1016/j.compbiomed.2006.09.007; Taplidou SA, 2010, IEEE T BIO-MED ENG, V57, P1596, DOI 10.1109/TBME.2010.2041777; Tse SM, 2013, J ALLERGY CLIN IMMUN, V132, P554, DOI 10.1016/j.jaci.2013.03.031	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171455	10.1371/journal.pone.0171455	http://dx.doi.org/10.1371/journal.pone.0171455			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178317	Green Published, Green Submitted, gold			2022-12-26	WOS:000393712500044
J	Lu, XL; Kang, XJ; Liu, YJ; Cui, Z; Guo, W; Zhao, CY; Li, Y; Chen, SL; Li, JY; Zhang, YQ; Zhao, HR				Lu, Xinli; Kang, Xianjiang; Liu, Yongjian; Cui, Ze; Guo, Wei; Zhao, Cuiying; Li, Yan; Chen, Suliang; Li, Jingyun; Zhang, Yuqi; Zhao, Hongru			HIV-1 molecular epidemiology among newly diagnosed HIV-1 individuals in Hebei, a low HIV prevalence province in China	PLOS ONE			English	Article							WESTERN YUNNAN; EVOLUTIONARY HISTORY; GENETIC DIVERSITY; GENOME SEQUENCE; IDENTIFICATION; CRF01-AE; AREA; MEN; SEX	New human immunodeficiency virus type 1 (HIV-1) diagnoses are increasing rapidly in Hebei. The aim of this study presents the most extensive HIV-1 molecular epidemiology investigation in Hebei province in China thus far. We have carried out the most extensive systematic cross-sectional study based on newly diagnosed HIV-1 positive individuals in 2013, and characterized the molecular epidemiology of HIV-1 based on full length gag-partial pol gene sequences in the whole of Hebei. Nine HIV-1 genotypes based on full length gag-partial pol gene sequence were identified among 610 newly diagnosed naive individuals. The four main genotypes were circulating recombinant form (CRF) 01_AE (53.4%), CRF07_BC (23.4%), subtype B (15.9%), and unique recombinant forms URFs (4.9%). Within 1 year, three new genotypes (subtype A1, CRF55_01B, CRF65_cpx), unknown before in Hebei, were first found among men who have sex with men (MSM). All nine genotypes were identified in the sexually contracted HIV-1 population. Among 30 URFs, six recombinant patterns were revealed, including CRF01_AE/BC (40.0%), CRF01_AE/B (23.3%), B/C (16.7%), CRF01_AE/C (13.3%), CRF01_AE/B/A2 (3.3%) and CRF01_AE/BC/A2 (3.3%), plus two potential CRFs. This study elucidated the complicated characteristics of HIV-1 molecular epidemiology in a low HIV-1 prevalence northern province of China and revealed the high level of HIV-1 genetic diversity. All nine HIV-1 genotypes circulating in Hebei have spread out of their initial risk groups into the general population through sexual contact, especially through MSM. This highlights the urgency of HIV prevention and control in China.	[Lu, Xinli; Kang, Xianjiang] Hebei Univ, Coll Life Sci, Baoding, Hebei, Peoples R China; [Lu, Xinli; Cui, Ze; Zhao, Cuiying; Li, Yan; Chen, Suliang; Zhang, Yuqi; Zhao, Hongru] Hebei Prov Ctr Dis Control & Prevent, Shjiazhuang, Hebei, Peoples R China; [Liu, Yongjian; Li, Jingyun] Beijing Inst Microbiol & Epidemiol, Dept AIDS Res, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Guo, Wei] 201 Hosp Peoples Liberat Army China, Liaoyang, Liaoning, Peoples R China	Hebei University; Beijing Institute of Microbiology & Epidemiology	Kang, XJ (corresponding author), Hebei Univ, Coll Life Sci, Baoding, Hebei, Peoples R China.; Chen, SL (corresponding author), Hebei Prov Ctr Dis Control & Prevent, Shjiazhuang, Hebei, Peoples R China.	xjkang@hbu.edu.cn; hebeicdc2013@sina.com	Liu, Yong/GWQ-6163-2022		Natural Science Fund of Hebei Province [H2016303006]	Natural Science Fund of Hebei Province	This study was implemented with the support of the Natural Science Fund of Hebei Province (H2016303006). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Chen M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-382; China M. o.H.o.t.P.s.R.o., 2012, EST HIV AIDS EP CHIN; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Duan S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-180; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Feng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19279; Feng Y, 2014, AIDS RES HUM RETROV, V30, P598, DOI [10.1089/aid.2013.0233, 10.1089/AID.2013.0233]; Han XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep18147; Han XX, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00050-12; He X., 2012, INT J ANTENN PROPAG, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0047289; Hsi J, 2014, AIDS RES HUM RETROV, V30, P389, DOI [10.1089/aid.2013.0234, 10.1089/AID.2013.0234]; Langford Simone E, 2007, AIDS Res Ther, V4, P11, DOI 10.1186/1742-6405-4-11; Li Lan, 2010, Laboratory Animal Research, V26, P1; Li L, 2011, J VISION, V11, DOI 10.1167/11.1.22; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075777; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046777; Li LN, 2014, AIDS RES HUM RETROV, V30, P160, DOI [10.1089/aid.2013.0144, 10.1089/AID.2013.0144]; Li X, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/563517; Li Xi, 2014, Trust and Trustworthy Computing. 7th International Conference, TRUST 2014. Proceedings: LNCS 8564, P1, DOI 10.1007/978-3-319-08593-7_1; Li XL, 2013, IEEE CONF IMAGING SY, P1, DOI 10.1109/IST.2013.6729651; Li YJ, 2014, AIDS, V28, P521, DOI 10.1097/QAD.0000000000000125; Liu Hui-xin, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P892; Lu XL, 2016, AIDS RES HUM RETROV, V32, P475, DOI [10.1089/aid.2016.0005, 10.1089/AID.2016.0005]; Lu XL, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-015-0087-2; Lu XL, 2015, AIDS RES HUM RETROV, V31, P1038, DOI [10.1089/aid.2015.0160, 10.1089/AID.2015.0160]; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Wang HQ, 2010, J NANOTECHNOL, V2010, DOI [10.1155/2010/479172, 10.1155/2010/345701]; Wang Ning, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P541; Wei HM, 2014, AIDS RES HUM RETROV, V30, P384, DOI [10.1089/aid.2013.0228, 10.1089/AID.2013.0228]; Wei HM, 2014, AIDS RES HUM RETROV, V30, P380, DOI [10.1089/aid.2013.0235, 10.1089/AID.2013.0235]; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Xu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059050; Yang Chaojun, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P70; Yang L, 2015, MOD PREV MED, V42, P156; Yang Li, 2015, Modern Preventive Medicine, V42, P137; ZENG Y, 1986, AIDS RES, V2, pS147; ZHANG W., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0099693; [赵翠英 ZHAO Cuiying], 2005, [中华微生物学和免疫学杂志, Chinese Journal of Microbiology and Immunology], V25, P533; Zhao CY, 2010, CHIN J HLTH LAB TECH, V20, P3136; Zheng Y Y, 1988, Zhonghua Yi Xue Za Zhi, V68, P5	42	22	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171481	10.1371/journal.pone.0171481	http://dx.doi.org/10.1371/journal.pone.0171481			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178737	Green Submitted, Green Published, gold			2022-12-26	WOS:000393712500046
J	Rasool, M; Ashraf, MAB; Malik, A; Waquar, S; Khan, SA; Qazi, MH; Ahmad, W; Asif, M; Khan, SU; Zaheer, A; Qaisrani, MM; Khan, AR; Iqbal, A; Raza, A; Iram, S; Kamran, K; Iqbal, A; Mustafa, MZ; Choudhry, H; Zamzami, MA; Abdulaal, WH; Jamal, MS				Rasool, Mahmood; Ashraf, Muhammad Abdul Basit; Malik, Arif; Waquar, Sulayman; Khan, Shahida Aziz; Qazi, Mahmood Husain; Ahmad, Waseem; Asif, Muhammad; Khan, Sami Ullah; Zaheer, Ahmad; Qaisrani, Muther Mansoor; Khan, Abdul Rehman; Iqbal, Aamir; Raza, Amir; Iram, Saima; Kamran, Kashif; Iqbal, Asim; Mustafa, Mohammad Zahid; Choudhry, Hani; Zamzami, Mazin A.; Abdulaal, Wesam H.; Jamal, Mohammad Sarwar			Comparative study of extrapolative factors linked with oxidative injury and anti-inflammatory status in chronic kidney disease patients experiencing cardiovascular distress	PLOS ONE			English	Article							ALPHA-TOCOPHEROL; NITRIC-OXIDE; VITAMIN-E; PROTEIN PRODUCTS; RENAL-FAILURE; STRESS; SUPEROXIDE; GLUTATHIONE; INFLAMMATION; ASCORBATE	Background Chronic kidney disease (CKD) is a group of heterogeneous abnormalities affecting the function and structure of the kidney and mostly further proceeds to cardiovascular damage prior to end stage renal disease (ESRD). The oxidative insult and inflammatory mediators have some undefined role in CKD and cardiovascular complications. It is therefore, aimed at to pin point the predictive factors in the development of cardiovascular disorder in patients with chronic kidney disease. Methods Fifty patients of CKD experiencing cardiovascular distress and twenty normal individuals having same age and sex acted as control during these observations. Blood samples (Each 5 ml) were drawn and subjected to centrifugation for 10-15 minutes to separate the serum at 4000-5000rpm. The levels of MDA, GSH, SOD, CAT, VIT C, VIT E, IL-1, TNF-alpha, nitric oxide (NO) and advanced oxidation protein products (AOPPs) were estimated and analyzed. Results The nitric oxide levels in the CKD patients decreased significantly (13.26 +/- 1.25 ng/ml) compared to controls (42.15 +/- 5.26 ng/ml). The serum vitamin E and C levels in these patients recorded 2.15 +/- 0.25 mu g/ml and 0.97 +/- 0.09 mu g/ml respectively as against their assigned controls which read 6.35 +/- 1.22 mu g/ml and 3.29 +/- 0.25 mu g/ml. Furthermore, a significantly higher level of Malondialdehyde (MDA) as1.25 +/- 0.07 nmol/ml was observed in CKD patients viz-a-viz relevant control. However, the serum SOD, catalase (CAT) and GSH levels in the same patients registered a significant decline as evident from respective figures 0.07 +/- 0.002 mu g/dl, 1.22 +/- 0.012 mu mol/mol, and 3.25 +/- 1.05 mu g/dl. The control for these was observed as 0.99 +/- 0.06 mu g/dl, 3.19 +/- 0.05 mu mol/mol, and 8.64 +/- 0.03 mu g/dL. On the other hand, the IL-1 levels in the CKD patients found quite higher (402.5 +/- 18.26 pg/ml). This clearly points to substantial increase in oxidative insult and reduced NO levels leading to the renal and cardiovascular damage. Conclusion Observations support the fact that the decrease in anti-oxidative capacity accompanied by higher inflammatory mediators in CKD is indicative of oxidative stress, consequently leading to CKD progression, in all probability to cardiovascular insult. The outcome reiterates that strategies be designed afresh to contain CKD progression to cardiovascular complications and ESRD. One way could be to focus on early detection of stress related to the disease. It requires analyzing the factors related to stress, such as the one reported here. Linking these factors with the symptoms could be a crucial step forward. And further, the disease could be monitored in a more disciplined manner.	[Rasool, Mahmood; Ahmad, Waseem] King Abdulaziz Univ, CEGMR, Jeddah, Saudi Arabia; [Ashraf, Muhammad Abdul Basit; Malik, Arif; Waquar, Sulayman] Univ Lahore, IMBB, Lahore, Pakistan; [Khan, Shahida Aziz; Jamal, Mohammad Sarwar] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Qazi, Mahmood Husain] Univ Lahore, Ctr Res Mol Med CRiMM, Lahore, Pakistan; [Asif, Muhammad] BUITEMS, Dept Biotechnol & Informat, Quetta, Pakistan; [Khan, Sami Ullah] Women Univ Azad Jammu & Kashmir, Dept Bot, Bagh, Pakistan; [Zaheer, Ahmad; Iqbal, Aamir; Raza, Amir] NIBGE, Faisalabad, Pakistan; [Qaisrani, Muther Mansoor] Ghazi Univ, Dept Bot, Dera Ghazi Khan, Pakistan; [Khan, Abdul Rehman] Univ Azad Jammu & Kashmir, Dept Chem, Obes & Diabet Res Lab, Muzaffarabad, Pakistan; [Iram, Saima] Bolan Med Hosp, Quetta, Pakistan; [Kamran, Kashif; Iqbal, Asim] Univ Balochistan, Fac Life Sci, Quetta, Pakistan; [Mustafa, Mohammad Zahid] Univ Balochistan, CASVAB, Quetta, Pakistan; [Choudhry, Hani] King Abdulaziz Univ, Dept Biochem, King Fahd Ctr Med Res,Canc Metab & Epigenet Unit, Fac Sci,Ctr Innovat Personalized Med,Canc & Mutag, Jeddah, Saudi Arabia; [Zamzami, Mazin A.; Abdulaal, Wesam H.] King Abdulaziz Univ, Canc & Mutagenesis Unit, King Fahd Ctr Med Res, Dept Biochem,Canc Metab & Epigenet Unit,Fac Sci, Jeddah, Saudi Arabia	King Abdulaziz University; University of Lahore; King Abdulaziz University; University of Lahore; Balochistan University of Information Technology, Engineering & Management Sciences BUITEMS; Pakistan Institute of Engineering & Applied Science; University of Azad Jammu & Kashmir; University of Balochistan; University of Balochistan; King Abdulaziz University; King Abdulaziz University	Jamal, MS (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.	sarwar4u@gmail.com	Khan, Shahida A/H-9636-2012; Qaisrani, Muther Mansoor/AAP-3143-2021; Jamal, Mohammad Sarwar/K-3842-2013; Asif, Muhammad/AAF-3615-2020; Rasool, Mahmood/H-9475-2012; Waquar, Sulayman/G-8809-2017; Waquar, Sulayman/K-8437-2019; Abdulaal, Wesam/AAT-9475-2021; Zaheer, Ahmad/H-4182-2013; Malik, Arif/A-5218-2016	Asif, Muhammad/0000-0003-4761-837X; Rasool, Mahmood/0000-0003-2997-5891; Waquar, Sulayman/0000-0003-0557-0064; Waquar, Sulayman/0000-0003-0557-0064; Abdulaal, Wesam/0000-0002-2510-1946; Zaheer, Ahmad/0000-0001-5131-3240; Malik, Arif/0000-0002-1894-6772; Choudhry, Hani/0000-0003-0401-6619	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to all participants of this study. This article was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah. The authors, therefore, acknowledge with thanks DSR technical and financial support.	Aebi H., 1974, METHODS ENZYMATIC AN, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]; Amann K, 2001, J AM SOC NEPHROL, V12, P2040, DOI 10.1681/ASN.V12102040; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Atamer A, 2008, J NEPHROL, V21, P924; Azzi A, 2002, FEBS LETT, V519, P8, DOI 10.1016/S0014-5793(02)02706-0; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bergmeijer H, 1983, METHODS ENZYMATIC AN; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; Capeillere-Blandin C, 2004, BBA-MOL BASIS DIS, V1689, P91, DOI 10.1016/j.bbadis.2004.02.008; CHINOY NJ, 1986, INT J FERTIL, V31, P232; Cooke JP, 2000, ARTERIOSCL THROM VAS, V20, P2032, DOI 10.1161/01.ATV.20.9.2032; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Devaraj S, 1998, CURR OPIN LIPIDOL, V9, P11, DOI 10.1097/00041433-199802000-00004; Feelisch M., 1996, METHODS NITRIC OXIDE; Fortuno A, 2005, KIDNEY INT, V68, P71; Fujisawa S, 2006, IN VIVO, V20, P445; Fumeron C, 2005, NEPHROL DIAL TRANSPL, V20, P1874, DOI 10.1093/ndt/gfh928; Gajjala PR, 2015, NEPHROL DIAL TRANSPL, V30, P1814, DOI 10.1093/ndt/gfv048; Gongora MC, 2008, AM J PATHOL, V173, P915, DOI 10.2353/ajpath.2008.080119; Graf J, 2009, OVERVIEW CHRONIC KID; Granata S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-388; Guo Q, 2000, FREE RADICAL BIO MED, V29, P368, DOI 10.1016/S0891-5849(00)00309-9; Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759; HORII Y, 1993, KIDNEY INT, V43, pS71; JOHNSON G, 1991, CRIT CARE MED, V19, P244, DOI 10.1097/00003246-199102000-00021; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kaneda H, 2002, ATHEROSCLEROSIS, V162, P221, DOI 10.1016/S0021-9150(01)00706-7; Karamouzis I, 2008, AM J NEPHROL, V28, P397, DOI 10.1159/000112413; Kobayashi M, 2005, KIDNEY INT, V68, P1018, DOI 10.1111/j.1523-1755.2005.00494.x; Korish AA, 2010, RENAL FAILURE, V32, P203, DOI 10.3109/08860221003592820; Kuchta A, 2011, KIDNEY BLOOD PRESS R, V34, P12, DOI 10.1159/000321508; Landmesser U, 2000, CIRCULATION, V101, P2264, DOI 10.1161/01.CIR.101.19.2264; Lash LH, 2002, J PHARMACOL EXP THER, V303, P476, DOI 10.1124/jpet.102.040220; May JM, 1996, FREE RADICAL BIO MED, V20, P543, DOI 10.1016/0891-5849(95)02130-2; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; MYERS SI, 1995, AM J SURG, V169, P604, DOI 10.1016/S0002-9610(99)80230-X; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pinkus R, 1996, J BIOL CHEM, V271, P13422, DOI 10.1074/jbc.271.23.13422; Popolo A, 2013, FREE RADICAL RES, V47, P346, DOI 10.3109/10715762.2013.779373; Rosenberg HR., 1992, CHEM PHYSL VITAMINS, P452; Saran R, 2003, NEPHROL DIAL TRANSPL, V18, P2415, DOI 10.1093/ndt/gfg406; SERBINOVA E, 1991, FREE RADICAL BIO MED, V10, P263, DOI 10.1016/0891-5849(91)90033-Y; Small DM, 2012, NEPHROLOGY, V17, P311, DOI 10.1111/j.1440-1797.2012.01572.x; Small DM, 2013, OXIDATIVE STRESS CHR, P233, DOI DOI 10.5772/51923; Sung C-C, 2013, OXIDATIVE MED CELLUL; Tain YL, 2007, AM J PHYSIOL-RENAL, V292, pF1404, DOI 10.1152/ajprenal.00260.2006; Tesch GH, 2010, NEPHROLOGY, V15, P609, DOI 10.1111/j.1440-1797.2010.01361.x; Witko-Sarsat V, 1998, J IMMUNOL, V161, P2524; Yan LJ, 1996, ARCH BIOCHEM BIOPHYS, V327, P330, DOI 10.1006/abbi.1996.0130; Yilmaz MI, 2006, AM J KIDNEY DIS, V47, P42, DOI 10.1053/j.ajkd.2005.09.029; Zalba G, 2005, ARTERIOSCL THROM VAS, V25, P1452, DOI 10.1161/01.ATV.0000168411.72483.08; Zalba G, 2006, NEPHROL DIAL TRANSPL, V21, P2686, DOI 10.1093/ndt/gfl398; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8	54	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171561	10.1371/journal.pone.0171561	http://dx.doi.org/10.1371/journal.pone.0171561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178330	gold, Green Submitted, Green Published			2022-12-26	WOS:000393712500050
J	Narimani, Z; Beigy, H; Ahmad, A; Masoudi-Nejad, A; Frohlich, H				Narimani, Zahra; Beigy, Hamid; Ahmad, Ashar; Masoudi-Nejad, Ali; Froehlich, Holger			Expectation propagation for large scale Bayesian inference of non-linear molecular networks from perturbation data	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; NESTED EFFECTS MODELS; SIGNALING NETWORKS; SYSTEMS; RECONSTRUCTION; ALGORITHM	Inferring the structure of molecular networks from time series protein or gene expression data provides valuable information about the complex biological processes of the cell. Causal network structure inference has been approached using different methods in the past. Most causal network inference techniques, such as Dynamic Bayesian Networks and ordinary differential equations, are limited by their computational complexity and thus make large scale inference infeasible. This is specifically true if a Bayesian framework is applied in order to deal with the unavoidable uncertainty about the correct model. We devise a novel Bayesian network reverse engineering approach using ordinary differential equations with the ability to include non-linearity. Besides modeling arbitrary, possibly combinatorial and time dependent perturbations with unknown targets, one of our main contributions is the use of Expectation Propagation, an algorithm for approximate Bayesian inference over large scale network structures in short computation time. We further explore the possibility of integrating prior knowledge into network inference. We evaluate the proposed model on DREAM4 and DREAM8 data and find it competitive against several state-of-the-art existing network inference methods.	[Narimani, Zahra; Masoudi-Nejad, Ali] Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran; [Beigy, Hamid] Sharif Univ Technol, Dept Comp Engn, Tehran, Iran; [Ahmad, Ashar; Froehlich, Holger] Univ Bonn, Bonn Aachen Int Ctr IT, Algorithm Bioinformat, Bonn, Germany; [Froehlich, Holger] UCB Biosci GmbH, Monheim, Germany	University of Tehran; Sharif University of Technology; University of Bonn	Masoudi-Nejad, A (corresponding author), Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran.; Frohlich, H (corresponding author), Univ Bonn, Bonn Aachen Int Ctr IT, Algorithm Bioinformat, Bonn, Germany.; Frohlich, H (corresponding author), UCB Biosci GmbH, Monheim, Germany.	amasoudin@ut.ac.ir; frohlich@bit.uni-bonn.de	Fröhlich, Holger/H-1976-2017; Masoudi-Nejad, Ali/ABH-2078-2021; Beigy, Hamid/ABF-7542-2020; AHMAD, ASHAR/ABH-9603-2020	Fröhlich, Holger/0000-0002-5328-1243; Beigy, Hamid/0000-0003-1679-2092; AHMAD, ASHAR/0000-0001-6417-4454; Narimani, Zahra/0000-0003-2534-9201	Deutscher Akademischer Austauschdienst (DAAD); University of Tehran	Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); University of Tehran(University of Tehran)	ZN would like to acknowledge the Deutscher Akademischer Austauschdienst (DAAD) and University of Tehran for partially supporting her visiting stay in Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. UCB Biosciences GmbH partially provided support in the form of salaries for author HF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2007, PLANT CELL, V19, P3327, DOI 10.1105/tpc.107.054700; Bansal M, 2006, BIOINFORMATICS, V22, P815, DOI 10.1093/bioinformatics/btl003; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Chambers JM., 1992, STAT MODELS S; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Eaton D, 2007, P MACHINE LEARNING R, V2, P107; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Forsythe G. E., 1977, COMPUTER METHODS MAT; Fraley C, 2012, NETWORKBMA REGRESSIO; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Frohlich H, 2015, BIOINFORMATICS, V31, P3290, DOI 10.1093/bioinformatics/btv379; Frohlich H, 2009, BIOMETRICAL J, V51, P304, DOI 10.1002/bimj.200800185; Gat-Viks I, 2006, J COMPUT BIOL, V13, P165, DOI 10.1089/cmb.2006.13.165; George EI, 1997, STAT SINICA, V7, P339; Hill S., 2015, NAT BIOTECH; Hill SM, 2016, NAT METHODS, V13, P310, DOI [10.1038/NMETH.3773, 10.1038/nmeth.3773]; Klamt S, 2010, BIOINFORMATICS, V26, P2160, DOI 10.1093/bioinformatics/btq342; LAURITZEN SL, 1992, J AM STAT ASSOC, V87, P1098, DOI 10.2307/2290647; Lo K, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-101; Maathuis MH, 2010, NAT METHODS, V7, P247, DOI 10.1038/nmeth0410-247; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Markowetz F, 2007, BIOINFORMATICS, V23, pI305, DOI 10.1093/bioinformatics/btm178; Mazloomian A, 2013, INTELL DATA ANAL, V17, P295, DOI 10.3233/IDA-130579; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Minka T., 2012, INFER NET 2 5; Minka T. P., 2001, P 17 C UNC ART INT, P362; Molinelli EJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003290; Morrissey ER, 2011, BIOSTATISTICS, V12, P682, DOI 10.1093/biostatistics/kxr009; Nelander S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.53; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Pe'er D., 2005, SCI STKE, V2005, P14, DOI DOI 10.1126/STKE.2812005PL4; Praveen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067410; Rau A, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1513; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tresch A, 2007, J COMPUT BIOL, V14, P1217, DOI 10.1089/cmb.2007.0085; Van Driessche N, 2005, NAT GENET, V37, P471, DOI 10.1038/ng1545; Wagner A, 2001, BIOINFORMATICS, V17, P1183, DOI 10.1093/bioinformatics/17.12.1183; Yavari F., 2008, 2008 2nd International Conference on Bioinformatics and Biomedical Engineering (ICBBE '08), P297, DOI 10.1109/ICBBE.2008.76; Yip KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008121; Young WC, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-47; Zacher B, 2012, BIOINFORMATICS, V28, P1714, DOI 10.1093/bioinformatics/bts257	45	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171240	10.1371/journal.pone.0171240	http://dx.doi.org/10.1371/journal.pone.0171240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166542	Green Submitted, Green Published, gold			2022-12-26	WOS:000393700100029
J	Hsia, HC; Hutti, JE; Baldwin, AS				Hsia, Hung-Ching; Hutti, Jessica E.; Baldwin, Albert S.			Cytosolic DNA Promotes Signal Transducer and Activator of Transcription 3 (STAT3) Phosphorylation by TANK-binding Kinase 1 (TBK1) to Restrain STAT3 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-RELATED KINASES; CYCLIC GMP-AMP; INNATE IMMUNITY; NEGATIVE REGULATOR; ANTIVIRAL RESPONSE; ANTITUMOR IMMUNITY; INTRACELLULAR DNA; PATHWAY; RECOGNITION; INTERFERON	Cytosolic DNA can elicit beneficial as well as undesirable immune responses. For example, viral or microbial DNA triggers cell-intrinsic immune responses to defend against infections, whereas aberrant cytosolic accumulation of self-DNA results in pathological conditions, such as autoimmunity. Given the importance of these DNA-provoked responses, a better understanding of their molecular mechanisms is needed. Cytosolic DNA engages stimulator of interferon genes (STING) to activate TANK-binding kinase 1 (TBK1), which subsequently phosphorylates the transcription factor interferon regulatory factor 3 (IRF3) to promote interferon expression. Recent studies have reported that additional transcription factors, including nuclear factor kappa B (NF-kappa B) and signal transducer and activator of transcription 6 (STAT6), are also activated by cytosolic DNA, suggesting that cytosolic DNA-induced gene expression is orchestrated by multiple factors. Here we show that cytosolic DNA activates STAT3, another member of the STAT family, via an autocrine mechanism involving interferon beta (IFN beta) and IL-6. Additionally, we observed a novel cytosolic DNA-induced phosphorylation at serine 754 in the transactivation domain of STAT3. Upon cytosolic DNA stimulation, Ser(754) is directly phosphorylated by TBK1 in a STING-dependent manner. Moreover, Ser(754) phosphorylation inhibits cytosolic DNA-induced STAT3 transcriptional activity and selectively reduces STAT3 target genes that are up-regulated in response to cytosolic DNA. Taken together, our results suggest that cytosolic DNA-induced STAT3 activation via IFN beta and IL-6 is restrained by Ser(754) phosphorylation of STAT3. Our findings reveal a new signaling axis downstream of the cytosolic DNA pathway and suggest potential interactions between innate immune responses and STAT3-driven oncogenic pathways.	[Hsia, Hung-Ching; Baldwin, Albert S.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Hsia, Hung-Ching; Hutti, Jessica E.; Baldwin, Albert S.] Univ N Carolina, Lineberger Canc Res Ctr, Chapel Hill, NC 27599 USA; [Hutti, Jessica E.] AbbVie Inc, 1 N Waukegan Rd, Abbott Pk, IL 60064 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; AbbVie	Baldwin, AS (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.; Baldwin, AS (corresponding author), Univ N Carolina, Lineberger Canc Res Ctr, Chapel Hill, NC 27599 USA.	albert_baldwin@med.unc.edu			National Institutes of Health (NIH) [AI35098, R35CA197684]; NATIONAL CANCER INSTITUTE [R35CA197684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI035098, R01AI035098] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) Grants AI35098 and R35CA197684 (to A. S. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Besser D, 1999, MOL CELL BIOL, V19, P1401; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Broz P, 2013, NAT REV IMMUNOL, V13, P551, DOI 10.1038/nri3479; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Hutti JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041494; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Korherr C, 2006, P NATL ACAD SCI USA, V103, P4240, DOI 10.1073/pnas.0511319103; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2008, CURR OPIN IMMUNOL, V20, P228, DOI 10.1016/j.coi.2008.03.010; Lawrence CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165005; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Marinis JM, 2012, MOL CELL BIOL, V32, P2479, DOI 10.1128/MCB.00106-12; Meliilo JA, 2010, J IMMUNOL, V184, P2638, DOI 10.4049/jimmunol.0902960; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Ng SL, 2011, P NATL ACAD SCI USA, V108, P21170, DOI 10.1073/pnas.1119137109; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Park OK, 2000, J BIOL CHEM, V275, P32244, DOI 10.1074/jbc.M005082200; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004; Reich Nancy C, 2013, JAKSTAT, V2, pe27080, DOI 10.4161/jkst.27080; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schaefer TS, 1997, MOL CELL BIOL, V17, P5307, DOI 10.1128/MCB.17.9.5307; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083639; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang T, 2012, BIOORG MED CHEM LETT, V22, P2063, DOI 10.1016/j.bmcl.2012.01.018; Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia TL, 2016, CANCER RES, V76, P6747, DOI 10.1158/0008-5472.CAN-16-1404; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhu QF, 2014, J IMMUNOL, V193, P4779, DOI 10.4049/jimmunol.1402051; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176	56	20	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5405	5417		10.1074/jbc.M116.771964	http://dx.doi.org/10.1074/jbc.M116.771964			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28188292	hybrid, Green Published			2022-12-26	WOS:000397875500021
J	Nakajima, H; Itakura, M; Kubo, T; Kaneshige, A; Harada, N; Izawa, T; Azuma, YT; Kuwamura, M; Yamaji, R; Takeuchi, T				Nakajima, Hidemitsu; Itakura, Masanori; Kubo, Takeya; Kaneshige, Akihiro; Harada, Naoki; Izawa, Takeshi; Azuma, Yasu-Taka; Kuwamura, Mitsuru; Yamaji, Ryouichi; Takeuchi, Tadayoshi			Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Aggregation Causes Mitochondrial Dysfunction during Oxidative Stress-induced Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION PORE; ENDOPLASMIC-RETICULUM STRESS; ACTIVE-SITE CYSTEINE; NITRIC-OXIDE; NEURODEGENERATIVE DISEASES; PROTEIN AGGREGATION; ALZHEIMERS-DISEASE; APOPTOSIS; ACTIVATION	Glycolytic glyceraldehyde-3-phosphatedehydrogenase(GAPDH) is a multifunctional protein that also mediates cell death under oxidative stress. Wereported previously that the active-site cysteine (Cys-152) of GAPDH plays an essential role in oxidative stress-induced aggregation of GAPDH associated with cell death, and a C152A-GAPDH mutant rescues nitric oxide (NO)induced cell death by interfering with the aggregation of wild type (WT)-GAPDH. However, the detailed mechanism underlying GAPDH aggregate-induced cell death remains elusive. Here we report that NO-induced GAPDH aggregation specifically causes mitochondrial dysfunction. First, we observed a correlation between NO-induced GAPDH aggregation and mitochondrial dysfunction, when GAPDH aggregation occurred at mitochondria in SH-SY5Y cells. In isolated mitochondria, aggregates of WT-GAPDH directly induced mitochondrial swelling and depolarization, whereas mixtures containing aggregates ofC152AGAPDH reduced mitochondrial dysfunction. Additionally, treatment with cyclosporin A improved WT-GAPDH aggregate-induced swelling and depolarization. In doxycycline-inducible SH-SY5Y cells, overexpression of WT-GAPDH augmented NO-induced mitochondrial dysfunction and increased mitochondrial GAPDH aggregation, whereas induced overexpression of C152A-GAPDH significantly suppressed mitochondrial impairment. Further, NO-induced cytochrome c release into the cytosol and nuclear translocation of apoptosis-inducing factor from mitochondria were both augmented in cells overexpressing WT-GAPDH but ameliorated in C152A-GAPDHoverexpressing cells. Interestingly, GAPDH aggregates induced necrotic cell death via a permeability transition pore (PTP) opening. The expression of either WT-or C152A-GAPDH did not affect other cell death pathways associated with protein aggregation, such as proteasome inhibition, gene expression induced by endoplasmic reticulum stress, or autophagy. Collectively, these results suggest that NO-induced GAPDH aggregation specifically induces mitochondrial dysfunction via PTP opening, leading to cell death.	[Nakajima, Hidemitsu; Itakura, Masanori; Kubo, Takeya; Kaneshige, Akihiro; Azuma, Yasu-Taka; Takeuchi, Tadayoshi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Lab Vet Pharmacol, Osaka 5988531, Japan; [Harada, Naoki; Yamaji, Ryouichi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Osaka 5988531, Japan; [Izawa, Takeshi; Kuwamura, Mitsuru] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Lab Vet Pathol, Osaka 5988531, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Nakajima, H (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Lab Vet Pharmacol, Osaka 5988531, Japan.	hnakajima@vet.osakafu-u.ac.jp	Harada, Naoki/AAP-2868-2020	Harada, Naoki/0000-0003-3846-388X; Nakajima, Hidemitsu/0000-0002-0441-1929; Izawa, Takeshi/0000-0003-3236-6050; Azuma, Yasu-Taka/0000-0002-3515-171X	JSPS KAKENHI [15J05838]; Japan Society for the Promotion of Science [AS232Z02185G, AS242Z02311Q];  [22580339];  [25450428];  [16H05029]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; 	This work was supported in part by Grants-in-aid 22580339, 25450428, and 16H05029 (to H.N.), JSPS KAKENHI Grant 15J05838 (to M. I.) from the Japan Society for the Promotion of Science, and Grants-in-aid AS232Z02185G and AS242Z02311Q for Exploratory Research in A-STEP. The authors declare that they have no conflicts of interest with the contents of this article.	Abbasabadi AO, 2013, INT J BIOL MACROMOL, V61, P212, DOI 10.1016/j.ijbiomac.2013.07.007; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Beal MF, 2000, TRENDS NEUROSCI, V23, P298, DOI 10.1016/S0166-2236(00)01584-8; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Bobba A, 2002, FEBS LETT, V515, P8, DOI 10.1016/S0014-5793(02)02231-7; Brenner C, 2006, ONCOGENE, V25, P4744, DOI 10.1038/sj.onc.1209609; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; Delavallee L, 2011, IUBMB LIFE, V63, P221, DOI 10.1002/iub.432; Du H, 2010, BBA-MOL BASIS DIS, V1802, P198, DOI 10.1016/j.bbadis.2009.07.005; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; GANTER C, 1990, BIOCHEMISTRY-US, V29, P9395, DOI 10.1021/bi00492a013; Glockzin S, 1999, J BIOL CHEM, V274, P19581, DOI 10.1074/jbc.274.28.19581; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Ishii T, 1999, BIOCHEM PHARMACOL, V58, P133, DOI 10.1016/S0006-2952(99)00060-X; Itakura M, 2015, J BIOL CHEM, V290, P26072, DOI 10.1074/jbc.M115.669291; Itakura M, 2015, BIOCHEM BIOPH RES CO, V467, P373, DOI 10.1016/j.bbrc.2015.09.150; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; Kohr MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111448; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Kubo T, 2016, NITRIC OXIDE-BIOL CH, V53, P13, DOI 10.1016/j.niox.2015.12.005; Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730; Lazarev VF, 2015, FEBS LETT, V589, P581, DOI 10.1016/j.febslet.2015.01.018; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; LETKO G, 1973, ACTA BIOL MED GER, V30, P365; Liu L, 2015, ADV DIFFER EQU-NY, DOI 10.1186/s13662-014-0345-y; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nakajima H, 2015, J BIOL CHEM, V290, P14493, DOI 10.1074/jbc.M114.635607; Nakajima H, 2009, BIOCHEM BIOPH RES CO, V390, P1066, DOI 10.1016/j.bbrc.2009.10.118; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Nicholls C, 2012, CLIN EXP PHARMACOL P, V39, P674, DOI 10.1111/j.1440-1681.2011.05599.x; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pierce A, 2008, J MOL BIOL, V382, P1195, DOI 10.1016/j.jmb.2008.07.088; Rodriguez-Pascual F, 2008, MOL CELL BIOL, V28, P7139, DOI 10.1128/MCB.01145-08; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Tsuchiya K, 2005, EUR J NEUROSCI, V21, P317, DOI 10.1111/j.1460-9568.2005.03870.x; Tsuchiya K, 2004, LIFE SCI, V74, P3245, DOI 10.1016/j.lfs.2003.11.029; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Xu K, 2009, ATHEROSCLEROSIS, V207, P123, DOI 10.1016/j.atherosclerosis.2009.04.019; Yamaji R, 2003, BBA-MOL CELL RES, V1593, P269, DOI 10.1016/S0167-4889(02)00397-X; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yogalingam G, 2013, J BIOL CHEM, V288, P18947, DOI 10.1074/jbc.M113.466870; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	63	38	38	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4727	4742		10.1074/jbc.M116.759084	http://dx.doi.org/10.1074/jbc.M116.759084			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28167533	Green Published, hybrid			2022-12-26	WOS:000397585100028
J	Khan, AR; Park, GS; Asaf, S; Hong, SJ; Jung, BK; Shin, JH				Khan, Abdur Rahim; Park, Gun-Seok; Asaf, Sajjad; Hong, Sung-Jun; Jung, Byung Kwon; Shin, Jae-Ho			Complete genome analysis of Serratia marcescens RSC-14: A plant growth-promoting bacterium that alleviates cadmium stress in host plants	PLOS ONE			English	Article							INDUCED SYSTEMIC RESISTANCE; SOLANUM-NIGRUM; LIPID-PEROXIDATION; INDUCTION; CUCUMBER; RHIZOBACTERIA; DIVERSITY; WILT; COMMUNITIES; ENDOPHYTES	Serratia marcescens RSC-14 is a Gram-negative bacterium that was previously isolated from the surface-sterilized roots of the Cd-hyperaccumulator Solanum nigrum. The strain stimulates plant growth and alleviates Cd stress in host plants. To investigate the genetic basis for these traits, the complete genome of RSC-14 was obtained by single-molecule real-time sequencing. The genome of S. marcescens RSC-14 comprised a 5.12-Mbp-long circular chromosome containing 4,593 predicted protein-coding genes, 22 rRNA genes, 88 tRNA genes, and 41 pseudogenes. It contained genes with potential functions in plant growth promotion, including genes involved in indole-3-acetic acid (IAA) biosynthesis, acetoin synthesis, and phosphate solubilization. Moreover, annotation using NCBI and Rapid Annotation using Subsystem Technology identified several genes that encode antioxidant enzymes as well as genes involved in antioxidant production, supporting the observed resistance towards heavy metals, such as Cd. The presence of IAA pathway-related genes and oxidative stress-responsive enzyme genes may explain the plant growth-promoting potential and Cd tolerance, respectively. This is the first report of a complete genome sequence of Cd-tolerant S. marcescens and its plant growth promotion pathway. The whole-genome analysis of this strain clarified the genetic basis underlying its phenotypic and biochemical characteristics, underpinning the beneficial interactions between RSC-14 and plants.	[Khan, Abdur Rahim; Park, Gun-Seok; Asaf, Sajjad; Hong, Sung-Jun; Jung, Byung Kwon; Shin, Jae-Ho] Kyungpook Natl Univ, Coll Agr & Life Sci, Sch Appl Biosci, Daegu, South Korea; [Khan, Abdur Rahim] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Kyungpook National University; University of California System; University of California Berkeley	Shin, JH (corresponding author), Kyungpook Natl Univ, Coll Agr & Life Sci, Sch Appl Biosci, Daegu, South Korea.	jhshin@knu.ac.kr	Khan, Abdur Rahim/N-5836-2015; khan, abdur Rahim/B-6034-2015; Asaf, Sajjad/ABA-3647-2021	Khan, Abdur Rahim/0000-0001-5370-6216; 	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A01057187]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF-2015R1D1A1A01057187).	Ahmed N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005831; Arcand MM, 2006, AN ACAD BRAS CIENC, V78, P791, DOI 10.1590/S0001-37652006000400013; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Aylward FO, 2013, GENOME ANNOUNC, V1; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bagchi D, 1997, FREE RADICAL BIO MED, V22, P471, DOI 10.1016/S0891-5849(96)00352-8; Behera BC, 2014, BIOCATAL AGR BIOTECH, V3, P97, DOI 10.1016/j.bcab.2013.09.008; Berendsen RL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1632-z; BERGAN T, 1983, CURR MICROBIOL, V8, P7, DOI 10.1007/BF01567306; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Chakraborty U, 2010, J PLANT INTERACT, V5, P261, DOI 10.1080/17429140903551738; Chen L, 2014, SOIL BIOL BIOCHEM, V68, P300, DOI 10.1016/j.soilbio.2013.10.021; Chen LA, 2010, APPL SOIL ECOL, V46, P383, DOI 10.1016/j.apsoil.2010.10.003; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Chung WC, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00126-13; Clarke BB, 2006, PLANT DIS, V90, P994, DOI 10.1094/PD-90-0994; D'Alessandro M, 2014, PLANT CELL ENVIRON, V37, P813, DOI 10.1111/pce.12220; De Maayer P, 2010, J BACTERIOL, V192, P2936, DOI 10.1128/JB.00060-10; dos Santos MF, 2010, J PROTEOMICS, V73, P917, DOI 10.1016/j.jprot.2009.12.005; Duca D, 2014, ANTON LEEUW INT J G, V106, P85, DOI 10.1007/s10482-013-0095-y; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Furnkranz M, 2012, MICROB ECOL, V63, P418, DOI 10.1007/s00248-011-9942-4; Guo JH, 2004, BIOL CONTROL, V29, P66, DOI 10.1016/S1049-9644(03)00124-5; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Holguin G, 2001, MICROBIAL ECOL, V41, P281, DOI 10.1007/s002480000040; Hussein KA, 2015, J KOREAN SOC APPL BI, V58, P847, DOI 10.1007/s13765-015-0114-y; Johnston-Monje D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020396; Kahlke T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-179; Khan AR, 2015, ENVIRON SCI POLLUT R, V22, P14032, DOI 10.1007/s11356-015-4647-8; Kisa D, 2016, APPL BIOL CHEM, V59, P813, DOI 10.1007/s13765-016-0229-9; Li PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123061; LIU L, 1995, PHYTOPATHOLOGY, V85, P843, DOI 10.1094/Phyto-85-843; LIU L, 1995, PHYTOPATHOLOGY, V85, P695, DOI 10.1094/Phyto-85-695; Lodewyckx C, 2002, CRIT REV PLANT SCI, V21, P583, DOI 10.1080/0735-260291044377; Louden BC, 2011, J MICROBIOL BIOL EDU, V12, P51, DOI 10.1128/jmbe.v12i1.249; Luo SL, 2011, APPL MICROBIOL BIOT, V89, P1637, DOI 10.1007/s00253-010-2927-2; MANCA D, 1994, ARCH TOXICOL, V68, P364, DOI 10.1007/s002040050083; Muller H, 2008, BIOCONTROL, V53, P905, DOI 10.1007/s10526-007-9111-3; Neupane S, 2012, STAND GENOMIC SCI, V7, P22, DOI 10.4056/sigs.2966299; Neupane S, 2012, STAND GENOMIC SCI, V6, P165, DOI 10.4056/sigs.2705996; Nicholson WL, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00548-13; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Ping LY, 2004, TRENDS PLANT SCI, V9, P263, DOI 10.1016/j.tplants.2004.04.008; Raupach GS, 1996, PLANT DIS, V80, P891, DOI 10.1094/PD-80-0891; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Ryu CM, 2013, PLANT PATHOLOGY J, V29, P182, DOI [10.5423/PPJ.SI.11.2012.0173, 10.5423/PPJ.SI.11.2012.0173.R2]; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Sessitsch A, 2012, MOL PLANT MICROBE IN, V25, P28, DOI 10.1094/MPMI-08-11-0204; Shah K, 2001, PLANT SCI, V161, P1135, DOI 10.1016/S0168-9452(01)00517-9; Singh RP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155026; Sukumar P, 2013, PLANT CELL ENVIRON, V36, P909, DOI 10.1111/pce.12036; Taghavi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115455; Taghavi S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000943; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; Tahtamouni M. E. W., 2006, The Plant Pathology Journal, V22, P107; Ulrich K, 2008, FEMS MICROBIOL ECOL, V63, P169, DOI 10.1111/j.1574-6941.2007.00419.x; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Wan Y, 2012, CHEMOSPHERE, V89, P743, DOI 10.1016/j.chemosphere.2012.07.005; Wei G, 1996, PHYTOPATHOLOGY, V86, P221, DOI 10.1094/Phyto-86-221; WEI G, 1991, Phytopathology, V81, P1508, DOI 10.1094/Phyto-81-1508; Wuana RA, 2011, ISRN ECOL, V2011, P1, DOI [10.5402/2011/402647, DOI 10.5402/2011/402647]; Yamagishi T, 2001, WATER RES, V35, P3089, DOI 10.1016/S0043-1354(01)00032-X; Zehnder G, 1997, J ECON ENTOMOL, V90, P391, DOI 10.1093/jee/90.2.391; Zhang LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19257	68	38	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171534	10.1371/journal.pone.0171534	http://dx.doi.org/10.1371/journal.pone.0171534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187139	gold, Green Published, Green Submitted			2022-12-26	WOS:000394244300027
J	Bartel, F; Vrenken, H; Bijma, F; Barkhof, F; van Herk, M; de Munck, JC				Bartel, Fabian; Vrenken, Hugo; Bijma, Fetsje; Barkhof, Frederik; van Herk, Marcel; de Munck, Jan C.			Regional analysis of volumes and reproducibilities of automatic and manual hippocampal segmentations	PLOS ONE			English	Article							ADNI HARMONIZED PROTOCOL; WHOLE-BRAIN RADIOTHERAPY; TEMPORAL-LOBE EPILEPSY; ALZHEIMERS-DISEASE; MAGNETIC-RESONANCE; MEMORY PERFORMANCE; METHODS FREESURFER; COGNITIVE DECLINE; ATROPHY RATES; MRI	Purpose Precise and reproducible hippocampus outlining is important to quantify hippocampal atrophy caused by neurodegenerative diseases and to spare the hippocampus in whole brain radiation therapy when performing prophylactic cranial irradiation or treating brain metastases. This study aimed to quantify systematic differences between methods by comparing regional volume and outline reproducibility of manual, FSL-FIRST and FreeSurfer hippocampus segmentations. Materials and methods This study used a dataset from ADNI (Alzheimer's Disease Neuroimaging Initiative), including 20 healthy controls, 40 patients with mild cognitive impairment (MCI), and 20 patients with Alzheimer's disease (AD). For each subject back-to-back (BTB) T1-weighted 3D MPRAGE images were acquired at time-point baseline (BL) and 12 months later (M12). Hippocampi segmentations of all methods were converted into triangulated meshes, regional volumes were extracted and regional Jaccard indices were computed between the hippocampi meshes of paired BTB scans to evaluate reproducibility. Regional volumes and Jaccard indices were modelled as a function of group (G), method (M), hemisphere (H), timepoint (T), region (R) and interactions. Results For the volume data the model selection procedure yielded the following significant main effects G, M, H, T and R and interaction effects G-R and M-R. The same model was found for the BTB scans. For all methods volumes reduces with the severity of disease. Significant fixed effects for the regional Jaccard index data were M, R and the interaction M-R. For all methods the middle region was most reproducible, independent of diagnostic group. FSL-FIRST was most and FreeSurfer least reproducible. Discussion/Conclusion A novel method to perform detailed analysis of subtle differences in hippocampus segmentation is proposed. The method showed that hippocampal segmentation reproducibility was best for FSL-FIRST and worst for Freesurfer. We also found systematic regional differences in hippocampal segmentation between different methods reinforcing the need of adopting harmonized protocols.	[Bartel, Fabian; Vrenken, Hugo; de Munck, Jan C.] Vrije Univ Amsterdam, Med Ctr, Dept Phys & Med Technol, Amsterdam, Netherlands; [Vrenken, Hugo; Barkhof, Frederik] Vrije Univ Amsterdam, Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Bijma, Fetsje] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands; [Barkhof, Frederik] Vrije Univ Amsterdam, Med Ctr, Image Anal Ctr, Amsterdam, Netherlands; [van Herk, Marcel] Univ Manchester, Dept Radiotherapy Phys, Manchester M13 9PL, Lancs, England	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Manchester	Bartel, F (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Phys & Med Technol, Amsterdam, Netherlands.	f.bartel@vumc.nl	van Herk, Marcel B/P-6307-2015; Barkhof, Frederik/AAJ-6226-2020	van Herk, Marcel B/0000-0001-6448-898X; Barkhof, Frederik/0000-0003-3543-3706; Vrenken, Hugo/0000-0001-9106-1172; De Munck, Jan/0000-0002-5206-0086				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aoyama H, 2007, INT J RADIAT ONCOL, V68, P1388, DOI 10.1016/j.ijrobp.2007.03.048; Apostolova LG, 2015, ALZHEIMERS DEMENT, V11, P139, DOI 10.1016/j.jalz.2015.01.001; Barnes J, 2008, NEUROIMAGE, V40, P1655, DOI 10.1016/j.neuroimage.2008.01.012; Basso M, 2006, PSYCHIAT RES-NEUROIM, V146, P251, DOI 10.1016/j.pscychresns.2006.01.007; Boccardi M, 2011, ADV ALZH DIS, V2, P111, DOI 10.3233/978-1-60750-793-2-111; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P126, DOI 10.1016/j.jalz.2014.02.009; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Cherbuin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005265; De Flores R, 2015, NEUROSCIENCE, V309, P29, DOI 10.1016/j.neuroscience.2015.08.033; den Heijer T, 2010, BRAIN, V133, P1163, DOI 10.1093/brain/awq048; Dewey J, 2010, NEUROIMAGE, V51, P1334, DOI 10.1016/j.neuroimage.2010.03.033; Dill V, 2015, NEUROINFORMATICS, V13, P133, DOI 10.1007/s12021-014-9243-4; Doring TM, 2011, J MAGN RESON IMAGING, V33, P565, DOI 10.1002/jmri.22473; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frisoni GB, 2015, ALZHEIMERS DEMENT, V11, P111, DOI 10.1016/j.jalz.2014.05.1756; Frisoni GB, 2008, BRAIN, V131, P3266, DOI 10.1093/brain/awn280; Germeyan SC, 2014, EPILEPSIA, V55, P1374, DOI 10.1111/epi.12694; Gondi V, 2010, INT J RADIAT ONCOL, V78, P1244, DOI 10.1016/j.ijrobp.2010.01.039; Gordon BA, 2013, J ALZHEIMERS DIS, V37, P41, DOI 10.3233/JAD-130011; Grimm O, 2015, J NEUROSCI METH, V253, P254, DOI 10.1016/j.jneumeth.2015.05.024; Hackert VH, 2002, NEUROIMAGE, V17, P1365, DOI 10.1006/nimg.2002.1248; Henneman WJP, 2009, NEUROLOGY, V72, P999, DOI 10.1212/01.wnl.0000344568.09360.31; Honeycutt N A, 1995, J Neuroimaging, V5, P95; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; JACK CR, 1994, EPILEPSIA, V35, pS21, DOI 10.1111/j.1528-1157.1994.tb05986.x; Jack CR, 2003, NEUROLOGY, V60, P253, DOI 10.1212/01.WNL.0000042480.86872.03; Kim H, 2012, NEUROIMAGE, V59, P3178, DOI 10.1016/j.neuroimage.2011.11.040; Lehmann M, 2010, NEUROIMAGE, V49, P2264, DOI 10.1016/j.neuroimage.2009.10.056; Likeman M, 2005, ARCH NEUROL-CHICAGO, V62, P1410, DOI 10.1001/archneur.62.9.1410; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Mulder ER, 2014, NEUROIMAGE, V92, P169, DOI 10.1016/j.neuroimage.2014.01.058; Mungas D, 2005, NEUROLOGY, V65, P565, DOI 10.1212/01.wnl.0000172913.88973.0d; Nugent AC, 2013, HUM BRAIN MAPP, V34, P2313, DOI 10.1002/hbm.22068; Oskan F, 2014, STRAHLENTHER ONKOL, V190, P337, DOI 10.1007/s00066-013-0518-8; Pardoe HR, 2009, EPILEPSIA, V50, P2586, DOI 10.1111/j.1528-1167.2009.02243.x; Patenaude B, 2007, DEP CLIN NEUROL, P247; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Sanchez-Benavides G, 2010, PSYCHIAT RES-NEUROIM, V181, P219, DOI 10.1016/j.pscychresns.2009.10.011; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shen L, 2010, BRAIN IMAGING BEHAV, V4, P86, DOI 10.1007/s11682-010-9088-x; Tae WS, 2008, NEURORADIOLOGY, V50, P569, DOI 10.1007/s00234-008-0383-9; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; van de Pol LA, 2007, NEUROLOGY, V69, P1491, DOI 10.1212/01.wnl.0000277458.26846.96; van Herk M, 1998, MED PHYS, V25, P2054, DOI 10.1118/1.598393; Welzel G, 2008, INT J RADIAT ONCOL, V72, P1311, DOI 10.1016/j.ijrobp.2008.03.009; Wenger E, 2014, HUM BRAIN MAPP, V35, P4236, DOI 10.1002/hbm.22473; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	55	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0166785	10.1371/journal.pone.0166785	http://dx.doi.org/10.1371/journal.pone.0166785			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182655	gold, Green Submitted, Green Published			2022-12-26	WOS:000394231800002
J	Kyaw, NTT; Harries, AD; Kumar, AMV; Oo, MM; Kyaw, KWY; Win, T; Aung, TK; Min, AC; Oo, HN				Kyaw, Nang Thu Thu; Harries, Anthony D.; Kumar, Ajay M. V.; Oo, Myo Minn; Kyaw, Khine Wut Yee; Win, Than; Aung, Thet Ko; Min, Aung Chan; Oo, Htun Nyunt			High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on firstline ART in Myanmar, 2005-2015	PLOS ONE			English	Article							1ST-LINE ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; OUTCOMES; CHALLENGES; MANAGEMENT; PREDICTORS	Background The number of people living with HIV on antiretroviral treatment (ART) in Myanmar has been increasing rapidly in recent years. This study aimed to estimate rates of virological failure on first-line ART and switching to second-line ART due to treatment failure at the Integrated HIV Care program (IHC). Methods Routinely collected data of all adolescent and adult patients living with HIV who were initiated on first-line ART at IHC between 2005 and 2015 were retrospectively analyzed. The cumulative hazard of virological failure on first-line ART and switching to second-line ART were estimated. Crude and adjusted hazard ratios were calculated using the Cox regression model to identify risk factors associated with the two outcomes. Results Of 23,248 adults and adolescents, 7,888 (34%) were tested for HIV viral load. The incidence rate of virological failure among those tested was 3.2 per 100 person-years follow-up and the rate of switching to second-line ART among all patients was 1.4 per 100 person-years follow-up. Factors associated with virological failure included: being adolescent; being lost to follow-up at least once; having WHO stage 3 and 4 at ART initiation; and having taken first-line ART elsewhere before coming to IHC. Of the 1032 patients who met virological failure criteria, 762 (74%) switched to second-line ART. Conclusions We found high rates of virological failure among one third of patients in the cohort who were tested for viral load. Of those failing virologically on first-line ART, about one quarter were not switched to second-line ART. Routine viral load monitoring, especially for those identified as having a higher risk of treatment failure, should be considered in this setting to detect all patients failing on first-line ART. Strategies also need to be put in place to prevent treatment failure and to treat more of those patients who are actually failing.	[Kyaw, Nang Thu Thu; Oo, Myo Minn; Kyaw, Khine Wut Yee; Aung, Thet Ko; Min, Aung Chan] Int Union TB & Lung Dis, Mandalay, Myanmar; [Harries, Anthony D.; Kumar, Ajay M. V.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London, England; [Kumar, Ajay M. V.] Union Southeast Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India; [Win, Than] Natl HIV AIDS Program, Mandalay, Myanmar; [Oo, Htun Nyunt] Natl HIV AIDS Program, Nay Pyi Taw, Myanmar	University of London; London School of Hygiene & Tropical Medicine	Kyaw, NTT (corresponding author), Int Union TB & Lung Dis, Mandalay, Myanmar.	nangthu82@gmail.com	Oo, Myo Minn/P-3720-2018; Kyaw, Khine Wut Yee/K-4130-2019	Oo, Myo Minn/0000-0003-4089-016X; Kyaw, Khine Wut Yee/0000-0003-0709-484X; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	Union and The Department for International Development (DFID), UK	Union and The Department for International Development (DFID), UK	This study was funded by The Union and The Department for International Development (DFID), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bila DCA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130580; Agwu AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18579; [Anonymous], 2003, Paediatr Child Health, V8, P577; [Anonymous], 2009, STAT STAT SOFTW VERS; Bacha T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-197; Boender TS, 2015, CLIN INFECT DIS, V61, P1453, DOI 10.1093/cid/civ556; Charles M, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17375; Crawford TN, 2014, AIDS CARE, V26, P1393, DOI 10.1080/09540121.2014.920076; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Fox MP, 2012, JAIDS-J ACQ IMM DEF, V60, P428, DOI 10.1097/QAI.0b013e3182557785; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Haas AD, 2015, LANCET HIV, V2, pE271, DOI 10.1016/S2352-3018(15)00087-9; Harries AD, 2010, LANCET INFECT DIS, V10, P60, DOI 10.1016/S1473-3099(09)70321-4; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; Jespersen S, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20243; Jobanputra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116144; Kanapathipillai R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086122; Landier J, 2011, AIDS CARE, V23, P75, DOI 10.1080/09540121.2010.498867; Ma Y, 2010, CLIN INFECT DIS, V50, P264, DOI 10.1086/649215; National AIDS Programme, 2011, GUID CLIN MAN HIV IN; National AIDS Programme, 2016, NAT STRAT PLAN HIV A; Ochieng W, 2015, JAIDS-J ACQ IMM DEF, V69, pE49, DOI 10.1097/QAI.0000000000000580; Petersen ML, 2014, AIDS, V28, P2097, DOI 10.1097/QAD.0000000000000349; Renaud-Thery F, ADULT ANTIRETROVIRAL; Ruperez M, 2015, J ANTIMICROB CHEMOTH, V70, P2639, DOI 10.1093/jac/dkv143; Shet A, 2016, CURR HIV RES, V14, P71, DOI 10.2174/1570162X13666150825123750; Thida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108615; Trotter AB, 2013, AIDS REV, V15, P162; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; World Health Organization, 2013, CONSOLIDATED GUIDELI	30	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171780	10.1371/journal.pone.0171780	http://dx.doi.org/10.1371/journal.pone.0171780			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182786	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000394231800109
J	Liu, C; Dong, JY; Yue, LL; Liu, SH; Wan, Y; Liu, H; Tan, WY; Guo, QQ; Zhang, D				Liu, Chao; Dong, Jian Yong; Yue, Lin Lin; Liu, Shao Hua; Wan, Yi; Liu, Hong; Tan, Wan Ye; Guo, Qian Qian; Zhang, Dong			Rapamycin/sodium hyaluronate binding on nano-hydroxyapatite coated titanium surface improves MC3T3-E1 osteogenesis	PLOS ONE			English	Article							OSTEOBLAST; DRUG; DIFFERENTIATION; APOPTOSIS	Endosseous titanium (Ti) implant failure due to poor biocompatibility of implant surface remains a major problem for osseointegration. Improving the topography of Ti surface may enhance osseointegration, however, the mechanism remains unknown. To investigate the effect of modified Ti surface on osteogenesis, we loaded rapamycin (RA) onto nano-hydroxyapatite (HAp) coated Ti surface which was acid-etched, alkali-heated and HAp coated sequentially. Sodium hyaluronate (SH) was employed as an intermediate layer for the load of RA, and a steady release rate of RA was maintained. Cell vitality of MC3T3-E1 was assessed by MTT. Osteogenesis of MC3T3-E1 on this modified Ti surface was evaluated by alkaline phosphatase (ALP) activity, mineralization and related osteogenesis genes osteocalcin (OCN), osteopontin (OPN), Collagen-I and Runx2. The result revealed that RA/SH-loaded nano-HAp Ti surface was innocent for cell vitality and even more beneficial for cell osteogenesis in vitro. Furthermore, osteogenesis of MC3T3-E1 showed significant association with the mammalian target of rapamycin (mTOR) phosphorylation by RA, which required further study about the mechanism. The approach to this modified Ti surface presented in this paper has high research value for the development of Ti-based implant.	[Liu, Chao; Liu, Shao Hua; Tan, Wan Ye; Zhang, Dong] Shandong Univ, Qilu Hosp, Dept Oral & Maxillofacial Surg, Jinan, Peoples R China; [Liu, Chao; Liu, Shao Hua; Tan, Wan Ye; Zhang, Dong] Shandong Univ, Qilu Hosp, Inst Dent Med, Jinan, Peoples R China; [Dong, Jian Yong; Yue, Lin Lin; Guo, Qian Qian] Shandong Univ, Sch Stomotol, Jinan, Peoples R China; [Wan, Yi] Shandong Univ, Sch Mech Engn, Key Lab High Efficiency & Clean Mech Manufacture, Minist Educ, Jinan, Peoples R China; [Liu, Hong] Shandong Univ, Ctr Bio & Micro Nano Funct Mat, State Key Lab Crystal Mat, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Zhang, D (corresponding author), Shandong Univ, Qilu Hosp, Dept Oral & Maxillofacial Surg, Jinan, Peoples R China.; Zhang, D (corresponding author), Shandong Univ, Qilu Hosp, Inst Dent Med, Jinan, Peoples R China.	qiluzhangdong@163.com	Liu, Hong/D-7288-2019	Liu, Hong/0000-0003-1640-9620; Dong, Jianyong/0000-0002-1147-176X	Natural Science Foundation of Shandong Provience, China [BS2015SW028]	Natural Science Foundation of Shandong Provience, China	This work was supported by the Natural Science Foundation of Shandong Provience, China (BS2015SW028), http://ww.sdnsf.gov.cn/portal/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Natural Science Foundation of Shandong Province, China (BS2015SW028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila G, 2009, IMPLANT DENT, V18, P17, DOI 10.1097/ID.0b013e318192cb7d; Cai KY, 2010, ACTA BIOMATER, V6, P2314, DOI 10.1016/j.actbio.2009.11.034; Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019; Darcy A, 2012, BONE, V50, P1294, DOI 10.1016/j.bone.2012.03.001; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Fukuda A, 2005, J BONE MINER RES, V20, P2245, DOI 10.1359/JBMR.050816; Hao XH, 2015, ACS NANO, V9, P9614, DOI 10.1021/nn507485j; Huang Y, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/6/065007; Hwang DS, 2010, BIOMATERIALS, V31, P1080, DOI 10.1016/j.biomaterials.2009.10.041; Jiang PL, 2015, ACS APPL MATER INTER, V7, P14384, DOI 10.1021/acsami.5b03172; Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009; Kim HM, 1997, J BIOMED MATER RES, V38, P121; Kirmanidou Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2908570; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Lai W, 2016, MAT SCI ENG C-MATER, V62, P166, DOI 10.1016/j.msec.2016.01.055; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee KW, 2010, STEM CELLS DEV, V19, P557, DOI 10.1089/scd.2009.0147; Li GL, 2016, ACS APPL MATER INTER, V8, P3840, DOI 10.1021/acsami.5b10633; Liu C, 2014, ANN HEMATOL, V93, P1177, DOI 10.1007/s00277-014-2024-1; Luo Y, 2010, J CONTROL RELEASE, V147, P278, DOI 10.1016/j.jconrel.2010.07.108; Mainardes RM, 2004, CURR DRUG TARGETS, V5, P449, DOI 10.2174/1389450043345407; Oshida Y, 2010, INT J MOL SCI, V11, P1580, DOI 10.3390/ijms11041580; Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518; Sato M, 2008, J BIOMED MATER RES A, V84A, P265, DOI 10.1002/jbm.a.31469; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Svanborg LM, 2014, INT J DENT, V2014, DOI 10.1155/2014/197581; Tan WY, 2013, ULTRASON SONOCHEM, V20, P216, DOI 10.1016/j.ultsonch.2012.07.020; Uskokovic V, 2011, J BIOMED MATER RES B, V96B, P152, DOI 10.1002/jbm.b.31746; Wang M, 2012, J NANOSCI NANOTECHNO, V12, P7692, DOI 10.1166/jnn.2012.6624; Wu JM, 2006, J AM CERAM SOC, V89, P2660, DOI 10.1111/j.1551-2916.2006.01104.x; Xuereb M, 2015, INT J PROSTHODONT, V28, P51, DOI 10.11607/ijp.4124; Zhao YY, 2015, J SHANDONG U HLTH SC, V53, P41	32	9	9	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171693	10.1371/journal.pone.0171693	http://dx.doi.org/10.1371/journal.pone.0171693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182765	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800091
J	Wu, LP; Pang, YL; Qin, GQ; Xi, GN; Wu, SN; Wang, XP; Chen, TS				Wu, Liping; Pang, Yilin; Qin, Guiqi; Xi, Gaina; Wu, Shengnan; Wang, Xiaoping; Chen, Tongsheng			Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives	PLOS ONE			English	Article							MEDIATED INTRINSIC PATHWAY; DIHYDROARTEMISININ INDUCES APOPTOSIS; MITOCHONDRIAL AMPLIFICATION LOOP; LUNG ADENOCARCINOMA CELLS; TRAIL-INDUCED APOPTOSIS; BREAST-CANCER CELLS; T-LEUKEMIA-CELLS; HEPATOCELLULAR-CARCINOMA; IN-VITRO; CURRENT MANAGEMENT	Dihydroartemisinin (DHA) and artesunate (ARS), two artemisinin derivatives, have efficacious anticancer activities against human hepatocarcinoma (HCC) cells. This study aims to study the anticancer action of the combination treatment of DHA/ARS and farnesylthiosalicylic acid (FTS), a Ras inhibitor, in HCC cells (Huh-7 and HepG2 cell lines). FTS pretreatment significantly enhanced DHA/ARS-induced phosphatidylserine (PS) externalization, Bak/Bax activation, mitochondrial membrane depolarization, cytochrome c release, and caspase-8 and -9 activations, characteristics of the extrinsic and intrinsic apoptosis. Pretreatment with Z-IETD-FMK (caspase-8 inhibitor) potently prevented the cytotoxicity of the combination treatment of DHA/ARS and FTS, and pretreatment with Z-VAD-FMK (pan-caspase inhibitor) significantly inhibited the loss of Delta psi m induced by DHA/ARS treatment or the combination treatment of DHA/ARS and FTS in HCC cells. Furthermore, silencing Bak/Bax modestly but significantly inhibited the cytotoxicity of the combination treatment of DHA/ARS and FTS. Interestingly, pretreatment with an antioxidant N-Acetyle-Cysteine (NAC) significantly prevented the cytotoxicity of the combination treatment of DHA and FTS instead of the combination treatment of ARS and FTS, suggesting that reactive oxygen species (ROS) played a key role in the anticancer action of the combination treatment of DHA and FTS. Similar to FTS, DHA/ARS also significantly prevented Ras activation. Collectively, our data demonstrate that FTS potently sensitizes Huh-7 and HepG2 cells to artemisinin derivatives via accelerating the extrinsic and intrinsic apoptotic pathways.	[Wu, Liping; Pang, Yilin; Qin, Guiqi; Xi, Gaina; Wu, Shengnan; Chen, Tongsheng] South China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Wu, Liping; Pang, Yilin; Qin, Guiqi; Xi, Gaina; Wu, Shengnan; Chen, Tongsheng] South China Normal Univ, Coll Biophoton, Inst Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Xiaoping] Jinan Univ, Dept Pain Management, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University; Jinan University	Chen, TS (corresponding author), South China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China.; Chen, TS (corresponding author), South China Normal Univ, Coll Biophoton, Inst Laser Life Sci, Guangzhou, Guangdong, Peoples R China.; Wang, XP (corresponding author), Jinan Univ, Dept Pain Management, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	txp2938@jnu.edu.cn; chentsh@scnu.edu.cn			National Natural Science Foundation of China [61527825, 81471699, 61308111]; Guangdong Province Science and Technology Plan Project [20146090901060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Science and Technology Plan Project	This work was supported by the National Natural Science Foundation of China (61527825, 81471699 and 61308111), the Guangdong Province Science and Technology Plan Project (20146090901060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alayev A, 2016, J CELL PHYSL, P1; Avila MA, 2006, ONCOGENE, V25, P3866, DOI 10.1038/sj.onc.1209550; Biran A, 2011, INT J CANCER, V128, P691, DOI 10.1002/ijc.25367; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Carlisi D, 2015, J CELL PHYSIOL, V230, P1276, DOI 10.1002/jcp.24863; Chang FM, 2003, INT J ONCOL, V22, P469; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Charette N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.200; Charette N, 2010, MOL CANCER, V9, P1; Chen Q, 2000, CELL DEATH DIFFER, V7, P227, DOI 10.1038/sj.cdd.4400629; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Conrad DM, 2008, INT J ONCOL, V32, P1325; Crespo-Ortiz MP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/247597; Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412; Efferth T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000693; Gana-Weisz M, 2002, CLIN CANCER RES, V8, P555; Gao N, 2011, APOPTOSIS, V16, P511, DOI 10.1007/s10495-011-0580-6; Gao WJ, 2013, APOPTOSIS, V18, P1201, DOI 10.1007/s10495-013-0857-z; Goldberg L, 2008, MOL CANCER THER, V7, P3609, DOI 10.1158/1535-7163.MCT-08-0488; Guha A, 1997, ONCOGENE, V15, P2755, DOI 10.1038/sj.onc.1201455; Guo W, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.276; Haklai R, 2008, CANCER CHEMOTH PHARM, V61, P89, DOI 10.1007/s00280-007-0451-6; He Q, 2014, CANCER BIOL THER, V9, P819; Hippe D, 2008, INFECT IMMUN, V76, P2905, DOI 10.1128/IAI.01546-07; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Jiang C, 2001, CANCER RES, V61, P3062; Jiang W, 2013, ASIAN PAC J CANCER P, V14, P4615, DOI 10.7314/APJCP.2013.14.8.4615; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Klein J, 2013, INT J RADIAT ONCOL, V87, P22, DOI 10.1016/j.ijrobp.2012.08.043; Kloog Y, 2000, MOL MED TODAY, V6, P398, DOI 10.1016/S1357-4310(00)01789-5; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Laheru D, 2012, INVEST NEW DRUG, V30, P2391, DOI 10.1007/s10637-012-9818-6; Lai HC, 2013, INVEST NEW DRUG, V31, P230, DOI 10.1007/s10637-012-9873-z; Li LN, 2007, INT J CANCER, V121, P1360, DOI 10.1002/ijc.22804; Li Y, 2014, LEUKEMIA LYMPHOMA, V55, P1366, DOI 10.3109/10428194.2013.829573; Liu Y, 2013, ASIAN PAC J CANCER P, V14, P5243, DOI 10.7314/APJCP.2013.14.9.5243; Lu YY, 2010, FEBS LETT, V584, P4019, DOI 10.1016/j.febslet.2010.08.014; MAROM M, 1995, J BIOL CHEM, V270, P22263, DOI 10.1074/jbc.270.38.22263; Marquardt JU, 2014, CANCER CELL, V25, P550, DOI 10.1016/j.ccr.2014.04.002; Mendizabal M, 2009, MED CLIN N AM, V93, P885, DOI 10.1016/j.mcna.2009.03.004; Metkar SS, 2003, J CELL BIOL, V160, P875, DOI 10.1083/jcb.200210158; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Mologni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051449; Onuki R, 2002, P NATL ACAD SCI USA, V99, P14716, DOI 10.1073/pnas.232177599; Pang YL, 2016, EXP CELL RES, V347, P251, DOI 10.1016/j.yexcr.2016.06.012; Perelman A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.171; Qin GQ, 2015, EXP CELL RES, V336, P308, DOI 10.1016/j.yexcr.2015.07.004; Qin GQ, 2015, APOPTOSIS, V20, P1072, DOI 10.1007/s10495-015-1132-2; Rampone B, 2010, CURR ONCOL REP, V12, P186, DOI 10.1007/s11912-010-0094-3; Shelton SN, 2009, J BIOL CHEM, V284, P11247, DOI 10.1074/jbc.M809392200; Singh NP, 2001, LIFE SCI, V70, P49, DOI 10.1016/S0024-3205(01)01372-8; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Takikawa Y, 2001, GASTROENTEROLOGY, V120, P1810, DOI 10.1053/gast.2001.24835; Thanaketpaisarn O, 2011, INT J ONCOL, V39, P279, DOI 10.3892/ijo.2011.1017; Tian X, 2002, SCI B, V47, P480; Wang Chun-Hsiang, 2015, Asian Pac J Cancer Prev, V16, P3595; Wang SJ, 2010, CANCER LETT, V293, P99, DOI 10.1016/j.canlet.2010.01.001; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Wolfson E, 2015, BIOL CELL, V107, P130, DOI 10.1111/boc.201400087; Wu GS, 2013, PHARMACOL REP, V65, P453, DOI 10.1016/S1734-1140(13)71021-1; Yang SH, 2006, APOPTOSIS, V11, P1987, DOI 10.1007/s10495-006-0084-y; Yu HN, 2013, MICROSC MICROANAL, V19, P171, DOI 10.1017/S1431927612014079; Zhang CZ, 2012, BIOCHEM PHARMACOL, V83, P1278, DOI 10.1016/j.bcp.2012.02.002; Zhang J, 2015, J MICROSC-OXFORD, V257, P104, DOI 10.1111/jmi.12189; Zhang J, 2016, MICRON, V88, P7, DOI 10.1016/j.micron.2016.04.005; Zhang QY, 2014, WORLD J GASTROENTERO, V20, P10082, DOI 10.3748/wjg.v20.i29.10082; Zhao CB, 2014, CELL SIGNAL, V26, P2223, DOI 10.1016/j.cellsig.2014.07.001; Zhao CB, 2014, APOPTOSIS, V19, P668, DOI 10.1007/s10495-013-0953-0; Zhou CJ, 2012, J CELL PHYSIOL, V227, P3778, DOI 10.1002/jcp.24086; Zundelevich A, 2007, MOL CANCER THER, V6, P1765, DOI 10.1158/1535-7163.MCT-06-0706	73	6	6	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171840	10.1371/journal.pone.0171840	http://dx.doi.org/10.1371/journal.pone.0171840			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182780	gold, Green Submitted, Green Published			2022-12-26	WOS:000394231800123
J	Liu, TE; Krysiak, K; Shirai, CL; Kim, S; Shao, J; Ndonwi, M; Walter, MJ				Liu, Tuoen; Krysiak, Kilannin; Shirai, Cara Lunn; Kim, Sanghyun; Shao, Jin; Ndonwi, Matthew; Walter, Matthew J.			Knockdown of HSPA9 induces TP53dependent apoptosis in human hematopoietic progenitor cells	PLOS ONE			English	Article							COMMONLY DELETED REGION; MYELODYSPLASTIC SYNDROMES; DEL(5Q); HAPLOINSUFFICIENCY; MUTATIONS; HSP70; GENE; P53; MORTALIN; IDENTIFICATION	Myelodysplastic syndromes (MDS) are the most common adult myeloid blood cancers in the US. Patients have increased apoptosis in their bone marrow cells leading to low peripheral blood counts. The full complement of gene mutations that contribute to increased apoptosis in MDS remains unknown. Up to 25% of MDS patients harbor and acquired interstitial deletion on the long arm of chromosome 5 [del(5q)], creating haploinsufficiency for a large set of genes including HSPA9. Knockdown of HSPA9 in primary human CD34+ hematopoietic progenitor cells significantly inhibits growth and increases apoptosis. We show here that HSPA9 knockdown is associated with increased TP53 expression and activity, resulting in increased expression of target genes BAX and p21. HSPA9 protein interacts with TP53 in CD34+ cells and knockdown of HSPA9 increases nuclear TP53 levels, providing a possible mechanism for regulation of TP53 by HSPA9 haploinsufficiency in hematopoietic cells. Concurrent knockdown of TP53 and HSPA9 rescued the increased apoptosis observed in CD34 + cells following knockdown of HSPA9. Reduction of HSPA9 below 50% results in severe inhibition of cell growth, suggesting that del(5q) cells may be preferentially sensitive to further reductions of HSPA9 below 50%, thus providing a genetic vulnerability to del(5q) cells. Treatment of bone marrow cells with MKT-077, an HSPA9 inhibitor, induced apoptosis in a higher percentage of cells from MDS patients with del(5q) compared to non-del(5q) MDS patients and normal donor cells. Collectively, these findings indicate that reduced levels of HSPA9 may contribute to TP53 activation and increased apoptosis observed in del(5q)associated MDS.	[Liu, Tuoen; Krysiak, Kilannin; Shirai, Cara Lunn; Kim, Sanghyun; Shao, Jin; Ndonwi, Matthew; Walter, Matthew J.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Walter, Matthew J.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63130 USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Walter, MJ (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.; Walter, MJ (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63130 USA.	mjwalter@wustl.edu	Walter, Matthew J/S-7758-2018	Kim, Sanghyun/0000-0001-9519-1994; Krysiak, Kilannin/0000-0002-6299-9230	National Cancer Institute of the National Institutes of Health [F31CA165702]; Siteman Cancer Biology Pathway Fellowship; National Heart Lung Blood Institute of the National Institutes of Health [R01HL109336]; Howard Hughes Medical Institute Physician-Scientist Early Career Award; Leukemia and Lymphoma Society Scholar Award; NCI Cancer Center Support Grant [P30 CA91842]; Neuroscience Blueprint Interdisciplinary Center Core Award [P30NS057105]; NIH [DK106829]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109336] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Siteman Cancer Biology Pathway Fellowship; National Heart Lung Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute Physician-Scientist Early Career Award(Howard Hughes Medical Institute); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Neuroscience Blueprint Interdisciplinary Center Core Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Cancer Institute of the National Institutes of Health (F31CA165702) and Siteman Cancer Biology Pathway Fellowship (KK) as well as the National Heart Lung Blood Institute of the National Institutes of Health (R01HL109336), a Howard Hughes Medical Institute Physician-Scientist Early Career Award, and a Leukemia and Lymphoma Society Scholar Award (MJW). The Siteman Flow Cytometry Core is supported in part by an NCI Cancer Center Support Grant (#P30 CA91842). Additional technical assistance was provided by the Hope Center Viral Vectors Core, which is supported by a Neuroscience Blueprint Interdisciplinary Center Core Award (P30NS057105). The Fred Hutchinson Cancer Research Center that supplied CD34+ cells is supported by a Cooperative Centers of Excellence in Hematology grant from NIH (DK106829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Bejar R, 2014, J CLIN ONCOL, V32, P2691, DOI 10.1200/JCO.2013.52.3381; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; Chen THP, 2011, BLOOD, V117, P1530, DOI 10.1182/blood-2010-06-293167; Craven SE, 2005, BLOOD, V105, P3528, DOI 10.1182/blood-2004-03-1089; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Frisan E, 2012, BLOOD, V119, P1532, DOI 10.1182/blood-2011-03-343475; Gagnon KT, 2014, NAT PROTOC, V9, P2045, DOI 10.1038/nprot.2014.135; Gestl EE, 2012, BIOCHEM BIOPH RES CO, V423, P411, DOI 10.1016/j.bbrc.2012.05.139; Graubert TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004583; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Jadersten M, 2011, J CLIN ONCOL, V29, P1971, DOI 10.1200/JCO.2010.31.8576; Jerez A, 2012, J CLIN ONCOL, V30, P1343, DOI 10.1200/JCO.2011.36.1824; Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kaul SC, 2002, EXP GERONTOL, V37, P1157, DOI 10.1016/S0531-5565(02)00135-3; Koya K, 1996, CANCER RES, V56, P538; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Krysiak K, 2015, EXP HEMATOL, V43, P319, DOI 10.1016/j.exphem.2014.12.005; Lane SW, 2010, BLOOD, V115, P3489, DOI 10.1182/blood-2009-11-251728; Li X, 2013, ACM T INTEL SYST TEC, V4, DOI 10.1145/2508037.2508039; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Lu WJ, 2011, INT J CANCER, V129, P1806, DOI 10.1002/ijc.25857; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Pellagatti A, 2010, BLOOD, V115, P2721, DOI 10.1182/blood-2009-12-259705; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Schmitz-Abe K, 2015, BLOOD, V126, P2734, DOI 10.1182/blood-2015-09-659854; Schneider RK, 2016, NAT MED, V22, P288, DOI 10.1038/nm.4047; Schneider RK, 2014, CANCER CELL, V26, P509, DOI 10.1016/j.ccr.2014.08.001; Sola S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018421; Sportoletti P, 2008, BLOOD, V111, P3859, DOI 10.1182/blood-2007-06-098251; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Stoddart A, 2014, BLOOD, V123, P1069, DOI 10.1182/blood-2013-07-517953; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tai-Nagara I, 2014, BLOOD, V123, P41, DOI 10.1182/blood-2013-06-508333; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Varney ME, 2015, J EXP MED, V212, P1967, DOI 10.1084/jem.20141898; Wadhwa R, 2002, EXP CELL RES, V274, P246, DOI 10.1006/excr.2002.5468; Wadhwa R, 2000, CANCER RES, V60, P6818; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Wang JH, 2010, BLOOD, V115, P3481, DOI 10.1182/blood-2009-11-251835; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Young DJ, 2014, HAEMATOLOGICA, V99, P1032, DOI 10.3324/haematol.2013.098657; Zaika A, 2001, J BIOL CHEM, V276, P11310, DOI 10.1074/jbc.M005737200; Zhao ND, 1997, P NATL ACAD SCI USA, V94, P6948, DOI 10.1073/pnas.94.13.6948	48	18	18	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170470	10.1371/journal.pone.0170470	http://dx.doi.org/10.1371/journal.pone.0170470			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178280	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500006
J	Yahiaoui, A; Meadows, SA; Sorensen, RA; Cui, ZH; Keegan, KS; Brockett, R; Chen, G; Queva, C; Li, L; Tannheimer, SL				Yahiaoui, Anella; Meadows, Sarah A.; Sorensen, Rick A.; Cui, Zhi-Hua; Keegan, Kathleen S.; Brockett, Robert; Chen, Guang; Queva, Christophe; Li, Li; Tannheimer, Stacey L.			PI3K delta inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3K delta and BTK inhibitors	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; BRUTONS TYROSINE KINASE; NON-HODGKIN-LYMPHOMA; I PI3 KINASE; CLINICAL-TRIAL; RECEPTOR; CANCER; IBRUTINIB; CLL; ACTIVATION	Activated B-cell-like diffuse large B-cell lymphoma relies on B-cell receptor signaling to drive proliferation and survival. Downstream of the B-cell receptor, the key signaling kinases Bruton's tyrosine kinase and phosphoinositide 3-kinase delta offer opportunities for therapeutic intervention by agents such as ibrutinib, ONO/GS-4059, and idelalisib. Combination therapy with such targeted agents could provide enhanced efficacy due to complimentary mechanisms of action. In this study, we describe both the additive interaction of and resistance mechanisms to idelalisib and ONO/GS-4059 in a model of activated B-cell-like diffuse large B-cell lymphoma. Significant tumor regression was observed with a combination of PI3K delta and Bruton's tyrosine kinase inhibitors in the mouse TMD8 xenograft. Acquired resistance to idelalisib in the TMD8 cell line occurred by loss of phosphatase and tensin homolog and phosphoinositide 3-kinase pathway upregulation, but not by mutation of PIK3CD. Sensitivity to idelalisib could be restored by combining idelalisib and ONO/GS-4059. Further evaluation of targeted inhibitors revealed that the combination of idelalisib and the phosphoinositidedependent kinase-1 inhibitor GSK2334470 or the AKT inhibitor MK-2206 could partially overcome resistance. Characterization of acquired Bruton's tyrosine kinase inhibitor resistance revealed a novel tumor necrosis factor alpha induced protein 3 mutation (TNFAIP3 0143*), which led to a loss of A20 protein, and increased p-I kappa B alpha. The combination of idelalisib and ONO/GS-4059 partially restored sensitivity in this resistant line. Additionally, a mutation in Bruton's tyrosine kinase at C481F was identified as a mechanism of resistance. The combination activity observed with idelalisib and ONO/GS-4059, taken together with the ability to overcome resistance, could lead to a new therapeutic option in activated B -cell-like diffuse large B -cell lymphoma. A clinical trial is currently underway to evaluate the combination of idelalisib and ONO/GS-4059 (NCT02457598).	[Yahiaoui, Anella; Meadows, Sarah A.; Sorensen, Rick A.; Cui, Zhi-Hua; Keegan, Kathleen S.; Brockett, Robert; Chen, Guang; Queva, Christophe; Li, Li; Tannheimer, Stacey L.] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA; [Queva, Christophe] iTeos Therapeut, Gosselies, Belgium	Gilead Sciences	Tannheimer, SL (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	Stacey.Tannheimer@gilead.com			Gilead Sciences, Inc.	Gilead Sciences, Inc.(Gilead Sciences)	This study was funded by Gilead Sciences, Inc. Since all authors were employees of the study sponsor at the time the study was conducted, the sponsor was involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Anthony Mato C N, 2015, BLOOD, V126, P719; Bojarczuk K, 2016, BLOOD, V127, P3192, DOI 10.1182/blood-2015-10-675009; Brown JR, 2016, SEMIN ONCOL, V43, P260, DOI 10.1053/j.seminoncol.2016.02.004; Burger MT, 2011, ACS MED CHEM LETT, V2, P774, DOI 10.1021/ml200156t; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Elkabets M, 2015, CANCER CELL, V27, P533, DOI 10.1016/j.ccell.2015.03.010; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Fritsch C, 2014, MOL CANCER THER, V13, P1117, DOI 10.1158/1535-7163.MCT-13-0865; Graf SA, 2016, EXPERT OPIN PHARMACO, V17, P265, DOI 10.1517/14656566.2016.1135130; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; Hamasy A, 2016, SUBSTITUTION SCANNIN; Huw LY, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.46; Jones JA, 2014, BLOOD, V123, P1455, DOI 10.1182/blood-2013-09-453092; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; Kim Y, 2014, HUM PATHOL, V45, P556, DOI 10.1016/j.humpath.2013.10.023; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kuo HP, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.505.505; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu TM, 2015, BLOOD, V126, P61, DOI 10.1182/blood-2015-02-626846; Liu YJ, 2015, CANC RES S, V75; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; Nakanishi Y, 2016, CANCER RES, V76, P1193, DOI 10.1158/0008-5472.CAN-15-2201; Niemann CU, 2013, SEMIN CANCER BIOL, V23, P410, DOI 10.1016/j.semcancer.2013.09.001; Nore BF, 2000, EUR J IMMUNOL, V30, P145, DOI 10.1002/1521-4141(200001)30:1<145::AID-IMMU145>3.0.CO;2-0; Nylander S, 2012, J THROMB HAEMOST, V10, P2127, DOI 10.1111/j.1538-7836.2012.04898.x; Patel L, 2016, J MED CHEM; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schwartz S, 2015, CANCER CELL, V27, P109, DOI 10.1016/j.ccell.2014.11.008; Somoza JR, 2015, J BIOL CHEM, V290, P8439, DOI 10.1074/jbc.M114.634683; Stevenson FK, 2011, BLOOD, V118, P4313, DOI 10.1182/blood-2011-06-338855; Trabucco SE, 2015, CLIN CANCER RES, V21, P113, DOI 10.1158/1078-0432.CCR-13-3346; Vanhaesebroeck B, 2016, J MOL MED, V94, P5, DOI 10.1007/s00109-015-1352-5; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Walter HS, 2016, BLOOD, V127, P411, DOI 10.1182/blood-2015-08-664086; Wilson WH, 2015, NAT MED, V21, P922, DOI 10.1038/nm.3884; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Woyach JA, 2012, BLOOD, V120, P1175, DOI 10.1182/blood-2012-02-362624; Yang QS, 2015, CLIN CANCER RES, V21, P1537, DOI 10.1158/1078-0432.CCR-14-2034; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Yeomans A, 2016, BLOOD, V127, P449, DOI 10.1182/blood-2015-07-660969; Zhang SQ, 2015, BRIT J HAEMATOL, V170, P445, DOI 10.1111/bjh.13427	47	37	38	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171221	10.1371/journal.pone.0171221	http://dx.doi.org/10.1371/journal.pone.0171221			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178345	gold, Green Published, Green Submitted			2022-12-26	WOS:000393712500032
J	Yu, XQ; Luo, QW; Smith, DP; Clements, MS; Patel, MI; O'Connell, DL				Yu, Xue Qin; Luo, Qingwei; Smith, David P.; Clements, Mark S.; Patel, Manish I.; O'Connell, Dianne L.			Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study	PLOS ONE			English	Article							ACTIVE SURVEILLANCE; ELDERLY-MEN; NEEDS; HEALTH; DIAGNOSIS; FUTURE; COHORT; RISK; PROJECTIONS; MANAGEMENT	Objective To develop a method for estimating the future numbers of prostate cancer survivors requiring different levels of care. Design, setting and participants Analysis of population-based cancer registry data for prostate cancer cases (aged 18-84 years) diagnosed in 1996-2007, and a linked dataset with hospital admission data for men with prostate cancer diagnosed during 2005-2007 in New South Wales (NSW), Australia. Methods Cancer registry data (1996-2007) were used to project complete prostate cancer prevalence in NSW, Australia for 2008-2017, and treatment information from hospital records (2005-2007) was used to estimate the inpatient care needs during the first year after diagnosis. The projected complete prevalence was divided into care needs-based groups. We first divided the cohort into two groups based on patient's age (<75 and 75-84 years). The younger cohort was further divided into initial care and monitoring phases. Cause of death data were used as a proxy for patients requiring last year of life prostate cancer care. Finally, episode data were used to estimate the future number of cases with metastatic progression. Results Of the estimated total of 60,910 men with a previous diagnosis of prostate cancer in 2017, the largest groups will be older patients (52.0%) and younger men who require monitoring (42.5%). If current treatment patterns continue, in the first year post-diagnosis 41% (1380) of patients (<75 years) will have a radical prostatectomy, and 52.6% (1752) will be likely to have either active surveillance, external beam radiotherapy or androgen deprivation therapy. About 3% will require care for subsequent metastases, and 1288 men with prostate cancer are likely to die from the disease in 2017. Conclusions This method extends the application of routinely collected population-based data, and can contribute much to the knowledge of the number of men with prostate cancer and their health care requirements. This could be of significant use in planning future cancer care services and facilities in Australia.	[Yu, Xue Qin; Luo, Qingwei; Smith, David P.; O'Connell, Dianne L.] Canc Council New South Wales, Canc Res Div, Sydney, NSW, Australia; [Yu, Xue Qin; Luo, Qingwei; O'Connell, Dianne L.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Smith, David P.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Clements, Mark S.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Clements, Mark S.] Nord Informat Act eSci Ctr, Stockholm, Sweden; [Clements, Mark S.] KTH, Dept Mech, Swedish E Sci Res Ctr, Stockholm, Sweden; [Patel, Manish I.] Univ Sydney, Discipline Surg, Sydney, NSW, Australia; [Patel, Manish I.] Westmead Hosp, Dept Urol, Sydney, NSW, Australia; [O'Connell, Dianne L.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia	Cancer Council New South Wales; University of Sydney; Griffith University; Menzies Health Institute Queensland; Karolinska Institutet; Royal Institute of Technology; University of Sydney; University of Sydney; University of Newcastle	Yu, XQ (corresponding author), Canc Council New South Wales, Canc Res Div, Sydney, NSW, Australia.; Yu, XQ (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.	xueqiny@nswcc.org.au	Clements, Mark/W-5906-2018; Luo, Qingwei/I-4143-2016; Yu, Xue Qin/E-7405-2013	Clements, Mark/0000-0003-4518-5670; Luo, Qingwei/0000-0002-8902-6869; Yu, Xue Qin/0000-0001-8638-7979; Smith, David/0000-0002-1474-3214	Prostate Cancer Foundation of Australia [PCFA-Y10410]; Australian NHM RC Early Career Fellowship [App1016598]	Prostate Cancer Foundation of Australia; Australian NHM RC Early Career Fellowship	This study was funded by the Prostate Cancer Foundation of Australia (PCFA-Y10410) (to Xue Qin Yu). David Smith was supported by an Australian NHM RC Early Career Fellowship (App1016598). However, the funders played no role in study design, data analysis and interpretation, the content of this paper or the decision where to submit the article for publication.	Australian Institute of Health and Welfare, 2007, OLD AUSTR GLANC; Autstralian Institute of Health and Welfare, 2013, CANC SER, V79; Bechis SK, 2011, J CLIN ONCOL, V29, P235, DOI 10.1200/JCO.2010.30.2075; Bian SX, 2013, SEMIN RADIAT ONCOL, V23, P198, DOI 10.1016/j.semradonc.2013.01.007; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; CHeReL, 2014, DAT DICT NSW ADM PAT; Cockle-Hearne J, 2013, BRIT J CANCER, V109, P2121, DOI 10.1038/bjc.2013.568; Dion P, 2015, CAN STUD POPUL, V42, P102, DOI 10.25336/P69K6X; Evans SM, 2013, MED J AUSTRALIA, V198, P540, DOI 10.5694/mja12.11241; Fritz A, 2000, INT CLASSIFICATION D; Ganz PA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-14; Goldsbury DE, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-253; Guise TA, 2006, ONCOLOGIST, V11, P1121, DOI 10.1634/theoncologist.11-10-1121; Keating NL, 2012, J NATL CANCER I, V104, P1518, DOI 10.1093/jnci/djs376; Klotz L, 2015, J CLIN ONCOL, V33, P272, DOI 10.1200/JCO.2014.55.1192; Konety BR, 2008, J UROLOGY, V179, P1797, DOI 10.1016/j.juro.2008.01.044; Konety BR, 2008, J UROLOGY, V179, P1803, DOI [10.1016/j.juro.2008.01.044, DOI 10.1016/J.JURO.2008.01.044]; Lintz K, 2003, PSYCHO-ONCOLOGY, V12, P769, DOI 10.1002/pon.702; Loeb S, 2013, J UROLOGY, V190, P1742, DOI 10.1016/j.juro.2013.05.054; Luo QW, 2015, CANCER EPIDEMIOL, V39, P617, DOI 10.1016/j.canep.2015.04.013; Maher EJ, 2007, CLIN ONCOL-UK, V19, P743, DOI 10.1016/j.clon.2007.08.007; Maher J, 2011, BRIT J CANCER, V105, pS5, DOI 10.1038/bjc.2011.417; Mariotto AB, 2006, CANCER CAUSE CONTROL, V17, P1215, DOI 10.1007/s10552-006-0072-0; Mohler JL, 2010, J NATL COMPR CANC NE, V8, P145, DOI 10.6004/jnccn.2010.0010; Ream E, 2008, BRIT J CANCER, V98, P1903, DOI 10.1038/sj.bjc.6604406; Ruseckaite R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2655-9; Smith DP, 2007, J CLIN ONCOL, V25, P2560, DOI 10.1200/JCO.2006.09.8046; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Thompson JC, 2007, BRIT MED BULL, V83, P341, DOI 10.1093/bmb/ldm018; Weerakoon M, 2015, BJU INT, V115, P50, DOI 10.1111/bju.13049; World Health Organization, 1996, CANC PAIN REL; Yip K, 2015, BRIT J CANCER, V112, P1594, DOI 10.1038/bjc.2014.650; Yu XQ, 2006, INT J CANCER, V119, P894, DOI 10.1002/ijc.21909; Yu XQ, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000104; Yu XQ, 2015, CANCER EPIDEMIOL, V39, P29, DOI 10.1016/j.canep.2014.11.009; Yu XQ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-936; Yu XQ, 2013, J CANCER SURVIV, V7, P641, DOI 10.1007/s11764-013-0303-9	37	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171013	10.1371/journal.pone.0171013	http://dx.doi.org/10.1371/journal.pone.0171013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178275	Green Published, gold, Green Submitted			2022-12-26	WOS:000393712500019
J	Cortes-Castell, E; Palazon-Bru, A; Pla, C; Goicoechea, M; Rizo-Baeza, MM; Juste, M; Gil-Guillen, VF				Cortes-Castell, Ernesto; Palazon-Bru, Antonio; Pla, Carolina; Goicoechea, Mercedes; Mercedes Rizo-Baeza, Maria; Juste, Mercedes; Francisco Gil-Guillen, Vicente			Impact of prematurity and immigration on neonatal screening for sickle cell disease	PLOS ONE			English	Article							THALASSEMIA; POPULATION	Background Others have described a relationship between hemoglobin A levels and gestational age, gender and ethnicity. However, studies are needed to determine normal cut-off points considering these factors. To address this issue we designed a study to determine the percentiles of normality of neonatal hemoglobin A levels taking these factors into account. Methods This cross-sectional study involved 16,025 samples for sickle cell disease screening in the province of Alicante, Spain, which has a high immigration rate. The primary variable was hemoglobin A, and the secondary variables were gender, gestational age (preterm and full term) and maternal origin (Spain, the rest of Europe, North Africa, Sub-Saharan Africa, Latin America and Asia). Percentiles of normality (1 and 99) were obtained by origin, gender and gestational age using quantile regression models and bootstrap samples. The association between these percentiles of normality and altered levels (>= 1%) of hemoglobin E was analyzed. We obtained the percentiles of normality (1 and 99) for each maternal origin, gender and gestational age. Results Of a total of 88 possible E carriers, 65 had above-normal hemoglobin A levels (74%). The levels of normality for hemoglobin A varied greatly according to the maternal origin and gestational age. Conclusion With the levels of normality that we established it is possible to discard samples with unrecorded blood transfusions. Our methodology could be applied to other diseases in the neonatal screening.	[Cortes-Castell, Ernesto; Juste, Mercedes] Miguel Hernandez Univ, Dept Pharmacol Pediat & Organ Chem, Alicante, Spain; [Palazon-Bru, Antonio; Francisco Gil-Guillen, Vicente] Miguel Hernandez Univ, Dept Clin Med, Alicante, Spain; [Pla, Carolina] Hosp Gen Univ Alicante, Dept Clin Anal, Alicante, Spain; [Goicoechea, Mercedes] Generalitat Valenciana, Ctr Adv Res Publ Hlth, Valencia, Spain; [Mercedes Rizo-Baeza, Maria] Univ Alicante, Dept Nursing, Alicante, Spain	Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche; General University Hospital of Alicante; Universitat d'Alacant	Palazon-Bru, A (corresponding author), Miguel Hernandez Univ, Dept Clin Med, Alicante, Spain.	antonio.pb23@gmail.com	Cortés-Castell, Ernesto/H-8528-2019; Rizo-Baeza, Mercedes/J-3974-2017; Guillén, Vicente Francisco Gil/AAE-8201-2019	Rizo-Baeza, Mercedes/0000-0002-6754-6505; Palazon-Bru, Antonio/0000-0002-5959-9631; CORTES CASTELL, ERNESTO/0000-0002-8079-1695; Gil-Guillen, Vicente F/0000-0003-3793-9786				COLOMBO B, 1976, BRIT J HAEMATOL, V32, P79, DOI 10.1111/j.1365-2141.1976.tb01877.x; Cooleys Anemia Foundation, 2007, AB THAL; Cortes E, 2014, MANUAL MED PERINATAL, P259; Espada M, 2001, QUIMICA CLIN, V20, P81; FALLETTA JM, 1995, J PEDIATR-US, V127, P685, DOI 10.1016/S0022-3476(95)70154-0; Galanello R, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-11; GARLICK RL, 1984, BIOCHIM BIOPHYS ACTA, V799, P29, DOI 10.1016/0304-4165(84)90323-4; Gonzalez FA, 2002, HAEMATOLOGICA S1, V87, P368; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; Hernandez JA, 2002, HAEMATOLOGICA, V87, P373; Hirst C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003427.pub2; King L, 2007, J MED SCREEN, V14, P117, DOI 10.1258/096914107782066185; Lerner NB, 2009, J PEDIATR-US, V154, P121, DOI 10.1016/j.jpeds.2008.06.039; Miguel-Morales Maydelín, 2012, Rev Cubana Hematol Inmunol Hemoter, V28, P423; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Pereira MM, 2009, J CLIN PATHOL, V62, P22, DOI 10.1136/jcp.2008.058834; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Purohit Prasanta, 2014, ISRN Hematol, V2014, P745245, DOI 10.1155/2014/745245; Qiu QW, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-63; Rellan S, 2008, RECIEN NACIDO PREMAT; Sanchaisuriya K, 2005, AM J CLIN PATHOL, V123, P113, DOI 10.1309/FUF9EVGQ24V1PKTP; Villegas A, 2001, HEMOGLOBIN, V25, P273, DOI 10.1081/HEM-100105220	22	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171604	10.1371/journal.pone.0171604	http://dx.doi.org/10.1371/journal.pone.0171604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170418	gold, Green Published, Green Submitted			2022-12-26	WOS:000393705500045
J	Hussein, M; Pillai, VV; Goddard, JM; Park, HG; Kothapalli, KS; Ross, DA; Ketterings, QM; Brenna, JT; Milstein, MB; Marquis, H; Johnson, PA; Nyrop, JP; Selvaraj, V				Hussein, Mahmoud; Pillai, Viju V.; Goddard, Joshua M.; Park, Hui G.; Kothapalli, Kumar S.; Ross, Deborah A.; Ketterings, Quirine M.; Brenna, J. Thomas; Milstein, Mark B.; Marquis, Helene; Johnson, Patricia A.; Nyrop, Jan P.; Selvaraj, Vimal			Sustainable production of housefly (Musca domestica) larvae as a protein-rich feed ingredient by utilizing cattle manure	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; FATTY-ACID COMPOSITION; SOLDIER FLY LARVAE; RAINBOW-TROUT; POULTRY MANURE; FISH-MEAL; ATLANTIC SALMON; SOYBEAN-MEAL; STABLE FLY; DIPTERA	The common housefly, Musca domestica, is a considerable component of nutrient recycling in the environment. Use of housefly larvae to biodegrade manure presents an opportunity to reduce waste disposal while the rapidly assimilated insect biomass can also be used as a protein rich animal feed. In this study, we examine the biodegradation of dairy cattle manure using housefly larvae, and the nutritional value of the resulting larva meal as a feed ingredient. Our results demonstrated that dairy cattle manure presents a balanced substrate for larval growth, and the spent manure showed reductions in concentration of total nitrogen (24.9%) and phosphorus (6.2%) with an overall reduction in mass. Larva yield at an optimum density was approximately 2% of manure weight. Nutritional analysis of M. domestica larva meal showed values comparable to most high protein feed ingredients. Larva meal was 60% protein with a well-balanced amino acid profile, and 20% fat with 57% monounsaturated fatty acids, and 39% saturated fatty acids. Larva meal lacked any significant amount of omega-3 fatty acids. Evaluation of micronutrients in larva meal suggested that it is a good source of calcium and phosphorus (0.5% and 1.1% respectively). The nutritional value of larva meal closely matches that of fishmeal, making it a potentially attractive alternative for use as a protein-rich feed ingredient for livestock and aquaculture operations.	[Hussein, Mahmoud; Pillai, Viju V.; Goddard, Joshua M.; Ross, Deborah A.; Ketterings, Quirine M.; Johnson, Patricia A.; Selvaraj, Vimal] Cornell Univ, Dept Anim Sci, Coll Agr & Life Sci, Ithaca, NY 14853 USA; [Park, Hui G.; Kothapalli, Kumar S.; Brenna, J. Thomas] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Milstein, Mark B.] Cornell Univ, Johnson Grad Sch Management, Ithaca, NY 14853 USA; [Marquis, Helene] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Nyrop, Jan P.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University	Selvaraj, V (corresponding author), Cornell Univ, Dept Anim Sci, Coll Agr & Life Sci, Ithaca, NY 14853 USA.	vs88@cornell.edu	Selvaraj, Vimal/AAC-2853-2022; Pillai, Viju/L-7557-2019	Pillai, Viju/0000-0002-2696-0451; Johnson, Patricia/0000-0001-9432-8039; Brenna, James Thomas/0000-0001-9494-4245	Atkinson Center for a Sustainable Future at Cornell University; GALS Charitable Trust Undergraduate Research Grant from Cornell University	Atkinson Center for a Sustainable Future at Cornell University; GALS Charitable Trust Undergraduate Research Grant from Cornell University	This work was funded by the Atkinson Center for a Sustainable Future at Cornell University to VS, and a GALS Charitable Trust Undergraduate Research Grant from Cornell University to JMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MJ, 2004, APPL ENVIRON MICROB, V70, P7578, DOI 10.1128/AEM.70.12.7578-7580.2004; Aniebo A. O., 2008, Livestock Research for Rural Development, V20, P205; [Anonymous], [No title captured]; Bell JG, 2002, J NUTR, V132, P222, DOI 10.1093/jn/132.2.222; BERGMANN ED, 1954, NATURE, V173, P211, DOI 10.1038/173211a0; BHATTACHARYA AN, 1975, J ANIM SCI, V41, P1438, DOI 10.2527/jas1975.4151438x; Bodenheimer F. S., 1951; BONDARI K, 1981, AQUACULTURE, V24, P103, DOI 10.1016/0044-8486(81)90047-8; BONDARI K, 1987, Aquaculture and Fisheries Management, V18, P209, DOI 10.1111/j.1365-2109.1987.tb00141.x; Bovera F, 2015, BRIT POULTRY SCI, V56, P569, DOI 10.1080/00071668.2015.1080815; Broce AB, 1999, J KANSAS ENTOMOL SOC, V72, P60; BROOKES VICTOR JACK, 1958, PHYSIOL ZOOL, V31, P208; BUCHAN PB, 1981, EXP GERONTOL, V16, P223, DOI 10.1016/0531-5565(81)90017-6; Caballero MJ, 2002, AQUACULTURE, V214, P253, DOI 10.1016/S0044-8486(01)00852-3; CALVERT CC, 1970, POULTRY SCI, V49, P588, DOI 10.3382/ps.0490588; Carter CG, 2000, AQUACULTURE, V185, P299, DOI 10.1016/S0044-8486(99)00353-1; Chouinard PY, 1999, J DAIRY SCI, V82, P2737, DOI 10.3168/jds.S0022-0302(99)75530-X; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; Cickova H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032798; Cotanch K, 2007, J ANIM SCI; ELBOUSHY AR, 1991, BIORESOURCE TECHNOL, V38, P45, DOI 10.1016/0960-8524(91)90220-E; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ; Food and Agriculture Organization [FAO], 2009, GLOBAL AGR 2050; Gaylord TG, 2006, J WORLD AQUACULT SOC, V37, P509, DOI 10.1111/j.1749-7345.2006.00064.x; Gollehon N., 2000, Agricultural Outlook, P12; GOMES EF, 1995, AQUACULTURE, V130, P177, DOI 10.1016/0044-8486(94)00211-6; Graczyk TK, 1999, AM J TROP MED HYG, V61, P500, DOI 10.4269/ajtmh.1999.61.500; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hard DL., 2002, INNOVATIVE DEV PRODU; Harel M, 2002, AQUACULTURE, V213, P347, DOI 10.1016/S0044-8486(02)00047-9; Hartel H., 1968, GEFLUGELKUNDE, V32, P13; HOUSE HL, 1961, ANNU REV ENTOMOL, V6, P13, DOI 10.1146/annurev.en.06.010161.000305; Ido A, 2015, APPL ENTOMOL ZOOL, V50, P213, DOI 10.1007/s13355-015-0325-z; Iwasa M, 1999, J MED ENTOMOL, V36, P108, DOI 10.1093/jmedent/36.1.108; Kaplan JD, 2004, AM J AGR ECON, V86, P688, DOI 10.1111/j.0002-9092.2004.00611.x; Khan HAA, 2012, PARASITOL RES, V111, P1165, DOI 10.1007/s00436-012-2947-1; LAZARUS WF, 1989, J ECON ENTOMOL, V82, P1145, DOI 10.1093/jee/82.4.1145; LEVINSON ZH, 1960, NATURE, V188, P427, DOI 10.1038/188427a0; Lock E R, 2015, AQUACULTURE NUTR, DOI 10.1111-anu.12343; LUSSENHOP J, 1986, OIKOS, V47, P233, DOI 10.2307/3566050; Makkar HPS, 2014, ANIM FEED SCI TECH, V197, P1, DOI 10.1016/j.anifeedsci.2014.07.008; Mallin MA, 2003, POPUL ENVIRON, V24, P369, DOI 10.1023/A:1023690824045; MILLER BF, 1974, BRIT POULTRY SCI, V15, P231, DOI 10.1080/00071667408416100; MILLER D, 1974, POULTRY SCI, V53, P226, DOI 10.3382/ps.0530226; Moon RD, 2001, J ECON ENTOMOL, V94, P1308, DOI 10.1603/0022-0493-94.5.1308; Muller Z. O., 1980, FEED ANIMAL WASTES S; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; NEWTON GL, 1977, J ANIM SCI, V44, P395, DOI 10.2527/jas1977.443395x; Park HG, 2015, FASEB J, V29, P3911, DOI 10.1096/fj.15-271783; Park WJ, 2012, J LIPID RES, V53, P1502, DOI 10.1194/jlr.M025312; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Schou MF, 2013, FLY, V7, DOI 10.4161/fly.22758; SILVERMAN PH, 1954, BIOCHEM J, V58, P291, DOI 10.1042/bj0580291; Steinfeld H., 2006, Livestock's long shadow: environmental issues and options; [Subcommittee on Poultry Nutrition NRC NRC], 1994, SUBC POULTR NUTR, P176; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tomberlin JK, 2015, J INSECTS FOOD FEED, V1, P307, DOI 10.3920/JIFF2015.0098; Tschirner M, 2015, J INSECTS FOOD FEED, V1, P249, DOI 10.3920/JIFF2014.0008; UNICEF, SOME FOOD LOSS IS UN; USDA-ARS, 2005, FY 2006 ANN REP MAN; Van Pelt CK, 1999, ANAL CHEM, V71, P1981, DOI 10.1021/ac981387f; van Zanten HHE, 2015, J CLEAN PROD, V102, P362, DOI 10.1016/j.jclepro.2015.04.106; WIESMANN D, 1988, AQUACULTURE, V69, P263, DOI 10.1016/0044-8486(88)90334-1; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	68	52	56	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171708	10.1371/journal.pone.0171708	http://dx.doi.org/10.1371/journal.pone.0171708			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170420	Green Published, Green Submitted, gold			2022-12-26	WOS:000393705500052
J	Link, J; Ramanujam, R; Auer, M; Ryner, M; Hassler, S; Bachelet, D; Mbogning, C; Warnke, C; Buck, D; Jensen, PEH; Sievers, C; Ingenhoven, K; Fissolo, N; Lindberg, R; Grummel, V; Donnellan, N; Comabella, M; Montalban, X; Kieseier, B; Sorensen, PS; Hartung, HP; Derfuss, T; Lawton, A; Sikkema, D; Pallardy, M; Hemmer, B; Deisenhammer, F; Broet, P; Donnes, P; Davidson, J; Fogdell-Hahn, A				Link, Jenny; Ramanujam, Ryan; Auer, Michael; Ryner, Malin; Hassler, Signe; Bachelet, Delphine; Mbogning, Cyprien; Warnke, Clemens; Buck, Dorothea; Jensen, Poul Erik Hyldgaard; Sievers, Claudia; Ingenhoven, Kathleen; Fissolo, Nicolas; Lindberg, Raija; Grummel, Verena; Donnellan, Naoimh; Comabella, Manuel; Montalban, Xavier; Kieseier, Bernd; Sorensen, Per Soelberg; Hartung, Hans-Peter; Derfuss, Tobias; Lawton, Andy; Sikkema, Dan; Pallardy, Marc; Hemmer, Bernhard; Deisenhammer, Florian; Broet, Philippe; Donnes, Pierre; Davidson, Julie; Fogdell-Hahn, Anna		ABIRISK Consortium	Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results	PLOS ONE			English	Article							NEUTRALIZING ANTIBODIES; REPORTER-GENE; IFN-BETA; DISEASE PROGRESSION; MS-PATIENTS; THERAPY; MULTICENTER; PREVALENCE; VALIDATION; ADALIMUMAB	Antibodies against biopharmaceuticals (anti-drug antibodies, ADA) have been a well-integrated part of the clinical care of multiple sclerosis (MS) in several European countries. ADA data generated in Europe during the more than 10 years of ADA monitoring in MS patients treated with interferon beta (IFN beta) and natalizumab have been pooled and characterized through collaboration within a European consortium. The aim of this study was to report on the clinical practice of ADA testing in Europe, considering the number of ADA tests performed and type of ADA assays used, and to determine the frequency of ADA testing against the different drug preparations in different countries. A common database platform (tranSMART) for querying, analyzing and storing retrospective data of MS cohorts was set up to harmonize the data and compare results of ADA tests between different countries. Retrospective data from six countries (Sweden, Austria, Spain, Switzerland, Germany and Denmark) on 20,695 patients and on 42,555 samples were loaded into tranSMART including data points of age, gender, treatment, samples, and ADA results. The previously observed immunogenic difference among the four IFN beta preparations was confirmed in this large dataset. Decreased usage of the more immunogenic preparations IFN beta-1a subcutaneous (s.c.) and IFN beta-1b s.c. in favor of the least immunogenic preparation IFN beta-1a intramuscular (i.m.) was observed. The median time from treatment start to first ADA test correlated with time to first positive test. Shorter times were observed for IFN beta-1b-Extavia s. c. (0.99 and 0.94 years) and natalizumab (0.25 and 0.23 years), which were introduced on the market when ADA testing was already available, as compared to IFN beta-1a i. m. (1.41 and 2.27 years), IFN beta-1b-Betaferon s. c. (2.51 and 1.96 years) and IFN beta-1a s. c. (2.11 and 2.09 years) which were available years before routine testing began. A higher rate of anti-IFN beta ADA was observed in test samples taken from older patients. Testing for ADA varies between different European countries and is highly dependent on the policy within each country. For drugs where routine monitoring of ADA is not in place, there is a risk that some patients remain on treatment for several years despite ADA positivity. For drugs where a strategy of ADA testing is introduced with the release of the drug, there is a reduced risk of having ADA positive patients and thus of less efficient treatment. This indicates that potential savings in health cost might be achieved by routine analysis of ADA.	[Link, Jenny; Ramanujam, Ryan; Ryner, Malin; Fogdell-Hahn, Anna] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Ramanujam, Ryan] KTH Royal Inst Technol, Stockholm, Sweden; [Auer, Michael; Deisenhammer, Florian] Med Univ Innsbruck, Innsbruck, Austria; [Hassler, Signe; Bachelet, Delphine; Mbogning, Cyprien; Broet, Philippe] Univ Paris Saclay, Univ Paris Sud, CESP, UVSQ,INSERM, Villejuif, France; [Warnke, Clemens; Ingenhoven, Kathleen; Kieseier, Bernd; Hartung, Hans-Peter] Univ Dusseldorf, Fac Med, Dept Neurol, Dusseldorf, Germany; [Buck, Dorothea; Grummel, Verena; Hemmer, Bernhard] Tech Univ Munich, Dept Neurol, Munich, Germany; [Jensen, Poul Erik Hyldgaard; Sorensen, Per Soelberg] Univ Copenhagen, Rigshosp, Danish Multiple Sclerosis Ctr, Copenhagen, Denmark; [Sievers, Claudia; Lindberg, Raija; Derfuss, Tobias] Univ Basel Hosp, Basel, Switzerland; [Fissolo, Nicolas; Comabella, Manuel; Montalban, Xavier] Hosp Univ Vall dHebron, Ctr Esclerosi Multiple Catalunya Cemcat, Barcelona, Spain; [Donnellan, Naoimh] Ipsen Biopharm Ltd, Slough, Berks, England; [Lawton, Andy; Sikkema, Dan; Davidson, Julie] GlaxoSmithKline R&D, Uxbridge, Middx, England; [Pallardy, Marc] Univ Paris Saclay, Univ Paris Sud, INSERM, Fac Pharm,UMR 996, Chatenay Malabry, France; [Broet, Philippe] Hop Paul Brousse, AP HP, Villejuif, France; [Donnes, Pierre] SciCross AB, Skovde, Sweden	Karolinska Institutet; Royal Institute of Technology; Medical University of Innsbruck; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Heinrich Heine University Dusseldorf; Technical University of Munich; Rigshospitalet; University of Copenhagen; University of Basel; Hospital Universitari Vall d'Hebron; Ipsen; GlaxoSmithKline; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Fogdell-Hahn, A (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	pierre@scicross.com; Anna.Fogdell-Hahn@ki.se	Mbogning, Cyprien/AAI-1788-2020; Montalban, Xavier/J-5938-2016; Ramanujam, Ryan/ABE-2426-2020; Hemmer, Bernhard/AAT-8388-2021; Fissolo, Nicolas/J-3067-2012; Bachelet, Delphine/AAD-8385-2022; Hemmer, Bernhard/GPX-8451-2022	Mbogning, Cyprien/0000-0002-6619-3883; Montalban, Xavier/0000-0002-0098-9918; Fissolo, Nicolas/0000-0002-7701-9346; Hemmer, Bernhard/0000-0001-5985-6784; Fogdell-Hahn, Anna/0000-0002-0311-9184; Derfuss, Tobias/0000-0001-8656-4250; Comabella Lopez, Manuel/0000-0002-2373-6657; Ramanujam, Ryan/0000-0001-7360-1497; Donnes, Pierre/0000-0002-4613-2952; /0000-0003-2185-151X; Link, Jenny/0000-0002-6134-9404; BROET, PHILIPPE/0000-0001-9122-2810	Innovative Medicines Initiative Joint Undertaking ABIRISK project [115303]; European Union's Seventh Framework Programme; EFPIA companies; research grants from NEURO Sweden; Stockholm County Council (ALF project); eTRIKS consortium	Innovative Medicines Initiative Joint Undertaking ABIRISK project; European Union's Seventh Framework Programme; EFPIA companies; research grants from NEURO Sweden; Stockholm County Council (ALF project)(Stockholm County Council); eTRIKS consortium	The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking ABIRISK project under grant agreement no. 115303, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies. This study was also supported by research grants from NEURO Sweden (www.neuroforbundet.se) and grants provided by the Stockholm County Council (ALF project). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professor Jan Hillert for support and for building the infrastructure that has enabled the collection of data of patients and samples from Sweden. We thank the eTRIKS consortium (www.etriks.org) for their support in the construction of the TranSMART database.	Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Bendtzen K, 2006, ARTHRITIS RHEUM-US, V54, P3782, DOI 10.1002/art.22214; Calabresi PA, 2007, NEUROLOGY, V69, P1391, DOI 10.1212/01.wnl.0000277457.17420.b5; Castrop F, 2013, NEUROPSYCH DIS TREAT, V9, P1339, DOI 10.2147/NDT.S33949; Deisenhammer F, 2009, CNS DRUGS, V23, P379, DOI 10.2165/00023210-200923050-00003; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Durelli L, 2002, LANCET, V359, P1453, DOI 10.1016/S0140-6736(02)08430-1; Farrell R, 2008, MULT SCLER, V14, P212, DOI 10.1177/1352458507082066; Francis G, 2001, NEUROLOGY, V56, P1628; Gneiss C, 2004, MULT SCLER J, V10, P507, DOI 10.1191/1352458504ms1074oa; Hegen H, 2014, MULT SCLER J, V20, P577, DOI 10.1177/1352458513503597; Hermanrud C, 2016, J IMMUNOL METHODS, V430, P1, DOI 10.1016/j.jim.2016.01.004; Hermanrud C, 2014, J INTERF CYTOK RES, V34, P498, DOI 10.1089/jir.2013.0097; Hesse D, 2007, EUR J NEUROL, V14, P850, DOI 10.1111/j.1468-1331.2007.01769.x; Hesse D, 2009, NEUROLOGY, V73, P372, DOI 10.1212/WNL.0b013e3181b04c98; Hoffmann S, 2008, AM J HUM GENET, V83, P219, DOI 10.1016/j.ajhg.2008.07.006; Hoxha A, 2016, JOINT BONE SPINE, V83, P167, DOI 10.1016/j.jbspin.2015.04.020; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jensen PEH, 2012, MULT SCLER J, V18, P1493, DOI 10.1177/1352458512441688; Jungedal R, 2012, MULT SCLER J, V18, P1775, DOI 10.1177/1352458512446036; Kappos L, 2004, MULT SCLER J, V10, pS46, DOI 10.1191/1352458504ms1030oa; KAWADE Y, 1986, METHOD ENZYMOL, V119, P558; Koch-Henriksen N, 2006, NEUROLOGY, V66, P1056, DOI 10.1212/01.wnl.0000204018.52311.ec; Lallemand C, 2008, J INTERF CYTOK RES, V28, P393, DOI 10.1089/jir.2007.0142; Lam R, 2008, J IMMUNOL METHODS, V336, P113, DOI 10.1016/j.jim.2008.03.014; Link J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090479; Lundkvist M, 2013, MULT SCLER J, V19, P757, DOI 10.1177/1352458512462920; Massart C, 2007, CLIN CHIM ACTA, V377, P185, DOI 10.1016/j.cca.2006.09.021; Newton Ashley N, 2011, Int J MS Care, V13, P128, DOI 10.7224/1537-2073-13.3.128; Pachner AR, 2003, NEUROLOGY, V61, P1444, DOI 10.1212/01.WNL.0000094198.37489.11; Panitch H, 2005, J NEUROL SCI, V239, P67, DOI 10.1016/j.jns.2005.08.003; Polman CH, 2010, LANCET NEUROL, V9, P740, DOI 10.1016/S1474-4422(10)70103-4; R Core Team, 2013, R LANG ENV STAT COMP; R Development Core Team, 2014, R LANG ENV STAT COMP, P409; Sominanda A, 2007, MULT SCLER, V13, P208, DOI 10.1177/1352458506070762; Sominanda A, 2008, J NEUROL NEUROSURG P; Sorensen PS, 2011, MULT SCLER J, V17, P1074, DOI 10.1177/1352458511404271; Sorensen PS, 2011, NEUROLOGY, V76, P759, DOI 10.1212/WNL.0b013e31820d62a4; Sorensen PS, 2005, EUR J NEUROL, V12, P817, DOI 10.1111/j.1468-1331.2005.01386.x; Sorensen PS, 2005, NEUROLOGY, V65, P33, DOI 10.1212/01.WNL.0000166049.51502.6A; Szalma S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-68; Walter E, 2014, MULT SCLER RELAT DIS, V3, P670, DOI 10.1016/j.msard.2014.09.003	42	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170395	10.1371/journal.pone.0170395	http://dx.doi.org/10.1371/journal.pone.0170395			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170401	Green Published, gold, Green Submitted			2022-12-26	WOS:000393705500005
J	Duncan, MC; Herrera, NG; Johnson, KS; Engel, JN; Auerbuch, V				Duncan, Miles C.; Herrera, Natalia G.; Johnson, Kevin S.; Engel, Joanne N.; Auerbuch, Victoria			Bacterial internalization is required to trigger NIK-dependent NF-kappa B activation in response to the bacterial type three secretion system	PLOS ONE			English	Article							YERSINIA-PSEUDOTUBERCULOSIS; INFLAMMASOME; PATHWAY; TUMORIGENESIS; RECOGNITION; EXPRESSION; MATURATION; RELEASE; KINASES; PROTEIN	Infection of human cells with Yersinia pseudotuberculosis expressing a functional type III secretion system (T3SS) leads to activation of host NF-kappa B. We show that the Yersinia T3SS activates distinct NF-kappa B pathways dependent upon bacterial subcellular localization. We found that wildtype Yersinia able to remain extracellular triggered NF-kappa B activation independently of the non-canonical NF-kappa B. kinase NIK in HEK293T cells. In contrast, Yersinia lacking the actin-targeting effectors YopEHO, which become internalized into host cells, induce a NIK-dependent response and nuclear entry of the non-canonical NF-kappa B subunit p52. Blocking actin polymerization and uptake of effector mutant bacteria using cytochalasin D shifted the host NF-kappa B response from NIK-independent to primarily NIK-dependent. We observed similar results using Pseudomonas aeruginosa, which expresses a related T3SS and the actin-targeting effector ExoT. As the NF-kappa B response of HEK293T cells to effectorless Yersinia has been used both as a screening tool for chemical inhibitors of the T3SS and for bacterial forward genetic screens, a better understanding of this response is important for tool optimization and interpretation.	[Duncan, Miles C.; Herrera, Natalia G.; Johnson, Kevin S.; Auerbuch, Victoria] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Engel, Joanne N.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Engel, Joanne N.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Duncan, Miles C.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Herrera, Natalia G.] Albert Einstein Coll Med, Program Biomed Sci, Bronx, NY USA	University of California System; University of California Santa Cruz; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Tufts University; Yeshiva University; Albert Einstein College of Medicine	Auerbuch, V (corresponding author), Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA.	vastone@ucsc.edu		Johnson, Kevin/0000-0002-1875-7007; Auerbuch, Victoria/0000-0002-9475-4756; Herrera, Natalia/0000-0003-1409-3554	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health [R01A1106930]; Faculty Research Grant from the UC Santa Cruz Committee on Research; University of California Cancer Research Coordinating Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM007910, R25GM058903] Funding Source: NIH RePORTER	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Faculty Research Grant from the UC Santa Cruz Committee on Research; University of California Cancer Research Coordinating Committee(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number R01A1106930, a Faculty Research Grant from the UC Santa Cruz Committee on Research, and a grant from the University of California Cancer Research Coordinating Committee (to VA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Hanh Lam for critical review of the manuscript. We thank Benjamin Abrams in the UCSC Life Sciences Microscopy Center for technical support, Ralph Isberg for the anti-Yersinia antibody, and Molly Bergman for the Delta yop6+YopJ strain. Research reported in this publication was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number R01AI106930, a Faculty Research Grant from the UC Santa Cruz Committee on Research, and a grant from the University of California Cancer Research Coordinating Committee (to VA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbuch V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000686; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Bliska JB, 2006, ACS CHEM BIOL, V1, P349, DOI 10.1021/cb600261k; Burstein D, 2015, MBIO, V6, DOI 10.1128/mBio.00161-15; Chung LK, 2016, CELL HOST MICROBE, V20, P296, DOI 10.1016/j.chom.2016.07.018; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Duncan MC, 2014, ANTIMICROB AGENTS CH, V58, P1118, DOI 10.1128/AAC.02025-13; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Mejia E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040003; Miller HK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004194; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Saitoh Y, 2008, BLOOD, V111, P5118, DOI 10.1182/blood-2007-09-110635; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Sheahan KL, 2015, MBIO, V6, DOI 10.1128/mBio.02023-14; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Shin H, 2007, CELL MICROBIOL, V9, P2893, DOI 10.1111/j.1462-5822.2007.01004.x; Solomon R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120471; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Thu YM, 2012, ONCOGENE, V31, P2580, DOI 10.1038/onc.2011.427; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Viboud GI, 2003, MOL MICROBIOL, V47, P1305, DOI 10.1046/j.1365-2958.2003.03350.x; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Zhao Y, 2015, IMMUNOL REV, V265, P85, DOI 10.1111/imr.12293; Zwack EE, 2015, MBIO, V6, DOI 10.1128/mBio.02095-14	30	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171406	10.1371/journal.pone.0171406	http://dx.doi.org/10.1371/journal.pone.0171406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166267	Green Published, gold			2022-12-26	WOS:000393700100038
J	Tai, CS; Lin, YR; Teng, TH; Lin, PY; Tu, SJ; Chou, CH; Huang, YR; Huang, WC; Weng, SL; Huang, HD; Chen, YL; Chen, WL				Tai, Chun-San; Lin, Yan-Ren; Teng, Tsung-Han; Lin, Ping-Yi; Tu, Siang-Jyun; Chou, Chih-Hung; Huang, Ya-Rong; Huang, Wei-Chih; Weng, Shun-Long; Huang, Hsien-Da; Chen, Yao-Li; Chen, Wen Liang			Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinoma	PLOS ONE			English	Article							CANCER STEM-CELLS; SERUM HAPTOGLOBIN; FUCOSYLATED HAPTOGLOBIN; PANCREATIC-CANCER; BIOMARKER; PROTEIN; MARKER	Elevated serum haptoglobin (Hp) is identified as a prognostic marker in multiple types of solid tumors, which is correlated with poor prognosis. HCC is one of the major causes of cancer deaths in worldwide, which remains poor prognosis and is clinically urgent for discovering early diagnostic markers. However, except for serum Hp, the correlation of tumor Hp expression with hepatocellular carcinoma (HCC) progression is still unclear. In this study, we evaluated and identified the tissue Hp expression as a prognostic marker to predict the survival rate of HCC patients. To evaluate the prognostic value of Hp expression for HCC, two cohorts were enrolled in our study, including total 130 matched pair tissue sections (both adjacent non-tumorous and tumor tissue derived from same patient) of HCC patients from Changhua Christian Hospital (CCH) and total 316 RNA-seq data with clinical information of HCC patients from The Cancer Genome Atlas (TCGA) database. In contrast to other types of cancers, HCC tumor tissues have lower Hp protein expression in CCH cohort and have lower Hp mRNA expression in TCGA cohort as compared with adjacent non-tumorous tissues (p < 0.001). Moreover, lower Hp expression is significantly correlated with different stages of HCC cancer differentiation in CCH cohort (one-way ANOVA, p < 0.001). Most importantly, lower Hp expression is highly correlated with poor five-year overall survival rate in TCGA cohort (p < 0.01). Based on our data, we conclude that tissue Hp expression positively correlates with better HCC tumor differentiation and increased five-year overall survival rate of HCC patients. The results indicated that tissue Hp is potentially a prognostic marker for HCC patients. Our findings may further provide a new insight of effective treatments along with biopsy diagnosis of HCC patients.	[Tai, Chun-San; Huang, Hsien-Da; Chen, Wen Liang] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Tai, Chun-San; Teng, Tsung-Han] Natl Chiao Tung Univ, Inst Mol Med & Bioengn, Hsinchu, Taiwan; [Tai, Chun-San] Natl Chiao Tung Univ, Program Interdisciplinary Neurosci, Hsinchu, Taiwan; [Lin, Yan-Ren] Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan; [Lin, Yan-Ren; Chen, Yao-Li] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Lin, Yan-Ren] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lin, Ping-Yi] Changhua Christian Hosp, Transplant Med & Surg Res Ctr, Changhua, Taiwan; [Lin, Ping-Yi] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Tu, Siang-Jyun; Chou, Chih-Hung; Huang, Ya-Rong; Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Weng, Shun-Long] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Weng, Shun-Long] Hsinchu MacKay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Weng, Shun-Long] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Chen, Yao-Li] Changhua Christian Hosp, Dept Gen Surg, Changhua, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Kaohsiung Medical University; Chung Shan Medical University; Changhua Christian Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; Mackay Medical College; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Changhua Christian Hospital	Huang, HD; Chen, WL (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.; Chen, YL (corresponding author), Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan.; Huang, HD (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.; Chen, YL (corresponding author), Changhua Christian Hosp, Dept Gen Surg, Changhua, Taiwan.	bryan@mail.nctu.edu.tw; ylchen.cch@gmail.com; wenurea@yahoo.com.tw	Huang, Hsien-Da/AAA-7376-2019; Chou, Chih-Hung/K-9077-2015; Lin, Yan-Ren/AAU-4136-2020	Chou, Chih-Hung/0000-0001-5714-1718; Lin, Yan-Ren/0000-0002-9015-2678	National Chiao Tung University; Changhua Christian Hospital; National Science Council [MOST 104-2314-B-371-010]; Hsinchu Mackay Memorial Hospital [MMH-HB-10506]	National Chiao Tung University; Changhua Christian Hospital; National Science Council(Ministry of Science and Technology, Taiwan); Hsinchu Mackay Memorial Hospital	This study was supported by National Chiao Tung University, Changhua Christian Hospital, National Science Council (MOST 104-2314-B-371-010) Hsinchu Mackay Memorial Hospital (MMH-HB-10506). Both fundings sponsored this study in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aoki R, 2010, J HEPATOL, V52, P854, DOI 10.1016/j.jhep.2010.01.027; Bicho MC, 2013, ACUTE PHASE PROTEINS; Brunt Elizabeth M, 2012, Clin Liver Dis (Hoboken), V1, P194, DOI 10.1002/cld.98; Carlsson MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026560; Chiba T, 2016, HEPATOL RES, V46, P50, DOI 10.1111/hepr.12548; Dobryszycka W, 1997, EUR J CLIN CHEM CLIN, V35, P647; Dong PP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030320; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Galicia G, 2011, HAPTOGLOBIN FUNCTION; Garibay-Cerdenares OL, 2015, CELL ADHES MIGR, V9, P394, DOI 10.1080/19336918.2015.1035504; Giannelli G, 2016, J HEPATOL; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Haas M, 2015, TUMOR BIOL, V36, P2631, DOI 10.1007/s13277-014-2885-x; Han K, 2016, WORLD J GASTROENTERO, V22, P407, DOI 10.3748/wjg.v22.i1.407; Ho DWY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037159; Hoagland LFM, 2007, CANCER-AM CANCER SOC, V110, P2260, DOI 10.1002/cncr.23049; Lee CC, 2013, CLIN CHEM LAB MED, V51, P429, DOI 10.1515/cclm-2012-0197; Lu J, 2016, ONCOTARGET; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Oikawa T, 2013, HEPATOLOGY, V57, P1469, DOI 10.1002/hep.26159; Okuyama N, 2006, INT J CANCER, V118, P2803, DOI 10.1002/ijc.21728; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Schlageter M, 2014, WORLD J GASTROENTERO, V20, P15955, DOI 10.3748/wjg.v20.i43.15955; Shu H, 2010, ONCOL REP, V24, P1271, DOI 10.3892/or_00000982; Sun LC, 2016, INT J CANCER, V138, P2724, DOI 10.1002/ijc.29993; Tabassum U, 2012, ASIAN PAC J CANCER P, V13, P4541, DOI 10.7314/APJCP.2012.13.9.4541; Takeda Y, 2012, CANCER-AM CANCER SOC, V118, P3036, DOI 10.1002/cncr.26490; Team RC, 2015, R LANG ENV STAT COMP; Wang RH, 2016, ONCOTARGET, V7, P5754, DOI 10.18632/oncotarget.6805; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024; Yu GR, 2007, EXP MOL MED, V39, P641, DOI 10.1038/emm.2007.70; Zhao CQ, 2007, NEOPLASIA, V9, P1, DOI 10.1593/neo.06619	33	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171269	10.1371/journal.pone.0171269	http://dx.doi.org/10.1371/journal.pone.0171269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158312	Green Submitted, Green Published, gold			2022-12-26	WOS:000396161700049
J	Zuo, LH; Shang, AQ; Zhang, S; Yu, XY; Ren, YC; Yang, MS; Wang, JM				Zuo, Li-Hui; Shang, Ai-Qin; Zhang, Shuang; Yu, Xiao-Yue; Ren, Ya-Chao; Yang, Min-Sheng; Wang, Jin-Mao			The first complete chloroplast genome sequences of Ulmus species by de novo sequencing: Genome comparative and taxonomic position analysis	PLOS ONE			English	Article							DNA; PLANT; MITOCHONDRIAL; GENES; RATES	L Elm (Ulmus) has a long history of use as a high-quality heavy hardwood famous for its resistance to drought, cold, and salt. It grows in temperate, warm temperate, and subtropical regions. This is the first report of Ulmaceae chloroplast genomes by de novo sequencing. The Ulmus chloroplast genomes exhibited a typical quadripartite structure with two single-copy regions (long single copy [LSC] and short single copy [SSC] sections) separated by a pair of inverted repeats (IRs). The lengths of the chloroplast genomes from five Ulmus ranged from 158,953 to 159,453 bp, with the largest observed in Ulmus davidiana and the smallest in Ulmus laciniata. The genomes contained 137-145 protein-coding genes, of which Ulmus davidiana var. japonica and U. davidiana had the most and U. pumila had the fewest. The five Ulmus species exhibited different evolutionary routes, as some genes had been lost. In total, 18 genes contained introns, 13 of which (trnL-TAA(+), trnL-TAA(-), rpoC1(-), rpl2(-), ndhA(-), ycf1, rps12(-), rps12(+), trnA-TGC(+), trnA-TGC(-), trnV-TAC(-), trnl-GAT(+), and trnlGAT) were shared among all five species. The intron of ycf1 was the longest (5,675bp) while that of trnF-AAA was the smallest (53bp). All Ulmus species except U. davidiana exhibited the same degree of amplification in the IR region. To determine the phylogenetic positions of the Ulmus species, we performed phylogenetic analyses using common protein-coding genes in chloroplast sequences of 42 other species published in NCBI. The cluster results showed the closest plants to Ulmaceae were Moraceae and Cannabaceae, followed by Rosaceae. Ulmaceae and Moraceae both belonged to Urticales, and the chloroplast genome clustering results were consistent with their traditional taxonomy. The results strongly supported the position of Ulmaceae as a member of the order Urticales. In addition, we found a potential error in the traditional taxonomies of U. davidiana and U. davidiana var. japonica, which should be confirmed with a further analysis of their nuclear genomes. This study is the first report on Ulmus chloroplast genomes, which has significance for understanding photosynthesis, evolution, and chloroplast transgenic engineering.	[Zuo, Li-Hui; Zhang, Shuang; Yu, Xiao-Yue; Ren, Ya-Chao; Yang, Min-Sheng; Wang, Jin-Mao] Agr Univ Hebei, Inst Forest Biotechnol, Coll Forestry, Baoding, Peoples R China; [Zuo, Li-Hui; Zhang, Shuang; Yu, Xiao-Yue; Ren, Ya-Chao; Yang, Min-Sheng; Wang, Jin-Mao] Hebei Key Lab Tree Genet Resources & Forest Prote, Baoding, Peoples R China; [Shang, Ai-Qin] Agr Univ Hebei, Hort Coll, Baoding, Peoples R China	Hebei Agricultural University; Hebei Agricultural University	Yang, MS; Wang, JM (corresponding author), Agr Univ Hebei, Inst Forest Biotechnol, Coll Forestry, Baoding, Peoples R China.; Yang, MS; Wang, JM (corresponding author), Hebei Key Lab Tree Genet Resources & Forest Prote, Baoding, Peoples R China.	yangms100@126.com; swjs224@aliyun.com		Zuo, lihui/0000-0002-3633-2088				BEDBROOK JR, 1976, P NATL ACAD SCI USA, V73, P4309, DOI 10.1073/pnas.73.12.4309; Bremer B, 2002, MOL PHYLOGENET EVOL, V24, P274, DOI 10.1016/S1055-7903(02)00240-3; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; Conde P, 2008, PLANT CELL TISS ORG, V92, P113, DOI 10.1007/s11240-007-9310-8; Dias MC, 2013, ACTA PHYSIOL PLANT, V35, P1281, DOI 10.1007/s11738-012-1167-8; Goremykin VV, 2012, PLANT J, V71, P615, DOI 10.1111/j.1365-313X.2012.05014.x; HALLICK RB, 1993, NUCLEIC ACIDS RES, V21, P3537, DOI 10.1093/nar/21.15.3537; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Liu C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-715; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Magee Alan M, 2010, Genome Res, V20, P1700, DOI 10.1101/gr.111955.110; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Ni LH, 2016, GENE, V577, P281, DOI 10.1016/j.gene.2015.12.005; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Reith M, 1995, PLANT MOL BIOL REP, V13, P333, DOI 10.1007/BF02669187; Revanna KV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-316; RIS H, 1962, J CELL BIOL, V13, P383, DOI 10.1083/jcb.13.3.383; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031468; Stegemann S, 2006, PLANT CELL, V18, P2869, DOI 10.1105/tpc.106.046466; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Tian Xin, 2002, Acta Botanica Yunnanica, V24, P170; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00280; Wiegrefe SJ, 1998, PLANT SYST EVOL, V210, P249, DOI 10.1007/BF00985671; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; WOLFE KH, 1992, J MOL EVOL, V35, P304, DOI 10.1007/BF00161168; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Zhang XW, 2010, PLOS ONE, V5; [赵静静 Zhao Jingjing], 2010, [食品与生物技术学报, Journal of Food Science and Biotechnology], V29, P755	35	53	55	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							E0171264	10.1371/journal.pone.0171264	http://dx.doi.org/10.1371/journal.pone.0171264			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158318	gold, Green Published, Green Submitted			2022-12-26	WOS:000396161700048
J	Lau, HY; Tang, J; Casey, PJ; Wang, M				Lau, H. Y.; Tang, J.; Casey, P. J.; Wang, M.			Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms	ONCOGENE			English	Article							SMALL-MOLECULE INHIBITOR; CARBOXYL METHYLTRANSFERASE; CANCER-CELLS; PROTEIN PRENYLATION; EPITHELIAL-CELLS; K-RAS; DISEASE; ONCOGENESIS; APOPTOSIS; GROWTH	Despite extensive effort, there has been limited progress in the development of direct RAS inhibitors. Targeting isoprenylcysteine carboxylmethyltransferase (ICMT), a unique enzyme of RAS post-translational modification, represents a promising strategy to inhibit RAS function. However, there lacks direct genetic evidence on the role of ICMT in RAS-driven human cancer initiation and maintenance. Using CRISPR/Cas9 genome editing, we have created Icmt loss-of-function isogenic cell lines for both RAS-transformed human mammary epithelial cells (HME1) and human cancer cell lines MiaPaca-2 and MDA-MB-231 containing naturally occurring mutant KRAS. In both in vitro and in vivo tumorigenesis studies, Icmt loss-of-function abolishes the tumor initiation ability of all major isoforms of mutant RAS in HME1 cells, and the tumor maintenance capacity of MiaPaca-2 and MDA-MB-231 cells, establishing the critical role of ICMT in RAS-driven cancers.	[Lau, H. Y.; Tang, J.; Casey, P. J.; Wang, M.] Duke NUS Med Sch, Canc & Stem Cell Biol Program, 8 Coll Rd, Singapore 169857, Singapore; [Wang, M.] Natl Univ Singapore, Dept Biochem, Singapore, Singapore	National University of Singapore; National University of Singapore	Wang, M (corresponding author), Duke NUS Med Sch, Canc & Stem Cell Biol Program, 8 Coll Rd, Singapore 169857, Singapore.	mei.wang@duke-nus.edu.sg		Wang, Mei/0000-0001-6887-6840; Casey, Patrick/0000-0002-7366-9309	National Medical Research Council of Singapore	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	We would like to thank Dr Shang Li and Muhammad Khairul Ramlee for their invaluable technical assistance and advice, as well as Dr Mathijs Voorhoeve and Dr Shi Yun Yeo for the gift of retroviral expression vectors. This work was supported by the National Medical Research Council of Singapore.	Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Court H, 2013, J CLIN INVEST, V123, P4681, DOI 10.1172/JCI65764; Cox AD, 2015, CLIN CANCER RES, V21, P1819, DOI 10.1158/1078-0432.CCR-14-3214; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; Dimri G, 2005, BREAST CANCER RES, V7, P171, DOI 10.1186/bcr1275; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Ibrahim MX, 2013, SCIENCE, V340, P1330, DOI 10.1126/science.1238880; Lampson BL, 2013, CURR BIOL, V23, P70, DOI 10.1016/j.cub.2012.11.031; Lau HY, 2014, CANCER BIOL THER, V15, P1280, DOI 10.4161/cbt.29692; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; Ramlee MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15587; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sun WT, 2016, EXP HEMATOL, V44, P189, DOI 10.1016/j.exphem.2015.12.002; Teh JT, 2015, ONCOGENE, V34, P3296, DOI 10.1038/onc.2014.260; Tsai FD, 2015, P NATL ACAD SCI USA, V112, P779, DOI 10.1073/pnas.1412811112; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Wahlstrom AM, 2008, BLOOD, V112, P1357, DOI 10.1182/blood-2007-06-094060; Wang LX, 2011, P NATL ACAD SCI USA, V108, pE803, DOI 10.1073/pnas.1103423108; Wang M, 2010, ONCOGENE, V29, P4959, DOI 10.1038/onc.2010.247; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Winter-Vann AM, 2005, P NATL ACAD SCI USA, V102, P4336, DOI 10.1073/pnas.0408107102; Wright LP, 2009, MOL CELL BIOL, V29, P1826, DOI 10.1128/MCB.01719-08	32	29	32	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 6	2017	36	27					3934	3942		10.1038/onc.2016.508	http://dx.doi.org/10.1038/onc.2016.508			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EZ6SM	28192404	hybrid, Green Published			2022-12-26	WOS:000404848200013
J	Lau, TS; Chan, LKY; Wong, ECH; Hui, CWC; Sneddon, K; Cheung, H; Yim, SF; Lee, JHS; Yeung, CSY; Chung, TKH; Kwong, J				Lau, T-S; Chan, L. K-Y; Wong, E. C-H; Hui, C. W-C; Sneddon, K.; Cheung, T-H; Yim, S-F; Lee, J. H-S; Yeung, C. S-Y; Chung, T. K-H; Kwong, J.			A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNF alpha-TGF alpha-EGFR	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; TUMOR-NECROSIS-FACTOR; THERAPEUTIC TARGET; MESOTHELIAL CELLS; DNA METHYLATION; EXPRESSION; MODEL; FIBROBLASTS; CARBOPLATIN; CARCINOMA	Peritoneum is the most common site for ovarian cancer metastasis. Here we investigate how cancer epigenetics regulates reciprocal tumor-stromal interactions in peritoneal metastasis of ovarian cancer. Firstly, we find that omental stromal fibroblasts enhance colony formation of metastatic ovarian cancer cells, and de novo expression of transforming growth factor-alpha (TGF-alpha) is induced in stromal fibroblasts co-cultured with ovarian cancer cells. We also observed an over-expression of tumor necrosis factoralpha (TNF-alpha) in ovarian cancer cells, which is regulated by promoter DNA hypomethylation as well as chromatin remodeling. Interestingly, this ovarian cancer-derived TNF-alpha induces TGF-alpha transcription in stromal fibroblasts through nuclear factor-kappa B (NF-kappa B). We further show that TGF-alpha secreted by stromal fibroblasts in turn promotes peritoneal metastasis of ovarian cancer through epidermal growth factor receptor (EGFR) signaling. Finally, we identify a TNF alpha-TGF alpha-EGFR interacting loop between tumor and stromal compartments of human omental metastases. Our results therefore demonstrate cancer epigenetics induces a loop of cancer-stroma-cancer interaction in omental microenvironment that promotes peritoneal metastasis of ovarian cancer cells via TNF alpha-TGF alpha-EGFR.	[Lau, T-S; Chan, L. K-Y; Sneddon, K.; Cheung, T-H; Yim, S-F; Lee, J. H-S; Yeung, C. S-Y; Chung, T. K-H; Kwong, J.] Chinese Univ Hong Kong, Fac Med, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Wong, E. C-H; Hui, C. W-C] Chinese Univ Hong Kong, Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Kwong, J (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Block E,1-F, Shatin, Hong Kong, Peoples R China.	josephkwong@cuhk.edu.hk	Kwong, Joseph/H-2368-2013; Wong, Chi Hang/C-6909-2015; Wong, Chi Hang/ABE-8673-2021; Lau, Tat San/R-6722-2019	Kwong, Joseph/0000-0002-3380-6882; Wong, Chi Hang/0000-0003-4157-6287; Wong, Chi Hang/0000-0003-4157-6287; Lee, Ho Sze Jacqueline/0000-0002-3175-1144; CHUNG, Tony/0000-0002-6362-8546; Lau, Tat San/0000-0003-2315-9690	CUHK Research Committee Funding; Hong Kong Obstetrical and Gynaceological Trust Fund; Charlie Lee Charitable Foundation	CUHK Research Committee Funding; Hong Kong Obstetrical and Gynaceological Trust Fund; Charlie Lee Charitable Foundation	This research was supported by CUHK Research Committee Funding (Direct Grants for Research), Hong Kong Obstetrical and Gynaceological Trust Fund, and The Charlie Lee Charitable Foundation. The authors give special thanks to Alex Shu-Wing NG (Brigham and Women's Hospital, Harvard Medical School) and Ronny Drapkin (The Penn Ovarian Cancer Center, University of Pennsylvanian) for the FTSEC190 and FTSEC194 cell lines. The authors give thanks to Dr Gene Chi-Wai MAN, Mr Jianzhang WANG, Mr Long CUI, and Mr John Chun-Kit LI for technical supports; to Ms. Flora Pui-Ling TAM for processing clinical samples; and to Dr Amy Kit-Ying CHUNG for revising the manuscript.	Alt E, 2011, BIOL CELL, V103, P197, DOI 10.1042/BC20100117; Andersen P, 2008, INT J CANCER, V122, P342, DOI 10.1002/ijc.23109; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BAUKNECHT T, 1991, ANTICANCER RES, V11, P1523; Blank SV, 2010, GYNECOL ONCOL, V119, P451, DOI 10.1016/j.ygyno.2010.08.008; Brustmann H, 2008, INT J GYNECOL PATHOL, V27, P380, DOI 10.1097/PGP.0b013e31815d060d; Burotto M, 2014, CANCER-AM CANCER SOC, V120, P3446, DOI 10.1002/cncr.28864; BUY JN, 1988, RADIOLOGY, V169, P691, DOI 10.1148/radiology.169.3.3186993; Cai J, 2012, CARCINOGENESIS, V33, P20, DOI 10.1093/carcin/bgr230; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Coscia F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12645; D'Antonio A, 2002, INT J ONCOL, V21, P941; GARDNER MJ, 1995, CANCER LETT, V91, P229, DOI 10.1016/0304-3835(95)03743-G; Glaysher S, 2013, BRIT J CANCER, V109, P1786, DOI 10.1038/bjc.2013.529; Gui T, 2012, CANCER EPIDEMIOL, V36, P490, DOI 10.1016/j.canep.2012.06.005; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; He C, 2015, ONCOGENE, V34, P6040, DOI 10.1038/onc.2015.52; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karki P, 2017, MOL NEUROBIOL, V54, P964, DOI 10.1007/s12035-016-9705-9; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Kenny HA, 2014, J CLIN INVEST, V124, P4614, DOI 10.1172/JCI74778; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; KOHLER M, 1992, EUR J CANCER, V28A, P1432, DOI 10.1016/0959-8049(92)90538-D; Kwong J, 2009, NEOPLASIA, V11, P529, DOI 10.1593/neo.09112; LANGDON SP, 1988, CANCER RES, V48, P6166; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lassus H, 2006, J MOL MED-JMM, V84, P671, DOI 10.1007/s00109-006-0054-4; Lau TS, 2014, J PATHOL, V232, P43, DOI 10.1002/path.4258; Li HX, 2014, ARCH GYNECOL OBSTET, V290, P1067, DOI 10.1007/s00404-014-3377-3; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Milagrel CS, 2015, CANCER RES, V75, P1255, DOI 10.1158/0008-5472.CAN-14-1801; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; NAYLOR MS, 1993, J CLIN INVEST, V91, P2194, DOI 10.1172/JCI116446; Niikura H, 1997, INT J GYNECOL PATHOL, V16, P60, DOI 10.1097/00004347-199701000-00010; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Ohta T, 2012, CANCER BIOL THER, V13, P408, DOI 10.4161/cbt.19292; Psyrri A, 2005, CLIN CANCER RES, V11, P8637, DOI 10.1158/1078-0432.CCR-05-1436; Qiu X, 2015, BIOCHEM BIOPH RES CO, V461, P128, DOI 10.1016/j.bbrc.2015.03.180; QWARNSTROM EE, 1994, J BIOL CHEM, V269, P30765; Radjabi AR, 2008, J BIOL CHEM, V283, P2822, DOI 10.1074/jbc.M704855200; Rizvi I, 2010, CANCER RES, V70, P9319, DOI 10.1158/0008-5472.CAN-10-1783; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Stadlmann S, 2006, MODERN PATHOL, V19, P607, DOI 10.1038/modpathol.3800575; Steffensen KD, 2008, CLIN CANCER RES, V14, P3278, DOI 10.1158/1078-0432.CCR-07-4171; Szlosarek PW, 2006, MOL CANCER THER, V5, P382, DOI 10.1158/1535-7163.MCT-05-0303; Teplinsky E, 2015, TRANSL CANCER RES, V4, P107, DOI 10.3978/j.issn.2218-676X.2015.01.01; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Vergote IB, 2014, J CLIN ONCOL, V32, P320, DOI 10.1200/JCO.2013.50.5669; Wang C, 2014, CANCER RES, V74, P3084, DOI 10.1158/0008-5472.CAN-13-3198; Wen W, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0366-5; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309	54	56	59	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 22	2017	36	25					3576	3587		10.1038/onc.2016.509	http://dx.doi.org/10.1038/onc.2016.509			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY3NL	28166193	Green Published, hybrid			2022-12-26	WOS:000403878600007
J	Sun, H; Peng, Z; Tang, H; Xie, D; Jia, Z; Zhong, L; Zhao, S; Ma, Z; Gao, Y; Zeng, L; Luo, R; Xie, K				Sun, H.; Peng, Z.; Tang, H.; Xie, D.; Jia, Z.; Zhong, L.; Zhao, S.; Ma, Z.; Gao, Y.; Zeng, L.; Luo, R.; Xie, K.			Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-beta signaling in and promote progression of hepatocellular carcinoma	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; MESENCHYMAL TRANSITION; POOR-PROGNOSIS; CROSS-TALK; EXPRESSION; BLOCKS; TARGET; KRUPPEL-LIKE-FACTOR-4; HEPATOCARCINOGENESIS; METASTASIS	Hyperactivation of transforming growth factor-beta ( TGF-alpha) signaling pathway is a common feature of hepatocellular carcinoma (HCC) progression. However, the driver factors leading to enhanced TGF-beta activity are not well characterized. Here, we explore the mechanisms that loss of Kruppel-like factor 4 (KLF4) exacerbates oncogenic TGF-beta signaling in human HCC. The expression of KLF4 and TGF-beta signaling components in primary HCC and their clinicopathologic relevance and significance was evaluated by using tissue microarray and immunohistochemistry. Cellular and molecular impacts of altered KLF4 expression and TGF-beta signaling were determined using immunofluorescence, western blot, reverse-transcriptase PCR, chromatin immunoprecipitation and promoter reporter assays. Loss of KLF4 expression in primary HCC closely correlated with decreased Smad7 expression, increased p-Smad2/3 expression and independently predicts reduced overall and relapse-free survival after surgery. TGF-beta signaling components were expressed in most HCC cells, and activation of TGF-beta signaling promoted cell migration and invasion. Enforced KLF4 expression blocked TGF-beta signal transduction and inhibited cell migration and invasion via activation of Smad7 transcription, whereas deletion of its C-terminal zinc-finger domain diminished this effect. KLF4 protein physically interacts with the Smad7 promoter. Promoter deletion and point mutation analyses revealed that a region between nucleotides -15bp and -9bp of the Smad7 promoter was required for the induction of Smad7 promoter activity by KLF4. Our data indicate that KLF4 suppresses oncogenic TGF-beta signaling by activation of Smad7 transcription, and that loss of KLF4 expression in primary HCC may contribute to activation of oncogenic TGF-beta signaling and subsequent tumor progression.	[Sun, H.; Jia, Z.; Xie, K.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Sun, H.; Peng, Z.; Zhong, L.; Zhao, S.] Shanghai Gen Hosp, Dept Gen Surg, 85 Wujin Rd, Shanghai 200080, Peoples R China; [Tang, H.] Shanghai Jiao Tong Univ, Dept Pathol, Affiliated Shanghai Gen Hosp, Shanghai, Peoples R China; [Xie, D.; Gao, Y.] Tongji Univ, Sch Med, Dept Oncol, Shanghai East Hosp, Shanghai, Peoples R China; [Xie, D.; Gao, Y.] Tongji Univ, Sch Med, Tumor Inst, Shanghai East Hosp, Shanghai, Peoples R China; [Ma, Z.] Fudan Univ, Liver Transplantat Sect, Ctr Organ Transplantat, Shanghai, Peoples R China; [Zeng, L.; Luo, R.] Southern Med Univ, Tumor Hosp, Guangzhou, Guangdong, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University; Tongji University; Tongji University; Fudan University; Southern Medical University - China	Peng, Z (corresponding author), Shanghai Gen Hosp, Dept Gen Surg, 85 Wujin Rd, Shanghai 200080, Peoples R China.; Luo, R (corresponding author), Southern Med Univ, Tumor Hosp, Guangzhou, Guangdong, Peoples R China.; Xie, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Unit 1644, 1515 Holcombe Blvd, Houston, TX 77030 USA.	xczmd@sjtu.edu.cn; luorc02@vip.163.com; kepxie@mdanderson.org			National Institutes of Health [R01-CA129956, R01-CA148954]; National Natural Science Foundation of China [81101623]; Science and Technology Commission of Shanghai Municipality [81101623, 81672846]; NATIONAL CANCER INSTITUTE [R01CA129956, R01CA148954, R01CA195651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Don Norwood for editorial comments. The work is supported in part by grants R01-CA129956 and R01-CA148954 from the National Institutes of Health (K Xie), grant # 81101623 from the National Natural Science Foundation of China and grant # 81101623 and # 81672846 from Science and Technology Commission of Shanghai Municipality (H Sun).	Baek HJ, 2011, HEPATOLOGY, V53, P1676, DOI 10.1002/hep.24128; Chen YW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-181; Ding Bo, 2015, Asian Pac J Cancer Prev, V16, P3629; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Fransvea E, 2009, HEPATOLOGY, V49, P839, DOI 10.1002/hep.22731; Giannelli G, 2014, CANCER RES, V74, P1890, DOI 10.1158/0008-5472.CAN-14-0243; Hu B, 2007, AM J RESP CELL MOL, V36, P78, DOI 10.1165/rcmb.2006-0043OC; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Li Q, 2012, GASTROENTEROLOGY, V143, P799, DOI 10.1053/j.gastro.2012.05.043; Lin TH, 2015, CLIN CANCER RES, V21, P3678, DOI 10.1158/1078-0432.CCR-14-1954; Lin ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043593; Matsuzaki K, 2000, CANCER RES, V60, P1394; Mazzocca A, 2012, CURR PHARM DESIGN, V18, P4148, DOI 10.2174/138161212802430431; Mazzocca A, 2010, HEPATOLOGY, V51, P523, DOI 10.1002/hep.23285; Mazzocca A, 2009, HEPATOLOGY, V50, P1140, DOI 10.1002/hep.23118; Meindl-Beinker NM, 2012, DIGEST DIS, V30, P514, DOI 10.1159/000341704; Mima K, 2012, CANCER RES, V72, P3414, DOI 10.1158/0008-5472.CAN-12-0299; Morris SM, 2012, HEPATOLOGY, V55, P121, DOI 10.1002/hep.24653; Park YN, 2004, HEPATO-GASTROENTEROL, V51, P396; Reichl P, 2012, CURR PHARM DESIGN, V18, P4135, DOI 10.2174/138161212802430477; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Stolfi C, 2013, INT J MOL SCI, V14, P23774, DOI 10.3390/ijms141223774; Sun HC, 2011, ONCOL REP, V25, P1533, DOI 10.3892/or.2011.1230; von Gersdorff G, 2000, J BIOL CHEM, V275, P11320, DOI 10.1074/jbc.275.15.11320; Wang J, 2013, J PATHOL, V230, P441, DOI 10.1002/path.4206; Wei DY, 2008, CANCER RES, V68, P4631, DOI 10.1158/0008-5472.CAN-07-5953; Wei DY, 2016, CANCER CELL, V29, P324, DOI 10.1016/j.ccell.2016.02.005; Xia HP, 2013, HEPATOLOGY, V58, P629, DOI 10.1002/hep.26369; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhang YD, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/705238; Zhou AD, 2016, NAT CELL BIOL, V18, P954, DOI 10.1038/ncb3396; Zhu HB, 2013, HEPATOLOGY, V58, P2012, DOI 10.1002/hep.26587	36	48	49	0	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 25	2017	36	21					2957	2968		10.1038/onc.2016.447	http://dx.doi.org/10.1038/onc.2016.447			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV7ZP	28192402	Green Accepted			2022-12-26	WOS:000402000400004
J	Shi, ZM; Wang, L; Shen, H; Jiang, CF; Ge, X; Li, DM; Wen, YY; Sun, HR; Pan, MH; Li, W; Shu, YQ; Liu, LZ; Peiper, SC; He, J; Jiang, BH				Shi, Z-M; Wang, L.; Shen, H.; Jiang, C-F; Ge, X.; Li, D-M; Wen, Y-Y; Sun, H-R; Pan, M-H; Li, W.; Shu, Y-Q; Liu, L-Z; Peiper, S. C.; He, J.; Jiang, B-H			Downregulation of miR-218 contributes to epithelialmesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS; CARCINOMA METASTASIS; PANCREATIC-CANCER; DRUG-RESISTANCE; OVARIAN-CANCER; COLON-CANCER; NUDE-MICE; TGF-BETA; CELLS	Epithelial-mesenchymal transition (EMT) has been recognized as a key element of cell migration and invasion in lung cancer; however, the underlying mechanisms are not fully elucidated. Recently, emerging evidence suggest that miRNAs have crucial roles in control of EMT and EMT-associated traits such as migration, invasion and chemoresistance. Here, we found that miR-218 expression levels were significantly downregulated in lung cancer tissues compared with adjacent non-cancerous tissues, and the levels of miR-218 were significantly associated with histological grades and lymph node metastasis. Overexpression of miR-218 inhibited cell migration and invasion as well as the EMT process. Of particular importance, miR-218 was involved in the metastatic process of lung cancer cells in vivo by suppressing local invasion and distant colonization. We identified Slug and ZEB2 as direct functional targets of miR-218. Inverse correlations were observed between miR-218 levels and Slug/ZEB2 levels in cancer tissue samples. In addition, overexpression of miR-218 in H1299 increased chemosensitivity of cells to cisplatin treatment through suppression of Slug and ZEB2. These findings highlight an important role of miR-218 in the regulation of EMT-related traits and metastasis of lung cancer in part by modulation of Slug/ZEB2 signaling, and provide a potential therapeutic strategy by targeting miR-218 in NSCLC.	[Shi, Z-M] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Shi, Z-M; Wang, L.; Jiang, C-F; Ge, X.; Li, D-M; Wen, Y-Y; Sun, H-R; Jiang, B-H] Nanjing Med Univ, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Key Lab Human Funct Genom Jiangsu Prov, State Key Lab Reprod Med,Canc Ctr,Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Shen, H.; Shu, Y-Q] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Pan, M-H] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Li, W.] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Liu, L-Z; Peiper, S. C.; He, J.; Jiang, B-H] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Suite 334,Jefferson Alumni Hall, Philadelphia, PA 19107 USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing University; Jefferson University	He, J; Jiang, BH (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Suite 334,Jefferson Alumni Hall, Philadelphia, PA 19107 USA.; Jiang, BH (corresponding author), Nanjing Med Univ, Dept Pathol, Nanjing 211166, Jiangsu, Peoples R China.	Jun.he@jefferson.edu; binghjiang@yahoo.com	sun, hao/GRS-7732-2022; Shu, Yongqian/ABD-5698-2021; Jiang, Chengfei/AFW-5879-2022	He, Jun/0000-0002-5162-6041; Jiang, Bing-Hua/0000-0003-4526-2031; Liu, Ling-Zhi/0000-0001-9234-457X; Hartl, Carla/0000-0001-9769-7462	National Natural Science Foundation of China [81472944, 81320108019, 81302182, 81270736, 81502170]; Research Special Fund for Public Welfare Industry of Health [201402008]; National Institutes of Health grants [R01ES020868, R01CA193511]; American Cancer Society [RSG NEC -129306]; NATIONAL CANCER INSTITUTE [R01CA193511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020868] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Special Fund for Public Welfare Industry of Health; National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Natural Science Foundation of China (81472944, 81320108019, 81302182, 81270736 and 81502170); The Research Special Fund for Public Welfare Industry of Health (201402008); by National Institutes of Health grants (R01ES020868 and R01CA193511); and by American Cancer Society (RSG NEC -129306).	An ZL, 1996, ANTICANCER RES, V16, P2545; [Anonymous], 2014, IEEE IJCNN; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chang TH, 2011, AM J RESP CRIT CARE, V183, P1071, DOI 10.1164/rccm.201009-1440OC; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Fang S, 2014, EXP MOL PATHOL, V96, P438, DOI 10.1016/j.yexmp.2014.04.008; FENG B, 2015, CLIN SCI, V129, P673; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guan HY, 2013, J CLIN ENDOCR METAB, V98, pE1334, DOI 10.1210/jc.2013-1053; Hahn S, 2013, EMBO J, V32, P3079, DOI 10.1038/emboj.2013.236; Hammond SM, 2015, ADV DRUG DELIVER REV, V87, P3, DOI 10.1016/j.addr.2015.05.001; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Heist RS, 2012, CANCER CELL, V21; Izumchenko E, 2014, CANCER RES, V74, P3995, DOI 10.1158/0008-5472.CAN-14-0110; Jin YJ, 2014, INT J CANCER, V134, P2294, DOI 10.1002/ijc.28568; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katz MH, 2004, CLIN EXP METASTAS, V21, P7, DOI 10.1023/B:CLIN.0000017160.93812.3b; Ko H, 2013, CANCER LETT, V335, P205, DOI 10.1016/j.canlet.2013.02.018; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Li CH, 2013, GASTROENTEROLOGY, V144, P1086, DOI 10.1053/j.gastro.2013.01.058; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Liu LZ, 2008, CANCER RES, V68, P8183, DOI 10.1158/0008-5472.CAN-08-0819; Mallini P, 2014, CANCER TREAT REV, V40, P341, DOI 10.1016/j.ctrv.2013.09.008; Miow QH, 2015, ONCOGENE, V34, P1899, DOI 10.1038/onc.2014.136; Nagaraju GP, 2015, MOL CARCINOGEN, V54, P1147, DOI 10.1002/mc.22185; Nasarre P, 2013, CANCER RES, V73, P7111, DOI 10.1158/0008-5472.CAN-13-1755; Okada N, 2014, GENE DEV, V28, P438, DOI 10.1101/gad.233585.113; Oktyabri D, 2014, BIOCHEM BIOPH RES CO, V453, P124, DOI 10.1016/j.bbrc.2014.09.082; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pavelic SK, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-22; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Qu JJ, 2015, INT J ONCOL, V47, P2141, DOI 10.3892/ijo.2015.3187; Sachdeva M, 2014, J CLIN INVEST, V124, P4305, DOI 10.1172/JCI77116; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sun L, 2012, ONCOGENE, V31, P432, DOI 10.1038/onc.2011.263; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Tu YY, 2013, CANCER RES, V73, P6046, DOI 10.1158/0008-5472.CAN-13-0358; Valeri N, 2014, CANCER CELL, V25, P469, DOI 10.1016/j.ccr.2014.03.006; Valeri N, 2010, P NATL ACAD SCI USA, V107, P21098, DOI 10.1073/pnas.1015541107; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang BR, 2016, ARCH TOXICOL, V90, P449, DOI 10.1007/s00204-014-1435-z; Wilson C, 2014, ONCOTARGET, V5, P7328, DOI 10.18632/oncotarget.2397; Wu YC, 2016, ONCOGENE, V35, P2123, DOI 10.1038/onc.2015.274; Xia HP, 2013, HEPATOLOGY, V58, P629, DOI 10.1002/hep.26369; Xie J, 2016, TUMOR BIOL, V37, P1197, DOI 10.1007/s13277-015-3831-2; Yang LH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13677; Yang M, 1999, CANCER RES, V59, P781; Zhang CL, 2013, ACTA BIOCH BIOPH SIN, V45, P1055, DOI 10.1093/abbs/gmt109; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhou XX, 2016, J AM SOC NEPHROL, V27, P2092, DOI 10.1681/ASN.2015040457; Zhu KG, 2016, ONCOTARGET, V7, P28075, DOI 10.18632/oncotarget.8576; Zhu X, 2016, ONCOGENE, V35, P323, DOI 10.1038/onc.2015.84	63	100	104	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 4	2017	36	18					2577	2588		10.1038/onc.2016.414	http://dx.doi.org/10.1038/onc.2016.414			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET9AN	28192397	Green Published, hybrid			2022-12-26	WOS:000400597300008
J	Wang, YF; Li, JP; Huang, YT; Dai, XQ; Liu, YB; Liu, ZJ; Wang, Y; Wang, NP; Zhang, P				Wang, Yinfang; Li, Jinping; Huang, Yitong; Dai, Xiuqin; Liu, Youbin; Liu, Zongjun; Wang, Ying; Wang, Nanping; Zhang, Peng			Tripartite motif-containing 28 bridges endothelial inflammation and angiogenic activity by retaining expression of TNFR-1 and-2 and VEGFR2 in endothelial cells	FASEB JOURNAL			English	Article						NF-kappa B; KMT5B; TRIM28	NF-KAPPA-B; E3 UBIQUITIN LIGASE; NEGATIVE REGULATOR; ANTIVIRAL RESPONSE; RIG-I; TRIM28; ALPHA; PROTEIN; TRANSCRIPTION; SUMOYLATION	Angiogenesis and inflammation are regarded as important factors in the pathogenesis of chronic inflammation, cancer, and wound healing. Recent studies have supported prior evidence that common signaling pathways are involved in angiogenesis and inflammatory responses; however, key factors controlling both processes remain unclear. Although tripartite motif-containing (TRIM)-28 is known to have an immunosuppressive role in immune cells, its expression level and role in endothelial cells (ECs) are still unclear. In this study, we investigated the role of TRIM28 in inflammatory responses and angiogenic activity of ECs for the first time. Weshowed that TRIM28 is the most abundant TRIM family member and is localized in nuclei of ECs. Small interfering RNA-mediated knockdown of TRIM28 strikingly suppressed expression of TNF receptor (TNFR)-1 and -2, decreased TNF-alpha-induced phosphorylation of IKK alpha/beta and IkBa and degradation of IkB alpha and nuclear translocation of p65, and suppressed basal level and TNF-alpha-induced expression of chemokines and adhesion molecules, including VCAM-1, IL-6, ICAM-1, E-selectin, and monocyte chemoattractant protein (MCP)-1. Unexpectedly, IL-8 was potentiated by TRIM28 knockdown in ECs in an NF-kappa B-inducing kinase-dependent manner. Meanwhile, knockdown of TRIM28 inhibited expression of VEGF receptor 2 and suppressed VEGF-induced proliferation and tube formation by ECs. Finally, knockdown of TRIM28 suppressed recruitment of ECs in vivo in a murine synthetic basement membrane model. In summary, we found that TRIM28 acts as a central factor in controlling endothelial inflammatory responses and angiogenic activities by retaining expression of TNFR-1 and -2 and VEGF receptor 2 in ECs.-Wang, Y., Li, J., Huang Y., Dai, X., Liu, Y., Liu, Z., Wang, Y., Wang, N., Zhang, P. Tripartite motif-containing 28 bridges endothelial inflammation and angiogenic activity by retaining expression of TNFR1 and -2 and VEGFR2 in endothelial cells.	[Wang, Yinfang; Li, Jinping; Huang, Yitong; Dai, Xiuqin; Zhang, Peng] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Cent Lab, 164 Lanxi Rd, Shanghai 200062, Peoples R China; [Liu, Youbin; Liu, Zongjun; Zhang, Peng] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Cardiovasc Med, Shanghai, Peoples R China; [Wang, Ying] Mayo Clin, Dept Biochem & Mol Biol, Jacksonville, FL 32224 USA; [Wang, Nanping] Dalian Med Univ, Adv Inst Med Sci, Dalian, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Mayo Clinic; Dalian Medical University	Zhang, P (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Cent Lab, 164 Lanxi Rd, Shanghai 200062, Peoples R China.	zhangnep@hotmail.com		Wang, Ying/0000-0002-7852-386X; Wang, Nanping/0000-0002-8528-8132	National Natural Science Foundation of China [81570398, 81502142, 31430045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (Grants 81570398, 81502142, and 31430045). The authors declare no conflicts of interest.	Addison JB, 2015, CANCER RES, V75, P344, DOI 10.1158/0008-5472.CAN-14-1561; Alexander KA, 2015, CELL REP, V13, P1194, DOI 10.1016/j.celrep.2015.09.078; Bentz GL, 2015, J VIROL, V89, P7465, DOI 10.1128/JVI.00711-15; Bhattacharyya S, 2010, J BIOL CHEM, V285, P39511, DOI 10.1074/jbc.M110.159681; Bieler G, 2007, ONCOGENE, V26, P5722, DOI 10.1038/sj.onc.1210354; Bunch H, 2014, NAT STRUCT MOL BIOL, V21, P876, DOI 10.1038/nsmb.2878; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101040; Chikuma S, 2012, NAT IMMUNOL, V13, P596, DOI 10.1038/ni.2293; Choi UY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099267; Coltrini D, 2013, ANGIOGENESIS, V16, P469, DOI 10.1007/s10456-012-9324-7; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Sio FRS, 2012, FASEB J, V26, P4561, DOI 10.1096/fj.12-206177; de Sio FRS, 2012, BLOOD, V119, P4675, DOI 10.1182/blood-2011-12-401117; Eames HL, 2012, IMMUNOBIOLOGY, V217, P1315, DOI 10.1016/j.imbio.2012.07.026; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gao BC, 2002, AM J PHYSIOL-CELL PH, V283, pC1196, DOI 10.1152/ajpcell.00064.2002; Gjyshi O, 2015, J VIROL, V89, P7874, DOI 10.1128/JVI.00895-15; Herzog M, 2011, DEV BIOL, V350, P548, DOI 10.1016/j.ydbio.2010.12.014; Hu MM, 2015, J IMMUNOL, V195, P4415, DOI 10.4049/jimmunol.1500859; Imhof BA, 2006, NAT MED, V12, P171, DOI 10.1038/nm0206-171; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Kamitani S, 2011, J IMMUNOL, V187, P2476, DOI 10.4049/jimmunol.1003243; Kimura T, 2015, J CELL BIOL, V210, P973, DOI 10.1083/jcb.201503023; Kondo T, 2012, BIOCHEM BIOPH RES CO, V422, P501, DOI 10.1016/j.bbrc.2012.05.028; Li Q, 2011, P NATL ACAD SCI USA, V108, P19341, DOI 10.1073/pnas.1110946108; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Luo QQ, 2015, INT J CLIN ONCOL, V20, P508, DOI 10.1007/s10147-014-0752-9; Luo Y, 2010, ARTERIOSCL THROM VAS, V30, P1307, DOI 10.1161/ATVBAHA.110.204222; Mapp PI, 2012, NAT REV RHEUMATOL, V8, P390, DOI 10.1038/nrrheum.2012.80; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; McNamara RP, 2016, MOL CELL, V61, P39, DOI 10.1016/j.molcel.2015.11.004; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Miles DC, 2017, STEM CELLS, V35, P147, DOI 10.1002/stem.2453; Narayan K, 2014, J VIROL, V88, P10748, DOI 10.1128/JVI.02593-13; Neo SH, 2015, MOL CELL BIOL, V35, P2851, DOI 10.1128/MCB.01064-14; Noguchi K, 2011, CARCINOGENESIS, V32, P995, DOI 10.1093/carcin/bgr068; Noort AR, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0527-3; Noort AR, 2014, J PATHOL, V234, P375, DOI 10.1002/path.4403; Qiu Hui, 2013, Virologica Sinica, V28, P209, DOI 10.1007/s12250-013-3343-4; Razani B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000778; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Santos J, 2014, IMMUNOL LETT, V162, P281, DOI 10.1016/j.imlet.2014.08.011; Shi MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5820; Shibata M, 2012, BIOCHEM BIOPH RES CO, V423, P104, DOI 10.1016/j.bbrc.2012.05.090; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Tanji K, 2010, NEUROBIOL DIS, V38, P210, DOI 10.1016/j.nbd.2010.01.007; Tsuruma R, 2008, ONCOGENE, V27, P3054, DOI 10.1038/sj.onc.1210952; Turelli P, 2014, GENOME RES, V24, P1260, DOI 10.1101/gr.172833.114; Wei CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29822; Yan J, 2014, J MOL CELL BIOL, V6, P154, DOI 10.1093/jmcb/mju005; Yoshimi R, 2009, J IMMUNOL, V182, P7527, DOI 10.4049/jimmunol.0804121; Yu SS, 2011, BIOCHEM BIOPH RES CO, V410, P247, DOI 10.1016/j.bbrc.2011.05.124; Zhang HF, 2008, J CLIN INVEST, V118, P3904, DOI 10.1172/JCI36168; Zhang LM, 2014, J VIROL, V88, P6873, DOI 10.1128/JVI.00283-14; Zhang R, 2003, J BIOL CHEM, V278, P51267, DOI 10.1074/jbc.M310678200; Zhao W, 2012, J IMMUNOL, V188, P5311, DOI 10.4049/jimmunol.1103506; Zhao W, 2012, J IMMUNOL, V188, P2567, DOI 10.4049/jimmunol.1103255; Zhou XF, 2012, P NATL ACAD SCI USA, V109, P20083, DOI 10.1073/pnas.1214704109	59	23	23	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2026	2036		10.1096/fj.201600988RR	http://dx.doi.org/10.1096/fj.201600988RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28159803				2022-12-26	WOS:000399195500023
J	Tejada, CAO; Triaca, LM; da Costa, FK; Hellwig, F				Oviedo Tejada, Cesar Augusto; Triaca, Livia Madeira; da Costa, Flavia Katrein; Hellwig, Franciele			The sociodemographic, behavioral, reproductive, and health factors associated with fertility in Brazil	PLOS ONE			English	Article								High fertility rates among disadvantaged subgroups are a public health problem because fertility levels significantly affect socioeconomic conditions and a population's welfare. This paper aims to analyze the sociodemographic, behavioral, and reproductive factors associated with fertility rates among Brazilian women aged between 15-49 years. A Poisson regression was used to analyze data from the 2006 PNDS (Pesquisa Nacional de Demografia e Saude da Crianga e da Mulher), which evaluates socioeconomic, demographic, geographic, reproductive, behavioral, and chronic disease variables. The results show that the following characteristics are positively associated with an increase in the number of children born: being aged 20-24, residing in the North, being nonwhite, not being in paid employment, having lower education levels, having lower socioeconomic status, being in a stable union, having the first sexual intercourse before the age of 16 and having the first child before the age of 20. Thus, it is important to implement efficient family planning policies targeting these subgroups in order to improve life conditions, reduce inequalities and avoid the adverse outcomes of high fertility.	[Oviedo Tejada, Cesar Augusto; Triaca, Livia Madeira; da Costa, Flavia Katrein] Univ Fed Pelotas, Posgrad Program Econ, Pelotas, RS, Brazil; [Hellwig, Franciele] Univ Fed Pelotas, Posgrad Program Epidemiol, Pelotas, RS, Brazil; [Triaca, Livia Madeira] Pontificia Univ Catolica Rio Grande do Sul, Posgrad Program Econ, Porto Alegre, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas; Pontificia Universidade Catolica Do Rio Grande Do Sul	Triaca, LM (corresponding author), Univ Fed Pelotas, Posgrad Program Econ, Pelotas, RS, Brazil.; Triaca, LM (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Posgrad Program Econ, Porto Alegre, RS, Brazil.	liviamtriaca@gmail.com	Tejada, Cesar Augusto Oviedo/AAN-9108-2020; Hellwig, Franciele/AAC-4924-2019; Triaca, Lívia/AAN-9118-2020	Hellwig, Franciele/0000-0002-2509-9866; Triaca, Livia/0000-0001-7192-6554				Alves JED, 2013, PROGRAMA BOLSA FAMIL, P502; Alves JED, 2008, TRANSICAO DEMOGRAFIC, P13; Angeles L, 2010, J POPUL ECON, V23, P99, DOI 10.1007/s00148-009-0255-6; [Anonymous], 2014, ENC DEM SAL FAM ENDE; Basu AM, 2002, WORLD DEV, V30, P1779, DOI 10.1016/S0305-750X(02)00072-4; BECKER GS, 1976, J POLIT ECON, V84, pS143, DOI 10.1086/260536; Berquo A E, 2004, ANAIS 14 ENCONTRO NA, P1; Berquo A E, 2008, PESQUISA NACL DEMOGR; Berquó Elza, 2006, Novos estud. CEBRAP, P11; Bongaarts J, 1996, POPUL DEV REV, V22, P639, DOI 10.2307/2137804; Casternile JB, 2010, DETERMINANTS CONSEQU; Chackiel Juan, 2004, Pap. poblac, V10, P9; Comision Economica para America Latina y el Caribe, 2008, FEC AM LAT DESC AC H; Coutinho Raquel Zanatta, 2015, Rev. bras. estud. popul., V32, P395, DOI 10.1590/S0102-30982015000000023; De Carvalho AA, 2016, REV LATINOAMERICANA; Duarte CM, 2006, REV PANAM SALUD PUBL, V19, P236, DOI 10.1590/S1020-49892006000400003; Ethiopian Society of Population Studies, 2008, LEV TRENDS DET LIF D; Gomes MMF, 2012, 18 ENC NAC EST POP, P1; Hashmi AR, 2013, SINGAP ECON REV, V58, DOI 10.1142/S0217590813500239; Klawon E, 2001, POPUL RES POLICY REV, V20, P423, DOI 10.1023/A:1013337201896; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S2; Llerena F, 2007, DETERMINANTS FERTILI; LUNDQUIST J, 2014, DEMOGRAPHY STUDY HUM; Madalozzo R, 2012, PLOS ONE, P7; MARTIN TC, 1995, STUD FAMILY PLANN, V26, P187, DOI 10.2307/2137845; Mendes MF, 2006, EDUCACAO FECUNDIDADE, P23; Nelson JO, 2013, FERTILITY BOLSA FAMI; Oliveira Isabel Tiago de, 2008, Anál. Social, P29; Simões Patrícia, 2012, Rev. Bras. Econ., V66, P445, DOI 10.1590/S0034-71402012000400004; StataCorp, 2011, STAT STAT SOFTW REL; Testa MR., 2014, ADV LIFE COURSE RES; Tuman JP, 2007, GLOB HEAL GOV, V1, P1; Wang WR, 1997, J POPUL ECON, V10, P273, DOI 10.1007/s001480050043; Weinberger M. B., 1987, International Family Planning Perspectives, V13, P35, DOI 10.2307/2947826	34	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171888	10.1371/journal.pone.0171888	http://dx.doi.org/10.1371/journal.pone.0171888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187167	gold, Green Published, Green Submitted			2022-12-26	WOS:000394244300057
J	Tunc-Ozdemir, M; Jones, AM				Tunc-Ozdemir, Meral; Jones, Alan M.			Ligand-induced dynamics of heterotrimeric G protein-coupled receptor-like kinase complexes	PLOS ONE			English	Article							NADPH OXIDASE RBOHD; ALPHA-SUBUNIT; BETA-SUBUNIT; ARABIDOPSIS; MEMBRANE; PHOSPHORYLATION; MECHANISMS; RESISTANCE; TRANSIENT; INTERACT	Background Arabidopsis, 7-transmembrane Regulator of G signaling protein 1 (AtRGS1) modulates canonical G protein signaling by promoting the inactive state of heterotrimeric G protein complex on the plasma membrane. It is known that plant leucine-rich repeat receptor like kinases (LRR RLKs) phosphorylate AtRGS1 in vitro but little is known about the in vivo interaction, molecular dynamics, or the cellular consequences of this interaction. Methods Therefore, a subset of the known RLKs that phosphorylate AtRGS1 were selected for elucidation, namely, BAK1, BIR1, FLS2. Several microscopies for both static and dynamic protein -protein interactions were used to follow in vivo interactions between the RLKs and AtRGS1 after the presentation of the Pathogen-associated Molecular Pattern, Flagellin 22 (FIg22). These microscopies included Forster Resonance Energy Transfer, Bimolecular Fluoresence Complementation, and Cross Number and Brightness Fluorescence Correlation Spectroscopy. In addition, reactive oxygen species and calcium changes in living cells were quantitated using luminometry and R-GECO1 microscopy. Results The LRR RLKs BAK1 and BIR1, interact with AtRGS1 at the plasma membrane. The RLK ligand f1g22 sets BAK1 in motion toward AtRGS1 and BIR1 away, both returning to the baseline orientations by 10 minutes. The C-terminal tail of AtRGS1 is important for the interaction with BAK1 and for the tempo of the AtRGS1/BIR1 dynamics. This window of time corresponds to the f1g22-induced transient production of reactive oxygen species and calcium release which are both attenuated in the rgs1 and the bak1 null mutants. Conclusions A temporal model of these interactions is proposed. flg22 binding induces nearly instantaneous dimerization between FLS2 and BAK1. Phosphorylated BAK1 interacts with and enables AtRGS1 to move away from BIR1 and AtRGS1 becomes phosphorylated leading to its endocytosis thus leading to de-repression by permitting AtGPA1 to exchange GDP for GTP. Finally, the G protein complex becomes dissociated thus AGB1 interacts with its effector proteins leading to changes in reactive oxygen species and calcium.	[Tunc-Ozdemir, Meral; Jones, Alan M.] Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27514 USA; [Jones, Alan M.] Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Jones, AM (corresponding author), Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27514 USA.; Jones, AM (corresponding author), Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC 27514 USA.	alan_jones@unc.edu			NIGMS [R01GM065989]; NSF [MCB-0718202]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-05er15671]	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE))	This work was supported by grants from the NIGMS (R01GM065989) and NSF (MCB-0718202) to AMJ and by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy through the grant DE-FG02-05er15671 to AMJ.	ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Booker F, 2012, PLANT CELL ENVIRON, V35, P668, DOI 10.1111/j.1365-3040.2011.02443.x; Chakravorty D, 2015, PLANT PHYSIOL; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen YN, 2012, PLANT J, V69, P266, DOI 10.1111/j.1365-313X.2011.04788.x; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Choudhury SR, 2015, PLANT CELL, V27, P3260, DOI 10.1105/tpc.15.00517; Chung EH, 2014, CELL HOST MICROBE, V16, P484, DOI 10.1016/j.chom.2014.09.004; Clark NM, 2016, ELIFE, P5; Colaneri AC, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-129; Digman MA, 2009, P NATL ACAD SCI USA, V106, P2170, DOI 10.1073/pnas.0806036106; Drechsel G, 2011, J EXP BOT, V62, P775, DOI 10.1093/jxb/erq313; Fu Y, 2014, CELL, V156, P1084, DOI 10.1016/j.cell.2014.01.013; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; Ishida T, 2014, EMBO REP, V15, P1202, DOI 10.15252/embr.201438660; Ishikawa A, 2009, BIOSCI BIOTECH BIOCH, V73, P47, DOI 10.1271/bbb.80449; Jiang K, 2012, PLANT PHYSIOL, V159, P975, DOI 10.1104/pp.112.196337; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Keinath NF, 2015, MOL PLANT, V8, P1188, DOI 10.1016/j.molp.2015.05.006; Lee JH, 2010, PLANT CELL, V22, P1716, DOI 10.1105/tpc.109.073783; Li L, 2014, CELL HOST MICROBE, V15, P329, DOI 10.1016/j.chom.2014.02.009; Liang X, 2016, ELIFE, P5; Liu JM, 2013, PLANT PHYSIOL, V161, P2146, DOI 10.1104/pp.112.212431; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; Lorek J, 2013, MOL PLANT MICROBE IN, V26, P991, DOI 10.1094/MPMI-03-13-0077-R; Maruta N, 2015, PLANT PHYSIOL, V167, P1004, DOI 10.1104/pp.114.255703; Aranda-Sicilia MN, 2015, J PLANT PHYSIOL, V188, P44, DOI 10.1016/j.jplph.2015.09.005; Oliviusson P, 2006, PLANT CELL, V18, P1239, DOI 10.1105/tpc.105.035907; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Rossow MJ, 2010, NAT PROTOC, V5, P1761, DOI 10.1038/nprot.2010.122; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Serna L, 2005, NEW PHYTOL, V165, P947, DOI 10.1111/j.1469-8137.2004.01278.x; Shamloul M, 2014, JOVE-J VIS EXP, DOI 10.3791/51204; Spallek T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004035; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Thung L, 2012, J PLANT PHYSIOL, V169, P542, DOI 10.1016/j.jplph.2011.11.010; Torres MA, 2013, MOL PLANT MICROBE IN; Tunc-Ozdemir M, 2016, METHODS MOL BIOL; Tunc-Ozdemir M, 2016, J BIOL CHEM; Urano D, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf9558; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Urano D, 2012, NAT CELL BIOL, V14, P1079, DOI 10.1038/ncb2568; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; Weiss CA, 1997, FEBS LETT, V407, P361, DOI 10.1016/S0014-5793(97)00378-5; Wolfenstetter S, 2012, PLANT CELL, V24, P215, DOI 10.1105/tpc.111.090415; Xu DB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116385; Yu TY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005933; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; 이상협, 2013, [The Journal of Korea Robotics Society, 로봇학회 논문지], V8, P8, DOI 10.7746/jkros.2013.8.1.008	52	30	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171854	10.1371/journal.pone.0171854	http://dx.doi.org/10.1371/journal.pone.0171854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187200	gold, Green Published, Green Submitted			2022-12-26	WOS:000394244300052
J	Kudo, M; Kobayashi-Nakamura, K; Tsuji-Naito, K				Kudo, Michiko; Kobayashi-Nakamura, Kumiko; Tsuji-Naito, Kentaro			Bifunctional effects of O-methylated flavones from Scutellaria baicalensis Georgi on melanocytes: Inhibition of melanin production and intracellular melanosome transport	PLOS ONE			English	Article							PROTEIN; SKIN; ANTIOXIDANT; RADIX; MITF; SLAC2-A/MELANOPHILIN; MELANOGENESIS; PIGMENTATION; DEGRADATION; TYROSINASE	The growing interest in skin lightening has recently renewed attention on the esthetic applications of Chinese herbal medicine. Although Scutellaria baicalensis Georgi is used for antipyretic and antiinflammatory purposes, its whitening effect remains unclear. This study reports three major findings: (1) S. baicalensis has a potent inhibitory effect on melanogenesis; (2) wogonin and its glycoside are the active components of S. baicalensis; and (3) O-methylated flavones from S. baicalensis, such as wogonin, inhibit intracellular melanosome transport. Using a melanin quantification assay, we showed that S. baicalensis potently inhibits melanogenesis in B16F10 cells. Componential analyses revealed that the main components of S. baicalensis are baicalin, wogonoside, baicalein, wogonin, and oroxylin A. Among these five flavones, wogonin and wogonoside consistently inhibited melanogenesis in both B16F10 melanoma cells and primary melanocytes. Wogonin exhibited the strongest inhibition of melanin production and markedly lightened the color of skin equivalents. We identified microphthalmia-associated transcription factor and tyrosinase-related proteins as potential targets of wogonin- and wogonoside-induced melanogenesis suppression. In culture, we found that the melanosomes in wogonin-treated B16F10 cells were localized to the perinuclear region. Immunoblotting analyses revealed that wogonin significantly reduced in melanophilin protein, which is required for actin-based melanosome transport. Other actin-based melanosome transport-related molecules, i.e., Rab27A and myosin Va, were not affected by wogonin. Cotreatment with MG132 blocked the wogonin-induced decrease in melanophilin, suggesting that wogonin promotes the proteolytic degradation of melanophilin via the calpain/proteasomal pathway. We determined that the structural specificities of the mono-O-methyl group in the flavone A-ring and the aglycone form were responsible for reducing melanosome transport. Furthermore, wogonin and two wogonin analogs, mono-O-methyl flavones, strongly suppressed melanosome transport. Our findings suggest the applicability of S. baicalensis in the esthetic field. Thus, we propose a novel pharmacologic approach for the treatment of hyperpigmentation.	[Kudo, Michiko; Kobayashi-Nakamura, Kumiko; Tsuji-Naito, Kentaro] DHC Corp, Fundamental Res Dept, Fundamental Res Lab, Chiba, Japan		Tsuji-Naito, K (corresponding author), DHC Corp, Fundamental Res Dept, Fundamental Res Lab, Chiba, Japan.	knaito@dhc.co.jp		Naito, Kentaro/0000-0001-5247-7159; Kobayashi-Nakamura, Kumiko/0000-0001-5579-3464	research grant from DHC Corporation	research grant from DHC Corporation	This work was supported by a research grant from DHC Corporation (http://top.dhc.co.jp/company/en/index.html). MK, KKN, and KTN are employed by DHC Corporation. The funder provided support in the form of salaries for authors MK, KKN, and KTN, but did not haveany additional role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ando H, 2004, J BIOL CHEM, V279, P15427, DOI 10.1074/jbc.M313701200; BENNETT DC, 1990, DEVELOPMENT, V110, P471; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Chang H, 2012, PIGM CELL MELANOMA R, V25, P765, DOI 10.1111/pcmr.12002; Cheli Y, 2009, J BIOL CHEM, V284, P18699, DOI 10.1074/jbc.M109.005819; Chiaverini C, 2008, J BIOL CHEM, V283, P12635, DOI 10.1074/jbc.M800130200; D'Mello SAN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071144; Fukuda M, 2004, J BIOL CHEM, V279, P22314, DOI 10.1074/jbc.401791200; Galvez M, 2005, J AGR FOOD CHEM, V53, P1927, DOI 10.1021/jf048076s; Gao ZH, 1999, BBA-GEN SUBJECTS, V1472, P643, DOI 10.1016/S0304-4165(99)00152-X; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Hata Y, 2009, Japan Patent Kokai, Patent No. [2009-294615, 2009294615]; Hearing Vincent J, 2011, J Invest Dermatol, V131, pE8, DOI 10.1038/skinbio.2011.4; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Itakura K, 2014, Japanese Patent, Patent No. 5507866; JULKUNENTIITTO R, 1985, J AGR FOOD CHEM, V33, P213, DOI 10.1021/jf00062a013; Kang YG, 2011, EXP DERMATOL, V20, P445, DOI 10.1111/j.1600-0625.2010.01236.x; Kondo Taisuke, 2011, Expert Rev Dermatol, V6, P97, DOI 10.1586/edm.10.70; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Li CR, 2011, BIOPHARM DRUG DISPOS, V32, P427, DOI 10.1002/bdd.771; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; LIU XF, 1990, MOL PHARMACOL, V37, P911; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Menasche G, 2003, J CLIN INVEST, V112, P450, DOI 10.1172/JCI200318264; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Murase D, 2013, J INVEST DERMATOL, V133, P2416, DOI 10.1038/jid.2013.165; Palmisano I, 2008, HUM MOL GENET, V17, P3487, DOI 10.1093/hmg/ddn241; Pan L, 2015, CELL PROLIFERAT, V48, P631, DOI 10.1111/cpr.12227; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Tsuji-Naito K, 2007, BIOORGAN MED CHEM, V15, P1967, DOI 10.1016/j.bmc.2006.12.042; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wolnicka-Glubisz A, 2015, ARCH DERMATOL RES, V307, P89, DOI 10.1007/s00403-014-1523-1; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Wu X, 2016, ONCOTARGETS THER, V9, P2935, DOI 10.2147/OTT.S105586; Xiao JR, 2014, J OCUL PHARMACOL TH, V30, P605, DOI 10.1089/jop.2014.0074; Yajima I, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/730170; Zhao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106458	44	21	23	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171513	10.1371/journal.pone.0171513	http://dx.doi.org/10.1371/journal.pone.0171513			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182699	gold, Green Submitted, Green Published			2022-12-26	WOS:000394231800067
J	Zagatto, AM; Miyagi, WE; Sousa, FAD; Gobatto, CA				Zagatto, Alessandro Moura; Miyagi, Willian Eiji; de Barros Sousa, Filipe Antonio; Gobatto, Claudio Alexandre			Relationship between anaerobic capacity estimated using a single effort and 30-s tethered running outcomes	PLOS ONE			English	Article							ACCUMULATED OXYGEN DEFICIT; TABLE-TENNIS; SPRINT TEST; POWER; MAOD; ENERGETICS; RELIABILITY; METABOLISM; EXHAUSTION; TIME	The purpose of the current study was to investigate the relationship between alternative anaerobic capacity method (MAOD(ALT)) and a 30-s all-out tethered running test. Fourteen male recreational endurance runners underwent a graded exercise test, a supramaximal exhaustive effort and a 30-s all-out test on different days, interspaced by 48h. After verification of data normality (Shapiro-Wilk test), the Pearson's correlation test was used to verify the association between the anaerobic estimates from the MAOD(ALT) and the 30-s all-out tethered running outputs. Absolute MAOD(ALT) was correlated with mean power (r = 0.58; P = 0.03), total work (r = 0.57; P = 0.03), and mean force (r = 0.79; P = 0.001). In addition, energy from the glycolytic pathway (E[La-]) was correlated with mean power (r = 0.58; P = 0.03). Significant correlations were also found at each 5s interval between absolute MAOD(ALT) and force values (r between 0.75 and 0.84), and between force values and E[La-] (r between 0.73 to 0.80). In conclusion, the associations between absolute MAOD(ALT) and the mechanical outputs from the 30-s all-out tethered running test evidenced the importance of the anaerobic capacity for maintaining force during the course of time in short efforts.	[Zagatto, Alessandro Moura; Miyagi, Willian Eiji] Sao Paulo State Univ Unesp, Sch Sci, Lab Physiol & Sports Performance LAFIDE, Bauru, SP, Brazil; [Zagatto, Alessandro Moura; Miyagi, Willian Eiji] Sao Paulo State Univ Unesp, Postgrad Program Movement Sci, Rio Claro, SP, Brazil; [de Barros Sousa, Filipe Antonio; Gobatto, Claudio Alexandre] Univ Estadual Campinas, Sch Appl Sci, Limeira, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual de Campinas	Zagatto, AM (corresponding author), Sao Paulo State Univ Unesp, Sch Sci, Lab Physiol & Sports Performance LAFIDE, Bauru, SP, Brazil.; Zagatto, AM (corresponding author), Sao Paulo State Univ Unesp, Postgrad Program Movement Sci, Rio Claro, SP, Brazil.	azagatto@yahoo.com.br	Sousa, Filipe A B/H-2444-2017; Gobatto, Claudio A/E-7388-2014; Zagatto, Alessandro M/F-9969-2012; Gobatto, Claudio/O-7257-2015	Zagatto, Alessandro M/0000-0003-1065-4158; Sousa, Filipe Antonio/0000-0001-8252-725X; Gobatto, Claudio/0000-0002-1441-7582	FAPESP [2013/129408]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was financially supported by a grant from FAPESP process numbers 2013/129408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade VL, 2015, INT J SPORTS MED, V36, P1156, DOI 10.1055/s-0035-1555935; Astorino TA, 2011, J SPORT MED PHYS FIT, V51, P11; Bangsbo J, 1996, Can J Appl Physiol, V21, P350; BAROR O, 1987, SPORTS MED, V4, P381, DOI 10.2165/00007256-198704060-00001; Bertuzzi R, 2015, BRAZ J MED BIOL RES, V48, P261, DOI [10.1590/1414-431X20144043, 10.1590/1414-431x20144043]; Bertuzzi RCM, 2010, INT J SPORTS MED, V31, P477, DOI 10.1055/s-0030-1253375; Billat VL, 1999, EUR J APPL PHYSIOL O, V80, P159, DOI 10.1007/s004210050573; Bogdanis GC, 1996, J APPL PHYSIOL, V80, P876, DOI 10.1152/jappl.1996.80.3.876; De Poli RDB, 2016, INT J SPORT NUTR EXE, V26, P549, DOI 10.1123/ijsnem.2016-0038; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cheetham M E, 1985, Br J Sports Med, V19, P81; di Prampero P E, 1981, Rev Physiol Biochem Pharmacol, V89, P143; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; Fitzsimons M., 1993, AUST J SCI MED SPORT, V25, P82; Gama MCT, 2016, INT J SPORT IN PRESS; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Lima MCS, 2011, INT J SPORTS MED, V32, P529, DOI 10.1055/s-0031-1273689; Mangine GT, 2014, J STRENGTH COND RES, V28, P1812, DOI 10.1519/JSC.0000000000000316; Margaria R, 1933, AM J PHYSIOL, V106, P689, DOI 10.1152/ajplegacy.1933.106.3.689; MEDBO JI, 1988, J APPL PHYSIOL, V64, P50, DOI 10.1152/jappl.1988.64.1.50; Milioni F, 2017, INT J SPORT IN PRESS; Milioni F, 2016, APPL PHYSIOL NUTR ME, V41, P498, DOI 10.1139/apnm-2015-0435; Minahan C, 2007, INT J SPORTS MED, V28, P836, DOI 10.1055/s-2007-964976; Morin JB, 2010, J BIOMECH, V43, P1970, DOI 10.1016/j.jbiomech.2010.03.012; Morin JB, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00404; Morin JB, 2012, EUR J APPL PHYSIOL, V112, P3921, DOI 10.1007/s00421-012-2379-8; Noordhof DA, 2010, SPORTS MED, V40, P285, DOI 10.2165/11530390-000000000-00000; Ozyener F, 2001, J PHYSIOL-LONDON, V533, P891, DOI 10.1111/j.1469-7793.2001.t01-1-00891.x; Padulo Johnny, 2014, Muscles Ligaments Tendons J, V4, P159; Papoti M, 2017, SCI REPORTS; Pereira VH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10489; Brisola GMP, 2015, APPL PHYSIOL NUTR ME, V40, P931, DOI 10.1139/apnm-2015-0036; Rowntree D, 2000, STAT TEARS INTRO NON; SCOTT CB, 1991, MED SCI SPORT EXER, V23, P618; Sousa FAB, 2015, MED SCI SPORT EXER, V47, P12, DOI 10.1249/01.mss.0000476425.05454.de; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; VANDEWALLE H, 1985, EUR J APPL PHYSIOL, V54, P222, DOI 10.1007/BF02335934; Zagatto A, 2011, SCAND J MED SCI SPOR, V21, pE222, DOI 10.1111/j.1600-0838.2010.01258.x; Zagatto AM, 2016, INT J SPORTS MED, V37, P700, DOI 10.1055/s-0042-104413; Zagatto AM, 2012, INT J SPORTS MED, V33, P613, DOI 10.1055/s-0032-1304648; Zagatto A. M., 2017, J SPORTS SC IN PRESS; Zagatto AM, 2009, J STRENGTH COND RES, V23, P1820, DOI 10.1519/JSC.0b013e3181b3df32; Zagatto AM, 2016, INT J SPORT PHYSIOL, V11, P1012, DOI 10.1123/ijspp.2015-0746; Zemkova E., 2004, KINESIOLOGY, V36, P165	46	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172032	10.1371/journal.pone.0172032	http://dx.doi.org/10.1371/journal.pone.0172032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182775	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800145
J	Zhang, SW; Liu, Y; Wang, F; Qiang, J; Liu, P; Zhang, J; Xu, JW				Zhang, Shuang-Wei; Liu, Yu; Wang, Fang; Qiang, Jiao; Liu, Pan; Zhang, Jun; Xu, Jin-Wen			Ilexsaponin A attenuates ischemia-reperfusion-induced myocardial injury through anti-apoptotic pathway	PLOS ONE			English	Article							TRITERPENE SAPONINS; PROTECTS; ROOTS; CARDIOPROTECTION; MECHANISMS; FRACTION; HEART	The protective effects of ilexsaponin A on ischemia-reperfusion-induced myocardial injury were investigated. Myocardial ischemia/reperfusion model was established in male Sprague-Dawley rats. Myocardial injury was evaluated by TTC staining and myocardial marker enzyme leakage. The in vitro protective potential of Ilexsaponin A was assessed on hypoxia/reoxygenation cellular model in neonatal rat cardiomyocytes. Cellular viability and apoptosis were evaluated by MTT and TUNEL assay. Caspase-3, cleaved caspase-3, bax, bcl2, p-Akt and Akt protein expression levels were detected by western-blot. Ilexsaponin A treatment was able to attenuate the myocardial injury in ischemia/reperfusion model by reducing myocardial infarct size and lower the serum levels of LDH, AST and CK-MB. The in vitro study also showed that ilexsaponin A treatment could increase cellular viability and inhibit apoptosis in hypoxia/reoxygenation cardiomyocytes. Proapoptotic proteins including caspase-3, cleaved caspase-3 and bax were significantly reduced and anti-apoptotic protein bcl-2 was significantly increased by ilexsaponin A treatment in hypoxia/reoxygenation cardiomyocytes. Moreover, Ilexsaponin A treatment was able to increase the expression levels of p-Akt in hypoxia/reoxygenation cellular model and myocardial ischemia/reperfusion animal model. Coupled results from both in vivo and in vitro experiments indicate that Ilexsaponin A attenuates ischemia-reperfusion-induced myocardial injury through anti-apoptotic pathway.	[Zhang, Shuang-Wei] Guangzhou Med Univ, Affiliated Hosp 2, Changgang East Rd, Guangzhou, Guangdong, Peoples R China; [Liu, Yu; Wang, Fang; Qiang, Jiao; Liu, Pan; Zhang, Jun; Xu, Jin-Wen] Guangzhou Univ Chinese Med, Sch Chinese Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Xu, Jin-Wen] Guangzhou Univ Chinese Med, Basic Med Coll, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Zhang, J; Xu, JW (corresponding author), Guangzhou Univ Chinese Med, Sch Chinese Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.; Xu, JW (corresponding author), Guangzhou Univ Chinese Med, Basic Med Coll, Guangzhou, Guangdong, Peoples R China.	zhangjun@gzucm.edu.cn; xujinwen@gzucm.edu.cn						Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Bassino E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119790; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Dou MY, 2016, EUR J PHARMACOL, V789, P395, DOI 10.1016/j.ejphar.2016.08.002; Downey JM, 2009, CIRC J, V73, P1171, DOI 10.1253/circj.CJ-09-0338; Duerr GD, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0425-x; Farrow SN, 1996, CURR OPIN GENET DEV, V6, P45, DOI 10.1016/S0959-437X(96)90009-X; Gao C, 2015, AM J PHYSIOL-HEART C, V308, pH1583, DOI 10.1152/ajpheart.00346.2014; Hai-Mei L, 2013, J CARDIOVASC PHARM, V62, P154, DOI 10.1097/FJC.0b013e31829497ea; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hausenloy DJ, 2013, CARDIOVASC RES, V98, P7, DOI 10.1093/cvr/cvt004; Jennings RB, 2013, CIRC RES, V113, P428, DOI 10.1161/CIRCRESAHA.113.300987; Jiang ZH, 2005, J NAT PROD, V68, P397, DOI 10.1021/np049735y; Li Q, 2016, BIOMED PHARMACOTHER, V84, P106, DOI 10.1016/j.biopha.2016.09.014; Liu CW, 2016, CARDIOVASC THER; Oikawa M, 2013, J MOL CELL CARDIOL, V64, P11, DOI 10.1016/j.yjmcc.2013.08.003; Rafiq K, 2014, CIRCULATION, V129, P2031, DOI 10.1161/CIRCULATIONAHA.113.007004; Singh SS, 2011, CURR PHARM DESIGN, V17, P1783; Vander Heide RS, 2013, CIRC RES, V113, P464, DOI 10.1161/CIRCRESAHA.113.300765; Wang JR, 2008, BIOL PHARM BULL, V31, P643, DOI 10.1248/bpb.31.643; Wang JR, 2008, CHEM BIODIVERS, V5, P1369, DOI 10.1002/cbdv.200890125; Wetzker R, 2004, CURR PHARM DESIGN, V10, P1915, DOI 10.2174/1381612043384402; Wu T, 2012, NAT PROD RES, V26, P1408, DOI 10.1080/14786419.2011.598155; Yang X, 2006, J ASIAN NAT PROD RES, V8, P505, DOI 10.1080/10286020500176344; Yang Y, 2013, CELL SIGNAL, V25, P615, DOI 10.1016/j.cellsig.2012.11.025; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yu LM, 2015, APOPTOSIS, V20, P796, DOI 10.1007/s10495-015-1122-4; Zhang YQ, 2015, AM J PHYSIOL-ENDOC M, V309, pE275, DOI 10.1152/ajpendo.00577.2014; Zhao WM, 1996, PHYTOCHEMISTRY, V42, P1131, DOI 10.1016/0031-9422(96)00086-6; Zhou YB, 2008, CHINESE CHEM LETT, V19, P550, DOI 10.1016/j.cclet.2008.03.017; Zhou Y, 2014, FITOTERAPIA, V97, P98, DOI 10.1016/j.fitote.2014.05.020; Zhou Y, 2013, PLANTA MED, V79, P70, DOI 10.1055/s-0032-1327927	32	21	21	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170984	10.1371/journal.pone.0170984	http://dx.doi.org/10.1371/journal.pone.0170984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182689	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800026
J	Zuo, XR; Chan, LS; Gao, JF				Zuo, Xuran; Chan, Lung Sang; Gao, Jian-Feng			Compression-extension transition of continental crust in a subduction zone: A parametric numerical modeling study with implications on Mesozoic-Cenozoic tectonic evolution of the Cathaysia Block	PLOS ONE			English	Article							SOUTH CHINA; SPATIAL-DISTRIBUTION; MARGIN TECTONICS; RHEOLOGY; INSIGHTS; INITIATION; BASIN; LITHOSPHERE; DEFORMATION; DYNAMICS	The Cathaysia Block is located in southeastern part of South China, which situates in the west Pacific subduction zone. It is thought to have undergone a compression-extension transition of the continental crust during Mesozoic-Cenozoic during the subduction of Pacific Plate beneath Eurasia-Pacific Plate, resulting in extensive magmatism, extensional basins and reactivation of fault systems. Although some mechanisms such as the trench roll-back have been generally proposed for the compression-extension transition, the timing and progress of the transition under a convergence setting remain ambiguous due to lack of suitable geological records and overprinting by later tectonic events. In this study, a numerical thermo-dynamical program was employed to evaluate how variable slab angles, thermal gradients of the lithospheres and convergence velocities would give rise to the change of crustal stress in a convergent subduction zone. Model results show that higher slab dip angle, lower convergence velocity and higher lithospheric thermal gradient facilitate the subduction process. The modeling results reveal the continental crust stress is dominated by horizontal compression during the early stage of the subduction, which could revert to a horizontal extension in the back-arc region, combing with the roll-back of the subducting slab and development of mantle upwelling. The parameters facilitating the subduction process also favor the compression-extension transition in the upper plate of the subduction zone. Such results corroborate the geology of the Cathaysia Block: the initiation of the extensional regime in the Cathaysia Block occurring was probably triggered by roll-back of the slowly subducting slab.	[Zuo, Xuran; Chan, Lung Sang] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China; [Gao, Jian-Feng] Chinese Acad Sci, Inst Geochem, State Key Lab Ore Deposit Geochem, Guiyang, Peoples R China	University of Hong Kong; Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS	Zuo, XR (corresponding author), Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China.	xuran.zuo@gmail.com	Gao, Jianfeng/L-7385-2019	Gao, Jianfeng/0000-0002-0553-025X; Zuo, Xuran/0000-0003-0549-7039	University of Hong Kong; Total Oil and Gas Company; Hundred Talent Program of Chinese Academy of Sciences	University of Hong Kong(University of Hong Kong); Total Oil and Gas Company; Hundred Talent Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	Xuran Zuo was supported by The University of Hong Kong and a grant from Total Oil and Gas Company while working on the project. Jian-Feng Gao was supported by the Hundred Talent Program of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; XZ wants to thank Prof. Evgeni Burov for providing the modeling code and modeling training during her master's study. We want to express our condolences to his decease months ago, which is a great loss to geodynamic modeling research. XZ also wants to express her gratitude to the University of Hong Kong for providing a 4-year-long PhD scholarship that made this study possible.	Angiboust S, 2012, EARTH PLANET SC LETT, V357, P238, DOI 10.1016/j.epsl.2012.09.012; Atwater T., 1970, GEOL SOC AM BULL, V81, P3513, DOI [DOI 10.1130/0016-7606(1970)81[3513:IOPTFT]2.0.CO;2, 10.1130/0016-7606(1970)81[3513:IOPTFT]2.0.CO;2]; Avouac JP, 1996, J GEOPHYS RES-SOL EA, V101, P17747, DOI 10.1029/96JB01344; Baitsch-Ghirardello B, 2014, GONDWANA RES, V25, P546, DOI 10.1016/j.gr.2012.11.003; BARAZANGI M, 1976, GEOLOGY, V4, P686, DOI 10.1130/0091-7613(1976)4<686:SDOEAS>2.0.CO;2; Beaumont C, 1999, J GEOPHYS RES-SOL EA, V104, P17573, DOI 10.1029/1999JB900136; Becker TW, 1999, J GEOPHYS RES-SOL EA, V104, P15207, DOI 10.1029/1999JB900140; Bercovici D, 2001, J GEOPHYS RES-SOL EA, V106, P8925, DOI 10.1029/2000JB900432; Burov E, 1997, EARTH PLANET SC LETT, V150, P7, DOI 10.1016/S0012-821X(97)00069-1; Burov EB, 2011, MAR PETROL GEOL, V28, P1402, DOI 10.1016/j.marpetgeo.2011.05.008; Burov E, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041535; Burov E, 2009, GEOPHYS J INT, V178, P1691, DOI 10.1111/j.1365-246X.2009.04238.x; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Capitanio FA, 2014, TECTONICS; Chen CH, 2008, LITHOS, V106, P83, DOI 10.1016/j.lithos.2008.06.009; CLOETINGH SAPL, 1982, NATURE, V297, P139, DOI 10.1038/297139a0; CLOETINGH SAPL, 1984, TECTONOPHYSICS, V109, P147, DOI 10.1016/0040-1951(84)90175-6; Connolly JAD, 2005, EARTH PLANET SC LETT, V236, P524, DOI 10.1016/j.epsl.2005.04.033; CUNDALL PA, 1989, ING ARCH, V59, P148, DOI 10.1007/BF00538368; ERICKSON SG, 1993, GEOLOGY, V21, P125, DOI 10.1130/0091-7613(1993)021<0125:SLLFAS>2.3.CO;2; Faccenda M, 2008, LITHOS, V103, P257, DOI 10.1016/j.lithos.2007.09.009; Faccenna C, 1999, J GEOPHYS RES-SOL EA, V104, P2749, DOI 10.1029/1998JB900072; Feldstein SN, 1999, J PETROL, V40, P1301, DOI 10.1093/petrology/40.8.1301; Francois T, 2012, TECTONOPHYSICS; Gerbault M, 1998, J STRUCT GEOL, V20, P301, DOI 10.1016/S0191-8141(97)00089-8; Gerya TV, 2011, J METAMORPH GEOL, V29, P7, DOI 10.1111/j.1525-1314.2010.00904.x; GILDER SA, 1991, TECTONOPHYSICS, V197, P225, DOI 10.1016/0040-1951(91)90043-R; GOETZE C, 1979, GEOPHYS J ROY ASTR S, V59, P463, DOI 10.1111/j.1365-246X.1979.tb02567.x; HAGER BH, 1978, TECTONOPHYSICS, V50, P111, DOI 10.1016/0040-1951(78)90130-0; Handy MR, 1996, GEOL RUNDSCH, V85, P832, DOI 10.1007/s005310050115; Heuret A, 2005, PHYS EARTH PLANET IN, V149, P31, DOI 10.1016/j.pepi.2004.08.022; Heuret A., 2005, DYNAMIQUE ZONES SUBD; Hole M.J., 1994, GEOLOGICAL SOC LONDO, V81, P265, DOI DOI 10.1144/GSL.SP.1994.081.01.15; Huet B, 2011, GEOPHYS J INT, V184, P611, DOI 10.1111/j.1365-246X.2010.04849.x; Huismans RS, 2001, J GEOPHYS RES-SOL EA, V106, P11271, DOI 10.1029/2000JB900424; Jabaloy A, 2003, TECTONOPHYSICS, V366, P55, DOI 10.1016/S0040-1951(03)00060-X; JARRARD RD, 1986, REV GEOPHYS, V24, P217, DOI 10.1029/RG024i002p00217; JORDAN TE, 1983, GEOL SOC AM BULL, V94, P341, DOI 10.1130/0016-7606(1983)94<341:ATRTGO>2.0.CO;2; KIRBY SH, 1987, REV GEOPHYS, V25, P1219, DOI 10.1029/RG025i006p01219; KOHLSTEDT DL, 1995, J GEOPHYS RES-SOL EA, V100, P17587, DOI 10.1029/95JB01460; Lallemand S, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000917; Lallemand S., 2009, SUBDUCTION ZONE GEOD; LARSON RL, 1972, GEOL SOC AM BULL, V83, P3645, DOI 10.1130/0016-7606(1972)83[3645:WCOMMA]2.0.CO;2; Li JH, 2014, EARTH-SCI REV, V134, P98, DOI 10.1016/j.earscirev.2014.03.008; Li ZX, 2012, TECTONOPHYSICS, V532, P271, DOI 10.1016/j.tecto.2012.02.011; Ludmann T, 1999, TECTONOPHYSICS, V311, P113, DOI 10.1016/S0040-1951(99)00155-9; MA XY, 1987, TECTONOPHYSICS, V133, P243, DOI 10.1016/0040-1951(87)90268-X; Maruyama S, 1997, ISL ARC, V6, P121, DOI 10.1111/j.1440-1738.1997.tb00043.x; MCCAFFREY R, 1995, SCIENCE, V267, P856, DOI 10.1126/science.267.5199.856; NORTHRUP CJ, 1995, GEOLOGY, V23, P719, DOI 10.1130/0091-7613(1995)023<0719:MOTPPR>2.3.CO;2; PEARCE JA, 1995, ANNU REV EARTH PL SC, V23, P251, DOI 10.1146/annurev.ea.23.050195.001343; Pfiffner OA, 2000, TECTONICS, V19, P1065, DOI 10.1029/2000TC900019; RANALLI G, 1987, TECTONOPHYSICS, V132, P281, DOI 10.1016/0040-1951(87)90348-9; Ranalli G., 1995, RHEOLOGY EARTH; Ren JY, 2002, TECTONOPHYSICS, V344, P175, DOI 10.1016/S0040-1951(01)00271-2; RUFF L, 1980, PHYS EARTH PLANET IN, V23, P240, DOI 10.1016/0031-9201(80)90117-X; Shao JA, 2001, ACTA GEOL SIN-ENGL, V75, P1; SHEA WT, 1992, J GEOPHYS RES-SOL EA, V97, P15201, DOI 10.1029/92JB00620; Shu LS, 2009, J ASIAN EARTH SCI, V34, P376, DOI 10.1016/j.jseaes.2008.06.004; Shu LS, 2007, ACTA GEOL SIN-ENGL, V81, P573; SIMPSON EL, 1989, GEOL SOC AM BULL, V101, P42, DOI 10.1130/0016-7606(1989)101<0042:SOTUFI>2.3.CO;2; Solomatov VS, 2000, J GEOPHYS RES-SOL EA, V105, P21795, DOI 10.1029/2000JB900197; STOCKMAL GS, 1986, AAPG BULL, V70, P181; Tamura Y, 2002, EARTH PLANET SC LETT, V197, P105, DOI 10.1016/S0012-821X(02)00465-X; Thielmann M, 2012, EARTH PLANET SC LETT, V359, P1, DOI 10.1016/j.epsl.2012.10.002; TIAN ZY, 1992, TECTONOPHYSICS, V208, P341, DOI 10.1016/0040-1951(92)90354-9; Tirel C, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2005JB003694; Turcotte D.L., 2002, GEODYNAMICS, DOI DOI 10.1002/GJ.987; Wang YJ, 2013, GONDWANA RES, V23, P1273, DOI 10.1016/j.gr.2012.02.019; WILKS KR, 1990, TECTONOPHYSICS, V182, P57, DOI 10.1016/0040-1951(90)90342-6; WOODS MT, 1982, EARTH PLANET SC LETT, V58, P161, DOI 10.1016/0012-821X(82)90191-1; XU JW, 1987, TECTONOPHYSICS, V134, P273, DOI 10.1016/0040-1951(87)90342-8; Yamato P, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004441; Yamato P, 2008, EARTH PLANET SC LETT, V271, P63, DOI 10.1016/j.epsl.2008.03.049; Yamato P, 2006, CONTRAINTES ZONES CO; YU HS, 1990, TECTONOPHYSICS, V183, P177, DOI 10.1016/0040-1951(90)90415-5; Zhou XM, 2006, EPISODES, V29, P26, DOI 10.18814/epiiugs/2006/v29i1/004; Zhou XM, 2000, TECTONOPHYSICS, V326, P269, DOI 10.1016/S0040-1951(00)00120-7; Zhu G, 2005, J STRUCT GEOL, V27, P1379, DOI 10.1016/j.jsg.2005.04.007; Zuo X., 2015, ACTIVE PASSIVE MARGI	80	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171536	10.1371/journal.pone.0171536	http://dx.doi.org/10.1371/journal.pone.0171536			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182640	gold, Green Published, Green Submitted			2022-12-26	WOS:000394231800071
J	Awadasseid, A; Hou, J; Gamallat, Y; Shang, XQ; Eugene, KD; Hago, AM; Bamba, D; Meyiah, A; Gift, C; Xin, Y				Awadasseid, Annoor; Hou, Jie; Gamallat, Yaser; Shang Xueqi; Eugene, Kuugbee D.; Hago, Ahmed Musa; Bamba, Djibril; Meyiah, Abdo; Gift, Chiwala; Xin, Yi			Purification, characterization, and antitumor activity of a novel glucan from the fruiting bodies of Coriolus Versicolor	PLOS ONE			English	Article							PSK INDUCES APOPTOSIS; BETA-GLUCANS; STRUCTURAL ELUCIDATION; POLYSACCHARIDES; CANCER; MUSHROOM; EXTRACTION; ANTIOXIDANT; CELLS	Cancer is one of the most common causes of deaths worldwide. Herein, we report an efficient natural anticancer glucan (CVG) extracted from Coriolus Versicolar (CV). CVG was extracted by the hot water extraction method followed by ethanol precipitation and purified using gas exclusion chromatography. Structural analysis revealed that CVG has a linear aglucan chain composed of only (1 -> 6)-alpha-D-Glcp. The antitumor activity of CVG on Sarcoma -180 cells was investigated in vitro and in vivo. Mice were treated with three doses of CVG (40, 100, 200 mg/kg body weight) for 9 days. Tumor weight, relative spleen, thymus weight, and lymphocyte proliferation were studied. A significant increase (P< 0.01) in relative spleen and thymus weight and a decrease (P< 0.01) in tumor weight at the doses of 100 and 200 mg/kg were observed. The results obtained demonstrate CVG has antitumor activity towards Sarcoma -180 cells by its immunomodulation activity.	[Awadasseid, Annoor; Hou, Jie; Gamallat, Yaser; Shang Xueqi; Eugene, Kuugbee D.; Bamba, Djibril; Meyiah, Abdo; Gift, Chiwala; Xin, Yi] Dalian Med Univ, Dept Biotechnol, Dalian, Peoples R China; [Awadasseid, Annoor] Northeast Normal Univ, Dept Biochem & Mol Biol, Changchun, Peoples R China; [Awadasseid, Annoor] Univ Kordofan, Dept Biochem & Food Sci, Al Ubayyid, Sudan; [Hago, Ahmed Musa] Dalian Med Univ, Dept Pathol & Pathophysiol, Dalian, Peoples R China	Dalian Medical University; Northeast Normal University - China; Dalian Medical University	Xin, Y (corresponding author), Dalian Med Univ, Dept Biotechnol, Dalian, Peoples R China.	jimxin@hotmail.com	Gamallat, Yaser/C-4157-2016; Bakheet, Ahmed/GMW-6033-2022; AWADASSEID, ANNOOR/ABB-6146-2020	Gamallat, Yaser/0000-0001-9980-2107; Bakheet, Ahmed/0000-0002-1016-2594; 	Science and Technology Department Program of Liaoning Province of China [2,011,225,013]	Science and Technology Department Program of Liaoning Province of China	This work was supported by the Science and Technology Department Program of Liaoning Province of China (2,011,225,013).	Aguirre MJ, 2009, CARBOHYD RES, V344, P1095, DOI 10.1016/j.carres.2009.03.024; Al-Fatimi Mohamed, 2016, Medicines (Basel), V3, DOI 10.3390/medicines3020010; Apaya MK, 2016, PHARMACOL THERAPEUT, V162, P58, DOI 10.1016/j.pharmthera.2016.03.001; Baeg IH, 2013, J GINSENG RES, V37, P1, DOI 10.5142/jgr.2013.37.1; Bi H, 2011, COMPLEMENTARY ALTERN, V2011; Casey SC, 2014, IMMUNOL RES, V58, P282, DOI 10.1007/s12026-014-8503-6; Castro P, 2016, WORLD SUSTAIN SER, P13, DOI 10.1007/978-3-319-32318-3_2; Choi Deok-Gyun, 2016, Journal of Ecology and Environment, V39, P81, DOI 10.5141/ecoenv.2016.009; Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004; Cui T, 2003, BIOTECHNOL ADV, V21, P109, DOI 10.1016/S0734-9750(03)00002-8; Ferreira SS, 2015, CARBOHYD POLYM, V132, P378, DOI 10.1016/j.carbpol.2015.05.079; Hirahara N, 2012, ANTICANCER RES, V32, P2631; Hirahara N, 2011, ANTICANCER RES, V31, P2733; Huang F, 2014, MOLECULES, V19, P3909, DOI 10.3390/molecules19043909; Ito G, 2012, EXP THER MED, V3, P925, DOI 10.3892/etm.2012.537; Jang SA, 2011, BIOMOL THER, V19, P438, DOI 10.4062/biomolther.2011.19.4.438; Jeff IB, 2016, CENT EUR J IMMUNOL, V41, P47, DOI 10.5114/ceji.2015.56962; Jia XJ, 2015, MOLECULES, V20, P20901, DOI 10.3390/molecules201119734; Kaviyarasan V., 2014, Proceedings of 8th International Conference on Mushroom Biology and Mushroom Products (ICMBMP8), New Delhi, India, 19-22 November 2014. Volume I & II, P385; Kodama Noriko, 2003, Journal of Medicinal Food, V6, P371, DOI 10.1089/109662003772519949; Kowalczewska M, 2016, IMMUNOL LETT, V174, P37, DOI 10.1016/j.imlet.2016.04.010; Li F, 2009, CARBOHYD POLYM, V78, P80, DOI 10.1016/j.carbpol.2009.04.005; Lili Z, 2013, AFRICAN J PHARM PHAR, V7, P721; Lim BO, 2011, PHYTOTHER RES, V25, P1257, DOI 10.1002/ptr.3378; Lu MK, 2010, FOOD CHEM, V118, P349, DOI 10.1016/j.foodchem.2009.04.126; Luk SU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019804; Luo KW, 2014, PHYTOMEDICINE, V21, P1078, DOI 10.1016/j.phymed.2014.04.020; Luo X, 2008, FOOD CHEM, V111, P357, DOI 10.1016/j.foodchem.2008.03.076; Mondal S, 2004, CARBOHYD RES, V339, P1135, DOI 10.1016/j.carres.2004.02.019; Moradali MF, 2007, INT IMMUNOPHARMACOL, V7, P701, DOI 10.1016/j.intimp.2007.01.008; Ni WH, 2009, CARBOHYD RES, V344, P2512, DOI 10.1016/j.carres.2009.08.042; Novak M, 2008, J IMMUNOTOXICOL, V5, P47, DOI 10.1080/15476910802019045; Ren DY, 2015, CHEM-BIOL INTERACT, V237, P166, DOI 10.1016/j.cbi.2015.06.017; Rendueles O, 2013, ENVIRON MICROBIOL, V15, P334, DOI 10.1111/j.1462-2920.2012.02810.x; Ringo E, 2016, AQUACULT NUTR, V22, P4, DOI 10.1111/anu.12349; Ruthes AC, 2016, CARBOHYD POLYM, V136, P358, DOI 10.1016/j.carbpol.2015.08.061; Ruthes AC, 2015, CARBOHYD POLYM, V117, P753, DOI 10.1016/j.carbpol.2014.10.051; Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005; Sekhon BK, 2013, FOOD CHEM, V138, P2201, DOI 10.1016/j.foodchem.2012.11.009; Semedo MC, 2015, J MICROBIOL METH, V109, P140, DOI 10.1016/j.mimet.2014.12.020; Shrestha B, 2012, MYCOL PROG, V11, P599, DOI 10.1007/s11557-012-0825-y; Stadler M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00127; Stamets P., 2000, GROWING GOURMET MED, V3; Thongbai B, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-015-1105-4; Velusamy B, 2016, INT J PHARM SCI RES, V7, P2065, DOI 10.13040/IJPSR.0975-8232.7(5).2065-73; Vetvicka V, 2009, J IMMUNOTOXICOL, V6, P30, DOI 10.1080/15476910802604317; Wan JMF, 2010, CHINESE MED, V5, P1; Wang Dao-feng, 2012, Cancer Biology Medicine, V9, P164, DOI 10.7497/j.issn.2095-3941.2012.03.002; Wang FF, 2014, LECT NOTES ELECTR EN, V249, P393, DOI 10.1007/978-3-642-37916-1_40; Wang JH, 2010, CARBOHYD RES, V345, P1023, DOI 10.1016/j.carres.2010.03.005; Wang ZX, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0100-5; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; Yang SF, 2015, MOL IMMUNOL, V64, P144, DOI 10.1016/j.molimm.2014.11.007; Yi Y, 2011, MOLECULES, V16, P6148, DOI 10.3390/molecules16076148; Yu RM, 2009, CARBOHYD POLYM, V75, P166, DOI 10.1016/j.carbpol.2008.07.023; Zaidman BZ, 2005, APPL MICROBIOL BIOT, V67, P453, DOI 10.1007/s00253-004-1787-z; Zheng YF, 2016, CARBOHYD POLYM, V144, P438, DOI 10.1016/j.carbpol.2016.02.073	57	18	19	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171270	10.1371/journal.pone.0171270	http://dx.doi.org/10.1371/journal.pone.0171270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178285	Green Published, Green Submitted, gold			2022-12-26	WOS:000393712500035
J	Guiot, J; Henket, M; Corhay, JL; Moermans, C; Louis, R				Guiot, J.; Henket, M.; Corhay, J. L.; Moermans, C.; Louis, R.			Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; INTERSTITIAL LUNG-DISEASES; BRONCHOALVEOLAR LAVAGE; YKL-40 LEVELS; SERUM-LEVEL; KL-6; INTERLEUKIN-8; INFLAMMATION; SARCOIDOSIS	Background Idiopathic pulmonary fibrosis (IPF) is a rare lung disease of unknown origin leading rapidly to death. This paper addresses the issue of whether sputum induction is a suitable tool to study respiratory tract inflammation and potential biomarkers in IPF compared to COPD, a fibrosing airway wall disease. Methods In a cross-sectional analysis, 15 IPF patients, 32 COPD and 30 healthy subjects underwent sputum induction. Total sputum cell counts and the amount of TGF-gamma, IGF-1, IGF-2, IGFBP-1, IGFBP-2, IGFBP-3, IL-8, IL-13, MMP-7, MMP-9, YKL-40, TNF-alpha and KL-6 in sputum supernatant were analysed. We also profiled gene expression of cells in the induced sputum for TGF-beta, MMP-7, YKL-40, IGFBP-2, IL-6, IL-8 and TNF-alpha. Results IPF patients, like COPD, had increased sputum absolute number of neutrophils, eosinophils, macrophages and epithelial cells compared to HS. IPF sputum supernatants had increased concentrations of IGFBP-2, IL-8, TGF-beta, MMP-7, MMP-9 and KL-6 (p<0.05, p<0.0001, p<0.05, p<0.05, p<0.0001, p<0.05 respectively) when compared to healthy subjects where COPD had higher IL-6 and TNF-alpha levels than IPF (p<0.05 and p<0.05 respectively) and HS (p<0.0001 and p<0.001 respectively) and higher IL-8 and MMP-9 than HS (p<0.0001 and p<0.001 respectively). Conversely to IL -6 and TNF-alpha, MMP-7 was increased in IPF compared to COPD (p<0.05). The KL-6 and MMP-7 protein levels in sputum were inversely correlated with total lung capacity (TLC, % of predicted) in IPF patients (r = -0.73 and r = -0.53 respectively). Sputum gene expression analysis identified a significant increase for IGFBP-2, IL -6, IL-8 and MMP-7 in IPF compared to HS (p<0.05, p<0.01, p<0.05 and p<0.0001 respectively) and for IGFBP-2, YKL-40, IL-6, IL-8 and MMP-7 compared to COPD (p<0.01, p<0.01, p<0.05, p<0.01 and p<0.0001 respectively). Furthermore, gene expression of TGF-beta was increased in IPF compared to COPD (p<0.001) but not to HS. Conclusion Our data show clear increase in expression and production of IGFBP-2, IL-8 and MMP-7 in sputum from patients with IPF that may contribute to the disease.	[Guiot, J.; Henket, M.; Corhay, J. L.; Moermans, C.; Louis, R.] CHU Liege, Dept Pneumol, Dept Pneumol, Domaine Univ Sart Tilman, Liege, Belgium	University of Liege	Guiot, J (corresponding author), CHU Liege, Dept Pneumol, Dept Pneumol, Domaine Univ Sart Tilman, Liege, Belgium.	J.Guiot@chu.ulg.ac.be		Guiot, Julien/0000-0001-7800-1730				Antoniou KM, 2005, SARCOIDOSIS VASC DIF, V22, P204; Antoniou KM, 2005, RESPIRATION, V72, P32, DOI 10.1159/000083398; Balestro E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154516; Beeh KM, 2003, SARCOIDOSIS VASC DIF, V20, P138; Beeh KM, 2003, RESP MED, V97, P634, DOI 10.1053/rmed.2003.1493; Chadelat K, 1998, EUR RESPIR J, V11, P1329, DOI 10.1183/09031936.98.11061329; da Silva J, 2016, CLIN EXPT ALLERGY J; Delvaux M, 2004, THORAX, V59, P111, DOI 10.1136/thorax.2003.011130; Domagaa-Kulawik J, 2012, INFLAMMATION, V35, P803, DOI 10.1007/s10753-011-9378-5; Doubkova M, 2016, SARCOIDOSIS VASC DIF, V33, P224; Fireman E, 1999, RESP MED, V93, P827, DOI 10.1016/S0954-6111(99)90269-X; Fireman E, 2006, CURR OPIN PULM MED, V12, P318, DOI 10.1097/01.mcp.0000239547.62949.82; Gielen V, 2010, EUR RESPIR J, V36, P646, DOI 10.1183/09031936.00095809; Guiot J, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0249-6; Huh JW, 2008, CHEST, V133, P1101, DOI 10.1378/chest.07-2116; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; KOBAYASHI J, 1995, CHEST, V108, P311, DOI 10.1378/chest.108.2.311; Korthagen NM, 2014, LUNG, V192, P975, DOI 10.1007/s00408-014-9647-9; Korthagen NM, 2011, RESP MED, V105, P106, DOI 10.1016/j.rmed.2010.09.012; Ley B, 2014, AM J PHYSIOL-LUNG C, V307, pL681, DOI 10.1152/ajplung.00014.2014; Meloni F, 2004, SARCOIDOSIS VASC DIF, V21, P111; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moermans C, 2011, CYTOKINE, V56, P298, DOI 10.1016/j.cyto.2011.07.010; Moodley YP, 2003, AM J PATHOL, V163, P345, DOI 10.1016/S0002-9440(10)63658-9; Ohshimo S, 2014, RESP MED, V108, P1031, DOI 10.1016/j.rmed.2014.04.009; Pardo A, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0343-6; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Samukawa T, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-55; Schnyder B, 1999, LAB INVEST, V79, P1403; Tajiri M, 2015, RESPIR INVESTIG, V53, P73, DOI 10.1016/j.resinv.2014.12.003; Ten Klooster L, 2015, CLIN EXPT IMMUNOLOGY; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vuga LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083120; Ziegenhagen MW, 1998, AM J RESP CRIT CARE, V157, P762, DOI 10.1164/ajrccm.157.3.9705014; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	36	55	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171344	10.1371/journal.pone.0171344	http://dx.doi.org/10.1371/journal.pone.0171344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178340	gold, Green Submitted, Green Published			2022-12-26	WOS:000393712500037
J	Lee, SW; Kim, HC; Lee, YH; Song, BM; Choi, H; Park, JH; Rhee, Y; Kim, CO				Lee, Seung Won; Kim, Hyeon Chang; Lee, Yong-ho; Song, Bo Mi; Choi, Hansol; Park, Ji Hye; Rhee, Yumie; Kim, Chang Oh			Association between HbA1c and carotid atherosclerosis among elderly Koreans with normal fasting glucose	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; PLASMA-GLUCOSE; GLYCOSYLATED HEMOGLOBIN; MYOCARDIAL-INFARCTION; GLYCATED HEMOGLOBIN; ARTERIAL STIFFNESS; INSULIN-RESISTANCE; METABOLIC SYNDROME	Aim We examined whether glycated haemoglobin (HbA1c) is associated to carotid atherosclerosis in an elderly Korean population with normal fasting glucose. Methods Using data from the Korean Urban Rural Elderly study, we conducted a cross-sectional analysis of 1,133 participants (335 men and 798 women) with a mean age of 71.8 years. All participants had fasting blood glucose less than 100mg/dL (5.6 mmol/L) and HbA1c level below 6.5% (48 mmol/mol). They were also free from a history of cardiovascular disease, known type 2 diabetes mellitus or use of anti-diabetes medications. Carotid atherosclerosis was assessed by intima-media thickness (IMT) using ultrasonography. The association between HbA1c and carotid IMT was investigated using multivariable linear regression analysis. Results HbA1c levels were independently and positively associated with carotid IMT (beta = 0.020, p = 0.045) after adjusting for sex, age, body mass index, systolic blood pressure, diastolic blood pressure, triglyceride, LDL cholesterol, smoking and alcohol intake. However, fasting insulin and glucose levels were not associated with carotid IMT. Conclusion HbA1c levels were positively associated with carotid atherosclerosis, as assessed by carotid IMT, in an elderly population with normoglycemia. Our study suggested that higher HbA1c level is an effective and informative marker of carotid atherosclerosis in an elderly population.	[Lee, Seung Won; Song, Bo Mi; Choi, Hansol; Park, Ji Hye] Yonsei Univ, Dept Publ Hlth, Grad Sch, Seoul, South Korea; [Lee, Seung Won; Kim, Hyeon Chang; Song, Bo Mi] Yonsei Univ, Cardiovasc & Metab Dis Etiol Res Ctr, Coll Med, Seoul, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Lee, Yong-ho; Rhee, Yumie; Kim, Chang Oh] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, HC (corresponding author), Yonsei Univ, Cardiovasc & Metab Dis Etiol Res Ctr, Coll Med, Seoul, South Korea.; Kim, HC (corresponding author), Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.; Kim, CO (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	hckim@yuhs.ac; cokim@yuhs.ac	Lee, Yong-ho/AAT-4106-2020; Rhee, Yumie/L-8020-2019; Kim, Hyeon Chang/F-8796-2019	Lee, Yong-ho/0000-0002-6219-4942; Rhee, Yumie/0000-0003-4227-5638; Kim, Hyeon Chang/0000-0001-7867-1240; Kim, Chang Oh/0000-0002-0773-5443	Korea Centers for Disease Control and Prevention [2012-E63001-001, 2013-E63007-00]; Korean Health Technology R&D Project, Ministry of Health Welfare, Korea [H113C0715]	Korea Centers for Disease Control and Prevention; Korean Health Technology R&D Project, Ministry of Health Welfare, Korea	This work was supported by the Korea Centers for Disease Control and Prevention (2012-E63001-001, 2013-E63007-00); and the Korean Health Technology R&D Project, Ministry of Health & Welfare, Korea (H113C0715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2002, CARDIOVASC DIABETOL, V1, DOI 10.1186/1475-2840-1-1; BLANKENHORN DH, 1993, CIRCULATION, V88, P20, DOI 10.1161/01.CIR.88.1.20; Bobbert T, 2010, DIABETES CARE, V33, P203, DOI 10.2337/dc09-1009; Bonora E, 1999, DIABETES CARE, V22, P1339, DOI 10.2337/diacare.22.8.1339; BOTS ML, 1994, J CLIN EPIDEMIOL, V47, P921, DOI 10.1016/0895-4356(94)90196-1; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; BOWIE A, 1993, ATHEROSCLEROSIS, V102, P63, DOI 10.1016/0021-9150(93)90084-8; Chen LY, 2015, ATHEROSCLEROSIS, V240, P345, DOI 10.1016/j.atherosclerosis.2015.03.031; Chistiakov DA, 2015, J CELLULAR MOL MED; Choi H, 2016, ARCH GERONTOL GERIAT, V64, P51, DOI 10.1016/j.archger.2016.01.005; Choi SW, 2011, J DIABETES COMPLICAT, V25, P7, DOI 10.1016/j.jdiacomp.2009.12.001; de Groot E, 2008, NAT CLIN PRACT CARD, V5, P280, DOI 10.1038/ncpcardio1163; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FURBERG CD, 1994, CIRCULATION, V90, P1679, DOI 10.1161/01.CIR.90.4.1679; Hirai FE, 2008, DIABETES CARE, V31, P493, DOI 10.2337/dc07-1161; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; Hung CS, 2011, CLIN ENDOCRINOL, V75, P780, DOI 10.1111/j.1365-2265.2011.04129.x; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; 이정현, 2016, [Journal of Health Informatics and Statistics, 보건정보통계학회지], V41, P49, DOI 10.210332/jhis.2016.41.1.49; Lee EY, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-33; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Lee YH, 2016, ATHEROSCLEROSIS, V247, P1, DOI 10.1016/j.atherosclerosis.2016.01.032; Marshall SM, 2000, DIABETIC MED, V17, P5, DOI 10.1046/j.1464-5491.2000.00228.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McNeely MJ, 2009, DIABETES CARE, V32, P1727, DOI 10.2337/dc09-0074; Mohan V, 2000, DIABETOLOGIA, V43, P494, DOI 10.1007/s001250051334; Monnier Louis, 2006, Endocr Pract, V12 Suppl 1, P42; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; PERSSON J, 1992, ARTERIOSCLER THROMB, V12, P261, DOI 10.1161/01.ATV.12.2.261; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; Selvin E, 2005, DIABETES CARE, V28, P1965, DOI 10.2337/diacare.28.8.1965; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Simsek E, 2010, TURKISH J PEDIATR, V52, P602; SINGER DE, 1992, DIABETES, V41, P202, DOI 10.2337/diabetes.41.2.202; Song BM, 2016, J AFFECT DISORDERS, V189, P357, DOI 10.1016/j.jad.2015.09.043; Song BM, 2014, NUTRIENTS, V6, P5806, DOI 10.3390/nu6125806; Succurro E, 2009, ATHEROSCLEROSIS, V207, P245, DOI 10.1016/j.atherosclerosis.2009.04.006; Temelkova-Kurktschiev TS, 2000, DIABETES CARE, V23, P1830, DOI 10.2337/diacare.23.12.1830; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Venkataraman V, 2012, J DIABETES COMPLICAT, V26, P526, DOI 10.1016/j.jdiacomp.2012.06.002; Vitelli LL, 1997, DIABETES CARE, V20, P1454, DOI 10.2337/diacare.20.9.1454	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171761	10.1371/journal.pone.0171761	http://dx.doi.org/10.1371/journal.pone.0171761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178313	gold, Green Submitted, Green Published			2022-12-26	WOS:000393712500068
J	Luthy, C; Gerstel, PF; Pugliesi, A; Piguet, V; Allaz, AF; Cedraschi, C				Luthy, Christophe; Gerstel, Patricia Francis; Pugliesi, Angela; Piguet, Valerie; Allaz, Anne-Francoise; Cedraschi, Christine			Bedside or not bedside: Evaluation of patient satisfaction in intensive medical rehabilitation wards	PLOS ONE			English	Article							CASE PRESENTATIONS; EXAMINATION ROOM; WORK-ROUNDS; CARE; PERSPECTIVES; PERCEPTIONS; VALIDATION; IMPACT; TRIAL	Background Concerns that bedside presentation (BsP) rounds could make patients uncomfortable led many residency programs to move daily rounds outside the patients' room (OsPR). We performed a prospective quasi-experimental controlled study measuring the effect of these two approaches on patient satisfaction. Methods Patient satisfaction was measured using the Picker questionnaire (PiQ). Results are expressed in problematic percentage scores scaled from 0 = best-100 = worst. During three months, 3 wards of a 6 ward medical rehabilitation division implemented BsP and 3 control wards kept their usual organization of rounds. In total, 90 patients of each group were included in the study and completed the PiQ. Results Socio-clinical characteristics were similar in both groups: mean age = 67 years (SD = 13), mean Charlson comorbidity index = 8.6 (2.4); mean length of stay = 22 days (12). During their stay, patients in the BsP units had a mean of 14.3 (8) BsP rounds and 0.5 (0.8) OsPR; control patients had a mean of 0.9 (0.7) BsP and 14.8 (7.3) OsPR (p< 0.0001). Patients in BsP units reported lower problematic scores regarding coordination of care (39% vs 45%, p = 0.029), involvement of family/friends (29 vs 41%, p = 0.006) and continuity/transition (44% vs 54%, p = 0.020); two questions of the PiQ had worse scores in the BsP: trust in nurses (46.7% vs 30 %, p = 0.021) and recommendation of the institution (61.1% vs 44.4%. p = 0.025). No worsening in dimensions such as respect for patient preferences was seen. Conclusions BsP rounds influenced the patient-healthcare professionals' encounter. These rounds were associated with improved patient satisfaction with care, particularly regarding interprofessional collaboration and discharge planning.	[Luthy, Christophe; Allaz, Anne-Francoise; Cedraschi, Christine] Univ Hosp Geneva, Div Gen Med Rehabil, Geneva, Switzerland; [Luthy, Christophe; Piguet, Valerie; Allaz, Anne-Francoise; Cedraschi, Christine] Univ Geneva, Geneva, Switzerland; [Gerstel, Patricia Francis] Univ Hosp Geneva, Div Qual Care, Geneva, Switzerland; [Pugliesi, Angela] Univ Hosp Geneva, Div Oncol, Geneva, Switzerland; [Piguet, Valerie] Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, Geneva, Switzerland; [Gerstel, Patricia Francis] Clin Colline, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Luthy, C (corresponding author), Univ Hosp Geneva, Div Gen Med Rehabil, Geneva, Switzerland.; Luthy, C (corresponding author), Univ Geneva, Geneva, Switzerland.	Christophe.luthy@hcuge.ch						Anderson RJ, 2002, AM J MED, V113, P657, DOI 10.1016/S0002-9343(02)01320-7; ASHTON CM, 1994, J GEN INTERN MED, V9, P208, DOI 10.1007/BF02600126; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chauke HL, 2006, SAMJ S AFR MED J, V96, P398; Conroy KM, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0060-1; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Gonzalo JD, 2014, J GEN INTERN MED, V29, P1040, DOI 10.1007/s11606-014-2817-x; Gonzalo JD, 2014, ACAD MED, V89, P326, DOI 10.1097/ACM.0000000000000100; Gonzalo JD, 2010, J GEN INTERN MED, V25, P792, DOI 10.1007/s11606-010-1344-7; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Jenkinson C, 2002, INT J QUAL HEALTH C, V14, P353, DOI 10.1093/intqhc/14.5.353; Kianmehr N, 2010, SAUDI MED J, V31, P565; Kim MM, 2010, ARCH INTERN MED, V170, P369, DOI 10.1001/archinternmed.2009.521; Kirthi V, 2012, OYAL COLL PHYS ROYAL, DOI [10.1136/bmiqs-2013-002436, DOI 10.1136/BMIQS-2013-002436]; KROENKE K, 1990, J GEN INTERN MED, V5, P229, DOI 10.1007/BF02600540; Kutney-Lee A, 2009, HEALTH AFFAIR, V28, pW669, DOI 10.1377/hlthaff.28.4.w669; Landry MA, 2007, PEDIATRICS, V120, P275, DOI 10.1542/peds.2007-0107; Lehmann LS, 1997, NEW ENGL J MED, V336, P1150, DOI 10.1056/NEJM199704173361606; LEWIS C, 1988, J PEDIATR-US, V112, P378, DOI 10.1016/S0022-3476(88)80316-0; LINFORS EW, 1980, NEW ENGL J MED, V303, P1230, DOI 10.1056/NEJM198011203032110; Luthy C, 2005, SWISS MED WKLY, V135, P82; Muller-Juge V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057570; New PW, 2008, J REHABIL MED, V40, P678, DOI 10.2340/16501977-0224; Norgaard K, 2004, MED EDUC, V38, P700, DOI 10.1111/j.1365-2929.2004.01840.x; Paice E, 2002, BMJ-BRIT MED J, V325, P707, DOI 10.1136/bmj.325.7366.707; Pannick S, 2015, JAMA INTERN MED, V175, P1288, DOI 10.1001/jamainternmed.2015.2421; Papastavrou E, 2014, BMC NURS, V13, DOI 10.1186/1472-6955-13-26; Perneger TV, 2003, MED CARE, V41, P1343, DOI 10.1097/01.MLR.0000100580.94559.AD; Ramani S, 2003, ACAD MED, V78, P384, DOI 10.1097/00001888-200304000-00014; Rogers HD, 2003, ACAD MED, V78, P945, DOI 10.1097/00001888-200309000-00023; Seo M, 2000, MED EDUC, V34, P409, DOI 10.1046/j.1365-2923.2000.00516.x; Sox HC, 2016, JAMA-J AM MED ASSOC, V316, P1205, DOI 10.1001/jama.2016.11409; Tariq M, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-53; Taylor SP, 2014, BMJ QUAL SAF, V23, P584, DOI 10.1136/bmjqs-2013-002436; WANGCHENG RM, 1989, J GEN INTERN MED, V4, P284, DOI 10.1007/BF02597397; Ward DR, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-37; WRAY NP, 1986, J MED EDUC, V61, P893; Wright SM, 1998, NEW ENGL J MED, V339, P1986, DOI 10.1056/NEJM199812313392706; Zwarentein M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000072.pub2	39	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170474	10.1371/journal.pone.0170474	http://dx.doi.org/10.1371/journal.pone.0170474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1SG	28170431	Green Published, gold, Green Submitted			2022-12-26	WOS:000393705500006
J	Soler, M; Ruiz-Raya, F; Roncalli, G; Ibanez-Alamo, JD				Soler, Manuel; Ruiz-Raya, Francisco; Roncalli, Gianluca; Diego Ibanez-Alamo, Juan			Relationships between egg-recognition and egg-ejection in a grasp-ejector species	PLOS ONE			English	Article							BILL-SIZE CONSTRAINTS; CUCULUS-CANORUS; PARASITIC EGGS; COWBIRD EGGS; REJECTION BEHAVIOR; BROOD PARASITISM; REED WARBLERS; TURDUS-MERULA; MODEL SYSTEM; CUCKOO	Brood parasitism frequently leads to a total loss of host fitness, which selects for the evolution of defensive traits in host species. Experimental studies have demonstrated that recognition and rejection of the parasite egg is the most common and efficient defence used by host species. Egg-recognition experiments have advanced our knowledge of the evolutionary and coevolutionary implications of egg recognition and rejection. However, our understanding of the proximate mechanisms underlying both processes remains poor. Egg rejection is a complex behavioural process consisting of three stages: egg recognition, the decision whether or not to reject the putative parasitic egg and the act of ejection itself. We have used the blackbird (Turdus merula) as a model species to explore the relationship between egg recognition and the act of egg ejection. We have manipulated the two main characteristics of parasitic eggs affecting egg ejection in this grasp-ejector species: the degree of colour mimicry (mimetic and non-mimetic, which mainly affects the egg-recognition stage of the egg-rejection process) and egg size (small, medium and large, which affects the decision to eject), while maintaining a control group of non-parasitized nests. The behaviour of the female when confronted with an experimental egg was filmed using a video camera. Our results show that egg touching is an indication of egg recognition and demonstrate that blackbirds recognized (i.e., touched) non-mimetic experimental eggs significantly more than mimetic eggs. However, twenty per cent of the experimental eggs were touched but not subsequently ejected, which confirms that egg recognition does not necessarily mean egg ejection and that accepting parasitic eggs, at least sometimes, is the consequence of acceptance decisions. Regarding proximate mechanisms, our results show that the delay in egg ejection is not only due to recognition problems as usually suggested, given that experimental eggs are not touched significantly more often. Thus, the delay in egg ejection is mainly the consequence of a delay in the decision to eject, probably triggered by mechanical constraints imposed by eggs that are harder to eject (i.e. larger). Our results offer important information on the relationships between recognition and ejection and contribute to a better understanding of host defences against brood parasites.	[Soler, Manuel; Ruiz-Raya, Francisco; Roncalli, Gianluca] Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain; [Diego Ibanez-Alamo, Juan] Univ Groningen, Behav & Physiol Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Diego Ibanez-Alamo, Juan] CSIC, Dept Wetland Ecol, Estn Biol Donana, Avda Sevilla, Seville, Spain	University of Granada; University of Groningen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Soler, M (corresponding author), Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain.	msoler@ugr.es	Roncalli, Gianluca/AFX-9281-2022; Ruiz-Raya, Francisco/L-8639-2019; Ibáñez-Álamo, Juan Diego/H-7624-2019	Roncalli, Gianluca/0000-0002-0593-115X; Ruiz-Raya, Francisco/0000-0002-4646-1975; Ibanez Alamo, Juan Diego/0000-0002-2136-1767	Junta de Andalucia [CVI-6653]; "Andalucia Talent Hub" program [TAHUB-104]; European's Union Seventh Framework Program Marie Sklodowska-Curie actions (COFUND); regional Government of Andalucia	Junta de Andalucia(Junta de Andalucia); "Andalucia Talent Hub" program; European's Union Seventh Framework Program Marie Sklodowska-Curie actions (COFUND); regional Government of Andalucia(Junta de Andalucia)	Financial support was provided by the Junta de Andalucia (research project CVI-6653). JDI is funded by a postdoctoral contract (TAHUB-104) from the "Andalucia Talent Hub" program (co-funded by the European's Union Seventh Framework Program Marie Sklodowska-Curie actions (COFUND) and the regional Government of Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was provided by the Junta de Andalucia (research project CVI-6653). JDI is funded by a postdoctoral contract from the "Andalucia Talent Hub" program (co-funded by the European's Union Seventh Framework Program Marie Sklodowska-Curie actions (COFUND) and the regional Government of Andalucia). No additional funding was received for this study. We thank two anonymous reviewers for their constructive and helpful comments, which have considerably improved and clarified our manuscript. We are especially indebted to Reviewer 1 for his/her constructive, exhaustive and detailed review, which went far beyond what reviewing requires. He/she contributed numerous suggestions that considerably improved this paper.	ALVAREZ F, 1976, ANIM BEHAV, V24, P907, DOI 10.1016/S0003-3472(76)80021-8; Antonov A, 2008, BEHAV ECOL, V19, P100, DOI 10.1093/beheco/arm102; Antonov A, 2006, AUK, V123, P419, DOI 10.1642/0004-8038(2006)123[419:ERIMWA]2.0.CO;2; Antonov A, 2009, BIOL LETTERS, V5, P169, DOI 10.1098/rsbl.2008.0645; Antonov A, 2008, ANIM BEHAV, V76, P1893, DOI 10.1016/j.anbehav.2008.08.016; BROOKE MD, 1988, NATURE, V335, P630; CRUZ A, 1989, EVOLUTION, V43, P55, DOI 10.1111/j.1558-5646.1989.tb04206.x; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; DAVIES NB, 1989, J ANIM ECOL, V58, P225, DOI 10.2307/4996; De Rosario-Martinez H., 2015, PHIA POSTHOC INTERAC; Ibanez-Alamo JD, 2010, BIOL J LINN SOC, V101, P759, DOI 10.1111/j.1095-8312.2010.01543.x; Fox J., 2019, R COMPANION APPL REG, V.; Grim T, 2011, J ANIM ECOL, V80, P508, DOI 10.1111/j.1365-2656.2010.01798.x; Guigueno MF, 2012, AUK, V129, P17, DOI 10.1525/auk.2011.11138; Hale K, 2007, J AVIAN BIOL, V38, P198, DOI 10.1111/j.0908-8857.2007.03734.x; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; HIGUCHI H, 1989, IBIS, V131, P94, DOI 10.1111/j.1474-919X.1989.tb02748.x; Honza M, 2005, J AVIAN BIOL, V36, P517, DOI 10.1111/j.0908-8857.2005.03358.x; Honza M, 2004, J ETHOL, V22, P175, DOI 10.1007/s10164-004-0119-1; Honza M, 2008, J ETHOL, V26, P389, DOI 10.1007/s10164-008-0093-0; Honza M, 2007, J AVIAN BIOL, V38, P385, DOI 10.1111/j.2007.0908-8857.03901.x; Honza M, 2007, ETHOLOGY, V113, P344, DOI 10.1111/j.1439-0310.2007.01340.x; Hoskatt E, 1993, ORNIS SCAND, V24, P28; Ibanez-Alamo JD, 2012, BEHAV ECOL SOCIOBIOL, V66, P1067, DOI 10.1007/s00265-012-1357-9; Jackman SD, 2015, PSCL CLASSES METHODS; LOTEM A, 1995, ANIM BEHAV, V49, P1185, DOI 10.1006/anbe.1995.0152; MARCHETTI K, 1992, P ROY SOC B-BIOL SCI, V248, P41, DOI 10.1098/rspb.1992.0040; Martin-Vivaldi M, 2002, J AVIAN BIOL, V33, P295, DOI 10.1034/j.1600-048X.2002.330311.x; Martin-Vivaldi M, 2013, IBIS, V155, P140, DOI 10.1111/ibi.12000; MOKSNES A, 1989, BEHAV ECOL SOCIOBIOL, V24, P25, DOI 10.1007/BF00300114; Moskat C, 2007, ANIM COGN, V10, P377, DOI 10.1007/s10071-007-0071-x; Moskat C, 2010, J EXP BIOL, V213, P1976, DOI 10.1242/jeb.040394; Polacikova L, 2010, J AVIAN BIOL, V41, P111, DOI 10.1111/j.1600-048X.2010.04983.x; Pozgayova M, 2011, BEHAV ECOL, V22, P46, DOI 10.1093/beheco/arq163; R Core Team, 2013, R LANG ENV STAT COMP; Rodriguez-Girones MA, 1999, AM NAT, V153, P633, DOI 10.1086/303198; Rohwer S, 1988, EVOL ECOL, V2, P27, DOI 10.1007/BF02071586; ROTHSTEIN SI, 1976, AUK, V93, P675; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; Ruiz-Raya F, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0148-y; Ruiz-Raya F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135624; Samas P, 2011, ETHOLOGY, V117, P606, DOI 10.1111/j.1439-0310.2011.01917.x; SEALY SG, 1995, CONDOR, V97, P369, DOI 10.2307/1369023; SEALY SG, 1992, CONDOR, V94, P40, DOI 10.2307/1368794; Sealy Spencer G., 2012, Chinese Birds, V3, P274; Skaug H., 2016, GEN LINEAR MIXED MOD; Soler JJ, 2001, ECOL LETT, V4, P470, DOI 10.1046/j.1461-0248.2001.00247.x; Soler JJ, 2000, OECOLOGIA, V125, P309, DOI 10.1007/s004420000487; Soler M, 2012, ANIM BEHAV, V84, P421, DOI 10.1016/j.anbehav.2012.05.016; Soler M, 2002, ETHOLOGY, V108, P1093, DOI 10.1046/j.1439-0310.2002.00841.x; SOLER M, 1990, ORNIS SCAND, V21, P212, DOI 10.2307/3676781; Soler M, 2015, J AVIAN BIOL, V46, P369, DOI 10.1111/jav.00571; Soler M, 2014, BIOL REV, V89, P688, DOI 10.1111/brv.12075; Soler M, 2012, ETHOLOGY, V118, P662, DOI 10.1111/j.1439-0310.2012.02058.x; Spottiswoode CN, 2010, J EVOLUTION BIOL, V23, P1792, DOI 10.1111/j.1420-9101.2010.02010.x; Underwood TJ, 2006, ANIM BEHAV, V71, P409, DOI 10.1016/j.anbehav.2005.06.004; Underwood TJ, 2002, OX ORN SER, V13, P280; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; Zuur Alain F., 2009, P1	62	28	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0166283	10.1371/journal.pone.0166283	http://dx.doi.org/10.1371/journal.pone.0166283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1SG	28170402	Green Published, Green Submitted, gold			2022-12-26	WOS:000393705500001
J	Morimoto, S; Takao, M; Hatsuta, H; Nishina, Y; Komiya, T; Sengoku, R; Nakano, Y; Uchino, A; Sumikura, H; Saito, Y; Kanemaru, K; Murayama, S				Morimoto, Satoru; Takao, Masaki; Hatsuta, Hiroyuki; Nishina, Yasushi; Komiya, Tadashi; Sengoku, Renpei; Nakano, Yuta; Uchino, Akiko; Sumikura, Hiroyuki; Saito, Yuko; Kanemaru, Kazutomi; Murayama, Shigeo			Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; BODY VARIANT; DES MENSCHEN; HUMAN BRAIN; L-DOPA; CSF; DIAGNOSIS; TAU	Dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) are the two most common causes of dementia. Both pathologies often coexist, and AD patients with concomitant neocortical LB pathology (referred to as the Lewy body variant of AD) generally show faster cognitive decline and accelerated mortality relative to patients with pure AD. Thus, discriminating among patients with DLB, AD, and coincident DLB and AD is important in clinical practice. We examined levels of homovanillic acid (HVA), 5-hydroxyindole acetic acid (5-HIAA), tau, phosphorylated tau (p-tau), and beta-amyloid (A beta) 1-42 in cerebrospinal fluid (CSF) to evaluate their viability as biomarkers to discriminate among different forms of dementia. We obtained a total of 3498 CSF samples from patients admitted to our hospital during the period from 1996 to 2015. Of these patients, we were able to carry out a brain autopsy in 94 cases. Finally, 78 neuropathologically diagnosed cases (10 AD, six DLB, five DLB with AD, five controls without neurological diseases, and 52 cases with other neurological diseases) were studied. CSF levels of HVA and 5-HIAA were consistently decreased in pathologically advanced Lewy body disorder (LBD; Braak LB stages >3) compared with pathologically incipient LBD (Braak LB stages <2). These results suggest that if an individual has LB pathology in the central nervous system, CSF levels of HVA and 5-HIAA may decrease after the onset of clinical symptoms. In addition, CSF levels of HVA and 5-HIAA decreased with LB pathology, and were especially low in cases of DLB and DLB with AD. Furthermore, the combination of HVA, 5-HIAA, and brain specific proteins t-tau, p-tau, and A beta 1-42 in CSF were useful for discriminating among DLB, DLB with AD, and AD with high diagnostic accuracy.	[Morimoto, Satoru; Takao, Masaki; Hatsuta, Hiroyuki; Nakano, Yuta; Uchino, Akiko; Sumikura, Hiroyuki; Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Dept Neuropathol, Tokyo, Japan; [Morimoto, Satoru; Hatsuta, Hiroyuki; Nishina, Yasushi; Sengoku, Renpei; Nakano, Yuta; Uchino, Akiko; Sumikura, Hiroyuki; Kanemaru, Kazutomi; Murayama, Shigeo] Inst Gerontol, Tokyo, Japan; [Morimoto, Satoru; Nishina, Yasushi; Sengoku, Renpei; Kanemaru, Kazutomi; Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Dept Neurol, Tokyo, Japan; [Takao, Masaki] Saitama Med Univ, Int Med Ctr, Dept Neurol & Stroke, Saitama, Japan; [Komiya, Tadashi] Natl Hosp Org, Tokyo Natl Hosp, Dept Neurol, Tokyo, Japan; [Saito, Yuko] Natl Ctr Neurol & Psychiat, Dept Lab Med, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology; Saitama Medical University; National Center for Neurology & Psychiatry - Japan	Murayama, S (corresponding author), Tokyo Metropolitan Geriatr Hosp, Dept Neuropathol, Tokyo, Japan.; Murayama, S (corresponding author), Inst Gerontol, Tokyo, Japan.; Murayama, S (corresponding author), Tokyo Metropolitan Geriatr Hosp, Dept Neurol, Tokyo, Japan.	smurayam@gmail.com	Nishina, Yuta/AHB-6194-2022; Morimoto, Satoru/L-1223-2013; Nishina, Yuta/B-2427-2011	Nishina, Yuta/0000-0002-4958-1753; Morimoto, Satoru/0000-0003-0022-9529; 	Ministry of Education, Science, Sports and Culture, Japan [221S0003, 24300133]; Ministry of Health, Labor and Welfare of Japan; National Center of Geriatric and Gerontology, Japan; Grants-in-Aid for Scientific Research [16H06277, 16K09736] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Center of Geriatric and Gerontology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, the Ministry of Education, Science, Sports and Culture, Japan (to SM: Comprehensive Brain Science Network, 221S0003), a Grant-in-Aid for Study on propagation of Lem body-associated synucleinopathy, Scientific Research B, the Ministry of Education, Science, Sports and Culture, Japan (to SM: 24300133); a Grant-in-Aid for intractable diseases (neurodegenerative disorders) the Ministry of Health, Labor and Welfare of Japan (to SM); and a Grant-in-Aid for establishment of high quality brain bank, Geriatric Research from the National Center of Geriatric and Gerontology, Japan (to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts MB, 2011, J ALZHEIMERS DIS, V27, P377, DOI 10.3233/JAD-2011-110482; Benito-Leon J., 2008, TRATADO TRASTORNOS M, V1, P133; Bernheimer H, 1966, Wien Klin Wochenschr, V78, P417; BERNHEIMER H, 1961, KLIN WOCHENSCHR, V39, P1056, DOI 10.1007/BF01487648; BERNHEIMER H, 1964, NATURE, V204, P587, DOI 10.1038/204587b0; BETHLEM J, 1960, J NEUROL NEUROSUR PS, V23, P74, DOI 10.1136/jnnp.23.1.74; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Clark CM, 2003, ARCH NEUROL-CHICAGO, V60, P1696, DOI 10.1001/archneur.60.12.1696; DAVIDSON DLW, 1977, J NEUROL NEUROSUR PS, V40, P1136, DOI 10.1136/jnnp.40.12.1136; Ehringer H, 1998, Parkinsonism Relat Disord, V4, P53, DOI 10.1016/S1353-8020(98)00012-1; ELDRUP E, 1995, ACTA NEUROL SCAND, V92, P116; Engelborghs S, 2003, NEUROCHEM RES, V28, P1145, DOI 10.1023/A:1024255208563; Funabe S, 2013, NEUROPATHOLOGY, V33, P47, DOI 10.1111/j.1440-1789.2012.01329.x; GULDBERG HC, 1967, CONFIN NEUROL, V29, P73; GUMPERT J, 1973, J NEUROL SCI, V19, P1, DOI 10.1016/0022-510X(73)90050-6; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; HANSEN L, 1990, NEUROLOGY, V40, P1; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; HORNYKIEWICZ O, 1962, DEUT MED WOCHENSCHR, V87, P1807, DOI 10.1055/s-0028-1114024; hrfelt O A, 2012, ARCH NEUROL-CHICAGO, V69, P1445, DOI [10.1001/archneurol.2012.1654, DOI 10.1001/ARCHNEUROL.2012]; Johansson B, 1967, Life Sci, V6, P1449, DOI 10.1016/0024-3205(67)90193-2; Kanemaru K, 2000, NEUROLOGY, V54, P1875, DOI 10.1212/WNL.54.9.1875; Kanemaru K, 1998, NEUROSCI LETT, V245, P121, DOI 10.1016/S0304-3940(98)00181-5; Kanemaru K, 2002, J NEUROL, V249, P1125, DOI 10.1007/s00415-002-0753-x; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; Koopman K, 2009, NEUROCHEM INT, V55, P214, DOI 10.1016/j.neuint.2009.02.017; Lindstrom V, 2014, IMMUNOTHERAPY-UK, V6, P141, DOI [10.2217/imt.13.162, 10.2217/IMT.13.162]; Luo XN, 2013, J NEUROCHEM, V127, P681, DOI 10.1111/jnc.12331; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mori E, 2012, ANN NEUROL, V72, P41, DOI 10.1002/ana.23557; Murayama S, 2004, NEUROPATHOLOGY, V24, P254, DOI 10.1111/j.1440-1789.2004.00571.x; OHAMA E, 1976, ACTA NEUROPATHOL, V34, P311, DOI 10.1007/BF00696560; Olichney JM, 1998, NEUROLOGY, V51, P351, DOI 10.1212/WNL.51.2.351; PULLAR IA, 1970, J NEUROL NEUROSUR PS, V33, P851, DOI 10.1136/jnnp.33.6.851; Raftopoulos C, 1996, MOVEMENT DISORD, V11, P59, DOI 10.1002/mds.870110111; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Samuel W, 1997, J NEUROPATH EXP NEUR, V56, P499, DOI 10.1097/00005072-199705000-00006; Schoonenboom NSM, 2012, NEUROLOGY, V78, P47, DOI 10.1212/WNL.0b013e31823ed0f0; Schultz K, 2009, NEUROSCI LETT, V453, P104, DOI 10.1016/j.neulet.2009.02.008; TOHGI H, 1993, NEUROSCI LETT, V150, P71, DOI 10.1016/0304-3940(93)90111-W; TOHGI H, 1993, J NEURAL TRANSM-PARK, V5, P17, DOI 10.1007/BF02260911; TOHGI H, 1993, NEUROSCI LETT, V159, P135, DOI 10.1016/0304-3940(93)90817-5; Tohgi H, 1997, J NEURAL TRANSM, V104, P441, DOI 10.1007/BF01277662; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Toledo JB, 2012, ACTA NEUROPATHOL, V124, P23, DOI 10.1007/s00401-012-0983-7; Weiner MF, 1996, AM J PSYCHIAT, V153, P1269; Wood Heather, 2014, Nat Rev Neurol, V10, P426, DOI 10.1038/nrneurol.2014.119	53	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171524	10.1371/journal.pone.0171524	http://dx.doi.org/10.1371/journal.pone.0171524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166276	Green Submitted, Green Published, gold			2022-12-26	WOS:000393700100051
J	Zou, Z; Liu, JT; Yang, LF; Xie, GS				Zou, Zhi; Liu, Jianting; Yang, Lifu; Xie, Guishui			Survey of the rubber tree genome reveals a high number of cysteine protease-encoding genes homologous to Arabidopsis SAG12	PLOS ONE			English	Article							TAPPING PANEL DRYNESS; HEVEA-BRASILIENSIS MUELL.; SENESCENCE-ASSOCIATED VACUOLES; MYB TRANSCRIPTION FACTOR; LEAF SENESCENCE; SUBSTRATE-SPECIFICITY; EXPRESSION PATTERNS; JASMONIC ACID; DRAFT GENOME; CELL-DEATH	Arabidopsis thaliana SAG12, a senescence-specific gene encoding a cysteine protease, is widely used as a molecular marker for the study of leaf senescence. To date, its potential orthologues have been isolated from several plant species such as Brassica napus and Nicotiana tabacum. However, little information is available in rubber tree (Hevea brasiliensis), a rubber-producing plant of the Euphorbiaceae family. This study presents the identification of SAG12-like genes from the rubber tree genome. Results showed that an unexpected high number of 17 rubber orthologues with a single intron were found, contrasting the single copy with two introns in Arabidopsis. The gene expansion was also observed in another two Euphorbiaceae plants, castor bean (Ricinus communis) and physic nut (Jatropha curcas), both of which contain 8 orthologues. In accordance with no occurrence of recent whole-genome duplication (WGD) events, most duplicates in castor and physic nut were resulted from tandem duplications. In contrast, the duplicated HbSAG12H genes were derived from tandem duplications as well as the recent WGD. Expression analysis showed that most HbSAG12H genes were lowly expressed in examined tissues except for root and male flower. Furthermore, HbSAG12H1 exhibits a strictly senescence-associated expression pattern in rubber tree leaves, and thus can be used as a marker gene for the study of senescence mechanism in Hevea.	[Zou, Zhi; Liu, Jianting; Yang, Lifu; Xie, Guishui] Chinese Acad Trop Agr Sci, Danzhou Invest & Expt Stn Trop Crops, Minist Agr, Rubber Res Inst, Danzhou, Hainan, Peoples R China; [Liu, Jianting] Fujian Acad Agr Sci, Crops Res Inst, Fuzhou, Fujian, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Fujian Academy of Agricultural Sciences	Zou, Z (corresponding author), Chinese Acad Trop Agr Sci, Danzhou Invest & Expt Stn Trop Crops, Minist Agr, Rubber Res Inst, Danzhou, Hainan, Peoples R China.	zouzhi2008@126.com	Zou, Zhi/F-1266-2018	Zou, Zhi/0000-0003-2881-1932	National Natural Science Foundation of China [31371556]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-34-GW5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Modern Agro-industry Technology Research System	This work was supported by the National Natural Science Foundation of China (31371556) and the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-34-GW5).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Avila-Ospina L, 2014, J EXP BOT, V65, P3799, DOI 10.1093/jxb/eru039; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Beyene G, 2006, J EXP BOT, V57, P1431, DOI 10.1093/jxb/erj123; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Carrion CA, 2013, J EXP BOT, V64, P4967, DOI 10.1093/jxb/ert285; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chen GH, 2002, PLANT CELL PHYSIOL, V43, P984, DOI 10.1093/pcp/pcf125; Chen SC, 2003, PLANT MOL BIOL, V51, P51, DOI 10.1023/A:1020719420867; Chow Keng-See, 2014, BMC Res Notes, V7, P69, DOI 10.1186/1756-0500-7-69; Chow KS, 2012, J EXP BOT, V63, P1863, DOI 10.1093/jxb/err363; Duan CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-30; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo YF, 2014, J EXP BOT, V65, P3901, DOI 10.1093/jxb/eru248; Guo YF, 2012, PLANT CELL ENVIRON, V35, P644, DOI 10.1111/j.1365-3040.2011.02442.x; Hao BZ, 2000, ANN BOT-LONDON, V85, P37, DOI 10.1006/anbo.1999.0995; HENSEL LL, 1993, PLANT CELL, V5, P553, DOI 10.1105/tpc.5.5.553; Hua YW, 2010, PLANT BREEDING, V129, P202, DOI 10.1111/j.1439-0523.2009.01663.x; Jiang YJ, 2014, PLANT CELL, V26, P230, DOI 10.1105/tpc.113.117838; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Jibran R, 2013, PLANT MOL BIOL, V82, P547, DOI 10.1007/s11103-013-0043-2; Kim J, 2016, MOL PLANT, V9, P813, DOI 10.1016/j.molp.2016.04.017; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leitch AR, 1998, GENOME, V41, P464, DOI 10.1139/gen-41-3-464; Li DJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23540; Li DJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-140; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu JP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1562-9; LOHMAN KN, 1994, PHYSIOL PLANTARUM, V92, P322, DOI 10.1111/j.1399-3054.1994.tb05343.x; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Mantello CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102665; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Noh YS, 1999, PLANT MOL BIOL, V41, P195, DOI 10.1023/A:1006389803990; Noh YS, 1999, PLANT MOL BIOL, V41, P181, DOI 10.1023/A:1006342412688; Otegui MS, 2005, PLANT J, V41, P831, DOI 10.1111/j.1365-313X.2005.02346.x; Ougham H, 2008, PLANT BIOLOGY, V10, P4, DOI 10.1111/j.1438-8677.2008.00081.x; Peng SQ, 2011, PLANT PHYSIOL BIOCH, V49, P1429, DOI 10.1016/j.plaphy.2011.09.007; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Putranto RA, 2015, INT J MOL SCI, V16, P17885, DOI 10.3390/ijms160817885; Roberts IN, 2012, PHYSIOL PLANTARUM, V145, P130, DOI 10.1111/j.1399-3054.2012.01574.x; Schippers JHM, 2015, CURR OPIN PLANT BIOL, V27, P77, DOI 10.1016/j.pbi.2015.06.018; Shen FF, 2004, CHINESE SCI BULL, V49, P2601, DOI 10.1360/982004-401; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang CR, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.73, 10.1038/nplants.2016.73]; Tang CR, 2010, PLANT CELL ENVIRON, V33, P1708, DOI 10.1111/j.1365-3040.2010.02175.x; Thakurta PG, 2004, BIOCHEMISTRY-US, V43, P1532, DOI 10.1021/bi0357659; Than ME, 2004, J MOL BIOL, V336, P1103, DOI 10.1016/j.jmb.2003.12.075; Triwitayakorn K, 2011, DNA RES, V18, P471, DOI 10.1093/dnares/dsr034; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Venkatachalam P, 2007, PLANTA, V226, P499, DOI 10.1007/s00425-007-0500-8; Wang YP, 2012, ANN NY ACAD SCI, V1256, P1, DOI 10.1111/j.1749-6632.2011.06384.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691; Wu PZ, 2015, PLANT J, V81, P810, DOI 10.1111/tpj.12761; Yeang H. Y., 2005, Journal of Rubber Research, V8, P160; Zhu JH, 2009, PLANT SIGNAL BEHAV, V4, P1072, DOI 10.4161/psb.4.11.9738; Zou Z, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00395; Zou Z, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2152-6; [邹智 Zou Zhi], 2012, [生物技术通报, Biotechnology Bulletin], P8; [邹智 ZOU Zhi], 2009, [植物生理学通讯, Plant Physiology Communications], V45, P1231; Zou Zhi, 2010, China Biotechnology, V30, P85	70	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171725	10.1371/journal.pone.0171725	http://dx.doi.org/10.1371/journal.pone.0171725			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166280	Green Published, Green Submitted, gold			2022-12-26	WOS:000393700100065
J	Garlich, J; Strecker, V; Wittig, I; Stuart, RA				Garlich, Joshua; Strecker, Valentina; Wittig, Ilka; Stuart, Rosemary A.			Mutational Analysis of the QRRQ Motif in the Yeast Hig1 Type 2 Protein Rcf1 Reveals a Regulatory Role for the Cytochrome c Oxidase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN; OXIDATIVE-PHOSPHORYLATION; SUPERCOMPLEX ORGANIZATION; MITOCHONDRIAL PROTEIN; CARDIOLIPIN; IDENTIFICATION; COMPONENTS; INSIGHT; GLUCOSE; HIGD1A	The yeast Rcf1 protein is a member of the conserved family of proteins termed the hypoxia-induced gene (domain) 1 (Hig1 or HIGD1) family. Rcf1 interacts with components of the mitochondrial oxidative phosphorylation system, in particular the cytochrome bc(1) (complex III)-cytochrome c oxidase (complex IV) supercomplex (termed III-IV) and the ADP/ATP carrier proteins. Rcf1 plays a role in the assembly and modulation of the activity of complex IV; however, the molecular basis for how Rcf1 influences the activity of complex IV is currently unknown. Hig1 type 2 isoforms, which include the Rcf1 protein, are characterized in part by the presence of a conserved motif, (Q/I) X-3(R/H) XRX(3)Q, termed here the QRRQ motif. We show that mutation of conserved residues within the Rcf1 QRRQ motif alters the interactions between Rcf1 and partner proteins and results in the destabilization of complex IV and alteration of its enzymatic properties. Our findings indicate that Rcf1 does not serve as a stoichiometric component, i.e. as a subunit of complex IV, to support its activity. Rather, we propose that Rcf1 serves to dynamically interact with complex IV during its assembly process and, in doing so, regulates a late maturation step of complex IV. We speculate that the Rcf1/Hig1 proteins play a role in the incorporation and/or remodeling of lipids, in particular cardiolipin, into complex IV and. possibly, other mitochondrial proteins such as ADP/ATP carrier proteins.	[Garlich, Joshua; Stuart, Rosemary A.] Marquette Univ, Dept Biol Sci, 530 N 15th St, Milwaukee, WI 53233 USA; [Strecker, Valentina; Wittig, Ilka] Goethe Univ, Funct Prote, SFB Core Unit 815, D-60590 Frankfurt, Germany	Marquette University; Goethe University Frankfurt	Stuart, RA (corresponding author), Marquette Univ, Dept Biol Sci, 530 N 15th St, Milwaukee, WI 53233 USA.	rosemary.stuart@marquette.edu			National Science Foundation [MCB1157722]; National Institutes of Health [R15-GM101594, R15GM117551]; Cluster of Excellence "Macromolecular Complexes" at the Goethe University Frankfurt (DFG) [EXC 115, SFB815]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM117551, R15GM101594] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cluster of Excellence "Macromolecular Complexes" at the Goethe University Frankfurt (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB1157722 and National Institutes of Health Grants R15-GM101594 and R15GM117551 (to R.A.S.), an Arthur J. Schmitt graduate fellowship award (to J.G.), and by Cluster of Excellence "Macromolecular Complexes" at the Goethe University Frankfurt (DFG Project EXC 115) and SFB815 Project Z1 (to I.W.).The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ameri K, 2015, CELL REP, V10, P891, DOI 10.1016/j.celrep.2015.01.020; Ameri K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062758; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen XJ, 2004, GENETICS, V167, P607, DOI 10.1534/genetics.103.023655; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86; Gallas MR, 2006, MOL BIOL CELL, V17, P4051, DOI 10.1091/mbc.E06-04-0366; Hayashi T, 2015, P NATL ACAD SCI USA, V112, P1553, DOI 10.1073/pnas.1419767112; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Jia LX, 2007, MOL BIOL CELL, V18, P1897, DOI 10.1091/mbc.E06-10-0925; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenaz G, 2009, INT J BIOCHEM CELL B, V41, P1750, DOI 10.1016/j.biocel.2009.04.003; Lundin CR, 2016, P NATL ACAD SCI USA, V113, pE4476, DOI 10.1073/pnas.1601196113; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mileykovskaya E, 2005, BIOCHEMISTRY-MOSCOW+, V70, P154, DOI 10.1007/s10541-005-0095-2; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Ogunjimi EO, 2000, J BIOENERG BIOMEMBR, V32, P617, DOI 10.1023/A:1005678729157; Pebay-Peyroula E, 2004, CURR OPIN STRUC BIOL, V14, P420, DOI 10.1016/j.sbi.2004.06.009; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Strecker V, 2016, BBA-MOL CELL RES, V1863, P1643, DOI 10.1016/j.bbamcr.2016.04.012; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Stuart RA, 2009, METHOD ENZYMOL, V456, P191, DOI 10.1016/S0076-6879(08)04411-X; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; Tamura Y, 2013, CELL METAB, V17, P709, DOI 10.1016/j.cmet.2013.03.018; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wang J, 2006, P NATL ACAD SCI USA, V103, P10636, DOI 10.1073/pnas.0604194103; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	41	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5216	5226		10.1074/jbc.M116.758045	http://dx.doi.org/10.1074/jbc.M116.758045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28167530	hybrid, Green Published			2022-12-26	WOS:000397875500006
J	Jones, AJY; Blaza, JN; Varghese, F; Hirst, J				Jones, Andrew J. Y.; Blaza, James N.; Varghese, Febin; Hirst, Judy			Respiratory Complex I in Bos taurus and Paracoccus denitrificans Pumps Four Protons across the Membrane for Every NADH Oxidized	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; CRYSTAL-STRUCTURE; ATP SYNTHASE; STOICHIOMETRY; INHIBITORS; REDUCTION; MECHANISM; SUBUNITS; GENES	Respiratory complex I couples electron transfer between NADH and ubiquinone to proton translocation across an ener-gy-transducing membrane to support the proton-motive force that drives ATP synthesis. The proton-pumping stoichiometry of complex I (i. e. the number of protons pumped for each two electrons transferred) underpins all mechanistic proposals. However, it remains controversial and has not been determined for any of the bacterial enzymes that are exploited as model systems for the mammalian enzyme. Here, we describe a simple method for determining the proton-pumping stoichiometry of complex I in inverted membrane vesicles under steady-state ADP-phosphorylating conditions. Our method exploits the rate of ATP synthesis, driven by oxidation of NADH or succinate with different sections of the respiratory chain engaged in catalysis as a proxy for the rate of proton translocation and determines the stoichiometry of complex I by reference to the known stoichiometries of complexes III and IV. Using vesicles prepared from mammalian mitochondria (from Bos taurus) and from the bacterium Paracoccus denitrificans, we show that four protons are pumped for every two electrons transferred in both cases. By confirming the four-proton stoichiometry for mammalian complex I and, for the first time, demonstrating the same value for a bacterial complex, we establish the utility of P. denitrificans complex I as a model system for the mammalian enzyme. P. denitrificans is the first system described in which mutagenesis in any complex I core subunit may be combined with quantitative proton-pumping measurements for mechanistic studies.	[Jones, Andrew J. Y.; Blaza, James N.; Varghese, Febin; Hirst, Judy] MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England		Hirst, J (corresponding author), MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	jh@mrc-mbu.cam.ac.uk	Hirst, Judy/F-4803-2011	Hirst, Judy/0000-0001-8667-6797; Blaza, Jamie/0000-0001-5420-2116; Varghese, Febin/0000-0003-4457-7736	Medical Research Council [U105663141]; MRC [MC_U105663141] Funding Source: UKRI; Medical Research Council [1095779, MC_U105663141, 1236985] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Grant U105663141 (to J. H.). The authors declare that they have no conflicts of interest with the contents of this article.	ABELE U, 1995, PROTEIN SCI, V4, P1262, DOI 10.1002/pro.5560040702; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Biason JV, 2011, J MOL BIOL, V406, P443, DOI 10.1016/j.jmb.2010.12.025; Birrell JA, 2010, FEBS LETT, V584, P4247, DOI 10.1016/j.febslet.2010.09.017; Bogachev AV, 1996, J BACTERIOL, V178, P6233, DOI 10.1128/jb.178.21.6233-6237.1996; BURSTEIN C, 1979, EUR J BIOCHEM, V94, P387, DOI 10.1111/j.1432-1033.1979.tb12905.x; Castro PJ, 2016, BBA-BIOENERGETICS, V1857, P928, DOI 10.1016/j.bbabio.2015.12.008; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; Devin A, 1997, BBA-BIOENERGETICS, V1319, P293, DOI 10.1016/S0005-2728(96)00172-7; Dimroth P, 2000, J EXP BIOL, V203, P51; ESPOSTI MD, 1993, BIOCHEM BIOPH RES CO, V190, P1090, DOI 10.1006/bbrc.1993.1161; Ferguson SJ, 2010, P NATL ACAD SCI USA, V107, P16755, DOI 10.1073/pnas.1012260107; Ferrieres L, 2010, J BACTERIOL, V192, P6418, DOI 10.1128/JB.00621-10; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Galkin A, 2006, BBA-BIOENERGETICS, V1757, P1575, DOI 10.1016/j.bbabio.2006.10.001; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; GARLID KD, 1989, BIOCHIM BIOPHYS ACTA, V976, P109, DOI 10.1016/S0005-2728(89)80219-1; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Hinkle PC, 2005, BBA-BIOENERGETICS, V1706, P1, DOI 10.1016/j.bbabio.2004.09.004; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; JOHN P, 1970, BIOCHIM BIOPHYS ACTA, V216, P342, DOI 10.1016/0005-2728(70)90225-2; Jones AJY, 2013, ANAL BIOCHEM, V442, P19, DOI 10.1016/j.ab.2013.07.018; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Klingenberg M., 2008, ENERGY TRANSFORMATIO, P105; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; KRAHENBUHL S, 1994, CLIN CHIM ACTA, V230, P177, DOI 10.1016/0009-8981(94)90270-4; LINNANE AW, 1958, BIOCHIM BIOPHYS ACTA, V29, P630, DOI 10.1016/0006-3002(58)90021-0; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Mitchell P, 2011, BBA-BIOENERGETICS, V1807, P1507, DOI 10.1016/j.bbabio.2011.09.018; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Morales-Rios E, 2015, P NATL ACAD SCI USA, V112, P13231, DOI 10.1073/pnas.1517542112; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; NICHOLLS DG, 2013, BIOENERGETICS; Otten MF, 2001, EUR J BIOCHEM, V268, P2486, DOI 10.1046/j.1432-1327.2001.02131.x; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Ripple MO, 2013, J BIOL CHEM, V288, P5374, DOI 10.1074/jbc.M112.438945; Roberts PG, 2012, J BIOL CHEM, V287, P34743, DOI 10.1074/jbc.M112.384560; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; VANSPANNING RJM, 1991, J BACTERIOL, V173, P6948, DOI 10.1128/jb.173.21.6948-6961.1991; Vignais PM, 2005, BIOCHEM SOC T, V33, P28, DOI 10.1042/BST0330028; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; WISKICH JT, 1977, ANNU REV PLANT PHYS, V28, P45, DOI 10.1146/annurev.pp.28.060177.000401; Zarco-Zavala M, 2014, FASEB J, V28, P2146, DOI 10.1096/fj.13-241430; Zharova TV, 1997, BBA-BIOENERGETICS, V1320, P256, DOI 10.1016/S0005-2728(97)00029-7; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	54	44	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4987	4995		10.1074/jbc.M116.771899	http://dx.doi.org/10.1074/jbc.M116.771899			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28174301	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000397590400020
J	Miller, MA; Crane, BT				Miller, Mark Andrew; Crane, Benjamin Thomas			Roll vection in migraine and controls using inertial nulling and certainty estimate techniques	PLOS ONE			English	Article							SELF-MOTION PERCEPTION; VISUAL-VESTIBULAR INTERACTIONS; ROOM TILT ILLUSION; OPTIC-FLOW; CORTICAL HYPEREXCITABILITY; ABSOLUTE IDENTIFICATION; MAGNITUDE ESTIMATION; VELOCITY STORAGE; CIRCULAR VECTION; VERTICAL AXIS	Vection is an illusory perception of self-motion that occurs when a visual motion is presented in the majority of the visual field. We used certainty estimate (CE) and inertial nulling (IN) techniques to study the effect of visual stimuli on roll perception in 10 migraine and 9 control subjects. A visual roll stimulus was presented for 1 to 8s. For the IN method, an inertial stimulus was delivered during the final 1s of the visual stimulus during which subjects judged the direction of perceived motion. The inertial motion was varied to find the point of subjective equality (PSE) at which both responses were equally likely to be reported. For the CE trials, the same durations of visual motion were used but without inertial motion and subjects rated their certainty of motion on a scale of 0 - 100. The overall difference in PSE between 1s and 8s subjects is significant (p = 0.03). Migraineurs had a ten fold larger effect in IN studies in the 8s than 1s (p = 0.01), but controls did not have a significant difference (p = 0.72). Unlike the control population, in migraineurs the perception of roll increased significantly with the duration of the visual stimulus. There was a large variation between subjects with both the CE and IN measures. The CE measure was poorly correlated with IN measures but demonstrated a similar trend with larger variation between subjects.	[Miller, Mark Andrew] Univ Rochester, Sch Med & Dent, 601 Elmwood Ave, Rochester, NY USA; [Crane, Benjamin Thomas] Univ Rochester, Dept Otolaryngol, Rochester, NY 14611 USA; [Crane, Benjamin Thomas] Univ Rochester, Dept Bioengn, Rochester, NY 14611 USA; [Crane, Benjamin Thomas] Univ Rochester, Dept Neurosci, Rochester, NY 14611 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Crane, BT (corresponding author), Univ Rochester, Dept Otolaryngol, Rochester, NY 14611 USA.; Crane, BT (corresponding author), Univ Rochester, Dept Bioengn, Rochester, NY 14611 USA.; Crane, BT (corresponding author), Univ Rochester, Dept Neurosci, Rochester, NY 14611 USA.	Benjamin_Crane@urmc.rochester.edu		Crane, Benjamin/0000-0002-8327-1257	NIDCD [K23 DC011298, R01 DC013580]; Triological Career Scientist Award; University of Rochester School of Medicine Office of Medical Education Research Grant	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Triological Career Scientist Award; University of Rochester School of Medicine Office of Medical Education Research Grant	This work was supported by NIDCD K23 DC011298, R01 DC013580, and a Triological Career Scientist Award (to Benjamin Crane), as well as a University of Rochester School of Medicine Office of Medical Education Research Grant (to Mark Miller). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2005, CEPHALALGIA, V25, P788, DOI 10.1111/j.1468-2982.2005.00949.x; Arjona A, 2002, NEUROLOGIA, V17, P338; BENSON AJ, 1986, AVIAT SPACE ENVIR MD, V57, P1088; BERTHOZ A, 1975, EXP BRAIN RES, V23, P471; Bertolini G, 2011, J NEUROPHYSIOL, V105, P209, DOI 10.1152/jn.00154.2010; Bubka A, 2008, PERCEPTION, V37, P704, DOI 10.1068/p5781; Bubka A, 2010, PERCEPTION, V39, P627, DOI 10.1068/p6315; Butler JS, 2011, SEEING PERCEIVING, V24, P453, DOI 10.1163/187847511X588070; CARPENTERSMITH TR, 1995, PERCEPT PSYCHOPHYS, V57, P35, DOI 10.3758/BF03211848; CARPENTERSMITH TR, 1992, ANN NY ACAD SCI, V656, P817, DOI 10.1111/j.1749-6632.1992.tb25262.x; COHEN B, 1981, ANN NY ACAD SCI, V374, P421, DOI 10.1111/j.1749-6632.1981.tb30888.x; Crane BT, 2014, JARO-J ASSOC RES OTO, V15, P87, DOI 10.1007/s10162-013-0423-y; Crane BT, 2013, EXP BRAIN RES, V224, P165, DOI 10.1007/s00221-012-3299-x; Crane BT, 2012, EXP BRAIN RES, V223, P89, DOI 10.1007/s00221-012-3243-0; Cuturi LF, 2014, CURR BIOL, V24, P2817, DOI 10.1016/j.cub.2014.10.015; Dominguez JML, 2007, NEUROLOGIA, V22, P58; Drummond PD, 2005, HEADACHE, V45, P653, DOI 10.1111/j.1526-4610.2005.05132.x; GESCHEIDER GA, 1988, ANNU REV PSYCHOL, V39, P169, DOI 10.1146/annurev.psych.39.1.169; Grabherr L, 2008, EXP BRAIN RES, V186, P677, DOI 10.1007/s00221-008-1350-8; Granziera C, 2006, PLOS MED, V3, P1915, DOI 10.1371/journal.pmed.0030402; GUEDRY FE, 1974, HDB SENSORY PHYSIO 2, V6, P3; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; Haigh SM, 2012, CEPHALALGIA, V32, P236, DOI 10.1177/0333102411433301; HUANG J, 1981, EXP BRAIN RES, V41, P172; HUANG JK, 1988, AVIAT SPACE ENVIR MD, V59, P611; HUANG JK, 1987, AVIAT SPACE ENVIR MD, V58, P1197; KAYAN A, 1984, BRAIN, V107, P1123, DOI 10.1093/brain/107.4.1123; KENYON RV, 1993, IEEE T SYST MAN CYB, V23, P183, DOI 10.1109/21.214776; Kitazaki M, 2003, PERCEPTION, V32, P475, DOI 10.1068/p5037; KRANTZ DH, 1972, J MATH PSYCHOL, V9, P168, DOI 10.1016/0022-2496(72)90025-9; LARISH JF, 1990, J EXP PSYCHOL HUMAN, V16, P295, DOI 10.1037/0096-1523.16.2.295; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Lewis RF, 2011, LARYNGOSCOPE, V121, P1124, DOI 10.1002/lary.21723; Matthews WJ, 2009, Q J EXP PSYCHOL, V62, P2014, DOI 10.1080/17470210802649285; McKendrick AM, 2006, CEPHALALGIA, V26, P1131, DOI 10.1111/j.1468-2982.2006.01182.x; MELCHER GA, 1981, PERCEPT PSYCHOPHYS, V30, P552, DOI 10.3758/BF03202009; Miller MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135335; Nakamura S, 2013, PERCEPTION, V42, P153, DOI 10.1068/p7321; Nakamura S, 2010, PERCEPTION, V39, P320, DOI 10.1068/p6534; Neuhauser H, 2001, NEUROLOGY, V56, P436, DOI 10.1212/WNL.56.4.436; OHMI M, 1988, PERCEPTION, V17, P5, DOI 10.1068/p170005; Palmisano S, 1998, PERCEPTION, V27, P1067, DOI 10.1068/p271067; Pouget A, 2016, NAT NEUROSCI, V19, P366, DOI 10.1038/nn.4240; PREVIC FH, 1993, PERCEPT PSYCHOPHYS, V54, P93, DOI 10.3758/BF03206941; REINHARDTRUTLAND AH, 1991, PERCEPTION, V20, P337, DOI 10.1068/p200337; Rey MCB, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00162; Roditi RE, 2012, EXP BRAIN RES, V219, P369, DOI 10.1007/s00221-012-3099-3; Roditi RE, 2012, JARO-J ASSOC RES OTO, V13, P381, DOI 10.1007/s10162-012-0318-3; RUSSELL MB, 1995, INT J EPIDEMIOL, V24, P612, DOI 10.1093/ije/24.3.612; Schwedt TJ, 2013, CURR OPIN NEUROL, V26, P248, DOI 10.1097/WCO.0b013e328360edb1; Seno T, 2012, PERCEPTION, V41, P577, DOI 10.1068/p7184; Seno T, 2011, VISION RES, V51, P2499, DOI 10.1016/j.visres.2011.10.007; Seno T, 2010, SEEING PERCEIVING, V23, P273, DOI 10.1163/187847510X532667; Shepherd AJ, 2001, BRAIN, V124, P2310, DOI 10.1093/brain/124.11.2310; Shepherd AJ, 2016, CEPHALALGIA; Singh P, 2016, INVEST OPHTH VIS SCI, V57, P1228, DOI 10.1167/iovs.15-17692; Stewart N, 2005, PSYCHOL REV, V112, P881, DOI 10.1037/0033-295X.112.4.881; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; TEGHTSOONIAN R, 1981, ACTA PSYCHOL, V49, P83, DOI 10.1016/0001-6918(81)90034-2; Yong NA, 2007, J NEUROPHYSIOL, V97, P1100, DOI 10.1152/jn.00694.2006; ZACHARIAS GL, 1981, EXP BRAIN RES, V41, P159; Zupan LH, 2008, EXP BRAIN RES, V191, P505, DOI 10.1007/s00221-008-1540-4	62	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171332	10.1371/journal.pone.0171332	http://dx.doi.org/10.1371/journal.pone.0171332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192443	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423800020
J	Qian, J; Mummalaneni, S; Phan, THT; Heck, GL; DeSimone, JA; West, D; Mahavadi, S; Hojati, D; Murthy, KS; Rhyu, MR; Spielman, AI; Ozdener, MH; Lyall, V				Qian, Jie; Mummalaneni, Shobha; Phan, Tam-Hao T.; Heck, Gerard L.; DeSimone, John A.; West, David; Mahavadi, Sunila; Hojati, Deanna; Murthy, Karnam S.; Rhyu, Mee-Ra; Spielman, Andrew I.; Ozdener, Mehmet Hakan; Lyall, Vijay			Cyclic-AMP regulates postnatal development of neural and behavioral responses to NaCl in rats	PLOS ONE			English	Article							EPITHELIAL NA+ CHANNEL; TYMPANI NERVE RESPONSES; TASTE CELLS; SODIUM-CHANNEL; AMILORIDE INHIBITION; GUSTATORY RESPONSES; MEDIATED REGULATION; ENAC; CAMP; VASOPRESSIN	During postnatal development rats demonstrate an age-dependent increase in NaCl chorda tympani (CT) responses and the number of functional apical amiloride-sensitive epithelial Na+ channels (ENaCs) in salt sensing fungiform (FF) taste receptor cells (TRCs). Currently, the intracellular signals that regulate the postnatal development of salt taste have not been identified. We investigated the effect of cAMP, a downstream signal for arginine vasopressin (AVP) action, on the postnatal development of NaCl responses in 19-23 day old rats. ENaC-dependent NaCl CT responses were monitored after lingual application of 8-chlorophenylthio-cAMP (8-CPT-cAMP) under open-circuit conditions and under +/- 60 mV lingual voltage clamp. Behavioral responses were tested using 2 bottle/24h NaCl preference tests. The effect of [deamino-Cys(1), D-Arg(8)]-vasopressin (dDAVP, a specific V2R agonist) was investigated on ENaC subunit trafficking in rat FF TRCs and on cAMP generation in cultured adult human FF taste cells (HBO cells). Our results show that in 19-23 day old rats, the ENaC-dependent maximum NaCl CT response was a saturating sigmoidal function of 8-CPT-cAMP concentration. 8-CPT-cAMP increased the voltage-sensitivity of the NaCl CT response and the apical Na+ response conductance. Intravenous injections of dDAVP increased ENaC expression and gamma-ENaC trafficking from cytosolic compartment to the apical compartment in rat FF TRCs. In HBO cells dDAVP increased intracellular cAMP and cAMP increased trafficking of gamma- and delta-ENaC from cytosolic compartment to the apical compartment 10 min post-cAMP treatment. Control 19-23 day old rats were indifferent to NaCl, but showed clear preference for appetitive NaCl concentrations after 8-CPT-cAMP treatment. Relative to adult rats, 14 day old rats demonstrated significantly less V2R antibody binding in circumvallate TRCs. We conclude that an age-dependent increase in V2R expression produces an AVP-induced incremental increase in cAMP that modulates the postnatal increase in TRC ENaC and the neural and behavioral responses to NaCl.	[Qian, Jie; Mummalaneni, Shobha; Phan, Tam-Hao T.; Heck, Gerard L.; DeSimone, John A.; West, David; Mahavadi, Sunila; Hojati, Deanna; Murthy, Karnam S.; Lyall, Vijay] Virginia Commonwealth Univ, Dept Physiol, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Qian, Jie; Mummalaneni, Shobha; Phan, Tam-Hao T.; Heck, Gerard L.; DeSimone, John A.; West, David; Mahavadi, Sunila; Hojati, Deanna; Murthy, Karnam S.; Lyall, Vijay] Virginia Commonwealth Univ, Dept Biophys, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Rhyu, Mee-Ra] Korea Food Res Inst, Sungnam Si, Gyeonggi Do, South Korea; [Spielman, Andrew I.] NYU, Coll Dent, New York, NY USA; [Ozdener, Mehmet Hakan] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA	Virginia Commonwealth University; Virginia Commonwealth University; Korea Food Research Institute (KFRI); New York University; Monell Chemical Senses Center	Lyall, V (corresponding author), Virginia Commonwealth Univ, Dept Physiol, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Lyall, V (corresponding author), Virginia Commonwealth Univ, Dept Biophys, Med Coll Virginia Campus, Richmond, VA 23284 USA.	vijay.lyall@vcuhealth.org	Ozdener, Mehmet Hakan/I-4097-2019; Spielman, Andrew I./ABG-1150-2021	Spielman, Andrew I./0000-0002-7052-3689	NIDDKD [DK-28300]; NIDCD [DC-011569]; KFRI [E094101, E0111501]; NCI [P30 CA16059]; National Cancer Institute [P30 CA16059];  [NIDCD-011569];  [DK28300];  [KFRI E094101]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011569] Funding Source: NIH RePORTER	NIDDKD; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); KFRI; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by funds from NIDDKD grant (DK-28300); NIDCD grant (DC-011569), KFRI grant (E094101 and E0111501), and NCI grant (P30 CA16059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants NIDCD-011569 (VL), DK28300 (KSM), and KFRI E094101, E0111501 (MR). Imaging cytometry was supported in part by National Cancer Institute Grant P30 CA16059. We also thank Dr Li Ya Qiao for use of her fluorescence microscope.	Abaffy T, 2003, AM J PHYSIOL-CELL PH, V284, pC1420, DOI 10.1152/ajpcell.00556.2002; Ackermann TF, 2011, CELL PHYSIOL BIOCHEM, V28, P137, DOI 10.1159/000331722; Bankir L, 2010, AM J PHYSIOL-RENAL, V299, pF917, DOI 10.1152/ajprenal.00413.2010; Baquero AF, 2011, AM J PHYSIOL-CELL PH, V300, pC860, DOI 10.1152/ajpcell.00318.2010; Barretto RPJ, 2015, NATURE, V517, P373, DOI 10.1038/nature13873; Blanchard A, 2011, CLIN J AM SOC NEPHRO, V6, P753, DOI 10.2215/CJN.06540810; Bugaj V, 2009, AM J PHYSIOL-RENAL, V297, pF1411, DOI 10.1152/ajprenal.00371.2009; Cai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076553; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Coleman J, 2011, J NEUROPHYSIOL, V106, P2606, DOI 10.1152/jn.00196.2010; COWART BJ, 1981, PSYCHOL BULL, V90, P43, DOI 10.1037/0033-2909.90.1.43; Denton DA, 1967, HANDBOOK PHYSIOLOG 6, V1, P433; DeSimone J. A., 2015, THESIS, P667; DeSimone JA, 2001, J NEUROPHYSIOL, V86, P2638, DOI 10.1152/jn.2001.86.5.2638; DeSimone JA, 2008, SENSES COMPREHENSIVE, V4, P281; DeSimone JA, 2015, CHEM SENSES, V40, P401, DOI 10.1093/chemse/bjv022; DeSimone JA, 2011, CHEM SENSES, V36, P389, DOI 10.1093/chemse/bjq148; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Ecelbarger CA, 2000, AM J PHYSIOL-RENAL, V279, pF46, DOI 10.1152/ajprenal.2000.279.1.F46; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; Fenton RA, 2007, AM J PHYSIOL-RENAL, V293, pF748, DOI 10.1152/ajprenal.00316.2006; FERRELL MF, 1981, J COMP NEUROL, V198, P37, DOI 10.1002/cne.901980105; GILBERTSON TA, 1993, NEURON, V10, P931, DOI 10.1016/0896-6273(93)90208-9; Guggino WB, 2000, P NATL ACAD SCI USA, V97, P9827, DOI 10.1073/pnas.97.18.9827; Hager H, 2001, AM J PHYSIOL-RENAL, V280, pF1093, DOI 10.1152/ajprenal.2001.280.6.F1093; Halpern BP, 1998, CHEM SENSES, V23, P501, DOI 10.1093/chemse/23.5.501; Halpern BP, 1998, NEUROSCI BIOBEHAV R, V23, P5, DOI 10.1016/S0149-7634(97)00063-8; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hendricks SJ, 2000, J NEUROPHYSIOL, V84, P1531, DOI 10.1152/jn.2000.84.3.1531; HETTINGER TP, 1990, BRAIN RES, V513, P24, DOI 10.1016/0006-8993(90)91085-U; HILL DL, 1983, J NEUROPHYSIOL, V50, P879, DOI 10.1152/jn.1983.50.4.879; HILL DL, 1987, J NEUROPHYSIOL, V57, P481, DOI 10.1152/jn.1987.57.2.481; HILL DL, 1982, J NEUROSCI, V2, P782; HILL DL, 1985, DEV BRAIN RES, V20, P310, DOI 10.1016/0165-3806(85)90121-X; HILL DL, 1980, BRAIN RES, V197, P27, DOI 10.1016/0006-8993(80)90432-1; Hochheimer A, 2014, CHEM SENSES, V39, P359, DOI 10.1093/chemse/bju009; Huque T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007347; Ji HL, 2012, AM J PHYSIOL-LUNG C, V303, pL1013, DOI 10.1152/ajplung.00206.2012; Kossel AH, 1997, J NEUROSCI, V17, P9634; KREISBERG JI, 1984, KIDNEY INT, V25, P874, DOI 10.1038/ki.1984.104; KREISBERG JI, 1986, IN VITRO CELL DEV B, V22, P392, DOI 10.1007/BF02623528; Kretz O, 1999, J HISTOCHEM CYTOCHEM, V47, P51, DOI 10.1177/002215549904700106; LAWRENCE TS, 1979, J CELL BIOL, V80, P21, DOI 10.1083/jcb.80.1.21; Lin WH, 1999, J COMP NEUROL, V405, P406, DOI 10.1002/(SICI)1096-9861(19990315)405:3<406::AID-CNE10>3.0.CO;2-F; Lindemann B, 1998, ANN NY ACAD SCI, V855, P116, DOI 10.1111/j.1749-6632.1998.tb10553.x; Loffing-Cueni D, 2006, J AM SOC NEPHROL, V17, P1264, DOI 10.1681/ASN.2005060659; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; Lyall V, 2004, J PHYSIOL-LONDON, V558, P147, DOI 10.1113/jphysiol.2004.065656; Lyall V, 2002, J NEUROPHYSIOL, V87, P399, DOI 10.1152/jn.00331.2001; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Mennella J. A., 2004, FETAL NEONATAL PHYSL, V2, P1819; Mironova E, 2012, P NATL ACAD SCI USA, V109, P10095, DOI 10.1073/pnas.1201978109; Morris RG, 2002, J GEN PHYSIOL, V120, P71, DOI 10.1085/jgp.20018547; Mummalaneni S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098049; NINOMIYA Y, 1988, BRAIN RES, V451, P319, DOI 10.1016/0006-8993(88)90777-9; Ozdener H, 2012, JOVE-J VIS EXP, DOI 10.3791/3730; Pittman DW, 2002, CHEM SENSES, V27, P333, DOI 10.1093/chemse/27.4.333; Pittman DW, 2002, PHYSIOL BEHAV, V77, P277, DOI 10.1016/S0031-9384(02)00852-1; RABITO CA, 1980, IN VITRO CELL DEV B, V16, P461, DOI 10.1007/BF02626458; Robins GG, 2013, J PHYSIOL BIOCHEM, V69, P419, DOI 10.1007/s13105-012-0223-6; Sauter D, 2006, KIDNEY INT, V69, P1024, DOI 10.1038/sj.ki.5000211; Schild L, 2010, BBA-MOL BASIS DIS, V1802, P1159, DOI 10.1016/j.bbadis.2010.06.014; Shigemura N, 2008, AM J PHYSIOL-REG I, V294, pR66, DOI 10.1152/ajpregu.00420.2007; Shigemura N, 2013, J NEUROSCI, V33, P6267, DOI 10.1523/JNEUROSCI.5599-12.2013; Shin YK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012729; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; SOLLARS SI, 1994, BEHAV NEUROSCI, V108, P981, DOI 10.1037/0735-7044.108.5.981; Soundararajan R, 2012, MOL CELL ENDOCRINOL, V350, P242, DOI 10.1016/j.mce.2011.11.003; Spector AC, 1996, J NEUROSCI, V16, P8115; Stahler F, 2008, CHEMOSENS PERCEPT, V1, P78, DOI 10.1007/s12078-008-9006-4; Stewart RE, 1996, AM J PHYSIOL-REG I, V270, pR704, DOI 10.1152/ajpregu.1996.270.4.R704; Stewart RE, 1997, AM J PHYSIOL-CELL PH, V272, pC1, DOI 10.1152/ajpcell.1997.272.1.C1; Stockand JD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00304; Stockand JD, 2010, KIDNEY INT, V78, P849, DOI 10.1038/ki.2010.276; VALENTICH JD, 1979, J CELL PHYSIOL, V100, P291, DOI 10.1002/jcp.1041000210; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Watson KJ, 2007, CHEM SENSES, V32, P411, DOI 10.1093/chemse/bjm006; YE Q, 1991, SCIENCE, V254, P724, DOI 10.1126/science.1948054; YE Q, 1993, J NEUROPHYSIOL, V70, P1713, DOI 10.1152/jn.1993.70.4.1713; Yu SJ, 2012, EXP NEUROL, V238, P209, DOI 10.1016/j.expneurol.2012.08.007; Zhou HP, 2006, AM J PHYSIOL-GASTR L, V291, pG728, DOI 10.1152/ajpgi.00138.2006	82	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171335	10.1371/journal.pone.0171335	http://dx.doi.org/10.1371/journal.pone.0171335			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192441	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800021
J	Cova, I; Pomati, S; Maggiore, L; Forcella, M; Cucumo, V; Ghiretti, R; Grande, G; Muzio, F; Mariani, C				Cova, Ilaria; Pomati, Simone; Maggiore, Laura; Forcella, Marica; Cucumo, Valentina; Ghiretti, Roberta; Grande, Giulia; Muzio, Fulvio; Mariani, Claudio			Nutritional status and body composition by bioelectrical impedance vector analysis: A cross sectional study in mild cognitive impairment and Alzheimer's disease	PLOS ONE			English	Article							ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; ELDERLY-PATIENTS; MASS INDEX; DEMENTIA; RECOMMENDATIONS; BIOIMPEDANCE; VALIDATION	Aims Analysis of nutritional status and body composition in Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI). Methods A cross-sectional study was performed in a University-Hospital setting, recruiting 59 patients with AD, 34 subjects with MCI and 58 elderly healthy controls (HC). Nutritional status was assessed by anthropometric parameters (body mass index; calf, upper arm and waist circumferences), Mini Nutritional Assessment (MNA) and body composition by bioelectrical impedance vector analysis (BIVA). Variables were analyzed by analysis of variance and subjects were grouped by cognitive status and gender. Results Sociodemographic variables did not differ among the three groups (AD, MCI and HC), except for females' age, which was therefore used as covariate in a general linear multivariate model. MNA score was significantly lower in AD patients than in HC; MCI subjects achieved intermediate scores. AD patients (both sexes) had significantly (p<0.05) higher height-normalized impedance values and lower phase angles (body cell mass) compared with HC; a higher ratio of impedance to height was found in men with MCI with respect to HC. With BIVA method, MCI subjects showed a significant displacement on the RXc graph on the right side indicating lower soft tissues (Hotelling's T-2 test: men = 10.6; women = 7.9;p < 0,05) just like AD patients (Hotelling's T-2 test: men = 18.2; women = 16.9; p<0,001). Conclusion Bioelectrical parameters significantly differ from MCI and AD to HC; MCI showed an intermediate pattern between AD and HC. Longitudinal studies are required to investigate if BIVA could reflect early AD-changes in body composition in subjects with MCI.	[Cova, Ilaria; Pomati, Simone; Maggiore, Laura; Forcella, Marica; Cucumo, Valentina; Ghiretti, Roberta; Grande, Giulia; Mariani, Claudio] Luigi Sacco Univ Hosp, ASST Fatebenefratelli Sacco, Ctr Res & Treatment Cognit Dysfunct, Inst Clin Neurol,Dept Clin Sci, Milan, Italy; [Muzio, Fulvio] Luigi Sacco Univ Hosp, ASST Fatebenefratelli Sacco, Dietet & Clin Nutr Unit, Milan, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital	Cova, I (corresponding author), Luigi Sacco Univ Hosp, ASST Fatebenefratelli Sacco, Ctr Res & Treatment Cognit Dysfunct, Inst Clin Neurol,Dept Clin Sci, Milan, Italy.	ilaria.cova@unimi.it	Grande, Giulia/K-4276-2018; Cova, Ilaria/K-9454-2016; Pomati, Simone/AAP-5414-2021	Cova, Ilaria/0000-0001-7831-6791; Pomati, Simone/0000-0001-8930-6361				Al-Gindan YY, 2014, AM J CLIN NUTR, V100, P1041, DOI 10.3945/ajcn.113.070466; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; [Anonymous], 1994, AM J CLIN NUTR, V64, p387S; Buffa R, 2014, EXP GERONTOL, V58, P30, DOI 10.1016/j.exger.2014.07.005; Buffa R, 2010, J NUTR HEALTH AGING, V14, P823, DOI 10.1007/s12603-010-0115-9; Martin MAC, 2015, NUTRITION, V31, P155, DOI 10.1016/j.nut.2014.06.006; Cova I, 2016, DEMENT GERIATR COGN, V41, P172, DOI 10.1159/000444216; Cova I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151710; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Grande G, 2016, J ALZHEIMERS DIS, V51, P57, DOI 10.3233/JAD-150786; Guigoz Y, 2006, J NUTR HEALTH AGING, V10, P466; Kawakami R, 2015, GERIATR GERONTOL INT, V15, P969, DOI 10.1111/ggi.12377; Lohman T. G., 1998, ANTROPOMETRIC STANDA; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Morris JK, 2014, BBA-MOL BASIS DIS, V1842, P1340, DOI 10.1016/j.bbadis.2014.04.012; Nazare JA, 2015, AM J CARDIOL, V115, P307, DOI 10.1016/j.amjcard.2014.10.039; Norman K, 2012, CLIN NUTR, V31, P854, DOI 10.1016/j.clnu.2012.05.008; Petersen RC, 2014, J INTERN MED, V275, P214, DOI 10.1111/joim.12190; PICCOLI A, 1994, KIDNEY INT, V46, P534, DOI 10.1038/ki.1994.305; Piccoli A, BIVA SOFTWARE; RENVALL MJ, 1993, J AM DIET ASSOC, V93, P47, DOI 10.1016/0002-8223(93)92130-P; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Saragat B, 2012, J NUTR HEALTH AGING, V16, P231, DOI 10.1007/s12603-011-0347-3; Schmand B, 1997, BRIT J PSYCHIAT, V171, P373, DOI 10.1192/bjp.171.4.373; Sergi G, 2013, P NUTR SOC, V72, P160, DOI 10.1017/S0029665112002753; Withers RT, 1999, AM J HUM BIOL, V11, P175, DOI 10.1002/(SICI)1520-6300(1999)11:2&lt;175::AID-AJHB5&gt;3.0.CO;2-C; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	28	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171331	10.1371/journal.pone.0171331	http://dx.doi.org/10.1371/journal.pone.0171331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187148	Green Published, Green Submitted, gold			2022-12-26	WOS:000394244300019
J	Su, WJ; Wang, LJ; Lei, J; Chai, SS; Liu, Y; Yang, YY; Yang, XS; Jiao, CH				Su, Wenjin; Wang, Lianjun; Lei, Jian; Chai, Shasha; Liu, Yi; Yang, Yuanyuan; Yang, Xinsun; Jiao, Chunhai			Genome-wide assessment of population structure and genetic diversity and development of a core germplasm set for sweet potato based on specific length amplified fragment (SLAF) sequencing	PLOS ONE			English	Article							BATATAS L. LAM.; SSR MARKERS; LINKAGE MAP; COLLECTION; AFLP; CONSTRUCTION; STRATEGIES; RESOURCES; DISTANCE; AMERICA	Sweet potato, Ipomoea batatas (L.) Lam., is an important food crop that is cultivated worldwide. However, no genome-wide assessment of the genetic diversity of sweet potato has been reported to date. In the present study, the population structure and genetic diversity of 197 sweet potato accessions most of which were from China were assessed using 62,363 SNPs. A model-based structure analysis divided the accessions into three groups: group 1, group 2 and group 3. The genetic relationships among the accessions were evaluated using a phylogenetic tree, which clustered all the accessions into three major groups. A principal component analysis (PCA) showed that the accessions were distributed according to their population structure. The mean genetic distance among accessions ranged from 0.290 for group 1 to 0.311 for group 3, and the mean polymorphic information content (PIC) ranged from 0.232 for group 1 to 0.251 for group 3. The mean minor allele frequency (MAF) ranged from 0.207 for group 1 to 0.222 for group 3. Analysis of molecular variance (AMOVA) showed that the maximum diversity was within accessions (89.569%). Using CoreHunter software, a core set of 39 accessions was obtained, which accounted for approximately 19.8% of the total collection. The core germplasm set of sweet potato developed will be a valuable resource for future sweet potato improvement strategies.	[Su, Wenjin; Wang, Lianjun; Lei, Jian; Chai, Shasha; Yang, Yuanyuan; Yang, Xinsun] Hubei Acad Agr Sci, Food Crops Inst, Wuhan, Peoples R China; [Su, Wenjin] China Agr Univ, Minist Educ, Lab Crop Heterosis & Utilizat, Beijing Key Lab Crop Genet Improvement, Beijing, Peoples R China; [Liu, Yi] Yangtze Univ, Coll Agr, Jingzhou, Peoples R China; [Jiao, Chunhai] Hubei Acad Agr Sci, Wuhan, Peoples R China	Hubei Academy of Agricultural Sciences; China Agricultural University; Yangtze University; Hubei Academy of Agricultural Sciences	Yang, XS (corresponding author), Hubei Acad Agr Sci, Food Crops Inst, Wuhan, Peoples R China.; Jiao, CH (corresponding author), Hubei Acad Agr Sci, Wuhan, Peoples R China.	yangxins013@163.com; jiaoch@hotmail.com		Yang, Xinsun/0000-0003-3942-1112	Hubei Engineering and Technology Research Center of Sweet Potato, Introduction and Utilization of Sweet Potato Germplasm Resources from America [2013-Z61]; Science and Technology Innovation Center of Hubei Academy of Agricultural Sciences [2007-620-001-03]; China Agriculture Research System [CARS-11-C-15]; Characteristic Discipline of Hubei Academy of Agricultural Sciences [2015TSXK06]; National Natural Science Foundation of China Grant [31301377]; Innovation and Application of Major Crops Germplasm Resources Introduced from Africa and Southeast Asia [2016ABA087]	Hubei Engineering and Technology Research Center of Sweet Potato, Introduction and Utilization of Sweet Potato Germplasm Resources from America; Science and Technology Innovation Center of Hubei Academy of Agricultural Sciences; China Agriculture Research System; Characteristic Discipline of Hubei Academy of Agricultural Sciences; National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Innovation and Application of Major Crops Germplasm Resources Introduced from Africa and Southeast Asia	This work was supported by Hubei Engineering and Technology Research Center of Sweet Potato, Introduction and Utilization of Sweet Potato Germplasm Resources from America (2013-Z61), Science and Technology Innovation Center of Hubei Academy of Agricultural Sciences (2007-620-001-03), China Agriculture Research System (CARS-11-C-15), Characteristic Discipline of Hubei Academy of Agricultural Sciences (2015TSXK06), National Natural Science Foundation of China Grant (31301377), Innovation and Application of Major Crops Germplasm Resources Introduced from Africa and Southeast Asia (2016ABA087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2009, CROP SCI, V49, P1336, DOI 10.2135/cropsci2008.06.0551; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Austin DF, 1987, 1 SWEET POT PLANN C, P27; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; Blair MW, 2009, THEOR APPL GENET, V119, P955, DOI 10.1007/s00122-009-1064-8; Choudhury DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113094; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; De Beukelaer H, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-312; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Department of Science Technology and Education of Ministry of Agriculture of China Department of Education Science and Culture of Ministry of Finance of China, 2010, AGR IND DEV REP CHIN; Dunteman G.H, 1989, PRINCIPAL COMPONENTS, P69; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fajardo S, 2002, GENET RESOUR CROP EV, V49, P463; Fang BP, 2004, GUANGDONG AGR SCI, V1, P1; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gichuki ST, 2003, GENET RESOUR CROP EV, V50, P429, DOI 10.1023/A:1023998522845; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; HE GH, 1995, GENOME, V38, P938, DOI 10.1139/g95-123; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Jansen J, 2007, THEOR APPL GENET, V114, P421, DOI 10.1007/s00122-006-0433-9; Jarret R. L., 1994, Genetic Resources and Crop Evolution, V41, P165, DOI 10.1007/BF00051633; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kuroda Y, 2009, GENET RESOUR CROP EV, V56, P1045, DOI 10.1007/s10722-009-9425-3; Li B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1086; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li XL, 2011, RICE SCI, V18, P46, DOI 10.1016/S1672-6308(11)60007-3; Liu DG, 2012, J INTEGR AGR, V11, P1424; Liu J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-34; Lopez-Sese AI, 2002, EUPHYTICA, V127, P41, DOI 10.1023/A:1019904224170; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Moulin MM, 2012, ACTA SCI-AGRON, V34, P139, DOI 10.4025/actasciagron.v34i2.12616; OBRIEN PJ, 1972, AM ANTHROPOL, V74, P342, DOI 10.1525/aa.1972.74.3.02a00070; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schafleitner R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-604; Skroch PW, 1998, CROP SCI, V38, P488, DOI 10.2135/cropsci1998.0011183X003800020036x; [苏文瑾 Su Wenjin], 2016, [中国农业科学, Scientia Agricultura Sinica], V49, P27; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thachuk C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-243; Troggio M, 2007, GENETICS, V176, P2637, DOI 10.1534/genetics.106.067462; Upadhyaya HD, 2011, PLANT GENET RESOUR-C, V9, P97, DOI 10.1017/S1479262110000419; Upadhyaya H. D., 2010, Electronic Journal of Plant Breeding, V1, P1294; van Treuren R, 2006, GENET RESOUR CROP EV, V53, P43, DOI 10.1007/s10722-004-0585-x; Veasey EA, 2008, GENET MOL BIOL, V31, P725, DOI 10.1590/S1415-47572008000400020; Wen WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032626; Xu XW, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00768; Yan WG, 2010, CROP SCI, V50, P2406, DOI 10.2135/cropsci2010.02.0096; Yang XS, 2015, J INTEGR AGR, V14, P633, DOI 10.1016/S2095-3119(14)60794-2; Yonezawa K., 1995, P35; Zhang DP, 2000, GENET RESOUR CROP EV, V47, P659, DOI 10.1023/A:1026520507223; Zhang DP, 2004, GENET RESOUR CROP EV, V51, P115, DOI 10.1023/B:GRES.0000020853.04508.a0; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141; Zhao N, 2013, MOL BREEDING, V32, P807, DOI 10.1007/s11032-013-9908-y	56	26	30	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172066	10.1371/journal.pone.0172066	http://dx.doi.org/10.1371/journal.pone.0172066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187178	Green Submitted, Green Published, gold			2022-12-26	WOS:000394244300077
J	Abdollahi, M; Ng, TSY; Rezaeizadeh, A; Aamidor, S; Twigg, SM; Min, DQ; McLennan, SV				Abdollahi, Maryam; Ng, Taria Shin Yi; Rezaeizadeh, Alireza; Aamidor, Sarah; Twigg, Stephen M.; Min, Danqing; McLennan, Susan V.			Insulin treatment prevents wounding associated changes in tissue and circulating neutrophil MMP-9 and NGAL in diabetic rats	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; MATRIX METALLOPROTEINASES; ACTIVATION; ANGIOGENESIS; INFLAMMATION; ULCERS; MODEL	Neutrophils are important for wound repair, but their persistence can impair the healing process. Neutrophils express matrix metalloproteinases including MMP-9 and its regulator neutrophil gelatinase associated lipocalin (NGAL). Whether wounding affects neutrophil MMP-9 and NGAL in diabetic animals is not known. Skin wound tissue MMP-9 and NGAL was examined by qRT-PCR and immunohistochemistry in control, diabetic and insulin treated diabetic rats. The temporal expression of MMP-9 and NGAL mRNA, MMP-9 activity and the NGAL/MMP-9 complex was also investigated in an implant model and their circulating neutrophils. The cellular localisation of MMP-9 and NGAL was confirmed by immunofluorescence and the ability of glucose to regulate these factors was examined in isolated neutrophils. In skin wound tissue compared with control, diabetes increased neutrophil infiltration, NGAL mRNA and MMP-9 protein (P<0.05). Diabetes significantly increased implant neutrophil NGAL and MMP-9 protein as well as NGAL mRNA, wound fluid NGAL/MMP-9 complex and MMP-9 activity (all <0.05). Circulating neutrophil MMP-9 and NGAL was also increased in these diabetic animals (P<0.05). These changes were prevented by insulin treatment. Ex vivo, high glucose (25mM) increased neutrophil NGAL and MMP-9 (both by 2 fold, P<0.05). NGAL and MMP-9 are increased in wound and circulating neutrophils in diabetic rodents. These changes and the association between higher NGAL and increased wound fluid MMP-9 activity suggest that increased neutrophil NGAL may contribute to increased MMP-9 in poorly healing diabetic wounds. Whether targeting neutrophil NGAL or MMP-9 can improve diabetic wound healing remains to be investigated.	[Abdollahi, Maryam; Ng, Taria Shin Yi; Rezaeizadeh, Alireza; Aamidor, Sarah; Twigg, Stephen M.; Min, Danqing; McLennan, Susan V.] Univ Sydney, Charles Perkins Ctr, Sydney Med Sch, Greg Brown Diabet & Endocrinol Labs, Sydney, NSW, Australia; [Twigg, Stephen M.; Min, Danqing; McLennan, Susan V.] Royal Prince Alfred Hosp, Dept Endocrinol, Sydney, NSW, Australia; [Twigg, Stephen M.; Min, Danqing; McLennan, Susan V.] Royal Prince Alfred Hosp, Ctr Diabet, Sydney, NSW, Australia; [McLennan, Susan V.] Royal Prince Alfred Hosp, NSW Hlth Pathol, Chem Pathol, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney	McLennan, SV (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney Med Sch, Greg Brown Diabet & Endocrinol Labs, Sydney, NSW, Australia.; McLennan, SV (corresponding author), Royal Prince Alfred Hosp, Dept Endocrinol, Sydney, NSW, Australia.; McLennan, SV (corresponding author), Royal Prince Alfred Hosp, Ctr Diabet, Sydney, NSW, Australia.; McLennan, SV (corresponding author), Royal Prince Alfred Hosp, NSW Hlth Pathol, Chem Pathol, Sydney, NSW, Australia.	sue.mclennan@sydney.edu.au		Min, Danqing/0000-0002-2576-4344; Aamidor, Sarah/0000-0002-5266-1340				Alba-Loureiro TC, 2007, BRAZ J MED BIOL RES, V40, P1037, DOI 10.1590/S0100-879X2006005000143; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Balasoiu D, 1997, DIABETES CARE, V20, P392, DOI 10.2337/diacare.20.3.392; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Bu DX, 2006, AM J PATHOL, V169, P2245, DOI 10.2353/ajpath.2006.050706; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; Dasu MR, 2014, WORLD J DIABETES, V5, P219, DOI 10.4239/wjd.v5.i2.219; Dasu MR, 2012, CLIN SCI, V122, P203, DOI 10.1042/CS20110357; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Feng G, 2014, FEBS J, V281, P5054, DOI 10.1111/febs.13043; Hobizal KB, 2012, DIABET FOOT ANKLE, V3, DOI 10.3402/dfa.v3i0.18409; Houreld NN, 2014, SCI WORLD J, DOI 10.1155/2014/398412; Kewcharoenwong C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03363; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012; Liu Y, 2009, DIABETES CARE, V32, P117, DOI [10.2337/dc08-0763, 10.2337/dc09-1394]; Mack JA, 2010, J INVEST DERMATOL, V130, P856, DOI 10.1038/jid.2009.305; Martins VL, 2013, CELL TISSUE RES, V351, P255, DOI 10.1007/s00441-012-1410-z; McKittrick IB, 2011, AM J PHYSIOL-RENAL, V301, pF1326, DOI 10.1152/ajprenal.00267.2011; McLennan SV, 2008, WOUND REPAIR REGEN, V16, P706, DOI 10.1111/j.1524-475X.2008.00421.x; Min DQ, 2009, AM J PHYSIOL-RENAL, V297, pF1229, DOI 10.1152/ajprenal.00074.2009; Min DQ, 2006, ELECTROPHORESIS, V27, P357, DOI 10.1002/elps.200500484; Muller M, 2008, DIABETIC MED, V25, P419, DOI 10.1111/j.1464-5491.2008.02414.x; Nishio N, 2008, AGE, V30, P11, DOI 10.1007/s11357-007-9043-y; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Osar Z, 2004, EXP DIABESITY RES, V5, P155, DOI 10.1080/15438600490424244; Rayment EA, 2008, BRIT J DERMATOL, V158, P951, DOI 10.1111/j.1365-2133.2008.08462.x; Serra R, 2013, WOUND REPAIR REGEN, V21, P395, DOI 10.1111/wrr.12035; Thomson SE, 2010, DIABETOLOGIA, V53, P572, DOI 10.1007/s00125-009-1610-6; Tschesche H, 2001, EUR J BIOCHEM, V268, P1918, DOI 10.1046/j.1432-1327.2001.02066.x; Wong SL, 2015, NATURE MED; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200	31	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170951	10.1371/journal.pone.0170951	http://dx.doi.org/10.1371/journal.pone.0170951			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182694	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800025
J	Hisa, K; Yanagimachi, MD; Naruto, T; Miyamae, T; Kikuchi, M; Hara, R; Imagawa, T; Yokota, S; Mori, M				Hisa, Kaori; Yanagimachi, Masakatsu D.; Naruto, Takuya; Miyamae, Takako; Kikuchi, Masako; Hara, Rhoki; Imagawa, Tomoyuki; Yokota, Shumpei; Mori, Masaaki			PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PEPTIDYLARGININE DEIMINASE-4; FUNCTIONAL HAPLOTYPE; ASSOCIATION; HLA; SUSCEPTIBILITY; POLYMORPHISMS; ALLELES; GENE; LOCALIZATION	Objective Both genetic and environmental factors are associated with susceptibility to juvenile idiopathic arthritis (JIA). Many studies have reported that both a ` shared epitope' (SE) encoded by several HLA-DRB1 alleles and the peptidyl arginine deiminase type 4 (PADI4) gene polymorphisms are associated with susceptibility to rheumatoid arthritis (RA). However, it is uncertain whether JIA and RA share the latter genetic risk factor. Therefore, here we investigated relationships between HLA-SE and PADI4 polymorphisms with clinical subtypes of JIA. Methods JIA patients (39 oligoarthritis, 48 RF-positive polyarthritis, 19 RF-negative polyarthritis and 82 systemic) and 188 healthy controls were genotyped for HLA-DRB1 by PCR-sequencespecific oligonucleotide probe methodology. Three PADI4 gene single nucleotide polymorphisms (SNPs), rs2240340, rs2240337 and rs1748033, were genotyped using TaqMan SNP Genotyping Assays. Results Frequencies of the HLA-SE were higher in RF-positive polyarticular JIA than in healthy controls. RF-positive polyarticular JIA was associated with HLA-SE (OR = 5.3, 95% CI = 2.5-11.9, pc < 0.001). No associations were found between clinical subtypes of JIA and PADI4 allele frequency. Nonetheless, rs2240337 in the PADI4 gene was significantly associated with anti-cyclic citrullinated peptide antibody (ACPA)-positivity in JIA. The A allele at rs2240337 was a significant risk factor for ACPA positivity in JIA (OR = 5.6, 95% CI = 1.71-23.7 pc = 0.03). Conclusion PADI4 gene polymorphism is associated with ACPA-positivity in JIA. The association of HLA-SE with RF-positive polyarticular JIA as well as RA is confirmed in Japanese. Thus, HLA-SE and PADI4 status both influence JIA clinical manifestations.	[Hisa, Kaori; Yanagimachi, Masakatsu D.; Naruto, Takuya; Miyamae, Takako; Kikuchi, Masako; Hara, Rhoki; Imagawa, Tomoyuki; Yokota, Shumpei; Mori, Masaaki] Yokohama City Grad Sch Med, Dept Pediat, Yokohama, Kanagawa, Japan; [Hisa, Kaori; Imagawa, Tomoyuki] Kanagawa Childrens Med Ctr, Dept Infect Dis & Immunol, Yokohama, Kanagawa, Japan; [Yanagimachi, Masakatsu D.] Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan; [Mori, Masaaki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Lifetime Clin Immunol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Yanagimachi, MD (corresponding author), Yokohama City Grad Sch Med, Dept Pediat, Yokohama, Kanagawa, Japan.; Yanagimachi, MD (corresponding author), Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan.	myanagimachi.ped@tmd.ac.jp			Japan Society for the Promotion of Science [16790583]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from Grand-in-Aid for Scientific Research from Japan Society for the Promotion of Science (No. 16790583). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeles-Han Sheila, 2010, Curr Rheumatol Rep, V12, P87, DOI 10.1007/s11926-010-0087-0; BARRON KS, 1992, J RHEUMATOL, V19, P1611; Cha S, 2007, ARTHRITIS RHEUM-US, V56, P1454, DOI 10.1002/art.22570; Chang X, 2005, RHEUMATOLOGY, V44, P40, DOI 10.1093/rheumatology/keh414; Cheng JL, 2012, J RHEUMATOL, V39, P1159, DOI 10.3899/jrheum.120007; CLEMENS LE, 1983, ANN RHEUM DIS, V42, P431, DOI 10.1136/ard.42.4.431; FORRE O, 1983, ARTHRITIS RHEUM, V26, P35, DOI 10.1002/art.1780260106; Foulquier C, 2007, ARTHRITIS RHEUM-US, V56, P3541, DOI 10.1002/art.22983; Gandjbakhch F, 2009, J RHEUMATOL, V36, P881, DOI 10.3899/jrheum.080398; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Ikari K, 2006, RHEUMATOLOGY, V45, P1345, DOI 10.1093/rheumatology/kel169; Ikari K, 2005, ARTHRITIS RHEUM, V52, P3054, DOI 10.1002/art.21309; Kang CP, 2006, ARTHRITIS RHEUM-US, V54, P90, DOI 10.1002/art.21536; Kochi Y, 2004, ARTHRITIS RHEUM, V50, P63, DOI 10.1002/art.11366; Kochi Y, 2010, NAT REV RHEUMATOL, V6, P290, DOI 10.1038/nrrheum.2010.23; Lee YH, 2016, CLIN RHEUMATOL, V35, P961, DOI 10.1007/s10067-015-3098-4; Lin YT, 2011, AUTOIMMUN REV, V10, P482, DOI 10.1016/j.autrev.2011.02.001; Lipinska J, 2012, J RHEUMATOL, V39, P1078, DOI 10.3899/jrheum.110879; Mellins ED, 2011, NAT REV RHEUMATOL, V7, P416, DOI 10.1038/nrrheum.2011.68; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; NEPOM BS, 1984, J CLIN INVEST, V74, P287, DOI 10.1172/JCI111413; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Petty RE, 2004, J RHEUMATOL, V31, P390; Plenge Robert M, 2009, Curr Rheumatol Rep, V11, P351, DOI 10.1007/s11926-009-0050-0; Prahalad S, 2012, ARTHRITIS RHEUM-US, V64, P925, DOI 10.1002/art.33376; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Rossi-Semerano L, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/480373; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Syed Reema H, 2008, Curr Rheumatol Rep, V10, P156, DOI 10.1007/s11926-008-0027-4; Thomson W, 2002, RHEUMATOLOGY, V41, P1183, DOI 10.1093/rheumatology/41.10.1183; VEHE RK, 1990, J RHEUMATOL, V17, P11; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Yanagimachi M, 2011, J HUM GENET, V56, P196, DOI 10.1038/jhg.2010.159	37	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171961	10.1371/journal.pone.0171961	http://dx.doi.org/10.1371/journal.pone.0171961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182665	Green Published, gold, Green Submitted			2022-12-26	WOS:000394231800138
J	Nazareno, AL; Hernandez, BS				Nazareno, Allen Lamarca; Hernandez, Bryan Sapon			A mathematical model of the interaction of abscisic acid, ethylene and methyl jasmonate on stomatal closure in plants	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; GUARD-CELLS; HYDROGEN-PEROXIDE; NITRIC-OXIDE; SIGNAL-TRANSDUCTION; ARABIDOPSIS; ABA; NETWORKS; STRESS; GENERATION	Stomatal closure is affected by various stimuli such as light, atmospheric carbon dioxide concentration, humidity and phytohormones. Our research focuses on phytohormones, specifically: abscisic acid (ABA), ethylene (ET) and methyl jasmonate (MeJA) that are responsible for the regulation of several plant processes, especially in guard cell signalling. While several studies show that these three phytohormones cause stomatal closure in plants, only two studies are notable for establishing a mathematical model of guard cell signalling involving phytohormones. Those two studies employed Boolean modelling and mechanistic ordinary differential equations modelling. In this study, we propose a new mathematical model of guard cell transduction network for stomatal closure using continuous logical modelling framework. Results showed how the different components of the network function. Furthermore, the model verified the role of antioxidants in the closure mechanism, and the diminished closure level of stomata with combined ABA-ET stimulus. The analysis was extended to ABA-ET-MeJA crosstalk.	[Nazareno, Allen Lamarca; Hernandez, Bryan Sapon] Univ Philippines Los Banos, Inst Math Sci & Phys, Laguna, Philippines; [Hernandez, Bryan Sapon] Malayan Coll Laguna, Coll Arts & Sci, Laguna, Philippines	University of the Philippines System; University of the Philippines Los Banos; Malayan Colleges Laguna	Nazareno, AL (corresponding author), Univ Philippines Los Banos, Inst Math Sci & Phys, Laguna, Philippines.	allennazareno@gmail.com	Hernandez, Bryan S./AAG-1811-2021	Hernandez, Bryan S./0000-0002-5632-216X; Nazareno, Allen/0000-0002-8969-6774				Beguerisse-Diaz M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-146; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Daszkowska-Golec A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00138; Desikan R, 2004, J EXP BOT, V55, P205, DOI 10.1093/jxb/erh033; Desikan R, 2006, PLANT J, V47, P907, DOI 10.1111/j.1365-313X.2006.02842.x; Garcia-Mata C, 2002, PLANT PHYSIOL, V128, P790, DOI 10.1104/pp.011020; Harrison Marcia A, 2012, PHYTOHORMONES ABIOTI, P49, DOI [10.1007/978-981-10-7479-0_12, DOI 10.1007/978-981-10-7479-0_12]; Hayashi M, 2011, PLANT SIGNAL BEHAV, V6, P1662, DOI 10.4161/psb.6.11.17800; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Kwak J. M., 2008, ARABIDOPSIS BOOK, V6, P1; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Macey R, 2001, BERKELEY MADONNA VER; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Munemasa S, 2011, PLANT SIGNAL BEHAV, V6, P939, DOI 10.4161/psb.6.7.15439; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Neill S, 2008, J EXP BOT, V59, P165, DOI 10.1093/jxb/erm293; PALLAS JE, 1982, PLANT PHYSIOL, V70, P598, DOI 10.1104/pp.70.2.598; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Reece J, 2010, CAMBELL BIOL; Saito N, 2008, PLANT CELL PHYSIOL, V49, P1396, DOI 10.1093/pcp/pcn106; Samaga R, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-43; Sankar M, 2011, BIOINFORMATICS, V27, P1404, DOI 10.1093/bioinformatics/btr158; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Suhita D, 2004, PLANT PHYSIOL, V134, P1536, DOI 10.1104/pp.103.032250; Tanaka Y, 2005, PLANT PHYSIOL, V138, P2337, DOI 10.1104/pp.105.063503; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; Zhang X, 2001, CELL RES, V11, P195, DOI 10.1038/sj.cr.7290086	29	16	16	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171065	10.1371/journal.pone.0171065	http://dx.doi.org/10.1371/journal.pone.0171065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182683	Green Published, Green Submitted, gold			2022-12-26	WOS:000394231800030
J	Moon, Y; McGinnis, RS; Seagers, K; Motl, RW; Sheth, N; Wright, JA; Ghaffari, R; Sosnoff, JJ				Moon, Yaejin; McGinnis, Ryan S.; Seagers, Kirsten; Motl, Robert W.; Sheth, Nirav; Wright, John A., Jr.; Ghaffari, Roozbeh; Sosnoff, Jacob J.			Monitoring gait in multiple sclerosis with novel wearable motion sensors	PLOS ONE			English	Article							STEP COUNT ACCURACY; AMBULATORY SYSTEM; OLDER-ADULTS; GO TEST; WALKING; PERFORMANCE; ACCELEROMETERS; INDIVIDUALS; PARAMETERS; ALGORITHM	Background Mobility impairment is common in people with multiple sclerosis (PwMS) and there is a need to assess mobility in remote settings. Here, we apply a novel wireless, skin-mounted, and conformal inertial sensor (BioStampRC, MC10 Inc.) to examine gait characteristics of PwMS under controlled conditions. We determine the accuracy and precision of BioStampRC in measuring gait kinematics by comparing to contemporary research-grade measurement devices. Methods A total of 45 PwMS, who presented with diverse walking impairment (Mild MS = 15, Moderate MS = 15, Severe MS = 15), and 15 healthy control subjects participated in the study. Participants completed a series of clinical walking tests. During the tests participants were instrumented with BioStampRC and MTx (Xsens, Inc.) sensors on their shanks, as well as pan activity monitor GT3X (Actigraph, Inc.) on their non-dominant hip. Shank angular velocity was simultaneously measured with the inertial sensors. Step number and temporal gait parameters were calculated from the data recorded by each sensor. Visual inspection and the MTx served as the reference standards for computing the step number and temporal parameters, respectively. Accuracy (error) and precision (variance of error) was assessed based on absolute and relative metrics. Temporal parameters were compared across groups using ANOVA. Results Mean accuracy precision for the BioStampRC was 2 2 steps error for step number, 6 +/- 9ms error for stride time and 6 +/- 7ms error for step time (0.6-2.6% relative error). Swing time had the least accuracy precision (25 +/- 19ms error, 5 4% relative error) among the parameters. GT3X had the least accuracy precision (8 +/- 14% relative error) in step number estimate among the devices. Both MTx and BioStampRC detected significantly distinct gait characteristics between PwMS with different disability levels (p<0.01). Conclusion BioStampRC sensors accurately and precisely measure gait parameters in PwMS across diverse walking impairment levels and detected differences in gait characteristics by disability level in PwMS. This technology has the potential to provide granular monitoring of gait both inside and outside the clinic.	[Moon, Yaejin; Sosnoff, Jacob J.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [McGinnis, Ryan S.] Univ Vermont, Dept Elect & Biomed Engn, Burlington, VT USA; [Seagers, Kirsten; Sheth, Nirav; Wright, John A., Jr.; Ghaffari, Roozbeh] MC10 Inc, Lexington, MA USA; [Motl, Robert W.] Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Vermont; University of Alabama System; University of Alabama Birmingham	Sosnoff, JJ (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA.	jsosnoff@illinois.edu	Sosnoff, Jacob/P-3397-2019; Ghaffari, Roozbeh/ABD-6718-2021	Sosnoff, Jacob/0000-0002-0286-9207; Seagers, Kirsten/0000-0003-1632-5611; Moon, Yaejin/0000-0002-1187-6847; McGinnis, Ryan/0000-0001-8396-6967	MC10 Inc.	MC10 Inc.	JJS received funding from MC10 Inc. for this research. The funder provided support in the form of salaries for authors RSM, KS, NS, JAW, and RG, but did not have any additional role in the study design, data collection, decision to publish, or preparation of the manuscript.	[Actigraph Actigraph I], 2016, US GUID ACTIGRAPH WG; Aminian K, 2002, J BIOMECH, V35, P689, DOI 10.1016/S0021-9290(02)00008-8; Aminian K, 1999, MED BIOL ENG COMPUT, V37, P686, DOI 10.1007/BF02513368; Balto JM, 2016, MULTIPLE SCLEROSIS J, V2; Bassett Jr DR, 2013, PHYS THERAPY REV; Bethoux Francois, 2011, Int J MS Care, V13, P4, DOI 10.7224/1537-2073-13.1.4; Bjartmar C, 2001, CURR OPIN NEUROL, V14, P271, DOI 10.1097/00019052-200106000-00003; Cameron MH, 2011, CURR NEUROL NEUROSCI, V11, P507, DOI 10.1007/s11910-011-0214-y; Comber L, 2016, GAIT POSTURE; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Faber MJ, 2006, PHYS THER, V86, P944, DOI 10.1093/ptj/86.7.944; Givon U, 2009, GAIT POSTURE, V29, P138, DOI 10.1016/j.gaitpost.2008.07.011; Goldman MD, 2007, MULTIPLE SCLEROSIS; Greene BR, 2010, MED BIOL ENG COMPUT, V48, P1251, DOI 10.1007/s11517-010-0692-0; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; HOHOL MJ, 1995, NEUROLOGY, V45, P251, DOI 10.1212/WNL.45.2.251; Jasiewicz JM, 2006, GAIT POSTURE, V24, P502, DOI 10.1016/j.gaitpost.2005.12.017; Kaufman M, 2000, MULT SCLER, V6, P286, DOI 10.1177/135245850000600411; Kavanagh JJ, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-9; Kim A., 2004, IEEE; Klaren RE, 2013, ARCH PHYS MED REHAB, V94, P2342, DOI 10.1016/j.apmr.2013.07.011; Korpan SM, 2015, J AGING PHYS ACTIV, V23, P377, DOI 10.1123/japa.2014-0033; Lee JK, 2011, MED BIOL ENG COMPUT, V49, P707, DOI 10.1007/s11517-011-0736-0; Montero-Odasso M, 2005, J GERONTOL A-BIOL, V60, P1304, DOI 10.1093/gerona/60.10.1304; Moon Y, 2015, MULT SCLER INT, V2015, DOI 10.1155/2015/964790; Motl RW, 2013, ACTA NEUROL SCAND, V127, P384, DOI 10.1111/ane.12036; Motl RW, 2013, PHYS MED REH CLIN N, V24, P325, DOI 10.1016/j.pmr.2012.11.004; Motl RW, 2012, EXPERT REV NEUROTHER, V12, P1079, DOI [10.1586/ern.12.74, 10.1586/ERN.12.74]; Motl RW, 2011, DISABIL HEALTH J, V4, P52, DOI 10.1016/j.dhjo.2010.02.003; National Multiple Sclerosis Society, 2006, MULT SCLER INF SOURC; Nilsagard Y, 2007, PHYSIOTHER RES INT, V12, P105, DOI 10.1002/pri.358; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pappas IPI, 2001, IEEE T NEUR SYS REH, V9, P113, DOI 10.1109/7333.928571; Pilutti LA, 2013, J NEUROL SCI, V334, P72, DOI 10.1016/j.jns.2013.07.2511; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Preiningerova JL, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0001-0; Ratzker PK, 1997, J NEUROL REHABIL, V11, P207; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Sabatini AM, 2005, IEEE T BIO-MED ENG, V52, P486, DOI 10.1109/TBME.2004.840727; Salarian A, 2004, IEEE T BIO-MED ENG, V51, P1434, DOI 10.1109/TBME.2004.827933; Sandroff BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093511; Sandroff BM, 2013, DISABIL REHABIL, V35, P725, DOI 10.3109/09638288.2012.707745; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Socie MJ, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/645197; Sosnoff JJ, 2012, J REHABIL RES DEV, V49, P1405, DOI 10.1682/JRRD.2011.11.0218; Sosnoff JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028021; Spain RI, 2012, GAIT POSTURE, V35, P573, DOI 10.1016/j.gaitpost.2011.11.026; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Thoumie P, 2005, MULT SCLER J, V11, P485, DOI 10.1191/1352458505ms1176oa; Webber SC, 2016, J AGING PHYS ACTIV, V24, P451, DOI 10.1123/japa.2015-0234; Zhang JT, 2013, PHYSIOL MEAS, V34, pN63, DOI 10.1088/0967-3334/34/8/N63	51	76	76	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171346	10.1371/journal.pone.0171346	http://dx.doi.org/10.1371/journal.pone.0171346			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1UY	28178288	Green Submitted, Green Published, gold			2022-12-26	WOS:000393712500038
J	Smeets, CCJ; Codd, V; Denniff, M; Samani, NJ; Hokken-Koelega, ACS				Smeets, Carolina C. J.; Codd, Veryan; Denniff, Matthew; Samani, Nilesh J.; Hokken-Koelega, Anita C. S.			Effects of size at birth, childhood growth patterns and growth hormone treatment on leukocyte telomere length	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; BODY-COMPOSITION; GH TREATMENT; LONG-TERM; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; DIABETES-MELLITUS; EARLY ORIGINS; RISK-FACTORS; WEIGHT-GAIN	Background Small size at birth and rapid growth in early life are associated with increased risk of cardiovascular disease in later life. Short children born small for gestational age (SGA) are treated with growth hormone (GH), inducing catch-up in length. Leukocyte telomere length (LTL) is a marker of biological age and shorter LTL is associated with increased risk of cardiovascular disease. Objectives To investigate whether LTL is influenced by birth size, childhood growth and long-term GH treatment. Methods We analyzed LTL in 545 young adults with differences in birth size and childhood growth patterns. Previously GH-treated young adults born SGA (SGA-GH) were compared to untreated short SGA (SGA-S), SGA with spontaneous catch-up to a normal body size (SGA-CU), and appropriate for gestational age with a normal body size (AGA-NS). LTL was measured using a quantitative PCR assay. Results We found a positive association between birth length and LTL (p = 0.04), and a trend towards a positive association between birth weight and LTL (p = 0.08), after adjustments for gender, age, gestational age and adult body size. Weight gain during infancy and childhood and fat mass percentage were not associated with LTL. Female gender and gestational age were positively associated with LTL, and smoking negatively. After adjustments for gender, age and gestational age, SGA-GH had a similar LTL as SGA-S (p = 0.11), SGACU (p = 0.80), and AGA-NS (p = 0.30). Conclusions Larger size at birth is positively associated with LTL in young adulthood. Growth patterns during infancy and childhood are not associated with LTL. Previously GH-treated young adults born SGA have similar LTL as untreated short SGA, SGA with spontaneous catch-up and AGA born controls, indicating no adverse effects of GH-induced catch-up in height on LTL.	[Smeets, Carolina C. J.; Hokken-Koelega, Anita C. S.] Erasmus Univ, Med Ctr, Dept Pediat, Subdiv Endocrinol, Rotterdam, Netherlands; [Codd, Veryan; Denniff, Matthew; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Codd, Veryan; Samani, Nilesh J.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Hokken-Koelega, Anita C. S.] Dutch Growth Res Fdn, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Smeets, CCJ (corresponding author), Erasmus Univ, Med Ctr, Dept Pediat, Subdiv Endocrinol, Rotterdam, Netherlands.	l.smeets@erasmusmc.nl		Codd, Veryan/0000-0002-9430-8254	British Heart Foundation; MRC [MR/M012816/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	VC, MD and NJS are funded by the British Heart Foundation and NJS is a UK National Institute for Health Research (NIHR) Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Boot AM, 1997, AM J CLIN NUTR, V66, P232, DOI 10.1093/ajcn/66.2.232; Breukhoven PE, 2011, J CLIN ENDOCR METAB, V96, P3710, DOI 10.1210/jc.2011-1658; Brouilette S, 2003, EUR HEART J, V24, P121, DOI 10.1016/S0195-668X(03)94107-8; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; [CentraalBureauStatistiek Statistiek CBvd], 2006, DUTCH STAND CLASS ED; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; de Zegher F, 2016, PEDIAT OBES; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Guo Y, 2004, OBES RES, V12, P1925, DOI 10.1038/oby.2004.241; Guzzardi MA, 2016, INT J OBESITY, V40, P1063, DOI 10.1038/ijo.2016.58; He QM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094385; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Kajantie E, 2012, INT J EPIDEMIOL, V41, P1400, DOI 10.1093/ije/dys127; Kerkhof GF, 2012, J CLIN ENDOCR METAB, V97, P2637, DOI 10.1210/jc.2012-1426; Kerkhof GF, 2009, J CLIN ENDOCR METAB, V94, P4243, DOI 10.1210/jc.2009-1036; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Latifovic L, 2016, CANCER EPIDEM BIOMAR, V25, P374, DOI 10.1158/1055-9965.EPI-14-1364; Leunissen RWJ, 2009, CLIN ENDOCRINOL, V70, P245, DOI 10.1111/j.1365-2265.2008.03320.x; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Samaras Thomas T., 2012, Nutrition and Health (Bicester), V21, P247, DOI 10.1177/0260106013510996; Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x; Savendahl L, 2012, J CLIN ENDOCR METAB, V97, pE213, DOI 10.1210/jc.2011-2882; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Smeets CCJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143951; USHER R, 1969, J PEDIATR-US, V74, P901, DOI 10.1016/S0022-3476(69)80224-6; van Dijk M, 2006, J CLIN ENDOCR METAB, V91, P1390, DOI 10.1210/jc.2005-1663; van Dijk M, 2007, J CLIN ENDOCR METAB, V92, P160, DOI 10.1210/jc.2006-1073; van Pareren Y, 2003, J CLIN ENDOCR METAB, V88, P3584, DOI 10.1210/jc.2002-021172; van Pareren Y, 2003, J CLIN ENDOCR METAB, V88, P347, DOI 10.1210/jc.2002-020458; Willemsen RH, 2008, J CLIN ENDOCR METAB, V93, P3449, DOI 10.1210/jc.2008-0623	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171825	10.1371/journal.pone.0171825	http://dx.doi.org/10.1371/journal.pone.0171825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178350	Green Published, Green Submitted, gold			2022-12-26	WOS:000393712500073
J	Methy, N; Meyer, L; Bajos, N; Velter, A				Methy, Nicolas; Meyer, Laurence; Bajos, Nathalie; Velter, Annie			Generational analysis of trends in unprotected sex in France among men who have sex with men: The major role of context-driven evolving patterns	PLOS ONE			English	Article							RISK BEHAVIOR; ANTIRETROVIRAL THERAPY; INTERNET SURVEY; HIV TREATMENT; GAY; INTERCOURSE; IMPACT; SURVEILLANCE; COUNTRIES; MSM	Objective Using a generational approach, this study analyses how unprotected anal intercourse has evolved since 1991 in France across different generations of men who have sex with men (MSM) whose sexual lives began at different periods in the history of the HIV epidemic. Design Data were collected from 18-59 year-old respondents to the French Gay Press surveys Enquetes Presse Gay, conducted repeatedly between 1991 and 2011 (N = 32,196) using self-administered questionnaires distributed in gay magazines and over the internet. Methods Trends in unprotected anal intercourse (i.e. condomless anal sex) with casual partners of unknown or different HIV serostatus (hereafter "UAId" in this manuscript) were studied. Responses were analysed according to year and then reorganised for age-cohort analyses by generation, based on the year respondents turned 18. Results UAId rates fell from 1991 to 1997, and then rose from 13.4% in 1997 to 25.5% in 2011 among seronegative respondents, and from 24.8% to 63.3%, respectively, among seropositive respondents. Both in seropositive and seronegative respondents, UAId increased over time for all generations, indicative of a strong period effect. Conclusion Analyses of data from several generations of MSM who started their sexual lives at different time points in the HIV epidemic, revealed very similar trends in UAId between generations, among both seropositive and seronegative respondents. This strong period effect suggests that sexual behaviours in MSM are influenced more by contextual than generational factors. The fact that prevention practices are simultaneously observed in different generations and that there are most likely underlying prevention norms among MSM, suggests that PrEP could become widely accepted by all generations of MSM exposed to the risk of HIV.	[Methy, Nicolas; Meyer, Laurence; Bajos, Nathalie; Velter, Annie] Univ Paris Saclay, INSERM, UVSQ, CESP,Univ Paris Sud, Villejuif, France; [Velter, Annie] Sante Publ France, St Maurice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institute of Public Health Surveillance	Velter, A (corresponding author), Univ Paris Saclay, INSERM, UVSQ, CESP,Univ Paris Sud, Villejuif, France.; Velter, A (corresponding author), Sante Publ France, St Maurice, France.	annie.velter@santepubliquefrance.fr	Bajos, Nathalie/M-4170-2018	Bajos, Nathalie/0000-0001-8073-9056	French National Agency for Research on AIDS; Viral Hepatitis (ANRS); French National Institute for Public Health Surveillance (InVS)	French National Agency for Research on AIDS(ANRS); Viral Hepatitis (ANRS)(ANRS); French National Institute for Public Health Surveillance (InVS)	The Gay Press surveys were funded by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) and the French National Institute for Public Health Surveillance (InVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Gay Press surveys were funded by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) and the French National Institute for Public Health Surveillance (InVS).	Adam P, 2011, RESULTATS PRELIMINAI; Bajos N., 2012, SEXUALITY FRANCE PRA; Balaji AB, 2013, AIDS LOND ENGL, V27; Beltzer N, 2013, AIDS, V27, P1011, DOI 10.1097/QAD.0b013e32835e1583; Berg RC, 2013, SOC SCI MED, V78, P61, DOI 10.1016/j.socscimed.2012.11.033; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Bolding G, 2005, AIDS, V19, P961, DOI 10.1097/01.aids.0000171411.84231.f6; Bozon M., 2012, SEXUALITY FRANCE PRA; Broqua C., 2003, HOMOSEXUALITES AU TE; Cazein F., 2015, B EPIDEMIOL HEBD, V9, P152; Chauvin S., 2013, SOCIOLOGIE HOMOSEXUA; Chen YH, 2016, AIDS BEHAV; Chen YY, 2013, CURR HIV-AIDS REP, V10, P79, DOI 10.1007/s11904-012-0144-6; Crepaz N, 2009, AIDS, V23, P1617, DOI 10.1097/QAD.0b013e32832effae; Elford J, 2009, EUROSURVEILLANCE, V14, P47; Girard G, 2016, CULT HEALTH SEX, V18, P15, DOI 10.1080/13691058.2015.1063813; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Halkitis PN, 2013, AM J PUBLIC HEALTH, V103, P889, DOI 10.2105/AJPH.2012.300963; Hart GJ, 2010, CURR OPIN INFECT DIS, V23, P39, DOI 10.1097/QCO.0b013e328334feb1; Hull P, 2016, SEX TRANSM INFECT; Janiec J, 2013, EUROSURVEILLANCE, V18, P20644; Kaye DK, 2013, J INFECT DEV COUNTR, V7, P436, DOI 10.3855/jidc.2644; Kellogg TA, 2013, SEX TRANSM DIS, V40, P689, DOI 10.1097/01.olq.0000431354.96087.50; Kennedy C, 2007, AIDS CARE, V19, P707, DOI 10.1080/09540120701203261; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Lot F, 2015, B EPIDEMIOL HEBD, V40-41, P744; Marcus U, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-826; McDaid LM, 2012, SEX TRANSM DIS, V39, P735, DOI 10.1097/OLQ.0b013e31825a3a3c; Methy N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123151; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Nguyen VK, 2011, AIDS, V25, P291, DOI 10.1097/QAD.0b013e3283402c3e; Paquette D, 2010, AIDS BEHAV, V14, P1252, DOI 10.1007/s10461-010-9743-7; Paz-Bailey G, 2016, AIDS LOND ENGL; Pharris A, 2015, EURO SURVEILL B EUR, V20; Philip SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012662; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Seng R, 2011, AIDS, V25, P977, DOI 10.1097/QAD.0b013e328345ef12; Shoveller J, 2016, CRIT PUBLIC HEALTH, V26, P487, DOI 10.1080/09581596.2015.1117577; Stromdahl S, 2015, EURO SURVEILL B EUR, V20; Sullivan PS, 2014, CURR OPIN HIV AIDS, V9, P199, DOI 10.1097/COH.0000000000000039; Vallabhaneni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045718; van den Boom W, 2014, JAIDS-J ACQ IMM DEF, V65, P375, DOI 10.1097/QAI.0000000000000051; Velter A, 2015, EURO SURVEILL B EUR, V20; Velter A, 2009, EURO SURVEILL B EUR, V14; Velter A, 2007, RAPPORT PRESSE GAY 2; Venkatesh KK, 2011, AIDS, V25, P1939, DOI 10.1097/QAD.0b013e32834b4ced; Zablotska IB, 2012, AIDS BEHAV, V16, P669, DOI 10.1007/s10461-011-9919-9	47	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171493	10.1371/journal.pone.0171493	http://dx.doi.org/10.1371/journal.pone.0171493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1SG	28170424	Green Published, gold, Green Submitted			2022-12-26	WOS:000393705500040
J	Zhang, JT; Wang, ZM; Liang, SB; Zhang, YH; Zhou, SL; Lu, LQ; Wang, RZ				Zhang, Jing-Ting; Wang, Zhi-Min; Liang, Shuang-Bo; Zhang, Ying-Hua; Zhou, Shun-Li; Lu, Lai-Qing; Wang, Run-Zheng			Quantitative study on the fate of residual soil nitrate in winter wheat based on a N-15-labeling method	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; DOUBLE CROPPING SYSTEM; FERTILIZER-NITROGEN; MAIZE ROTATION; CHINA; MANAGEMENT; CORN; AGRICULTURE; GROUNDWATER; IRRIGATION	A considerable amount of surplus nitrogen (N), which primarily takes the form of nitrate, accumulates in the soil profile after harvesting crops from an intensive production system in the North China Plain. The residual soil nitrate (RSN) is a key factor that is included in the N recommendation algorithm. Quantifying the utilization and losses of RSN is a fundamental necessity for optimizing crop N management, improving N use efficiency, and reducing the impact derived from farmland N losses on the environment. In this study, a N-15-labeling method was introduced to study the fate of the RSN quantitatively during the winter wheat growing season by N-15 tracer technique combined with a soil column study. A soil column with a 2 m height was vertically divided into 10 20-cm layers, and the RSN in each layer was individually labeled with a 15 N tracer before the wheat was sown. The results indicated that approximately 17.68% of the crop N derived from RSN was located in the 0-2 m soil profile prior to wheat sowing. The wheat recovery proportions of RSN at various layers ranged from 0.21% to 33.46%. The percentages that still remained in the soil profile after the wheat harvest ranged from 47.08% to 75.44%, and 19.46-32.64% of the RSN was unaccounted for. Upward and downward movements in the RSN were observed, and the maximum upward and downward distances were 40 cm and 100 cm, respectively. In general, the N-15-labeling method contributes to a deeper understanding of the fates of the RSN. Considering the low crop recovery of the RSN from deep soil layers, water and N saving practices should be adopted during crop production.	[Zhang, Jing-Ting; Wang, Zhi-Min; Zhang, Ying-Hua; Zhou, Shun-Li] China Agr Univ, Key Lab Farming Syst, Minist Agr, Coll Agron & Biotechnol, Beijing, Peoples R China; [Zhang, Jing-Ting; Liang, Shuang-Bo] Hebei Acad Agr & Forestry Sci, Inst Cereal & Oil Crops, Shijiazhuang, Hebei, Peoples R China; [Lu, Lai-Qing; Wang, Run-Zheng] China Agr Univ, Wuqiao Expt Stn, Beijing, Hebei, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Hebei Academy of Agricultural & Forestry Sciences; China Agricultural University	Zhou, SL (corresponding author), China Agr Univ, Key Lab Farming Syst, Minist Agr, Coll Agron & Biotechnol, Beijing, Peoples R China.	zhoushl@cau.edu.cn			National Natural Science Foundation of China [31071367]; New Century Excellent Talents in University [NCET-10-0790]; Special Fund for Agro-scientific Research in the Public Interest [201203031, 201303133]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Special Fund for Agro-scientific Research in the Public Interest	This work was funded by the National Natural Science Foundation of China (31071367), the Program for New Century Excellent Talents in University (NCET-10-0790), and the Special Fund for Agro-scientific Research in the Public Interest (201203031, 201303133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINFORD GD, 1992, AGRON J, V84, P53, DOI 10.2134/agronj1992.00021962008400010012x; Chen X. P., 2003, THESIS; COLBOURN P, 1984, PLANT SOIL, V76, P213, DOI 10.1007/BF02205581; Cui ZL, 2008, AGRON J, V100, P1527, DOI 10.2134/agronj2008.0005; DAVIES DB, 1995, J SCI FOOD AGR, V68, P399, DOI 10.1002/jsfa.2740680402; Fageria NK, 2005, ADV AGRON, V88, P97, DOI 10.1016/S0065-2113(05)88004-6; Fang QX, 2006, PLANT SOIL, V284, P335, DOI 10.1007/s11104-006-0055-7; Ferguson RB, 2002, SOIL SCI SOC AM J, V66, P544, DOI 10.2136/sssaj2002.0544; Gao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033982; Hansen B, 2011, ENVIRON SCI TECHNOL, V45, P228, DOI 10.1021/es102334u; Hu XK, 2013, ENVIRON POLLUT, V176, P198, DOI 10.1016/j.envpol.2013.01.040; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Ju XiaoTang, 2003, Acta Pedologica Sinica, V40, P538; Kristensen HL, 2004, PLANT SOIL, V265, P93, DOI 10.1007/s11104-005-0696-y; Leip A, 2011, ENVIRON POLLUT, V159, P3243, DOI 10.1016/j.envpol.2011.01.040; LeMonte JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146761; [李虎 Li Hu], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P141; Liu T, 2013, ENVIRON SCI TECHNOL, V47, P13412, DOI 10.1021/es403357m; Liu X.H., 1993, FARMING SYSTEMS CHIN; Liu XJ, 2003, FIELD CROP RES, V83, P111, DOI 10.1016/S0378-4290(03)00068-6; NEWBOULD P, 1989, PLANT SOIL, V115, P297, DOI 10.1007/BF02202596; ONKEN AB, 1985, SOIL SCI SOC AM J, V49, P134, DOI 10.2136/sssaj1985.03615995004900010027x; PETERSON GA, 1979, AGRON J, V71, P371, DOI 10.2134/agronj1979.00021962007100020036x; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Ren CP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141458; Richter J, 2000, NUTR CYCL AGROECOSYS, V57, P33, DOI 10.1023/A:1009802225307; ROTH GW, 1990, J ENVIRON QUAL, V19, P243, DOI 10.2134/jeq1990.00472425001900020008x; SMEETS J, 1981, WATER AIR SOIL POLL, V15, P483, DOI 10.1007/BF00279429; Sogbedji JM, 2000, J ENVIRON QUAL, V29, P1813, DOI 10.2134/jeq2000.00472425002900060011x; Steinheimer TR, 1998, ENVIRON SCI TECHNOL, V32, P1039, DOI 10.1021/es970598j; TIMMONS DR, 1981, J ENVIRON QUAL, V10, P421, DOI 10.2134/jeq1981.00472425001000030036x; Wang Z.M., 2006, REV CHINA AGR SCI TE, V8, P38; Wu YC, 2009, AGRON J, V101, P925, DOI 10.2134/agronj2008.0171; Xu ZW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092850; Yadav SN, 1997, J ENVIRON QUAL, V26, P808, DOI 10.2134/jeq1997.00472425002600030031x; Zhang LiJuan, 2004, Plant Nutrition and Fertilizer Science, V10, P455; Zhang WL, 1996, AGR ECOSYST ENVIRON, V59, P223, DOI 10.1016/0167-8809(96)01052-3; Zhao RF, 2006, AGRON J, V98, P938, DOI 10.2134/agronj2005.0157; [赵荣芳 Zhao Rongfang], 2009, [土壤学报, Acta Pedologica Sinica], V46, P684; Zhou MH, 2013, PLANT SOIL, V362, P149, DOI 10.1007/s11104-012-1269-5; [周顺利 Zhou Shunli], 2002, [生态学报, Acta Ecologica Sinica], V22, P48; Zhou SL, 2008, ENVIRON POLLUT, V152, P677; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067; Zhu ZL, 1998, PRESENT SITUATION NI	44	5	6	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171014	10.1371/journal.pone.0171014	http://dx.doi.org/10.1371/journal.pone.0171014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170440	Green Published, Green Submitted, gold			2022-12-26	WOS:000393705500019
